note_id,input,target,input_tokens,target_tokens
10000032-DS-21,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___ <CHIEF COMPLAINT> Worsening ABD distension and pain <MAJOR SURGICAL OR INVASIVE PROCEDURE> Paracentesis <HISTORY OF PRESENT ILLNESS> ___ HCV cirrhosis c/b ascites, hiv on ART, h/o IVDU, COPD, bioplar, PTSD, presented from OSH ED with worsening abd distension over past week. Pt reports self-discontinuing lasix and spirnolactone ___ weeks ago, because she feels like ""they don't do anything"" and that she ""doesn't want to put more chemicals in her."" She does not follow Na-restricted diets. In the past week, she notes that she has been having worsening abd distension and discomfort. She denies ___ edema, or SOB, or orthopnea. She denies f/c/n/v, d/c, dysuria. She had food poisoning a week ago from eating stale cake (n/v 20 min after food ingestion), which resolved the same day. She denies other recent illness or sick contacts. She notes that she has been noticing gum bleeding while brushing her teeth in recent weeks. she denies easy bruising, melena, BRBPR, hemetesis, hemoptysis, or hematuria. Because of her abd pain, she went to OSH ED and was transferred to ___ for further care. Per ED report, pt has brief period of confusion - she did not recall the ultrasound or bloodwork at osh. She denies recent drug use or alcohol use. She denies feeling confused, but reports that she is forgetful at times. In the ED, initial vitals were 98.4 70 106/63 16 97%RA Labs notable for ALT/AST/AP ___ ___: ___, Tbili1.6, WBC 5K, platelet 77, INR 1.6 <PAST MEDICAL HISTORY> 1. HCV Cirrhosis 2. No history of abnormal Pap smears. 3. She had calcification in her breast, which was removed previously and per patient not, it was benign. 4. For HIV disease, she is being followed by Dr. ___ Dr. ___. 5. COPD 6. Past history of smoking. 7. She also had a skin lesion, which was biopsied and showed skin cancer per patient report and is scheduled for a complete removal of the skin lesion in ___ of this year. 8. She also had another lesion in her forehead with purple discoloration. It was biopsied to exclude the possibility of ___'s sarcoma, the results is pending. 9. A 15 mm hypoechoic lesion on her ultrasound on ___ and is being monitored by an MRI. 10. History of dysplasia of anus in ___. 11. Bipolar affective disorder, currently manic, mild, and PTSD. 12. History of cocaine and heroin use. <SOCIAL HISTORY> ___ <FAMILY HISTORY> She a total of five siblings, but she is not talking to most of them. She only has one brother that she is in touch with and lives in ___. She is not aware of any known GI or liver disease in her family. Her last alcohol consumption was one drink two months ago. No regular alcohol consumption. Last drug use ___ years ago. She quit smoking a couple of years ago. <PHYSICAL EXAM> VS: 98.1 107/61 78 18 97RA General: in NAD HEENT: CTAB, anicteric sclera, OP clear Neck: supple, no LAD CV: RRR,S1S2, no m/r/g Lungs: CTAb, prolonged expiratory phase, no w/r/r Abdomen: distended, mild diffuse tenderness, +flank dullness, cannot percuss liver/spleen edge ___ distension GU: no foley Ext: wwp, no c/e/e, + clubbing Neuro: AAO3, converse normally, able to recall 3 times after 5 minutes, CN II-XII intact Discharge: PHYSICAL EXAMINATION: VS: 98 105/70 95 General: in NAD HEENT: anicteric sclera, OP clear Neck: supple, no LAD CV: RRR,S1S2, no m/r/g Lungs: CTAb, prolonged expiratory phase, no w/r/r Abdomen: distended but improved, TTP in RUQ, GU: no foley Ext: wwp, no c/e/e, + clubbing Neuro: AAO3, CN II-XII intact <PERTINENT RESULTS> ___ 10: 25PM GLUCOSE-109* UREA N-25* CREAT-0.3* SODIUM-138 POTASSIUM-3.4 CHLORIDE-105 TOTAL CO2-27 ANION GAP-9 ___ 10: 25PM estGFR-Using this ___ 10: 25PM ALT(SGPT)-100* AST(SGOT)-114* ALK PHOS-114* TOT BILI-1.6* ___ 10: 25PM LIPASE-77* ___ 10: 25PM ALBUMIN-3.3* ___ 10: 25PM WBC-5.0# RBC-4.29 HGB-14.3 HCT-42.6 MCV-99* MCH-33.3* MCHC-33.5 RDW-15.7* ___ 10: 25PM NEUTS-70.3* LYMPHS-16.5* MONOS-8.1 EOS-4.2* BASOS-0.8 ___ 10: 25PM PLT COUNT-71* ___ 10: 25PM ___ PTT-30.9 ___ ___ 10: 25PM ___ . CXR: No acute cardiopulmonary process. U/S: 1. Nodular appearance of the liver compatible with cirrhosis. Signs of portal hypertension including small amount of ascites and splenomegaly. 2. Cholelithiasis. 3. Patent portal veins with normal hepatopetal flow. Diagnostic para attempted in the ED, unsuccessful. On the floor, pt c/o abd distension and discomfort. <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Furosemide 20 mg PO DAILY 2. Spironolactone 50 mg PO DAILY 3. Albuterol Inhaler 2 PUFF IH Q4H: PRN wheezing, SOB 4. Raltegravir 400 mg PO BID 5. Emtricitabine-Tenofovir (Truvada) 1 TAB PO DAILY 6. Nicotine Patch 14 mg TD DAILY 7. Ipratropium Bromide Neb 1 NEB IH Q6H SOB <DISCHARGE MEDICATIONS> 1. Albuterol Inhaler 2 PUFF IH Q4H: PRN wheezing, SOB 2. Emtricitabine-Tenofovir (Truvada) 1 TAB PO DAILY 3. Furosemide 40 mg PO DAILY RX *furosemide 40 mg 1 tablet(s) by mouth Daily Disp #*30 Tablet Refills: *3 4. Ipratropium Bromide Neb 1 NEB IH Q6H SOB 5. Nicotine Patch 14 mg TD DAILY 6. Raltegravir 400 mg PO BID 7. Spironolactone 50 mg PO DAILY 8. Acetaminophen 500 mg PO Q6H: PRN pain <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Ascites from Portal HTN <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Ms. ___, It was a pleasure taking care of you! You came to us with stomach pain and worsening distension. While you were here we did a paracentesis to remove 1.5L of fluid from your belly. We also placed you on you 40 mg of Lasix and 50 mg of Aldactone to help you urinate the excess fluid still in your belly. As we discussed, everyone has a different dose of lasix required to make them urinate and it's likely that you weren't taking a high enough dose. Please take these medications daily to keep excess fluid off and eat a low salt diet. You will follow up with Dr. ___ in liver clinic and from there have your colonoscopy and EGD scheduled. Of course, we are always here if you need us. We wish you all the best! Your ___ Team. ","___ HCV cirrhosis c/b ascites, hiv on ART, h/o IVDU, COPD, bioplar, PTSD, presented from OSH ED with worsening abd distension over past week and confusion. # Ascites - p/w worsening abd distension and discomfort for last week. likely ___ portal HTN given underlying liver disease, though no ascitic fluid available on night of admission. No signs of heart failure noted on exam. This was ___ to med non-compliance and lack of diet restriction. SBP negative diuretics: > Furosemide 40 mg PO DAILY > Spironolactone 50 mg PO DAILY, chosen over the usual 100mg dose d/t K+ of 4.5. CXR was wnl, UA negative, Urine culture blood culture negative. Pt was losing excess fluid appropriately with stable lytes on the above regimen. Pt was scheduled with current PCP for ___ check upon discharge. Pt was scheduled for new PCP with Dr. ___ at ___ and follow up in Liver clinic to schedule outpatient screening EGD and ___. ",1946,231
10000032-DS-22,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> Percocet <ATTENDING> ___. <CHIEF COMPLAINT> abdominal fullness and discomfort <MAJOR SURGICAL OR INVASIVE PROCEDURE> ___ diagnostic paracentesis ___ therapeutic paracentesis <HISTORY OF PRESENT ILLNESS> ___ with HIV on HAART, COPD, HCV cirrhosis complicated by ascites and HE admitted with abdominal distention and pain. She was admitted to ___ for the same symptoms recently and had 3L fluid removed (no SBP) three days ago and felt better. Since discharge, her abdomen has become increasingly distended with pain. This feels similar to prior episodes of ascites. Her diuretics were recently decreased on ___ due to worsening hyponatremia 128 and hyperkalemia 5.1. Patient states she has been compliant with her HIV and diuretic medications but never filled out the lactulose prescription. She states she has had ___ BMs daily at home. She has had some visual hallucinations and forgetfulness. Her appetite has been poor. In the ED, initial vitals were 98.9 88 116/88 18 97% RA. CBC near baseline, INR 1.4, Na 125, Cr 0.6. AST and ALT mildly above baseline 182 and 126 and albumin 2.8. Diagnostic para with 225 WBC, 7% PMN, total protein 0.3. UA with few bact, 6 WBC, mod leuk, neg nitr, but contaminated with 6 epi. CXR clear. RUQ US with no PV thrombus, moderate ascites. She was given ondansetron 4mg IV and morphine 2.5mg IV x1 in the ED. On the floor, she is feeling improved but still has abdominal distention and discomfort. ROS: +Abdominal distention and pain. No black/bloody stools. No ___ pain or swelling. No fevers or chills. Denies chest pain, nausea, vomiting. No dysuria or frequency. <PAST MEDICAL HISTORY> 1. HCV Cirrhosis 2. No history of abnormal Pap smears. 3. She had calcification in her breast, which was removed previously and per patient not, it was benign. 4. For HIV disease, she is being followed by Dr. ___ Dr. ___. 5. COPD 6. Past history of smoking. 7. She also had a skin lesion, which was biopsied and showed skin cancer per patient report and is scheduled for a complete removal of the skin lesion in ___ of this year. 8. She also had another lesion in her forehead with purple discoloration. It was biopsied to exclude the possibility of ___'s sarcoma, the results is pending. 9. A 15 mm hypoechoic lesion on her ultrasound on ___ and is being monitored by an MRI. 10. History of dysplasia of anus in ___. 11. Bipolar affective disorder, currently manic, mild, and PTSD. 12. History of cocaine and heroin use. <SOCIAL HISTORY> ___ <FAMILY HISTORY> She a total of five siblings, but she is not talking to most of them. She only has one brother that she is in touch with and lives in ___. She is not aware of any known GI or liver disease in her family. <PHYSICAL EXAM> ADMISSION PHYSICAL EXAM: VS: T98.1 105/57 79 20 97RA 44.6kg GENERAL: Thin chronically ill appearing woman in no acute distress HEENT: Sclera anicteric, MMM, no oral lesions HEART: RRR, normal S1 S2, no murmurs LUNGS: Clear, no wheezes, rales, or rhonchi ABD: Significant distention with visible veins, bulging flanks, nontender to palpation, tympanitic on percussion, normal bowel sounds EXT: no ___ edema, 2+ DP and ___ pulses NEURO: alert and oriented, not confused, no asterixis DISCHARGE PE: VS: T 98.4 BP 95/55 (SBP ___ HR 80 RR 18 O2 95RA I/O 240/150 this am GENERAL: Thin chronically ill appearing woman in no acute distress HEENT: Sclera anicteric, MMM, no oral lesions HEART: RRR, normal S1 S2, no murmurs LUNGS: Clear, no wheezes, rales, or rhonchi ABD: Significant distention with visible veins, bulging flanks, nontender to palpation, tympanitic on percussion, normal bowel sounds EXT: no ___ edema, 2+ DP and ___ pulses NEURO: alert and oriented, not confused, no asterixis <PERTINENT RESULTS> LABS ON ADMISSION: ___ 04: 10PM BLOOD ___ ___ Plt ___ ___ 04: 10PM BLOOD ___ ___ ___ 04: 10PM BLOOD ___ ___ ___ 04: 10PM BLOOD ___ ___ ___ 04: 10PM BLOOD ___ ___ 04: 39PM BLOOD ___ LABS ON DISCHARGE: ___ 05: 10AM BLOOD ___ ___ Plt ___ ___ 05: 10AM BLOOD ___ ___ ___ 05: 10AM BLOOD ___ ___ ___ 05: 10AM BLOOD ___ ___ ___ 05: 10AM BLOOD ___ MICRO: ___ 10: 39 pm URINE Source: ___. **FINAL REPORT ___ URINE CULTURE (Final ___: MIXED BACTERIAL FLORA ( >= 3 COLONY TYPES), CONSISTENT WITH SKIN AND/OR GENITAL CONTAMINATION. ___ 7: 00 pm PERITONEAL FLUID PERITONEAL FLUID. GRAM STAIN (Final ___: 1+ (<1 per 1000X FIELD): POLYMORPHONUCLEAR LEUKOCYTES. NO MICROORGANISMS SEEN. This is a concentrated smear made by cytospin method, please refer to hematology for a quantitative white blood cell count.. FLUID CULTURE (Final ___: NO GROWTH. ANAEROBIC CULTURE (Preliminary): NO GROWTH. ___ 7: 00 pm PERITONEAL FLUID PERITONEAL FLUID. GRAM STAIN (Final ___: 1+ (<1 per 1000X FIELD): POLYMORPHONUCLEAR LEUKOCYTES. NO MICROORGANISMS SEEN. This is a concentrated smear made by cytospin method, please refer to hematology for a quantitative white blood cell count.. FLUID CULTURE (Final ___: NO GROWTH. ANAEROBIC CULTURE (Preliminary): NO GROWTH. Diagnositc Para: ___ 07: 00PM ASCITES ___ ___ ___ 07: 00PM ASCITES ___ IMAGING: ___ CXR- No acute cardiopulmonary abnormality. ___ RUQ US- 1. Extremely coarse and nodular liver echotexture consistent with a history of cirrhosis. 2. Moderate ascites. 3. Patent portal vein. <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Albuterol Inhaler 2 PUFF IH Q6H: PRN wheezing, SOB 2. ___ (Truvada) 1 TAB PO DAILY 3. Furosemide 20 mg PO DAILY 4. Raltegravir 400 mg PO BID 5. Spironolactone 50 mg PO DAILY 6. Acetaminophen 500 mg PO Q6H: PRN pain,fever 7. Tiotropium Bromide 1 CAP IH DAILY 8. Rifaximin 550 mg PO BID 9. Calcium Carbonate 1250 mg PO BID 10. Lactulose 15 mL PO TID 11. Sulfameth/Trimethoprim DS 1 TAB PO DAILY <DISCHARGE MEDICATIONS> 1. Acetaminophen 500 mg PO Q6H: PRN pain,fever 2. Albuterol Inhaler 2 PUFF IH Q6H: PRN wheezing, SOB 3. Calcium Carbonate 1250 mg PO BID 4. ___ (Truvada) 1 TAB PO DAILY 5. Furosemide 40 mg PO DAILY 6. Lactulose 15 mL PO TID 7. Raltegravir 400 mg PO BID 8. Rifaximin 550 mg PO BID 9. Sulfameth/Trimethoprim DS 1 TAB PO DAILY 10. Tiotropium Bromide 1 CAP IH DAILY <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Primary: diuretic refractory ascites Secondary: HCV cirrhosis, HIV, hyponatremia, COPD <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear ___, ___ was a pleasure to take care of you at ___ ___. You were admitted with abdominal fullness and pain from your ascites. You had a diagnostic and therapeutic paracentesis with 4.3 L removed. Your spironolactone was discontinued because your potassium was high. Your lasix was increased to 40mg daily. You are scheduled for another paracentesis on ___ prior to your other appointments that day. Please call tomorrow to find out the time of the paracentesis. Please continue to follow a low sodium diet and fluid restriction. You should call your liver doctor or return to the emergency room if you have abdominal pain, fever, chills, confusion, or other concerning symptoms. Sincerely, Your ___ medical team ","___ with HIV on HAART, HCV cirrhosis with ascites and HE, h/o IVDU, COPD, bipolar disorder presents with abdominal discomfort due to ___ ascites. # ASCITES. Now diuretic refractory given last tap was three days ago with 3L removed and she has already built up moderate ascites. Infectious workup negative, with CXR clear, UA contaminated but not grossly positive so will f/u culture, diagnostic para with only 225 WBC, RUQ US with no PV thrombus. Compliant with diuretics but not following low sodium diet or fluid restriction. Dr. ___ discussed possible TIPS in the office but due to lung disease, that was on hold pending further cardiac evaluation. Diuretics were recently decreased due to hyponatremia and hyperkalemia. Held spironolactone for now due to K 5.2 and increased lasix 20 -> 40. No evidence of severe hyponatremia (Na<120) or renal failure Cr>2.0 to stop diuretics at present. Diagnostic paracentesis negative for infection. Ascitic total protein 0.3 so warrants SBP prophylaxis (<1.0) and fortunately already on Bactrim for PCP prophylaxis which would be appropriate for SBP ppx also. Patient did admit to eating pizza and some ___ food prior to admission. She had therapeutic paracentesis with 4.3L removed and received 37.5G albumin IV post procedure. She felt much better with resolution of abdominal discomfort. Patient is scheduled for repeat paracentesis as outpatient on ___. # HEPATIC ENCEPHALOPATHY. History of HE from Hep C cirrhosis. Now with mild encephalopathy (hallucinations and forgetfulness) due to medication noncompliance, but not acutely encephalopathic and without asterixis on exam. Infectious workup negative thus far. Continue lactulose 30mL TID and titrate to 3 BMs daily and continue rifaximin 550mg BID. # HYPONATREMIA. Na 125 on admission, 128 four days ago, and 135 one month ago. Likely due to third spacing from worsening ascites and fluid overload. 1.5L fluid restriction, low salt diet. S/p therapeutic paracentesis with albumin replacement. # CIRRHOSIS, HEPATITIS C. MELD score of 10 and Child's ___ class B on this admission. Now decompensated due to ascites. Hepatitis C genotype IIIB. Dr. ___ starting ___ and ___ with patient in clinic and the insurance process was started by her office. No history of EGD, needs this as outpatient for varices screening. # NUTRITION. Unclear if truly compliant with low salt diet. Poor oral intake. Low albumin 2.8 on admission. Met with nutrition. # COAGULOPATHY. INR 1.4 four days ago. No evidence of active bleeding. Very mild thrombocytopenia with plts 143. # HIV. Most recent CD4 173. On HAART. No established ID provider. Continue Truvada and Isentress, Bactrim DS daily for PCP ___. Needs outpatient ID appointment # COPD. Stable. States she is on intermittent home O2 for comfort at night and with abdominal distentiom. Continued home COPD meds and home O2 as needed **Transitional Issues** - Discontinued spironolactone ___ elevated potassium - Increased furosemide to 40mg daily - Please recheck electrolytes at next visit - Had paracentesis ___ with 4.3 L removed, received 37.5G albumin - Needs outpatient ID provider - ___ needs more frequent paracentesis ",2183,810
10000117-DS-21,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> omeprazole <ATTENDING> ___. <CHIEF COMPLAINT> dysphagia <MAJOR SURGICAL OR INVASIVE PROCEDURE> Upper endoscopy ___ <HISTORY OF PRESENT ILLNESS> ___ w/ anxiety and several years of dysphagia who p/w worsened foreign body sensation. She describes feeling as though food gets stuck in her neck when she eats. She put herself on a pureed diet to address this over the last 10 days. When she has food stuck in the throat, she almost feels as though she cannot breath, but she denies trouble breathing at any other time. She does not have any history of food allergies or skin rashes. In the ED, initial vitals: 97.6 81 148/83 16 100% RA Imaging showed: CXR showed a prominent esophagus Consults: GI was consulted. Pt underwent EGD which showed a normal appearing esophagus. Biopsies were taken. Currently, she endorses anxiety about eating. She would like to try eating here prior to leaving the hospital. <PAST MEDICAL HISTORY> - GERD - Hypercholesterolemia - Kidney stones - Mitral valve prolapse - Uterine fibroids - Osteoporosis - Migraine headaches <SOCIAL HISTORY> ___ <FAMILY HISTORY> + HTN - father + Dementia - father <PHYSICAL EXAM> - ADMISSION/DISCHARGE EXAM - VS: 97.9 PO 109 / 71 70 16 97 ra GEN: Thin anxious woman, lying in bed, no acute distress HEENT: Moist MM, anicteric sclerae, NCAT, PERRL, EOMI NECK: Supple without LAD, no JVD PULM: CTABL no w/c/r COR: RRR (+)S1/S2 no m/r/g ABD: Soft, non-tender, non-distended, +BS, no HSM EXTREM: Warm, well-perfused, no ___ edema NEURO: CN II-XII grossly intact, motor function grossly normal, sensation grossly intact <PERTINENT RESULTS> - ADMISSION LABS - ___ 08: 27AM BLOOD WBC-5.0 RBC-4.82 Hgb-14.9 Hct-44.4 MCV-92 MCH-30.9 MCHC-33.6 RDW-12.1 RDWSD-41.3 Plt ___ ___ 08: 27AM BLOOD ___ PTT-28.6 ___ ___ 08: 27AM BLOOD Glucose-85 UreaN-8 Creat-0.9 Na-142 K-3.6 Cl-104 HCO3-22 AnGap-20 ___ 08: 27AM BLOOD ALT-11 AST-16 LD(LDH)-154 AlkPhos-63 TotBili-1.0 ___ 08: 27AM BLOOD Albumin-4.8 - IMAGING - CXR ___: IMPRESSION: Prominent esophagus on lateral view, without air-fluid level. Given the patient's history and radiographic appearance, barium swallow is indicated either now or electively. NECK X-ray ___: IMPRESSION: Within the limitation of plain radiography, no evidence of prevertebral soft tissue swelling or soft tissue mass in the neck. EGD: ___ Impression: Hiatal hernia Angioectasia in the stomach Angioectasia in the duodenum (biopsy, biopsy) Otherwise normal EGD to third part of the duodenum Recommendations: - no obvious anatomic cause for the patient's symptoms - follow-up biopsy results to rule out eosinophilic esophagitis - follow-up with Dr. ___ if biopsies show eosinophilic esophagitis <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Omeprazole 20 mg PO BID <DISCHARGE MEDICATIONS> 1. Omeprazole 20 mg PO BID <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> PRIMARY DIAGNOSIS: -dysphagia and foreign body sensation SECONDARY DIAGNOSIS: -GERD <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Ms. ___, You were hospitalized at ___. You came in due to difficulty swallowing. You had an endoscopy to look for any abnormalities in the esophagus. Thankfully, this was normal. They took biopsies, and you will be called with the results. You should have a test called a barium swallow as an outpatient. We wish you all the best! -Your ___ Team ","Ms. ___ is a ___ with history of GERD who presents with subacute worsening of dysphagia and foreign body sensation. This had worsened to the point where she placed herself on a pureed diet for the last 10 days. She underwent CXR which showed a prominent esophagus but was otherwise normal. She was evaluated by Gastroenterology and underwent an upper endoscopy on ___. This showed a normal appearing esophagus. Biopsies were taken. TRANSITIONAL ISSUES: -f/u biopsies from EGD -if results show eosinophilic esophagitis, follow-up with Dr. ___. ___ for management -pt should undergo barium swallow as an outpatient for further workup of her dysphagia -f/u with ENT as planned #Code: Full (presumed) ",1060,172
10000117-DS-22,"<SEX> F <SERVICE> ORTHOPAEDICS <ALLERGIES> omeprazole / Iodine and Iodide Containing Products / hallucinogens <ATTENDING> ___. <CHIEF COMPLAINT> Left hip pain <MAJOR SURGICAL OR INVASIVE PROCEDURE> Status post left CRPP ___, ___ <HISTORY OF PRESENT ILLNESS> REASON FOR CONSULT: Femur fracture HPI: ___ female presents with the above fracture s/p mechanical fall. This morning, pt was walking ___, when dog pulled on leash. Pt fell on L hip. Immediate pain. ___ ___ with movement. Denies Head strike, LOC or blood thinners. Denies numbness or weakness in the extremities. <PAST MEDICAL HISTORY> - GERD - Hypercholesterolemia - Kidney stones - Mitral valve prolapse - Uterine fibroids - Osteoporosis - Migraine headaches <SOCIAL HISTORY> ___ <FAMILY HISTORY> + HTN - father + Dementia - father <PHYSICAL EXAM> General: Well-appearing female in no acute distress. Left Lower extremity: - Skin intact - No deformity, edema, ecchymosis, erythema, induration - Soft, non-tender thigh and leg - Full, painless ROM knee, and ankle - Fires ___ - SILT S/S/SP/DP/T distributions - 1+ ___ pulses, WWP <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Lactaid (lactase) 3,000 unit oral DAILY: PRN 2. Calcium Citrate + D (calcium citrate-vitamin D3) 315-200 mg-unit oral DAILY <DISCHARGE MEDICATIONS> 1. Acetaminophen 1000 mg PO Q6H: PRN Pain - Mild/Fever 2. Bisacodyl 10 mg PO/PR DAILY: PRN Constipation 3. Docusate Sodium 100 mg PO BID 4. Enoxaparin Sodium 40 mg SC QHS RX *enoxaparin 40 mg/0.4 mL 40 mg Subcutaneously Nightly Disp #*30 Syringe Refills: *0 5. OxyCODONE (Immediate Release) ___ mg PO Q4H: PRN Pain - Moderate RX *oxycodone 5 mg 1 tablet(s) by mouth q4 PRN Disp #*25 Tablet Refills: *0 6. Senna 8.6 mg PO BID 7. Calcium Citrate + D (calcium citrate-vitamin D3) 315-200 mg-unit oral DAILY 8. Lactaid (lactase) 3,000 unit oral DAILY: PRN 9. Multivitamins 1 TAB PO DAILY 10. Vitamin D 400 UNIT PO DAILY <DISCHARGE DISPOSITION> Home With Service Facility: ___ <DISCHARGE DIAGNOSIS> Left valgus impacted femoral neck fracture <DISCHARGE CONDITION> AVSS NAD, A&Ox3 LLE: Incision well approximated. Dressing clean and dry. Fires FHL, ___, TA, GCS. SILT ___ n distributions. 1+ DP pulse, wwp distally. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> INSTRUCTIONS AFTER ORTHOPAEDIC SURGERY: - You were in the hospital for orthopedic surgery. It is normal to feel tired or ""washed out"" after surgery, and this feeling should improve over the first few days to week. - Resume your regular activities as tolerated, but please follow your weight bearing precautions strictly at all times. ACTIVITY AND WEIGHT BEARING: - Weightbearing as tolerated left lower extremity MEDICATIONS: 1) Take Tylenol ___ every 6 hours around the clock. This is an over the counter medication. 2) Add oxycodone as needed for increased pain. Aim to wean off this medication in 1 week or sooner. This is an example on how to wean down: Take 1 tablet every 3 hours as needed x 1 day, then 1 tablet every 4 hours as needed x 1 day, then 1 tablet every 6 hours as needed x 1 day, then 1 tablet every 8 hours as needed x 2 days, then 1 tablet every 12 hours as needed x 1 day, then 1 tablet every before bedtime as needed x 1 day. Then continue with Tylenol for pain. 3) Do not stop the Tylenol until you are off of the narcotic medication. 4) Per state regulations, we are limited in the amount of narcotics we can prescribe. If you require more, you must contact the office to set up an appointment because we cannot refill this type of pain medication over the phone. 5) Narcotic pain relievers can cause constipation, so you should drink eight 8oz glasses of water daily and continue following the bowel regimen as stated on your medication prescription list. These meds (senna, colace, miralax) are over the counter and may be obtained at any pharmacy. 6) Do not drink alcohol, drive a motor vehicle, or operate machinery while taking narcotic pain relievers. 7) Please take all medications as prescribed by your physicians at discharge. 8) Continue all home medications unless specifically instructed to stop by your surgeon. ANTICOAGULATION: - Please take Lovenox daily for 4 weeks ","The patient presented to the emergency department and was evaluated by the orthopedic surgery team. The patient was found to have a left valgus impacted femoral neck fracture and was admitted to the orthopedic surgery service. The patient was taken to the operating room on ___ for left closed reduction and percutaneous pinning of hip, which the patient tolerated well. For full details of the procedure please see the separately dictated operative report. The patient was taken from the OR to the PACU in stable condition and after satisfactory recovery from anesthesia was transferred to the floor. The patient was initially given IV fluids and IV pain medications, and progressed to a regular diet and oral medications by POD#1. The patient was given ___ antibiotics and anticoagulation per routine. The patient's home medications were continued throughout this hospitalization. The patient worked with ___ who determined that discharge to home with services was appropriate. The ___ hospital course was otherwise unremarkable. At the time of discharge the patient's pain was well controlled with oral medications, incisions were clean/dry/intact, and the patient was voiding/moving bowels spontaneously. The patient is weightbearing as tolerated in the left lower extremity, and will be discharged on Lovenox for DVT prophylaxis. The patient will follow up with Dr. ___ routine. A thorough discussion was had with the patient regarding the diagnosis and expected post-discharge course including reasons to call the office or return to the hospital, and all questions were answered. The patient was also given written instructions concerning precautionary instructions and the appropriate follow-up care. The patient expressed readiness for discharge. ",1195,330
10000248-DS-10,"<SEX> M <SERVICE> MEDICINE <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> Right flank bruising and pain s/p fall <MAJOR SURGICAL OR INVASIVE PROCEDURE> None <HISTORY OF PRESENT ILLNESS> Mr. ___ is a ___ with history of factor VIII deficiency who presents with right neck swelling after snowboarding accident. The patient reports that he fell while snowboarding with loss of consciousness on ___. He was initially seen at ___ where CT imaging of head/neck showed no intracranial hemorrhage. A CTA neck showed a thickened right platysma muscle with surrounding hematoma and a focus of active contrast extravasation within the right platysma muscle. He also developed a right shoulder hematoma although shoulder plain films didn't show acute abnormality. He was seen by ___ Hematology and gave him one dose of DDAVP IV. A factor VIII assay was 139 and vW level was >200 per report. Per report, his hemoglobin decreased from 13.2 on ___ to 11.6 on ___. Repeat imaging in the morning showed stable injuries. The patient saw his hematologist on ___ and was found to have a hemoglobin of 10.4. Because of the continued mild decrease, the patient followed up with his PCP ___ ___ at which time his hemoglobin was 9.9. He was found to have an enlarging flank hematoma, thus was referred given concern for retroperitoneal bleed. The patient has been using DDAVP intranasally intermittently since the accident. He denies lightheadedness or palpitations, any increase in neck swelling over the course of the week. He does endorse pain in his right shoulder ___ resting, ___ moving), though this has improved over the course of the week. In the ED, initial vital signs were 99.2 87 124/75 18 100%/RA. Initial labs demonstrated hemoglobin 10.6, though repeat was 9.7. Chemistries and coags were unremarkable. FVIII activity was 103. A CTAP was performed which demonstrated muscular hemorrhage along the flank, but no retroperitoneal bleed on preliminary read. The patient's outpatient hematologist, Dr. ___, was contacted and it was decided to give the patient desmopressin 0.3mg/kg IV. The patient was then admitted for futher management. Per review of records, the patient has a history of significant bleeding after his circumcision, requiring blood transfusion. Throughout childhood, he also had a tendency to bruise easily. He was tested and found to have ___ disease. Later, after wisdom tooth extraction, the patient experienced late (e.g. ___ days later) bleeding despite treatment with DDAVP. The patient was retested by a hematologist associated with the ___ and was diagnosed with hemophilia A. His FVIII activity has been checked on multiple occasions, sometimes testing normal, though has been as low as ~50. Upon arrival to the floor, the patient is comfortable without complaint. Review of Systems: (+) per HPI (-) fever, chills, night sweats, headache, vision changes, rhinorrhea, congestion, sore throat, cough, shortness of breath, chest pain, abdominal pain, nausea, vomiting, diarrhea, constipation, BRBPR, melena, hematochezia, dysuria, hematuria. <PAST MEDICAL HISTORY> -Factor VIII deficiency (mild) <SOCIAL HISTORY> ___ <FAMILY HISTORY> The patient's mother had tendency to bleed. <PHYSICAL EXAM> ON ADMISSION VS: 98 120/40 64 20 100RA GENERAL: lying flat in bed, no acute distress HEENT: NCAT, MMM, OP clear NECK: Supple CARDIAC: RRR, S1/S2, no murmurs, gallops, or rubs LUNG: Generally CTA b/l ABDOMEN: Soft, non-tender, non-distended EXTREMITIES: Warm, well-perfused PULSES: 2+ DP pulses bilaterally NEURO: CN II-XII intact SKIN: Hematomas on right aspect of neck and flank ON DISCHARGE Vitals: 98.0, 100-120/40-58, 66, 20, 99 on RA GENERAL: lying flat in bed, no acute distress HEENT: NCAT, MMM, OP clear NECK: Supple CARDIAC: RRR, S1/S2, no murmurs, gallops, or rubs LUNG: Generally CTA b/l ABDOMEN: Soft, non-tender, non-distended EXTREMITIES: Warm, well-perfused PULSES: 2+ DP pulses bilaterally NEURO: CN II-XII intact SKIN: Hematomas on right aspect of neck and flank <PERTINENT RESULTS> ADMISSION, DISCHARGE, PERTINENT LABS: ___ 07: 03PM BLOOD WBC-6.6 RBC-3.58* Hgb-10.6*# Hct-29.8*# MCV-83 MCH-29.6 MCHC-35.6* RDW-14.7 Plt ___ ___ 07: 03PM BLOOD Neuts-69.7 ___ Monos-7.2 Eos-2.4 Baso-0.2 ___ 07: 03PM BLOOD ___ PTT-35.2 ___ ___ 07: 03PM BLOOD Plt ___ ___ 07: 03PM BLOOD FacVIII-103 ___ 07: 03PM BLOOD Glucose-93 UreaN-15 Creat-0.8 Na-139 K-4.1 Cl-101 HCO3-28 AnGap-14 ___ 11: 00PM BLOOD WBC-6.6 RBC-3.30* Hgb-9.7* Hct-27.0* MCV-82 MCH-29.4 MCHC-36.0* RDW-14.7 Plt ___ ___ 07: 25AM BLOOD WBC-5.2 RBC-3.14* Hgb-9.3* Hct-26.2* MCV-83 MCH-29.7 MCHC-35.7* RDW-14.6 Plt ___ ___ 03: 25PM BLOOD WBC-6.3 RBC-3.27* Hgb-9.9* Hct-27.1* MCV-83 MCH-30.3 MCHC-36.5* RDW-14.7 Plt ___ ___ 07: 50PM URINE Color-Yellow Appear-Clear Sp ___ ___ 07: 50PM URINE Blood-NEG Nitrite-NEG Protein-30 Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.0 Leuks-NEG ___ 07: 50PM URINE RBC-<1 WBC-1 Bacteri-FEW Yeast-NONE Epi-0 ___ 07: 50PM URINE Mucous-RARE IMAGING/STUDIES: ___ CT A/P Acute hemorrhage along right posterior flank musculature and probably layering over it, only partly imaged and hard to distinguish musculature from hemorrhage. No active extravasation seen. Probable old hematoma along posterior left flank. <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Desmopressin Nasal ___ mcg NAS PRN bleeding <DISCHARGE MEDICATIONS> 1. Acetaminophen 1000 mg PO Q8H pain 2. Desmopressin Nasal ___ mcg NAS PRN bleeding 3. Outpatient Lab Work CBC on ___ or ___. Last hemoglobin 9.9 ___ ___. <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> PRIMARY: - Acute muscular hematoma, right flank - Hemophilia, factor VIII deficiency <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Mr. ___, It was our pleasure caring for you at ___ ___. You were admitted with bruising on your right side and low blood counts after a snowboarding fall. With your history of hemophilia, it was important to evaluate internal bleeding which did show a right muscular flank blood collection. Your facotr VIII level was 103 and you received IV DDAVP under our care. Your blood counts were stable to improved on the day of admission. It is important that you not participate in any dangerous activities given your recent bleed and your hemophilia. Bleeding in hemophiliacs has more potential to be life-threatening. Please get your blood counts checked at ___ site on either ___ or ___. Follow up with your regular doctor early next week. Best wishes, Your ___ Care Team ","Mr. ___ is a ___ with history of mild FVIII deficiency who presents after snowboarding accident with multiple hematomas and falling hemoglobin concerning for ongoing bleeding. # FACTOR VIII DEFICIENCY, MULTIPLE HEMATOMAS: Patient presented after recent snowboarding accident. At ___ ___, imaging was notable for neck and shoulder hematomas. Upon reevaluation by his PCP, the patient was found to have a flank hematoma. Given falling hemoglobin, there was concern for retroperitoneal bleed. CTAP in the ED demonstrated hematoma over his flank musculature, but no active extravasation. He was given IV DDAVP, but FVIII activity was 103 (wnl). CBC remained stable and patient declined further inpatient monitoring. Atrius hematology recommended continued outpatient hemoglobin monitoring, but did not think further DDAVP was indicated given normal FVIII level. # TRANISTIONAL ISSUES: - PCP ___ ___ - CBC ___ - ___ at ___ - Caution to avoid dangerous activity - Code: presumed full - Emergency Contact: ___ ___ - wife) ",1961,230
10000560-DS-15,"<SEX> F <SERVICE> UROLOGY <ALLERGIES> Patient recorded as having No Known Allergies to Drugs <ATTENDING> ___. <CHIEF COMPLAINT> renal mass <MAJOR SURGICAL OR INVASIVE PROCEDURE> right laparascopic radical nephrectomy- Dr. ___, Dr. ___ ___ <HISTORY OF PRESENT ILLNESS> ___ y/o healthy female with incidental finding of right renal mass suspicious for RCC following MRI on ___. <PAST MEDICAL HISTORY> PMH: nonspecific right axis deviation PSH- cesarean section ALL-NKDA <SOCIAL HISTORY> ___ <FAMILY HISTORY> no history of RCC <PERTINENT RESULTS> ___ 07: 15AM BLOOD WBC-7.6 RBC-3.82* Hgb-11.9* Hct-33.8* MCV-89 MCH-31.2 MCHC-35.2* RDW-12.8 Plt ___ ___ 07: 15AM BLOOD Glucose-150* UreaN-10 Creat-0.9 Na-138 K-3.8 Cl-104 HCO3-27 AnGap-11 <MEDICATIONS ON ADMISSION> none <DISCHARGE MEDICATIONS> 1. Hydrocodone-Acetaminophen ___ mg Tablet Sig: ___ Tablets PO Q6H (every 6 hours) as needed for break through pain only (score >4) . Disp: *60 Tablet(s)* Refills: *0* 2. Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day). Disp: *60 Capsule(s)* Refills: *2* <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> renal cell carcinoma <DISCHARGE CONDITION> stable <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> -You may shower but do not bathe, swim or immerse your incision. -Do not eat constipating foods for ___ weeks, drink plenty of fluids -Do not lift anything heavier than a phone book (10 pounds) or drive until you are seen by your Urologist in follow-up -Tylenol should be used as your first line pain medication. If your pain is not well controlled on Tylenol you have been prescribed a narcotic pain medication. Use in place of Tylenol. Do not exceed 4 gms of Tylenol in total daily -Do not drive or drink alcohol while taking narcotics -Resume all of your home medications, except hold NSAID (aspirin, advil, motrin, ibuprofen) until you see your urologist in follow-up -If you have fevers > 101.5 F, vomiting, or increased redness, swelling, or discharge from your incision, call your doctor or go to the nearest ER -Call Dr. ___ to set up follow-up appointment and if you have any urological questions. ___ ","Patient was admitted to Urology after undergoing laparoscopic right radical nephrectomy. No concerning intraoperative events occurred; please see dictated operative note for details. The patient received perioperative antibiotic prophylaxis. The patient was transferred to the floor from the PACU in stable condition. On POD0, pain was well controlled on PCA, hydrated for urine output >30cc/hour, provided with pneumoboots and incentive spirometry for prophylaxis, and ambulated once. On POD1,foley was removed without difficulty, basic metabolic panel and complete blood count were checked, pain control was transitioned from PCA to oral analgesics, diet was advanced to a clears/toast and crackers diet. On POD2, diet was advanced as tolerated. The remainder of the hospital course was relatively unremarkable. The patient was discharged in stable condition, eating well, ambulating independently, voiding without difficulty, and with pain control on oral analgesics. On exam, incision was clean, dry, and intact, with no evidence of hematoma collection or infection. The patient was given explicit instructions to follow-up in clinic with ___ in 3 weeks. ",645,240
10000764-DS-11,"<SEX> M <SERVICE> MEDICINE <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___ <CHIEF COMPLAINT> Epistaxis <MAJOR SURGICAL OR INVASIVE PROCEDURE> None <HISTORY OF PRESENT ILLNESS> Mr. ___ is an ___ with history of AAA s/p repair complicated by MI, hypertension, and hyperlipidemia who presents upon transfer from outside hospital with nasal fractures and epistaxis secondary to fall. The patient reports that he was at the ___ earlier this afternoon. While coughing, he tripped on the curb and suffered trauma to his face. He had no loss of consciousness. However, he had a persistent nosebleed and appeared to have some trauma to his face, thus was transferred to ___ for further care. There, a CT scan of the head, neck, and face were remarkable for a nasal bone and septal fracture. Given persistent epistaxis, bilateral RhinoRockets were placed. He had a small abrasion to the bridge of his nose which was not closed. Bleeding was well controlled. While in the OSH ED, he had an episode of nausea and coughed up some blood. At that time, he began to feel lightheaded and was noted to be hypotensive and bradycardic. Per report, he had a brief loss of consciousness, though quickly returned to his baseline. His family noted that his eyes rolled back into his head. The patient recalls the event and denies post-event confusion. He had no further episodes of syncope or hemodynamic changes. Given the syncopal event and epistaxis, the patient was transferred for further care. In the ED, initial vital signs 98.9 92 140/77 18 100%/RA. Labs were notable for WBC 11.3 (91%N), H/H 14.1/40.2, plt 147, BUN/Cr 36/1.5. HCTs were repeated which were stable. A urinalysis was negative. A CXR demonstrated a focal consolidation at the left lung base, possibly representing aspiration or developing pneumonia. The patient was given Tdap, amoxicillin-clavulanate for antibiotic prophylaxis, ondansetron, 500cc NS, and metoprolol tartrate 50mg. Clopidogrel was held. <PAST MEDICAL HISTORY> MI after AAA repair when he was ___ y/o HTN Hypercholesterolemia <SOCIAL HISTORY> ___ <FAMILY HISTORY> Patient is unaware of a family history of bleeding diathesis. <PHYSICAL EXAM> ADMISSION: VS: 98.5 142/65 95 18 98RA GENERAL: Alert, oriented, no acute distress HEENT: Sclerae anicteric, MMM, oropharynx clear, bruising under both eyes, swollen nose with mild tenderness, RhinoRockets in place NECK: Supple, without LAD RESP: Generally CTA bilaterally CV: RRR, (+)S1/S2 no m/r/g ABD: Soft, non-tender, non-distended GU: Deferred EXT: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema NEURO: CN II-XII grossly intact, motor function grossly normal SKIN: No excoriations or rash. DISCHARGE: VS: 98.4 125/55 73 18 94RA GENERAL: Alert, oriented, no acute distress HEENT: Sclerae anicteric, MMM, oropharynx clear, bruising under both eyes, swollen nose with mild tenderness, RhinoRockets in place NECK: Supple, without LAD RESP: Generally CTA bilaterally CV: RRR, (+)S1/S2 no m/r/g ABD: Soft, non-tender, non-distended GU: Deferred EXT: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema NEURO: CN II-XII grossly intact, motor function grossly normal SKIN: No excoriations or rash. <PERTINENT RESULTS> ADMISSION: ___ 08: 15PM BLOOD WBC-11.3* RBC-4.30* Hgb-14.1 Hct-40.2 MCV-93 MCH-32.8* MCHC-35.1* RDW-12.8 Plt ___ ___ 08: 15PM BLOOD Neuts-91.1* Lymphs-4.7* Monos-3.8 Eos-0.3 Baso-0.1 ___ 08: 15PM BLOOD ___ PTT-26.8 ___ ___ 08: 15PM BLOOD Glucose-159* UreaN-36* Creat-1.5* Na-141 K-4.1 Cl-106 HCO3-21* AnGap-18 ___ 06: 03AM BLOOD CK(CPK)-594* CARDIAC MARKER TREND: ___ 07: 45AM BLOOD cTropnT-0.04* ___ 06: 03AM BLOOD CK-MB-36* MB Indx-6.1* cTropnT-0.57* ___ 03: 03PM BLOOD CK-MB-23* MB Indx-4.2 cTropnT-0.89* ___ 05: 59AM BLOOD CK-MB-8 cTropnT-1.28* ___ 01: 16PM BLOOD CK-MB-5 cTropnT-1.29* ___ 06: 10AM BLOOD CK-MB-4 cTropnT-1.48* ___ 07: 28AM BLOOD CK-MB-2 cTropnT-1.50* DISCHARGE LABS: ___ 07: 28AM BLOOD WBC-4.2 RBC-3.85* Hgb-12.5* Hct-36.0* MCV-94 MCH-32.5* MCHC-34.7 RDW-12.9 Plt ___ ___ 07: 28AM BLOOD Glucose-104* UreaN-30* Creat-1.6* Na-142 K-4.3 Cl-106 HCO3-26 AnGap-14 IMAGING: ___ CXR PA and lateral views of the chest provided. The lungs are adequately aerated. There is a focal consolidation at the left lung base adjacent to the lateral hemidiaphragm. There is mild vascular engorgement. There is bilateral apical pleural thickening. The cardiomediastinal silhouette is remarkable for aortic arch calcifications. The heart is top normal in size. ___ ECHO The left atrium is mildly dilated. Left ventricular wall thicknesses and cavity size are normal. There is mild regional left ventricular systolic dysfunction with focal apical hypokinesis. The remaining segments contract normally (LVEF = 55 %). No masses or thrombi are seen in the left ventricle. Right ventricular chamber size and free wall motion are normal. There are three aortic valve leaflets. There is mild aortic valve stenosis (valve area 1.7cm2). Mild (1+) aortic regurgitation is seen. The mitral valve leaflets are mildly thickened. Trivial mitral regurgitation is seen. The pulmonary artery systolic pressure could not be determined. There is a trivial/physiologic pericardial effusion. IMPRESSION: Normal left ventricular cavity size with mild regional systolic dysfunction most c/w CAD (distal LAD distribution). Mild aortic valve stenosis. Mild aortic regurgitation. <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Clopidogrel 75 mg PO DAILY 2. Metoprolol Tartrate 50 mg PO TID 3. Pravastatin 80 mg PO QPM <DISCHARGE MEDICATIONS> 1. Clopidogrel 75 mg PO DAILY 2. Acetaminophen 650 mg PO Q8H: PRN pain Please avoid NSAID medications like ibuprofen given your bleeding. 3. Aspirin 81 mg PO DAILY Duration: 30 Days 4. Metoprolol Tartrate 75 mg PO TID RX *metoprolol tartrate 25 mg 3 tablet(s) by mouth three times daily Disp #*270 Tablet Refills: *0 5. Atorvastatin 40 mg PO QPM RX *atorvastatin 40 mg 1 tablet(s) by mouth every evening Disp #*30 Tablet Refills: *0 6. Oxymetazoline 1 SPRY NU BID: PRN nosebleed This can be purchased over-the-counter, the brand name is ___. <DISCHARGE DISPOSITION> Home With Service Facility: ___ <DISCHARGE DIAGNOSIS> Nasal fracture Epistaxis NSTEMI <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Mr. ___, You were admitted after you fell and broke your nose. You had nose bleeds that were difficult to control, thus plugs were placed in your nose to stop the bleeding. During your hospital course, you were found to have high troponins, a blood test for the heart. A ultrasound of your heart was performed. You should follow-up with your PCP to discuss stress test. It was a pleasure participating in your care, thank you for choosing ___. ","Mr. ___ is an ___ with history of AAA s/p repair complicated by MI, hypertension, and hyperlipidemia who presented with nasal fractures and epistaxis after mechanical fall with hospital course complicated by NSTEMI. #Epistaxis, nasal fractures Patient presenting after mechanical fall with Rhinorockets placed at outside hospital for ongoing epistaxis. CT scan from that hospital demonstrated nasal bone and septal fractures. The Rhinorockets were maintained while inpatient and discontinued prior to discharge. He was encouraged to use oxymetolazone nasal spray and hold pressure should bleeding reoccur. #NSTEMI Patient found to have mild elevation of troponin in the ED. This was trended and eventually rose to 1.5, though MB component downtrended during course of admission. The patient was without chest pain or other cardiac symptoms. Cardiology was consulted who thought that this was most likely secondary to demand ischemia (type II MI) secondary to his fall. An echocardiogram demonstrated aortic stenosis and likely distal LAD disease based on wall motion abnormalities. The patient's metoprolol was uptitrated, his pravastatin was converted to atorvastatin, his clopidogrel was maintained, and he was started on aspirin. #Hypoxemia/L basilar consolidation Patient reported to be mildly hypoxic in the ED, though he maintained normal oxygen saturations on room air. He denied shortness of breath or cough, fevers, or other infectious symptoms and had no leukocytosis. A CXR revealed consolidation in left lung, thought to be possibly related to aspirated blood. -monitor O2 saturation, temperature, trend WBC. He was convered with antibiotics while inpatient as he required prophylaxis for the Rhinorockets, but this was discontinued upon discharge. #Acute kidney injury Patient presented with creatinine of 1.5 with last creatinine at PCP 1.8. Patient was unaware of a history of kidney disease. The patient was discharged with a stable creatinine. #Peripheral vascular disease Patient had a history of AAA repair in ___ without history of MI per PCP. Patient denied history of CABG or cardiac/peripheral stents. A cardiac regimen was continued, as above. TRANSITIONAL ISSUES -Outpatient stress echo for futher evaluation distal LAD disease (possibly a large myocardial territory at risk). -Repeat echocardiogram in ___ years to monitor mild AS/AR. -If epistaxis returns, can use oxymetolazone nasal spray. -Repeat chest x-ray in ___ weeks to ensure resolution of the LLL infiltrative process. -Consider follow-up with ENT or Plastic Surgery for later evaluation of nasal fractures. -Repeat CBC in one week to ensure stability of HCT and platelets. -Consider conversion of metoprolol tartrate to succinate for ease-of-administration. ",2108,607
10000883-DS-4,"<SEX> M <SERVICE> PSYCHIATRY <ALLERGIES> Patient recorded as having No Known Allergies to Drugs <ATTENDING> ___ <CHIEF COMPLAINT> I have been overwhelmed and I felt suicidal."" <MAJOR SURGICAL OR INVASIVE PROCEDURE> none <HISTORY OF PRESENT ILLNESS> HPI: Mr. ___ is a ___ yo ___ freshman at ___ (___) c h/o depressed mood and anxiety symptoms (panic) who was sent to ___ at recommendation of ___, his therapist of 4 months at ___ for evaluation of 3 weeks of worsening depression with anhedonia, social isolation & withdrawal, escalating feelings of guilt, poor sleep secondary to ruminations of guilt. Patient is also having trouble concentrating and going to his other classes because of his depression and anxiety. He has been eating fine and taking care of himself w/r/t hygiene. Mr. ___ reported that what seems have caused his recent bout of anxiety is the culmination of stress in a professional relationship with one of his teachers at his program. For reasons that are not completely clear, patient was removed from a studio class with a particular instructor. Patient referred me to speak with ___ to explain the specifics, but ___ was not available and patient felt too overwhelmed to give me the story in detail--in fact had a panic attack during our talk. For the past weeks, since being removed from the class, Mr. ___ has written letters, called (did not leave messages) and emailed this instructor w/o getting any response. The lack of response has caused an escalating pattern of guilt that Mr. ___ has been dealing with by cutting himself with a knife (cut left wrist, no stitches). Last night, in the context of this guilt, not sleeping and having more anxiety, Mr. ___ began feeling suicidal and developed a plan to kill himself by cutting himself with a knife. He decided that the only way he could deal with his overwhelming feelings would be suicide. Mr. ___ told his counselor about these thoughts and his counselor recommended that he come to the ED. Mr. ___ reported that he has felt ""highs,"" but never for more than a day and never impacting sleep or resulting in dramatically impaired decision-making (e.g., spending too much, indiscriminate sexual relationships, etc). Mr. ___ has no h/o ___ psychotic symptoms, although his level of guilt has reached a near psychotic proportion. Mr. ___ denied ever being asked by the instructor never to contact him, but he feels the instructor not answering his calls or responding to emails means that the instructor does not like him. He denied any thoughts of trying to harm the instructor. Mr. ___ reported feeling anxious a great deal, having a rare panic attack. <PAST MEDICAL HISTORY> PAST PSYCH HX: No previous medication trials or psychiatric hospitalizations. One previous episode of being kept in a psychiatric ED in ___ in the context of having chest pain which turned out to be a panic attack. Gets occasional panic attacks (although not frequently enough to make a diagnosis of panic d/o). Has been seeing a counselor ___ at ___ x 4 months. Prior to 3 weeks ago, no h/o self-injurious behaviors, although has had suicidal ideation in the past (once or twice prior to last night, but never with intent like now). Saw a counselor in high school to help with ""coping"" with feeling different in school. Mr. ___ reported that he had thoughts of fighting with a fellow student a few months ago, which is why he started in counseling (he said he did not want to get into details re. that situation). He said that ultimately he was able to come to terms with this person w/o fighting. He denied any h/o violent behavior. PMH: Essentially healthy young man. Had repair of meniscus of left knee several months ago secondary to injury while running. No other surgeries. <SOCIAL HISTORY> ___ SOCIAL/FAMILY HX: Only child born to now divorced parents. Parents separated when patient was ___. Raised by mother in ___, but also has a relationship with father. Father struggled with active alcohol dependence for many years, but is now sober. Patient denied any h/o physical or sexual abuse while growing up. Described feeling ""different"" and having trouble fitting in, but could not give more details. Had some behavioral troubles in school as a child, was suspended at least 3 times in high school, struggled academically, but did graduate. Currently a freshman at ___ with an area of concentration in the clarinet, but having a difficult time as above. Mr. ___ lives alone in student housing. No current romantic relationships, has dated a girl in the past, but the relationship ended because the girl did not feel ready to continue. Mr. ___ denied any legal problems and denied having access to any guns. <FAMILY HISTORY> Family history remarkable for father with alcohol problems (in remission) and mother with h/o hypothyroidism. No other family medical or psychiatric problems known by patient. <PHYSICAL EXAM> MSE- Mr. ___ is a ___ white male, dressed in hospital ___. Appears anxious, had a panic attack during the interview. Speech normal rate, tone & volume. Normal language. Mood is ""depressed"" with a constricted affective range in anxious realm. Thoughts organized, but themes of guilt. Endorsed suicidal ideation with plan to commit suicide using a knife to cut himself, vacillating intent. Denied thoughts of harming others. Insight into need for help is good, judgment fair. <PERTINENT RESULTS> ___ 03: 58PM GLUCOSE-96 UREA N-17 CREAT-0.9 SODIUM-140 POTASSIUM-4.2 CHLORIDE-103 TOTAL CO2-29 ANION GAP-12 ___ 03: 58PM estGFR-Using this ___ 03: 58PM TSH-1.4 ___ 03: 58PM ASA-NEG ETHANOL-NEG ACETMNPHN-NEG bnzodzpn-NEG barbitrt-NEG tricyclic-NEG ___ 03: 58PM URINE HOURS-RANDOM ___ 03: 58PM URINE HOURS-RANDOM ___ 03: 58PM URINE GR HOLD-HOLD ___ 03: 58PM URINE bnzodzpn-NEG barbitrt-NEG opiates-NEG cocaine-NEG amphetmn-NEG mthdone-NEG ___ 03: 58PM WBC-7.6 RBC-5.09 HGB-14.5 HCT-42.6 MCV-84 MCH-28.5 MCHC-34.0 RDW-12.7 ___ 03: 58PM NEUTS-55.6 ___ MONOS-3.7 EOS-1.4 BASOS-0.5 ___ 03: 58PM PLT COUNT-287 ___ 03: 58PM URINE COLOR-Yellow APPEAR-Clear SP ___ ___ 03: 58PM URINE BLOOD-NEG NITRITE-NEG PROTEIN-NEG GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-6.5 LEUK-NEG <MEDICATIONS ON ADMISSION> none <DISCHARGE MEDICATIONS> 1. Citalopram 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). Disp: *30 Tablet(s)* Refills: *0* 2. Clonazepam 0.5 mg Tablet Sig: One (1) Tablet PO QAM and QHS. Disp: *12 Tablet(s)* Refills: *0* <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Axis I: Major depressive disorder, severe, without psychotic features Anxiety disorder not otherwise specified II- deferred III- status post meniscus repair (knee) IV- moderately severe psychosocial stressors identified V- GAF upon discharge: 45 <DISCHARGE CONDITION> MSE: general- thin caucasian man,seated, NAD behavior= calm, no tremors, no PMA speech- normal, not pressured affect: more emotionally reactive than prior, smiles appropriately, even and euthymic TC: no delusions, no AVH TP: linear and goal-directed; safety- denies SI, SIB, intent, plan cog: AOx3 I/J; fair/fair <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Please take medications as prescribed. Please attend outpatient appointments as scheduled. If you are feeling unsafe or that your condition is worsening, call ___ or go to your nearest ED ","1) Psychiatric: Pt arrived on floor denying passive abd active SI, intent, plan but admitted to still feeling depressed, anxious. he was eager to start treatment and meds. Consequently, celexa 10 mg and klonopin 0.5 QHS and 0.5 BID prns anxiety were started. No side effects, pt reported significant anxiety reduction and resolution of depressive symptoms (slept throughout the night) and all SI/SIB urges within days of arrival. He stated he realized he had overreacted in his dealings with the teacher and wanted to be discharged so that he could return to school. However, in speaking with ___ (counselor at ___) ___ and the Academic ___ @___, ___ ___, both expressed concerns over pt's ""repeated acts of impulsivity (apparently in ___ he got in a fight with another student who he thought was talking about him. He then ran back to his roomatte's dorm and asked the roommate to kill hm by cutting his throat). They both stated the pt had ""burned a lot more bridges"" than just the one teacher he had a falling out with, that other teachers at ___ are still ""unwilling or concerned to take him on as a student given his growing reputation as impulsive"". They stated the NEC may recommend pt take the rest of the semester off on medical leave. We had a meeting with team, the academic ___ of ___, and the patient where all parties agreed that the pt should take the rest of the semester off on medical leave of absence with the possibility of returning next year. The patient stated, after speaking with his family, that he would return to ___ ___ immediately to be close to his family, ""for extra support"" during his time of medical leave. he strongly agreed that he needed to continue taking his medications and would followup with psychiatric care arranged in ___ for him. The school was satisfied with his mental status at this joint meeting and felt he was safe to be discharged. Pt continued to deny depression, SI, SIB, was future oriented and goal oriented and was deemed safe for discharge on ___. 2) Medical: No active issues during hospital stay. 3) Groups/Behavioral: Pt attended groups, remained visible and calm in unit milieu. no disruptive or threatening behavior. no quiet room, 1:1 sitter, physical or chemical restraints needed at any time. 4) Legal: ___ ",1818,500
10000935-DS-18,"<SEX> F <SERVICE> SURGERY <ALLERGIES> Sulfonamides / Codeine / Bactrim <ATTENDING> ___. <CHIEF COMPLAINT> abdominal pain and vomiting <MAJOR SURGICAL OR INVASIVE PROCEDURE> ___ Exploratory laparotomy, lysis of adhesions, small bowel resection with enteroenterostomy. <HISTORY OF PRESENT ILLNESS> The patient is a ___ year old woman s/p hysterectomy for uterine fibroids and s/p R lung resection for carcinoid tumor who is seen in surgical consultation for abdominal pain, nausea, and vomiting. The patient was feeling well until early this morning at approximately 1: 00am, when she developed cramping abdominal pain associated with nausea and bilious emesis without blood. She vomited approximately ___ times which prompted her presentation to the ED. At the time of her emesis, she had diarrhea and moved her bowels > 3 times. She has never had this or similar pain in the past, and she states that she has never before had a small bowel obstruction. She has never had a colonoscopy. <PAST MEDICAL HISTORY> PMH: carcinoid tumor as above Vitamin B12 deficiency depression hyperlipidemia PSH: s/p R lung resection in ___ at ___ s/p hysterectomy in ___ s/p R arm surgery <SOCIAL HISTORY> ___ <FAMILY HISTORY> non contributory <PHYSICAL EXAM> Temp 96.9 HR 105 BP 108/92 100%RA NAD, appears non-toxic but uncomfortable heart tachycardic but regular, no murmurs appreciated lungs clear to auscultation; decreased breath sounds on R; well-healed R thoracotomy scar present abdomen soft, very obese, minimally distended, somewhat tender to palpation diffusely across abdomen; no guarding; no rebound tenderness, low midline abdominal wound c/d/i, no drainage, no erythema <PERTINENT RESULTS> ___ 04: 40AM WBC-12.5*# RBC-4.46 HGB-13.6 HCT-39.7 MCV-89 MCH-30.5 MCHC-34.2 RDW-13.0 ___ 04: 40AM NEUTS-91.1* LYMPHS-7.4* MONOS-0.8* EOS-0.3 BASOS-0.2 ___ 04: 40AM PLT COUNT-329 ___ 04: 40AM GLUCOSE-151* UREA N-10 CREAT-0.8 SODIUM-142 POTASSIUM-3.8 CHLORIDE-105 TOTAL CO2-28 ANION GAP-13 ___ 04: 40AM ALT(SGPT)-12 AST(SGOT)-16 LD(LDH)-180 ALK PHOS-62 ___ CT of abdomen and pelvis : 1. Slightly dilated loops of small bowel with fecalization of small bowel contents and distal collapsed loops, together indicating early complete or partial small-bowel obstruction. 2. Post-surgical changes noted at the right ribs as detailed above. ___ CT of abdoman and pelvis : 1. Interval worsening of small bowel obstruction. Transition point in the left mid abdomen. (The patient went to the OR on the evening of the study). 2. Trace free fluid in the pelvis is likely physiologic. ___ 10: 57PM URINE COLOR-Yellow APPEAR-Hazy SP ___ ___ 10: 57PM URINE BLOOD-LG NITRITE-NEG PROTEIN-TR GLUCOSE-NEG KETONE-15 BILIRUBIN-NEG UROBILNGN-NEG PH-6.5 LEUK-NEG ___ 10: 57PM URINE RBC->50 ___ BACTERIA-MOD YEAST-NONE EPI-0 ___ 10: 57PM URINE MUCOUS-OCC ___ 04: 40AM GLUCOSE-151* UREA N-10 CREAT-0.8 SODIUM-142 POTASSIUM-3.8 CHLORIDE-105 TOTAL CO2-28 ANION GAP-13 ___ 04: 40AM estGFR-Using this ___ 04: 40AM ALT(SGPT)-12 AST(SGOT)-16 LD(LDH)-180 ALK PHOS-62 TOT BILI-0.2 ___ 04: 40AM LIPASE-17 ___ 04: 40AM WBC-12.5*# RBC-4.46 HGB-13.6 HCT-39.7 MCV-89 MCH-30.5 MCHC-34.2 RDW-13.0 ___ 04: 40AM NEUTS-91.1* LYMPHS-7.4* MONOS-0.8* EOS-0.3 BASOS-0.2 ___ 04: 40AM PLT COUNT-329 <MEDICATIONS ON ADMISSION> Albuteral MDI prn wheezes Flovent inhaler prn wheezes Srtraline 200 mg oral daily Simvastatin 20 mg oral daily Trazadone 100 mg oral daily at bedtime Wellbutrin 75 mg oral twice a day <DISCHARGE MEDICATIONS> 1. Albuterol Sulfate 90 mcg/Actuation HFA Aerosol Inhaler Sig: Two (2) Puff Inhalation Q6H (every 6 hours) as needed for wheezing, shortness of breath. 2. Fluticasone 110 mcg/Actuation Aerosol Sig: Two (2) Puff Inhalation BID (2 times a day). 3. Oxycodone-Acetaminophen ___ mg Tablet Sig: ___ Tablets PO Q4H (every 4 hours) as needed for pain. Disp: *40 Tablet(s)* Refills: *0* 4. Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day). Disp: *60 Capsule(s)* Refills: *2* 5. Simvastatin 20 mg Tablet Sig: One (1) Tablet PO once a day. Disp: *30 Tablet(s)* Refills: *2* 6. Trazodone 100 mg Tablet Sig: One (1) Tablet PO at bedtime. 7. Wellbutrin 75 mg Tablet Sig: One (1) Tablet PO twice a day. <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> High grade small bowel obstruction <DISCHARGE CONDITION> Henodynamically stable, tolerating a regular diet, having bowel movements, adequate pain control <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Please call your doctor or nurse practitioner or return to the Emergency Department for any of the following: *You experience new chest pain, pressure, squeezing or tightness. *New or worsening cough, shortness of breath, or wheeze. *If you are vomiting and cannot keep down fluids or your medications. *You are getting dehydrated due to continued vomiting, diarrhea, or other reasons. Signs of dehydration include dry mouth, rapid heartbeat, or feeling dizzy or faint when standing. *You see blood or dark/black material when you vomit or have a bowel movement. *You experience burning when you urinate, have blood in your urine, or experience a discharge. *Your pain in not improving within ___ hours or is not gone within 24 hours. Call or return immediately if your pain is getting worse or changes location or moving to your chest or back. *You have shaking chills, or fever greater than 101.5 degrees Fahrenheit or 38 degrees Celsius. *Any change in your symptoms, or any new symptoms that concern you. Please resume all regular home medications , unless specifically advised not to take a particular medication. Also, please take any new medications as prescribed. Please get plenty of rest, continue to ambulate several times per day, and drink adequate amounts of fluids. Avoid lifting weights greater than ___ lbs until you follow-up with your surgeon. Avoid driving or operating heavy machinery while taking pain medications. Incision Care: *Please call your doctor or nurse practitioner if you have increased pain, swelling, redness, or drainage from the incision site. *Avoid swimming and baths until your follow-up appointment. *You may shower, and wash surgical incisions with a mild soap and warm water. Gently pat the area dry. *If you have staples, they will be removed at your follow-up appointment. *If you have steri-strips, they will fall off on their own. Please remove any remaining strips ___ days after surgery. *Please look at the site every day for signs of infection (increased redness or pain, swelling, odor, yellow or bloody ","This ___ year old female was admitted to the hospital and was made NPO, IV fluids were started and she had a nasogastric tube placed. She was pan cultured for a temperature of 101 and was followed with serial KUB's and physical exam. Her nasogastric tube was clamped on hospital day 2 and she soon developed increased abdominal pain prompting repeat CT of abdomen and pelvis. This demonstrated an increase in the degree of obstruction and she was subsequently taken to the operating room for the aforementioned procedure. She tolerated the procedure well, remained NPO with nasogastric tube in place and treated with IV fluids. Her pain was initially controlled with a morphine PCA . Her nasogastric tube was removed on post op day #2 and she began a clear liquid diet which she tolerated well. This was gradually advanced over 36 hours to a regular diet and was tolerated well. She was having bowel movements and tolerated oral pain medication. Her incision was healing well and staples were intact. After an uncomplicated course she was discharged home on ___ ",1901,217
10000935-DS-19,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> Sulfa (Sulfonamide Antibiotics) / Codeine / Bactrim <ATTENDING> ___ <CHIEF COMPLAINT> nausea, vomiting, cough <MAJOR SURGICAL OR INVASIVE PROCEDURE> none <HISTORY OF PRESENT ILLNESS> ___ female, with past medical history significant for depression, hyperlipidemia, Hysterectomy, B12 deficiency, back pain, carcinoid, cervical DJD, depression, hyperlipidemia, osteoarthritis, and history of Exploratory laparotomy, lysis of adhesions, and small bowel resection with enteroenterostomy for a high grade SBO ___ who presents with nausea, vomiting, weakness x 2 weeks. She has been uable to tolerate PO liquids, and solids. Had similar presentation ___ for high grade SBO. Denies passing flatus today. However reports having last normal bowel movement this AM, without hematochezia, melena. Also reporting subjective fever (100.0), non productive cough. Denies HA, myalgias. Takes NSAIDS sparingly. Denies alcohol use. Denies sick contacs/ travel or recent consumption of raw foods. Has never had a colonoscopy. . In ED VS were 97.8 120 121/77 20 98% RA Labs were remarkable for lactate 2.8, alk phos 293, HCT 33, WBC 13.9 Imaging: CT abdomen showed mult masses in the liver, consistent with malignancy. CXR also showed multiple nodules EKG: sinus, 112, NA, NI, TWI in III, but largely unchanged from prior Interventions: zofran, tylenol, 2L NS, GI was contacted and they are planning on upper / lower endoscopy for cancer work-up. . Vitals on transfer were 99.2 113 119/47 26 98% <PAST MEDICAL HISTORY> PMH: # high grade SBO ___ s/p exploratory laparotomy, lysis of adhesions, and small bowel resection with enteroenterostomy # carcinoid # hyperlipidemia # vitamin B12 deficiency # cervical DJD # osteoarthritis PSH: s/p R lung resection in ___ at ___ s/p hysterectomy in ___ s/p R arm surgery <SOCIAL HISTORY> ___ <FAMILY HISTORY> non contributory <PHYSICAL EXAM> On admission VS: 98.9 137/95 117 20 100 RA GENERAL: AOx3, NAD HEENT: MMM. no JVD. neck supple. HEART: Regular tachycardic, S1/S2 heard. no murmurs/gallops/rubs. LUNGS: CTAB, non labored ABDOMEN: soft, tender to palpation in epigastrium. EXT: wwp, no edema. DPs, PTs 2+. SKIN: dry, no rash NEURO/PSYCH: CNs II-XII intact. strength and sensation in U/L extremities grossly intact. gait not assessed. On Discharge: VS: 98.7 118/78 97 20 99RA GENERAL: Patient is sitting in a chair, appears comfortable, A+Ox3, cooperative. HEENT: EOMI, PERRLA, No Pallor or Jaundice, MMM, no JVD, neck supple. HEART: RRR, no m/r/g. LUNGS: CTAB ABDOMEN: obese, soft, mild tenderness on mid +right epigastrium w/o peritoneal signs, no shifting dullness, difficult to appreciate organomegaly. EXT: wwp, no edema, no signs of DVT SKIN: no rash, normal turgor NEURO: no gross deficits PSYCH: appropriate affect, no preceptual disturbances, no SI, normal judgment. <PERTINENT RESULTS> ___ 03: 14PM ___ ___ 12: 50PM URINE HOURS-RANDOM ___ 12: 50PM URINE UHOLD-HOLD ___ 12: 50PM URINE COLOR-Straw APPEAR-Clear SP ___ ___ 12: 50PM URINE BLOOD-NEG NITRITE-NEG PROTEIN-NEG GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-5.5 LEUK-TR ___ 12: 50PM URINE RBC-2 WBC-2 BACTERIA-NONE YEAST-NONE EPI-2 ___ 09: 54AM LACTATE-2.8* ___ 09: 45AM GLUCOSE-96 UREA N-7 CREAT-0.5 SODIUM-138 POTASSIUM-3.5 CHLORIDE-100 TOTAL CO2-27 ANION GAP-15 ___ 09: 45AM estGFR-Using this ___ 09: 45AM ALT(SGPT)-17 AST(SGOT)-46* ALK PHOS-293* TOT BILI-0.5 ___ 09: 45AM LIPASE-14 ___ 09: 45AM ALBUMIN-3.0* ___ 09: 45AM ___ AFP-1.7 ___ 09: 45AM WBC-13.9* RBC-3.94* HGB-9.8* HCT-33.0* MCV-84# MCH-25.0*# MCHC-29.9* RDW-16.1* ___ 09: 45AM NEUTS-75.2* LYMPHS-17.9* MONOS-5.9 EOS-0.7 BASOS-0.3 ___ 09: 45AM PLT COUNT-657*# CT abdomen/pelvis 1. Innumerable hepatic and pulmonary metastases. No obvious primary malignancy is identified on this study. 2. No evidence of small bowel obstruction, ischemic colitis, fluid collection, or perforation. CXR: New nodular opacities within both upper lobes, left greater than right. Findings are compatible with metastases, as was noted in the lung bases on the subsequent CT of the abdomen and pelvis performed later the same day. <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete 1. Albuterol Inhaler ___ PUFF IH Q6H: PRN wheezing/SOB 2. BuPROPion 150 mg PO DAILY 3. Gabapentin 300 mg PO TID 4. Ibuprofen 800 mg PO Q8H: PRN pain 5. Sertraline 200 mg PO DAILY 6. Simvastatin 40 mg PO DAILY 7. Tizanidine 4 mg PO BID: PRN muscle spasms/pain 8. traZODONE 100 mg PO HS: PRN sleep 9. Triamcinolone Acetonide 0.1% Cream 1 Appl TP TID <DISCHARGE MEDICATIONS> 1. Albuterol Inhaler ___ PUFF IH Q6H: PRN SOB 2. BuPROPion 150 mg PO DAILY 3. Gabapentin 300 mg PO TID 4. Sertraline 200 mg PO DAILY 5. Simvastatin 40 mg PO DAILY 6. Tizanidine 4 mg PO BID: PRN muscle spasms/pain 7. traZODONE 100 mg PO HS: PRN sleep 8. Ibuprofen 800 mg PO Q8H: PRN pain 9. Triamcinolone Acetonide 0.1% Cream 1 Appl TP TID 10. Benzonatate 100 mg PO TID: PRN cough RX *benzonatate 100 mg 1 capsule(s) by mouth TID: PRN cough Disp #*60 Capsule Refills: *0 11. Guaifenesin ___ mL PO Q6H: PRN cough RX *guaifenesin 100 mg/5 mL ___ ml by mouth Q6H: PRN cough Disp #*1 Bottle Refills: *0 <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Liver and Lung Mets of unkown primary <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear ___, ___ were seen in the ED for ongoing cough, nausea and vomiting and had imaging studies which unfortunately showed spots in your liver and lungs which are likely due to wide-spread cancer. ___ were admitted for further work-up and treatment of your symptoms. ___ chose to not have any more work-up in the hospital and wanted to be discharged home as soon as possible. Please make sure ___ keep well hydrated by taking water sips throughout the day. I also prescribed some symptomatic treatment for your nausea and cough. I updated your PCP and ___ and have set up ___ appointments as below. ","___ Female with PMH significant for depression, hyperlipidemia, Hysterectomy, B12 deficiency, OA, carcinoid, cervical DJD, depression, SBO who presented with nausea, vomiting, weakness x 2 weeks and was found to have multiple liver and lung masses per CT consistent with metastatic cancer of unknown primary. Patient was treated with IV fluids overnight for dehydration. She refused to stay in the hospital for any further work-up or treatment and stated she would rather go home to to think and see to her affairs over the weekend and consider pursuing further work-up as an outpatient. She tolerated oral fluids well w/o vomiting. She remained hemodynamically stable and afebrile throughout her stay. Of note patient has psychiatric history of depressive symptoms and isolation tendencies. She denied any SI/SA or any risk to herself. She has little social supports but does have a good relationship with her driver and friend who came in and was updated by the medical team on the morning of discharge and will be taking her home. She sees a mental health provider at ___ once a month and has a good relationship with her primary care physician. Patient was dischaerged home at her request. Home medications were continued to which we added some symptomatic treatment for her cough with benzonatate and Guaifenesin. We held off on anti-emetics for now as she did not want to stay inhouse to make sure these would be well tolerated (would need to monitor for drug interactions given multiple QTc prolonging and serotonergic medications on her home meds). She was instructed to maintain good hydration and try a soft diet at home if she can not tolerate regular diet. The patient met with SW who provided her with resources for community councelling. Outpatient appointments with oncology, GI and her PCP were set up and her PCP and mental health provider were updated. Her PCP ___ also ___ with her later today by telephone. ",1998,394
10000935-DS-20,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> Sulfa (Sulfonamide Antibiotics) / Codeine / Bactrim <ATTENDING> ___. <CHIEF COMPLAINT> Weakness, nausea/vomiting <MAJOR SURGICAL OR INVASIVE PROCEDURE> none <HISTORY OF PRESENT ILLNESS> This is a ___ yo f with h/o recently diagnosed metastatic cancer of unknown prior presenting with nausea, vomiting, and fever to 101 today. Patient has been vomiting over the past 6 - 8 weeks, since before she was diagnosed with metastatic cancer. She also reports pain over her upper abdomen and has very poor PO intake. She has been feeling progressively weak over this time period. Her vomiting and abdominal pain has not increased from the past weeks, but she just feels more fatigued. She has a chronic non-productive cough as well. No URI symptoms, no urinary complaints. She has been constipated, which improves when she stops her anti-emetics. Last bowel movement was yesterday. She is passing gas. She has lower extremity edema, which has been present for the past several weeks. Of note, she was supposed to have one of her liver mets biopsied in the past several weeks, but she was taking ibuprofen so the biopsy had to be postponed. In the ED, initial VS were: 97.6 117 128/74 18 95% RA. Labs were significant for WBC of 18.7, with 77% polys. UA was significant for ketones. Patient received zofran, NS. She had a CXR that showed new left sided opacity that may reflect PNA superimposed on metastatic diseae vs. lymphangiitic spread of cancer. She received vanc and cefepime for pneumonia. Vitals on transfer are: 99.6 110 118/78 20 99%. Currently, she continues to feel weak and nauseous. She is trying to take her pants off, but feels too weak and tired to do so. REVIEW OF SYSTEMS: (+) per HPI (-) night sweats, headache, vision changes, rhinorrhea, congestion, sore throat, BRBPR, melena, hematochezia, dysuria, hematuria. <PAST MEDICAL HISTORY> PMH: # high grade SBO ___ s/p exploratory laparotomy, lysis of adhesions, and small bowel resection with enteroenterostomy # carcinoid # hyperlipidemia # vitamin B12 deficiency # cervical DJD # osteoarthritis PSH: s/p R lung resection in ___ at ___ s/p hysterectomy in ___ s/p R arm surgery <SOCIAL HISTORY> ___ <FAMILY HISTORY> Mother - ___ cancer d. at ___ Youngest of ___ - not in touch with siblings Father - ___ d. at ___ <PHYSICAL EXAM> Admission <PHYSICAL EXAM> VS: 98.6, 130/80, 111, 24, 98% on RA GENERAL: Obese woman, appears comfortable, in no acute distress HEENT: PERRLA, EOMI, sclerae anicteric, slightly dry mucus membranes NECK: supple, obese LUNGS: Distant breath sounds, decreased on the right, few crackles b/l HEART: RRR, no MRG, nl S1-S2 ABDOMEN: + bowel sounds, soft, epigastric and RUQ tenderness to palpation, markedly enlarged liver, with liver edge palpable 5 cm below rib cage. No rebound/guarding. EXTREMITIES: 2+ lower extremity edema, 2+ pulses radial and dp NEURO: awake, A&Ox3, CNs II-XII grossly intact, muscle strength ___ throughout Discharge <PHYSICAL EXAM> Vitals- Tm 99.8 BP 125/76 HR 105 RR 20 99RA General- Alert, oriented, no acute distress, obese appearing woman HEENT- Sclera anicteric, MMM, oropharynx clear Neck- supple, JVP not elevated, no LAD Lungs- Clear to auscultation bilaterally with decreased breath sound on left posterior basilar lung field, no wheezes, rales, ronchi CV- Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Abdomen- soft, obese, diffusely tender, non-distended, bowel sounds present, no rebound tenderness or guarding, no organomegaly GU- no foley Ext- warm, well perfused, 2+ pulses, no clubbing, cyanosis, 2+ pitting edema Neuro- CNs2-12 intact, motor function grossly normal Labs: Reviewed, please see below. <PERTINENT RESULTS> ADMIT LABS: ___ 04: 35PM BLOOD WBC-18.7*# RBC-3.49* Hgb-9.2* Hct-31.2* MCV-90 MCH-26.5* MCHC-29.6* RDW-18.6* Plt ___ ___ 04: 35PM BLOOD Neuts-77.4* Lymphs-14.9* Monos-6.8 Eos-0.5 Baso-0.4 ___ 04: 35PM BLOOD Plt ___ ___ 04: 35PM BLOOD Glucose-90 UreaN-8 Creat-0.5 Na-139 K-3.5 Cl-99 HCO3-29 AnGap-15 ___ 04: 35PM BLOOD ALT-12 AST-48* AlkPhos-328* TotBili-0.9 ___ 07: 45AM BLOOD Calcium-8.4 Phos-2.5*# Mg-2.0 ___ 04: 35PM BLOOD Albumin-2.8* ___ 06: 42PM BLOOD Lactate-2.0 DISCHARGE LABS: ___ 06: 05AM BLOOD WBC-16.8* RBC-3.20* Hgb-8.3* Hct-28.7* MCV-90 MCH-25.9* MCHC-28.9* RDW-18.1* Plt ___ ___ 06: 05AM BLOOD Glucose-87 UreaN-10 Creat-0.4 Na-136 K-3.7 Cl-99 HCO3-27 AnGap-14 ___ 06: 05AM BLOOD ALT-11 AST-45* LD(LDH)-517* AlkPhos-282* TotBili-0.8 ___ 06: 05AM BLOOD Calcium-8.4 Phos-2.7 Mg-2.2 IMAGING: ___ Final Report HISTORY: New diagnosis of metastatic cancer with unknown primary. Assess for extent of lesions. COMPARISON: CT abdomen and pelvis dated ___. TECHNIQUE: Multidetector CT of the torso was performed with intravenous and oral contrast. Coronal and sagittal reformations were provided. Images are substantially degraded due to the patient's body habitus. FINDINGS: CHEST: There are innumerable pulmonary nodules, which have an upper lobe predilection, particularly in the left upper lobe. The largest nodule measures 6 mm in diameter (sequence 3 image 8). Calcification is noted within the right pleural cavity (sequence 3 image 24), which is likely related to the patient's history of previous right lung surgery. No pleural effusion. No pneumothorax. No significant mediastinal, axillary or hilar adenopathy. Cardiac size is normal. No pericardial effusion. ABDOMEN: The liver is enlarged and there are innumerable ___ density lesions throughout both lobes of the liver which are replacing the vast majority of the hepatic parenchyma. The portal vein is patent. No intra or extrahepatic duct dilatation. The gallbladder is unremarkable. There is a small amount of ascites adjacent to the right lobe of the liver. The right kidney is mildly compressed anteriorly due to the enlarged liver. There is a subcentimeter ___ density lesion in the upper pole of the right kidney, likely representing a subcentimeter cyst (sequence 5 image 31). The right kidney is otherwise unremarkable. The left kidney is within normal limits. The adrenals and spleen are unremarkable. The pancreas is within normal limits. The small and large bowel are unremarkable. No retroperitoneal or mesenteric adenopathy. PELVIS: The images of the pelvis are substantially degraded secondary to the patient's body habitus. No pelvic masses are identified. The bladder is unremarkable. The patient is status post supracervical hysterectomy. No pelvic adenopathy. No free fluid within the pelvis. OSSEOUS STRUCTURES: Bilateral symmetrical sclerosis is identified on the iliac side of the sacroiliac joints, consistent with osteitis condensans ilii. There is severe degenerative change within the right hip joint with joint space loss and osteophyte formation. No destructive osseous lesions. IMPRESSION: Multiple pulmonary and hepatic metastases. No separate primary lesion identified. <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Albuterol Inhaler ___ PUFF IH Q6H: PRN SOB 2. BuPROPion 150 mg PO DAILY 3. Gabapentin 300 mg PO HS 4. Sertraline 200 mg PO DAILY 5. Simvastatin 40 mg PO DAILY 6. traZODONE 100 mg PO HS: PRN sleep 7. Ibuprofen 800 mg PO Q12H: PRN pain 8. Hydrochlorothiazide 12.5 mg PO DAILY 9. Ondansetron 4 mg PO Q8H: PRN nausea <DISCHARGE MEDICATIONS> 1. Albuterol Inhaler ___ PUFF IH Q6H: PRN SOB 2. BuPROPion 150 mg PO DAILY 3. Gabapentin 300 mg PO HS 4. Sertraline 200 mg PO DAILY 5. traZODONE 100 mg PO HS: PRN sleep 6. Ondansetron 4 mg PO Q8H: PRN nausea 7. Bisacodyl 10 mg PO/PR DAILY: PRN constipation 8. OxycoDONE (Immediate Release) 5 mg PO Q6H: PRN pain please hold for sedation, RR<10 RX *oxycodone 5 mg 1 tablet(s) by mouth every 6 hours Disp #*30 Tablet Refills: *0 9. Enoxaparin Sodium 40 mg SC DAILY <DISCHARGE DISPOSITION> Extended Care Facility: ___ <DISCHARGE DIAGNOSIS> Metastatic disease of unknown primary: Weakness and nausea likely from tumor burden <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Ms. ___, You were admitted to ___ for evaluation of several weeks of weakness and nausea. You had some markers of infection, so you were initially given antibiotics. However, a scan of your torso showed metastatic disease from a cancer of unknown origin in your liver and lungs. Your weakness and nausea are most likely due to your enlarged liver. You are scheduled to see your oncologist this week, so please follow-up with them so that they may proceed with the further diagnosis and treatment of your malignancy. You are being discharged to a rehabilitation facility to help you regain some strength before going home. Your anticipated length of stay is LESS THAN 30 DAYS. Please see the attached sheet for your updated medication list. It was a pleasure taking care of you in the hospital. We wish you all the best. ","___ yo f with h/o recently diagnosed metastatic cancer of unknown primary presenting with nausea, vomiting, and fever to 101 on day of admission. . # Fever/leukocytosis: Patient presented with fever and leukocytosis, which was initially concerning for post obstructive PNA. Patient was treated with vanc-cefepime-azithro for a day and a half, however CT torso was concerning for ongoing malignancy without evidence of primary tumor. There was no concern for a pneumonia. Consequently, abx were stopped on ___. Patient felt weak and unable to go home, as she lives alone and so was screened by physical therapy and discharged to rehab facility. . # Failure to thrive: Patient presents with 6 weeks of nausea, vomiting and poor PO intake likely from her enlarged liver. She continues to have bowel movements and pass gas. Patient now with albumin of 2.8, ketones in her urine, weight loss and new peripheral edema, concerning for poor nutrition/starvation ketosis. Nutrition consult followed the patient throughout her hospital stay and recommended ___ fat Carnation Instant Breakfast with Beneprotein. . # Chronic back pain: Patient was continued on her home gabapentin. . # Depression: Patient was continued on home bupropion, sertraline . # HCTZ: Patient's hctz was discontinued during her hospitalization due to poor PO intake and concern for dehydration. Blood pressures were well-controlled such that HCTZ was not deemed necessary. This issue should be readdressed by PCP. . # Hyperlipidemia: Given patient's metastatic process, statin was discontinued during hospitalization to simplify her medical regimen. . # Insomnia: Continued home trazodone . TRANSITION ISSUES # CODE: FULL (Confirmed) # CONTACT: ___ (friend) ___ # HCTZ discontinued on admission- consider restarting if considered medically necessary by PCP # ___ fat Carnation Instant Breakfast with Beneprotein with meals # Follow up with oncology for further diagnosis and management of malignancy ",2611,422
10000935-DS-21,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> Sulfa (Sulfonamide Antibiotics) / Codeine / Bactrim <ATTENDING> ___. <CHIEF COMPLAINT> Shortness of breath <MAJOR SURGICAL OR INVASIVE PROCEDURE> Percutaneous liver biopsy <HISTORY OF PRESENT ILLNESS> Ms. ___ is a ___ with metastatic cancer of unknown primary (known lesions in lungs and liver) presenting with shortness of breath. She initially presented to ___ in ___ with abdominal pain and failure to thrive. Evaluation at that time included an abdominal CT scan that showed multiple lung and liver metastases. She has yet to undergo definite diagnosis with biopsy, and per recent oncology documentation seems disengaged with care. She was reportedly in her usual state of health until the evening prior to admission, when she developed acute on chronic shortness of breath while at rest. She reported midsternal chest ache associated with this shortness of breath. Pain is exacerbated by direct pressure; nothing seems to alleviate pain. She denied any pleuritic or exertional component to the chest pain or shortness of breath. She feels that symptoms are secondary to her ""cancer"" and ""feels as if the cancer has spread"". She reports stable, chronic nonproductive cough, which has been present over the preceding months. She was seen recently in the ED for evaluation of left greater than right lower extremity edema with lower extremity venous ultrasounds negative, without change in edema since since that visit. She denies associated fever, chills, sweats, PND, orthopnea, or positional component to pain. In the ED, initial vital signs were: 98.0 116 100/49 24 99% RA. Labs notable for leukocytosis to 17.9, hematocrit of 32, and lactate of 2.8. Urinalysis was positive, but with 19 epithelial cells. CTA was negative for central pulmonary embolus, focal consolidation, or pleural effusion, though did reveal innumerable pulmonary nodules, as well as enlarged liver with stable metastases. EKG was interpreted as sinus tachycardia and was overall consistent with prior. Ceftriaxone/azithromycin were initiated for possible pneumonia. Vital signs on transfer were as follows: 97.9 107 100/60 22 100% RA. On arrival to the floor, she reports that shortness of breath has improved and that she is chest pain free. <PAST MEDICAL HISTORY> Per OMR: # metastatic cancer of unknown primary # high grade SBO ___ s/p exploratory laparotomy, lysis of adhesions, and small bowel resection with enteroenterostomy # carcinoid # hyperlipidemia # vitamin B12 deficiency # cervical DJD # osteoarthritis s/p R lung resection in ___ at ___ s/p hysterectomy in ___ s/p R arm surgery <SOCIAL HISTORY> ___ <FAMILY HISTORY> Per OMR: Mother - Died of pancreatic cancer at age ___. Father - Died of ___ disease at age ___. <PHYSICAL EXAM> On admission: VS: 97.9 114/71 105 sinus 18 95%2L GENERAL: non-toxic appearing, speaking in full sentences HEENT: NC/AT, PERRLA, EOMI, sclerae anicteric, MMM NECK: supple, no LAD, no JVD CHEST: mild reproducible pain on palp of midsternum; no palpable mass LUNGS: poor aeration but relatively CTA bilat, no r/rh/wh, resp unlabored, no accessory muscle use HEART: clear and audible heart sounds, tachycardiac but regular rhythm, sofy SEM, nl S1-S2 ABDOMEN: normal bowel sounds, soft, mild tenderness to palp throughout and more pronounced in the RUQ, non-distended, no rebound or guarding, palpable liver edge EXTREMITIES: left > right 1+ pitting edema to mid shin, 2+ pulses radial and dp NEURO: awake, A&Ox3, CNs II-XII grossly intact, muscle strength ___ throughout, sensation grossly intact At discharge: VS - Tc 99.7, 116/59, 131, 18, 99% RA GENERAL: obese, NAD, lying in bed comfortably, flat affect and poor eye contact HEENT: NCAT, EOMI, mild scleral icterus, pink conjunctiva, MMM, poor dentition, mild palor of conjunctiva NECK: supple, no LAD CARDIAC: tachycardic but regular, S1/S2, no m/r/g LUNG: CTAB in anterior fields, decreased breath sounds at right base, exam limited secondary to body habitus and mobility, no w/r/r, no accessory muscle use ABDOMEN: obese, ND, +BS, no rebound/guarding, localized area of firmness in mid-upper abdomen and tender to palpation over this area EXTREMITIES: WWP, 2+ DP pulses bilaterally, 1+ pitting edema to torso bilateraly NEURO: no asterixis, moving all four extremities, minimal movement ___ to gravity but distal muscles 4+/5, good hand grip strength today <PERTINENT RESULTS> On admission: ___ 12: 50PM BLOOD WBC-17.9* RBC-3.69* Hgb-9.5* Hct-32.1* MCV-87 MCH-25.8* MCHC-29.7* RDW-19.1* Plt ___ ___ 12: 50PM BLOOD Neuts-82.8* Lymphs-11.7* Monos-4.4 Eos-0.7 Baso-0.3 ___ 12: 50PM BLOOD ___ PTT-31.2 ___ ___ 12: 50PM BLOOD Glucose-97 UreaN-12 Creat-0.6 Na-140 K-2.7* Cl-92* HCO3-31 AnGap-20 ___ 12: 50PM BLOOD ALT-17 AST-73* LD(___)-586* CK(CPK)-218* AlkPhos-340* TotBili-2.6* DirBili-1.8* IndBili-0.8 ___ 12: 50PM BLOOD CK-MB-1 cTropnT-<0.01 ___ 12: 50PM BLOOD Albumin-2.5* Mg-2.2 ___ 12: 50PM BLOOD Hapto-307* ___ 05: 12PM BLOOD Lactate-2.8* ___ 06: 00PM URINE Color-YELLOW Appear-Cloudy Sp ___ ___ 06: 00PM URINE Blood-NEG Nitrite-NEG Protein-30 Glucose-NEG Ketone-10 Bilirub-SM Urobiln-8* pH-6.0 Leuks-MOD ___ 06: 00PM URINE RBC-0 WBC-66* Bacteri-FEW Yeast-NONE Epi-14 ___ 06: 00PM URINE CastHy-6* At discharge: ___ 08: 30AM BLOOD WBC-16.1* RBC-3.06* Hgb-8.3* Hct-29.2* MCV-95 MCH-27.1 MCHC-28.5* RDW-22.5* Plt ___ ___ 08: 30AM BLOOD Glucose-95 UreaN-7 Creat-0.3* Na-143 K-3.5 Cl-110* HCO3-20* AnGap-17 ___ 08: 30AM BLOOD Calcium-8.3* Phos-2.4* Mg-1.9 Microbiology: Blood x2 (___): No growth Urine (___): No growth Blood x2 (___): No growth Pathology: Liver biopsy (___): Liver, core needle biopsy (A): Adenocarcinoma, involving the liver (see note). Note: Immunohistochemical stains are performed. The tumor cells are positive for CK20 and CDX-2, and negative for CK7 and TTF-1. These results are consistent with metastasis from a colorectal primary. Imaging: EKG (___): Sinus tachycardia. Low voltage. Diffuse non-specific repolarization abnormalities. Compared to the previous tracing of ___ repolarization abnormalities are slightly more prominent. ___ ___ Portable CXR (___): Innumerable pulmonary metastases. Possible mild pulmonary vascular congestion. Low lung volumes. CTA (___): 1. No central or segmental filling defect in the pulmonary arteries. Evaluation is slightly limited due to suboptimal IV bolus. 2. Innumerable bilateral pulmonary nodules, simas seen on the prior CT study on ___, slightly increased. No focal consolidation or pleural effusion. 3. Enlarged liver with multiple hypodense lesions, with suggestion of increased burden of disease. Right upper quadrant ultrasound (___): Extensive diffuse hepatic metastatic disease. No evidence of biliary duct obstruction. Portable CXR (___): 1. Low lung volumes and mild pulmonary vascular congestion is unchanged. 2. New small right fissural pleural effusion. 3. No new focal opacities to suggest pneumonia. Noncontrast head CT (___): No acute intracranial process. No mass is identified. MRI is more sensitive for evaluation of metastases. Left hip XR (___): No definite lytic lesion; however, an MRI can be performed to evaluate for an osseous lesion if indicated. Portable abdomen (___): Radiographs of the abdomen and pelvis demonstrate a nonobstructed bowel gas pattern. A relative paucity of bowel gas is present in the upper and mid abdomen, likely due to marked enlargement of the liver, displacing bowel loops. Note that the upright view is technically suboptimal, and limits evaluation for free intraperitoneal air. If free intraperitoneal air is suspected clinically, a left lateral decubitus view of the abdomen would be recommended. <MEDICATIONS ON ADMISSION> The Preadmission Medication list may be inaccurate and requires futher investigation. 1. Albuterol Inhaler ___ PUFF IH Q6H: PRN SOB 2. BuPROPion 150 mg PO DAILY 3. Gabapentin 300 mg PO HS 4. Sertraline 200 mg PO DAILY 5. traZODONE 100 mg PO HS: PRN sleep 6. Ondansetron 4 mg PO Q8H: PRN nausea 7. Bisacodyl 10 mg PO/PR DAILY: PRN constipation 8. OxycoDONE (Immediate Release) 5 mg PO Q6H: PRN pain please hold for sedation, RR<10 9. Enoxaparin Sodium 40 mg SC DAILY <DISCHARGE MEDICATIONS> 1. BuPROPion 150 mg PO DAILY 2. Ondansetron 4 mg PO Q8H: PRN nausea 3. TraMADOL (Ultram) 50 mg PO Q4H: PRN pain RX *tramadol 50 mg 1 tablet(s) by mouth every four (4) hours Disp #*60 Tablet Refills: *0 4. Senna 1 TAB PO BID: PRN constipation RX *sennosides [___] 8.6 mg 1 tablet by mouth twice a day Disp #*60 Tablet Refills: *0 5. Omeprazole 20 mg PO DAILY RX *omeprazole 20 mg 1 capsule,delayed ___ by mouth Daily Disp #*30 Capsule Refills: *0 6. Hospital Bed Bariatric Hospital Bed and Therapeutic Mattress: BariMaxxII 7. Hospice Order Please Screen and Admit to Hospice. 8. Bisacodyl 10 mg PO/PR DAILY: PRN constipation 9. Docusate Sodium 100 mg PO BID 10. Sertraline 200 mg PO DAILY 11. traZODONE 100 mg PO HS: PRN sleep 12. Polyethylene Glycol 17 g PO DAILY: PRN constipation <DISCHARGE DISPOSITION> Home With Service Facility: ___ <DISCHARGE DIAGNOSIS> Primary: Metastatic colon adenocarcinoma <DISCHARGE CONDITION> Mental Status: Confused - sometimes. Level of Consciousness: Alert and interactive. Activity Status: Bedbound. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Ms. ___, It was a pleasure taking part in your care during your admission to ___. As you know, you were admitted for shortness of breath, likely due to your underlying cancer, and there was no evidence of pneumonia or blood clot in the blood vessels of your lungs. Your shortness of breath resolved, but you were found to have weakness in your left thigh and abdominal pain. You declined imaging studies for further investigation of these findings. You underwent biopsy of your liver that revealed that the cancer known to affect your liver and lungs originated in your colon (large bowel). You were transferred to the oncology service, but unfortunately chemotherapy would do more harm for you than good. After a long discussion with you and your health care proxy, it was decided that you will go home to be with your family and loved ones. We will also set up hospice services for you so that they can help with any issues that arise while you are at home. ","Ms. ___ is a ___ with metastatic cancer of unknown primary, including lesions in the liver and lungs, who initially presented with shortness of breath, likely due to worsening intrapulmonary tumor burden, and later underwent percutaneous liver biopsy with pathology consistent with metastatic colon cancer, prompting transfer to the oncology service and eventually discharged home with hospice. Active Issues: (1) Metastatic colon adenocarcinoma: CTA to exclude pulmonary embolus and right upper quadrant ultrasound on admission demonstrated progression of previously recognized metastatic cancer of unknown primary involving the liver and lungs, which had evaded diagnosis in the outpatient setting due to patient reluctance to engage with care. Percutaneous liver biopsy ultimately revealed primary colonic adenocarcinoma. Following discussion with her outpatient oncology providers, she was transferred to the inpatient oncology service for potential trial of FLOX. However, given the patient's very poor functional and nutritional status a goals of care discussion was held with the patient's HCP, ___ and it was decided to focus goals of care of comfort and symptom management and the patient was discharged home with home hospice. (2) Left thigh weakness/spinous tenderness: She was found to have focal left thigh weakness in association with diffuse spinous tenderness of unclear chronicity in the setting of preserved rectal tone without saddle anesthesia. She was noted to be incontinent of urine, but not feces. Given underlying malignancy, there was concern for bony metastases or cord involvement, with alternative consideration given to epidural abscess, prompting transient initiation of empiric antibiotic coverage with vancomycin/cefepim ___ to ___. Despite frequent persuasive efforts, she declined multiple attempts at lumbosacral MRI, including with lorazepam premedication, citing claustrophobia. Neuro exam was monitored and remained stable. (3) Abdominal pain: She experienced intermittent abdominal pain and tenderness without peritoneal signs, concerning for obstruction in the setting of intraabdominal malignancy, particularly given episodes of emesis/hematemesis as below. While multiple KUBs were negative for obstruction, CT abdomen was planned to evaluate for alternative sources of intraabdominal pathology, but she declined on multiple occasions. Pain was controlled with acetaminophen and tramadol as needed. (4) ? Hematemesis: She experienced a single episode of small volume emesis, reportedly approximately 100cc, streaked with blood and found to be guiac positive. Vital signs and hematocrit remained stable. IV pantoprazole was initiated for gastrointestinal prophylaxis, with subsequent discontinuation of PPI given no recurrence and questionable if first episode was true blood vs. red popsicle was eating at time. Esophagogastroduodenoscopy was deferred in the absence of recurrent hematemesis; no prior EGDs were available in OMR. (5) Altered mental status: She was intermittently altered throughout admission, never oriented to more than person and place, with occasional difficulty following simple commands as compared to an uncertain baseline. Infectious work up, including blood and urine cultures and CTA on admission with subsequent CXRs, was unrevealing. Noncontrast head CT was negative for acute intracranial process. Brain MRI for definitive exclusion of metastases could not be obtained due to claustrophobia/MRI aversion as above. ABG on ___ without signs of CO2 retention. History of opiates making patient sleepy per HCP as possible contributing factor and therefore these were discontinued. Hepatic encephalopathy also on differential given metastatic lesions to liver and asterixis on exam. AMS could also be ___ to severe depression. Mental status monitored and remained stable and patient at baseline per HCP on discharge. (6) Shortness of breath: She presented with acute onset shortness of breath without frank hypoxia. CTA on admission was negative for pulmonary embolus, though (subsegmental clot could not be excluded definitively), pleural effusion, or focal infiltrate. EKG and cardiac enzymes were reassuring against acute coronary syndrome. Low voltages on EKG were consistent with prior, hence limited suspicion for pericardial effusion. Shortness of breath resolved over the course of admission without dedicated treatment, with the exception of nebulizers and expectorants as needed. (7) Leukocytosis: White blood cell count was elevated and peaked at 20.6, consistent with recent baseline, likely reflecting underlying malignancy. As noted above, infectious work up including CTA, urine and blood cultures, and CXRs, was unrevealing. She remained afebrile, with the exception of isolated transient fever to 100, with stable vital signs. (8 )Liver function test abnormalities: AST remained elevated ___ to ___, alkaline phosphatase 260s to 380s, and total bilirubin 2.1 to 2.6, likely due to hepatic infiltration of malignancy. Right upper quadrant ultrasound was negative for cholecystitis or obstructive process. The possibility of superimposed intraabdominal process, such as infection, could not be excluded in the setting of abdominal pain with emesis as above, but she declined CT for further evaluation. (9) Elevated lactate: Lactate was found to be 2.7-3.8 throughout admission despite copious IV fluids, likely reflecting compromised hepatic clearance in the setting of malignant infiltration. (10) Sinus tachycardia: She remained persistently tachycardic 100s to 115s throughout admission in the setting of poor PO intake, but incompletely responsive to copious IV fluids. Tachycardia has been present since at least ___. Despite concurrent leukocytosis and elevated lactate, there was no clear infectious source, hence low suspicion for sepsis. Subsegmental pulmonary embolus could not be excluded on the basis of admission CTA, but shortness of breath was short lived, and she was never hypoxic. Hematocrit remained stable without signs of active bleeding, with the exception of transient hematemesis as above. (11) Depression: She appeared depressed with flat affect and seeming anhedonia throughout admission, with underlying depression likely affecting motivation to seek diagnosis and treatment of known malignancy. She denied active suicidal ideation and frequently declined home sertraline, particularly prior to liver biopsy, believing that it was supposed to be held preprocedurally despite explanation to the contrary. She was seen by social work throughout admission. (12) Normocytic anemia: Hematocrit remained stable and consistent with recent baseline at 27 to 33 throughout admission, seemingly due to anemia of chronic disease on the basis of preadmission labs. Vital signs remained stable, with the exception of persistent tachycardia, without signs of active bleeding apart from isolated blood streaked emesis as above. (13) Coagulopathy: INR of 1.2 to 1.8 was felt to reflect synthetic dysfunction in the setting of hepatic infiltration of malignancy, as well as poor oral intake. There were no signs of active bleeding, with the exception of transient hematemesis as above. Transitional Issues: -Patient discharge home with home hospice ",2964,1509
10000980-DS-20,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___ <CHIEF COMPLAINT> Shortness of breath <MAJOR SURGICAL OR INVASIVE PROCEDURE> None <HISTORY OF PRESENT ILLNESS> ___ yo woman with h/o hypertension, hyperlipidemia, diabetes mellitus on insulin therapy, h/o cerebellar-medullary stroke in ___, CKD stage III-IV presenting with fatigue and dyspnea on exertion (DOE) for a few weeks, markedly worse this morning. Over the past few weeks, the patient noted DOE and shortness of breath (SOB) even at rest. She has also felt more tired than usual. She notes no respiratory issues like this before. She cannot walk up stair due to DOE, and feels SOB after only a short distance. She is unsure how long the episodes last, but states that her breathing improves with albuterol which she gets from her husband. She had a bad cough around a month ago, but denies any recent fevers, chills, or night sweats. No chest pain, nausea, or dizziness. <PAST MEDICAL HISTORY> 1. CAD RISK FACTORS: +Diabetes, +Dyslipidemia, +Hypertension 2. CARDIAC HISTORY: MI in ___ 3. OTHER PAST MEDICAL HISTORY: Hypertension Hyperlipidemia Diabetes mellitus on insulin therapy h/o cerebellar-medullary stroke in ___ CKD stage III-IV PVD <SOCIAL HISTORY> ___ <FAMILY HISTORY> Denies cardiac family history. Family hx of DM and HTN; otherwise non-contributory. <PHYSICAL EXAM> Admission exam: GENERAL- Oriented x3. Mood, affect appropriate. VS- T= 98.1 BP= 200/103 HR= 65 RR= 26 O2 sat= 100% on RA HEENT- NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no pallor or cyanosis of the oral mucosa. No xanthalesma. NECK- JVD to angle of mandible CARDIAC- RR, normal S1, S2. No murmurs, rubs or gallops. No thrills, lifts. LUNGS- Kyphosis. Resp were labored, mild exp wheezes bilaterally. ABDOMEN- Soft, non-tender, not distended. Abd aorta not enlarged by palpation. No abdominal bruits. EXTREMITIES- No clubbing, cyanosis or edema. No femoral bruits. SKIN- No stasis dermatitis, ulcers, scars, or xanthomas. NEURO- CNII-XII grossly intact. Strength ___ in LEs and UEs. Diminished sensation along lateral aspect of left leg to light touch Discharge exam: Lungs: CTAB Otherwise unchanged <PERTINENT RESULTS> Admission Labs ___ 01: 18PM BLOOD WBC-6.4# RBC-3.15* Hgb-9.5* Hct-30.1* MCV-96 MCH-30.1 MCHC-31.5 RDW-14.1 Plt ___ ___ 01: 18PM BLOOD Glucose-150* UreaN-33* Creat-1.6* Na-144 K-4.8 Cl-111* HCO3-18* AnGap-20 ___ 01: 18PM BLOOD CK(CPK)-245* ___ 01: 18PM BLOOD cTropnT-0.05* ___ 01: 18PM BLOOD CK-MB-6 proBNP-4571* ___ 03: 56AM BLOOD Calcium-9.4 Phos-4.9* Mg-2.0 Cholest-230* Pertinent Labs ___ 06: 09AM BLOOD WBC-4.3 RBC-3.27* Hgb-9.9* Hct-31.4* MCV-96 MCH-30.4 MCHC-31.6 RDW-14.5 Plt ___ ___ 06: 09AM BLOOD Glucose-138* UreaN-31* Creat-1.4* Na-144 K-4.3 Cl-107 HCO3-26 AnGap-15 ___ 06: 09AM BLOOD ALT-20 AST-17 ___ 03: 56AM BLOOD Triglyc-97 HDL-65 CHOL/HD-3.5 LDLcalc-146* ___ 03: 56AM BLOOD %HbA1c-8.1* eAG-186* ___ 01: 18PM BLOOD CK(CPK)-245* CK-MB-6 cTropnT-0.05* ___ 08: 43PM BLOOD CK(CPK)-198 CK-MB-5 cTropnT-0.03* ___ 03: 56AM BLOOD CK(CPK)-173 CK-MB-5 cTropnT-0.04* ___ 06: 09AM BLOOD cTropnT-0.01 ___ 01: 18PM proBNP-4571* ECG ___ 7: 56: 06 ___ Baseline artifact. Sinus rhythm. The Q-T interval is 400 milliseconds. Q waves in leads V1-V2 with ST-T wave abnormalities extending to lead V6. Consider prior anterior myocardial infarction. Since the previous tracing of ___ atrial premature beats are not seen. The Q-T interval is shorter. ST-T wave abnormalities are less prominent. CXR ___: PA and lateral views of the chest demonstrate low lung volumes. Tiny bilateral pleural effusions are new since ___. No signs of pneumonia or pulmonary vascular congestion. Heart is top normal in size though this is stable. Aorta is markedly tortuous, unchanged. Aortic arch calcifications are seen. There is no pneumothorax. No focal consolidation. Partially imaged upper abdomen is unremarkable. IMPRESSION: Tiny pleural effusions, new. Otherwise unremarkable. ECHO ___: The left atrium is mildly dilated. The estimated right atrial pressure is ___ mmHg. Left ventricular wall thickness, cavity size and regional/global systolic function are normal (LVEF >55%). Right ventricular chamber size and free wall motion are normal. The diameters of aorta at the sinus, ascending and arch levels are normal. The aortic valve leaflets (3) are mildly thickened but aortic stenosis is not present. No masses or vegetations are seen on the aortic valve, but cannot be fully excluded due to suboptimal image quality. Trace aortic regurgitation is seen. The mitral valve leaflets are structurally normal. An eccentric, anteriorly directed jet of mild to moderate (___) mitral regurgitation is seen. Moderate [2+] tricuspid regurgitation is seen. There is moderate pulmonary artery systolic hypertension. The end-diastolic pulmonic regurgitation velocity is increased suggesting pulmonary artery diastolic hypertension. There is an anterior space which most likely represents a prominent fat pad. IMPRESSION: Suboptimal image quality. Normal biventricular cavity sizes with preserved global and regional biventricular systolic function. Pulmonary artery hypertension. Mild-moderate mitral regurgitation. Moderate tricuspid regurgitation. Compared with the prior study (images reviewed) of ___, the severity of mitral and tricuspid regurgitation are increased and moderate PA hypertension is now identified. <MEDICATIONS ON ADMISSION> ATENOLOL - 100 mg Tablet - 1.5 Tablet(s) by mouth once a day CLONIDINE - 0.1 mg/24 hour Patch Weekly - place on shoulder once a week CLOPIDOGREL [PLAVIX] - 75 mg Tablet - 1 Tablet(s) by mouth once a day generic is available preferable, please call Dr ___ an appointment FENOFIBRATE MICRONIZED - 134 mg Capsule - 1 Capsule(s) by mouth once a day HYDROCHLOROTHIAZIDE - 25 mg Tablet - 1 (One) Tablet(s) by mouth once a day NIFEDIPINE [NIFEDIAC CC] - 60 mg Tablet Extended Release - 2 Tablet(s) by mouth once a day NITROGLYCERIN [NITROSTAT] - 0.3 mg Tablet, Sublingual - 1 Tablet(s) sublingually sl as needed for prn chest pain may use 3 doses, 5 minutes apart; if no relief, ED visit RANITIDINE HCL - 300 mg Tablet - 1 Tablet(s) by mouth once a day SIMVASTATIN - 80 mg Tablet - 1 Tablet(s) by mouth at bedtime Medications - OTC ASPIRIN [ENTERIC COATED ASPIRIN] - 325 mg Tablet, Delayed Release (E.C.) - 1 (One) Tablet(s) by mouth once a day INSULIN NPH & REGULAR HUMAN [HUMULIN 70/30] - 100 unit/mL (70-30) Suspension - 30 units at dinner at dinner MULTIVITAMIN - (OTC) - Tablet - 1 Tablet(s) by mouth once a day <DISCHARGE MEDICATIONS> 1. clopidogrel 75 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). Disp: *30 Tablet(s)* Refills: *2* 2. nitroglycerin 0.4 mg Tablet, Sublingual Sig: One (1) Tablet, Sublingual Sublingual PRN (as needed) as needed for chest pain: may take up to 3 over 15 minutes. Disp: *30 Tablet, Sublingual(s)* Refills: *0* 3. multivitamin Tablet Sig: One (1) Tablet PO DAILY (Daily). Disp: *30 Tablet(s)* Refills: *2* 4. ranitidine HCl 150 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily). Disp: *60 Tablet(s)* Refills: *2* 5. pravastatin 80 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). Disp: *30 Tablet(s)* Refills: *2* 6. aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable PO DAILY (Daily). Disp: *30 Tablet, Chewable(s)* Refills: *2* 7. lisinopril 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). Disp: *30 Tablet(s)* Refills: *2* 8. nifedipine 60 mg Tablet Extended Release Sig: Two (2) Tablet Extended Release PO DAILY (Daily). Disp: *30 Tablet Extended Release(s)* Refills: *2* 9. furosemide 40 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). Disp: *30 Tablet(s)* Refills: *2* 10. insulin NPH & regular human 100 unit/mL (70-30) Insulin Pen Sig: Thirty (30) units Subcutaneous at dinner. Disp: *900 units* Refills: *2* 11. albuterol sulfate 90 mcg/actuation HFA Aerosol Inhaler Sig: ___ puffs Inhalation every ___ hours as needed for shortness of breath or wheezing. Disp: *1 inhaler* Refills: *1* <DISCHARGE DISPOSITION> Home With Service Facility: ___ <DISCHARGE DIAGNOSIS> -Hypertension with hypertensive urgency -Myocardial infarction attributed to demand myonecrosis -Acute on chronic left ventricular diastolic heart failure -Chronic kidney disease, stage ___ -Chronic obstructive pulmonary disease -Prior cerebellar-medullary stroke -Hyperlipidemia -Diabetes mellitus requiring insulin therapy -Medication non-adherence <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Ms. ___, You were admitted for shortness of breath. You were found to have elevated blood pressure on admission in the setting of not taking all of your medications regularly. We obtained an echocargiogram of your heart which showed some strain on your heart possibly related to your elevated blood pressures. You will be contacted about an outpatient stress test. This will be completed within the next month. You will be prescribed several new medications as shown below. A visiting nurse ___ come to your home to help with managing your medications. You should dispose of all your home medications and only take the medications shown on this discharge paperwork. Medications: STOP Hydrochlorothiazide STOP Simvastatin STOP Clonidine STOP Atenolol due to low heart rate CHANGE 325mg to 81mg once daily START Lisinopril 20mg once daily START Lasix 40mg once daily START Pravastin 80mg once daily If you experience any chest pain, excessive shortness of breath, or any other symptoms concerning to you, please call or come into the emergency department for further evaluation. Thank you for allowing us at the ___ to participate in your care. ","___ woman with h/o hypertension, hypelipidemia, diabetes mellitus on insulin, cerebellar-medullary stroke in ___, stage ___ CKD followed by Dr ___ presenting with fatigue and DOE for a few weeks, markedly worse the morning of admission. The patient has known diastolic dysfunction. Of note, she has been noncompliant with her medications at home. On arrival to the floor, she required hydralazine 20 mg to bring down her BP. She has likely had elevated BPs at home for a while, which is contributing to her SOB, CHF exacerbation, and secondary demand myonecrosis (hypertensive urgency) with mildly elevated troponin. # CAD: Although she did not have a classic anginal presentation, patient has several risk factors for acute coronary syndrome. Her only symptom was SOB in the setting of elevated BPs attributed to medication noncompliance at home. Her troponin fell from 0.05 at admission to 0.01 at discharge in the setting of renal dysfunction, but there was not a clear rise and fall to suggest an acute infarction from plaque rupture and thrombosis. She was scheduled for an outpatient stress test to evaluate for evidence of ischemia from flow-limiting CAD. We decreased ASA to 81 mg from 325 mg daily to decrease the risk of bleeding. Her LDL was found to be 146. We wanted to change her from simvastatin to the more potent atorvastatin (and avoid issues with drug-drug interactions), but her insurance would not cover atorvastatin. She was therefore switched to pravastatin 80 mg at discharge. From a cardiac standpoint, we did not feel that Plavix was necessary for CAD, but her neurologist was contacted and wanted Plavix continued. We had to stop metoprolol due to HR in the ___ during admission even off metoprolol. # Pump: Last echo in ___ showed low normal LVEF. Her current presentation was consistent with CHF exacerbation with bilateral pleural effusions, dyspnea, and elevated NT-Pro-BNP. Her TTE showed mild-moderate mitral and moderate tricuspid regurgitation, LVEF 50-55%, and pulmonary hypertension. We changed her HCTZ to Lasix 40 mg PO at discharge. This medication can be uptitrated as needed. # Hypertension: The patient's nephrologist, Dr. ___, agreed with our proposed medication adjustments, but recommended staying away from clonidine. There has been a H/O medication non-adherence. Social work was involved in discharge planning, and ___ will be assisting the patient at home. We added lisinopril 20 mg daily, Lasix 40 mg daily and continued nifedipine 120 mg daily. Her atenolol was stopped due to her renal dysfunction, but her metoprolol had to be stopped due to bradycardia. She should continue on once a day medication dosing to help with compliance. # ? COPD: The patient may have a component of COPD as she was wheezing on admission and responded to albuterol. She was given a prescription for albuterol prn. Transitional Issues: - She will be scheduled for outpt stress stress test - She has follow-up appointments with Dr. ___ and Dr. ___ and both can work on uptitrating her BP meds as needed. - ___ will need to work with patient on medication compliance. ",2905,735
10000980-DS-21,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> dyspnea <MAJOR SURGICAL OR INVASIVE PROCEDURE> Cardiac catheterization ___ <HISTORY OF PRESENT ILLNESS> This is a ___ M with history of diabetes, diastolic CHF, hypertension, ?CAD, peripheral vascular disease, CKD presenting with ___ days of increasing dyspnea and non-productive cough. She denies fevers, chills, chest pain, nausea, vomiting. Did report feeling somewhat wheezy. Denies leg swelling, has possibly had a 2 lb weight gain. Denies missed medication doses. Does report 2 pillow orthopnea last night. Her husband has also been sick with a cough for the past day or so. She is a non-smoker. She lives at home and has had no recent hospitalizations or courses of antibiotics. In the ED, initial vitals: 97.8 80 132/83 25 97% ra. CXR showed probable RUL PNA. Normal WBC and lactate, Cr at baseline. Troponin 0.09 with normal CK-MB. BNP 2826. She was started on bipap due to tachypnea and increased work of breathing. She was given 40mg IV lasix and started on vancomycin, cefepime and levofloxacin. On transfer, vitals were: 69 141/82 28 100% bipap On arrival to the MICU, patient reports improved breathing on bipap. Review of systems: (+) Per HPI <PAST MEDICAL HISTORY> - hypertension - diabetes - hx CVA (cerebellar-medullary stroke in ___ - CAD (has never been cathed, hx of MI in ___ - peripheral arterial disease- claudication, followed by vascular, managed conservatively - stage IV CKD (baseline 2.5-2.8) - GERD/esophageal rings <SOCIAL HISTORY> ___ <FAMILY HISTORY> Niece had some sort of cancer. Otherwise, no family history of cancer or early heart disease. <PHYSICAL EXAM> ADMISSION EXAM: General- appears comfortable on BiPap HEENT- PERRL, EOMI Neck- difficult to assess JVP due to habitus and presence of BiPap strap CV- RRR, no gallops Lungs- good air entry. diffuse crackles R>L, rhonchi in RUL. scattered inspiratory wheezing Abdomen- soft, NTND Ext- trace edema, faint peripheral pulses Neuro- A and O x 3, moving all 4 extremities. mildly decreased strength in LLL DISCHARGE EXAM: VS: T98.9 BP144/83 P66 RR18 99RA 76.1kg GENERAL: Laying in bed, sleeping. No acute distress. HEENT: Moist mucous membranes. NECK: Supple, unable to visualize JVP. CARDIAC: Regular rate and rhythm. Normal S1, S2. No S3, S4. ___ systolic murmur. LUNGS: Clear to auscultation bilaterally. No crackles, wheezes, rhonchi. ABDOMEN: +BS, soft, nondistended, nontender to palpation. EXTREMITIES: Warm and well perfused. Pulses 2+. Trace peripheral edema. <PERTINENT RESULTS> ON ADMISSION: ___ 06: 48AM BLOOD WBC-5.3 RBC-2.94* Hgb-9.5* Hct-27.3* MCV-93 MCH-32.4* MCHC-34.9 RDW-13.5 Plt ___ ___ 06: 48AM BLOOD Neuts-65.6 ___ Monos-5.2 Eos-2.7 Baso-0.4 ___ 08: 03PM BLOOD ___ PTT-69.6* ___ ___ 06: 48AM BLOOD Glucose-89 UreaN-37* Creat-2.3* Na-144 K-3.9 Cl-109* HCO3-21* AnGap-18 ___ 06: 48AM BLOOD CK-MB-6 proBNP-2826* ___ 06: 48AM BLOOD cTropnT-0.09* ___ 12: 58PM BLOOD CK-MB-9 cTropnT-0.11* ___ 07: 52AM BLOOD Lactate-1.7 ___ 07: 40AM URINE Color-Straw Appear-Clear Sp ___ ___ 07: 40AM URINE Blood-NEG Nitrite-NEG Protein-NEG Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.0 Leuks-NEG ON DISCHARGE: ___ 09: 00AM BLOOD WBC-4.8 RBC-2.53* Hgb-8.0* Hct-23.6* MCV-94 MCH-31.5 MCHC-33.7 RDW-12.9 Plt ___ ___ 09: 26AM BLOOD Glucose-121* UreaN-52* Creat-2.2* Na-142 K-4.5 Cl-108 HCO3-24 AnGap-15 ___ 09: 26AM BLOOD Calcium-9.9 Phos-4.8* Mg-2.5 CXR: ___ Right upper lobe pneumonia or mass. However, given right hilar fullness, a mass resulting in post-obstructive pneumonia is within the differential. Recommend chest CT with intravenous contrast for further assessment. TTE: ___ The left atrium is elongated. There is mild symmetric left ventricular hypertrophy with normal cavity size. There is mild to moderate regional left ventricular systolic dysfunction with near-akinesis of the inferior, inferolateral and basal lateral segments. The remaining segments contract normally (LVEF = 35-40%). Right ventricular chamber size and free wall motion are normal. The aortic valve leaflets (3) are mildly thickened but aortic stenosis is not present. No aortic regurgitation is seen. The mitral valve leaflets are mildly thickened. An eccentric jet of moderate to severe (3+) mitral regurgitation is seen. There is moderate pulmonary artery systolic hypertension. There is no pericardial effusion. IMPRESSION: Mild to moderate regional left ventricular systolic dysfunction, c/w CAD. Moderate to severe mitral regurgitation. Moderate pulmonary hypertension. Compared with the prior study (images reviewed) of ___, regional LV wall motion abnormalities are new. Severity of mitral regurgitation has increased. CARDIAC CATH: ___ 1. Selective coronary angiography of this right dominant system revealed three vessel coronary artery disease. The LMCA had no obstructive disease. The LAD had a moderate disease in the mid artery and a diagonal branch had an 80% proximal lesion. The Lcx had a 70% proximal lesion. The RCA was totally occluded mid-vessel. FINAL DIAGNOSIS: 1. Three vessel coronary artery disease. 2. Recommend CABG evaluation CT CHEST: ___ 1. Diffuse confluent ground-glass opacities predominantly in the right upper lobe and right lower lobe most likely represent residual pulmonary edema, localized to the right lung because of direction of jet in mitral regurgitation. 2. Possible pulmonary hypertension. 3. Moderate coronary artery disease. CAROTID US: ___ No evidence of hemodynamically significant internal carotid stenosis on either side. ECHO ___- PCI) There is mild symmetric left ventricular hypertrophy with normal cavity size. There is mild regional left ventricular systolic dysfunction with inferior and infero-lateral hypokinesis. No masses or thrombi are seen in the left ventricle. There is no ventricular septal defect. Right ventricular chamber size and free wall motion are normal. The mitral valve leaflets are mildly thickened. An eccentric jet of mild (1+) mitral regurgitation is seen. There is no pericardial effusion. Compared with the prior study (images reviewed) of ___, the LVEF has increased. The degree of MR seen has decreased. <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Lisinopril 30 mg PO DAILY 2. NIFEdipine CR 60 mg PO DAILY 3. Ranitidine 300 mg PO DAILY 4. Pravastatin 80 mg PO DAILY 5. HumuLIN 70/30 (insulin NPH and regular human) 30 units subcutaneous daily 6. Ferrous Sulfate 325 mg PO BID 7. Furosemide 40 mg PO DAILY 8. Multivitamins 1 TAB PO DAILY 9. Nitroglycerin SL 0.3 mg SL PRN chest pain 10. DiphenhydrAMINE 25 mg PO HS: PRN insomnia 11. sevelamer CARBONATE 800 mg PO TID W/MEALS 12. Clopidogrel 75 mg PO DAILY (was not taking regularly) 13. Aspirin 81 mg PO DAILY 14. Vitamin D ___ UNIT PO DAILY <DISCHARGE MEDICATIONS> 1. Aspirin 81 mg PO DAILY 2. Clopidogrel 75 mg PO DAILY 3. Furosemide 40 mg PO DAILY 4. Lisinopril 30 mg PO DAILY 5. Multivitamins 1 TAB PO DAILY 6. Ranitidine 300 mg PO DAILY 7. sevelamer CARBONATE 800 mg PO TID W/MEALS 8. Atorvastatin 80 mg PO DAILY RX *atorvastatin 80 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills: *0 9. Metoprolol Succinate XL 25 mg PO DAILY RX *metoprolol succinate 25 mg 1 tablet extended release 24 hr(s) by mouth daily Disp #*30 Tablet Refills: *0 10. DiphenhydrAMINE 25 mg PO HS: PRN insomnia 11. HumuLIN 70/30 (insulin NPH and regular human) 30 units subcutaneous daily 12. Nitroglycerin SL 0.3 mg SL PRN chest pain 13. Vitamin D ___ UNIT PO DAILY 14. NIFEdipine CR 60 mg PO DAILY <DISCHARGE DISPOSITION> Home With Service Facility: ___ <DISCHARGE DIAGNOSIS> PRIMARY DIAGNOSIS: Severe mitral regurgitation Coronary artery disease SECONDARY DIAGNOSIS: Hypertension Diabetes <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Ms. ___, It was a pleasure caring for you at ___ ___. As you recall, you were admitted for shortness of breath. This was because one of your heart valves was weak, which caused fluid to build up in your lungs. Your heart valve was weak because there was a blockage in one of your heart arteries. You underwent a procedure, called cardiac catheterization, which opened up the blocked arteries. Your valve and heart are pumping much more efficiently now. We are glad you are feeling better. Please weigh yourself every morning, and call your MD if your weight goes up more than 3 lbs over 24 hours. ","___ female with ___, HTN, diabetes, CKD presented with increased dyspnea and non-productive cough without fevers or elevated white count, initially admitted to ___ with concern for pneumonia. However, was found to have ST-changes, enzyme leak, new wall motion abnormality consistent with a recent cardiac event and had no evidence of pneumonia (no fevers, wbc, lactate, normal vitals, CXR with likely one sided pulmonary edema from mitral regurgitation). She was seen by cardiology who transferred the patient to cardiology floor. # Acute systolic CHF exacerbation/mitral regurgitation: Likely secondary to ischemic valvular disease resulting in worsening mitral regurgitation. ECHO also with akinetic inferior wall segments, which also supports an ischemic event. Cardiac cath revealed 3 vessel disease. Patient was managed medically with lasix, lisinopril, and metoprolol. Cardiac surgery was consulted for possible CABG and mitral valve repair/replacement. However, given her multiple comorbidities, she is extremely high risk and surgery was deferred. Therefore, the decision was made to revascularize the patient with PCI to see if the patient would regain function of her mitral valve. Patient received a bare metal stent in the LCx and plain old balloon angioplasty in the diagonal artery. Repeat echo showed improvement of her mitral regurgitation. # NSTEMI/CAD: As evidenced by EKG changes and troponin leak. Patient was briefly started on a heparin drip prior to her first cardiac catheterization. As above, cardiac catheterization revealed 3-vessel disease. Patient was initially medically managed with aspirin, plavix, metoprolol, lisinopril, and atorvastatin. As the patient would be too high risk for CABG, patient returned to the cath lab and had a bare metal stent and POBA. She will require plavix for at least 1 month. # Hypertension: Patient remained normotensive. Continued nifedipine at half of her home dose. Continued on lisinopril. She was also started on metoprolol as above for CHF. # Diabetes: Continued home insulin regime. # CKD stage IV: Baseline Cr 2.5-2.8 per renal notes. Currently at baseline. # History of CVA: Continued home aspirin and clopidogrel. # GERD: Continued home ranitidine. TRANSITIONAL ISSUES: * Will need follow up with a cardiologist. Patient will be scheduled to follow up with the first available CMED cardiologist. * Will need plavix for at least one month (day of bare metal stent placement = ___. * Atorvastatin dose increased to 80mg (per pharmacy, her insurance will cover. Her co-pay will be $10/month). * Consider titrating nifedipine dose back to 120mg if still hypertensive. * Please recheck Chem7 at next appointment to evaluate for ___ secondary to dye received during cardiac catheterization. ",2558,651
10000980-DS-22,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> Dyspnea and chest tightness <MAJOR SURGICAL OR INVASIVE PROCEDURE> ___ Pharmacologic nuclear stress test <HISTORY OF PRESENT ILLNESS> ___ year old female with history of HTN, HLD, hx of CVA, CAD s/p BMS to circumflex and POBA (___), on Aspirin and Plavix, CHF (EF 45% in ___, diabetes, presenting with acute onset shortness of breath and substernal chest tightness since ___ evening. Patient notes that ___ evening had a large seafood dinner which is not usual for her, and then later around 10pm had acute onset of SOB feeling like she could not take deep breaths with chest tightness (patient notes this is her ""angina""). Denies pleuritic component to CP, described as central and across lower rib cage, persistent since onset, no radiation to the shoulders/jaw/back, no diaphoreses. Worsens with activity, improves somewhat with rest. Patient does not it feels like other episodes when she then required her stent placement. Took a SLNx1, which improved her symptoms though these persisted, but almost immediately led to abdominal discomfort with vomiting x1, nonbloody with dinner pieces. ___, 1 day prior to admission, decided to see if her pain improved on its own, then when it persisted on ___, husband arranged for UC appt at ___ ___. At PCP, ___, SBP up to 200s, EKG with ST depressions in the precordial leads, specifically V3, V4 and V5, given full dose ASA and SLNx1, and sent to the ED given concern for ACS versus HTN emergency. Patient reporting baseline sleeps with 2 pillows, unchanged recently, no cough, PND, orthopnea with 2 pillows. Worsening DOE since onset of symptoms, now unable to complete a block where she used to be able to walk a few blocks at a time without stopping ___ SOB/CP. Denies new ___ edema (baseline says L leg > R). Also had emesis last night x 1; no diaphoresis, no chest pain, no radiation of symptoms anywhere. No diarrhea or constipation, no dysuria, no focal weakness/numbness. On ROS, also with some L leg tingling intermittently, stable and chronic. Had diarrhea x1 on ___ following ___ seafood dinner, normal BMs since then. In the ED initial vital signs; T 98 P 88 BP 190/120 R 18 O2 Sat 98% 3L nasal cannula. Labs notable for Cr 2.1 (baseline 2.1-2.7), BUN 29. wbc 4.3, H/H 8.6/26.0, Plt 147. Initial and rpt Tn <0.01. BNP 4279. CXR showed no pulmonary edema, pleural effusions, or consolidation, borderline cardiomegaly. The patient received carvedilol, nebulizers, and IV lasix. It is unclear how much UOP the patient has as it was not documented in the ED. The patient was seen by cardiology in the ED who felt that in the setting of systolic heart failure, her dyspnea was likely due to a CHF exacerbation in the setting of dietary indiscretion. Diuresis was recommended in addition to increasing carvedilol to 12.5mg BID, as well as a nuclear stress test this morning. On the floor, the patient c/o of some improved dyspnea/chest tightness as well as wheezing (no COPD/asthma history, no significant smoking history), but otherwise has no acute complaints. Given her continued SOB and wheezing, she was written for nebulizers and steroids for reactive airway disease overnight. <PAST MEDICAL HISTORY> - hypertension - diabetes - hx CVA (cerebellar-medullary stroke in ___ - CAD (hx of MI in ___ BMS to circumflex and POBA ___ - peripheral arterial disease- claudication, followed by vascular, managed conservatively - stage IV CKD (baseline 2.1-2.6) - GERD/esophageal rings <SOCIAL HISTORY> ___ <FAMILY HISTORY> Niece had some sort of cancer. Father died in his ___ due to lung disease. Mother died in her ___ due to an unknown cause. No early CAD or sudden cardiac death. No other known history of cancer. <PHYSICAL EXAM> ADMISSION PHYSICAL EXAM: -========== Vitals: Tm 98, Tc 98, HR 68 (68-78), BP 191/103 (163-191/86-103), RR 18 (24 on my check), O2 Sat 94-100%RA FSBS 250s General: Obese woman lying in bed in NAD, audible wheezing with some tachypnea. Speaking in ___ word sentences with slow speech. HEENT: PERRL, EOMI with ___ beats of nystagmus on rightward gaze in both eyes, no other nystagmus, sclera anicteris, some conjunctibal pallor, MMM, clear posterior OP, no lesions, symmetric palate elevation, tongue midline. Neck: No cervical/supraclavicular LAD, no notable JVD (difficult to assess ___ body habitus) CV: RRR, soft S1, normal S2, no murmurs noted. Lungs: Diffuse expiratory rhonchi this morning, no wheezing on lung exam, with crackles in bilateral bases up ___ of back. Poor air movement overall. Abdomen: soft, obese, nontender, nondistended, +BS. Unable to adequately assess organomegaly. GU: No foley Ext: wwp, 2+ peripheral pulses, 3+ pitting edema to knee on L, 2+ pitting edema in R leg. Neuro: CN2-12 notable for rightward gaze nystagmus ___ beats), otheriwse intact. A+O to person, hospital, month, year (date was wrong on calendar so did not know date). No pronator drift, some positional tremor in bilateral hands. FNF with hesitancy at end-action. No asterixis. Sensation to light touch grossly intact in all extremities. No truncal ataxia sitting upright in bed during exam. Gait testing deferred. Noted to have repetitive movements at rest with L hand (wringing sheets, tapping, etc. seemingly patient unaware). Skin: No obvious rashes/excoriations on extremities and abdomen/back. DISCHARGE PHYSICAL EXAM: -========== Vitals: Tm 98.1, 146/64 (SBP 110-146), 70-76, 18, 98%RA Weight: 75.9 kg General: Obese woman in NAD. HEENT: PERRL, EOMI with ___ beats of nystagmus on rightward gaze in both eyes, no other nystagmus, sclera anicteris, some conjunctibal pallor, MMM, clear posterior OP, no lesions, symmetric palate elevation, tongue midline. Neck: No notable JVD (difficult to assess ___ body habitus) CV: RRR, soft S1, normal S2, no murmurs noted. Lungs: CTAB Abdomen: soft, obese, nontender, nondistended, +BS. Unable to adequately assess organomegaly. Ext: wwp, 2+ peripheral pulses, no pitting edema <PERTINENT RESULTS> ==== ADMISSION LABS ==== ___ 04: 00PM BLOOD WBC-4.3 RBC-2.84* Hgb-8.6* Hct-26.0* MCV-92 MCH-30.4 MCHC-33.2 RDW-14.2 Plt ___ ___ 04: 00PM BLOOD Neuts-71.5* ___ Monos-4.5 Eos-2.6 Baso-0.1 ___ 04: 00PM BLOOD ___ PTT-24.5* ___ ___ 04: 00PM BLOOD Glucose-325* UreaN-29* Creat-2.1* Na-141 K-4.0 Cl-106 HCO3-24 AnGap-15 ___ 07: 55AM BLOOD Calcium-9.5 Phos-3.5# Mg-1.5* ___ 07: 00PM URINE Color-Yellow Appear-Clear Sp ___ ___ 07: 00PM URINE Blood-NEG Nitrite-NEG Protein-100 Glucose-300 Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.0 Leuks-SM ___ 07: 00PM URINE RBC-2 WBC-4 Bacteri-FEW Yeast-NONE Epi-1 ___ 07: 00PM URINE CastHy-6* ___ 04: 00PM BLOOD cTropnT-<0.01 proBNP-4279* ___ 09: 30PM BLOOD cTropnT-<0.01 ==== IMAGING ==== ___ CHEST (PA AND LAT): The lungs are clear of consolidation, effusion, or edema. Cardiac silhouette is top normal. Descending thoracic aorta is tortuous with atherosclerotic calcification seen at the arch. No acute osseous abnormalities identified. IMPRESSION: No acute cardiopulmonary process. ___ P-MIBI: Clinical Indication: SS CHEST TIGHTNESS ASSESS FOR EVIDENCE OF ISCHEMIA HISTORY: ___ yo woman with a history of CAD and CHF referred for evaluation of chest pain and dyspnea. SUMMARY FROM THE EXERCISE LAB: For pharmacologic coronary vasodilatation dipyridamole was infused intravenously for 4 minutes at a dose of 0.142 milligram/kilogram/min. She had no anginal symptoms or ischemic ECG changes. TECHNIQUE: ISOTOPE DATA: (___) 11.0 mCi Tc-99m Sestamibi Rest; (___) 29.6 mCi Tc-99m Sestamibi Stress; DRUG DATA: (Non-NM admin) Dipyridamole; IMAGING METHOD: Resting perfusion images were obtained with Tc-99m sestamibi. Tracer was injected approximately 45 minutes prior to obtaining the resting images. Following resting images and following intravenous infusion, approximately three times the resting dose of Tc-99m sestamibi was administered intravenously. Stress images were obtained approximately 30 minutes following tracer injection. Imaging protocol: Gated SPECT. This study was interpreted using the 17-segment myocardial perfusion model. FINDINGS: The image quality is adequate but limited due to soft tissue and breast attenuation. Left ventricular cavity size is increased. Rest and stress perfusion images reveal uniform tracer uptake throughout the left ventricular myocardium. Gated images reveal normal wall motion. The calculated left ventricular ejection fraction is 59% with an EDV of 117 ml. IMPRESSION: 1. Normal myocardial perfusion. 2. Increased left ventricular cavity size with normal systolic function. Compared with prior study of ___, the cavity size is larger. <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Aspirin 81 mg PO DAILY 2. Clopidogrel 75 mg PO DAILY 3. Furosemide 40 mg PO DAILY 4. Multivitamins 1 TAB PO DAILY 5. Ranitidine 300 mg PO DAILY 6. Atorvastatin 80 mg PO DAILY 7. HumuLIN 70/30 (insulin NPH and regular human) 30 units subcutaneous daily 8. Nitroglycerin SL 0.3 mg SL PRN chest pain 9. Vitamin D ___ UNIT PO DAILY 10. NIFEdipine CR 60 mg PO BID 11. Lisinopril 40 mg PO DAILY 12. Allopurinol ___ mg PO DAILY 13. Ferrous Sulfate 325 mg PO DAILY 14. Carvedilol 6.25 mg PO BID <DISCHARGE MEDICATIONS> 1. Outpatient Lab Work Please draw Chem-10 and CBC on ___. Indication: 428.0 (CHF) and anemia (280.1) Send results to Dr. ___ (fax: ___ 2. Nitroglycerin SL 0.3 mg SL PRN chest pain 3. Vitamin D ___ UNIT PO DAILY 4. Ranitidine 300 mg PO DAILY 5. NIFEdipine CR 60 mg PO DAILY 6. Multivitamins 1 TAB PO DAILY 7. Allopurinol ___ mg PO DAILY 8. Aspirin 81 mg PO DAILY 9. Atorvastatin 80 mg PO DAILY 10. Clopidogrel 75 mg PO DAILY 11. Ferrous Sulfate 325 mg PO DAILY 12. Furosemide 40 mg PO DAILY RX *furosemide 40 mg 1 tablet(s) by mouth qday Disp #*30 Tablet Refills: *0 13. HumuLIN 70/30 (insulin NPH and regular human) 30 units subcutaneous daily 14. Lisinopril 40 mg PO DAILY 15. Carvedilol 12.5 mg PO BID RX *carvedilol 12.5 mg 1 tablet(s) by mouth twice a day Disp #*60 Tablet Refills: *0 <DISCHARGE DISPOSITION> Home With Service Facility: ___ <DISCHARGE DIAGNOSIS> Primary Diagnosis: - Acute on chronic decompensated systolic heart failure <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear ___, ___ were admitted to ___ on ___ with shortness of breath. ___ were diagnosed with an exacerbation of your heart failure, a result of retaining too much fluid. ___ were treated with diuretics and removal of this fluid with subsequent improvement in your symptoms. We also increased your carvedilol dose for better blood pressure control. It is very important that ___ weigh yourself every morning, call MD if weight goes up more than 3 lbs. Taking your furosemide will keep ___ from retaining fluid. Sincerely, Your ___ Team ","___ year old female with history of HTN, CVA, CAD (s/p BMS to circumflex in ___, CHF (EF 45% in ___ who presented with acute onset shortness of breath and substernal chest tightness. # Shortness of breath: Patient with acute onset SOB following seafood meal with associated chest tightness (see below). Patient with crackles and expiratory rhonchi on lung exam. CXR did not show significant pulmonary edema, pleural effusions, or consolidation although her BNP was elevated. Per pharmacy records, patient had not refilled lasix prescription since ___. Overall, presentation was most consistent with a mild CHF exacerbation. She received treatment with IV lasix and her shortness of breath subsequently improved quickly. She was able to be transitioned to a PO regimen of lasix 40mg qday on ___ (day of discharge). Dry weight on day of discharge was 75.9kg. # Chest Tightness: Patient reported chest tightness associated with her shortness of breath. Was given aspirin and SL nitroglycerin in her PCP's office prior to being directed to the ED. Troponin was negative x2. EKG without evidence of acute ischemia. Due to her significant CAD history, she underwent a P-MIBI on ___ which was unremarkable. Her chest tightness was thought to be of non-cardiac etiology. # HTN: Patient presented with SBP of 190-200. Cardiology was consulted and recommended increasing her carvedilol from 6.25mg BID to 12.5mg BID. With this change, and continuation of her other home medications, her blood pressure decreased to systolics in range of 110-146 on day of discharge. It is unclear whether her very elevated BP on admission was occurring in the setting of medication non-compliance. Nifedipine was decreased from BID to daily given increased carvedilol and addition of Lasix (which patient was believed to have been non-compliant with prior to this admission). ==== TRANSITIONAL ISSUES ==== # CHF: - ___ services for medication teaching and pill-box, as well as weights - Follow up with her cardiologist Dr. ___ on ___ - Please check repeat Chem-10 and CBC on ___ - Continue furosemide 40mg qday # Hct Drop: Patient with chronic anemia and Hgb drop on day of discharge from 9.3 to 8.5. - Repeat CBC check on ___ # HTN: - Increased carvedilol to 12.5mg BID - Nifedipine was decreased from BID to daily given increased carvedilol and addition of lasix (with which patient was likely non-compliant prior to this admission). # Health Screening - Patient is due for colonoscopy this year. - PCP follow up with Dr. ___ on ___ # Weight at discharge: 75.9 kg # Code: Full (confirmed with patient) # Emergency Contacts: - ___, ___ (___) - Alternate HCP ______) ",3212,637
10000980-DS-23,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> DVT <MAJOR SURGICAL OR INVASIVE PROCEDURE> EGD <HISTORY OF PRESENT ILLNESS> This is a ___ y/o female with PMHx significant for CAD, HTN, HLD, T2DM, CKD stage IV, PVD (s/p in ___, left superficial femoral artery), presents with lower Left leg numbness and pain since yesterday evening. The numbness started last night in bed. The onset was gradual, and it was associated with pain/cramping over her lateral calf, radiating down into her foot. She has had sx like this before, usually when resting or lying in bed, not with exertion. She denies leg weakness at this time, and is able to walk without assistance. Today the pain and numbness is improved; residual numbness in her lateral calf. Denies hx DVT. Denies spine sx: no trauma, no back pain, no incontinence, no fevers/chills. No numbness elsewhere. Additionally, she denies headache, visual changes, chest pain, chest pressure, chest palpitations, shortness of breath abdominal pain, dysuria, or diarrhea. <PAST MEDICAL HISTORY> - hypertension - diabetes - hx CVA (cerebellar-medullary stroke in ___ - CAD (hx of MI in ___ BMS to circumflex and POBA ___ - peripheral arterial disease- claudication, followed by vascular, managed conservatively - stage IV CKD (baseline 2.1-2.6) - GERD/esophageal rings <SOCIAL HISTORY> ___ <FAMILY HISTORY> Niece had some sort of cancer. Father died in his ___ due to lung disease. Mother died in her ___ due to an unknown cause. No early CAD or sudden cardiac death. No other known history of cancer. <PHYSICAL EXAM> ADMISSION PHYSICAL EXAM: Vitals: 97.7, 166/85, 59, 16, 100% on RA. General: Pleasant affect, laying in bed, resting comfortably in NAD. HEENT: Sclera anicteric, MMM, oropharynx clear, EOMI, PERRL Neck: Supple, JVP not elevated. CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Lungs: Minimal bibasilar crackles improved with cough. Abdomen: obese abdomen, soft, non-tender, non-distended, no rebound or guarding. Ext: Warm, well perfused, 1+ pulses, right calf swelling greater than left calf swelling. No calf tenderness to palpation. Thick toenails, dry skin along toes. Hallux valgus. Neuro: CNII-XII intact, ___ strength upper/lower extremities, grossly normal sensation. DISCHARGE PHYSICAL EXAM Vitals: Tmax 99.1 HR ___ BP 97-168/50s-70s RR 18 SpO2 97-100%RA FSG 90-307 General: Pleasant affect, laying in bed, resting comfortably in NAD. HEENT: Sclera anicteric, MMM, oropharynx clear, EOMI, PERRL Neck: Supple, JVP not elevated. CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Lungs: clear to auscultation in all fields without wheezes or ronchi Abdomen: obese abdomen, soft, non-tender, non-distended, no rebound or guarding. Ext: Warm, well perfused, dopplerable pulses ___ on RLE, dopplerable ___ pulse on LLE, dopplerable DP pulse on LLE, R radial pulse 2+, L radial pulse 1+, mild right calf swelling greater than left calf swelling. No calf tenderness to palpation. No pain to palpation on left dorsal and lateral foot - callous present on left lateral foot. Thick toenails, dry skin along toes. Non-tender indurated cord in left antecubital fossa. Neuro: alert and oriented x 3, CNII-XII intact, ___ RUE, ___ strength LUE, ___ hip flexor strength, ___ dorsi and plantar flexion of bilateral lower extremities (4+/5 on right lower extremity, 4- on LLE), fine touch sensation on extremities bilaterally <PERTINENT RESULTS> ADMISSION LABS: ___ 02: 45PM BLOOD WBC-5.1 RBC-2.50* Hgb-7.7* Hct-23.4* MCV-94 MCH-30.8 MCHC-32.9 RDW-14.7 RDWSD-50.0* Plt ___ ___ 02: 45PM BLOOD Neuts-74.4* Lymphs-15.1* Monos-7.7 Eos-2.4 Baso-0.2 Im ___ AbsNeut-3.79 AbsLymp-0.77* AbsMono-0.39 AbsEos-0.12 AbsBaso-0.01 ___ 02: 45PM BLOOD ___ PTT-26.1 ___ ___ 02: 45PM BLOOD Glucose-107* UreaN-72* Creat-2.9* Na-141 K-4.3 Cl-108 HCO3-21* AnGap-16 ___ 02: 45PM BLOOD calTIBC-303 Ferritn-153* TRF-233 PERTINENT LABS/IMAGING: -She received 1U pRBCs on admission on ___ 07: 00AM BLOOD WBC-6.0 RBC-2.83* Hgb-8.7* Hct-26.3* MCV-93 MCH-30.7 MCHC-33.1 RDW-14.7 RDWSD-50.2* Plt ___ -She had one large episode of coffee ground emesis- ___ 05: 10PM BLOOD WBC-5.6 RBC-2.44* Hgb-7.4* Hct-22.7* MCV-93 MCH-30.3 MCHC-32.6 RDW-14.7 RDWSD-49.8* Plt ___ -She received 500cc NS and 2UpRBCs- ___ 07: 45AM BLOOD WBC-5.7 RBC-3.49*# Hgb-10.7*# Hct-32.3* MCV-93 MCH-30.7 MCHC-33.1 RDW-14.9 RDWSD-49.1* Plt ___ ___ bilateral lower extremity doppler U/S IMPRESSION: 1. Deep venous thrombosis in the bilateral posterior tibial veins. 2. 2.0 x 1.3 x 1.8 cm right-sided ___ cyst. EGD ___ Small amount of hematin without evidence of ulceration or active bleeding seen at the GE junction. The stomach is significantly deformed. Diffuse erythema and superficial ulcerations in the stomach consistent with severe gastritis. No active bleeding identified. Medium hiatal hernia Erythema and superficial ulcerations in the duodenal bulb consistent with duodenitis. Otherwise normal EGD to third part of the duodenum ___ Left upper extremity ultrasound IMPRESSION: 1. No evidence of deep vein thrombosis in the left upper extremity. 2. Likely evolving hematoma in the left antecubital fossa. ___ CT head non contrast IMPRESSION: 1. No evidence of acute infarction, hemorrhage, fractures. DISCHARGE LABS: ___ 07: 30AM BLOOD WBC-5.8 RBC-2.44* Hgb-7.4* Hct-22.9* MCV-94 MCH-30.3 MCHC-32.3 RDW-14.6 RDWSD-50.2* Plt ___ ___ 07: 30AM BLOOD Plt ___ ___ 07: 30AM BLOOD Glucose-78 UreaN-45* Creat-1.7* Na-142 K-4.7 Cl-109* HCO3-20* AnGap-18 ___: 30AM BLOOD Calcium-9.4 Phos-4.5 Mg-2.0 ___ 07: 30AM BLOOD EDTA ___ <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Lisinopril 40 mg PO DAILY 2. Allopurinol ___ mg PO DAILY 3. Atorvastatin 80 mg PO QPM 4. Carvedilol 12.5 mg PO BID 5. Clopidogrel 75 mg PO DAILY 6. Furosemide 40 mg PO DAILY 7. Ranitidine 150 mg PO DAILY: PRN reflux 8. Aspirin 81 mg PO DAILY 9. Multivitamins 1 TAB PO DAILY 10. Vitamin D ___ UNIT PO DAILY 11. NIFEdipine CR 60 mg PO BID 12. Nitroglycerin SL 0.3 mg SL Q5MIN: PRN chest pain 13. 70/30 30 Units Dinner <DISCHARGE MEDICATIONS> 1. Allopurinol ___ mg PO EVERY OTHER DAY 2. Aspirin 81 mg PO DAILY 3. Atorvastatin 80 mg PO QPM 4. Carvedilol 12.5 mg PO BID 5. 70/30 30 Units Dinner 6. Lisinopril 40 mg PO DAILY 7. Multivitamins 1 TAB PO DAILY 8. NIFEdipine CR 30 mg PO BID 9. Vitamin D ___ UNIT PO DAILY 10. Docusate Sodium 100 mg PO BID 11. Gabapentin 100 mg PO QHS neuropathic pain 12. Pantoprazole 40 mg PO Q12H 13. Senna 8.6 mg PO BID constipation 14. Warfarin 5 mg PO DAILY16 please dose and adjust for INR 15. Nitroglycerin SL 0.3 mg SL Q5MIN: PRN chest pain 16. Furosemide 20 mg PO DAILY 17. Polyethylene Glycol 17 g PO DAILY 18. Acetaminophen 325-650 mg PO Q6H: PRN pain or fever <DISCHARGE DISPOSITION> Extended Care Facility: ___ <DISCHARGE DIAGNOSIS> Primary: Deep vein thrombosis (DVT) Secondary: Upper GI bleed L arm hematoma Superficial thrombophlebitis, L antecubital fossa Chronic kidney disease (Stage IV) Peripheral vascular disease Diabetes mellitus type II Coronary artery disease <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear ___, It was a pleasure caring for you at ___. You were admitted for leg swelling and pain. Diagnostic tests were performed and you were diagnosed with deep vein thrombosis, blood clots in your legs. You were treated with blood thinning medications that you will continue at home. You had an episode of upper GI bleeding during your stay for which you are being treated with medication and you underwent an EGD. You developed a left arm hematoma as well during your stay which will resolve on its own over time. For your blood clots, you were started on a new drug called warfarin. You will need to have your blood checked to adjust the dosing. For your upper GI bleed, you were started on Pantoprazole 40mg twice daily. You will continue this drug as an outpatient for at least 8 weeks. Additionally, you will no longer be taking Clopidogrel (Plavix), until you speak with your cardiologist. It was a pleasure taking care you during your hospital stay. Best wishes, Your ___ Care Team ","Outpatient Providers: ___ with PMHx significant for CAD, HTN, HLD, T2DM, CKD stage IV, PVD (s/p in ___, left superficial femoral artery), presents with lower left leg numbness and pain, found to have bilateral unprovoked DVT. She was treated with a heparin drip and had many bleeding events during her stay: she developed an upper GIB, had an EGD, and was followed by GI during her admission. The heparin drip was stopped and then re-started once her coffee-ground emesis resolved. Her stools were guiac positive, however no active blood was found on rectal exam. GI felt that colonoscopy could be deferred to out patient. Additionally she developed a left arm hematoma. The heparin drip was stopped and then re-started once her hematoma was felt to be stable. She had left radial as well as bilateral lower extremity ___ dopplerable pulses throughout admission. Hematology was consulted after the patient developed a left arm hematoma and the drip was slowly uptitrated as per their recommendations. She was successfully bridged to coumadin with an INR on discharge of 2.0. She was discharged to rehab as per ___ recs. Please see below for a more problem based/detailed summary and transitional issues. = = = = = = = = = = = = = = = = = = ================================================================ ___ y/o female with PMHx significant for CAD, HTN, HLD, T2DM, CKD stage IV, PVD (s/p in ___, left superficial femoral artery), presented with lower Left leg numbness and pain since yesterday evening, with ultrasound bilateral lower extremities showing bilateral posterior tibial veins DVT's. # Unprovoked Bilateral DVTs: No clinical signs of PE on admission or during stay, positive bilateral DVTs on LENIs. Pain and swelling improved on anticoagulation. Patient was bridged with heparin drip to therapeutic warfarin with INR goal ___. Due to continually supratherapeutic PTT > 150 on heparin drip, hematology was consulted and no further workup was deemed necessary. Heparin drip was carefully uptitrated as needed. Clopidogrel was stopped per outpatient cardiologist. Patient will need age-appropriate cancer screening including colonoscopy and mammogram. Patient will follow-up in ___ clinic for anticoagulation management and should continue on warfarin for at least 3 months. # Upper GI bleed: Patient developed 1 episode large coffee ground emesis while on heparin drip with PTT > 150. Received 2U pRBCs. GI consulted and EGD showed gastritis and superficial erosions but no active bleeding. Incidental finding of medium sized hiatal hernia. Stool h. pylori antigen was negative. GI recommended 8 weeks of high dose PPI. # Left antecubital hematoma: Patient developed large left antecubital hematoma in setting of phlebotomy and PTT > 150 on heparin gtt. Heparin gtt held while hematoma improved. Repeat h/h were stable. # Acute on CKD Stage IV: Patient with creatinine of 2.9 on admission with baseline 2.0-2.5. Improved with hydration. Home lasix and lisinopril were initially held. Home lasix restarted on discharge at 20mg daily. # Normocytic Anemia: Patient has normocytic anemia. Rectal exam in ED was guaiac negative. In past treated with aransep as well as EPO. Etiology likely related to underlying CKD, however also must consider slow GI bleed (patient has gastritis/duodenitis on EGD but no evidence of active bleeding. Iron studies were normal. # HFpEF: Home furosemide and Lisinopril were held on admission for ___ followed by GI bleed. Carvedilol and nifedine were held in setting of GIB (see above). Nifedipine was restarted at 30mg bid and lasix was decreased from 40mg to 20mg daily. # CAD: hx of MI in ___ BMS to circumflex and POBA ___. Per discussions with Dr. ___, patient's cardiologist, clopidogrel was held given GI bleed and initiation of warfarin. Lasix initially held as above, but restarted on discharge at 20mg daily. Home ASA, statin, and carvedilol were continued. # HTN: Nifedipine was decreased to 30mg BID from 60mg BID given multiple bleeding episodes and normal blood pressures. Home carvedilol continued. Patient's nifedipine was decreased to 30mg daily given acute bleed and SBPs in the ___ Lasix was decreased from 40 daily to 20 daily. # Diabetes Mellitus: Stable on home 30 units 70/30 insulin at bedtime. TRANSITIONAL ISSUES: - Out patient hypercoaguability work up including screening colonoscopy (last in ___ and mammogram - Patient will need to complete an 8 week course of high dose PPI (started 40mg pantoprazole PO twice daily on ___ with projected end date ___ for upper GI bleed likely from gastritis. - Patient's hypertension medications (Lisinopril and nifedipine) were held due to upper GI bleed. - Patient's furosemide was decreased to 20mg daily - Patient's nifedipine was decreased to 30mg daily given acute bleed and SBPs in the ___ - Patient was started on Coumadin. Clopidogrel was stopped per cardiology. ASA 81mg was continued. - Please address patient's home environment for fall risk given recent ""trip"" at home and new anticoagulation. - please ensure patient has outpatient anticoagulation follow-up and management upon discharge from rehab ",2668,1247
10000980-DS-24,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> fatigue, anemia <MAJOR SURGICAL OR INVASIVE PROCEDURE> None <HISTORY OF PRESENT ILLNESS> Ms. ___ is a ___ year old woman with a past medical history of type-2 DM, hypertension, stage IV CKD, CAD s/p distant MI and bare metal stent, stroke, recent unprovoked DVTs on Coumadin, and recent upper GI bleeding, who was sent to ___ by her physician for anemia (Hgb 6.5). The patient was admitted to ___ in ___ with unprovoked bilateral lower extremity DVTs. She was started on heparin as an inpatient, but anticoagulation was complicated by severely elevated PTT (>150) and upper GI bleed. Endoscopy was notable for significant erythema, superficial ulceration, and gastritis without active bleeding. She was placed on BID PPI prophylaxis. She was eventually bridged to Coumadin for a planned 6 month course. Her INR is managed by her rehab facility, and she is followed by Dr. ___ in ___ clinic. For the last two weeks she has noted increasing fatigue along with shortness of breath, exertional sub-sternal chest pain relieved with rest, and symmetrical lower extremity swelling. During this period she reports that her appetite remained good, and he bowel function was normal. She denies bloody stools or dark stool. On ___ she presented to her PCP office from rehab reporting increasing shortness of breath and fatigue. She was found to have a Hgb of 6.5, with an unconcerning CXR. She was sent to the ___ ED. In the ED, her initial vitals were T: 97.5 P: 60 BP: 156/76 RR: 16 SPO2: 100% RA. Exam was notable for guiac negative stool. Imaging was notable for: ""1. Nonocclusive deep vein thrombosis of one of the paired posterior tibial veins bilaterally. The extent of thrombus bilaterally has decreased. No new deep venous thrombosis in either lower extremity. 2. Right complex ___ cyst."" The patient was transfused with 2 units of pRBCs, with appropriate increase in Hgb to 9.0. Following transfusion, a repeat CXR was notable for pulmonary edema with bilateral pleural effusions. She was given 20mg PO Lasix and 40mg IV Lasix in the ED. The decision was made to admit the patient for anemia and flash pulmonary edema. On the floor, vitals notable for T: 97.9 BP: 154/75 P: 65 R: 20 O2: 99RA FSBG: 76. She reports no acute complaints, and that her shortness of breath has resolved. She denies chest pain, dizziness, lightheadedness. <PAST MEDICAL HISTORY> - hypertension - diabetes - hx CVA (cerebellar-medullary stroke in ___ - CAD (hx of MI in ___ BMS to circumflex and POBA ___ - peripheral arterial disease- claudication, followed by vascular, managed conservatively - stage IV CKD (baseline 2.1-2.6) - GERD/esophageal rings <SOCIAL HISTORY> ___ <FAMILY HISTORY> Niece had some sort of cancer. Father died in his ___ due to lung disease. Mother died in her ___ due to an unknown cause. No early CAD or sudden cardiac death. No other known history of cancer. <PHYSICAL EXAM> ADMISSION PHYSICAL EXAM: Vitals: T: 97.9 BP: 154/75 P: 65 R: 20 O2: 99RA FSBG: ___ General: Overweight woman, alert, oriented, no acute distress HEENT: Sclera anicteric, MMM, oropharynx clear Neck: supple, JVP not elevated Lungs: Crackles to the mid-lungs bilaterally CV: Regular rate and rhythm, normal S1 + S2, no murmurs or gallops Abdomen: soft, non-tender, non-distended, bowel sounds present, no rebound tenderness or guarding, no organomegaly Ext: Warm, well perfused, 2+ pulses, no clubbing or cyanosis. 2+ pitting edema in dependent areas to the buttocks Skin: no rashes noted Neuro: ___ strength in deltoids, biceps, triceps, wrist extensors, finger extensors, hip flexors, hamstrings, quadriceps, gastrocs, tibialis anterior, bilaterally. Sensation intact bilaterally. PSYCH: Alert and fully oriented; normal mood and affect. sometimes slow to respond and responding with repetitive answers but otherwise appropriate DISCHARGE PHYSICAL EXAM: VS: T: 97.6 BP: 150s-160s/70s-80s P: 60s-70s RR: 18 SPO2: 100RA General: Overweight woman, alert, oriented, no acute distress HEENT: Sclera anicteric, MMM, oropharynx clear Neck: supple, JVP not elevated Lungs: Clear to auscultation bilaterally CV: Regular rate and rhythm, normal S1 + S2, no murmurs or gallops Abdomen: soft, non-tender, non-distended, bowel sounds present, no rebound tenderness or guarding, no organomegaly Ext: Warm, well perfused, 2+ pulses, no clubbing or cyanosis. 1+ pitting edema in shins bilaterally Skin: no rashes noted <PERTINENT RESULTS> LABORATORY STUDIES ON ADMISSION --=========== ___ 12: 30PM WBC-4.4 RBC-2.03* HGB-6.5* HCT-20.6* MCV-102*# MCH-32.0 MCHC-31.6* RDW-16.3* RDWSD-59.6* ___ 12: 30PM ___ ___ 12: 30PM ALBUMIN-4.1 CALCIUM-9.2 PHOSPHATE-4.7* IRON-61 ___ 12: 30PM calTIBC-303 FERRITIN-155* TRF-233 ___ 12: 30PM UREA N-42* CREAT-2.3* SODIUM-142 POTASSIUM-4.7 CHLORIDE-109* TOTAL CO2-23 ANION GAP-15 ___ 04: 50PM LD(___)-247 TOT BILI-0.2 ___ 04: 50PM HAPTOGLOB-188 IMAGING: --============ LENIs (___) 1. Nonocclusive deep vein thrombosis of one of the paired posterior tibial veins bilaterally. The extent of thrombus bilaterally has decreased. No new deep venous thrombosis in either lower extremity. 2. Right complex ___ cyst. CXR (___): 1. New mild pulmonary edema with persistent small bilateral pleural effusions. 2. Severe cardiomegaly is likely accentuated due to low lung volumes and patient positioning. CXR (___): As compared to ___, the lung volumes have slightly decreased. Signs of mild overinflation and moderate pleural effusions persist. Moderate cardiomegaly. Elongation of the descending aorta. No pneumonia. LABORAROTY STUDIES ON DISCHARGE --============ ___ 05: 45AM BLOOD WBC-3.4* RBC-2.93* Hgb-8.9* Hct-28.0* MCV-96 MCH-30.4 MCHC-31.8* RDW-17.5* RDWSD-59.7* Plt ___ ___ 05: 45AM BLOOD ___ PTT-30.6 ___ ___ 05: 45AM BLOOD Glucose-116* UreaN-41* Creat-2.1* Na-144 K-4.0 Cl-108 HCO3-25 AnGap-15 ___ 04: 50PM BLOOD LD(LDH)-247 TotBili-0.2 ___ 05: 45AM BLOOD Calcium-9.4 Phos-4.7* Mg-1.7 <MEDICATIONS ON ADMISSION> The Preadmission Medication list may be inaccurate and requires futher investigation. 1. Allopurinol ___ mg PO EVERY OTHER DAY 2. Aspirin 81 mg PO DAILY 3. Atorvastatin 80 mg PO QPM 4. Carvedilol 12.5 mg PO BID 5. Lisinopril 40 mg PO DAILY 6. Multivitamins 1 TAB PO DAILY 7. NIFEdipine CR 30 mg PO BID 8. Vitamin D ___ UNIT PO DAILY 9. Docusate Sodium 100 mg PO BID 10. Gabapentin 100 mg PO QHS neuropathic pain 11. Pantoprazole 40 mg PO Q12H 12. Senna 8.6 mg PO BID constipation 13. Warfarin 4 mg PO 3X/WEEK (___) 14. Nitroglycerin SL 0.3 mg SL Q5MIN: PRN chest pain 15. Furosemide 20 mg PO DAILY 16. Polyethylene Glycol 17 g PO DAILY 17. Acetaminophen 325-650 mg PO Q6H: PRN pain or fever 18. Warfarin 3 mg PO 4X/WEEK (___) 19. 70/30 30 Units Dinner <DISCHARGE MEDICATIONS> 1. Acetaminophen 325-650 mg PO Q6H: PRN pain or fever RX *acetaminophen 325 mg ___ tablet(s) by mouth Q6H: PRN Disp #*120 Tablet Refills: *0 2. Aspirin 81 mg PO DAILY RX *aspirin 81 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills: *0 3. Atorvastatin 80 mg PO QPM RX *atorvastatin 80 mg 1 tablet(s) by mouth QPM Disp #*30 Tablet Refills: *0 4. Carvedilol 12.5 mg PO BID RX *carvedilol 12.5 mg 1 tablet(s) by mouth twice a day Disp #*60 Tablet Refills: *0 5. Docusate Sodium 100 mg PO BID RX *docusate sodium 100 mg 1 capsule(s) by mouth twice a day Disp #*60 Capsule Refills: *0 6. Gabapentin 100 mg PO QHS neuropathic pain RX *gabapentin 100 mg 1 capsule(s) by mouth at bedtime Disp #*30 Capsule Refills: *0 7. Lisinopril 40 mg PO DAILY RX *lisinopril 40 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills: *0 8. Multivitamins 1 TAB PO DAILY RX *multivitamin 1 capsule(s) by mouth daily Disp #*30 Capsule Refills: *0 9. NIFEdipine CR 30 mg PO BID RX *nifedipine 30 mg 1 tablet(s) by mouth twice a day Disp #*60 Tablet Refills: *0 10. Nitroglycerin SL 0.3 mg SL Q5MIN: PRN chest pain RX *nitroglycerin [Nitrostat] 0.3 mg 1 tablet(s) sublingually Q5MIN: PRN Disp #*10 Tablet Refills: *0 11. Pantoprazole 40 mg PO Q12H RX *pantoprazole 40 mg 1 tablet(s) by mouth every twelve (12) hours Disp #*60 Tablet Refills: *0 12. Polyethylene Glycol 17 g PO DAILY RX *polyethylene glycol 3350 17 gram/dose 1 powder(s) by mouth daily Refills: *0 13. Senna 8.6 mg PO BID constipation RX *sennosides [senna] 8.6 mg 1 capsule by mouth twice a day Disp #*60 Capsule Refills: *0 14. Vitamin D ___ UNIT PO DAILY RX *ergocalciferol (vitamin D2) 2,000 unit 1 tablet(s) by mouth daily Disp #*30 Tablet Refills: *0 15. Warfarin 4 mg PO 3X/WEEK (___) RX *warfarin 4 mg 1 tablet(s) by mouth 3X/WEEK Disp #*30 Tablet Refills: *0 16. Warfarin 3 mg PO 4X/WEEK (___) RX *warfarin 3 mg 1 tablet(s) by mouth 4X/WEEK Disp #*30 Tablet Refills: *0 17. Furosemide 20 mg PO DAILY RX *furosemide 20 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills: *0 18. Allopurinol ___ mg PO EVERY OTHER DAY RX *allopurinol ___ mg 1 tablet(s) by mouth EVERY OTHER DAY Disp #*30 Tablet Refills: *0 19. 70/30 30 Units Dinner RX *insulin NPH and regular human [Humulin 70/30 KwikPen] 100 unit/mL (70-30) 30 units SC Take 30 Units before DINER Disp #*2 Package Refills: *0 <DISCHARGE DISPOSITION> Home With Service Facility: ___ <DISCHARGE DIAGNOSIS> Primary diagnosis: Anemia Congestive heart failure exacerbation Secondary diagnosis: Hypertension DMII on insulin Coronary artery disease Stage IV chronic kidney disease Deep vein thrombosis <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear ___, It was a pleasure caring for you. You were admitted to the hospital with fatigue, chest pain, and shortness of breath. You were found to have too few red blood cells (anemia). We gave you blood, and your symptoms improved. Additionally, you were found to have too much fluid in your legs and lungs. We treated you with a diuretic, which helped eliminate the fluid. Weigh yourself every morning, call MD if weight goes up more than 3 lbs. Sincerely, Your ___ Team ","Ms. ___ is a ___ year old woman with a past medical history of type-2 DM, hypertension, stage IV CKD, CAD s/p distant MI and bare metal stent, stroke, recent unprovoked DVTs on Coumadin, and recent upper GI bleed, who was sent to ___ by her physician for anemia. # Anemia: Patient presented with Hgb of 6.5, down from her recent baseline of ~7.5 since her ___ hospitalization. Upon presentation she had a new macrocytic anemia. Hemolysis labs were negative. She received two units of packed red cells with an appropriate rise in her Hgb to 9.0. Stool was guiac negative, with no reports of dark stool or blood in stool. Her hemoglobin remained stable at this level, there was no overt bleeding, and her stool was guiac negative. After transfusion the patient reported significant improvement in her shortness of breath and fatigue. Given her history of gastritis and diverticulosis, a GI bleed was believed responsible for her anemia. Patient should receive an EGD/colonoscopy as an outpatient. # Acute exacerbation of heart failure with preserved ejection fraction: The patient was also found to be slightly volume overloaded, and was treated with 2x40mg IV Lasix, with good urine output and symptomatic improvement. Her pulmonary edema and peripheral edema resolved with diuresis. CHRONIC ISSUES: # Gastic ulceration: Continued on home pantoprazole BID # Hypertension: Continued on home nifedipine, carvadilol, lisinopril. # Stage IV Chronic Kidney Disease: Creatinine remained at baseline (b/l Cr 2.1-2.6) during admission. TRANSITIONAL ISSUES ====================== --Patient's Anemia is thought to be due to slow GI bleed given history of gastritis and diverticulosis. Please schedule EGD/colonoscopy within the next month --Patient continued on Coumadin for bilateral DVTs; please continue to weigh the risks and benefits of anticoagulation given history of bleed. --Discharge weight: 167.7 # CONTACT: ___ ___ # CODE: full, confirmed ",3242,468
10000980-DS-25,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> dyspnea on exertion <MAJOR SURGICAL OR INVASIVE PROCEDURE> None <HISTORY OF PRESENT ILLNESS> ___ with a history of of HTN, CAD s/p DES with ischemic MR and systolic dysfunction, ___ on torsemide, hx of DVT, who presents with 4 days of dyspnea on exertion, leg swelling, and 10 weight gain. Of note, patient was seen in the Heart Failure Clinic with Dr. ___ on ___ where she noted that she has had persistent dyspnea on exertion and PND after a lengthy prior hospitalization for DVT/GIB. At that time she was started on 40mg po torsemide which initially improved her symptoms. Over the holiday she indulged in a high salt diet and developed slow-onset dyspnea on exertion. Denies any medication noncompliance, chest pain, palpitations, palpitations. Describes PND, worsening exercise tolerance (unable to walk >50 feet) and orthopnea. In the ED, patient was found to have 1+ bilateral lower extremity edema, and have bibasilar crackles on exam. Patient underwent CXR, BNP, and was given one dose of IV 40mg Lasix. In the ED initial vitals were: 97.8 73 199/100 18 95% RA. Prior to transfer, vitals were 74 188/95 18 100% RA. Patient's labs were remarkable for sodium 146, Chloride 115, K 5.4, Bicarb 19, BUN 39, Creatinine 2.3. Patient had CK 229, with MB 6, Trop < 0.01. Patient had BNP of 10,180. Patient also had Hgb 8.1, Hct 26.8, Platelet 168, WBC 5.4. Urinalysis still pending upon discharge. EKG: notable for SR 76, with LAD, TWI in the inferior leads which appears unchanged from prior on ___ On the floor she is symptomatically improved since coming to the ED. <PAST MEDICAL HISTORY> - hypertension - diabetes - hx CVA (cerebellar-medullary stroke in ___ - CAD (hx of MI in ___ BMS to circumflex and POBA ___ - peripheral arterial disease- claudication, followed by vascular, managed conservatively - stage IV CKD (baseline 2.1-2.6) - GERD/esophageal rings <SOCIAL HISTORY> ___ <FAMILY HISTORY> Father died in his ___ due to lung disease. Mother died in her ___ due to an unknown cause. No early CAD or sudden cardiac death. No other known history of cancer. <PHYSICAL EXAM> ADMISSION PHYSICAL EXAMINATION: VS: T=98.0 BP: 168/96 HR=67 RR=16 O2 sat=100% on 2L NC Admission weight 178lbs GENERAL: WDWN, obese, sitting upright in bed, in NAD. AOx3. Mood, affect appropriate. HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no pallor or cyanosis of the oral mucosa. NECK: Supple with JVP of 8cm. CARDIAC: PMI located in ___ intercostal space, midclavicular line. RR, normal S1, S2, +S3. No murmurs/rubs/gallops. No thrills, lifts. LUNGS: Resp were unlabored, no accessory muscle use, dyspneic at the end of a long sentence. Bibasilar crackles ___ up thorax, diffuse wheezing. ABDOMEN: Soft, NTND. No HSM or tenderness. EXTREMITIES: 2+ edema to shins. No femoral bruits. PULSES: Distal pulses palpable and symmetric DISCHARGE PHYSICAL EXAMINATION: VS: T=98.0 BP: 135/72 HR=67 RR=16 O2 sat=100% on RA weight: 74kg GENERAL: WDWN, obese, sitting upright in bed, in NAD. AOx3. Mood, affect appropriate. HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no pallor or cyanosis of the oral mucosa. NECK: Supple with JVP of 7cm. CARDIAC: PMI located in ___ intercostal space, midclavicular line. RR, normal S1, S2, +S3. No murmurs/rubs/gallops. No thrills, lifts. LUNGS: Resp were unlabored, no accessory muscle use. Bibasilar crackles trace, diffuse wheezing. ABDOMEN: Soft, NTND. No HSM or tenderness. EXTREMITIES: dry. No femoral bruits. PULSES: Distal pulses palpable and symmetric <PERTINENT RESULTS> ADMISSION LABS ___ 11: 55AM BLOOD WBC-5.4 RBC-2.63* Hgb-8.1* Hct-26.8* MCV-102*# MCH-30.8 MCHC-30.2* RDW-17.2* RDWSD-64.7* Plt ___ ___ 11: 55AM BLOOD Neuts-80.6* Lymphs-11.2* Monos-5.0 Eos-2.4 Baso-0.2 Im ___ AbsNeut-4.38 AbsLymp-0.61* AbsMono-0.27 AbsEos-0.13 AbsBaso-0.01 ___ 12: 45PM BLOOD ___ PTT-32.9 ___ ___ 07: 30AM BLOOD Ret Aut-2.4* Abs Ret-0.06 ___ 11: 55AM BLOOD Glucose-153* UreaN-39* Creat-2.3* Na-146* K-5.4* Cl-115* HCO3-19* AnGap-17 ___ 11: 55AM BLOOD CK-MB-6 cTropnT-<0.01 ___ ___ 07: 38PM BLOOD CK-MB-6 cTropnT-<0.01 ___ 11: 55AM BLOOD Calcium-9.0 Phos-3.9 Mg-1.8 DISCHARGE LABS ===== ___ 07: 10AM BLOOD WBC-3.9* RBC-2.81* Hgb-8.6* Hct-26.7* MCV-95 MCH-30.6 MCHC-32.2 RDW-16.0* RDWSD-56.4* Plt ___ ___ 07: 10AM BLOOD ___ ___ 07: 10AM BLOOD Glucose-100 UreaN-37* Creat-1.9* Na-144 K-3.9 Cl-105 HCO3-29 AnGap-14 ___ 07: 10AM BLOOD Calcium-9.5 Phos-4.4 Mg-1.8 IMAGING ===== ___ CXR FINDINGS: There is mild pulmonary edema with superimposed region of more confluent consolidation in the left upper lung. There are possible small bilateral pleural effusions. Moderate cardiomegaly is again seen as well as tortuosity of the descending thoracic aorta. No acute osseous abnormalities. IMPRESSION: Mild pulmonary edema with superimposed left upper lung consolidation, potentially more confluent edema versus superimposed infection. <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Acetaminophen 325-650 mg PO Q6H: PRN pain or fever 2. Aspirin 81 mg PO DAILY 3. Atorvastatin 80 mg PO QPM 4. Carvedilol 12.5 mg PO BID 5. Docusate Sodium 100 mg PO BID 6. Gabapentin 100 mg PO QHS neuropathic pain 7. Lisinopril 40 mg PO DAILY 8. Multivitamins 1 TAB PO DAILY 9. NIFEdipine CR 30 mg PO BID 10. Nitroglycerin SL 0.3 mg SL Q5MIN: PRN chest pain 11. Pantoprazole 40 mg PO Q12H 12. Polyethylene Glycol 17 g PO DAILY 13. Senna 8.6 mg PO BID constipation 14. Vitamin D ___ UNIT PO DAILY 15. Warfarin 5 mg PO DAILY16 16. Allopurinol ___ mg PO EVERY OTHER DAY 17. Torsemide 40 mg PO DAILY 18. HumuLIN 70/30 (insulin NPH and regular human) 100 unit/mL (70-30) subcutaneous 25 units with dinner <DISCHARGE MEDICATIONS> 1. HumuLIN 70/30 (insulin NPH and regular human) 100 unit/mL (70-30) subcutaneous 25 units with dinner 2. Warfarin 5 mg PO DAILY16 3. Vitamin D ___ UNIT PO DAILY 4. Acetaminophen 325-650 mg PO Q6H: PRN pain or fever 5. Allopurinol ___ mg PO EVERY OTHER DAY 6. Aspirin 81 mg PO DAILY 7. Atorvastatin 80 mg PO QPM 8. Docusate Sodium 100 mg PO BID 9. Gabapentin 100 mg PO QHS neuropathic pain 10. Lisinopril 40 mg PO DAILY 11. Multivitamins 1 TAB PO DAILY 12. Nitroglycerin SL 0.3 mg SL Q5MIN: PRN chest pain 13. Polyethylene Glycol 17 g PO DAILY 14. Senna 8.6 mg PO BID constipation 15. Torsemide 40 mg PO DAILY RX *torsemide 20 mg 2 tablet(s) by mouth once daily Disp #*60 Tablet Refills: *0 16. Pantoprazole 20 mg PO Q12H 17. Carvedilol 25 mg PO BID 18. NIFEdipine CR 60 mg PO BID RX *nifedipine 20 mg 3 capsule(s) by mouth twice daily Disp #*180 Capsule Refills: *0 <DISCHARGE DISPOSITION> Home With Service Facility: ___ <DISCHARGE DIAGNOSIS> Primary Diagnoses: Acute on chronic decompensated congestive Heart Failure Hypertension Secondary Diagnoses: Anemia Diabetes mellitus Prior deep vein thrombosis Chronic Kidney Disease <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Mrs. ___, ___ were admitted to ___ for treatment of your congestive heart failure and hypertension. ___ were given IV diuretics with improvement in your symptoms, labs and exam. We increased one of your blood pressure medications and continued your other home medicines. It was a pleasure taking care of ___ during your stay- we wish ___ all the best! - Your ___ Team ","___ year-old female with history of hypertension, CAD s/p DES with ischemic MR and systolic dysfunction, ___, hx of DVT, who admitted for CHF exacerbation. # Acute on chronic decompensated heart failure: presented in the setting of high salt diet with dyspnea on exertion, decreased exercise tolerance, ___ edema, crackles on exam, elevated BNP to 10K, 8lbs above dry weight and pulmonary congestion on CXR. Later discovered on pharmacy review that patient had not filled torsemide after last outpatient Cardiology appointment where she was instructed to start taking it. Troponins cycled and negative. On admission, she was placed on a salt and fluid restricted diet. She was diuresed with IV Lasix 80mg for 2 days and then transitioned to po torsemide 40mg with steady weight decline and net negative fluid balance of goal -___ and stable renal function. Electrolytes repleted for goal Mg>2 and K>4. She was continued on home carvedilol 12.5mg BID, atorvastatin 80mg daily and lisinopril 40mg daily for blood pressure control and increased home nifedipine CR from 30 to 60mg BID to achieve goal SBP <140. Discharged with close PCP and ___ to monitor weights and blood pressure control. # Hypertension: She was continued on home carvedilol 12.5mg BID, atorvastatin 80mg daily and lisinopril 40mg daily for blood pressure control and increased home nifedipine CR from 30 to 60mg BID to achieve goal SBP <140. # Positive U/A: patient asymptomatic but with 32WBCs, ___, +bacteria (although 3 epis). Asymptomatic with no fevers/dysuria/malaise. Urine culture negative. # Left upper lung consolidation: infiltrate per Radiology read on admission CXR. No cough, fevers, leukocytosis. Rereviewed with on-call radiologist who favored pulmonary edema with no need for repeat imaging or PNA treatment unless clinically indicated. Monitored without any significant clinical findings. # DVT: anticoagulated on Coumadin goal 2.0-3.0, no signs of thrombus on exam. Daily INR trended and continued on home Coumadin 5mg daily. # Anemia: no signs of external loss, specifically denying any melena. Chronically anemic with baseline ___, presented with Hgb 8. Likely ___ renal disease and ACD however elevated MCV indicates possible reticulocytosis. Altogether low suspicion for GIB so Coumadin was continued. Reticulocytes 2.4 which is inappropriate arguing against acute loss. Trended daily CBC with noted uprising by discharge. # Chronic kidney disease, stage IV- baseline ___, likely ___ HTN and DM. Renally dosed medications and trended Cr with no significant change. # HLD: continued home atorvastatin # DM: held home 25U 70/30. Patient maintained on aspart ISS and glargine qHS with good glycemic control. TRANSITIONAL ISSUES ================== CHF: diuresed with IV lasix, transitioned to po diuretics, discharged home on 40mg po torsemide, to take in the AM and take a banana. Pt complained of unilateral R-sided incomplete hearing loss on day of discharge- was not felt to be related to diuretics but would ___. HTN: increased nifedipine CR to 60mg BID given elevated SBPs. Please f/u at next appointments. Anemia: multiple prior workups showing ACD. Hgb 8s during admission Prior DVT/PE: continued on warfarin, will need continued monitoring DM: stopped home 70/30 while in-house and put on aspart/glargine, discharged on home regimen Discharge weight: 74kg Discharge Cr: 1.9 ",2539,858
10001186-DS-10,"<SEX> F <SERVICE> NEUROSURGERY <ALLERGIES> Penicillins / Paxil / Wellbutrin <ATTENDING> ___. <CHIEF COMPLAINT> Exposed hardware <MAJOR SURGICAL OR INVASIVE PROCEDURE> Exposed hardware removal <HISTORY OF PRESENT ILLNESS> The is a ___ year old female who had prior surgery for a possible right parietal anaplastic astrocytoma with craniotomy for resection on ___ by Dr. ___ in ___ followed by involved-field irradiation to 6,120 cGy ___ in ___, 3 cycles of Temodar ended ___ and a second craniotomy for tumor recurrence on ___ by Dr. ___ at ___ with PCV(comb chemo) ___ - ___. In ___ she presented with exposed hardware to the office and she needed admission an complex revision for a plate that had eroded through the skin; Plastics and I reconstructed the scalp at that time. The patient presents today again with some history of pruritus on the top of her head and newly diagnosed exposed hardware. She reports that she had her husband look at the top of her head "" a few ago"" and saw that metal hardware from her prior surgery was present. <PAST MEDICAL HISTORY> right parietal anaplastic astrocytoma, Craniotomy ___ by Dr. ___ in ___ irradiation to 6,120 cGy ___ in ___,3 cycles of Temodar ended ___ craniotomy on ___ by Dr. ___ at ___ ___ - ___ wound revision and removal of the exposed craniotx hardware, Accutane for 2 weeks only ___ disease since ___, tubal ligation,tonsillectomy, bronchitis, depression. seizures <SOCIAL HISTORY> ___ <FAMILY HISTORY> NC <PHYSICAL EXAM> AF VSS obese Gen: WD/WN, comfortable, NAD. HEENT: ___ bilat EOMs: intact Neck: Supple. no LNN RRR no SOB obese Extrem: Warm and well-perfused, Neuro: Mental status: Awake and alert, cooperative with exam, normal affect but VERY simple construct. Orientation: Oriented to person, place, and date. Recall: ___ objects at 5 minutes. Language: Speech fluent with good comprehension and repetition. Naming intact. No dysarthria or paraphasic errors. Cranial Nerves: I: Not tested II: Pupils equally round and reactive to light, 3 to 2 mm bilaterally. Visual fields are full to confrontation. III, IV, VI: Extraocular movements intact bilaterally without nystagmus. V, VII: Facial strength and sensation intact and symmetric. VIII: Hearing intact to voice. IX, X: Palatal elevation symmetrical. XI: Sternocleidomastoid and trapezius normal bilaterally. XII: Tongue midline without fasciculations. Motor: Normal bulk and tone bilaterally. No abnormal movements W: there is an area over the R hemiconvexity that shows a chronic skin defect where the underlying harware has eroded through the skin. Different from previous repaired portion and represents piece of the implanted miniplates; No discharge; no reythemal no swelling; surprisingly benign aspect. PHYSICAL EXAM PRIOR TO DISCHARGE: AF VSS obese Gen: WD/WN, comfortable, NAD. HEENT: ___ bilat EOMs: intact Neck: Supple. Incision: clean, dry, intact. No redness, swelling, erythema or discharge. Sutures in place. <PERTINENT RESULTS> ___: Hematology COMPLETE BLOOD COUNT WBC RBC Hgb Hct MCV MCH MCHC RDW Plt Ct ___ 06: 25 4.8 3.49* 11.2* 34.4* 98 31.9 32.5 16.3* 245 BASIC COAGULATION ___, PTT, PLT, INR) Plt Ct ___ 06: 25 245 Chemistry RENAL & GLUCOSE Glucose UreaN Creat Na K Cl HCO3 AnGap ___ 06: 25 ___ 142 3.4 110* 23 12 <MEDICATIONS ON ADMISSION> The Preadmission Medication list may be inaccurate and requires futher investigation. 1. ALPRAZolam 0.5 mg PO TID 2. Azathioprine 100 mg PO BID 3. DiCYCLOmine 10 mg PO Q6H: PRN abdominal pain 4. Fluticasone-Salmeterol Diskus (500/50) 1 INH IH BID 5. Hydrocodone-Acetaminophen (5mg-500mg) 1 TAB PO Q4H: PRN pain 6. Infliximab 100 mg IV Q6 WEEKS 7. Levothyroxine Sodium 50 mcg PO DAILY 8. Mesalamine 500 mg PO QID 9. Omeprazole 20 mg PO DAILY 10. Promethazine 25 mg PO Q6H: PRN n/v 11. Topiramate (Topamax) 200 mg PO BID 12. Venlafaxine XR 150 mg PO DAILY 13. Zolpidem Tartrate 15 mg PO HS <DISCHARGE MEDICATIONS> 1. ALPRAZolam 0.5 mg PO TID 2. Azathioprine 100 mg PO BID 3. DiCYCLOmine 10 mg PO Q6H: PRN abdominal pain 4. Levothyroxine Sodium 50 mcg PO DAILY 5. Mesalamine 500 mg PO QID 6. Omeprazole 20 mg PO DAILY 7. Topiramate (Topamax) 200 mg PO BID 8. Venlafaxine XR 150 mg PO DAILY 9. Zolpidem Tartrate 15 mg PO HS 10. Hydrocodone-Acetaminophen (5mg-500mg) 1 TAB PO Q4H: PRN pain 11. Acetaminophen 325-650 mg PO Q6H: PRN temperature; pain 12. Docusate Sodium 100 mg PO BID: PRN constipation RX *docusate sodium 100 mg 100 capsule(s) by mouth twice a day Disp #*30 Capsule Refills: *0 13. Fluconazole 200 mg PO Q24H Duration: 4 Days RX *fluconazole 200 mg 1 tablet(s) by mouth daily Disp #*4 Tablet Refills: *0 14. OxycoDONE (Immediate Release) 5 mg PO Q6H: PRN for moderate pain RX *oxycodone 5 mg ___ tablet(s) by mouth every six (6) hours Disp #*40 Tablet Refills: *0 15. Cephalexin 500 mg PO Q12H Duration: 7 Days RX *cephalexin 500 mg 1 tablet(s) by mouth twice a day Disp #*14 Tablet Refills: *0 <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Hardware removal <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> - Please take Fluconazole 200mg once daily for 4 days. Please take Keflex for 7 days for wound infection. Clearance to drive and return to work will be addressed at your post-operative office visit. CALL YOUR SURGEON IMMEDIATELY IF YOU EXPERIENCE ANY OF THE FOLLOWING -New onset of tremors or seizures. -Any confusion or change in mental status. -Any numbness, tingling, weakness in your extremities. -Pain or headache that is continually increasing, or not relieved by pain medication. -Any signs of infection at the wound site: increasing redness, increased swelling, increased tenderness, or drainage. -Fever greater than or equal to 101.5 F. ","The patient presented to the ___ neurosurgical service on ___ for treatment of exposed hardware from a previous surgery on her head. She went to the OR on ___, where a was performed removal of exposed hardware by Dr. ___. Postoperatively, the patient was stable. Infectious disease consulted the patient and recommended fluconazole 200 mg PO for 5 days for yeast infection and Keflex ___ mg PO BID for 7 days. For DVT prophylaxis, the patient received subcutaneous heparin and SCD's during her stay. At the time of discharge, the patient was able to tolerate PO, was ambulatoryand able to void independently. She was able to verbalize agreement and understanding of the discharge plan. ",1763,153
10001186-DS-8,"<SEX> F <SERVICE> NEUROSURGERY <ALLERGIES> Penicillins / Paxil / Wellbutrin <ATTENDING> ___. <CHIEF COMPLAINT> exposed craniotomy hardware <MAJOR SURGICAL OR INVASIVE PROCEDURE> wound revision and hardware removal <HISTORY OF PRESENT ILLNESS> This is a ___ year old female with prior surgery which includes right parietal anaplastic astrocytoma with Craniotomy for resection on ___ by Dr. ___ in ___ followed by involved-field irradiation to 6,120 cGy ___ in ___, 3 cycles of Temodar ended ___ and a second craniotomy for tumor recurrence on ___ by Dr. ___ at ___ with PCV(comb chemo) ___ - ___. The patient presents today with ___ month history of pruritus on the top of her head. She reports that she had her husband look at the top of her head ___ days ago and saw that metal hardware from her prior surgery was present. The patient and her husband presented to their local Emergency and was told to follow up here. The patient denies fever, chills, nausea vomiting, nuchal rigidity, numbness or tingling sensation, vision or hearing changes, bowel or bladder incontinence. She denies new onset weakness. She reports baseline tremors in arms due to her hyperthyroid disease and baseline left sided weakness since her initial surgery. She does not ambulate with a walker <PAST MEDICAL HISTORY> right parietal anaplastic astrocytoma,Craniotomy ___ by Dr. ___ in ___ irradiation to 6,120 cGy ___ in ___,3 cycles of Temodar ended ___ craniotomy on ___ by Dr. ___ at ___ ___ - ___ for 2 weeks only ___ disease since ___, tubal ligation,tonsillectomy, bronchitis, depression. seizures <SOCIAL HISTORY> ___ <FAMILY HISTORY> NC <PHYSICAL EXAM> O: T: 96.7 BP: 139/73 HR: 114 R: 20 O2Sats: 100% ra Gen: WD/WN, comfortable, NAD. HEENT: Pupils: 3-2mm bilat EOMs: intact Neck: Supple. Extrem: Warm and well-perfused, arms hands tremulous- (patient states this is her baseline due to hyperthyroid disease) Neuro: Mental status: Awake and alert, cooperative with exam, normal affect. Orientation: Oriented to person, place, and date. Recall: ___ objects at 5 minutes. Language: Speech fluent with good comprehension and repetition. Naming intact. No dysarthria or paraphasic errors. Cranial Nerves: I: Not tested II: Pupils equally round and reactive to light, 3 to 2 mm bilaterally. Visual fields are full to confrontation. III, IV, VI: Extraocular movements intact bilaterally without nystagmus. V, VII: Facial strength and sensation intact and symmetric. VIII: Hearing intact to voice. IX, X: Palatal elevation symmetrical. XI: Sternocleidomastoid and trapezius normal bilaterally. XII: Tongue midline without fasciculations. Motor: Normal bulk and tone bilaterally. No abnormal movements, tremors. Strength full power ___ on right 4+/5 on left. No pronator drift Sensation: Intact to light touch bilaterally. Toes downgoing bilaterally Coordination: normal on finger-nose-finger, rapid alternating movements, heel to shin <PERTINENT RESULTS> CT Head 1. No evidence of abscess formation. 2. Stable appearance of postoperative changes related to right frontal mass resection with residual encephalomalacia and edema in a similar distribution as ___ MR exam. <MEDICATIONS ON ADMISSION> azathioprine, Pentasa, topiramate, alprazolam, omeprazole, zolpidem, venlafaxine hcl er 30, popylthiouracil, promethazine- patient does not have doses at the time of the exam. <DISCHARGE MEDICATIONS> 1. acetaminophen 325 mg Tablet Sig: ___ Tablets PO Q6H (every 6 hours) as needed for pain. 2. azathioprine 50 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 3. alprazolam 1 mg Tablet Sig: 0.5 Tablet PO TID (3 times a day) as needed for anxiety. 4. promethazine 25 mg Tablet Sig: One (1) Tablet PO Q6H (every 6 hours) as needed for nausea. 5. omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) Capsule, Delayed Release(E.C.) PO DAILY (Daily). 6. cephalexin 500 mg Capsule Sig: One (1) Capsule PO Q6H (every 6 hours) for 13 days. Disp: *52 Capsule(s)* Refills: *0* 7. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day). 8. zolpidem 5 mg Tablet Sig: Two (2) Tablet PO HS (at bedtime) as needed for for sleep. 9. mesalamine 250 mg Capsule, Extended Release Sig: Two (2) Capsule, Extended Release PO QID (4 times a day). 10. topiramate 100 mg Tablet Sig: Two (2) Tablet PO BID (2 times a day). 11. fluticasone-salmeterol 250-50 mcg/dose Disk with Device Sig: One (1) Disk with Device Inhalation BID (2 times a day). 12. propylthiouracil 50 mg Tablet Sig: Two (2) Tablet PO Q8H (every 8 hours). 13. venlafaxine 75 mg Capsule, Ext Release 24 hr Sig: One (1) Capsule, Ext Release 24 hr PO DAILY (Daily). 14. venlafaxine 75 mg Capsule, Ext Release 24 hr Sig: Two (2) Capsule, Ext Release 24 hr PO DAILY (Daily). 15. hydrocodone-acetaminophen ___ mg Tablet Sig: ___ Tablets PO Q8H (every 8 hours) as needed for back pain. Disp: *45 Tablet(s)* Refills: *0* <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> exposure of craniotomy hardware and infection <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> -Have a friend/family member check your incision daily for signs of infection. -Take your pain medicine as prescribed. -Exercise should be limited to walking; no lifting, straining, or excessive bending. -You may wash your hair only after sutures and/or staples have been removed. -Increase your intake of fluids and fiber, as narcotic pain medicine can cause constipation. We generally recommend taking an over the counter stool softener, such as Docusate (Colace) while taking narcotic pain medication. -Unless directed by your doctor, do not take any anti-inflammatory medicines such as Motrin, Aspirin, Advil, and Ibuprofen etc. -Clearance to drive and return to work will be addressed at your post-operative office visit. -Make sure to continue to use your incentive spirometer while at home, unless you have been instructed not to. CALL YOUR SURGEON IMMEDIATELY IF YOU EXPERIENCE ANY OF THE FOLLOWING -New onset of tremors or seizures. -Any confusion or change in mental status. -Any numbness, tingling, weakness in your extremities. -Pain or headache that is continually increasing, or not relieved by pain medication. -Any signs of infection at the wound site: redness, swelling, tenderness, or drainage. -Fever greater than or equal to 101 F. ",patient presented to the ED at ___ on ___ with complaints of itchy head and exposed hardware. She was admitted to the floor for observation and pre-operative planning. On 3.5 she was taken to the OR for wound revision and removal of the exposed hardware. She tolerated the procedure well and was transferred to the ___ post-operatively. She was transferred to the floor for further management and remained stable. On the morning of ___ she was deemed fit for discharge and was given instructions for close follow-up of her incision. ,1772,106
10001186-DS-9,"<SEX> F <SERVICE> PLASTIC <ALLERGIES> Penicillins / Paxil / Wellbutrin <ATTENDING> ___. <CHIEF COMPLAINT> exposed craniotomy hardware <MAJOR SURGICAL OR INVASIVE PROCEDURE> Right scalp flap with split thickness skin graft and wound VAC placement <HISTORY OF PRESENT ILLNESS> ___ year old female with multiple prior surgeries for right parietal anaplastic astrocytoma diagnosed in ___. She has also undergone chemo and radiation. She presented to ___ in ___ with ___ month history of pruritus on the top of her head. She reports that she had her husband look at the top of her head and her found her metal hardware from her prior surgery was present. On ___ Dr. ___ metal hardware (removal of harware but not the bone flap). She presented today for a rotational flap and skin graft for proper coverage of wound. <PAST MEDICAL HISTORY> right parietal anaplastic astrocytoma,Craniotomy ___ by Dr. ___ in ___ irradiation to 6,120 cGy ___ in ___,3 cycles of Temodar ended ___ craniotomy on ___ by Dr. ___ at ___ ___ - ___ wound revision and removal of the exposed craniotx hardware, Accutane for 2 weeks only ___ disease since ___, tubal ligation,tonsillectomy, bronchitis, depression. seizures <SOCIAL HISTORY> ___ <FAMILY HISTORY> NC <PHYSICAL EXAM> Afebrile. vital signs stable. Right scalp incision clean, dry and intact with xeroform dressing in place. Right STSG site with bolstered xeroform dressing in place. No drainage or bleeding. <PERTINENT RESULTS> None this admission. <MEDICATIONS ON ADMISSION> ___: azathioprine, Pentasa, topiramate, alprazolam, omeprazole, zolpidem, venlafaxine hcl er 30, popylthiouracil, promethazine, keflex <DISCHARGE MEDICATIONS> 1. azathioprine 75 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 2. dicyclomine 10 mg Capsule Sig: One (1) Capsule PO Q8H (every 8 hours) as needed for abdominal pain. 3. fluticasone-salmeterol 500-50 mcg/dose Disk with Device Sig: One (1) Disk with Device Inhalation BID (2 times a day). 4. mesalamine 250 mg Capsule, Extended Release Sig: Two (2) Capsule, Extended Release PO QID (4 times a day). 5. omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) Capsule, Delayed Release(E.C.) PO DAILY (Daily). 6. topiramate 100 mg Tablet Sig: Two (2) Tablet PO BID (2 times a day). 7. venlafaxine 75 mg Capsule, Ext Release 24 hr Sig: Three (3) Capsule, Ext Release 24 hr PO DAILY (Daily). 8. propylthiouracil 50 mg Tablet Sig: Two (2) Tablet PO Q8H (every 8 hours). 9. bacitracin zinc 500 unit/g Ointment Sig: One (1) Appl Topical BID (2 times a day). Disp: *1 tube* Refills: *2* 10. cefadroxil 500 mg Capsule Sig: One (1) Capsule PO twice a day for 7 days. Disp: *14 Capsule(s)* Refills: *0* 11. hydrocodone-acetaminophen ___ mg Tablet Sig: ___ Tablets PO every six (6) hours as needed for pain: Max 8/day. . Disp: *40 Tablet(s)* Refills: *0* 12. alprazolam 0.25 mg Tablet Sig: Two (2) Tablet PO TID (3 times a day) as needed for anxiety. <DISCHARGE DISPOSITION> Home With Service Facility: ___ <DISCHARGE DIAGNOSIS> exposed craniotomy wound Status post hardware removal, split thickness skin graft application to scalp, donor site from leg <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> -The hemovac drain should always be collapsed so as to apply constant suction to the wound. Does not need to be emptied unless not collapsed and does not have suction. -Your skin graft site on your scalp should be covered with a Xeroform dressing and you should apply bacitracin ointment with Qtips UNDER the xeroform dressing twice a day. WARNING: do NOT change the xeroform that is sewn/sutured in place already...leave that in place. -Please keep your skin graft site free of any pressure or extreme temperatures (cover with loose hat that does not sit on your graft site). -You may shower 48 hours after surgery but do not let water run on your head/scalp area. You may shower from the neck down only. -your thigh 'donor site' should be left 'open to air' and left to dry out. The old xeroform dressing will peel back/fall off on its own. When you shower you must cover your thigh 'donor site' with Plastic wrap to keep it free of water while you shower. You may remove plastic wrap when you are done and leave the donor site open to air again to dry out. . Diet/Activity: 1. You may resume your regular diet. 2. DO NOT bend over, avoid heavy lifting and do not engage in strenuous activity until instructed by Dr. ___. . Medications: 1. Resume your regular medications unless instructed otherwise and take any new meds as ordered. 2. You may take your prescribed pain medication for moderate to severe pain. You may switch to Tylenol or Extra Strength Tylenol for mild pain as directed on the packaging. Please note that Percocet and Vicodin have Tylenol as an active ingredient so do not take these meds with additional Tylenol. 4. Take prescription pain medications for pain not relieved by tylenol. 5. Take your antibiotic as prescribed. 6. Take Colace, 100 mg by mouth 2 times per day, while taking the prescription pain medication. You may use a different over-the-counter stool softener if you wish. 7. Do not drive or operate heavy machinery while taking any narcotic pain medication. You may have constipation when taking narcotic pain medications (oxycodone, percocet, vicodin, hydrocodone, dilaudid, etc.); you should continue drinking fluids, you may take stool softeners, and should eat foods that are high in fiber. 8. do not take any medicines such as Motrin, Aspirin, Advil or Ibuprofen etc . Call the office IMMEDIATELY if you have any of the following: 1. Signs of infection: fever with chills, increased redness, welling, warmth or tenderness at the surgical site, or unusual drainage from the incision(s). 2. A large amount of bleeding from the incision(s) or drain(s). 3. Fever greater than 101.5 oF 4. Severe pain NOT relieved by your medication. . Return to the ER if: * If you are vomiting and cannot keep in fluids or your medications. * If you have shaking chills, fever greater than 101.5 (F) degrees or 38 (C) degrees, increased redness, swelling or discharge from incision, chest pain, shortness of breath, or anything else that is troubling you. * Any serious change in your symptoms, or any new symptoms that concern you. ","The patient was admitted to the plastic surgery service on ___ and had a flap and skin graft to your scalp defect. The patient tolerated the procedure well. . Neuro: Post-operatively, the patient received vicodin with good pain relief noted. . CV: The patient was stable from a cardiovascular standpoint; vital signs were routinely monitored. . Pulmonary: The patient was stable from a pulmonary standpoint; vital signs were routinely monitored. . GI/GU: Post-operatively, the patient was given IV fluids until tolerating oral intake. Her diet was advanced when appropriate, which was tolerated well. She was also started on a bowel regimen to encourage bowel movement. Intake and output were closely monitored. . ID: Post-operatively, the patient was started on IV cefazolin, then switched to PO cefadroxil for discharge home. The patient's temperature was closely watched for signs of infection. . Prophylaxis: The patient received subcutaneous heparin during this stay, and was encouraged to get up and ambulate as early as possible. . At the time of discharge on POD#1, the patient was doing well, afebrile with stable vital signs, tolerating a regular diet, ambulating, voiding without assistance, and pain was well controlled. Her scalp graft site was clean and pink and she had xeroform dressing intact. Her right thing graft donor site had original xeroform dressing in place to left open to air to dry out. ",1716,303
10001217-DS-4,"<SEX> F <SERVICE> NEUROSURGERY <ALLERGIES> Penicillins <ATTENDING> ___ <CHIEF COMPLAINT> Left hand and face numbness, left hand weakness and clumsiness, fever, and headache. <MAJOR SURGICAL OR INVASIVE PROCEDURE> Right parietal craniotomy for abscess incision and drainage. <HISTORY OF PRESENT ILLNESS> Mrs. ___ is a ___ y/o F from ___ with history of MS presents with headaches and left hand clumsiness. Patient states that her headaches first presented on ___ of this week in which she did not think much of, but on ___, developed left hand clumsiness. She states that she had difficulty with grasping objects and using her fingers. She also reported some numbness in the hand. Today, she presented to the ED because she was found to have a temperature of 101.7 in which she took Tylenol and was normothermic after. Once in the ED, patient was seen by neurology who recommended an MRI head. MRI head revealed a R parietal lesion concerning for MS, metastatic disease, or abscess. Neurosurgery was consulted for further evaluation. She reports a mild headache, numbness on the left side of face and difficulty using her left hand. She denies any recent travel outside of ___ and the ___. or ingesting any raw or uncooked meats. She also denies any changes in vision, dysarthria, weakness, nausea, vomitting, diarrhea, cough, or chills. <PAST MEDICAL HISTORY> Multiple sclerosis <SOCIAL HISTORY> ___ <FAMILY HISTORY> Mother with pancreatic cancer, brother-lung cancer, two sisters with brain cancer. <PHYSICAL EXAM> PHYSICAL EXAM ON ADMISSION: O: T: 99 BP: 160/102 HR: 81 R: 16 O2Sats: 97% RA Gen: WD/WN, comfortable, NAD. HEENT: atraumatic, normocephalic Pupils: 4-3mm bilaterally EOMs: intact Neuro: Mental status: Awake and alert, cooperative with exam, normal affect. Orientation: Oriented to person, place, and date. Recall: ___ objects at 5 minutes. Language: Speech fluent with good comprehension and repetition. Naming intact. No dysarthria or paraphasic errors. Cranial Nerves: I: Not tested II: Pupils equally round and reactive to light, 4 to 3 mm bilaterally. Visual fields are full to confrontation. III, IV, VI: Extraocular movements intact bilaterally without nystagmus. V, VII: Facial strength and sensation intact and symmetric. VIII: Hearing intact to voice. IX, X: Palatal elevation symmetrical. XI: Sternocleidomastoid and trapezius normal bilaterally. XII: Tongue midline without fasciculations. Motor: Normal bulk and tone bilaterally. No abnormal movements, tremors. Strength L FI ___, otherwise full power ___ throughout. No pronator drift Sensation: Intact to light touch PHYSICAL EXAM ON DISCHARGE: T: 98.1 BP: 133/95 HR: 95 RR: 18 O2Sats: 98% RA Gen: WD/WN, comfortable, NAD. HEENT: atraumatic, normocephalic, with right craniotomy incision. Pupils: 4-3mm bilaterally, EOMs: intact Neuro: Mental status: Awake and alert, cooperative with exam, normal affect. Orientation: Oriented to person, place, and date. Recall: ___ objects at 5 minutes. Language: Speech fluent with good comprehension and repetition. Naming intact. No dysarthria or paraphasic errors. Cranial Nerves: I: Not tested II: Pupils equally round and reactive to light, 4 to 3 mm bilaterally. Visual fields are full to confrontation. III, IV, VI: Extraocular movements intact bilaterally without nystagmus. V, VII: Facial strength and sensation intact and symmetric. VIII: Hearing intact to voice. IX, X: Palatal elevation symmetrical. XI: Sternocleidomastoid and trapezius normal bilaterally. XII: Tongue midline without fasciculations. Motor: Normal bulk and tone bilaterally. No abnormal movements,tremors. Strength L FI ___, otherwise full power ___ throughout. No pronator drift Sensation: Intact to light touch <PERTINENT RESULTS> ___ MRI HEAD W/WO CONTRAST IMPRESSION: 1. Ring-enhancing lesion identified in the area of the right precentral sulcus frontal lobe, with associated vasogenic edema, restricted diffusion, possibly consistent with an abscess, other entities cannot be completely ruled out such as metastases or primary brain neoplasm. 2. Multiple FLAIR and T2 hyperintense lesions in the subcortical white matter along the callososeptal region, consistent with known multiple sclerosis disease. ___ MRI HEAD W/ CONTRAST IMPRESSION: Unchanged ring-enhancing lesion identified in the area of the right precentral sulcus of the frontal lobe, with associated vasogenic edema. The differential diagnosis again includes possible abscess, other entities, however, cannot be completely excluded. ___ NON CONTRAST HEAD CT IMPRESSION: 1. Status post right parietal craniotomy with mixed density lesion in the right precentral sulcus and surrounding edema not significantly changed from prior MR of ___ allowing for difference in technique. 2. No acute intracranial hemorrhage or major vascular territorial infarct. 3. Bifrontal subcortical white matter hypodensities compatible with underlying multiple sclerosis. ___ 2: 37 am CSF;SPINAL FLUID TUBE #1. GRAM STAIN (Final ___: NO POLYMORPHONUCLEAR LEUKOCYTES SEEN. NO MICROORGANISMS SEEN. This is a concentrated smear made by cytospin method, please refer to hematology for a quantitative white blood cell count.. FLUID CULTURE (Preliminary): NO GROWTH. <MEDICATIONS ON ADMISSION> Ibuprofen <DISCHARGE MEDICATIONS> 1. Acetaminophen 325-650 mg PO Q6H: PRN pain RX *acetaminophen 325 mg ___ tablet(s) by mouth every six (6) hours Disp #*112 Tablet Refills: *0 2. CeftriaXONE 2 gm IV Q12H RX *ceftriaxone 2 gram 2 gm IV every twelve (12) hours Disp #*84 Vial Refills: *0 3. Docusate Sodium 100 mg PO BID RX *docusate sodium [Colace] 100 mg 1 capsule(s) by mouth twice a day Disp #*45 Capsule Refills: *0 4. LeVETiracetam 1000 mg PO BID RX *levetiracetam [Keppra] 1,000 mg 1 tablet(s) by mouth twice a day Disp #*56 Tablet Refills: *0 5. MetRONIDAZOLE (FLagyl) 500 mg PO TID RX *metronidazole [Flagyl] 500 mg 1 tablet(s) by mouth three times a day Disp #*126 Tablet Refills: *0 6. OxycoDONE (Immediate Release) 5 mg PO Q6H: PRN pain RX *oxycodone [Oxecta] 5 mg 1 tablet, oral only(s) by mouth every six (6) hours Disp #*168 Tablet Refills: *0 7. Heparin Flush (10 units/ml) 2 mL IV DAILY and PRN, line flush RX *heparin lock flush (porcine) [heparin lock flush] 10 unit/mL 1 ml IV every eight (8) hours Disp #*126 Vial Refills: *0 8. Sodium Chloride 0.9% Flush 10 mL IV Q8H and PRN, line flush Flush before and after each infusion of antibiotics. RX *sodium chloride 0.9 % [Normal Saline Flush] 0.9 % 10 ml IV q12 Disp #*168 Syringe Refills: *1 <DISCHARGE DISPOSITION> Home With Service Facility: ___ <DISCHARGE DIAGNOSIS> Brain abscess <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> -Have a friend/family member check your incision daily for signs of infection. -Take your pain medicine as prescribed. -Exercise should be limited to walking; no lifting, straining, or excessive bending. -**Your wound was closed with sutures. You may wash your hair only after sutures and/or staples have been removed. -You may shower before this time using a shower cap to cover your head. -Increase your intake of fluids and fiber, as narcotic pain medicine can cause constipation. We generally recommend taking an over the counter stool softener, such as Docusate (Colace) while taking narcotic pain medication. -Unless directed by your doctor, do not take any anti-inflammatory medicines such as Motrin, Aspirin, Advil, and Ibuprofen etc. -You have been discharged on Keppra (Levetiracetam), you will not require blood work monitoring. -Clearance to drive and return to work will be addressed at your post-operative office visit. -Make sure to continue to use your incentive spirometer while at home, unless you have been instructed not to. ","Mrs. ___ presented to the ___ Emergency Department on ___ with left-sided numbness of her hand and face and left hand clumsiness. She was evaluated in the ED and initially believed to have an MS flare and she was evaluted by Neurology service which resulted in the recommendation for an MRI brain. The MRI was read to demonstrate a right parietal lesion concerning for MS, metastatic disease or abscess. She was admitted to Neurosurgery for further evaluation and treatment. On ___, Mrs. ___ was taken to the OR for a right parietal craniotomy with cordisectomy, drainage and irrigation of brain abscess. She tolerated the procedure well. She was taken to PACU to recover then to the ICU. ID recommmend Vancomycin and Meropenem. Gram stain PRELIM: gram negative rods and gram positive cocci in pairs and chains. Post operative head CT showed post operative changes. On post operative exam she had left arm weakness. On ___ the patient continued on vancomycin and Meropenem. WBC was elevated to 19.0 from 15.7 on ___. She was transferred to the floor. Left arm weakness was slightly improved. the patient reported lethargy and left leg weakness. on exam the patient was sleepy but awake. she was oriented to person place and time. right sided strength was ___ and left upper extremity was ___ and left lower extremity was full except for IP which was 5-. A stat NCHCT was performed which was stable. On ___, consent for picc line placement obtained, picc line placed by IV nurse. She will continue with vanco and meropenum IV. Final abcess culture result is still pending. Exam remains stable. On ___ ___ evaluated the patient and found that she continues to have an unsteady gait and would not be safe to go home. They planned to visit her again on ___ for re-evaluation and to perform stair maneuvers with her. The final results on the abcess culture was streptococcus Milleri. New ID recommendations were to discontiniu Vanco and Meropenum, she was started on Ceftriaxone 2 grams and and Flagyl Tid. On ___, patient was re-evaluated by ___ and OT and cleared to be discharged home with the assistance of a cane. They also recommend services while patient is at home. She remained stable on examination. On ___, Mrs. ___ was seen and evaluated, she complained of headache and a non-contrast head CT was ordered. This showed the stable post-operative changes. Home services were established and the patient was discharged. ",2099,538
10001217-DS-5,"<SEX> F <SERVICE> NEUROSURGERY <ALLERGIES> Penicillins <ATTENDING> ___ <CHIEF COMPLAINT> Wound Infection <MAJOR SURGICAL OR INVASIVE PROCEDURE> Right Craniotomy and Evacuation of Abscess on ___ <HISTORY OF PRESENT ILLNESS> Ms. ___ is a ___ y/o woman with a past medical history of MS, and a right parietal brain abscess which was discovered approxiamtely one month ago, when she presented with left arm and face numbness. The abscess was drained in the OR on ___, and she was initially started on broad spectrum antibiotics until culture data returned with S. anginosus and fusobacterium, she was then transitioned to Ceftriaxone 2g IV q12h, and flagyl 500mg TID, which she has been on since through her PICC line. On ___, she was seen in ___ clinic and a repeat MRI was performed which revealed increased edema with persistent ring enhancing abnormality at the right parietal surgical site, concerning for ongoing abscess. She was therefore scheduled for repeat drainage on ___. She was seen as an outpatient in the infectious disease office today, ___, and it was recommended that she be admitted to the hospital one day early for broadening of her antibiotic regimen prior to drainage. She states that over the past month, her symptoms, including left upper extremity weakness and numbness, have come and gone, although she thinks that overall they have worsened slightly. She denies any fevers/chills, or headaches. No changes in vision, leg weakness or trouble with coordination or balance. She denies shortness of breath, chest pain, abdominal pain. <PAST MEDICAL HISTORY> Multiple sclerosis <SOCIAL HISTORY> ___ <FAMILY HISTORY> Mother with pancreatic cancer, brother-lung cancer, two sisters with brain cancer. <PHYSICAL EXAM> PHYSICAL EXAMINATION ON ADMISSION: General <PHYSICAL EXAM> General - Appears comfortable HEENT - MMM, no scleral icterus, no proptosis, sclera and conjunctiva with no edema/injection. Neck is supple. CV - RRR, no murmurs, rubs, or gallops. No carotid bruits Pulm - CTA b/l Abd - soft, non-tender, normal bowel sounds Extremities - no cyanosis, no edema Skin - warm and pink with no rashes Neurologic Exam: MENTAL STATUS: Awake and alert, oriented x 3, responds to multi-step commands which cross the midline. Knows recent and distant events. No hemisensory or visual neglect. PHYSICAL EXAMINATION ON DISCHARGE: XXXXXX <PERTINENT RESULTS> MRI Brain for Operative Planning: ___ Decrease in size of known right frontal vertex rim-enhancing lesion, but unchanged vasogenic edema and mass effect. Non-Contrast Head CT: ___ POST-OP SCAN IMPRESSION: Status post redo right parietal vertex craniotomy with no evidence of hemorrhage. Stable vasogenic edema extending in the right frontal and parietal lobes. <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. CeftriaXONE 1 gm IV Q12H 2. MetRONIDAZOLE (FLagyl) 500 mg PO TID 3. OxycoDONE (Immediate Release) 5 mg PO Q6H: PRN pain 4. Acetaminophen 325-650 mg PO Q6H: PRN pain 5. LeVETiracetam 1000 mg PO BID <DISCHARGE DISPOSITION> Home With Service Facility: ___ <DISCHARGE DIAGNOSIS> Brain Abscess <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> -Your staples should stay clean and dry until they are removed. -Have a friend or family member check the wound for signs of infection such as redness or drainage daily. -Take your pain medicine as prescribed if needed. You do not need to take it if you do not have pain. -Exercise should be limited to walking; no lifting >10lbs, straining, or excessive bending. -Increase your intake of fluids and fiber, as narcotic pain medicine can cause constipation. We generally recommend taking an over the counter stool softener, such as Docusate (Colace) while taking narcotic pain medication. -DO not take any anti-inflammatory medicines such as Motrin, Aspirin, Advil, or Ibuprofen etc. until follow up. -You have been discharged on Keppra (Levetiracetam) for anti-seizure medicine; you will not require blood work monitoring. -Do not drive until your follow up appointment. ","Ms. ___ is a ___ y/o F who was admitted to the neurosurgery service on the day of admission, ___ from the Infectious Disease Clinic in anticipation for evacuation of the brain abscess. She underwent a MRI prior surgery for operative planning. She underwent a right craniotomy and evacuation of abscess on ___. She tolerated the procedure well and was extubated in the operating room. She was then transferred to the ICU for recovery. She underwent a post-operative non-contrasat head CT which revealed normal post operative changes and no new hemorrahge. On ___, she was sitting in the chair, hemodynamically and neurologically intact. She transfered to the floor in stable conditions. Mrs. ___ was followed by Infectious Disease. They recommended that the patient be started on vancomycin and meropenem until culture data from her head wound was obtained. On ___, cultures revealed no growth. The patient was continued on Vancomycin, meropenem was changed to ertapenum. The patient continued to progress well, although she had some residual left-sided weakness. She also complained of some left-handed numbness and pain. On ___, the patient had a MR head with and without contrast including DWI, which showed slight improvement. She was discharged home on ___ with appropriate follow-up, and all questions were answered before discharge. ",1056,279
10001338-DS-6,"<SEX> F <SERVICE> SURGERY <ALLERGIES> Patient recorded as having No Known Allergies to Drugs <ATTENDING> ___. <CHIEF COMPLAINT> diverticulitis <MAJOR SURGICAL OR INVASIVE PROCEDURE> s/p laparoscopic sigmoid colectomy <HISTORY OF PRESENT ILLNESS> Mrs. ___ is a ___ F with history of recurrent diverticulitis, originally diagnosed ___ ___. Pt reports a one month history of LLQ pain varying ___ intensity. Pt was prescribed a 10 day course of Cipro/Flagyl PO which she completed on ___. Pt was doing well until abdominal pain returned ___, one week after finishing antibiotic course. Pt reports no nausea or vomiting, pt has been able to maintain hydration with regular PO intake although appetite has been somewhat decreased. Pt has been having regular, non-bloody bowel movements, pt reports several small, soft-brown bowel movements today. No diarrhea. Pt presents to ___ today as a direct admission for refractory LLQ pain. <PAST MEDICAL HISTORY> diverticulitis Migraines Left finger cellulitis <SOCIAL HISTORY> ___ <FAMILY HISTORY> father with h/o colitis <PHYSICAL EXAM> Crimson Admission Temp 98.6, HR 70, BP 110/70, RR 18, 96% RA Gen: well, NAD, A&O CV: RRR, No R/G/M RESP: CTAB ABD: Focal tenderness LLQ inferolateral to umbilicus, otherwise NT, ND, no guarding or rebound EXT: No edema <PERTINENT RESULTS> RADIOLOGY Final Report CT PELVIS W/CONTRAST ___ 2: 58 AM UNDERLYING MEDICAL CONDITION: ___ year old woman with diverticulitis, increasing RLQ pain IMPRESSION: Moderate uncomplicated diverticulitis at the junction of the descending colon and sigmoid colon. Stable mildly enlarged retroperitoneal lymph nodes may be reactive ___ nature. If surgery has not been contemplated, a followup is recommended ___ six weeks, to assess for complete resolution of these findings. . ___ 06: 05AM BLOOD WBC-9.9 RBC-2.85* Hgb-8.9* Hct-25.9* MCV-91 MCH-31.3 MCHC-34.4 RDW-13.0 Plt ___ ___ 09: 10AM BLOOD WBC-23.2*# RBC-3.73* Hgb-11.6* Hct-33.5* MCV-90 MCH-31.0 MCHC-34.5 RDW-13.0 Plt ___ ___ 05: 25AM BLOOD WBC-10.5 RBC-3.98* Hgb-12.7 Hct-34.4* MCV-87 MCH-32.0 MCHC-37.0* RDW-12.8 Plt ___ ___ 06: 05AM BLOOD Plt ___ ___ 05: 15AM BLOOD ___ PTT-28.3 ___ ___ 05: 25AM BLOOD ___ PTT-28.4 ___ ___ 06: 05AM BLOOD Glucose-109* UreaN-9 Creat-1.9* Na-138 K-3.2* Cl-100 HCO3-30 AnGap-11 ___ 05: 25AM BLOOD Glucose-127* UreaN-5* Creat-0.6 Na-138 K-4.0 Cl-102 HCO3-27 AnGap-13 ___ 06: 05AM BLOOD ALT-85* AST-49* LD(LDH)-204 AlkPhos-208* TotBili-0.7 ___ 05: 25AM BLOOD ALT-15 AST-14 LD(LDH)-149 AlkPhos-47 Amylase-42 TotBili-1.7* ___ 06: 05AM BLOOD Albumin-2.8* Calcium-8.2* Phos-2.8 Mg-2.4 ___ 05: 25AM BLOOD Albumin-4.0 Calcium-8.9 Phos-3.5 Mg-2.0 ___ 05: 15AM BLOOD Vanco-25.0* . ___ 12: 23 pm SWAB Site: ABDOMEN Fluid should not be sent ___ swab transport media. Submit fluids ___ a capped syringe (no needle), red top tube, or sterile cup. GRAM STAIN (Final ___: 1+ (<1 per 1000X FIELD): POLYMORPHONUCLEAR LEUKOCYTES. 4+ (>10 per 1000X FIELD): GRAM POSITIVE COCCI. ___ PAIRS, CHAINS, AND CLUSTERS FLUID CULTURE (Final ___: STAPH AUREUS COAG +. MODERATE GROWTH. CLINDAMYCIN PER ID.. This isolate is presumed to be resistant to clindamycin based on the detection of inducible resistance . ANAEROBIC CULTURE (Preliminary): NO ANAEROBES ISOLATED. ACID FAST SMEAR (Final ___: NO ACID FAST BACILLI SEEN ON DIRECT SMEAR. ACID FAST CULTURE (Preliminary): A swab is not the optimal specimen for recovery of mycobacteria or filamentous fungi. A negative result should be interpreted with caution. Whenever possible tissue biopsy or aspirated fluid should be submitted. FUNGAL CULTURE (Preliminary): NO FUNGUS ISOLATED. A swab is not the optimal specimen for recovery of mycobacteria or filamentous fungi. A negative result should be interpreted with caution. Whenever possible tissue biopsy or aspirated fluid should be submitted. . Pathology Examination SPECIMEN SUBMITTED: sigmoid colon. Procedure date ___ DIAGNOSIS: Sigmoid colon, segmental resection: Colonic segment with organizing pericolic abscess, consistent with ruptured diverticulum. Unremarkable regional lymph nodes. No intrinsic mucosal abnormalities seen. Clinical: Diverticulitis. . RADIOLOGY Final Report CT ABDOMEN W/CONTRAST ___ 10: 22 AM Reason: Rule out subcutaneous air or fluid. IV contrast ONLY. HISTORY: ___ female with recurrent diverticulitis, status post laparoscopic sigmoid colectomy, now with incisional erythema. Rule out subcutaneous air or fluid. IMPRESSION: 1. Status post sigmoid colectomy with a small amount of post-operative free intraperitoneal air and fluid within the pelvis. 2. Small amount of scattered subcutaneous air ___ the mid and lower anterior abdominal wall consistent with postsurgical change, without evidence of discrete fluid collection. <MEDICATIONS ON ADMISSION> Lexapro 10, nasonex <DISCHARGE MEDICATIONS> 1. Escitalopram 10 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 2. Fluticasone 50 mcg/Actuation Spray, Suspension Sig: One (1) Spray Nasal DAILY (Daily). 3. Colace 100 mg Capsule Sig: One (1) Capsule PO twice a day as needed for constipation for 1 months. Disp: *60 Capsule(s)* Refills: *0* 4. Lorazepam 0.5 mg Tablet Sig: One (1) Tablet PO Q8H (every 8 hours) as needed for anxiety. 5. Hydrocortisone 2.5 % Cream Sig: One (1) Appl Rectal TID (3 times a day) as needed for hemorrhoids. 6. Cephalexin 250 mg/5 mL Suspension for Reconstitution Sig: Two (2) PO q12hrs () for 5 days. Disp: *qs * Refills: *0* 7. Tylenol ___ mg Tablet Sig: Two (2) Tablet PO every ___ hours as needed for fever or pain. 8. Outpatient Lab Work Please check serum Creatinine on ___. **Call result to PCP and Dr. ___ ___ Disposition: Home With Service Facility: ___ <DISCHARGE DIAGNOSIS> Primary: Recurrent Diverticulitis Post-op wound cellulitis Post-op hypovolemia Post-op fever . Secondary: Anxiety diverticulosis <DISCHARGE CONDITION> Stable Tolerating a regular, low-residue diet Adequate pain control with oral medication <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Please call your doctor or return to the ER for any of the following: * You experience new chest pain, pressure, squeezing or tightness. * New or worsening cough or wheezing. * If you are vomiting and cannot keep ___ fluids or your medications. * You are getting dehydrated due to continued vomiting, diarrhea or other reasons. Signs of dehydration include dry mouth, rapid heartbeat or feeling dizzy or faint when standing. * You see blood or dark/black material when you vomit or have a bowel movement. * Your pain is not improving within ___ hours or not gone within 24 hours. Call or return immediately if your pain is getting worse or is changing location or moving to your chest or back. *Avoid driving or operating heavy machinery while taking pain medications. * You have shaking chills, or a fever greater than 101.5 (F) degrees or 38(C) degrees. * Any serious change ___ your symptoms, or any new symptoms that concern you. * Please resume all regular home medications and take any new meds as ordered. * Continue to ambulate several times per day. . WOUND CARE: *Assess surgical wound site daily. *Change packing at least once per day, and as needed. *Pack with moistened gauze (Normal Saline) into incisional cavity. Apply dry gauze on top, and adhere with paper tape. **Changed top (dry gauze) if saturated to prevent irritation to surrounding skin. **If wound continues to weep, pack with Aquacel or DSD. -You may shower briefly, and wash around surgical incisions. -Avoid swimming and tub baths until wound completely healed -Please call the doctor if you have increased pain, swelling, redness, or drainage from the incision sites. . CREATININE: *Please have the ___ check your creatinine on ___. Please call Dr. ___ and/or your PCP's office with the result. ","Mrs. ___ was directly admitted to ___ from Dr. ___ office with persistent abdominal pain likely related to diverticulitis flare. Her vitals signs and labwork remained stable excluding a slightly decreased hematocrit. She was started on IV Cipro & Flagyl, made NPO with IVF hydration, pain managment, and serial abdominal exams. . HD2-HD7-She underwent a abd CT scan which revealed uncomplicated diverticulitis. She continued with the above mentioned treatment regimen. Her abdominal pain responded well to IV Dilaudid. She had multiple non-bloody stools. She continued to ambulate without difficulty, and refused SC Heparing injections. Surgical options were discussed b/w patient and Dr. ___. Surgery planned for ___. TPN & PICC was not indicated. She was started on Ensure supplements. Operative consent, labwork, CXR, & EKG were collected. . HD8-She was made NPO overnight for surgery. Continue with IVF. Surgery was performed on ___. Her operative course was uncomplicated. Routinely observed ___ PACU, and transferred to ___. . POD1-Continued with IVF, NPO, and foley. PCA for pain management with adequate relief. . POD2-3-Reported flatus and had a small BM. Abdomen appropriately TTP/ND with active bowel sounds. Ffanesstial incision with increased erythema extending to right. IV Vancomycin started. No improvement ___ wound x 24 hrs. Zosyn added to regimen. Pain medication switched to PO medication. ___ pump removed. . POD4-5-Temp spike to 102.5, IV antibiotics started. WBC spike to 23 from 8 with 10% bands. Reports of persistent nausea-zofran mildly effective. Compazine added to regimen with improved effects. IVF continued. ID team consulted regarding antibiotic regimen. Underwent CT scan of abd with no significatn intra-abd findings. Wound opened at bedside on ___. Cultures of serous fluid sent to ___. Site packed with w-d dressing. Infectious reaction likely r/t GAS or staphylococcus aureus. Nasal swab for staphy collected & sent to Micro. Clindamycin IV added to regimen. Cultures were followed, and wound checked serially. T-max 100.7. Bump ___ creatinine noted 0.6 to 1.7. . POD6-wound culture positive for MSSA. IV Nafcillin added with continued Clinda. IV Vanco & Zosyn discontinued. CDIFF cultures negative x 3. Nasal swab for Staph cultured collected. Patient reports nausea still present, but better. Has been eating small amount of regular food with continued flatus and liquid stool production. Continues with IVF due to elevated Creatinine to 1.9. Adequate urine output. Ambulating independently. LFT's slightly elevated as well. . POD7-IV Clindamycin discontinued due to culture resistance. Nafcillin continued. Patient's status contiues to improve. Remains afebrile, decreased WBC, and improved appearance of wound including erythema. IVF switched to maintenance. . POD8-Nasal swab-no growth. Continues IVF & Nafcillin. Improved PO intake. Continues with complaints of intermittent nausea, improving slowly, & responsive to Compazine. Ambulating independently. Remains afebrile. POD9-Discharge day: Creatinine continued to decrease. Currently 1.4. Creatinine level will be collected per Home ___ on ___ ___, and called into PCP/Dr. ___. Continued to tolerate food with intermittent nausea, improved with eating. All PO narcotics discontinued, and Keflex switched to suspension which patient was better able to tolerate. ___ was set up for wound care. ",2244,808
10001338-DS-8,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> ___ <ATTENDING> ___. <CHIEF COMPLAINT> Abdominal pain <MAJOR SURGICAL OR INVASIVE PROCEDURE> Colonoscopy with biopsy ___ <HISTORY OF PRESENT ILLNESS> This patient is a ___ year old female with Hx of sigmoid diverticulitis s/p resection in ___, who complains of RLQ abdominal pain. The patient states that her pain began yesterday afternoon, worsened overnight and causing her to present to the ED around 3AM. She describes it as a ""gnawing"" pain, nonradiating, constant and ___ intensity. She states this feels similar to her episode of diverticulitis several years ago, only is present on the other side of her abdomen. She denies any fever, nausea, vomiting, SOB, Chest pain, BRBPR. She does endorse subjective feeling of chills. . Prior to the current episode, the patient reports having a ""sinus infection"" about 3 weeks ago that resolved over one week ago. About 2 weeks ago she also began taking a low dose OCP in order to treate perimenopausal cramping. On the second week she started to have spotting, with intermittent bleeding and LH this past week. She had an episode of diarrhea one week ago ___ morning), that was nonbloody and resolved on its own. Starting on ___ she has had a feeling of ""lightheadedness"" associated with diaphoresis and nausea. . In the ED, initial VS were: 8 97.2 88 117/64 18 100%. Patient was given morphine 4 mg IV, dilaudid 0.5 mg IV x 6, zofran 4 mg IV, and 3 L NS. She underwent bimanual exam that was reportedly without signs of mass, CMT, or adnexal tenderness. Labs were notable for a leukocytosis of 11, but were otherwise unremarkable. CT abdomen showed normal appendix but thick-walled cecum with appearance of possible mass. Pelvic ultrasound did not show any source of her pain. As she did not have adequate relief with pain medications, she was admitted to the medical service for pain control. . Vitals on transfer were 97.2 68 98/55 18 100%RA . On the floor, patient reported continued ___ pain in the RLQ, along with some mild nausea. . Review of systems: (+) Per HPI (-) Denies fever, chills, night sweats, recent weight loss or gain. Denies headache, sinus tenderness, rhinorrhea or congestion. Denied cough, shortness of breath. Denied chest pain or tightness, palpitations. Denied vomiting, diarrhea, constipation or BRBPR. No dysuria. Denied arthralgias or myalgias. <PAST MEDICAL HISTORY> Hx diverticulitis s/p sigmoid resection ___ Anxiety Allergic rhinitis GERD Eczema Migraine headaches Eustacian tube dysfunction <SOCIAL HISTORY> ___ <FAMILY HISTORY> Father with hx of colitis, F died lung Ca, Aunt with breast ___, Paternal GM with stomach Ca, Mother with CHF and DM2 <PHYSICAL EXAM> Vitals: T: 97.6 BP: 96/62 P: 68 R: 18 O2: 99% on RA General: Alert, oriented, no acute distress HEENT: Sclera anicteric, MMM, oropharynx clear Neck: supple, JVP not elevated, no LAD Lungs: Clear to auscultation bilaterally, no wheezes, rales, rhonchi CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Abdomen: soft, non-distended, bowel sounds present, TTP in RLQ with deep palpation only, no rebound tenderness or guarding, no organomegaly Ext: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema <PERTINENT RESULTS> Laboratory Findings: ___ 03: 30AM BLOOD WBC-11.3* RBC-3.93* Hgb-12.2 Hct-34.9* MCV-89 MCH-31.0 MCHC-34.8 RDW-12.8 Plt ___ ___ 03: 30AM BLOOD Neuts-76.5* ___ Monos-2.8 Eos-1.8 Baso-0.4 ___ 05: 26AM BLOOD ___ ___ 03: 30AM BLOOD Glucose-123* UreaN-16 Creat-0.8 Na-137 K-4.6 Cl-101 HCO3-25 AnGap-16 ___ 03: 30AM BLOOD ALT-16 AST-37 AlkPhos-36 TotBili-0.5 ___ 03: 30AM BLOOD Lipase-28 ___ 05: 27AM BLOOD Calcium-8.3* Phos-2.0*# Mg-2.0 ___ 03: 39AM BLOOD Lactate-0.9 ___ 05: 26AM BLOOD WBC-5.4 RBC-3.41* Hgb-10.6* Hct-30.6* MCV-90 MCH-31.1 MCHC-34.7 RDW-12.5 Plt ___ ___ 05: 26AM BLOOD Glucose-88 UreaN-5* Creat-0.7 Na-144 K-4.1 Cl-106 HCO3-28 AnGap-14 ___ 03: 30AM URINE Color-Straw Appear-Clear Sp ___ ___ 03: 30AM URINE Blood-TR Nitrite-NEG Protein-NEG Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.5 Leuks-MOD ___ 03: 30AM URINE RBC-<1 WBC-3 Bacteri-FEW Yeast-NONE Epi-0 Microbiology: URINE CULTURE (Final ___: <10,000 organisms/ml Blood Culture ___: No growth (not final at time of discharge) Imaging: Pelvic U/S ___: FINDINGS: Transabdominally the uterus measures 8.6 x 4.6 x 5.4 cm, and is slightly heterogeneous in appearance with no distinct fibroids seen. Transvaginal exam was performed for better evaluation of the uterus and adnexa. The endometrial stripe measures 5 mm. The left ovary measures 3.5 x 1.6 x 1.8 cm. The right ovary measures 2.9 x 1.4 x 1.7 cm. There is a small echogenic focus within the right ovary measuring 5 x 4 x 4 mm, likely a small hemorrhagic cyst. Both ovaries demonstrate normal arterial and venous waveforms. IMPRESSION: 1. No evidence of ovarian torsion. 2. Small right ovarian hemorrhagic cyst. . CT abd/pelvis w/o contrast ___: Scattered calcified granulomas in the lung bases are stable. There is no new focal pulmonary nodule, consolidation, or effusion. The cardiac apex is within normal limits. Complete evaluation of the intra-abdominal viscera is limited by the non-contrast technique. However, the liver appears homogeneous without focal lesion. No intra- or extra-hepatic biliary ductal dilatation is identified. The gallbladder, spleen, and pancreas appear within normal limits. The adrenal glands are symmetric without focal nodule. The kidneys appear homogeneous without focal lesion or hydronephrosis. The abdominal aorta is non-aneurysmal throughout its visualized course. The second and third portions of the duodenum are equivocally thickened which may be due to underdistension. No small bowel obstruction is identified. The appendix is well visualized and is normal in appearance. There is no free fluid or free air. CT PELVIS WITHOUT INTRAVENOUS CONTRAST ___: Initial images demonstrated a solid mass like abnormality in the cecal tip measuring approximately 3 cm (2: 51). As this was potentially concerning for a cecal mass, rescanning of a limited portion of pelvis was performed after passage of oral contrast, confirming the finding and demonstrating a 3 cm mass with thickening of the adjacent cecal wall (601: 15). The adjacent appendix is normal and there is no pericecal inflammatory change. The remainder of the colon is normal without evidence of obstruction or inflammation. The surgical anastomosis within the lower midline pelvis appears unremarkable. There is no pelvic free fluid. The uterus and adnexa appear within normal limits. The bladder is markedly distended but is otherwise unremarkable. No pathologically enlarged pelvic or inguinal lymph nodes are identified. OSSEOUS STRUCTURES: No bone destructive lesion or acute fracture is identified. IMPRESSION: 1. Findings consistent with a 3 cm cecal mass and thickening of the cecal tip concerning for neoplasm. Atypical infectious process causing this appearance is felt less likely due to lack of inflammatory stranding. Recommend colonoscopy for further evaluation. 2. Normal appendix, no signs of inflammation. 3. No small or large bowel obstruction. 4. Equivocal thickening of duodenum likely related to underdistention. Colonoscopy ___: Findings: Lumen: Evidence of a previous end to end ___ anastomosis was seen at the sigmoid colon. Protruding Lesions A ulcerated 3 cm mass of malignant appearance was found in the cecum. The scope traversed the lesion. Cold forceps biopsies were performed for histology at the cecum. Excavated Lesions Multiple diverticula with small openings were seen in the descending colon. Impression: Mass in the cecum (biopsy) Diverticulosis of the descending colon Previous end to end ___ anastomosis of the sigmoid colon Otherwise normal colonoscopy to cecum and terminal ileum . PATHOLOGY: DIAGNOSIS: ""Cecal mass"", mucosal biopsies: Colonic mucosa with focal ischemic change and abundant associated ulceration, exudate, and granulation tissue formation; no carcinoma or dysplasia in these samples. Five levels are examined. <MEDICATIONS ON ADMISSION> -Fish Oil 1,000 mg Cap -Axert 12.5 mg Tab 1 Tablet(s) by mouth at onset of HA may repeat in 2 hour up till 2 a day -Lexapro 10 mg Tab daily -Cholecalciferol (Vitamin D3) 1,000 unit Tab -lorazepam 0.5 mg Tab qd prn -Omeprazole 20 mg Cap, Delayed Release BID -tramadol 50 mg Tab every six (6) hours as needed for pain -oxycodone 5 mg Tab ___ Tablet(s) by mouth qhs prn as needed for pain -Multivitamin Cap -Zantac 150 mg Cap 1 Capsule(s) by mouth twice a day -Fluticasone 50 mcg/Actuation Nasal Spray, Susp 2 sprays(s) intranasally for 7d, then 1 spray qd -Calcium Citrate 1,000 mg Tab -OCPs - Camrasce? started 2 weeks ago <DISCHARGE MEDICATIONS> 1. omega-3 fatty acids Capsule Sig: One (1) Capsule PO DAILY (Daily). 2. Axert 12.5 mg Tablet Sig: One (1) Tablet PO once a day as needed for migraine. 3. escitalopram 10 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 4. cholecalciferol (vitamin D3) 1,000 unit Capsule Sig: One (1) Capsule PO once a day. 5. lorazepam 0.5 mg Tablet Sig: One (1) Tablet PO HS (at bedtime) as needed for anxiety. 6. omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) Capsule, Delayed Release(E.C.) PO BID (2 times a day). 7. multivitamin Tablet Sig: One (1) Tablet PO DAILY (Daily). 8. ranitidine HCl 150 mg Tablet Sig: One (1) Tablet PO BID (2 times a day). 9. fluticasone 50 mcg/Actuation Spray, Suspension Sig: One (1) Spray Nasal DAILY (Daily). 10. calcium carbonate 500 mg calcium (1,250 mg) Tablet Sig: Two (2) Tablet PO once a day. <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Cecal Mass Hemorrhagic ovarian cyst <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Ms. ___, You were admitted to the hospital for abdominal pain, which we think was related to a hemorrhagic ovarian cyst. You were treated with analgesics, and your pain resolved. You also had a CAT scan showing a mass in the cecum. You underwent a colonoscopy to biopsy this mass, and you should follow-up with your gastroenterologist. You should also see your gynecologist regarding the need to restart your oral contraceptive. We did not make any changes to your home medications. ","The patient is a ___ year-old female with history significant for diverticulitis s/p sigmoid resection in ___, who presented with abdominal pain and was found to have cecal mass. . # Abdominal pain: Was most likely related to hemorrhagic ovarian cyst. Initially, patient had significant pain that was not relieved with dilaudid. However, over the course of several days her pain resolved on its own and she no longer required any pain medications. Bloodwork and imaging were not suggestive of any intra-abdominal infection. The patient was advised to follow-up with her gynecologist regarding her ovarian cyst, and the need for continued therapy with low dose oral contraceptive. . # Cecal Mass: During the workup of this patient's abdominal pain, a CT of the abdomen and pelvis revealed a 3 cm cecal mass concerning for malignancy. During this hospitalization she underwent colonoscopy with biopsy of the mass. She was instructed to follow-up with her outpatient gastroenterologist regarding the results of this biopsy in one week. The biopsy was negative for malignancy. . # Anxiety - Patient was continued on home regimen of zoloft and ativan. . # Gerd - Patient continued on omeprazole, zantac BID per outpatient regimen. ",2952,261
10001401-DS-17,"<SEX> F <SERVICE> UROLOGY <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> Bladder cancer <MAJOR SURGICAL OR INVASIVE PROCEDURE> robotic anterior exenteration and open ileal conduit <HISTORY OF PRESENT ILLNESS> ___ with invasive bladder cancer, pelvic MRI concerning for invasion into anterior vaginal wall, now s/p robotic anterior exent (Dr ___ and open ileal conduit (Dr ___. <PAST MEDICAL HISTORY> Hypertension, laparoscopic cholecystectomy six months ago, left knee replacement six to ___ years ago, laminectomy of L5-S1 at age ___, two vaginal deliveries. <SOCIAL HISTORY> ___ <FAMILY HISTORY> Negative for bladder CA. <PHYSICAL EXAM> A&Ox3 Breathing comfortably on RA WWP Abd S/ND/appropriate postsurgical tenderness to palpation Urostomy pink, viable <PERTINENT RESULTS> ___ 06: 50AM BLOOD WBC-7.6 RBC-3.41* Hgb-10.6* Hct-32.5* MCV-95 MCH-31.1 MCHC-32.6 RDW-14.4 RDWSD-50.2* Plt ___ ___ 06: 50AM BLOOD Plt ___ ___ 06: 45AM BLOOD Glucose-117* UreaN-23* Creat-0.6 Na-136 K-4.4 Cl-104 HCO3-23 AnGap-13 ___ 06: 45AM BLOOD Calcium-7.9* Phos-3.4 Mg-2.0 <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Heparin 5000 UNIT SC ONCE Start: in O.R. Holding Area 2. Losartan Potassium 50 mg PO DAILY 3. Atorvastatin 10 mg PO QPM 4. Levothyroxine Sodium 175 mcg PO DAILY <DISCHARGE MEDICATIONS> 1. Acetaminophen 650 mg PO Q6H 2. Docusate Sodium 100 mg PO BID take while taking narcotic pain meds RX *docusate sodium [Colace] 100 mg 1 capsule(s) by mouth twice a day Disp #*50 Capsule Refills: *0 3. Enoxaparin Sodium 40 mg SC DAILY Start: ___, First Dose: Next Routine Administration Time RX *enoxaparin 40 mg/0.4 mL 40 mg sc daily Disp #*28 Syringe Refills: *0 4. Nitrofurantoin Monohyd (MacroBID) 100 mg PO DAILY take while ureteral stents are in place RX *nitrofurantoin monohyd/m-cryst [Macrobid] 100 mg 1 capsule(s) by mouth daily Disp #*14 Capsule Refills: *0 5. OxyCODONE (Immediate Release) 5 mg PO Q4H: PRN Pain - Moderate RX *oxycodone 5 mg 1 tablet(s) by mouth q4h prn Disp #*30 Tablet Refills: *0 6. Atorvastatin 10 mg PO QPM 7. Levothyroxine Sodium 175 mcg PO DAILY 8. Losartan Potassium 50 mg PO DAILY <DISCHARGE DISPOSITION> Extended Care Facility: ___ <DISCHARGE DIAGNOSIS> Bladder cancer <DISCHARGE CONDITION> WdWn, NAD, AVSS Abdomen soft, appropriately tender along incision Incision is c/d/I (steris) Stoma is well perfused; Urine color is yellow Ureteral stent noted via stoma JP drain has been removed Bilateral lower extremities are warm, dry, well perfused. There is no reported calf pain to deep palpation. No edema or pitting <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> -Please also refer to the handout of instructions provided to you by your Urologist -Please also refer to the instructions provided to you by the Ostomy nurse specialist that details the required care and management of your Urostomy -You will be sent home with Visiting Nurse ___ services to facilitate your transition to home care of your urostomy -Resume your pre-admission/home medications except as noted. Always call to inform, review and discuss any medication changes and your post-operative course with your primary care doctor -___ you have been prescribed IBUPROFEN, please note that you may take this in addition to the prescribed NARCOTIC pain medications and/or tylenol. FIRST, alternate Tylenol (acetaminophen) and Ibuprofen for pain control. -REPLACE the Tylenol with the prescribed narcotic if the narcotic is combined with Tylenol (examples include brand names ___, Tylenol #3 w/ codeine and their generic equivalents). ALWAYS discuss your medications (especially when using narcotics or new medications) use with the pharmacist when you first retrieve your prescription if you have any questions. Use the narcotic pain medication for break-through pain that is >4 on the pain scale. -The MAXIMUM dose of Tylenol (ACETAMINOPHEN) is 4 grams (from ALL sources) PER DAY and remember that the prescribed narcotic pain medication may also contain Tylenol (acetaminophen) so this needs to be considered when monitoring your daily dose and maximum. -If you are taking Ibuprofen (Brand names include ___ this should always be taken with food. If you develop stomach pain or note black stool, stop the Ibuprofen. -Please do NOT drive, operate dangerous machinery, or consume alcohol while taking narcotic pain medications. -Do NOT drive and until you are cleared to resume such activities by your PCP or urologist. You may be a passenger -Colace may have been prescribed to avoid post surgical constipation and constipation related to narcotic pain medication. Discontinue if loose stool or diarrhea develops. Colace is a stool-softener, NOT a laxative. -You may shower 2 days after surgery, but do not tub bathe, swim, soak, or scrub incision for 2 weeks -If you had a drain or skin clips (staples) removed from your abdomen; bandage strips called steristrips have been applied to close the wound OR the site was covered with a gauze dressing. Allow any steristrips/bandage strips to fall off on their own ___ days). PLEASE REMOVE any ""gauze"" dressings within two days of discharge. Steristrips may get wet. -No heavy lifting for 4 weeks (no more than 10 pounds). Do ""not"" be sedentary. Walk frequently. Light household chores (cooking, folding laundry, washing dishes) are generally ok but AGAIN, avoid straining, pulling, twisting (do NOT vacuum). ","Ms. ___ was admitted to the Urology service after undergoing [robotic anterior exenteration with ileal conduit]. No concerning intrao-perative events occurred; please see dictated operative note for details. Patient received ___ intravenous antibiotic prophylaxis and deep vein thrombosis prophylaxis with subcutaneous heparin. The post-operative course was notable for several episodes of emesis prompting NGT placement on ___. Pt self removed the NGT on ___, but nausea/emesis resolved thereafter and pt was gradually advanced to a regular diet with passage of flatus without issue. With advacement of diet, patient was transitioned from IV pain medication to oral pain medications. The ostomy nurse saw the patient for ostomy teaching. At the time of discharge the wound was healing well with no evidence of erythema, swelling, or purulent drainage. Her drain was removed. The ostomy was perfused and patent, and one ureteral stent had fallen out spontaneously. ___ was consulted and recommended disposition to rehab. Post-operative follow up appointments were arranged/discussed and the patient was discharged to rehab for further recovery. ",1521,231
10001401-DS-18,"<SEX> F <SERVICE> UROLOGY <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> Abdominal pain, distention, nausea <MAJOR SURGICAL OR INVASIVE PROCEDURE> Interventional radiology placement of abdominal abscess drain <HISTORY OF PRESENT ILLNESS> ___ F with h/o muscle invasive bladder cancer, returning to the ED POD 15 with abdominal pain, nausea, and distension. She has been obstipated for nearly three days. KUB and CT scan notable for dilated loops, air fluids, and tapering small bowel without an obvious transition point. Labwork notable for ___ and leukocytosis. Concerned for small bowel obstruction or an ileus in presence ___ and leukocytosis she was re-admitted for IVF, bowel rest, NGT decompression. <PAST MEDICAL HISTORY> Hypertension, laparoscopic cholecystectomy, left knee replacement six to ___ years ago, laminectomy of L5-S1 at age ___, two vaginal deliveries. s/p ___: 1. Robot-assisted laparoscopic bilateral pelvic lymph node dissection. 2. Robot-assisted hysterectomy and bilateral oophorectomy for large uterus, greater than 300 grams, with large fibroid. 3. Laparoscopic radical cystectomy and anterior vaginectomy with vaginal reconstruction. <SOCIAL HISTORY> ___ <FAMILY HISTORY> Negative for bladder CA. <PHYSICAL EXAM> WdWn, NAD, AVSS Abdomen soft, appropriately tender along incision Incision is c/d/I Stoma is well perfused; Urine color is yellow Bilateral lower extremities are warm, dry, well perfused. There is no reported calf pain to deep palpation. Bilateral lower extremities have 2+ pitting edema but no erythema, callor, pain. Pigtail drain has been removed - dressing c/d/i <PERTINENT RESULTS> ___ 05: 58AM BLOOD WBC-9.9 RBC-2.76* Hgb-8.2* Hct-26.2* MCV-95 MCH-29.7 MCHC-31.3* RDW-13.9 RDWSD-47.3* Plt ___ ___ 06: 45AM BLOOD WBC-10.3* RBC-2.87* Hgb-8.7* Hct-27.7* MCV-97 MCH-30.3 MCHC-31.4* RDW-14.0 RDWSD-49.4* Plt ___ ___ 05: 13AM BLOOD WBC-11.6* RBC-3.27* Hgb-9.8* Hct-31.0* MCV-95 MCH-30.0 MCHC-31.6* RDW-13.6 RDWSD-47.5* Plt ___ ___ 07: 06PM BLOOD WBC-22.5*# RBC-3.58* Hgb-10.9* Hct-34.0 MCV-95 MCH-30.4 MCHC-32.1 RDW-13.9 RDWSD-47.9* Plt ___ ___ 07: 06PM BLOOD Neuts-89* Bands-1 Lymphs-5* Monos-3* Eos-0 Baso-0 ___ Metas-1* Myelos-0 Hyperse-1* AbsNeut-20.48* AbsLymp-1.13* AbsMono-0.68 AbsEos-0.00* AbsBaso-0.00* ___ 01: 04PM BLOOD ___ PTT-30.9 ___ ___ 05: 58AM BLOOD Glucose-106* UreaN-26* Creat-0.4 Na-136 K-4.6 Cl-107 HCO3-26 AnGap-8 ___ 06: 45AM BLOOD Glucose-114* UreaN-32* Creat-0.4 Na-137 K-4.1 Cl-106 HCO3-25 AnGap-10 ___ 06: 00AM BLOOD Glucose-121* UreaN-39* Creat-0.4 Na-140 K-3.6 Cl-107 HCO3-26 AnGap-11 ___ 07: 06PM BLOOD Glucose-117* UreaN-60* Creat-1.7*# Na-133 K-5.0 Cl-96 HCO3-21* AnGap-21* ___ 08: 30AM BLOOD ALT-20 AST-19 AlkPhos-77 ___ 05: 58AM BLOOD Calcium-7.6* Phos-2.8 Mg-2.2 ___ 06: 45AM BLOOD Calcium-7.7* Phos-2.4* Mg-2.1 ___ 08: 30AM BLOOD Albumin-1.8* Calcium-7.7* Phos-3.5 Mg-2.1 Iron-23* ___ 07: 06PM BLOOD Calcium-8.0* Phos-5.5* Mg-2.2 ___ 08: 30AM BLOOD calTIBC-116* Ferritn-789* TRF-89* ___ 05: 09AM BLOOD Triglyc-106 ___ 08: 30AM BLOOD Triglyc-89 ___ 07: 06PM BLOOD Lactate-1.5 ___ 03: 00PM ASCITES Creat-0.4 Amylase-18 Triglyc-29 Lipase-8 ___ 03: 00PM OTHER BODY FLUID Creat-0.5 ___ 7: 12 pm BLOOD CULTURE **FINAL REPORT ___ Blood Culture, Routine (Final ___: CITROBACTER KOSERI. FINAL SENSITIVITIES. SENSITIVITIES: MIC expressed in MCG/ML _________________________________________________________ CITROBACTER KOSERI | CEFEPIME-------------- <=1 S CEFTAZIDIME----------- <=1 S CEFTRIAXONE----------- <=1 S CIPROFLOXACIN---------<=0.25 S GENTAMICIN------------ <=1 S MEROPENEM-------------<=0.25 S PIPERACILLIN/TAZO----- <=4 S TOBRAMYCIN------------ <=1 S TRIMETHOPRIM/SULFA---- <=1 S Aerobic Bottle Gram Stain (Final ___: GRAM NEGATIVE ROD(S). Reported to and read back by ___ ___, @14: 35 ON ___. ___ 3: 00 pm ABSCESS . PELVIC ASPIRATION. **FINAL REPORT ___ GRAM STAIN (Final ___: 4+ (>10 per 1000X FIELD): POLYMORPHONUCLEAR LEUKOCYTES. 1+ (<1 per 1000X FIELD): GRAM NEGATIVE ROD(S). WOUND CULTURE (Final ___: NO GROWTH. ANAEROBIC CULTURE (Final ___: BACTEROIDES FRAGILIS GROUP. SPARSE GROWTH. BETA LACTAMASE POSITIVE. ___ 10: 52 am STOOL CONSISTENCY: NOT APPLICABLE Source: Stool. **FINAL REPORT ___ C. difficile DNA amplification assay (Final ___: Negative for toxigenic C. difficile by the Illumigene DNA amplification assay. (Reference Range-Negative). <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Atorvastatin 10 mg PO QPM 2. Levothyroxine Sodium 175 mcg PO DAILY 3. Losartan Potassium 50 mg PO DAILY 4. Acetaminophen 650 mg PO Q6H 5. Docusate Sodium 100 mg PO BID 6. Enoxaparin Sodium 40 mg SC DAILY 7. Nitrofurantoin Monohyd (MacroBID) 100 mg PO DAILY 8. OxyCODONE (Immediate Release) 5 mg PO Q4H: PRN Pain - Moderate <DISCHARGE MEDICATIONS> 1. Ciprofloxacin HCl 500 mg PO Q12H Duration: 7 Days Last dose ___ 2. MetroNIDAZOLE 500 mg PO Q6H Duration: 7 Days Last dose ___ 3. Senna 8.6 mg PO BID 4. Acetaminophen 650 mg PO Q6H 5. Atorvastatin 10 mg PO QPM 6. Docusate Sodium 100 mg PO BID 7. Enoxaparin Sodium 40 mg SC DAILY Start: ___, First Dose: Next Routine Administration Time 8. Levothyroxine Sodium 175 mcg PO DAILY 9. LORazepam 0.25 mg PO BID: PRN anxiety 10. Losartan Potassium 50 mg PO DAILY 11. Nitrofurantoin Monohyd (MacroBID) 100 mg PO DAILY 12. OxyCODONE (Immediate Release) 5 mg PO Q4H: PRN Pain - Moderate <DISCHARGE DISPOSITION> Extended Care Facility: ___ <DISCHARGE DIAGNOSIS> bladder cancer, post-operative ileus, bacteremia (CITROBACTER KOSERI) and abdominal-pelvic abscess (BACTEROIDES FRAGILIS GROUP) requiring ___ drainage <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> -Please also refer to the instructions provided to you by the Ostomy nurse specialist that details the required care and management of your Urostomy -Resume your pre-admission/home medications except as noted. Always call to inform, review and discuss any medication changes and your post-operative course with your primary care doctor -___ (acetaminophen) and Ibuprofen for pain control. -Ciprofloxacin and Metronidazole are new ANTIBIOTIC medications to treat your infection. Continue for 7 days through ___. -The MAXIMUM dose of Tylenol (ACETAMINOPHEN) is 3 grams (from ALL sources) PER DAY -If you are taking Ibuprofen (Brand names include ___ this should always be taken with food. If you develop stomach pain or note black stool, stop the Ibuprofen. -Please do NOT drive, operate dangerous machinery, or consume alcohol while taking narcotic pain medications. -Do NOT drive and until you are cleared to resume such activities by your PCP or urologist. You may be a passenger -Colace may have been prescribed to avoid post surgical constipation and constipation related to narcotic pain medication. Discontinue if loose stool or diarrhea develops. Colace is a stool-softener, NOT a laxative. -No heavy lifting for 4 weeks (no more than 10 pounds). Do ""not"" be sedentary. Walk frequently. Light household chores (cooking, folding laundry, washing dishes) are generally ok but AGAIN, avoid straining, pulling, twisting (do NOT vacuum). ","Ms. ___ was admitted to Dr. ___ service for management of ileus. Upon admission, a nasogastric tube was placed for decompression. On ___, PICC was placed and TPN started. Blood cultures grew gram negative rods and ceftriaxone was started. On ___, pt started to pass small amount of flatus. ___ CT scan demonstrated improving ileus, but concern for possible urine leak and increased free fluid. On ___, a LLQ drain was placed by interventional radiology. on ___, pt passed clamp trial and NGT was removed. Pt continued to pass flatus and also started to have bowel movements. On ___, pt was advanced to a clear liquid diet. Repeat blood cultures were negative and positive blood culture from admission grew citrobacter. Diet was gradually advanced and ensure added. IV medications were gradually converted to PO and she was re-evaluated by physical therapy for rehabilitative services. She was ambulating with walker assistance and prepared for discharge to her ___ facility (___). TPN was continued up until day before discharge. At time of discharge, she was tolerating regular diet, passing flatus regularly and having bowel movements. ",2475,241
10001401-DS-19,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___ <CHIEF COMPLAINT> dyspnea on exertion <MAJOR SURGICAL OR INVASIVE PROCEDURE> None <HISTORY OF PRESENT ILLNESS> Patient is a ___ year old woman s/p robotic radical cystectomy ___ (with ileal conduit creation) with postop course complicated by bacteremia and abscess, LLE DVT (on prophylactic dosing lovenox) who presents with dyspnea on exertion for past 3 days. Briefly, patient was initially admitted to the Urology service from ___ for robotic anterior exenteration with ileal conduit. She was discharged to rehab on prophylactic dosing lovenox for 1 month. She was then readmitted from ___ for ileus requiring NGT decompression, TPN. BCx grew Citrobacter, for which CTX was started. CT showed intra-abdominal, interloop, simple fluid collection and LLQ drain was placed by ___. Patient improved, passing BMs and tolerating PO, and was discharged on cipro/flagyl. She was also discharged on PO Bactrim for presumed UTI, though unclear if she actually took this. During this admission, she was noted to have new bilateral ___ edema. LENIs at the time showed aute deep vein thrombosis of the duplicated mid and distal left femoral veins. She was discharged on Enoxaparin Sodium 40 mg SC daily. She reports that her PCP started PO ___ 20mg daily and since then there has been improvement of the swelling. Per her report, a repeat ___ at the rehab facility (___) was negative for DVT. Patient reports that she recovered well post-operatively and was doing well at her assisted living facility up until a week ago when she began experiencing dyspnea on exertion. She states that she typically is able to ambulate a block before stopping to catch her breath, however in the past week she has been unable to take more than a few steps. She states that it has become increasingly more difficult to ambulate from her bedroom to the bathroom. When visited by the NP her ambulatory saturation was noted to be in the ___ with associated tachycardia to 110, pallor and diaphoresis. She endorses associated leg swelling left worse than right, and she states that her thighs ""feel heavy"". She denies any associated chest pain, fever, chills, pain with deep inspiration, abdominal pain, rashes, dizziness, lightheadedness. In the ED, initial VS were: 97.7 72 136/93 20 100% Nasal Cannula ED physical exam was recorded as patient resting comfortably with NC, pursed lip breathing, unable to speak in full sentences before becoming short of breath, urostomy pouch in RLQ, stoma pink, 2+ edema to bilateral lower extremities L>R. ED labs were notable for: Hb 9, Hct 29, plt 479, UA: large ___, >182 WBC, many bact 0 epi. Trop neg x1, proBNP normal CTA chest showed: 1. Extensive pulmonary embolism with thrombus seen extending from the right main pulmonary artery into the segmental and subsegmental right upper, middle, and lower lobe pulmonary arteries. No right heart strain identified. 2. Additionally, there are smaller pulmonary emboli seen in the segmental and subsegmental branches of the left upper and lower lobes. 3. Several pulmonary nodules are noted, as noted previously, with the largest appearing spiculated and measuring up to 1 cm in the right middle lobe, suspicious for malignancy on the previous PET-CT. 4. Re- demonstration of 2 left breast nodules for which correlation with mammography and ultrasound is suggested. EKG showed NSR with frequent PAC Patient was given: ___ 20: 26 PO/NG Ciprofloxacin HCl 500 mg ___ 20: 26 IV Heparin 6600 UNIT ___ 20: 26 IV Heparin Transfer VS were: 98.1 77 145/63 20 99% Nasal Cannula When seen on the floor, she reports significant dyspnea with minimal exertion. Denies chest pain, palpitations, lightheadedness. A ten point ROS was conducted and was negative except as above in the HPI. <PAST MEDICAL HISTORY> Hypertension, laparoscopic cholecystectomy, left knee replacement six to ___ years ago, laminectomy of L5-S1 at age ___, two vaginal deliveries. s/p ___: 1. Robot-assisted laparoscopic bilateral pelvic lymph node dissection. 2. Robot-assisted hysterectomy and bilateral oophorectomy for large uterus, greater than 300 grams, with large fibroid. 3. Laparoscopic radical cystectomy and anterior vaginectomy with vaginal reconstruction. <SOCIAL HISTORY> ___ <FAMILY HISTORY> Negative for bladder CA. <PHYSICAL EXAM> ADMISSION EXAM: Gen: NAD, speaking in 3 word sentences, pursed lip breathing, no accessory muscle use, lying in bed Eyes: EOMI, sclerae anicteric ENT: MMM, OP clear Cardiovasc: RRR, no MRG, full pulses, 1+ edema bilaterally with compression stockings in place, no JVD Resp: normal effort, no accessory muscle use, lungs CTA ___ to anterior auscultation. GI: soft, NT, ND, BS+. Urostomy site does not appear infected MSK: No significant kyphosis. No palpable synovitis. Skin: No visible rash. No jaundice. Neuro: AAOx3. No facial droop. Psych: Full range of affect DISCHARGE EXAM: vitals: 98.3 140/42 90 24 96% 1L Gen: Lying in bed in no apparent distress HEENT: Anicteric, MMM Cardiovascular: RRR normal S1, S2, no right sided heave, ___ systolic murmur Pulmonary: Lung fields clear to auscultation throughout. No crackles or wheezing. GI: Soft, distended, nontender, bowel sounds present, urostomy in place. Extremities: no edema, though left leg appears larger than right leg, warm, well perfused with motor function intact. Her left lower leg is wrapped. <PERTINENT RESULTS> LABS: -========= Admission labs: ___ 02: 40PM GLUCOSE-101* UREA N-22* CREAT-0.7 SODIUM-136 POTASSIUM-4.1 CHLORIDE-98 TOTAL CO2-22 ANION GAP-20 ___ 02: 40PM cTropnT-<0.01 ___ 02: 40PM proBNP-567 ___ 02: 40PM WBC-7.7 RBC-3.07* HGB-9.0* HCT-29.1* MCV-95 MCH-29.3 MCHC-30.9* RDW-14.9 RDWSD-52.1* ___ 02: 40PM PLT COUNT-479* ___ 02: 40PM ___ PTT-33.4 ___ Discharge labs: ___ 06: 55AM BLOOD WBC-11.0* RBC-2.60* Hgb-7.5* Hct-24.5* MCV-94 MCH-28.8 MCHC-30.6* RDW-14.8 RDWSD-51.4* Plt ___ ___ 06: 55AM BLOOD Glucose-99 UreaN-10 Creat-0.5 Na-141 K-4.3 Cl-105 HCO3-26 AnGap-14 ___ 06: 55AM BLOOD Calcium-8.2* Phos-3.8 Mg-2.0 ___ 07: 15AM BLOOD calTIBC-134* Ferritn-507* TRF-103* ___ 07: 15AM BLOOD Iron-18* MICROBIOLOGY -========= ___ 4: 30 pm URINE **FINAL REPORT ___ URINE CULTURE (Final ___: MIXED BACTERIAL FLORA ( >= 3 COLONY TYPES), CONSISTENT WITH SKIN AND/OR GENITAL CONTAMINATION. ENTEROCOCCUS SP.. >100,000 CFU/mL. PREDOMINATING ORGANISM INTERPRET RESULTS WITH CAUTION. SENSITIVITIES: MIC expressed in MCG/ML _________________________________________________________ ENTEROCOCCUS SP. | AMPICILLIN------------ <=2 S NITROFURANTOIN-------- <=16 S TETRACYCLINE---------- <=1 S VANCOMYCIN------------ 1 S IMAGING -========= ___ CXR IMPRESSION: Hilar congestion without frank edema. No convincing signs of pneumonia. ___ CTA chest showed: 1. Extensive pulmonary embolism with thrombus seen extending from the right main pulmonary artery into the segmental and subsegmental right upper, middle, and lower lobe pulmonary arteries. No right heart strain identified. 2. Additionally, there are smaller pulmonary emboli seen in the segmental and subsegmental branches of the left upper and lower lobes. 3. Several pulmonary nodules are noted, as noted previously, with the largest appearing spiculated and measuring up to 1 cm in the right middle lobe, suspicious for malignancy on the previous PET-CT. 4. Re- demonstration of 2 left breast nodules for which correlation with mammography and ultrasound is suggested. ___ ___: IMPRESSION: 1. Interval progression of deep vein thrombosis in the left lower extremity, with occlusive thrombus involving the entire femoral vein, previously only involving the mid and distal femoral vein. There is additional nonocclusive thrombus in the deep femoral vein. The left common femoral and popliteal veins are patent. 2. The bilateral calf veins were not visualized due to an overlying dressing. Otherwise no evidence of deep venous thrombosis in the right lower extremity. ___ TTE: Conclusions The left atrium is normal in size. The estimated right atrial pressure is ___ mmHg. Left ventricular wall thickness, cavity size, and global systolic function are normal (LVEF>55%). Doppler parameters are most consistent with Grade I (mild) left ventricular diastolic dysfunction. Right ventricular chamber size and free wall motion are normal. The aortic valve leaflets are mildly thickened (?#). There is no aortic valve stenosis. Trivial mitral regurgitation is seen. There is mild pulmonary artery systolic hypertension. ___ CXR IMPRESSION: Compared to chest radiographs ___ through ___. Heart size top-normal. Lungs grossly clear. No pleural abnormality or evidence of central lymph node enlargement. <MEDICATIONS ON ADMISSION> The Preadmission Medication list may be inaccurate and requires futher investigation. 1. Acetaminophen 650 mg PO Q6H 2. Docusate Sodium 100 mg PO BID 3. Enoxaparin Sodium 40 mg SC DAILY Start: ___, First Dose: Next Routine Administration Time 4. Levothyroxine Sodium 175 mcg PO DAILY 5. Atorvastatin 10 mg PO QPM 6. Losartan Potassium 50 mg PO DAILY 7. OxyCODONE (Immediate Release) 5 mg PO Q4H: PRN Pain - Moderate 8. LORazepam 0.25 mg PO BID: PRN anxiety 9. Senna 8.6 mg PO BID <DISCHARGE MEDICATIONS> 1. Nitrofurantoin Monohyd (MacroBID) 100 mg PO Q12H Last day: ___. Enoxaparin Sodium 90 mg SC Q12H Start: Today - ___, First Dose: Next Routine Administration Time 3. LORazepam 0.25 mg PO QHS: PRN insomnia RX *lorazepam 0.5 mg 0.5 (One half) tab by mouth QHS: prn Disp #*3 Tablet Refills: *0 4. Acetaminophen 650 mg PO Q6H 5. Atorvastatin 10 mg PO QPM 6. Docusate Sodium 100 mg PO BID 7. Levothyroxine Sodium 175 mcg PO DAILY 8. OxyCODONE (Immediate Release) 5 mg PO Q4H: PRN Pain - Moderate RX *oxycodone 5 mg 1 tablet(s) by mouth Q8H: prn Disp #*3 Tablet Refills: *0 9. Senna 8.6 mg PO BID <DISCHARGE DISPOSITION> Extended Care Facility: ___ <DISCHARGE DIAGNOSIS> PE <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Out of Bed with assistance to chair or wheelchair. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Ms. ___ it was a pleasure taking care you during your admission to ___. You were admitted for a clot in your lungs and leg. You were treated with a blood thinner. You will need to continue the blood thinner. You were also treated for a urinary tract infection. For your pulmonary nodules, you should follow up with your primary care doctor. ","Ms. ___ is a ___ woman s/p robotic radical cystectomy ___omplicated by bacteremia and abscess, LLE DVT, currently on daily lovenox who presents with dyspnea on exertion and dyspnea on exertion and found to have large PE and progression of DVT. # PE/DVT: Likely due to undertreatment of known LLE DVT with prophylactic dosing of lovenox. Given underdosing of lovenox, this was not thought to be treatment failure and IVC filter was deferred. She had no signs of right heart strain on imaging, EKG, exam. TTE showed no evidence of right heart strain. She was treated with a heparin gtt, then transitioned to treatment dose lovenox given malignancy associated thrombosis as noted in CLOT trial. She is quite symptomatic and requires oxygen supplementation, though improved during hospitalization. Please wean oxygen as tolerated. # Pulmonary nodules: Known spiculated masses that were noted on CT in ___, concerning for primary lung malignancy vs mets. Current CT showed stable nodules still concerning for malignancy. She was evaluated by the thoracic team who recommended CT biopsy vs. surveillance. Given her current PE/DVT, the family and the patient decided for surveillance at this time. They will follow up with her primary care provider. # Enterococcal UTI She was noted to have rising WBC in the setting of UCX from urostomy growing Enterococcus. Given her rising leukocytosis, we proceeded with treatment. She was started on IV Ampicillin and transitioned to macrobid, based on sensitivies. Leukocytosis improved on antibiotics. She should complete a 7 day course (day 1: ___, day 7: ___. # Normocytic Anemia: No signs of bleeding, or hemolysis. Hb dropped to nadir of 7.3, stable at discharge at 7.5. Iron studies consistent with likely combination iron deficiency anemia and anemia of chronic disease with low iron but elevated ferritin and low TIBC. Would recommend checking again as outpatient and work-up as needed. # ___ swelling: Likley multifactorial including venous insufficiency, as well as known LLE DVT. She responded quite well with compression stockings. # Hx of bladder cancer: s/p ___ TURBT, high-grade TCC, T1 (no muscle identified). Then in ___, pelvic MRI showed bladder mass invasion, perivesical soft tissue, anterior vaginal wall on right (C/W T4 lesion). In ___, underwent robotic TAH-BSO, lap radical cystectomy and anterior vaginectomy with pathology showing pT2b, node and margins negative. No plan for any further therapy at this time per Dr ___. The patient is safe to discharge today, and >30min were spent on discharge day management services. Transitional issues: - She will need follow up chest CT for pulmonary nodules in 3 months (___) - To complete 7 day course for UTI with macrobid (day 7: ___ - Continue oxygen therapy and wean as tolerated to maintain O2 sat > 92% - Please check CBC on ___ to ensure stability of h/h and demonstrate resolution of leukocytosis - HCP: son, Dr. ___ ___ ",2942,698
10001401-DS-20,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> subjective fevers, lethargy, and bloody drain output <MAJOR SURGICAL OR INVASIVE PROCEDURE> ___: For the large pelvic fluid collections, CT-guided repositioning of existing drain and placement of an additional drain. ___: Removal of more recently placed drain <HISTORY OF PRESENT ILLNESS> Ms. ___ is an ___ with PMH of hypertension and bladder cancer (high grade invasive urothelial carcinoma pT2b) s/p TAH/BSO, radical cystectomy w/ileal conduit c/b intra-abdominal infection and pelvic fluid collection s/p ___ guided drain placement ___ who presents with 2 days of generalized malaise and 1 day of fevers. Patient underwent ___ guided JP drain placement for intra-abdominal fluid collection and infection, thought to be complicated of recent TAH/BSO, radical cystectomy and pelvic lymph node biopsy. This procedure was done on ___. Over the past 2 days she had noticed generalized malaise and 1 day of fever w/rigors to Tmax 101.5 at home. She notes that the drainage from her intra-abdominal drain is darker, but her urostomy output has been unchanged. She notes some associated mild LLQ pain. She denies diarrhea, BRBPR, rash, cough, headache, neck stiffness. She presented initially to OSH, where she was evaluated with BCx and drain culture and was started on zosyn and vancomycin and given 650mg acetaminophen. She was transferred to ___ for further management. <PAST MEDICAL HISTORY> - Hypertension - s/p lap chole - s/p left knee replacement - s/p laminectomy of L5-S1 at age ___ - Bladder Cancer high grade TCC, T1 diagnosed in ___, then ___ pelvic MRI w/invasion into bladder wall, perivesical soft tissue and anterior vaginal wall c/w T4 staging - s/p hysterectomy and bilateral oophorectomy for large uterus w/fibroid, s/p laparascopic b/l pelvic lymph node resection, s/p radical cystectomy and anterior vaginectomy with vaginal reconstruction with ileal conduit creation ___, course complicated by bacteremia and development of intra-abdominal fluid collection, no s/p drain placement by ___ ___ - h/o LLE DVT and PE on lovenox <SOCIAL HISTORY> ___ <FAMILY HISTORY> Negative for bladder CA. <PHYSICAL EXAM> ADMISSION EXAM: -== Vital Signs: 100.9 PO 130 / 54 L Lying 80 24 95 RA General: Alert, oriented, no acute distress HEENT: Sclerae anicteric, MMM, oropharynx clear CV: RRR, normal S1 S2, systolic murmur RUBS, no rubs, gallops Lungs: Clear to auscultation bilaterally, no wheezes, rales, rhonchi Abdomen: Soft, non-tender, non-distended, bowel sounds present, +ileal conduit drain in RLQ, with pigtail drain in LLQ draining dark/sang fluid GU: No foley Ext: Warm, well perfused, 1+ nonpitting edema LLE Neuro: CN2-12 grossly intact, moving all extremities spontaneously DISCHARGE EXAM: -== Vital signs: 98.3 134/64 71 20 96 RA General: AxO x3 HEENT: Sclera anicteric Neck: supple Lungs: Clear to auscultation bilaterally, no wheezes, rales, rhonchi on anterior auscultation CV: Regular rate and rhythm, normal S1 + S2, III/VI SEM Abdomen: +BS, ileal conduit draining clear yellow urine. Has one LLQ drain in place draining serosanguinous fluid. Ext: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema <PERTINENT RESULTS> ADMISSION LABS: -== ___ 07: 10PM BLOOD WBC-19.4*# RBC-2.53* Hgb-6.9* Hct-22.9* MCV-91 MCH-27.3 MCHC-30.1* RDW-15.1 RDWSD-49.5* Plt ___ ___ 07: 10PM BLOOD Neuts-81.4* Lymphs-9.4* Monos-7.4 Eos-0.0* Baso-0.1 Im ___ AbsNeut-15.77*# AbsLymp-1.81 AbsMono-1.43* AbsEos-0.00* AbsBaso-0.02 ___ 07: 10PM BLOOD ___ PTT-33.4 ___ ___ 07: 10PM BLOOD Ret Aut-2.9* Abs Ret-0.07 ___ 07: 10PM BLOOD Glucose-118* UreaN-25* Creat-1.1 Na-133 K-5.0 Cl-97 HCO3-23 AnGap-18 ___ 07: 10PM BLOOD ALT-9 AST-9 AlkPhos-56 TotBili-0.3 ___ 07: 10PM BLOOD Lipase-9 ___ 07: 10PM BLOOD Albumin-2.5* Iron-6* ___ 07: 10PM BLOOD calTIBC-170* Hapto-518* Ferritn-489* TRF-131* ___ 07: 13PM BLOOD Lactate-1.0 DISCHARGE LABS: -== ___ 06: 00AM BLOOD WBC-6.9 RBC-2.92* Hgb-8.3* Hct-26.8* MCV-92 MCH-28.4 MCHC-31.0* RDW-15.4 RDWSD-52.4* Plt ___ ___ 06: 00AM BLOOD ___ PTT-31.2 ___ ___ 06: 00AM BLOOD Plt ___ ___ 06: 00AM BLOOD Glucose-86 UreaN-8 Creat-0.8 Na-143 K-3.6 Cl-106 HCO3-25 AnGap-16 ___ 06: 00AM BLOOD Calcium-7.5* Phos-3.7 Mg-2.3 MICROBIOLOGY: - Blood cultures x3 pending ___ 4: 35 pm pelvic aspiration GRAM STAIN (Final ___: 1+ (<1 per 1000X FIELD): POLYMORPHONUCLEAR LEUKOCYTES. NO MICROORGANISMS SEEN. FLUID CULTURE (Final ___: NO GROWTH. ANAEROBIC CULTURE (Preliminary): NO GROWTH. PERTINENT IMAGING: -= CT ABD&PEL W/ CONTRAST ___ 1. Interval decrease in size of the right hemipelvis fluid collection (7.0 x 6.5 x 11.3 cm, previously 10.0 x 12.7 x 14.8 cm) with the anterior approach pigtail catheter unchanged in position. The pigtail is again located partly within the collection and partly outside its wall. 2. Interval increase in size of the left pelvic fluid collection, now measuring 14.7 x 16.2 x 23.3 cm (previously 13.6 x 13.9 x 23.0 cm). Increased peripheral enhancement may suggest superimposed infection. 3. No new fluid collection identified. CTA ABD & PELVIS ___ 1. Decrease in size of right lower quadrant fluid collection that has percutaneous drain within it, with areas of high attenuation on noncontrast exam consistent with blood products, and associated hyperemia which is likely inflammatory, but without evidence of contrast extravasation. 2. There is large stable fluid collection in the low left abdomen, pelvis with mild linear peripheral enhancement, infection cannot be excluded. 3. There is severe left, and moderate to severe right hydroureteronephrosis, with delayed left nephrogram, stable from today. Mass effect about anastomosis between distal ureters and neobladder has resolved all since ___, and while hydronephrosis may be from residual edema, if this does not resolve, alternative etiologies including stenosis, tumor infiltration should be excluded. 4. Tiny hepatic lesion segment ___, attention to this area on subsequent followups recommended. CT INTERVENTIONAL PROCEDURE ___ 1. Complete collapse the patient has recently drained left lower quadrant collection. The catheter from this collection was removed. 2. Near complete collapse of the patient is originally drained collection in the mid pelvis, with pigtail catheter in place. 3. Left lower quadrant and deep pelvic collections as above. These findings were discussed with the team. Given the patient's improving clinical status, the decision was made to pursue no further collection drainage at this time. 4. Severe bilateral hydronephrosis, as on prior examinations. RECOMMENDATION: Given persistence of severe hydronephrosis, percutaneous nephrostomy tubes should be considered. <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Acetaminophen 650 mg PO Q6H 2. Atorvastatin 10 mg PO QPM 3. Enoxaparin Sodium 90 mg SC Q12H Start: ___, First Dose: Next Routine Administration Time 4. Levothyroxine Sodium 175 mcg PO DAILY 5. LORazepam 0.25-0.5 mg PO DAILY: PRN anxiety <DISCHARGE MEDICATIONS> 1. Ertapenem Sodium 1 g IV 1X Duration: 1 Dose please give ertapenem daily, preferably at nighttime to not interfere with her daily activities 2. Milk of Magnesia 30 mL PO Q6H: PRN constipation 3. Enoxaparin Sodium 70 mg SC Q12H Start: Today - ___, First Dose: Next Routine Administration Time 4. Acetaminophen 650 mg PO Q6H 5. Atorvastatin 10 mg PO QPM 6. Levothyroxine Sodium 175 mcg PO DAILY 7. LORazepam 0.25-0.5 mg PO DAILY: PRN anxiety <DISCHARGE DISPOSITION> Extended Care Facility: ___ <DISCHARGE DIAGNOSIS> Primary diagnosis: Pelvic fluid collection infection, ___, acute blood loss anemia Secondary diagnosis: acute renal failure, acute on chronic anemia, recent pulmonary embolism, invasive high-grade urothelial carcinoma, left breast mass (BIRADS 5), hypothyroidism <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear ___, ___ did you come to the hospital? - You were feeling tired and your drain output was bloody. What happened at the hospital? - A CT scan showed very large fluid collections in your pelvis - The radiologists placed another drain and removed it once it appeared that the large fluid collection was gone - You were given a blood transfusion - We placed a PICC (a long IV) so that you can receive antibiotics after you get discharged from the hospital What needs to happen when you leave the hospital? - Please continue seeing the doctors that are ___ your lung and breast lesions and follow their recommendations. - Continue taking Lovenox every day to treat the blood clot in your lung. - If the infectious disease doctor has not contacted you by ___, please call the following number to set up an appointment: ___. - Please make sure you have a repeat CT scan done BEFORE your appointment with the infectious disease doctor - You will be getting IV antibiotics for several weeks. The infectious disease doctor ___ determine how long you will need to be on it. It was a pleasure taking care of you. Your ___ team ","BRIEF SUMMARY: ============== ___ year old women with a history of bladder cancer s/p cystectomy, hysterectomy, and BSO now with ileal conduit, whose post operative course has been complicated by DVT/PE, ileus, and pelvic fluid collections w/ one LLQ drain presented with subjective fevers, lethargy, and bloody drain output. She was found to have worsening anemia and was given 2 units of pRBC with appropriate increase in hemoglobin noted. She was also found on CT imaging to have an interval increase in size of a left abdominal fluid collection. Decision was made to place a drain per ID. Fluid was sent and revealed: negative cultures, negative malignant cells, no evidence of lymphatic or urinary fluid. This new drain was subsequently removed per ___ as fluid collection was completely drained. The prior drain was still draining serosanguinous fluid and was kept in but repositioned. ID was consulted for the fevers, leukocytosis and fluid collections and was deemed to need antibiotics and tranisitioned from broad spectrum to IV ertapenem at discharge. Will require multiple follow ups and imaging as specified in the transitional issues. ACUTE ISSUES: ============= #Pelvic fluid collections: patient arrived with one anterior drain putting out serosanguinous fluid. CT abdomen/pelvis revealed enlarging left fluid collection, and decision was made to place a drain per ___. The fluid was negative for malignant cells. The fluid had Cr 1 and triglycerides <9 suggesting that fluid collection is neither urine nor lymphatic fluid. Fluid culture was negative for bacteria. On interval imaging, the new enlarging fluid collection had completely collapsed and the drain was removed. As for the other fluid collection that already had a drain putting out serosanguinous fluid, it continued to drain serosanguinous fluid but at a lower rate than prior to admission. The drain was left in place as the fluid collection on imaging had not completely collapsed. BID - N cultures for the aforementioned fluid collection came back positive for MSSA but per ID, does not reflect rue intra-abdominal infection. Given that patient had a fever at OSH and a leukocytosis, she was placed on broad spectrum antibiotics with vanc, ceftaz and flagyl. This was tapered per ID team to IV zosyn. On discharge, ID recommended ertapenem for approximately 4 weeks with final length of treatment to be determined by fluid collection changes on repeat imaging on outpatient basis. Mrs. ___ remained afebrile, and leukocytosis resolved. #Pulmonary embolism: Likely developed in the setting of being diagnosed with a post-op DVT. She was placed on lovenox. She was transitioned to heparin ggt as she needed ___ procedures and was transitioned back to lovenox but at a lower dose per weight dosing to 70mg q12H upon discharge. #Acute renal injury: SCr has been steadily rising from a baseline of around 0.04-0.06 in ___ to 1.1, likely ___ obstructed uropathy ___ large pelbic fluid collections. ___ resolved over the course of her hospital stay with final Cr 0.8. #Hydronephrosis: bilateral and worsening on interval imaging from prior studies. Given patient's age, adequate urinary output, adequate creatinine clearance, and no significant electrolyte abnormalities, patient likely would not significantly benefit from intervention at this time. Per urology consult, deemed stable for discharge and recommended outpatient urology followup. #Anemia: likely a combination of anemia of chronic inflammation and acute blood loss ___ to anterior abdominal drain showing serosanguinous fluid. Labs not consistent with hemolysis. Received 2 units of pRBC with appropriate response. Patient was discharged with Hgb of 8.3 per hem/onc recommendation for threshold Hgb>8 as patient feels and functionally performs better with higher blood counts. #Hypokalemia: was hypokalemic and was repleted with oral KCl PRN. CHRONIC ISSUES: =============== #Invasive high-grade urothelial carcinoma, involving the deep muscularis propria S/p cystectomy, hysterectomy, and BSO now with ileal conduit, whose post operative course has been complicated by DVT/PE, ileus, and pelvic fluid collections. Patient stating that there is no plan for chemo and radiation, her PET scan does show concerning foci of metastatic disease in the lung and peritoneum. Per patient's son, Mrs. ___ has seen a doctor to work up the lung mass. Will need ongoing discussion with outpatient hem/onc regarding how to best manage concerning lesions. #Breast mass ___ mammogram showing BI-RADS 5, Solid mass in the 3 o'clock left breast with features of a highly suspicious for malignancy. Per patient's son, she has seen a doctor for evaluating the new breast mass. Would recommend ongoing discussion with aforementioned doctor and outpatient hem/onc about plan to manage. # HLD: continued atorvastatin without changes. Consider evaluation regarding stopping atorvastatin on outpatient basis # Hypothyroidism: continued levothyroxine without changes. #HCP: Dr. ___ (son, ___ physician) ___ #Code status: full code (confirmed with patient on ___ TRANSITIONAL ISSUES: ==================== [ ] Will need infectious disease follow up. If ID has not contacted Mrs ___ by ___, she should call ___ to set up an appointment. The ID appointment needs to be AFTER her CT abdomen/pelvis has already been done [ ] Assure that Mrs ___ has her CT abdomen & pelvis with contrast in the week of ___ [ ] She should get weekly lab draws of the following: CBC with differential, BUN, Cr, AST, ALT, TB, ALK PHOS. ALL LAB REQUESTS SHOULD BE ANNOTATED WITH: **ATTN: ___ CLINIC - FAX: ___ [ ] If possible, please give ertapenem at night-time so it does not interfere with her daily activities. Tentatively, she will be receiving ertapenem for ___ weeks but with final treatment length determined by the infectious disease team. [ ] Will need ongoing discussion with outpatient PCP and hem/onc regarding how to manage new breast lesion and lung/peritoneum lesions. [ ] Reevaluate need for atorvastatin [ ] Will need outpatient follow up with urology, Dr. ___ his team regarding worsening hydronephrosis ",2655,1357
10001401-DS-21,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> Hematuria, weakness <MAJOR SURGICAL OR INVASIVE PROCEDURE> None <HISTORY OF PRESENT ILLNESS> ___ y/o female with h/o PE (on lovenox), bladder cancer s/p Robotic TAH-BSO, lap radical cystectomy with ileal loop diversion and anterior vaginectomy in ___ c/b abdominal fluid requiring placement of drainage catheters. Recent abdominal imaging noted worsening of her bilateral severe hydronephrosis and her Cr was noted to have risen from 0.8 to 1.3(outside lab value). Patient recently underwent bilateral nephrostomy tube placement by ___ on ___. She first started feeling weak during ___ yesterday doing the exercises. Had palpitations with ambulation. Has tightness in chest with ambulating since yesterday. Felt light headed with ambulation. SNF noticed increased hematuria with R bag darker than L bag since yesterday. Her Urostomy (placed in ___ also positive for hematuria. She was transferred to ___ ED for further management. In the ED, initial vitals were: Temp. 98.1, HR 72, BP 139/56, RR 16, 99% RA - Labs notable for: WBC 5.9, Hg 8.1, platelets 374. Na 140, K 4.3, Cl 103, biacrb 22, BUN 29, Cr 1.0 UA from bilateral nephrostomy tubes with > 100 WBC, moderate leukocytes, and large blood. - Imaging was notable for: CT abd/pelvis w/o contrast: Interval placement of bilateral percutaneous nephroureterostomy tubes with resolved hydroureteronephrosis. No RP hematoma. - Patient was given: LR Upon arrival to the floor, patient reports that she noticed shortness of breath today with walking in conjunction with bloody output from her ostomy tubes. She notes that the output from her nephrostomy tubes was pink tinged when she left the hospital 2 days ago. She also endorses associated chest tightness but no pain or pressure. She denies cough, fever, chills, abdominal pain, or diarrhea. She notes that she has an ostomy and nephroureterostomy without sensation of dysuria. Patient notes feeling dizzy and lightheaded previously though is currently asymptomatic. <PAST MEDICAL HISTORY> - Hypertension - s/p lap chole - s/p left knee replacement - s/p laminectomy of L5-S1 at age ___ - Bladder Cancer high grade TCC, T1 diagnosed in ___, then ___ pelvic MRI w/invasion into bladder wall, perivesical soft tissue and anterior vaginal wall c/w T4 staging - s/p hysterectomy and bilateral oophorectomy for large uterus w/fibroid, s/p laparascopic b/l pelvic lymph node resection, s/p radical cystectomy and anterior vaginectomy with vaginal reconstruction with ileal conduit creation ___, course complicated by bacteremia and development of intra-abdominal fluid collection, no s/p drain placement by ___ ___ - h/o LLE DVT and PE on lovenox <SOCIAL HISTORY> ___ <FAMILY HISTORY> Negative for bladder CA. <PHYSICAL EXAM> -======== ADMISSION PHYSICAL EXAM: -======== VITAL SIGNS: Temp. 98.1 PO BP 158 / 66 HR 72 RR 18 Spo2 95 RA GENERAL: well-appearing elderly woman in no acute distress CARDIAC: RRR, no murmurs LUNGS: clear to auscultation bilaterally ABDOMEN: soft, non-tender to palpation, normal bowel sounds. Ostomy draining brown stool. Nephroureterostomy draining dark red bloody urine. Bilateral nephrostomy tubes draining blood urine. EXTREMITIES: No edema, warm and well-perfused. -======== DISCHARGE PHYSICAL EXAM: -======== VS - 98.3 PO 139/67 71 18 94 RA GENERAL: well-appearing elderly woman in no acute distress CARDIAC: RRR, no murmurs LUNGS: clear to auscultation bilaterally ABDOMEN: soft, non-tender to palpation, normal bowel sounds. Nephroureterostomy draining dark red bloody urine. Bilateral nephrostomy tubes capped. EXTREMITIES: No edema, warm and well-perfused <PERTINENT RESULTS> -=== ADMISSION LABS -=== ___ 05: 20PM BLOOD WBC-5.9 RBC-2.90* Hgb-8.1* Hct-26.6* MCV-92 MCH-27.9 MCHC-30.5* RDW-15.4 RDWSD-51.2* Plt ___ ___ 05: 48AM BLOOD WBC-4.6 RBC-2.46* Hgb-7.0* Hct-22.6* MCV-92 MCH-28.5 MCHC-31.0* RDW-15.3 RDWSD-51.7* Plt ___ ___ 05: 20PM BLOOD Neuts-56.3 ___ Monos-12.6 Eos-1.5 Baso-0.3 Im ___ AbsNeut-3.29# AbsLymp-1.69 AbsMono-0.74 AbsEos-0.09 AbsBaso-0.02 ___ 05: 20PM BLOOD Glucose-101* UreaN-29* Creat-1.0 Na-140 K-4.3 Cl-103 HCO3-22 AnGap-19 - IMAGING/STUDIES - ___ CT Abd/Pel w/o Contrast: IMPRESSION: 1. Interval placement of bilateral percutaneous nephroureterostomy tubes with resolved hydroureteronephrosis. No RP hematoma. 2. Partially imaged nodular opacity in the right middle lobe which can be further assessed on a nonemergent dedicated CT chest. ___ CXR AP portable upright view of the chest. Right upper extremity access PICC line is seen with its tip in the upper SVC. Overlying EKG leads are present. Lungs are clear. Cardiomediastinal silhouette is stable. Bony structures are intact. -= MICROBIOLOGY -= ___ 6: 35 pm URINE LEFT NEPHROSTOMY TUBE. **FINAL REPORT ___ URINE CULTURE (Final ___: NO GROWTH. -=== DISCHARGE LABS -=== ___ 05: 08AM BLOOD WBC-5.4 RBC-2.86* Hgb-8.2* Hct-26.5* MCV-93 MCH-28.7 MCHC-30.9* RDW-15.3 RDWSD-51.8* Plt ___ ___ 05: 08AM BLOOD Glucose-94 UreaN-29* Creat-0.9 Na-143 K-4.0 Cl-106 HCO3-26 AnGap-15 ___ 05: 08AM BLOOD Calcium-8.8 Phos-5.2* Mg-2.1 <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Atorvastatin 10 mg PO QPM 2. Enoxaparin Sodium 70 mg SC Q12H Start: ___, First Dose: Next Routine Administration Time 3. Levothyroxine Sodium 175 mcg PO DAILY 4. Multivitamins 1 TAB PO DAILY 5. Probiotic-Digestive Enzymes (L. acidophilus-dig ___ 5) ___ mg oral daily <DISCHARGE MEDICATIONS> 1. Atorvastatin 10 mg PO QPM 2. Levothyroxine Sodium 175 mcg PO DAILY 3. Multivitamins 1 TAB PO DAILY 4. Probiotic-Digestive Enzymes (L. acidophilus-dig ___ 5) ___ mg oral daily <DISCHARGE DISPOSITION> Extended Care Facility: ___ <DISCHARGE DIAGNOSIS> Primary Diagnoses: Hematuria, anemia Secondary Diagnoses: Bladder cancer, hydronephrosis, hypothyroidism, DVT/PE <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Ms. ___, It was a pleasure taking care of you at ___. WHY DID YOU COME TO THE HOSPITAL? You noticed blood in your urine, and you were feeling weak/lightheaded. WHAT HAPPENED WHILE YOU WERE HERE? We did not give you your blood thinner medication (Lovenox), and we gave you a unit of blood. The blood in your urine cleared up. WHAT SHOULD YOU DO WHEN YOU LEAVE THE HOSPITAL? Along with your oncologist Dr. ___ have decided that you no longer need to take any Lovenox. You should continue to follow up with your doctors, and take all of your medications as prescribed. Your followup appointments are listed below. Again, it was a pleasure taking care of you! Sincerely, Your ___ Team ","Ms. ___ is an ___ year old woman with history of provoked DVT/PE (on lovenox), bladder cancer s/p Robotic TAH-BSO, lap radical cystectomy with ileal loop diversion and anterior vaginectomy in ___ c/b abdominal fluid requiring placement of drainage catheters, and recent hydronephrosis requiring placement of bilateral PCN tubes on ___, presenting from rehab with hematuria and weakness. On arrival, pt had evidence of frank hematuria in her urostomy bag and PCN tubes. Her hemoglobin was initially 8.1, which subsequently dropped to 7.0 Her lovenox was held, and she was transfused with 1 U PRBC with an appropriate hemoglobin bump to 8.2. Hematuria was likely caused by recent instrumentation in the setting of anticoagulation. Her hematuria improved, as did her dizziness/weakness. ___ was consulted and recommending capping her PCN tubes. After discussion with the patient's hematologist, it was decided to stop her lovenox treatment given that her DVT/PE were provoked in the setting of her recovery from surgery, and that she had received almost 6 months of treatment. Secondary Issues: # Asymptomatic bacteruria: Patient with asymptomatic bacteruria in setting of recent procedural manipulation. She was afebrile and without leukocytosis, so treatment with antibiotics was deferred. # Hyperlipidemia: continued atorvastatin 10 mg daily # Hypothyroidism: continue levothyroxine 175 mcg daily =================== TRANSITIONAL ISSUES =================== Medication Changes: Lovenox stopped [ ] CT Abdomen/Pelvis showed partially imaged nodular opacity in the right middle lobe which can be further assessed on a nonemergent dedicated CT chest. [ ] Pt's PCN tubes were capped per ___ recommendation during her hospitalization; she was discharged with scheduled followup to decide on long term management [ ] If pt develops hematuria and/or lightheadedness or other symptoms of anemia, a CBC should be rechecked to assess for bleeding [ ] Hemoglobin/Hematocrit on discharge: 8.2/26.5 # CODE: presumed full # CONTACT: ___ (MD) ___ (cell) ___ (home) ",2050,484
10001401-DS-22,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> Fevers and chills <MAJOR SURGICAL OR INVASIVE PROCEDURE> ___ -- stent exchange <HISTORY OF PRESENT ILLNESS> Ms. ___ is a ___ female with the past medical history notable for history of bladder cancer status post robotic TAH-BSO, lap radical cystectomy with ileal loop diversion and anterior vaginectomy in ___ complicated by abdominal fluid requiring placement of drainage catheters, further complicated by a severe bilateral hydronephrosis requiring bilateral urostomy tube placement and then ultimately ureteral stent placements with improvement who presented to the hospital for routine stent exchange and cystoscopy. The patient underwent an uncomplicated procedure but then postoperatively in the PACU she developed a fever to 102.4 and was tachycardic 105 and as such was felt to need admission for treatment of sepsis. At that time she was given ampicillin and gentamicin given her history of drug resistant organisms. She reported at that time she was feeling feverish and chills with nausea and vomiting x1. She received IV fluids and her IV antibiotics and her symptoms improved. She was admitted to the medical service for further evaluation and management On the floor the patient reports that she continues to have persistent chills. She feels slightly nauseous. She denies any abdominal pain. She otherwise reports that she is feeling better than she did immediately postprocedural but is still significantly off of her baseline. She reports that she has a history of urinary tract infections and was most recently on ciprofloxacin and ___. She reports that she was on this medication for 7-day course. No ___ acute complaints. <PAST MEDICAL HISTORY> - Hypertension - s/p lap chole - s/p left knee replacement - s/p laminectomy of L5-S1 at age ___ - Bladder Cancer high grade TCC, T1 diagnosed in ___, then ___ pelvic MRI w/invasion into bladder wall, perivesical soft tissue and anterior vaginal wall c/w T4 staging - s/p hysterectomy and bilateral oophorectomy for large uterus w/fibroid, s/p laparascopic b/l pelvic lymph node resection, s/p radical cystectomy and anterior vaginectomy with vaginal reconstruction with ileal conduit creation ___, course complicated by bacteremia and development of intra-abdominal fluid collection, no s/p drain placement by ___ ___ - h/o LLE DVT and PE no longer on anticoagulation. <SOCIAL HISTORY> ___ <FAMILY HISTORY> Negative for bladder CA. <PHYSICAL EXAM> ADMISSION EXAM: VITALS: ___ 2227 Temp: 99.3 PO BP: 119/54 HR: 80 RR: 16 O2 sat: 98% O2 delivery: RA Dyspnea: 0 RASS: 0 Pain Score: ___ GENERAL: Alert and in no apparent distress, facial twitches EYES: Anicteric, pupils equally round ENT: Ears and nose without visible erythema, masses, or trauma. Oropharynx without visible lesion, erythema or exudate CV: Heart regular, no murmur, no S3, no S4. No JVD. RESP: Lungs clear to auscultation with good air movement bilaterally. Breathing is non-labored GI: Abdomen soft, non-distended, non-tender to palpation. Bowel sounds present. No HSM GU: No suprapubic fullness or tenderness to palpation, foley catheter in place MSK: Neck supple, moves all extremities, strength grossly full and symmetric bilaterally in all limbs SKIN: No rashes or ulcerations noted NEURO: Alert, oriented, face symmetric, gaze conjugate with EOMI, speech fluent, moves all limbs, sensation to light touch grossly intact throughout PSYCH: pleasant, appropriate affect DISCHARGE EXAM: AVSS, ambulating comfortably at baseline. Urostomy bag in place with no surround erythema or pain. <PERTINENT RESULTS> LABORATORY RESULTS: ___ 05: 30AM BLOOD WBC-16.5* RBC-3.23* Hgb-9.8* Hct-31.8* MCV-99* MCH-30.3 MCHC-30.8* RDW-14.5 RDWSD-52.3* Plt ___ ___ 06: 09AM BLOOD WBC-14.1* RBC-3.39* Hgb-10.2* Hct-33.2* MCV-98 MCH-30.1 MCHC-30.7* RDW-14.6 RDWSD-52.7* Plt ___ ___ 06: 10AM BLOOD WBC-10.0 RBC-3.55* Hgb-10.5* Hct-33.6* MCV-95 MCH-29.6 MCHC-31.3* RDW-14.1 RDWSD-49.9* Plt ___ ___ 05: 30AM BLOOD Glucose-115* UreaN-34* Creat-1.6* Na-142 K-4.2 Cl-106 HCO3-22 AnGap-14 ___ 06: 10AM BLOOD Glucose-99 UreaN-29* Creat-1.3* Na-141 K-3.8 Cl-104 HCO3-23 AnGap-14 ___ 05: 30AM BLOOD Calcium-8.1* Phos-3.4 Mg-1.8 MICROBIOLOGY: ___ 3: 00 pm URINE Site: CYSTOSCOPY RIGHT KIDNEY WASH. **FINAL REPORT ___ URINE CULTURE (Final ___: ENTEROCOCCUS FAECIUM. >10,000 CFU/ML. ___ (___) REQUESTS SUSCEPTIBILITY TESTING ___. STAPHYLOCOCCUS, COAGULASE NEGATIVE. 1,000 - 10,000 CFU/ML. CORYNEBACTERIUM SPECIES (DIPHTHEROIDS). 1,000 - 10,000 CFU/ML. SENSITIVITIES: MIC expressed in MCG/ML _________________________________________________________ ENTEROCOCCUS FAECIUM | AMPICILLIN------------ 8 S NITROFURANTOIN-------- <=16 S TETRACYCLINE---------- =>16 R VANCOMYCIN------------ 2 S Blood cultures NGTD <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Acetaminophen 650 mg PO Q6H: PRN Pain - Mild/Fever 2. Atorvastatin 10 mg PO QPM 3. Cyanocobalamin 1000 mcg PO DAILY 4. Docusate Sodium 100 mg PO BID 5. Levothyroxine Sodium 175 mcg PO DAILY 6. LORazepam 0.5 mg PO Q12H: PRN anxiety 7. Losartan Potassium 50 mg PO BID 8. Multivitamins 1 TAB PO DAILY 9. Polyethylene Glycol 17 g PO DAILY: PRN Constipation - First Line 10. Trimethoprim 100 mg PO Q24H <DISCHARGE MEDICATIONS> 1. Ampicillin 500 mg IV Q8H RX *ampicillin sodium 500 mg 500 mg IV Every eight hours Disp #*15 Vial Refills: *0 RX *ampicillin sodium 500 mg 500 mg IV Every eight hours Disp #*27 Vial Refills: *0 2. Acetaminophen 650 mg PO Q6H: PRN Pain - Mild/Fever 3. Atorvastatin 10 mg PO QPM 4. Cyanocobalamin 1000 mcg PO DAILY 5. Docusate Sodium 100 mg PO BID 6. Levothyroxine Sodium 175 mcg PO DAILY 7. LORazepam 0.5 mg PO Q12H: PRN anxiety 8. Losartan Potassium 50 mg PO BID 9. Multivitamins 1 TAB PO DAILY 10. Polyethylene Glycol 17 g PO DAILY: PRN Constipation - First Line 11. HELD- Trimethoprim 100 mg PO Q24H This medication was held. Do not restart Trimethoprim until after you finish your ampicillin. <DISCHARGE DISPOSITION> Extended Care Facility: ___ <DISCHARGE DIAGNOSIS> Complicated E. faecium UTI <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> You were admitted to the hospital after you developed fevers and chills after you developed fevers and chills from your stent exchange. Your urine grew the enterococcus species -- the source of your infection. Because it was enterococcus, a PICC line was placed and you will finish a total 14-day course of IV ampicillin. You also had kidney injury, likely from infection, that resolved with antibiotics and fluids. It was a pleasure taking care of you! ","Ms. ___ was admitted with sepsis from a urinary tract infection after her stent exchange. She was placed empirically on vancomycin and cefepime (narrowed to vanc/ceftriaxone on HD#1), because of her history of resistant organisms. She rapidly improved. Her urine grew E. faecium, sensitive to ampicillin. Therefore, a PICC line was placed, and she will complete two weeks total of ampicillin for a complicated urinary tract infection (additional day days). She will follow up with Dr. ___ as an outpatient. She will stop her prophylactic TMP while on ampicillin, but then resume after finishing her course. - ampicillin 500 mg TID x 9 additional days - restart TMP 100 mg daily for ppx after antibiotic course - follow up with Dr. ___ ___ problems addressed this hospitalization: 1. ___. Ms. ___ initially had an ___, likely prerenal from her sepsis. She received IV fluids and antibiotics as above, and her creatinine down-trended. Losartan was initially held, but restarted on discharge. 2. Hyperlipidemia: continued atorvastatin 10 mg daily 3. Hypothyroidism: continue levothyroxine 175 mcg daily > 30 minutes spent on discharge activities. ",2054,285
10001667-DS-10,"<SEX> F <SERVICE> NEUROLOGY <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> slurred speech <MAJOR SURGICAL OR INVASIVE PROCEDURE> None <HISTORY OF PRESENT ILLNESS> ___ year old right-handed woman with hx of Atrial fibrillation on Eliquis (only once daily), hypertension, hyperlipidemia, CHF presents as transfer from OSH after she had acute onset dysarthria and CTA showed possible partial thrombus or stenosis in superior division of L MCA. Transferred here for closer monitoring and possible thrombectomy if her exam acutely worsens. History obtained from patient and daughter at bedside. Patient is an excellent historian. On ___, she had dinner with friends and then returned to her apartment and was fooling around on her computer. Last known well was around 8: 00 ___. Then, she had an odd sensation and started throwing her arms around. She went to living room to sit down and tried to read but could not see the words very clearly. Then, two family members were knocking at the door and she had a tough time standing up to open door. She was able to eventually stand up with great difficulty and walked with her walker. She usually walks with a walker because of knee replacement. Finally, got up out of chair with walker and walked to the door to unlock. She noticed problems talking to family members. She had difficulty forming words and pronouncing words. Denies word finding difficulty. She could tell it was slurred like a person who had too much to drink. EMTs asked if she was intoxicated but she was not. She was very aware of her dysarthria and told her daughters that she thinks she's having a stroke. Then, she said she had trouble sitting down but has no idea why she thought that. When she was standing, she was able to walk with walker but she felt unsteady and almost fell. No visual changes. No numbness or tingling. Denies focal weakness; she just had trouble standing up. She was able to unlock her door without issue but she felt shaky. She was brought by EMS to ___ where NIHSS was 1 for slurred speech. There, she felt the same but her symptoms started to improve when she started to be transferred. Paramedics said her speech was improving rapidly en route. Last month, started needing naps. Her hearing is poor at baseline and she normally uses hearing aids. For the past ___ months, she has had ___ nocturia nightly. No dysuria. She has noticed more frequent headaches lately in the past ___ months. Last headache was yesterday. She takes tramadol and acetaminophen up to a couple times a night. She reports headaches at night which wake her up. She denies that the headache is positional; it is the same sitting up or lying down. She has had some gradual weight loss over the past ~12 months; ___ year ago she was almost 140 lbs, and now she is ___ lbs. Her appetite is still good and she enjoys eating but she is less hungry that she used to be. Daughter says that she has had marked decline in memory in past ___ weeks. Over past few years, she has been forgetting plans, times for pickpup, and dinner plans, which has become normal. Over the past ___ weeks, family has noticed dramatic worsening. She doesn't remember which grandkids were coming to visit when she bought the plane tickets herself. She endorses 2 pillow orthopnea. <PAST MEDICAL HISTORY> Divertoculosis Atrial fibrillation on Eliquis CHF Hypercholesterolemia Hypertension <SOCIAL HISTORY> ___ <FAMILY HISTORY> Father - severe alcoholic, schizophrenia Mother - CHF Brother - stroke, carotid stenosis <PHYSICAL EXAM> ADMISSION EXAM: Vitals: T: 97.9 HR: 79 BP: 164/121 RR: 19 SaO2: 94% on RA General: Awake, cooperative elderly woman, NAD. HEENT: NC/AT, no scleral icterus noted, MMM, no lesions noted in oropharynx. Neck: Supple. No nuchal rigidity. Pulmonary: Normal work of breathing. Cardiac: RRR, warm, well-perfused. Abdomen: Soft, non-distended. Extremities: No ___ edema. Skin: ecchymoses in L shin, more extensive on R shin. Neurologic: -Mental Status: Alert, oriented ___. Able to relate history without difficulty. Attentive, able to name ___ backward without difficulty. Language is fluent with intact repetition and comprehension. Normal prosody. There were no paraphasic errors. Able to name both high and low frequency objects. Able to read without difficulty. No dysarthria. Able to follow both midline and appendicular commands. There was no evidence of apraxia or neglect. -Cranial Nerves: II, III, IV, VI: PERRL 3 to 2mm and brisk. EOMI without nystagmus. Normal saccades. VFF to confrontation. V: Facial sensation intact to light touch and pinprick. VII: No facial droop, facial musculature symmetric. VIII: Hearing intact to finger snapping b/l. Did not bring her hearing aids. IX, X: Palate elevates symmetrically. XI: ___ strength in trapezii bilaterally. XII: Tongue protrudes in midline with good excursions. Strength full with tongue-in-cheek testing. -Motor: Normal bulk and tone throughout. No pronator drift. No adventitious movements, such as tremor or asterixis noted. [___] L 5 5 5 5 5 5 5 5 5 5 5 5 R 5 5 5 5 5 5 5 5 5 5 5 5 -Sensory: No deficits to light touch, pinprick, temperature throughout. Decreased vibratory sense in b/l feet up to ankles. Joint position sense intact in b/l great toes. No extinction to DSS. Romberg absent. -Reflexes: [Bic] [Tri] [___] [Pat] [Ach] L 2+ 2 2 2+ 0 R 2+ 2 2 2+ 0 Plantar response was flexor bilaterally. -Coordination: No intention tremor. No dysmetria on FNF bilaterally. HKS with L heel without dysmetria. Unable to bend R knee due to knee surgery. -Gait: unable to assess as patient needs a walker at baseline DISCHARGE EXAM: 24 HR Data (last updated ___ @ 419) Temp: 97.4 (Tm 98.6), BP: 146/76 (116-155/65-94), HR: 53 (53-86), RR: 17 (___), O2 sat: 96% (92-97), O2 delivery: Ra General: Awake, cooperative elderly woman, NAD. HEENT: NC/AT, no scleral icterus noted, MMM, no lesions noted in oropharynx. Neck: Supple. No nuchal rigidity. Pulmonary: Normal work of breathing. Cardiac: NR, RR, warm, well-perfused. Abdomen: Soft, non-distended. Extremities: No ___ edema. Skin: ecchymoses in L shin, more extensive on R shin. Neurologic: -Mental Status: Alert, oriented to person and situation. Able to relate history without difficulty. Attentive to examiner. Language is fluent with intact comprehension. Normal prosody. There were no paraphasic errors. No dysarthria. Able to follow both midline and appendicular commands. There was no evidence of apraxia or neglect. -Cranial Nerves: II, III, IV, VI: PERRL 3 to 2mm and brisk. EOMI without nystagmus. Normal saccades. V: Facial sensation intact to light touch. VII: No facial droop, facial musculature symmetric. VIII: Hearing intact to conversation. IX, X: Palate elevates symmetrically. XI: ___ strength in trapezii bilaterally. XII: Tongue protrudes in midline with good excursions. -Motor: Normal bulk and tone throughout. No pronator drift. No adventitious movements, such as tremor or asterixis noted. [Delt][Bic][Tri][ECR][FEx][IO][IP][Quad][Ham][TA][Gas] L 5 5 5 5 5 5 5 5 5 5 5 R 5 5 5 5 5 5 5 * * 5 5 *Knee cannot bend after prior surgery -Sensory: No deficits to light touch throughout. -Coordination: No intention tremor. No dysmetria on FNF bilaterally. -Gait: needs a walker at baseline <PERTINENT RESULTS> ___ 01: 50AM BLOOD WBC-7.2 RBC-4.75 Hgb-14.6 Hct-45.5* MCV-96 MCH-30.7 MCHC-32.1 RDW-13.2 RDWSD-46.5* Plt ___ ___ 01: 50AM BLOOD Neuts-53.1 ___ Monos-8.2 Eos-1.5 Baso-0.3 Im ___ AbsNeut-3.81 AbsLymp-2.63 AbsMono-0.59 AbsEos-0.11 AbsBaso-0.02 ___ 01: 50AM BLOOD ___ PTT-29.7 ___ ___ 01: 50AM BLOOD Glucose-97 UreaN-18 Creat-0.7 Na-139 K-4.3 Cl-102 HCO3-26 AnGap-11 ___ 07: 35AM BLOOD CK-MB-4 cTropnT-<0.01 ___ 07: 35AM BLOOD Calcium-9.3 Phos-3.6 Mg-1.8 Cholest-207* ___ 07: 35AM BLOOD Triglyc-62 HDL-69 CHOL/HD-3.0 LDLcalc-126 ___ 10: 57AM BLOOD %HbA1c-5.5 eAG-111 ___ 05: 22AM BLOOD VitB12-249 ___ 05: 22AM BLOOD TSH-5.8* ___ 05: 22AM BLOOD Trep Ab-NEG ___ 03: 12AM URINE Color-Straw Appear-Clear Sp ___ ___ 03: 12AM URINE Blood-NEG Nitrite-NEG Protein-NEG Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.5 Leuks-NEG ___ OSH CTA head/neck ___ opinion (___) IMPRESSION: 1. Segmental left vertebral artery occlusion of indeterminate chronicity. No evidence of ischemia. 2. Somewhat small caliber attenuated left M2 inferior branch, without evidence of focal occlusion. 3. No acute intracranial abnormality on noncontrast CT head. ___ MRI head w/o contrast IMPRESSION: 1. No acute intracranial abnormality. Specifically, no large territory infarction or hemorrhage. 2. Scattered foci of T2/high-signal intensity in the subcortical and periventricular white matter are nonspecific and may reflect changes due to chronic small vessel disease. ___ TTE IMPRESSION: No structural source of thromboembolism identified (underlying rhythm predisposes to thrombus formation). Preserved left ventricular systolic function in the setting of beat-to-beat variability due to arrhythmia. Mild to moderate mitral and tricuspid regurgitation. Normal pulmonary pressure. Very small pericardial effusion <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Atenolol 50 mg PO DAILY 2. Apixaban 2.5 mg PO DAILY 3. Losartan Potassium 50 mg PO DAILY 4. Digoxin 0.125 mg PO DAILY 5. LevoFLOXacin 500 mg PO Q24H <DISCHARGE MEDICATIONS> 1. Atorvastatin 40 mg PO QPM RX *atorvastatin 40 mg 1 tablet(s) by mouth once daily at bedtime Disp #*30 Tablet Refills: *5 2. Cyanocobalamin 500 mcg PO DAILY RX *cyanocobalamin (vitamin B-12) 500 mcg 1 tablet(s) by mouth once daily Disp #*30 Tablet Refills: *5 3. Apixaban 2.5 mg PO BID 4. Atenolol 50 mg PO DAILY 5. LevoFLOXacin 500 mg PO Q24H 6. Losartan Potassium 50 mg PO DAILY <DISCHARGE DISPOSITION> Home With Service Facility: ___ <DISCHARGE DIAGNOSIS> transient dysarthria not secondary to TIA or stroke Mild Vitamin B12 deficiency <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Ms. ___, You were hospitalized due to symptoms of slurred speech due to concern for an ACUTE ISCHEMIC STROKE, a condition where a blood vessel providing oxygen and nutrients to the brain is blocked by a clot. The brain is the part of your body that controls and directs all the other parts of your body, so damage to the brain from being deprived of its blood supply can result in a variety of symptoms. However, the MRI of your brain did not show evidence of stroke or TIA. Your symptoms could have been related to blood pressure, dehydration, alcohol use, or a combination of these factors. We are changing your medications as follows: Increase apixaban to 2.5mg twice daily Start Vitamin B12 daily supplement Please take your other medications as prescribed. Please follow up with your primary care physician as listed below. You should also follow up with your cardiologist as you were noted to have occasional pauses on cardiac monitoring. If you experience any of the symptoms below, please seek emergency medical attention by calling Emergency Medical Services (dialing 911). In particular, please pay attention to the sudden onset and persistence of these symptoms: - Sudden partial or complete loss of vision - Sudden loss of the ability to speak words from your mouth - Sudden loss of the ability to understand others speaking to you - Sudden weakness of one side of the body - Sudden drooping of one side of the face - Sudden loss of sensation of one side of the body Sincerely, Your ___ Neurology Team ","Ms. ___ is a ___ year old female with AFib on Eliquis, CHF, HLD, HTN who presented w/ sudden onset dysarthria, abnormal arm movements, and poor balance (walker at baseline). NIHSS 1 for slurred speech at OSH. There, a CTA head and neck was completed, and there was concern for left M2 branch attenuation concerning for stenosis or occlusion, and she was subsequently transferred for consideration of thrombectomy but NIHSS 0 on arrival so she was not deemed a candidate. She was admitted to the Neurology stroke service for further evaluation of possible TIA vs stroke. No further symptoms noted during admission. MRI head w/o contrast were without evidence of stroke. Reports recent echocardiogram per outpatient PCP/cardiologist, reported as no acute findings and so this was not repeated. She mentioned concern about worsening memory, but able to perform ADLs w/ meals/cleaning provided by ALF (moved 10 months ago); it appears there has been no acute change. She was taking apixiban 2.5mg once daily (unclear why as this is a BID medication), and so her dose was increased to 2.5mg BID (she was not a candidate for 5mg BID due to her age and weight). She was started on atorvastatin for her hyperlipidemia (LDL 126). EP cardiology was consulted for frequent sinus pauses noted on telemetry that persisted despite holding home atenolol, recommending discontinuing home digoxin and close cardiology ___. Discharged to home w/ ___ & ___ and close PCP ___. #Transient slurred speech and instability, c/f TIA - ___ consult - cleared for home with home services - Started on atorvastatin for HLD and increased home apixaban to therapeutic level - ___ with stroke neurology after discharge Her stroke risk factors include the following: 1) DM: A1c 5.5% 2) Likely chronic segmental left vertebral artery occlusion and somewhat small caliber attenuated left M2 inferior branch 3) Hyperlipidemia: LDL 126 4) Obesity 5) No concern noted for sleep apnea - she does not carry the diagnosis An echocardiogram did not show a PFO on bubble study. AHA/ASA Core Measures for Ischemic Stroke and Transient Ischemic Attack 1. Dysphagia screening before any PO intake? (X) Yes, confirmed done - () Not confirmed () No 2. DVT Prophylaxis administered? (X) Yes - () No 3. Antithrombotic therapy administered by end of hospital day 2? (X) Yes - () No 4. LDL documented? (X) Yes (LDL = 126) - () No 5. Intensive statin therapy administered? (simvastatin 80mg, simvastatin 80mg/ezetemibe 10mg, atorvastatin 40mg or 80 mg, rosuvastatin 20mg or 40mg, for LDL > 100) (X) Yes - () No [if LDL if LDL >70, reason not given: [ ] Statin medication allergy [ ] Other reasons documented by physician/advanced practice nurse/physician ___ (physician/APN/PA) or pharmacist [ ] LDL-c less than 70 mg/dL] 6. Smoking cessation counseling given? () Yes - (X) No [reason (X) non-smoker - () unable to participate] 7. Stroke education (personal modifiable risk factors, how to activate EMS for stroke, stroke warning signs and symptoms, prescribed medications, need for followup) given (verbally or written)? (X) Yes - () No 8. Assessment for rehabilitation or rehab services considered? (X) Yes - () No 9. Discharged on statin therapy? (X) Yes - () No [if LDL >70, reason not given: [ ] Statin medication allergy [ ] Other reasons documented by physician/advanced practice nurse/physician ___ (physician/APN/PA) or pharmacist [ ] LDL-c less than 70 mg/dL 10. Discharged on antithrombotic therapy? (X) Yes [Type: () Antiplatelet - (X) Anticoagulation] - () No 11. Discharged on oral anticoagulation for patients with atrial fibrillation/flutter? (X) Yes - () No - () N/A #Cognitive complaints - B12 249 - one time IM supplementation, then start oral B12 supplementation - Treponemal antibodies negative - consider cognitive neurology referral as outpatient for memory difficulties not appreciated on our examination #Afib #frequent sinus pauses - stopped digoxin, will ___ closely w/ otpt cardiologist (also PCP) - increased to appropriate therapeutic dosing at Eliquis 2.5 mg BID (reduced dose given age and weight <60 kg) #HLD - started atorvastatin #HTN - continue home antihypertensives #elevated troponin (RESOLVED) - Troponin elevated at OSH, negative on admission #elevated TSH - should recheck as otpt w/ PCP ___ ",3247,1118
10001725-DS-12,"<SEX> F <SERVICE> OBSTETRICS/GYNECOLOGY <ALLERGIES> Codeine / gabapentin / morphine / Amoxicillin / metronidazole / propoxyphene / rofecoxib / Macrobid / furosemide / Amitiza / Sulfa (Sulfonamide Antibiotics) / Tylenol / Hydromorphone / Toradol <ATTENDING> ___ <CHIEF COMPLAINT> For admission: elective gynecologic surgery for urinary retention For MICU transfer: Anaphylaxis <MAJOR SURGICAL OR INVASIVE PROCEDURE> Stage 2 interstim w/ posterior colporrhaphy for rectocele + enterocele ___ <HISTORY OF PRESENT ILLNESS> <HISTORY OF PRESENT ILLNESS> Ms. ___ is a ___ w/ Hx of cervical CA s/p radical hysterectomy c/b chronic ___ lymphedema and urinary retention, for which she frequently self-caths, Asthma, GERD, IBS, anxiety/depression, fibromyalgia and other issues who was admitted for an elective gynecologic surgery (stage 2 interstim and posterior colporrhaphy w/ graft) for urinary retention and rectocele + enterocele. <PAST MEDICAL HISTORY> Cervical CA s/p radical hysterectomy c/b chronic ___ lymphedema ADHD Anxiety/Depression Asthma Insomnia GERD Raynaud's IBS Fibromyalgia <SOCIAL HISTORY> ___ <FAMILY HISTORY> +Hx of atopy in son, daughter; both w/ frequent allergy rxns requiring epi pens <PHYSICAL EXAM> MICU ADMISSION EXAM: -------------------- Vitals: T: 98.7 BP: 113/83 P: 79 R: 18 O2: 97% ___ ___: Well appearing female in no acute distress, slightly muffled voice, somewhat flushed skin HEENT: Moist mucous membranes, mild lip swelling, tongue not grossly edematous, no angioedema Neck: JVP non elevated CV: Regular rate and rhythm, normal S1 S2, no murmurs Lungs: Clear to auscultation bilaterally, no wheezes/rales/rhonchi Abdomen: Soft, normoactive bowel sounds, nontender, nondistended, no rebound or guarding GU: Foley in place Ext: Warm, trace ___ edema, peripheral pulses 2+ ___ Neuro: alert and oriented to person, hospital, and date MICU DISCHARGE EXAM: -------------------- Vitals: T: 97.5 BP: 107/62 P: 84 R: 16 O2: 99% ___ ___: Well appearing female in no acute distress, normal voice, somewhat flushed skin, most prominent in malar distribution on face HEENT: Moist mucous membranes, appearance of face unchanged from yesterday, tongue not edematous, no angioedema Neck: JVP non elevated CV: Regular rate and rhythm, normal S1 S2, no murmurs Lungs: Clear to auscultation bilaterally, no wheezes/rales/rhonchi Abdomen: Soft, normoactive bowel sounds, nontender, nondistended, no rebound or guarding GU: Foley in place Ext: Warm, trace ___ edema, peripheral pulses 2+ ___ Neuro: alert and oriented to person, hospital, and date GYN Floor discharge exam: VSS, AF Gen: NAD A&O x 3 Resp: no visible respiratory distress, speaking in full sentences Abd: soft, NT ND Ext: moving all 4 extremities <PERTINENT RESULTS> MICU ADMISSION LABS: ___ 06: 02PM BLOOD WBC-17.0* RBC-4.33 Hgb-13.9 Hct-39.1 MCV-90 MCH-32.2* MCHC-35.6* RDW-11.8 Plt ___ ___ 06: 02PM BLOOD Neuts-94.5* Lymphs-4.3* Monos-0.7* Eos-0.1 Baso-0.3 ___ 06: 02PM BLOOD ___ PTT-31.8 ___ ___ 06: 02PM BLOOD Glucose-146* UreaN-16 Creat-0.8 Na-140 K-3.9 Cl-106 HCO3-24 AnGap-14 ___ 06: 02PM BLOOD Calcium-9.1 Phos-3.1 Mg-1.5* ___ 06: 02PM BLOOD TRYPTASE-PND MICU DISCHARGE LABS: ___ 02: 59AM BLOOD WBC-20.1* RBC-3.98* Hgb-12.6 Hct-36.3 MCV-91 MCH-31.6 MCHC-34.7 RDW-11.9 Plt ___ ___ 02: 59AM BLOOD Plt ___ ___ 02: 59AM BLOOD Glucose-152* UreaN-18 Creat-0.8 Na-138 K-3.5 Cl-102 HCO3-24 AnGap-16 ___ 02: 59AM BLOOD Calcium-9.1 Phos-4.0 Mg-2.8* PERTINENT LABS: ___ 06: 02PM BLOOD WBC-17.0* RBC-4.33 Hgb-13.9 Hct-39.1 MCV-90 MCH-32.2* MCHC-35.6* RDW-11.8 Plt ___ ___ 06: 02PM BLOOD Neuts-94.5* Lymphs-4.3* Monos-0.7* Eos-0.1 Baso-0.3 ___ 06: 02PM BLOOD ___ PTT-31.8 ___ ___ 06: 02PM BLOOD Glucose-146* UreaN-16 Creat-0.8 Na-140 K-3.9 Cl-106 HCO3-24 AnGap-14 ___ 06: 02PM BLOOD Calcium-9.1 Phos-3.1 Mg-1.5* ___ 06: 02PM BLOOD TRYPTASE-PND PERTINENT IMAGING: None PERTINENT MICRO: None <MEDICATIONS ON ADMISSION> Albuterol sulfate 2.5 mg/3 mL (0.083 %) Neb TID PRN Albuterol ProAir HFA 90 mcg INH 1 puff BID PRN Cephalexin 250 mg Q6H Adderall XR 15 mg BID Ergocalciferol (vitamin D2) 50,000 U Q week Nexium 40 mg ___ QAM Vivelle 0.075 mg/24 hr Transderm Patch 2x / week Diflucan 200 mg Q ___ Hydroxyzine HCl 25 mg QD PRN Ibuprofen 600 mg Q8H PRN Linzess (linactolide) 145 mcg QD Ativan 1 mg QD PRN Metolazone 2.5 mg QD Zofran 8 mg PO PRN Oxycodone 5 mg PO Q6H PRN Potassium chloride 10 % Oral Liquid 30ml PO QID Propranolol ER 80 mg ER QHS Spironolactone 100 mg QD Trimethoprim 100 mg tablet QD Ambien 10 mg QHS #14 ___ catheter Docusate sodium 100 mg BID LACTOBACILLUS COMBINATION <DISCHARGE MEDICATIONS> 1. Docusate Sodium (Liquid) 100 mg PO BID RX *docusate sodium 100 mg 1 tablet by mouth twice a day Disp #*60 Capsule Refills: *0 2. Bisacodyl 10 mg PO/PR DAILY: PRN Constipation RX *bisacodyl 5 mg ___ tablet,delayed release (___) by mouth constipation Disp #*20 Tablet Refills: *0 3. Metolazone 2.5 mg PO DAILY 4. NexIUM (esomeprazole magnesium) 40 mg Oral once Duration: 1 Dose 5. OxycoDONE (Immediate Release) ___ mg PO Q6H: PRN pain do not drive and drink on this medication RX *oxycodone 5 mg ___ tablet(s) by mouth every 6 hrs Disp #*20 Tablet Refills: *0 6. Propranolol LA 80 mg PO DAILY 7. Spironolactone 100 mg PO DAILY 8. Zolpidem Tartrate 5 mg PO HS 9. Trimethoprim 100 mg PO DAILY 10. Vivelle (estradiol) 0.075 mg/24 hr Transdermal twice/week 11. Lorazepam 1 mg PO DAILY: PRN anxiety 12. Potassium Chloride 40 mEq PO DAILY Duration: 24 Hours Hold for K > <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> urinary retention, rectocele <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear ___, You were admitted to the Gynecology service after your scheduled Stage 2 Insterstim placement and posterior colporrhaphy with graft for urinary retention and rectocele and enterocele. You tolerated the procedure well. However, after your operation, you had a severe allergic reaction, and had to go to the ICU for monitoring. Since then, you have recovered well, and we have determined that you are in stable condition for discharge. Please take your medication and follow-up at your appointments as scheduled. ___ instructions: * Take your medications as prescribed. * Do not drive while taking narcotics. * Take a stool softener such as colace while taking narcotics to prevent constipation * Do not combine narcotic and sedative medications or alcohol * Do not take more than 4000mg acetaminophen (APAP) in 24 hrs * No strenuous activity until your post-op appointment * Nothing in the vagina (no tampons, no douching, no sex) for 6 weeks * No heavy lifting of objects >10lbs for 6 weeks. * You may eat a regular diet * or anything that concerns you Incision care: * You may shower and allow soapy water to run over incision; no scrubbing of incision. No bath tubs for 6 weeks. Call your doctor for: * fever > 100.4 * severe abdominal pain * difficulty urinating * vaginal bleeding requiring >1 pad/hr * abnormal vaginal discharge * redness or drainage from incision * nausea/vomiting where you are unable to keep down fluids/food or your medication * or anything that concerns you To reach medical records to get the records from this hospitalization sent to your doctor at home, call ___. ","Ms. ___ is a ___ y/o F w/ Hx of cervical CA s/p radical hysterectomy c/b chronic ___ lymphedema and urinary retention, Asthma, GERD, anxiety/depression, fibromyalgia. Please refer to the operative report for full details. Her post-operative course was uncomplicated. Immediately post-op, her pain was controlled with IV dilaudid and toradol. However, in the PACU, the patient started feeling itchy. Once the pt returned to the floor, she noted sensation of tongue / lip swelling, difficulty swallowing secretions, and a change in her voice. No SOB, no flushing, no stridor or wheeze. She was administered an Epi-pen, Solumedrol 100 mg IV, Famotidine 20 mg IV, and Hydroxyzine 25 mg IM. She was transferred to the MICU for closer monitoring. The patient has numerous drug allergies and was administered the following medications intra-operatively: Midazolam, Rocuronium, Fentanyl, Dexamethasone, Hydromorphone, Ondansetron, Lidocaine, Propofol, Cefazolin, Glycopyrrolate, Phenylephrine, and Ketorolac. In the MICU, initial VS were HR 87, BP 100/63, RR 17, S 100% ___. The patient was in NAD, without wheeze or poor air movement on exam, but complained of persistent voice change and difficulty swallowing, for which she required 2 more epi pens. Has remained hemodynamically stable and without respiratory compromise. ACTIVE ISSUES: *) Post operative care Her pain was controlled immediately post-op with IV dilaudid and toradol. This was transitioned to po oxycodone as it was difficult to determine what was causing an allergic reaction in Ms. ___. Her vaginal packing was removed on POD 1, on post-operative day 2, her urine output was adequate and her Foley was removed. The patient was able to void spontaneously, but did require self-catheterization ___ times a day based on a sensation of bladder fullness. *) Anaphylaxis: In the PACU the patient awoke and started feeling pruritis. Once she arrived to the floor, the patient noted difficulty talking, subjectively swollen lips/tongue, and vocal changes. No SOB, no flushing, no stridor or wheeze. A trigger was called for anaphyllaxis and she recieved an Epi-pen, Solumedrol 100 mg IV, Famotidine 20 mg IV, and Hydroxyzine 25 mg IM. She was transferred to the MICU for closer monitoring. In the MICU, initial VS were HR 87, BP 100/63, RR 17, S 100% ___. The patient was in NAD, without wheeze or poor air movement on exam, but complained of persistent voice change and difficulty swallowing, for which she required 2 more epi pens. Has remained hemodynamically stable and without respiratory compromise. Of note, patient was lying comfortable in bed around 2200 and continuing to inquire about more Epi-pens vs epinephrine gtt despite comfortable respiration, vocalization, non-edematous oral structures. She also perseverated about her Ativan and Ambien, as well as her propranolol for essential tremor despite explanation that beta blockers can worsen bronchoconstriction and respiratory compromise in anaphylaxis. On the day she was called out to the floor, the pt complained of persistent facial flushing. She was afebrile, hemodynamically stable, and without respiratory compromise or systemic symptoms. Symptomatic care with hydroxyzine and eucerin lotion was provided. Upon step down to the floor, the patient again reported to nursing that she felt throat constriction. Epinephrine and solumedrol were given and the patient felt relief. Allergy was consulted, and they asked us to stop all new medications given to her while at the hospital, and to report all of them as allergies. In addition, we sent out a tryptase level, as well as coordinated outpatient follow-up with them. #Chronic ___ edema: Continue home Metolazone, spironolactone, potassium repletion as not hypotensive. We monitored her K during her stay, which was WNL. #Asthma: Home Albuterol use ___ per week, did not require in the MICU. #GERD: Nexium (was initially held on admission, but per pt request was given on ___ prior to advancing diet) #ADHD: On Adderall, held on admission # Anxiety/depression/fibromyalgia: lorazepam # Insomnia: zolpidem By post-operative day 1, she was tolerating a regular diet, ambulating independently, and pain was controlled with oral medications. She was the discharged home in stable condition with outpatient follow-up scheduled. She was also scheduled to have an appointment with Allergy and Immunology. ",2395,1058
10001860-DS-12,"<SEX> M <SERVICE> ORTHOPAEDICS <ALLERGIES> Sulfa (Sulfonamide Antibiotics) / Penicillins <ATTENDING> ___. <CHIEF COMPLAINT> neck pain s/p fall <MAJOR SURGICAL OR INVASIVE PROCEDURE> None on this Admission <HISTORY OF PRESENT ILLNESS> ___ male transferred from outside hospital for evaluation of cervical ___ fracture. Today the patient was attempting to use the bathroom and bent forward and fell hitting the back of his head. There was no loss of consciousness. The patient complains of headache and neck pain. The outside hospital the patient had the head laceration stapled. A CT scan did demonstrate the fracture. The patient denies any numbness, tingling in his arms or legs. No weakness in his arms or legs. Denies any bowel incontinence or bladder retention. No saddle anesthesia. Denies any chest pain, shortness of breath or abdominal pain. <PAST MEDICAL HISTORY> PMH: a. fib, colon ca, htn, copd MED: warfarin, allopurinol, asacol ALL: pcn, sulfa <SOCIAL HISTORY> ___ <FAMILY HISTORY> NC <PHYSICAL EXAM> C collar in place UEC5C6C7C8T1 (lat arm) (thumb) (mid fing) (sm finger) (med arm) Rintact intact intact intact intact Lintact intact intact intact intact T2-L1 (Trunk) intact ___ L2 L3 L4 L5S1S2 (Groin)(Knee) (Med Calf) (Grt Toe) (Sm Toe) (Post Thigh) Rintactintactintactintact intactintact Lintactintactintactintact intactintact Motor: UEDlt(C5)Bic(C6)WE(C6)Tri(C7)WF(C7)FF(C8)FinAbd(T1) R 5 5 5 5 ___ L 5 5 5 5 ___ ___ Flex(L1) Add(L2) Quad(L3) TA(L4) ___ ___ R ___ 5 5 5 5 L ___ 5 5 5 5 Babinski: negative Clonus: not present <DISCHARGE INSTRUCTIONS> You have undergone the following operation: Anterior Cervical Decompression and Fusion Immediately after the operation: -Activity: You should not lift anything greater than 5 lbs for 2 weeks. You will be more comfortable if you do not sit in a car or chair for more than ~45 minutes without getting up and walking around. -Rehabilitation/ Physical Therapy: o2-3 times a day you should go for a walk for ___ minutes as part of your recovery. You can walk as much as you can tolerate. oIsometric Extension Exercise in the collar: 2x/day x ___xercises as instructed. -Swallowing: Difficulty swallowing is not uncommon after this type of surgery. This should resolve over time. Please take small bites and eat slowly. Removing the collar while eating can be helpful  however, please limit your movement of your neck if you remove your collar while eating. -Cervical Collar / Neck Brace: You need to wear the brace at all times until your follow-up appointment which should be in 2 weeks. You may remove the collar to take a shower. Limit your motion of your neck while the collar is off. Place the collar back on your neck immediately after the shower. -Wound Care: Monitor laceration at scalp for drainage/redness. Your PCP may take these staples out. -You should resume taking your normal home medications. -You have also been given Additional Medications to control your pain. Please allow 72 hours for refill of narcotic prescriptions, so plan ahead. You can either have them mailed to your home or pick them up at the clinic located on ___. We are not allowed to call in narcotic (oxycontin, oxycodone, percocet) prescriptions to the pharmacy. In addition, we are only allowed to write for pain medications for 90 days from the date of surgery. -Follow up: oPlease Call the office ___ and make an appointment with Dr. ___ 2 weeks after the day of your operation if this has not been done already. oAt the 2-week visit we will check your incision, take baseline x rays and answer any questions. oWe will then see you at 6 weeks from the day of the operation. At that time we will most likely obtain Flexion/Extension X-rays and often able to place you in a soft collar which you will wean out of over 1 week. Please call the office if you have a fever>101.5 degrees Fahrenheit, drainage from your wound, or have any questions. Physical Therapy: activity as tolerated C-collar full time for 12 weeks may use ambulatory assistive devices for safety no bending twisting, or lifting >5lbs Treatment Frequency: monitor skin at chin and back of head for breakdown in C-collar ","Patient was admitted to the ___ ___ Surgery Service for observation after a C2 fracture. TEDs/pnemoboots were used for postoperative DVT prophylaxis. Diet was advanced as tolerated. The patient was tolerated oral pain medication. Physical therapy was consulted for mobilization OOB to ambulate. He remained hypertensive from 160 - >180. Medicine consult appreciated - felt this was long standing. recommended PRN antihypertensives but cautioned against bringing pressure too low too quickly. Hospital course was otherwise unremarkable. On the day of discharge the patient was afebrile with stable vital signs, comfortable on oral pain control and tolerating a regular diet. Discharge Medications: 1. Acetaminophen 650 mg PO Q4H:PRN pain, temp >100.5, headache 2. Allopurinol ___ mg PO DAILY 3. Mesalamine ___ 400 mg PO TID 4. Metoprolol Tartrate 25 mg PO BID 5. Omeprazole 20 mg PO DAILY 6. Warfarin 1 mg PO DAILY 7. OxycoDONE (Immediate Release) 2.5-5 mg PO Q4H:PRN pain 8. Diazepam 2 mg PO Q12H:PRN spasms Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: C2 fracture Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Followup Instructions: ___",1067,333
10001884-DS-24,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> Atypical chest pain <MAJOR SURGICAL OR INVASIVE PROCEDURE> Stess Echo <HISTORY OF PRESENT ILLNESS> ___ y/o woman with intermittent chest pain past several months. Pain is located on left posterior shoulder and radiates down arm to fingers where it turns into ""pins-n-needles"" symptom. No SOB/N/V. Patient does endorse some minimal diaphoresis and gerd like symptoms accompanying it. Pain has been controlled with tylenol #3. <PAST MEDICAL HISTORY> HTN Asthma Diverticulitis several years ago R hip replacement in ___ <SOCIAL HISTORY> ___ <FAMILY HISTORY> Mother: ___, HTN Father: ___ CA Brother: CA? Brother: ___ Physical ___: Vtals: T: 97.6 BP: 167/88 P: 83 R: 20 O2: 99% 2L General: Alert, oriented, no acute distress HEENT: Sclera anicteric, MMM, oropharynx clear Neck: supple, JVP not elevated, no LAD Lungs: Clear to auscultation bilaterally, no wheezes, rales, ronchi CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Abdomen: soft, non-tender, non-distended, bowel sounds present, no rebound tenderness or guarding, no organomegaly Ext: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema <PERTINENT RESULTS> ___ 03: 20PM BLOOD WBC-6.2 RBC-4.51 Hgb-13.1 Hct-38.6 MCV-86 MCH-29.1 MCHC-33.9 RDW-15.4 Plt ___ ___ 07: 15AM BLOOD WBC-6.0 RBC-4.91 Hgb-13.8 Hct-41.7 MCV-85 MCH-28.1 MCHC-33.0 RDW-15.1 Plt ___ ___ 07: 50AM BLOOD WBC-5.2 RBC-4.67 Hgb-13.4 Hct-39.4 MCV-84 MCH-28.7 MCHC-34.1 RDW-15.2 Plt ___ ___ 03: 20PM BLOOD Glucose-95 UreaN-21* Creat-0.8 Na-139 K-3.5 Cl-100 HCO3-30 AnGap-13 ___ 09: 10PM BLOOD Glucose-120* UreaN-17 Creat-0.9 Na-137 K-3.3 Cl-99 HCO3-31 AnGap-10 ___ 07: 15AM BLOOD Glucose-100 UreaN-15 Creat-0.8 Na-138 K-4.4 Cl-98 HCO3-35* AnGap-9 ___ 03: 20PM BLOOD cTropnT-<0.01 ___ 09: 10PM BLOOD CK-MB-3 cTropnT-<0.01 ___ 07: 15AM BLOOD CK-MB-4 cTropnT-<0.01 . ___ ___ F ___ ___ Cardiology Report Stress Study Date of ___ EXERCISE RESULTS RESTING DATA EKG: SINUS WITH AEA, LBBB HEART RATE: 68 BLOOD PRESSURE: 146/86 PROTOCOL MODIFIED ___ - TREAD___ STAGE TIME SPEED ELEVATION HEART BLOOD RPP (MIN) (MPH) (%) RATE PRESSURE 0 ___ 1.0 8 100 176/88 ___ 1 ___ 1.7 10 114 178/92 ___ 2.5 12 126 184/98 ___ TOTAL EXERCISE TIME: 9 % MAX HRT RATE ACHIEVED: 83 SYMPTOMS: ATYPICAL PEAK INTENSITY: ___ INTERPRETATION: ___ yo woman was referred to evaluate an atypical chest discomfort. The patient completed 9 minutes of a Gervino protocol representing a fair exercise tolerance for her age; ~ ___ METS. The exercise test was stopped at the patient's request secondary to fatigue. During exercise, the patient reported a non-progressive, isolated upper left-sided chest discomfort; ___. The area of discomfort was reportedly tender to palpation. This discomfort resolved with rest and was absent 2.5 minutes post-exercise. In the presence of the LBBB, the ST segments are uninterpretable for ischemia. The rhythm was sinus with frequent isolated APDs and occasional atrial couplets and atrial triplets. Resting mild systolic hypertension with normal blood pressure response to exercise. The heart rate response to exercise was mildly blunted. IMPRESSION: Fair exercise tolerance. No anginal symptoms with uninterpretable ECG to achieved workload. Resting mild systolic hypertension with appropriate blood pressure response to exercise. Suboptimal study - target heart rate not achieved. SIGNED: ___ <MEDICATIONS ON ADMISSION> Tylenol ___ Q4h PRN pain Albuterol Sulfate 2 puffs q4-6h PRN SOB Fluticasone 50 mcg spray/suspension 2 whiffs PRN allergies Adviar 500/50 1 INH BID HCTZ 50mg One PO daily Singulari 10mg tablet One PO QD omeprazole 20mg 1 PO QD simvastatin 20mg 1 PO QD theophylline 200mg sustained release one PO TID spiriva 18 mcg w/ inhalation ASA 81mg Calcium sig unknown Cod liver oil Sig unk Multivitamin <DISCHARGE MEDICATIONS> 1. acetaminophen 325 mg Tablet Sig: One (1) Tablet PO Q4H (every 4 hours) as needed for pain. 2. albuterol sulfate 90 mcg/Actuation HFA Aerosol Inhaler Sig: Two (2) Puff Inhalation Q6H (every 6 hours) as needed for SOB wheeze. 3. fluticasone-salmeterol 500-50 mcg/dose Disk with Device Sig: One (1) Disk with Device Inhalation BID (2 times a day). 4. fluticasone 50 mcg/Actuation Spray, Suspension Sig: ___ Nasal once a day as needed for allergy symptoms. 5. hydrochlorothiazide 50 mg Tablet Sig: One (1) Tablet PO once a day. 6. omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) Capsule, Delayed Release(E.C.) PO DAILY (Daily). 7. simvastatin 20 mg Tablet Sig: One (1) Tablet PO once a day. 8. tiotropium bromide 18 mcg Capsule, w/Inhalation Device Sig: One (1) Cap Inhalation DAILY (Daily). 9. aspirin 81 mg Tablet Sig: One (1) Tablet PO once a day. 10. multivitamin Tablet Sig: One (1) Tablet PO DAILY (Daily). 11. diltiazem HCl 120 mg Tablet Sustained Release 24 hr Sig: One (1) Tablet Sustained Release 24 hr PO once a day. Disp: *30 Tablet Sustained Release 24 hr(s)* Refills: *2* 12. nitroglycerin 0.3 mg Tablet, Sublingual Sig: One (1) Sublingual every 5 min as needed for chest pain: take one at onset of chest pain. ___ repeat every 5 min x3 with continued chest pain. Call PCP if chest pain persists. Disp: *30 tabs* Refills: *0* <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Coronary Artery Disease <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> You were admitted to ___ because you had back and arm pain that was worrisome for heart disease. A strees test found that you have coronary artery disease. You were started on a new blood pressure medication and tolerated this well. You should keep all of you follow up appointments as listed below. . While you were here we made the following changes to your medications: . We STARTED you on Diltiazem 120mg once a day . We STOPPED ___ theophylline . We STARTED nitroglycerine to take when you have chest pain . YOU NEED TO STOP SMOKING. IT WILL KILL YOU. ","___ ___ with several month history of left sided arm and chest wall pain in the setting of LBBB presenting for ___. . . # Chest Pain:The patient's symptoms were not typically anginal in nature to suggest ACS. However she does have several cardiac risk factors and a LBBB, so physicians could not r/oMI with EKG alone. Trop. results were negative x3. Stress Echo revealed new regional dysfunction with hypokinesis of the inferior and inferolateral walls consistent with single vessel disease in the PDA distribution. A cardiology consult was obtained and they felt she could be managed medically. Patient was already on an aspirin, and a statin. Given history to suggest asthma B-blocker was contraindicated. She was discharged on 120 mg extended release diltiazem with instructions to follow up in cardiology and with her PCP. . # Supraventricular tachycardia: The patient had multiple runs of SVT that was likley MAT in the setting of severe obstructive lung disease and chronic theophylline use. Cardiology reccomended that we discontinue her theophylline. We spoke with her pulmonologist who agreed this would be the best course of action for her. She was discharged with instructions to discontinue use of theophylline and follow up with her pulmonologist and cardiology. ",1944,284
10001884-DS-25,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> Chest Pain <MAJOR SURGICAL OR INVASIVE PROCEDURE> None <HISTORY OF PRESENT ILLNESS> Ms. ___ is a ___ y/o female with a history of hypertension, asthma and recent diagnosis of CAD based on stress echo done on ___, thought to be single vessel disease who presents with intermittent chest pain since her recent discharge on ___. During her recent hospitalization she was ruled out for an MI with three negative sets of cardiac enzymes, she had a stress echo which showed inducible ischemia at the achieved workload, thought to be single vessel disease per the echo report. At that time the plan was for medical management, given her severe underlying pulmonary disease she was not started on a beta blocker, but was started on diltiazem 120mg daily. Also during that admission she was found to have intermittent episodes of MAT. Today she was on the phone with her ___ year old aunt, who is very hard or hearing, she says that she became frustrated when her aunt was ___ to hear her on the phone and she started to have some chest pain. The pain began in the ___ her chest, as a dull pain then moved up to her left shoulder and under her left breast, at its worst was a ___. She took three SL nitro's at home, with some minor improvement in her CP but when it did not resolve she called Dr. ___ referred her to the ER. She denied any associated SOB, nausea/vomiting. She denies any orthopnea, PND, ___ edema or palpitations. . In the ED, initial vitals were 98.7, 73, 183/92, 20, 98% on RA. Her EKG had a LBBB that was unchanged from prior, CXR with no acute process. Patient given aspirin 243mg since she had already taken 81mg of aspirin at home. She was not given anything for her episodes of chest pain as they resolved without further intervention. Vitals on transfer were 71, 121/56, 22, 100% on RA. . On arrival to the floor, patient's initial VS were: 98.9, 140/86, 68, 18, 97% on RA. She says that she currently may have a little bit of cental CP, but otherwise feels well and has no complaints. <PAST MEDICAL HISTORY> HTN Asthma Diverticulitis several years ago R hip replacement in ___ Exertional Atypical Chest Pain <SOCIAL HISTORY> ___ <FAMILY HISTORY> Mother: ___, HTN Father: ___ CA Brother: CA? Brother: ___ Physical ___: On Admission: VS: T=98.9 BP=140/86 HR=68 RR=18 O2 sat=97% on RA GENERAL: WDWN female in NAD. Oriented x3. Mood, affect appropriate. HEENT: NCAT. Sclera anicteric. Conjunctiva were pink, no pallor or cyanosis of the oral mucosa. No xanthalesma. NECK: Supple CARDIAC: RR, normal S1, S2. No m/r/g. No thrills, lifts. No S3 or S4. LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp were unlabored, no accessory muscle use. decreased breath sounds throughout, although CTA, no crackles, wheezes or rhonchi. ABDOMEN: Soft, NTND. No tenderness. EXTREMITIES: No c/c/e. SKIN: No stasis dermatitis, ulcers, scars, or xanthomas. PULSES: Right: DP 2+ ___ 2+ Left: DP 2+ ___ 2+ <PERTINENT RESULTS> ___ 03: 55PM ___ PTT-26.0 ___ ___ 03: 55PM PLT COUNT-215 ___ 03: 55PM NEUTS-53.2 ___ MONOS-5.7 EOS-0.9 BASOS-0.5 ___ 03: 55PM WBC-5.6 RBC-4.66 HGB-13.2 HCT-39.4 MCV-85 MCH-28.3 MCHC-33.4 RDW-15.0 ___ 03: 55PM cTropnT-<0.01 ___ 03: 55PM estGFR-Using this ___ 03: 55PM GLUCOSE-94 UREA N-21* CREAT-0.9 SODIUM-138 POTASSIUM-4.0 CHLORIDE-100 TOTAL CO2-27 ANION GAP-15 ___ 04: 04PM GLUCOSE-91 K+-4.1 ___ 12: 00AM CK-MB-3 cTropnT-<0.01 ___ 12: 00AM CK(CPK)-189 CXR: Emphysema without superimposed pneumonia or CHF. <MEDICATIONS ON ADMISSION> -acetaminophen 325 mg Q4H as needed for pain. -albuterol sulfate 90 mcg: Two (2) Puff Inhalation Q6H (every 6 hours) as needed for SOB or wheeze. -fluticasone-salmeterol 500-50 mcg: Inhalation BID -fluticasone 50 mcg: ___ Nasal once a day -hydrochlorothiazide 50 mg once a day. -omeprazole 20 mg DAILY -simvastatin 20 mg once a day. -tiotropium bromide 18 mcg DAILY -aspirin 81 mg once a day. -multivitamin 1 Tablet DAILY -diltiazem HCl 120 mg Tablet Sustained Release 24 hr daily -singulair 10mg QHS <DISCHARGE MEDICATIONS> 1. acetaminophen 325 mg Tablet Sig: One (1) Tablet PO every four (4) hours as needed for pain. 2. albuterol sulfate 90 mcg/Actuation HFA Aerosol Inhaler Sig: Two (2) Puff Inhalation Q6H (every 6 hours) as needed for sob, wheezing . 3. fluticasone-salmeterol 500-50 mcg/dose Disk with Device Sig: One (1) Disk with Device Inhalation BID (2 times a day). 4. fluticasone 50 mcg/Actuation Spray, Suspension Sig: One (1) Spray Nasal DAILY (Daily). 5. hydrochlorothiazide 12.5 mg Capsule Sig: One (1) Capsule PO once a day. 6. omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) Capsule, Delayed Release(E.C.) PO DAILY (Daily). 7. simvastatin 20 mg Tablet Sig: One (1) Tablet PO once a day. 8. tiotropium bromide 18 mcg Capsule, w/Inhalation Device Sig: One (1) Cap Inhalation DAILY (Daily). 9. aspirin 81 mg Tablet Sig: One (1) Tablet PO once a day. 10. multivitamin Tablet Sig: One (1) Tablet PO DAILY (Daily). 11. montelukast 10 mg Tablet Sig: One (1) Tablet PO QHS (once a day (at bedtime)). 12. isosorbide mononitrate 30 mg Tablet Sustained Release 24 hr Sig: One (1) Tablet Sustained Release 24 hr PO once a day. Disp: *30 Tablet Sustained Release 24 hr(s)* Refills: *2* 13. diltiazem HCl 180 mg Capsule, Sust. Release 24 hr Sig: One (1) Capsule, Sust. Release 24 hr PO once a day. Disp: *30 Capsule, Sust. Release 24 hr(s)* Refills: *2* <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> PRIMARY: 1. atypical chest pain Secondary: 1. Hypertension 2. Asthma 3. Diverticulitis <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> You were admitted to the hospital for atypical chest pain. You were monitored on telemetry. Your EKG was unchanged. Your cardiac enzymes were normal, without evidence for heart damage or heart attack. We have started you on a long acting nitrate medication to control your chest pain symptoms. We also increased your diltiazem for better blood pressure and heart rate control. . Finally, we have set you up with a 48 hour holter monitor to get a better idea of your heart rhythm over time. Please discuss these results with ___. ___ at your upcoming cardiology appointment. . MEDICATION CHANGES: - START imdur 30 mg daily - INCREASE diltiazem to 180 mg daily . Please continue your other medications as prescribed. . Please seek medical attention for worsening chest pain, shortness of breath, or any other symptoms. ","ASSESSMENT AND PLAN: Ms. ___ is a ___ year old female with a recent diagnosis of CAD, HTN and asthma who presents with intermittent episodes of chest pain since her recent discharge. ...................................... Active Issues: . # CORONARIES: patient with intermittent episodes of left chest burning, that are not typical of angina since they resolve without intervention, are not relieved by nitro and have no association with exercise. However, given the findings on her recent stress echo of inducible ischemia it is concerning that her current symptoms could be related to her underlying CAD. Her troponins were negative during this hospital stay. On this admission, she was started on Imdur 30 in addition to the medications started on last discharge as it was decided that she may need better medical management prior to resorting to PCI (which may be a possibility in the future). After administration of IMDUR, we walked the patient down the hall, as well as up several flights of stairs. She denied feeling short of breath, nor did she endorse any other cardiac symtpoms, such as chest pain. In fact, she stated that she felt well walking. . # RHYTHM: LBBB on EKG from yesterday, regular. patient with a new diagnosis of MAT on last admission. We continued her on Diltiazem. She had several episodes of MAT on tele, but was asymptomatic. Given frequent PAT, ___ of Hearts monitor was arranged for her on discharge to exclude the possibility that symptoms are due to a tachyarrhythmia. ............................................. Inactive Issues: # Hypertension: continued home HCTZ and diltiazem.. # Asthma:continued home medications. # GERD: continued home omeprazole . CODE: full code ..................................... Transitional Issues: 1) Patient was started on Imdur 30mg daily in additon to her other medications. She is being medically managed for her coronary artery disease but may be a candidate for PCI in the future if the symtpoms of chest pain return. 2) Follow-up event monitor for evaluation of arrhythmias ",2040,435
10001884-DS-26,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> Fever, non-productive cough <MAJOR SURGICAL OR INVASIVE PROCEDURE> None <HISTORY OF PRESENT ILLNESS> ___ yo F w/ HTN, CAD, COPD p/w fevers, non-productive cough, since ___. Pt said she was in her usual state of health until ___ evening when she developed a cough producing ___ sputum. She took some robitussin and went to bed. She woke up the next morning and had general malaise, nasal congestion, intermittently productive cough. She did not want to eat and had 4 episodes of water diarrhea and one episode of vomiting without nausea. She denied fevers, chills or sweats at that time. She called her PCP who prescribed ___ Z-pack. Her symptoms persisted and she developed pain with coughing around her upper abdomen and lower chest. Denies other joint or muscle pain. She went to see her PCP on the day of admission. In her PCP's office was hypoxic on RA, here is 89% on RA. Has had flu vaccine this year and pneumovax last year. wheezy on exam, on 2L with o2 sat mid-90s. . In ED VS were afebrile 70 113/66 94%2L, On exam had wheezes with peak flow of 150 (no baseline), speaking in full sentences and no accessory muscle use, euvolemic and no ___ edema. Flu screen not performed, CXR unremarkable compared to prior. Given levoflox, nebs, pred 50 mg. <PAST MEDICAL HISTORY> ASTHMA HYPERTENSION HYPERLIPIDEMIA HEADACHE OSTEOARTHRITIS ATYPICAL CHEST PAIN TOBACCO ABUSE ABNORMAL CHEST XRAY COPD <SOCIAL HISTORY> ___ <FAMILY HISTORY> Mother: ___, HTN Father: ___ CA Brother: CA? Brother: ___ Physical ___: On Admission: VS: T: , BP: 142/70, HR: 70, RR 20, O2 93% on RA (96% 2L) GA: AOx3, pt with nasal cannula on in no respiratory distress HEENT: MMM. no LAD. no JVD. neck supple. Cards: RRR S1/S2 heard. no murmurs/gallops/rubs. Pulm: CTAB no crackles or wheezes, good inspiratory effort, but not great air movement, slightly prolonged expiratory phase. Abd: soft, NT, +BS. no g/rt. neg HSM. Extremities: wwp, no edema. DPs, PTs 2+. Skin: no noticeable rashes Neuro/Psych: CNs II-XII intact . ON DISCHARGE: VS: T: , BP: 142/70, HR: 70, RR 20, O2 93% on RA (96% 2L) GA: AOx3, pt with nasal cannula on in no respiratory distress HEENT: MMM. no LAD. no JVD. neck supple. Cards: RRR S1/S2 heard. no murmurs/gallops/rubs. Pulm: CTAB no crackles or wheezes, good inspiratory effort, but not great air movement, slightly prolonged expiratory phase. Abd: soft, NT, +BS. no g/rt. neg HSM. Extremities: wwp, no edema. DPs, PTs 2+. Skin: no noticeable rashes Neuro/Psych: CNs II-XII intact <PERTINENT RESULTS> LABS: ___ 03: 26PM BLOOD WBC-4.9 RBC-4.25 Hgb-12.7 Hct-36.5 MCV-86 MCH-30.0 MCHC-34.9 RDW-15.3 Plt ___ ___ 06: 50AM BLOOD WBC-8.2# RBC-4.03* Hgb-12.2 Hct-34.8* MCV-87 MCH-30.4 MCHC-35.1* RDW-15.3 Plt ___ ___ 03: 26PM BLOOD Glucose-123* UreaN-14 Creat-0.9 Na-136 K-3.3 Cl-97 HCO3-31 AnGap-___ 06: 50AM BLOOD Glucose-95 UreaN-17 Creat-0.8 Na-139 K-3.5 Cl-98 HCO3-30 AnGap-15 . MICRO: **FINAL REPORT ___ DIRECT INFLUENZA A ANTIGEN TEST (Final ___: POSITIVE FOR INFLUENZA A VIRAL ANTIGEN. REPORTED BY PHONE TO ___ AT 1153 ___. . IMAGING: CXR ___: IMPRESSION: 1. No acute chest pathology with stable pleural parenchymal scar. 2. Flattening of the hemidiaphragms consistent with COPD. <MEDICATIONS ON ADMISSION> 1. Lisinopril 5mg PO Daily 2. B complex-vitamin C-folic acid 1 mg Capsule Sig: One (1) Cap PO DAILY (Daily). 3. cinacalcet 30 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily). 4. simvastatin 10 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily). 5. metoprolol succinate 100 mg Tablet Sustained Release 24 hr Sig: One (1) Tablet Sustained Release 24 hr PO once a day. 6. doxazosin 4 mg Tablet Sig: Two (2) Tablet PO HS (at bedtime). 7. aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable PO DAILY (Daily). 8. venlafaxine 75 mg Capsule, Sust. Release 24 hr Sig: Two (2) Capsule, Sust. Release 24 hr PO DAILY (Daily). 9. venlafaxine 37.5 mg Capsule, Sust. Release 24 hr Sig: One (1) Capsule, Sust. Release 24 hr PO DAILY (Daily). 10. sevelamer HCl 400 mg Tablet Sig: Six (6) Tablet PO TID W/MEALS (3 TIMES A DAY WITH MEALS). Disp: *540 Tablet(s)* Refills: *2* 11. clonazepam 1 mg Tablet Sig: One (1) Tablet PO at bedtime. <DISCHARGE MEDICATIONS> 1. acetaminophen 325 mg Tablet Sig: One (1) Tablet PO every four (4) hours as needed for pain. 2. albuterol sulfate 90 mcg/Actuation HFA Aerosol Inhaler Sig: Two (2) Inhalation every ___ hours. 3. azithromycin 250 mg Tablet Sig: One (1) Tablet PO Q24H (every 24 hours) for 2 days. Disp: *2 Tablet(s)* Refills: *0* 4. oseltamivir 75 mg Capsule Sig: One (1) Capsule PO BID (2 times a day) for 3 days. Disp: *5 Capsule(s)* Refills: *0* 5. prednisone 10 mg Tablet Sig: Five (5) Tablet PO once a day for 7 days: Take 5 tabs for 2 days, then 4 tabs for 2 days, then 2 tabs for 2 days, then 1 tab for 2 days. Disp: *19 Tablet(s)* Refills: *0* 6. diltiazem HCl 180 mg Capsule, Extended Release Sig: Two (2) Capsule, Extended Release PO DAILY (Daily). 7. fluticasone 50 mcg/Actuation Spray, Suspension Sig: One (1) Spray Nasal DAILY (Daily). 8. fluticasone-salmeterol 500-50 mcg/dose Disk with Device Sig: One (1) Disk with Device Inhalation BID (2 times a day). 9. hydrochlorothiazide 12.5 mg Capsule Sig: One (1) Capsule PO DAILY (Daily). 10. isosorbide mononitrate 60 mg Tablet Extended Release 24 hr Sig: One (1) Tablet Extended Release 24 hr PO DAILY (Daily). 11. montelukast 10 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 12. omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) Capsule, Delayed Release(E.C.) PO DAILY (Daily). 13. tiotropium bromide 18 mcg Capsule, w/Inhalation Device Sig: One (1) Cap Inhalation DAILY (Daily). 14. calcium carbonate 200 mg (500 mg) Tablet, Chewable Sig: One (1) Tablet, Chewable PO DAILY (Daily). 15. multivitamin Tablet Sig: One (1) Tablet PO DAILY (Daily). 16. aspirin 81 mg Tablet Sig: One (1) Tablet PO once a day. 17. Oxygen Home Oxygen @ 2LPM Continuous via nasal cannula, conserving device for portability. Pulse dose for portability. <DISCHARGE DISPOSITION> Home With Service Facility: ___ <DISCHARGE DIAGNOSIS> Primary Diagnosis: Influenza COPD exacerbation . Secondary Diagnosis: ASTHMA HYPERTENSION HYPERLIPIDEMIA HEADACHE OSTEOARTHRITIS ATYPICAL CHEST PAIN TOBACCO ABUSE ABNORMAL CHEST XRAY COPD <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> You are being discharged from ___. It was a pleasure taking care of you. You were admitted to the hospital for symptoms that were similar to a common cold as well as worsening respiratory status. You tested positive for the flu and we also believe that you are having a COPD exacerbation. You were started on high dose steroids, azithromycin, tamiflu and nebulizers. You were also placed on oxygen. You are now doing better, but may require O2 at home for some time as your infection resolves and your inflammation improves. . The Following medications were STARTED: Prednisone 50mg 1 day, on ___ decrease to 40mg Daily for 2 days, on ___ decrease to 20mg Daily for 2 days, on ___ take 10mg Daily for 2 days then stop Azithromycin 250mg by mouth Daily 1 day (last dose on ___ Tamiflu 75mg two times a day for 2.5 days (last dose on ___ You will also be sent on home O2 . Please take your other medications as prescribed. ","A/P: ___ year old woman with recent onset of fevers, productive cough and costochondral vs. pleuritic pain who tested positive for influenza A. . # Fevers, malaise, cough: Pt seemed to have onset of symptoms consistent with viral infection. She was admitted to the hospital and placed on droplet precautions because there was concern that she had the flu. She was empirically started on Oseltamivir 75mg PO BID. nasopharyngeal swab was positive for influenza A. She was continued on a five day regiment of oseltamivir for her flu and will follow up with Dr. ___ in the outpatient setting. . # COPD exacerbation: Pt tested positive for the flu, but seemed to also be having a COPD exacerbation with worsening dyspnea and sputum production. She was started on prednisone 50mg PO Daily, Azithromycin and O2 via nasal cannula. Her resting O2 sat was initially 85%, but at the time of discharge she was satting 96% on RA, but would desaturate to 84% after walking 75-100feet. She Was given a 5 day course of azithromycin, 5 days of prednisone at 50mg PO Daily and then a week long taper and discharged on home O2 while her symptoms improved. The patient was breathing more comfortably and ambulating well at the time of discharge. She will follow up with Dr. ___ as well as Dr. ___ in the outpatient setting. . # ASTHMA: pt with wheezing in the ED and at PCP office, but not present on my exams, however, she had received duonebs prior to my exam. Likely having asthma symptoms in setting of COPD exacerbations. She was continued on her home regiment and also on standing nebulizers. She was discharged with nebulizer treamtents as well as her home medications. Respiratory status was described above. . HYPERTENSION: Pt slightly hypertensive in the ED, but will continue meds at current regiment and reassess in the morning. Her BP meds are actively being uptitrated in the outpatient setting. She remained normotensive during her hospital stay on the floor. We continued Diltiazem ER 360mg PO Q24H, HCTZ 12.5mg PO DAILY, IMDUR ER 60 mg PO DAILY. . GERD: Currently asymptomatic. We continued omeprazole 20mg PO Daily . CAD: Pt was recently diagnosed with single vessel disease. She is asymptomatic at this time, but we will continue to monitor her for symptoms during this admission. We continued aspirin 81mg PO DAILY . TOBACCO ABUSE: Pt had been smoking for many years, but said that she quit yesterday and has no need for a nicotine patch or gum at this time. . ",2435,606
10001884-DS-27,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> s/p tachyarrhythmia <MAJOR SURGICAL OR INVASIVE PROCEDURE> None <HISTORY OF PRESENT ILLNESS> ___ yo F smoker with PMH of asthma/COPD on theophylline, CAD, HTN, hyperlipidemia, and atypical chest pain presenting with malaise and SOB during an episode of tachyarrythmia at home which has since resolved. Pt recalls that she took her VS on the telehealth monitor, then nurse called and asked her to recheck them. ___ services came and measured HR at 110s, but pt was without CP, SOB, visual sx, HA, palps. Also denies F/C, N/V, abd pain, change in bowel or bladder. Per her PCP, ___ ___, the patient does have a history of tachyarrythmias even though the patient denies this history. She also took theophylline for some time, although it is not on her med list and she states she hasn't taken it since ___. However, PCP concern is that the theophylline may be contributing. Recent stress test with reversible lesion being treated conservatively. . In ED VS were 98.8 78 154/82 20 95%. Has CXR in ED which was unremarkable. Transfer VS were HR=60, BP=126/75, RR=18, POx=94% RA . On the floor, pt asymptomatic and feels well. Only upset because she's been in the hospital every month so far this year. <PAST MEDICAL HISTORY> -ASTHMA -HYPERTENSION -HYPERLIPIDEMIA -HEADACHE -OSTEOARTHRITIS -ATYPICAL CHEST PAIN -TOBACCO ABUSE -ABNORMAL CHEST XRAY -COPD <SOCIAL HISTORY> ___ <FAMILY HISTORY> Mother: ___, HTN Father: ___ CA Brother: CA? Brother: ___ Physical ___: ADMISSION PEx: VS: 97.9, 155/90, 64, 16@94%(RA) GA: AOx3, NAD HEENT: PERRLA. MMM. no LAD. no JVD. neck supple. Cards: PMI palpable at ___ IC space. No RVH. RRR S1/S2 heard. no murmurs/gallops/rubs. Pulm: scattered exp wheezing with minimal air movment Abd: soft, NT, +BS. no g/rt. Extremities: wwp, no edema. DPs, PTs 2+. Skin: no rashes, eccymoses, lesions Neuro/Psych: CNs II-XII intact. ___ strength in muscle groups tested, sensation symmetric. DISCHARGE PEx: <PERTINENT RESULTS> Relevant and representative labs: CBC and coags: -___ 03: 30PM BLOOD WBC-6.7 RBC-4.40 Hgb-13.2 Hct-38.9 MCV-88 MCH-29.9 MCHC-33.9 RDW-15.7* Plt ___ -___ 05: 55AM BLOOD WBC-5.9 RBC-4.32 Hgb-12.8 Hct-38.4 MCV-89 MCH-29.6 MCHC-33.2 RDW-15.6* Plt ___ -___ 03: 30PM BLOOD ___ PTT-26.2 ___ Chem: -___ 03: 30PM BLOOD Glucose-105* UreaN-18 Creat-0.9 Na-139 K-3.5 Cl-101 HCO3-31 -___ 05: 55AM BLOOD Glucose-101* UreaN-20 Creat-0.9 Na-139 K-4.2 Cl-99 HCO3-32 CEs: -___ 03: 30PM BLOOD cTropnT-<0.01 -___ 09: 10PM BLOOD CK-MB-4 cTropnT-<0.01 -___ 05: 55AM BLOOD CK-MB-3 cTropnT-<0.01 Misc: -___ 05: 55AM BLOOD Triglyc-96 HDL-50 CHOL/HD-3.2 LDLcalc-90 Cholest-159 <MEDICATIONS ON ADMISSION> -acetaminophen 325 mg Tablet Sig: One (1) Tablet PO every four (4) hours as needed for pain. -albuterol sulfate 90 mcg/Actuation HFA Aerosol Inhaler Sig: Two (2) Inhalation every ___ hours. -diltiazem HCl 180 mg Capsule, Extended Release Sig: Two (2) Capsule, Extended Release PO DAILY (Daily). -fluticasone 50 mcg/Actuation Spray, Suspension Sig: One (1) Spray Nasal DAILY (Daily). -fluticasone-salmeterol 500-50 mcg/dose Disk with Device Sig: One (1) Disk with Device Inhalation BID (2 times a day). -hydrochlorothiazide 12.5 mg Capsule Sig: One (1) Capsule PO DAILY (Daily). -isosorbide mononitrate 60 mg Tablet Extended Release 24 hr Sig: One (1) Tablet Extended Release 24 hr PO DAILY (Daily). -montelukast 10 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). -omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) Capsule, Delayed Release(E.C.) PO DAILY (Daily). -tiotropium bromide 18 mcg Capsule, w/Inhalation Device Sig: One (1) Cap Inhalation DAILY (Daily). -calcium carbonate 200 mg (500 mg) Tablet, Chewable Sig: One (1) Tablet, Chewable PO DAILY (Daily). -multivitamin Tablet Sig: One (1) Tablet PO DAILY (Daily). -aspirin 81 mg Tablet Sig: One (1) Tablet PO once a day. -simvastatin 20mg qday <DISCHARGE MEDICATIONS> 1. simvastatin 40 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). Disp: *30 Tablet(s)* Refills: *0* 2. hydrochlorothiazide 12.5 mg Capsule Sig: One (1) Capsule PO DAILY (Daily). 3. fluticasone 50 mcg/Actuation Spray, Suspension Sig: ___ Sprays Nasal DAILY (Daily) as needed for congestion. 4. isosorbide mononitrate 60 mg Tablet Extended Release 24 hr Sig: One (1) Tablet Extended Release 24 hr PO DAILY (Daily). 5. montelukast 10 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 6. fluticasone-salmeterol 500-50 mcg/dose Disk with Device Sig: One (1) Disk with Device Inhalation BID (2 times a day). 7. acetaminophen-codeine 300-30 mg Tablet Sig: One (1) Tablet PO every four (4) hours as needed for pain. 8. albuterol sulfate 90 mcg/Actuation HFA Aerosol Inhaler Sig: Two (2) puffs Inhalation every ___ hours as needed for shortness of breath or wheezing. 9. omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) Capsule, Delayed Release(E.C.) PO DAILY (Daily). 10. Spiriva with HandiHaler 18 mcg Capsule, w/Inhalation Device Sig: One (1) capsule Inhalation once a day. 11. aspirin 81 mg Tablet Sig: One (1) Tablet PO once a day. 12. calcium carbonate 200 mg (500 mg) Tablet, Chewable Sig: One (1) Tablet, Chewable PO DAILY (Daily). 13. diltiazem HCl 180 mg Capsule, Extended Release Sig: Two (2) Capsule, Extended Release PO DAILY (Daily). 14. multivitamin Tablet Sig: One (1) Tablet PO DAILY (Daily). 15. theophylline 200 mg Capsule, Ext Release 24 hr Sig: One (1) Capsule, Ext Release 24 hr PO three times a day. Disp: *90 Capsule, Ext Release 24 hr(s)* Refills: *0* 16. albuterol sulfate 0.63 mg/3 mL Solution for Nebulization Sig: One (1) treatment Inhalation every ___ hours as needed for shortness of breath or wheezing for 15 doses. Disp: *15 ampules* Refills: *0* <DISCHARGE DISPOSITION> Home With Service Facility: ___ <DISCHARGE DIAGNOSIS> Primary: -Tachyarrhythmia -Hyperlipidemia -Asthma, COPD Secondary: -Hypertension -Tobacco Use <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Mrs. ___, ___ were hospitalized because the visiting nurses were concerned about an elevated heart rate, but by the time ___ came to the hospital, your elevated heart rate had resolved. Nevertheless, ___ were admitted to ensure that your heart hadn't suffered any damage, and to see the inpatient cardiologist. Your labs were unremarkable from a cardiac standpoint, and ___ saw the cardiologist (who recommend no intervention at this time). ___ should follow-up with your pulmonologist as an outpatient for your breathing issues. The best thing ___ can do for your lung health is to quit smoking, and we encourage ___ to do so. The following changes were made to your medications: -INCREASE your simvastatin to 40mg daily in order to lower your cholesterol to goal (as recommended by the cardiologist) -RESTART theophylline 200mg three times a day -We will also be giving ___ a prescription for albuterol nebulizers to use instead of your inhaler (when needed), but refills will have to be through your primary physician or pulmonologist ___ discuss your theophylline dose and breathing status with your primary provider (Dr. ___ and your pulmonologist (Dr. ___. ","To Do: 1) follow-up theophylline level ___ yo F smoker with PMH of asthma/COPD managed with theophylline until ___ when theophylline was discontinued because of tachycardia, CAD, HTN, and hyperlipidemia who presented from home with asymptomatic tachyarrythmia. . ACTIVE ISSUES: . # Tachycarrhymia in context of recent inducible ischemia seen on ECHO stress test (___): At the time of admission, her symptoms had resolved, no abnormalities were seen on imaging or labs, and her VS and PEx were remarkable only for non-acute lung findings. MI was ruled out by trop negative x3, no EKG changes. Cardiology was consulted to evaluate need for catheterization vs other intervention, but did not feel that any urgent inpatient work-up was necessary, especially in the context of asymptomatic tachycardia. She had already had Holter and ECHO prior to this admission. Cardiology recommended restarting theophylline if, in fact, she received such benefit from pulmonary point of view. She was restarted on theophylline 200mg TID, which was her dose prior to discontinuation. She received tobacco cessation education, was continued on home diltiazem and aspirin (dose was temporarily increased to 325mg prior to ruling out MI). Admission theopylline level was pending at the time of discharge. . # Asthma and COPD: patient was given Albuterol and ipratropium nebs, and she was continued on her home doses of fluticasone, montelukast, fluticasone-salmetrol. She was given O2 PRN. After cardiology consult, she was restarted on her theophylline at 200mg TID, with pulm and cardiology follow-up. . # Tobacco abuse: she declined nicotine patch, and education was given regarding the health hazards of smoking. . # HL: patient was continued oh her simvastatin, but because her LDL was not at goal (<70), her dose was increased to 40mg daily. . INACTIVE ISSUES: . # HTN: continued isosorbide and hydrochlorothiazide at home doses. . # Code: Full ",2333,481
10001884-DS-28,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> IV Dye, Iodine Containing Contrast Media / Oxycodone / cilostazol <ATTENDING> ___. <CHIEF COMPLAINT> Pneumonia identified by outpatient CXR <MAJOR SURGICAL OR INVASIVE PROCEDURE> None <HISTORY OF PRESENT ILLNESS> ___ PMH of Asthma, COPD, tobacco use, p/w 4 days of ""cold like"" symptoms. Pt noted that she has a chronic cough at baseline, worse at night, but noted that her cough was now productive of ___ sputum and was a/w wheezing and subjective fevers (but did not take her temperature). Pt also noted that baseline DOE increased to mild shortness of breath at rest during the same time period. Pt took tylenol and robitussin to good effect. Pt denied any CP, but noted that she felt her heart ""flutter"" during this time period. No changed in her 2 pillow orthopnea. Pt did not have any recent sick contacts and denied any association w/ headache, sore throat, sneezing, rhinorrhea, nausea, vomiting, diarrhea, abdominal pain. In ED VS were T97.8 P78 BP136/97 R18 O296%NC. WBC was normal but pt noted to have wheezing on exam, and CXR was suggestive of RML PNA so was given 125mg methylprednisone, 750mg levaquin, and combo nebs (albuterol/ipratropim). CHEM/Coags/UA negative. Given co-morbidities, decision was made to admit pt while initiating Abx therapy. <PAST MEDICAL HISTORY> ASTHMA/COPD/Tobacco use Peripheral Arterial disease s/p recent common iliac stenting ATRIAL TACHYCARDIA ATYPICAL CHEST PAIN CERVICAL RADICULITIS CERVICAL SPONDYLOSIS CORONARY ARTERY DISEASE HEADACHE HIP REPLACEMENT HYPERLIPIDEMIA HYPERTENSION OSTEOARTHRITIS HERPES ZOSTER TOBACCO ABUSE ATRIAL FIBRILLATION ANXIETY GASTROINTESTINAL BLEEDING OSTEOARTHRITIS ATHEROSCLEROTIC CARDIOVASCULAR DISEASE PERIPHERAL VASCULAR DISEASE URINARY TRACT INFECTION CATARACT SURGERY ___ Surgery: BILATERAL COMMON ILIAC ARTERY STENTING ___ BUNIONECTOMY HIP REPLACEMENT PRIOR CESAREAN SECTION GANGLION CYST <SOCIAL HISTORY> ___ <FAMILY HISTORY> Mother: ___, HTN Father: ___ CA Brother: CA? Brother: ___ Physical ___: ADMISSION PHYSICAL EXAM: -=========== Tm98.4, BP141/82, P71, R20, O297%RA GENERAL: AOx3, pleasant affect, NAD HEENT: MMM. no LAD. no JVD HEART: RRR, S1/S2 normal, no murmurs/gallops/rubs. LUNGS: Coarse breath sounds b/l with expiratory wheezing diffusely, RML/RLL crackles, no incr WOB (no accessory muscle use), no resp distress ABDOMEN: soft, nontender, nondistended. normoactive BS EXT: Warm, dry, well perfused, 1+ peripheral edema to mid calves b/l SKIN: dry, warm, no rashes NEURO/PSYCH: AOx3, fluent speech, MAE spontaneously DISCHARGE PHYSICAL EXAM: -=========== Tm: 98.7, BP148-154/76-89, P72-81, R20, O29___-99RA GENERAL: AOx3, pleasant affect, NAD HEENT: MMM. no LAD. no JVD HEART: RRR, S1/S2 normal, no murmurs/gallops/rubs. LUNGS: Coarse breath sounds b/l with scant expiratory wheeze, no incr WOB (no accessory muscle use), no resp distress ABDOMEN: soft, nontender, nondistended. normoactive BS EXT: Warm, dry, well perfused, 1+ peripheral edema to mid calves b/l SKIN: dry, warm, no rashes NEURO/PSYCH: AOx3, fluent speech, MAE spontaneously <PERTINENT RESULTS> PERTINENT LABS: -========= ___ 05: 13PM BLOOD WBC-5.0 RBC-4.70 Hgb-13.8 Hct-42.7 MCV-91 MCH-29.3 MCHC-32.3 RDW-14.3 Plt ___ ___ 06: 05AM BLOOD WBC-9.0# RBC-4.25 Hgb-12.6 Hct-38.6 MCV-91 MCH-29.7 MCHC-32.7 RDW-14.4 Plt ___ ___ 05: 13PM BLOOD Neuts-53.9 ___ Monos-6.6 Eos-0.5 Baso-0.8 ___ 05: 13PM BLOOD ___ PTT-31.7 ___ ___ 12: 39PM BLOOD UreaN-16 Creat-0.8 Na-138 K-3.5 Cl-98 HCO3-29 AnGap-15 ___ 06: 05AM BLOOD Glucose-142* UreaN-15 Creat-0.7 Na-138 K-3.5 Cl-100 HCO3-29 AnGap-13 ___ 12: 39PM BLOOD proBNP-233 ___ 05: 13PM BLOOD Calcium-9.9 Phos-2.5* Mg-1.8 ___ 05: 35PM BLOOD Lactate-1.5 PERTINENT MICRO: -========= Urinalysis: ___ 05: 30PM URINE Blood-NEG Nitrite-NEG Protein-TR Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-7.0 Leuks-NEG ___ 05: 30PM URINE RBC-0 WBC-<1 Bacteri-NONE Yeast-NONE Epi-1 Blood Cx (___): NGTD (preliminary) PERTINENT STUDIES: -========= EKG: Sinus rhythm with frequent atrial premature beats. Left bundle-branch block with extensive repolarization abnormalities. Compared to the previous tracing of ___ the rhythm is now sinus CXR (___): Right middle lobe opacity concerning for pneumonia. <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Albuterol 0.083% Neb Soln 1 NEB IH Q6H: PRN shortness of breath 2. Albuterol Inhaler 2 PUFF IH Q4H: PRN shortness of breath 3. Symbicort (budesonide-formoterol) 160-4.5 mcg/actuation inhalation BID 4. Clopidogrel 75 mg PO DAILY 5. Diltiazem Extended-Release 180 mg PO DAILY 6. Fluticasone Propionate NASAL 2 SPRY NU DAILY: PRN nasal congestion 7. Hydrochlorothiazide 50 mg PO DAILY 8. Isosorbide Mononitrate (Extended Release) 240 mg PO DAILY 9. Latanoprost 0.005% Ophth. Soln. 1 DROP LEFT EYE HS 10. Simvastatin 20 mg PO DAILY 11. Theophylline ER 300 mg PO BID 12. Tiotropium Bromide 1 CAP IH DAILY 13. Acetaminophen 325 mg PO Q4H: PRN pain 14. Aspirin 81 mg PO DAILY 15. Calcarb 600 With Vitamin D (calcium carbonate-vitamin D3) 315/200 mg oral daily 16. cod liver oil 1,250-135 unit oral BID 17. Multivitamins W/minerals 1 TAB PO DAILY <DISCHARGE MEDICATIONS> 1. Acetaminophen 325 mg PO Q4H: PRN pain 2. Albuterol 0.083% Neb Soln 1 NEB IH Q6H: PRN shortness of breath 3. Aspirin 81 mg PO DAILY 4. Clopidogrel 75 mg PO DAILY 5. Diltiazem Extended-Release 180 mg PO DAILY 6. Fluticasone Propionate NASAL 2 SPRY NU DAILY: PRN nasal congestion 7. Hydrochlorothiazide 50 mg PO DAILY 8. Isosorbide Mononitrate (Extended Release) 240 mg PO DAILY 9. Latanoprost 0.005% Ophth. Soln. 1 DROP LEFT EYE HS 10. Multivitamins W/minerals 1 TAB PO DAILY 11. Simvastatin 20 mg PO DAILY 12. Theophylline ER 300 mg PO BID 13. Tiotropium Bromide 1 CAP IH DAILY 14. Albuterol Inhaler 2 PUFF IH Q4H: PRN shortness of breath 15. Calcarb 600 With Vitamin D (calcium carbonate-vitamin D3) 315/200 mg oral daily 16. cod liver oil 1,250-135 unit oral BID 17. Symbicort (budesonide-formoterol) 160-4.5 mcg/actuation INHALATION BID 18. Cepastat (Phenol) Lozenge 2 LOZ PO Q2H: PRN sore throat RX *phenol [Cepastat] 14.5 mg 2 lozenges every ___ as needed for sore throat Disp #*36 Lozenge Refills: *0 19. Levofloxacin 750 mg PO Q24H Duration: 2 Days RX *levofloxacin 750 mg 1 tablet(s) by mouth daily Disp #*2 Tablet Refills: *0 20. PredniSONE 40 mg PO DAILY Duration: 2 Days RX *prednisone 20 mg 2 tablet(s) by mouth daily Disp #*4 Tablet Refills: *0 <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Community Acquired Pneumonia COPD Asthma <DISCHARGE CONDITION> <DISCHARGE CONDITION> Stable Mental Status: AOx3 (Baseline) Ambulatory Status: Baseline <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Ms. ___, It was a pleasure taking care of you while you were hospitalized at ___. As you know, you were admitted for initial treatment of pneumonia, to ensure that you were responding well to the antibiotics, given your history of COPD/Asthma. Fortunately, you responded quite well to the Antiobiotics, Steroids, and Nebulizer treatments that were administered. Since your breathing was stable and you were responding appropriately to treatments, you were discharged to home. However, you should be vigilant in making sure that you continue the antibiotics & steroids for the short course listed on the medication page. You should also be sure to see Dr. ___ at your next appointment to ensure that your pneumonia has resolved. ","=========================== ___ PMH of Asthma, COPD, CAD, tobacco use, who presented w/ 4 days of shortness of breath and productive cough ___ sputum), who was found to have RML opacity on CXR at outpatient clinic so was referred to the ED. ACTIVE ISSUES: =========================== #Community Acquired Pneumonia Pt presented to outpatient cardiology appointment w/ 4 days of shortness of breath and productive cough ___ sputum), and was referred to primary care clinic (Dr. ___. Dr ___ ___ a CXR which showed RML opacity on CXR. Given pt's underlying lung pathology (COPD ___ longstanding tobacco use), and multiple co-morbidities, she was admitted briefly to initiate antibiotics/steroids and ensure that she remained clinically stable. While RML opacification was suggestive of CAP, COPD flare was also consideration given afebrile status and normal WBC. Exam significant for afebrile status, saturation of 97% on RA (baseline 95% RA), and coarse breath sounds w/ diffuse expiratory wheezing. Pt was treated w/ Levaquin 750mg daily (planned 5d course), steroids (recieved 125 methylprednisone then 4d course of PO prednisone), and had nebulizer treatments for symptom relief. Given her clinical stability, she was discharged home with an outpatient f/u w/ PCP (Dr. ___ on ___. Until then, pt will need to complete course of Antibiotics and Steroids. Pt was instructed to continue her outpatient COPD treatment regimen on discharge. CHRONIC ISSUES: ========================== #Coronary Artery Disease Pt has a known history of CAD, but did not have any chest pain during this hospitalization and EKG was unchanged from prior. Accordingly, she was continued on home dosages of plavix, aspirin, isosorbid mononitrate and diltiazem #Hypertension Pt has a known history of hypertension and was continued on her home dose hydrochlorothiazide. #Glaucoma Pt was continued on latanoprost drops before bed. #Hyperlipidemia Pt was continued on home dose simvastatin. Transitional Issues: ===================== 1. Pt will need to continue Levaquin 750mg daily to complete 5 day course (Day 1 - ___ 2. Pt will need to continue Prednisone 40mg daily to complete 4 day course (Day 1 - ___ 3. Pt will need to f/u w/ PCP ___ ___ to assess response to tx and for general health care maintenance 4. Pt will need to use Nebulizer treatments at home for symptomatic relief for the next wk until pneumonia clears Code Status: FULL (confirmed w/ pt) Contact: ___ (husband ___, ___ (___) ",2523,598
10001884-DS-29,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> IV Dye, Iodine Containing Contrast Media / Oxycodone / cilostazol / Varenicline <ATTENDING> ___. <CHIEF COMPLAINT> Dyspnea <MAJOR SURGICAL OR INVASIVE PROCEDURE> None. <HISTORY OF PRESENT ILLNESS> ___ y/o F with asthma, CAD s/p stents (reported by patient), COPD, PAD, HTN, who presents with shortness of breath. The patient was sitting at home ewhen she suddenly felt short of breath. She drank some water and took nebulizers which she felt helped some. She also has noticed hoarseness of her voice. She presented because her symptoms have gotten worse throughout the day. Denies fever/chills, sore throat. Says she does have a cough from asthma and noticed increased wheezing. She had an episode of substernal chest pain this morning that lasted ___ minutes that was nonextertional. No radiation to jaw, arm, or back. It resolved without any intervention. She reported some leg swelling but says that has resolved. She denies PND, orthopnea. In the ED, initial vitals were: 96.5 77 143/68 22 97% RA Labs were notable for: - Labs were significant for neg trop x1, normal CBC, normal chemistry panel. - CXR was negative. EKG shows LBBB consistent with prior. Patient was given: The patient was given albuterol/ipra nebs, prednisone 60 mg x 1. Consults: ED spoke with Dr. ___ wanted admission for stress test in morning. ED did not feel she is CDU candidate given she is on theophylline and would require more than one day in hospital. Vitals prior to transfer were: 71 149/73 20 94% RA On arrival to floor, she denies chest pain. Shortness of breath has improved after receiving inhalers. <PAST MEDICAL HISTORY> ASTHMA/COPD/Tobacco use, Peripheral Arterial disease s/p recent common iliac stenting, ATRIAL TACHYCARDIA, ATYPICAL CHEST PAIN, CERVICAL RADICULITIS, CERVICAL SPONDYLOSIS, CORONARY ARTERY DISEASE HEADACHE, HIP REPLACEMENT, HYPERLIPIDEMIA, HYPERTENSION, OSTEOARTHRITIS, HERPES ZOSTER, TOBACCO ABUSE, ATRIAL FIBRILLATION ANXIETY,GASTROINTESTINAL BLEEDING, OSTEOARTHRITIS, ATHEROSCLEROTIC CARDIOVASCULAR DISEASE, PERIPHERAL VASCULAR DISEASE, CATARACT SURGERY ___ Surgery: BILATERAL COMMON ILIAC ARTERY STENTING ___ BUNIONECTOMY HIP REPLACEMENT PRIOR CESAREAN SECTION GANGLION CYST <SOCIAL HISTORY> ___ <FAMILY HISTORY> Mother: ___, HTN Father: ___ CA Brother: CA? Brother: ___ Physical ___: -== ADMISSION PHYSICAL -== Vitals: 98.9 ___ 74 18 96% RA General: Alert, oriented, no acute distress, breathing comfortably HEENT: Sclera anicteric, MMM, oropharynx clear, EOMI, PERRL Neck: Supple, JVP not elevated, no LAD CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Lungs: Scattered wheezes throughout, bibasilar crackles, moderate air movement. Abdomen: Soft, non-tender, non-distended, bowel sounds present, no organomegaly, no rebound or guarding GU: No foley Ext: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema Neuro: Moves all extremities well -= DISCHARGE PHYSICAL -= Vitals: T: 98.3 BP: 149/87 P: 83 R: 18 O2: 98% ra General: NAD Lungs: Diffuse end expiratory wheezing. No crackles or rhonchi CV: RRR. no M/R/G Abdomen: NTND Ext: No edema <PERTINENT RESULTS> -==== ADMISSION LABS -==== ___ 06: 15PM BLOOD WBC-5.7 RBC-4.46 Hgb-12.9 Hct-40.2 MCV-90 MCH-28.9 MCHC-32.1 RDW-14.6 RDWSD-48.5* Plt ___ ___ 06: 15PM BLOOD Neuts-62.1 ___ Monos-9.4 Eos-0.3* Baso-0.3 Im ___ AbsNeut-3.55 AbsLymp-1.59 AbsMono-0.54 AbsEos-0.02* AbsBaso-0.02 ___ 06: 15PM BLOOD Glucose-96 UreaN-15 Creat-0.9 Na-138 K-3.8 Cl-96 HCO3-32 AnGap-14 -=== PERTINENT LABS -=== ___ 05: 55AM BLOOD cTropnT-<0.01 ___ 12: 16AM BLOOD cTropnT-<0.01 ___ 06: 15PM BLOOD cTropnT-<0.01 -=== DISCHARGE LABS -=== ___ 05: 55AM BLOOD WBC-4.8 RBC-4.13 Hgb-11.9 Hct-37.2 MCV-90 MCH-28.8 MCHC-32.0 RDW-14.6 RDWSD-47.8* Plt ___ ___ 05: 55AM BLOOD ___ PTT-29.0 ___ ___ 05: 55AM BLOOD Glucose-149* UreaN-17 Creat-0.8 Na-137 K-4.5 Cl-99 HCO3-29 AnGap-14 ___ 05: 55AM BLOOD Calcium-9.6 Phos-2.9 Mg-2.0 -=== EKG -=== ___ Baseline artifact. Probable ectopic atrial rhythm with frequent premature atrial contractions. Left bundle-branch block. Compared to the previous tracing of ___ ectopic atrial rhythm is new. -=== CXR -=== ___ IMPRESSION: No acute cardiopulmonary process. <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Acetaminophen 325 mg PO Q4H: PRN pain 2. Albuterol 0.083% Neb Soln 1 NEB IH Q6H: PRN shortness of breath 3. Aspirin 81 mg PO DAILY 4. Clopidogrel 75 mg PO DAILY 5. Diltiazem Extended-Release 180 mg PO DAILY 6. Fluticasone Propionate NASAL 2 SPRY NU DAILY: PRN nasal congestion 7. Hydrochlorothiazide 50 mg PO DAILY 8. Isosorbide Mononitrate (Extended Release) 120 mg PO DAILY 9. Latanoprost 0.005% Ophth. Soln. 1 DROP LEFT EYE HS 10. Multivitamins W/minerals 1 TAB PO DAILY 11. Theophylline ER 300 mg PO BID 12. Tiotropium Bromide 1 CAP IH DAILY 13. Albuterol Inhaler 2 PUFF IH Q4H: PRN shortness of breath 14. Calcarb 600 With Vitamin D (calcium carbonate-vitamin D3) 315/200 mg oral daily 15. cod liver oil 1,250-135 unit oral BID 16. Atorvastatin 10 mg PO QPM 17. Fluticasone-Salmeterol Diskus (250/50) 1 INH IH BID 18. Guaifenesin-CODEINE Phosphate 5 mL PO Q6H: PRN cough 19. TraMADOL (Ultram) 50 mg PO Q6H: PRN pain 20. Ranitidine 150 mg PO BID 21. Lorazepam 0.5 mg PO QHS: PRN insomnia <DISCHARGE MEDICATIONS> 1. Acetaminophen 325 mg PO Q4H: PRN pain 2. Albuterol 0.083% Neb Soln 1 NEB IH Q6H: PRN shortness of breath 3. Aspirin 81 mg PO DAILY 4. Atorvastatin 10 mg PO QPM 5. Clopidogrel 75 mg PO DAILY 6. Diltiazem Extended-Release 180 mg PO DAILY 7. Fluticasone Propionate NASAL 2 SPRY NU DAILY: PRN nasal congestion 8. Fluticasone-Salmeterol Diskus (250/50) 1 INH IH BID 9. Hydrochlorothiazide 50 mg PO DAILY 10. Isosorbide Mononitrate (Extended Release) 120 mg PO DAILY 11. Latanoprost 0.005% Ophth. Soln. 1 DROP LEFT EYE HS 12. Lorazepam 0.5 mg PO QHS: PRN insomnia 13. Multivitamins W/minerals 1 TAB PO DAILY 14. Ranitidine 150 mg PO BID 15. TraMADOL (Ultram) 50 mg PO Q6H: PRN pain 16. PredniSONE 40 mg PO DAILY Duration: 4 Days RX *prednisone 20 mg 2 tablet(s) by mouth once a day Disp #*6 Tablet Refills: *0 17. Theophylline ER 300 mg PO BID 18. Tiotropium Bromide 1 CAP IH DAILY 19. Guaifenesin-CODEINE Phosphate 5 mL PO Q6H: PRN cough 20. cod liver oil 1,250-135 unit oral BID 21. Calcarb 600 With Vitamin D (calcium carbonate-vitamin D3) 315/200 mg oral daily <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Primary Diagnosis: COPD exacerbation <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Ms. ___, You were admitted to the hospital for shortness of breath and mild chest pain. While in the hospital we received an EKG and blood work which suggested that your pain was not coming from your heart. Your shortness of breath is likely from a COPD attack and we gave you steroids and breathing treatments for your symptoms. You have a follow up appointment with Dr. ___ as detailed below. We are also sending you home with a short course of steroids for your COPD. Your other medications are detailed in your discharge medication list. It was a pleasure taking care of you at ___. Sincerely, Your ___ Care Team ","___ y/o F with asthma, CAD s/p stents (reported by patient), COPD, PAD, HTN, who presents with shortness of breath and intermittent episode of chest pain. # Mild COPD exacerbation: Patient with shortness of breath at rest, no cough or increased sputum production. Exam with wheezes on examination and some improvement with nebs/pred. Lower suspicion for PNA given normal WBC and lack of fevers. Also no evidence of volume overload on examination. Since patient only has a mild exacerbation she will not require antibiotics. Paitent will recieve 5 days of predinose (last day ___ in addition to taking her home albuterol, fluticasone and tiotropoium inhalers. # Episode of chest pain: There was a concern for ACS given cardiac history but trops x 2 negative. EKG with no significant changes from prior. The chest pain was non-exertional, resolved without intervention prior to arriving at the hospital, likely related to her COPD exacerbation. TRANSITIONAL ISSUES: [ ] Please confirm patient completed course of prednisone (last day ___ with resolution of symptoms [ ] Consider outpatient stress testing if chest pain returns ",2479,254
10001884-DS-30,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> IV Dye, Iodine Containing Contrast Media / Oxycodone / cilostazol / Varenicline <ATTENDING> ___. <CHIEF COMPLAINT> Nonexertional Chest pain <MAJOR SURGICAL OR INVASIVE PROCEDURE> none <HISTORY OF PRESENT ILLNESS> This is a ___ year old female with PMHx CAD, PVD and COPD presenting with chest pain. She reports that she woke up at 3 am with substernal pressure like pain which was associated with shortness of breath. She rated the pain a ___ and reports that it lasted for about 5 minutes and resolved spontaneously. She had several more episodes of the same pain lasting about 5 minutes at a time throughout the morning but which were much less severe. She hasn't had an episode of pain since 1 pm. She denies palpitations, lightheadedness, dizziness, nausea, vomiting, diaphoresis. In the ED, initial vitals were: 98.0 50 156/73 20 99% - Labs were significant for: - Na 137 K 3.0 Cl 94 CO2 32 BUN 16 Cr 0.8 - Ca: 10.6 Mg: 1.9 P: 2.9 - WBC 5.9 Hgb 13.6 Hct 41.1 Plt 238 - ___: 10.7 PTT: 28.7 INR: 1.0 - Lactate: 2.0 - Trop-T: <0.01 - Imaging revealed: - CXR: No acute cardiopulmonary process - The patient was given: PO Aspirin 243, IH Albuterol 0.083% Neb, IH Ipratropium Bromide Neb, PO Potassium Chloride 40 mEq, 40 mEq Potassium Chloride / 1000 mL NS - Vitals prior to transfer were: 98.1 84 163/118 17 100% RA Upon arrival to the floor, patient denies chest pain, shortness of breath, palpitations, lightheadedness, dizziness. REVIEW OF SYSTEMS: (+) Per HPI <PAST MEDICAL HISTORY> ASTHMA/COPD/Tobacco use, Peripheral Arterial disease s/p recent common iliac stenting, ATRIAL TACHYCARDIA, ATYPICAL CHEST PAIN, CERVICAL RADICULITIS, CERVICAL SPONDYLOSIS, CORONARY ARTERY DISEASE HEADACHE, HIP REPLACEMENT, HYPERLIPIDEMIA, HYPERTENSION, OSTEOARTHRITIS, HERPES ZOSTER, TOBACCO ABUSE, ATRIAL FIBRILLATION ANXIETY,GASTROINTESTINAL BLEEDING, OSTEOARTHRITIS, ATHEROSCLEROTIC CARDIOVASCULAR DISEASE, PERIPHERAL VASCULAR DISEASE, CATARACT SURGERY ___ Surgery: BILATERAL COMMON ILIAC ARTERY STENTING ___ BUNIONECTOMY HIP REPLACEMENT PRIOR CESAREAN SECTION GANGLION CYST <SOCIAL HISTORY> ___ <FAMILY HISTORY> Mother: ___, HTN Father: ___ CA Brother: CA? Brother: ___ Physical ___: Admission PE: Vitals: 98.4 159/66 91 16 93% RA Wt: 66.2 General: Alert, oriented, no acute distress HEENT: Sclera anicteric, MMM, oropharynx clear, EOMI, PERRL Neck: Supple, JVP not elevated, no LAD CV: Regular rate and rhythm, normal S1 + S2, ___ systolic murmur heard best at RUSB, no rubs or gallops Lungs: inspiratory and expiratory wheezes, no rales or rhonchi Abdomen: Soft, non-tender, non-distended, bowel sounds present, no organomegaly, no rebound or guarding GU: No foley Ext: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema Discharge PE: Vitals: 98.5 ___ 20 ___ 98%RA Weight: 64.5 Weight on admission: 66.2 General: NAD HEENT: Sclera anicteric Neck: JVP not elevated CV: Regular rhythm with frequent skipped beats, normal S1 + S2, ___ systolic murmur heard best at RUSB, no rubs or gallops Lungs: mild expiratory wheezes, diffuse mild rhonchi (pre-nebulizer) Abdomen: Soft, non-tender, non-distended, bowel sounds present, no organomegaly, no rebound or guarding Ext: Warm, well perfused, no edema <PERTINENT RESULTS> Admission Labs: ___ 07: 49PM ___ PTT-28.7 ___ ___ 07: 05PM LACTATE-2.0 ___ 05: 58PM GLUCOSE-103* UREA N-16 CREAT-0.8 SODIUM-137 POTASSIUM-3.0* CHLORIDE-94* TOTAL CO2-32 ANION GAP-14 ___ 05: 58PM estGFR-Using this ___ 05: 58PM cTropnT-<0.01 ___ 05: 58PM CALCIUM-10.6* PHOSPHATE-2.9 MAGNESIUM-1.9 ___ 05: 58PM WBC-5.9 RBC-4.62 HGB-13.6 HCT-41.1 MCV-89 MCH-29.4 MCHC-33.1 RDW-14.7 RDWSD-47.1* ___ 05: 58PM NEUTS-57.8 ___ MONOS-9.3 EOS-0.3* BASOS-0.2 IM ___ AbsNeut-3.41 AbsLymp-1.88 AbsMono-0.55 AbsEos-0.02* AbsBaso-0.01 ___ 05: 58PM PLT COUNT-238 Discharge Labs: ___ 06: 20AM BLOOD WBC-6.1 RBC-4.60 Hgb-13.4 Hct-41.2 MCV-90 MCH-29.1 MCHC-32.5 RDW-14.9 RDWSD-47.8* Plt ___ ___ 06: 20AM BLOOD Plt ___ ___ 06: 20AM BLOOD Glucose-97 UreaN-17 Creat-1.0 Na-134 K-4.2 Cl-96 HCO3-24 AnGap-18 ___ 06: 25AM BLOOD ALT-19 AST-22 LD(LDH)-260* AlkPhos-81 TotBili-0.4 ___ 06: 20AM BLOOD Calcium-9.7 Phos-3.7 Mg-1.9 Studies: 1. CXR ___: No acute cardiopulmonary process 2. ___: Exercise stress test INTERPRETATION: This ___ year old woman with a history of PAD and LBBB was referred to the lab from the ER following negative serial cardiac markers for evaluation of chest discomfort. The patient was referred for a dipyridamole stress test but due to her theophylline therapy we were not able to proceed. Due to her frequent atrial ectopy we chose not to give her dobutamine but had her walk on the treadmill instead. She exercised for 3 minutes of a modified ___ protocol and stopped due to leg claudication. The estimated peak MET capacity was 2.5 which represents a poor functional capacity for her age. No arm, neck, back or chest discomfort was reported by the patient throughout the study. The ST segments are uninterpretable for ischemia in the setting of the baseline LBBB. The rhythm was sinus with frequent isolated apbs, occasional atrial couplets and a 6 beat run of PSVT. Rare isolated vpbs were also noted. Resting mild systolic hypertension with a pprorpriate increase in BP with exercise and recovery. IMPRESSION: No anginal type symptoms or interpretable ST segments at a high cardiac demand and poor functional capacity. Nuclear report sent separately. 3. ___ CATH: LMCA: short, no CAD. LAD: mild focal origin disease (20%) and mild proximal disease (30%). LCX: minimal luminal irregularities. RCA: 30%. 4. ECG ___: sinus rhythm with multiple PACs, left axis deviation, old LBBB 5. ECG ___: Likely atrial tachycardia. Left bundle-branch block. Compared to the previous tracing atrial tachycardia has replaced sinus rhythm with premature atrial contractions. Left bundle-branch block was previously noted. 6. ECHO ___: Conclusions The left atrium is normal in size. No atrial septal defect is seen by 2D or color Doppler. The estimated right atrial pressure is ___ mmHg. Left ventricular wall thickness, cavity size and regional/global systolic function are normal (LVEF >55%). There is considerable beat-to-beat variability of the left ventricular ejection fraction due to an irregular rhythm/premature beats. Tissue Doppler imaging suggests a normal left ventricular filling pressure (PCWP<12mmHg). Right ventricular chamber size and free wall motion are normal. The aortic valve leaflets are mildly thickened (?#). There is no aortic valve stenosis. No aortic regurgitation is seen. The mitral valve leaflets are mildly thickened. There is no mitral valve prolapse. Physiologic mitral regurgitation is seen (within normal limits). The left ventricular inflow pattern suggests impaired relaxation. The estimated pulmonary artery systolic pressure is normal. There is no pericardial effusion. Compared with the prior study (images reviewed) of ___, frequent atrial ectopy is seen; biventricular function appears similar. Micro: ___: Bcx pending <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Acetaminophen 325 mg PO Q4H: PRN pain 2. Albuterol 0.083% Neb Soln 1 NEB IH Q6H: PRN shortness of breath 3. Aspirin 81 mg PO DAILY 4. Atorvastatin 10 mg PO QPM 5. Clopidogrel 75 mg PO DAILY 6. Diltiazem Extended-Release 180 mg PO DAILY 7. Fluticasone Propionate NASAL 2 SPRY NU DAILY: PRN nasal congestion 8. Fluticasone-Salmeterol Diskus (250/50) 1 INH IH BID 9. Hydrochlorothiazide 50 mg PO DAILY 10. Isosorbide Mononitrate (Extended Release) 120 mg PO DAILY 11. Latanoprost 0.005% Ophth. Soln. 1 DROP LEFT EYE HS 12. Lorazepam 0.5 mg PO QHS: PRN insomnia 13. Multivitamins W/minerals 1 TAB PO DAILY 14. Ranitidine 150 mg PO BID 15. TraMADOL (Ultram) 50 mg PO Q6H: PRN pain 16. Theophylline ER 300 mg PO BID 17. Tiotropium Bromide 1 CAP IH DAILY 18. Guaifenesin-CODEINE Phosphate 5 mL PO Q6H: PRN cough 19. cod liver oil 1,250-135 unit oral BID 20. Calcarb 600 With Vitamin D (calcium carbonate-vitamin D3) 315/200 mg oral daily <DISCHARGE MEDICATIONS> 1. Amiodarone 200 mg PO BID RX *amiodarone 200 mg 1 tablet(s) by mouth twice a day Disp #*60 Tablet Refills: *1 2. Rivaroxaban 20 mg PO DINNER RX *rivaroxaban [Xarelto] 20 mg 1 tablet(s) by mouth qpm Disp #*30 Tablet Refills: *1 3. Acetaminophen 325 mg PO Q4H: PRN pain 4. Albuterol 0.083% Neb Soln 1 NEB IH Q6H: PRN shortness of breath 5. Aspirin 81 mg PO DAILY 6. Atorvastatin 10 mg PO QPM 7. Diltiazem Extended-Release 180 mg PO DAILY 8. Fluticasone Propionate NASAL 2 SPRY NU DAILY: PRN nasal congestion 9. Fluticasone-Salmeterol Diskus (250/50) 1 INH IH BID 10. Guaifenesin-CODEINE Phosphate 5 mL PO Q6H: PRN cough 11. Hydrochlorothiazide 50 mg PO DAILY 12. Isosorbide Mononitrate (Extended Release) 120 mg PO DAILY 13. Latanoprost 0.005% Ophth. Soln. 1 DROP LEFT EYE HS 14. Lorazepam 0.5 mg PO QHS: PRN insomnia 15. Multivitamins W/minerals 1 TAB PO DAILY 16. Ranitidine 150 mg PO BID 17. Theophylline ER 300 mg PO BID 18. Tiotropium Bromide 1 CAP IH DAILY 19. TraMADOL (Ultram) 50 mg PO Q6H: PRN pain 20. Artificial Tears Preserv. Free ___ DROP BOTH EYES PRN eye irritation RX *dextran 70-hypromellose [Artificial Tears] 1 drop OPTH QID: prn Refills: *0 RX *dextran 70-hypromellose [Artificial Tears (PF)] ___ drops eye as needed Disp #*1 Package Refills: *1 21. Erythromycin 0.5% Ophth Oint 0.5 in RIGHT EYE TID RX *erythromycin 5 mg/gram (0.5 %) 0.5 (One half) inch OPTH TID: prn Refills: *0 22. Calcarb 600 With Vitamin D (calcium carbonate-vitamin D3) 315/200 mg oral daily 23. cod liver oil 1,250-135 unit oral BID <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Rapid Atrial Fibrillation/Flutter COPD <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Ms. ___, You were admitted to ___ due to concerning chest pain symptoms which we think are due to infrequent bursts of a rapid heart rate. Since the rapid rate makes you at increased risk for stroke, you were started on a blood thinning medication called Rivaroxaban which you will need to take every day. Our specialized cardiologists who deal specifically with the electrical rhythm of the heart evaluated you and felt that you would benefit from a medication called amiodarone which was also started. You will need to follow up with them in their clinic regarding this abnormal rhythm. In the meantime, you were outfitted with a Holter monitor to record your heart rate at home. It is very important that you follow up with Dr. ___ your cardiologist. We wish you all the best, Sincerely, Your care team at ___ "," =========================================================== ___ PMH of CAD, PVD, and COPD presenting with recurrent non-exertional substernal chest pain. The patient has a history of mild CAD but labs were significant for negative troponins and EKG was without ischemic changes. During her admission, she also developed multiple episodes of atrial tachycardia (AFib vs. Aflutter) and was started on Amiodarone for rate/rhythm control and Rivaroxaban for anticoagulation, and kept on home dose of Diltiazem also for rate control. She did not have any episodes of chest pain during hospitalization, so was discharged once atrial fibrillation/flutter was controlled. She will need to follow up with her primary care doctor regarding vague chest pain which led to admission. Acute Issues: ======================================================== #Atrial Tachycardia: During admission pt had runs of wide complex tachyarrythmia, thought likely supraventricular in origin: rapid Atrial Fibrillation/ Flutter vs. atrial tachycardia, with abberancy (complexes with similar morphology to native LBBB). She was treated with Diltiazem and Amiodarone and had fewer episodes of tachycardia. EP team evaluated patient and recommended anticoagulation and outpatient follow up to consider EP study and possible ablation of Atrial Flutter. Patient was discharged with ___ of Hearts monitor, Amiodarone 200mg twice daily x 1 week followed by 200 mg daily thereafter. Diltiazem continued at home dose. Rivaroxaban added for anticoagulation. As per outpatient cardiologist (Dr. ___, plavix was discontinued in light of addition of Rivaroxaban and interest in avoiding triple therapy in this patient. Pt was given follow up appointments with Drs. ___. She was scheduled to see Dr. ___ EP evaluation in 2 months. #Chest pain: Pt presented with substernal chest pain that occurred at rest and was ruled out for MI with no troponin elevation or significant new ECG changes. Likely her chest pain was related to periods of tachycardia, although while in the hospital the runs of atrial tachycardia did not reproduce chest pain. She did not have any episodes of chest pain during hospitalization, so was discharged once atrial fibrillation/flutter was controlled. She will need to follow up with her primary care doctor regarding vague chest pain which led to admission. #Dry eyes: pt had erythema and pain of R eye, found to have dry eyes per optholmology. Sent out with Artificial tears and erythromycin eye drops. Patient had follow up appointment already scheduled with optholmology and was instructed to attend appointment. Chronic Issues: ============================================================= # COPD Pt appeared to be at baseline respiratory status. She was sent home with her home albuterol neb, albuterol inhaler, Fluticasone nasal spray, fluticasone-salmeterol diskus, tiotropium bromide nebs, and theophylline # PAD: As above, we stopped Clopidogrel as patient is now on Rivaroxaban and wanted to avoid triple therapy as per her cardiologist Dr. ___. Transitional Issues: ============================================================== 1. Patient was discharged on Amiodarone 200 mg po twice daily for one week until ___ and then 200mg po daily thereafter until her EP appointment with Dr. ___ in approximately 2 months. 2. Pt was discharged on Rivaroxaban 20 mg qpm with dinner 3. Pt discharged with outpatient ___ of Hearts monitor with results to be interpreted by Cardiologist. 4. She presented with chest pain but did not have elevated biomarkers or EKG changes concerning for myocardial damage. Moreover, pt remained asymptomatic during periods of supraventricular tachycardia while she was hospitalized. Patient may benefit from outpatient stress test if such symptoms return. 5. On day of discharge, pt had significant R eye pain and redness, was evaluated by Optholmology, who felt that it was just dry eyes, treated with erythromycin drops and artifiical tears. Patient already has appt w/ Opthamology in 5 days which she will need to attend. Full Code Contact: CONTACT: ___ (husband) ___ ___ (daughter) ___ ",3463,915
10001884-DS-32,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> IV Dye, Iodine Containing Contrast Media / Oxycodone / cilostazol / Varenicline <ATTENDING> ___ <CHIEF COMPLAINT> Dyspnea, Atrial Fibrillation <MAJOR SURGICAL OR INVASIVE PROCEDURE> None <HISTORY OF PRESENT ILLNESS> ___ F with pmhx of COPD (nighttime O2), htn, afib who presents with dyspnea, currently being treated for COPD and admitted for Afib with RVR. The patient went to the ED on ___ and was diagnosed with a COPD flare. She was discharged with a prednisone taper (currently on 60mg) and azithromycin. This AM she initially felt well, then developed dyspnea at rest, worsening with exertion. Her inhalers improved her SOB. She felt that these symptoms were consistent with her COPD. She saw her PCP ___ today in clinic where she was found to be in Afib w/ RVR, rate around 110-120. She has a history of afib. He referred her to the ED for persistent SOB and afib with RVR. She states she been compliant with nebs and steroid/azithro regimen. She denies any ___ edema, orthopnea. She denies recent travel, surgeries. She had an episode of chest tightness this AM that felt like her COPD flares. Denies fevers or coughing or production of sputum, hemomptysis. <PAST MEDICAL HISTORY> ASTHMA/COPD ATYPICAL CHEST PAIN CERVICAL RADICULITIS CERVICAL SPONDYLOSIS CORONARY ARTERY DISEASE HEADACHE HIP REPLACEMENT HYPERLIPIDEMIA HYPERTENSION OSTEOARTHRITIS HERPES ZOSTER ATRIAL FIBRILLATION ANXIETY GASTROINTESTINAL BLEEDING OSTEOARTHRITIS ATHEROSCLEROTIC CARDIOVASCULAR DISEASE PERIPHERAL VASCULAR DISEASE <SOCIAL HISTORY> ___ <FAMILY HISTORY> Mother: ___, HTN Father: ___ CA Brother: CA? Brother: ___ Physical ___: ADMISSION PHYSICAL EXAM: VS: 98.14 154/74 71 24 98% 2L GENERAL: Well appearing, NAD, no accessory muscle use. HEENT: NCAT. Sclera anicteric. PERRL, EOMI. NECK: No JVD CARDIAC: Irregular rhythm, normal rate. Normal S1, S2. No murmurs/rubs/gallops. LUNGS: Moving air well bilaterally. Trace inspiratory wheezing and louder expiratory wheezing in all lung fields. No crackles/rhonchi. ABDOMEN: Soft, NTND. No HSM or tenderness. EXTREMITIES: No c/c/e. No femoral bruits. DISCHARGE PHYSICAL EXAM: VS: Tm 98.8 Tc 98.4 ___ RA GENERAL: NAD HEENT: NCAT. Sclera anicteric. Conjunctivae noninjected. OM clear. NECK: No JVD CARDIAC: RRR. Normal S1, S2. No murmurs/rubs/gallops. LUNGS: Mildly reduced air movement, significant wheezing bilaterally, +rhonchi, no crackles ABDOMEN: Soft, NTND. No HSM or tenderness. EXTREMITIES: No c/c/e. <PERTINENT RESULTS> ADMISSION LABS: ___ 03: 38PM BLOOD WBC-7.2 RBC-4.06 Hgb-9.4* Hct-31.4* MCV-77* MCH-23.2* MCHC-29.9* RDW-16.9* RDWSD-47.2* Plt ___ ___ 03: 38PM BLOOD Neuts-93.8* Lymphs-4.2* Monos-1.3* Eos-0.0* Baso-0.0 Im ___ AbsNeut-6.74*# AbsLymp-0.30* AbsMono-0.09* AbsEos-0.00* AbsBaso-0.00* ___ 03: 38PM BLOOD ___ PTT-30.3 ___ ___ 03: 38PM BLOOD Glucose-141* UreaN-20 Creat-1.0 Na-133 K-3.8 Cl-93* HCO3-30 AnGap-14 ___ 03: 38PM BLOOD Calcium-9.9 Phos-2.8 Mg-2.1 PERTINENT LABS: ___ 03: 58PM BLOOD cTropnT-<0.01 ___ 06: 50AM BLOOD CK-MB-4 cTropnT-<0.01 ___ 06: 50AM BLOOD calTIBC-398 Ferritn-16 TRF-306 ___ 06: 50AM BLOOD TSH-4.5* ___ 09: 31AM BLOOD ___ pO2-73* pCO2-58* pH-7.35 calTCO2-33* Base XS-3 ___ 07: 15AM BLOOD T4, FREE, DIRECT DIALYSIS-Test DISCHARGE LABS: ___ 05: 30AM BLOOD WBC-13.2* RBC-3.97 Hgb-9.0* Hct-31.1* MCV-78* MCH-22.7* MCHC-28.9* RDW-17.4* RDWSD-48.7* Plt ___ ___ 05: 30AM BLOOD Glucose-85 UreaN-23* Creat-0.9 Na-136 K-3.9 Cl-95* HCO3-30 AnGap-15 ___ 06: 30AM BLOOD Calcium-9.7 Phos-3.0 Mg-2.0 IMAGING: ___ Chest X ray: Relative increase in opacity over the lung bases bilaterally felt due to overlying soft tissue rather than consolidation. Lateral view may be helpful for confirmation. ___ Chest X ray: There is hyperinflation. There is no pneumothorax, effusion, consolidation or CHF. There is probable osteopenia. <DISCHARGE INSTRUCTIONS> Dear Ms. ___, You were hospitalized at ___ because you were having difficulty breathing and were found in clinic to have a fast heart rate. Your difficulty breathing was due to your COPD flaring. Your fast heart rate was due to your atrial fibrillation, which is an irregular heart rate that can sometimes cause the heart to beat very quickly. Medications that you were taking, such as theophylline, were likely contributing. Your heart rate was lowered using the same medication that you take at home, diltiazem, given through your IV. Your COPD was likely worsened because of a cold. However, your flare was very serious requiring IV steroids and many inhaled treatments. You should follow up with the lung doctors as ___ as with pulmonary rehab to make sure your lung disease is being treated as well as possible to prevent you from coming into the hospital as often. Please call ___ to schedule an appointment with them. It was a pleasure participating in your care. We wish you all the best in the future. Sincerely, Your ___ team ","___ is a ___ with a history of CAD, PVD, and COPD and history of recurrent chest pain who presented with afib with RVR and COPD exacerbation. ACUTE PROBLEMS: #COPD exacerbation: Ms. ___ had had two recent ED visits for COPD exacerbation, most recently ___ when she was started on prednisone 60 mg. She presented to her PCP's office with worsening dyspnea despite this therapy and was also complaining of nasal congestion, suggesting a viral URI trigger. In clinic she was also noted to be in afib with RVR so was referred to the ED where she was admitted after control of her heart rate (see below). On admission to the floor, she was noted to have wheezing, increased work of breathing, and poor air movement. She was treated with 125 mg solumedrol and maintained on 60 mg PO prednisone daily. Her home theophylline was decreased from 400 mg BID to ___ mg BID due to concerns it was contributing to her tachyarrhythmia. She was placed on ipratropium nebs q6h, albuterol nebs q2h, and fluticasone-salmeterol. Pulmonary was consulted and recommended a trial of diuresis so she received 10 mg IV Lasix as well. Azithromycin was not given due to concerns for QT prolongation with theophylline and amiodarone (QTc was 460). She was started on a 5 day course of ceftriaxone instead, and discharged to finish the course with cefpodoxime. She was discharged with a prednisone taper (10 mg decrease q3d until at 10 mg, then stay at 10 mg until pulm follow up) as well as follow up with pulmonary rehab and a pulmonologist she previously followed with, Dr. ___. She was also discharged on 2L supplemental O2 to be worn at all times. #Atrial fibrillation: Ms. ___ has known atrial fibrillation for which she was on amiodarone and apixaban but was found to have HR in the 120s in her PCP's office, prompting her referral to the ED. Her COPD exacerbation was the likely precipitant, with medications also possibly contributing, particularly theophylline. She was started on a diltiazem gtt in the ED to control her rates than transitioned to diltiazem 90 mg q6h. After arrival to the floor, her rates remained controlled. Her amiodarone and apixaban were continued. Her theophylline was decreased to 200 mg BID from 400 mg BID. #Iron deficiency anemia. Patient was found to have microcytic anemia with low iron and ferritin. She was started on IV iron 125 mg ferric gluconate x4 doses and wasdischarged on PO iron with a bowel regimen. Her H/H was stable throughout the hospitalized; there was no evidence of bleeding. Transitional issues: - patient discharged on prednisone taper: decrease by 10 mg every 3 days until at 10 mg, then keep at 10 mg until seen by pulmonology - patient discharged with plan to follow up with pulmonology and pulmonary rehab. Can call ___ to schedule appointment with pulmonary rehab. - patient discharged on with 2 days of cefpodoxime to complete 5 day course of antibiotics for severe COPD exacerbation - patient discharged with O2 concentrator for continuous home O2 - patient's theophylline decreased from 300 mg BID to ___ mg BID due to her afib with RVR; may want to consider further theophylline wean, and addition of azithromycin (if QTc is decreased as patient also on amiodarone), and/or roflumilast therapy - patient found to be iron deficient, started on IV iron repletion, discharged on PO iron - patient found to have elevated TSH, please follow up free T4 which was pending on discharge - Code: full - Emergency Contact ___ (Husband) ___ Daughter ___: ___ ___ on Admission: The Preadmission Medication list is accurate and complete. 1. Acetaminophen 650 mg PO Q6H:PRN pain 2. Apixaban 5 mg PO BID 3. Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN shortness of breath 4. Amiodarone 200 mg PO DAILY 5. Atorvastatin 10 mg PO QPM 6. Artificial Tears ___ DROP BOTH EYES PRN irritation 7. Latanoprost 0.005% Ophth. Soln. 1 DROP LEFT EYE QHS 8. Diltiazem Extended-Release 180 mg PO BID 9. Fluticasone Propionate NASAL 1 SPRY NU BID 10. Fluticasone-Salmeterol Diskus (250/50) 1 INH IH BID 11. Hydrochlorothiazide 50 mg PO DAILY 12. Isosorbide Mononitrate (Extended Release) 240 mg PO DAILY 13. Lorazepam 0.5 mg PO QHS:PRN insomnia 14. Theophylline ER 300 mg PO BID 15. Ranitidine 300 mg PO DAILY 16. Tiotropium Bromide 1 CAP IH DAILY 17. Multivitamins W/minerals 1 TAB PO DAILY 18. Aspirin 81 mg PO DAILY 19. Dorzolamide 2% Ophth. Soln. 1 DROP BOTH EYES BID Discharge Medications: 1. Home O2 2 Liters continuous nasal cannula with exertion Diagnosis: chronic obstructive pulmonary disease (J44.9) Length of Needs: ongoing (years) 2. Acetaminophen 650 mg PO Q6H:PRN pain 3. Amiodarone 200 mg PO DAILY 4. Apixaban 5 mg PO BID 5. Albuterol 0.083% Neb Soln 1 NEB IH Q2H:PRN shortness of breath 6. Artificial Tears ___ DROP BOTH EYES PRN irritation 7. Aspirin 81 mg PO DAILY 8. Atorvastatin 10 mg PO QPM 9. Diltiazem Extended-Release 180 mg PO BID 10. Dorzolamide 2% Ophth. Soln. 1 DROP BOTH EYES BID 11. Fluticasone Propionate NASAL 1 SPRY NU BID 12. Fluticasone-Salmeterol Diskus (250/50) 1 INH IH BID 13. Hydrochlorothiazide 50 mg PO DAILY 14. Isosorbide Mononitrate (Extended Release) 240 mg PO DAILY 15. Latanoprost 0.005% Ophth. Soln. 1 DROP LEFT EYE QHS 16. Lorazepam 0.5 mg PO QHS:PRN insomnia 17. Multivitamins W/minerals 1 TAB PO DAILY 18. Ranitidine 300 mg PO DAILY 19. Tiotropium Bromide 1 CAP IH DAILY 20. Theophylline SR 200 mg PO BID RX *theophylline 200 mg 1 tablet(s) by mouth twice a day Disp #*60 Tablet Refills:*0 21. Cefpodoxime Proxetil 200 mg PO Q12H Duration: 2 Days RX *cefpodoxime 200 mg 1 tablet(s) by mouth twice a day Disp #*4 Tablet Refills:*0 22. Ferrous Sulfate 325 mg PO DAILY RX *ferrous sulfate 325 mg (65 mg iron) 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 23. Docusate Sodium 100 mg PO BID RX *docusate sodium 100 mg 1 capsule(s) by mouth twice a day Disp #*60 Capsule Refills:*0 24. Polyethylene Glycol 17 g PO DAILY RX *polyethylene glycol 3350 17 gram/dose 1 powder(s) by mouth daily Refills:*0 25. Ipratropium Bromide Neb 1 NEB IH Q6H:PRN dyspnea, wheezing RX *ipratropium bromide 0.2 mg/mL (0.02 %) 1 neb INH Every six hours Disp #*30 Nebule Refills:*0 26. PredniSONE 10 mg PO ASDIR 50 mg ___, then 40 mg ___, then 30 mg ___, then 20 mg ___, then 10 mg ongoing Tapered dose - DOWN RX *prednisone 10 mg 1 to 5 tablet(s) by mouth As directed Disp #*50 Tablet Refills:*0 Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: Primary diagnoses: Chronic obstructive pulmonary disease Atrial fibrillation with rapid ventricular response Secondary diagnoses: Hypertension Coronary artery disease Peripheral vascular disease Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Followup Instructions: ___",1638,2024
10001884-DS-33,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> IV Dye, Iodine Containing Contrast Media / Oxycodone / cilostazol / Varenicline <ATTENDING> ___. <CHIEF COMPLAINT> cough, dyspnea <MAJOR SURGICAL OR INVASIVE PROCEDURE> None <HISTORY OF PRESENT ILLNESS> HPI: ___ year old female with history of COPD (on home O2), HTN, Afib admitted with dyspnea and cough. Pt states inc dyspnea since this am, also one episode of retrosternal chest pressure lasting 2minuts on way to ED. No cp currently. on home O2. no fevers/chills or abd sx. Patient was recently admitted from ___ with COPD flare and afib with RVR. She could not receive azithromycin due to concern for QTc prolongation and so was treated with ceftriaxone/cefpodoxime. She was treated with 60mg PO prednisone and discharged with a prednisone taper of 10 mg decrease q3d until at 10 mg, then stay at 10 mg until pulm follow up. She was also counseled to do pulmonary rehab and follow up with Dr. ___. She was discharged on 2L supplemental O2 to be worn at all times. He theophylline was decreased from 300 mg BID to ___ mg BID due to her afib with RVR. She was also seen in the ED on ___ and ___ due to dyspnea which was felt to be a continuation of her COPD flare in the setting of patient not taking her home medications. She was given nebulizers and improved. She was DCed home with ___ for assistance with medications. She declined pulmonary rehab facility disposition. In the ED, initial vitals: - Exam notable for: diffuse insp/esp wheezing, dry oropharynx - Labs notable for: nl WBC. Trop X1 neg. EKG in sinus. - Imaging notable for: CXR no acute process. - Pt given: duoneb X 3. methylpred 125mg. Aspirin 325mg, 1L NS, and azithromycin 500mg. Peak flow 150, baseline per pt. Symptoms overall improved after nebs. - Vitals prior to transfer: 98.2 76 138/72 20 97NC. On arrival to the floor, pt reports feeling much improved and minimal wheezing. ROS: No fevers, chills, night sweats, or weight changes. No changes in vision or hearing, no changes in balance. No cough, no shortness of breath, no dyspnea on exertion. No chest pain or palpitations. No nausea or vomiting. No diarrhea or constipation. No dysuria or hematuria. No hematochezia, no melena. No numbness or weakness, no focal deficits. <PAST MEDICAL HISTORY> ASTHMA/COPD ATYPICAL CHEST PAIN CERVICAL RADICULITIS CERVICAL SPONDYLOSIS CORONARY ARTERY DISEASE HEADACHE HIP REPLACEMENT HYPERLIPIDEMIA HYPERTENSION OSTEOARTHRITIS HERPES ZOSTER ATRIAL FIBRILLATION ANXIETY GASTROINTESTINAL BLEEDING OSTEOARTHRITIS ATHEROSCLEROTIC CARDIOVASCULAR DISEASE PERIPHERAL VASCULAR DISEASE <SOCIAL HISTORY> ___ <FAMILY HISTORY> Mother: ___, HTN Father: ___ CA Brother: CA? Brother: ___ Physical ___: Admission Vitals: 99 142/80 77 20 95/2L General: Alert, oriented, no acute distress, appears very calm and can talk in full sentences HEENT: Sclerae anicteric, MMM, oropharynx clear Neck: supple, JVP not elevated, no LAD Lungs: scattered wheezing CV: II/VI RUSB systolic murmur, Nl S1, S2, No MRG Abdomen: soft, NT/ND bowel sounds present, no rebound tenderness or guarding, no organomegaly GU: no foley Ext: warm, well perfused, 2+ pulses, no clubbing, cyanosis, 2+ edema b/l Neuro: CN2-12 intact, no focal deficits Vitals: 98.5 122/69(130-150) 76(70s) 18 100/2L General: Alert, oriented, no acute distress, appears very calm and can talk in full sentences HEENT: Sclerae anicteric, MMM, oropharynx clear Neck: supple, JVP not elevated, no LAD Lungs: scattered wheezing CV: II/VI RUSB systolic murmur, Nl S1, S2, No MRG Abdomen: soft, NT/ND bowel sounds present, no rebound tenderness or guarding, no organomegaly GU: no foley Ext: warm, well perfused, 2+ pulses, no clubbing, cyanosis, 2+ edema b/l Neuro: CN2-12 intact, no focal deficits <PERTINENT RESULTS> Admission ___ 01: 46PM BLOOD WBC-8.3 RBC-4.52 Hgb-10.8* Hct-36.2 MCV-80* MCH-23.9* MCHC-29.8* RDW-21.6* RDWSD-52.4* Plt ___ ___ 01: 46PM BLOOD Neuts-93.4* Lymphs-4.0* Monos-1.8* Eos-0.1* Baso-0.1 Im ___ AbsNeut-7.77* AbsLymp-0.33* AbsMono-0.15* AbsEos-0.01* AbsBaso-0.01 ___ 01: 46PM BLOOD ___ PTT-31.9 ___ ___ 01: 46PM BLOOD Glucose-121* UreaN-19 Creat-1.1 Na-134 K-3.7 Cl-91* HCO3-31 AnGap-16 ___ 01: 46PM BLOOD cTropnT-<0.01 ___ 01: 46PM BLOOD Calcium-10.1 Phos-2.7 Mg-2.1 ___ 01: 58PM BLOOD Lactate-1.6 DISCHARGE ___ 05: 52AM BLOOD WBC-14.1*# RBC-3.81* Hgb-9.4* Hct-30.8* MCV-81* MCH-24.7* MCHC-30.5* RDW-22.5* RDWSD-58.1* Plt ___ ___ 05: 52AM BLOOD Glucose-107* UreaN-26* Creat-0.9 Na-136 K-3.5 Cl-94* HCO3-35* AnGap-11 CXR ___ IMPRESSION: No acute cardiopulmonary process. <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Acetaminophen 650 mg PO Q6H: PRN pain 2. Amiodarone 200 mg PO DAILY 3. Apixaban 5 mg PO BID 4. Albuterol 0.083% Neb Soln 1 NEB IH Q2H: PRN SOB 5. Artificial Tears ___ DROP BOTH EYES PRN irritation 6. Aspirin 81 mg PO DAILY 7. Atorvastatin 10 mg PO QPM 8. Diltiazem Extended-Release 180 mg PO BID 9. Dorzolamide 2% Ophth. Soln. 1 DROP BOTH EYES BID 10. Fluticasone Propionate NASAL 1 SPRY NU BID 11. Fluticasone-Salmeterol Diskus (250/50) 1 INH IH BID 12. Hydrochlorothiazide 50 mg PO DAILY 13. Isosorbide Mononitrate (Extended Release) 240 mg PO DAILY 14. Latanoprost 0.005% Ophth. Soln. 1 DROP LEFT EYE QHS 15. Lorazepam 0.5 mg PO QHS: PRN insomnia 16. Multivitamins W/minerals 1 TAB PO DAILY 17. Ranitidine 300 mg PO DAILY 18. Tiotropium Bromide 1 CAP IH DAILY 19. Theophylline SR 200 mg PO BID 20. Ferrous Sulfate 325 mg PO DAILY 21. Docusate Sodium 100 mg PO BID 22. Polyethylene Glycol 17 g PO DAILY 23. Ipratropium Bromide Neb 1 NEB IH Q6H: PRN SOB 24. PredniSONE 30 mg PO DAILY Start: ___, First Dose: Next Routine Administration Time This is dose # 1 of 2 tapered doses 25. PredniSONE 20 mg PO DAILY Start: After 30 mg DAILY tapered dose This is dose # 2 of 2 tapered doses 26. PredniSONE 10 mg PO DAILY Start: After last tapered dose completes This is the maintenance dose to follow the last tapered dose <DISCHARGE MEDICATIONS> 1. Acetaminophen 650 mg PO Q6H: PRN pain 2. Amiodarone 200 mg PO DAILY 3. Apixaban 5 mg PO BID 4. Artificial Tears ___ DROP BOTH EYES PRN irritation 5. Aspirin 81 mg PO DAILY 6. Atorvastatin 10 mg PO QPM 7. Diltiazem Extended-Release 180 mg PO BID 8. Docusate Sodium 100 mg PO BID 9. Dorzolamide 2% Ophth. Soln. 1 DROP BOTH EYES BID 10. Ferrous Sulfate 325 mg PO DAILY 11. Fluticasone Propionate NASAL 1 SPRY NU BID 12. Fluticasone-Salmeterol Diskus (250/50) 1 INH IH BID 13. Hydrochlorothiazide 50 mg PO DAILY 14. Isosorbide Mononitrate (Extended Release) 240 mg PO DAILY 15. Latanoprost 0.005% Ophth. Soln. 1 DROP LEFT EYE QHS 16. Lorazepam 0.5 mg PO QHS: PRN insomnia 17. Multivitamins W/minerals 1 TAB PO DAILY 18. Polyethylene Glycol 17 g PO DAILY 19. Ranitidine 300 mg PO DAILY 20. Theophylline SR 200 mg PO BID 21. Tiotropium Bromide 1 CAP IH DAILY 22. Albuterol Inhaler ___ PUFF IH Q6H: PRN SOB 23. Ipratropium Bromide Neb 1 NEB IH Q6H: PRN SOB 24. Albuterol 0.083% Neb Soln 1 NEB IH Q2H: PRN SOB 25. Doxycycline Hyclate 100 mg PO Q12H Duration: 2 Days to end ___ 26. PredniSONE 10 mg PO ASDIR Take ___- Tapered dose - DOWN <DISCHARGE DISPOSITION> Extended Care Facility: ___ <DISCHARGE DIAGNOSIS> Primary COPD exacerbation Secondary CORONARY ARTERY DISEASE HYPERLIPIDEMIA HYPERTENSION OSTEOARTHRITIS ATRIAL FIBRILLATION ANXIETY GASTROINTESTINAL BLEEDING OSTEOARTHRITIS <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear ___, ___ were admitted with exacerbation of your COPD. We gave ___ some treatments and ___ improved. ___ were evaluated by the physical therapy team who recommended a rehab stay for strengthening and improve your breathing. Please take your medications as prescribed and follow up with your providers. Sincerely, ___ medical team ","___ year old female with history of COPD (on home O2), HTN, Afib admitted with dyspnea and cough. # COPD exacerbation: Presenting with cough, significant wheezing and poor air movement initially consistent with COPD exacerbation. No PNA on CXR. No ischemic EKG changes. Symptoms improved with duonebs, prednisone and doxycycline. Evaluated by ___ and discharged to rehab facility for physical strengthening and respiratory rehab. Discharged on home COPD meds and steroid taper and abx course. # pAfib: currently rate well controlled. on apixaban - continued diltiazam - continued apixaban - continued amiodarone # Anemia: Fe def anemia on recent admission, discharged on Fe, continued iron supplement # CAD: continue aspirin, atorvastatin # Constipation: continue home bowel reg # Anxiety: continued home meds TRANSITIONAL - Discharged on steroid taper with maintenance dose of 10mg daily until she sees PCP * Take ___- - Doxycycline 100mg BID to ___ ",2740,232
10001884-DS-34,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> IV Dye, Iodine Containing Contrast Media / Oxycodone / cilostazol / Varenicline <ATTENDING> ___. <CHIEF COMPLAINT> Shortness of breath <MAJOR SURGICAL OR INVASIVE PROCEDURE> None <HISTORY OF PRESENT ILLNESS> Ms. ___ is a ___ yo woman with a PMH notable for COPD on home O2(hospitalized ___, multiple recent ED visits), Afib on apixaban, HTN, CAD, and HLD who presents with several days of worsening dyspnea. Patient has had several ED visits for dyspnea and a recent hospitalization for a COPD exacerbation in ___. She has been on steroid therapy with several attempts to taper over the last several months. After her most recent ED visit on ___ she was on placed on 60 mg PO prednisone with a taper down by 10 mg each day. Her SOB worsened with the taper and she was seen on ___ by her PCP who started her on a course of prednisone 30 mg PO to be tapered down by 5 mg every 3 days. With the taper she is currently on prednisone 25 mg QD. She reports that her SOB improved slightly after starting the steroids on ___. However, last night it acutely worsened and she was unable to sleep. She usually uses 3 pillows to sleep but was only comfortable seated upright last night. This morning she increased her oxygen to 3L and felt better. She is usually on 2L NC at home. She reports that for the last several months she has been using two different albuterol inhalers each every ___ hours. She knows that this is more than they are prescribed for but it makes her comfortable. She mostly stays put on the second floor of her home. She states that she can walk to the bathroom without being short of breath, but does not use the stairs unless she has to leave the house because it worsens her breathing. She endorses a cough occasionally productive of ___ sputum. This is consistent with her baseline. She endorses one episode of non-exertional chest pain today that spontaneously resolved. She denies fever, chills, recent sick contacts, and lower extremity edema. In the ED, initial vital signs were: T 98.5 P 80 BP 154/97 R 20 O2 sat 97% NC. - Exam notable for: Diffuse expiratory wheezing, prolonged expiratory phase, left inspiratory crackles, irregularly irregular rhthym, minimal pedal edema - Labs were notable for CBC wnl, proBNP 235, Trop 0.02, chem notable for bicarb 31, AG 13, UA notable for 40 RBCs - Studies performed include CXR with stable mild/moderate cardiomegaly, atelectasis at bases, otherwise clear lung fields - Patient was given Albuterol neb x 1, ipratropium neb x 1, Azithromycin 500 mg PO, Prednisone 25 mg PO Upon arrival to the floor, the patient states that she is doing well. She says that her SOB has improved since this morning and is better than last night when she could not sleep. Review of Systems: (+) per HPI (-) fever, chills, night sweats, headache, vision changes, rhinorrhea, congestion, sore throat, abdominal pain, nausea, vomiting, diarrhea, constipation, BRBPR, melena, hematochezia, dysuria, hematuria. <PAST MEDICAL HISTORY> ASTHMA/COPD ATYPICAL CHEST PAIN CERVICAL RADICULITIS CERVICAL SPONDYLOSIS CORONARY ARTERY DISEASE HEADACHE HIP REPLACEMENT HYPERLIPIDEMIA HYPERTENSION OSTEOARTHRITIS HERPES ZOSTER ATRIAL FIBRILLATION ANXIETY GASTROINTESTINAL BLEEDING OSTEOARTHRITIS PERIPHERAL VASCULAR DISEASE (s/p bilateral iliac stents) <SOCIAL HISTORY> ___ <FAMILY HISTORY> Mother: ___, HTN Father: ___ CA Brother: CA? Brother: ___ Physical ___: - ADMISSION EXAM: - Vitals- T 98.0 BP 148/70 HR 70 RR 24 O2Sat 96% on 2L NC GENERAL: AOx3, NAD, sitting up in bed HEENT: Normocephalic, atraumatic. Pupils equal, round, and reactive bilaterally, extraocular muscles intact. No conjunctival pallor or injection, sclera anicteric and without injection. Moist mucous membranes, good dentition. Oropharynx is clear. NECK: Supple. JVD not visualized. CARDIAC: Irregularly irregular, ___ systolic murmur best at the LSB, no rubs or gallops. LUNGS: Poor air movement throughout. Mild diffuse inspiratory and expiratory wheezes. No use of accessory muscles of breathing. No rhonchi or rales. BACK: No CVA tenderness ABDOMEN: Normal bowels sounds, non distended, non-tender to deep palpation in all four quadrants. No organomegaly. EXTREMITIES: No clubbing or cyanosis. Bilateral pitting edema to the mid shin. Pulses DP/Radial 2+ bilaterally. SKIN: No rash or ulcers NEUROLOGIC: CN2-12 intact. Moves all extremities spontaneously. Normal sensation. - DISCHARGE EXAM: - Vitals- T 98.7 BP 154/85 HR 77 RR 18 O2Sat 99% on 3L NC GENERAL: AOx3, NAD, sitting up in bed HEENT: NCAT. PERRL. EOMI. Sclera anicteric and not injected. MMM. Oropharynx is clear. NECK: Supple. No LAD. JVP not appreciated at 45 degrees. CARDIAC: Irregularly irregular, normal rate. ___ systolic murmur at the RUSB. No rubs or gallops. LUNGS: Poor air movement throughout all zones of the lungs. No wheezes. No prolonged expiratory phase. No rhonchi or rales. Does typically sit cross legged in the bed with forearms on her legs in a tripod position. BACK: No CVA tenderness. ABDOMEN: +BS, soft, nontender, nondistended EXTREMITIES: Trace pitting edema to the mid shin. 2+ DP pulses bilaterally. No TTP. SKIN: No rash or ulcers. NEUROLOGIC: CN2-12 intact. Moves all extremities spontaneously. Normal sensation. <PERTINENT RESULTS> -= ADMISSION LABS: -= ___ 02: 27PM BLOOD WBC-7.4 RBC-4.57 Hgb-12.3 Hct-39.3 MCV-86 MCH-26.9 MCHC-31.3* RDW-23.6* RDWSD-70.9* Plt ___ ___ 02: 27PM BLOOD Neuts-86.5* Lymphs-6.1* Monos-6.6 Eos-0.0* Baso-0.0 Im ___ AbsNeut-6.38* AbsLymp-0.45* AbsMono-0.49 AbsEos-0.00* AbsBaso-0.00* ___ 02: 27PM BLOOD Glucose-132* UreaN-17 Creat-1.0 Na-137 K-3.7 Cl-93* HCO3-31 AnGap-17 -= PERTINENT RESULTS: -= LABS: -= ___ 12: 15AM BLOOD ___ pO2-103 pCO2-49* pH-7.42 calTCO2-33* Base XS-5 === ___ 02: 27PM BLOOD cTropnT-0.02* proBNP-235 ___ 09: 05PM BLOOD CK-MB-6 cTropnT-<0.01 ___ 07: 45AM BLOOD CK-MB-6 cTropnT-0.02* === ___ 07: 45AM BLOOD THEOPHYLLINE-17.3 (10.0-20.0) -= IMAGING: -= CXR (___): PA and lateral views the chest provided. Biapical pleural parenchymal scarring noted. No focal consolidation concerning for pneumonia. No effusion or pneumothorax. No signs of congestion or edema. Cardiomediastinal silhouette is stable with an unfolded thoracic aorta and top-normal heart size. Bony structures are intact. === CT Chest (___): 1. Moderate upper lobe predominant centrilobular and paraseptal emphysema. 2. New left lower lobe nodule, potentially measuring as large as 6 x 8 mm, warrants close follow-up. Stable to slightly smaller 4 mm right middle lobe nodule. 3. Severe coronary artery calcifications. Aortic valve calcifications. 4. Enlargement of the main and right pulmonary arteries is suggestive of chronic pulmonary arterial hypertension. 5. Fusiform aneurysmal dilatation of the abdominal aorta measuring up to 3.7 cm has progressed compared to prior examination. -= DISCHARGE LABS: -= ___ 07: 45AM BLOOD WBC-7.8 RBC-4.74 Hgb-12.7 Hct-41.0 MCV-87 MCH-26.8 MCHC-31.0* RDW-23.7* RDWSD-71.7* Plt ___ ___ 07: 45AM BLOOD Glucose-94 UreaN-18 Creat-1.0 Na-135 K-3.3 Cl-93* HCO3-31 AnGap-14 ___ 07: 45AM BLOOD Calcium-9.8 Phos-2.8 Mg-2.0 <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. PredniSONE 5 mg PO DAILY Tapered dose - DOWN 2. Acetaminophen 325 mg PO Q4H: PRN Pain 3. Ipratropium Bromide Neb 1 NEB IH Q6H: PRN Wheezing 4. Tiotropium Bromide 1 CAP IH DAILY 5. Guaifenesin 1 teaspoon PO Q3H: PRN cough 6. Lorazepam 0.5 mg PO QHS vertigo/insomnia 7. Diltiazem Extended-Release 240 mg PO BID 8. Dorzolamide 2% Ophth. Soln. 1 DROP BOTH EYES BID 9. Docusate Sodium 100 mg PO BID 10. Fluticasone Propionate NASAL 2 SPRY NU DAILY: PRN allergies 11. Apixaban 5 mg PO BID 12. Ranitidine 300 mg PO DAILY 13. Atorvastatin 10 mg PO QPM 14. Ferrous Sulfate 325 mg PO DAILY 15. Multivitamins 1 TAB PO DAILY 16. Isosorbide Mononitrate (Extended Release) 240 mg PO DAILY 17. Fluticasone-Salmeterol Diskus (250/50) 1 INH IH BID 18. Latanoprost 0.005% Ophth. Soln. 1 DROP BOTH EYES QHS 19. Calcitrate-Vitamin D (calcium citrate-vitamin D3) 315 mg - 200 units oral DAILY 20. Theophylline SR 300 mg PO BID 21. Aspirin 81 mg PO DAILY 22. albuterol sulfate 90 mcg/actuation inhalation Q4H 23. Hydrochlorothiazide 50 mg PO DAILY 24. cod liver oil 1 capsule oral BID <DISCHARGE MEDICATIONS> 1. Acetaminophen 325 mg PO Q4H: PRN Pain 2. Apixaban 5 mg PO BID 3. Aspirin 81 mg PO DAILY 4. Atorvastatin 10 mg PO QPM 5. Diltiazem Extended-Release 240 mg PO BID 6. Docusate Sodium 100 mg PO BID 7. Dorzolamide 2% Ophth. Soln. 1 DROP BOTH EYES BID 8. Ferrous Sulfate 325 mg PO DAILY 9. Fluticasone Propionate NASAL 2 SPRY NU DAILY: PRN allergies 10. Hydrochlorothiazide 50 mg PO DAILY 11. Isosorbide Mononitrate (Extended Release) 240 mg PO DAILY 12. Latanoprost 0.005% Ophth. Soln. 1 DROP BOTH EYES QHS 13. Multivitamins 1 TAB PO DAILY 14. PredniSONE 30 mg PO DAILY RX *prednisone 10 mg 3 tablet(s) by mouth Daily Disp #*30 Tablet Refills: *0 15. Ranitidine 300 mg PO DAILY 16. Theophylline SR 300 mg PO BID 17. Tiotropium Bromide 1 CAP IH DAILY 18. Guaifenesin 1 teaspoon PO Q3H: PRN cough 19. Ipratropium Bromide Neb 1 NEB IH Q6H: PRN Wheezing 20. cod liver oil 1 capsule oral BID 21. Calcitrate-Vitamin D (calcium citrate-vitamin D3) 315 mg - 200 units oral DAILY 22. albuterol sulfate 90 mcg/actuation inhalation Q4H 23. Fluticasone-Salmeterol Diskus (500/50) 1 INH IH BID RX *fluticasone-salmeterol [Advair Diskus] 500 mcg-50 mcg/dose 1 dose Inhaled Twice a day Disp #*1 Disk Refills: *1 24. Lorazepam 0.5 mg PO Q8H: PRN Anxiety RX *lorazepam [Ativan] 0.5 mg 0.5 (One half) mg by mouth Every 8 hours Disp #*30 Tablet Refills: *0 <DISCHARGE DISPOSITION> Home With Service Facility: ___ <DISCHARGE DIAGNOSIS> Primary Diagnosis: Chronic obstruction pulmonary disease exacerbation Secondary Diagnoses: Tobacco use disorder Atrial fibrillation Hypertension Anxiety Coronary Artery Disease <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Ms. ___, It was a privilege taking care of you during your admission to ___. You were admitted to the hospital for shortness of breath and concern that you were having a flare of your COPD. While in the hospital we increased your dose of steroids to help your breathing. You also received several nebulizer treatments that helped your breathing. You were also expressing some anxiety that may have been contributing to your shortness of breath. You were given a medication called Ativan for your anxiety that also seemed to help your breathing. During your admission you were seen by the pulmonary specialists. They recommended a CT scan that showed that you have extensive COPD but did not show any infection. They also suggested increasing the dose of your Advair inhaler, which we did. If you feel short of breath, first please check your oxygen level. If it is less than 90, you can use oxygen and your inhaler. If not, try to wait a few minutes, take a few deep breaths and see if your shortness of breath improves. You can use the medication called Ativan(lorazepam) to help with the shortness of breath(no more than three times a day). If still not improved, you can use one of the inhalers/oxygen. Please follow-up with all your appointments as listed below and continue to take all of your medications as prescribed. If you experience any of the danger signs listed you should call your doctor immediately or go to the Emergency Room. We wish you the best! Sincerely, Your ___ Care Team ","Ms. ___ is a ___ y/o woman with a PMH notable for COPD on home O2 (hospitalized ___, multiple recent ED visits), Afib on apixaban, HTN, CAD, and HLD who presented with dyspnea and orthopnea in the setting of a steroid taper for recent COPD exacerbation. Her dyspnea was thought to be multifactorial due to her severe COPD and with a component of anxiety. The patient was not thought to be having an acute COPD exacerbation. ================ ACTIVE ISSUES: ================ # Dyspnea: Patient was admitted after one night of worsened orthopnea and dyspnea in the setting of a steroid taper from 30 mg to 25 mg. Her dyspnea was thought to be multifactorial due to her severe COPD and with a component of anxiety. The patient was not thought to be having an acute COPD exacerbation. The patient was treated with occasional duonebs and lorazepam 0.5 mg PRN that helped relieve her dyspnea. Pulmonology was consulted. The patient underwent CT that showed emphysema but no evidence of infection such as ___. The patient was initiated on a steroid taper on ___ of prednisone 30 mg for 3 days, then 20 mg for 3 days, then 10 mg until outpatient follow-up. Pulmonology recommended increasing her Advair dose to 500/50, which was done. They also recommended switching from theophylline to roflumilast and initiation of long-term azithromycin therapy provided the patient's QTc was not prolonged; this was deferred to the outpatient setting. Throughout her admission she had O2 sats greater than 95% on 2L NC. She did not desaturate on ambulation. # Anxiety/Insomnia: Patient with a history of anxiety and insomnia, thought to be contributing to her experience of dyspnea. The patient was discharged with lorazepam Q8H as needed for anxiety. The patient would likely benefit from therapy with an SSRI. # Demand Ischemia: Patient with troponin 0.02, <0.01, then 0.02. ECG without acute ischemic changes. # Microscopic hematuria: On admission the patient had a UA with 40 RBCs. Occasional UAs over the last year in OMR with microscopic hematuria. Would recommend repeat UA as an outpatient or work-up for microscopic hematuria. ================ CHRONIC ISSUES: ================ # Smoking: Patient recently quit smoking one month ago. Patient was provided with a nicotine patch 7 mg while in house; could consider continuing as an outpatient if patient endorses cravings. # Atrial fibrillation: Patient continued on diltiazem 240 mg PO BID and apixaban 5 mg BID. # HTN: Patient with a history of hypertension. Blood pressure well-controlled. Continued on isosorbide mononitrate ER 240 mg PO daily and hydrochlorothiazide 50 mg PO daily. # CAD: Cardiac catheterization in ___ without evidence of significant stenosis of coronaries. ECHO on ___ with EF>55% and no regional or global wall motion abnormalities. The patient was continued on aspirin 81 mg daily and atorvastatin 10 mg QPM. =================== TRANSITIONAL ISSUES: =================== #New Medications: -Prednisone 30 mg PO QD through ___, then on ___ mg for 3 days, then on ___ mg until outpatient follow-up -Increased Advair (Fluticasone-Salmeterol) to 500/50 dose -Lorazepam 0.5 mg PO Q8H PRN for anxiety #Follow-up: -Appointment arranged with PCP, ___ ___ -Appointment arranged with Pulmonologist, Dr. ___, ___ #COPD: Patient was seen by pulmonology during admission who had the following recommendations to consider as an outpatient. -Switch to roflumilast from theophylline -Daily azithromycin for treatment of chronic inflammation provided QTc within normal limits. -Patient may benefit from treatment of anxiety with an SSRI, as her anxiety is likely contributing to her experience of dyspnea. -In the future, palliative care consult for consideration of opioid treatment of dyspnea #Microscopic hematuria: Patient had a UA with 40 RBCs on admission -Recommend repeat UA as an outpatient or work-up for microscopic hematuria #Lung nodule: New left lower lobe nodule, potentially measuring as large as 6 x 8 mm, warrants close follow-up. Stable to slightly smaller 4 mm right middle lobe nodule. Follow-up CT in ___ months as per ___ guidelines for evaluation of new left lower lobe pulmonary nodule. #Code Status: Full code #Emergency Contact/HCP: ___ (HUSBAND) ___ ",3616,1035
10001884-DS-35,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> IV Dye, Iodine Containing Contrast Media / Oxycodone / cilostazol / Varenicline <ATTENDING> ___. <CHIEF COMPLAINT> Shortness of Breath <MAJOR SURGICAL OR INVASIVE PROCEDURE> N/A <HISTORY OF PRESENT ILLNESS> Ms. ___ is a ___ female with history of COPD on home O2, atrial fibrillation on apixaban, hypertension, CAD, and hyperlipidemia who presents with shortness of breath, cough, and wheezing for one day. The patient reports shortness of breath, increased cough productive of ___ red-flected sputum, and wheezing since yesterday evening. She has been using albuterol IH more frequently (___) with ipratropium nebs every 4 hours with minimal relief. She had to increase her O2 flow up to 4L without significant improvement. She was currently taking 10mg of prednisone. She has also been taking tiotropium IH, theophylline, advair IH at home as prescribed. She denies sick contacts. She quit smoking approximately 1 month ago. She reports an episode of chest pain in waiting room while sitting down, non-exertional, resolved after 2 minutes. She denies fever/chills, abdominal pain, nausea/vomiting, palpitations, and diaphoresis. She was recently admitted from ___ to ___ for dyspnea that was thought to be secondary to steroid taper for recent COPD exacerbation with a component of anxiety (not an acute COPD exacerbation) and was treated with steroids and duonebs but no antibiotics. She had a CT that showed emphysema but no evidence of infection such as ___. Pulmonary was consulted and recommended increasing her Advair dose to 500/50 (which was done) and switching from theophylline to roflumilast and initiation of long-term azithromycin therapy (which was deferred for outpatient follow-up) She was initiated on a steroid taper on ___ of prednisone 30 mg for 3 days, then 20 mg for 3 days, then 10 mg until outpatient follow-up. In the ED, initial vital signs were: 97.6 67 132/82 22 97% 4L. Exam was notable for limited air movement with wheezing bilaterally. Labs were notable for WBC 7.1, H/H 12.8/41.1, Plt 233, Na 133, K 3.6, BUN/Cr ___, trop < 0.01, BNP 181, lactate 1.5, VBG 7.43/___. Imaging with CXR showed mild basilar atelectasis without definite focal consolidation. The patient was given Duonebs and solumedrol 125mg IV. Vitals prior to transfer were: Upon arrival to the floor, she reports her breathing is improved. REVIEW OF SYSTEMS: Per HPI. Denies headache, visual changes, pharyngitis, rhinorrhea, nasal congestion, fevers, chills, sweats, weight loss, abdominal pain, nausea, vomiting, diarrhea, constipation, hematochezia, dysuria, rash, paresthesias, and weakness. <PAST MEDICAL HISTORY> - COPD/Asthma on home 2L O2 - Atypical Chest Pain - Hypertension - Hyperlipidemia - Osteroarthritis - Atrial Fibrillation on Apixaban - Anxiety - Cervical Radiculitis - Cervical Spondylosis - Coronary Artery Disease - Headache - Herpes Zoster - GI Bleeding - Peripheral Vascular Disease s/p bilateral iliac stents - s/p hip replacement <SOCIAL HISTORY> ___ <FAMILY HISTORY> Mother with asthma and hypertension. Father with colon cancer. Brother with leukemia. <PHYSICAL EXAM> ADMISSION PHYSICAL EXAM: -========= VITALS: Temp 97.3, HR 76, O2 sat 160/80, RR 20, O2 sat 94% 4L GENERAL: AOx3, speaking in full sentences, NAD, resting in bed comfortably. HEENT: NCAT. PERRL. EOMI. Sclera anicteric and not injected. MMM. Oropharynx is clear. NECK: Supple. No LAD. JVP not appreciated at 45 degrees. CARDIAC: Irregularly irregular, normal rate. ___ systolic murmur at the RUSB. No rubs or gallops. LUNGS: Expiratory wheezes throughout with poor air movement. ABDOMEN: +BS, soft, nontender, and nondistended. EXTREMITIES: Warm and well-perfused. No edema. 2+ DP pulses bilaterally. NEUROLOGIC: A&Ox3, CNII-XII intact, strength and sensation grossly intact bilaterally. DISCHARGE PHYSICAL EXAM: -========== VITALS: Tm 99.1, 146/69 (143-159/69-77), 94, 22, 94-95%% 2L GENERAL: speaking in full sentences, NAD, resting in bed comfortably. CARDIAC: rrr, normal rate. ___ systolic murmur at the RUSB LUNGS: +mild wheezes throughout ABDOMEN: +BS, soft, nontender, and nondistended. EXTREMITIES: Warm and well-perfused. 1+ b/l ___ edema. NEUROLOGIC: grossly nonfocal, aaox3 <PERTINENT RESULTS> ADMISSION LABS: -======== ___ 05: 54PM BLOOD WBC-7.1 RBC-4.74 Hgb-12.8 Hct-41.1 MCV-87 MCH-27.0 MCHC-31.1* RDW-22.6* RDWSD-69.0* Plt ___ ___ 05: 54PM BLOOD Neuts-81.8* Lymphs-9.6* Monos-7.6 Eos-0.3* Baso-0.1 Im ___ AbsNeut-5.82 AbsLymp-0.68* AbsMono-0.54 AbsEos-0.02* AbsBaso-0.01 ___ 06: 35AM BLOOD Calcium-9.9 Phos-4.1 Mg-2.0 ___ 05: 54PM BLOOD ___ pO2-52* pCO2-49* pH-7.43 calTCO2-34* Base XS-6 ___ 05: 54PM BLOOD Lactate-1.5 ___ 05: 54PM BLOOD proBNP-181 ___ 05: 54PM BLOOD cTropnT-<0.01 STUDIES: -======== + CXR (___): Mild basilar atelectasis without definite focal consolidation. + EKG: Sinus rhythm at 69, left bundle branch block, no acute ST or T wave changes. DISCHARGE LABS: -======== ___ 06: 38AM BLOOD WBC-14.4*# RBC-4.34 Hgb-11.8 Hct-37.6 MCV-87 MCH-27.2 MCHC-31.4* RDW-22.5* RDWSD-69.4* Plt ___ ___ 06: 38AM BLOOD Glucose-113* UreaN-18 Creat-0.8 Na-137 K-3.1(repleted)* Cl-94* HCO3-31 AnGap-15 <DISCHARGE INSTRUCTIONS> Dear Ms. ___, You were admitted to ___ after you developed shortness of breath and wheezing at home shortly after your last discharge. You were treated for a COPD exacerbation and your breathing quickly got better. Our physical therapists evaluated you and recommended that you have a short stay at Pulmonary ___ before going home to improve your breathing. We wish you all the best at rehab and send our condolences to your family on your recent loss. It was truly a pleasure taking care of you. Your ___ Team ","Ms. ___ is a ___ female with history of COPD on home O2, atrial fibrillation on apixaban, hypertension, CAD, and hyperlipidemia who presents with shortness of breath, cough, and wheezing for one day. Pt recently DC'd from hospital for dyspnea, treated only w/nebs and steroids as not thought ___ true COPD exacerbation, c/f anxiety component. Pt re-admitted w/similar Sx, thought ___ COPD exacerbation, received nebs, steroids, azithromycin. Pt's wheezing, cough, SOB improved shortly after admission, O2 titrated down & satting well on 2L in mid-90s which is baseline. Evaluated by ___, recommended DC to pulmonary rehab, pt was agreeable. ACTIVE ISSUES ================= # Shortness of Breath: Patient with history of COPD and recent admission for dyspnea in the setting of steroid taper. Her symptoms on presentation were consistent with severe COPD given diffuse wheezing and poor air movement. She likely had an exacerbation in the setting of a decrease in her steroids. There may also be a component of anxiety. She underwent CT last admission that was negative for infections such as ___. She was continued on home spiriva, theophylline, advair. She was started on standing duonebs q6h and albuterol q2h prn and prednisone was started at 40mg daily with slow taper. She was also given azithromycin to complete 5 day course. She had improvement in her wheezing and returned to baseline O2 requirement after 48 hours. She was seen by ___ who felt that she would benefit from discharge to inpatient pulmonary rehabilitation program. On DC to ___ rehab, recommended continued Prendisone 40mg daily for 1x week with slow taper by 5mg every 5 days. ___ also consider starting bactrim ppx with extended duration of steroids if unable to wean less than 20mg qd. Will also f/u as outpatient with pulm. CHRONIC ISSUES: ================== # Anxiety/Insomnia: Continued home lorazepam. Consider starting SRRI as an outpatient. # Atrial Fibrillation: Continued dilt for rate control and apixaban for anticoagulation. # Hypertension: Continued home imdur, hydrochlorothiazide, and diltiazem. # CAD: Cardiac catheterization in ___ without evidence of significant stenosis of coronaries. ECHO on ___ with EF > 55% and no regional or global wall motion abnormalities. Continued home aspirin and atorvastatin. # Anemia: Continued home iron supplements. TRANSITIONAL ISSUES: ========================== [] For pt's continued COPD exacerbations, recommend finishing 5d course of Azithromycin, 250mg qd until ___ [] Recommend extended prednisone taper for pt, 5d 40mg Prednisone (to finish ___ followed by 10mg taper every 5 days (35mg from ___, 30mg ___, etc...). [] Would consider PCP prophylaxis with ___ if unable to wean prednisone to less than 20mg daily. [] Pt's SOB may have an anxiety component, may benefit from starting SSRI in addition to home benzos already prescribed # CONTACT: Full Code # CODE STATUS: ___ (husband/HCP) ___ ___ on Admission: The Preadmission Medication list is accurate and complete. 1. Acetaminophen 325 mg PO Q4H:PRN Pain 2. Apixaban 5 mg PO BID 3. Aspirin 81 mg PO DAILY 4. Atorvastatin 10 mg PO QPM 5. Diltiazem Extended-Release 240 mg PO BID 6. Docusate Sodium 100 mg PO BID 7. Dorzolamide 2% Ophth. Soln. 1 DROP BOTH EYES BID 8. Ferrous Sulfate 325 mg PO DAILY 9. Fluticasone Propionate NASAL 2 SPRY NU DAILY:PRN allergies 10. Hydrochlorothiazide 50 mg PO DAILY 11. Isosorbide Mononitrate (Extended Release) 240 mg PO DAILY 12. Latanoprost 0.005% Ophth. Soln. 1 DROP BOTH EYES QHS 13. Multivitamins 1 TAB PO DAILY 14. PredniSONE 10 mg PO DAILY 15. Ranitidine 300 mg PO DAILY 16. Theophylline SR 300 mg PO BID 17. Tiotropium Bromide 1 CAP IH DAILY 18. Ipratropium Bromide Neb 1 NEB IH Q6H:PRN Wheezing 19. cod liver oil 1 capsule oral BID 20. Calcitrate-Vitamin D (calcium citrate-vitamin D3) 315 mg - 200 units oral DAILY 21. albuterol sulfate 90 mcg/actuation inhalation Q4H 22. Fluticasone-Salmeterol Diskus (500/50) 1 INH IH BID 23. Lorazepam 0.5 mg PO Q8H:PRN Anxiety 24. Guaifenesin ___ mL PO Q4H:PRN cough Discharge Medications: 1. Acetaminophen 325 mg PO Q4H:PRN Pain 2. albuterol sulfate 90 mcg/actuation inhalation Q4H 3. Apixaban 5 mg PO BID 4. Aspirin 81 mg PO DAILY 5. Atorvastatin 10 mg PO QPM 6. Diltiazem Extended-Release 240 mg PO BID 7. Docusate Sodium 100 mg PO BID 8. Dorzolamide 2% Ophth. Soln. 1 DROP BOTH EYES BID 9. Ferrous Sulfate 325 mg PO DAILY 10. Fluticasone Propionate NASAL 2 SPRY NU DAILY:PRN allergies 11. Fluticasone-Salmeterol Diskus (500/50) 1 INH IH BID 12. Guaifenesin ___ mL PO Q4H:PRN cough 13. Hydrochlorothiazide 50 mg PO DAILY 14. Isosorbide Mononitrate (Extended Release) 240 mg PO DAILY 15. Latanoprost 0.005% Ophth. Soln. 1 DROP BOTH EYES QHS 16. Lorazepam 0.5 mg PO Q8H:PRN Anxiety 17. Multivitamins 1 TAB PO DAILY 18. Ranitidine 300 mg PO DAILY 19. Theophylline SR 300 mg PO BID 20. Tiotropium Bromide 1 CAP IH DAILY 21. Calcitrate-Vitamin D (calcium citrate-vitamin D3) 315 mg - 200 units oral DAILY 22. cod liver oil 1 capsule oral BID 23. Ipratropium Bromide Neb 1 NEB IH Q6H:PRN Wheezing 24. Nicotine Patch 7 mg TD DAILY 25. Azithromycin 250 mg PO Q24H Duration: 4 Doses please take until ___. PredniSONE 40 mg PO DAILY Duration: 5 Days 40mg until ___ Tapered dose - DOWN Discharge Disposition: Extended Care Facility: ___ ___ Diagnosis: PRIMARY: COPD Exacerbation SECONDARY: Afib Anxiety HTN CAD Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Followup Instructions: ___",1790,1705
10001884-DS-36,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> IV Dye, Iodine Containing Contrast Media / Oxycodone / cilostazol / Varenicline <ATTENDING> ___. <CHIEF COMPLAINT> Shortness of breath <MAJOR SURGICAL OR INVASIVE PROCEDURE> None <HISTORY OF PRESENT ILLNESS> Ms. ___ is a ___ with hx COPD on home O2, atrial fibrillation on apixaban, hypertension, CAD, and hyperlipidemia who presented with dyspnea. She has had multiple prior admissions for dyspnea. She was recently discharged on ___ after 3 day inpatient admission for COPD exacerbation. She was discharged on extended prednisone taper with plan for 5d 40mg Prednisone (to finish ___ followed by 10mg taper every 5 days (35mg from ___, 30mg ___, etc...). She initially went to rehab and subsequently went home 2 days prior to admission. Upon arrival at home she subsequently had recrudescence of fatigue, wheezing, dyspnea. She also had increased O2 requirements (up to 3L, using oxygen 24hr instead of during day only). Also with new cough, non-productive. Denies f/c, CP. No n/v, no myalgias. Decreased hearing in right ear with fullness for past 4 days. She was seen by PCP ___ noted to have inspiratory/expiratory wheezes, as well as decreased hearing and bulging TM right ear. She was referred to the ___ ED for further management. In the ED, initial vital signs were: 98.4 74 142/69 16 100%(2L NC) - Labs were notable for: 136 95 17 140 3.5 29 1.0 BNP 254 CBC within normal limits, but with neutrophil predominance UA with 30 protein VBG: pH 7.45, pCO2 43, pO2 59, HCO3 31 Flu PCR negative - Imaging: CXR notable for no acute cardiopulmonary process. - The patient was given: ___ 16: 03 IH Albuterol 0.083% Neb Soln 1 NEB ___ 16: 03 IH Ipratropium Bromide Neb 1 NEB ___ 17: 12 IH Albuterol 0.083% Neb Soln 1 NEB ___ 17: 12 IH Ipratropium Bromide Neb 1 NEB ___ 18: 12 IH Albuterol 0.083% Neb Soln 1 NEB ___ 18: 12 IH Ipratropium Bromide Neb 1 NEB ___ 21: 05 IH Albuterol 0.083% Neb Soln 1 NEB ___ 21: 05 PO PredniSONE 60 mg ___ 21: 05 IV Magnesium Sulfate 2 gm ___ 21: 33 IH Albuterol 0.083% Neb Soln 1 NEB Vitals prior to transfer were: 98.8 87 131/83 16 97% (2L) Upon arrival to the floor, she complained of wheezing and SOB, and persistent decreased hearing with fullness in right ear. REVIEW OF SYSTEMS: Per HPI. Denies headache, visual changes, pharyngitis, rhinorrhea, nasal congestion, cough, fevers, chills, sweats, weight loss, dyspnea, chest pain, abdominal pain, nausea, vomiting, diarrhea, constipation, hematochezia, dysuria, rash, paresthesias, and weakness. <PAST MEDICAL HISTORY> - COPD/Asthma on home 2L O2 - Atypical Chest Pain - Hypertension - Hyperlipidemia - Osteroarthritis - Atrial Fibrillation on Apixaban - Anxiety - Cervical Radiculitis - Cervical Spondylosis - Coronary Artery Disease - Headache - Herpes Zoster - GI Bleeding - Peripheral Vascular Disease s/p bilateral iliac stents - s/p hip replacement <SOCIAL HISTORY> ___ <FAMILY HISTORY> Mother with asthma and hypertension. Father with colon cancer. Brother with leukemia. <PHYSICAL EXAM> PHYSICAL EXAMINATION ON ADMISSION: -- VITALS: 98.1 139/79 78 22 98RA GENERAL: Pleasant, well-appearing, in no apparent distress. HEENT - normocephalic, atraumatic, no conjunctival pallor or scleral icterus, PERRLA, EOMI, OP clear. NECK: Supple, no LAD, no thyromegaly, JVP flat. CARDIAC: Normal S1/S2, no murmurs rubs or gallops. PULMONARY: Inspiratory and expiratory wheezes in all lung fields ABDOMEN: Normal bowel sounds, soft, non-tender, non-distended, no organomegaly. EXTREMITIES: Warm, well-perfused, no cyanosis, clubbing or edema. SKIN: Without rash. NEUROLOGIC: A&Ox3, CN II-XII grossly normal, normal sensation, with strength ___ throughout. PHYSICAL EXAMINATION ON DISCHARGE: -- VITALS: 98.2 130-140/70'S 70-80's 20 98RA GENERAL: Pleasant, well-appearing, in no apparent distress. HEENT - normocephalic, atraumatic, no conjunctival pallor or scleral icterus, PERRLA, EOMI, OP clear. NECK: Supple, no LAD, no thyromegaly, JVP flat. CARDIAC: Normal S1/S2, no murmurs rubs or gallops. PULMONARY: Decreased inspiratory and expiratory wheezes in all lung fields ABDOMEN: Normal bowel sounds, soft, non-tender, non-distended, no organomegaly. EXTREMITIES: Warm, well-perfused, no cyanosis, clubbing or edema. SKIN: Without rash. NEUROLOGIC: A&Ox3, CN II-XII grossly normal, normal sensation, with strength ___ throughout. <PERTINENT RESULTS> LABS ON ADMISSION: -= ___ 04: 00PM BLOOD Neuts-92.1* Lymphs-4.5* Monos-2.7* Eos-0.0* Baso-0.0 Im ___ AbsNeut-5.51 AbsLymp-0.27* AbsMono-0.16* AbsEos-0.00* AbsBaso-0.00* ___ 04: 00PM BLOOD Plt ___ ___ 04: 00PM BLOOD Glucose-140* UreaN-17 Creat-1.0 Na-136 K-3.5 Cl-95* HCO3-29 AnGap-16 ___ 04: 00PM BLOOD proBNP-254 ___ 03: 58PM BLOOD ___ pO2-59* pCO2-43 pH-7.45 calTCO2-31* Base XS-4 LABS ON DISCHARGE: -= ___ 08: 00AM BLOOD WBC-5.8 RBC-4.37 Hgb-11.9 Hct-38.2 MCV-87 MCH-27.2 MCHC-31.2* RDW-20.4* RDWSD-65.6* Plt ___ ___ 08: 00AM BLOOD Plt ___ ___ 08: 00AM BLOOD Glucose-156* UreaN-21* Creat-0.9 Na-134 K-3.4 Cl-92* HCO3-30 AnGap-15 ___ 08: 00AM BLOOD Calcium-9.7 Phos-3.6 Mg-2.0 STUDIES: ======== CXR ___: No acute cardiopulmonary process EKG: NSR rate 72, QTC 469, LBBB <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Acetaminophen 325 mg PO Q4H: PRN Pain 2. albuterol sulfate 90 mcg/actuation inhalation Q4H 3. Apixaban 5 mg PO BID 4. Aspirin 81 mg PO DAILY 5. Atorvastatin 10 mg PO QPM 6. Diltiazem Extended-Release 240 mg PO BID 7. Docusate Sodium 100 mg PO BID 8. Dorzolamide 2% Ophth. Soln. 1 DROP BOTH EYES BID 9. Ferrous Sulfate 325 mg PO DAILY 10. Fluticasone Propionate NASAL 2 SPRY NU DAILY: PRN allergies 11. Fluticasone-Salmeterol Diskus (500/50) 1 INH IH BID 12. Guaifenesin ___ mL PO Q4H: PRN cough 13. Hydrochlorothiazide 50 mg PO DAILY 14. Isosorbide Mononitrate (Extended Release) 240 mg PO DAILY 15. Latanoprost 0.005% Ophth. Soln. 1 DROP BOTH EYES QHS 16. Lorazepam 0.5 mg PO Q8H: PRN Insomnia, anxiety, vertigo 17. Multivitamins 1 TAB PO DAILY 18. Ranitidine 300 mg PO DAILY 19. Theophylline SR 300 mg PO BID 20. Tiotropium Bromide 1 CAP IH DAILY 21. Calcitrate-Vitamin D (calcium citrate-vitamin D3) 315 mg - 200 units oral DAILY 22. cod liver oil 1 capsule oral BID 23. Ipratropium Bromide Neb 1 NEB IH Q6H: PRN Wheezing 24. PredniSONE 30 mg PO DAILY Tapered dose - DOWN <DISCHARGE MEDICATIONS> 1. Acetaminophen 325 mg PO Q4H: PRN Pain 2. albuterol sulfate 90 mcg/actuation inhalation Q4H 3. Apixaban 5 mg PO BID 4. Aspirin 81 mg PO DAILY 5. Atorvastatin 10 mg PO QPM 6. Diltiazem Extended-Release 240 mg PO BID 7. Docusate Sodium 100 mg PO BID 8. Dorzolamide 2% Ophth. Soln. 1 DROP BOTH EYES BID 9. Ferrous Sulfate 325 mg PO DAILY 10. Fluticasone Propionate NASAL 2 SPRY NU DAILY: PRN allergies 11. Fluticasone-Salmeterol Diskus (500/50) 1 INH IH BID 12. Guaifenesin ___ mL PO Q4H: PRN cough 13. Hydrochlorothiazide 50 mg PO DAILY 14. Isosorbide Mononitrate (Extended Release) 240 mg PO DAILY 15. Latanoprost 0.005% Ophth. Soln. 1 DROP BOTH EYES QHS 16. Lorazepam 0.5 mg PO Q8H: PRN Insomnia, anxiety, vertigo 17. Multivitamins 1 TAB PO DAILY 18. PredniSONE 30 mg PO DAILY Please decrease dose by 5mg every 2 weeks Tapered dose - DOWN RX *prednisone 10 mg 3 tablets(s) by mouth once a day Disp #*45 Dose Pack Refills: *0 19. Ranitidine 300 mg PO DAILY 20. Theophylline SR 300 mg PO BID 21. Tiotropium Bromide 1 CAP IH DAILY 22. Levofloxacin 750 mg PO DAILY Duration: 5 Days RX *levofloxacin 750 mg 1 tablet(s) by mouth once a day Disp #*4 Tablet Refills: *0 23. Sulfameth/Trimethoprim SS 1 TAB PO DAILY prophylaxis for long term steroid use RX *sulfamethoxazole-trimethoprim 400 mg-80 mg 1 tablet(s) by mouth once a day Disp #*30 Tablet Refills: *0 24. Calcitrate-Vitamin D (calcium citrate-vitamin D3) 315 mg - 200 units oral DAILY 25. cod liver oil 1 capsule oral BID 26. Ipratropium Bromide Neb 1 NEB IH Q6H: PRN Wheezing <DISCHARGE DISPOSITION> Home With Service Facility: ___ <DISCHARGE DIAGNOSIS> PRIMARY DIAGNOSIS: COPD exacerbation SECONDARY DIAGNOSES: CAD Hypertension anxiety <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear ___, ___ was a great pleasure taking care of you at ___ ___. You came here because you were experiencing worsening shortness of breath as well as nasal congestion and decreased hearing. Your symptoms are likely related to an upper respiratory tract infection and exacerbation of your COPD. We started you on antibiotics and continued your prednisone. The dose of prednisone will be decreased by 5 mg every two weeks; please take your prednisone as follows: - Prednisone 30 mg for two weeks (Day 1= ___ end ___ - Prednisone 25 mg for two weeks (Day 1= ___ end ___ - Prednisone 20 mg for two weeks (Day 1= ___ end ___ - Discuss with Dr. ___ further taper at f/u Please take all your medications on time and follow up with your doctors as ___. Best regards, Your ___ team ","___ yo F with history of COPD on home O2, atrial fibrillation on apixaban, hypertension, CAD, hyperlipidemia, and recurrent hospitalization for COPD exacerbation over the last 4 months, who presented with dyspnea consistent with COPD exacerbation, possibly secondary to acute viral URI with concurrent sinusitis / Eustachian tube dysfunction # COPD exacerbation: Patient has been experiencing recurrent COPD exacerbations over the last 4 months. She presented with dyspnea consistent with COPD exacerbation, possibly secondary to acute viral URI with concurrent sinusitis / Eustachian tube dysfunction. We continued home spiriva, theophylline, and advair. We continued her steroid therapy at 30mg prednisone daily with a slow taper (5mg every 2 weeks). We also treated her with levofloxacin (Day ___ with plan for 5-day course given COPD exacerbation with concurrent concern for sinusitis / bulging right tympanic membrane. CHRONIC ISSUES: ================== # Anxiety/Insomnia: We continued home lorazepam. # Atrial Fibrillation: We continued diltiazem for rate control and apixaban for anticoagulation. # Hypertension: We continued home imdur, hydrochlorothiazide, and diltiazem. # CAD: Cardiac catheterization in ___ without evidence of significant stenosis of coronaries. ECHO on ___ with EF > 55% and no regional or global wall motion abnormalities. We continued home aspirin and atorvastatin. # Anemia: We continued home iron supplements. ***TRANSITIONAL ISSUES:*** - Continue levofloxacin with plan for 5-day course (Day ___ end ___ - Patient was started Bactrim PPX (1 tab SS daily) given extended courses of steroids, stop after discontinuation of steroids - Patient was discharged on prednisone 30 mg with plan for taper by 5mg every 2 weeks: Prednisone 30 mg for two weeks (Day 1= ___ end ___ Prednisone 25 mg for two weeks (Day 1= ___ end ___ Prednisone 20 mg for two weeks (Day 1= ___ end ___ etc... # CONTACT: ___ (husband/HCP) ___ # CODE STATUS: Full confirmed ",3109,487
10001884-DS-37,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> IV Dye, Iodine Containing Contrast Media / Oxycodone / cilostazol / Varenicline <ATTENDING> ___. <CHIEF COMPLAINT> Shortness of breath <MAJOR SURGICAL OR INVASIVE PROCEDURE> None <HISTORY OF PRESENT ILLNESS> Ms. ___ is a ___ with hx COPD on home O2, atrial fibrillation on apixaban, hypertension, CAD, and hyperlipidemia, with recurrent hospitalizations for COPD exacerbations, who presented with dyspnea. She has had multiple prior admissions for dyspnea. She was recently discharged on ___ after 3 day inpatient admission for COPD exacerbation. She was discharged on extended prednisone taper with plan for 5d 40mg Prednisone (to finish ___ followed by 10mg taper every 5 days (35mg from ___, 30mg ___, etc...). On the evening prior to presentation, patient experienced worsening shortness of breath, nonproductive cough and wheezing c/w prior COPD exacerbations. She reported taking inhalers as directed, without relief. The patient reported that this is almost identical to her last presentation. She also felt that she was taking too many medications and does not wish to continue to take prednisone. The patient was also noted to have increased O2 requirement and she was referred to the ___ ED for further management. Of note, please see prior admission note for details regarding prior admission. In the ED, initial vital signs were: 88 143/105 26 94% RA. Labs were notable for normal BNP and a creatinine of 1.2. Patient was given azithromycin and duoneb. Patient was scheduled to have methylpred but did not have it administered until arrival to the floor. Upon arrival to the floor, she complained of wheezing and SOB. She otherwise felt well. She agreed to take the methyprednisone but does not wish to take prednisone any more. REVIEW OF SYSTEMS: Per HPI. Denies headache, visual changes, pharyngitis, fevers, chills, sweats, weight loss, chest pain, abdominal pain, nausea, vomiting, diarrhea, constipation, hematochezia, dysuria, rash, paresthesias, and weakness. <PAST MEDICAL HISTORY> - COPD/Asthma on home 2L O2 - Atypical Chest Pain - Hypertension - Hyperlipidemia - Osteroarthritis - Atrial Fibrillation on Apixaban - Anxiety - Cervical Radiculitis - Cervical Spondylosis - Coronary Artery Disease - Headache - Herpes Zoster - GI Bleeding - Peripheral Vascular Disease s/p bilateral iliac stents - s/p hip replacement <SOCIAL HISTORY> ___ <FAMILY HISTORY> Mother with asthma and hypertension. Father with colon cancer. Brother with leukemia. <PHYSICAL EXAM> PHYSICAL EXAMINATION ON ADMISSION: -- VITALS: 97.3 159/91 75 16 94% on 2L GENERAL: Pleasant, well-appearing, in no apparent distress. HEENT: Normocephalic, atraumatic, no conjunctival pallor or scleral icterus, PERRLA, EOMI, OP clear. NECK: Supple, no LAD, no thyromegaly, JVP flat. CARDIAC: Normal S1/S2, no murmurs rubs or gallops. PULMONARY: Mild expiratory wheezes in all lung fields ABDOMEN: Normal bowel sounds, soft, non-tender, non-distended, no organomegaly. EXTREMITIES: Warm, well-perfused, no cyanosis, clubbing or edema. SKIN: Without rash. NEUROLOGIC: A&Ox3, CN II-XII grossly normal, normal sensation, with strength ___ throughout. PHYSICAL EXAMINATION ON DISCHARGE: -- VITALS: 98.6 127-150/50-60 70-90'S 16 98% on 3L GENERAL: Pleasant, well-appearing, in no apparent distress. HEENT: Normocephalic, atraumatic, no conjunctival pallor or scleral icterus, PERRLA, EOMI, OP clear. NECK: Supple, no LAD, no thyromegaly, JVP flat. CARDIAC: Normal S1/S2, no murmurs rubs or gallops. PULMONARY: Minimally decreased bilateral air entry, no wheezes in all lung fields ABDOMEN: Normal bowel sounds, soft, non-tender, non-distended, no organomegaly. EXTREMITIES: Warm, well-perfused, no cyanosis, clubbing or edema. SKIN: Without rash. NEUROLOGIC: A&Ox3, CN II-XII grossly normal, normal sensation, with strength ___ throughout. <PERTINENT RESULTS> LABS ON ADMISSION: -= ___ 06: 15PM BLOOD WBC-7.7 RBC-4.92 Hgb-13.5 Hct-42.4 MCV-86 MCH-27.4 MCHC-31.8* RDW-19.6* RDWSD-61.2* Plt ___ ___ 06: 15PM BLOOD Neuts-87.4* Lymphs-5.7* Monos-6.1 Eos-0.0* Baso-0.1 Im ___ AbsNeut-6.72* AbsLymp-0.44* AbsMono-0.47 AbsEos-0.00* AbsBaso-0.01 ___ 06: 15PM BLOOD ___ PTT-29.6 ___ ___ 06: 15PM BLOOD Plt ___ ___ 06: 15PM BLOOD Glucose-122* UreaN-21* Creat-1.2* Na-136 K-3.4 Cl-92* HCO3-31 AnGap-16 ___ 06: 15PM BLOOD ALT-52* AST-34 AlkPhos-69 TotBili-0.3 ___ 06: 15PM BLOOD Lipase-28 ___ 06: 15PM BLOOD cTropnT-<0.01 proBNP-325 ___ 06: 15PM BLOOD Albumin-4.2 LABS ON DISHCHARGE: -== ___ 06: 40AM BLOOD WBC-10.3* RBC-4.20 Hgb-11.8 Hct-37.0 MCV-88 MCH-28.1 MCHC-31.9* RDW-19.9* RDWSD-65.1* Plt ___ ___ 06: 40AM BLOOD Plt ___ ___ 06: 40AM BLOOD Glucose-112* UreaN-18 Creat-0.9 Na-137 K-3.6 Cl-96 HCO3-28 AnGap-17 ___ 06: 40AM BLOOD Calcium-9.5 Phos-2.6* Mg-2.1 IMAGING: ======== ___ CXR: No acute cardiopulmonary process. <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Acetaminophen 325 mg PO Q4H: PRN Pain 2. albuterol sulfate 90 mcg/actuation inhalation Q4H 3. Apixaban 5 mg PO BID 4. Aspirin 81 mg PO DAILY 5. Atorvastatin 10 mg PO QPM 6. Diltiazem Extended-Release 240 mg PO BID 7. Docusate Sodium 100 mg PO BID 8. Dorzolamide 2% Ophth. Soln. 1 DROP BOTH EYES BID 9. Ferrous Sulfate 325 mg PO DAILY 10. Fluticasone Propionate NASAL 2 SPRY NU DAILY: PRN allergies 11. Fluticasone-Salmeterol Diskus (500/50) 1 INH IH BID 12. Guaifenesin ___ mL PO Q4H: PRN cough 13. Hydrochlorothiazide 50 mg PO DAILY 14. Isosorbide Mononitrate (Extended Release) 240 mg PO DAILY 15. Latanoprost 0.005% Ophth. Soln. 1 DROP BOTH EYES QHS 16. Lorazepam 0.5 mg PO Q8H: PRN Insomnia, anxiety, vertigo 17. Multivitamins 1 TAB PO DAILY 18. PredniSONE 30 mg PO DAILY Tapered dose - DOWN 19. Ranitidine 300 mg PO DAILY 20. Theophylline SR 300 mg PO BID 21. Tiotropium Bromide 1 CAP IH DAILY 22. Levofloxacin 750 mg PO DAILY 23. Sulfameth/Trimethoprim SS 1 TAB PO DAILY prophylaxis for long term steroid use 24. Calcitrate-Vitamin D (calcium citrate-vitamin D3) 315 mg - 200 units oral DAILY 25. cod liver oil 1 capsule oral BID 26. Ipratropium Bromide Neb 1 NEB IH Q6H: PRN Wheezing <DISCHARGE MEDICATIONS> 1. Acetaminophen 325 mg PO Q4H: PRN Pain 2. Calcitrate-Vitamin D (calcium citrate-vitamin D3) 315 mg - 200 units oral DAILY 3. Tiotropium Bromide 1 CAP IH DAILY 4. Theophylline SR 300 mg PO BID 5. Sulfameth/Trimethoprim SS 1 TAB PO DAILY prophylaxis for long term steroid use 6. Ranitidine 300 mg PO DAILY 7. PredniSONE 40 mg PO DAILY 8. Lorazepam 0.5 mg PO Q8H: PRN Insomnia, anxiety, vertigo 9. Latanoprost 0.005% Ophth. Soln. 1 DROP BOTH EYES QHS 10. Isosorbide Mononitrate (Extended Release) 240 mg PO DAILY 11. Ipratropium Bromide Neb 1 NEB IH Q6H Wheezing 12. Hydrochlorothiazide 50 mg PO DAILY 13. Guaifenesin ___ mL PO Q4H: PRN cough 14. Fluticasone-Salmeterol Diskus (500/50) 1 INH IH BID 15. Fluticasone Propionate NASAL 2 SPRY NU DAILY: PRN allergies 16. Ferrous Sulfate 325 mg PO DAILY 17. Dorzolamide 2% Ophth. Soln. 1 DROP BOTH EYES BID 18. albuterol sulfate 90 mcg/actuation inhalation Q4H 19. Apixaban 5 mg PO BID 20. Aspirin 81 mg PO DAILY 21. Atorvastatin 10 mg PO QPM 22. Diltiazem Extended-Release 240 mg PO BID 23. Docusate Sodium 100 mg PO BID 24. Sodium Chloride Nasal ___ SPRY NU QID: PRN nasal discomfort RX *sodium chloride 0.65 % ___ spray QID nasal congestion Disp #*1 Spray Refills: *0 25. Morphine Sulfate (Oral Solution) 2 mg/mL 5 mg PO Q4H: PRN shortness of breath RX *morphine 10 mg/5 mL 2.5 mL by mouth every four (4) hours Disp ___ Milliliter Milliliter Refills: *0 26. Budesonide Nasal Inhaler 180 mcg Other DAILY RX *budesonide [Pulmicort Flexhaler] 180 mcg/actuation (160 mcg delivered) 1 puff INH DAILY Disp #*1 Inhaler Refills: *0 <DISCHARGE DISPOSITION> Home With Service Facility: ___ <DISCHARGE DIAGNOSIS> PRIMARY DIAGNOSIS: Severe COPD SECONDARY DIAGNOSES: CAD Hypertension Atrial fibrillation <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear ___, ___ was a great pleasure taking care of you at ___ ___. You came to the hospital because you were experiencing worsening shortness of breath. Pulmonary team saw you and reviewed your condition, and your symptoms are thought to be related to severe COPD. We did some changes in your medications and increased the dose of prednisone. The Palliative Care team was consulted and started you on morphine liquid suspension to help with your breathing symptoms. Please take all your medications on time and follow up with your doctors as ___. Best regards, Your ___ team ","___ yo F with history of COPD on home O2, atrial fibrillation on apixaban, hypertension, CAD, hyperlipidemia, and recurrent hospitalization for COPD exacerbation over the last 4 months, who presented with dyspnea and increased wheezing secondary to severe COPD. #Recurrent COPD exacerbation: Patient presented with increased dyspnea and diffuse wheezing, likely secondary to COPD exacerbation. She has a history of multiple recurrent COPD hospitalizations. According to Pulmonary, patient has severe COPD based on her obstructive deficits on PFTs as well as her severe symptoms even at rest, as well as her more frequent exacerbations and is likely approaching end-stage disease. We continued Advair 500/50 BID, Spiriva, standing nebulizers, and theophylline. Pulmonary recommended additional budesonide inhalers to allow reduction of PO prednisone dose. Prednisone dose was increased back to 40mg (where patient was better) with a plan for slow wean by 5mg every 2 weeks. Also, patient was started on chronic azithromycin for chronic anti-inflammation; after discussion with Dr. ___ was agreed to stop azithromycin on discharge due to inability to monitor QT the week after discharge, with plan to restart azithromycin once Dr. ___ is able to see the patient. Patient did not want to go to pulmonary rehab. She was seen by Palliative Care who recommended initiation of morphine liquid suspension as needed for shortness of breath. # Acute kidney injury: Creatinine was slightly elevated to 1.2 from a baseline of 1.0. She likely had poor PO intake. Creatinine on discharge was 0.9. CHRONIC ISSUES: ================== # Anxiety/Insomnia: We continued home lorazepam. # Atrial fibrillation: We continued diltiazem for rate control and apixaban for anticoagulation. # Hypertension: We continued home imdur, hydrochlorothiazide, and diltiazem. # CAD: Cardiac catheterization in ___ showed no evidence of significant stenosis of coronaries. ECHO on ___ showed EF > 55% and no regional or global wall motion abnormalities. We continued home aspirin and atorvastatin. # Anemia: We continued home iron supplements. ***TRANSITIONAL ISSUES:*** - Continue Advair 500/50 BID, Spiriva, and theophylline - Make sure patient receives standing nebulizers - Added additional budesonide inhalers to allow reduction of PO prednisone dose - Start chronic azithromycin for chronic anti-inflammation. (Patient was started on azithromycin in the hospital and QTc on ___ was 472 ms. ___ discussion with Dr. ___ was agreed to stop azithromycin on discharge due to inability to monitor QT the week after discharge, with the plan to restart azithromycin once Dr. ___ is able to see the patient.) - Would recommend audiology testing at some point while patient is on chronic azithromycin - Continue supplemental oxygen for comfort - Follow up with Dr. ___ discharge - Continue Bactrim PPX (1 tab SS daily) given extended courses of steroids - Patient was discharged on prednisone 40 mg with plan for taper by 5mg every 2 weeks: Prednisone 40 mg for two weeks (Day 1= ___ end ___ Prednisone 35 mg for two weeks (Day 1= ___ end ___ Prednisone 30 mg for two weeks (Day 1= ___ end ___ etc... # CONTACT: ___ (husband/HCP) ___ # CODE STATUS: Full confirmed ",2911,781
10001884-DS-38,"<SEX> F <SERVICE> CARDIOTHORACIC <ALLERGIES> IV Dye, Iodine Containing Contrast Media / Oxycodone / cilostazol / Varenicline <ATTENDING> ___. <CHIEF COMPLAINT> Shortness of breath <MAJOR SURGICAL OR INVASIVE PROCEDURE> Intubation & Mechanical Ventilation (Extubated) Temporary Pacer Placement CVL Insertion <HISTORY OF PRESENT ILLNESS> ___ with COPD who has been admitted 9 times since ___ for dyspnea, CAD, atrial fibrillation on apixaban who presented with shortness of breath since being discharged on ___. She was discharged home with services. Mrs. ___ has significant COPD, with recent PFTs on ___ showing severely reduced FEV1 and moderately reduced FEV1/FVC. She was generally feeling better since discharged on ___, continuing her prednisone (at 40mg today) until the day prior to presentation. She subsequently began to become short of breath, especially with exertion, and developed a cough productive of brown sputum. No fever, chills, nausea, vomiting, diarrhea. She sleeps with three pillows laying on her side, which is stable. Her secondary concern is that she is having trouble walking due to pain in her R-hip to R-thigh with weight bearing. This was new. No falls or trauma. No loss of sensation, numbness, weakness, urinary or fecal incontinence or difficulty urinating. In the ED, initial vital signs were: 99.0 80 116/66 24 98% Nasal Cannula - Exam was notable for: diffuse ronchi worst in the RLL, tripoding - Labs were notable for: flu swab negative, WBC 7.5 with left shift, CBC otherwise WNL, BNP 425, lactate 3.0, U/A cloudy with 30 protein but otherwise negative, BUN/Cr ___ - Imaging: CXR with mild bibasilar atelectasis, though ED physicians concerned for pneumonia on lateral view - The patient was given: 1g Vancomycin, 2g cefepime, 500 mg PO azithromycin, 1 duoneb, 20 mg prednisone (total 60 mg that day) - Consults: none Vitals prior to transfer were: 98.2 87 148/76 18 92% RA Upon arrival to the floor, Mrs. ___ stated her breathing was slightly better, but she continued to have shortness of breath. She felt as though her ears are clogged up, and this was her as well. She stated she has been taking all her medications as prescribed. <PAST MEDICAL HISTORY> - COPD/Asthma on home 2L O2 - Atypical Chest Pain - Hypertension - Hyperlipidemia - Osteroarthritis - Atrial Fibrillation on Apixaban - Anxiety - Cervical Radiculitis - Cervical Spondylosis - Coronary Artery Disease - Headache - Herpes Zoster - GI Bleeding - Peripheral Vascular Disease s/p bilateral iliac stents - s/p hip replacement <SOCIAL HISTORY> ___ <FAMILY HISTORY> Mother with asthma and hypertension. Father with colon cancer. Brother with leukemia. <PHYSICAL EXAM> PHYSICAL EXAMINATION ON ADMISSION: -- VITALS: 98.4 140/83 77 22 94% RA GENERAL: breathing somewhat heavily with audible wheeze HEENT - no pallor or icterus, no oropharyngeal lesion, no sinus tenderness NECK: Supple, JVP flat CARDIAC: RRR, unable to appreciate any m/r/g due to breathing PULMONARY: diffuse wheezes and ronchi ABDOMEN: NT/ND, +BS EXTREMITIES: 1+ lower extremity edema up shins, patient is sitting ___ style and I do not appreciate tenderness at the R hip SKIN: Without rash. NEUROLOGIC: A&Ox3, moving all extremities with purpose PHYSICAL EXAMINATION ON DISCHARGE: -- HR and RR went to zero on continuous telemetry. Patient did not respond to vocal or tactile stimuli. Pupils were non-reactive to light. She had no heart or lung sounds for > 1 minute on auscultation. She was pronounced dead at 0515. Family was notified, they had previously declined an autopsy. <PERTINENT RESULTS> LABS ON ADMISSION: -= ___ 04: 38PM BLOOD WBC-7.5 RBC-4.39 Hgb-12.3 Hct-38.6 MCV-88 MCH-28.0 MCHC-31.9* RDW-18.0* RDWSD-56.9* Plt ___ ___ 04: 38PM BLOOD Neuts-92.1* Lymphs-3.9* Monos-3.5* Eos-0.0* Baso-0.0 Im ___ AbsNeut-6.91* AbsLymp-0.29* AbsMono-0.26 AbsEos-0.00* AbsBaso-0.00* ___ 04: 38PM BLOOD Plt ___ ___ 04: 38PM BLOOD Glucose-143* UreaN-20 Creat-1.1 Na-135 K-3.5 Cl-91* HCO3-29 AnGap-19 ___ 04: 38PM BLOOD ALT-50* AST-41* AlkPhos-73 TotBili-0.3 ___ 04: 38PM BLOOD proBNP-425 ___ 04: 38PM BLOOD Albumin-4.4 Calcium-10.3 Phos-3.6 Mg-2.0 ___ 10: 40AM BLOOD ___ pO2-130* pCO2-41 pH-7.42 calTCO2-28 Base XS-2 Comment-GREEN TOP ___ 04: 44PM BLOOD Lactate-3.0* LABS ON DISCHARGE: -= ___ 04: 15AM BLOOD WBC-13.4* RBC-2.42* Hgb-7.0* Hct-22.9* MCV-95 MCH-28.9 MCHC-30.6* RDW-17.5* RDWSD-56.8* Plt ___ ___ 04: 15AM BLOOD Glucose-94 UreaN-15 Creat-0.6 Na-138 K-4.2 Cl-97 HCO3-37* AnGap-8 ___ 04: 15AM BLOOD Calcium-8.3* Phos-3.0 Mg-2.0 SELECT IMAGING: -== ___ CXR: COMPARISON: ___ FINDINGS: Heart size is mildly enlarged. There is mild unfolding of the thoracic aorta. Cardiomediastinal silhouette and hilar contours are otherwise unremarkable. There is mild bibasilar atelectasis. Lungs are otherwise clear. Pleural surfaces are clear without effusion or pneumothorax. Focus of air seen under the right hemidiaphragm, likely represents colonic interposition. IMPRESSION: No acute cardiopulmonary abnormality. ___ RUE U/S: IMPRESSION: 4 cm acute deep vein thrombosis noted within the mid right brachial vein as detailed above. ___ CXR: IMPRESSION: The endotracheal tube tip is 6 cm above the carina. Nasogastric tube tip is beyond the GE junction and off the edge of the film. A left central line is present in the tip is in the mid SVC. A pacemaker is noted on the right in the lead projects over the right ventricle. There is probable scarring in both lung apices. There are no new areas of consolidation. There is upper zone redistribution and cardiomegaly suggesting pulmonary venous hypertension. There is no pneumothorax. <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Acetaminophen 325 mg PO Q4H: PRN Pain 2. Calcitrate-Vitamin D (calcium citrate-vitamin D3) 315 mg - 200 units oral DAILY 3. Tiotropium Bromide 1 CAP IH DAILY 4. Theophylline SR 300 mg PO BID 5. Sulfameth/Trimethoprim SS 1 TAB PO DAILY prophylaxis for long term steroid use 6. Ranitidine 300 mg PO DAILY 7. PredniSONE 40 mg PO DAILY 8. Lorazepam 0.5 mg PO Q8H: PRN Insomnia, anxiety, vertigo 9. Latanoprost 0.005% Ophth. Soln. 1 DROP BOTH EYES QHS 10. Isosorbide Mononitrate (Extended Release) 240 mg PO DAILY 11. Ipratropium Bromide Neb 1 NEB IH Q6H Wheezing 12. Hydrochlorothiazide 50 mg PO DAILY 13. Guaifenesin ___ mL PO Q4H: PRN cough 14. Fluticasone-Salmeterol Diskus (500/50) 1 INH IH BID 15. Fluticasone Propionate NASAL 2 SPRY NU DAILY: PRN allergies 16. Ferrous Sulfate 325 mg PO DAILY 17. Dorzolamide 2% Ophth. Soln. 1 DROP BOTH EYES BID 18. albuterol sulfate 90 mcg/actuation inhalation Q4H 19. Apixaban 5 mg PO BID 20. Aspirin 81 mg PO DAILY 21. Atorvastatin 10 mg PO QPM 22. Diltiazem Extended-Release 240 mg PO BID 23. Docusate Sodium 100 mg PO BID 24. Sodium Chloride Nasal ___ SPRY NU QID: PRN nasal discomfort 25. Morphine Sulfate (Oral Solution) 2 mg/mL 5 mg PO Q4H: PRN shortness of breath 26. Budesonide Nasal Inhaler 180 mcg Other DAILY <DISCHARGE MEDICATIONS> None. <DISCHARGE DISPOSITION> Expired <DISCHARGE DIAGNOSIS> PRIMARY DIAGNOSES: s/p PEA Arrest Respiratory Failure COPD Sinusitis RUE DVT SECONDARY DIAGNOSES: Atrial fibrillation Hypertension CAD <DISCHARGE CONDITION> Deceased. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> N/A ","___ hx severe COPD, AFib, CAD, HTN, HLD, recent hospitalizations for recurrent COPD exacerbations over the last several months, who presented with dyspnea and increased wheezing secondary to severe COPD. She was treated for her COPD with nebulizers and steroids, but continued to decline eventually suffering a PEA arrest thought due to hypoxemia requiring endotracheal intubation and mechanical ventilation. A temporary pacemaker was placed for periods of bradycardia that may also have contributed to her PEA arrest (versus being a manifestation of severe hypoxemia/severe hypercarbia preceding her arrest). She made a cognitive recovery but was unable to be successfully weaned from her ventilator. She had capacity and was able to make it understand that she did not wish: continued intubation & mechanical ventilation; re-intubation and mechanical ventilation once extubated; or, positive non-invasive pressure ventilation. After extensive discussions with her and her family, she was transitioned to DNR/DNI and comfort-oriented care. She was extubated to spend quality time with her family before passing from respiratory failure on the morning of ___ at 0515. Autopsy was declined by family. She was incidentally found to have a RUE DVT that was treated with heparin gtt (which was also used for anticoagulation for her atrial fibrillation; she was temporarily transitioned to argatroban for concern of HIT, but PF4 antibodies returned at very low OD, making this diagnosis unlikely). She was also treated for an acute sinusitis with Augmentin during her hospital stay. ",2340,341
10001919-DS-20,"<SEX> M <SERVICE> SURGERY <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> Locally advanced gastric carcinoma <MAJOR SURGICAL OR INVASIVE PROCEDURE> Cystoscopy for foley catheter placement; Laparoscopy with biopsy; Gastroscopy <HISTORY OF PRESENT ILLNESS> Mr. ___ is a ___ year old male with locally advanced gastric cancer (stage II [T3N2]) who arrives to ___ for curative-intent surgical resection after completion of induction chemotherapy. He was started on neoadjuvant chemotherapy with FLOT4 on ___. Overall he tolerated the chemotherapy well without any significant side effects. However, last month he developed right upper extremity edema and was noted to have a thrombosis in the R SVC. He was started on Lovenox 1 mg/kg BID, which he is compliant with. Denies any fever, nausea, emesis, chills, weight loss, melena, hematochezia or hematuria. He comes after recent repeat staging (___) with torso CT scan demonstrating no evidence of disease. He is now now taken to the operating room for minimally invasive and possibly open radical distal gastrectomy with lymphadenectomy. The risks and benefits of surgery have been described with the patient in detail and are documented by Dr. ___ in a separate note. <PAST MEDICAL HISTORY> <PAST MEDICAL HISTORY> Prostate cancer, Thyroid nodule, Hypothyroid, GERD mild, Diverticulosis on colonoscopy ___ anemia iron def. anemia which resolved and no workup Past Surgical History: Prostate cancer external beam ___, Achilles tendon repair ___, Shattered right tibia and fibula, Tonsillectomy age ___. <SOCIAL HISTORY> ___ <FAMILY HISTORY> Father died at ___ from Lymphoma. Mother died at ___ with type II DM, Dementia. <PHYSICAL EXAM> VS: 24 HR Data (last updated ___ @ 1118) Temp: 98.1 (Tm 98.9), BP: 116/73 (108-118/59-77), HR: 79 (77-86), RR: 18 (___), O2 sat: 99% (97-99), O2 delivery: Ra GEN: A&Ox3, NAD, resting comfortably HEENT: NCAT, EOMI, sclera anicteric CV: RRR PULM: no respiratory distress ABD: soft, NT, ND, no rebound or guarding EXT: warm, well-perfused, no edema PSYCH: normal insight, memory, and mood WOUND(S): Incision c/d/i <MEDICATIONS ON ADMISSION> Medications - Prescription BIO-THROID - Bio-Throid . 65 mg. once a day - (Prescribed by Other Provider) ENOXAPARIN - enoxaparin 120 mg/0.8 mL subcutaneous syringe. 120 mg SC daily OMEPRAZOLE - omeprazole 20 mg capsule,delayed release. 1 capsule(s) by mouth twice daily UBIQUINOL - ubiquinol . (100 mg) 2 tabs mouth twice a day - (Prescribed by Other Provider) Medications - OTC FERROUS SULFATE - ferrous sulfate 325 mg (65 mg iron) tablet. 1 tablet(s) by mouth twice a day - (Prescribed by Other Provider) LACTOBACILLUS COMBINATION NO.4 [PROBIOTIC] - Dosage uncertain - (Prescribed by Other Provider; daily) <DISCHARGE MEDICATIONS> 1. Acetaminophen 1000 mg PO TID 2. Docusate Sodium 100 mg PO BID 3. Senna 8.6 mg PO BID: PRN Constipation - First Line 4. TraMADol 50 mg PO Q6H: PRN Pain - Moderate This medication is a low dose narcotic and may cause constipation. RX *tramadol 50 mg 1 (One) tablet(s) by mouth every six (6) hours Disp #*20 Tablet Refills: *0 5. Enoxaparin Sodium 120 mg SC DAILY <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Metastatic gastric cancer (stage IV [T3N2M1]) Urethral stricture <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Mr. ___, It was a pleasure taking care of you here at ___ ___. You were admitted to our hospital for gastric cancer. You had an attempted Robot-assisted laparoscopic partial gastrectomy and gastroscopy on ___ without complications. You tolerated the procedure well and are ambulating, stooling, tolerating a regular diet, and your pain is controlled by pain medications by mouth. You are now ready to be discharged to home. Please follow the recommendations below to ensure a speedy and uneventful recovery. ACTIVITY: - Do not drive until you have stopped taking pain medicine and feel you could respond in an emergency. - You may climb stairs. You should continue to walk several times a day. - You may go outside, but avoid traveling long distances until you see your surgeon at your next visit. - You may start some light exercise when you feel comfortable. Slowly increase your activity back to your baseline as tolerated. - Heavy exercise may be started after 6 weeks, but use common sense and go slowly at first. - No heavy lifting (10 pounds or more) until cleared by your surgeon, usually about 6 weeks. - You may resume sexual activity unless your doctor has told you otherwise. HOW YOU MAY FEEL: - You may feel weak or ""washed out"" for 6 weeks. You might want to nap often. Simple tasks may exhaust you. - You may have a sore throat because of a tube that was in your throat during the surgery. YOUR BOWELS: - Constipation is a common side effect of narcotic pain medicine such as oxycodone. If needed, you may take a stool softener (such as Colace, one capsule) or gentle laxative (such as milk of magnesia, 1 tbs) twice a day. You can get both of these medicines without a prescription. - If you go 48 hours without a bowel movement, or have pain moving the bowels, call your surgeon. - After some operations, diarrhea can occur. If you get diarrhea, don't take anti-diarrhea medicines. Drink plenty of fluids and see if it goes away. If it does not go away, or is severe and you feel ill, please call your surgeon. PAIN MANAGEMENT: - You are being discharged with a prescription for **oxycodone for pain control. You may take Tylenol as directed, not to exceed 3500mg in 24 hours. Take regularly for a few days after surgery but you may skip a dose or increase time between doses if you are not having pain until you no longer need it. You may take the oxycodone for moderate and severe pain not controlled by the Tylenol. You may take a stool softener while on narcotics to help prevent the constipation that they may cause. Slowly wean off these medications as tolerated. - Your pain should get better day by day. If you find the pain is getting worse instead of better, please contact your surgeon. If you experience any of the following, please contact your surgeon: - sharp pain or any severe pain that lasts several hours - chest pain, pressure, squeezing, or tightness - cough, shortness of breath, wheezing - pain that is getting worse over time or pain with fever - shaking chills, fever of more than 101 - a drastic change in nature or quality of your pain - nausea and vomiting, inability to tolerate fluids, food, or your medications - if you are getting dehydrated (dry mouth, rapid heart beat, feeling dizzy or faint especially while standing) -any change in your symptoms or any symptoms that concern you Additional: *- pain that is getting worse over time, or going to your chest or back *- urinary: burning or blood in your urine or the inability to urinate MEDICATIONS: - Take all the medicines you were on before the operation just as you did before, unless you have been told differently. - If you have any questions about what medicine to take or not to take, please call your surgeon. WOUND CARE: - dressing removal: - You may remove your dressings tomorrow ___ and shower that same day with any bandage strips that may be covering your wound. Do not scrub and do not soak or swim, and pat the incision dry. If you have steri strips, they will fall off by themselves in ___ weeks. If any are still on in two weeks and the edges are curling up, you may carefully peel them off. Do not take baths, soak, or swim for 6 weeks after surgery unless told otherwise by your surgical team. -Notify your surgeon is you notice abnormal (foul smelling, bloody, pus, etc) or increased drainage from your incision site, opening of your incision, or increased pain or bruising. Watch for signs of infection such as redness, streaking of your skin, swelling, increased pain, or increased drainage. Please call with any questions or concerns. Thank you for allowing us to participate in your care. We hope you have a quick return to your usual life and activities. Home with ___: You had a Foley catheter in your bladder placed by urology on the day of your surgery after difficulty trying to place it. You will keep the catheter until your appointment with Urology in 5 days (please call the number below to schedule your appointment), who will decide if you need it longer or attempt to remove it and see if you are able to void. Empty the bag as needed and as shown to you by nursing staff. You will be given a leg bag before your discharge, that you may use for short trips. This is a smaller bag that straps to your leg, to take home and wear if you are traveling outside your home. This holds a smaller amount than the bag you have now, so it needs to be emptied more often. Some people find it easier to use the larger bad when they are at home or carry it with them. -- Your ___ Care Team ","Mr. ___ is a ___ year old Male who presented on ___ for a planned minimally invasive and possibly open radical distal gastrectomy with lymphadenectomy for locally advanced gastric carcinoma after chemotherapy. After placement of the Right upper quadrant port, insufflation revealed the right upper quadrant port to be penetrating the omentum. It appeared to miss the transverse mesocolon as well as the colon itself. During the surgery, there were visually obvious peritoneal deposits on all peritoneal surfaces in all four quadrants, which demonstrated undetected carcinomatosis, poorly -differentiated adenocarcinoma involving the peritoneum. For this reason, the procedure was then aborted. Post-operatively the patient was taken to the PACU until stable and then transferred to the wards until stable to go home. #NEURO: The patient was alert and oriented throughout hospitalization; pain was initially managed with dilaudid PCA which he was not using and then transitioned to tramadol which he got only one dose. Pain was very well controlled. #CV: The patient remained stable from a cardiovascular standpoint; vital signs were routinely monitored. #PULMONARY: The patient remained stable from a pulmonary standpoint; vital signs were routinely monitored. Good pulmonary toilet, early ambulation and incentive spirometry were encouraged throughout hospitalization. #GI/GU/FEN: Before the procedure started, OR nurse was unable to pass Foley after attempt with standard and coude type. PA ___, with usual sterile technique, re-attempted foley placement after 10cc urojet application with ___ and ___ coude-type catheters but was also unable to get passed the prostate. Urology was consulted and they performed a flexible cystoscope demonstrating a normal urethra. Using a flexible guidewire, cystoscope was advanced into the bladder. The scope was withdrawn and a ___ council was advanced over the wire, passed the prostate and into the bladder. The patient was discharged with the Foley in place with instructions to follow-up with urology as outpatient in 5 to 7 days for a voiding trial. No antibiotics were administered. The patient was tolerating a regular diet prior to discharge. #ID: The patient's fever curves were closely watched for signs of infection, of which there were none. #HEME: Patient received BID SQH for DVT prophylaxis, in addition to encouraging early ambulation and Venodyne compression devices. On POD1 the patient was restarted on his home enoxaparin before discharge. #TRANSITIONAL ISSUES -------------------- At the time of discharge, the patient was doing well, afebrile with stable vital signs. The patient was tolerating diet as above per oral, ambulating, and pain was well controlled. The patient was discharged home with the Foley catheter with appropriate teaching for care. The patient received discharge teaching and follow-up instructions with understanding verbalized and agreement with the discharge plan. ",2239,600
10002013-DS-10,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> lisinopril <ATTENDING> ___. <CHIEF COMPLAINT> Back Pain <MAJOR SURGICAL OR INVASIVE PROCEDURE> None <HISTORY OF PRESENT ILLNESS> The patient is a ___ y/o F with pMHx significant for HTN, GERD, CAD s/p CABG and stenting, IDDM with periperal neuropathy who presents with R flank pain. Per patient, this pain has been going on for the past 3 weeks but has worsened over the past 2 days. It is worsened with coughing and moving. She otherwise denies any dysuria, urinary frequency, abdominal pain, n/v, chest pain, shortness of breath or dizziness. She endorses 4 episodes of diarrhea today. In the ED initial vitals were: 10 98.2 106 167/84 16 99% RA. RR later trended up to 20, HR down to 89. Labs were significant for positive UA (WBC 19), lactate 3.0, WBC 9.4% (70% PMN), AST 53, ALT 16, Lip 70, trop-T < 0.01, Chem hemolyzed but Cr 1.4 (baseline 1.0 in ___, repeat K 3.6. Hyperglycemic to 446, 340 on repeat. CXR showed no acute process. Patient was given 1L NS, 1g CTX, 14 units insulin. Unclear if she received her home long-acting insulin. UCx and BCx's were sent after antibiotics initiated. Vitals prior to transfer were: 3 98.4 89 152/80 20 100% RA. <PAST MEDICAL HISTORY> COPD CAD s/p CABG and stenting Depression DM GERD HTN Migraines Chronic shoulder pain on narcotics OSA Peripheral neuropathy Restless leg <SOCIAL HISTORY> ___ <FAMILY HISTORY> Mother Unknown ALCOHOL ABUSE pt was ward of state, doesn't know full details of family hx Father ___ ___ HODGKIN'S DISEASE per old records <PHYSICAL EXAM> Admission <PHYSICAL EXAM> Vitals - 98.3 155/88 92 20 99% on RA GENERAL: NAD HEENT: NCAT CARDIAC: RRR, S1/S2, no murmurs, gallops, or rubs LUNG: CTAB, no wheezes, rales, rhonchi, breathing comfortably without use of accessory muscles ABDOMEN: nondistended, +BS, nontender in all quadrants, no rebound/guarding EXTREMITIES: no cyanosis, clubbing or edema, moving all 4 extremities with purpose BACK: no tenderness to spinal processes, no pain the left side, +CVA tenderness, tenderness to palpation of the R sided paraspinal muscles along entire length of spinal cord Discharge <PHYSICAL EXAM> Vitals: 97.8 107/59 78 18 97/RA General: awake, alert, NAD HEENT: NCAT EOMI MMM grossly normal oropharynx CV: RRR nl S1+S2 no g/r/m no JVD/HJR. Lungs: CTAB no w/r/r, good movement in all fields Abdomen: obese, soft nt/nd normoactive BS Back: ttp along right paraspinal region from sacrum to shoulder. + CVA tenderness. Ext: dry and WWP. no c/c/e Neuro: AAOx3, moving all extrem with purpose, facial movements symmetric, no focal deficits. Skin: no rashes, lesions, excoriations <PERTINENT RESULTS> CT ABD/PELVIS ___: Noncontrast imaging of the abdomen and pelvis demonstrates a punctate nonobstructing calculus in the right collecting system (02: 31). There is no left renal calculus. There is no evidence of ureteral or urinary bladder calculus. There is symmetric renal enhancement and excretion of intravenous contrast. Subcentimeter cortically based hypodensity in the left interpolar region (06: 30) is too small to accurately characterize but likely represents renal cyst. There is no evidence of collecting system filling defect. There are segments of the mid to distal ureters are not well opacified, possibly secondary to peristalsis, however there is no evidence of inflammatory change or mass about the ureters. The adrenal glands are unremarkable. Low hepatic attenuation on noncontrast imaging is consistent with hepatic steatosis. There is no evidence of focal hepatic mass. There is no intrahepatic or extrahepatic biliary ductal dilatation. There are numerous gallstones within the gallbladder without evidence of acute cholecystitis. The spleen is not enlarged. There is no pancreatic ductal dilatation or evidence of pancreatic mass. There are no dilated loops of bowel. There is no evidence of bowel wall thickening. There is no intraperitoneal free air or free fluid. There are no enlarged inguinal, iliac chain, retrocrural, or retroperitoneal lymph nodes. Abdominal aorta has a normal course and caliber with moderate atherosclerotic calcification. There is atherosclerotic calcification of the superior mesenteric artery origin. There is no suspicious osseous lesion. IMPRESSION: 1. Tiny nonobstructing right collecting system calculus. 2. Hepatic steatosis. 3. 3 nodular pulmonary densities in the left basilar region measuring up to 8 x 8 mm. These findings may may represent areas of rounded atelectasis, however short-term followup with nonemergent CT chest is recommended. ADMISSION LABS: ___ 08: 30PM BLOOD WBC-9.4 RBC-3.95* Hgb-13.3 Hct-37.4 MCV-95 MCH-33.7* MCHC-35.5* RDW-13.5 Plt ___ ___ 08: 30PM BLOOD Neuts-70.1* ___ Monos-5.2 Eos-1.6 Baso-0.7 ___ 08: 30PM BLOOD Glucose-446* UreaN-18 Creat-1.4* Na-133 K-5.6* Cl-97 HCO3-21* AnGap-21* ___ 08: 30PM BLOOD ALT-16 AST-54* AlkPhos-65 TotBili-0.4 ___ 08: 30PM BLOOD Albumin-4.1 Calcium-9.1 Phos-3.9 Mg-1.8 ___ 08: 30PM BLOOD cTropnT-<0.01 ___ 08: 30PM BLOOD Lipase-70* ___ 10: 53PM BLOOD ___ pO2-38* pCO2-45 pH-7.37 calTCO2-27 Base XS-0 ___ 10: 53PM BLOOD Lactate-3.0* K-3.6 ___ 10: 53PM BLOOD O2 Sat-69 ___ 10: 40PM URINE Blood-NEG Nitrite-POS Protein-NEG Glucose-1000 Ketone-TR Bilirub-NEG Urobiln-NEG pH-6.0 Leuks-MOD ___ 10: 40PM URINE RBC-3* WBC-19* Bacteri-FEW Yeast-NONE Epi-1 TransE-<1 ___ 10: 40PM URINE Color-Straw Appear-Clear Sp ___ DISHCARGE LABS: ___ 07: 00AM BLOOD WBC-7.0 RBC-3.37* Hgb-11.2* Hct-31.8* MCV-94 MCH-33.2* MCHC-35.2* RDW-12.9 Plt ___ ___ 06: 23AM BLOOD Neuts-53.5 ___ Monos-5.0 Eos-1.8 Baso-0.6 ___ 07: 00AM BLOOD Glucose-254* UreaN-13 Creat-1.0 Na-136 K-3.9 Cl-101 HCO3-24 AnGap-15 ___ 07: 00AM BLOOD ALT-14 AST-17 AlkPhos-50 ___ 07: 00AM BLOOD Calcium-8.5 Phos-3.5 Mg-1.5* <MEDICATIONS ON ADMISSION> The Preadmission Medication list may be inaccurate and requires futher investigation. 1. Losartan Potassium 25 mg PO DAILY 2. Metoprolol Succinate XL 200 mg PO DAILY 3. Atorvastatin 80 mg PO HS 4. Isosorbide Mononitrate (Extended Release) 120 mg PO DAILY 5. Nitroglycerin SL 0.3 mg SL Q5MIN: PRN pain 6. Ropinirole 0.5 mg PO QPM 7. Oxycodone-Acetaminophen (5mg-325mg) 1 TAB PO Q8H: PRN pain 8. Fluticasone Propionate 110mcg 2 PUFF IH BID 9. Pantoprazole 40 mg PO Q12H 10. Aspirin 325 mg PO DAILY 11. albuterol sulfate 90 mcg/actuation inhalation q4hrs wheezing 12. TraZODone 150 mg PO HS 13. Vitamin D 1000 UNIT PO DAILY 14. Levemir Flexpen (insulin detemir) 90 units subcutaneous in the evening 15. HumaLOG KwikPen (insulin lispro) per sliding scale subcutaneous as directed <DISCHARGE MEDICATIONS> 1. Oxycodone-Acetaminophen (5mg-325mg) 1 TAB PO Q8H: PRN pain 2. Nitroglycerin SL 0.3 mg SL Q5MIN: PRN pain 3. Metoprolol Succinate XL 200 mg PO DAILY 4. Levemir Flexpen (insulin detemir) 90 units subcutaneous in the evening 5. HumaLOG KwikPen (insulin lispro) 0 SUBCUTANEOUS AS DIRECTED 6. albuterol sulfate 90 mcg/actuation inhalation q4hrs wheezing 7. Ciprofloxacin HCl 500 mg PO Q12H Duration: 7 Days RX *ciprofloxacin [Cipro] 500 mg 1 tablet(s) by mouth twice a day Disp #*11 Tablet Refills: *0 8. Vitamin D 1000 UNIT PO DAILY 9. TraZODone 150 mg PO HS 10. Isosorbide Mononitrate (Extended Release) 120 mg PO DAILY 11. Aspirin 325 mg PO DAILY 12. Atorvastatin 80 mg PO HS 13. Fluticasone Propionate 110mcg 2 PUFF IH BID 14. Pantoprazole 40 mg PO Q12H 15. Ropinirole 0.5 mg PO QPM <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Primary Diagnosis: UTI Secondary Diagnosis: Back Pain Diabetes <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear ___, ___ were seen in the emergency department for back pain. ___ were admitted to the hospital where ___ were also diagnosed with a urinary tract infection. ___ were treated with antibiotics, IV fluids and pain medication. Due to the concern of your back pain, a CT scan was as performed and it was determined that ___ did not have a kidney stone or an infection. Your diabetes was controlled with an insulin scale while ___ were an inpatient. ___ will be discharged home on antibiotics and intent to follow up with your primary care provider, Dr. ___. Please take all medications as prescribed and keep all scheduled appointments. Weigh yourself every morning, call MD if weight goes up more than 3 lbs. It was a pleasure taking care of ___! Your ___ Care Team ","___ PMH with HTN, GERD, CAD s/p CABG and stenting, IDDM with R flank pain presumed to musculoskeletal in nature due to negative workup. Incidental UTI / asymptomatic bacturia. ACUTE ISSUES: # UTI / Bacturia: Patient presented without any history of urinary or systemic symptoms, but was started on ceftriaxone in the ED after U/A with ___ positive and 19 WBCs. Antibiotics were taken prior to drawing urinary or blood cultures, and there was no yield. Patient switched to ciprofloxacin and received a three day total antibiotic course. CT scan performed did not have any evidence of pyelonephritis. Antibiotics were discontinued at time of discharge. # Flank Pain: Patient reported 3 weeks of back/flank pain, constant and achy in nature and worsened by movement. Treated with anti-inflammatories with minimal effect. CT scan demonstrated no nephrolithiasis. CXR showed no bony abnormality, but could not totally exclude multiple rib fractures. Patient's pain was well controlled and tolerating PO medications, so she was discharged with PCP following for further workup. # Diabetes / Hyperglycemia: Patient had persistently # IDDM: Last A1C (___) 8.0. Serum glucose initially in the 400s and Chem-7 with gap; however, this was likely ___ lactate and unlikely to be DKA given normal pH on ABG. AM glucose 218. - continue home dose lantus 90 units qPM - per ___ records, is on a very aggressive ISS, will decrease for now and uptitrate as necessary depending on ___ # ___ on CKD: Cr elevated at 1.4 from baseline 1.0. Most likely pre-renal in the setting of infection. Now s/p 2L IVF in the ED and creatinine has corrected to 1.0. Appears euvolemic, maybe slightly up. - consider further workup if no improvement (urine lytes, spinning urine, renal u/s) - renally dose medications for now CHRONIC ISSUES: # HF with pEF/CAD s/p CABG and stents: Was not an active issue whil inpatient. Fluid use was judicious. Metoprolo converted to short acting while in house, isosorbide, aspirin and atorvastatin were continued. Losartan held as below. # HTN: home metoprolol and isosorbide continued, losartan held while inpt as pressures were soft and within normal range. Discharged home off losartan. # Restless leg syndrome: home ropinarole continued # Shoulder pain: oxycodone and tylenol seperately dose while inpatient # COPD: home advair and PRN albuterol nebs were continued # GERD: home pantoprazole continued # Insomnia: home trazodone continued TRANSITIONAL ISSUES: - Losartan held inpatient and at discharge andpatient blood pressures were low-normal. PCP to determine restart. - Patient to follow up with PCP for resolution of UTI and back pain symptoms - Patient should have insulin regiment adjustments for optimal glycemic control - no changes to regimen were made at discharge. ",2719,694
10002013-DS-11,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> lisinopril <ATTENDING> ___ <CHIEF COMPLAINT> Chest pain <MAJOR SURGICAL OR INVASIVE PROCEDURE> None <HISTORY OF PRESENT ILLNESS> Ms. ___ is a ___ year old woman with extensive cardiac history including multivessel vessel CAD S/P stenting of the LAD with in-stent restenosis and stenting of the CX, S/P CABG in ___ with known occluded SVG-D1 with patent LIMA-LAD and SVG-OM in ___, poorly controlled type 2 diabetes mellitus, hypertension, COPD, GERD, now presenting with new chest pain. At 5 pm on the day of presentation, she was resting at home when she had onset of severe stabbing pain left of the sternum. This pain radiated across her chest but not to the arm or jaw. She took 1 nitroglycerin, which improved her pain slightly. She reports that the pain came in waves lasting 5 minutes. She also endorsed left chest wall tenderness. She did not remember when she last had chest pain prior to this. The pain was not clearly exertional. The sharp pains occurred when she was lying down. She says the area is very tender. Lying on the left side causes pain. She did have nausea the past 3 mornings which resolved. She denied vomiting, diaphoresis, fevers or chills. She had an episode of diarrhea yesterday, but no abdominal pain. She already took a full dose aspirin on the day of presentation. In the ED, initial vitals were: T 98.0, HR 88, BP 127/65, RR 16, SaO2 100% on RA. FSBG 302->94. Labs notable for Troponin-T < 0.01, CK-MB < 1, D-Dimer 268, Cr 1.2, Mg 1.4. Normal LFTs; CBC, Chem 7, coags WNL. CXR showed no acute cardiopulmonary abnormality. Bedside echocardiogram showed no substantial pericardial effusion or tamponade. Patient was given fluticasone propionate inhaled, OxyCODONE--Acetaminophen (5mg-325mg), Magnesium Sulfate 2 gm IV. On arrival to the cardiology ward, the patient reported that her pain was still there but it felt ""slow"" ___ but at its worse was ___. The area was tender. She had no breathing complaints. She felt a little congested this evening when the pain started. <PAST MEDICAL HISTORY> -COPD -CAD s/p CABG and stenting, as above -Depression -DM -GERD -Hypertension -Migraines -Chronic shoulder pain on narcotics -OSA -Peripheral neuropathy -Restless leg <SOCIAL HISTORY> ___ <FAMILY HISTORY> Patient was ward of the ___, doesn't know full details of family history. Mother with possible alcohol abuse. Father deceased at ___ from Hodgkin's Disease per old records. <PHYSICAL EXAM> On admission General: Obese middle aged ___ woman, alert, oriented, in no acute distress Vital Signs: T 98.7, BP 98/65, HR 79, RR 18, SaO2 95% on RA Weight: 89 kg HEENT: Sclera anicteric, mucous membranes moist, oropharynx clear NECK: difficult to appreciate JVP CV: Regular rate and rhythm, normal S1 + S2; no murmurs, rubs, gallops Chest: Tenderness to palpation of the left anterior chest wall Lungs: Clear to auscultation bilaterally--no wheezes, rales, rhonchi Abdomen: Soft, non-tender, non-distended, obese GU: No Foley Ext: Warm, well perfused; no clubbing, cyanosis or edema Exam unchanged at discharge, left chest wall tender with palpation with pain after change in position <PERTINENT RESULTS> ___ 10: 31PM BLOOD WBC-9.4 RBC-3.51* Hgb-12.0 Hct-34.3 MCV-98 MCH-34.2* MCHC-35.0 RDW-11.8 RDWSD-42.3 Plt ___ ___ 10: 31PM BLOOD Glucose-105* UreaN-21* Creat-1.2* Na-137 K-3.4 Cl-97 HCO3-24 AnGap-19 ___ 10: 31PM BLOOD ALT-15 AST-16 CK(CPK)-39 AlkPhos-53 TotBili-0.3 ___ 10: 31PM BLOOD Albumin-3.9 Calcium-9.1 Phos-4.4 Mg-1.4* ___ 10: 57PM BLOOD D-Dimer-268 ___ 10: 31PM BLOOD CK-MB-1 cTropnT-<0.01 ___ 06: 00AM BLOOD CK-MB-<1 cTropnT-<0.01 ___ 06: 00AM BLOOD WBC-9.3 RBC-3.44* Hgb-11.8 Hct-33.1* MCV-96 MCH-34.3* MCHC-35.6 RDW-11.9 RDWSD-41.3 Plt ___ ___ 06: 00AM BLOOD Glucose-147* UreaN-21* Creat-1.2* Na-139 K-3.0* Cl-99 HCO3-24 AnGap-19 ___ 06: 00AM BLOOD Calcium-8.7 Phos-4.4 Mg-2.0 ECG ___ 8: 33: 29 ___ Baseline artifact. Sinus rhythm. Borderline P-R interval prolongation. Prominent voltage in leads I and aVL but does not meet criteria for left ventricular hypertrophy. There are marked ST segment depressions and T wave inversions in leads I, II, aVL and apical lateral leads. Compared to the previous tracing of ___ the rate then was faster. ST-T wave abnormalities were similar. Consider left ventricular hypertrophy as before. Clinical correlation is suggested. CXR ___ Patient is status post median sternotomy and CABG. Heart size is normal. Mediastinal and hilar contours are unchanged. Pulmonary vasculature is normal. No focal consolidation, pleural effusion or pneumothorax is seen. No acute osseous abnormality is detected. IMPRESSION: No acute cardiopulmonary abnormality. Dipyridamole-MIBI Stress test ___ ___ yp woman with HL, HTN, DM, PVD and diastolic CHF; s/p MI and multiple PCIs f/b CABG x 3 in ___ with known SVG-OM occlusion was referred to evaluate an atypical chest discomfort. The patient was administered 0.142 mg/kg/min of Persantine over 4 minutes. Prior to the procedure the patient reported an isolated left-sided chest discomfort that had been present since admission and was tender to mild palpation; ___. This discomfort did not change in intensity during the procedure. In the presence of diffuse ST-T wave changes, no additional ECG changes were noted during the procedure. The hemodynamic response to the Persantine infusion was appropriate. Post-infusion, the patient was administered 125 mg Aminophylline IV. IMPRESSION: Non-anginal type symptoms with no additional ST segment changes from baseline. Imaging: Left ventricular cavity size is normal. Rest and stress perfusion images reveal uniform tracer uptake throughout the left ventricular myocardium. The previously noted perfusion defect involving the inferolateral wall has resolved. Gated images reveal normal wall motion. The calculated left ventricular ejection fraction is 64%. IMPRESSION: Normal myocardial perfusion study. Interval normalization of prior LCx territory perfusion defect. <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Oxycodone-Acetaminophen (5mg-325mg) 1 TAB PO Q8H: PRN pain 2. Nitroglycerin SL 0.3 mg SL Q5MIN: PRN pain 3. Metoprolol Succinate XL 250 mg PO DAILY 4. Levemir Flexpen (insulin detemir) 90 units subcutaneous in the evening 5. albuterol sulfate 90 mcg/actuation inhalation q4hrs wheezing 6. Vitamin D 1000 UNIT PO DAILY 7. TraZODone 100 mg PO HS 8. Isosorbide Mononitrate (Extended Release) 120 mg PO DAILY 9. Aspirin 325 mg PO DAILY 10. Atorvastatin 80 mg PO HS 11. Fluticasone Propionate 110mcg 2 PUFF IH BID 12. Pantoprazole 40 mg PO Q12H 13. Ropinirole 0.5 mg PO QPM 14. HumaLOG KwikPen (insulin lispro) 0 SUBCUTANEOUS AS DIRECTED 15. Albuterol 0.083% Neb Soln 1 NEB IH Q6H: PRN wheeze 16. Methocarbamol 500 mg PO TID: PRN muscle pain 17. Losartan Potassium 25 mg PO DAILY 18. Furosemide 20 mg PO DAILY 19. diclofenac sodium 1 % topical TID: PRN pain <DISCHARGE MEDICATIONS> 1. Albuterol 0.083% Neb Soln 1 NEB IH Q6H: PRN wheeze 2. Atorvastatin 80 mg PO HS 3. Fluticasone Propionate 110mcg 2 PUFF IH BID 4. Methocarbamol 500 mg PO TID: PRN muscle pain 5. Nitroglycerin SL 0.3 mg SL Q5MIN: PRN pain 6. Pantoprazole 40 mg PO Q12H 7. Ropinirole 0.5 mg PO QPM 8. TraZODone 100 mg PO HS 9. Vitamin D 1000 UNIT PO DAILY 10. albuterol sulfate 90 mcg/actuation INHALATION Q4HRS wheezing 11. diclofenac sodium 1 % topical TID: PRN pain 12. Furosemide 20 mg PO DAILY 13. Isosorbide Mononitrate (Extended Release) 120 mg PO DAILY 14. Metoprolol Succinate XL 250 mg PO DAILY 15. HumaLOG KwikPen (insulin lispro) 0 SUBCUTANEOUS AS DIRECTED 16. Levemir Flexpen (insulin detemir) 90 units subcutaneous in the evening 17. Losartan Potassium 25 mg PO DAILY 18. Oxycodone-Acetaminophen (5mg-325mg) 1 TAB PO Q8H: PRN pain 19. Aspirin 650 mg PO Q6H RX *aspirin 650 mg 1 tablet(s) by mouth every six (6) hours Disp #*28 Tablet Refills: *0 <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> - Chest wall pain atypical for angina - Musculoskeletal pain - Known native coronary artery and bypass graft disease - Type 2 Diabetes mellitus, with - Chronic kidney disease, stage 3 - Acute kidney injury - Chronic obstructive pulmonary disease - Hypertension - Hypotension - Hypokalemia - Chronic shoulder pain on narcotics - Obstructive sleep apnea - Gastroseophageal reflux disease <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Ms. ___, It was our pleasure participating in your care here at ___. You were admitted with severe chest pain. You underwent a stress test that showed the pain is unlikely from a big blockage in the arteries that feed your heart. Your lab work also did not suggest injury to the heart. The pain you are experiencing is most likely musculoskeletal and should hopefully improve with supportive measures such as Tylenol (maximum 3 grams per day) and time. You will also be prescribed high dose aspirin (650mg). Please try this for two days and if there is improvement in your symptoms continue it for the week. If your symptoms worsen, you develop shortness of breath or any other concerning symptom, please let your doctor know right away. Again, it was our pleasure participating in your care. We wish you the very ___, Your ___ Cardiology Team ","This is a ___ with type 2 diabetes mellitus on insulin, CAD s/p MI, S/P multiple PCIs and CABG ___ (LIMA-LAD, SVG-OM1; also SVG-D1 known occluded ___ with chronic stable angina admitted with atypical, stabbing, focal chest pain. # Chest pain: Initially the patient was started on a heparin drip and other ACS protocol medications. Her home losartan and furosemide were held due to low blood pressures. Suspicion for cardiac etiology of chest pain was ultimately not high. She had an isolated ongoing ___ left-sided chest discomfort exacerbated by changes in position and with chest wall tenderness to light palpation. Despite prolonged chest pain, troponin-T and CK-MB negative x2 and EKGs mostly unchanged from prior. Given known H/O CAD, a vasodilator nuclear stress test was performed and was reassuring. Her discomfort did not change in intensity during the stress test drug infusion. In the presence of diffuse ST-T wave changes, no additional ECG changes were noted during the procedure. The hemodynamic response to the Persantine infusion was appropriate. Her perfusion study was normal with interval normalization of prior LCx territory perfusion defect. Given the stabbing quality and tenderness to palpation of the area of discomfort, her symptoms were most likely related to costochondritis or other musculoskeletal causes. She was started on aspirin 650 mg q6h with plans to trial for 2 days and continue through the week if symptoms improve. Chronic medical problems: # Diabetes mellitus: Continued levemir and was switched to a sliding scale of Humalog. # Hypertension: Losartan was held as above due to hypotension and once daily isosorbide mononitrate was switched temporarily to isosorbide dinitrate TID. # For her hyperlipidemia, COPD and GERD, her home regimens were continued. TRANSITIONAL ISSUES: - Patient had low blood pressures initially (88-92 systolic). Would benefit from close monitoring and titration of blood pressure medications as an outpatient - She was hypokalemic (K 3.0) during admission (with ___ and furosemide already held). Please recheck CHEM-10 at ___ ___ visit on ___ to determine whether she might benefit from K supplementation - Cr elevated to 1.2 on discharge (up from most recent 1.1.1). Please recheck at ___ office on ___ - Full code ",2810,518
10002013-DS-13,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> lisinopril <ATTENDING> ___. <CHIEF COMPLAINT> Left diabetic foot ulcer <MAJOR SURGICAL OR INVASIVE PROCEDURE> Left partial hallux amputation <HISTORY OF PRESENT ILLNESS> ___ with poorly controlled diabetes (complicated by retinopathy, neuropathy, PAD, foot ulcer L hallux), CAD with ___ s/p CABG, and narcotics agreement, presenting with 3 days subjective fever, chills, increased pain in L great toe. Pt recently had ulcer debrided by podiatry on ___, ulcer had healed to the size of a pin, but within the span of a week enlarged to size of a tennis ball. Presented to ___ urgent care in ___, found to be febrile to ___, given Tylenol, sent to ER and was afebrile and normotensive upon arrival, though sustained tachycardia to low 100s. Podiatry consulted in ER, wound to left medial hallux probes to bone w/ high c/f osteomyelitis. X-rays show bony erosion but no subcutaneous gas. Plan for IV antibiotics and partial amputation of left great toe tomorrow (___). ___ n/v, abd pain, diarrhea, excessive urination, orthostasis, dyspnea, chest pain. In the ED: Initial vital signs were notable for: afebrile, tachycardia to 118, normotensive Exam notable for: PE: warm, slightly diaphoretic CV: RRR, +S1/S2 Resp : lungs clear b/l MSK: erythema involving L big toe, tracking along inferior base. Tenderness tracking along path of great saphenous on L calf. Limited dorsiflexion and plantar flexion. Limited ROM of ankle and toe. Mental Status: A&ox4 Lines & Drains: 20g L hand Labs were notable for: 136 98 26* AGap=20 ------------<266* 4.2 18* 1.6* Lactate elevated: 2.4 Whites elevated: 23.4, neut predominance Studies performed include: Xray Foot Ap,Lat & Obl Left (prelim read): Re-demonstration of ulceration along the medial distal aspect of the great toe and erosion along the medial base of the distal phalanx of the great toe perhaps slightly progressed in the interval. Findings again remain concerning for osteomyelitis and MRI with contrast could be obtained for further assessment. Patient was given: Piperacillin-Tazobactam Vancomycin Consults: Podiatry Vitals on transfer: T100.5, BP 154/80, HR117, RR18, 99 Ra Upon arrival to the floor, patient resting comfortably in bed, complains of chills, which resolve with blankets. Left foot wrapped in gauze dressing, very tender up to midcalf. REVIEW OF SYSTEMS: Complete ROS obtained and is otherwise negative <PAST MEDICAL HISTORY> -COPD -CAD s/p BMS proximal-LAD ___, DES to mid LAD ___, DES to edge ISR of mid LAD DES and stenosis distal to stent ___, DES to OM1 ___, s/p 3 v CABG LIMA-LAD, SVG-OM1, ___ -HFpEF -Depression -DM -GERD -Hypertension -Migraines -Chronic shoulder pain on narcotics -OSA -Peripheral neuropathy -Restless leg <SOCIAL HISTORY> ___ <FAMILY HISTORY> Patient was ward of the ___, doesn't know full details of family history. Mother with possible alcohol abuse. Father deceased at ___ from Hodgkin's Disease per old records. <PHYSICAL EXAM> ADMISSION EXAM -= VITALS: T100.5, BP 154/80, HR117, RR18, 99 Ra GENERAL: Alert and interactive. In no acute distress. HEENT: NCAT. MMM. CARDIAC: RRR, no MRG LUNGS: Normal WOB, CTA B/L ABDOMEN: Soft, nontender to deep palpation, nondistended, normoactive bowel sounds. EXTREMITIES: left foot wrapped in gauze dressing, mildly erythematous and very tender up to lower calf, RLE no edema, thready DP pulses NEUROLOGIC: Sensory and motor function grossly intact. DISCHARGE EXAM -= VS: 98.5, 134 / 75,75, 18, 97% RA General Appearance: Well-groomed, in NAD. HEENT: Atraumatic, normocephalic. Sclera anicteric b/l. MMM. No oropharyngeal lesions. No LAD. Lungs: Equal chest rise. Good air movement. No increased work of breathing. Decreased breath sounds in LLL. Rales in left base. No wheezes or rhonchi. CV: RRR. Normal S1, S2. No murmurs, gallops, or rubs. No carotid bruits b/l. +2 carotid pulses b/l, +2 radial pulses b/l, +1 dorsalis pedis pulse on right, unable to palpate on left due to surgical bandage. Abdomen: Non-distended. Bowel sounds present. Soft, non-tender to palpation throughout. Extremities: No clubbing or cyanosis. Left foot dressing clean today. Erythema and edema around margin of surgical site is improved today. Suture site is clean with no pus. Skin: No rashes or lesions besides surgical site. Neuro: A+O to person, place, and time. CN III-XII grossly intact. <PERTINENT RESULTS> ADMISSION LABS -= ___ 05: 50PM BLOOD WBC-23.4* RBC-4.01 Hgb-13.3 Hct-37.9 MCV-95 MCH-33.2* MCHC-35.1 RDW-12.0 RDWSD-42.1 Plt ___ ___ 05: 50PM BLOOD Neuts-81.4* Lymphs-10.5* Monos-7.1 Eos-0.0* Baso-0.3 Im ___ AbsNeut-19.09* AbsLymp-2.47 AbsMono-1.66* AbsEos-0.00* AbsBaso-0.06 ___ 05: 50PM BLOOD Glucose-266* UreaN-26* Creat-1.6* Na-136 K-4.2 Cl-98 HCO3-18* AnGap-20* ___ 05: 50PM BLOOD CRP-180.1* ___ 07: 45PM BLOOD ___ pO2-22* pCO2-44 pH-7.32* calTCO2-24 Base XS--4 ___ 05: 50PM BLOOD Lactate-2.4* ___ 07: 40PM URINE Color-Straw Appear-Clear Sp ___ ___ 07: 40PM URINE Blood-NEG Nitrite-NEG Protein-TR* Glucose-1000* Ketone-TR* Bilirub-NEG Urobiln-NEG pH-6.0 Leuks-SM* ___ 07: 40PM URINE RBC-4* WBC-7* Bacteri-FEW* Yeast-NONE Epi-1 TransE-<1 ___ 07: 40PM URINE Mucous-RARE* PERTINENT INTERVAL LABS -====== ___ 09: 48AM BLOOD ALT-25 AST-29 LD(LDH)-210 AlkPhos-130* TotBili-0.8 DISCHARGE LABS -= ___ 07: 17AM BLOOD WBC-9.9 RBC-3.07* Hgb-9.8* Hct-30.4* MCV-99* MCH-31.9 MCHC-32.2 RDW-12.3 RDWSD-44.2 Plt ___ ___ 07: 29AM BLOOD Glucose-109* UreaN-18 Creat-1.2* Na-140 K-4.0 Cl-100 HCO3-25 AnGap-15 ___ 07: 29AM BLOOD Calcium-8.8 Phos-4.3 Mg-1.8 ___ 07: 29AM BLOOD CRP-44.6* IMAGING ======= LEFT FOOT XRAY (___) IMPRESSION: Re-demonstration of ulceration along the medial distal aspect of the great toe and erosion along the medial base of the distal phalanx of the great toe, the latter of which is perhaps slightly progressed in the interval. Findings again remain concerning for osteomyelitis and MRI with contrast could be obtained for further assessment. NIAS (___) --------------- FINDINGS: On the right side, triphasic Doppler waveforms are seen in the right femoral, popliteal, and dorsalis pedis arteries. Absent waveform in the posterior tibial artery. The right ABI was 1.6, artifactually elevated due to noncompressible vessels. On the left side, triphasic Doppler waveforms are seen at the left femoral and popliteal arteries. Monophasic waveforms are seen in the posterior tibial and dorsalis pedis arteries. The left ABI could not be calculated Pulse volume recordings showed decreased amplitudes at the level the right calf, ankle and metatarsal. IMPRESSION: Significant bilateral tibial arterial insufficiency to the lower extremities at rest, more significant on the right side. CXR (___) -------------- IMPRESSION: Comparison to ___. No relevant change is noted. Alignment of the sternal wires is unremarkable. Mild elongation of the descending aorta. Borderline size of the heart. No pleural effusions. No pneumonia, no pulmonary edema. MRI LEFT FOOT (___) IMPRESSION: 1. Nonenhancing stump soft tissue and the plantar fat pad under the middle phalanges, concerning for devitalized tissue. No evidence of drainable abscess. 2. 4 mm focus of low T1 signal with edema at the most distal cortex of the first metatarsal. This is nonspecific as there was no comparison study and focus of osteomyelitis cannot be excluded. 3. 2 sinus tracts medial to the head of the first metatarsal, status post amputation at the first MTP with postsurgical changes. 4. Dorsal swelling and diffuse skin edema. CXR PICC PLACEMENT (___) IMPRESSION: New right PICC with tip projecting over the junction of the superior vena cava and right atrium. No pneumothorax. Clear lungs. PATHOLOGY ========== SURGICAL TISSUE (___) - Bone with reparative changes, consistent with chronic osteomyelitis. - There is no evidence of acute osteomyelitis. SURGICAL TISSUE (___) 1. LEFT GREAT TOE, EXCISION: - Acute osteomyelitis, focal. - Bone with reparative changes. - Skin and subcutis with ulceration and acute inflammation. - Atherosclerosis, severe. 2. PROXIMAL PHALANX BASE MARGIN, LEFT, EXCISION: - Bone with reparative changes. - There is no evidence of acute osteomyelitis. 3. PROXIMAL PHALANX, LEFT, EXCISION: - Bone with reparative changes. - There is no evidence of acute osteomyelitis. MICROBIOLOGY ============ ___ 10: 00 am TISSUE PROXIMAL PHALYNX. GRAM STAIN (Final ___: 2+ ___ per 1000X FIELD): POLYMORPHONUCLEAR LEUKOCYTES. 2+ ___ per 1000X FIELD): GRAM POSITIVE COCCI IN PAIRS. Reported to and read back by ___ (___) ON ___ AT 1: 20PM. TISSUE (Final ___: STAPH AUREUS COAG +. SPARSE GROWTH. Susceptibility testing performed on culture # ___ ___. ANAEROBIC CULTURE (Final ___: NO ANAEROBES ISOLATED. ACID FAST SMEAR (Final ___: NO ACID FAST BACILLI SEEN ON DIRECT SMEAR. ACID FAST CULTURE (Preliminary): __________________________________________________________ ___ 7: 00 pm BLOOD CULTURE **FINAL REPORT ___ Blood Culture, Routine (Final ___: NO GROWTH. __________________________________________________________ ___ 5: 38 pm BLOOD CULTURE **FINAL REPORT ___ Blood Culture, Routine (Final ___: NO GROWTH. __________________________________________________________ ___ 12: 34 am BLOOD CULTURE **FINAL REPORT ___ Blood Culture, Routine (Final ___: NO GROWTH. __________________________________________________________ ___ 11: 00 pm BLOOD CULTURE **FINAL REPORT ___ Blood Culture, Routine (Final ___: NO GROWTH. __________________________________________________________ ___ 12: 18 am BLOOD CULTURE **FINAL REPORT ___ Blood Culture, Routine (Final ___: NO GROWTH. __________________________________________________________ ___ 10: 53 pm BLOOD CULTURE **FINAL REPORT ___ Blood Culture, Routine (Final ___: NO GROWTH. <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. canagliflozin 100 mg oral DAILY 2. Nitroglycerin SL 0.4 mg SL Q5MIN: PRN angina 3. rOPINIRole 0.5 mg PO QHS restless leg syndrome 4. TraZODone 50 mg PO QHS: PRN insomnia 5. Pantoprazole 40 mg PO BID 6. Gabapentin 400 mg PO QHS: PRN Neuropathic pain 7. Atorvastatin 80 mg PO QPM 8. Fluticasone Propionate 110mcg 2 PUFF IH BID 9. linaGLIPtin 5 mg oral DAILY 10. Losartan Potassium 25 mg PO DAILY 11. OxyCODONE--Acetaminophen (5mg-325mg) 1 TAB PO TID: PRN Pain - Severe 12. Lidocaine 5% Patch 1 PTCH TD QPM 13. Furosemide 20 mg PO DAILY 14. Metoprolol Succinate XL 150 mg PO DAILY 15. albuterol sulfate 90 mcg/actuation inhalation Q4H: PRN 16. Aspirin EC 325 mg PO DAILY 17. MetronidAZOLE Topical 1 % Gel 1 Appl TP DAILY Rosacea 18. nystatin 100,000 unit/gram topical DAILY: PRN <DISCHARGE MEDICATIONS> 1. Acetaminophen 1000 mg PO Q8H RX *acetaminophen 500 mg 2 tablet(s) by mouth Every 8 hours for foot pain Disp #*60 Tablet Refills: *0 2. Bisacodyl 10 mg PO DAILY: PRN Constipation - Second Line RX *bisacodyl 5 mg 2 tablet(s) by mouth Once a day as needed for constipation Disp #*60 Tablet Refills: *0 3. Docusate Sodium 100 mg PO BID RX *docusate sodium 100 mg 1 capsule(s) by mouth Twice a day Disp #*30 Capsule Refills: *0 4. Nafcillin 2 g IV Q4H RX *nafcillin in dextrose iso-osm 2 gram/100 mL 2 g IV Every four hours Disp #*84 Intravenous Bag Refills: *0 5. OxyCODONE (Immediate Release) 5 mg PO Q8H: PRN Pain - Moderate RX *oxycodone 5 mg 1 capsule(s) by mouth Once every 8 hours as needed for severe foot pain. Disp #*15 Capsule Refills: *0 6. Senna 8.6 mg PO BID: PRN Constipation - First Line RX *sennosides [senna] 8.6 mg 1 tablet by mouth Twice a day as needed for constipation Disp #*30 Tablet Refills: *0 7. Novolog 18 Units Breakfast Novolog 18 Units Lunch Novolog 18 Units Dinner 8. albuterol sulfate 90 mcg/actuation inhalation Q4H: PRN 9. Aspirin EC 325 mg PO DAILY 10. Atorvastatin 80 mg PO QPM 11. canagliflozin 100 mg oral DAILY 12. Fluticasone Propionate 110mcg 2 PUFF IH BID 13. Furosemide 20 mg PO DAILY 14. Gabapentin 400 mg PO QHS: PRN Neuropathic pain 15. Lidocaine 5% Patch 1 PTCH TD QPM 16. linaGLIPtin 5 mg oral DAILY 17. Losartan Potassium 25 mg PO DAILY 18. Metoprolol Succinate XL 150 mg PO DAILY 19. MetronidAZOLE Topical 1 % Gel 1 Appl TP DAILY Rosacea 20. Nitroglycerin SL 0.4 mg SL Q5MIN: PRN angina 21. nystatin 100,000 unit/gram topical DAILY: PRN 22. OxyCODONE--Acetaminophen (5mg-325mg) 1 TAB PO TID: PRN Pain - Severe 23. Pantoprazole 40 mg PO BID 24. rOPINIRole 0.5 mg PO QHS restless leg syndrome 25. ___ SoloStar U-300 Insulin (insulin glargine) 300 unit/mL (1.5 mL) subcutaneous QHS Inject 48U QHS 26. TraZODone 50 mg PO QHS: PRN insomnia 27.Outpatient Lab Work ICD-10: E11.621 DATE: weekly: draw on ___ and ___ LAB TEST: CBC with differential, BUN, Cr, AST, ALT, Total Bili, ALK PHOS, ESR, CRP PLEASE FAX RESULTS TO: ATTN: ___ CLINIC - FAX: ___ 28.Rolling Walker EQUIPMENT: Rolling Walker DIAGNOSIS: Left hallux amputation ICD-10: ___ PX: Good ___: 13 months <DISCHARGE DISPOSITION> Home With Service Facility: ___ <DISCHARGE DIAGNOSIS> PRIMARY DIAGNOSIS - Osteomyelitis of left hallux SECONDARY DIAGNOSES -== Hypertension Type 2 Diabetes Mellitus <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Ms. ___, It was a pleasure taking care of you. WHY WAS I ADMITTED TO THE HOSPITAL? You had a diabetic foot ulcer on your left toe that was very infected and had caused an infection in your bone. WHAT WAS DONE WHILE I WAS HERE? Your big left toe was removed because you had a bad bone infection. You were treated with antibiotics to fight the infection and will need to go home on IV antibiotics. WHAT DO I NEED TO DO WHEN I LEAVE? Please continue to take your medications as directed. You will go home with an antibiotic infusion pump and will have a visiting nurse come to your house to teach you how to use it. You will need to administer antibiotics through the pump every 4 hours. We changed your diabetic medication regimen, so please follow along as instructed below and keep close track of your sugars at home. Check your sugars 4 times a day and log the results. Bring the results in with you to your ___ appointment on ___ at 1: 00 pm so that they can adjust your medication regimen appropriately. Please follow-up with Dr. ___ team on ___ at 11: 00 am. Please follow up with Dr. ___ your antibiotic regimen on ___ at 10: 30 am. Please follow-up with Dr. ___ in ___ ___ on ___ at 1: 00 pm. Be well, Your ___ Care Team ","============= SUMMARY ============= ___ yo F with hx of DMII, HTN who presented with diabetic foot ulcer on her left hallux complicated by osteomyelitis. She underwent surgical debridement and partial tissue and bone removal on ___. However the infection persisted, and she underwent left hallux amputation on ___. She was started on IV nafcillin for MSSA infection with plan to continue home infusions of nafcillin until at least ___ ACTIVE ISSUES ============= #Osteomyelitis of left hallux: Due to diabetic ulcer of left hallux. Patient underwent partial left hallux amputation on ___ by podiatry. She was initially placed on IV Vancomycin, Flagyl, and cefepime. Initial surgical cultures came back positive for MSSA, so was changed to IV nafcillin. Patient continued to be afebrile, but her left foot continued to have erythema, edema, pain, and the ulcer was not healing well. There was concern for poor arterial blood flow and therefore underwent noninvasive arterial studies on bilateral lower extremities. The studies showed mild atherosclerotic disease in her left leg and foot, and severe atherosclerotic disease in her right leg and foot. Vascular surgery was consulted for potential intervention, but they felt that no further vascular intervention was warranted prior to podiatric surgery. The patient was brought back to the OR by podiatry on ___ for total left hallux amputation given lack of clinical improvement. Her ___ blood cell count continued to down trend. The pathology report showed clean margins. However, patient was continuing to have pain, and there was increased erythema and swelling around surgical site. An MRI of the left foot was done, which showed devitalization of the surgical flap, some edema, and a hyperintense focal spot at the site of the surgery. There were no signs of abscess or fluid collection. Podiatry team felt patient did not need any acute surgical intervention and will have close follow-up on ___. A PICC line was placed in the right arm ___ with tentative plan to complete a two-week course of IV nafcillin on ___. For the wound, podiatry recommends daily dressing changes to left foot surgical site: Betadine moistened gauze, 4x4 gauze, and kerlix. #Cough: During her stay the patient developed cough that was nonproductive. It was thought to be due to atelectasis after surgery, especially since her rales on exam would clear with coughing. A repeat chest x-ray was negative for any acute cardiopulmonary processes and on comparison to previous chest x-ray during this hospital stay there were no changes. Will restart home Lasix at discharge. #Hypertension: Patient's antihypertensives were held upon admission given that her blood pressures were low with systolic blood pressures in the ___ likely due to sepsis in the setting of her osteomyelitis from her diabetic foot ulcer. After her first debridement, patient's blood pressures increase to 160s-170s so we restarted her losartan and furosemide. However her blood pressure dipped back down again to the ___ systolic and her creatinine bumped up to 1.8 so we discontinued her losartan and furosemide. Her metoprolol was continued with holding parameters, and it was held when her systolic blood pressure was less than 110. Her ___ resolved, and she became hypertensive again, so we restarted her losartan while in the hospital and instructed the patient to restart her Lasix upon discharge from the hospital. #Acute Kidney Injury: Her baseline creatinine is 1.0. It bumped up to 1.8 in the setting of sepsis, restarting her losartan and furosemide, and hypotension. We gave her IV fluids and stopped her losartan and furosemide. Her creatinine continued to improve with these measures and upon discharge it was 1.1-1.2, which is around her baseline. CHRONIC ISSUES ============== #Diabetes Mellitus Type 2: Upon admission, patient was started on 80% of home insulin doses. Her Lantus inpatient dose was 32 units, and her Humalog inpatient dose was 12 units 3 times daily. Patient's blood sugars were hard to control while she was inpatient. Working with the ___ diabetes consult team we adjusted her insulin doses as needed. ___ recommended discharging the patient on 48 units of Toujeo and 18 units of Novolog with meals as well as resuming her Trajenta and Jardiance. #CODE STATUS: Full (presumed) #CONTACT: ___ (grandson's girlfriend) ___ TRANSITIONAL ISSUES =================== [ ] Patient is on oxycodone 5 mg Q8H for her foot pain from the surgery. She was given enough to get her to her PCP appointment, which is ___. Please re-assess pain management. [ ] Osteomyelitis, infected diabetic foot ulcer: Surgical margin from total left hallux amputation on ___ was negative for osteomyelitis. Patient to complete a 2 week course of nafcillin for ongoing soft tissue infection and will follow up with ID prior to completion of antibiotics to ensure resolution. Will be discharged on q4 hour nafcillin to be infused via a pump. Once finished an antibiotic should also have right arm PICC line removed. For the wound, podiatry recommends daily dressing changes to left foot surgical site: Betadine moistened gauze, 4x4 gauze, and kerlix [ ] Diabetes mellitus type 2: Patient's blood sugars were very labile. Given that she came in with a diabetic foot ulcer suggesting that her blood sugars are not well-controlled at home, she needs close follow-up to optimize her diabetic medication regimen. She is being discharged on reduced dose Toujeo and regular home Novolog along with her usual Trajenta and Jardiance with close follow-up with ___ provider on ___, ___ at 1 ___. Please reassess patient's need for Jardiance given history of recurrent AKIs [ ] Cough: Patient developed non-productive cough while in hospital but afebrile, no leukocytosis, CXR no signs of pleural effusion or consolidation. Suspect due to atelectasis in post-op period after foot surgery. Will discharge on incentive spirometer and restarting home Lasix as outpatient. If not improved once back on outpatient Lasix, would consider further workup. [ ] Hypertension: Patient was discharged on her regular home medications. While she was an inpatient, she became hypotensive when we restarted her on all of her antihypertensives. Please follow her blood pressure to ensure that she is on the right regimen. If too low, might consider removing furosemide. [ ] ___: Discharge creatinine 1.2 on ___. Suspect patient will have a slight bump in creatinine after restarting losartan on ___. Patient had weekly labs checked with IV antibiotic infusions. If continues to rise, may be due to nafcillin and would consider switching antibiotic to cefazolin. #CODE STATUS: Full (presumed) #CONTACT: ___ (grandson's girlfriend) ___ >30 minutes spent on complex discharge ",4440,1535
10002013-DS-4,"<SEX> F <SERVICE> PODIATRY <ALLERGIES> Patient recorded as having No Known Allergies to Drugs <ATTENDING> ___. <CHIEF COMPLAINT> L posterior tibial tendonitis/tear L tarsal tunnel release <MAJOR SURGICAL OR INVASIVE PROCEDURE> L ___ tendon repair L tarsal tunnel release <HISTORY OF PRESENT ILLNESS> ___ with DM, CAD, HTN admitted post-operatively following correction of her left posterior tibial tendon and a tarsal tunnel release. Pt has had pain in her left foot for quite some time, an MRI revealed a possible tear, intra-operatively there was a large posterior tear to the ___ tendon. Also, a tarsal tunnel release was done and scar tissue removed along the tibial nerve. Pt has a history of pulmonary issues, will want to observe patient post-operatively as she underwent GA to make sure she does not have problems. <PAST MEDICAL HISTORY> asthma, emphysema, chronic bronchitis, HTN, CAD (MIx2, 2 cardiac stents ___, migraines, GERD, DM (takes pills and insulin), Anemia, neuropathy, anxiety <SOCIAL HISTORY> ___ <FAMILY HISTORY> parents not known. daughter htn Physical ___: Appearance: NAD HEENT: PERLA Heart: RRR Lungs: faint wheezes otherwise clear Abdomen: obese, NT/ND VASCULAR Pedal Pulses: [x] Palpable [] Non-palpable Sub-Papillary VFT: [x] < 3 sec. [] > 3 sec. [] Immediate NEUROLOGICAL Sensation: [x] Intact [] Absent Proprioception: [] Intact [x] Absent <PERTINENT RESULTS> Admission Labs: ___ 02: 07PM BLOOD WBC-9.6 RBC-3.64* Hgb-12.3 Hct-33.1* MCV-91 MCH-33.7* MCHC-37.0*# RDW-12.9 Plt ___ ___ 11: 10AM BLOOD UreaN-15 Creat-0.7 Na-140 K-3.7 Cl-98 HCO3-28 AnGap-18 ___ 11: 10AM BLOOD ALT-17 AST-19 ___ 11: 10AM BLOOD Cholest-187 ___ 11: 10AM BLOOD %HbA1c-10.0* ___ 11: 10AM BLOOD Triglyc-185* HDL-54 CHOL/HD-3.5 LDLcalc-96 <MEDICATIONS ON ADMISSION> Advair250/50 daily, Albuterol Aerosol prn, EC ASA, Atenolol 100 Insulin levimir 30 units AM; 60 units ___, Isosorbide Mononitrate 120, Lisinopril 10, Metformin [Glucophage] 500 mg TID, Nitroglycerin SL, Omeprazole 40 mg daily, Plavix 75 mg daily, Potassium chloride 20 mEq, Simvastatin 80 mg <DISCHARGE MEDICATIONS> 1. Albuterol 90 mcg/Actuation Aerosol Sig: ___ Puffs Inhalation Q4H (every 4 hours) as needed for wheeze. 2. Aspirin 325 mg Tablet, Delayed Release (E.C.) Sig: One (1) Tablet, Delayed Release (E.C.) PO DAILY (Daily). 3. Atenolol 50 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily). 4. Isosorbide Mononitrate 60 mg Tablet Sustained Release 24 hr Sig: Two (2) Tablet Sustained Release 24 hr PO DAILY (Daily). 5. Lisinopril 10 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 6. Metformin 500 mg Tablet Sig: One (1) Tablet PO TID (3 times a day). 7. Nitroglycerin 0.3 mg Tablet, Sublingual Sig: One (1) Tablet, Sublingual Sublingual PRN (as needed). 8. Omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: Two (2) Capsule, Delayed Release(E.C.) PO DAILY (Daily). 9. Clopidogrel 75 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 10. Potassium Chloride 20 mEq Tab Sust.Rel. Particle/Crystal Sig: One (1) Tab Sust.Rel. Particle/Crystal PO DAILY (Daily). 11. Simvastatin 40 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily). 12. Fluticasone-Salmeterol 250-50 mcg/Dose Disk with Device Sig: One (1) Disk with Device Inhalation BID (2 times a day). 13. Insulin levimir 30 units qAM and 60 units qPM 14. Compazine 10 mg Tablet Sig: One (1) Tablet PO every six (6) hours as needed for nausea. Disp: *30 Tablet(s)* Refills: *0* 15. Oxycodone-Acetaminophen ___ mg Tablet Sig: ___ Tablets PO Q4H (every 4 hours) as needed for pain. Disp: *50 Tablet(s)* Refills: *0* 16. Oxycodone 10 mg Tablet Sustained Release 12 hr Sig: ___ Tablet Sustained Release 12 hrs PO Q12H (every 12 hours). Disp: *40 Tablet Sustained Release 12 hr(s)* Refills: *1* 17. Docusate Sodium 100 mg Tablet Sig: Two (2) Tablet PO twice a day. Disp: *60 Tablet(s)* Refills: *2* <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Left posterior tibialis tendonitis Left tarsal tunnel <DISCHARGE CONDITION> Good <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Please resume all pre-admission medications. You were given new prescriptions, please take as directed. . Keep your dressing/cast clean and dry at all times. You will not have any dressing changes. . You are to remain NON WEIGHT BEARING on your left foot in a cast with crutches/walker/wheelchair at all times. Keep your left foot elevated to prevent swelling. . Call your doctor or go to the ED for any increase in left foot redness, swelling or purulent drainage from your wound, for any nausea, vomiting, fevers greater than 101.5, chills, night sweats or any worsening symptoms. ","The patient was admitted post-operatively for L ___ repair and L tarsal tunnel release. The patient was placed in a BK cast following the completion of the case. The patient tolerated the procedure and anesthesia well without apparent complications (see op report for full details). On POD1 Pt given 25mg PO benadryl for RUE rash and shortly after, Pt triggered for hypotension with SBP into 80's. Pt asymptomatic with other vital signs stable, saturating well on room air. Pt given several 500cc boluses of NS with return to normal pressures of 110's systolic. Effects of Benadryl likely exacerbated by Pt concomitantly on narcotics for LLE surgery. . The patient was seen by ___ for NWB status and was cleared for discharge home. The patient's LLE cast was bivalved and wrapped in ACE. The patient was given strict instructions for ___ LLE. Please see discharge intructions for full details. . Advised to follow up with Dr. ___. . Discharged in good condition with VSS. ",1486,222
10002013-DS-5,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> Patient recorded as having No Known Allergies to Drugs <ATTENDING> ___ <CHIEF COMPLAINT> CP <MAJOR SURGICAL OR INVASIVE PROCEDURE> None <HISTORY OF PRESENT ILLNESS> ___ yo F with hx CAD (BMS x 1 ___, ___ 2 in ___ and ___ to LAD), poorly controlled type 2 IDDM, HTN presented to PCP's office this AM reporting episode of CP last night. Over the past week patient's jan___ duties have increased and has felt weak and fatigued. Admits to radiation to R arm. At approx 10pm last night, patient felt faint and c/o ___ chest tightness, relieved by took 2 NTG. Denies any associated SOB, Diaphoresis. Patient c/o perisistent ___ CP Today and feels mildly SOB. In the ER, patient's VS were 97.2, 99, 145/97, 15, 100% 2L NC. Patient had CP relief to 2 SL NTG. On transfer to floor, patient has no chest pain. . Patient denies any N, V, D, CP, SOB currently. All other ROS negative unless otherwise specified <PAST MEDICAL HISTORY> asthma, emphysema, chronic bronchitis, HTN, CAD (MIx2, 2 cardiac stents ___, migraines, GERD, DM (takes pills and insulin), Anemia, neuropathy, anxiety <SOCIAL HISTORY> ___ <FAMILY HISTORY> parents not known. daughter htn Physical ___: VS - 98.3, 142/77, 89, 16, 93%RA Gen: WDWN middle aged male in NAD. Oriented x3. Mood, affect appropriate. HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no pallor or cyanosis of the oral mucosa. No xanthalesma. Neck: No JVD CV: RR, normal S1, S2. No m/r/g. No thrills, lifts. No S3 or S4. Chest: CTAB, no crackles, wheezes or rhonchi. Abd: Soft, NTND. No HSM or tenderness. Abd aorta not enlarged by palpation. No abdominial bruits. Ext: No c/c/e. No femoral bruits. Skin: No stasis dermatitis, ulcers, scars, or xanthomas. . Pulses: Right: Carotid 2+ DP 2+ ___ 2+ Left: Carotid 2+ DP 2+ ___ 2+ <PERTINENT RESULTS> ___ Stress INTERPRETATION: This ___ yo Type II IDDM woman with a h/o MI and stent in ___ was referred for evaluation of chest pain. The patient was infused with 0.142mg/kg/min of persantine over 4 minutes. During infusion, the patient reported ___ mid-sternal chest ""pressure"" which was increased slightly with inspiration. This symptom was relieved after 125mg of IV aminophylline was given post-isotope injection. No significant ST segment changes were noted. The rhythm was sinus without ectopy. Hemodynamic response to infusion was appropriate. IMPRESSION: Possible anginal type symptoms in the absence of ischemic EKG changes. Nuclear report sent separately. IMPRESSION: Normal myocardial perfusion and function (EF 57%) ___ 06: 25AM BLOOD WBC-7.5 RBC-3.94* Hgb-13.0 Hct-36.1 MCV-92 MCH-32.9* MCHC-36.0* RDW-13.1 Plt ___ ___ 07: 00AM BLOOD WBC-7.1 RBC-3.84* Hgb-12.9 Hct-35.3* MCV-92 MCH-33.7* MCHC-36.6* RDW-12.1 Plt ___ ___ 05: 30AM BLOOD WBC-8.1 RBC-3.76* Hgb-12.6 Hct-34.9* MCV-93 MCH-33.6* MCHC-36.2* RDW-13.2 Plt ___ ___ 06: 25AM BLOOD Plt ___ ___ 07: 00AM BLOOD Plt ___ ___ 05: 30AM BLOOD Plt ___ ___ 06: 25AM BLOOD Glucose-68* UreaN-17 Creat-0.8 Na-141 K-4.0 Cl-102 HCO3-32 AnGap-11 ___ 07: 00AM BLOOD Glucose-90 UreaN-18 Creat-0.7 Na-139 K-4.1 Cl-101 HCO3-31 AnGap-11 ___ 05: 30AM BLOOD Glucose-178* UreaN-22* Creat-0.8 Na-136 K-3.9 Cl-101 HCO3-24 AnGap-15 <MEDICATIONS ON ADMISSION> Advair 250/50 daily Albuterol Aerosol prn ASA 325mg daily Atenolol 100mg qday Insulin levimir 50 units AM; 60 units ___, Isosorbide Mononitrate 120mg daily Lisinopril 10mg daily Metformin 500 mg TID, Nitroglycerin SL Omeprazole 40 mg daily Plavix 75 mg daily, Potassium chloride 20 mEq Simvastatin 80 mg <DISCHARGE MEDICATIONS> 1. Fluticasone-Salmeterol 250-50 mcg/Dose Disk with Device Sig: One (1) Disk with Device Inhalation BID (2 times a day). 2. Aspirin 325 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 3. Albuterol 90 mcg/Actuation Aerosol Sig: ___ Puffs Inhalation Q6H (every 6 hours) as needed. 4. Clopidogrel 75 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 5. Simvastatin 40 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily). 6. Omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: Two (2) Capsule, Delayed Release(E.C.) PO DAILY (Daily). 7. Oxycodone-Acetaminophen ___ mg Tablet Sig: ___ Tablets PO Q6H (every 6 hours) as needed. 8. Levemir 100 unit/mL Solution Sig: One (1) Subcutaneous twice a day: 50units qAM, 60 qPM. 9. Metformin 500 mg Tablet Sig: One (1) Tablet PO three times a day. 10. Potassium Chloride 10 mEq Capsule, Sustained Release Sig: Two (2) Capsule, Sustained Release PO once a day. 11. Nitroglycerin 0.4 mg Tablet, Sublingual Sig: One (1) tablet Sublingual q5min as needed for chest pain: Sit down prior to taking. Take one tab every 5 minutes until chest pain resolves. If pain not resolved, please call EMS. 12. Lisinopril 5 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). Disp: *30 Tablet(s)* Refills: *2* 13. Metoprolol Tartrate 25 mg Tablet Sig: 1.5 Tablets PO BID (2 times a day). Disp: *90 Tablet(s)* Refills: *2* 14. Isosorbide Mononitrate 30 mg Tablet Sustained Release 24 hr Sig: One (1) Tablet Sustained Release 24 hr PO DAILY (Daily). Disp: *30 Tablet Sustained Release 24 hr(s)* Refills: *2* <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Primary - Atypical Chest pain - Coronary artery disase Secondary - Hypertension - Diabetes, insulin dependent <DISCHARGE CONDITION> Afebrile, Chest pain free, stable. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> You were hospitalized because you had chest pain. You did not have a heart attack. Your chest pain resolved. Your blood pressure was a little low on the regimen you had previously been taking at home. Several of your doses have been changed: We made the following changes to your medications: 1. We changed your imdur to 30mg daily 2. We changed your lisinopril to 5mg daily 3. We discontinued your atenolol. 4. We started metoprolol 37.5mg, twice daily. You had a stress test that was normal. Please continue to adhere to a healthy diet and exercise daily. If you experience any additional chest pain, shortness of breath, nausea, vomiting, please call your PCP or return to the ER. ","Patient is a ___ y/o F with a history of CAD with BMS x 1 ___, ___ 2 in ___ and ___ to LAD, DM, HTN, Hypercholesterolemia who presents with atypical chest pain. . #. CAD: Pt with hx CAD, poorly controlled DM, episode of CP prior to admission concerning for angina. Patient's EKG showed TWI in AVL that is nonspecific. Patient ruled out for MI. Patient's CP that was likely of noncardiac origin, given the multiple episodes of waxing and waning CP with rest and or exertion, and lack of EKG changes and negative cardiac enzymes. Patient had a nuclear stress as an inpatient and was negative for any perfusion defects. - Continue ASA, Plavix - Contine ACE, BB - Continue Statin . #. Pump: Euvolemic on exam. . #. Rhythm: NSR. . # HTN: SBP 120-140s on discharge. Concern that patient may be non compliant with medication regimen. Patient had dropped SBP into ___ on admission once home medications were administered. Her does of BB and Imdur have been decreased, SBPs have been controlled, but may need outpatient titration. - Continue BP meds. . #. DM - HbA1c 10.0 on ___. Poorly controlled. Currently on Levemir 50 units sq in AM, 60 in ___, Metformin 500 mg tid, although not compliant with this. - Continue metformin - Continue Lantus 50u qAM/60u qHS . #. hyperlipidemia - Continue Lipitor 80 mg qday. ",1984,353
10002013-DS-6,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> Chest pain <MAJOR SURGICAL OR INVASIVE PROCEDURE> Cardiac catheterization with stenting with drug eluting stent to the left circumflex <HISTORY OF PRESENT ILLNESS> ___ year old woman with diastolic CHF, COPD, DM, HTN, HLD, and CAD (h/o MI in ___ with LAD stenting, repeat stenting with DES in ___ and ___, who presents with chest pain. She has been having chest pain episodes over the past 2 weeks. A tightness located in the ___ her chest that usually occurs with exertion or when lying flat at night, but she has also experienced at rest. It radiates to the left arm, and is relieved with NTG. It is not pleuritic, but is reproducible when she presses over the ___ her chest. Somewhat different from the chest pain that she had prior to her previous PCIs. Associated with dsyspnea and lightheadedness. She came to the ED today after having a more severe episode yesterday. . In the ED initial VS were: 97.5, 67, 127/73, 16, 100%RA. EKG showed SR with non-specific ST and T changes. CXR negative for acute process. Labs notable for negative troponin but Creat 1.7 (was 1.4 in ___ and normal prior to that). She received ASA 325mg. VS prior to transfer were: 97.6, 70, 119/60, 16, 99%RA. . On arrival to the floor, patient is comfortable and denies chest pain. . REVIEW OF SYSTEMS: As noted in HPI. In addition, denies fevers, chills, sweats, presyncope, syncope, cough, PND, orthopnea, leg swelling, abdominal pain, nausea, vomiting, hematemesis, diarrhea, constipation, red or black stools, dysuria, hematuria, myalgias, arthralgias, or rash. No history of DVT or PE. <PAST MEDICAL HISTORY> - CAD: MI in ___ with LAD stenting, repeat stenting with DES in ___ and ___ - Diastolic CHF - DM - HTN - HLD - COPD - Depression - Right shoulder pain (bursitis, rotator cuff injury) <SOCIAL HISTORY> ___ <FAMILY HISTORY> She was a ward of the ___ and does not know her family. <PHYSICAL EXAM> Admission physical exam: VS: 98, 139/76, 71, 18, 100% RA GENERAL: WDWN woman in NAD. Oriented x3. Mood, affect appropriate. HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no pallor or cyanosis of the oral mucosa. No xanthalesma. NECK: Supple. JVP not elevated. CARDIAC: RR, normal S1, S2. No m/r/g. No S3 or S4. Pain reproducible with palpation over ___ chest and left breast. LUNGS: Resp unlabored, no accessory muscle use. CTAB. ABDOMEN: Soft, NTND. No HSM or tenderness. Abd aorta not enlarged by palpation. No abdominial bruits. EXTREMITIES: No edema. WWP. SKIN: No stasis dermatitis, ulcers, scars, or xanthomas. PULSES: Right: Carotid 2+ Femoral 2+ DP 2+ ___ 2+ Left: Carotid 2+ Femoral 2+ DP 2+ ___ 2+ . Discharge physical exam: Vitals: Tc 98.1 BP 169/82 (130-169/63-86) HR 71 (70-77) RR 18 O2 Sat 98% RA General: Patient lying in bed in NAD HEENT: EOMI. MMM. Neck: Supple. No JVD appreciated. CV: RRR. No M/R/G Lungs: Clear to auscultation bilaterally. No crackles or wheezes. Nml work of breathing. Abd: Obese. NABS+. Soft. NT/ND. Ext: WWP. 2+ DPs bilaterally. No clubbing, cyanosis, or edema. <PERTINENT RESULTS> Admission labs: ___ 10: 10PM BLOOD WBC-10.9 RBC-3.78* Hgb-12.4 Hct-36.9 MCV-98 MCH-32.7* MCHC-33.6 RDW-12.5 Plt ___ ___ 10: 10PM BLOOD Neuts-58.7 ___ Monos-4.6 Eos-1.9 Baso-0.7 ___ 06: 05AM BLOOD ___ PTT-27.8 ___ ___ 10: 10PM BLOOD Glucose-338* UreaN-32* Creat-1.7* Na-134 K-4.3 Cl-100 HCO3-21* AnGap-17 ___ 10: 10PM BLOOD cTropnT-<0.01 Discharge labs: ___ 06: 05AM BLOOD WBC-10.1 RBC-3.74* Hgb-12.5 Hct-35.5* MCV-95 MCH-33.5* MCHC-35.2* RDW-12.8 Plt ___ ___ 06: 05AM BLOOD Glucose-99 UreaN-29* Creat-1.4* Na-135 K-3.5 Cl-102 HCO3-26 AnGap-11 ___ 06: 05AM BLOOD Calcium-9.0 Phos-4.3 Mg-2.0 Cardiac enzymes: ___ 06: 05AM BLOOD CK(CPK)-61 ___ 06: 05AM BLOOD CK-MB-2 cTropnT-<0.01 ___ 10: 10PM BLOOD cTropnT-<0.01 EKG: Sinus rhythm at a rate of 69. Normal axis. The PR interval is prolonged at 204ms (slightly more than prior ekg). Q wave in III. Non-specific ST and T changes. Nuclear Stress Test: INTERPRETATION: The image quality is adequate but limited due to soft tissue and breast attenuation. There is activity adjacent to the heart in the rest and stress images. Left ventricular cavity size is increased. Rest and stress perfusion images reveal a reversible, moderate reduction in photon counts involving the mid and basal inferolateral walls and the distal lateral wall. Gated images reveal normal wall motion. The calculated left ventricular ejection fraction is 52% with an EDV of 107 ml (reprocessed at workstation). IMPRESSION: 1. Reversible, medium sized, moderate severity perfusion defect involving the LCx territory. 2. Increased left ventricular cavity size with normal systolic function. Compared to the prior study of ___, the defect is new. . Cardiac catheterization: COMMENTS: 1. Selective coronary angiography of this right-dominant system demonstrated three-vessel coronary artery disease. The ___ did not have angiographically-apparent flow-limiting stenoses. The LAD had 60% in-stent restenosis at the junction of the old Cypher stent placed in ___ and the new Promus stent placed in ___ the D2 branch was jailed with 60% origin stenosis. The LCx had a 50% stenosis at its origin; there was a 90% stenosis of the OM1 branch. The mid-RCA had a 50% stenosis. 2. Limited resting hemodynamics revealed mild systemic arterial hypertension, with a central aortic pressure of 142/74 mmHg. 3. Successful PTCA and stenting of OM1 with a 3.0x15mm PROMUS stent which was postdilated to 3.5mm. Final angiography revealed no residual stenosis, no angiographically apparent dissection and TIMI III flow (see PTCA comments). FINAL DIAGNOSIS: 1. Three vessel coronary artery disease. 2. Successful PTCA and stenting of the OM1 with a DES. . <MEDICATIONS ON ADMISSION> - Clopidogrel 75 mg daily - Asprin 325 mg daily - Atorvastatin 40 mg daily - Lisinopril 10 mg daily - Metoprolol succinate 100 mg daily - Isosorbide mononitrate 30 mg daily - Furosemide 20 mg daily - Nitroglycerin 0.4 mg SL prn - Glargine insulin 80 units QHS - Lispro insulin sliding scale - Albuterol 90 mcg, 2 puffs Q4-6 hrs prn - Fluticasone 110 mcg, 2 puffs BID - Pantoprazole 40 mg BID - Oxycode-Acetaminophen 5 mg-325 mg Q8h prn pain - Potassium chloride 20 mEq BID - Cholecalciferol 1,000 unit daily - Metronidazole 0.75% lotion for ___ <DISCHARGE MEDICATIONS> 1. clopidogrel 75 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 2. aspirin 325 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 3. atorvastatin 40 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 4. metoprolol succinate 100 mg Tablet Extended Release 24 hr Sig: One (1) Tablet Extended Release 24 hr PO once a day. 5. isosorbide mononitrate 30 mg Tablet Extended Release 24 hr Sig: One (1) Tablet Extended Release 24 hr PO DAILY (Daily). 6. nitroglycerin 0.4 mg Tablet, Sublingual Sig: One (1) tablet Sublingual PRN as needed for chest pain. 7. insulin glargine 100 unit/mL Solution Sig: Eighty (80) units Subcutaneous at bedtime. 8. insulin lispro 100 unit/mL Solution Sig: Sliding scale units of insulin Subcutaneous three times a day: As directed by outpatient provider . 9. albuterol sulfate 90 mcg/actuation HFA Aerosol Inhaler Sig: Two (2) Puff Inhalation every ___ hours as needed for SOB, wheezing. 10. fluticasone 110 mcg/actuation Aerosol Sig: Two (2) Puff Inhalation BID (2 times a day). 11. pantoprazole 40 mg Tablet, Delayed Release (E.C.) Sig: One (1) Tablet, Delayed Release (E.C.) PO Q12H (every 12 hours). 12. oxycodone-acetaminophen ___ mg Tablet Sig: One (1) Tablet PO Q8H (every 8 hours) as needed for pain. 13. cholecalciferol (vitamin D3) 1,000 unit Capsule Sig: One (1) Capsule PO once a day. 14. metronidazole 0.75 % Lotion Sig: One (1) application Topical as directed . <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Primary diagnosis: Atypical chest pain Secondary diagnosis: Coronary artery disease Hypertension Hyperlipidemia Type 2 Diabetes Mellitus <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> It was a pleasure taking care of you during your hospitalization at ___. You were hospitalized with chest pain and had a nuclear stress test that was abnormal. You subsequently had a cardiac catheterization and you were found to have a blockage in the left circumflex coronary artery (one of the heart vessels). Take all medication as instructed. Please note the following medication changes: 1. Stop taking your potassium supplement for now, as your potassium levels were normal in the hospital. 2. Increase your atorvastatin (lipitor) dose from 40mg to 80mg daily. 3. Stop your lisinopril and lasix (furosemide) until otherwise instructed by your primary care physician. You will need repeat bloodwork on ___, which should be sent to your primary care physician, ___. Keep all hospital follow-up appointments. Your up-coming appointments are listed below. ","# Unstable angina: Description of the pain was somewhat atypical for angina in that she experiences in when she lays down and it is also reproducible. However, given her history of CAD status post multiple PCIs and many risk factors, the patient underwent stress test to rule out CAD. Nuclear stress test showed a reversible, medium sized, moderate severity perfusion defect involving the left circumflex territory. In light of these stress test findings, the patient underwent cardiac catheterization. Prior to cardiac catheterization, she was prehydrated given her acute kidney injury. The patient had a drug-eluting stent placed to the obtuse marginal branch. The patient became acutely hypertensive during cardiac catheterization and was started on a nitroglycerin drip (see discussion below). The patient was weaned from this quickly. The patient was continued on aspirin (full-dose), plavix, metoprolol, and imdur. Her home dose of atorvastatin was increased given evidence of coronary artery disease. Serial cardiac enzymes were negative times 3. OUTPATIENT ISSUES: Patient is to continue taking aspirin 325mg and plavix 75mg daily for the next year. Patient will have cardiology follow-up as an outpatient with the ___ ___ ___ group in ___. . # Acute kidney injury: Creatinine currently 1.7, up from 1.4 in ___. Renal function previously was normal. Upon admission, the patient's lisinopril and furosemide were discontinued. Of note, hte patient was started on furosemide approximately ___ months ago, which coincides with the development of the patient's elevated serum creatinine. Serum creatinine was trended through the admission and improved. The patient was restarted on her home lisinopril, though her serum creatinine was noticed to be increasing so was discontinued with instructions to restart this medication after follow-up with her primary care physician. The patient was instructed to have a basic metabolic panel drawn ___. . # Diastolic heart failure: Patient was euvolemic through her admission. Her home lasix was discontinued during this admission given her acute kidney injury. The patient will follow-up with her primary care physician regarding ___ of lasix. OUTPATIENT ISSUES: Outpatient BMP for monitoring of serum creatinine and reinitiation of lasix by the primary care physician. . # Type 2 Diabetes Melltius, insulin dependent: Moderately controlled with last A1c 7.9% in ___. Lantus and sliding scale was continued through the hospitalization. She was discharged home on her home doses of lantus and her home insulin sliding scale. . # Hypertension: Through most of the patient's admission, her blood pressure was well controlled (goal <130/80). She was continued on metoprolol and imdur, though furosemide and lisinopril were discontinued in light of the patient's elevated serum creatinine. However, during the patient's cardiac catheterization, she was noted to have elevated systolic blood pressures and was started on a nitroglycerin drip for control of blood pressures. The patient was weaned from the nitroglycerin drip with in 4 hours after cardiac catheterization. The patient received a dose of lisinopril, but because of rising serum creatinine, the patient's next dose was held. OUTPATIENT ISSUES: Follow-up with primary care physician regarding recent hospitalization and anti-hypertensive regimen in light of elevated serum creatinine. . # Hyperlipidemia: Well controlled with last LDL 50 in ___ (goal LDL<70), though triglycerides mildly elevated. Atorvastatin was increased to 80mg daily given the new CAD lesions. Patient also had a fasting lipid panel that was drawn, which was pending at time of discharge. OUTPATIENT ISSUES: Follow-up of pending fasting lipid panel. . # COPD: Currently asymptomatic. Patient was continue fluticasone and albuterol as needed. ",2794,839
10002013-DS-7,"<SEX> F <SERVICE> CARDIOTHORACIC <ALLERGIES> lisinopril <ATTENDING> ___ <CHIEF COMPLAINT> Substernal chest pain and throat tightness with exertion <MAJOR SURGICAL OR INVASIVE PROCEDURE> ___ 1. Off pump coronary artery bypass graft x3, left internal mammary artery to left anterior descending artery and saphenous vein grafts to diagonal, and obtuse marginal arteries. 2. Endoscopic harvesting of the long saphenous vein. <HISTORY OF PRESENT ILLNESS> This is a ___ patient with extensive coronary artery disease history with previous stenting presented again with symptoms and was investigated and found to have a significant lesion in the left anterior descending artery diagonal and the obtuse marginal arteries. Left ventricular function is well preserved and she was electively admitted for off pump coronary artery bypass grafting. <PAST MEDICAL HISTORY> Coronary artery disease(s/p MI ___, BMS to proximal LAD ___, DES to mid LAD ___, DES to edge ISR of mid LAD DES and stenosis distal to stent ___, DES to OM1, ___. diastolic congestive heart failure Hypertension Dyslipidemia Morbid obesity COPD GERD Rt rotator cuff injury/bursitis(outpt ___, Migraines, Depression/Anxiety DJD Hemorrhoids Rosacea Left foot tendion repair <SOCIAL HISTORY> ___ <FAMILY HISTORY> She was a ward of the ___ and does not know her family. <PHYSICAL EXAM> Physical Exam Pulse: 86 Resp: 20 O2 sat: 98% B/P Right: 132/68 Left: Height: 5'2 Weight: 210 General: AAOx3, NAD Skin: Dry [x] intact [x] HEENT: PERRLA [x] EOMI [x] Neck: Supple [x] Full ROM [x] Chest: Lungs clear bilaterally [x] Heart: RRR [x] Irregular [] Murmur [] grade ______ Abdomen: Soft [x]non-distended [x]non-tender [x]bowel sounds +[x] Extremities: Warm [x], well-perfused [x] Edema [] _____ Varicosities: None [x] Neuro: Grossly intact [x] Pulses: Femoral Right: +2 Left: +2 DP Right: +2 Left: +2 ___ Right: +2 Left: +2 Radial Right: cath site Left: +2 Carotid Bruit: None <PERTINENT RESULTS> Echocargiogram ___ LEFT ATRIUM: Normal LA size. RIGHT ATRIUM/INTERATRIAL SEPTUM: Normal RA size. A catheter or pacing wire is seen in the RA and extending into the RV. Left-to-right shunt across the interatrial septum at rest. LEFT VENTRICLE: Wall thickness and cavity ___ were obtained from 2D images. Normal regional LV systolic function. Overall normal LVEF (>55%). RIGHT VENTRICLE: Normal RV chamber size and free wall motion. AORTA: Normal diameter of aorta at the sinus, ascending and arch levels. Simple atheroma in ascending aorta. Normal descending aorta diameter. Simple atheroma in descending aorta. AORTIC VALVE: Normal aortic valve leaflets (3). No AS. No AR. MITRAL VALVE: Normal mitral valve leaflets with trivial MR. ___ VALVE: Normal tricuspid valve leaflets with trivial TR. PULMONIC VALVE/PULMONARY ARTERY: Normal pulmonic valve leaflet. No PS. Physiologic PR. PERICARDIUM: No pericardial effusion. Conclusions Pre operative: The left atrium is normal in size. There is a small PFO with a left-to-right shunt across the interatrial septum. Regional left ventricular wall motion is normal. Overall left ventricular systolic function is normal (LVEF>55%). Right ventricular chamber size and free wall motion are normal. The diameters of aorta at the sinus, ascending and arch levels are normal. There are simple atheroma in the ascending aorta. There are simple atheroma in the descending thoracic aorta. The aortic valve leaflets (3) appear structurally normal with good leaflet excursion and no aortic stenosis or aortic regurgitation. The mitral valve appears structurally normal with trivial mitral regurgitation. There is no pericardial effusion. Chest X-Ray ___ There is mild-to-moderate cardiomegaly. Bilateral pleural effusions are small. Aside from atelectasis in the left lower lobe, the lungs are grossly clear. Almost complete resolution of atelectasis in the left upper lobe. Sternal wires are aligned. Widened mediastinum has improved. A small air-fluid level in the retrosternal region suggests the presence of a tiny pneumothorax and small effusion. These are most likely located in the left side. ___ 06: 05AM BLOOD WBC-11.7* RBC-3.06* Hgb-10.4* Hct-30.5* MCV-100* MCH-33.9* MCHC-34.0 RDW-13.5 Plt ___ ___ 06: 15AM BLOOD WBC-11.1* RBC-3.23* Hgb-11.1* Hct-32.1* MCV-99* MCH-34.4* MCHC-34.6 RDW-13.3 Plt ___ ___ 08: 20AM BLOOD WBC-14.0* RBC-3.26* Hgb-10.8* Hct-32.3* MCV-99* MCH-33.2* MCHC-33.4 RDW-13.3 Plt ___ ___ 06: 05AM BLOOD Na-137 K-4.1 Cl-97 ___ 06: 15AM BLOOD Glucose-161* UreaN-19 Creat-1.1 Na-136 K-4.0 Cl-97 HCO3-29 AnGap-14 ___ 08: 00AM BLOOD Glucose-230* UreaN-14 Creat-0.9 Na-136 K-4.1 Cl-98 HCO3-26 AnGap-16 ___ 08: 20AM BLOOD Glucose-238* UreaN-16 Creat-1.0 Na-134 K-4.6 Cl-100 HCO3-22 AnGap-17 ___: 00AM BLOOD Glucose-98 UreaN-13 Creat-0.9 Na-136 K-4.7 Cl-106 HCO___ AnGap-12 <MEDICATIONS ON ADMISSION> Preadmission medications listed are correct and complete. Information was obtained from webOMR. 1. Atorvastatin 40 mg PO DAILY 2. Albuterol Inhaler 2 PUFF IH Q4H: PRN wheezing 3. Benzonatate 100 mg PO TID: PRN tos 4. Clopidogrel 75 mg PO DAILY 5. Fluticasone Propionate 110mcg 2 PUFF IH BID 6. Glargine 80 Units Bedtime Insulin SC Sliding Scale using HUM Insulin 7. Isosorbide Mononitrate (Extended Release) 60 mg PO DAILY 8. Metoprolol Succinate XL 100 mg PO DAILY 9. Metronidazole Gel 0.75%-Vaginal 1 Appl VG HS 10. Naproxen 500 mg PO Q8H: PRN pain 11. Nitroglycerin SL 0.4 mg SL PRN cp 12. Oxycodone-Acetaminophen (5mg-325mg) 1 TAB PO Q6H: PRN pain 13. Pantoprazole 40 mg PO Q12H 14. Ropinirole 0.25 mg PO QPM 15. Valsartan 80 mg PO DAILY 16. Aspirin 325 mg PO DAILY 17. Vitamin D 400 UNIT PO DAILY <DISCHARGE MEDICATIONS> 1. Aspirin EC 81 mg PO DAILY 2. Atorvastatin 40 mg PO DAILY RX *atorvastatin 40 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills: *0 3. Clopidogrel 75 mg PO DAILY RX *clopidogrel 75 mg 1 tablet(s) by mouth daily Disp #*90 Tablet Refills: *1 4. Fluticasone Propionate 110mcg 2 PUFF IH BID RX *fluticasone [Flovent HFA] 220 mcg 2 puffs twice a day Disp #*1 Inhaler Refills: *0 5. Glargine 50 Units Bedtime Insulin SC Sliding Scale using HUM Insulin 6. Oxycodone-Acetaminophen (5mg-325mg) 1 TAB PO Q6H: PRN pain RX *oxycodone-acetaminophen 5 mg-325 mg 1 tablet(s) by mouth Q 4 hrs Disp #*30 Tablet Refills: *0 7. Pantoprazole 40 mg PO Q24H RX *pantoprazole 40 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills: *0 8. Ropinirole 0.25 mg PO QPM 9. Furosemide 40 mg PO DAILY Duration: 7 Days RX *furosemide [Lasix] 40 mg 1 tablet(s) by mouth daily Disp #*7 Tablet Refills: *0 10. Ibuprofen 600 mg PO Q6H: PRN pain take with food RX *ibuprofen 600 mg 1 tablet(s) by mouth three times a day Disp #*90 Tablet Refills: *0 11. Metoprolol Tartrate 25 mg PO TID Hold for HR < 55 or SBP < 90 and call medical provider. RX *metoprolol tartrate 25 mg 1 tablet(s) by mouth three times a day Disp #*90 Tablet Refills: *1 12. Potassium Chloride 20 mEq PO DAILY RX *potassium chloride 20 mEq 1 tablet by mouth daily Disp #*7 Tablet Refills: *0 13. Albuterol Inhaler 2 PUFF IH Q4H: PRN wheezing RX *albuterol 2 puffs PRN Q 4 hrs Disp #*1 Inhaler Refills: *0 14. Vitamin D 400 UNIT PO DAILY <DISCHARGE DISPOSITION> Home With Service Facility: ___ ___ Diagnosis: Coronary artery disease(s/p MI ___, BMS to proximal LAD ___, DES to mid LAD ___, DES to edge ISR of mid LAD DES and stenosis distal to stent ___, DES to OM1, ___. diastolic congestive heart failure Hypertension Dyslipidemia Morbid obesity COPD GERD Rt rotator cuff injury/bursitis(outpt ___, Migraines, Depression/Anxiety DJD Hemorrhoids Rosacea Left foot tendion repair <DISCHARGE CONDITION> Alert and oriented x3 nonfocal Ambulating, gait steady Sternal pain managed with oral analgesics Sternal Incision - healing well, no erythema or drainage <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Please shower daily including washing incisions gently with mild soap, no baths or swimming, and look at your incisions Please NO lotions, cream, powder, or ointments to incisions Each morning you should weigh yourself and then in the evening take your temperature, these should be written down on the chart No driving for approximately one month and while taking narcotics, will be discussed at follow up appointment with surgeon when you will be able to drive No lifting more than 10 pounds for 10 weeks **Please call cardiac surgery office with any questions or concerns ___. Answering service will contact on call person during off hours** Females: Please wear bra to reduce pulling on incision, avoid rubbing on lower edge ","The patient was brought to the Operating Room on ___ where the patient underwent Off pump coronary artery bypass graft x3, left internal mammary artery to left anterior descending artery and saphenous vein grafts to diagonal, and obtuse marginal arteries. Endoscopic harvesting of the long saphenous vein. Overall the patient tolerated the procedure well and post-operatively was transferred to the CVICU in stable condition for recovery and invasive monitoring. She required Nitroglycerin for hypertension her first night post op but was transitioned to oral betablocker and diuretics. POD 1 found the patient extubated, alert and oriented and breathing comfortably. The patient was neurologically intact and hemodynamically stable. The patient was transferred to the telemetry floor for further recovery. Chest tubes and pacing wires were discontinued without complication. She was started on plavix due to being done off pump and will it need to be continued for six months. Blood sugars were closely monitored and she was restarted on her home regime which have slowly improved. The patient was evaluated by the physical therapy service for assistance with strength and mobility. By the time of discharge on POD 5 the patient was ambulating freely, the wound was healing and pain was controlled with oral analgesics. The patient was discharged home with visiting nurse services in good condition with appropriate follow up instructions. ",2696,275
10002013-DS-8,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> lisinopril <ATTENDING> ___. <CHIEF COMPLAINT> chest pain <MAJOR SURGICAL OR INVASIVE PROCEDURE> cardiac catheterization <HISTORY OF PRESENT ILLNESS> ___ w/ PMH of CAD s/p PCI x3, s/p off-pump CABG x3 ___ (___-->LAD, SVG -->diag, OM), type 2 DM on insulin, HTN, hyperlipidemia presents with a 3 day history of ___ sharp, left-sided chest pain and SOB. She describes the chest pain as ""pinching all the way down to the bone."" She endorses ___ episodes of pain/day, always at rest. The episodes of pain last approximately 5 minutes and are relieved by nitroglycerin. Her pain is not worsened by exertion or eating. She described her symptoms to her PCP over the phone, who told her to come to the ED. She says they feel similar to her MI in the past. She also endorsed vomiting last night. She denies any diaphoresis. She also endorses a cough. The patient has developed increased shortness of breath over the past few days. She has experienced orthopnea for the past few years, but denies PND and lower extremity edema. On exam in the ED she was tachycardic, in a regular rhythm. Lungs were CTAB. She had trace edema in her left lower extremity, none in her right leg. In the ED, initial vitals were 96.8 111 177/86 18 97%. Labs and imaging significant for a CXR with new moderate left pleural effusion with adjacent atelectasis in the left lung base, CBC within normal limits, electrolytes within normal limits, Cr. 1.2, troponin 0.08 and D-dimer 2350. A CT of the chest was performed, which showed no CT evidence for pulmonary embolus, but small left pleural effusion with adjacent atelectasis. Patient given aspirin 81mg x 4, SL nitroglycerin x 1 and heparin bolus. Vitals on transfer were 99.2 112 162/82 22 98% RA On arrival to the floor, patient is AAOx3, and comfortable. REVIEW OF SYSTEMS On review of systems, she denies any prior history of stroke, TIA, deep venous thrombosis, pulmonary embolism, bleeding at the time of surgery, myalgias, joint pains, cough, hemoptysis, black stools or red stools. She denies recent fevers, chills or rigors. She denies exertional buttock or calf pain. All of the other review of systems were negative. <PAST MEDICAL HISTORY> 1. CARDIAC RISK FACTORS: (-)Diabetes, (+)Dyslipidemia, (+)HTN 2. CARDIAC HISTORY: -Coronary artery disease -Diastolic congestive heart failure -CABG: CABG x 3 (Off pump coronary artery bypass graft x3, left internal mammary artery to left anterior descending artery and saphenous vein grafts to diagonal, and obtuse marginal arteries) -PERCUTANEOUS CORONARY INTERVENTIONS: BMS to proximal LAD ___, DES to mid LAD ___, DES to edge ISR of mid LAD DES and stenosis distal to stent ___, DES to OM1, ___ -PACING/ICD: none Morbid obesity. COPD GERD Right rotator cuff injury/bursitis Migraines Depression DJD Hemorrhoids Rosacea <SOCIAL HISTORY> ___ <FAMILY HISTORY> She was a ward of the ___ and does not know her family. <PHYSICAL EXAM> Admission: VS- T 99.4 BP 157/88 HR 118 RR 24 96% RA GENERAL- WDWN F in NAD. Oriented x3. Mood, affect appropriate. HEENT- NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no pallor or cyanosis of the oral mucosa. No xanthalesma. NECK- Supple without JVP CARDIAC- PMI located in ___ intercostal space, midclavicular line. RRR Nl S1/S2. Midline scar from recent surgery C/D/I LUNGS - No chest wall deformities, scoliosis or kyphosis. Resp were unlabored, no accessory muscle use. CTAB, no crackles, wheezes or rhonchi. ABDOMEN- Soft, NTND. No HSM or tenderness. EXTREMITIES- No c/c/e. Discharge: Vitals: T: 98.4 BP: 151/90 P: 86 R: 20 O2: 97 RA I/O: Intake: 840 mL; Output: Voided x2 (not recorded) GENERAL - Alert, interactive, well-appearing in NAD HEENT - PERRLA, EOMI, sclerae anicteric, dry mucous membranes, OP clear, no JVP visualized HEART - RRR, nl S1-S2, no MRG. Scar from recent surgery present at midline. Wound is healing well, no tenderness along scar. Slight erythema at base. A 2 cm area of newer scar is present from previous debridement as reported per patinent. LUNGS - Bibasilar crackles present at bases. No wheezes or rhonci. Respirations unlabored. ABDOMEN - NABS, soft/NT/ND, no masses or HSM EXTREMITIES - WWP, no c/c/e, 2+ peripheral pulses NEURO - awake, A&Ox3, CNs II-XII grossly intact <PERTINENT RESULTS> Admission labs: ___ 03: 45PM WBC-8.9 RBC-3.69* HGB-12.3 HCT-34.9* MCV-95 MCH-33.2* MCHC-35.1* RDW-13.1 ___ 03: 45PM NEUTS-67.9 ___ MONOS-5.5 EOS-2.6 BASOS-0.9 ___ 03: 45PM GLUCOSE-484* UREA N-16 CREAT-1.2* SODIUM-135 POTASSIUM-3.7 CHLORIDE-95* TOTAL CO2-26 ANION GAP-18 ___ 04: 25PM ___ PTT-27.8 ___ ___ 03: 45PM cTropnT-0.08* ___ 03: 45PM CK(CPK)-51 ___ 03: 45PM D-DIMER-2350* Pertinent labs: ___ 03: 45PM BLOOD cTropnT-0.08* ___ 12: 09AM BLOOD CK-MB-3 cTropnT-0.12* ___ 07: 15AM BLOOD CK-MB-3 cTropnT-0.13* Imaging/studies: EKG on admission- Sinus tachycardia. Extensive ST segment changes may be due to ischemia. Compared to the previous tracing no change. CXR ___- New moderate left pleural effusion with adjacent atelectasis in the left lung base. CTA Chest ___. No CT evidence for pulmonary embolus. 2. Small left pleural effusion with adjacent atelectasis. 3. Possible calcified splenic artery aneurysm in the region of the hilum. Cardiac catheterization ___. Selective coronary angiography of this right dominant system demonstrated 2 vessel coronary disease in the native vessels. The ___ had no angiographically apparent disease. The LAD had a 70% lesion in a prior stent, and a jailed diagnoal which was small and had poor flow. The LCx had a 70-80% stenosis at its origin. The RCA had no angiographically apparent disease. 2. Arterial conduit angiography demonstrated the LIMA graft to be patent. 3. Venous conduit angiography demonstrated a patent SVG to OM with retrograde stenosis involving a small sub-branch of the OM. The SVG to small diagonal was presumed occluded and unable to be identified. 4. Limited resting hemodynamics revealed systemic hypertension with aortic pressure of 184/105 mm Hg. FINAL DIAGNOSIS: 1. Two vessel coronary artery disease in the native arteries 2. Patent LIMA to LAD, patent SVG to OM, occluded SVG to small diagonal branch. <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Albuterol Inhaler 2 PUFF IH Q6H: PRN SOB 2. Atorvastatin 40 mg PO DAILY 3. Clopidogrel 75 mg PO DAILY 4. Fluticasone Propionate 110mcg 2 PUFF IH BID 5. Glargine 50 Units Bedtime Insulin SC Sliding Scale using HUM Insulin 6. Metoprolol Tartrate 25 mg PO TID Hold for SBP <100, HR<60 7. Metrogel *NF* (metroNIDAZOLE) 0.75% Topical Daily 8. Oxycodone-Acetaminophen (5mg-325mg) 1 TAB PO Q8H: PRN severe pain 9. Pantoprazole 80 mg PO Q24H 10. Ropinirole 0.25 mg PO QPM 11. Aspirin 325 mg PO DAILY 12. Vitamin D 1000 UNIT PO DAILY 13. Ibuprofen 600 mg PO Q6H: PRN pain <DISCHARGE MEDICATIONS> 1. Albuterol Inhaler 2 PUFF IH Q6H: PRN SOB 2. Aspirin 81 mg PO DAILY RX *aspirin 81 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills: *0 3. Atorvastatin 80 mg PO DAILY RX *atorvastatin 80 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills: *0 4. Glargine 50 Units Bedtime Insulin SC Sliding Scale using HUM Insulin 5. Metoprolol Tartrate 50 mg PO TID RX *metoprolol tartrate 50 mg 1 tablet(s) by mouth three times a day Disp #*90 Tablet Refills: *0 6. Pantoprazole 40 mg PO Q24H RX *pantoprazole 40 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills: *0 7. Ropinirole 0.25 mg PO QPM 8. Vitamin D 1000 UNIT PO DAILY 9. Isosorbide Mononitrate (Extended Release) 30 mg PO DAILY RX *isosorbide mononitrate 30 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills: *0 10. Metrogel *NF* (metroNIDAZOLE) 0.75% Topical Daily 11. Oxycodone-Acetaminophen (5mg-325mg) 1 TAB PO Q8H: PRN severe pain 12. Losartan Potassium 25 mg PO DAILY RX *losartan 25 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills: *0 13. Clopidogrel 75 mg PO DAILY 14. Fluticasone Propionate 110mcg 2 PUFF IH BID <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Primary: non-ST elevation MI coronary artery disease Secondary: diabetes mellitus type 2 hypertension hyperlipidemia <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> It was a pleasure taking care of you during your recent admission to ___. You were admitted with chest pain/pressure concerning for a heart attack. A cardiac catheterization showed that one of your grafts from your recent cardiac bypass surgery is clotted and no longer working, potentially causing your symptoms. We have increased and added medications to control your symptoms. The changes are below: START losartan START isosorbide mononitrate INCREASE atorvastatin INCREASE metoprolol DECREASE aspirin DECREASE pantoprazole STOP ibuprofen (you were taking too much. take tylenol ___ for pain) Once you leave the hospital, we recommend further workup of a fluid collection seen around your left lung and better management of your diabetes with the help of your PCP. ","___ year old female with a history of CAD s/p PCI x3, s/p CABG x3 (___), type 2 DM on insulin, HTN, and HLD who presented with a 3 day history of left sided chest pain and SOB. # Chest Pain- Patient with significant CAD history, s/p recent CABG, presenting with chest pain and rising troponins, with new ST depressions inferiorly in V4-V6, consistent with NSTEMI. Patient's troponins plateaued at 0.13. She has initiated on a heparin gtt in the ED, and was taken to cardiac cath the following morning. Catheterization showed occlusion of the SVG to the diagonal, possibly causing her current symptoms. No intervention was performed. Patient was medically optimized with increased metoprolol, initiation of losartan, and initiation of imdur. Other potential causes of her chest pain were considered including PE (ruled out with negative CTA), pericarditis (symptoms consistent, but exam and EKG not consistent, also patient has been essentially treated as she has been taking consistent NSAIDs), costochondritis (symptoms intermittently reproducible on exam), or pleuritis secondary to pleural effusion (very small effusion, stable since CABG). If pain persists, patient was instructed to speak with her cardiologist about increasing imdur should her blood pressure tolerate. # Acute renal insufficiency- On admission, creatinine elevated to 1.2, likely due to dehydration, as creatinine improved overnight with gentle fluids and remained stable. # COPD- Continued on home inhalers (albuterol, fluticasone) # DM- Continued with glargine 50 units Q6 and ISS # HLD- Continued on home atorvastatin # GERD- Continued on home pantoprazole # Transitional issues- - NEW MEDICATIONS- losartan and imdur - MEDICATION CHANGES- metoprolol increased to 50mg po TID (from 25 TID) - if ongoing chest pain, consider titrating up on imdur if c/w anginal pain. Also may consider treating for costochondritis and pericarditis ",2828,462
10002131-DS-16,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> Penicillins / Dilantin Kapseal / Zofran (as hydrochloride) <ATTENDING> ___. <CHIEF COMPLAINT> Right hip pain <MAJOR SURGICAL OR INVASIVE PROCEDURE> None <HISTORY OF PRESENT ILLNESS> ___ is a ___ y/o F with PMHx CHF, Afib not on anticoagulation, severe advanced Alzheimer's dementia, osteoporosis, HTN, who presents from assisted living facility with R hip pain. The patient has severe dementia, with short term memory loss so is unable to provide history. Much of the history is obtained from multiple family members in the room. She has multiple family members who live close by and are involved intimately in her care. They were called from the assisted living facility this morning when the patient was in ___ right hip pain. This occurred suddenly. No trauma. No reported falls. She was not complaining of other symptoms. She was brought to the ED. Discussing with the patient, she moved into the Assisted living facility in ___ in ___ given worsening of her dementia. She was in her USOH, bowling weekly and very social, until ___ when she developed acute SOB with ambulation prompting admission to ___ where she was noted to be in Afib. She had a week long hospital stay complicated by an ICU course for an allergic reaction to a medication (family thinks Zofran). Since returning from this hospitalization, she has not been back to baseline and has deteriorated. She has spent much of her time wheelchair bound given deconditioning. She has worsening memory function, now with severe short term memory loss. Decreased appetite and PO intake. She was recently seen in ___ clinic by Dr. ___ new diagnosis of CHF. She underwent an TTE at ___ yesterday ___ to evaluate her systolic function. In the ED, initial vitals were: 98.7, 96, 122/48, 20, 96% RA. Exam was significant for: R hip TTP greater trochanter, neg straight leg raise. ___ pulses 2+ LLE 2+ edema, unknown duration Labs were significant for : K 2.8 Cr 0.8 CBC: 13.9/12.5/39.2/168 UA: WBC 22, moderate leuks, negative nitrites Studies: Lower extremity ultrasound: 1. Deep vein thrombosis of the left common femoral vein extending into at least the popliteal vein. Left calf veins were not clearly identified and possibly also occluded. 2. No DVT in the right lower extremity. CXR Bilateral pleural effusions, large on the right and small on the left. No definite focal consolidation identified, although evaluation is limited secondary to these effusions. She was given 80 mEq of K and 60mg Enoxaparin Sodium. Vitals on transfer were: 97.9, 79, 125/53, 18, 100% Nasal Cannula. On the floor, she is resting comfortably in bed. History is obtained as above with family members. She sleeps with 2 pillows at home and has DOE. She has not had a bowel movement in 2 days. Review of systems: (+) Per HPI (-) Denies fever, chills, night sweats. denies headache, sinus tenderness, rhinorrhea or congestion. Denies cough. Denies nausea, vomiting, diarrhea, constipation or abdominal pain. No dysuria. Denies arthralgias or myalgias. <PAST MEDICAL HISTORY> Hypertension Dementia Osteoporosis Irritable bowel syndrome Macrocytosis of unclear etiology Left ear hearing loss Status post hysterectomy Status post appendectomy Status post ovarian cyst removal Cataract surgery Glaucoma <SOCIAL HISTORY> ___ <FAMILY HISTORY> Not relevant to the current admission. <PHYSICAL EXAM> ADMISSION EXAM -= Vital Signs: 98.3, 107/43, 72, 16, 99 2L NC General: AOx1, pleasant, smiling, at baseline per family members at bedside ___: Sclera anicteric, MMM, oropharynx clear, EOMI, PERRL, neck supple, JVP not elevated, no LAD CV: Regular rate and rhythm, normal S1 + S2, soft ___ systolic murmur. Lungs: Moderate inspiratory effort, decreased breath sounds bilaterally at bases L>R. No wheezes, rales, rhonchi Abdomen: Soft, non-tender, non-distended, bowel sounds present, no organomegaly, no rebound or guarding GU: No foley Ext: Warm, well perfused, 2+ pulses, L>R lower extremity swelling with left leg erythematous and tender to palpation, 2+ pitting edema tender, right lower extremity with e/o chronic venous stasis changes, 1+ pitting edema non tender. Neuro: AOx1, strength ___ upper and lower exteremities, all facial movements in tact, sensation grossly in tact, gait deferred. DISCHARGE EXAM -= Vitals: T: 97.9, 144/59, 72, 20, 93 RA General: AOx1, pleasant, smiling, at baseline per family members at bedside ___: Sclera anicteric, MMM CV: Irregularly irregular, normal S1 + S2, soft ___ systolic murmur. Lungs: Moderate inspiratory effort, decreased breath sounds bilateral bases Ext: Warm, well perfused, 2+ pulses, L>R lower extremity swelling with left leg erythematous and minimal tender to palpation, 2+ pitting edema tender, right lower extremity with e/o chronic venous stasis changes, 1+ pitting edema non tender. Neuro: AOx1 <PERTINENT RESULTS> ADMISSION LABS -= ___ 11: 35AM URINE RBC-2 WBC-22* BACTERIA-NONE YEAST-NONE EPI-<1 TRANS EPI-<1 ___ 11: 35AM URINE BLOOD-NEG NITRITE-NEG PROTEIN-NEG GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-5.5 LEUK-MOD ___ 12: 00PM PLT COUNT-168 ___ 12: 00PM NEUTS-81.1* LYMPHS-10.8* MONOS-6.7 EOS-0.1* BASOS-0.2 IM ___ AbsNeut-11.29* AbsLymp-1.51 AbsMono-0.94* AbsEos-0.02* AbsBaso-0.03 ___ 12: 00PM WBC-13.9* RBC-3.78* HGB-12.5 HCT-39.2 MCV-104* MCH-33.1* MCHC-31.9* RDW-13.6 RDWSD-51.9* ___ 12: 00PM CALCIUM-7.8* PHOSPHATE-3.7 MAGNESIUM-1.6 ___ 12: 00PM cTropnT-0.03* proBNP-8428* ___ 12: 00PM GLUCOSE-118* UREA N-26* CREAT-0.8 SODIUM-144 POTASSIUM-2.8* CHLORIDE-95* TOTAL CO2-38* ANION GAP-14 STUDIES ======= CXR Bilateral pleural effusions, large on the right and small on the left. No definite focal consolidation identified, although evaluation is limited secondary to these effusions. Pelvis Xray There is no acute fracture or dislocation. No focal lytic or sclerotic osseous lesion is seen. There is no radiopaque foreign body. Vascular calcifications are noted. The visualized bowel gas pattern is nonobstructive. IMPRESSION: No acute fracture or dislocation. Lower extremity ultrasound 1. Deep vein thrombosis of the left common femoral vein extending into at least the popliteal vein. Left calf veins were not clearly identified, possibly also occluded. 2. No right DVT. LAST LABS BEFORE DISCHARGE --= ___ 06: 55AM BLOOD WBC-14.9* RBC-3.51* Hgb-11.5 Hct-36.8 MCV-105* MCH-32.8* MCHC-31.3* RDW-13.8 RDWSD-53.1* Plt ___ ___ 06: 55AM BLOOD Glucose-109* UreaN-32* Creat-0.9 Na-144 K-3.7 Cl-96 HCO3-37* AnGap-15 ___ 06: 55AM BLOOD Albumin-2.5* Calcium-8.0* Phos-3.2 Mg-1.5* <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Metoprolol Succinate XL 150 mg PO BID 2. Torsemide 40 mg PO DAILY 3. Aspirin 81 mg PO DAILY 4. Donepezil 10 mg PO QHS 5. raloxifene 60 mg oral DAILY 6. Multivitamins 1 TAB PO DAILY 7. Namenda XR (MEMAntine) 21 mg oral DAILY 8. Ascorbic Acid ___ mg PO DAILY 9. Calcium Carbonate 1500 mg PO DAILY 10. Vitamin D 1000 UNIT PO DAILY 11. Fish Oil (Omega 3) 1000 mg PO DAILY <DISCHARGE MEDICATIONS> 1. Donepezil 10 mg PO QHS 2. Metoprolol Succinate XL 200 mg PO DAILY 3. Namenda XR (MEMAntine) 21 mg oral DAILY 4. Acetaminophen 1000 mg PO TID 5. Glycopyrrolate 0.1 mg IV Q6H: PRN excess secretions 6. Hyoscyamine 0.125 mg SL QID: PRN excess secretions <DISCHARGE DISPOSITION> Extended Care Facility: ___ <DISCHARGE DIAGNOSIS> Primary Diagnosis --------------- Deep Vein Thrombosis Secondary Diagnosis ------------------ Congestive heart failure Atrial fibrillation Constipation Malnutrition Hypertension Alzheimer's dementia <DISCHARGE CONDITION> Mental Status: Confused - always. Level of Consciousness: Alert and interactive. Activity Status: Out of Bed with assistance to chair or wheelchair. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear ___, It was a pleasure taking care of you during your hospitalization. Briefly, you were hospitalized with right hip pain. We did Xrays of your hip which did not show any fractures. We also found a blood clot in your left leg and noticed that your heart wasn't pumping very efficiently. We talked with you and your family, who shared with us many of your wishes about being hospitalized and the type of care you would like to receive. We decided to focus on your comfort. Because of this, you are being discharged to ___ for hospice care. We wish you and your family the ___, Your ___ Treatment Team ","___ is a ___ y/o F with PMHx CHF, Afib not on anticoagulation, severe advanced Alzheimer's dementia, osteoporosis, HTN, who presents from assisted living facility with R hip pain, found to have DVT left common femoral vein with volume overload. During a meeting with patient and her family, decision was made to transition care to comfort-directed measures only and to pursue hospice services on discharge. ACTIVE ISSUES ============= # CMO. The team had a family meeting on ___ and decision was made to transition care to CMO and pursue 24 hour hospice services on discharge. Family did not want to pursue active treatments such as Lasix, which would make her uncomfortable given incontinence or shots such as lovenox for treatment of DVT. Home medications metoprolol, donepezil and Memantine were continued for comfort. She was discharged to an ___ ___ facility. OTHER HOSPITAL ISSUES ===================== # DVT. Deep vein thrombosis of the left common femoral vein extending into at least the popliteal vein diagnosed on ultrasound on admission. This was likely acquired in the setting of immobility, as the patient had been restricted to her wheelchair at her assisted living for greater than 1 month due to deconditioning. She was initially started on Lovenox for treatment but this was discontinued in the setting of transition to care to CMO as above. # Acute CHF. Patient was volume overloaded on presentation with pleural effusions. She was diuresed with IV Lasix. Home metoprolol was continued at a decreased dose. In the setting of transition to care to CMO, Lasix was discontinued. She was continued on metoprolol for comfort. She remained on room air without respiratory distress. # Afib. She presented in sinus rhythm, rate controlled on metoprolol. Metoprolol was continued at a decreased dose for comfort. # Hip pain. The right hip pain that she presented with was resolved by the time of admission. Pelvic xray was without fracture. She was treated with Tylenol scheduled for pain control. # Al___ Dementia. She was AOx1 at her baseline per family members. She was continued on Aricept/Namenda. TRANSITIONAL ISSUES =================== - ___ facility to continue writing orders for pain/anxiety/secretions and other symptoms. - Continued metoprolol succinate and Memantine and donepezil on discharge for comfort. Continuation of these medications can be further decided at inpatient hospice. - MOLST form: DNR/DNI, do not re-hospitalize # CODE: DNR/DNI, CMO # CONTACT: HCP ___ (daughter) ___ Primary, secondary ___ (son) ___ ",2476,574
10002155-DS-10,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> Codeine <ATTENDING> ___ <CHIEF COMPLAINT> Difficulty in breathing <MAJOR SURGICAL OR INVASIVE PROCEDURE> none <HISTORY OF PRESENT ILLNESS> The patient is a ___ year-old female with a history of NSCLC (stage IV) who presents with shortness of breath. . The patient was in her usual state of health until the evening before admission when she began to feel somewhat short of breath. The next morning, this sensation persisted, so she became concerned. She also reports a few day history of a non-productive cough. Denies sick contacts, recent travel or sedentary lifestyle. She denied chest pain, fever, chills, dizziness, lightheadedness or syncope. She presented to the ED where she was found to be hypoxic to the ___ on room air. . In the ED, she was placed on a non-rebreather with sats up to the high 90's. Attempts were made to wean her to NC but they were unsuccessful, as she was satting 88% on 4L NC. She remained afebrile in the ED but was found to have WBC of 17. Given that, she received levofloxacin and vancomycin. Blood cultures were drawn prior to antibiotic administration. CXR did not show PNA, but demonstrated progression of known lung cancer. She underwent a CT head to rule out metastases, which was negative. On transfer, patient was afebrile with HR- 77, BP- 112/49, RR- 16, SaO2- 98% on 15L NRB . On transfer to the ICU, the patient was stable and comfortable. Sats were 97% on 5L NC and 95% high-flow with a face-tent. . ROS: The patient denies any fevers, chills, weight change, nausea, vomiting, abdominal pain, diarrhea, constipation, melena, hematochezia, chest pain, orthopnea, PND, lower extremity edema, cough, urinary frequency, urgency, dysuria, lightheadedness, gait unsteadiness, focal weakness, vision changes, headache, rash or skin changes. . <PAST MEDICAL HISTORY> CAD s/p MI ___ s/p CABG ___ Hypertension Dyslipidemia CVA: small left posterior frontal infarct in ___ Macular Degeneration NSCLC- stage IV (oncology history below) . -- ___ presented in with unresolving right-sided pulmonary infiltrate and an unrelated myocardial infarction. -- ___ Sputumcytology confirmed adenocarcinoma with a pattern of stainpositivity consistent with lung origin (CK7 and TTF-1 positive). She had stage IV nonsmall cell lung cancer, based on the multiple intrapulmonary lesions. She has no evidence of extrathoracic or central nervous system involvement with metastasis. -- ___: Status post 6 cycles of pemetrexed 500->400>200 mg/m2 on ___, ___, and ___. Her course was complicated by cytopenias and development of increased creatinine levels. -- ___ Chest CT showed partial response with interval improvement in the consolidation of the superior segment of the right lower lobe and nodular densities of the left lower lobe. Still widely disseminated BAC. -- ___ CT Chest shows increased density of right lower lobe consolidation and worsened peribronchiolar ground-glass opacities in the lingula are most consistent with worsening of widely disseminated non-small cell lung cancer, much less likely due to infection. -- ___ Chest CT: slight interval progression of known disease, no new sites. <SOCIAL HISTORY> ___ <FAMILY HISTORY> Her father died due to CAD at age ___. Her mother had stomach cancer and osteosarcoma. No history of lung cancer, colon cancer or breast cancer. <PHYSICAL EXAM> On Admission: Vitals: T: 96.9 BP: 118/51 HR: 94 RR: 18 O2Sat: 94% on 5L with face tent GEN: Well-appearing female in no acute distress HEENT: EOMI, PERRL, sclera anicteric, MMM, OP Clear NECK: No JVD, no cervical lymphadenopathy, trachea midline COR: Regular rate and rhythm, no M/G/R, normal S1 S2 PULM: Decreased breath sounds throughout. minimally faint bibasilar crackles. Good effort. ABD: Soft, NT, ND, +BS, no HSM, EXT: No C/C/E NEURO: alert, oriented to person, place, and time. CN II  XII grossly intact. Moves all 4 extremities. SKIN: No jaundice, cyanosis, or gross dermatitis. No ecchymoses. . <PERTINENT RESULTS> ___ 08: 30PM WBC-17.9*# RBC-3.36*# HGB-8.1* HCT-25.5* MCV-76* MCH-24.2* MCHC-31.8 RDW-15.8* ___ 08: 30PM PLT COUNT-341 ___ 08: 30PM NEUTS-84* BANDS-7* LYMPHS-2* MONOS-7 EOS-0 BASOS-0 ___ MYELOS-0 ___ 08: 30PM HYPOCHROM-3+ ANISOCYT-1+ POIKILOCY-NORMAL MACROCYT-1+ MICROCYT-2+ POLYCHROM-1+ OVALOCYT-1+ TEARDROP-1+ ENVELOP-1+ ___ 08: 30PM ___ PTT-26.5 ___ ___ 08: 30PM GLUCOSE-117* UREA N-71* CREAT-2.8* SODIUM-135 POTASSIUM-4.9 CHLORIDE-98 TOTAL CO2-23 ANION GAP-19 ___ 08: 43PM LACTATE-2.6* ___ 08: 30PM cTropnT-<0.01 ___ 10: 46PM URINE COLOR-Straw APPEAR-Clear SP ___ ___ 10: 46PM URINE BLOOD-NEG NITRITE-NEG PROTEIN-NEG GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-5.0 LEUK-NEG . Micro: Legionella Urinary Antigen (Final ___: NEGATIVE FOR LEGIONELLA SEROGROUP 1 ANTIGEN . Urine cx: URINE CULTURE (Final ___: NO GROWTH. Blood cx: NGTD . Studies/Imaging: . EKG: ___ Sinus rhythm at 68 bpm, normal axis, normal intervals, poor R-wave progresion, ST-depressions in V4-V6. . CXR: ___ SINGLE AP VIEW OF THE CHEST: Patient is status post median sternotomy. The cardiac, mediastinal and hilar contours are unchanged. There continues to be progression of disease with increased extent of consolidative opacity within the right lung base. Ill-defined opacities within the lingula and left lower lobe are similar to prior. Small right pleural effusion is present. There is no pneumothorax. There is hyperinflation of the lungs. IMPRESSION: Evidence of disease progression. . CT Head: ___ FINDINGS: There is no evidence of acute hemorrhage, edema, mass effect or recent infarction. An area of encephalomalacia in the left frontal lobe, compatible with chronic infarct is unchanged. Prominence of the ventricles and sulci reflects generalized atrophy, notably in the bifrontal extraaxial spaces. Areas of periventricular and subcortical white matter hypodensity likely reflect sequela of chronic small vessel ischemic disease. No concerning osseous lesion is seen. There are calcifications of the bilateral carotid siphons. The visualized paranasal sinuses are grossly unremarkable. IMPRESSION: No evidence of acute intracranial process or mass effect . LENIs: ___ IMPRESSION: No evidence of DVT. . CT chest ___ IMPRESSION: 1. Interval worsening of diffuse bilateral ground-glass opacities, bronchiolar nodules and dense consolidation within the lingula and right middle lobe. After review of multiple recent prior chest x-rays and CTs, these findings can all be explained by worsening bronchioalveolar carcinoma, given the absence of any change rapid enough to suggest pneumonia. Of course pneumonia might be present and unrecognized, and treatment should be made on the basis of clinical findings. 2. Stable mild cardiomegaly. 3. Moderate emphysema. 4. Cholelithiasis without evidence of cholecystitis. <MEDICATIONS ON ADMISSION> amlodipine 5 mg Tablet- one Tablet(s) by mouth one daily atorvastatin [Lipitor] 80 mg Tablet- one Tablet(s) by mouth one daily calcitriol 0.25 mcg Capsule- 1 Capsule(s) by mouth once a day clopidogrel [Plavix] 75 mg Tablet 1 Tablet(s) by mouth once a day folic acid- 1 mg Tablet one Tablet(s) by mouth one daily furosemide 40 mg Tablet- 1 Tablet(s) by mouth daily loperamide 2 mg Capsule- one Capsule(s) by mouth one twice daily as needed lorazepam 0.5 mg Tablet ___ Tablet(s) by mouth q6 hours as needed for Nausea metoprolol tartrate [Lopressor] 50 mg Tablet- one Tablet(s) by mouth ___ AM and one in ___ tramadol 50 mg Tablet- 0.5 (One half) Tablet(s) by mouth three times a day as needed for Pain trazodone 50 mg Tablet- one Tablet(s) by mouth one daily as needed aspirin 81 mg Tablet, Chewable- 2 Tablet(s) by mouth one daily ranitidine HCl [Acid Control] 150 mg Tablet- one Tablet(s) by mouth one daily <DISCHARGE MEDICATIONS> 1. oxygen ___ continuous, pulse dose for portability Dx: lung cancer 2. levofloxacin 500 mg Tablet Sig: One (1) Tablet PO Q48H (every 48 hours) for 2 weeks: last day ___. Disp: *4 Tablet(s)* Refills: *0* 3. atorvastatin 40 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily). 4. metoprolol tartrate 25 mg Tablet Sig: One (1) Tablet PO twice a day: PLEASE NOTE THIS IS A CHANGE FROM YOUR PREVIOUS EVENING DOSING. 5. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day): hold if loose stools. 6. trazodone 50 mg Tablet Sig: One (1) Tablet PO HS (at bedtime) as needed for insomnia. 7. clopidogrel 75 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 8. ranitidine HCl 150 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 9. calcitriol 0.25 mcg Capsule Sig: One (1) Capsule PO DAILY (Daily). 10. folic acid 1 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 11. aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable PO DAILY (Daily). <DISCHARGE DISPOSITION> Home With Service Facility: ___ <DISCHARGE DIAGNOSIS> # post-obstructive pneumonia # non small cell lung cancer stage IV, progressing . SECONDARY DIAGNOSES: # anemia of acute inflammation # CAD s/p MI # chronic systolic CHF # HTN # CKD stage III <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> You were admitted with cough and found to have low oxygen levels which required the Intensive Care Unit. Your CT shows progression of your lung cancer with a probable superimposed pneumonia. You were treated with antibiotics and oxygen and improved, and you were tranferred to the medical floor. You were continued on antibiotics, and your oxygen levels were monitored closely. We communicated with your primary oncologist, Dr. ___, who will weigh the risks and benefits of additional chemotherapy, as it will be complicated by your kidney dysfunction and other medical problems. He plans to repeat your CT scan once you finish your antibiotics to further evaluate the rate of your disease progression. Your congestive heart failure has been stable. Please note we stopped your lasix and amlodipine for now, and you will need to be re-evaluated by your PCP to see when you should restart them. We also decreased your evening dose of metoprolol. As usual, please weigh yourself every morning, and call MD if weight goes up more than 3 lbs. ","___ female with NSCLC stage IV presents with hypoxia. . #. Hypoxia. On admission patient with chief complaints of progressive shortness of breath and non-productive cough. No home oxygen requirement at baseline. On admission she was placed on NRB for treatment of O2 saturations in ___ saturations in the ___. Admission CXR with no definite infiltrate, though concern for progression of her known lung disease. In setting of elevated WBC. concern for infectious process and empirically treated with levofloxacin and vancomycin in the ED. Transitioned to monotherapy with levofloxacin on ___ and ceftriaxone was later added on ___. CXR on ___ demonstrates new left lower lobe consolidation. Additional hypoxia work-up notable for negative biomarkers, negative LENIs; unable to perform CTA due to chronic kidney disease and creatinine 2.8. Patient was able to be weaned back to room air by the end of her FICU stay. She was transferred to the medical floor on ___, where she demonstrated exertional hypoxia, usually asymptomatic. Home O2 was arranged. . # Post-obstructive pneumonia. Consolidation of left lower lobe evident on ___ likely secondary to infection rather than progression of disease due to short time course of infiltrate development (although on CT scan of ___, the radiologist concluded the opposite: that changes seen were likely caused by her NSCLC, though pneumonia could not be absolutely ruled out). Continued course of ceftriaxone, levofloxacin, which was eventually narrowed to levofloxacin alone. Blood cultures no growth to date. Multiple sputum cultures obtained; however, all contaminated with oral flora. Urine legionella negative. Patient did improve clinically with antibiotics, so she should complete a ___ day course of levofloxacin. . # NSCLC- stage IV. Not currently receiving chemotherapy. Outpatient oncologist Dr. ___ is planning on continued surveillance with plan for possible further palliative systemic chemotherapy if symptomatic progression of her disease is noted. CT scan for evaluation of disease progression was obtained and did show further progression. Dr. ___ plans to weigh the risks and benefits of additional chemotherapy, as it will be complicated by her kidney dysfunction and other comorbidities. He plans to repeat her CT scan once she completes her antibiotics to further evaluate the rate of disease progression. . # CAD s/p MI. Patient without chest pain; however, EKG with new ST-depressions. Biomarkers cycled and negative x2. Patient continued on home beta-blocker at a decreased dose due to relative hypotension. She was maintained on aspirin, plavix, and statin. . # chronic systolic CHF (LVEF ___ by TTE ___: Well-compensated. As described below, lasix was held but B-blocker was given at a lower dose given relative hypotension and exertional tachycardia. . # CKD stage III: Creatinine on admission 2.8, down to 2.4 by the time of discharge. She was given minimal IV fluids in the ICU and her lasix was held. Throughout stay, patient had adequate urine output. . # Microcytic anemia. On presentation, patient's Hct likely hemoconcentrated. Follow-up Hct found to be 20. No signs of bleeding on exam. Patient transfused 2units of pRBC due to history of CAD with appropriate elevation in hematocrit. The hematocrit did remain steady during FICU course following tranfusion. Just before transfer from ___, the patient's stool guaiac was positive, which may call for further work-up. The patient's anemia is most likely secondary to acute inflammation in the setting of underlying chronic disease. . ",2882,790
10002155-DS-11,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> Codeine <ATTENDING> ___. <CHIEF COMPLAINT> Dyspnea and melena <MAJOR SURGICAL OR INVASIVE PROCEDURE> None <HISTORY OF PRESENT ILLNESS> Ms. ___ is a ___ F with history of stage IV non-small cell lung cancer, CAD and CKD who presents with dyspnea, productive cough and melena. Patient has had ___ days of melena without abdominal pain and dyspnea with worsening cough for the past day. She denies fevers or chest pain. . In the ER, initial vitals were 97.2, 89, 156/53, 22, 86% 4L. Her hct was 22 from recent baseline of 25 (she has transfusion dependent anemia), and she initially was hypoxic. ABG was 7.29/64/42/32 and lactate was 2.4. Patient responded to nebs, stress dose steroids, levaquin and ceftriaxone with improvement in her sats to mid ___ on 5L NC. She was started on IV PPI for her guaiac positive dark brown stool. CXR showed large R pleural effusion and questionable L lower lobe collapse. EKG showed sinus tach with ST depressions in V2-6. Vitals on transfer to the MICU were 97.2, 105, 127/50, 29, 96% 5L NC. . In the MICU, she reports feeling better after her breathing treatments today. She cannot recall when her difficulty breathing started and per her family, she has difficulty hearing but no memory loss. Patient had intermittent dyspnea for weeks for which she previously took codeine syrup but then a period of improvement. She developed worsening dypsnea and cough yesterday without fevers, chills or chest pain. She denies prior history of melena but has had stable nausea and poor appetite for months. No heartburn or dysphagia. <PAST MEDICAL HISTORY> Stage IV nonsmall cell lung cancer, adenocarcinoma, EGFR wild-type, KRAS mutated CAD s/p CABG in ___, MI ___ s/p PCI to LAD. Chronic renal insufficiency - Patient with GFR < 50. CVA - small left posterior frontal infarct in ___. Hypercholesterolemia. Macular Degeneration <SOCIAL HISTORY> ___ <FAMILY HISTORY> Her father died due to CAD at age ___. Her mother had stomach cancer and osteosarcoma. <PHYSICAL EXAM> General: Elderly, chronically ill appearing female in NAD HEENT: NC/AT, EOMI, sclera anicteric, MMM Neck: supple, JVP not elevated, 1+ firm bilateral submandibular LAD Lungs: Decreased percussion ___ way up right lung with decreased breath sounds, L basalar crackles, upper lobes with some mild wheezing CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops appreciated Abdomen: soft, non-tender, non-distended, bowel sounds present, no rebound tenderness or guarding, no organomegaly GU: no foley Ext: warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema Discharge: expired <PERTINENT RESULTS> ___ 07: 42PM BLOOD WBC-9.8# RBC-2.60* Hgb-7.5* Hct-22.4* MCV-86 MCH-28.7 MCHC-33.3 RDW-18.8* Plt ___ ___ 07: 42PM BLOOD Neuts-83.0* Lymphs-8.5* Monos-5.7 Eos-2.4 Baso-0.4 ___ 07: 42PM BLOOD ___ PTT-24.5 ___ ___ 07: 42PM BLOOD Glucose-133* UreaN-45* Creat-1.4* Na-120* K-5.7* Cl-85* HCO3-26 AnGap-15 ___ 07: 42PM BLOOD ALT-20 AST-24 LD(LDH)-297* CK(CPK)-73 AlkPhos-81 TotBili-0.3 ___ 07: 42PM BLOOD CK-MB-4 cTropnT-<0.01 ___ 02: 04AM BLOOD CK-MB-10 MB Indx-10.1* cTropnT-0.05* ___ 11: 02PM BLOOD Calcium-8.4 Phos-2.6* Mg-1.8 ___ 07: 42PM BLOOD Osmolal-268* ___ 07: 42PM BLOOD ___ pO2-42* pCO2-64* pH-7.29* calTCO2-32* Base XS-1 Comment-GREEN TOP ___ 12: 15AM BLOOD Type-ART pO2-55* pCO2-43 pH-7.32* calTCO2-23 Base XS--3 ___ 04: 39AM BLOOD Lactate-4.2* ___ 01: 46AM BLOOD Lactate-5.9* ___ 12: 15AM BLOOD Lactate-7.7* ___ 07: 42PM BLOOD Lactate-2.4* ___ 12: 58AM URINE Color-Straw Appear-Clear Sp ___ ___ 12: 58AM URINE Blood-NEG Nitrite-NEG Protein-TR Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-5.0 Leuks-NEG ___ 12: 58AM URINE RBC-1 WBC-<1 Bacteri-NONE Yeast-NONE Epi-<1 ___ 12: 58AM URINE CastGr-1* CastHy-1* ___ 12: 58AM URINE Hours-RANDOM Creat-65 Na-21 K-37 Cl-19 ___ 12: 58AM URINE Osmolal-469 PCXR: Interval enlargement of the now massive right pleural effusion. Denser and larger consolidation of the left lung, possibly extension of tumor or focal, acute infiltrate, or combination thereof. <MEDICATIONS ON ADMISSION> Robitussin with codeine ___ tsp QHS ATORVASTATIN [LIPITOR] - 80 mg Tablet - one Tablet(s) by mouth one daily - No Substitution BENZONATATE - 100 mg Capsule - 1 Capsule(s) by mouth three times a day CALCITRIOL - 0.25 mcg Capsule - 1 Capsule(s) by mouth every other day CITALOPRAM - (Prescribed by Other Provider) - 10 mg Tablet - 1 Tablet(s) by mouth once a day CLOPIDOGREL [PLAVIX] - (Prescribed by Other Provider) - 75 mg Tablet - 1 Tablet(s) by mouth once a day FOLIC ACID - 1 mg Tablet - one Tablet(s) by mouth one daily - No Substitution LORAZEPAM - 0.5 mg Tablet - ___ Tablet(s) by mouth q6 hours as needed for Nausea METOPROLOL TARTRATE [LOPRESSOR] - (Prescribed by Other Provider) - 50 mg Tablet - one Tablet(s) by mouth ___ BID - No Substitution TRAMADOL - (Prescribed by Other Provider) - 50 mg Tablet - 0.5 (One half) Tablet(s) by mouth three times a day as needed for Pain TRAZODONE - 50 mg Tablet - one Tablet(s) by mouth one daily as needed - No Substitution ASPIRIN - (Prescribed by Other Provider: ___.) - 81 mg Tablet, Chewable - 1 Tablet(s) by mouth one daily - No Substitution RANITIDINE HCL [ACID CONTROL] - 150 mg Tablet - one Tablet(s) by mouth one daily - No Substitution <DISCHARGE MEDICATIONS> N/A <DISCHARGE DISPOSITION> Expired <DISCHARGE DIAGNOSIS> 1. Non small cell lung cancer 2. Melena <DISCHARGE CONDITION> Expired <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> N/A ",The patient was admitted to the MICU and placed on BiPAP for comfort. Her outpt. oncologist was contacted overnight. She underwent thoracentesis for palliation with significant volume taken off. Palliative care was consulted and the decision was made to focus on comfort. Her oncologist visited with her and her family. SHe was transitioned out of the ICU and expired on the floor soon after. ,1836,84
10002155-DS-8,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> Codeine <ATTENDING> ___. <CHIEF COMPLAINT> chest pressure <MAJOR SURGICAL OR INVASIVE PROCEDURE> Cardiac cathetherization <HISTORY OF PRESENT ILLNESS> ___ is a ___ yo female with a past medical history of CAD with a 1 vessel CABG (SVG to LAD) in ___ who presents with chest pressure. She woke up at 8 am with substernal chest pressure. It was severe initially. She took SL NTG x3 with relief of CP for a short period of time. The CP radiated to her right side and eventually down both arms. She reports diaphoresis, but denied associated nausea, vomiting, lightheadedness or dizziness. She reports that she has felt mildly SOB since her recent pneumonia (first diagnosed appox ___ weeks ago). She denied worsening dyspnea. Her cough has improved substantially and is very minimal at this time. She went to her PCP's office and was found to have a new LBBB and anterior ST elevations. She was transferred to the ED. She received Plavix 300mg, Aspirin, boluses of heparin and integrillin. Code STEMI was called and went to the cath lab. Cath showed occluded SVG, Native 3vd, occluded proximal LAD. Wiring the LAD was difficult and there was concern about a possible dissection. One BMS was placed in the proximal LAD. Distal LAD is diminutive past ___ septal and diag branches. She has been hemodynamically stable with HR 60-70s and SBP 120-130s. On the floor, she is currently chest pain free and feels well. . . On review of systems, she denies any prior history of deep venous thrombosis, pulmonary embolism, bleeding at the time of surgery, myalgias, joint pains, cough, hemoptysis, black stools or red stools. She denies recent fevers, chills or rigors. All of the other review of systems were negative. . Cardiac review of systems is notable for absence of chest pain, dyspnea on exertion, paroxysmal nocturnal dyspnea, orthopnea, ankle edema, palpitations, syncope or presyncope. <PAST MEDICAL HISTORY> 1. CARDIAC RISK FACTORS: - Diabetes, + Dyslipidemia, + Hypertension 2. CARDIAC HISTORY: -CABG: Pt with MI in ___ and subsequent 1 vessel CABG SVG ->LAD -PERCUTANEOUS CORONARY INTERVENTIONS: none -PACING/ICD: none 3. OTHER PAST MEDICAL HISTORY: # CVA - small left posterior frontal infarct in ___ for which she is on ___ tab of plavix daily # hypercholesterolemia. # small PFO. # Macular Degereration <SOCIAL HISTORY> ___ <FAMILY HISTORY> Her father died due to CAD at age ___. Her mother had stomach cancer and bone cancer. <PHYSICAL EXAM> GENERAL: WDWN in NAD. Oriented x3. Mood, affect appropriate. HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no pallor or cyanosis of the oral mucosa. No xanthalesma. NECK: Supple with JVP of 8 cm. CARDIAC: PMI located in ___ intercostal space, midclavicular line. RR, normal S1, S2. No m/r/g. No thrills, lifts. No S3 or S4. LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp were unlabored, no accessory muscle use. CTA anteriorly, no crackles, wheezes or rhonchi. ABDOMEN: Soft, NTND. No HSM or tenderness. Abd aorta not enlarged by palpation. No abdominial bruits. EXTREMITIES: No c/c/e. Femoral sheath in place in right groin. SKIN: No stasis dermatitis, ulcers, scars, or xanthomas. PULSES: Right: Carotid 2+ DP 2+ ___ 2+ Left: Carotid 2+ DP 2+ ___ 2+ <PERTINENT RESULTS> EKG: new LBBB with STE in V1 -V3 & V5 that in some leads are >5mm. TELEMETRY: NSR 75, few NSVTs. 2D-ECHOCARDIOGRAM: pending ETT: n/a . CARDIAC CATH: LMCA: 40% distal LAD: Occluded difficult to cross; was crossed and stented in proximal LAD. Distal LAD diffuse diseased. LCX: occluded OM2, 50% LCX RCA: Occluded <MEDICATIONS ON ADMISSION> # Clopidogrel [Plavix] 75 mg Tablet PO Daily # Ezetimibe-Simvastatin [Vytorin ___ 10 mg-20 mg PO daily # Nifedipine 30 mg SR PO qday # Nitroglycerin 0.4 mg/hour Patch 24 hr 1 patch once a day # Nitroglycern sublingual tabs PRN - has not used recently prior to today # Propranolol 80 mg Tablet PO once a day # Multivitamin <DISCHARGE DISPOSITION> Extended Care Facility: ___ <DISCHARGE DIAGNOSIS> Primary: ST elevation myocardial infarction Presumed broncheoalveolar carcinoma <DISCHARGE CONDITION> stable, with 5L oxygen requirement and O2 Sat in the low ___ <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> You were admitted to the hospital for chest pressure and found to have a heart attack. You had a cardiac catheterization and had a bare metal stent placed. After this, you had some trouble breathing and had a scan that showed some nodules in your lungs. A sputum sample was sent and malignant cells were seen. This was thought to be broncheoalveolar lung cancer, and you were treated with one dose of chemotherapy for this. Please follow-up with Dr. ___ to determine if further treatment will be needed. Weigh yourself every morning, call MD if weight goes up more than 3 lbs. The following changes were made to your medications: 1. You were started on plavix, a medication to thin your blood. You must take this medication for 1 month to ensure that your heart stent does not become blocked. ","___ is a ___ yo female with a history of CAD who presented with an STEMI s/p catheterization and was incidentally found to have multiple pulmonary nodules consistent with adenocarcinoma. #. STEMI: Pt presented with an anterior STEMI. Her TIMI risk score was 7 indicating a 41% risk at 14 days of mortality, new or recurrent MI, or severe recurrent ischemia requiring urgent revascularization. Her SVG found to be completely occluded and a BMS was placed in the proximal LAD. Due to the timing of the SVG placement over ___ years ago, it was thought that her LAD had managed to self revascularize and was partially supplied by the RCA. She was started on routine ACS medications: eptifibatide for 18 hrs, plavix 75 and aspirin 325mg, metoprolol, captopril, and atorvastatin. Cardiac enzymes trended down appropriately with peak Ck and CKMB at 107 and 18.2. There was concern for acute heart failure from ischemic insult oxygen requirement. However, she was noted to also have a RLL pneumonia and no significant pulmonary edema (see below). ECHO showed moderate to severe regional left ventricular systolic dysfunction with anterior and anterospetal akinesis and inferior/inferolateral hypokinesis. Initially, patient was started on coumadin for ventricular thrombus prophylaxis, but this was subsequantly discontinued as risk of bleeding outweighed benefit. # Hypoxia: Upon hospitalization, patient was maintaing saturations in low ___ on 6L from baseline 92% on RA. CXR showed RLL pneumonia, and patient was subsequantly started on ceftriaxone, azithromycin, metronidazole. As the patient had history recurrent RLL pneumonia, a CT scan was obtained which showed severe right lower lobe consolidation and extensive, new diffuse lung nodules with sputum cytology positive for adenocarcinoma. Hypoxia was initially felt to be a combination of postobstructive pneumonia and tumor burden from adenocarcinoma. Antibiotics were changed to vancomycin, levofloxacin and flagyl of which she completed a 10 day course. Repeat CT scan showed little interval improvement in right lower lobe infiltrate. Respiratory status remained tenuous, patient requiring high flow O2 with 6LNC with desaturations to high ___ with activity. Prior to discharge O2 requirement was 5L by nasal cannula. She was breathing comfortably with oxygen saturation in the low ___. Likely this will continue to be necessary for some time. A shovel mask may be used to assist with oxygenation as needed. # Lung nodules/ Broncheoalveolar carcinoma: CT scan with diffuse pulmonary nodules and sputum cytology positive for adenocarcinoma. Etiology was felt to be primary bronchioalveolar vs metastatic thyroid dx (prior dx of possible microfollicular carcinoma) although routine cancer screening was not up-to-date. A tissue diagnosis was not attained given the patient's high oxygen requirement and anticoagulation with plavix/asa in the setting of recent ___ placement. Although patient did not have imaging of her head, staging based on CT torso was IIIa with pulmonary nodules in both lung fields without obvious distal LAD or metastasis. Empiric therapy with single agent chemotherapy was initiated on ___ with Pemetrexed. She tolerated this well. She received dexamethasone on ___ to prevent rash. # Chronic renal insufficiency - Patient with GFR 48. Medications were renally dosed and renal function was carefully followed. She was treated prophylactically with mucomyst prior to and post IV contrast dose. Creatinine remained stable at ___. # Hyperkalemia: The patient was mildly hyperkalemic the day prior to discharge to 5.6 without EKG changes. This responded promptly to kayexalate. Electrolytes should be checked daily until stable. If necessary ACEI could be stopped. # HTN: She was normotensive on ACEI and b-blocker. ",1442,876
10002155-DS-9,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> Codeine <ATTENDING> ___. <CHIEF COMPLAINT> Fever <MAJOR SURGICAL OR INVASIVE PROCEDURE> None <HISTORY OF PRESENT ILLNESS> ___ woman with stage IV lung adenocarcinoma on pemetrexed, CAD, CVA presented with fever from home. Patient was found to have temp of 101.9 by husband on ___, down to 100.4 with cool compresses and acetaminophen. Patient reports having had intermittent nonproductive coughs, mild sore throat, and nasal congestion for the past 3 weeks. She states that she might be now more tired than usual. Patient was referred to the ED. In ED, T 99.2, HR 96, BP 132/64, RR 16, 95%RA. Exam unremarkable. Labs notable for ANC 1200, Na 129, Cr 2.5 (recent baseline 1.5-2.0). CXR showed old LLL consolidation and no new process. Admitted to OMED for further management. <PAST MEDICAL HISTORY> ONCOLOGIC HISTORY: Stage IV lung adenocarcinoma: - In ___: diagnosed with stage IV lung adenoca after admission for STEMI. Received the first cycle of pemetrexed on ___. Most recent chemo was C6 of pemetrexed on ___ - She had been treated over the course of the last year with multiple courses of antibiotics for RLL pneumonia, which failed to resolve on serial chest imaging. NON-ONCOLOGIC HISTORY: # Dyslipidemia # Hypertension # CAD: MI in ___ and subsequent 1 vessel CABG SVG ->LAD, s/p BMS in LAD in ___ after anterior STEMI # CVA - small left posterior frontal infarct in ___ small PFO # Macular Degereration <SOCIAL HISTORY> ___ <FAMILY HISTORY> Her father died due to CAD at age ___. Her mother had stomach cancer and osteosarcoma. No history of lung cancer, colon cancer or breast cancer. <PHYSICAL EXAM> Gen: elderly woman in NAD HEENT: EOMI, OP moist without lesion Neck: supple, no LAD CV: RRR, normal S1/S2, no m/r/g Lungs: Poor aeration at L base Abd: soft, NT, ND, BS present Ext: no c/c/e <PERTINENT RESULTS> WBC-2.0*# RBC-2.39* HGB-7.4* HCT-22.7* MCV-95 NEUTS-62 BANDS-2 LYMPHS-14* MONOS-13* EOS-4 BASOS-1 ATYPS-4* ___ MYELOS-0 PLT COUNT-111*# GLUCOSE-124* UREA N-57* CREAT-2.5* SODIUM-129* POTASSIUM-4.9 CHLORIDE-96 TOTAL CO2-25 LACTATE-0.6 URINE COLOR-Yellow APPEAR-Clear SP ___ URINE BLOOD-TR NITRITE-NEG PROTEIN-25 GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-5.0 LEUK-NEG URINE ___ BACTERIA-FEW YEAST-NONE ___ TRANS ___ STUDIES: Chest Xray ___: 1. In setting of extensive bronchoalveolar carcinoma, and the absence of recent comparable studies, new pneumonia would be difficult to recognize in the right lower and middle lobes. CT Chest ___: 1. Increased bronchial and peribronchial nodules with ground-glass halos since ___, predominating upper and middle lobes, most consistent with infection. 2. Stable right lower lobe reticular opacities with areas of consolidation and widespread nodules predominantly involving the right upper and middle lobes, consistent with known bronchioalveolar cell carcinoma. 3. Stable large left thyroid mass. 4. Stable abdominal aortic intimal calcification displacement. 5. Stable renal cysts. Miniscule nonobstructive right renal calculus. 6. Moderate emphysema. <MEDICATIONS ON ADMISSION> amlodipine 5 mg daily atorvastatin 80 mg daily clopidogrel 75 mg daily aspirin 81 mg daily ranitidine 150 mg daily folate loperamide prn lorazepam prn metoclopramide prn ondansetron prn trazodone 50 mg daily prn <DISCHARGE MEDICATIONS> 1. Amlodipine 5 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 2. Atorvastatin 80 mg Tablet Sig: One (1) Tablet PO once a day. 3. Clopidogrel 75 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 4. Aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable PO DAILY (Daily). 5. Ranitidine HCl 150 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 6. Folic Acid 1 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 7. Loperamide 2 mg Tablet Sig: One (1) Tablet PO four times a day as needed for diarrhea. 8. Lorazepam Oral 9. Metoclopramide Oral 10. Zofran Oral 11. Trazodone 50 mg Tablet Sig: One (1) Tablet PO at bedtime as needed for insomnia. 12. Azithromycin 250 mg Tablet Sig: One (1) Tablet PO Q24H (every 24 hours) for 3 days: First dose on ___. Disp: *3 Tablet(s)* Refills: *0* 13. Cefuroxime Axetil 500 mg Tablet Sig: One (1) Tablet PO twice a day for 8 days: First dose on night of ___. Please take antibiotic to its completion. Disp: *17 Tablet(s)* Refills: *0* 14. Senna 8.6 mg Tablet Sig: One (1) Tablet PO twice a day as needed for constipation. 15. Metoprolol Tartrate 50 mg Tablet Sig: One (1) Tablet PO BID (2 times a day). 16. Polyethylene Glycol 3350 17 gram/dose Powder Sig: One (1) PO DAILY (Daily) as needed for constipation. <DISCHARGE DISPOSITION> Home With Service Facility: ___ <DISCHARGE DIAGNOSIS> Primary Diagnosis: Community-Acquired Pneumonia Secondary Diagnosis: Non-small cell lung cancer Coronary Artery Disease <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> You were admitted to the hospital after a fever. You underwent a CT scan of your chest that showed that you likely have pneumonia in your right lung. You were started on antibiotics to treat this pneumonia. You now have an increased oxygen requirement and should ALWAYS wear supplemental oxygen at rate of 2 liters per minute. You also had a low blood count and were given a blood transfusion. It was felt that your blood count was low due to chemotherapy. You should weigh yourself every morning and call your doctor if you gain more than 3 pounds or notice increasing shortness of breath, or leg swelling. Changes to your medications: ADDED continuous supplemental oxygen at 2 liters per minute ADDED cefuroxime 500 mg BID for 8 more days ADDED azithromycin 250mg by mouth for 3 more days ADDED Senna 1 tab twice daily as needed for constipation ADDED Polyethylene Glycol (Miralax) 1 packet daily as needed for constipation ","___ year old woman with stage IV lung adenoca, CAD who presented with fever at home. #. Fever: She presented with ___ weeks of fatigue, nonproductive cough that is chronic, and 1 day of fevers. Chest xray was unremarkable but could not rule out infection given the location of her lung cancer. She had negative blood and urine cultures. She underwent CT chest on admission, as she was due for a repeat CT scan the following week routinely. The CT chest was concerning for a new infectious process in the right upper and middle lobes, as well as stable areas of consolidation and nodules consistent with bronchioalveolar carcinoma. She was started on ceftriaxone and azithromycin and was discharged on cefuroxime and azithromycin. She was also discharged on home oxygen (she already used oxygen sometimes at home and was instructed to use it full-time after discharge). #. Acute renal failure: She had an elevated creatinine on admission to 2.5 from a recent baseline of 1.3-1.8. This was felt to be prerenal azotemia and it improved with IV hydration. However, she still has new renal insufficiency and would likely benefit from follow-up with nephrology after discharge. She was also instructed to follow a low potassium diet. #. Hyponatremia: She had low serum sodium on admission, felt to be related to hypovolemia in the setting of her illness. Her sodium improved to normal levels with IV fluids. #. Stage IV Lung Adenocarcinoma: She is s/p 6 cycles of pemetrexed. She should follow-up with her primary oncologist for further treatment. #. Anemia: She was given 1 unit of PRBCs for anemia on admission. Her anemia was felt to be related to her recent chemotherapy. #. CAD: She was continued on a statin, aspirin, and clopidogrel. #. HTN: She was continued on amlodipine. ",1732,428
10002167-DS-10,"<SEX> F <SERVICE> SURGERY <ALLERGIES> ___ <ATTENDING> ___. <CHIEF COMPLAINT> Nausea/Vomiting <MAJOR SURGICAL OR INVASIVE PROCEDURE> Band adjustment <HISTORY OF PRESENT ILLNESS> Ms. ___ is a ___ s/p lap band in ___ who prsents with a 1 week history of nausea, non-bilious non-bloody emesis of undigested food after eating, intolerance to solids/softs, hypersalivation, and moderate post-prandial epigastric discomfort. She denies fever, chills, hematemesis, BRBPR, melena, diarrhea, or sympotoms of dehydration, but was recently evaluated for dizziness in an ED with a diagnosis given of BPPV. Of note, the patient underwent an unfill of her band from 5.8 to 3.8ml on ___ for similar symptoms, the band was subseqently been filled to 4.8 on ___, 5.2 on ___, and most recently to 5.6ml on ___. <PAST MEDICAL HISTORY> PMHx: Hyperlipidemia and with elevated triglyceride, iron deficiency anemia, irritable bowel syndrome, allergic rhinitis, dysmenorrhea, vitamin D deficiency, question of hypothyroidism with elevated TSH level, thalassemia trait, fatty liver and cholelithiasis by ultrasound study. A history of kissing tonsils that was associated with obstructive sleep apnea and gastroesophageal reflux, these have resolved completely after the tonsillectomy in ___. History of polycystic ovary syndrome <SOCIAL HISTORY> ___ <FAMILY HISTORY> bladder CA; with diabetes, breast neoplasia, colon CA, ovarian CA and sarcoma <PHYSICAL EXAM> VS: Temp: 97.9, HR: 72, BP: 113/64, RR: 16, O2sat: 100% RA GEN: A&O, NAD HEENT: No scleral icterus, MMM CV: RRR PULM: No W/R/C, no increased work of breathing ABD: Soft, nondistended, non-tender to palpation in epigastric region, no rebound or guarding, palpable port Ext: No ___ edema, warm and well perfused <PERTINENT RESULTS> ___ 12: 16AM PLT COUNT-243 ___ 12: 16AM NEUTS-46.0 ___ MONOS-6.9 EOS-1.8 BASOS-0.5 IM ___ AbsNeut-4.88 AbsLymp-4.72* AbsMono-0.73 AbsEos-0.19 AbsBaso-0.05 ___ 12: 16AM estGFR-Using this ___ 01: 02AM URINE MUCOUS-RARE ___ 01: 02AM URINE HYALINE-1* ___ 01: 02AM URINE RBC-4* WBC-4 BACTERIA-MOD YEAST-NONE EPI-11 ___ 01: 02AM URINE BLOOD-NEG NITRITE-NEG PROTEIN-30 GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-6.5 LEUK-TR ___ 01: 02AM URINE COLOR-Yellow APPEAR-Hazy SP ___ ___ 01: 02AM URINE UCG-NEGATIVE ___ 01: 02AM URINE HOURS-RANDOM ___ 01: 02AM URINE HOURS-RANDOM <DISCHARGE INSTRUCTIONS> You were admitted to ___ for your Nausea and vomiting. Your band was tight enough to cause your nausea and vomiting, 1.5 cc has been taken out from your band in which 2.5cc total left. you subsequently tolerated a water bolus test. You have been deemed fit to be discharged from the hospital. Please return if your nausea becomes untolerable or you start vomiting again. Please continue taking your home medications. Thank you for letting us participate in your healthcare. ","___ was admitted from ED on ___ for nausea and vomiting after any po intake. Of note, she has had similar symptomes last year. She was started on IV fluids for rehydration. Her laboratory values were unremarkable on admission and her symptoms gradually improved with anti-emetic medications and IV fluid therapy. She was back to her baseline clinical status after unfilling the band by 1.5cc. Water challenge test was done after band adjustment and was negative for any pain, nausea or vomiting. She was discharged in good condition with instructions to follow up with Dr. ___ ___ after 2. Discharge Medications: 1. Lorazepam 0.5 mg PO BID:PRN anxiety 2. BusPIRone 5 mg PO TID Discharge Disposition: Home Discharge Diagnosis: nausea and vomiting due to tight band Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Followup Instructions: ___",894,208
10002167-DS-9,"<SEX> F <SERVICE> SURGERY <ALLERGIES> ___ <ATTENDING> ___. <CHIEF COMPLAINT> Morbid obesity <MAJOR SURGICAL OR INVASIVE PROCEDURE> ___: 1. Laparoscopic repair of paraesophageal hernia. 2. Laparoscopic adjustable gastric band. <HISTORY OF PRESENT ILLNESS> Per Dr. ___ has class III morbid obesity with ___ of 238.4 pounds as of ___ with initial screen ___ of 241.4 pounds on ___, height is 64 inches and BMI of 40.9. Her previous ___ loss efforts have included ___ Watchers, ___ Loss, Slim-Fast, over-the-counter pancreatic lipase inhibitor ___ visits. She has lost up to 20 pounds but unable to maintain the ___. Her lowest ___ as an adult was 180 pounds and her highest ___ was her initial screen ___ of 241.4 pounds. She weighed 225.4 pounds ___ years ago and 235 pounds one year ago. She stated that she has been struggling with ___ since ___ years of age and cites as factors contributing to her excess ___ genetics, inconsistent meal pattern, late night eating, large portions, too many carbohydrates, grazing and emotional eating at times. For exercise she does ___ one hour ___ times per week, elliptical ___ minutes ___ times per week and some kettle bell training. She denied history of eating disorders and does have depression, has not been seen by a therapist nor has she been hospitalized for any mental health issues and she is not on any psychotropic medications at this time. <PAST MEDICAL HISTORY> PMHx: Hyperlipidemia and with elevated triglyceride, iron deficiency anemia, irritable bowel syndrome, allergic rhinitis, dysmenorrhea, vitamin D deficiency, question of hypothyroidism with elevated TSH level, thalassemia trait, fatty liver and cholelithiasis by ultrasound study. A history of kissing tonsils that was associated with obstructive sleep apnea and gastroesophageal reflux, these have resolved completely after the tonsillectomy in ___. History of polycystic ovary syndrome <FAMILY HISTORY> bladder CA; with diabetes, breast neoplasia, colon CA, ovarian CA and sarcoma <PHYSICAL EXAM> VSS Constitutional: NAD Neuro: Alert and oriented x 3 Cardiac: RRR, NL S1,S2 Lungs: CTA B Abd: Obese, soft, non-distened, appropriate ___ tenderness, no rebound tenderness/guarding Wounds: Abd lap sites with primary dsg, slight serosanguinous staining x 1, no periwound erythema Ext: No edema <PERTINENT RESULTS> LABS: ___ 09: 20AM BLOOD WBC-9.8 RBC-5.19 Hgb-14.0 Hct-41.9 MCV-81* MCH-27.0 MCHC-33.5 RDW-13.5 Plt ___ ___ 09: 20AM BLOOD Plt ___ ___ UGI SGL CONTRAST W/ KUB: IMPRESSION: Slightly horizontally positioned lap band with a patent stoma and no evidence of leak. <MEDICATIONS ON ADMISSION> The Preadmission Medication list may be inaccurate and requires futher investigation. 1. Multivitamins W/minerals 1 TAB PO DAILY 2. Ascorbic Acid ___ mg PO DAILY 3. cholecalciferol (vitamin D3) *NF* 3,000 unit Oral daily 4. Cyclobenzaprine ___ mg PO TID: PRN muscle spasms <DISCHARGE MEDICATIONS> 1. OxycoDONE-Acetaminophen Elixir ___ mL PO Q4H: PRN Pain RX *oxycodone-acetaminophen [Roxicet] 5 mg-325 mg/5 mL ___ ml by mouth every four (4) hours Disp #*250 Milliliter Refills: *0 2. Docusate Sodium (Liquid) 100 mg PO BID: PRN Constipation RX *docusate sodium 50 mg/5 mL ___ ml by mouth twice a day Disp #*250 Milliliter Refills: *0 3. Ascorbic Acid ___ mg PO DAILY 4. cholecalciferol (vitamin D3) *NF* 3,000 unit Oral daily 5. Multivitamins W/minerals 1 TAB PO DAILY <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Morbid obesity Obstructive sleep apnea <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> <DISCHARGE INSTRUCTIONS> Please call your surgeon or return to the emergency department if you develop a fever greater than 101.5, chest pain, shortness of breath, severe abdominal pain, pain unrelieved by your pain medication, severe nausea or vomiting, severe abdominal bloating, inability to eat or drink, foul smelling or colorful drainage from your incisions, redness or swelling around your incisions, or any other symptoms which are concerning to you. Diet: Stay on Stage III diet until your follow up appointment. Do not self advance diet, do not drink out of a straw or chew gum. Medication Instructions: Resume your home medications except please do not take your cyclobenzaprine while taking pain medicaiton. CRUSH ALL PILLS. You will be starting some new medications: 1. You are being discharged on medications to treat the pain from your operation. These medications will make you drowsy and impair your ability to drive a motor vehicle or operate machinery safely. You MUST refrain from such activities while taking these medications. 2. You should begin taking a chewable complete multivitamin with minerals. No gummy vitamins. 3. You should take a stool softener, Colace, twice daily for constipation as needed, or until you resume a normal bowel pattern. 4. You must not use NSAIDS (non-steroidal anti-inflammatory drugs) Examples are Ibuprofen, Motrin, Aleve, Nuprin and Naproxen. These agents will cause bleeding and ulcers in your digestive system. Activity: No heavy lifting of items ___ pounds for 6 weeks. You may resume moderate exercise at your discretion, no abdominal exercises. Wound Care: You may shower, no tub baths or swimming. If there is clear drainage from your incisions, cover with clean, dry gauze. Your steri-strips will fall off on their own. Please remove any remaining strips ___ days after surgery. Please call the doctor if you have increased pain, swelling, redness, or drainage from the incision sites. ","Ms. ___ presented to ___ on ___. Pt was evaluated by anaesthesia and taken to the operating room where she underwent a laparoscopic adjustable gastric band placement and repair of paraesophageal hernia. There were no adverse events in the operating room; please see the operative note for details. Pt was extubated, taken to the PACU until stable, then transferred to the ward for observation. Post-operatively, the patient remained afebrile with stable vital signs. The patients pain was well controlled with oral Roxicet prn. The patient remained stable from both a cardiovascular and pulmonary standpoint; she was maintained on CPAP overnight for known sleep apnea. The patient was initially on a bariatric stage 1 diet, but was made NPO at ___ POD1 for an UGI series. The UGI was negative for leak or obstruction, therefore, the patient's diet advanced sequentially to bariatric stage 3 and well tolerated; pts intake and output were closely monitored. Urine output remained adequate throughout the hospitalization. The received subcutaneous heparin and venodyne boots were used during admission; early and frequent ambulation were strongly encouraged. The patient was subsequently discharged to home on POD1. The patient received discharge teaching and follow-up instructions with understanding verbalized and agreement with the discharge plan. She will follow-up with Dr. ___ the bariatric dietitian in clinic in 2 weeks. ",1462,297
10002221-DS-10,"<SEX> F <SERVICE> SURGERY <ALLERGIES> Codeine / Augmentin / Topamax <ATTENDING> ___ ___ Complaint: left breast swelling and pain <MAJOR SURGICAL OR INVASIVE PROCEDURE> Evacuation of hematoma <HISTORY OF PRESENT ILLNESS> ___ woman on anticoagulation with L breast IDC Grade 3 now s/p L breast lumpectomy and SLNB with left breast swelling and pain concerning for a hematoma. <PAST MEDICAL HISTORY> Dyslipidemia, varicose veins (R>L) s/p ligation, COPD, OSA (+CPap), recent URI (received course of Zithromax), bilateral PEs (___), antiphospholipid antibody syndrome (on lifelong anticoagulation), T2DM (last A1C 6.2 on ___, cerebral aneurysm (followed by Dr. ___, unchanged), GERD, diverticulosis, h/o colon polyps, depression, s/p right CMC joint arthroplasty, b/l rotator cuff repair, excision right ___ digit mass, CCY w/stone & pancreatic duct exploration (___), hysterectomy, tonsillectomy <SOCIAL HISTORY> ___ <FAMILY HISTORY> No family hx of DVT or PE, two sisters have atrial fibrillation. <PHYSICAL EXAM> <PHYSICAL EXAM> VS: ___ 0313 Temp: 98.2 PO BP: 98/62 HR: 79 RR: 18 O2 sat: 95% O2 delivery: RA GEN: NAD, pleasant, conversant HEENT: NCAT, EOMI, sclera anicteric CV: RRR PULM: no increased work of breathing, comfortable on RA BREAST: L breast with dependent ecchymosis, mildly ttp inferior breast, incision C/D/I. JP drain with serosanguineous output. ABD: soft, non-tender, non-distended, no masses or hernia EXT: Warm, well-perfused, no edema, no tenderness NEURO: A&Ox3, no focal neurologic deficits PSYCH: normal judgment/insight, normal memory, normal mood/affect <PERTINENT RESULTS> ___ 07: 33AM BLOOD WBC-4.8 RBC-2.86* Hgb-8.6* Hct-27.2* MCV-95 MCH-30.1 MCHC-31.6* RDW-14.7 RDWSD-48.7* Plt ___ ___ 07: 33AM BLOOD ___ PTT-26.2 ___ ___ 07: 33AM BLOOD Glucose-130* UreaN-7 Creat-0.8 Na-141 K-4.2 Cl-101 HCO3-31 AnGap-9* ___ 07: 33AM BLOOD Calcium-8.2* Phos-3.8 Mg-2.0 EXAMINATION: CTA CHEST WITH CONTRAST COMPARISON: Chest CT dated ___. FINDINGS: HEART AND VASCULATURE: There is no central pulmonary embolism. The thoracic aorta is normal in caliber without evidence of dissection or intramural hematoma. The heart, pericardium, and great vessels are within normal limits. No pericardial effusion is seen. AXILLA, HILA, AND MEDIASTINUM: There is a 8.8 x 5.8 x 9.8 cm collection in the left breast, with density measuring 39 Hounsfield units, consistent with hematoma. There are few foci of air within the collection, likely from prior aspiration, as well as few punctate hyperdensities at the periphery. No axillary, mediastinal, or hilar lymphadenopathy is present. The right axilla is not included on the study. No mediastinal mass. PLEURAL SPACES: No pleural effusion or pneumothorax. LUNGS/AIRWAYS: Partially visualized lungs are clear without masses or areas of parenchymal opacification. The airways are patent to the level of the segmental bronchi bilaterally. BASE OF NECK: Visualized portions of the base of the neck show no abnormality. BONES: No suspicious osseous abnormality is seen.? There is no acute fracture. IMPRESSION: 8.8 x 5.8 x 9.8 cm left breast hematoma, with no evidence of active bleed. Please note, timing was suboptimal as the patient needed to be re-scanned due to incomplete field-of-view on initial images, however, the density of the collection was unchanged on all series. <MEDICATIONS ON ADMISSION> Active Medication list as of ___: Medications - Prescription ALBUTEROL SULFATE - albuterol sulfate 2.5 mg/3 mL (0.083 %) solution for nebulization. 3 ml inhalation four times a day as needed for cough, wheeze ALBUTEROL SULFATE [PROAIR HFA] - ProAir HFA 90 mcg/actuation aerosol inhaler. 2 puffs inhalation q4-6 hours as needed for cough/wheeze ATORVASTATIN - atorvastatin 40 mg tablet. 1 (One) tablet(s) by mouth at bedtime - (Prescribed by Other Provider; Dose adjustment - no new Rx) ENOXAPARIN - enoxaparin 100 mg/mL subcutaneous syringe. 100 mg SC twice daily approximately 12 hours apart (will start ___, last dose ___ AM). - (Prescribed by Other Provider; Dose adjustment - no new Rx) ERYTHROMYCIN - erythromycin 5 mg/gram (0.5 %) eye ointment. Apply ___ inch affected eye four times a day FUROSEMIDE - furosemide 20 mg tablet. ___ tablet(s) by mouth once a day as needed for leg swelling HYDROMORPHONE - hydromorphone 2 mg tablet. ___ tablet(s) by mouth every four (4) hours as needed for severe pain do not drink alcohol or drive while taking this medication NEBULIZER AND COMPRESSOR [PORTABLE NEBULIZER SYSTEM] - Portable Nebulizer System. Use with albuterol nebulizer soln four times a day as needed for cough/wheeze OMEPRAZOLE - omeprazole 20 mg capsule,delayed release. TAKE 1 CAPSULE TWICE DAILY FOR GASTROESOPHAGEAL REFLUXDISEASE SERTRALINE - sertraline 100 mg tablet. 1.5 tablet(s) by mouth once a day TRAMADOL - tramadol 50 mg tablet. one tablet(s) by mouth three times a day TRAZODONE - trazodone 50 mg tablet. 1 tablet(s) by mouth at bedtime as needed for insomia WARFARIN - warfarin 5 mg tablet. 1 (One) tablet(s) by mouth 2 times a ___, ___ tabs po 5 times a week (last dose per ___ clinic ___ - (Prescribed by Other Provider; Dose adjustment - no new Rx) Medications - OTC ACETAMINOPHEN - acetaminophen 500 mg tablet. 2 tablet(s) by mouth 3 times daily as needed for pain - ___ DC med rec) CHOLECALCIFEROL (VITAMIN D3) - cholecalciferol (vitamin D3) 2,000 unit tablet. 1 tablet(s) by mouth once a day - (OTC) POLYETHYLENE GLYCOL 3350 [MIRALAX] - Miralax 17 gram/dose oral powder. 1 powder(s) by mouth once a day as needed for constipation - (Prescribed by Other Provider; Dose adjustment - no new Rx) SENNOSIDES [SENNA] - senna 8.6 mg tablet. 1 tablet(s) by mouth once a day as needed for constipation - (OTC) <DISCHARGE MEDICATIONS> 1. TraMADol 50 mg PO Q4H: PRN Pain - Moderate Reason for PRN duplicate override: Alternating agents for similar severity RX *tramadol 50 mg 1 tablet(s) by mouth Q4hr prn Disp #*7 Tablet Refills: *0 2. Atorvastatin 40 mg PO QPM 3. Docusate Sodium 100 mg PO BID 4. Omeprazole 20 mg PO BID 5. Senna 17.2 mg PO HS 6. Sertraline 150 mg PO DAILY 7. TraZODone 50 mg PO QHS: PRN sleep <DISCHARGE DISPOSITION> Home With Service Facility: ___ <DISCHARGE DIAGNOSIS> breast hematoma <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Personal Care: 1. You may keep your incisions open to air or covered with a clean, sterile gauze that you change daily. 2. Clean around the drain site(s), where the tubing exits the skin, with soap and water. 3. Strip drain tubing, empty bulb(s), and record output(s) ___ times per day. 4. A written record of the daily output from each drain should be brought to every follow-up appointment. Your drains will be removed as soon as possible when the daily output tapers off to an acceptable amount. 5. You may wear a surgical bra or soft, loose camisole for comfort. 6. Do not shower while your drain is in place. 7. The Dermabond skin glue will begin to flake off in about ___ days. Activity: 1. You may resume your regular diet. 2. Walk several times a day. 3. DO NOT lift anything heavier than 5 pounds or engage in strenuous activity for 6 weeks following surgery. Medications: 1. Resume your regular medications unless instructed otherwise and take any new meds as ordered . 2. You may take your prescribed pain medication for moderate to severe pain. You may switch to Tylenol or Extra Strength Tylenol for mild pain as directed on the packaging. Please note that Percocet and Vicodin have Tylenol as an active ingredient so do not take these meds with additional Tylenol. 3. Take prescription pain medications for pain not relieved by Tylenol. 4. Take Colace, 100 mg by mouth 2 times per day, while taking the prescription pain medication. You may use a different over-the-counter stool softener if you wish. 5. Do not drive or operate heavy machinery while taking any narcotic pain medication. You may have constipation when taking narcotic pain medications (oxycodone, percocet, vicodin, hydrocodone, dilaudid, etc.); you should continue drinking fluids, you may take stool softeners, and should eat foods that are high in fiber. Call the office IMMEDIATELY if you have any of the following: 1. Signs of infection: fever with chills, increased redness, swelling, warmth or tenderness at the surgical site, or unusual drainage from the incision(s). 2. A large amount of bleeding from the incision(s) or drain(s). 3. Fever greater than 101.5 oF 4. Severe pain NOT relieved by your medication. Return to the ER if: * If you are vomiting and cannot keep in fluids or your medications. * If you have shaking chills, fever greater than 101.5 (F) degrees or 38 (C) degrees, increased redness, swelling or discharge from incision, chest pain, shortness of breath, or anything else that is troubling you. * Any serious change in your symptoms, or any new symptoms that concern you. ANTICOAGULATION: You should begin taking your home warfarin dose this evening (___) and resume taking warfarin at your regular scheduled doses. You will not need a bridge therapy to begin warfarin. DRAIN DISCHARGE INSTRUCTIONS You are being discharged with drains in place. Drain care is a clean procedure. Wash your hands thoroughly with soap and warm water before performing drain care. Perform drainage care twice a day. Try to empty the drain at the same time each day. Pull the stopper out of the drainage bottle and empty the drainage fluid into the measuring cup. Record the amount of drainage fluid on the record sheet. Reestablish drain suction. Please assist patient with drain care. A daily log of individual drain outputs should be maintained and brought with patient to follow up appointment with your surgeon. ","Ms. ___ is a ___ woman who was admitted to the breast service following a left breast lumpectomy for invasive carcinoma performed on ___. She presented with a recurrent left breast hematoma after it was evacuated by needle aspiration in clinic on ___. She was admitted for observation and surgical evacuation of her hematoma. On ___ she was brought to the operating room for evacuation of the left ___ hematoma and placement of a surgical drain. Hospital course as detailed below: Neuro: pain was controlled with oral pain medication including acetaminophen and tramadol. ___: Vital signs were monitored per protocol. She was continued on her home medications. Resp: she was continued on her home albuterol medications FEN/GI: she was continued on a regular diet throughout her admission. She was briefly made NPO for the operating room and hydrated with IV fluids in the perioperative period. GU: She voided without issue throughout her hospital course Heme: H/H was closely monitored with daily labs and found to be stable. Her home anticoagulation was held during her hospital course. She was resumed on her home dose of warfarin on discharge without a lovenox bridge. She remained on compression boots during her hospital course to prevent DVTs. ID: She was given ancef 2gm IV Q8hrs for prophylaxis, she remained afebrile and did not develop a leukocytosis during her hospital course. Endo: Due to a history of metabolic syndrome and pre-diabetes she was kept on a constant carbohydrate diet. On the day of discharge she was tolerating a regular diet w/o nausea or emesis. She was ambulating independently. Her pain was controlled with oral pain medications. She was afebrile and did not have a leukocytosis, all antibiotics were discontinued. She was discharged home with ___ for drain management and close follow up with Dr. ___ in clinic for drain removal. She will also follow up with Dr. ___ in clinic in early ___ for routine follow up. ",2773,413
10002221-DS-11,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> Codeine / Augmentin / Topamax <ATTENDING> ___. <CHIEF COMPLAINT> RLE pain and swelling <MAJOR SURGICAL OR INVASIVE PROCEDURE> Ultrasound guided steroid injection of the right trochanteric bursa (right hip) <HISTORY OF PRESENT ILLNESS> This is a ___ woman with a history of breast cancer with BRCA1 gene mutation, COPD, cerebral aneurysm, sleep apnea, depression, hyperlipidemia, antiphospholipid syndrome with hx DVT/PE ___ ago on warfarin who presents for evaluation of severe right lower extremity pain. She was just admitted to the hospital for lumpectomy (infiltrating ductal carcinoma of left breast) and sentinel lymph node biopsy on ___, complicated by hematoma status post evacuation on ___. Prior to these procedures, she had severe right lower extremity pain similar to today and underwent a DVT ultrasound on ___ which was negative. Her anticoagulation was held in the hospital due to the hematoma, and she had DVT prophylaxis with pneumoboots. During her postoperative hematoma her anticoagulation was held. She did not have extremity pain during her time in the hospital. However, upon returning home, she developed severe pain which she describes as cramps in her mid calf on the right. She also has pain that intermittently occurs in the right thigh which she describes as spasms. She has not had numbness, tingling, or weakness on that side. She was seen in breast clinic today where she complained of this pain, and was referred to the ED for further evaluation. She initially triggered as a pulseless extremity because of nonpalpable pulses in the right foot. She has been taking Tylenol as well as tramadol with minimal pain relief. Of note, she resumed her warfarin without any enoxaparin bridge this past ___. She has been wearing compression stockings and elevating her leg in an attempt to relieve the pain. In the ED, initial vitals: T 98.7 HR 85 BP 175/77 RR 20 O2 Sat 98% RA - Exam notable for: Right lower extremity with dopplerable pulses, palpable pulses in the left lower extremity. The right lower extremity is warm. There is tenderness to palpation of the right calf. Tenderness to palpation of the right thigh. - Labs notable for: Chem panel: Unremarkable with Cr 0.8 CK 67 CBC: WBC 5.6, Hgb 10.8 with MCV 93, Plt 264 Coags: ___ 14.8, PTT 28.2, INR 1.4 Lactate 1.1 UA: Mod Leuk, few bacteria - Imaging notable for: RLE Ultrasound ___ Right calf veins not visualized. Otherwise, no evidence of deep venous thrombosis in the right lower extremity veins. CT Lower Extremity Right ___ Unremarkable contrast enhanced CT of the right calf with a two vessel runoff to the foot. The veins of the lower extremity are not opacified therefore cannot be assessed for patency. Consider repeat ultrasound to more fully evaluate. No focal collection or obvious muscular abnormality identified by CT. - Pt given: IV Morphine 4mg IV APAP 1g IV NS IV Dilaudid 5 mg total (1mg x 5) Warfarin 7.5mg Atorvastatin 40mg Omeprazole 20mg Surgery was consulted: Recommend vascular surgery consult for possible dvt with history of multiple vein stripping procedures and DVTs. Also recommend admission to medicine for pain control. Vascular surgery was consulted: There is no clear vascular etiology for her pain. - Vitals prior to transfer: T 98.3 HR 83 BP 140/55 RR 20 O2 Sat 100% RA Upon arrival to the floor, the patient reports the pain is ___. She reports again that this pain is similar to the pain she had on ___ but even then an ultrasound showed no DVT. She is able to move her toes but has pain with lifting her leg. She has never had this kind of pain before, even with the vein stripping that she had in the past (age ___. She has no chest pain or shortness of breath. She has had no recent travel or trauma to her leg. <PAST MEDICAL HISTORY> Dyslipidemia, Varicose veins (R>L) s/p ligation, COPD, OSA (+CPap), recent URI (received course of Zithromax), bilateral PEs (___), antiphospholipid antibody syndrome (on lifelong anticoagulation), T2DM (last A1C 6.2 on ___, cerebral aneurysm (followed by Dr. ___, unchanged), GERD, diverticulosis, h/o colon polyps, depression, s/p right CMC joint arthroplasty, b/l rotator cuff repair, excision right ___ digit mass, CCY w/stone & pancreatic duct exploration (___), hysterectomy, tonsillectomy <SOCIAL HISTORY> ___ <FAMILY HISTORY> Mother ___ ___ OVARIAN CANCER dx age ___ Father ___ ___ BRAIN CANCER PGM OVARIAN CANCER Aunt OVARIAN CANCER paternal aunt in ___ MGM ENDOMETRIAL CANCER MGF PROSTATE CANCER Brother ___ ___ KIDNEY CANCER RENAL FAILURE CONGESTIVE HEART FAILURE DIABETES MELLITUS TOBACCO ABUSE ALCOHOL ABUSE Sister ___ ___ OVARIAN CANCER dx age ___ Brother ___ THROAT CANCER dx age ___, died in ___ Sister BRCA1 MUTATION, BREAST CANCER Daughter Living ___ ABNORMAL PAP SMEAR ___ SUBSTANCE ABUSE Son Died ___ SUBSTANCE ABUSE ___ - heroin overdose on ___. <PHYSICAL EXAM> ADMISSION EXAM: -= VITALS: T 97.9 BP 125 / 80 HR 82 RR 16 O2 Sat 94 RA General: Alert, oriented, no acute distress HEENT: MMM, oropharynx clear, EOMI, PERRL, neck supple, JVP not elevated Chest: L breast incisions well healed. S/p L axilla surgical drain removal. CV: Regular rate and rhythm, normal S1 + S2, no murmurs Lungs: Clear to auscultation bilaterally, no wheezes or crackles Abdomen: Soft, non-tender, non-distended, bowel sounds present Ext: Warm, well perfused, right lower extremity is tender to palpation and movement limited by pain. Swelling of RLE > LLE. Palpable 2+ ___ pulses bilaterally. Skin: Warm, dry, varicose veins noted in lower extremities. Neuro: CNII-XII intact, grossly normal strength and sensation and symmetric bilaterally DISCHARGE EXAM: -=== VITALS: Temp: 98.2 (Tm 98.9), BP: 133/74 (127-147/72-83), HR: 76 (76-91), RR: 18, O2 sat: 99% (90-99), O2 delivery: Ra General: Alert, oriented, no acute distress HEENT: MMM, oropharynx clear, EOMI, PERRL, neck supple, JVP not elevated Chest: L breast incisions well healed. S/p L axilla surgical drain removal. CV: RRR, no murmurs Lungs: Clear Abdomen: Soft, non-tender, non-distended, bowel sounds present Ext: Warm, well perfused. No asymmetric swelling. Minimally tender to palpation along the right trochanteric bursa and minimally tender to palpation along the right tibia. Normal ROM though pain elicited with knee flexion; improves with leg raise and extension. Palpable 2+ ___ pulses bilaterally. Skin: varicose veins noted in lower extremities. Neuro: lower extremity sensation is equal on both sides to light touch. Normal bilateral lower extremity strength. Negative babinsky. Ambulating in hallway independently though it precipitates right tibial pain <PERTINENT RESULTS> ADMISSION LABS: -=== ___ 12: 00PM BLOOD WBC-5.6 RBC-3.48* Hgb-10.8* Hct-32.3* MCV-93 MCH-31.0 MCHC-33.4 RDW-14.7 RDWSD-48.6* Plt ___ ___ 12: 00PM BLOOD Neuts-73.6* ___ Monos-4.9* Eos-0.9* Baso-0.7 Im ___ AbsNeut-4.09 AbsLymp-1.08* AbsMono-0.27 AbsEos-0.05 AbsBaso-0.04 ___ 12: 00PM BLOOD ___ PTT-28.2 ___ ___ 12: 00PM BLOOD Glucose-107* UreaN-7 Creat-0.8 Na-139 K-4.0 Cl-100 HCO3-26 AnGap-13 ___ 05: 40AM BLOOD Calcium-8.6 Phos-4.8* Mg-2.2 Iron-36 ___ 05: 40AM BLOOD calTIBC-291 VitB12-331 Ferritn-50 TRF-224 ___ 07: 15AM BLOOD 25VitD-45 ___ 12: 25PM BLOOD Lactate-1.1 DISCHARGE LABS: -=== ___ 04: 41AM BLOOD WBC-5.6 RBC-3.36* Hgb-10.1* Hct-31.1* MCV-93 MCH-30.1 MCHC-32.5 RDW-14.5 RDWSD-48.7* Plt ___ ___ 04: 41AM BLOOD ___ ___ 04: 41AM BLOOD Glucose-132* UreaN-15 Creat-0.7 Na-140 K-5.0 Cl-103 HCO3-26 AnGap-11 ___ 04: 41AM BLOOD Calcium-9.2 Phos-4.0 Mg-2.4 IMAGING: -== Unilat lower extremity vein- R ___ Right calf veins not visualized. Otherwise, no evidence of deep venous thrombosis in the right lower extremity veins. CT RLE ___ Unremarkable contrast enhanced CT of the right calf with a two vessel runoff to the foot. The veins of the lower extremity are not opacified therefore cannot be assessed for patency. Consider repeat ultrasound to more fully evaluate. No focal collection or obvious muscular abnormality identified by CT ___: 1.. Uneventful ultrasound-guided injection of long-acting anesthetic and steroid into theright greater trochanteric bursa. 2. Prior injection, small amount of fluid in the right greater trochanteric bursa and dystrophic calcification within the bursal space. Findings raise suspicion for chronic trochanteric bursitis. <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Atorvastatin 40 mg PO QPM 2. Docusate Sodium 100 mg PO BID 3. Omeprazole 20 mg PO BID 4. Senna 8.6 mg PO HS 5. Sertraline 150 mg PO DAILY 6. TraZODone 50 mg PO QHS: PRN sleep 7. TraMADol 50 mg PO Q8H: PRN Pain - Moderate Reason for PRN duplicate override: Alternating agents for similar severity 8. Polyethylene Glycol 17 g PO DAILY: PRN Constipation - First Line 9. ProAir HFA (albuterol sulfate) 90 mcg/actuation inhalation Q4H: PRN 10. Acetaminophen 1000 mg PO Q8H: PRN Pain - Mild/Fever 11. Albuterol 0.083% Neb Soln 1 NEB IH Q6H: PRN cough, wheeze 12. Vitamin D ___ UNIT PO DAILY 13. Erythromycin 0.5% Ophth Oint 0.5 in BOTH EYES QID 14. Furosemide 20 mg PO DAILY: PRN Leg swelling 15. HYDROmorphone (Dilaudid) 2 mg PO Q4H: PRN Pain - Severe 16. Warfarin 7.5 mg PO 2X/WEEK (___) 17. Warfarin 5 mg PO 5X/WEEK (___) <DISCHARGE MEDICATIONS> 1. Gabapentin 600 mg PO TID RX *gabapentin 600 mg 1 tablet(s) by mouth three times daily Disp #*90 Tablet Refills: *0 2. Lidocaine 5% Patch 1 PTCH TD QAM right hip RX *lidocaine 5 % Apply ___ patches daily Disp #*12 Patch Refills: *0 3. TraMADol 50 mg PO Q6H: PRN Pain - Moderate RX *tramadol 50 mg 1 tablet(s) by mouth Every six hours as needed Disp #*15 Tablet Refills: *0 4. Acetaminophen 1000 mg PO Q8H: PRN Pain - Mild/Fever 5. Albuterol 0.083% Neb Soln 1 NEB IH Q6H: PRN cough, wheeze 6. Atorvastatin 40 mg PO QPM 7. Docusate Sodium 100 mg PO BID 8. Erythromycin 0.5% Ophth Oint 0.5 in BOTH EYES QID 9. Furosemide 20 mg PO DAILY: PRN Leg swelling 10. Omeprazole 20 mg PO BID 11. Polyethylene Glycol 17 g PO DAILY: PRN Constipation - First Line 12. ProAir HFA (albuterol sulfate) 90 mcg/actuation inhalation Q4H: PRN 13. Senna 8.6 mg PO HS 14. Sertraline 150 mg PO DAILY 15. TraZODone 50 mg PO QHS: PRN sleep 16. Vitamin D ___ UNIT PO DAILY 17. Warfarin 5 mg PO 2X/WEEK (___) 18. Warfarin 7.5 mg PO 5X/WEEK (___) <DISCHARGE DISPOSITION> Home With Service Facility: ___ <DISCHARGE DIAGNOSIS> PRIMARY: - Right trochanteric bursitis Right anterior leg pain Right sided varicose veins SECONDARY: - Iron deficiency anemia History of DVT/PE on warfarin Antiphospholipid antibody syndrome Subtherapeutic INR Vitamin D deficiency <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear ___, You were admitted because you were having a lot of leg pain, making it difficult to walk. In the hospital, we gave you a steroid injection near your right thigh for a condition called, Trochanteric Bursitis. We also gave you a medication called Gabapentin to help with your leg pain lower down. We also started you on a medication called Lovenox in order to bridge you back to your warfarin - currently, your warfarin dose is 7.5 mg daily and your INR was 1.9 at discharge (goal ___. Finally, you received 1 dose of intravenous iron because you are iron deficient which may be why you are more fatigued than usual. When you go home, please take your medications as prescribed and make an appointment with your primary care doctor. We do not know what exactly is causing the lower leg pain, so you may want to talk to your doctor about having an MRI of your spine. You can also ask your doctor about prescribing a medication called DICLOFENAC GEL, also called VOLTAREN. This is essentially Motrin or Advil in a topical form and may help your pain. Additionally, please talk to your doctor about why you may be iron deficient. It was a pleasure taking part in your care. We wish you all the best with your health. Sincerely, The team at ___ ","SUMMARY: ================== Ms. ___ is a ___ with a PMH significant for antiphospholipid syndrome with DVTs and PEs on Coumadin, recent L-sided breast cancer s/p lumpectomy, who presented to the ED with acute on chronic right lower extremity and right hip pain, making it difficult to ambulate. Right lower extremity U/S and CT did not reveal a DVT though calf veins were not well visualized. ACTIVE ISSUES: ================== # Right trochanteric bursitis # Right anterior lower leg pain # Right sided varicose veins Pt endorsed >4mths of pain in RLE that became acutely worse over the last few wks. Her initial exam was most consistent with severe trochanteric bursitis on the right. She also has some focal pain along the right tibia which she felt was most consistent with pain from her varicose veins. The XRs of her tibia/fibula and right hip were without obvious pathology. There are no concerning neurologic symptoms to suggest a radiculopathy, no weakness or numbness though she may have some degree of chronic sciatica. Mildly decreased patellar reflex on the right as compared to left may have been in the setting of pain and guarding; strength was normal bilaterally as was her sensation. She underwent U/S guided steroid injection of her trochanteric bursa w/ significant improvement in symptoms; ___ stated that there was some fluid near the bursa, suggestive of acute on chronic trochanteric bursitis. Her anterior shin pain improved with initiation of gabapentin and lidocaine patch in addition to her home tylenol and an increase in the frequency of her home tramadol (q8h PRN to q4h PRN). Pt was not given her home hydromorphone PRN, though she did require one dose of 0.5 mg IV hydromorphone following her injection in the setting of an acute pain episode. She was discharged with Tramadol 50mg x15 tablets given increased requirement. By discharge, she was able ambulate and was felt safe for discharge home with a cane per ___ evaluation. Pt was eager to leave and will reach out to her vascular surgeon for an appointment early in the new year for treatment of her painful varicose veins. # Iron deficiency anemia: Anemia is new since ___. Normocytic. Downtrended overnight to 8.9 from 10.8. No concern for active bleeding. Per iron studies, she is iron deficient with a ferritin of 50. She endorses fatigue and restless leg syndrome. Etiology is unclear, though it may be related to the recent left breast hematoma of her breast (unlikely though the timing fits). Prior EGD with gastritis (___) for which she is on a BID PPI; prior colonoscopy ___ with findings that may be suggestive of celiac disease, though ttg at that time was normal with a normal IgA. She also had two polyps biopsied and were normal. On this admission, a vitamin D level was obtained to assess for evidence of malabsorption iso daily supplementation: level was 45. She was given ferric gluconate IV x1 on ___. TTG was repeated and pending at discharge. CHRONIC ISSUES: =================== # History of DVT/PE on warfarin: # Antiphospholipid antibody syndrome: # Subtherapeutic INR: Lupus anticoagulant positive in ___. She has been taking her home dose of warfarin (5 mg ___ and 7.5 mg other days). Her warfarin was held last ___ iso hematoma and she was not bridged with Lovenox upon reinitiation. INR on this admission was subtherapeutic at 1.4. Bridged during this hospitalization with Lovenox for goal INR ___. She was given an increased dose of warfarin, 7.5 mg daily while in house. INR at discharge was 1.9, with plan to continue home warfarin regimen. Patient will get repeat INR on ___. # Vitamin D deficiency: pt takes 2,000 U vitamin D daily. Repeat level IS 45 which suggests against malabsorption to account for her iron deficiency. TRANSITIONAL ISSUES: ==================== Code status: Full, presumed HCP: ___, granddaughter - ___. - Right trochanteric bursitis: [] Consider repeat injection [] Consider physical therapy - Right anterior leg pain [] discharged on gabapentin 600 mg three times daily [] discharged with tramadol 50mg, home regimen is Q8hrs and required Q4hrs during hospitalization. Will give two day supply of increased dose. Plan to see PCP next week. [] Consider outpatient MRI of the lumbar spine for chronic pain [] Consider EMG [] Vascular surgery follow up as outpt for treatment of painful veins - Iron deficiency anemia: [] Consider repeat IV iron infusion [] F/u pending TTG [] Consider further work up (though may be related to left breast hematoma) - History of DVT/PE, antiphospholipid antibody syndrome, subtherapeutic INR: [] F/u ___ clinic on ___. Patient can continue home Warfarin regimen ",3628,1105
10002221-DS-12,"<SEX> F <SERVICE> ORTHOPAEDICS <ALLERGIES> Codeine / Augmentin / Topamax <ATTENDING> ___. <CHIEF COMPLAINT> Low back pain with radiation down the right leg <MAJOR SURGICAL OR INVASIVE PROCEDURE> DECOMPRESSION L2-S1, FUSION L4-L5, DURAPLASTY on ___ <HISTORY OF PRESENT ILLNESS> Ms. ___ is a ___ female with a past medical history significant for cerebral aneurysm, abdominal aortic aneurysm, antiphospholipid syndrome w/ multiple DVTs and one event of bilateral large PEs on warfarin, BRCA1 mutation w/ L-sided breast cancer s/p lumpectomy, who presents with over one month of right lower back pain with radicular pain down the right leg pain. She had recent admission ___ for acute worsening of RLE pain and swelling in background of about 4 months right leg pain. RLE US did not show evidence of DVT. Exam was most consistent with right trochanteric bursitis and pt received a steroid injection. Her right tibia pain was felt to be ___ to her varicose veins. On this admission Imaging notable for: Normal CT A/P with no e/o nephrolithiasis, MR ___ spine with disc bulge at L2-L3 and L3-4 cause severe narrowing of the spinal canal with crowding of the traversing cauda equina. <PAST MEDICAL HISTORY> Dyslipidemia, Varicose veins (R>L) s/p ligation, COPD, OSA (+CPap), recent URI (received course of Zithromax), bilateral PEs (___), antiphospholipid antibody syndrome (on lifelong anticoagulation), T2DM (last A1C 6.2 on ___, cerebral aneurysm (followed by Dr. ___, unchanged), GERD, diverticulosis, h/o colon polyps, depression, s/p right CMC joint arthroplasty, b/l rotator cuff repair, excision right ___ digit mass, CCY w/stone & pancreatic duct exploration (___), hysterectomy, tonsillectomy <SOCIAL HISTORY> ___ <FAMILY HISTORY> Mother ___ ___ OVARIAN CANCER dx age ___ Father ___ ___ BRAIN CANCER PGM OVARIAN CANCER Aunt OVARIAN CANCER paternal aunt in ___ MGM ENDOMETRIAL CANCER MGF PROSTATE CANCER Brother ___ ___ KIDNEY CANCER RENAL FAILURE CONGESTIVE HEART FAILURE DIABETES MELLITUS TOBACCO ABUSE ALCOHOL ABUSE Sister ___ ___ OVARIAN CANCER dx age ___ Brother ___ THROAT CANCER dx age ___, died in ___ Sister BRCA1 MUTATION, BREAST CANCER Daughter Living 40 ABNORMAL PAP SMEAR ___ SUBSTANCE ABUSE Son Died ___ SUBSTANCE ABUSE ___ - heroin overdose on ___. <PHYSICAL EXAM> Physical Exam On Admission: VITALS: ___ 1104 Temp: 97.9 PO BP: 129/79 R Lying HR: 82 RR: 16 O2 sat: 96% O2 delivery: Ra General: Tearful, expressing right back and leg pain with spasms Chest: L breast incisions well healed. S/p L axilla surgical drain removal. CV: Regular rate and rhythm, normal S1 + S2, no murmurs Lungs: Clear to auscultation bilaterally, no wheezes or crackles Abdomen: Soft, non-tender, non-distended, bowel sounds present Ext: Warm, well perfused, right lower extremity is tender to palpation and movement limited by pain. Swelling of RLE > LLE. Palpable 2+ ___ pulses bilaterally. Skin: Warm, dry, varicose veins noted in lower extremities. Neuro: Grossly oriented MSK exam: Right SI Joint tenderness. Radicular pain worsened with back flexion and relieved with extension. ___ strength bilaterally w/ hip flexion and extension, knee flexion and extension, foot plantar and dorsiflexion, sensation in tact bilaterally ___ Ortho Spine Exam PE: VS ___ ___ Temp: 98.7 PO BP: 135/66 R Lying HR: 99 RR: 18 O2 sat: 94% O2 delivery: Ra ___ ___ Temp: 98.7 PO BP: 135/66 R Lying HR: 99 RR: 18 O2 sat: 94% O2 delivery: Ra NAD, A&Ox4 nl resp effort RRR Sensory: UE C5 C6 C7 C8 T1 (lat arm) (thumb) (mid fing) (sm finger) (med arm) R SILT SILT SILT SILT SILT L SILT SILT SILT SILT SILT T2-L1 (Trunk) SILT ___ L2 L3 L4 L5 S1 S2 (Groin) (Knee) (Med Calf) (Grt Toe) (Sm Toe) (Post Thigh) R SILT SILT SILT SILT SILT SILT L SILT SILT SILT SILT SILT SILT Motor: UE Dlt(C5) Bic(C6) WE(C6) Tri(C7) WF(C7) FF(C8)FinAbd(T1) R 5 5 5 5 5 5 5 L 5 5 5 5 5 5 5 ___ Flex(L1) Add(L2) Quad(L3) TA(L4) ___ ___ R 5 5 5 5 5 5 5 L 5 5 5 5 5 5 5 Reflexes Bic(C4-5) BR(C5-6) Tri(C6-7) Pat(L3-4) Ach(L5-S1) R 2 2 2 2 2 L 2 2 2 2 2 ___: Negative Babinski: Downgoing Clonus: No beats <PERTINENT RESULTS> IMAGING: MR THORACIC SPINE W/O CONTRAST; MR ___ SPINE W/O CONTRAST ___ IMPRESSION: 1. Severe central canal narrowing at L4-5 level from degenerative changes. 2. Large right paramedian, superior disc extrusion L4-5 level, extends into right L4 lateral recess, mass effect on exiting right L4, traversing L5 nerves, severe right L4-5 foraminal narrowing.. 3. Advanced degenerative changes lumbar spine. 4. Moderate central canal narrowing L2-L3, moderate to severe at L3-L4 levels. 5. Multilevel significant foraminal narrowing lumbar spine, as above. 6. Degenerative changes thoracic spine, mild-to-moderate central canal narrowing, foraminal narrowing. CT ABD & PELVIS WITH CONTRAST ___ IMPRESSION: 1. No acute CT findings in the abdomen or pelvis to correlate with patient's reported symptoms. Specifically, no evidence of obstructive renal stone or pyelonephritis. 2. Sigmoid diverticulosis without evidence of acute diverticulitis. Admission Labs: ___ 12: 49PM BLOOD WBC-6.3 RBC-3.97 Hgb-11.9 Hct-37.2 MCV-94 MCH-30.0 MCHC-32.0 RDW-14.3 RDWSD-49.1* Plt ___ ___ 12: 49PM BLOOD ___ PTT-34.3 ___ ___ 12: 49PM BLOOD Glucose-117* UreaN-11 Creat-0.8 Na-143 K-4.3 Cl-106 HCO3-26 AnGap-11 ___ 10: 06AM BLOOD WBC-5.8 RBC-2.81* Hgb-8.5* Hct-26.1* MCV-93 MCH-30.2 MCHC-32.6 RDW-14.0 RDWSD-47.6* Plt ___ ___ 05: 53AM BLOOD WBC-6.6 RBC-2.88* Hgb-8.9* Hct-27.6* MCV-96 MCH-30.9 MCHC-32.2 RDW-14.4 RDWSD-50.4* Plt ___ ___ 04: 30AM BLOOD WBC-6.9 RBC-3.40* Hgb-10.2* Hct-32.6* MCV-96 MCH-30.0 MCHC-31.3* RDW-14.4 RDWSD-50.3* Plt ___ ___ 10: 06AM BLOOD Plt ___ ___ 04: 30AM BLOOD Glucose-107* UreaN-10 Creat-0.7 Na-142 K-4.8 Cl-105 HCO3-25 AnGap-12 ___ 04: 30AM BLOOD Glucose-147* UreaN-12 Creat-0.9 Na-142 K-4.8 Cl-99 HCO3-28 AnGap-15 ___ 08: 49AM BLOOD Glucose-128* UreaN-10 Creat-0.9 Na-141 K-4.3 Cl-102 HCO3-28 AnGap-11 ___ 04: 30AM BLOOD Calcium-8.2* Phos-2.9 Mg-2.0 ___ 08: 49AM BLOOD Calcium-9.5 Phos-4.3 Mg-2.1 ___ 04: 30AM BLOOD Calcium-8.8 Phos-4.6* Mg-2.1 <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Acetaminophen 1000 mg PO Q8H: PRN Pain - Mild/Fever 2. Albuterol 0.083% Neb Soln 1 NEB IH Q6H: PRN cough, wheeze 3. Atorvastatin 40 mg PO QPM 4. Docusate Sodium 100 mg PO BID 5. Omeprazole 20 mg PO BID 6. Polyethylene Glycol 17 g PO DAILY: PRN Constipation - First Line 7. Senna 8.6 mg PO HS 8. Sertraline 150 mg PO DAILY 9. TraZODone 50 mg PO QHS: PRN sleep 10. Vitamin D ___ UNIT PO DAILY 11. Warfarin 7.5 mg PO 2X/WEEK (___) 12. Lidocaine 5% Patch 1 PTCH TD QAM right hip 13. Furosemide 20 mg PO DAILY: PRN Leg swelling 14. ProAir HFA (albuterol sulfate) 90 mcg/actuation inhalation Q4H: PRN 15. Warfarin 5 mg PO 5X/WEEK (___) 16. Gabapentin 600 mg PO TID 17. TraMADol 50 mg PO Q6H: PRN Pain - Moderate <DISCHARGE MEDICATIONS> 1. Diazepam 5 mg PO Q8H: PRN pain/spasm may cause drowsiness RX *diazepam 5 mg 1 tablet by mouth every eight (8) hours Disp #*25 Tablet Refills: *0 2. Enoxaparin Sodium 110 mg SC Q12H Antiphospholipid Syndrome Treatment Bridge Dosing 3. Morphine Sulfate ___ 15 mg PO Q6H: PRN Pain - Severe please do not operate heavy machinery, drink alcohol or drive RX *morphine 15 mg 1 tablet(s) by mouth every six (6) hours Disp #*30 Tablet Refills: *0 4. Furosemide 10 mg PO DAILY: PRN Leg swelling 5. Acetaminophen 1000 mg PO Q8H: PRN Pain - Mild/Fever 6. Albuterol 0.083% Neb Soln 1 NEB IH Q6H: PRN cough, wheeze 7. Atorvastatin 40 mg PO QPM 8. Docusate Sodium 100 mg PO BID 9. Lidocaine 5% Patch 1 PTCH TD QAM right hip 10. Omeprazole 20 mg PO BID 11. Polyethylene Glycol 17 g PO DAILY: PRN Constipation - First Line 12. ProAir HFA (albuterol sulfate) 90 mcg/actuation inhalation Q4H: PRN 13. Senna 8.6 mg PO HS 14. Sertraline 150 mg PO DAILY 15. TraZODone 50 mg PO QHS: PRN sleep 16. Vitamin D ___ UNIT PO DAILY 17. Warfarin 5 mg PO 5X/WEEK (___) 18. Warfarin 7.5 mg PO 2X/WEEK (___) <DISCHARGE DISPOSITION> Extended Care Facility: ___ <DISCHARGE DIAGNOSIS> -Lumbar spinal stenosis. -Spondylolisthesis, L4-L5. -UTI -Constipation Secondary Diagnoses: - History of DVT/PE - Antiphospholipid antibody syndrome - AAA - OSA on CPAP <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> It was a pleasure to care for you at the ___ ___. Why did you come to the hospital? - You came to the hospital because you were having worsening back pain with pain radiating down your right leg. This pain started about a month ago and progressively got worse, making it difficult to walk. You also had burning pain with urination. What did you receive in the hospital? - You had an MRI that showed significant disc herniation in your lower back, which was the cause of your pain. The spine surgeons felt that you would benefit from surgery given that your pain was constant and worsening over the past month. We gave you pain medications and stopped your warfarin until it was safe for you to have surgery. You had a spinal decompression on ___. We also gave you antibiotics for your burning pain with urination, which we believe was caused by a urinary tract infection. What should you do once you leave the hospital? Lumbar Decompression With Fusion: You have undergone the following operation: Lumbar Decompression With Fusion Immediately after the operation: - Activity: You should not lift anything greater than 10 lbs for 2 weeks.You will be more comfortable if you do not sit or stand more than~45 minutes without getting up and walking around. - Rehabilitation/ Physical ___ times a day you should go for a walk for ___ minutes as part of your recovery.You can walk as much as you can tolerate.Limit any kind of lifting. - Diet: Eat a normal healthy diet.You may have some constipation after surgery.You have been given medication to help with this issue. - Brace: You may have been given a brace.If you have been given a brace,this brace is to be worn when you are walking.You may take it off when sitting in a chair or while lying in bed. - Wound Care: Please keep the incision covered with a dry dressing on until your follow up appointment. Do not soak the incision in a bath or pool.If the incision starts draining at anytime after surgery,do not get the incision wet.Call the office at that time. - You should resume taking your normal home medications. - You have also been given Additional Medications to control your pain.Please allow 72 hours for refill of narcotic prescriptions,so please plan ahead.You can either have them mailed to your home or pick them up at the clinic located on ___.We are not allowed to call in or fax narcotic prescriptions(oxycontin,oxycodone,percocet) to your pharmacy.In addition,we are only allowed to write for pain medications for 90 days from the date of surgery. - Follow up: Please Call the office and make an appointment for 2 weeks after the day of your operation if this has not been done already. At the 2-week visit we will check your incision,take baseline X-rays and answer any questions.We may at that time start physical therapy We will then see you at 6 weeks from the day of the operation and at that time release you to full activity. Please call the office if you have a fever>101.5 degrees Fahrenheit and/or drainage from your wound. Physical Therapy: 1)Weight bearing as tolerated.2)Gait,balance training.3)No lifting >10 lbs.4)No significant bending/twisting. Treatments Frequency: Please keep the incision covered with a dry dressing on until your follow up appointment. Do not soak the incision in a bath or pool.If the incision starts draining at anytime after surgery,do not get the incision wet.Call the office at that time. ","Initial Admission: ACTIVE ISSUES: ================== # R Low Back pain and Leg Pain # Radiculopathy Patient presents with severe right lower back pain with prominent lancinating component. CT A/P with no evidence of visceral pathology or nephrolithiasis. MRI L spine with significant disc bulge at L2-L3 and L3-4 cause severe narrowing of the spinal canal and extrusion at L4-5 with significant L4 nerve root compression, likely the cause of patient's pain. She was recently admitted with right leg pain, with exam notable for trochanteric bursitis, now s/p injection of corticosteroid. Currently neruovascularly intact, with no evidence of cord compression by history or on exam. Per ortho spine, would benefit from decompression. She had a DECOMPRESSION L2-S1, FUSION L4-L5, DURAPLASTY on ___ w/ ortho-spine once her INR was 1.2. She was started on a heparin bridge on ___ when her INR dropped below 2.0 and transitioned to lovenox bridge to coumadin on ___ # Dysuria (resolved) # UTI States she has been having burning pain with urination recently. She also feels that she needs to push on her abdomen to urinate. Most concerning for UTI. UA demonstrating large leukocytes and 8 WBC. However, urine culture showing mixed bacterial flora consistent with contamination. Will treat given symptoms. Abdominal pain could also be from constipation in the setting of opioid use. Reports resolution of symptoms on ___. Was treated with bactrim DS BID for 3 days starting ___ and ending ___. CHRONIC ISSUES: =================== # History of DVT/PE # Antiphospholipid antibody syndrome: Lupus anticoagulant positive in ___. Had bilateral PE in ___. She has been taking her home dose of warfarin (7.5 mg ___ and 5 mg other days). Warfarin held on admission for procedure with heparin drip until procedure. # AAA Has a reported history of AAA in chart, but does not follow up with anyone for surveillance and CT abd/pelvis did not show an abdominal aortic aneurysm. # Vitamin D deficiency: - Continued Vitamin D ___ daily # OSA - Remained on CPAP #Other Home Meds: - Continued omeprazole 20mg BID for GERD - Continued sertraline 150mg PO daily for depression - Continued Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN cough, wheeze - Held ProAir - Held trazadone while getting opioids - Held furosemide 20mg PO daily PRN: takes rarely - d/c gabapentin: not helping and not taking - d/c erythromycin- no longer taking Admission to Ortho spine: Ms. ___ is a ___ female with a past medical history significant for OSA, cerebral aneurysm, abdominal aortic aneurysm, antiphospholipid syndrome w/ multiple DVTs and one event of bilateral large PEs on warfarin, BRCA1 mutation w/ L-sided breast cancer s/p lumpectomy, who presents with over one month of right lower back pain with radicular pain down the right leg pain found to have significant disc herniations at L2-L5. She is now s/p L2-5 lami, L4-5 discectomy, and non-instrumented fusion c/b durotomy s/p ___, ___ Post op course: Patient was admitted to the ___ Spine Surgery Service and taken to the Operating Room for the above procedure.Refer to the dictated operative note for further details.The surgery was without complication and the patient was transferred to the PACU in a stable condition. Postoperative DVT ___ drip post op with trasition back to lovenox bridge to coumadin on ___. Activity remained flat/bedrest for dural tear precautions for 48 hours. Activity was advanced after 48 hours. Intravenous antibiotics were continued for 24hrs postop per standard protocol. Initial postop pain was controlled with oral and IV pain medication.Diet was advanced as tolerated.Foley was removed on POD#3. Physical therapy and Occupational therapy were consulted for mobilization OOB to ambulate and ADL's. Post op course was notable for acute blood loss anemia, constipation, pain and hypokalemia. Acute blood loss anemia is stable and did not require intervention. She was treated with Immediate release morphine, Valium and Tylenol for pain control. Oral Potassium was given for hypokalemia of 3.3 on ___. Vitals and labs are otherwise stable. Hospital course was otherwise unremarkable.On the day of discharge the patient was afebrile with stable vital signs, comfortable on oral pain control and tolerating a regular diet. ",3736,1038
10002221-DS-9,"<SEX> F <SERVICE> ORTHOPAEDICS <ALLERGIES> Codeine / Augmentin / Topamax <ATTENDING> ___. <CHIEF COMPLAINT> left knee osteoarthritis/pain <MAJOR SURGICAL OR INVASIVE PROCEDURE> ___: left total knee arthroplasty <HISTORY OF PRESENT ILLNESS> ___ year old female w/left knee osteoarthritis/pain who failed conservative measures, now admitted for left total knee arthroplasty. <PAST MEDICAL HISTORY> Dyslipidemia, varicose veins (R>L) s/p ligation, COPD, OSA (+CPap), recent URI (received course of Zithromax), bilateral PEs (___), antiphospholipid antibody syndrome (on lifelong anticoagulation), T2DM (last A1C 6.2 on ___, cerebral aneurysm (followed by Dr. ___, unchanged), GERD, diverticulosis, h/o colon polyps, depression, s/p right CMC joint arthroplasty, b/l rotator cuff repair, excision right ___ digit mass, CCY w/stone & pancreatic duct exploration (___), hysterectomy, tonsillectomy <SOCIAL HISTORY> ___ <FAMILY HISTORY> No family hx of DVT or PE, two sisters have atrial fibrillation. <PHYSICAL EXAM> Well appearing in no acute distress Afebrile with stable vital signs Pain well-controlled Respiratory: CTAB Cardiovascular: RRR Gastrointestinal: NT/ND Genitourinary: Voiding independently Neurologic: Intact with no focal deficits Psychiatric: Pleasant, A&O x3 Musculoskeletal Lower Extremity: * Aquacel dressing with scant serosanguinous drainage * Thigh full but soft * No calf tenderness * ___ strength * SILT, NVI distally * Toes warm <PERTINENT RESULTS> ___ 06: 30AM BLOOD WBC-6.8 RBC-2.69* Hgb-8.3* Hct-25.3* MCV-94 MCH-30.9 MCHC-32.8 RDW-13.0 RDWSD-44.0 Plt ___ ___ 06: 10AM BLOOD WBC-6.4 RBC-2.77* Hgb-8.6* Hct-26.0* MCV-94 MCH-31.0 MCHC-33.1 RDW-13.1 RDWSD-44.7 Plt ___ ___ 06: 22AM BLOOD WBC-7.6 RBC-3.31* Hgb-10.2*# Hct-30.5*# MCV-92 MCH-30.8 MCHC-33.4 RDW-12.8 RDWSD-42.6 Plt ___ ___ 06: 30AM BLOOD Plt ___ ___ 06: 30AM BLOOD ___ ___ 06: 10AM BLOOD Plt ___ ___ 06: 10AM BLOOD ___ ___ 06: 22AM BLOOD Plt ___ ___ 06: 22AM BLOOD ___ ___ 10: 55AM BLOOD ___ ___ 06: 22AM BLOOD Glucose-136* UreaN-8 Creat-0.7 Na-138 K-3.7 Cl-96 HCO3-27 AnGap-15 ___ 06: 22AM BLOOD Calcium-8.4 Phos-3.1 Mg-1.7 <MEDICATIONS ON ADMISSION> 1. Albuterol 0.083% Neb Soln 2 NEB IH Q4H: PRN wheezing, cough 2. Atorvastatin 40 mg PO QPM 3. econazole 1 % topical BID 4. Enoxaparin Sodium 110 mg SC Q12H Start: Today - ___, First Dose: Next Routine Administration Time 5. Furosemide ___ mg PO DAILY: PRN leg swelling 6. MetFORMIN (Glucophage) 500 mg PO QPM 7. Omeprazole 20 mg PO BID 8. Sertraline 100 mg PO DAILY 9. TraZODone 50 mg PO QHS: PRN insomnia 10. Triamcinolone Acetonide 0.1% Ointment 1 Appl TP BID: PRN rash/itching 11. Warfarin ___ mg PO DAILY16 12. Aspirin 81 mg PO DAILY 13. Vitamin D ___ UNIT PO DAILY <DISCHARGE MEDICATIONS> 1. Docusate Sodium 100 mg PO BID 2. Gabapentin 100 mg PO TID 3. HYDROmorphone (Dilaudid) ___ mg PO Q4H: PRN Pain - Moderate do NOT drink alcohol or drive while taking med 4. Senna 8.6 mg PO BID 5. Acetaminophen 1000 mg PO Q8H 6. Warfarin 5 mg PO TO BE DOSED DAILY PER PCP DOSED DAILY PER PCP, GOAL INR 1.8-2.2 7. Albuterol Inhaler ___ PUFF IH Q6H: PRN shortness of breath 8. Aspirin 81 mg PO DAILY 9. Atorvastatin 40 mg PO QPM 10. econazole 1 % topical BID 11. Furosemide ___ mg PO DAILY: PRN leg swelling 12. MetFORMIN XR (Glucophage XR) 500 mg PO DAILY 13. Omeprazole 20 mg PO BID 14. Sertraline 100 mg PO DAILY 15. TraZODone 50 mg PO QHS: PRN insomnia 16. Triamcinolone Acetonide 0.1% Ointment 1 Appl TP BID: PRN rash/itching 17. Vitamin D ___ UNIT PO DAILY <DISCHARGE DISPOSITION> Extended Care Facility: ___ <DISCHARGE DIAGNOSIS> left knee osteoarthritis/pain <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> 1. Please return to the emergency department or notify your physician if you experience any of the following: severe pain not relieved by medication, increased swelling, decreased sensation, difficulty with movement, fevers greater than 101.5, shaking chills, increasing redness or drainage from the incision site, chest pain, shortness of breath or any other concerns. 2. Please follow up with your primary physician regarding this admission and any new medications and refills. 3. Resume your home medications unless otherwise instructed. 4. You have been given medications for pain control. Please do not drive, operate heavy machinery, or drink alcohol while taking these medications. As your pain decreases, take fewer tablets and increase the time between doses. This medication can cause constipation, so you should drink plenty of water daily and take a stool softener (such as Colace) as needed to prevent this side effect. Call your surgeons office 3 days before you are out of medication so that it can be refilled. These medications cannot be called into your pharmacy and must be picked up in the clinic or mailed to your house. Please allow an extra 2 days if you would like your medication mailed to your home. 5. You may not drive a car until cleared to do so by your surgeon. 6. Please call your surgeon's office to schedule or confirm your follow-up appointment. 7. SWELLING: Ice the operative joint 20 minutes at a time, especially after activity or physical therapy. Do not place ice directly on the skin. You may wrap the knee with an ace bandage for added compression. Please DO NOT take any non-steroidal anti-inflammatory medications (NSAIDs such as Celebrex, ibuprofen, Advil, Aleve, Motrin, naproxen etc) until cleared by your physician. 8. ANTICOAGULATION: Lovenox discontinued on ___ due to INR 1.8. INR goal is 1.8-2.2. Please continue Coumadin 5mg daily. INR to be checked day after discharge. Please direct all INR results to patient's PCP. You may continue your dose of Aspirin 81mg daily. 9. WOUND CARE: Please remove Aquacel dressing on POD#7 after surgery. It is okay to shower after surgery after 5 days but no tub baths, swimming, or submerging your incision until after your four (4) week checkup. Please place a dry sterile dressing on the wound after aqaucel is removed each day if there is drainage, otherwise leave it open to air. Check wound regularly for signs of infection such as redness or thick yellow drainage. 10. ___ (once at home): Home ___, dressing changes as instructed, and wound checks. 11. ACTIVITY: Weight bearing as tolerated on the operative extremity. Two crutches or walker. Wean assistive device as able. Mobilize. ROM as tolerated. No strenuous exercise or heavy lifting until follow up appointment. Physical Therapy: WBAT LLE No range of motion restrictions Wean assistive devices as able Mobilize frequently Treatments Frequency: remove aquacel POD#7 after surgery apply dry sterile dressing daily if needed after aquacel dressing is removed wound checks daily after aquacel removed ","The patient was admitted to the Orthopaedic surgery service and was taken to the operating room for above described procedure. Please see separately dictated operative report for details. The surgery was uncomplicated and the patient tolerated the procedure well. Patient received perioperative IV antibiotics. Postoperative course was remarkable for the following: POD #1, patient was administered 500ml bolus of IV fluids for hypotension ___, which she responded to appropriately. She reported nausea on oxycodone and was switched to dilaudid with no reported adverse effects. POD #2, patient had INR of 1.8 and lovenox was discontinued. Patient will continue Coumadin 5mg daily. Next INR check day after discharge. Please direct results and all questions to PCP for INR monitoring/Coumadin dosing. POD #3, INR 2.0 and patient will be due for 5mg Coumadin upon arrival to rehab facility. Otherwise, pain was controlled with a combination of IV and oral pain medications. The patient received Coumadin starting on POD#0 with a Lovenox bridge starting on POD#1. Lovenox to be continued until INR > 1.5 and discontinued on POD #2 with INR 1.8. Coumadin was dosed daily based on her INR levels. The surgical dressing will remain on until POD#7 after surgery. The patient was seen daily by physical therapy. Labs were checked throughout the hospital course and repleted accordingly. At the time of discharge the patient was tolerating a regular diet and feeling well. The patient was afebrile with stable vital signs. The patient's hematocrit was acceptable and pain was adequately controlled on an oral regimen. The operative extremity was neurovascularly intact and the dressing was intact. The patient's weight-bearing status is weight bearing as tolerated on the operative extremity. Please use walker or 2 crutches, wean as able. Ms. ___ is discharged to rehab in stable condition. **Patient will be in rehab facility for less than 30 days** ",2092,429
10002348-DS-13,"<SEX> F <SERVICE> NEUROSURGERY <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> Headaches <MAJOR SURGICAL OR INVASIVE PROCEDURE> ___ - Suboccipital craniotomy for resection of cerebellar lesion <HISTORY OF PRESENT ILLNESS> ___ is a ___ female with hx cerebral aneurysm clipping in ___ who presents from OSH with left cerebellar hypodensity concerning for underlying lesion. Patient reports that three weeks ago she started having headaches, which is abnormal for her. She describes the headaches to be global and resolve with Tylenol, but at the worst was an ___. She also reports having difficulty walking, which also started about three weeks ago. She describes her walking as ""staggering side to side."" She denies any vision changes, nausea, vomiting, confusion, or word finding difficulty. She saw her eye doctor this morning for routine visit, who referred her to the ED for evaluation of these symptoms. OSH CT showed an area of hypodensity in the left cerebellum, concerning for underlying lesion. She was subsequently transferred to ___. Of note, patient reports her aneurysm clip is not MRI compatible. <PAST MEDICAL HISTORY> - ___ - Hypertension - S/p aneurysm clipping ___ at ___ by Dr. ___ <SOCIAL HISTORY> ___ <FAMILY HISTORY> No known history of stroke, cancer, aneurysm. <PHYSICAL EXAM> ON ADMISSION: O: T: 97.9 BP: 130/62 HR: 64 R 16 O2Sats 98% RA Gen: WD/WN, comfortable, NAD. HEENT: Pupils: L ___, R ___ EOMs full Neck: Supple. Extrem: Warm and well-perfused. Neuro: Mental status: Awake and alert, cooperative with exam, normal affect. Orientation: Oriented to person, place, and date. Language: Speech fluent with good comprehension and repetition. Naming intact. No dysarthria or paraphasic errors. Cranial Nerves: I: Not tested II: Left pupil 5-4mm, right 4-3mm, both equally reactive to light. III, IV, VI: Extraocular movements intact bilaterally without nystagmus. V, VII: Facial strength and sensation intact and symmetric. XI: Sternocleidomastoid and trapezius normal bilaterally. XII: Tongue midline without fasciculations. Motor: Normal bulk and tone bilaterally. No abnormal movements, tremors. Strength full power ___ throughout. Slight left upward drift Sensation: Intact to light touch Coordination: normal on finger-nose-finger and heel to shin ---=== ON DISCHARGE: Exam: Opens eyes: [x]Spontaneous [ ]To voice [ ]To noxious Orientation: [x]Person [x]Place [x]Time Follows commands: [ ]Simple [x]Complex [ ]None Pupils: Right 4-3mm Left 5-4mm - chronic EOM: [ ]Full [x]Restricted - chronic, most prominent left lateral Face Symmetric: [x]Yes [ ]NoTongue Midline: [x]Yes [ ]No Pronator Drift: [ ]Yes [x]No Speech Fluent: [x]Yes [ ]No Comprehension Intact: [x]Yes [ ]No Motor: TrapDeltoid BicepTricepGrip Right 5 5 5 5 5 Left 5 5 5 5 5 IPQuadHamATEHLGast Right5 5 5 5 5 5 Left5 5 5 5 5 5 [x]Sensation intact to light touch <PERTINENT RESULTS> Please see OMR for pertinent lab and imaging results. <MEDICATIONS ON ADMISSION> - ASA 81mg - Alendronate 70mg weekly - Vitamin D3 ___ units daily - Levothyroxine 88mcg daily - Lisinopril 20mg daily <DISCHARGE MEDICATIONS> 1. Acetaminophen 650 mg PO Q6H: PRN Pain - Mild/Fever 2. Bisacodyl 10 mg PO/PR DAILY 3. Dexamethasone 3 mg PO Q8H Duration: 6 Doses start ___: 3tabsq8hrs x2, 2tabsq8hrs x6, 2tabsq12hrs maintenance dose. This is dose # 2 of 3 tapered doses RX *dexamethasone 1 mg 3 tablet(s) by mouth every eight (8) hours Disp #*120 Tablet Refills: *1 4. Docusate Sodium 100 mg PO BID 5. Famotidine 20 mg PO Q24H RX *famotidine 20 mg 1 tablet(s) by mouth twice a day Disp #*60 Tablet Refills: *1 6. Polyethylene Glycol 17 g PO DAILY: PRN Constipation - First Line 7. Senna 17.2 mg PO HS 8. Levothyroxine Sodium 88 mcg PO DAILY 9. Lisinopril 20 mg PO DAILY 10. PrednisoLONE Acetate 1% Ophth. Susp. 1 DROP LEFT EYE QID 11. ValACYclovir 1000 mg PO Q8H 12. Vitamin D ___ UNIT PO DAILY 13. HELD- Alendronate Sodium 70 mg PO 1X/WEEK (___) This medication was held. Do not restart Alendronate Sodium until POD ___ - ___ 14. HELD- Aspirin 81 mg PO DAILY This medication was held. Do not restart Aspirin until POD 14 - ___ ___ glucometer ___ Freestyle glucometer. Check blood sugars ___ hours after a starchy meal. Record numbers and show to your Oncologist. ___ test strips #50. Check blood sugars QD. 3 refills. ___ Lancets #50. Check blood sugars QD. 3 refills. <DISCHARGE DISPOSITION> Home With Service Facility: ___ <DISCHARGE DIAGNOSIS> Brain tumor <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Surgery: - You underwent surgery to remove a brain lesion from your brain. - A sample of tissue from the lesion in your brain was sent to pathology for testing. - Please keep your incision dry until your sutures are removed. - You may shower at this time but keep your incision dry. - It is best to keep your incision open to air but it is ok to cover it when outside. - Call your surgeon if there are any signs of infection like redness, fever, or drainage. Activity: - We recommend that you avoid heavy lifting, running, climbing, or other strenuous exercise until your follow-up appointment. - You make take leisurely walks and slowly increase your activity at your own pace once you are symptom free at rest. ___ try to do too much all at once. - No driving while taking any narcotic or sedating medication. - If you experienced a seizure while admitted, you are NOT allowed to drive by law. - No contact sports until cleared by your neurosurgeon. You should avoid contact sports for 6 months. Medications: - Please do NOT take any blood thinning medication (Aspirin, Ibuprofen, Plavix, Coumadin) until cleared by the neurosurgeon. We held your Aspirin 81mg daily. You are cleared to resume this medication on POD 14 (___). - We held your home Alendronate during this admission. You are cleared to resume this medication on POD 14 (___). - You may use Acetaminophen (Tylenol) for minor discomfort if you are not otherwise restricted from taking this medication. - You were started on Dexamethasone, a steroid that treats intracranial swelling. This Dexamethasone is being tapered down to a maintenance dose of 2mg BID. Please take this medication as prescribed. - While admitted, you had elevated blood glucose levels that needed to be treated by Insulin. You should continue to check your blood sugars daily at home with the prescribed glucometer. You visiting nurse should teach you how to use this device at home. Please record your blood sugars and follow-up with your PCP and ___ regarding the results. Your goal blood sugar is less than 200. What You ___ Experience: - You may experience headaches and incisional pain. - You may also experience some post-operative swelling around your face and eyes. This is normal after surgery and most noticeable on the second and third day of surgery. You apply ice or a cool or warm washcloth to your eyes to help with the swelling. The swelling will be its worse in the morning after laying flat from sleeping but decrease when up. - You may experience soreness with chewing. This is normal from the surgery and will improve with time. Softer foods may be easier during this time. - Feeling more tired or restlessness is also common. - Constipation is common. Be sure to drink plenty of fluids and eat a high-fiber diet. If you are taking narcotics (prescription pain medications), try an over-the-counter stool softener. When to Call Your Doctor at ___ for: - Severe pain, swelling, redness or drainage from the incision site. - Fever greater than 101.5 degrees Fahrenheit - Nausea and/or vomiting - Extreme sleepiness and not being able to stay awake - Severe headaches not relieved by pain relievers - Seizures - Any new problems with your vision or ability to speak - Weakness or changes in sensation in your face, arms, or leg Call ___ and go to the nearest Emergency Room if you experience any of the following: - Sudden numbness or weakness in the face, arm, or leg - Sudden confusion or trouble speaking or understanding - Sudden trouble walking, dizziness, or loss of balance or coordination - Sudden severe headaches with no known reason ","#Brain lesion Patient was found to have cerebellar hypodensity on NCHCT from OSH. CT w/wo contrast was obtained while in the ED at ___ which was concerning for underlying mass lesion and hydrocephalus. (Of note, she was unable to get MRI due to reportedly having a non-compatible aneurysm clip that was placed in ___ at ___. Patient was admitted to the ___ for close monitoring and surgical planning. She was started on dexamethasone 4mg Q6hr for mass effect. CT torso was obtained which showed two lung nodules, see below for more information. Neuro and radiation oncology were consulted. Plan was made for surgical resection of the lesion. On ___, it was determined that her aneurysm clip was MRI compatible and she was able to have a MRI Brain for surgical planning. She went to the OR the evening of ___ for a suboccipital craniotomy for resection of her cerebellar lesion. Postoperatively she was monitored in Neuro ICU, where she remained neurologically and hemodynamically stable. She was transferred to the ___ on POD#2 and made floor status. Her Dexamethasone was ordered to taper down to a maintenance dose of 2mg BID over the course of one week. Her pathology finalized as small cell lung carcinoma. #Lung lesions CT torso was obtained which showed two lung nodules, one in the left paramedian abutting the aortic arch and the other in the right upper lobe. Pulmonary was consulted and stated that no further intervention was indicated until final pathology was back. Heme-Onc was also consulted, and made recommendations that no further lung imaging or separate lung biopsy was needed. Both Pulmonary and Heme-Onc stated that staging and treatment could be determined based on the tissue pathology from resection of the brain lesion. Her final pathology came back as small cell lung carcinoma. She will follow-up with the thoracic oncologist on ___. #Steroid-induced hyperglycemia Throughout her admission, the patient intermittently required sliding scale Insulin for elevated blood sugars while on Dexamethasone. She was evaluated by the ___ inpatient team on ___, who decided that she did not need to go home on Insulin. They recommended discharging her with a glucometer so that she could check her blood sugars daily with a goal blood sugar less than 200. She was advised to record her readings and follow-up with her PCP and ___. #Bradycardia She was due to transfer out to the ___ on POD1, however was kept in the ICU for asymptomatic bradycardia to the ___. She remained asymptomatic, and her heartrate improved with fluids, and administration of her levothyroxine. She intermittently dipped to the ___, however remained asymptomatic. #Bell's palsy The patient was resumed on her home Valacyclovir and Prenisolone gtts. #Urinary urgency On POD 2, the patient complained of urinary urgency and increased frequency. U/A was negative and culture was negative. Her symptoms had resolved at the time of discharge. #Dispo The patient was evaluated by ___ and OT who cleared her for home with services. She was discharged on ___ in stable condition. She will follow up in ___ on ___. ",2205,685
10002430-DS-4,"<SEX> M <SERVICE> SURGERY <ALLERGIES> Corgard / Vasotec <ATTENDING> ___. <CHIEF COMPLAINT> incarcerated inguinal hernia <MAJOR SURGICAL OR INVASIVE PROCEDURE> Left inguinal hernia repair <HISTORY OF PRESENT ILLNESS> ___ with afib on apixiban, CAD s/p CABG, b/l carotid disease, COPD/emphysema with recent pneumonia presents for elective left inguinal hernia repair (large, with incarcerated sigmoid colon) <PAST MEDICAL HISTORY> <PAST MEDICAL HISTORY> BILATERAL MODERATE CAROTID DISEASE CONGESTIVE HEART FAILURE CORONARY ARTERY DISEASE GASTROESOPHAGEAL REFLUX HYPERTENSION SEVERE EMPHYSEMA PULMONARY HYPERTENSION RIGHT BUNDLE BRANCH BLOCK BENIGN PROSTATIC HYPERTROPHY HYPERLIPIDEMIA PAROXYSMAL ATRIAL FIBRILLATION H/O HISTIOPLASMOSIS Past Surgical History: CARDIOVERSION ___ RIGHT LOWER LOBE LOBECTOMY ___ CORONARY BYPASS SURGERY ___ <SOCIAL HISTORY> ___ <FAMILY HISTORY> Non-contributory <PHYSICAL EXAM> Gen: Awake and alert CV: Irregularly irregular rhythm, normal rate Resp: CTAB GI: Soft, appropriately tender near incision, non-distended Incision clean, dry, and intact with no erythema Ext: Warm and well perfused <PERTINENT RESULTS> <DISCHARGE INSTRUCTIONS> Dear Mr. ___, It was a pleasure taking care of you here at ___ ___. You were admitted to our hospital after undergoing repair of your inguinal hernia. You have recovered from surgery and are now ready to be discharged home. Please follow the recommendations below to ensure a speedy and uneventful recovery. ACTIVITY: - Do not drive until you have stopped taking pain medicine and feel you could respond in an emergency. - You may climb stairs. - You may go outside, but avoid traveling long distances until you see your surgeon at your next visit. - Don't lift more than 10 lbs for 6 weeks. (This is about the weight of a briefcase or a bag of groceries.) This applies to lifting children, but they may sit on your lap. - You may start some light exercise when you feel comfortable. - You will need to stay out of bathtubs or swimming pools for a time while your incision is healing. Ask your doctor when you can resume tub baths or swimming. - Heavy exercise may be started after 6 weeks, but use common sense and go slowly at first. - You may resume sexual activity unless your doctor has told you otherwise. HOW YOU MAY FEEL: - You may feel weak or ""washed out"" for 6 weeks. You might want to nap often. Simple tasks may exhaust you. - You may have a sore throat because of a tube that was in your throat during surgery. - You might have trouble concentrating or difficulty sleeping. You might feel somewhat depressed. - You could have a poor appetite for a while. Food may seem unappealing. - All of these feelings and reactions are normal and should go away in a short time. If they do not, tell your surgeon. YOUR INCISION: - Your incision may be slightly red around the edges. This is normal. - If you have steri strips, do not remove them for 2 weeks. (These are the thin paper strips that are on your incision.) But if they fall off before that that's okay). - You may gently wash away dried material around your incision. - It is normal to feel a firm ridge along the incision. This will go away. - Avoid direct sun exposure to the incision area. - Do not use any ointments on the incision unless you were told otherwise. - You may see a small amount of clear or light red fluid staining your dressing or clothes. If the staining is severe, please call your surgeon. - You may shower. As noted above, ask your doctor when you may resume tub baths or swimming. - Over the next ___ months, your incision will fade and become less prominent. YOUR BOWELS: - Constipation is a common side effect of medicine such as Percocet or codeine. If needed, you may take a stool softener (such as Colace, one capsule) or gentle laxative (such as milk of magnesia, 1 tbs) twice a day. You can get both of these medicines without a prescription. - If you go 48 hours without a bowel movement, or have pain moving your bowels, call your surgeon. - After some operations, diarrhea can occur. If you get diarrhea, don't take anti-diarrhea medicines. Drink plenty of fluids and see if it goes away. If it does not go away, or is severe and you feel ill, please call your surgeon. PAIN MANAGEMENT: - It is normal to feel some discomfort/pain following abdominal surgery. This pain is often described as ""soreness"". - Your pain should get better day by day. If you find the pain is getting worse instead of better, please contact your surgeon. -You will receive a prescription from your surgeon for pain medicine to take by mouth. It is important to take this medicine as directed. - Do not take it more frequently than prescribed. Do not take more medicine at one time than prescribed. - Your pain medicine will work better if you take it before your pain gets too severe. - If you are experiencing no pain, it is okay to skip a dose of pain medicine. If you experience any of the folloiwng, please contact your surgeon: - sharp pain or any severe pain that lasts several hours - pain that is getting worse over time - pain accompanied by fever of more than 101 - a drastic change in nature or quality of your pain MEDICATIONS: - Take all the medicines you were on before the operation just as you did before, unless you have been told differently. - If you have any questions about what medicine to take or not to take, please call your surgeon. ","Mr. ___ was admitted to ___ ___ on ___ after undergoing repair of a left incarcerated inguinal hernia. For details of the procedure, please refer to the operative report. His postoperative course was uncomplicated. After a brief stay in the PACU, he was transferred to the regular nursing floor. His pain was controlled with IV medication. On POD #1, he was started on a regular diet, and his pain was controlled with PO pain medication. He voided without issue. He was ambulating independently in the halls. He was given a bowel regimen, and passed flatus. On POD #2, he continued to tolerate his diet, his pain was well-controlled on oral medication, and he continued to ambulate independently. He was discharged home in stable condition on POD #2 with plans to follow-up with Dr. ___. Discharge Medications: 1. Amiodarone 200 mg PO DAILY 2. Apixaban 5 mg PO BID 3. Aspirin 81 mg PO DAILY 4. Docusate Sodium 100 mg PO BID 5. Losartan Potassium 25 mg PO DAILY 6. Omeprazole 10 mg PO DAILY 7. Triamterene-HCTZ (37.5/25) 1 CAP PO DAILY 8. Acetaminophen 1000 mg PO Q6H:PRN pain or fever Do not exceed 4 grams per day. RX *acetaminophen 500 mg ___ tablet(s) by mouth every 6 hours Disp #*60 Tablet Refills:*0 9. OxycoDONE (Immediate Release) 5 mg PO Q4H:PRN pain RX *oxycodone 5 mg ___ tablet(s) by mouth every 4 hours Disp #*40 Tablet Refills:*0 10. Senna 17.2 mg PO HS Take this while you are taking oxycodone. RX *sennosides [Evac-U-Gen (sennosides)] 8.6 mg 1 capsule by mouth daily Disp #*30 Tablet Refills:*0 11. Align (bifidobacterium infantis) 4 mg oral DAILY 12. coenzyme Q10 100 mg oral DAILY 13. Rosuvastatin Calcium 40 mg PO QPM 14. Vitamin D 1000 UNIT PO DAILY Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: Inguinal hernia Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Followup Instructions: ___",1297,557
10002430-DS-5,"<SEX> M <SERVICE> MEDICINE <ALLERGIES> Corgard / Vasotec <ATTENDING> ___ <CHIEF COMPLAINT> leg edema <MAJOR SURGICAL OR INVASIVE PROCEDURE> None <HISTORY OF PRESENT ILLNESS> HISTORY OF PRESENTING ILLNESS: Mr. ___ is an ___ year old gentleman with history of CAD (s/p 3V CABG ___, LM PCI ___, pulmonary HTN, AFib on anticoagulation, ___ (EF 50%) who presents with volume overload and new found RV dilation on office echocardiogram. Patient reports he has had 10 days of waking up feeling nervous and jittery. He also endorses weight gain, and new onset lower extremity swelling. He has not had chest pain, palpitations, orthopnea, or PND. He has not had any fevers, cough, recent travel, medication non compliance, increased salty food intake. He also has not had dyspnea on exertion and rides 4 miles per day on a stationary bike and does 6 minutes of weight lifting. He presented to Dr. ___ today for evaluation. There he had a TTE that showed new RV dilation and was referred to the ___ ED for further evaluation with concern for pulmonary embolism. In the ED, initial vitals were: T98. HR 70, BP 166/65, RR 16, 100% RA. Exam in ED notable for bilateral pitting edema to knees. Labs notable for mild hyponatremia, Cr 1.1. ALT/AST mildly elevated at 81/64. WBC 4, Hgb 11.3, INR 1.3. DDimer <150. UA unremarkable. CXR with mild cardiomegaly but no evidence of consolidation or pulmonary edema. CTA was negative for PE, showed severe emphysema and dilated pulmonary artery. Patient received 20 mg IV Lasix with significant urine output per patient. He was then admitted to the heart failure service for acute heart failure exacerbation and further workup of RV dilation. Vitals on transfer: Afebrile, HR 66, BP 129/54, RR 19, 95%RA. On review of systems, he denies any prior history of stroke, TIA, deep venous thrombosis, pulmonary embolism, bleeding at the time of surgery, myalgias, joint pains, cough, hemoptysis, black stools or red stools. He denies recent fevers, chills or rigors. He denies exertional buttock or calf pain. All of the other review of systems were negative. Cardiac review of systems is notable for absence of chest pain, paroxysmal nocturnal dyspnea, orthopnea, palpitations, syncope or presyncope. <PAST MEDICAL HISTORY> <PAST MEDICAL HISTORY> BILATERAL MODERATE CAROTID DISEASE CONGESTIVE HEART FAILURE CORONARY ARTERY DISEASE GASTROESOPHAGEAL REFLUX HYPERTENSION SEVERE EMPHYSEMA PULMONARY HYPERTENSION RIGHT BUNDLE BRANCH BLOCK BENIGN PROSTATIC HYPERTROPHY HYPERLIPIDEMIA PAROXYSMAL ATRIAL FIBRILLATION H/O HISTIOPLASMOSIS Past Surgical History: CARDIOVERSION ___ RIGHT LOWER LOBE LOBECTOMY ___ CORONARY BYPASS SURGERY ___ <SOCIAL HISTORY> ___ <FAMILY HISTORY> Non-contributory <PHYSICAL EXAM> ADMISSION Vitals: 98 159/62 16 98% on RA weight 143 lbs (bed scale) General: very pleasant older gentleman lying in bed speaking in full sentences in NAD HEENT: PERRL, EOMI, no scleral icterus, oropharynx clear Neck: supple, JVP at 6cm, no adenopathy CV: regular rate and rhythm, normal S1, physiologic split S2, ___ systolic murmur at LLSB. No rubs or gallops. Lungs: CTAB, no crackles, wheezes, or rhonchi Abdomen: soft, non distended, non tender to deep palpation, +BS GU: no CVA tenderness, no foley Extr: warm, well perfused, 2+ pulses in radial and DP, 2+ edema in bilateral lower extremities to knees Neuro: aoxo3, CN2-12 grossly intact, moving all 4 extremities without deficit, stable gait Skin: warm, well perfused, dry, no rashes or lesions DISCHARGE Vitals: 98.3 100-121/49-59 54-62 18 96RA Tele: no tele Last 8 hours I/O: ___ Last 24 hours I/O: 1200/3150 Weight on admission: 64.3 Today's weight: 63.1 General: elderly, NAD Neck: JVP at base of clavicle when 90 degrees Lungs: CTAB no crackles CV: RRR, split S2 Abdomen: slightly obese, soft, NTND, NABS Ext: no edema <PERTINENT RESULTS> ADMISSION ___ 04: 02PM BLOOD WBC-4.0 RBC-4.32* Hgb-11.3* Hct-35.1* MCV-81* MCH-26.2 MCHC-32.2 RDW-16.3* RDWSD-48.3* Plt ___ ___ 04: 02PM BLOOD ___ PTT-35.8 ___ ___ 04: 02PM BLOOD Glucose-93 UreaN-17 Creat-1.1 Na-131* K-3.8 Cl-93* HCO3-27 AnGap-15 ___ 04: 02PM BLOOD ALT-81* AST-64* AlkPhos-89 TotBili-0.7 ___ 04: 02PM BLOOD CK-MB-3 cTropnT-<0.01 proBNP-1284* ___ 04: 02PM BLOOD Albumin-4.2 Calcium-9.7 Mg-2.2 ___ 04: 34PM BLOOD D-Dimer-<150 ___ 04: 02PM BLOOD TSH-3.0 DISCHARGE ___ 04: 04AM BLOOD WBC-6.5# RBC-4.57* Hgb-12.2* Hct-36.8* MCV-81* MCH-26.7 MCHC-33.2 RDW-16.4* RDWSD-47.8* Plt ___ ___ 04: 04AM BLOOD ___ PTT-34.1 ___ ___ 04: 04AM BLOOD Glucose-113* UreaN-32* Creat-1.4* Na-133 K-3.9 Cl-94* HCO3-26 AnGap-17 ___ 04: 04AM BLOOD ALT-79* AST-57* AlkPhos-83 TotBili-0.6 ___ 04: 04AM BLOOD Calcium-10.0 Phos-4.4 Mg-2.0 ECHO ___ The left atrium is moderately dilated. The right atrium is moderately dilated. No atrial septal defect is seen by 2D or color Doppler. Left ventricular wall thicknesses and cavity size are normal. There is mild regional left ventricular systolic dysfunction with hypokinesis of the mid-anterior and mid-distal inferior wall. The estimated cardiac index is normal (>=2.5L/min/m2). Doppler parameters are indeterminate for left ventricular diastolic function. The right ventricular cavity is mildly dilated with depressed free wall contractility (RV free wall is not well seen). The aortic valve leaflets (3) are mildly thickened but aortic stenosis is not present. The mitral valve leaflets are mildly thickened. There is no mitral valve prolapse. Trivial mitral regurgitation is seen. The tricuspid valve leaflets are mildly thickened. Moderate [2+] tricuspid regurgitation is seen. There is moderate pulmonary artery systolic hypertension. The pulmonic valve leaflets are thickened. There is no pericardial effusion. IMPRESSION: Mild regional left ventricular dysfunction c/w multivessel CAD, with overall mildly depressed global systolic function. Mildly dilated right ventricle with depressed free wall systolic function. Moderate tricuspid regurgitation with moderate pulmonary hypertension. <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Amiodarone 200 mg PO DAILY 2. Apixaban 5 mg PO BID 3. Aspirin 81 mg PO DAILY 4. Docusate Sodium 100 mg PO BID 5. Losartan Potassium 25 mg PO DAILY 6. Omeprazole 10 mg PO DAILY 7. Triamterene-HCTZ (37.5/25) 1 CAP PO DAILY 8. Senna 17.2 mg PO HS 9. Align (bifidobacterium infantis) 4 mg oral DAILY 10. coenzyme Q10 100 mg oral DAILY 11. Rosuvastatin Calcium 40 mg PO QPM 12. Vitamin D 1000 UNIT PO DAILY 13. Tamsulosin 0.4 mg PO QHS <DISCHARGE MEDICATIONS> 1. Amiodarone 200 mg PO DAILY 2. Apixaban 5 mg PO BID 3. Aspirin 81 mg PO DAILY 4. Docusate Sodium 100 mg PO BID 5. Losartan Potassium 25 mg PO DAILY 6. Rosuvastatin Calcium 40 mg PO QPM 7. Senna 17.2 mg PO HS RX *sennosides [senna] 8.6 mg 1 capsule by mouth once a day Disp #*30 Capsule Refills: *0 8. Vitamin D 1000 UNIT PO DAILY 9. Torsemide 5 mg PO DAILY RX *torsemide 5 mg 1 tablet(s) by mouth once a day Disp #*30 Tablet Refills: *0 10. Align (bifidobacterium infantis) 4 mg oral DAILY 11. coenzyme Q10 100 mg oral DAILY 12. Omeprazole 10 mg PO DAILY 13. Tamsulosin 0.4 mg PO QHS <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Primary: Acute on chronic diastolic congestive heart failure Cor pulmonale Secondary: Pulmonary hypertension Paroxysmal atrial fibrillation Hyponatremia <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Mr. ___, You were hospitalized for progressive leg swelling over the past week and a half. We started you on a new medication here that should help prevent this from happening. Of note, Dr. ___ was concerned about a clot in your lungs, but our scans showed NO clot. With this news, you were discharged home with PCP and cardiology follow up. Please continue to take your torsemide in order to maintain your weight. Please weight yourself everyday and call your cardiologist if you weight changes by three pounds. You also have ""pulmonary hypertension,"" which may be due to your underlying lung disease. Amiodarone can also cause lung changes and we recommend following up with the lung doctors as ___ outpatient to see if this may be contributing. It was a pleasure taking care of you! Your ___ team ","Mr. ___ is an ___ year old gentleman with history of CAD (s/p CABG and PCI), pAF, PAH, diastolic CHF who presents with weight gain, leg swelling and new evidence of right ventricle dilation concerning for acute on chronic heart failure exacerbation. #Acute on Chronic Diastolic Heart Failure Exacerbation: with component of RV failure by report of OSH echo. Likely primary process is lung disease causing elevated RV pressures and subsequent poor filling of LV. He diuresed quite well with 20 IV Lasix which is consistent with RV failure. Started on torsemide 10 daily but this is likely too aggressive. We obtained an echo but read PND at time of discharge. We sent him home on a diuretic regimen on torsemide 5 mg daily (and discontinued home triamterene-HCTZ). Close follow up with Dr. ___ ensured. #Elevated Transaminases: Patient with mildly elevated AST and ALT. Most likely etiologies in this patient include amiodarone toxicity and congestive hepatopathy. Encouraged outpatient trending. #Pulmonary disease: patient with extensive emphysema on CTA though patient has no history of smoking. As this may be driving R heart failure, Dr. ___ requested pulmonology consult prior to discharge but patient was insistent on leaving. Instead scheduled outpatient appointment. #Atrial Fibrillation: Continue home amiodarone 200mg daily, Apixaban 5mg BID #CAD: Continue ASA 81mg, rosuvastatin 40mg qHS #HTN: continue home losartan 25mg qD. TRANSITIONAL ISSUES [] New medication: Torsemide 5 mg daily [] Discontinued triamterene/HCTZ in favor of above [] LFTs mild elevated in house; consider possible discontinuing/changing amiodarone [] Please check LFT's and Creatinine at follow up appointment as these were elevated while hospitalized [] Follow up appointment with cardiology, Dr. ___ [] Follow up appointment with pulmonology [] Follow up appointment with PCP ***Discharge weight 63.1 kg*** ",2585,450
10002430-DS-6,"<SEX> M <SERVICE> MEDICINE <ALLERGIES> Corgard / Vasotec <ATTENDING> ___. <CHIEF COMPLAINT> Dyspnea on Exertion <MAJOR SURGICAL OR INVASIVE PROCEDURE> None <HISTORY OF PRESENT ILLNESS> ---==== ___ FAILURE ADMISSION NOTE ---==== OUTPATIENT CARDIOLOGIST: ___., MD ___ cardiology), ___ ___., MD(CHF) PCP: ___., MD CHIEF COMPLAINT: Dyspnea on Exertion HISTORY OF PRESENTING ILLNESS: Mr. ___ is a ___ gentleman with a past medical history pertinent for HFrEF (35% ___ CAD s/p CABG and subsequent PCI, moderate tricuspid regurgitation, right ventricular dysfunction, moderate pulmonary hypertension, and paroxysmal atrial fibrillation on apixaban, stage III chronic kidney disease (Baseline Cr 2.0-2.1), cerebrovascular disease, and metastatic melanoma of unknown primary on checkpoint inhibitor pembrolizumab who was found volume overloaded with increased DOE, admitted to ___ for IV diuresis. Per most recent outpatient CHF notes: He was seen by his primary car primary Cardiologist, Dr. ___ increased fatigue and exertional dyspnea. Dr. ___ a ___ and felt his LVEF was ~30% and reduced from prior. He was started on low-dose Entresto, but couldn't tolerate it from a BP prospective. He was previously on losartan which was stopped due to this lightheadedness, dizziness and worsening renal function. Dr. ___ concern about the possibility of myocarditis secondary to the checkpoint inhibitor. When he followed up with the Oncology team on ___, his symptoms were somewhat improved. Cardiac biomarkers were notable for a rising NTproBNP to >10K but normal CK-MB and minimally elevated troponin T of 0.03, which is not unexpected in the setting of decompensated ___ failure and chronic kidney disease. He was planned to receive immunotherapy on ___, but treatment was held due to elevated Cr. Recheck showed improvement. The patient restarted pembrolizumab on ___. Pembrolizumab was again held in ___ for diarrhea and elevated LFTs In addition, he also received intravenous hydration. Subsequently, he was noted to be more volume overloaded, at which time Torsemide from 20 mg daily to 30 mg daily then 40 mg daily. Troponin testing showed Trop-T of 0.04, attributed to renal insufficiency. The patient was also noted to have mild hyperkalemia (K 5.7) for which potassium supplementation was stopped and torsemide dose increased. He was also seen in the Emergency room in the ___ ___ due to a fall with resultant scalp laceration. CT head and neck was unremarkable. He presented this morning ___ for his scheduled visit at ___ clinic where he noted that his weight had been 126 lbs most recently on his home scale. He also reported decreased appetite that he attributes to eating a different diet. He currently has a ___ care taker that makes ___ food for him, adhering to a low sodium diet, that he does not like as much as his regular diet. He drinks ___ glasses of water or juice daily. He was taking torsemide 40 mg daily, that he decreased to 30 mg daily several days ago as he felt he was urinating too frequently. He also ran out of tamsulosin several days ago so stopped taking this around the same time. He noted becoming short of breath after taking 20 steps or less. Due to his volume overloaded noted on exam he was recommended for admission to ___ for IV diuresis On the floor, he endorses the above history. He noted that his SOB has progressive gotten worse. Mostly occurs with activity. None at rest. He noted that his weight has been slowly decreasing due lack of appetite and him being to lazy. He has a home health aid everyday from 11am-7pm, who helps him with ADL. He endorses abdominal bloading. Cardiac review of systems is notable for absence of chest pain, paroxysmal nocturnal dyspnea, orthopnea, palpitations, syncope, or presyncope. ROS otherwise negative, unless otherwise noted above <PAST MEDICAL HISTORY> <PAST MEDICAL HISTORY> BILATERAL MODERATE CAROTID DISEASE CONGESTIVE ___ FAILURE CORONARY ARTERY DISEASE GASTROESOPHAGEAL REFLUX HYPERTENSION SEVERE EMPHYSEMA PULMONARY HYPERTENSION RIGHT BUNDLE BRANCH BLOCK BENIGN PROSTATIC HYPERTROPHY HYPERLIPIDEMIA PAROXYSMAL ATRIAL FIBRILLATION H/O HISTIOPLASMOSIS Past Surgical History: CARDIOVERSION ___ RIGHT LOWER LOBE LOBECTOMY ___ CORONARY BYPASS SURGERY ___ <SOCIAL HISTORY> ___ <FAMILY HISTORY> Non-contributory <PHYSICAL EXAM> ADMISSION PHYSICAL EXAMINATION: --= 24 HR Data (last updated ___ @ 1335) Temp: 97.4 (Tm 97.4), BP: 115/66, HR: 61, RR: 18, O2 sat: 99%, O2 delivery: ra, Wt: 130.73 lb/59.3 kg GENERAL: Well developed, well nourished male in NAD. Oriented x3. Mood, affect appropriate. HEENT: Scalp laceration noted. Sclera slightly icteric. PERRL. EOMI. Conjunctiva were pink. No pallor or cyanosis of the oral mucosa. No xanthelasma. NECK: Supple. JVP ~ 20 cm with positive hepatojugular reflex. CARDIAC: Regular rate and rhythm. Normal S1, S2. ___ holosystolic murmur at the LLSB and the apex, no rubs, or gallops. No thrills or lifts. LUNGS: No chest wall deformities or tenderness. Respiration is unlabored with no accessory muscle use. Bibasilar crackles ABDOMEN: mildly distended; normoactive bowel sounds; soft and non-tender to palpation; there is no appreciable organomegaly or mass EXTREMITIES: Cool, 1+ pitting edema to knee caps. bilateral status dermatitis. SKIN: Eccymosis noted on left hand, Multiple open biopsy excision sites on left shin and right calf PULSES: Distal pulses palpable and symmetric. Discharge Physical exam -====== 24 HR Data (last updated ___ @ 751) Temp: 98.2 (Tm 98.6), BP: 110/61 (100-121/54-63), HR: 72 (60-99), RR: 16 (___), O2 sat: 91% (91-95), O2 delivery: Ra General: elderly gentleman in NAD HEENT: dressing in place on scalp from recent fall/scalp laceration/c/d/i. Sclera mildly icteric, pupils equally round, MMM NECK: JVP~10cm, with positive hepatojugular reflex CV: irregularly irregular ; the precordium is quiet without RV heave; normal S1 with fixed split S2; there is a soft ___ holosystolic murmur at the LLSB and the apex; LUNGS: Normal effort. Fine Bibasilar crackles Abd: soft, mildy distended, no guarding / rebound. EXT: 1+ pitting edema to the mid-calf L leg > R leg SKIN: Multiple excision biopsy wounds on legs, covered with dressing c/d/i NEURO: Speech fluent, strength grossly intact <PERTINENT RESULTS> ___ 01: 00PM ___ PTT-34.4 ___ ___ 01: 00PM PLT COUNT-169 ___ 01: 00PM NEUTS-81.6* LYMPHS-6.6* MONOS-10.4 EOS-0.1* BASOS-0.1 IM ___ AbsNeut-6.00 AbsLymp-0.49* AbsMono-0.77 AbsEos-0.01* AbsBaso-0.01 ___ 01: 00PM WBC-7.4 RBC-3.02* HGB-9.1* HCT-30.2* MCV-100* MCH-30.1 MCHC-30.1* RDW-16.4* RDWSD-59.2* ___ 01: 00PM calTIBC-352 FERRITIN-111 TRF-271 ___ 01: 00PM CALCIUM-9.2 PHOSPHATE-3.7 MAGNESIUM-2.8* IRON-88 ___ 01: 00PM CK-MB-4 cTropnT-0.01 ___ ___ 01: 00PM ALT(SGPT)-56* AST(SGOT)-52* LD(LDH)-277* ALK PHOS-135* TOT BILI-0.7 ___ 01: 00PM estGFR-Using this ___ 01: 00PM GLUCOSE-100 UREA N-52* CREAT-2.1* SODIUM-135 POTASSIUM-5.4 CHLORIDE-100 TOTAL CO2-24 ANION GAP-11 ___ 04: 54PM URINE HYALINE-1* ___ 04: 54PM URINE RBC-0 WBC-<1 BACTERIA-NONE YEAST-NONE EPI-<1 ___ 04: 54PM URINE BLOOD-NEG NITRITE-NEG PROTEIN-TR* GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-7.0 LEUK-NEG ___ 04: 54PM URINE COLOR-Straw APPEAR-Clear SP ___ ___ 07: 53AM BLOOD WBC-6.5 RBC-2.70* Hgb-8.2* Hct-26.5* MCV-98 MCH-30.4 MCHC-30.9* RDW-16.0* RDWSD-56.3* Plt ___ ___ 07: 53AM BLOOD Plt ___ ___ 07: 53AM BLOOD Glucose-105* UreaN-43* Creat-2.2* Na-140 K-4.2 Cl-102 HCO3-27 AnGap-11 ___: 04AM BLOOD ALT-45* AST-42* AlkPhos-113 TotBili-0.6 ___ 07: 53AM BLOOD Calcium-8.6 Phos-3.5 Mg-2.4 ___ 01: 00PM BLOOD calTIBC-352 Ferritn-111 TRF-271 <MEDICATIONS ON ADMISSION> The Preadmission Medication list may be inaccurate and requires further investigation. 1. Amiodarone 200 mg PO DAILY 2. Aspirin 81 mg PO DAILY 3. Docusate Sodium 100 mg PO BID 4. Senna 17.2 mg PO HS 5. Vitamin D 1000 UNIT PO DAILY 6. Align (bifidobacterium infantis) 4 mg oral DAILY 7. coenzyme Q10 100 mg oral DAILY 8. Tamsulosin 0.4 mg PO QHS 9. Torsemide 40 mg PO DAILY 10. Ferrous Sulfate 325 mg PO DAILY 11. Sertraline 50 mg PO DAILY 12. Potassium Chloride 30 mEq PO BID 13. Apixaban 2.5 mg PO BID 14. Cephalexin 500 mg PO Q6H <DISCHARGE MEDICATIONS> 1. Potassium Chloride 40 mEq PO DAILY RX *potassium chloride 20 mEq 2 packet(s) by mouth once a day Disp #*60 Tablet Refills: *0 2. Align (bifidobacterium infantis) 4 mg oral DAILY 3. Amiodarone 200 mg PO DAILY 4. Apixaban 2.5 mg PO BID 5. Aspirin 81 mg PO DAILY 6. coenzyme Q10 100 mg oral DAILY 7. Docusate Sodium 100 mg PO BID 8. Ferrous Sulfate 325 mg PO DAILY 9. Senna 17.2 mg PO HS 10. Sertraline 50 mg PO DAILY 11. Tamsulosin 0.4 mg PO QHS RX *tamsulosin 0.4 mg 1 capsule(s) by mouth nightly Disp #*30 Capsule Refills: *0 12. Torsemide 40 mg PO DAILY 13. Vitamin D 1000 UNIT PO DAILY <DISCHARGE DISPOSITION> Home With Service Facility: ___ <DISCHARGE DIAGNOSIS> Primary Diagnosis - HFrEF excerterbation Secondary diagnosis -== Transaminitis Metastatic melanoma CKD Coronary artery disease, s/p CABG and LAD PCI <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> -======== DISCHARGE INSTRUCTIONS -========= Dear Mr. ___ , It was a pleasure taking care of you at ___ ___. WHY WAS I ADMITTED TO THE HOSPITAL? You were feeling short of breath because you had fluid in your lungs. This was caused by a condition called ___ failure, where your ___ does not pump hard enough and fluid backs up into your lungs. WHAT HAPPENED WHILE I WAS IN THE HOSPITAL? You were given medications to help get the fluid out. Your breathing got better and were ready to leave the hospital. WHAT DO YOU NEED TO DO WHEN YOU LEAVE THE HOSPITAL? - Take all of your medications as prescribed (listed below) - Follow up with your doctors as listed below - Weigh yourself every morning. Your weight on discharge is 122.57 lbs. Call your doctor if your weight goes up more than 3 pounds. - Call you doctor if you notice any of the ""danger signs"" below. We wish you the best! Your ___ Care Team ","TRANSITIONAL ISSUES ==================== DISCHARGE WEIGHT: 55.6 kg (122.57 lb) DISCHARGE Cr/BUN: Cr 2.2, BUN 43 DISCHARGE DIURETIC: 40 Torsemide daily MEDICATION CHANGES: Decreased daily potassium to 40 mEq daily (from 30 mEq twice dailye) [] Please obtain repeat Chem10 within 2 weeks and after 4 weeks. Adjust electrolyte repletion accordingly. [] Please follow up weight and volume status and adjust torsemide accordingly. #CODE STATUS: Presumed full Health care proxy chosen: Yes Name of health care proxy: ___ ___: son Phone number: ___ ==================== PATIENT SUMMARY: ==================== Mr. ___ is a ___ gentleman with PMHx of CAD s/p CABG and subsequent PCI, HFrEF (35% ___, moderate tricuspid regurgitation, right ventricular dysfunction, moderate pulmonary hypertension, and paroxysmal atrial fibrillation on apixaban, stage III chronic kidney disease (Baseline Cr 2.0-2.1), cerebrovascular disease, and metastatic melanoma of unknown primary on checkpoint inhibitor pembrolizumab who was found volume overloaded with increased DOE, admitted to acute ___ failure for IV diuresis, now transitioned to oral duiretics. # CORONARIES: Left Main and two vessel coronary disease (___). # PUMP: 35% ___ # RHYTHM: Ectopic rhythm, PR prolongation, left axis deviation, RBBB ACTIVE ISSUES: ============== # ___ Failure with reduced ejection fraction # Right ventricular dysfunction, TR, pulm HTN # Volume overload His ___ failure exacerbation is likely secondary to his recent administration of IV fluids in addition to his self down titration of his torsemide over the last week. In addition, he does not follow a restricted fluid intake and drinks ___ glasses of water or juice daily. Furthermore, he has not tolerated guideline directed medical therapy due to recurrent issues with acute kidney injury and elevated transaminitis while on pembrolizumab therapy. He was clinically volume overloaded with elevated BNP 16020. We initiated IV lasix 160 bolus and put him on a lasix gtt with good response, however he his Cr increased from 2.1-->2.7. His Cr. improved with transition to PO Torsemide 40 mg daily. We monitored and aggressively repleted his potassium. No afterload reduction or neural hormonal blockade was added. # Chronic Kidney Disease: Baseline 2.1-2.3 . Cr 2.1 on admission(Stable )- Cr on discharge:2.2 Cr initially uptrended above baseline from 2.1---> 2.7. Felt likely due to increased diuretic usage as it improved with stopping diuretics. Less likely cardiorenal syndrome. In addition,patient was recently seen in follow-up by nephrology. They felt his CKD was less likely to be related to pembrolizumab and more likely related to age-related decline in renal function. Creatinine 2.2 on discharge (stable). # Metastatic Melanoma He is followed by Dr. ___. He was previously on Pembrolizumab which was held due diarrhea, elevated LFTs and worsening kidney function. Negative troponin and CK MB, no concern for drug-induced myocarditis at this point. Followup in ___ clinic in 2weeks after discharge # Elevated transaminiatis Stable. Statin and ___ had previously been held. No changes made during admission. # Urinary frequency Likely due to diuretic use. Afebrile and asx otherwise -Continued home tamsulosin # Coronary artery disease, s/p CABG and LAD PCI. -Continued aspirin 81 mg daily -Statin stopped prior to admission due to elevated LFTs. Continued holding. CHRONIC ISSUES: ============== # Paroxysmal Atrial fibrillation Rythym: Continue amiodarone 200mg for rhythm control strategy (monitoring safety labs) -Continued anticoagulation with apixaban 2.5mg twice daily # Hypertension: Stable. ",3157,888
10002430-DS-7,"<SEX> M <SERVICE> MEDICINE <ALLERGIES> Corgard / ___ <ATTENDING> ___. <MAJOR SURGICAL OR INVASIVE PROCEDURE> None attach <PERTINENT RESULTS> ADMISSION LABS: -== ___ 12: 48AM BLOOD WBC-10.3* RBC-3.71* Hgb-10.6* Hct-36.6* MCV-99* MCH-28.6 MCHC-29.0* RDW-18.6* RDWSD-55.8* Plt ___ ___ 12: 48AM BLOOD ___ PTT-82.4* ___ ___ 12: 48AM BLOOD Glucose-128* UreaN-47* Creat-2.2* Na-144 K-3.8 Cl-105 HCO3-22 AnGap-17 ___ 12: 48AM BLOOD ALT-75* AST-55* AlkPhos-150* TotBili-1.1 ___ 12: 48AM BLOOD ___ ___ 12: 48AM BLOOD Calcium-9.2 Phos-4.0 Mg-2.3 ___ 01: 19AM BLOOD ___ pO2-59* pCO2-42 pH-7.34* calTCO2-24 Base XS--2 RELEVANT LABS: -= ___ 12: 48AM BLOOD ___ IMAGING: ======== CXR: ___ No comparison. The lung volumes are low. Moderate cardiomegaly is present. Normal alignment of the sternal wires after CABG. Mild bilateral pleural effusions. Signs of moderate pulmonary edema. Retrocardiac atelectasis, no evidence of pneumonia. CXR: ___ There are stable postsurgical changes following wedge resection the right lower lobe. Small bilateral effusions right greater than left are unchanged. Cardiomediastinal silhouette is stable. There is moderate cardiomegaly. No pneumothorax. Mild pulmonary edema is unchanged. DISCARHGE LABS: -== ___ 08: 00AM BLOOD WBC-5.4 RBC-3.54* Hgb-10.3* Hct-34.1* MCV-96 MCH-29.1 MCHC-30.2* RDW-19.0* RDWSD-65.7* Plt ___ ___ 08: 00AM BLOOD Glucose-94 UreaN-44* Creat-2.0* Na-140 K-3.6 Cl-99 HCO3-27 AnGap-14 ___ 08: 00AM BLOOD ALT-38 AST-46* LD(LDH)-198 AlkPhos-108 TotBili-0.5 ___ 08: 00AM BLOOD Calcium-9.0 Phos-3.5 Mg-2.3 <DISCHARGE INSTRUCTIONS> Dear Mr. ___, It was a pleasure taking care of you at the ___ ___. WHY WAS I IN THE HOSPITAL? -========= - You were admitted because of you were short of breath WHAT HAPPENED IN THE HOSPITAL? -- - You were found to have fluid on your lungs. This was because you have a medical condition called heart failure, where your heart does not pump hard enough and fluid backs up into your lungs. - You were given a diuretic medication to help get the fluid out. You improved considerably and are ready to leave the hospital. WHAT SHOULD I DO WHEN I GO HOME? --== - Be sure to take all your medications and attend all of your appointments listed below. - Your weight at discharge is 116.18 lbs. Please weigh yourself today at home and use this as your new baseline - Please weigh yourself every day in the morning. Call your doctor or the HeartLine at ___ if your weight goes up by more than 3 lbs or you experience significant chest pain and shortness of breath. Thank you for allowing us to be involved in your care, we wish you all the best! Sincerely, Your ___ Team ","TRANSITIONAL ISSUES: ==================== [] Consider discontinuing amiodarone given persistence of AF despite this medication [] Consider starting beta blocker, if BP is able to tolerate. Patient previously did not tolerate this medication while on pembrolizumab (dizziness and ___, but patient has been off of pembrolizumab since ___ [] Consider starting spironolactone and ___ pending blood pressures; trialed losartan and spironolactone during this admission, but ultimately held due to hypotension. [] His LFTs should be rechecked ~2 weeks after discharge (___). He has a history of transaminitis attributed in part to statin use in the past; he was restarted on rosuvastatin this admission (given history of CAD s/p CABG), and LFTs on day of admission were ALT 38, AST 46, Alk phos 108, Tbili 0.5. [] Follow up with Oncology regarding melanoma. [] Monitor for resolution of supplemental O2 requirement after discharge. He was requiring ___ of O2 by NC at time of discharge, in the setting of recovering from pneumonia. DISCHARGE WT: 116.18 lbs DISCHARTE Cr: 2.0 DISCHARGE DIURETIC: torsemide 60 mg PO BID SUMMARY: =============== Mr. ___ is a ___ man with PMH of HFrEF (35% ___, CAD s/p 3v CABG (___) and subsequent PCI to the LAD (___), moderate tricuspid regurgitation, right ventricular dysfunction, moderate pulmonary hypertension, and paroxysmal atrial fibrillation on apixaban, stage III chronic kidney disease (Baseline Cr 2.0-2.1), cerebrovascular disease, and metastatic melanoma of unknown primary on Pembrolizumab (on hold since ___ iso worsening transaminitis and concern for cardiotoxicity). He was admitted with volume overload from heart failure exacerbation and pneumonia with high oxygen requirements. He initially required CCU admission for high flow oxygen, weaned to nasal cannula after aggressive IV diuresis and treatment of pneumonia with 5 day course of Zosyn after receiving vancomycin at OSH. He was transferred to cardiology floor where he continued to diurese well and his oxygen requirement was weaned to ___. He was transitioned to 60 mg torsemide PO BID which adequately maintained euvolemia. ACUTE ISSUES: ============= # Acute on chronic systolic heart failure exacerbation Patient with history of heart failure with etiology likely ischemic cardiomyopathy given history of CAD s/p CABG and PCI. Admitted with fluid overload and pleural effusion. Trigger for current exacerbation could be infectious given evidence of pneumonia in left lower lobe on admission. Patient with high oxygen requirements prior to admission but responded appropriately to diuresis with Lasix. After IV diuresis, patient was transitioned PO torsemide and maintained at euvolemia. With effective diuresis, the patient's oxygen requirement gradually lowered from 4L NC to ___ NC. He was discharged on torsemide 60 mg PO BID. He was unable to tolerate afterload reducing agents or neurohormonal blockade agents due to hypotension. # Lower left lobe pneumonia Patient with evidence of pneumonia in the left lower lobe, received vanc/zosyn at outside hospital and continued on Zosyn here for a total of 5 day course with resolution of symptoms. We suspect that his lingering O2 requirement is at least in part due to slowly resorbing consolidation left over from his infection. He was requiring ___ of supplemental O2 by NC at time of discharge. # Pleural effusion, bilateral Patient with evidence of right pleural effusion. Etiology likely fluid overload given heart failure with reduced ejection fraction. Pleural effusion resolved improved with diuresis and his oxygen requirement trended down to ___ NC. Given this, thoracentesis was deferred. # Atrial fibrillation Patient with chronic history of atrial fibrillation. In afib throughout this admission. Continued amiodarone and apixaban. Rates appropriately controlled. CHRONIC ISSUES ================ # Coronary artery disease s/p CABG Patient with history of 3 vessel CABG on ___ (___) and subsequent PCI to LAD (___). Continued home aspirin. Patient was started on low dose rosuvastatin 5 mg daily. On review, it appears he had been on this medication at this dose in the past but it was discontinued due to transamnitis; however, at the time it was unclear whether this was an effect of the statin or pembrolizumab. Given that the patient has not had his checkpoint inhibitor therapy since ___, the decision was to restart rosuvastatin. # Chronic kidney disease Baseline Cr appears to be 2.1-2.2 over past year. Cr remained between 1.8-2.4 throughout admission. # Anemia Chronic, although worsening since ___. On admission hemoglobin 10.6 and remained stable. # Thrombocytopenia Uncertain etiology, appears subacute/chronic. On admission platelets 130 down-trended to 100s. No concern for bleeding throughout admission. # Melanoma Patient with history of metastatic melanoma with unknown primary. On treatment with pembrolizumab, but held since ___ iso toxicity. CODE: DNR/DNI CONTACT: ___ (___) Relationship: Son Phone number: ___ ___ on Admission: The Preadmission Medication list is accurate and complete. 1. Amiodarone 200 mg PO DAILY 2. Apixaban 2.5 mg PO BID 3. Aspirin 81 mg PO DAILY 4. Docusate Sodium 100 mg PO BID 5. Ferrous Sulfate 325 mg PO DAILY 6. Senna 17.2 mg PO HS 7. Sertraline 50 mg PO DAILY 8. Tamsulosin 0.4 mg PO QHS 9. Torsemide 40 mg PO DAILY 10. coenzyme Q10 100 mg oral DAILY 11. Align (bifidobacterium infantis) 4 mg oral DAILY 12. Potassium Chloride 40 mEq PO DAILY Discharge Medications: 1. Rosuvastatin Calcium 5 mg PO QPM 2. Vitamin D 1000 UNIT PO DAILY 3. Torsemide 60 mg PO BID 4. Align (bifidobacterium infantis) 4 mg oral DAILY 5. Amiodarone 200 mg PO DAILY 6. Apixaban 2.5 mg PO BID 7. Aspirin 81 mg PO DAILY 8. coenzyme Q10 100 mg oral DAILY 9. Docusate Sodium 100 mg PO BID 10. Ferrous Sulfate 325 mg PO DAILY 11. Potassium Chloride 40 mEq PO DAILY 12. Senna 17.2 mg PO HS 13. Sertraline 50 mg PO DAILY 14. Tamsulosin 0.4 mg PO QHS ___ and mineralocorticoid receptor antagonist held in the setting of hypotension and CKD. Patient is intolerant of beta blockers due to dizziness/hypotension previously. Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: Primary diagnosis: ===================== Acute on chronic systolic heart failure exacerbation Lower left lobe pneumonia Bilateral pleural effusion Atrial fibrillation Secondary diagnosis: ===================== Coronary artery disease status post CABG Chronic kidney disease Anemia Thrombocytopenia Metastatic melanoma Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Followup Instructions: ___",867,1687
10002443-DS-15,"<SEX> M <SERVICE> MEDICINE <ALLERGIES> No Allergies/ADRs on File <ATTENDING> ___. <CHIEF COMPLAINT> chest pain <MAJOR SURGICAL OR INVASIVE PROCEDURE> ___ - bedside pericardiocentesis at ___ <HISTORY OF PRESENT ILLNESS> HISTORY OF PRESENTING ILLNESS: Mr. ___ is a ___ male with rheumatoid arthritis, DMARD holiday, and recent, brief hospitalization for presumptive pericarditis, returned to outside hospital with probable cardiac tamponade now post-bedside pericardiocentesis with drain placement prior to transfer. Importantly, patient was hospitalized at ___ on ___ with acute pleuritic chest pain of two-day duration in the context of constellation of fatigue, malaise, upper respiratory symptoms, and non-productive cough. While CTA exonerated pulmonary embolism, thickened pericardium and small effusion were noted, suggesting pericarditis. ECG revealed subtle diffuse ST elevations in keeping with pericarditis. Echocardiogram confirmed said effusion, though no features of tamponade were appreciated. He was discharged the same day with ibuprofen 600 mg TID and colchicine 0.6 mg BID. He had persistence of minor residual chest pain, which began to worsen two days later, but was tolerable until yesterday evening when it evolved to severe, unrelenting pain across his precordium likened to ""wearing shoulder pads bearing down on him."" He notes a new concurrent substernal chest pain that ""goes straight to his back."" He then became dyspneic, prompting him to seek care. He arrived at ___ hypotensive with SBP in the 80-range. He was borderline tachycardic and in mild respiratory distress, but oxygenation was acceptable. He rapidly received three liters of fluid for presumptive tamponade within the confines of poor windows on bedside echocardiogram. Pericardiocentesis yielded 400 cc or more of serous fluid and a pericardial drain was placed. Hemodynamics rapidly improved. On arrival to ___ ED, patient was indeed hemodynamically stable but was then in moderate respiratory distress, requiring non-rebreather. He was given Lasix 20 mg IV. Bedside echocardiogram was limited, but preliminarily suggestive of small residual effusion. In the CCU, patient notes resurgence of said chest pain. His dyspnea is improving. An additional 250 cc was drained. <PAST MEDICAL HISTORY> PAST MEDICAL HISTORY: Cardiac History: -Pericarditis, as above. -Hypertension. -Dyslipidemia. Other PMH: -Rheumatoid arthritis. -Remote traumatic DVT. -Cholecystectomy. -Appendectomy. -Tonsillectomy. -Left wrist reconstruction. -Right rotator cuff reconstruction. <SOCIAL HISTORY> ___ <FAMILY HISTORY> paternal history of ureothelial carcinoma. Maternal history of diabetes. <PHYSICAL EXAM> ADMISSION PHYSICAL EXAMINATION: --=== VS: T 96.7, HR 81, BP 136/81, O2 94% 6L GENERAL: obese male in mild to moderate respiratory distress. HEENT: anicteric sclerae. Oropharynx clear. NECK: JVP at mandibular angle. CARDIAC: tachycardic, regular with rare ectopy, S1/S2 within the confines of body habitus. Subtle pericardial rub. Pericardial drain with serosanguinous fluid. Sternal tenderness. LUNGS: Conversational dyspnea but tachypnea is slowing. Diffuse wheezing and crackles in bilateral lung fields. ABDOMEN: obese, soft, non-tender. EXTREMITIES: Warm, well perfused, 2+ pitting edema to knees. SKIN: Chronic bilateral venous stasis dermatitis. PULSES: Distal pulses palpable and symmetric. NEURO: non-focal. DISCHARGE PHYSICAL EXAMINATION: --=== GENERAL: obese male in mild to moderate respiratory distress. HEENT: anicteric sclerae. Oropharynx clear. NECK: JVP not appreciated. CARDIAC: normal rate and rhythm, S1/S2 within the confines of body habitus. No pericardial rub appreciated. LUNGS: Decreased respiratory effort compared to yesterday. Expiratory wheezing and bibasilar crackles. ABDOMEN: obese, soft, non-tender, non-distended. EXTREMITIES: Warm, well perfused, 1 to 2+ pitting edema to knees. SKIN: Chronic venous stasis dermatitis. PULSES: Distal pulses palpable and symmetric. NEURO: non-focal. <PERTINENT RESULTS> ADMISSION LABS: -== ___ 10: 57PM WBC-16.9* RBC-4.63 HGB-14.2 HCT-43.1 MCV-93 MCH-30.7 MCHC-32.9 RDW-13.1 RDWSD-44.1 ___ 10: 57PM NEUTS-85.5* LYMPHS-4.3* MONOS-9.4 EOS-0.1* BASOS-0.2 IM ___ AbsNeut-14.43* AbsLymp-0.72* AbsMono-1.58* AbsEos-0.01* AbsBaso-0.04 ___ 10: 57PM ___ PTT-27.2 ___ ___ 10: 57PM GLUCOSE-269* UREA N-20 CREAT-0.9 SODIUM-135 POTASSIUM-5.3 CHLORIDE-106 TOTAL CO2-18* ANION GAP-11 ___ 10: 57PM CALCIUM-7.4* PHOSPHATE-3.1 MAGNESIUM-1.6 ___ 10: 57PM cTropnT-<0.01 ___ 11: 03PM LACTATE-2.0 ___ 01: 05AM PLEURAL FLUID STUDIES ___ Polys-94* Lymphs-2* Monos-4* IMAGING: ======== ___ TTE The left atrium is normal in size. The inferior vena cava is dilated (>2.5 cm). There is normal left ventricular wall thickness with a normal cavity size. There is suboptimal image quality to assess regional left ventricular function. Overall left ventricular systolic function is normal. Quantitative biplane left ventricular ejection fraction is 66 %. Left ventricular cardiac index is normal (>2.5 L/min/m2). No ventricular septal defect is seen. Normal right ventricular cavity size with normal free wall motion. There is abnormal interventricular septal motion. The aortic sinus diameter is normal for gender with normal ascending aorta diameter for gender. The aortic arch diameter is normal. There is no evidence for an aortic arch coarctation. The aortic valve leaflets (?#) appear structurally normal. There is no aortic valve stenosis. There is no aortic regurgitation. The mitral valve is not well visualized. The tricuspid valve is not well seen. The pulmonary artery systolic pressure could not be estimated. There is no pericardial effusion. MICRO: ====== ___ 1: 05 am FLUID,OTHER PERICARDIAL FLUID. GRAM STAIN (Final ___: 4+ (>10 per 1000X FIELD): POLYMORPHONUCLEAR LEUKOCYTES. NO MICROORGANISMS SEEN. This is a concentrated smear made by cytospin method, please refer to hematology for a quantitative white blood cell count.. FLUID CULTURE (Preliminary): Reported to and read back by ___ ___ 1: 53PM. STAPHYLOCOCCUS, COAGULASE NEGATIVE. 1 COLONY ON 1 PLATE. ANAEROBIC CULTURE (Preliminary): NO ANAEROBES ISOLATED. FUNGAL CULTURE (Preliminary): ACID FAST SMEAR (Final ___: NO ACID FAST BACILLI SEEN ON DIRECT SMEAR. ACID FAST CULTURE (Preliminary): DISCHARGE LABS: -== ___ 04: 01AM BLOOD WBC-13.0* RBC-4.05* Hgb-12.3* Hct-37.3* MCV-92 MCH-30.4 MCHC-33.0 RDW-13.0 RDWSD-43.8 Plt ___ ___ 03: 30PM BLOOD Glucose-115* UreaN-22* Creat-0.6 Na-138 K-4.1 Cl-100 HCO3-24 AnGap-14 ___ 04: 01AM BLOOD ALT-43* AST-27 AlkPhos-99 TotBili-0.5 ___ 03: 30PM BLOOD Calcium-8.2* Phos-2.9 Mg-1.9 ___ 10: 57PM BLOOD proBNP-110 ___ 03: 29AM BLOOD TSH-0.93 ___ 11: 04AM BLOOD ___ pO2-82* pCO2-42 pH-7.34* calTCO2-24 Base XS--2 <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Atorvastatin 10 mg PO QPM 2. Colchicine 0.6 mg PO BID 3. Ibuprofen 600 mg PO TID 4. Famotidine 20 mg PO DAILY 5. lisinopril-hydrochlorothiazide ___ mg oral DAILY 6. Methotrexate 20 mg PO 1X/WEEK (___) 7. Sertraline 100 mg PO DAILY 8. FoLIC Acid 1 mg PO DAILY <DISCHARGE MEDICATIONS> 1. Albuterol Inhaler 2 PUFF IH Q6H: PRN wheezing, shortness of breath RX *albuterol sulfate [ProAir HFA] 90 mcg 2 puffs ih every 6 hours as needed Disp #*1 Inhaler Refills: *0 2. MetFORMIN (Glucophage) 500 mg PO BID RX *metformin 500 mg 1 tablet(s) by mouth Twice a day Disp #*60 Tablet Refills: *2 3. Metoprolol Succinate XL 50 mg PO DAILY RX *metoprolol succinate 50 mg 1 tablet(s) by mouth Daily Disp #*30 Tablet Refills: *2 4. Omeprazole 20 mg PO DAILY RX *omeprazole 20 mg 1 capsule(s) by mouth Daily Disp #*30 Capsule Refills: *2 5. Atorvastatin 10 mg PO QPM 6. Colchicine 0.6 mg PO BID RX *colchicine 0.6 mg 1 capsule(s) by mouth Twice a day Disp #*60 Capsule Refills: *2 7. FoLIC Acid 1 mg PO DAILY 8. Ibuprofen 600 mg PO TID 9. Sertraline 100 mg PO DAILY 10. HELD- lisinopril-hydrochlorothiazide ___ mg oral DAILY This medication was held. Do not restart lisinopril-hydrochlorothiazide until instructed by your primary care doctor or cardiologist 11. HELD- Methotrexate 20 mg PO 1X/WEEK (___) This medication was held. Do not restart Methotrexate until a doctor tells you to <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Primary Diagnosis: inflammatory pericarditis Secondary Diagnosis: rheumatoid arthritis <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Mr. ___, WHY WERE YOU ADMITTED TO THE HOSPITAL? - You were admitted to the hospital with chest pain. WHAT WAS DONE WHILE YOU WERE IN THE HOSPITAL? - You were found to have inflammation and a build up of fluid in the lining of the heart. - You had a procedure to remove the fluid from the lining of the heart and a temporary drain placed. This was removed before you left the hospital. - You received medication to help you pee off the excess fluid in your body. - You developed an abnormal heart rhythm (afib) while in the hospital. You were started on a new medication for this (metoprolol). - You were diagnosed with diabetes during this admission. You were started on a new medication for this (metformin). WHAT DO YOU NEED TO DO WHEN YOU LEAVE THE HOSPITAL? - Take all of your medications as prescribed (listed below) - Follow up with your doctors as listed below - Weigh yourself every morning, seek medical attention if your weight goes up more than 3 lbs. - Seek medical attention if you have new or concerning symptoms or you develop swelling in your legs, abdominal distention, or shortness of breath at night. Please see below for more information on your hospitalization. It was a pleasure taking part in your care here at ___! We wish you all the best! - Your ___ Care Team ","SUMMARY: ===================== ___ male with rheumatoid arthritis, DMARD holiday, and recent, brief hospitalization for presumptive pericarditis, returned to outside hospital with pericardial effusion with possible tamponade physiology now post-bedside pericardiocentesis prior to transfer, with persistent pericardial effusion now s/p drain placement with course complicated by acute hypercapneic respiratory distress. #CORONARIES: unknown. #PUMP: normal biventricular structure and function. #RHYTHM: NSR. pAF ___ TRANSITIONAL ISSUES: ==================== [] He was discharged on ibuprofen 600mg TID and colchicine 0.6mg BID for his inflammatory pericarditis. He should continue colchicine for 3 months. He should have his ibuprofen tapered weekly following resolution of his symptoms over 3 weeks to reduce the risk of recurrence. [] He was discharged on a PPI and should continue this while on ibuprofen. [] Strongly recommend that patient receive outpatient PFTs given high suspicion for baseline obstructive/restrictive pulmonary disease [] Patient developed paroxysmal afib with RVR during this admission which is a new diagnosis. CHADSVASC 2 for hypertension and diabetes. Anticoagulation was not started during this admission given that he was felt to have relatively low risk for CVA, however please make a note of this new diagnosis and reassess need for anticoagulation as medically appropriate. [] He was newly diagnosed with DM (HbA1c 7.9 at ___ and will be discharged on metformin 500 BID. Will require outpatient follow-up for this and can consider uptitration in the outpatient setting. [] Please reassess need for diuretic in the outpatient setting. He had no echocardiographic evidence of heart failure during this admission so was not discharged on diuretics. New medications: Metformin 500mg BID Metoprolol XL 50mg QD Omeprazole 20mg QD Continued medications: Atorvastatin 10mg QPM Colchicine 0.6mg BID Ibuprofen 600mg TID Folic acid 1mg PO QD Sertraline 100mg PO QD Stopped medications: Methotrexate 20mg PO Famotidine 20mg QD ACUTE ISSUES: ============= #) Acute pericarditis #) Cardiac tamponade, now s/p pericardiocentesis and drain placement He presented with inflammatory pericarditis of probable viral nature in the context of viral-like prodrome versus rheumatic pericarditis, given serologic positive active disease in the absence of DMARD. Pericardial fluid cultures from ___ negative, cultures here with 1 colony on 1 plate of coag negative staph felt to be contaminant, negative acid fast smear. No biochemical evidence of myocardial injury on admission, unlikely to have concurrent myocarditis or cardiac event sequelae. At ___ was initially noted to have SBPs in the ___ and received fluid resuscitation and pericardiocentesis given concern for tamponade physiology. Hemodynamics subsequently stabilized and remained so throughout the duration of his admission here. TTE on ___ showed no pericardial effusion. Pericardial drain was initially left to gravity due to continued output, and was removed ___. He was treated with colchicine 0.6mg BID which he will continue for 3 months after discharge. He also received ibuprofen 600mg PO TID and will be discharged on a slow taper; he received PPI while receiving NSAIDs. #) Acute hypercapnic respiratory failure - resolving Probable flash pulmonary edema from rapid large-volume fluid administration on tamponade, as evidenced by radiographic pulmonary edema. Earlier echocardiogram otherwise not suggestive of ventricular dysfunction and BNP is within normal limits. TTE on ___ was without evidence of cardiac etiology for his pulmonary edema/respiratory failure. Patient likely has unappreciated restrictive pulmonary physiology. Additionally, no emphysematous changes noted on CT one week ago, but background obstructive defect is conceivable, given compelling smoking history. He had a negative CTA one week prior to admission. Patient had leukocytosis on admission without clear radiographic consolidation suggestive of pneumonia - one dose of empiric azithromycin was given overnight and discontinued on ___. He received IV diuresis with significant improvement in his respiratory status. O2 weaned ___ morning. He was breathing comfortably on RA at the time of discharge with ambulatory saturations >90%. #) Paroxysmal AFib, new diagnosis Patient went into Afib with RVR on ___, and subsequently received metoprolol. He subsequently flipped back into NSR. His CHADsVASC = 2 (DM, HTN). Anticoagulation was discussed but ultimately deferred at the time of discharge given the patient's lower overall risk for CVA and concerns regarding medication adherence/cost. He was discharged on metoprolol. He should have his need for anticoagulation reassessed as an outpatient as medically appropriate. #) Type II diabetes: He was newly diagnosed with DM with a A1C of 7.9% during this admission. He was maintained on an insulin sliding scale during this admission and will be discharged on metformin 500mg BID. CHRONIC/STABLE ISSUES: ==================== #) Rheumatoid arthritis: RF and anti-CCP positive per outpatient rheumatology. Not currently endorsing sx suggestive of RA flare. Per discussion with OP rheumatologist, deferred restarting MTX and/or other DMARD until outpatient. #) HTN His home BP meds were held initially due to soft BPs and were stopped at the time of discharge as he remained normotensive. CORE MEASURES: ============== #CODE: DNR/DNI. #CONTACT/HCP: ___, ex-wife (___) ",2963,1260
10002495-DS-13,"<SEX> M <SERVICE> MEDICINE <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> cardiogenic ___, NSTEMI <MAJOR SURGICAL OR INVASIVE PROCEDURE> - cardiac catheterization with DES to mid-LAD occlusion via R radial access - IABP placement and removal <HISTORY OF PRESENT ILLNESS> Mr. ___ is a ___ M with HTN, HLD, DMII, and prior MI with medical management w/o cath presented to ___ with ___ transferred to ___ for catheterization for concern for STEMI. Patient has long standing angina pain w/ exertion. On ___ night had acute onset b/l non-radiating ___ CP not resolved with SL NTG that persisted on ___ morning. In addition had 3 episodes of diarrhea and weakness/malaise so he went to ___. No orthopnea, PND, ___ edema, palpitations, or SOB. In the ED, initial vitals were: Exam: Chest pain ___ nonradiating Labs: Trop I 1.14, WBC 29.6, Hct 38.7, Plt 148, INR 1.25, Na 127, K+ 4.6, BUN 30/Cr1.86 Imaging: EKG showed ST elevations in AVR (2mm), borderline elevation in V1, and otherwise diffuse ST depressions. Bedside ECHO w/ septal wall motion abnormalities. CXR w/o any acute abnormalities. Patient was given: Heparin gtt, Nitro gtt, ASA 324mg, Ticagrelor 180mg @ 1500, Vanco 125mg PO, ___ Transferred to ___ for cardiac cath. Vitals on transfer were: 106/64, 86, 100% on 2L, afebrile Cath lab where he still had ___ pain on heparin and nitro gtt. Catheterization showed mid-LAD septal occlusion, diffuse disease throughout RCA, complete occlusion of circumflex w/ collaterals, and 20% stenosis of L main. DES to mid-LAD occlusion via R radial access. Hypotensive throughout so given 750cc IVF. Coughing post-procedure with LVEDP 25 so given Lasix 20mg IV. Was then hypertensive to 150 so given further Lasix 40mg IV. Admitted to CCU for hypotension throughout procedure, WBC 30, and lack of ___ beds. In the CCU, patient reports no chest pain but continues to have productive cough and diarrhea. Of note, two weeks ago had endoscopy and diagnosed with H Pylori. Currently on clarithromycin and amoxicillin. On ___ night developed diarrhea. Also had 15lb weight loss in past 4 months. <PAST MEDICAL HISTORY> 1) HTN 2) HLD 3) DMII 4) CAD s/p MI - medically managed 5) H. Pylori 6) Spinal stenosis <SOCIAL HISTORY> ___ <FAMILY HISTORY> Father: possible dilated cardiomyopathy No family history of early MI, arrhythmia, or sudden cardiac death; otherwise non-contributory. <PHYSICAL EXAM> On admission: --------------- VS: afebrile, 160/80, 114, 94% on 15L Non-rebreather Weight: 69kg Tele: NSR Gen: Slightly tachypneic older man audibly wheezing but comfortably finishing sentences HEENT: EOMI, PERRLA, NECK: No JVD CV: Tachycardic, difficult to appreciate heart sounds due to significant rhonchi LUNGS: b/l rhonchi throughout w/ mild end expiratory wheezing and R base crackles ABD: Soft, Non-tender, non-distended EXT: 2+ L radial pulses, R arm w/ band in place and normal motor/sensory function intact distally, RLE non-palpable DP but dopplerable, 1+ LLE DP. b/l ___ slightly cold but normal sensation w/ full motor strength and ROM SKIN: No rashes or chronic edematous changes NEURO: Alert and attentive, AOX3, Moving all extremities At discharge: -------------- Weight: 63.7kg (63.4) I/O: 980/800 T 98.4 BP 123/68 (102-133/62-87) P 86 (71-100) RR 20 O2 99% RA Gen: awake, alert, oriented to self, date, hospital HEENT: EOMI, PERRLA, NECK: No JVD CV: Tachycardic, difficult to appreciate heart sounds LUNGS: Bibasilar crackles ABD: Soft, Non-tender, non-distended EXT: 2+ b/l radial pulses, R arm normal motor/sensory function intact distally, RLE non-palpable DP but dopplerable, trace edema b/l. b/l ___ slightly cold but normal sensation w/ full motor strength and ROM SKIN: No rashes or chronic edematous changes NEURO: Alert and attentive, AOX3, Moving all extremities <PERTINENT RESULTS> Labs on Admission: ------------------- ___ 09: 23PM WBC-36.8* RBC-4.40* HGB-14.0 HCT-40.6 MCV-92 MCH-31.8 MCHC-34.5 RDW-12.5 RDWSD-41.8 ___ 09: 23PM PLT SMR-NORMAL PLT COUNT-176 ___ 09: 23PM NEUTS-81* BANDS-10* LYMPHS-3* MONOS-6 EOS-0 BASOS-0 ___ MYELOS-0 AbsNeut-33.49* AbsLymp-1.10* AbsMono-2.21* AbsEos-0.00* AbsBaso-0.00* ___ 09: 23PM ___ PTT-49.6* ___ ___ 09: 23PM GLUCOSE-264* UREA N-30* CREAT-1.4* SODIUM-129* POTASSIUM-4.1 CHLORIDE-96 TOTAL CO2-14* ANION GAP-23* ___ 09: 23PM CALCIUM-8.2* PHOSPHATE-3.0 MAGNESIUM-1.7 CHOLEST-157 ___ 09: 23PM %HbA1c-5.9 eAG-123 ___ 09: 23PM CK-MB-44* cTropnT-0.69* ___ 09: 23PM TRIGLYCER-90 HDL CHOL-42 CHOL/HDL-3.7 LDL(CALC)-97 ___ 09: 23PM HYPOCHROM-NORMAL ANISOCYT-NORMAL POIKILOCY-1+ MACROCYT-NORMAL MICROCYT-NORMAL POLYCHROM-NORMAL BURR-1+ Labs at Discharge: ------------------- ___ 05: 50AM BLOOD WBC-11.2* RBC-3.59* Hgb-11.2* Hct-34.7* MCV-97 MCH-31.2 MCHC-32.3 RDW-13.2 RDWSD-46.7* Plt ___ ___ 05: 50AM BLOOD Neuts-76* Bands-0 Lymphs-16* Monos-5 Eos-2 Baso-0 ___ Metas-1* Myelos-0 AbsNeut-8.51* AbsLymp-1.79 AbsMono-0.56 AbsEos-0.22 AbsBaso-0.00* ___ 05: 50AM BLOOD ___ PTT-27.3 ___ ___ 05: 50AM BLOOD Glucose-165* UreaN-43* Creat-1.1 Na-136 K-4.3 Cl-103 HCO3-22 AnGap-15 ___ 05: 50AM BLOOD ALT-38 AST-32 LD(LDH)-481* AlkPhos-99 TotBili-0.4 ___ 05: 50AM BLOOD Albumin-3.3* Calcium-8.4 Phos-3.6 Mg-2.4 Relevant Imaging: ----------------- TTE ___: The left atrium is mildly dilated. The estimated right atrial pressure is ___ mmHg. Left ventricular wall thicknesses and cavity size are normal. Overall left ventricular systolic function is moderately depressed (LVEF= ? 35-40% - assessment limited by suboptimal image quality and significant beat to beat variability). There is hypokinesis of the mid-distal LV segments and apex. There is no ventricular septal defect. Right ventricular chamber size and free wall motion are normal. The ascending aorta is mildly dilated. The number of aortic valve leaflets cannot be determined. There is mild aortic valve stenosis (valve area 1.2-1.9cm2). No aortic regurgitation is seen. The mitral valve appears structurally normal with trivial mitral regurgitation. The pulmonary artery systolic pressure could not be determined. There is a trivial/physiologic pericardial effusion. Compared with the prior focused study (images reviewed) of ___, left ventricular systolic function is probably similar, although suboptimal image quality of both studies precludes definite comparison. ___ CXR IMPRESSION: Generalized improvement in both lungs is probably due to decrease in pulmonary edema, now mild, and decrease in previous moderate right pleural effusion. There is still substantial consolidation in the right upper lobe probably pneumonia but the bilateral lower lobe components have improved. Heart size top-normal. No pneumothorax. MICRO ======== FINAL REPORT ___ C. difficile DNA amplification assay (Final ___: CLOSTRIDIUM DIFFICILE. Positive for toxigenic C. difficile by the Illumigene DNA amplification. (Reference Range-Negative). ___ 12: 53 pm SPUTUM Source: Expectorated. GRAM STAIN (Final ___: <10 PMNs and <10 epithelial cells/100X field. 2+ ___ per 1000X FIELD): GRAM NEGATIVE ROD(S). 2+ ___ per 1000X FIELD): BUDDING YEAST. QUALITY OF SPECIMEN CANNOT BE ASSESSED. RESPIRATORY CULTURE (Preliminary): Further incubation required to determine the presence or absence of commensal respiratory flora. KLEBSIELLA PNEUMONIAE. SPARSE GROWTH. Cefazolin interpretative criteria are based on a dosage regimen of 2g every 8h. GRAM NEGATIVE ROD #2. SPARSE GROWTH. SENSITIVITIES: MIC expressed in MCG/ML _________________________________________________________ KLEBSIELLA PNEUMONIAE | AMPICILLIN/SULBACTAM-- 4 S CEFAZOLIN------------- <=4 S CEFEPIME-------------- <=1 S CEFTAZIDIME----------- <=1 S CEFTRIAXONE----------- <=1 S CIPROFLOXACIN---------<=0.25 S GENTAMICIN------------ <=1 S MEROPENEM-------------<=0.25 S PIPERACILLIN/TAZO----- <=4 S TOBRAMYCIN------------ <=1 S TRIMETHOPRIM/SULFA---- <=1 S <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Gabapentin 600 mg PO TID 2. Naproxen 500 mg PO DAILY 3. MetFORMIN (Glucophage) 500 mg PO BID 4. Metoprolol Succinate XL 25 mg PO DAILY 5. GlipiZIDE 2.5 mg PO BID 6. Simvastatin 40 mg PO QPM 7. Isosorbide Mononitrate (Extended Release) 60 mg PO DAILY 8. Lisinopril 10 mg PO DAILY 9. Digoxin 0.125 mg PO DAILY 10. Aspirin 325 mg PO DAILY <DISCHARGE MEDICATIONS> 1. Aspirin EC 81 mg PO DAILY 2. Digoxin 0.125 mg PO DAILY 3. Metoprolol Succinate XL 50 mg PO DAILY 4. Atorvastatin 80 mg PO QPM 5. Warfarin 4 mg PO DAILY16 6. GlipiZIDE 2.5 mg PO BID 7. Clopidogrel 75 mg PO DAILY 8. Omeprazole 20 mg PO BID 9. Vancomycin Oral Liquid ___ mg PO Q6H 10. MetFORMIN (Glucophage) 500 mg PO BID 11. Gabapentin 600 mg PO TID 12. Lisinopril 2.5 mg PO DAILY 13. Furosemide 20 mg PO DAILY <DISCHARGE DISPOSITION> Extended Care Facility: ___ <DISCHARGE DIAGNOSIS> NSTEMI s/p ___, likely mixed cardiogenic/distributive Hematuria Dyspnea C. dif, severe GERD Delirium <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Mr. ___, You were admitted to ___ because you were experiencing chest pain due to a heart attack. In the cath lab you were found to have blockage of your arteries, and a stent was placed. We also managed your low blood pressure, infectious diarrhea, and trauma from foley placement. You responded well. Please continue taking your medications as prescribed. You are being started on coumadin. Please do not take any non-steroidal antiinflammatory drugs (NSAIDS) such as ibuprofen, advil, motrin, aleve, naproxen. Please also follow-up with your cardiology and PCP appointments as scheduled It was a pleasure taking care of you, Your ___ Care Team ","Mr. ___ is a ___ M w/ HTN, HLD, DMII, and old MI transferred from ___ w/ NSTEMI w/ diffuse 3 vessel disease s/p DES to mid-LAD occlusion found to have severe Cdiff. ACTIVE ISSUES ============== # NSTEMI NSTEMI based on STE aVR and V1 but o/w ST depressions w/ significant multi vessel disease but significant stenosis in LAD s/p DES that occluded diagnonal. Repeat cath unchanged. He was started on plavix, atorvastatin, ACE-I, and metoprolol. Echo showed LVEF 35-40% with hypokinesis of mid-distal LV segments and apex. He was started on warfarin for his hypokinetic LV as well as his atrial fibrillation as discussed below. # ___ Possibly mixed cardiogenic/distributive given mixed venous O2 65%, CI 2.1, PCWP 25. He initially required pressors and balloon pump and was then successfully weaned off both. He remained hemodynamically stable during rest of hospital course. # Atrial Fibrillation Patient with a reported history of paroxysmal afib per his PCP for which he was maintained on digoxin as well as aspirin 325mg PO daily prior to admission. He was found to be in atrial fibrillation during admission and the decision was made to anticoagulate with Coumadin. He was continued on home dose digoxin. His home dose aspirin was decreased as discussed above with initiation of Coumadin. # Hematuria: Likely traumatic in setting of systemic anticoagulation, as patient pulled at ___. Cytology was negative. He will followup outpatient with urology. # Dyspnea: Patient had acute episodes of dyspnea. This was mainly attributed to pulmonary edema and improved with diruesis. Additionally, CXR showed possible consolidation of RUL, concerning for aspiration pneumonia. However, treatment was deferred as he had no other focal signs of infectious pna. He did have sputum cultures which grew Klebsiella pneumonia but on discussion with ID, felt this did not warrant any treatment as he was asymptomatic. He was discharged on po lasix 20 mg daily with next electrolytes to be checked ___. # C diff, severe: Had loose stool in setting of antibiotic tx for Hpylori (initiated outpatient). Given WBC >15, ___, age >___ treated as severe. Patient was started on vancomycin 125mg PO qid for 14 day course (day ___, last day ___. # GASTROESOPHAGEAL REFLUX DISEASE (GERD): Endoscopy confirmed H Pylori treated with PPI + clarithromycin/amoxicillin since ___ for 14 days. Omeprazole was continued. Antibiotics held in setting of c.diff infection. # Delirium: Patient with frequent sundowning during hospitalization requiring Seroquel po. CHRONIC ISSUES =============== # Spinal Stenosis: Continued gabapentin, d/ced naproxen. Did not complain of pain throughout hospital course. Explained he should not take any more NSAIDS in setting of recent ACS and now on Coumadin, Plavix and asa. # DM: maintained on ISS during admission and discharged on home glipizide and metformin # HTN: Home dose metoprolol uptitrated. Home dose lisinopril decreased. Home dose imdur discontinued. # HLD: Transitioned home dose simvastatin to atorvastatin TRANSITIONAL ISSUES ===================== - Discharge weight: 63.7kg - patient will require urology followup given hematuria during admission. Urine cytology negative. - patient will need to be treated for hpylori once he completes a course of PO Vancomycin for Severe CDiff - Please check electrolytes on ___ on lasix - Coumadin initiated given atrial fibrillation, ASA decreased from 325 mg to 81 mg daily - Started on Plavix given recent stent placement, atorvastatin 80 mg (stopped simvastatin), and Lasix 20 mg po daily - Home metoprolol was increased from 25 mg XL to 50 mg XL daily, lisinopril decreased to 2.5 mg po daily and home imdur was discontinued - patient will need to continue a 14 day course of PO Vanc (day ___- ___ last day ___ for cdiff infection - Patient instructed to not take any NSAIDS - SLP treatment at rehab for pharyngeal strengthening exercises ",3121,985
10002528-DS-17,"<SEX> F <SERVICE> NEUROLOGY <ALLERGIES> amoxicillin <ATTENDING> ___. <CHIEF COMPLAINT> Weakness and lethargy <MAJOR SURGICAL OR INVASIVE PROCEDURE> None <HISTORY OF PRESENT ILLNESS> Patient is a ___ year old female with history of chronic abdominal pain and anemia w/ recent Fe sucrose infusion (___) complicated by infusion reaction (mottling and discoloration of feet) s/p IV steroids who presents with increasing lethargy and headache. History per ___ records and per her Aunt as patient cannot provide much history. Per her aunt, ___ has been doing well recently without any illness, behavioral change. She had a cold she was getting over but otherwise doing well. She had an Fe transfusion on ___ around 3: 30P at ___ and the aunt accompanied her to the visit. Towards the end of the infusion, ___ developed mottle purple lower extremities and was having nausea, heart racing. She was sent to ___ where she had SBP up to 144. Her exam per ___ records notable for ""shivering... doesn't open her eyes...mottled hands and feet"". There was no concern for respiratory distress. She was given 50 mg IV Benadryl, 100 mg IV hydrocortisone and observed for 5 hours and then discharged. At that time ___ was reportedly ""lethargic"" meaning sleeping frequently but able to sit up and walk without issue. They arrived home and ___ went to bed. Around 6: 00 AM on ___, ___ aunt check on her and she was still sleeping. She was reporting a headache (which the transfusion place said would happen) but did not mention other characteristic. ___ aunt gave her acetaminophen and water and ___ went back to sleep. Over the next few hours, she heard ___ awake several times and use the bathroom. Then as it got later and later into the day and ___ was not up and about yet, her aunt became worried. She told ___ to call the ___ which she was able to do. She reportedly said she continued to have a headache and felt sleepy. She was instructed to go to the ED. She went to the ED at ___ for evaluation. At ___ she had T 99.5, P 58, RR 15 and sat 100%. BP 110/67. She was reportedly drowsy and arousing to voice, ""alert oriented x3"", consistent eye fluttering, pupils reactive to light and extraocular eye movements full, with reportedly ""non focal exam"". Lab work notable for WBC 7.2, Hgb 13.2, Na 142, bicarb 26, Cr 0.9, Ca 9.4, normal LFTs, Fe 360, Ferritin 438. VBG pH was 7.43, PCO2 was 45.She had a normal ___ and LP with WBC 2, 100% monocytes glucose 57, protein 24, no xanthochromia. She ultimately had MRA and MRV which showed no thrombus or venoous thrombosis. She was transferred to ___ for further management. On my interview she cannot provide much history other than to say she is here because ""I'm tired"". She keeps her eyes closed during questioning. She reports headache but cannot describe where it is or features other than +photophobia. She is unable to participate in other questioning, often getting tearful and saying ""the questions are hard"". Per her father and aunt, she has no history of seizures, or CNS infection. She did have a concussion at ___ years old. <PAST MEDICAL HISTORY> Anemia <SOCIAL HISTORY> ___ <FAMILY HISTORY> Mother with a celiac disease and autoimmune hypothyroidism. Dad is healthy. She has a cousin with seizures. <PHYSICAL EXAM> Admission exam: 98.1 76 130/78 14 96% RA General: appears to be sleeping, occasional eye lid fluttering, lip movements, occasional slow movements of head from side to side HEENT: no trauma, no jaundice, no lesions of oropharynx CV: RRR, wwp Pulm: breathing comfortably on RA Ext: clammy, warm and no rash Neurologic: -Mental Status: She frequently gets upset during exam and is tearful at times, then abulic at other times. Eyes open only briefly to voice. She is oriented to ___ but not full date. Knows she is in a ""hospital"" but not the name. She says she is in the hospital because, ""I'm tired"". She is unable to provide history. Speech is not dysarthric, says ___ words when asked questions, no spontaneous speech output. Follows simple commands like open eyes, lift legs. She is able to name ""key"" and ""feather"" on stroke card but then stops naming and closes her eyes. She reads the first sentence on stroke card but then no more and closes her eyes. When asked to describe stroke card picture she says, ""dishes"". She does not participate in further exam. -Cranial Nerves: II, III, IV, VI: Pupils 8 mm->6 mm. EOMI without nystagmus. VFF to confrontation. Fundoscopic exam revealed no papilledema, exudates, or hemorrhages. VII: No facial droop, facial musculature symmetric with grimace. VIII: Hearing intact to exam IX, X: Palate elevates symmetrically. XII: Tongue protrudes in midline. -Motor: Normal bulk, tone throughout. She says she cannot move her arms. When arms placed over her head, her arms slowly miss her face and slowly drops to the bed in a controlled fashion. She does lift her arms to hold the side rails of the bed spontaneously. She lifts her legs antigravity and holds them without drift. -Sensory: slightly withdrawals in upper extremities and says ""ouch"", briskly withdrawals in lower extremities to noxious stimuli and says ""ouch"" -DTRs: ___ Tri ___ Pat Ach L 2 2 0 3 2 R 2 2 0 3 2 Plantar response was flexor bilaterally. -Coordination: patient could not participate -Gait: could not assess as patient would not get out of bed Discharge Exam: General: sitting up in her chair with eyes closed HEENT: no trauma, no jaundice, no lesions of oropharynx CV: sinus bradycardia, no m/r/g Pulm: Breathing comfortably on RA Ext: Warm and well perfused, no rash or mottling Neurologic: -Mental Status: Answering questions with slow short sentence. More humor and complex sentences observed today. Eyes intermittently close while she is talking. Speech is not dysarthric, no spontaneous speech output. Follows simple commands. -Cranial Nerves: II, III, IV, VI: Pupils 8 mm->4 mm. EOMI without nystagmus. V: facial sensation intact throughout VII: No facial droop, facial musculature symmetric with grimace but limited facial movements. IX, X, XII: palate elevates symmetrically, tongue midline -Motor: Normal bulk, tone throughout. Lifting arms and legs against gravity but not against resistance (___) -Sensory: Sensation intact to touch and temperature throughout -DTRs: 1+ patellar, biceps, brachioradialis throughout -Coordination: No dysmetria or tremor. -Gait: Ambulated well with a ___. <PERTINENT RESULTS> Admission labs: -== ___ 12: 59PM GLUCOSE-77 UREA N-8 CREAT-0.7 SODIUM-142 POTASSIUM-3.8 CHLORIDE-104 TOTAL CO2-24 ANION GAP-14 ___ 12: 59PM ALT(SGPT)-9 AST(SGOT)-13 ALK PHOS-39 TOT BILI-0.3 ___ 12: 59PM CALCIUM-8.7 PHOSPHATE-4.0 MAGNESIUM-1.7 ___ 12: 59PM tTG-IgA-7 ___ 12: 59PM WBC-5.0 RBC-3.89* HGB-11.5 HCT-34.4 MCV-88 MCH-29.6 MCHC-33.4 RDW-12.4 RDWSD-39.8 ___ 12: 59PM PLT COUNT-235 ___ 05: 11AM URINE HOURS-RANDOM ___ 05: 11AM URINE UCG-NEGATIVE ___ 05: 11AM URINE bnzodzpn-NEG barbitrt-NEG opiates-NEG cocaine-NEG amphetmn-NEG oxycodn-NEG mthdone-NEG ___ 05: 11AM URINE COLOR-Straw APPEAR-Clear SP ___ ___ 05: 11AM URINE BLOOD-LG* NITRITE-NEG PROTEIN-NEG GLUCOSE-NEG KETONE-TR* BILIRUBIN-NEG UROBILNGN-NEG PH-7.0 LEUK-NEG ___ 05: 11AM URINE RBC-5* WBC-1 BACTERIA-FEW* YEAST-NONE EPI-0 ___ 05: 11AM URINE MUCOUS-RARE* ___ 04: 34AM ___ PTT-27.2 ___ ___ 04: 28AM WBC-6.4 RBC-4.17 HGB-12.6 HCT-37.4 MCV-90 MCH-30.2 MCHC-33.7 RDW-12.4 RDWSD-40.8 ___ 04: 28AM NEUTS-58.2 ___ MONOS-7.1 EOS-0.2* BASOS-0.6 IM ___ AbsNeut-3.70 AbsLymp-2.14 AbsMono-0.45 AbsEos-0.01* AbsBaso-0.04 ___ 04: 28AM PLT COUNT-246 ___ 04: 11AM ___ PO2-50* PCO2-34* PH-7.44 TOTAL CO2-24 BASE XS-0 COMMENTS-GREEN TOP ___ 04: 10AM GLUCOSE-84 UREA N-7 CREAT-0.8 SODIUM-143 POTASSIUM-3.6 CHLORIDE-106 TOTAL CO2-23 ANION GAP-14 ___ 04: 10AM estGFR-Using this ___ 04: 10AM ALT(SGPT)-9 AST(SGOT)-14 CK(CPK)-67 ALK PHOS-41 TOT BILI-0.3 ___ 04: 10AM CK-MB-<1 ___ 04: 10AM ALBUMIN-3.9 CALCIUM-8.8 PHOSPHATE-2.9 MAGNESIUM-1.8 ___ 04: 10AM VIT B12-227* ___ 04: 10AM TSH-2.7 ___ 04: 10AM TSH-2.6 ___ 04: 10AM ___ TITER-1: 1280* CRP-3.4 dsDNA-NEGATIVE ___ 04: 10AM C3-121 C4-27 ___ 04: 10AM ASA-NEG ETHANOL-NEG ACETMNPHN-NEG tricyclic-NEG EEG ___: -= IMPRESSION: This telemetry captured no pushbutton activations. The background showed normal waking and sleep patterns. There were no focal abnormalities, epileptiform features, or electrographic seizures. A bradycardia was noted. IMAGING: ======== MRI BRAIN WITH/WITHOUT CONTRAST ___ FINDINGS: A 5 mm FLAIR hypointense and T1 isointense lesion at midline between the anterior and posterior pituitary is noted. There is no evidence of hemorrhage, edema, mass effect, midline shift or infarction. The ventricles and sulci are normal in caliber and configuration. There is no abnormal enhancement after contrast administration. IMPRESSION: A 5 mm FLAIR hypointense and T1 isointense lesion at midline between the anterior and posterior pituitary likely represents a Rathke's cleft cyst. Further evaluation is needed, dedicated pituitary MR may be obtained. <MEDICATIONS ON ADMISSION> famotidine 40 mg daily birth control per her aunt ___: 1. ___ 250 mcg PO DAILY 2. Famotidine 40 mg PO DAILY 3. Metoprolol Tartrate 12.5 mg PO DAILY 4. Multivitamins W/minerals 1 TAB PO DAILY 5. Nortriptyline 10 mg PO QHS 6. ___ 1 item miscellaneous ONCE Prognosis: Good ___: 13 months RX ___ Once Disp #*1 Each Refills: *0 <DISCHARGE DISPOSITION> Extended Care Facility: ___ <DISCHARGE DIAGNOSIS> Functional neurological syndrome <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Lethargic but arousable. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Ms. ___, It was a pleasure taking care of you at ___ ___. You were in the hospital because of headache, lethargy, and weakness after an iron infusion. You had a number of tests performed in the hospital, all of which were reassuring. An MRI of your brain showed no evidence of stroke or inflammation. An EEG to monitor your brain waves showed no evidence of seizure. Your weakness gradually improved over the course of your hospitalization and will continue to improve after you leave the hospital. After leaving the hospital, you should continue to work on improving your strength. It will improve as long as you work hard! We wish you the best, Your ___ Care Team ",See worksheet ,3018,3
10002528-DS-18,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> amoxicillin / iron <ATTENDING> ___. <MAJOR SURGICAL OR INVASIVE PROCEDURE> None attach <PERTINENT RESULTS> ADMISSION LABS: -== ___ 10: 45PM PLT COUNT-244 ___ 10: 45PM NEUTS-55.7 ___ MONOS-10.8 EOS-0.7* BASOS-0.9 IM ___ AbsNeut-2.99 AbsLymp-1.70 AbsMono-0.58 AbsEos-0.04 AbsBaso-0.05 ___ 10: 45PM WBC-5.4 RBC-4.19 HGB-13.4 HCT-41.2 MCV-98 MCH-32.0 MCHC-32.5 RDW-12.4 RDWSD-44.2 ___ 10: 45PM ASA-NEG ETHANOL-NEG ACETMNPHN-NEG tricyclic-NEG ___ 10: 45PM ALBUMIN-4.8 CALCIUM-9.6 PHOSPHATE-3.0 MAGNESIUM-2.1 ___ 10: 45PM LIPASE-31 ___ 10: 45PM ALT(SGPT)-20 AST(SGOT)-26 ALK PHOS-48 TOT BILI-0.4 ___ 10: 45PM GLUCOSE-128* UREA N-15 CREAT-1.1 SODIUM-137 POTASSIUM-3.7 CHLORIDE-100 TOTAL CO2-23 ANION GAP-14 ___ 03: 17AM URINE BLOOD-NEG NITRITE-NEG PROTEIN-NEG GLUCOSE-NEG KETONE-10* BILIRUBIN-NEG UROBILNGN-NORMAL PH-6.5 LEUK-NEG ___ 03: 17AM URINE COLOR-Straw APPEAR-CLEAR SP ___ ___ 03: 17AM URINE bnzodzpn-NEG barbitrt-NEG opiates-NEG cocaine-NEG amphetmn-NEG oxycodn-NEG mthdone-NEG ___ 03: 17AM URINE UCG-NEGATIVE ___ 03: 17AM URINE HOURS-RANDOM PERTINENT LABS: -== ___ 05: 45AM BLOOD VitB12-956* ___ 05: 45AM BLOOD TSH-0.99 ___ 05: 45AM BLOOD Free T4-1.3 ___ 05: 45AM BLOOD VITAMIN B1-WHOLE BLOOD-PND MICRO: ====== ___ 3: 17 am URINE **FINAL REPORT ___ URINE CULTURE (Final ___: MIXED BACTERIAL FLORA ( >= 3 COLONY TYPES), CONSISTENT WITH SKIN AND/OR GENITAL CONTAMINATION. IMAGING: ======== none DISCHARGE LABS: -== no labs on day of discharge DISCHARGE PHYSICAL EXAM: -======= VITALS: ___ 1136 Temp: 98.1 PO BP: 107/68 R lying HR: 68 RR: 18 O2 sat: 100% O2 delivery: RA GENERAL: NAD, sitting up in chair, smiling, moving head around EYES: Sclera anicteric and without injection. CARDIAC: RRR. Audible S1 and S2. No murmurs/rubs/gallops. RESP: Clear to auscultation bilaterally. No wheezes, rhonchi or rales. No increased work of breathing. ABDOMEN: Normal bowels sounds, non distended, non-tender. EXTREMITIES: Pulses DP/Radial 2+ bilaterally. SKIN: Warm. Cap refill <2s. No rash. NEUROLOGIC: Speech slow but markedly improved today and speaks in simple sentences. Sitting in a chair and able to move all extremities, follow commands such as moving fingers/toes on command and sticking thumb up. PSYCH: Alert and awake, pleasant, smiling <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Nortriptyline 10 mg PO QHS <DISCHARGE MEDICATIONS> 1. Multivitamins W/minerals 1 TAB PO DAILY 2. Ondansetron ODT 4 mg PO Q8H: PRN Nausea/Vomiting - First Line 3. Thiamine 100 mg PO DAILY 4. Nortriptyline 10 mg PO QHS <DISCHARGE DISPOSITION> Extended Care Facility: ___ <DISCHARGE DIAGNOSIS> #Functional neurological disorder #GAD/depression #PTSD #H/o disordered eating <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Out of Bed with assistance to chair or wheelchair. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Ms. ___, It was a privilege taking care of you at ___ ___. WHY WAS I ADMITTED TO THE HOSPITAL? --= -You came to the hospital because you acutely had trouble moving and speaking. WHAT HAPPENED WHILE I WAS IN THE HOSPITAL? --======== -You were seen by the neurologists who diagnosed you with functional neurological disorder. -You worked with physical and occupational therapists. -Your symptoms began to improve. WHAT SHOULD I DO AFTER I LEAVE THE HOSPITAL? --========== - Please continue to take all your medications and follow up with your doctors at your ___ appointments. - Please continue to work with your physical and occupational therapists. We wish you all the best! Sincerely, Your ___ Care Team ","BRIEF HOSPITAL SUMMARY: ======================= ___ female with history of disordered eating, PTSD, GAD with panic disorder, depression and functional neurological disorder presenting from a therapy session with weakness, abnormal movement, and aphasia concerning for an acute functional neurological episode. She was evaluated by neurology and psychology who felt this was consistent with functional neurological disorder, similar to her prior presentation. She began working with ___ and OT and had made great improvement at time of discharge to acute rehab. TRANSITIONAL ISSUES: ==================== For rehab: [] Please continue aggressive ___ and OT for further improvement in functional status. [] On discharge, please ensure patient has follow up with her PCP and her therapist. [] Patient was having some intermittent nausea as appetite improved. Please continue Zofran TID prn. QTc was 441 on EKG on ___. If continuing Zofran use for >1 week, please recheck QTc on ___ and d/c medication if prolonged. [] Patient has a history of disordered and restrictive eating. She does well eating with encouragement and did not show any evidence of eating disorder while inpatient. Please continue ensure supplements TID with meals. For PCP/therapist: [] Please refer patient to psychiatrist for further titration of psychiatric medications, given report of previous sensitivity to medications and concern for possible bipolar disorder diagnosis. [] Please follow up pending thiamine level. ACUTE ISSUES: ============= # GAD/Panic disorder # Depression # PTSD # Functional neurological disorder Patient presented from a therapy session where she had acute onset of weakness, abnormal movement and aphasia in the setting of potential trigger of seeing shadows outside the door. Per her therapist, over the past several weeks she has been increasingly more hypervigilant and stressed about going home for the holidays to see her mom, which is a major trigger for her PTSD. Her therapist also reports a history of sexual/physical/verbal abuse but patient is very guarded about it and will not discuss it. On presentation to the ___ had significant and acute functional neurological symptoms, including weakness, abnormal movement, and aphasia, resulting in impaired functioning. There was concern for catatonia and she improved after 1 mg IV ativan in the ER. She endorsed significant anxiety, but denied SI and, per Psychiatry, she did not meet ___ criteria. She had a similar episode in ___ after IV iron infusion and was admitted to the neurology service, where she was diagnosed with functional neurological disorder and she improved with ___ and rehab. She was also started on nortriptyline 10 mg QHS at that time. Per her therapist, she is sensitive to medications and when she was on SSRIs she became manic, although she has not formally been diagnosed with bipolar disorder. Once admitted, she was re-evaluated by neuro and psychiatry who determined this was not consistent with catatonia and instead was likely functional neurological disorder. She was recommended for acute rehab to continue aggressive ___. She was continued on home nortriptyline 10mg qhs. #Disordered eating #Restrictive eating #Over-exercising She has a history of restrictive eating and over-exercising and in the past she has had bradycardia and electrolyte abnormalities. Per her therapist, her disordered eating has become much worse over the past few months in the setting of traveling a lot for work. She started an intensive outpatient program at ___ Eating ___ on ___. Per her therapist, she restricts her calories to about 1,000 or less a day and over-exercises and is good at hiding it from people. From review of OMR, her BMI seems to be normal (between ___ and she currently does not have any electrolyte abnormalities but she has been intermittently bradycardic with HR in the ___. Her appetite improved as her neurological symptoms began resolving. Per nutrition evaluation, no need for eating disorder protocol while inpatient. She received Ensure supplements. Heart rates were stable, bradycardic in ___. Electrolytes were monitored. TSH, T4 and B12 levels were all normal. She received thiamine supplementation. She received Zofran PRN for nausea (QTc 441). CORE MEASURES ============= #CODE: full code #CONTACT: Per patient's request, do not contact her mother (___) -Emergency Contacts: ___ (___) ___ and ___ (Uncle) ___ -Therapist: ___, ___ ___ and coordinates all of her care and available for questions/calls at anytime ",1260,925
10002557-DS-6,"<SEX> F <SERVICE> SURGERY <ALLERGIES> Ciprofloxacin Hcl <ATTENDING> ___. <CHIEF COMPLAINT> RUQ and epigastric pain <MAJOR SURGICAL OR INVASIVE PROCEDURE> Laparoscopic cholecystectomy. <HISTORY OF PRESENT ILLNESS> ___ is an ___ year old female who presents with a one day history of RUQ and epigastric pain. The pain has been intermittent and associated with nausea. She reports that the pain is somewhat improved now, but not completely alleviated. She denies any emesis. She denies any fevers or chills. She has had a couple episodes of pain that was similar in the past. She continues to have flatus and bowel movements. She has not had any po intake since the pain began, so she is not sure if the pain is increased with po intake. She reports decreased appetite today. Last po intake was this morning. <PAST MEDICAL HISTORY> PMH: Multinodular goiter, Osteopenia, GERD, Gallbladder stone disease, Breast Cancer, chronic constipation, chronic migraines PSH: Right mastectomy, partial thyroidectomy x2, appendectomy <SOCIAL HISTORY> ___ <FAMILY HISTORY> Unknown <PHYSICAL EXAM> Admission PE: VS: 97.9 64 137/84 16 96% RA Gen: no acute distress, alert, responsive Pulm: unlabored breathing CV: regular rate and rhythm Abd: soft, mildly tender in the epigastric region and the RUQ, non-distended, no rebound, no gaurding, negative ___ sign Ext: warm and well perfused Discharge PE: VS: Temp: 98.9, HR: 64, BP: 128/61, RR: 18, O2: 95% RA General: A+Ox3, NAD, MAE. CV: RRR Resp: CTA b/l Abdomen: soft, non-distended, mildly tender to palpation Skin: abd lap sites w/ dsgs c/d/i Extremeties: no edema <PERTINENT RESULTS> ___ 08: 10PM URINE HOURS-RANDOM ___ 08: 10PM URINE HOURS-RANDOM ___ 08: 10PM URINE UHOLD-HOLD ___ 08: 10PM URINE GR HOLD-HOLD ___ 08: 10PM URINE COLOR-Straw APPEAR-Clear SP ___ ___ 08: 10PM URINE BLOOD-NEG NITRITE-NEG PROTEIN-NEG GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-6.5 LEUK-SM ___ 08: 10PM URINE RBC-<1 WBC-1 BACTERIA-NONE YEAST-NONE EPI-0 ___ 08: 10PM URINE MUCOUS-RARE ___ 07: 45PM GLUCOSE-90 UREA N-19 CREAT-0.7 SODIUM-140 POTASSIUM-3.5 CHLORIDE-104 TOTAL CO2-27 ANION GAP-13 ___ 07: 45PM estGFR-Using this ___ 07: 45PM ALT(SGPT)-106* AST(SGOT)-309* ALK PHOS-140* TOT BILI-0.7 ___ 07: 45PM LIPASE-36 ___ 07: 45PM ALBUMIN-4.1 ___ 07: 45PM WBC-8.8 RBC-3.83* HGB-11.6* HCT-33.9* MCV-89 MCH-30.4 MCHC-34.4 RDW-14.5 ___ 07: 45PM NEUTS-82.6* LYMPHS-12.5* MONOS-4.8 EOS-0.1 BASOS-0.1 ___ 07: 45PM PLT COUNT-169 Imaging: ___: Ultrasound: Porcelain gallbladder with calcification of the wall of the gallbladder, similar to previous. Stable dilatation of the common bile duct. ___: CXR: No evidence of acute cardiopulmonary disease. ___: Hida Scan: Findings are consistent with acute cholecystitis ___: Intraoperative Cholangiogram Contrast is seen opacifying the remaining biliary system, without filling defect. <MEDICATIONS ON ADMISSION> amlodipine 10 mg', atorvastatin 40 mg', Fioricet 50 mg-325 mg-40 mg'', Premarin 0.625 mg/gram vaginal cream, hydrochlorothiazide 25 mg', lorazepam 0.5 mg', metoprolol succinate ER 50 mg', omeprazole 20 mg', tramadol 50 mg'', valsartan 320 mg', zolpidem 5mg', aspirin 81 mg', Vit D <DISCHARGE MEDICATIONS> 1. Acetaminophen 1000 mg PO Q8H do NOT exceed more than 3gm in 24 hours. RX *acetaminophen 500 mg 2 tablet(s) by mouth every eight (8) hours Disp #*40 Tablet Refills: *0 2. Acetaminophen-Caff-Butalbital ___ TAB PO Q8H: PRN headache 3. Amlodipine 10 mg PO DAILY 4. Aspirin 81 mg PO DAILY 5. Atorvastatin 40 mg PO QPM 6. Docusate Sodium 100 mg PO BID RX *docusate sodium 100 mg 1 capsule(s) by mouth twice a day Disp #*20 Capsule Refills: *0 7. Lorazepam 0.5 mg PO QHS: PRN insomnia 8. Metoprolol Succinate XL 50 mg PO DAILY 9. Omeprazole 20 mg PO DAILY 10. OxycoDONE (Immediate Release) 2.5-10 mg PO Q4H: PRN Pain please do NOT drive while taking this medication. RX *oxycodone 5 mg ___ tablet(s) by mouth every four (4) hours Disp #*25 Tablet Refills: *0 11. Polyethylene Glycol 17 g PO DAILY: PRN Constipation 12. Senna 8.6 mg PO BID: PRN constipation please hold for loose stools 13. TraMADOL (Ultram) 50 mg PO BID: PRN pain 14. Valsartan 320 mg PO DAILY 15. Zolpidem Tartrate 5 mg PO QHS: PRN insomnia <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> 1. Cholelithiasis 2. Chronic cholecystitis. <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Ms. ___, You were admitted to the hospital with acute cholecystitis. You were taken to the operating room and had your gallbladder removed laparoscopically. You tolerated the procedure well and are now being discharged home to continue your recovery with the following instructions. Please follow up in the Acute Care Surgery clinic at the appointment listed below. ACTIVITY: o Do not drive until you have stopped taking pain medicine and feel you could respond in an emergency. o You may climb stairs. o You may go outside, but avoid traveling long distances until you see your surgeon at your next visit. o Don't lift more than ___ lbs for 4 weeks. (This is about the weight of a briefcase or a bag of groceries.) This applies to lifting children, but they may sit on your lap. o You may start some light exercise when you feel comfortable. o You will need to stay out of bathtubs or swimming pools for a time while your incision is healing. Ask your doctor when you can resume tub baths or swimming. HOW YOU MAY FEEL: o You may feel weak or ""washed out"" for a couple of weeks. You might want to nap often. Simple tasks may exhaust you. o You may have a sore throat because of a tube that was in your throat during surgery. o You might have trouble concentrating or difficulty sleeping. You might feel somewhat depressed. o You could have a poor appetite for a while. Food may seem unappealing. o All of these feelings and reactions are normal and should go away in a short time. If they do not, tell your surgeon. YOUR INCISION: o Tomorrow you may shower and remove the gauzes over your incisions. Under these dressing you have small plastic bandages called steri-strips. Do not remove steri-strips for 2 weeks. (These are the thin paper strips that might be on your incision.) But if they fall off before that that's okay). o Your incisions may be slightly red around the stitches. This is normal. o You may gently wash away dried material around your incision. o Avoid direct sun exposure to the incision area. o Do not use any ointments on the incision unless you were told otherwise. o You may see a small amount of clear or light red fluid staining your dressing or clothes. If the staining is severe, please call your surgeon. o You may shower. As noted above, ask your doctor when you may resume tub baths or swimming. YOUR BOWELS: o Constipation is a common side effect of narcotic pain medications. If needed, you may take a stool softener (such as Colace, one capsule) or gentle laxative (such as milk of magnesia, 1 tbs) twice a day. You can get both of these medicines without a prescription. o If you go 48 hours without a bowel movement, or have pain moving the bowels, call your surgeon. PAIN MANAGEMENT: o It is normal to feel some discomfort/pain following abdominal surgery. This pain is often described as ""soreness"". o Your pain should get better day by day. If you find the pain is getting worse instead of better, please contact your surgeon. o You will receive a prescription for pain medicine to take by mouth. It is important to take this medicine as directed. o Do not take it more frequently than prescribed. Do not take more medicine at one time than prescribed. o Your pain medicine will work better if you take it before your pain gets too severe. o Talk with your surgeon about how long you will need to take prescription pain medicine. Please don't take any other pain medicine, including non-prescription pain medicine, unless your surgeon has said its okay. o If you are experiencing no pain, it is okay to skip a dose of pain medicine. o Remember to use your ""cough pillow"" for splinting when you cough or when you are doing your deep breathing exercises. If you experience any of the following, please contact your surgeon: - sharp pain or any severe pain that lasts several hours - pain that is getting worse over time - pain accompanied by fever of more than 101 - a drastic change in nature or quality of your pain MEDICATIONS: Take all the medicines you were on before the operation just as you did before, unless you have been told differently. If you have any questions about what medicine to take or not to take, please call your surgeon. ","The patient was admitted to the General Surgical Service on ___ for evaluation and treatment of abdominal pain. Admission abdominal ultra-sound showed calcification of the wall of the gallbladder as well as stable dilatation of the common bile duct. Next she had a hida scan which was positive for acute cholecystitis. On ___, the patient underwent laparoscopic cholecystectomy with an introperative cholangiogram, which went well without complication (reader referred to the Operative Note for details). After a brief, uneventful stay in the PACU, the patient arrived on the floor tolerating a clear liquid diet, on IV fluids, and po pain medicine for pain control. The patient was hemodynamically stable. Pain was well controlled. Diet was progressively advanced as tolerated to a regular diet with good tolerability. The patient voided without problem. During this hospitalization, the patient ambulated early and frequently, was adherent with respiratory toilet and incentive spirometry, and actively participated in the plan of care. The patient received subcutaneous heparin and venodyne boots were used during this stay. On POD2, pt was noted to have saturated RUQ lap site dsgs with ongoing oozing, requiring a bedside cauderization which the patient tolerated well. Post-cauderization, good hemostasis was achieved. At the time of discharge the patient was doing well, afebrile with stable vital signs. The patient was tolerating a regular diet, ambulating, voiding without assistance, and pain was well controlled. The patient was discharged home without services. The patient and her family received discharge teaching and follow-up instructions with the use of an interpreter and the patient verbalized understanding and agreement with the discharge plan. She has a follow-up appointment scheduled in 2 weeks in the ___ clinic. ",2470,377
10002559-DS-7,"<SEX> M <SERVICE> MEDICINE <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> fever <MAJOR SURGICAL OR INVASIVE PROCEDURE> Lumbar puncture <HISTORY OF PRESENT ILLNESS> Mr ___ is a ___ male presents with 1 day general malaise, fever, altered mental status Per patient notes one day of chills, sore throat, dry cough and intermittent headache. He was later brought in by ambulance after being noted by his roommates to be altered. While being assessed by EMS patient was tachycardic to 160. Upon arrival to ED patient was disoriented to time and place. VS: 102.7 136 117/62 18 100% 4L. He underwent LP due to concern for meningitis. LP revealed protein 24 glucose 61. UA negative. CXR wnl. Urine/blood tox screen negative. Patient received 4L IVF, CTX 2gm, 4mg IV ativan pre-treatment for LP. VS prior to transfer: 99.9 119 94/44 18 98%. On arrival to the floor, patient is sleeping but arousable; oriented x3 but intermittently confused. Reports mild HA, sore throat, fever, dry cough, sweats, chills. No recent travel. No known sick contacts. No recent sexual activity. No genital ulcers/lesions. No skin rashes. Lives with 4roommates. Denies recent exposures, ingestions. Last EtOH use on ___ night. <PAST MEDICAL HISTORY> None <SOCIAL HISTORY> ___ <FAMILY HISTORY> Father: HTN, pre-DM No psych history <PHYSICAL EXAM> ADMISSION PHYSICAL EXAM: VS: 98.2 110/52 113regular 18 97%RA GENERAL: Sleeping but arousable, NAD, mildly diaphoretic HEENT: NC/AT, PERRLA, EOMI, no nystagmus, sclerae anicteric, MMM NECK: supple, no appreciable LAD LUNGS: CTA bilat, no r/rh/wh, good air movement, resp unlabored, no accessory muscle use HEART: tacycardiac, no MRG, nl S1-S2 ABDOMEN: thin, NABS, soft/NT/ND, no masses or HSM, no rebound/guarding SKIN: no obvious rashes, petechiae EXTREMITIES: WWP, no edema bilaterally in lower extremities, no erythema, induration, or evidence of injury or infection NEURO: A&Ox3, CNs II-XII grossly intact, muscle strength ___ throughout, sensation grossly intact throughout, DTRs 2+ and symmetric, no clonus, no rigidity, unsteady gait. DISCHARGE PHYSICAL EXAM: VS: 98.3, 112/70, 91, 18, 100%RA GENERAL: awake, NAD HEENT: NC/AT, sclerae anicteric, MMM, red/swollen bilat tonsils without evidence of exudate NECK: supple, no neck stiffness LUNGS: CTA bilat, no r/rh/wh, good air movement, resp unlabored, no accessory muscle use HEART: RRR, no MRG, nl S1-S2 ABDOMEN: thin, NABS, soft/NT/ND, no masses or HSM, no rebound/guarding SKIN: no obvious rashes, petechiae EXTREMITIES: WWP, no edema bilaterally in lower extremities, no erythema, induration, or evidence of injury or infection NEURO: A&Ox3, CNs II-XII grossly intact, gait normal, no focal deficits <PERTINENT RESULTS> ADMISSION LABS: ___ 12: 00AM GLUCOSE-104* UREA N-14 CREAT-0.8 SODIUM-136 POTASSIUM-3.4 CHLORIDE-99 TOTAL CO2-20* ANION GAP-20 ___ 12: 12AM LACTATE-2.1* ___ 12: 00AM ALT(SGPT)-25 AST(SGOT)-26 LD(LDH)-187 CK(CPK)-89 ALK PHOS-78 TOT BILI-1.0 ___ 12: 00AM CALCIUM-10.4* PHOSPHATE-0.8* MAGNESIUM-1.7 ___ 12: 00AM TSH-2.3 ___ 12: 00AM WBC-13.6* RBC-5.02 HGB-15.2 HCT-43.8 MCV-87 MCH-30.2 MCHC-34.7 RDW-12.3 ___ 12: 00AM URINE bnzodzpn-NEG barbitrt-NEG opiates-NEG cocaine-NEG amphetmn-NEG mthdone-NEG MICRO: - ___ 1: 17 am CSF;SPINAL FLUID Source: LP. **FINAL REPORT ___ GRAM STAIN (Final ___: NO POLYMORPHONUCLEAR LEUKOCYTES SEEN. NO MICROORGANISMS SEEN. This is a concentrated smear made by cytospin method, please refer to hematology for a quantitative white blood cell count.. FLUID CULTURE (Final ___: NO GROWTH. - ___ 1: 15 pm SEROLOGY/BLOOD **FINAL REPORT ___ RAPID PLASMA REAGIN TEST (Final ___: NONREACTIVE. Reference Range: Non-Reactive. - ___ 1: 15 pm SEROLOGY/BLOOD **FINAL REPORT ___ LYME SEROLOGY (Final ___: NO ANTIBODY TO B. BURGDORFERI DETECTED BY EIA. Reference Range: No antibody detected. Negative results do not rule out B. burgdorferi infection. Patients in early stages of infection or on antibiotic therapy may not produce detectable levels of antibody. Patients with clinical history and/or symptoms suggestive of lyme disease should be retested in ___ weeks. - ___ 5: 22 am Rapid Respiratory Viral Screen & Culture Source: Nasopharyngeal swab. **FINAL REPORT ___ Respiratory Viral Culture (Final ___: No respiratory viruses isolated. Culture screened for Adenovirus, Influenza A & B, Parainfluenza type 1,2 & 3, and Respiratory Syncytial Virus.. Detection of viruses other than those listed above will only be performed on specific request. Please call Virology at ___ within 1 week if additional testing is needed. Respiratory Viral Antigen Screen (Final ___: Negative for Respiratory Viral Antigen. Specimen screened for: Adeno, Parainfluenza 1, 2, 3, Influenza A, B, and RSV by immunofluorescence. Refer to respiratory viral culture for further information. - Herpes Simplex Virus PCR Specimen Source CSF Result Negative - Test (Serum) Result Reference Range/Units HSV 1 IGG TYPE SPECIFIC AB 3.61 H index HSV 2 IGG TYPE SPECIFIC AB <0.90 index Index Interpretation <0.90 Negative 0.90-1.10 Equivocal >1.10 Positive ___ 01: 15PM BLOOD HIV Ab-NEGATIVE <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. This patient is not taking any preadmission medications <DISCHARGE MEDICATIONS> 1. Acetaminophen 325-650 mg PO Q6H: PRN fever, pain 2. Amoxicillin-Clavulanic Acid ___ mg PO Q12H RX *amoxicillin-pot clavulanate 875 mg-125 mg 1 tablet(s) by mouth every twelve (12) hours Disp #*14 Tablet Refills: *0 <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Primary: Fever, acute encephalopathy, pharyngitis Secondary: None <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Mr. ___, It was a pleasure taking care of you at ___ ___. You were admitted for evaluation of your acute confusion and fever. While you were here you had a lumbar puncture and blood work to check for evidence of an infection. You were treated with antibiotics, and your symptoms improved. None of the tests which were run show any evidence of infection around your brain or in your blood. The antibiotics were stopped, and you continued to do well. The exact cause of your acute confusion and fever is unknown. ","___ male presents with 1 day general malaise, fever; found to be altered, febrile and tachycardic in the ED. # Altered Mental Status: Was noted to have confusion when at home with roommates, who called EMS given their concern. There was no history of ingestion, and tox screen was negtaive. Blood culture showed no growth, and influenza swab was negative as well. He was noted to be febrile, raising concern for possible meningitis/encephalitis. LP did not show any evidence of infection, and culture results were negative. All other infectious processes which were tested (HIV, RPR, lyme, CSF HSV) were also negative, but arborovirus is still pending at this time. His mental status returned to baseline shortly after he was admitted. # Throat Pain: Complained of throat pain with swallowing. Noted to have erythematous, slightly enlarged tonsils without evidence of exudates. Swab was negative for Strep. He was treated with 7 days of augmentin empirically. ",1942,227
10002751-DS-7,"<SEX> M <SERVICE> MEDICINE <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___ <CHIEF COMPLAINT> Abdominal pain <MAJOR SURGICAL OR INVASIVE PROCEDURE> None <HISTORY OF PRESENT ILLNESS> <HISTORY OF PRESENT ILLNESS> Mr ___ is a ___ year old male with one week of acute onset abdominal pain. He describes the pain as colicy and it lasts seconds. The pain began one week ago. He reports chills and cold sweats. He denies any subjetive fevers. He decided to go to the ED on ___ morning for further evaluation. In the ED they performed a CT exam and found isolated elevated liver enzymes. The CT showed mildly dilated and fluid-filled loops of jejunum that could be seen with a focal ileus which may reflect a mild inflammatory process such as gastroenteritis. He was discharged home. . On ___ night he again had an episode of severe pain that woke him up at night and came to the ED again for evaluation. In the ED they performed a KUB which showed air-fluid levels which are non-specific without evidence for bowel dilatation; obstruction was not entirely excluded however. They also performed an ultrasound of the liver which showed no evidence of acute cholecystitis. The exam also showed fatty infiltration of the liver, although other forms of more advanced liver disease, including cirrhosis, could not be excluded. . Since his admission on ___, he has not had a bowel movement. He reporets that prior to two days ago his stool was normal without melena or blood. He denies any diarrhea or constipation. He also has been unable to eat for the past two days. He says he has lost his appetite. He says his lack of appetite is not secondary to nausea or abdominal pain. The patient says he occasionally has nausea and feels like vomiting, but has not vomited since his pain began one week ago. The pain returned again last night and he decided to come to the ED for IV antibiotics. . Of note he has been diagnosed with H. pylori in the past but did not complete a full treatment course. . Initial VS in the ED: 96.4 66 165/110 18 100% . Patient was given 2L NS and morphine 2mg and required oxygen for desaturation to 91% afterward. He was admitted for futher workup. . Review of systems: (+) Per HPI (-) Denies fever, chills, night sweats, recent weight loss or gain. Denies headache, sinus tenderness, rhinorrhea or congestion. Denied cough, shortness of breath. Denied chest pain or tightness, palpitations. Denied nausea, vomiting, diarrhea, constipation or abdominal pain. No recent change in bowel or bladder habits. No dysuria. Denied arthralgias or myalgias. <PAST MEDICAL HISTORY> <PAST MEDICAL HISTORY> - Appendectomy - GERD <SOCIAL HISTORY> ___ <FAMILY HISTORY> <FAMILY HISTORY> Non contributory <PHYSICAL EXAM> Exam on Admission Vitals: T: 98 BP: 140/90 P: 67 R: 18 18 O2: 98% RA General: Alert, oriented, comfortable, moderately obese HEENT: Sclera anicteric, MMM, oropharynx clear Neck: Supple, JVP not elevated, no LAD Lungs: Clear to auscultation bilaterally, no wheezes, rales, ronchi CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Abdomen: Soft, non-distended, bowel sounds present, tender in right upper quadrant and feels bloated bilaterally in left and right lower quadrant, no rebound tenderness or guarding Ext: Warm, well perfused, no clubbing, cyanosis or edema Exam on Discharge Vitals: T: 97.5-98.4 ___ R: 20 O2: 96% RA, 900/700+ General: Alert, oriented, comfortable, moderately obese HEENT: Sclera anicteric, MMM, oropharynx clear Neck: Supple, JVP not elevated, no LAD Lungs: Clear to auscultation bilaterally, no wheezes, rales, ronchi CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Abdomen: Soft, non-distended, bowel sounds present, tender in right upper quadrant but less tender than yesterday. Ext: Warm, well perfused, no clubbing, cyanosis or edema <PERTINENT RESULTS> ___ 05: 30AM BLOOD WBC-9.8 RBC-4.66 Hgb-14.0 Hct-42.5 MCV-91 MCH-30.1 MCHC-33.0 RDW-12.9 Plt ___ ___ 09: 05AM BLOOD WBC-10.7 RBC-4.99 Hgb-14.6 Hct-45.3 MCV-91 MCH-29.3 MCHC-32.3 RDW-13.1 Plt ___ ___ 12: 10PM BLOOD WBC-11.4* RBC-4.91 Hgb-14.7 Hct-44.9 MCV-91 MCH-30.0 MCHC-32.8 RDW-13.2 Plt ___ ___ 09: 05AM BLOOD Neuts-76.2* Lymphs-17.8* Monos-4.7 Eos-0.9 Baso-0.4 ___ 12: 10PM BLOOD Neuts-85.3* Lymphs-12.2* Monos-2.2 Eos-0.2 Baso-0.2 ___ 05: 30AM BLOOD Plt ___ ___ 09: 05AM BLOOD Plt ___ ___ 09: 05AM BLOOD ___ PTT-28.5 ___ ___ 12: 10PM BLOOD Plt ___ ___ 05: 30AM BLOOD Glucose-108* UreaN-13 Creat-0.9 Na-136 K-3.6 Cl-100 HCO3-23 AnGap-17 ___ 09: 05AM BLOOD Glucose-122* UreaN-14 Creat-0.9 Na-138 K-3.8 Cl-99 HCO3-25 AnGap-18 ___ 12: 10PM BLOOD Glucose-111* UreaN-15 Creat-0.8 Na-140 K-4.2 Cl-103 HCO3-24 AnGap-17 ___ 05: 30AM BLOOD ALT-70* AST-82* LD(LDH)-215 AlkPhos-66 TotBili-0.5 ___ 09: 05AM BLOOD ALT-89* AST-128* AlkPhos-74 TotBili-0.7 ___ 12: 10PM BLOOD ALT-83* AST-164* AlkPhos-78 TotBili-0.4 ___ 09: 05AM BLOOD Lipase-30 ___ 12: 10PM BLOOD Lipase-45 ___ 07: 20PM BLOOD cTropnT-<0.01 ___ 05: 30AM BLOOD Calcium-9.2 Phos-4.0 Mg-2.1 ___ 07: 20PM BLOOD Iron-60 ___ 09: 05AM BLOOD Albumin-4.9 ___ 12: 10PM BLOOD Albumin-4.7 ___ 07: 20PM BLOOD calTIBC-341 Ferritn-253 TRF-262 ___ 09: 05AM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG Bnzodzp-NEG Barbitr-NEG Tricycl-NEG ___ 09: 24AM BLOOD Lactate-2.1* <MEDICATIONS ON ADMISSION> Preadmissions medications listed are incomplete and require futher investigation. Information was obtained from PatientFamily/Caregiver. 1. Omeprazole 40 mg PO DAILY 2. Fish Oil (Omega 3) 1000 mg PO BID 3. Sertraline 75 mg PO DAILY <DISCHARGE MEDICATIONS> 1. Omeprazole 20 mg PO BID 2. Amoxicillin 1000 mg PO Q12H RX *amoxicillin 500 mg twice a day Disp #*48 Capsule Refills: *0 3. Clarithromycin 500 mg PO Q12H RX *clarithromycin 500 mg twice a day Disp #*19 Tablet Refills: *0 4. OxycoDONE (Immediate Release) 5 mg PO Q6H: PRN Pain hold for sedation or rr<12 RX *oxycodone 5 mg take once if severe pain Disp #*4 Capsule Refills: *0 5. Fish Oil (Omega 3) 1000 mg PO BID 6. Sertraline 75 mg PO DAILY 7. Docusate Sodium 100 mg PO BID: PRN constipation hold for loose stools RX *docusate sodium 100 mg daily Disp #*30 Capsule Refills: *0 8. Senna 1 TAB PO BID: PRN constipation hold for loose stools 9. Simethicone 40-80 mg PO QID RX *simethicone 180 mg up to four times a day Disp #*60 Capsule Refills: *0 10. Polyethylene Glycol 17 g PO DAILY: PRN constipation hold for diarrhea RX *polyethylene glycol 3350 17 gram/dose daily Disp #*30 Packet Refills: *0 <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Gastritis complicated by constipation and H. pylori infection <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Mr ___, You were admitted to the hospital with abdominal pain and elevated liver function tests. We believe your abdominal pain may be related to the liver but it could also be due to untreated H. pylori infection. We started you on medications to treat this infection and you will need to complete a full course of treatment. You should take these medications for ten days total (last dose on ___. While your liver tests were initially midly elevated, they have been trending towards normal again. You had no evidence of gall stones but your ultrasound and CT scan did show fatty liver. Some of your blood tests were not back yet and we recommend that you discuss these results with your primary care doctor and get repeat liver tests next week. Overall we were feel that you are safe to go home. Because you are experiencing constipation which can also contribute to your abdominal pain, we will send you home with some medications that will help you have regular bowel movements. Medicaion Changes START omeprazole 20mg twice a day, after ___ you can start taking your normal home dose of omeprazole once a day (to treat H pylori) START Amoxicillin 1000 mg every 12 hours (last dose on ___ to treat H pylori START Clarithromycin 500 mg every 12 hours (last dose on ___ to treat H pylori Take the following medications if you have constipation Miralax Colace Take the following medications if you have pain Oxycodone (note this medication can make you constipated) Simethicone Thank you for the opportunity to participate in your care. ","# Elevated LFTs: CT, KUB and RUQ US did not show evidence of acute cholecystetis, despite the positive ___ sign. It is possible the patient has underlying viral hepatitis, the serologies were sent in the ED. We are reassured by downtrending LFTs. Iron studies were within normal limits making hemochromotosis less likely. The patient felt significant relief with his bowel movement, and therefore it is likely he had a degree of constipation contributing to his presentation. Troponins were negative and EKG was unremarkable making a cardiac etiology unlikely. He tolerated food well and his pain was significantly improved with minimal need for oxycodone. . # GERD/H. pylori: Patient has known history of GERD and is treated with prilosec with relief of symptoms. He also has a history of untreated H. pylory diagnosed in ___. The patient was given perscriptions at that time by his PCP but he never filled the perscriptions. We started treatment for presumed H. pylori with omeprazole 20mg BID, amoxicillin 1g BID and clarithromycin 500mg BID for ten days . # Anxiety: Patient takes sertraline 75mg daily, we will continue in house. . # Transition issues: Hepatitis serologies were pending at time of discharge. The patient also had stool studies which were pending. His LFTs have been trending downward, but he will need repeat LFTs once he follows up with his PCP. ",2536,322
10002760-DS-9,"<SEX> M <SERVICE> CARDIOTHORACIC <ALLERGIES> Patient recorded as having No Known Allergies to Drugs <ATTENDING> ___. <CHIEF COMPLAINT> decreased energy <MAJOR SURGICAL OR INVASIVE PROCEDURE> ___ AVR ( 23 mm ___ mechanical) <HISTORY OF PRESENT ILLNESS> ___ year old man with a known childhood murmur who was echoed during a recent admission for pneumonia and found to have severe aortic stenosis. Referred for AVR after cath showed clean coronaries. <PAST MEDICAL HISTORY> bicuspid aortic valve, aortic stenosis, aortic insufficiency, valvular induced cardiomyopathy, moderate pulmonary hypertension (52/23), recent pneumonia <SOCIAL HISTORY> ___ <FAMILY HISTORY> non-contributory <PHYSICAL EXAM> Pulse: 82 O2 sat: 96% B/P Left: 96/57 Height: 73"" Weight: 90.9kg General: Well-developed male in no acute distress Skin: Dry [x] intact [xx] HEENT: PERRLA [x] EOMI [x] Neck: Supple [x] Full ROM [x] Chest: Lungs clear bilaterally [x] Heart: RRR [x] Irregular [] Murmur II/VI SEM radiating to carotids and across precordium Abdomen: Soft [x] non-distended [x] non-tender [x] bowel sounds + [x] Extremities: Warm [x], well-perfused [x] Edema/Varicosities: None [x] Neuro: Grossly intact [x] Pulses: Femoral Right: 2+ Left: 2+ DP Right: 2+ Left: 2+ ___ Right: 2+ Left: 2+ Radial Right: 2+ Left: 2+ Carotid Bruit Right: - Left: - <PERTINENT RESULTS> Conclusions PRE-CPB: 1. The left atrium is moderately dilated. No spontaneous echo contrast is seen in the left atrial appendage. No thrombus is seen in the left atrial appendage. 2. No atrial septal defect is seen by 2D or color Doppler. 3. There is moderate symmetric left ventricular hypertrophy. The left ventricular cavity is moderately dilated. Doppler parameters are most consistent with Grade II (moderate) left ventricular diastolic dysfunction. 4. Right ventricular chamber size and free wall motion are normal. 5. There are simple atheroma in the descending thoracic aorta. 6. The aortic valve is bicuspid. There is severe aortic valve stenosis (valve area 0.8-1.0cm2). Moderate (2+) aortic regurgitation is seen. The severity of aortic regurgitation may be underestimated. The aortic regurgitation jet is eccentric, directed toward the anterior mitral leaflet. 7. The mitral valve appears structurally normal with trivial mitral regurgitation. There is bilateral retraction of the mitral valve. 8. There is a small to moderate sized pericardial effusion. 9. A moderate left pleural effusion is seen. Drs. ___ were notified in person of the results. POST-CPB: On infusions of epi, neo. AV pacing , then a pacing. Well-seated mechanical valve in the aortic position. Coronary flow seen in LMCA and RCA. Trace AI consistent with washing jets. Preserved ventricular function on inotropic support. LVEF is now 40%. Trace MR. ___ contour is normal post decannulation. I certify that I was present for this procedure in compliance with ___ regulations. Electronically signed by ___, MD, Interpreting physician ___ ___ 14: 13 <MEDICATIONS ON ADMISSION> lasix 20mg daily zocor 40mg daily KCL 20mEq daily coreg 3.125mg daily Amox 500mg (cont. after dental d/t symptoms from pna) ASA <DISCHARGE MEDICATIONS> 1. Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day). 2. Aspirin 81 mg Tablet, Delayed Release (E.C.) Sig: One (1) Tablet, Delayed Release (E.C.) PO DAILY (Daily). 3. Acetaminophen 325 mg Tablet Sig: Two (2) Tablet PO Q4H (every 4 hours) as needed for pain. 4. Hydromorphone 2 mg Tablet Sig: ___ Tablets PO Q3H (every 3 hours) as needed for pain. Disp: *65 Tablet(s)* Refills: *0* 5. Simvastatin 40 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). Disp: *30 Tablet(s)* Refills: *2* 6. Magnesium Hydroxide 400 mg/5 mL Suspension Sig: Thirty (30) ML PO HS (at bedtime) as needed for constipation. 7. Metoprolol Tartrate 25 mg Tablet Sig: 0.5 Tablet PO BID (2 times a day). Disp: *30 Tablet(s)* Refills: *2* 8. Furosemide 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). Disp: *30 Tablet(s)* Refills: *2* 9. Potassium Chloride 20 mEq Tab Sust.Rel. Particle/Crystal Sig: One (1) Tab Sust.Rel. Particle/Crystal PO once a day. 10. Coumadin 2.5 mg Tablet Sig: as directed Tablet PO once a day: goal INR 2.5-3.0 for mechcanical aortic valve. take 2.5 mg on ___ then as directed by Dr. ___. Disp: *60 Tablet(s)* Refills: *2* 11. Outpatient Lab Work ___ for coumadin dosing indication mechanical aortic valve - goal INR 2.5-3.0 with results to ___ clinic fax # ___ ___ clinic and Dr ___ - first draw ___ <DISCHARGE DISPOSITION> Home With Service Facility: ___ <DISCHARGE DIAGNOSIS> Aortic stenosis, aortic insufficiency s/p Aortic valve replacement (Mech -#23mm St. ___ valvular-induced cardiomyopathy pulmonary hypertension recent Pneumonia chronic systolic/diastolic heart failure <DISCHARGE CONDITION> alert and oriented ambulating with steady gait Sternal pain managed with dilaudid <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Please shower daily including washing incisions gently with mild soap, no baths or swimming, and look at your incisions Please NO lotions, cream, powder, or ointments to incisions Each morning you should weigh yourself and then in the evening take your temperature, these should be written down on the chart No driving for approximately one month until follow up with surgeon No lifting more than 10 pounds for 10 weeks Please call with any questions or concerns ___ ","Mr. ___ was admitted on ___ and underwent AVR( mech AVR #23 ___ with Dr. ___. See operative note for details. Post operatively he remained intubated and was transferred to the CVICU in stable condition on epinephrine, phenylephrine, propofol, and lidocaine drips. He awoke neurologically intact, was weaned from the ventilator and extubated. Vasoactive medications were weaned after hemodynamic stability was achieved. Betablockers, diuretics and statin therapies were initiated and titrated. Chest tubes and temporary pacing wires were removed per protocol. Coumadin therpay was intiated for mechanical AVR. He was evaluated and treated by physical therapy for strength and conditioning. Mr. ___ was cleared for discharge to home on POD#4 with an INR of 2.0 by Dr. ___. ",1552,184
10002769-DS-15,"<SEX> F <SERVICE> SURGERY <ALLERGIES> Ms ___ / Iodine; Iodine Containing <ATTENDING> ___. <CHIEF COMPLAINT> venous stasis ulcer <MAJOR SURGICAL OR INVASIVE PROCEDURE> Split-thickness skin graft left thigh to left ankle. <PAST MEDICAL HISTORY> - hypertension - hypercholesterolemia - DVTs, ___ years ago (post-partum) and ___, on coumadin for ___ years, stopped about ___ years ago, PCP started hypercoagulable ___ after learning patient d/c coumadin but this was negative - diverticulosis - skin graft for unhealed left leg ulcer ___ (followed for ___ yr) - fibroids - s/p TAH/BSO ___ years ago for bleeding fibroids in the setting of anticoagulation - hepBcAb pos, hepBsAb and Ag neg in ___ <SOCIAL HISTORY> ___ <FAMILY HISTORY> - HTN in both parents - mother died age ___ of ESRD (on HD) from HTN - father died age ___ of lung cancer - sister died in ___ of leukemia - no known h/o of hypercoagulable states, DM - two brothers, two sisters who are healthy <PHYSICAL EXAM> GENERAL: Well-appearing overweight ___ female in no apparent distress. HEENT: EOMI/PERRL. OP clear with moist mucous membranes. NECK: No cervical lymphadenopathy. No thyromegaly. LUNGS: Clear to auscultation bilaterally. ___: Regular rate and rhythm. Normal S1/S2. No murmurs auscultated. ABDOMEN: Soft, nontender/nondistended. No hepatomegaly. well-healed low transverse abdominal scar. EXT: Left lower extremity wrapped in Ace bandage. Tender to palpation anywhere over the bandage. No lower extremity edema noted. Right knee with palpable metal implant. Calves were atrophied bilaterally. NEUROLOGIC: 2+ biceps and patellar reflexes. <PERTINENT RESULTS> ___ 07: 55AM BLOOD WBC-8.0 RBC-4.16* Hgb-12.9 Hct-39.6 MCV-95 MCH-31.0 MCHC-32.6 RDW-13.4 Plt ___ ___ 07: 55AM BLOOD Neuts-48.3* Lymphs-42.9* Monos-4.0 Eos-4.3* Baso-0.5 ___ 07: 55AM BLOOD Glucose-99 UreaN-11 Creat-0.8 Na-140 K-4.1 Cl-106 HCO3-20* AnGap-18 ___ 12: 15AM URINE Color-Straw Appear-Clear Sp ___ URINE Blood-NEG Nitrite-NEG Protein-NEG Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-7.0 Leuks-NEG URINE Hours-RANDOM Creat-31 Na-80 URINE Osmolal-288 ___ 12: 15 am URINE URINE CULTURE (Final ___: NO GROWTH. ___ 3: 05 pm TISSUE LEFT ANKLE. GRAM STAIN (Final ___: NO POLYMORPHONUCLEAR LEUKOCYTES SEEN. 4+ (>10 per 1000X FIELD): GRAM POSITIVE COCCI. IN PAIRS AND CHAINS. 2+ ___ per 1000X FIELD): GRAM NEGATIVE ROD(S). STAPH AUREUS COAG +. SPARSE GROWTH. STAPH AUREUS COAG + | CLINDAMYCIN-----------<=0.25 S ERYTHROMYCIN----------<=0.25 S GENTAMICIN------------ <=0.5 S LEVOFLOXACIN---------- 0.25 S OXACILLIN------------- 0.5 S TRIMETHOPRIM/SULFA---- <=0.5 S ANAEROBIC CULTURE (Final ___: NO ANAEROBES ISOLATED. <MEDICATIONS ON ADMISSION> amlodipine 5 qd, atenolol 50 bid, gabapentin 300 tid, lisinopril 40 qd, ibuprofen prn <DISCHARGE MEDICATIONS> 1. DiCLOXacillin 250 mg Capsule Sig: One (1) Capsule PO Q6H (every 6 hours) for 2 weeks. Disp: *56 Capsule(s)* Refills: *0* 2. Atenolol 50 mg Tablet Sig: One (1) Tablet PO BID (2 times a day). 3. Amlodipine 5 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 4. Gabapentin 300 mg Capsule Sig: One (1) Capsule PO TID (3 times a day). 5. Lisinopril 20 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily). 6. Ibuprofen 400 mg Tablet Sig: One (1) Tablet PO Q8H (every 8 hours) as needed for pain. 7. Percocet ___ mg Tablet Sig: ___ Tablets PO every ___ hours for 10 days: prn. Disp: *40 Tablet(s)* Refills: *0* 8. Cerovite Silver Tablet Sig: One (1) Tablet PO once a day. <DISCHARGE DISPOSITION> Home With Service Facility: ___ <DISCHARGE DIAGNOSIS> Venous stasis ulcer HTN <DISCHARGE CONDITION> Stable <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Postoperative Care: Do not expose recipient site to prolonged sunlight Follow instructions given for bandaging the grafted area to provide it with appropriate support during the healing process, and to prevent contractures even after healing is complete Inspect site for healing and good circulation, as shown by healthy pink coloration Keep the recipient site clean and dry Outcome A successful skin graft will result in transplanted skin adhering and growing into the recipient area. Cosmetic results may vary, based on factors such as type of skin graft used, and area of recipient site. Call Your Doctor ___ Any of the Following Occurs Cough, shortness of breath, chest pain, or severe nausea or vomiting Headache, muscle aches, dizziness, or general ill feeling Redness, swelling, increasing pain, excessive bleeding, or discharge from the incision site Signs of infection, including fever and chills ","Mrs. ___ was admitted on ___ with Left venous stasis ulcer. She agreed to have an elective surgery. Pre-operatively, she was consented. A CXR, EKG, UA, CBC, Electrolytes, T/S - were obtained, all other preperations were made. It was decided that she would undergo a Split-thickness skin graft left thigh to left ankle. She was prepped, and brought down to the operating room for surgery. Intra-operatively, she was closely monitored and remained hemodynamically stable. She tolerated the procedure well without any difficulty or complication. VAC dressing placed Post-operatively, she was extubated and transferred to the PACU for further stabilization and monitoring. She was then transferred to the VICU for further recovery. While in the VICU she recieved monitered care. When stable she was delined. Her diet was advanced. When she was stabalized from the acute setting of post operative care, she was transfered to floor status. She remained on bedrext x 5 days. The VAC was taken down. Graft site looks good. Pt antibiotics tailored to her OR sensitivities. On the floor, she remained hemodynamically stable with his pain controlled. She progressed with physical therapy to improve her strength and mobility. She continues to make steady progress without any incidents. She was discharged home in stable condition on PO AB. ",1442,288
10002769-DS-16,"<SEX> F <SERVICE> SURGERY <ALLERGIES> Ms ___ / Iodine; Iodine Containing <ATTENDING> ___. <CHIEF COMPLAINT> Venous ulcerations with DVT <MAJOR SURGICAL OR INVASIVE PROCEDURE> None <HISTORY OF PRESENT ILLNESS> ___ presented to the ED ___ complaining of increased pain in her LLE at the ulcer site. She's a ___ year old female with history ___ venous stasis with open ulcers on her medial malleous. She has failed 2 STSG and 1 Apligraft before her latest Apligraft 2 weeks ago with Dr. ___. The graft appeared well on her follow up visit on ___. However, patient reported feeling severe pain after being on her feet all day on ___. The pain got worse last night and patient was instructed to come to the ED. She stated that she felt as if the dressing was too constricted. She endorsed some swelling of her LLE but attributed it to being on her feet all day at work. In the ED, her outer dressing was removed and she reported feeling better. She stated that she hasn't taken Dicloxacillin due to nausea with emesis after taking the medication. Upon further questions, patient also reported having multiple watery bowel movements in the past few days. She reported having hx of C. diff in the past. She otherwise denied any fever, chills, cp/sob. <PAST MEDICAL HISTORY> - hypertension - hypercholesterolemia - DVTs, ___ years ago (post-partum) and ___, on coumadin for ___ years, stopped about ___ years ago, PCP started hypercoagulable ___ after learning patient d/c coumadin but this was negative - diverticulosis - skin graft for unhealed left leg ulcer ___ (followed for ___ yr) - fibroids - s/p TAH/BSO ___ years ago for bleeding fibroids in the setting of anticoagulation - hepBcAb pos, hepBsAb and Ag neg in ___ <SOCIAL HISTORY> ___ <FAMILY HISTORY> - HTN in both parents - mother died age ___ of ESRD (on HD) from HTN - father died age ___ of lung cancer - sister died in ___ of leukemia - no known h/o of hypercoagulable states, DM - two brothers, two sisters who are healthy <PHYSICAL EXAM> Vitals: 98.7 HR; 57 BP: 124/90 RR: 20 Spo2: 95% Gen: NAD, A&Ox3 Chest: CTAB CV: RRR, S1S2 ___: soft, nt/nd Extrem: b/l ___ skin changes, more on L side. There are two ulcers, the large one about 3x7cm and the smaller one more distal about 2x3cm. The Apligraft appeared to be disintergrated. There is minimal erythema around the wound edges. LLE is more swollen compared to RLE, no calf tenderness. Pulses: Fem Pop DP ___ R p p p d L p p p d <PERTINENT RESULTS> ___ 06: 00AM BLOOD WBC-8.2 RBC-3.73* Hgb-11.7* Hct-35.1* MCV-94 MCH-31.4 MCHC-33.4 RDW-14.9 Plt ___ ___ 06: 25AM BLOOD WBC-10.2 RBC-3.93* Hgb-12.2 Hct-37.4 MCV-95 MCH-31.2 MCHC-32.8 RDW-15.0 Plt ___ ___ 01: 15PM BLOOD WBC-9.8 RBC-4.65 Hgb-14.6 Hct-42.7 MCV-92 MCH-31.3 MCHC-34.1 RDW-15.1 Plt ___ ___ 01: 15PM BLOOD Neuts-63.9 ___ Monos-4.5 Eos-2.7 Baso-0.8 ___ 10: 25AM BLOOD ___ PTT-30.6 ___ ___ 06: 00AM BLOOD Plt ___ ___ 06: 25AM BLOOD Plt ___ ___ 01: 15PM BLOOD Plt ___ ___ 01: 15PM BLOOD ___ PTT-20.0* ___ ___ 01: 15PM BLOOD ESR-14 ___ 06: 00AM BLOOD Glucose-80 UreaN-10 Creat-0.7 Na-133 K-3.9 Cl-106 HCO3-22 AnGap-9 ___ 06: 25AM BLOOD Glucose-91 UreaN-14 Creat-0.8 Na-140 K-3.7 Cl-109* HCO3-23 AnGap-12 ___ 08: 50PM BLOOD Creat-1.1 Na-142 K-3.8 Cl-110* ___ 01: 15PM BLOOD Glucose-97 UreaN-15 Creat-1.2* Na-140 K-2.9* Cl-103 HCO3-24 AnGap-16 ___ 06: 00AM BLOOD Calcium-8.6 Phos-3.0 Mg-1.6 ___ 06: 25AM BLOOD Calcium-8.4 Phos-3.6 Mg-1.7 ___ 01: 15PM BLOOD Calcium-9.4 Phos-3.4 Mg-1.9 ___ 5: 52 am SWAB Source: Left leg. GRAM STAIN (Final ___: 2+ ___ per 1000X FIELD): POLYMORPHONUCLEAR LEUKOCYTES. NO MICROORGANISMS SEEN. WOUND CULTURE (Preliminary): Due to mixed bacterial types (>=3) an abbreviated workup is performed; P.aeruginosa, S.aureus and beta strep. are reported if present. Susceptibility will be performed on P.aeruginosa and S.aureus if sparse growth or greater.. ANAEROBIC CULTURE (Preliminary): ___ ___ F ___ ___ Radiology Report BILAT LOWER EXT VEINS Study Date of ___ 2: 55 ___ ___ EU ___ 2: 55 ___ BILAT LOWER EXT VEINS Clip # ___ Reason: LT CALF PAIN ,R/O DVT UNDERLYING MEDICAL CONDITION: ___ year old woman with left calf pain REASON FOR THIS EXAMINATION: ? DVT Wet Read: ___ ___ 5: 24 ___ 1. positive for left DVT, with nonocclusive thrombus seen in the mid SFV extending to occlusive thrombus in the left popliteal and calf veins. 2. no RLE dvt. Wet Read Audit # 1 Final Report INDICATION: ___ female with left calf pain, evaluate for DVT. COMPARISON: None. FINDINGS: Grayscale and color sonographic imaging of the lower extremity veins was performed. On the left, the common femoral and proximal superficial femoral veins demonstrate normal compressibility and flow. However, there is partially occlusive thrombus seen in the mid superficial femoral vein, extending to occlusive thrombus in the left popliteal vein, with a lack of compressibility and no flow seen. Additional occlusive thrombus is seen in the left calf veins. The right leg was also interrogated, demonstrating normal compressibility, flow, and augmentation in the common femoral, superficial femoral, popliteal, and calf veins. IMPRESSION: 1. Left leg DVT in the mid superficial femoral (partially occlusive), and popliteal and calf veins (fully occlusive). 2. No right lower extremity DVT. The study and the report were reviewed by the staff radiologist. <MEDICATIONS ON ADMISSION> amlodipine 5 qd, atenolol 50 bid, gabapentin 300 tid, lisinopril 40 qd, ibuprofen prn <DISCHARGE MEDICATIONS> 1. enoxaparin 80 mg/0.8 mL Syringe Sig: One (1) Subcutaneous Q12H (every 12 hours). Disp: *10 * Refills: *1* 2. amoxicillin-pot clavulanate 500-125 mg Tablet Sig: One (1) Tablet PO Q8H (every 8 hours) for 10 days. Disp: *30 Tablet(s)* Refills: *0* 3. warfarin 5 mg Tablet Sig: One (1) Tablet PO Once Daily at 4 ___: Call PCP ___. ___ for Refills. Disp: *30 Tablet(s)* Refills: *2* 4. amlodipine 5 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 5. acetaminophen 325 mg Tablet Sig: ___ Tablets PO Q6H (every 6 hours) as needed for fever/pain. 6. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day) as needed for Constipation. 7. atenolol 50 mg Tablet Sig: One (1) Tablet PO BID (2 times a day). 8. cholecalciferol (vitamin D3) 400 unit Tablet Sig: One (1) Tablet PO DAILY (Daily). 9. Percocet ___ mg Tablet Sig: ___ Tablets PO every four (4) hours. Disp: *40 Tablet(s)* Refills: *0* 10. Outpatient Lab Work ___ to draw labs (INR) q2 days and fax to PCP @ ___. (PCP: ___. ___ or ___ to schedule PCP ___ <DISCHARGE DISPOSITION> Home With Service Facility: ___ <DISCHARGE DIAGNOSIS> Left DVT Venous ulcers <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Uses Cane <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> You were admitted to ___ for your venous stasis ulcers and were found to have a blood clot in your left leg. The decision was made to start you on a blood thinning medication (Coumadin). You will be discharged today with Lovenox until your INR level is greater then 2. You should take coumadin everyday. Your PCP ___ ___ or ___ will be following your blood levels. ","___ The patient was admitted from the ED with Left ___ DVT with chronic venous ulcerations. She was admitted to the Vascular service. Pain management overnight with Percocet and Dilaudid. DVT confirmed with venous duplex (see report). The decision was made by Dr. ___ anticoagulation. The patient was started on a Lovenox/Coumadin bridge. Her PCP was contacted and agreed to manage the patient's INR during lovenox/coumadin bridge and refer to ___ for additional management. Lovenox teaching was done by nursing, the patient has a good understanding of administration. She was discharged on ___ with ___ services for wound care and ___ checks. She will follow up with Dr. ___ week with a duplex. She was discharged on a 10 day course of Augmentin. ",2298,172
10002800-DS-14,"<SEX> F <SERVICE> SURGERY <ALLERGIES> Percocet / cucumber <ATTENDING> ___ <CHIEF COMPLAINT> Left breast invasive ductal carcinoma <MAJOR SURGICAL OR INVASIVE PROCEDURE> LEFT BREAST TOTAL MASTECTOMY W/ SENTINEL LYMPH NODE BIOPSY ___ <HISTORY OF PRESENT ILLNESS> Ms ___ is a ___ year old pregnant female with breast cancer. She had a palpable left breast lump, underwent ultrasound, MRI, and core biopsy that showed a grade 2 invasive ductal carcinoma, ER positive, PR positive, HER2 negative. She later was found to be pregnant. She is currently feeling fine apart from tiredness. She reports that her levothyroxine dose was increased earlier this week. She also notes some left nipple crusting, that there initially (after the biopsy) was some bloody output that has since declined and become mild and crusty. Otherwise no changes. <PAST MEDICAL HISTORY> PAST MEDICAL HISTORY: thyroid CA, postsurgical hypothyroidism, IBS, ovarian cysts, PID, spine arthritis, asthma, mononucleosisreported history of Lyme disease status post 3 weeks of antibiotic therapy. Hashimotos negative prior to surgery per her report <SOCIAL HISTORY> ___ <FAMILY HISTORY> Family history: Aunt and mother with ALS. Mother, aunt, grandmother: ___. Father--prostate cancer (age ___. <PHYSICAL EXAM> VS: Refer to flowsheet GEN: WD, WN in NAD CV: RRR PULM: no respiratory distress BREAST: L breast - No evidence of hematoma, seroma. Small amount of ecchymoses. Mildly tender to palpation. Incision healing well. ABD: soft, NT, ND EXT: WWP NEURO: A&Ox3 <MEDICATIONS ON ADMISSION> Meds/<ALLERGIES> reviewed in OMR and medications listed here ALBUTEROL SULFATE [PROAIR HFA] - Dosage uncertain - (Prescribed by Other Provider) LEVOTHYROXINE - levothyroxine 175 mcg tablet. 1 tablet(s) by mouth daily in the morning on empty stomach, 90 minutes prior to any food or other meds PNV ___ FUMARATE-FA [PRENATAL] - Dosage uncertain - (Prescribed by Other Provider) <DISCHARGE MEDICATIONS> 1. Acetaminophen 1000 mg PO Q6H 2. Docusate Sodium 100 mg PO BID 3. HYDROmorphone (Dilaudid) ___ mg PO Q3H: PRN Pain - Severe 4. Albuterol Inhaler ___ PUFF IH Q6H: PRN wheezing, dyspnea 5. Levothyroxine Sodium 175 mcg PO DAILY 6. Prenatal Vitamins 1 TAB PO DAILY <DISCHARGE DISPOSITION> Home With Service Facility: ___ <DISCHARGE DIAGNOSIS> left breast invasive ductal carcinoma <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Ms. ___, You were admitted to ___ for LEFT BREAST TOTAL MASTECTOMY W/ SENTINEL LYMPH NODE BIOPSY. You are now stable for discharge. Personal Care: 1. You may keep your incisions open to air or covered with a clean, sterile gauze that you change daily. 2. Clean around the drain site(s), where the tubing exits the skin, with soap and water. 3. Strip drain tubing, empty bulb(s), and record output(s) ___ times per day. 4. A written record of the daily output from each drain should be brought to every follow-up appointment. Your drains will be removed as soon as possible when the daily output tapers off to an acceptable amount. 5. You may wear a surgical bra or soft, loose camisole for comfort. 6. You may shower daily with assistance as needed. Be sure to secure your drains so they don't hang down loosely and pull out. 7. The Dermabond skin glue will begin to flake off in about ___ days. Activity: 1. You may resume your regular diet. 2. Walk several times a day. 3. DO NOT lift anything heavier than 5 pounds or engage in strenuous activity for 6 weeks following surgery. Medications: 1. Resume your regular medications unless instructed otherwise and take any new meds as ordered . 2. You may take your prescribed pain medication for moderate to severe pain. You may switch to Tylenol or Extra Strength Tylenol for mild pain as directed on the packaging. Please note that Percocet and Vicodin have Tylenol as an active ingredient so do not take these meds with additional Tylenol. 3. Take prescription pain medications for pain not relieved by Tylenol. 4. Take Colace, 100 mg by mouth 2 times per day, while taking the prescription pain medication. You may use a different over-the-counter stool softener if you wish. 5. Do not drive or operate heavy machinery while taking any narcotic pain medication. You may have constipation when taking narcotic pain medications (oxycodone, percocet, vicodin, hydrocodone, dilaudid, etc.); you should continue drinking fluids, you may take stool softeners, and should eat foods that are high in fiber. Call the office IMMEDIATELY if you have any of the following: 1. Signs of infection: fever with chills, increased redness, swelling, warmth or tenderness at the surgical site, or unusual drainage from the incision(s). 2. A large amount of bleeding from the incision(s) or drain(s). 3. Fever greater than 101.5 oF 4. Severe pain NOT relieved by your medication. Return to the ER if: * If you are vomiting and cannot keep in fluids or your medications. * If you have shaking chills, fever greater than 101.5 (F) degrees or 38 (C) degrees, increased redness, swelling or discharge from incision, chest pain, shortness of breath, or anything else that is troubling you. * Any serious change in your symptoms, or any new symptoms that concern you. DRAIN DISCHARGE INSTRUCTIONS You are being discharged with drains in place. Drain care is a clean procedure. Wash your hands thoroughly with soap and warm water before performing drain care. Perform drainage care twice a day. Try to empty the drain at the same time each day. Pull the stopper out of the drainage bottle and empty the drainage fluid into the measuring cup. Record the amount of drainage fluid on the record sheet. Reestablish drain suction. Please assist patient with drain care. A daily log of individual drain outputs should be maintained and brought with patient to follow up appointment with your surgeon. ","The patient was admitted on ___ with left breast invasive ductal carcinoma for left total mastectomy and left axillary sentinel lymph node biopsy with Dr. ___. Please see operative note. The patient tolerated the procedure well. There were no immediate complications. She was awoken from general anesthesia in the operating room and transferred to the recovery room in stable condition. On post-operative check, she reported pain at the site of the incision and nausea, and had an episode of emesis. The OB/GYN team recommended pain control with Dilaudid. She was placed on subQ heparin and compression devices for prophylaxis. She tolerated a regular diet. On ___, the pain continued to have pain, which was discussed with OB/GYN, and her dosage of Dilaudid was increased. She was given stool softener given the usage of narcotics. She reported some mild pink spotting, which was discussed with OB, and they performed an ultrasound which showed a strong fetal heart rate of 158. Per their report, she has been spotting since earlier in the pregnancy as well. The dressing on the incision site continued to be clean dry and intact. There was no ecchymoses or hematoma on the chest wall. Drain output was serosanguineous. At the time of discharge on ___, vitals were stable, pain well-controlled, and patient felt ready for discharge to home with ___, with follow up appointments in place. ",1505,292
10002800-DS-15,"<SEX> F <SERVICE> OBSTETRICS/GYNECOLOGY <ALLERGIES> Percocet / cucumber / Tegaderm <ATTENDING> ___. <CHIEF COMPLAINT> cracked tooth, s/p fall <MAJOR SURGICAL OR INVASIVE PROCEDURE> tooth extraction <HISTORY OF PRESENT ILLNESS> Patient is a ___ year old G1P0 at ___ by U/S w/ h/o breast CA on DDAC chemotherapy in pregnancy and thyroid CA who presents after transfer from ED for tooth pain and for evaluation after a fall two days ago when she tripped on the ice and hit her shoulder. She reports progressive dental pain in the right lower molar. She has been unable to get dental treatment of her fractured molar in the outpatient setting due to concerns about pregnancy and medical complexity. She was therefore referred to the ED. OMFS was consulted while she was in the ED w/ plan for removal in the OR tomorrow. Findings included cracked tooth #29 w/ carriers extending to pulp. The patient was sent to OB triage given the mechanical fall. The patient denies any abdominal trauma or bruising. She has been having very irregular cramping, no contractions. She also reports intermittent sharp shooting pain from the groin to her belly button. Not exacerbated by anything. Pain cannot be reproduced. She denies and VB or LOF. <PAST MEDICAL HISTORY> PNC: - ___ ___ by US - Labs: Rh+/ab neg/RPRNR/RI/HBsAg neg/HIV neg/ GBS unknown - Genetics: LR ERA - FFS: wnl - GLT: wnl - US: ___, 67%, breech, ___, nl fluid, anterior placenta - Issues: *) breast cancer in pregnancy: unilateral mastectomy w/ sentinel LN biopsy, s/p chemotherapy completed ___, plan for PP tamoxifen *) mild asthma *) History of papillary thyroid cancer x 2, on levothyroxine 175mcg daily; labs ___ - TSH 4.3 (elevated) but normal FT4 (1.1) ROS: per hpi GYNHx: h/o breast cancer OBHx: G1, current PMH: h/o breast cancer, mild asthma, h/o papillary PSH: s/p unilateral mastectomy w/ sentinel LN biopsy <SOCIAL HISTORY> ___ <FAMILY HISTORY> Family history: Aunt and mother with ALS. Mother, aunt, grandmother: ___. Father--prostate cancer (age ___ <PHYSICAL EXAM> On admission: ___ 19: 03Temp.: 98.0F ___ 19: 03BP: 121/65 (76) ___ ___: 69 ___ ___: 67 GEN: NAD Respiratory: no increased WOB Abdomen: no bruising, non-tender, gravid SVE: LCP TAUS: vtx, anterior placenta, no sonographic evidence of abruption, MVP 5.4 FHT: 130/moderate/+accels/ no decels On discharge: VS: 98.0, 114/71, 73, 16, O2 96% Gen: [x] NAD Resp: [x] No evidence of respiratory distress Abd: [x] soft [x] non-tender Ext: [x] no edema [x] non-tender Date: ___ Time: ___ FHT: 120s, mod var, +accels, no decels reactive Toco: occ ctx <PERTINENT RESULTS> n/a <MEDICATIONS ON ADMISSION> albuterol, levothyroxine <DISCHARGE MEDICATIONS> Acetaminophen 1000 mg PO Q6H: PRN Pain - Mild RX *acetaminophen 500 mg ___ tablet(s) by mouth every 6 hours Disp #*50 Tablet Refills: *0 Levothyroxine Sodium 200 mcg PO DAILY <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Cracked tooth <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Ms. ___, You were admitted to the ___ service for monitoring after a fall and prior to your procedure with the oral surgeons for a tooth extraction. You procedure went well and your baby was monitored before and after the procedure. You are now stable to be discharged home. Please see instructions below. You should continue biting down on a piece of gauze for 30 minute interval. You may stop after ___ gauze changes. You should NOT have any hot/solid foods for the time being. You may continue drinking cool liquids. You may transition to soft foods (eggs, pasta, pancake) tonight. For pain control, you may take Tylenol as needed (do not take more than 4000mg in 24 hours). Please call your primary dentist with any questions or concerns. Please call the office for: - Worsening, painful or regular contractions - Vaginal bleeding - Leakage of water or concern that your water broke - Abdominal pain - Nausea/vomiting - Fever, chills - Decreased fetal movement - Other concerns ","Patient is a ___ year old G1 with hx of breast CA on DDAC chemotherapy in pregnancy and thyroid CA admitted at 34w2d after a fall. On admission, she had no evidence of abruption or preterm labor. She reported mild cramping and her cervix was LCP. Fetal testing was reassuring. She also had a painful, cracked tooth and had been evaluated by OMFS in the emergency room. A plan was made for extraction in the OR. On HD#2, she underwent an uncomplicated tooth extraction under local anesthesia. Her pain resolved. She continued to have some intermittent cramping and pink discharge, however, she had no evidence of preterm labor. She was discharged to home in stable condition on HD#3 and will have close outpatient follow up. ",1118,161
10002804-DS-15,"<SEX> M <SERVICE> ORTHOPAEDICS <ALLERGIES> Aspirin <ATTENDING> ___. <CHIEF COMPLAINT> L wrist pain <MAJOR SURGICAL OR INVASIVE PROCEDURE> None <HISTORY OF PRESENT ILLNESS> ___ year old otherwise healthy male presents to ED with 1 day history of L wrist pain. Patient states that he was walking across the street yesterday when he suffered a mechanical fall, landing on his outstretched L hand. He experienced immediate onset of pain but did not present to the hospital until today. He denies numbness or tingling in his fingers or any other symptoms. <PAST MEDICAL HISTORY> Glaucoma <SOCIAL HISTORY> ___ <FAMILY HISTORY> NC <PHYSICAL EXAM> A&O x 3 Calm and comfortable LUE Skin clean and intact No visible deformity. Diffuse tenderness surrounding the wrist. No erythema, edema, induration or ecchymosis Arms and forearm compartments soft Axillary, Radial, Median, Ulnar SILT EPL FPL EIP EDC FDP FDS fire Fingers WWP <PERTINENT RESULTS> ___ 05: 38AM BLOOD WBC-8.8# RBC-4.53* Hgb-14.1 Hct-40.1 MCV-89 MCH-31.0 MCHC-35.1* RDW-13.3 Plt ___ ___ 05: 38AM BLOOD ___ PTT-27.0 ___ <DISCHARGE INSTRUCTIONS> MEDICATIONS: - Please take all medications as prescribed by your physicians at discharge. - Continue all home medications unless specifically instructed to stop by your surgeon. - Do not drink alcohol, drive a motor vehicle, or operate machinery while taking narcotic pain relievers. - Narcotic pain relievers can cause constipation, so you should drink eight 8oz glasses of water daily and take a stool softener (colace) to prevent this side effect. ACTIVITY AND WEIGHT BEARING: - Nonweightbearing left upper extremity. - Please remain in your splint and refrain from getting your splint wet until your follow up appointment. ","The patient presented to the emergency department and was evaluated by the orthopedic surgery team. The patient was found to have a left distal radius fracture and was admitted to the orthopedic surgery service. The patient was reduced and splinted during this admission, but otherwise treated non-operatively. The patient will have outpatient follow-up for assessment and evaluation for any possible surgery intervention following discharge. The patients home medications were continued throughout this hospitalization. The ___ hospital course was otherwise unremarkable. At the time of discharge the patient was afebrile with stable vital signs that were within normal limits, pain was well controlled with oral medications, and the patient was voiding/moving bowels spontaneously. The patient is nonweightbearing in the left upper extremity. The patient will follow up with Dr. ___ in the hand clinic. A thorough discussion was had with the patient regarding the diagnosis and expected post-discharge course, and all questions were answered prior to discharge. Discharge Medications: 1. Docusate Sodium 100 mg PO BID RX *docusate sodium [Colace] 100 mg 1 capsule(s) by mouth twice daily Disp #*30 Capsule Refills:*2 2. Senna 1 TAB PO BID RX *sennosides [senna] 8.6 mg 1 tab by mouth twice daily Disp #*30 Tablet Refills:*2 3. Acetaminophen 650 mg PO Q6H:PRN pain RX *acetaminophen [8 HOUR PAIN RELIEVER] 650 mg 1 tablet extended release(s) by mouth every 6 hours Disp #*60 Tablet Refills:*1 Discharge Disposition: Home Discharge Diagnosis: L distal radius fracture Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Followup Instructions: ___",469,395
10002870-DS-14,"<SEX> F <SERVICE> OBSTETRICS/GYNECOLOGY <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> Pelvic mass and uterine fibroid. <MAJOR SURGICAL OR INVASIVE PROCEDURE> Total abdominal hysterectomy, bilateral salpingo-oophorectomy. <HISTORY OF PRESENT ILLNESS> Ms. ___ is a ___, postmenopausal female, who was found to have a left-sided pelvic mass on routine exam. . Pelvic ultrasound revealed large left adnexal mass. Pelvic MRI was done which revealed a 7.9cm left ovarian mass with some imaging features suggestive a fibroma/fibrothecoma but other features atypical for this diagnosis. There was also a multi-fibroid uterus with material within the endometrial cavity at the level of the fundus. A preoperative CA-125 was 17. An endometrial biopsy showed inactive endometrium. She presents today for definitive surgical management. . She reports baseline urinary frequency, urgency, irritable bowel and abdominal bloating. She denies any vaginal bleeding or abdominal/pelvic pain. <PAST MEDICAL HISTORY> PMH: R Breast Dysplasia, Hypercholesterolemia, Anxiety, Osteoarthritis, Hypothyroidism, Herpes. PSH: L leg muscle graft, knee arthroscopy, R hand ganglion cyst removal, R thyroid lobe removal. OB/GYN: G3P1, post-menopausal, last Pap ___ no hx abnl paps, STIs, gyn dx. <SOCIAL HISTORY> ___ <FAMILY HISTORY> no h/o ovarian, breast, uterine or colon cancer. <PHYSICAL EXAM> On day of discharge: Afebrile, vitals stable General: No acute distress CV: regular rate and rhythm Pulm: clear to auscultation bilaterally Abd: soft, appropriately tender, nondistended, incision clean/dry/intact, no rebound/guarding ___: nontender, nonedematous <PERTINENT RESULTS> ___ 06: 05AM BLOOD WBC-12.1* RBC-4.01* Hgb-12.7 Hct-37.8 MCV-94 MCH-31.8 MCHC-33.7 RDW-14.7 Plt ___ ___ 06: 05AM BLOOD Neuts-71.7* ___ Monos-5.6 Eos-1.9 Baso-0.5 ___ 06: 05AM BLOOD Plt ___ ___ 06: 05AM BLOOD Glucose-100 UreaN-11 Creat-0.6 Na-139 K-4.4 Cl-104 HCO3-28 AnGap-11 ___ 06: 05AM BLOOD Calcium-8.0* Phos-3.2 Mg-1.9 <MEDICATIONS ON ADMISSION> hydrocodone 5 mg-acetaminophen 325 mg PO QID ibuprofen 800 mg PO BD prn pain levothyroxine 100 mcg, 1 tablet QD for 5 days, 1.5 tablets for 2 days/wk sertraline 100 mg, PO, QD simvastatin 40 mg, PO, QD valacyclovir 500 mg, PO, BD for 4 days prn breakout <DISCHARGE MEDICATIONS> 1. Ibuprofen 600 mg PO Q6H: PRN pain RX *ibuprofen 600 mg 1 tablet(s) by mouth every six (6) hours Disp #*60 Tablet Refills: *1 2. Docusate Sodium 100 mg PO BID Take to prevent constipation while taking narcotics. RX *docusate sodium 100 mg 1 capsule(s) by mouth twice a day Disp #*60 Capsule Refills: *1 3. Levothyroxine Sodium 150 mcg PO 2X/WEEK (MO,FR) 4. Levothyroxine Sodium 100 mcg PO 5X/WEEK (___) 5. Sertraline 100 mg PO DAILY 6. Oxycodone-Acetaminophen (5mg-325mg) ___ TAB PO Q4H: PRN pain Do not exceed 4000 mg of acetaminophen in 24h. Do not drive. RX *oxycodone-acetaminophen 5 mg-325 mg ___ tablet(s) by mouth every four (4) hours Disp #*60 Tablet Refills: *0 <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Benign ovarian fibroma and fibroid uterus. <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Ms. ___, You were admitted to the gynecologic oncology service after undergoing the procedures listed below. You have recovered well after your operation, and the team feels that you are safe to be discharged home. Please follow these instructions: * Take your medications as prescribed. * Do not drive while taking narcotics. * Do not combine narcotic and sedative medications or alcohol. * Do not take more than 4000mg acetaminophen (APAP) in 24 hrs. * No strenuous activity until your post-op appointment. * Nothing in the vagina (no tampons, no douching, no sex) for 12 weeks. * No heavy lifting of objects >10 lbs for 6 weeks. * You may eat a regular diet. * It is safe to walk up stairs. . Incision care: * You may shower and allow soapy water to run over incision; no scrubbing of incision. No bath tubs for 6 weeks. To reach medical records to get the records from this hospitalization sent to your doctor at home, call ___. ","Ms. ___ ___ was admitted to the gynecologic oncology service after undergoing total abdominal hysterectomy, bilateral salpingo-oophorectomy, and washings. Please see the operative report for full details. . Her post-operative course is detailed as follows. Immediately postoperatively, her pain was controlled with IV Dilaudid/Toradol. Her diet was advanced without difficulty and she was transitioned to PO Oxycodone and Ibuprofen. On post-operative day #1, her urine output was adequate so her Foley catheter was removed and she voided spontaneously. . By post-operative day #1, she was tolerating a regular diet, voiding spontaneously, ambulating independently, and pain was controlled with oral medications. She was then discharged home in stable condition with outpatient follow-up scheduled. ",1299,166
10002930-DS-10,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___ <CHIEF COMPLAINT> Hypoglycemia, Alcohol intoxication, Suicidality <MAJOR SURGICAL OR INVASIVE PROCEDURE> None <HISTORY OF PRESENT ILLNESS> ___ is a ___ F with a history of HCV, HIV, and multiple prior admissions for suicidal ideation who presented to the ___ ED this morning after being found down, somnolent and was ultimately found to have an EtOH level of 117 and initial FSBG 42. She was being observed in the ED but hypoglycemia did not readily improve. She is being transferred to the MICU for close monitoring and treatment of refractory hypoglyemia. Per the patient she reports trying to drink ""as much as possible"" to try and kill herself. She is not sure if she took anything else. She does not recall any other details about last evening. In the ED, initial vitals were 98.0 84 110/65 12 100% RA In the ED, she received: - 4 amps of dextrose - Started on D5 NS gtt - Diazepam 10mg PO @ 10: 45a - Octreotide 100mcg - Folic acid 1mg IV x 1 - Thiamine 100mg IV x 1 - Multivitamin Labs/imaging were significant for: - Urine tox: positive for cocaine and benzodiazepines - Serum tox: positive for benzodiazepines, EtOH level of 117 - VBG ___ with AG = 18, lactate 3 - CT head without acute intracranial abnormality on prelim read Vitals prior to transfer were T 95.6 HR 89 BP 106/65 RR 16 SpO2 100% On arrival to the MICU, the patient reports no current complaints. Review of systems: (+) Per HPI, headache <PAST MEDICAL HISTORY> PAST MEDICAL HISTORY: - HIV (dx ___: Previously on ARV - Hepatitis C: Diagnosed ___, genotype 1 - Truamatic brain injury (1980s) - pt reports she was ""assaulted"" and subsequently received 300 stitches, was hospitalized x 2wks, and underwent rehab at ___ she denies LOC or persistent deficits but receives SSDI for this injury PSYCHIATRIC HISTORY: (per OMR) Dx/Sxs- Per pt, depression, panic attacks, polysubstance (ETOH, crack, heroin) abuse/dependence. Hospitalizations- Per pt, multiple hospitalizations at ___ (last, ___ and ___ (last, 5+ yrs ago). Per OMR, multiple (>20) detox admissions. No record of treatment at ___ in Partners system. SA/SIB- Per pt, OD on Ultram ""probably to hurt [her]self"" ___ ago) Psychiatrist- None Therapist- None Medication Trials- Amitriptyline <SOCIAL HISTORY> ___ <FAMILY HISTORY> Denies h/o psychiatric illness, suicide attempts, addictions. <PHYSICAL EXAM> ADMISSION EXAM: Vitals- Tmax: 37.3 C (99.2 F) Tcurrent: 37.3 C (99.2 F) HR: 89 (87 - 89) bpm BP: 104/51(62) {104/51(62) - 133/70(80)} mmHg RR: 14 (14 - 20) insp/min SpO2: 100% Heart rhythm: SR (Sinus Rhythm) General- Well appearing, no apparent distress HEENT- Tattoo on right neck. Pupils 4mm, reactive. Neck- No JVD CV- RRR, III/VI SEM heard best at ___ Lungs- CTAB Abdomen- Soft, nontender. Specifically no tenderness of RUQ. No stigmata of chronic liver disease. GU- No foley Ext- Warm, well perfused. No edema. Neuro- CN II-XII grossly intact. No tremor. DISCHARGE PHYSICAL EXAM Vitals: T98.3 HR83 BP106/73 RR18 100%RA General- Well appearing, no apparent distress HEENT- Tattoo on right neck. Pupils 4mm, reactive. Neck- No JVD CV- RRR, III/VI SEM heard best at ___ Lungs- CTAB Abdomen- Soft, nontender. Specifically no tenderness of RUQ. No stigmata of chronic liver disease. GU- No foley Ext- Warm, well perfused. No edema. Neuro- CN II-XII grossly intact. No tremor. <PERTINENT RESULTS> ADMISSION LABS: ___ 03: 36AM BLOOD WBC-2.4* RBC-3.64* Hgb-7.7* Hct-27.6* MCV-76* MCH-21.1* MCHC-27.8* RDW-18.5* Plt ___ ___ 03: 36AM BLOOD Glucose-107* UreaN-15 Creat-0.6 Na-136 K-3.4 Cl-107 HCO3-21* AnGap-11 ___ 07: 35AM BLOOD ALT-49* AST-105* CK(CPK)-224* AlkPhos-69 TotBili-0.2 ___ 03: 36AM BLOOD Calcium-7.8* Phos-2.6*# Mg-1.8 ___ 07: 35AM BLOOD Osmolal-321* ___ 07: 35AM BLOOD ASA-NEG ___ Acetmnp-NEG Bnzodzp-POS Barbitr-NEG Tricycl-NEG ___ 09: 05AM BLOOD ___ Temp-36.7 pO2-47* pCO2-36 pH-7.26* calTCO2-17* Base XS--9 Intubat-NOT INTUBA ___ 11: 10AM BLOOD Glucose-51* Lactate-2.1* HeaD CT: IMPRESSION: 1. No acute intracranial abnormality. 2. Prominence of the posterior nasopharyngeal soft tissues is seen and correlation with direct visualization is recommended. 3. Encephalomalacia in the left parietal lobe with overlying bony defect, possibly from prior trauma. DISCHARGE LABS ___ 03: 36AM BLOOD WBC-2.4* RBC-3.64* Hgb-7.7* Hct-27.6* MCV-76* MCH-21.1* MCHC-27.8* RDW-18.5* Plt ___ ___ 06: 35AM BLOOD Glucose-97 UreaN-15 Creat-0.5 Na-139 K-3.7 Cl-109* HCO3-23 AnGap-11 ___ 07: 35AM BLOOD ALT-49* AST-105* CK(CPK)-224* AlkPhos-69 TotBili-0.2 ___ 06: 35AM BLOOD Calcium-8.2* Phos-2.7 Mg-1.4* <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. This patient is not taking any preadmission medications <DISCHARGE MEDICATIONS> 1. Bisacodyl 10 mg PO DAILY: PRN constipation 2. Docusate Sodium 100 mg PO BID 3. FoLIC Acid 1 mg PO DAILY 4. Multivitamins W/minerals 1 TAB PO DAILY 5. Polyethylene Glycol 17 g PO 1X Duration: 1 Dose 6. Senna 8.6 mg PO BID: PRN Constipation 7. Thiamine 100 mg PO DAILY <DISCHARGE DISPOSITION> Extended Care Facility: ___ <DISCHARGE DIAGNOSIS> Primary diagnosis: hypoglycemia secondary to poor po intake, suicidal ideation, severe depression <DISCHARGE CONDITION> Flat affect, active suicidal ideation Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Ms. ___, It was a pleasure to take care of you at ___. You were admitted to the ICU for low blood sugars that you had when you arrived. You have not had any further blood sugars since. They were probably caused by not eating enough while drinking excessive alcohol. You were transferred back to the general floor and monitored. You continue to have suicidal thoughts and will therefore be going to ___ when you leave ___. We wish you all the best in your recovery. Your ___ tem. ","___ F with HCV, HIV presenting after being found down with +EtOH, cocaine, benzodiazepines and transferred to the MICU for hypoglycemia, now resolving. 1) HYPOGLYCEMIA: Suspect related to poor PO intake. Hypoglycemia resolved with eating and patient has remained euglycemic for the remainder of her hospital stay. 2) SUICIDALITY: Patient has had prior admissions to psychiatry for SI and has active SI currently. On ___. Psych was following in house. 1:1 sitter at all times. Patient transferred to ___ for active suicidality. 3) ETOH WITHDRAWAL: No active etoh withdrawal during hospital stay. CIWA scale but not scoring. 4) HEPATITIS C INFECTION: Chronic. Elevated transaminases currently, but in classic 2:1 pattern for EtOH and given recent ingestion history, this is more likely the explanation. - Follow-up as outpatient issue 5) HIV: Will bear in mind as transitional issue to consider re-initiating ARVs CODE STATUS: Unable to assess given active suicidality # Transitional issues - New murmur work up - chronic leukopenia - reinitiating HIV treatment and consideration for initiation of HCV treatment - Nystagmus work-up as outpatient ",1931,283
10002930-DS-12,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> alcohol intoxication <MAJOR SURGICAL OR INVASIVE PROCEDURE> none <HISTORY OF PRESENT ILLNESS> ___ y/o ___ homeless F with PMH of TBI, HIV+, HCV, polysubstance abuse (alcohol, crack cocaine, and heroin), unspecified mood disorder (MDD with psychotic features vs. substance-induced mood disorder), and chronic AH who presented from ___ station via EMS with complaint of multiple head strikes found to have EtOH intoxication and SI admitted to MICU for EtOH withdrawal and CIWA monitoring. Patient is noted to be a poor historian; however she reports she hit her head ""multiple"" times today ___ falling asleep. Of note, she reports active EtOH use and states her last drink was at 1200 on ___. She is unsure if she used other drugs/medications. In addition, she reports concern that she is having auditory hallucinations with the voices increasing in frequency. In addition, patient reports active SI although she does not have a plan. In the ED, initial vitals: 98.2 88 150/98 16 100% RA. During time in ED, patient became febrile to 101; a urinalysis/urine cx, CXR, and blood cultures were sent. - Exam notable for: pleasant patient with poor hygiene/dress, tangential and appearing to respond to internal stimuli, neuro intact, no clear HEENT trauma, mild upper thoracic tenderness, (+) tongue fasiculation - Labs were notable for: 2.9>9.9/33.6<168 Na 140 K 3.5 Cl 103 HCO3 24 BUN 15 Cr 0.6 Gluc 111 AGap=17 ALT 77 AST 196 AP 98 Tbili 0.6 Alb 3.9 Serum EtOH 21 Serum ASA, Acetmnphn, ___, Tricyc Negative Lactate 1.0 U/A with ketones, 6 WBCs, few bacteria, negative leuks, negative nitrites - Imaging showed: NCHCT (___): 1. No acute intracranial abnormality. 2. Stable left parietal encephalomalacia. CXR (___): No acute cardiopulmonary abnormality or fracture. - Patient was given: 40mg diazepam 100mg thiamine MVI 1mg folic acid 30mg ketorolac 2L NS 1gm Tylenol - Psychiatry was consulted who felt patient was disorganized and endorsing AH and SI (no plan). Per their recommendations, patient was placed on a ___ with a 1: 1 sitter with admission to medicine for EtOH withdrawal On arrival to the MICU, she was sleeping comfortably. Would open eyes to voice and answer questions, but was overall very sleepy. Denies pain. Cannot articulate when last drink was, says ""yesterday."" Denies taking anything else. <PAST MEDICAL HISTORY> Per Dr. ___ (___), confirmed with patient and updated as relevant: - HIV - Hepatitis C - H/o head injury (Per Deac 4 DC summary ___: ""pt reports she was ""assaulted"" and subsequently received 300 stitches, was hospitalized x 2wks, and underwent rehab at ___ she denies LOC or persistent deficits but receives SSDI for this injury"" <SOCIAL HISTORY> Per Dr. ___ (___), confirmed with patient and updated as relevant: ""The patient reports that she was born and raised in ___ and that her parents were separated while she was growing up. She states that she lives with her grandmother her whole life until ___ years ago when her mother died and that she has been living in the ___ since. She states that she has 2 daughters (age ___ and ___, named ___ and ___ who are both enrolled at ___ and that she also has 2 grandchildren. Denies contact with parents, whom she reports are not supportive. "" On today's interview patient reports no contact with her family, reports having 3 living children (2 daughters and 1 son) and 1 dead son. She has no contact with her children. She did not wish to elaborate further. Confirms living at ___. <FAMILY HISTORY> Unknown (pt refused to answer in past) <PHYSICAL EXAM> ADMISSION PHYSICAL EXAM: -========== Vitals: 98.2 103 138/77 22 99% ra GEN: lying in bed, somnolent, but wakes to voice, NAD HEENT: no scleral icterus, PERRL, mmm, nl OP NECK: supple, no JVD CV: tachycardic, regular rhythm, II/VI systolic murmur PULM: nl wob on ra, LCAB, no wheezes or crackles ABD: soft, mild distension, normal bs, nontender EXT: warm, trace bilateral edema, 2+ DP pulses SKIN: no rashes or visible track marks NEURO: sleepy, oriented to person, didn't answer re place or time, answering questions then falls asleep, moving all 4 extremities ACCESS: PIV DISCHARGE PHYSICAL EXAM: -========== stable vital signs lying comfortably in bed. bilateral knee ecchymosis. <PERTINENT RESULTS> ADMISSION LABS: -========== ___ 03: 27PM BLOOD WBC-2.9* RBC-3.81* Hgb-9.9* Hct-33.6* MCV-88 MCH-26.0 MCHC-29.5* RDW-17.9* RDWSD-56.8* Plt ___ ___ 03: 27PM BLOOD Neuts-74.0* ___ Monos-4.5* Eos-0.7* Baso-0.3 AbsNeut-2.16 AbsLymp-0.60* AbsMono-0.13* AbsEos-0.02* AbsBaso-0.01 ___ 03: 27PM BLOOD Glucose-111* UreaN-15 Creat-0.6 Na-140 K-3.5 Cl-103 HCO3-24 AnGap-17 ___ 03: 27PM BLOOD ALT-77* AST-196* AlkPhos-98 TotBili-0.6 ___ 03: 27PM BLOOD Albumin-3.9 ___ 03: 27PM BLOOD Osmolal-295 ___ 03: 27PM BLOOD ASA-NEG Ethanol-21* Acetmnp-NEG Bnzodzp-NEG Barbitr-NEG Tricycl-NEG MICRO: -========== -Blood cx pending -Urine cx pending IMAGING/STUDIES: -========== -NCHCT (___): 1. No acute intracranial abnormality. 2. Stable left parietal encephalomalacia. -CXR (___): No acute cardiopulmonary abnormality or fracture. DISCHARGE LABS: -========== <MEDICATIONS ON ADMISSION> The Preadmission Medication list may be inaccurate and requires futher investigation. 1. Amitriptyline 25 mg PO QHS 2. Triamcinolone Acetonide 0.1% Cream 1 Appl TP BID 3. Sulfameth/Trimethoprim DS 1 TAB PO DAILY (not taking) 4. Emtricitabine-Tenofovir (Truvada) 1 TAB PO DAILY (not taking) 5. Darunavir 600 mg PO BID (not taking) 6. RiTONAvir 100 mg PO DAILY (not taking) <DISCHARGE MEDICATIONS> 1. Sulfameth/Trimethoprim DS 1 TAB PO DAILY 2. FoLIC Acid 1 mg PO DAILY 3. Thiamine 100 mg PO DAILY <DISCHARGE DISPOSITION> Extended Care Facility: ___ <DISCHARGE DIAGNOSIS> Polysubstance abuse <DISCHARGE CONDITION> Mental Status: Confused - sometimes. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Ms. ___, You were admitted to ___ for evaluation of numerous falls, alcohol and substance abuse. While you were here you were briefly in the intensive care unit where you were started on phenobarbital to help you withdrawal from alcohol and prevent delirium tremens. You also disclosed that you were not taking any of your HIV medications. You were started on Bactrim as prophylaxis for opportunistic infections, and should follow up with your outpatient providers regarding restarting your HIV medications and for evaluation of your hepatitis C. You were deemed medically stable for discharge to a psychiatric facility. ","___ y/o ___ homeless F with PMHx of TBI, HIV+, HCV, polysubstance abuse (alcohol, crack cocaine, and heroin), unspecified mood disorder (MDD with psychotic features vs. substance-induced mood disorder), and chronic AH who presented from ___ station via EMS with complaint of multiple head strikes found to have EtOH intoxication and SI admitted to MICU for EtOH withdrawal and CIWA monitoring, now stabilized and transferred to the floor, now medically stable for discharge to psychiatric facility ACTIVE ISSUES: ======================== # EtOH intoxication/withdrawal: on phenobarbital withdrawal protocol. Last drink ___. Patient was loaded with phenobarbital, which may continue if the accepting psychiatric facility is okay with administering, however there is no contraindication to discontinuing. -Phenobarb protocol while inpatient, stopped at discharge -Continued MVI, thiamine, folate -Hydroxyzine PRN for additional agitation -seen by psychiatry and social work - appreciated. # Suicidal ideation: patient repeatedly stating ""I have suicidal thoughts"" and ""I'm depressed,"" though is unable to fully elaborate. Psychiatry saw the patient and had the following recommendations: -Patient meets ___ criteria for involuntary admission, may not leave AMA, should continue 1:1 observation. -Would hold on any psychiatric medications given acute alcohol withdrawal. -If chemical restraint necessary, please call psychiatry for specific recs. Please be aware that patient has cited ""jaw locking"" with Haldol administration in the past, thus would consider alternative antipsychotic. - seen by psychiatry - recommended inpatient psychiatric placement, and transferred to deac 4. # FEVER: Patient febrile to 101 in the ED. No localizing signs of symptoms of infection. Suspect that this was likely related to acute ingestion, however given her murmur which has not been documented previously, obtained TTE which showed no evidence of vegetation or endocarditis. # Psychosis: suspect this is part of underlying psych disorder and not necessarily alcoholic hallucinosis. Will defer to psychiatry. -Appreciate Psychiatry recs CHRONIC STABLE ISSUES: ======================== # HIV: not on HAART, started Bactrim for PCP prophylaxis given last CD4 count was <200, will send repeat CD4 count on ___ if still inpatient. Patient was previously not taking her HAART medications, will defer to outpatient. # HCV: not on active treatment - Monitor LFTs, as above Transitioanl issues: Should see PCP re HIV and HCV once psychiatrically stabilized. ",1930,543
10002930-DS-13,"<SEX> F <SERVICE> PSYCHIATRY <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> ""I'm still hearing the voices"" <MAJOR SURGICAL OR INVASIVE PROCEDURE> None <HISTORY OF PRESENT ILLNESS> Please see psychiatry consult notes by Drs ___, and ___ dated ___ for details of HPI, past psychiatric, medical, family, and social histories. Additionally, please refer to medicine discharge summary dated ___ for details of medicine ICU and floor course. Briefly, this is a ___ y/o homeless ___ F with PMH of TBI, HIV (not on HAART), HCV (not treated), and past psychiatric hx of polysubstance abuse (EtOH, crack cocaine, and heroin), unspecified mood disorder (MDD with psychotic features vs. ___ mood disorder), and chronic AH who presented to the ED from ___ station with tangential thoughts and complaint of repeat head strikes after multiple falls. She was found to be exhibiting signs of severe EtOH withdrawal and was admitted to the ICU where she was initiated on the phenobarb protocol. She was transferred to the medical On arrival to Deac 4: Pt stated that she was continuing to hear voices and have suicidal thoughts. She declined to give details regarding her SI, stating, ""why would I tell you about it? I would just do it."" She also notes, ""and obviously you guys are not gonna give me a razor to shave with or anything."" She reported that the voices she hears are both male and female. They are not voices that she recognizes, and she cannot make out what they are saying. They are frequently worse as she tries to fall asleep. She has a difficult time discerning whether they have been bothering her more frequently during the past several weeks, because she has been drinking and ""maybe doing crack."" She becomes fixated on a story about smoking a crack pipe and throwing it onto the ground ""where any kid could pick it up and light it and smoke it,"" and she retells this multiple times. <PAST MEDICAL HISTORY> PAST PSYCHIATRIC HISTORY: Per Dr. ___ note (___), confirmed with ___ and updated as relevant: - Diagnosis on discharge from ___ 4 on ___: MDD with psychotic features vs. ___ mood disorder - Hospitalizations: ___ reports many prior hospitalizations (>10, including Arbour; >20 detox admissions per OMR). Most recent hospitalization at ___ with discharge one day prior to ED presentation (___). - Suicide ___ stated she ODed on Amitriptyline ___ years ago, per prior records stated she took ___ pills, went to sleep on a park bench, and then woke up and went to her shelter, did not go to the hospital. In the past she has also reported ingestion of alcohol as a possible suicide attempt and a suicide attempt in ___ by overdose on unknown pills to ED staff. ___ 4 discharge summary dated ___: ""Per pt, OD on Ultram ""probably to hurt [her]self"" ___ yrs ago)"" - Violence: ___ - Medication Trials: Reports h/o successful treatment with Zoloft (denies knowledge of when). Also reports being txed with Haldol ""once"" and states she ""took too much, and my jaw was locked for ___ hours."" Past documentation from ___ 4 discharge summary dated ___ stated h/o treatment with Elavil. BEST indicated previous reported treatment with Risperdal. OMR reveals past tx with Risperdal and Zoloft (last filled ___. Stabilized on Deac 4 during most recent hospitalization with Amitriptyline and Seroquel. - Treaters: Denies past or present outpatient psychiatric treaters. Per records, last had pending appointment at ___ for psychiatry (Dr. ___, ___ at 9 AM). Currently states she doesn't remember last time she saw psych. -Access to weapons: Denies PAST MEDICAL HISTORY: PCP: ___, MD - HIV (not currently taking antiretrovirals) - today denies that she has HIV at all. - Hepatitis C - H/o head injury (Per ___ 4 ___ summary ___: ""pt reports she was ""assaulted"" and subsequently received 300 stitches, was hospitalized x 2wks, and underwent rehab at ___ she denies LOC or persistent deficits but receives SSDI for this injury"") HOME MEDICATIONS: Not currently taking any medications. Per Deac 4 Discharge Summary dated ___: 1. Amitriptyline 50 mg PO QHS 2. QUEtiapine Fumarate 50 mg PO QHS <SOCIAL HISTORY> SUBSTANCE ABUSE HISTORY: Per Dr. ___ note (___), confirmed with ___ and updated as relevant: - Alcohol: ___ reports starting drinking age ___ due to conflict with parents. Reports numerous detox admissions (>20 per OMR). States that she was sober from ___ and only involved with AA for 1 week of that time, which she stopped because she ""did not like it"". Most recent drink was 13 nips of vodka today. Currently states she drinks about 1x/week. Denies history of complicated alcohol withdrawal but has required benzodiazepines during detox admissions. - Benzodiazepines: Denies lifetime illicit use. Reports only use in detox when prescribed. - Marijuana: Reports remote use in high school, denies recent use. - Crack cocaine: Denies current use, though say she has used in the past. - Heroin: Reports h/o IVDU w/ heroin ___ years, previously reported ending ___ yrs ago. Denies current use. - Tobacco: past smoker, but denies currently. FORENSIC HISTORY: Says ""not lately"" and can't remember last time. Per Dr. ___ note (___): Inconsistent history: said she spent ___ yrs"" in jail for ""shoplifting, drug related issues."" Then states she was last in jail ""probably in early ___ <FAMILY HISTORY> States she doesn't know. <PHYSICAL EXAM> VS: T: 98.4 P: 106 BP: 137/90 RR: 16 SpO2: 100%(RA) * General: ___, in no apparent distress. Appears stated age. * HEENT: Normocephalic. PERRL, EOMI. Oropharynx clear. * Neck: Supple, trachea midline. No adenopathy or thyromegaly. * Back: No significant deformity, no focal tenderness. * Lungs: Clear to auscultation; no crackles or wheezes. * CV: Regular rate and rhythm; no murmurs/rubs/gallops; 2+ pedal pulses. * Abdomen: Soft, nontender, nondistended; no masses or organomegaly. * Extremities: No clubbing, cyanosis, or edema. * Skin: Warm and dry, no rashes, scars, or lesions. Neurological: *Cranial Nerves- I: Not tested. II: Pupils equally round and reactive to light bilaterally. Visual fields are full to confrontation. III, IV, VI: Extraocular movements intact bilaterally; significant horizontal nystagmus (>7 beats) bilaterally. V, VII: Facial strength and sensation intact and symmetric. VIII: Hearing intact to voice. IX, X: Palatal elevation symmetrical. XI: Sternocleidomastoid and trapezius normal bilaterally. XII: Tongue midline without fasciculations. *Motor- Normal bulk and tone bilaterally. No abnormal movements, no tremor. Strength full power ___ throughout. No gross focal motor or sensory deficits, normal gait. *Coordination- Normal on ___. *Deep tendon reflexes- 2+ and symmetrical, toes downgoing. *Sensation- intact to light touch, position sense intact. *Gait- steady, no truncal ataxia, normal stance and posture. *Romberg- negative. <PERTINENT RESULTS> ___ 06: 05AM ___ ___ ___ 06: 05AM ___ ___ IM ___ ___ ___ 06: 05AM PLT ___ ___ 06: 05AM ___ ___ ABS ___ ABS ___ ABS ___ ABS ___ <MEDICATIONS ON ADMISSION> ___ was not taking medications prior to admission. Per Deac 4 Discharge Summary dated ___: 1. Amitriptyline 50 mg PO QHS 2. QUEtiapine Fumarate 50 mg PO QHS <DISCHARGE MEDICATIONS> 1. Sulfameth/Trimethoprim DS 1 TAB PO DAILY RX ___ [Bactrim DS] 800 ___ mg 1 tablet(s) by mouth once a day Disp #*30 Tablet Refills: *0 2. QUEtiapine Fumarate 300 mg PO BID RX *quetiapine [Seroquel] 100 mg 3 tablet(s) by mouth twice a day Disp #*180 Tablet Refills: *0 3. Sertraline 25 mg PO DAILY RX *sertraline [Zoloft] 25 mg 1 tablet(s) by mouth once a day Disp #*30 Tablet Refills: *0 <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Unspecified psychotic disorder ___ vs. schizophrenia spectrum) EtOH use disorder Cocaine use disorder Heroin use disorder (in full sustained remission) <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Mental Status Examination: *Appearance: Woman who appears older than stated age, wearing jeans and a sweater, tattoo on neck, hair in a bun, appropriate hygiene, no acute distress. Behavior: Good eye contact, cooperative, engaged. No psychomotor agitation/retardation. *Mood and Affect: 'Good' / Mostly euthymic, some smiling. *Speech: Normal rate, volume, rhythm, prosody, articulation. Fluent in ___. *Thought process: Linear and ___. No loosening of associations. *Thought Content: Denies SI/HI and AVH. Focused on maintaining her sobriety. *Judgment and Insight: Fair/Fair. ___ recognizes effect drug use has had on her mental health, social situation, and interpersonal relationships. She has a history of multiple relapses, failing to ___, and medication nonadherence but keeps repeating that this admission is different and that she wants to maintain her sobriety. Cognition: Awake, alert, attentive throughout interview. Memory intact to recent and remote history. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> You were hospitalized at ___ for alcohol detox, depressed mood, and suicidal ideation. We adjusted your medications, and you are now ready for discharge and continued treatment on an outpatient basis. -Please follow up with all outpatient appointments as listed - take this discharge paperwork to your appointments. -Please continue all medications as directed. -Please avoid abusing alcohol and any drugs--whether prescription drugs or illegal drugs--as this can further worsen your medical and psychiatric illnesses. -Please contact your outpatient psychiatrist or other providers if you have any concerns. -Please call ___ or go to your nearest emergency room if you feel unsafe in any way and are unable to immediately reach your health care providers. It was a pleasure to have worked with you, and we wish you the best of health. ","SAFETY: ___ was placed on 15 minute checks on admission and remained here on that level of observation throughout. She was unit restricted. There were no acute safety issues during this hospitalization. LEGAL: ___ PSYCHIATRIC: ___ is a ___ year old ___ female with a history of TBI, HIV (not on HAART therapy), HCV (not treated), polysubstance use (EtOH, crack cocaine, and heroin), unspecified mood disorder, and chronic auditory hallucinations who presented to the emergency department on ___ with alcohol intoxication, tangential thoughts, and complaints of repeated head strikes, now s/p ICU/medicine course for alcohol withdrawal with phenobarbital taper. On the unit, ___ was started on quetiapine (uptitrated to 300 mg BID) and on sertraline 25 mg daily to good effect. ___ did well on the unit and attended groups regularly. She recognized effect illicit drugs and alcohol have had on her mental health, social situation, and interpersonal relationships. Although she has a history of multiple relapses, failing to ___, and medication nonadherence, she kept repeating that this admission was different and that she wants to maintain her sobriety. She showered daily and had no issues with sleep or appetite. On the day of discharge, ___ endorsed/exhibited ""good"" mood and euthymic affect. Denied SI/HI and AVH. She expressed continued motivation to maintain her sobriety, do 90 AA meetings in 90 days, and desire to ___ at ___. A ___ application was submitted. Her PCP was updated on the plan and ___ appointments were coordinated. MEDICAL: #HIV: ___ not currently taking HAART. Most recent CD4 count 42 on ___. - Continued Bactrim DS 1 tab daily for PCP ppx - ___ has appointment with Dr. ___ on ___ on ___ to discuss reinitiation of HAART #Hepatitis C: HCV Ab positive on ___. Not treated. - ___ has appointment with Dr. ___ on ___ on ___ to discuss treatment PSYCHOSOCIAL: #) GROUPS/MILIEU: ___ was encouraged to participate in units groups, milieu, and therapy opportunities. Usage of coping skills, mindfulness, and relaxation methods were encouraged. Therapy addressed family, social, work, and housing issues. The ___ enjoyed groups and participated. She also participated in AA meetings on the unit. #) COLLATERAL CONTACTS: -Treaters- PCP (Dr. ___ -Records- Per OMR -Family- ___ refused family meetings #) FAMILY INVOLVEMENT: Despite encouragement from the team throughout her admission, ___ refused family meetings. #) INTERVENTIONS: -D___ Referral: The team submitted a DMH application for the ___ to receive services and ___ support. -Pharmacological treatment: Quetiapine and sertraline as above. -Individual/group/milieu therapy -Coordinated aftercare with SW INFORMED CONSENT: -Quetiapine, sertraline The Team discussed the indications for, intended benefits of, and possible side effects and risks of this medication, and risks and benefits of possible alternatives, including not taking the medication, with this ___. We discussed the ___ right to decide whether to take this medication as well as the importance of the ___ actively participating in the treatment and discussing any questions about medications with the treatment team, and I answered the ___ questions. The ___ appeared able to understand and consented to begin the medication. RISK ASSESSMENT: Low imminent risk of harm/violence to self/others. #) Chronic/Static Risk Factors: Chronic mental illness, chronic medical illness, single, ongoing homelessness. #) Modifiable Risk Factors: -Acute major mood episode with suicidal ideation - Modified by medication adjustments and psychotherapeutic interventions as above. -Active polysubstance misuse - Modified by phenobarbital taper while on medical floor for alcohol withdrawal and detox; attendance to AA meetings on the unit; list of free substance use recovery resources in the community. -Limited outpatient/social support - Modified by aftercare planning with SW; outpatient appointments; list of community resources. -___ - Modified by counseling on the unit. ___ was adherent with medications on the unit. #) Protective Factors: Protective factors include current outpatient providers/treatment, knowledge of community resources, motivation to maintain sobriety, ___, and ___ behaviors. PROGNOSIS: Good: ___ was engaged on the unit, adherent with medications, and attended groups regularly. She has outpatient appointments and community resources. Current risk is low for intentional ___ given that ___ denies suicidal ideation, intent and plan, is accepting of treatment, is currently sober and is ___ with plans. ",2414,987
10002930-DS-9,"<SEX> F <SERVICE> PSYCHIATRY <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> ""depression and thoughts of suicide"" <MAJOR SURGICAL OR INVASIVE PROCEDURE> None <HISTORY OF PRESENT ILLNESS> ___ F w/ h/o HIV, head injury, polysubstance abuse/dependence and reported depression who p/w onset of SI in the context of alcohol and crack cocaine use. Pt reports that she has been feeling ""depressed"" for ""a few days."" She describes poor sleep (none over the past night), low energy, decreased appetite, poor self care (not showering, dressing), and anhedonia (""I don't want to do anything""). Acknowledges that drinking ""a couple of beers"" and smoking crack yesterday worsened her mood. She reports onset of SI overnight that she describes and ""just not wanting to live anymore."" She denies any plan, but states, ""I don't trust myself right now"" and ""I have nothing to do except contemplate suicide."" She is unable to identify any acute or chronic stressors. Asked what she would think would be most helpful, she replies, ""I probably would rather be hospitalized...Before, it helped."" She reports that she does not currently have any outpatient mental health providers. On psychiatric review of systems, pt endorses AH (intermittent ""voices...mutters""- alleviated by Elavil, no a/w substance use), panic attacks (characterized by SOB, palpitations, tremor, diaphoresis, anxiety), and paranoia (intermittent; unable to further describe). She denies current or past decreased need for sleep, IOR, TI/TB, HI, impairment of concentration/memory. <PAST MEDICAL HISTORY> HIV (dx ___ h/o Head injury (___) - pt reports she was ""assaulted"" and subsequently received 300 stitches, was hospitalized x 2wks, and underwent rehab at ___ she denies LOC or persistent deficits but receives SSDI for this injury PSYCHIATRIC HISTORY: Dx/Sxs- Per pt, depression, panic attacks, polysubstance (ETOH, crack, heroin) abuse/dependence. Hospitalizations- Per pt, multiple hospitalizations at ___ (last, ___ and ___ (last, 5+ yrs ago). Per OMR, multiple (>20) detox admissions. No record of treatment at ___ in Partners system. SA/SIB- Per pt, OD on Ultram ""probably to hurt [her]self"" ___ ago) Psychiatrist- None Therapist- None Medication Trials- Elavil SUBSTANCE ABUSE HISTORY: ETOH- reports current use < 1/month; reports ""a couple of beers"" yesterday, last drink at noon; h/o dependence; denies h/o withdrawal seizures or DTs, but has required inpatient detox. Cocaine- reports current use < 1/month; h/o dependence Opiates- h/o IV heroin use; reports last use ___ ago (per OMR note in ___, she endorsed using heroin at that time) Tobacco- ___ Denies use of all other illicit or prescription drugs. <SOCIAL HISTORY> ___ <FAMILY HISTORY> Denies h/o psychiatric illness, suicide attempts, addictions. <PHYSICAL EXAM> *VS: BP: 118/79 HR: 86 temp: 98.3 resp: 16 O2 sat: 98%height: 62"" weight: 136 lbs. Neurological: *station and gait: steady and non-ataxic *tone and strength: full strength cranial nerves: II-XII intact abnormal movements: no adventitious movements or tremors *Appearance: thin woman, hair pulled back, appears clean in hospital gown Behavior: appropriate, calm, irritable and superficially cooperative *Mood and Affect: ""depressed"", affect somewhat constricted and dysthymic *Thought process: linear, logical, without loose associations *Thought Content: no evidence for delusions or hallucinations SI/HI: Endorses ongoing SI without plan, no HI *Judgment and Insight: both generally limited Cognition: *Attention, *orientation, and executive function: alert, oriented, to person, place, time *Memory: recall intact *Fund of knowledge: appropriate Calculations: not tested Abstraction: not tested Visuospatial: not tested *Speech: appropriate rate, rhythm, tone *Language: appropriate vocabulary for context Gen: Thin well-developed female appearing stated age HEENT: NCAT, MMM, PERRL, CV: RRR no murmur Resp: CTAB ___: NT/ND Neuro: MAEW, CNII-XII intact, gait stable and non ataxic Skin: no rashes or excoriations Heme: no hemorrhage or bruising <PERTINENT RESULTS> ___ 05: 40AM WBC-4.3 RBC-3.87* HGB-10.8* HCT-33.8* MCV-87 MCH-27.9 MCHC-32.0 RDW-16.7* ___ 05: 40AM NEUTS-58.7 ___ MONOS-2.9 EOS-0.2 BASOS-0.4 ___ 05: 40AM PLT COUNT-313 ___ 05: 40AM GLUCOSE-107* UREA N-16 CREAT-0.6 SODIUM-138 POTASSIUM-3.9 CHLORIDE-103 TOTAL CO2-21* ANION GAP-18 ___ 05: 40AM ALT(SGPT)-40 AST(SGOT)-49* CK(CPK)-216* ALK PHOS-80 TOT BILI-0.2 ___ 05: 40AM CALCIUM-9.0 PHOSPHATE-5.0* MAGNESIUM-1.9 ___ 05: 40AM cTropnT-<0.01 ___ 05: 40AM TSH-0.90 ___ 03: 30PM VIT B12-406 FOLATE-15.9 ___ 03: 30PM HCG-<5 ___ 05: 40AM ASA-NEG ETHANOL-66* ACETMNPHN-NEG bnzodzpn-NEG barbitrt-NEG tricyclic-NEG ___ 05: 40AM URINE bnzodzpn-NEG barbitrt-NEG opiates-NEG cocaine-POS amphetmn-NEG mthdone-NEG <MEDICATIONS ON ADMISSION> (Medication confirmed with Dr. ___ MD ___ Dr. ___ Amytriptiline 50 mg PO qhs Truvada 200-300 1 tab PO daily Prezista 600 1 tab PO BID Norvir 100 PO daily *Additionally patient reports taking Vicodin 750 TID but covering physician denied this ___ Disposition: Home <DISCHARGE DIAGNOSIS> Depressive disorder Not-Otherwise-Specified (Considerations include Major depressive disorder and Substance-induced mood disorder) HIV h/o Head injury <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. VSS MSE: Mood 'alright', denies SI/HI, feels ok for d/c home, TC WNL, TP linear, logical, speech WNL <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> -Please follow up with all outpatient appointments as listed - take this discharge paperwork to your appointments. -Please continue all medications as directed. -Please avoid abusing alcohol and any drugs--whether prescription drugs or illegal drugs--as this can further worsen your medical and psychiatric illnesses. -Please contact your outpatient psychiatrist or other providers if you have any concerns. -Please call ___ or go to your nearest emergency room if you feel unsafe in any way and are unable to immediately reach your health care providers. *It was a pleasure to have worked with you, and we wish you the best of health.* ","___ F w/ h/o HIV, head injury, polysubstance abuse/dependence and reported depression admitted ___ following onset of SI in the context of alcohol and crack cocaine use. # Depression: Patient unable to identify stressors but notes that she had stopped attending support groups at ___ prior to admission. Also appears to have some degree of housing instability, given ""housing court"" appearance scheduled for ___. It is unclear how h/o head injury might affect her current presentation or perception of it. Attempts to obtain collateral from PCP ___ infectious disease specialist) regarding depression and substance abuse were unsuccessful, but messages were left to alert provider of ___ admission. Patient declined consent to contact any social supports, including family members. Patient was continued on home amitriptyline. Given previous positive response to sertraline, this was restarted at 25mg and tolerated well. Patient reported improvement in depressed mood, low energy and sleep over the course of admission. SI resolved. Patient felt that poor sleep was likely the trigger for relapse of depression and discussed ways to support good sleep and intervene sooner if she begins to have sleep difficulties. Patient reported no current or previous outpatient mental health providers and requested referrals. Patient remained in good behavioral control on the unit and was appropriate in interactions with staff and other patients. She participated in some groups but was observed to frequently be isolated to her room. # Substance abuse/dependence: Patient reports a history of heavy alcohol and crack cocaine use for which she has undergone multiple detoxes. However, she reports only occasional use in recent months/years. While acknowledging that both substances worsened her mood, she denied any other withdrawal symptoms and did not require detox on this admission. # HIV: CD4 282 on admission. Followed at ___ by ID specialist Dr. ___. Continued on home darunavir (Prezista), ritonavir (Norvir), Truvada. Patient required considerable education and reassurance surrounding naming of her HIV meds, as she refused them initially because she did not recognize the generic names. # Safety: No acute safety concerns. Maintained on Q15min checks. # Legal: ___ ",1706,434
10002976-DS-2,"<SEX> M <SERVICE> MEDICINE <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> Left shoulder pain <MAJOR SURGICAL OR INVASIVE PROCEDURE> Muscle biopsy of the left deltoid <HISTORY OF PRESENT ILLNESS> ___ y.o male with past medical history significant for DM, remote heart attack who presents with acute onset shoulder pain of 5 days duration. The pain became worse the day after onset, and he presented to the emergency room where he was ruled out for a myocardial infarction. Aspiration of the joint yielded no fluid. The patient went to his primary care provider who referred him to orthopedics, where he was ordered an MRI. His MRI the day prior to admission showed diffuse edema of his deltoid and trapezius muscles. The patient finds that any sort of movement causes the pain to be much worse. He took some motrin and percocet at home which provided some relief ___ -> ___ pain. Of note, the patient reports that several months ago he had what was a presumed gout attack in his hands that his son, an ER physician prescribed him prednisone. This entirely resolved his symptoms, but a definitive diagnosis was never made. He denies any recent upper respiratory symptoms, fevers, chills, or other symptoms at home. He has not had any recent medication changes. He has no history of trauma or abnormal movement of his shoulder and cannot remember any injury to that area. In the ED, initial VS were 98 69 88/54 18 100%; The patient received morphine and percocet with mild improvement of his pain. His creatinine was also found to be elevated at 2.1 from 4 days prior. ROS: Denies fever, chills, night sweats, headache, vision changes, rhinorrhea, congestion, sore throat, cough, shortness of breath, chest pain, abdominal pain, nausea, vomiting, diarrhea, constipation, BRBPR, melena, hematochezia, dysuria, hematuria. <PAST MEDICAL HISTORY> DM (DIABETES MELLITUS), TYPE 2, UNCONTROLLED Familial hemochromatosis H63D Carrier MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED NEPHROLITHIASIS CORONARY ARTERY DISEASE - NATIVE CORONARY ARTERY HISTORY COLONOSCOPY & POLYPECTOMY MYOCARDIAL INFARCTION CORONARY ANGIOPLASTY HYPERTENSION - ESSENTIAL <SOCIAL HISTORY> ___ <FAMILY HISTORY> no h/o rheumatologic disease <PHYSICAL EXAM> ADMISSION PHYSICAL EXAM VS: 98.3 126/69 18 99% on RA GENERAL: Well-appearing man in NAD, comfortable, appropriate. HEENT: NC/AT, PERRLA, EOMI, sclerae anicteric, MMM, OP clear. NECK: Supple, no thyromegaly, no JVD, no carotid bruits. HEART: RRR, ___ systolic murmur at base, normal S1, S2. LUNGS: Mild crackles at left base.. ABDOMEN: Soft/NT/ND, no masses or HSM, no rebound/guarding. EXTREMITIES: WWP, no c/c/e, 2+ peripheral pulses. Diabetic foot ulcer at base of left hallix. Marked pain with passive and active movement of left shoulder, localizing to deltoid region. SKIN: No rashes or lesions. LYMPH: No cervical LAD. NEURO: Awake, A&Ox3, CNs II-XII grossly intact, muscle strength ___ throughout, sensation grossly intact throughout, DTRs 2+ and symmetric, cerebellar exam intact, steady gait. DISCHARGE PHYSICAL EXAM Vitals: afebrile T 98(99.1) BP 118/67(118-154/65-78) P 83 RR 18 SA 96%RA General: Awake, AxO3, no acute distress HEENT: NC/AT, EOMI, sclera anicteric, MMM, no lesions noted in oropharynx Neck: Supple, no LAD chain. Lymph node was nontender and soft with mild enlargement. Pulmonary: Lungs generally clear to auscultation without R/R/W no crackles appreciated. Although examined in the supine position due to pain. Cardiac: RRR, nl S1S2, w/o R/G, grade ___ systolic murmur noted on exam. Abdomen: Soft, nontender, w/ bowel sounds present. No organomegaly noted. Extremities: WWP, no c/c/e, 2+ pulses bilaterally. Significantly increased range of motion. Decreased tenderness on both passive and active movement. Pt describes mild tenderness on palpation along pes anserinus. Tenderness on pes anserinus palpation. Skin: Ulcer noted on first MPJ with bandage. Prominent callus noted on right MPJ. <PERTINENT RESULTS> ADMISSION LABS ___ 06: 00PM BLOOD WBC-6.2 RBC-4.49* Hgb-14.3 Hct-41.3 MCV-92 MCH-31.8 MCHC-34.6 RDW-13.4 Plt ___ ___ 06: 00PM BLOOD Neuts-78.7* Lymphs-13.9* Monos-5.7 Eos-0.3 Baso-1.3 ___ 06: 00PM BLOOD Glucose-155* UreaN-43* Creat-2.1* Na-136 K-4.6 Cl-99 HCO3-23 AnGap-19 ___ 12: 26PM BLOOD CK-MB-4 ___ 12: 26PM BLOOD CK(CPK)-421* ___ 06: 17PM BLOOD K-3.8 PERTINENT LABS ___ 09: 20AM BLOOD ESR-87* ___ 08: 20AM BLOOD Calcium-8.6 Phos-2.6* Mg-2.1 Iron-19* ___ 08: 20AM BLOOD calTIBC-213* Ferritn-905* TRF-164* ___ 07: 30AM BLOOD HBsAg-NEGATIVE HBsAb-NEGATIVE ___ 07: 30AM BLOOD ANCA-NEGATIVE B ___ 07: 30AM BLOOD CRP-243.8* ___ 02: 31PM BLOOD TRICHINELLA IGG ANTIBODY-PND MICROBIOLOGY ASO titer 400-800 Lyme serology negative Blood Cx x 2 on ___: NGTD Muscle Bx Cx/Gram stain ___ 10: 30 am TISSUE Site: SHOULDER LEFT DELTOID MUSCLE. GRAM STAIN (Final ___: 1+ (<1 per 1000X FIELD): POLYMORPHONUCLEAR LEUKOCYTES. NO MICROORGANISMS SEEN. TISSUE (Preliminary): ANAEROBIC CULTURE (Preliminary): FUNGAL CULTURE (Preliminary): IMAGING MRI SHOULDER ___ IMPRESSION: Trace fluid in the acromioclavicular joint with minimal irregularity of the articular surfaces and large amount of edema in the trapezius and deltoid muscles. The spectrum of findings could be seen in the setting of acute injury as in a grade 1 sprain of the acromioclavicular joint. However, given the absence of any history of trauma the findings are consistent with nonspecific myositis of the trapezius and deltoid muscles. Given the trace amount of fluid in the acromioclavicular joint superimposed infection in this region cannot be excluded. The amount of fluid would not be amenable to image-guided joint aspiration. This would be an atypical location for diabetic myonecrosis. EKG ___ Sinus rhythm. Non-specific ST-T wave abnormalities. Cannot exclude ischemia. Compared to the previous tracing of ___ T wave abnormalities are more prominent in leads V2-V4. US LEFT SHOULDER ___ There is no evidence of focal fluid collection around the region of pain. No soft tissue calcifications are identified. MR THIGHS ___ IMPRESSION: Myositis involving the left quadriceps groups, most severely affecting the left vastus lateralis and vastus medialis as detailed above. Differential considerations include infectious and inflammatory myositis, including drug reaction, as well as diabetic myonecrosis. No evidence of focal fluid collection or other sign of abscess formation. PATHOLOGY ___ Muscle Biopsy - Pending at time of discharge <MEDICATIONS ON ADMISSION> Hydrocodone-Acetaminophen ___ mg Oral Tablet take 1 to 2 tablets every ___ hours as needed for pain Simvastatin 40 mg Oral Tablet take 1 and ___ tablet by mouth every evening for cholesterol Atenolol 25 mg Oral Tablet take 1 tablet daily Losartan 25 mg Oral Tablet Take 1 tablet daily Insulin Glargine (LANTUS) 100 unit/mL Subcutaneous Solution inject 50 units AS DIRECTED Clotrimazole (LOTRIMIN) 1 % Topical Cream Apply to affected area twice daily --> NOT USING Insulin Lispro (HUMALOG KWIKPEN) 100 unit/mL Subcutaneous Insulin Pen Use as directed, ___ units pre meal. HUMALOG 100 UNIT/ML SUB-Q (INSULIN LISPRO) inject 50 units daily in divided doses NITROQUICK 0.4 MG SUBLINGUAL TAB (NITROGLYCERIN) PLACE 1 TABLET UNDER THE TONGUE AS NEEDED FOR CHEST PAIN AS DIRECTED LACTULOSE 10 GRAM/15 ML ORAL SOLN take 1 tablespoon(15mls) by mouth twice daily -- NOT USING NOVOLOG 100 UNIT/ML SUB-Q (INSULIN ASPART) inject 50 units DAILY in divided doses ssi: 80-100 none, 100-149: 12, 150-199: 14, 200-249: 16, 250-299: 18, 300> 20 <-- max dose ASPIRIN TABLET ___ 325MG PO 1 TAB PO daily <DISCHARGE MEDICATIONS> 1. atenolol 25 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 2. losartan 25 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 3. insulin glargine 100 unit/mL Solution Sig: Fifty (50) units Subcutaneous once a day. 4. insulin lispro 100 unit/mL Solution Sig: asdir units Subcutaneous asdir: As per your sliding scale at home. 5. nitroglycerin Sublingual 6. lactulose 10 gram Packet Sig: Fifteen (15) cc PO twice a day as needed for constipation. Disp: *30 packets* Refills: *0* 7. aspirin 325 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 8. acetaminophen 500 mg Tablet Sig: Two (2) Tablet PO TID (3 times a day). Disp: *90 Tablet(s)* Refills: *1* 9. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day). Disp: *60 Capsule(s)* Refills: *2* 10. senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a day) as needed for constipation. Disp: *30 Tablet(s)* Refills: *0* 11. Outpatient Physical Therapy Please see patient for left shoulder pain for exercises and further therapy 12. prednisone 5 mg Tablet Sig: ___ Tablets PO asdir for 6 days: 6 pills on ___ (day 1), 5 pills on day 2, 4 pills on day 3, 3 pills on day 4, 2 pills on day 5, 1 pill on day 6. Disp: *21 Tablet(s)* Refills: *0* 13. simvastatin 40 mg Tablet Sig: 1.5 Tablets PO at bedtime. <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> PRIMARY DIAGNOSIS Myositis SECONDARY DIAGNOSES Diabetes Mellitus (Insulin dependent) Hypertension Arthritis <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> It was a pleasure taking care of you during your hospitalization. You were admitted to ___ with left shoulder pain. We sent a variety of lab tests that showed you have inflammation, however no obvious diagnosis. We asked our rheumatology team to see you as well. It is possible that you have both a problem in your joint as well as your muscles, and it may be as simple as a traumatic fall causing these symptoms. However, we did a muscle biopsy in an effort to get at the definitive diagnosis, and you should follow up with a rheumatologist about the results. PLEASE MAKE THE FOLLOWING CHANGES TO YOUR MEDICATIONS - START taking PREDNISONE 5 mg pills as follows: 6 pills starting tomorrow 5 pills the next day 4 pills the next day 3 pills the next day 2 pills the next day 1 pill the next day - START taking DOCUSATE 100 MG by mouth twice daily - START taking SENNA 1 tab by mouth twice daily as needed for constipation - START taking LACTULOSE 15CC by mouth twice daily as needed for constipation - START taking TYLENOL ___ mg by mouth three times daily - DO NOT take IBUPROFEN for your pain because of your kidneys - BE SURE to check your blood sugars regularly while you are on your prednisone Please follow up with you physicians as indicated below ","___ y.o male with history of DM and remote MI who presents to the hospital today with right shoulder pain and MRI findings showing edema of the trapezius and deltoid muscles. Pt was admitted to the medicine service where pain control was initiated with tylenol and oxycodone. His renal failure resolved with IVF. Trial of NSAIDs was used x 2 however each with bump in Cr, so pt was discharged off of NSAIDs. Rheumatology was consulted and as per their recommendations, MRI of thighs was done (read in previous section) and mm bx of left deltoid done with with ACS c/s. Given lack of microrganisms on the gram stain, and PMNs likely c/w inflammation, steroids were started once an infx was r/o. The patient was also seen by ___ who recommended outpt ___ as well as shoulder exercises for the patient. Statin was briefly stopped, however restarted given normalizing CK with hydration. # Myositis/arthropathy - Upon presentation, ddx was broad and as such, many tests were checked including ASO (titer 400-800, positive), lyme serology (negative), CK for statin induced myopathy (400, resolved with IVF), and trichinella Ab (pending at time of discharge). Pt's family most concerned with PMR, however reassured pattern does not seem c/w this. ESR and CRP were checked which were elevated (87 and 243 respectively). Blood Cx were also checked given possible pyomyositis, thought from diabetic foot ulcer, however they remained NGTD throughout hospitalization. Rheumatology was c/s who felt that MRI thigh was indicated which showed unilateral myositis in the left quadriceps group. Notably, on exam the patient seemed to show pain to both passive and active movement, and as such we felt that he likely had both a problem in his joints as well as the actual muscles. A muscle biopsy was done with the ___ team c/s which upon initial gram stain was negative for microorganisms, which allowed us to start steroids (we were concerned about possible pyomyositis). Also of concern was diabetic myonecrosis, however unlikely given that multiple mm groups with different blood supply was involved. Rheumatology felt it was possible that the pain in both the left AC joint as well as the pes anserinus on the right leg (which developed on HD3), may both be crystal arthropathy/bursitis, and as such recommended steroids. We held off on empiric steroids until after the bx, and upon initiation, drastic improvement on sxs was noted. Ultimately, thought was that possibly myositis ___ traumatic fall on left hand side with underlying crystal arthropathy (however not enough fluid on MRI or US to tap). he will have rheumatology f/u in the ___ system, and our rheumatology c/s attdg will attempt to contact his outpt rheumatologist for continuity of care. He was discharged with a prednisone taper and close f/u with his PCP. # Acute renal failure - Fena was <1%, and BUN/Cr ratio >10. As such thought was that this was likely prerenal. With hydration, Cr down to 1.0. NSAIDs were attempted for pain relief which helped, unfortunately his Cr again bumped so NSAIDs were discontinued and the patient was asked to avoid them at time of discharge. # Diabetes - continued home regimen of lantus and HISS. Notably, pt did have higher blood sugars upon initation of his steroids. The patient was advised to closely monitor his BS at home to cover himself with SSI. notably, diabetic myonecrosis was on the ddx however we felt this was unlikely given the location of the myositis. There was also thought of possible contribution of his diabetes and insulin usage to a possible adhesive capsulitis in the left shoulder. # Anemia: Pt's hct was 40 upon presentation, and dropped to 32 over his hospitalization in the setting of aggressive hydration for ARF. Notably, guaiac was negative, and iron studies were c/w anemia of chronic inflammation # Constipation: Pt developed narcotic induced constipation, and an aggressive bowel regimen was written for him. he required an enema in order to pass stools, and as such, he was discharged with an aggressive prescription regimen for his constipation. # Foot ulcer: Pt has known DM with foot ulcer, followed by podiatry. Wound c/s was asked to see patient who assisted with foot ulcer care. No concern of osteo. Out of slight concern of possible contribution to a ""pyomyositis-like picture,"" we checked blood Cx which were negative at time of discharge. # Hypertension - continued atenolol. # History of CAD - continued ASA, atenolol as prior. Statin was briefly stopped and reinitiated at time of discharge given normal CK. # FOLLOW UP ISSUES Pt had blood cx and a trichinella ag test pending at time of discharge Pt will need to f/u with rheumatology within ___. Our rheumatology attending at the ___ will attempt to contact his new rheumatologist for continuity of care. ",3094,1078
10002976-DS-3,"<SEX> M <SERVICE> MEDICINE <ALLERGIES> Shellfish <ATTENDING> ___. <CHIEF COMPLAINT> Septic Arthritis, Foot Cellulitis, Bacteremia <MAJOR SURGICAL OR INVASIVE PROCEDURE> ___- Incision and Drainage of Left shoulder joint by Dr. ___ ___- PICC line placement in Right arm <HISTORY OF PRESENT ILLNESS> ___ year old Male with Type 2 Diabetes, CAD s/p 2 stents ___ discharged after admission for shoulder and thigh pain thought to be myositis and sent out on steroids, who now presents from clinic with gram positive cocci from AC shoulder joint aspiration. He originally presented ___ with progressive left shoulder, Right knee, and Left thigh pain for several weeks. During this hospitalization, a rheumatology consult was obtained. He had an MRI of the Left shoulder that showed edema in the trapezius and deltoid muscles, consistent with nonspecific myositis and trace amount of fluid in the acromioclavicular joint. MRI of the thigh showed myositis involving the left quadriceps. Ultrasound of the shoulder showed no focal fluid collection. A muscle biopsy of the left shoulder muscle was also performed, final path is still pending but gram stain was negative and to date tissue cultures have been negative. Remainder of the extensive workup included: lyme, ASO, and blood cultures that have all been negative, GC/chlamydia still are pending. Pt was sent home and started a short course of steroids which he completed ___ for presumed inflammatory myositis. Pt states that on discharge he had some improvement in his shoulder pain with the steroids. On day of admission, he had fevers to 101, rigors and chills. He denies rash, nausea, dyspnea, recent trauma or surgeries. He was seen by his PCP on the day of admission for increaced pain and new cellulities of the Left foot. Labs showed elevated ESR/CRP (100/202) concerning for acute infection. He was then evaluated by rheumatology, where his AC joint was again aspirated this time with fluid washout and a prelim culture/gramstain grew gram positive cocci. In the ED, initial VS: T 989.8, BP 107/56, HR 73, RR 18. His labs were notable for leukocytosis 16.7 w/ left shift, UA neg, Cr 1.2. CXR wnl. Ortho was consulted who recommended iv abx, admission for washout of the AC joint in the OR. Pt received iv zosyn/vancomycin. <PAST MEDICAL HISTORY> DM (DIABETES MELLITUS), TYPE 2, UNCONTROLLED Familial hemochromatosis H63D Carrier MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED NEPHROLITHIASIS CORONARY ARTERY DISEASE - NATIVE CORONARY ARTERY HISTORY COLONOSCOPY & POLYPECTOMY MYOCARDIAL INFARCTION CORONARY ANGIOPLASTY HYPERTENSION - ESSENTIAL s/p muscle biopsy of left deltoid ___ <SOCIAL HISTORY> ___ <FAMILY HISTORY> no h/o rheumatologic disease <PHYSICAL EXAM> PHYSICAL EXAM on admission: VSS: 98.3, 120/60, 65, 16, 95%RA GEN: NAD Pain: ___ HEENT: EOMI, MMM, - OP Lesions, Fundus: limited by non-dilated but no ___ spots or other sx of embolic disease PUL: CTA B/L COR: RRR, S1/S2, - MRG ABD: NT/ND, +BS, - CVAT EXT: - CCE, no splinters, possible small lesion on left ___ digit, multiple small punctate lesions on right shin, Right great toe with plantar ulcer 2cm NEURO: CAOx3, Non-Focal Physical exam on Discharge: 98.6, 136/80, 66, 18, 98%RA Gen: AAOx3, in NAD, appropriately conversant HEENT: EOMI, MMM PUL: clear to auscultation bilaterally Cardiac: Regular rate and rhythm, no MRG appreciated Abdomen: soft, nontender nondistended, no rebound tenderness. No palpable masses or organomegaly Extremities: Left shoulder. Deltoid scar is well held, no fluctuance, erythema or induration. Incision and Drainage scar- well approximated with sutures intact, no erythema, warmth or edema. Left UE exma- decreased ROM, but able to lift upper arm off of bed against gravity. Reflexes in tact, hand grip strength ___. Left foot- wrapped in dry gauze dressing, no erythema, edema or warmth. Plantar ulcer located at the base of second digit. Neuro: AAOx3, No focal deficits <PERTINENT RESULTS> ___ 11: 38AM BLOOD WBC-16.5*# RBC-4.15* Hgb-12.9* Hct-40.4 MCV-97 MCH-31.1 MCHC-31.9 RDW-12.7 Plt ___ ___ 04: 37AM BLOOD WBC-7.0 RBC-3.43* Hgb-10.3* Hct-31.2* MCV-91 MCH-30.2 MCHC-33.2 RDW-12.9 Plt ___ ___ 11: 38AM BLOOD Neuts-84.1* Lymphs-9.3* Monos-5.6 Eos-0.8 Baso-0.2 ___ 05: 35AM BLOOD Neuts-69.4 ___ Monos-5.8 Eos-3.4 Baso-0.4 ___ 11: 38AM BLOOD ESR-114* ___ 05: 35AM BLOOD ESR-132* ___ 06: 45PM BLOOD Glucose-103* UreaN-25* Creat-1.2 Na-136 K-4.6 Cl-99 HCO3-26 AnGap-16 ___ 05: 35AM BLOOD Glucose-138* UreaN-14 Creat-0.9 Na-137 K-4.5 Cl-101 HCO3-27 AnGap-14 ___ 11: 38AM BLOOD ALT-25 AlkPhos-227* TotBili-0.6 ___ 05: 35AM BLOOD ALT-15 AST-9 LD(LDH)-128 AlkPhos-392* TotBili-0.3 ___ 04: 37AM BLOOD ALT-15 AST-9 AlkPhos-348* TotBili-0.2 ___ 06: 40AM BLOOD Calcium-8.3* Phos-2.5* Mg-1.9 ___ 05: 35AM BLOOD Albumin-2.8* Calcium-9.0 Phos-4.1 Mg-2.1 ___ 11: 38AM BLOOD PTH-27 ___ 11: 38AM BLOOD CRP-202.4* ___ 05: 35AM BLOOD CRP-253.0* ___ 11: 38AM BLOOD C3-306* C4-49* Blood Culture, Routine (Final ___: BETA STREPTOCOCCUS GROUP G. SENSITIVITIES REQUESTED PER ___ ___ ___. FINAL SENSITIVITIES. This isolate is presumed to be resistant to clindamycin based on the detection of inducible resistance . SENSITIVITIES: MIC expressed in MCG/ML _________________________________________________________ BETA STREPTOCOCCUS GROUP G | CLINDAMYCIN----------- R ERYTHROMYCIN---------- 2 R PENICILLIN G----------<=0.06 S VANCOMYCIN------------ <=1 S Anaerobic Bottle Gram Stain (Final ___: Reported to and read back by ___. ___ ON ___ AT 0600. GRAM POSITIVE COCCI IN PAIRS AND CHAINS. Aerobic Bottle Gram Stain (Final ___: GRAM POSITIVE COCCI IN PAIRS AND CHAINS. -GRAM STAIN (Final ___: NO POLYMORPHONUCLEAR LEUKOCYTES SEEN. 1+ (<1 per 1000X FIELD): GRAM POSITIVE COCCI. ___ IN PAIRS. Reported to and read back by ___ ___ ___ ___. FLUID CULTURE (Final ___: BETA STREPTOCOCCUS GROUP G. SPARSE GROWTH. OF TWO COLONIAL MORPHOLOGIES. ___ 12: 50 pm SWAB LEFT AC JOINT . GRAM STAIN (Final ___: NO POLYMORPHONUCLEAR LEUKOCYTES SEEN. NO MICROORGANISMS SEEN. WOUND CULTURE (Final ___: BETA STREPTOCOCCUS GROUP G. SPARSE GROWTH. ANAEROBIC CULTURE (Final ___: NO ANAEROBES ISOLATED. FUNGAL CULTURE (Preliminary): NO FUNGUS ISOLATED. A swab is not the optimal specimen for recovery of mycobacteria or filamentous fungi. A negative result should be interpreted with caution. Whenever possible tissue biopsy or aspirated fluid should be submitted. FOOT AP,LAT & OBL LEFT ___ Three views of the left foot demonstrate patchy osteopenia of the forefoot. No frank osteomyelitis identified. No cortical erosions. Small os naviculare and small os peroneum. Small dorsal and plantar calcaneal enthesophytes. Mild dorsal soft tissue swelling. MRI of foot ___ 1. No evidence of osteomyelitis of the first metatarsal head. 2. Diffuse edema pattern of the mid foot, in absence of direct extension of soft tissue abnormality is suggestive of Charcot osteoarthropathy; osteomyelitis is considered much less likely. 3. Tiny fluid collection at the plantar aspect of the second intermetatarsal space could be due to altered mechanics in the setting of neuroarthropathy however presence of infection is not excluded. Please note, that this would not be amenable to percutaneous aspiration. Larger focal fluid in close proximity to the peroneus longus tendon, similarly, can represent focal tenosynovitis, though, alternatively, infected fluid collection may be present. Transthoracic Echo ___ The left atrium is elongated. The right atrium is moderately dilated. There is mild symmetric left ventricular hypertrophy. Overall left ventricular systolic function is normal (LVEF 70%). Right ventricular chamber size and free wall motion are normal. The ascending aorta is mildly dilated. The aortic arch is mildly dilated. The aortic valve leaflets (3) are mildly thickened but aortic stenosis is not present. No aortic regurgitation is seen. The mitral valve leaflets are mildly thickened. There is no mitral valve prolapse. Trivial mitral regurgitation is seen. The left ventricular inflow pattern suggests impaired relaxation. The pulmonary artery systolic pressure could not be determined. There is no pericardial effusion. No vegetations seen. If clinically suggested, the absence of a vegetation by 2D echocardiography does not exclude endocarditis. CXR ___ The PICC line tip is at the level of cavoatrial junction. Cardiomediastinal silhouette is unchanged including mild cardiomegaly. Lungs are essentially clear except for scarring at the left lower lung laterally. No pleural effusion, no pneumothorax noted. <MEDICATIONS ON ADMISSION> Insulin SC (per Insulin Flowsheet) Atenolol 25 mg PO/NG DAILY Losartan Potassium 25 mg PO/NG DAILY Aspirin 325 mg PO/NG DAILY Morphine Sulfate ___ mg IV Q4H: PRN pain Acetaminophen 1000 mg PO/NG Q 8H Docusate Sodium 100 mg PO BID Senna 1 TAB PO/NG BID: PRN constipation <DISCHARGE MEDICATIONS> 1. Outpatient Physical Therapy Evaluate and Treat 2x/week x 6weeks 2. ceftriaxone 2 gram Recon Soln Sig: One (1) bag Intravenous once a day for 36 days: Last dose ___. Disp: *36 bags* Refills: *0* 3. lab draw Please check weekly CBC with diff, BUN/Cr, LFTS, ESR/CRP. Please fax the results to the Infectious Disease clinic at ___ at fax ___, phone # ___ attn: Dr. ___ 4. atenolol 25 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 5. aspirin 325 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 6. senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a day) as needed for constipation for 7 days: Please take daily to soften stool while taking pain medications. Disp: *14 Tablet(s)* Refills: *0* 7. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day) as needed for constipation for 7 days: Please take if you have not moved your bowels for more than one day. Disp: *14 Capsule(s)* Refills: *0* 8. losartan 25 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 9. polyethylene glycol 3350 17 gram/dose Powder Sig: One (1) PO BID (2 times a day) as needed for constipation for 7 days: Please take if you still have constipation after trying the docusate and senna for constipaion. Disp: *14 * Refills: *0* 10. acetaminophen 500 mg Tablet Sig: Two (2) Tablet PO three times a day as needed for pain for 7 days: Do not take more than 6 tablets in one day. Disp: *42 Tablet(s)* Refills: *0* 11. Lantus 100 unit/mL Solution Sig: One (1) Subcutaneous at bedtime: 50 units at bedtime. 12. heparin flush heparin flush per infusion guidelines 13. naproxen 250 mg Tablet Sig: One (1) Tablet PO three times a day as needed for pain for 6 days: Take one tablet with food three times a day as needed for pain. . Disp: *21 Tablet(s)* Refills: *0* 14. Nitrostat 0.3 mg Tablet, Sublingual Sig: One (1) Sublingual prn as needed for chest pain. 15. oxycodone 5 mg Tablet Sig: Three (3) Tablet PO three times a day as needed for pain for 7 days: Please take ___ tablets by mouth up to three times a day for pain. Do NOT drink alcohol or operate a vehicle while taking this medication. . Disp: *30 Tablet(s)* Refills: *0* <DISCHARGE DISPOSITION> Home With Service Facility: ___ <DISCHARGE DIAGNOSIS> Septic arthritis Bacteremia- Strep Group G Cellulitis <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> You were admitted to the hospital because of positive bacteria cultures from your shoulder aspirate. During your stay you were found to be bactermic (bacteria in your blood) and to have cellulitis of your left foot (skin infection of the skin of your left foot). You had a transthoracic echo (ultrasound of your heart) which showed no signs of endocarditis as the cause of the bacteremia. The blood cultures and swab of shoulder joint grew out the bacteria Streptococcus Group G and we narrowed your antibiotic treatment to ceftriaxone which was started on ___. You had an Incision and Drainage of your shoulder to clean out the bacteria. This infection requires a long course of antibiotics so you were given a PICC (peripherally inserted central catheter)on ___ prior to being discharged to receive your antibiotics at home. Your foot with the chronic ulcer on the left foot showed signs of cellulitis (infection of the skin) in the left foot. You had both an xray and an MRI which showed no evidence of osteomyelitis (bone infection) of the bones of your foot/ankle. The cellulitis improved with your IV antibiotic treatment during your stay. Physical therapy saw you and felt that you would benefit from outpatient physical therapy after discharge. For your diabetes you were kept on your home dose of insulin. You were constipated throughout your hospital stay but passed stool on the day of discharge. . The following changes were made to your medications: Added-1. Ceftriaxone 2gm IV once a day(last dose to be given ___ Added-2. Oxycodone ___ one tablet by mouth three times a day as needed for pain Added- 3. Naproxen 250 mg, one tablet by mouth three times a day as needed for foot discomfort Added- 4. Ducosate prn for constipation Added- 5. Senna Added- 6. Miralax prn for constipation ","___ yo M with type II diabetes mellitus, CAD (s/p 2 stents in ___, and recent admission for work up of myositis was admitted with positive culture of left shoulder joint admitted with septic arthritis and found to be bacteremic and to ahve cellulitis. #Septic Arthritis of Left AC joint, Bacteremia and Cellulitis: Patient was found to have Beta Hemolytic Group G streptococuss septic arthritis and bactermeia. He was originally started on vancomycin and then switched to vancomycin for better coverage of streptococus on ___. He underwent an I&D of his left AC joint by orthopedics without complication. After antibiotics were on board for multiple days patient remained afebrile. At no point was he hemodynamically under or showing signs of sepsis. For his foot cellulitis he had an xray and MRI which did not show any evidence of osteomyelitis. In work-up for the source of this infection, he underwent a TTE which did not show any vegetations. A TEE was deferred per Infectious disease as his course of treatment would not be changed. A PICC Line was placed in his right antecub on ___ and position was verified with cxr. He will be receiving home IV abx until ___. He will have follow- up in ID outpatient clinic, with weekly labs faxed to them by the ___. He will have follow-up by orthopedics for his post-op I&D. He has follow-up with his own outside podiatrist for his foot ulcer and cellulitis. # Elevated alk phos- The day prior to his discharge a repeat alkphos showed elevation compared to earlier in his hospitalization with an associated elevated GGT. THe next day there was a decrease and ID felt comfortable with discharging him on ceftriaxone with weekly monitoring for any hepatic problems from the antibiotics. #Constipation- Patient had constipation during his hospital stay. He at no time complained of abdominal pain, and moved his bowels prior to discharge. He was discharged on a bowel regimen and encouraged to use it while on narcotic pain medications. #Diabetes, type 2 uncontrolled with complications- Patient was kept on his home Insulin of 50units of glargine at bedtime except while NPO. He will be discharged on this same regimen without changes. #HTN/CAD, native- Patient had no episodes of hypertensive urgency or chest pain during his admission Transitional Care -Pt still has outstanding pending blood cultures -Pt requires follow-up for physical therapy of his left foot and his left shoulder -Pt will have follow-up with his PCP, ___, orthopedics and podiatry -Pt will require weekly blood draws to be faxed to the ___ clinic -Pt has a PICC line in his Right antecubital fossa, placed on ___ and verified position by chest xray -Pt is full code -As this is his second admission during the past month there is concern for readmission, however as the etiology of his shoulder pain has been identified and is being treated with clinical improvement, it is unlikely he will be admitted. -Pt is full code ",3816,662
10003046-DS-9,"<SEX> M <SERVICE> CARDIOTHORACIC <ALLERGIES> Penicillins / Shellfish Derived <ATTENDING> ___. <CHIEF COMPLAINT> Esophageal cancer. <MAJOR SURGICAL OR INVASIVE PROCEDURE> ___: Minimally-invasive esophagectomy surgery(thoracoscopic laparoscopic ___, laparoscopic jejunostomy tube, pericardial fat pad buttress (adjusted adjacent tissue transfer). <HISTORY OF PRESENT ILLNESS> The patient is a ___ gentleman who was found to have biopsy-proven intramucosal adenocarcinoma arising in high-grade dysplasia ___. He presents for resection. <PAST MEDICAL HISTORY> GERD x ___ years ___ esophagus with high-grade dysplasia. Colon polyps ___ years ago. <SOCIAL HISTORY> ___ <FAMILY HISTORY> His mother died at the age of ___ from breast cancer. Father died at age of ___ from coronary artery disease. He has no brothers or sisters. <PHYSICAL EXAM> Discharge VS: T 96.3, BP 112/66, HR 86, RR 20, O2 sats 97%RA General: ___ year-old male in no apparent distress HEENT: normocephalic, mucus membranes moist Card: RRR normal ___ HSM murmer Resp: clear b/l GI: soft, NT, NT J-tube site clean , dry, intact. Incision C/D/I Ext: warm no edema Incisions: R chest incision site clean dry intact, margins well approximated Neuro: AA&O x3, no focal deficits <PERTINENT RESULTS> ___ 06: 40AM BLOOD WBC-15.6* RBC-4.56* Hgb-13.4* Hct-39.2* MCV-86 MCH-29.4 MCHC-34.2 RDW-14.2 Plt ___ ___ 06: 40AM BLOOD WBC-13.0* RBC-4.33* Hgb-13.0* Hct-37.1* MCV-86 MCH-30.0 MCHC-35.1* RDW-13.7 Plt ___ ___ 06: 50AM BLOOD WBC-13.0* RBC-4.22* Hgb-12.8* Hct-36.2* MCV-86 MCH-30.3 MCHC-35.3* RDW-13.7 Plt ___ ___ 06: 40AM BLOOD Plt ___ ___ 06: 40AM BLOOD Plt ___ ___ 06: 50AM BLOOD Plt ___ ___ 06: 40AM BLOOD Glucose-128* UreaN-18 Creat-0.8 Na-138 K-4.3 Cl-105 HCO3-23 AnGap-14 ___ 06: 40AM BLOOD Glucose-80 UreaN-22* Creat-0.7 Na-136 K-3.6 Cl-103 HCO3-23 AnGap-14 ___ 06: 50AM BLOOD Glucose-78 UreaN-20 Creat-0.7 Na-141 K-4.2 Cl-106 HCO3-26 AnGap-13 ___ 06: 40AM BLOOD Mg-1.9 ___ 06: 40AM BLOOD Calcium-8.0* Phos-3.3 Mg-2.0 ___ 06: 50AM BLOOD Calcium-7.7* Phos-2.7 Mg-1.8 ___ PA and Lat CXR: IMPRESSION: PA and lateral chest compared to ___: There is no pneumothorax, appreciable pleural effusion, or mediastinal widening relative to ___ following removal of midline and pleural drains. Large cardiomediastinal silhouette and right basal atelectasis are stable as is the caliber of the distended neoesophagus, with small flecks of residual contrast agent from the swallow performed earlier today and reported separately. ___ Barium swallow: FINDINGS: Contrast passes freely through the neoesophagus into the remainder of the stomach and small bowel. There is slight holdup within the stomach, which may be postoperative. There is no evidence for leak or stricture. IMPRESSION: No evidence for leak or stricture. <MEDICATIONS ON ADMISSION> Protonix 40 mg bid <DISCHARGE MEDICATIONS> 1. Jevity Full Strength Goal 105 mL x 18 hrs Flush J-tube with 50 mL of water before, after starting tube feeds and at NOON Refills: 11 Feeding pump and supplies 2. Prevacid SoluTab 30 mg Tablet,Rapid Dissolve, ___ Sig: One (1) Tablet,Rapid Dissolve, ___ ___ a day. Disp: *60 Tablet,Rapid Dissolve, ___ Refills: *6* 3. Roxicet ___ mg/5 mL Solution Sig: ___ ml ___ every ___ hours as needed for pain. Disp: *500 ml* Refills: *0* 4. docusate sodium 50 mg/5 mL Liquid Sig: Ten (10) ml ___ twice a day: take while on narcotics for pain, hold for loose stool. <DISCHARGE DISPOSITION> Home With Service Facility: ___ <DISCHARGE DIAGNOSIS> GERD ___ esophagus w high-grade dysplasia Colon polyps <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Call Dr. ___ ___ if you experience: -Fevers greater than 101 or chills -Increased shortness of breath, cough or chest pain -Nausea, vomiting (take anti-nausea medication) -Increased abdominal pain -Incision develops drainage -Chest tube site remove dressing and cover site with a bandaid Pain -Roxicet via J-tube as needed for pain -Take stool softners with narcotics Activity -Shower daily. Wash incision with mild soap & water, rinse, pat dry -No tub bathing, swimming or hot tub until incision healed -No driving while taking narcotics -No lifting greater than 10 pounds until seen -Walk ___ times a day for ___ minutes increase to a Goal of 30 minutes daily -Remove chest tube and j-tube site bandages ___ and replace with a bandaid, changing daily until healed. J-tube site: If your j-tube falls out call Dr. ___ ___ immediately. You may keep this covered changing dressing daily to protect site while wearing pants. If not drainage around j-tube you may keep site open to air. ","Mr. ___ was admitted ___ following minimally-invasive esophagectomy surgery (thoracoscopic laparoscopic ___, laparoscopic jejunostomy tube, pericardial fat pad buttress (adjusted adjacent tissue transfer) by Dr. ___. He was extubated in the operating room, and transferred to the ICU with right chest tube, JP, NGT, Foley and Epidural for pain. He transfered to the floor POD 2. Below is a systems review of Mr. ___ hospital course: Respiratory: Postoperative day 1 he had respiratory acidosis secondary to hypoventilation. With aggressive pulmonary toilet, incentive spirometer and good pain control he titrated off oxygen with saturations of 97% on RA. Chest-tube: right with minimal drainage was removed ___ without PTX on postpull films. Card: Sinus tachycardia 110's- IV Lopressor titrated to HR < 90 converted to ___ once diet initiated. BP stable 110-130's. On discharge his heart rate was sinus rhythm 70's and his lopressor was discontinued. GI: PPI, bowel regime continued. Pt had bowel movements following surgery. Nutrition: Jevity was started POD 1 titrated to Goal 105 ml x 18 hours as recommended by the dietician. On ___ he was started on a full liquid following a negative barium swallow which he tolerated. NGT was dc'd on POD 4 Chest tube and JP were removed following barium swallow that showed no leak, POD 6. Renal: He had normal renal function. Electrolytes were replete as needed. Daily weights were stable. The Foley was removed ___ with good urine output thereafter Pain: Epidural was split on POD2 with PCA dilaudid and removed ___. He transitioned to ___ roxicet via J-tube with good control. Disposition: He was seen by physical therapy and deemed safe for home. He was discharged on ___ with his family and ___ ___. He will follow-up with Dr. ___ as an outpatient. ",1449,431
10003203-DS-19,"<SEX> F <SERVICE> ORTHOPAEDICS <ALLERGIES> No Allergies/ADRs on File <ATTENDING> ___. <CHIEF COMPLAINT> R shoulder pain <MAJOR SURGICAL OR INVASIVE PROCEDURE> ___ ORIF R humerus <HISTORY OF PRESENT ILLNESS> This is a deligthful ___ year-old woman RHD with Hx of severe RA who was in her USOH until the day of presentation when the patient sustained a mechanical fall, with immediate right arm pain. She does recall that she did not loose her consciousness. The patient was transferred from on OSH and presented to the ED for evaluation and the orthopaedic service was consulted when imaging was concerning for fracture. <PAST MEDICAL HISTORY> RA, HTN, HLD, shingles, h/o herpetic encephalopathy, feels like she has been declining over past year (refers to lumps in back of head which she does not have an explanation for), knee arthritis, back pain, wears Depends because she cannot make it to bathroom in time, s/p breast reduction <SOCIAL HISTORY> Lives in retirement facility, has medical services. A Minimal smoking, no current alcohol or drugs <PHYSICAL EXAM> admit: A&O x 3 Calm and comfortable BUE skin clean and intact, nonthreatened. Tender over right proximal humerus. Pain with shoulder elevation, internal and external rotation. Arms and forearm compartments soft Axillary, Radial, Median, Ulnar SILT EPL FPL EIP EDC FDP DIO fire 2+ radial pulses bilaterally Elbow stable to varus, valgus, rotatory stresses. d/c: A&O x 3 Calm and comfortable RUE incision c/d/i Arms and forearm compartments soft Axillary, Radial, Median, Ulnar SILT EPL FPL EIP EDC FDP DIO fire 2+ radial pulses bilaterally Elbow stable to varus, valgus, rotatory stresses. <PERTINENT RESULTS> ___ 02: 00AM GLUCOSE-120* UREA N-38* CREAT-1.2* SODIUM-139 POTASSIUM-4.9 CHLORIDE-104 TOTAL CO2-24 ANION GAP-16 ___ 02: 00AM estGFR-Using this ___ 02: 00AM WBC-12.3* RBC-3.73* HGB-10.1* HCT-32.5* MCV-87 MCH-27.1 MCHC-31.1 RDW-15.0 ___ 02: 00AM NEUTS-77.3* LYMPHS-14.3* MONOS-7.3 EOS-0.6 BASOS-0.4 ___ 02: 00AM PLT COUNT-385 ___ 02: 00AM ___ PTT-24.3* ___ <MEDICATIONS ON ADMISSION> Inderal LA 80 mg capsule,extended release oral QD Nexium 40 mg capsule,delayed release oral QD folic acid 1 mg tablet oral QD prednisone 5 mg tablet oral QD methotrexate sodium 25 mg/mL injection solution injection 0.5ml solution(s) Once monthly on the ___ (12.5mg) leucovorin calcium 10 mg tablet oral 1 tablet(s) Once monthly on ___, 12 hours after methotrexate Vitamin D3 400 unit capsule oral 1 capsule(s) Once Daily lovastatin 20 mg tablet oral 1 tablet(s) Once Daily ___ 8.6 mg-50 mg tablet oral alendronate 70 mg tablet oral 1 tablet(s) Once weekly on ___ <DISCHARGE MEDICATIONS> 1. Acetaminophen 1000 mg PO Q8H 2. Alendronate Sodium 70 mg PO QFRI 3. Atorvastatin 20 mg PO DAILY 4. Calcium Carbonate 1250 mg PO Q24H 5. Docusate Sodium 100 mg PO BID 6. Milk of Magnesia 30 ml PO BID: PRN Constipation 7. NexIUM (esomeprazole magnesium) 40 mg oral qd 8. OxycoDONE (Immediate Release) 2.5 mg PO Q4H: PRN Pain RX *oxycodone 5 mg 0.5 (One half) tablet(s) by mouth q4hrs Disp #*30 Tablet Refills: *0 9. PredniSONE 5 mg PO DAILY 10. Propranolol LA 80 mg PO DAILY 11. Senna 1 TAB PO BID 12. Vitamin D 1000 UNIT PO DAILY 13. Aspirin 325 mg PO DAILY Duration: 6 Weeks <DISCHARGE DISPOSITION> Extended Care Facility: ___ <DISCHARGE DIAGNOSIS> R proximal humerus fx/dislocation <DISCHARGE CONDITION> stable <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Medications You will be given a prescription for pain medicine. The pain medication is a codeine derivative and should be taken as directed. Please take one full strength aspirin (325 mg) each day for six weeks to decrease the risk of having a complication related to a blood clot. Please take a stool softener, like Colace (Docusate Sodium 100mg), twice a day while taking narcotics to prevent constipation. Dressing Leave your dressing for 48 hours after your surgery. After 48 hours, you may remove your dressing. LEAVE THE TAPE STRIPS OVER YOUR INCISIONS. These will stay on for 1.5 to 2 weeks and will slowly peel off. Showering You may shower 48 hours after your surgery and get your incisions wet. DO NOT immerse in a tub or pool for 7  10 days to avoid excessive scarring and risk of infection. When you shower, let your arm hang at your side (Do NOT raise your arm). To wash under your arm, lean forward carefully and let your arm hang. Using your other hand, wash under your operative arm. Do NOT scrub the incision. When you are done, stand up and let your arm hang at your side. Pat yourself dry and put your sling on. Ice Packs Keep Ice Packs on at all times exchanging every hour while awake. Icing is very important to decrease swelling and pain and improve mobility. After 24 hours, continue to use the cuff 3  4 times a day, 15  20 minutes each time to keep swelling to a minimum. Activity - Take it easy. - Wear your sling for comfort and safety. - Keep your arm at your side at ALL TIMES  no reaching, grabbing or pulling with your operative arm. When to Contact Us If you experience severe pain that your pain medication does not help, please let us know. If you have a temperature over 101.5, please contact our office at ___. Physical Therapy: Activity: Activity: Activity as tolerated Activity: OOB to chair for meals Right lower extremity: Non weight bearing Encourage turn, cough and deep breathe q2h when awake Treatments Frequency: Wound care: Site: Incision Type: Surgical Dressing: Gauze - dry Comment: To be changed DAILY by ___ starting POD ___. RN - please overwrap any dressing bleedthrough with ABDs and ACE ","The patient presented to the emergency department and was evaluated by the orthopedic surgery team. The patient was found to have R ___ humerus fx/dislocation and was admitted to the orthopedic surgery service. The patient was taken to the operating room on ___ for ORIF R humerus, which the patient tolerated well (for full details please see the separately dictated operative report). The patient was taken from the OR to the PACU in stable condition and after recovery from anesthesia was transferred to the floor. The patient was initially given IV fluids and IV pain medications, and progressed to a regular diet and oral medications by POD#1. The patient was given perioperative antibiotics and anticoagulation per routine. The patients home medications were continued throughout this hospitalization. The patient worked with ___ who determined that discharge to rehab was appropriate. The ___ hospital course was otherwise unremarkable. At the time of discharge the patient was afebrile with stable vital signs that were within normal limits, pain was well controlled with oral medications, incisions were clean/dry/intact, and the patient was voiding/moving bowels spontaneously. The patient is NWB in the RUE extremity, and will be discharged on ASA 325mg for DVT prophylaxis. The patient will follow up in two weeks per routine. A thorough discussion was had with the patient regarding the diagnosis and expected post-discharge course, and all questions were answered prior to discharge. ",1604,295
10003299-DS-10,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> Iodine-Iodine Containing <ATTENDING> ___. <CHIEF COMPLAINT> Throat Pain, confusion, worsening L hemiparesis <MAJOR SURGICAL OR INVASIVE PROCEDURE> ___ and biopsy <HISTORY OF PRESENT ILLNESS> Ms. ___ is a ___ w/ stage IIIA squamous cell carcinoma of lung, s/p completion of concurrent ___ ___, also w/ a h/o multiple strokes w/ residual left hemiparesis, HTN, DL, and prior colon cancer s/p hemicolectomy who is transferred from ___ for continuity of care. Dr ___, the oncology service resident, called me for signout. She presented there on ___ with subacute worsening of her chronic L-sided hemiparesis and confusion. She was seen by neurology and her head CT and brain MRI did not reveal any new/acute stroke or other acute process. The neurologic symptoms were therefore felt to be recrudescence of prior stroke symptoms in the setting of dehydration, deconditioning, malnutrition. She had a CXR that was concerning for pneumonia. She had a Chest CT which revealed no pneumonia but did reveal b/l scapular mets. Her confusion resolved with some maintenance fluids and her lue weakness improved. Nutrition and ___ saw her as well. Her symptoms of poor po intake and esophagitis are known to her oncology team and they have been working closely together, respecting her wishes to remain independent at home. She was even recently admitted ___ and her sx improved w/ oral liquid lidocaine formulation. She states this helps and is not taking it because she doesn't have it at home. I spoke w/ her daughter, who is her HCP and she noted that her mom has been having increased confusion for weeks now at least. She thinks she may have dementia. She notes that she does have a new bottle of lidocaine at home. She notes worsening PO intake. REVIEW OF SYSTEMS: A complete 10-point review of systems was performed and was negative unless otherwise noted in the HPI. <PAST MEDICAL HISTORY> PAST ONCOLOGIC HISTORY: Briefly, patient initially presented to care in ___ with hemoptysis. She was subsequently admitted for workup of same and had a CT of the chest which showed a right infrahilar mass with complete occlusion of the right middle lobe bronchus and atelectasis of the right middle lobe with high suspicion for lung cancer; there was evidence of bilateral intrathoracic adenopathy. During her hospital admission, she was seen by the interventional pulmonary team and scheduled for outpatient bronchoscopy. She underwent bronchoscopy with EBUS under Dr. ___ care on ___. FNA of the right middle lobe mass showed findings consistent with squamous cell carcinoma; there was biopsy-proven involvement of the level 4L lymph node; sampling of the 11 L lymph node showed no malignant cells. Patient underwent staging PET scan on ___. This showed an FDG avid 3.2 cm mass in the right infrahilar region with evidence of occlusion of the right middle lobe bronchus and atelectasis of the right middle lobe. FDG avid subcarinal adenopathy measuring up to 1.3 cm was noted; additionally enlarged mediastinal and and hilar lymph nodes are also noted. A 2.2 cm left lower lobe subpleural FDG avid lesion was also noted. No other distant metastatic sites of disease were noted. -___: weekly ___ and radiation started -___ completed weekly ___ + RT -___ ED visit for fall, head scrape -___ ED visit for hypokalemia -___ Admission for esophagitis PAST MEDICAL HISTORY: - H/o paramedian pontine infarct in ___ - H/o right-sided lenticulostriate territory infarct in ___ - Hypertension - Dyslipidemia - Colon cancer, s/p right hemicolectomy in ___ - Cholecystectomy for chronic cholecystitis and gallstones in ___ - Diverticulosis - Hemorrhoids - Tobacco Abuse <SOCIAL HISTORY> ___ <FAMILY HISTORY> Mother had stroke in her ___ or ___. Her paternal grandfather, father, and brother all had colon cancer. Two brothers had gastric cancer. Sister had ovarian cancer. <PHYSICAL EXAM> ADMISSION PHYSICAL EXAM: VS: Temp 98.3, 74, 140/64, 100% on RA GENERAL: Pleasant woman, in no distress, lying in bed omfortably. HEENT: Anicteric, PERLL, OP clear. CARDIAC: RRR, normal s1/s2, no m/r/g. LUNG: Appears in no respiratory distress, clear to auscultation bilaterally, no crackles, wheezes, or rhonchi. ABD: Soft, non-tender, non-distended, normal bowel sounds. EXT: Warm, well perfused, no lower extremity edema, erythema or tenderness. NEURO: A&Ox3, L temporal field deficit, CN XI weak, ___ LUE, good attention and linear thought, CN III-XII otherwise intact but she has a mild R facial drop but symmetric smile. Strength ___ RUE and RLE, but 3+/5 proximal LLE with ___ on plantar flexion and dorsiflexion. No nystagmus. gait not assessed SKIN: xerosis on upper extremities ACCESS: Right chest wall port without erythema, accessed, dressing c/d/i DISCHARGE PHYSICAL EXAM: VS: ___ 0740 Temp: 99.0 PO BP: 133/79 HR: 96 RR: 18 O2 sat: 100% O2 delivery: RA GENERAL: Pleasant, in no distress, lying in bed comfortably HEENT: Anicteric sclera, EOMI CARDIAC: RRR, normal s1/s2, no m/r/g. LUNG: Appears in no respiratory distress, clear to auscultation bilaterally, no crackles, wheezes, or rhonchi. ABD: Soft, non-tender, non-distended, normal bowel sounds. EXT: Warm, well perfused, no lower extremity edema, erythema or tenderness. NEURO: A&Ox3, strength ___ RLE&RUE, ___ LLE&LUE SKIN: xerosis on upper extremities ACCESS: Right chest wall port without erythema, accessed, dressing c/d/i <PERTINENT RESULTS> ADMISSION LABS: -= ___ 05: 39AM BLOOD WBC-21.5* RBC-3.78* Hgb-9.6* Hct-29.9* MCV-79* MCH-25.4* MCHC-32.1 RDW-23.9* RDWSD-69.0* Plt ___ ___ 05: 39AM BLOOD Neuts-89.5* Lymphs-5.0* Monos-3.9* Eos-0.2* Baso-0.3 Im ___ AbsNeut-18.96* AbsLymp-1.07* AbsMono-0.83* AbsEos-0.04 AbsBaso-0.06 ___ 05: 39AM BLOOD ___ PTT-30.1 ___ ___ 05: 39AM BLOOD Glucose-174* UreaN-5* Creat-0.6 Na-145 K-3.6 Cl-107 HCO3-23 AnGap-15 ___ 05: 39AM BLOOD ALT-21 AST-15 LD(LDH)-343* AlkPhos-240* TotBili-0.4 ___ 05: 39AM BLOOD Albumin-2.5* Calcium-9.2 Phos-3.2 Mg-2.0 MICRO: ====== ___ c diff stool test - negative IMAGING/STUDIES: -== ___ second opinion CT Torso: 1. Within the confines of a motion limited, unenhanced study, the known, approximately 1.8 cm right hilar mass appears stable. 2. Stable postobstructive collapse of the right middle lobe in the setting of right hilar mass. 3. Stable 3 mm left upper lobe pulmonary nodule. No definite new or growing pulmonary nodules. 4. Moderate paraseptal emphysema. ___ right upper extremity US: 1. Nonocclusive thrombus is seen in the right internal jugular vein. 2. The remaining visualized veins of the right upper extremity are patent. ___ EGD: - erythema in middle third of esophagus, consistent with non-erosive esophagitis - esophageal hiatal hernia - erythema and erosion in gastric antrum and stomach body consistent with non-erosive gastritis - duodenitis - ring in the distal esophagus ___ x-rays of pelvis and femurs: No evidence of lytic or sclerotic lesions within either femur or pelvis. DISCHARGE LABS: -= ___ 05: 21AM BLOOD WBC-22.4* RBC-3.44* Hgb-8.8* Hct-27.3* MCV-79* MCH-25.6* MCHC-32.2 RDW-23.0* RDWSD-65.7* Plt ___ ___ 05: 21AM BLOOD Plt ___ ___ 05: 21AM BLOOD Glucose-178* UreaN-8 Creat-0.6 Na-147 K-3.6 Cl-109* HCO3-25 AnGap-13 ___ 04: 40AM BLOOD ALT-17 AST-13 AlkPhos-242* TotBili-0.4 ___ 05: 21AM BLOOD Calcium-9.2 Phos-2.7 Mg-2.5 <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Nicotine Patch 21 mg/day TD DAILY 2. Cyanocobalamin ___ mcg PO DAILY 3. Multivitamins W/minerals 1 TAB PO DAILY 4. Lidocaine Viscous 2% 15 mL PO QID: PRN throat pain 5. Potassium Chloride (Powder) 20 mEq PO DAILY 6. Aspirin 81 mg PO DAILY 7. Atorvastatin 40 mg PO QPM 8. Oxybutynin 5 mg PO DAILY 9. Clopidogrel 75 mg PO DAILY <DISCHARGE MEDICATIONS> 1. Enoxaparin Sodium 80 mg SC DAILY RX *enoxaparin 80 mg/0.8 mL 80 mg SC daily Disp #*30 Syringe Refills: *3 2. Morphine Sulfate (Concentrated Oral Solution) 20 mg/mL 10 mg PO Q4H: PRN Pain - Severe RX *morphine concentrate 100 mg/5 mL (20 mg/mL) 10 mg by mouth q4hrs PRN Refills: *0 3. Naloxone Nasal Spray 4 mg IH ONCE MR1 Duration: 1 Dose RX *naloxone [Narcan] 4 mg/actuation 1 spray nasal once AS NEEDED Disp #*1 Spray Refills: *0 4. Omeprazole 40 mg PO DAILY RX *omeprazole 40 mg 1 capsule(s) by mouth daily Disp #*30 Capsule Refills: *3 5. Lidocaine Viscous 2% 15 mL PO QID: PRN throat pain 6. Nicotine Patch 21 mg/day TD DAILY 7. Oxybutynin 5 mg PO DAILY 8. Potassium Chloride (Powder) 20 mEq PO DAILY Hold for K > 4.0 <DISCHARGE DISPOSITION> Home With Service Facility: ___ <DISCHARGE DIAGNOSIS> Primary Diagnosis -= 1) Odynophagia/Dysphagia 2) Failure to Thrive 3) H pylori gastritis 4) Stage IIA squamous cell carcinoma of the lung 5) Non-occlusive thrombus of the right IJ 6) Severe protein calorie malnutrition Secondary Diagnosis -== 1) History of CVA 2) Tobacco Abuse <DISCHARGE CONDITION> Level of Consciousness: Alert and interactive. Mental Status: Clear and coherent. Activity Status: Bedbound. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Ms. ___, It was a pleasure caring for you at ___ ___. WHY WAS I IN THE HOSPITAL? - You were having pain in your throat and body. You were not getting enough to eat and drink. Because of this, you were weaker than usual, which made your old stroke symptoms seem worse. Your children were concerned that you were more confused than usual. WHAT HAPPENED TO ME IN THE HOSPITAL? - You received scans to make sure that you did not have a new stroke. - You were watched closely for signs of infection. - You were supported with fluids and nutritious food. - You underwent an endoscopy procedure, which showed a lot of inflammation that is probably causing your swallowing pain. You were given liquid lidocaine for throat pain, as well as an acid blocker medicine. - Your body pain was treated with morphine. WHAT SHOULD I DO AFTER I LEAVE THE HOSPITAL? - Continue to take all your medicines and keep your appointments. We wish you the best! Sincerely, Your ___ Team ","SUMMARY: ========= ___ w/ stage IIIA squamous cell carcinoma of lung, s/p completion of concurrent ___ ___, also w/ a h/o multiple strokes w/ residual left hemiparesis, HTN, DL, and prior colon cancer s/p hemicolectomy who is transferred from ___ for continuity of care after presenting there w/ confusion and worsening LUE weakness. ACTIVE ISSUES: ============ #Odynophagia/Dysphagia: Most likely radiation esophagitis, reflux esophagitis. ___ EGD with esophagitis, gastritis, duodenitis. Gastric biopsy showed H. pylori. She was given viscous lidocaine with meals, BID PPI, fluids as needed, and a regular diet. We had long discussions about her goals of care with both her outpatient oncology team as well as her palliative care team (detailed below) and it was ultimately decided to not pursue full antibiotic therapy for H. pylori as her primary symptom of odynophagia is most likely primarily related to strictures and radiation esophagitis. #Failure to thrive Seems like most likely etiology is poor po intake. Felt to be due to progressive esophagitis (presumably radiation induced). She has odynophagia. TSH wnl. No e/o pulmonary infection. UA neg at OSH. C diff negative this admission. Geriatrics was involved in the patient's care during this admission. Her throat and body pain was controlled with IV morphine, and she received viscous lidocaine to help her eat/drink more comfortably. She was supported with IVF as needed. ___ and OT evaluated her and recommended rehab placement however after long discussions of her GOC and it was decided that she would not want tube feeding and would like to go home on hospice. #Nonocclusive thrombus in right IJ In the setting of being hypercoagulable from malignancy. HAS-BLED score is 3 (HTN, stroke Hx, age she is at high risk for major bleeding, but is hypercogulable iso malignancy. The definitive treatment for her hypercoagulable state is treatment of her malignancy, if within GOC. Her home ASA/Plavix were continued, and she was started on enoxaparin 80 mg SC daily, with the plan to treat for 1 month. #Stage IIIA Squamous Cell Lung Carcinoma #Bilateral lytic scapular lesions Most recent imaging, CT chest on ___, revealed substantial decrease in size of the pre-existing right hilar mass, which now measures 20 x 20 mm in diameter. However CT abd revealed ""new 1.3 cm hepatic segment VII lesion ... suspicious for metastasis."" ___ elevated this admission, consistent with liver involvement. Now CT from ___ revealed new bilateral lytic scapular lesions. Outpatient team arranging PET scan in ___, with future cancer treatment directed therapies to be determined. Her outpatient oncology team (Drs ___ was contacted with updates. Hip/femur x-rays were obtained to eval for osseous/lytic lesions (because of delays with scheduling a bone scan). #Encephalopathy She's been having episodes of confusion for some time now per daughter. She locked herself in the bathroom last week. ""Thetiles have me locked in the bathroom and I can't get out."" But the bathroom was not locked. A few weeks ago, she had left the stove on during a hot day, and she stated she was heating food for her son (who was murdered ___. Daughter is concerned about dementia. MRI brain did not reveal mets or new stroke. although pt is oriented x 3, she seems to have poor insight into reason for admission and her hospitalization. Confusion possibly also due to impaired sleep (sleeps during day, as lives with her son who works nights), dehydration, pain from malignancy. Geriatrics was consulted and assisted with her care. Her nutrition and hydration status were optimized and her pain was controlled with IV morphine. She received high dose thiamine for possible Wernicke's encephalopathy. She received folic acid repletion for severe protein calorie malnutrition. CHRONIC/RESOLVED ISSUES: ======================== #Worsening LUE and LLE weakness - stable #History of CVA w/ residual hemiparesis Likely recrudescence from prior CVA and improved w/ hydration and nutrition. Her home aspirin, Plavix, and atorvastatin were continued. Her neurologic status was checked daily. She was started on Lovenox ___aily. #Severe protein calorie malnutrition: - Nutrition was consulted. She received a regular diet, high dose thiamine, folic acid and MVI. Her electrolytes were monitored daily and repleted as needed. #Tobacco Abuse: Continued nicotine patch. TRANSITIONAL ISSUES: ==================== [] Due to esophageal spasms seen during EGD, outpatient esophageal mannometry should be considered to further work up her dysphagia/odynophagia. [] Consider starting a bisphosphonate, if osseous metastases are confirmed through bone scan/bone biopsy. Code status: DNR/DNI EMERGENCY CONTACT HCP: ___ (daughter) ___ This patient was prescribed, or continued on, an opioid pain medication at the time of discharge (please see the attached medication list for details). As part of our safe opioid prescribing process, all patients are provided with an opioid risks and treatment resource education sheet and encouraged to discuss this therapy with their outpatient providers to determine if opioid pain medication is still indicated. ",2946,1180
10003299-DS-4,"<SEX> F <SERVICE> NEUROLOGY <ALLERGIES> Iodine; Iodine Containing <ATTENDING> ___. <CHIEF COMPLAINT> gait instabilityq <MAJOR SURGICAL OR INVASIVE PROCEDURE> none <HISTORY OF PRESENT ILLNESS> Ms. ___ is a ___ year old woman with hypertension, untreated hyperlipidemia prior paramedian pontine infarct now presenting with difficulty walking and slowed speech. She awoke yesterday morning with difficulty walking and felt her speech my be slower than normal. The difficulty walking is intermittent and she ___ still able to manage. When she spoke with her friends they told her that her speech was slow. Friends thought she had a left facial droop, but when the pt looked in the mirror she thought it was normal. She denies being able to find the right words. denied headache, loss of vision, blurred vision, diplopia, dysarthria, dysphagia, lightheadedness, vertigo, tinnitus or hearing difficulty. Denied difficulties comprehending speech. Denied focal weakness, numbness, parasthesiae. No bowel or bladder incontinence or retention. On general review of systems, the pt denied recent fever or chills. No night sweats or recent weight loss or gain. Denied cough, shortness of breath. Denied chest pain or tightness, palpitations. Denied nausea, vomiting. She has chronic diarrhea. no constipation or abdominal pain. No recent change in bowel or bladder habits. No dysuria. Denied arthralgias or myalgias. Denied rash. <PAST MEDICAL HISTORY> - ? Hypertension - Hyperlipidemia- stopped simvastatin due to ""bobbing legs"" -Colon cancer originally resected in ___ (right colectomy) and who had a prolonged stuttering course of adjuvant chemotherapy (diagnosed in setting of GI bleeding) -Cholecystectomy for chronic cholecystitis and gallstones in ___ -Diverticulosis -Hemorrhoids <SOCIAL HISTORY> ___ <FAMILY HISTORY> Mother had stroke in her ___ or ___. Her paternal grandfather, father, and brother all had colon cancer. Sister had ovarian cancer and has prostate cancer in her family. <PHYSICAL EXAM> Vitals: T 97.9 BP 156/91 P 72 RR 20 SaO2 100 RA General: well appearing, pleasant, NAD HEENT: NC/AT, sclerae anicteric, MMM, no exudates in oropharynx Neck: no bruits bilat, no rigiduty Lungs: scattered wheeze. CV: regular rate and rhythm, no MRG Abdomen: soft, obese, non-tender, non-distended, BS+ Ext: warm, dry, no edema, pedal pulses appreciated Skin: no rashes Neurologic Examination: Mental Status: Awake and alert, able to relay history, cooperative with exam, normal affect Oriented to person, place, time Attention: can say days of week backward Language: fluent, non-dysarthric speech, no paraphasic errors, naming, comprehension, repetition intact; reading and writing intact. No evidence of apraxia or neglect Cranial Nerves: Optic disc margins sharp. Visual fields are full to confrontation. Pupils equally round and reactive to light, 3 to 2 mm bilaterally. Extraocular movements intact with odd superior conjugate R gaze preference however pt is able to deviate both eyes superiorly, no false image or diplopia. no nystagmus. Facial sensation intact to LT bilaterally. Facial movement normal and symmetric. Hearing intact to finger rub bilaterally. Palate elevates midline. Tongue protrudes midline, no fasciculations. Trapezii full strength bilaterally. Motor: Normal bulk throughout, increased tone in the legs bilaterally, left more than right. no pronator drift. No tremor or asterixis. D T B WE FiF ___ IP Q H TA ___ Right ___ 5 5 ___ ___ 5 5 Left ___ 5 5 ___ ___ 5 5 Sensation: Normal light touch, cold sensation. vibration and proprioception intact at toes. Reflexes: B T Br Pa Pl Right ___ 0 0 Left ___ 0 0 Toes upgoing on the left, downgoing on the right. Coordination: No intention tremor noted. RAM symmetric. FNF and HKS normal. Gait: Good initiation. Narrow-based, normal stride and arm swing. Tandems with some astasia, abasia. Romberg absent. <PERTINENT RESULTS> ___ 01: 48PM BLOOD WBC-9.1 RBC-4.85 Hgb-13.8 Hct-40.4 MCV-83 MCH-28.5 MCHC-34.3 RDW-14.2 Plt ___ ___ 01: 48PM BLOOD Neuts-68.3 ___ Monos-5.3 Eos-0.4 Baso-0.3 ___ 01: 48PM BLOOD ___ PTT-29.5 ___ ___ 01: 48PM BLOOD Glucose-113* UreaN-9 Creat-1.0 Na-143 K-3.7 Cl-108 HCO3-27 AnGap-12 ___ 01: 48PM BLOOD CK(CPK)-112 ___ 01: 48PM BLOOD cTropnT-<0.01 ___ 01: 48PM BLOOD CK-MB-2 ___ 07: 00AM BLOOD Cholest-246* ___ 07: 00AM BLOOD %HbA1c-6.7* ___ 07: 00AM BLOOD Triglyc-195* HDL-41 CHOL/HD-6.0 LDLcalc-166* ___ 07: 00AM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG Bnzodzp-NEG Barbitr-NEG Tricycl-NEG ___ 08: 09AM URINE Color-Yellow Appear-Clear Sp ___ ___ 08: 09AM URINE Blood-NEG Nitrite-NEG Protein-NEG Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-5.0 Leuks-NEG ___ 08: 09AM URINE bnzodzp-NEG barbitr-NEG opiates-NEG cocaine-NEG amphetm-NEG mthdone-NEG NCHCT ___: IMPRESSION: 1. No intracranial hemorrhage or edema. 2. Old left pontine infarct corresponds to lesion detected on ___. CXR ___: CHEST, TWO VIEWS: Lung volumes are low which results in bronchovascular crowding and extent and accentuates the cardiac silhouette. Within this limitation, the lungs are clear, without airspace consolidation. Hilar contours, and pulmonary vasculature are within normal limits. Osseous structures are intact. Surgical clips within the left upper quadrant are noted. IMPRESSION: No acute intrathoracic process. MRI brain, MRA head/neck ___: BRAIN MRI: There is evidence of restricted diffusion seen in the right lenticulostriate territory extending from the putaminal to the periventricular region. Findings are indicative of acute infarct. The chronic left pontine infarct is identified. Several prominent perivascular spaces are seen in the basal ganglia region. Small right subcortical frontal infarct is also identified which appears acute given the slow diffusion. Mild changes of small vessel disease are seen. There is no midline shift or hydrocephalus. IMPRESSION: Acute right-sided lenticulostriate territory infarct involving the predominant in the periventricular region. Small acute right posterior frontal subcortical infarct. Chronic left pontine infarct. Mild changes of small vessel disease. MRA OF THE NECK: Neck MRA demonstrates normal flow in both carotid and right vertebral arteries. The left vertebral artery is small in size, which could be a congenital variation. IMPRESSION: Small left vertebral artery, otherwise unremarkable MRA of the neck. MRA OF THE HEAD: Head MRA is somewhat limited with the motion limiting the evaluation at the skull base. Otherwise, the MRA is normal in appearance in the arteries of anterior and posterior circulation. IMPRESSION: Somewhat limited evaluation of the skull base. However, this area is well visualized on the neck MRA. Otherwise, MRA of the head is normal. <MEDICATIONS ON ADMISSION> Folate Aspirin 325mg daily Recently stopped simvastatin because it made her gait ""wobbly"" no myalgias. <DISCHARGE MEDICATIONS> 1. Aspirin 325 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 2. Folic Acid Oral 3. Omega-3 Fatty Acids 1,000 mg Capsule Sig: One (1) Capsule PO twice a day. Disp: *60 Capsule(s)* Refills: *2* 4. Zetia 10 mg Tablet Sig: One (1) Tablet PO once a day. Disp: *30 Tablet(s)* Refills: *2* <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Primary diagnosis: Acute right-sided lenticulostriate territory infarct Small acute right posterior frontal subcortical infarct Hyperlipidemia Secondary diagnosis: History of a left pontine stroke History of colon cancer Cholecystectomy Diverticulosis Hemorrhoids <DISCHARGE CONDITION> Mild difficulty with tandem gait and conjugate superior right gaze preference with upgaze only, diminished in legs bilaterally and upgoing left toe. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> You have had multiple strokes (a small acute right posterior frontal subcortical infarct and an acute right sided lenticulostriate territory infract). These were likely small vessel in origin and can be prevented in the future if you successfully quit smoking, start a cholesterol lowering medication and have a well controlled blood pressure. You should continue to take Aspirin 325mg daily to help prevent future strokes. Please take medications as prescribed. Please keep your follow-up appointments. If you have any worsening or worrying symptoms, please contact your PCP or return to the ED. ","This ___ yo woman was admitted with complaints to gait instability and slowness of speech as outlined in the HPI. She had an otherwise normal neuro exam, but given her history of prior stroke and vascular risk factors, she received a brain MRI and MRA of the head and neck, which showed 2 small infarcts in the right lenticulostriate area and right frontal subcortical area. These were thought to be due to a small vessel disease. Her MRA was unrevealing. Her bloodwork revealed elevated lipids, for which she was started on Zetia and omega-3 fatty acids as she indicated that she could not tolerate lipitor in the past because it made her weak. Her HgbA1C was mildly elevated to 6.7, and she was counceled that she may have, at the least, glucose intolerence. She was instructed to modify her diet, be physically active, and follow this up with her PCP. Because she became angry when told of the possibilty of diabetes, these instructions, along with her med changes, were discussed with both her son and daughter. She was also counceled to stop smoking, and to be compliant with her medications. The patient will be scheduled for an echicardiogram as an outpatient to complete her work-up. ",2241,272
10003299-DS-5,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> Iodine-Iodine Containing <ATTENDING> ___. <CHIEF COMPLAINT> bright red blood per rectum <MAJOR SURGICAL OR INVASIVE PROCEDURE> None <HISTORY OF PRESENT ILLNESS> Mrs. ___ is a ___ w/ h/o stage III splenic flexure colon cancer s/p resection with colonic anastamosis, HTN, DMII, CAD who presents with one episode of bright red blood per rectum this morning. She never has constipation, but some loose stools since her surgery over a decade ago. Today, she had a normal BM for her, and had some blood on top of the BM, small amount, also some red blood on toilet paper. She states she had some mild left sided abdominal pain that came and went with belching, so she thought it was gas pain. She saw her primary care physician today who noticed a small amount of bright red blood in the rectal vault, she was subsequently sent in to us for evaluation. PCP exam ___ few hours ago with anoscopy demonstrated hemorrhoid and stool with small amount of blood in vault. In the ED intial vitals were: 98.1 58 155/80 18 98% RA - Labs were significant for normal coags, normal CBC, normal LFTs, normal coags. UA shows few bacteria and 2 epithelial cells, otherwise normal. - Urine and blood cultures were sent. Vitals prior to transfer were: 98.4 68 121/65 17 97% RA On the floor, vitals are 98.4 158/86 84 18 100%RA. She is in good spirits, in no distress, in no pain and has had no more red blood since earlier today. <PAST MEDICAL HISTORY> -COLON CANCER -DIABETES TYPE II -HYPERCHOLESTEROLEMIA -LACTOSE INTOLERANCE -STROKE -INFERIOR MYOCARDIAL INFARCTION -HYPERTENSION -HYPERLIPIDEMIA -DIZZINESS <SOCIAL HISTORY> ___ <FAMILY HISTORY> Mother had stroke in her ___ or ___. Her paternal grandfather, father, and brother all had colon cancer. Sister had ovarian cancer and has prostate cancer in her family. <PHYSICAL EXAM> ADMISSION PHYSICAL EXAM: Vitals - 98.4 158/86 84 18 100%RA GENERAL: NAD HEENT: PERRL, pink conjunctiva, MMM CARDIAC: RRR, S1/S2, no murmurs, gallops, or rubs LUNG: CTAB, no wheezes, rales, rhonchi, breathing comfortably without use of accessory muscles ABDOMEN: nondistended, +BS, nontender in all quadrants, no rebound/guarding, no hepatosplenomegaly EXTREMITIES: moving all extremities well, no cyanosis, clubbing or edema PULSES: 2+ DP pulses bilaterally NEURO: CN II-XII intact SKIN: warm and well perfused, no excoriations or lesions, no rashes DISCHARGE PHYSICAL EXAM: VS: 99.1 ___ 58-64 18 99/RA GENERAL: NAD HEENT: PERRL, pink conjunctiva, MMM CARDIAC: RRR, S1/S2, no murmurs, gallops, or rubs LUNG: CTAB, no wheezes, rales, rhonchi, breathing comfortably without use of accessory muscles ABDOMEN: nondistended, +BS, nontender in all quadrants, no rebound/guarding, no hepatosplenomegaly EXTREMITIES: moving all extremities well, no cyanosis, clubbing or edema PULSES: 2+ DP pulses bilaterally NEURO: CN II-XII intact SKIN: warm and well perfused, no excoriations or lesions, no rashes <PERTINENT RESULTS> ADMISSION LABS: ___ 05: 51PM BLOOD ___ PTT-31.3 ___ ___ 05: 30PM BLOOD Glucose-101* UreaN-10 Creat-1.0 Na-142 K-3.7 Cl-107 HCO3-26 AnGap-13 ___ 05: 30PM BLOOD ALT-34 AST-24 AlkPhos-106* TotBili-0.3 ___ 05: 30PM BLOOD Albumin-4.0 ___ 06: 20PM BLOOD Lactate-1.3 ___ 05: 49PM BLOOD Hgb-14.7 calcHCT-44 DISCHARGE LABS: ___ 08: 00AM BLOOD WBC-8.1 RBC-4.75 Hgb-13.6 Hct-40.7 MCV-86 MCH-28.6 MCHC-33.4 RDW-13.6 Plt ___ ___ 08: 00AM BLOOD Glucose-122* UreaN-8 Creat-0.9 Na-144 K-3.7 Cl-109* HCO3-24 AnGap-15 URINE: ___ 06: 05PM URINE Color-Yellow Appear-Clear Sp ___ ___ 06: 05PM URINE RBC-1 WBC-1 Bacteri-FEW Yeast-NONE Epi-2 ___ 06: 05PM URINE Mucous-RARE ___ 6: 05 pm URINE ___. **FINAL REPORT ___ URINE CULTURE (Final ___: MIXED BACTERIAL FLORA ( >= 3 COLONY TYPES), CONSISTENT WITH SKIN AND/OR GENITAL CONTAMINATION. EKG ___: Sinus bradycardia. Borderline left atrial abnormality. Right bundle-branch block. Left axis deviation. Left anterior fascicular block. Diffuse non-specific repolarization abnormalities. Compared to the previous tracing of ___ complete right bundle-branch block is now present. EKG ___: Sinus bradycardia. Non-specific intraventricular conduction delay. Left axis deviation. Left anterior fascicular block. Compared to the previous tracing right bundle-branch block is no longer present. <MEDICATIONS ON ADMISSION> The Preadmission Medication list may be inaccurate and requires futher investigation. 1. Lisinopril 10 mg PO DAILY 2. Oxybutynin 5 mg PO DAILY 3. Rosuvastatin Calcium 10 mg PO DAILY 4. Aspirin 81 mg PO DAILY 5. Multivitamins 1 TAB PO DAILY 6. Calcium Carbonate 500 mg PO TID: PRN . 7. FoLIC Acid 1 mg PO DAILY 8. Fish Oil (Omega 3) 1000 mg PO BID 9. Nicotine Lozenge 2 mg PO Q8H: PRN smoking cessation <DISCHARGE MEDICATIONS> 1. Aspirin 81 mg PO DAILY 2. Multivitamins 1 TAB PO DAILY 3. Oxybutynin 5 mg PO DAILY 4. Calcium Carbonate 500 mg PO TID: PRN . 5. Nicotine Lozenge 2 mg PO Q8H: PRN smoking cessation 6. Rosuvastatin Calcium 10 mg PO DAILY 7. Fish Oil (Omega 3) 1000 mg PO BID 8. FoLIC Acid 1 mg PO DAILY 9. Lisinopril 10 mg PO DAILY 10. Simethicone 80 mg PO QID: PRN gas RX *simethicone 80 mg 1 tablet by mouth four times a day Disp #*30 Tablet Refills: *0 <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Primary diagnosis: - Bright red blood per rectum Secondary Diagnoses -HTN -Chronic Dizziness <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Ms. ___, It was our pleasure participating in your care here at ___. You were admitted here on ___ after having some bright red blood with your bowel movements. Fortunately, your blood counts remained stable. It will be very important that you have a colonoscopy as an outpatient. Please call ___ to schedule your colonoscopy. Please try to schedule this before your ___ appointments. If you should have more abdominal pain, chest pain, bleeding or any other concerning symptom, please let your doctor know. Again, it was our pleasure participating in your care. We wish you the best! -- Your ___ Medicine Team -- ","PRIMARY REASON FOR ADMISSION: Mrs. ___ is a ___ h/o stage III splenic flexure colon cancer s/p resection, DMII, CAD, HTN who presents from clinic with one episode of bright red blood per rectum this morning. ACTIVE ISSUES: # Rectal Bleeding: Patient with mild abdominal pain earlier today with small amount of blood in stool and on toilet paper. It is likely that her abdominal pain could have been gas pain given the mild intermittent crampy nature that resolved with passing gas. Hemodynamically she was stable, Hct was normal and she had no further bleeding. Given she does have hemorrhoids, it is most likely that this is the cause of her bleeding, but given her history of colorectal cancer, she should have expedited outpatient colonoscopy. She will also be discharged with simethicone. # Abdominal pain/chest pain: Seemed most consistent with gas pain given her description and improvement with belching and passing flatus. EKG was without evidence of new ischemia. # Benign Hypertension: Stable from her baseline. Prescribed lisinopril but does not take. # CAD: On aspirin, statin. # Hyperlipidemia: continue rosuvastatin TRANSITIONAL ISSUES: - She should have an outpatient colonoscopy - She may benefit from hemorrhoidal banding (was refered to ___ clinic) ",1916,290
10003299-DS-6,"<SEX> F <SERVICE> NEUROLOGY <ALLERGIES> Iodine-Iodine Containing <ATTENDING> ___. <CHIEF COMPLAINT> Acute onset left sided weakness <MAJOR SURGICAL OR INVASIVE PROCEDURE> None <HISTORY OF PRESENT ILLNESS> Ms. ___ is a delightful ___ year old woman with prior paramedian pontine infarct (___) and right-sided lenticulostriate territory infarct (___), hypertension, hyperlipidemia, colon cancer s/p resection and chemotherapy in ___, and extensive tobacco use who presents with acute onset left sided weakness that started at 2200 last night with her left leg and evolved this AM to involve the left arm. As per Ms. ___, she returned from election campaign headquarters last night between ___-22: 30 and noted that her left leg was giving way under her. She needed to use her cane to walk. She had no sensory symptoms, no dysarthria, aphasia, arm or facial weakness at this time. She spoke to her daughter on the phone and then went to bed. This AM when she awoke, she noticed that her left arm was weak as well. However, her left leg weakness was much improved and she was able to walk without her cane this AM. Of note, Ms. ___ was admitted to ___ two times with above mentioned strokes and is followed by Dr. ___ in stroke clinic. His note from ___ notes that Ms. ___ often has vertiginous symptoms/ dizziness and has had repeated falls as a result. Moreover, her eyesight and hearing have declined. His note seems to suggest that she should be on 325mg ASA, but patient taking only 81mg. On neuro ROS, the pt denies headache, loss of vision, blurred vision, diplopia, dysarthria, dysphagia, tinnitus or hearing difficulty. Denies difficulties producing or comprehending speech. Denies numbness, parasthesiae. No bowel incontinence or retention. Has bladder incontinence at baseline she says and takes a ""blue pill"" for it. Denies difficulty with gait. On general review of systems, the pt denies recent fever or chills. No night sweats or recent weight loss or gain. Denies cough, shortness of breath. <PAST MEDICAL HISTORY> - prior paramedian pontine infarct (___) - right-sided lenticulostriate territory infarct ___ - Hypertension as per prior medical records(patient denies) - Dyslipidemia - Colon cancer 2/p right colectomy in ___ with prolonged stuttering course of adjuvant chemotherapy (diagnosed in setting of GI bleeding) - Cholecystectomy for chronic cholecystitis and gallstones in ___ - Diverticulosis - Hemorrhoids <SOCIAL HISTORY> ___ <FAMILY HISTORY> Mother had stroke in her ___ or ___. Her paternal grandfather, father, and brother all had colon cancer. Sister had ovarian cancer and has prostate cancer in her family. <PHYSICAL EXAM> -==== ADMISSION EXAM: -==== <PHYSICAL EXAM> Vitals: T: 98.1 P: 60 R: 16 BP: 131/61 SaO2: 99% RA General: Awake, cooperative, NAD. HEENT: NC/AT, bilateral cataracts, no scleral icterus noted, MMM, no lesions noted in oropharynx. Neck: Supple Pulmonary: Lungs CTA bilaterally Cardiac: RRR, nl. I/VI systolic murmur Abdomen: soft, NT/ND. Extremities: warm and well perfused. Skin: no rashes or lesions noted. Feet are dry and fissured. Neurologic: -Mental Status: Alert, oriented x 3. Able to relate history without difficulty. Language is fluent with intact repetition and comprehension. Normal prosody. There were no paraphasic errors. Pt was able to name both high and low frequency objects. Able to read without difficulty. Speech was not dysarthric. Able to follow both midline and appendicular commands. There was no evidence of apraxia or neglect. -Cranial Nerves: I: Olfaction not tested. II: PERRL 3 to 2mm and brisk. VFF to confrontation. III, IV, VI: EOMI without nystagmus. Normal saccades. V: Facial sensation intact to light touch. VII: No facial droop, facial musculature symmetric. VIII: Hearing intact to finger-rub bilaterally. IX, X: Palate elevates symmetrically. XI: ___ strength in trapezii and SCM on the right, SCM ___ on the left. XII: Tongue protrudes in midline. -Motor: Normal bulk, tone throughout. L arm held pronated. No adventitious movements, such as tremor, noted. Delt Bic Tri WrE IP Quad Ham TA Gastroc L 3 ___ 5- 5 5 5 5- R 5 ___ 5 5 5 5 5 -Sensory: No deficits to light touch and cold sensation throughout. No extinction to DSS. -DTRs: Bi Tri ___ Pat Ach L 2brisk 2 2 2brisk 1 R 2 2 2 2 1 Plantar response was mute bilaterally. -Coordination: No dysmetria on FNF or HKS bilaterally. -====== DISCHARGE EXAM: -====== <PHYSICAL EXAM> Vitals: *** General: Awake, cooperative, NAD. HEENT: NC/AT, bilateral cataracts, no scleral icterus noted, MMM, no lesions noted in oropharynx. Neck: Supple Pulmonary: Lungs CTA bilaterally Cardiac: RRR, nl. I/VI systolic murmur Abdomen: soft, NT/ND. Extremities: warm and well perfused. Skin: no rashes or lesions noted. Feet are dry and fissured. Neurologic: -Mental Status: Alert, oriented x 3. Able to relate history without difficulty. Language is fluent with intact repetition and comprehension. Normal prosody. There were no paraphasic errors. Pt was able to name both high and low frequency objects. Speech was not dysarthric. Able to follow both midline and appendicular commands. There was no evidence of apraxia or neglect. -Cranial Nerves: I: Olfaction not tested. II: PERRL 3 to 2mm and brisk. VFF to confrontation. III, IV, VI: EOMI without nystagmus. Normal saccades. V: Facial sensation intact to light touch. VII: No facial droop, facial musculature symmetric. VIII: Hearing intact to finger-rub bilaterally. IX, X: Palate elevates symmetrically. XI: ___ strength in trapezii and SCM on the right, SCM ___ on the left. XII: Tongue protrudes in midline. -Motor: Normal bulk, tone throughout. L arm held pronated. No adventitious movements, such as tremor, noted. Delt Bic Tri WrE IP Quad Ham TA Gastroc L 5 ___ 5 5 5 5 5 R 5 ___ 5 5 5 5 5 -Sensory: No deficits to light touch and cold sensation throughout. No extinction to DSS. -DTRs: Bi Tri ___ Pat Ach L 2 2 2 2 1 R 2 2 2 2 1 Plantar response was mute bilaterally. -Coordination: No dysmetria on FNF or HKS bilaterally. <PERTINENT RESULTS> -= ADMISSION LABS: -= ___ 09: 30AM NEUTS-63.7 ___ MONOS-5.6 EOS-1.2 BASOS-0.3 ___ 09: 30AM WBC-8.7 RBC-5.02 HGB-14.5 HCT-42.1 MCV-84 MCH-28.8 MCHC-34.4 RDW-14.7 ___ 09: 30AM ASA-NEG ETHANOL-NEG ACETMNPHN-NEG bnzodzpn-NEG barbitrt-NEG tricyclic-NEG ___ 09: 30AM TSH-0.98 ___ 09: 30AM ALBUMIN-3.9 ___ 09: 30AM cTropnT-<0.01 ___ 09: 30AM ALT(SGPT)-13 AST(SGOT)-27 ALK PHOS-93 TOT BILI-0.3 ___: 30AM GLUCOSE-137* UREA N-12 CREAT-1.0 SODIUM-140 POTASSIUM-5.3* CHLORIDE-106 TOTAL CO2-25 ANION GAP-14 ___ 01: 06PM %HbA1c-6.5* eAG-140* ___ 10: 28AM ___ PTT-31.6 ___ -= DISCHARGE LABS: -= ___ 07: 30AM BLOOD WBC-8.1 RBC-4.78 Hgb-13.9 Hct-41.3 MCV-87 MCH-29.0 MCHC-33.5 RDW-14.7 Plt ___ ___ 07: 30AM BLOOD Plt ___ ___ 07: 30AM BLOOD Glucose-132* UreaN-14 Creat-0.9 Na-144 K-4.0 Cl-111* HCO3-24 AnGap-13 ___ 07: 30AM BLOOD Triglyc-PND HDL-PND -= IMAGING STUDIES: -= ___: EKG Sinus bradycardia. Right bundle-branch block. Left anterior fascicular block. Compared to the previous tracing of ___ the recording is of poor technical quality. The ST-T wave flattening in the inferolateral leads has improved. Otherwise, no diagnostic interim change. ___: CHEST (PA & LAT) IMPRESSION: Unchanged, mild to moderate cardiomegaly without a superimposed acute intrathoracic process. ___: MR HEAD W & W/O CONTRAST; MRA BRAIN W/O CONTRAST; MRA NECK W/CONTRAST IMPRESSION: 1. No evidence of acute intracranial hemorrhage or mass effect. 2. Multiple punctate foci of slow diffusion with corresponding low ADC signal within the right MCA distribution, as described, compatible with acute to subacute infarcts. 3. Brain parenchymal volume loss and presumed sequelae of chronic small vessel ischemic disease. 4. Intracranial vascular irregularity which is typical atheromatous disease though no evidence of hemodynamically significant stenosis, focal vessel cut off, or aneurysm within the intracranial vasculature. 5. The left vertebral artery is small and its origin is not well seen which is felt to likely represent stenosis. ___: BILAT LOWER EXT VEINS IMPRESSION: No evidence of deep venous thrombosis in the bilateral lower extremity veins. ___: <MEDICATIONS ON ADMISSION> 1. FoLIC Acid 1 mg PO DAILY 2. Oxybutynin 5 mg PO DAILY 3. Rosuvastatin Calcium 10 mg PO DAILY 4. Aspirin 81 mg PO DAILY 5. Calcium Carbonate 500 mg PO TID 6. Fish Oil (Omega 3) 1000 mg PO DAILY 7. Vitamin D 1000 UNIT PO DAILY <DISCHARGE MEDICATIONS> 2. FoLIC Acid 1 mg PO DAILY 3. Oxybutynin 5 mg PO DAILY 4. Rosuvastatin Calcium 40 mg PO DAILY RX *rosuvastatin [Crestor] 40 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills: *5 5. Clopidogrel 75 mg PO DAILY RX *clopidogrel 75 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills: *0 6. Calcium Carbonate 500 mg PO TID 7. Fish Oil (Omega 3) 1000 mg PO DAILY 8. Vitamin D 1000 UNIT PO DAILY 9. Outpatient Physical Therapy ___ y/o F with R-sided strokes, left-sided weakness <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Cerebral embolism with infarction <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Ms. ___, You were hospitalized due to symptoms of acute onset left sided weakness that lasted 30mins, resulting from an ACUTE ISCHEMIC STROKE, a condition in which a blood vessel providing oxygen and nutrients to the brain is blocked by a clot. The brain is the part of your body that controls and directs all the other parts of your body, so damage to the brain from being deprived of its blood supply can result in a variety of symptoms. Stroke can have many different causes, so we assessed you for medical conditions that might raise your risk of having stroke. In order to prevent future strokes, we plan to modify those risk factors. Your risk factors are: hypertension hyperlipidemia extensive tobacco use We are changing your medications as follows: Plavix 75mg DAILY Atovarstatin 80mg DAILY Please take your other medications as prescribed. It is important to comply with the prescribed regimen and to STOP smoking. Please followup with Neurology and your primary care physician as listed below. If you experience any of the symptoms below, please seek emergency medical attention by calling Emergency Medical Services (dialing 911). In particular, since stroke can recur, please pay attention to the sudden onset and persistence of these symptoms: - sudden partial or complete loss of vision - sudden loss of the ability to speak words from your mouth - sudden loss of the ability to understand others speaking to you - sudden weakness of one side of the body - sudden drooping of one side of the face - sudden loss of sensation of one side of the body - sudden difficulty pronouncing words (slurring of speech) - sudden blurring or doubling of vision - sudden onset of vertigo (sensation of your environment spinning around you) - sudden clumsiness of the arm and leg on one side or sudden tendency to fall to one side (left or right) - sudden severe headache accompanied by the inability to stay awake It was a pleasure providing you with care during this hospitalization. The ___ Neurology service ","___ year old woman with prior paramedian pontine infarct (___) and right-sided lenticulostriate territory infarct (___), hypertension, hyperlipidemia, colon cancer s/p resection and chemotherapy in ___, and extensive tobacco use who presents with acute onset left sided weakness concerning for stroke. #left sided weakness: On the day of admission (___), patient's left-sided weakness improved without a history of sensory changes or other neurological symptoms. Her exam on admission was notable for left SCM, deltoid, and triceps weakness, as well as mild weakness of her left IP and brisker reflexes on the left. Patient underwent CT head, which revealed a new hypodensity in the right frontal lobe, suggesting for acute and subacute infarct, particularly given her extensive history of infarcts in the past. Patient also underwent MRI brain and MRA, which showed multiple R-sided scattered infarcts that could explain her symptoms. Her infarcts seemed embolic. We wondered about artery-to-artery due to atherosclerotic ICA disease vs. cardioembolic source. Of note, patient admitted that she was non-compliant with her meds and continues to smoke. Echo showed LVEF >55% with no masses or thrombi. She was sent home with a Holter monitor x 30 days. Because of patient's risk factors, she was started on Plavix 75mg. It was discussed with patient that she needed to be on high dose statin therapy, and atorvastatin 80mg would be recommended, but patient declined atorva stating that she had a side effect to another statin other than rosuvastatin, and preferred to stay on rosuvastatin. I explained that Crestor would not be ideal with current guidelines, but based on her preference, she was sent home with Crestor 40mg daily. Upon discharge, patient was back to her baseline functional level and was symptom-free. She will continue to follow up with Dr. ___ in the clinic. =========================================================== AHA/ASA Core Measures for Ischemic Stroke and Transient Ischemic Attack 1. Dysphagia screening before any PO intake? (x) Yes [performed and documented by admitting resident]  () No 2. DVT Prophylaxis administered by the end of hospital day 2? (x) Yes - () No 3. Antithrombotic therapy administered by end of hospital day 2? (x) Yes - () No 4. LDL documented (required for all patients)? (x) Yes (LDL = 101) - () No 5. Intensive statin therapy administered? (x) Yes - () No [if LDL >= 100, reason not given: ____ ] (intensive statin therapy = simvastatin 80mg, simvastatin 80mg/ezetemibe 10mg, atorvastatin 40mg or 80 mg, rosuvastatin 20mg or 40mg, for LDL >= 100) 6. Smoking cessation counseling given? (x) Yes - () No [if no, reason: () non-smoker - () unable to participate] 7. Stroke education given (written form in the discharge worksheet)? (x) Yes - () No (stroke education = personal modifiable risk factors, how to activate EMS for stroke, stroke warning signs and symptoms, prescribed medications, need for followup) 8. Assessment for rehabilitation or rehab services considered? (x) Yes - () No [if no, reason not assessed: ____ ] 9. Discharged on statin therapy? (x) Yes - () No [if LDL >= 100 or on a statin prior to hospitalization, reason not discharged on statin: ____ ] 10. Discharged on antithrombotic therapy? (x) Yes [Type: (x) Antiplatelet - () Anticoagulation] - () No 11. Discharged on oral anticoagulation for patients with atrial fibrillation/flutter? () Yes - () No [if no, reason not discharge on anticoagulation: ____ ] - (x) N/A ",3193,876
10003299-DS-7,"<SEX> F <SERVICE> NEUROLOGY <ALLERGIES> Iodine-Iodine Containing <ATTENDING> ___. <CHIEF COMPLAINT> left leg weakness, falls <MAJOR SURGICAL OR INVASIVE PROCEDURE> None <HISTORY OF PRESENT ILLNESS> ___ is a ___ RH female with a PMHx of paramedian pontine infarct (___), right-sided lenticulostriate territory infarct (___), multiple strokes in the right posterior MCA/PCA watershed region (thought to be cardioembolic but no source identified, ___, followed by Dr. ___, on Plavix and ASA), hypertension, hyperlipidemia, prior MI, colon cancer s/p resection and chemotherapy in ___, extensive tobacco use, recent DM diagnosis, and recent diagnosis of B12 deficiency who presents with ___ weeks of frequent falls and 4 weeks of left leg weakness. The left leg weakness was gradual in onset and began about 4 weeks ago; it has remained relatively stable. She now needs help getting off a toilet or up off of chairs. The falls occur when she is pivoting while using her cane, and she has had 5 falls in the last week including once into her bathtub. Her legs feel like ""they get tangled up."" She has only landed on her bottom; no headstrikes or LOC. No prodrome prior to falls. She also has baseline LUE weakness that remains unchanged since her strokes in ___ she has trouble twisting caps and opening jars, but she does not have trouble reaching up. Denies missing Plavix doses. Missed ___ doses of atorvastatin since starting it. She has also had urinary and fecal incontinence (3 months per prior notes; since last stroke in ___ per patient); per prior notes, she loses control just after getting the urge to urinate or move her bowels; today, she says she sometimes does not get the urge to go. She sometimes does not have time to make it to the bathroom, but this is not the chief reason for incontinence. Reports 2 days of lower back pain (midline). Denies saddle anesthesia. She was seen by her PCP ___ she was noted to be dragging her left foot on the ground and she was noted to have left ankle dorsiflexion>plantarflexion, knee flexion/extension, and hip flexion/extension weakness with more brisk reflexes on that side. Per ED, she was noted to have ___ left hip flexion, 4+ hip extension, 4+ knee extension, upgoing toes on left, left arm."" Of note, she last saw Dr. ___ in ___ in clinic. At that time, she was noted to have SCM weakness, mild L pronation with upward drift, and ___ left deltoid strength. She had brisk reflexes at left biceps and patella, and her plantar response was mute bilaterally. She also had a broad-based gait with small steps that was safe. She was continued on Plavix 75mg daily, and a stronger statin was recommended, but the patient preferred to stay on rosuvastatin (Crestor). +: Left facial droop noticed during sleep by daughter one week which subsequently resolved (date of resolution unknown), per patient On neuro ROS, the pt denies headache, loss of vision, blurred vision, diplopia, dysarthria, dysphagia, lightheadedness, vertigo, tinnitus, and hearing difficulty. Denies difficulties producing or comprehending speech. Denies focal numbness and parasthesiae. On general review of systems, the pt denies recent fever or chills. No night sweats or recent weight loss or gain. Denies cough, shortness of breath. Denies chest pain or tightness, palpitations. Denies nausea, vomiting, diarrhea, constipation, or abdominal pain. No dysuria. Denies arthralgias or myalgias. Denies rash. <PAST MEDICAL HISTORY> - prior paramedian pontine infarct (___) - right-sided lenticulostriate territory infarct ___ - Hypertension as per prior medical records(patient denies) - Dyslipidemia - Colon cancer 2/p right colectomy in ___ with prolonged stuttering course of adjuvant chemotherapy (diagnosed in setting of GI bleeding) - Cholecystectomy for chronic cholecystitis and gallstones in ___ - Diverticulosis - Hemorrhoids <SOCIAL HISTORY> ___ <FAMILY HISTORY> Mother had stroke in her ___ or ___. Her paternal grandfather, father, and brother all had colon cancer. Sister had ovarian cancer and has prostate cancer in her family. <PHYSICAL EXAM> Admission Exam: Vitals: T: 97.4 P: 65 R: 16 BP: 153/70 SaO2: 97%RA General: Awake, cooperative, NAD. HEENT: NC/AT, no scleral icterus noted, MMM, no lesions noted in oropharynx Neck: Supple, no carotid bruits appreciated. No nuchal rigidity Pulmonary: Lungs CTA bilaterally without R/R/W Cardiac: RRR, nl. S1S2, no M/R/G noted Abdomen: soft, NT/ND, normoactive bowel sounds, no masses or organomegaly noted. Extremities: No C/C/E bilaterally, 2+ radial, DP pulses bilaterally. Skin: no rashes or lesions noted. Neurologic: NIHSS as above. -Mental Status: Alert, oriented x 3. Able to relate history without difficulty. Attentive, able to name ___ backward without difficulty. Language is fluent with intact repetition and comprehension. Normal prosody. There were no paraphasic errors. Pt was able to name both high and low frequency objects. Able to read without difficulty. Speech was not dysarthric. Able to follow both midline and appendicular commands. Pt was able to register 3 objects and recall ___ at 5 minutes ___ with prompting). There was no evidence of apraxia or neglect. No cortical sensory loss. -Cranial Nerves: II, III, IV, VI: PERRL 3 to 2mm and brisk. EOMI without nystagmus. Normal saccades. VFF to confrontation. Visual acuity ___ bilaterally. Fundoscopic exam revealed no papilledema, exudates, or hemorrhages. V: Facial sensation intact to light touch. VII: Mild L NLFF. VIII: Hearing intact to finger-rub bilaterally. IX, X: Palate elevates symmetrically. XI: ___ strength in trapezii and SCM bilaterally. XII: Tongue protrudes in midline. -Motor: Normal bulk and tone. Subtle LUE pronation without drift. RUE orbiting around left. No adventitious movements, such as tremor, noted. No asterixis noted. [___] [C5] [C5] [C7] [C6] [C7] [T1][L2] [L3] [L5] [L4] [S1][L5] L 5- 5 5 5 5 5 4+ 5 5 5- 5 5 R 5 5 5 5 5 5 5 5 5 5 5 5 -Sensory: No deficits to light touch, pinprick, cold sensation, vibratory sense. ___ errors to proprioception in LLE. No extinction to DSS. No spinal sensory level. -DTRs: brisk diffusely L>R. Left toe upgoing, right downgoing. -Coordination: Missed target mildly with RUE on FNF. RAM slow bilaterally. FNF ok. HKS ok. -Gait: Dragging left leg when ambulating with some circumduction. ****************** Discharge exam: Vitals: T: 97.4 P: 65 R: 16 BP: 164/70 SaO2: 97%RA General: Awake, cooperative, NAD. HEENT: NC/AT, no scleral icterus noted, MMM, no lesions noted in oropharynx Neck: Supple, no carotid bruits appreciated. No nuchal rigidity Pulmonary: Lungs CTA bilaterally without R/R/W Cardiac: RRR, nl. S1S2, no M/R/G noted Abdomen: soft, NT/ND, normoactive bowel sounds, no masses or organomegaly noted. Extremities: No C/C/E bilaterally, 2+ radial, DP pulses bilaterally. Skin: no rashes or lesions noted. Neurologic: NIHSS as above. -Mental Status: Alert, oriented x 3. Able to relate history without difficulty. Attentive, able to name ___ backward without difficulty. Language is fluent with intact repetition and comprehension. Normal prosody. There were no paraphasic errors. Pt was able to name both high and low frequency objects. Able to read without difficulty. Speech was not dysarthric. Able to follow both midline and appendicular commands. There was no evidence of apraxia or neglect. -Cranial Nerves: II, III, IV, VI: PERRL 3 to 2mm and brisk. EOMI without nystagmus. Normal saccades. VFF to confrontation. Visual acuity ___ bilaterally. V: Facial sensation intact to light touch. VII: symmetric VIII: Hearing intact to finger-rub bilaterally. IX, X: Palate elevates symmetrically. XI: ___ strength in trapezii and SCM bilaterally. XII: Tongue protrudes in midline. -Motor: Normal bulk and tone. Subtle LUE pronation without drift. RUE orbiting around left. No adventitious movements, such as tremor, noted. No asterixis noted. [___] [C5] [C5] [C7] [C6] [C7] [T1][L2] [L3] [L5] [L4] [S1][L5] L 5- 5 5 5 4 5 5 5 5 ___ R 5 5 5 5 5 5 5 5 5 5 5 5 -Sensory: No deficits to light touch, pinprick, cold sensation, vibratory sense. Intact proprioception b/l. No extinction to DSS. No spinal sensory level. -DTRs: brisk diffusely L>R. Left toe upgoing, right downgoing. -Coordination: Missed target mildly with RUE on FNF. RAM slow bilaterally. FNF ok. HKS ok. -Gait: Dragging left leg but stable with cane <PERTINENT RESULTS> ___ 01: 10PM GLUCOSE-125* UREA N-9 CREAT-0.9 SODIUM-144 POTASSIUM-4.2 CHLORIDE-105 TOTAL CO2-26 ANION GAP-17 ___ 01: 10PM estGFR-Using this ___ 01: 10PM ALT(SGPT)-18 AST(SGOT)-30 ALK PHOS-97 TOT BILI-0.5 ___ 01: 10PM ALBUMIN-3.7 CALCIUM-11.2* PHOSPHATE-3.4 MAGNESIUM-2.3 ___ 01: 10PM ASA-NEG ACETMNPHN-NEG bnzodzpn-NEG barbitrt-NEG tricyclic-NEG ___ 01: 10PM WBC-9.4 RBC-4.87 HGB-13.4 HCT-41.0 MCV-84 MCH-27.5 MCHC-32.7 RDW-14.4 RDWSD-44.0 ___ 01: 10PM NEUTS-64.6 ___ MONOS-5.8 EOS-0.5* BASOS-0.2 IM ___ AbsNeut-6.06 AbsLymp-2.68 AbsMono-0.54 AbsEos-0.05 AbsBaso-0.02 ___ 01: 10PM PLT COUNT-276 CT head IMPRESSION: 1. Small right caudate hypodensity/lacunar infarct is new from ___, but otherwise appears chronic to possibly subacute, lacunar infarct. Correlate with clinical symptoms. MRI is more sensitive in detecting acute ischemia. 2. Sequelae of prior right frontal lobe infarct and left pontine infarct. 3. Nonspecific bilateral white matter changes are similar the prior exam and consistent with sequelae of chronic small vessel ischemic disease. 4. No acute intracranial hemorrhage. 5. Cortical atrophy. CXR IMPRESSION: No focal consolidation to suggest pneumonia. Possible minimal pulmonary vascular congestion. Stable mild cardiomegaly. MRI/MRA brain and neck IMPRESSION: 1. Substantially motion limited exam. 2. Punctate, likely subacute infarcts of the right frontal periventricular white matter, posterior limb of the right internal capsule or right thalamus , and right periatrial white matter. 3. Chronic right frontal cortical infarct is again seen. Extensive supratentorial white matter signal abnormalities, similar to prior, nonspecific but likely sequela of chronic small vessel ischemic disease in this age group. 4. Nondominant left vertebral artery is diminutive and not adequately assessed on this motion limited exam. 0 5. Atherosclerosis of the proximal right internal carotid artery is again seen but could be exaggerated by artifact. Apparent irregularity of the left proximal internal carotid artery, of the V2 and V3 segments of the right vertebral artery, of the left greater than right carotid siphons, and of the distal M1 and M2 segments of the left middle cerebral artery probably represents a combination of atherosclerosis and artifacts. <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Aspirin 81 mg PO DAILY 2. Oxybutynin 5 mg PO DAILY 3. MetFORMIN (Glucophage) 500 mg PO DAILY 4. Vitamin D 1000 UNIT PO DAILY 5. Clopidogrel 75 mg PO DAILY 6. Atorvastatin 80 mg PO QPM <DISCHARGE MEDICATIONS> 1. Aspirin 81 mg PO DAILY 2. Atorvastatin 80 mg PO QPM 3. Clopidogrel 75 mg PO DAILY 4. MetFORMIN (Glucophage) 500 mg PO DAILY 5. Oxybutynin 5 mg PO DAILY 6. Vitamin D 1000 UNIT PO DAILY <DISCHARGE DISPOSITION> Home With Service Facility: ___ <DISCHARGE DIAGNOSIS> Ischemic stroke <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear ___ were hospitalized due to symptoms of left leg weakness and falls resulting from an ACUTE ISCHEMIC STROKE, a condition where a blood vessel providing oxygen and nutrients to the brain is blocked by a clot. The brain is the part of your body that controls and directs all the other parts of your body, so damage to the brain from being deprived of its blood supply can result in a variety of symptoms. Stroke can have many different causes, so we assessed ___ for medical conditions that might raise your risk of having stroke. In order to prevent future strokes, we plan to modify those risk factors. Your risk factors are: HTN atherosclerotic disease No changes to your medications were made since ___ are already on the appropriate secondary stroke prevention. Please take your other medications as prescribed. Please follow up with Neurology and your primary care physician as listed below. If ___ experience any of the symptoms below, please seek emergency medical attention by calling Emergency Medical Services (dialing 911). In particular, since stroke can recur, please pay attention to the sudden onset and persistence of these symptoms: - Sudden partial or complete loss of vision - Sudden loss of the ability to speak words from your mouth - Sudden loss of the ability to understand others speaking to ___ - Sudden weakness of one side of the body - Sudden drooping of one side of the face - Sudden loss of sensation of one side of the body Sincerely, Your ___ Neurology Team ","___ RH female with a PMHx of paramedian pontine infarct (___), right-sided lenticulostriate territory infarct (___), multiple strokes in the right posterior MCA/PCA watershed region (thought to be cardioembolic but no source identified, ___ Plavix and ASA, HTN, HLD, prior MI, colon cancer s/p resection and chemotherapy in ___, extensive tobacco use, recent DM diagnosis, and recent diagnosis of B12 deficiency presents with 4 week hx of progressively worsening left leg weakness and falls. On exam she had no signs of neuropathy, intact sensation to light touch, temperature and Pin Prick as well as intact proprioception. CT Head with right caudate hypodensity of indeterminate age, but appears subacute/chronic. MRI/MRA brain and neck with punctate, likely subacute infarcts of the right frontal periventricular white matter, posterior limb of the right internal capsule or right thalamus and right periatrial white matter. Etiology most likely secondary to known intracranial athero seen on imaging vs. small vessel disease. Patient already on appropriate secondary stroke prophylaxis and thus no changes to her medications were made. She was evaluated by physical therapy who recommended home ___. Stroke risk factors: LDL 48, A1C6.6 AHA/ASA Core Measures for Ischemic Stroke and Transient Ischemic Attack 1. Dysphagia screening before any PO intake? (x) Yes, confirmed done - () Not confirmed () No 2. DVT Prophylaxis administered? (x) Yes - () No 3. Antithrombotic therapy administered by end of hospital day 2? (x) Yes - () No 4. LDL documented? (x) Yes (LDL =48 ) - () No 5. Intensive statin therapy administered? (simvastatin 80mg, simvastatin 80mg/ezetemibe 10mg, atorvastatin 40mg or 80 mg, rosuvastatin 20mg or 40mg, for LDL > 100) (x) Yes - () No [if LDL >100, reason not given: ] 6. Smoking cessation counseling given? (x) Yes - () No [reason () non-smoker - () unable to participate] 7. Stroke education (personal modifiable risk factors, how to activate EMS for stroke, stroke warning signs and symptoms, prescribed medications, need for followup) given (verbally or written)? (x) Yes - () No 8. Assessment for rehabilitation or rehab services considered? (x) Yes - () No 9. Discharged on statin therapy? (x) Yes - () No [if LDL >100, reason not given: ] 10. Discharged on antithrombotic therapy? (x) Yes [Type: (x) Antiplatelet - () Anticoagulation] - () No 11. Discharged on oral anticoagulation for patients with atrial fibrillation/flutter? () Yes - () No - (x) N/A ",3605,659
10003299-DS-8,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> Iodine-Iodine Containing <ATTENDING> ___. <CHIEF COMPLAINT> hematemesis <MAJOR SURGICAL OR INVASIVE PROCEDURE> None. <HISTORY OF PRESENT ILLNESS> Ms. ___ is a ___ female with medical history notable for DM2, HTN, HLD, multiple strokes on Plavix and aspirin, inferior MI, tobacco use, primary hyperparathyroidism, and colon cancer s/p colectomy and chemotherapy who presented with hemoptysis. Patient was initially seen for hemoptysis at ___ on ___ HPI reported ""She first noticed coughing and hemoptysis approximately ___ weeks ago, and noticed very small blood clots at that time. She saw her PCP in clinic on ___ for this, and CT with contrast was ordered, but has not yet been scheduled (note, she has allergy to contrast). Over the past 3 days, she has noticed worsening of her cough, sputum production, and hemoptysis, with large clots on the order of teaspoons. No fevers or chills, shortness of breath, chest pain, or lightheadedness. Has some weight loss. No night sweats, homelessness, or prison exposure. No recent travel, surgery, immobility, ___ swelling/pain. Notes some LUQ abdominal pain that began last night, that is worsened by cough. It is not associated with food, and she has no n/v/d/constipation, and has regular BMs with no hematochezia or melena."" A CT chest was obtained which was notable for infrahilar mass with complete occlusion of the right middle lobe. She was not able to connect with her PCP to discuss the results. In the ED, initial VS: Pain 0 Temp 97.7 HR 78 BP 170/88 RR 16 POx 97% RA Exam: O: lung mild wheeze in the RLL. Work-up: Leukocytosis to 16, Elevated Ca ___ She received: PO Oxybutynin 5 mg PO Azithromycin 500 mg IV CefTRIAXone (1 g ordered) Consults: IP: Decision was made to admit for expedited oncology work-up. On arrival to the floor, the patient the endorsed the history per above. In addition, she clarified that she has lost 3 pounds in the past month. She denies any decrease PO intake or abdominal pain. She denies SOB. She says she feels a lot better after receiving medications in the ED. <PAST MEDICAL HISTORY> - prior paramedian pontine infarct (___) - right-sided lenticulostriate territory infarct ___ - Hypertension as per prior medical records(patient denies) - Dyslipidemia - Colon cancer 2/p right colectomy in ___ with prolonged stuttering course of adjuvant chemotherapy (diagnosed in setting of GI bleeding) - Cholecystectomy for chronic cholecystitis and gallstones in ___ - Diverticulosis - Hemorrhoids <SOCIAL HISTORY> ___ <FAMILY HISTORY> Mother had stroke in her ___ or ___. Her paternal grandfather, father, and brother all had colon cancer. Sister had ovarian cancer and has prostate cancer in her family. <PHYSICAL EXAM> Admission: General: Older woman who appears stated ago, NAD, lying flat on bed HEENT: EOMI, PERRLA, MMM Neck: No JVD, no JVP elevation, neck supple, no cervical lymphadenopathy Lungs: Decreased breath sounds on R side, L side CTAB @ bases, b/l ronchi in b/l upper lobes CV: RRR, distant heart sounds, bradycardic, no murmurs/rubs/or gallops Lymph: 0.5 cm x 2 R enlarged supraclaviular node, 0.5 cm x1 L enlarged supraclavicular node GI: Soft, nondistended, nonrigid, nontender to palpation Ext: No lower extremity swelling, distal pulses b/l intact in UE and ___ ___: CNII-XII intact, L eyebrow lower than R eyebrow, no lower facial droop, ___ strength R grip strength, RUE flexion and extension @ elbow, RLE ___ strength on plantar flexion and dorsiflexion, RUE +antigravity, L grip strength ___, LUE ___ flexion and extension @ elbow joint, LLE +antigravity, LLE plantar and dorsiflexion ___, A&O grossly Discharge: No significant changes <PERTINENT RESULTS> Admission: ___ 06: 57AM PTH-106* ___ 06: 57AM WBC-13.3* RBC-4.63 HGB-12.1 HCT-36.7 MCV-79* MCH-26.1 MCHC-33.0 RDW-14.5 RDWSD-41.5 ___ 06: 57AM PLT COUNT-275 ___ 12: 05AM ___ PTT-30.5 ___ ___ 10: 18PM GLUCOSE-110* UREA N-12 CREAT-1.1 SODIUM-146 POTASSIUM-4.4 CHLORIDE-104 TOTAL CO2-28 ANION GAP-14 ___ 10: 18PM estGFR-Using this ___ 10: 18PM ALT(SGPT)-7 AST(SGOT)-15 LD(LDH)-362* ALK PHOS-107* TOT BILI-<0.2 ___ 10: 18PM ALBUMIN-3.4* CALCIUM-10.5* PHOSPHATE-3.0 MAGNESIUM-2.3 URIC ACID-6.7* ___ 10: 18PM WBC-16.9* RBC-4.99 HGB-13.3 HCT-39.5 MCV-79* MCH-26.7 MCHC-33.7 RDW-14.7 RDWSD-41.8 ___ 10: 18PM NEUTS-75.3* LYMPHS-18.1* MONOS-5.8 EOS-0.2* BASOS-0.2 IM ___ AbsNeut-12.72* AbsLymp-3.05 AbsMono-0.98* AbsEos-0.04 AbsBaso-0.03 ___ 10: 18PM PLT COUNT-348 Imaging: CT Chest ___: IMPRESSION: Right infrahilar mass with complete occlusion of the right middle lobe bronchus with complete atelectasis of the right middle lob, concerning for bronchogenic carcinoma mediastinal bilateral hilar adenopathy. Diffuse enlargement the thyroid with multiple hypodense areas within it which most likely represent goiter. <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Aspirin 325 mg PO DAILY 2. Atorvastatin 80 mg PO QPM 3. Clopidogrel 75 mg PO DAILY 4. Oxybutynin 5 mg PO DAILY 5. Vitamin D ___ UNIT PO DAILY <DISCHARGE MEDICATIONS> 1. Aspirin 325 mg PO DAILY 2. Atorvastatin 80 mg PO QPM 3. Oxybutynin 5 mg PO DAILY 4. Vitamin D ___ UNIT PO DAILY 5. HELD- Clopidogrel 75 mg PO DAILY This medication was held. Do not restart Clopidogrel until you have spoken with your doctors and it is safe to resume. Certainly, not before ___ <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Primary: Hemoptysis Secondary: Hypercalcemia <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear ___ was a pleasure taking part in your ___ here at ___! Why was I admitted to the hospital? You were admitted because you were on blood thinners and were coughing up blood. What was done for me while I was in the hospital? - We were concerned about the blood that you were coughing up, so we did a number of tests. We also stopped your Plavix, a medicine that can make you bleed easier - and that helped to reduce the amount of blood that you were coughing up. - The lung doctors spoke with ___ about the results of your recent lung CT, and explained that they will need to get a sample of tissue in order to find out what is in your lungs. - You also got a head MRI to look for any changes in your brain. Since you were stable and did not need to be in the hospital for any other tests, it was decided that you could go home safely. What should I do when I leave the hospital? -You have a bronchoscopy schedule for ___. Please DO NOT eat after 11: 59PM on ___ and do not eat breakfast or lunch. You can take your morning medicines with water. -Your appointments are as below -Please DO NOT TAKE Plavix (clopidogrel) UNTIL after your procedure with the pulmonary doctors -___ call Health ___ Associates to make a follow-up appointment with your primary ___ doctor about this hospitalization (number below) Sincerely, Your ___ ___ Team ","Mrs. ___ is a ___ female with a medical history notable for DM2, HTN, HLD, multiple strokes, inferior MI, tobacco use, and colon cancer, who presented with 3 weeks of increasing hemoptysis i/s/o a R hilar lung mass found on CT. #Hemoptysis, R hilar mass Her hemoptysis and R hilar mass is concerning for bronchogenic carcinoma given her history of smoking, colon cancer, and weight loss. She was stable without hypoxia or respiratory distress. Her home Plavix and aspirin were held, and her hemoptysis improved. IP consulted and planned for biopsy electrocautery/cryo +/- stent placement on ___, ___. She had a brain MRI on the evening of discharge that showed nothing acute, though follow-up on final read will be needed. She will also need a PET-CT for complete staging. She has been told to hold home Plavix until further notice (last dose ___ but continue her home aspirin. #Hypercalcemia She has a history of primary hyperparathyroidism, but an elevated calcium level can also be seen as paraneoplastic syndrome. Her Ca was 10.5 on admission, in the same range as has been historically. She received her home Vitamin D, but no specific treatment was started. # CVA We held her home Plavix and aspirin per above. # T2DM She was on SSI, but did not require any. # HLD We continued her home statin. # Tobacco use She was given a Nicotine patch. TRANSITIONAL ISSUES: ==================== [] MRI wet read negative for acute pathology, will need to be followed up for final read [] PET/CT scan to complete staging [] ___, ___ flex and rigid bronchoscopy + EBUS TBNA and possible stenting [] Discuss restarting Plavix post-procedurally [] Smoking cessation discussion ------------- CODE: Full (confirmed) CONTACT: ___ (Daughter) ___ ",2049,406
10003299-DS-9,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> Iodine-Iodine Containing <ATTENDING> ___. <CHIEF COMPLAINT> difficulty with swallowing painful swallowing diarrhea <MAJOR SURGICAL OR INVASIVE PROCEDURE> None <HISTORY OF PRESENT ILLNESS> Ms. ___ is a ___ female with history of stage IIIA squamous cell carcinoma of lung undergoing chemoradiation completed at end of ___, multiple strokes, hypertension, hyperlipidemia, DMII, and prior colon cancer s/p hemicolectomy who presents with throat pain and difficulty swallowing. She was recently seen in the ED on ___ after a fall with head strike. Imaging was negative and she was discharged home. K was noted to be 3.2 so she was called back to the ED. Her K was repleted and she was discharged home. Since then she has had significant odynophagia with difficulty swallowing leading to poor appetite, weakness, poor PO intake, and continued weight loss. She has also been having diarrhea that is occasionally bloody. She also notes persistent dry cough. She called her Oncologist who recommended she present to the ED for further evaluation. On arrival to the ED, initial vitals were 96.8 84 ___ 18 100% RA. Exam was notable for fatigued-appearing woman. Labs were notable for WBC 2.9, H/H 10.5/31.9, Plt 178, Na 145, K 3.0, BUN/Cr ___, and lactate 1.1. Blood cultures were done. No imaging obtained. Patient was given 40mEq IV potassium. Prior to transfer vitals were 98.1 72 134/69 20 100% RA. On arrival to the floor, patient endorses the above history. She has no acute issues or concerns. She denies fevers/chills, night sweats, headache, vision changes, dizziness/lightheadedness, weakness/numbnesss, shortness of breath, hemoptysis, chest pain, palpitations, abdominal pain, nausea/vomiting, hematemesis, dysuria, hematuria, and new rashes. REVIEW OF SYSTEMS: A complete 10-point review of systems was performed and was negative unless otherwise noted in the HPI. PAST ONCOLOGIC HISTORY: Briefly, patient initially presented to care in ___ with hemoptysis. She was subsequently admitted for workup of same and had a CT of the chest which showed a right infrahilar mass with complete occlusion of the right middle lobe bronchus and atelectasis of the right middle lobe with high suspicion for lung cancer; there was evidence of bilateral intrathoracic adenopathy. During her hospital admission, she was seen by the interventional pulmonary team and scheduled for outpatient bronchoscopy. She underwent bronchoscopy with EBUS under Dr. ___ care on ___. FNA of the right middle lobe mass showed findings consistent with squamous cell carcinoma; there was biopsy-proven involvement of the level 4L lymph node; sampling of the 11 L lymph node showed no malignant cells. Patient underwent staging PET scan on ___. This showed an FDG avid 3.2 cm mass in the right infrahilar region with evidence of occlusion of the right middle lobe bronchus and atelectasis of the right middle lobe. FDG avid subcarinal adenopathy measuring up to 1.3 cm was noted; additionally enlarged mediastinal and and hilar lymph nodes are also noted. A 2.2 cm left lower lobe subpleural FDG avid lesion was also noted. No other distant metastatic sites of disease were noted. ___: Weekly ___ and radiation started. <PAST MEDICAL HISTORY> - prior paramedian pontine infarct (___) - right-sided lenticulostriate territory infarct ___ - Hypertension as per prior medical records(patient denies) - Dyslipidemia - Colon cancer 2/p right colectomy in ___ with prolonged stuttering course of adjuvant chemotherapy (diagnosed in setting of GI bleeding) - Cholecystectomy for chronic cholecystitis and gallstones in ___ - Diverticulosis - Hemorrhoids <SOCIAL HISTORY> ___ <FAMILY HISTORY> Mother had stroke in her ___ or ___. Her paternal grandfather, father, and brother all had colon cancer. Sister had ovarian cancer and has prostate cancer in her family. <PHYSICAL EXAM> ADMISSION PHYSICAL EXAM: -========== VS: Temp 98.3, BP 110/62, HR 66, RR 18, O2 sat 100% RA. GENERAL: Pleasant woman, in no distress, lying in bed comfortably. HEENT: Anicteric, PERLL, OP clear. CARDIAC: RRR, normal s1/s2, no m/r/g. LUNG: Appears in no respiratory distress, clear to auscultation bilaterally, no crackles, wheezes, or rhonchi. ABD: Soft, non-tender, non-distended, normal bowel sounds. EXT: Warm, well perfused, no lower extremity edema, erythema or tenderness. NEURO: A&Ox3, good attention and linear thought, CN II-XII intact. Strength full throughout. Sensation to light touch intact. SKIN: No significant rashes. ACCESS: Right chest wall port without erythema. DISCHARGE PHYSICAL EXAM: -========== VS: 24 HR Data (last updated ___ @ 2327) Temp: 98.3 (Tm 98.4), BP: 127/66 (115-131/53-69), HR: 66 (58-73), RR: 18 (___), O2 sat: 97% (97-99%), O2 delivery: Ra GENERAL: Pleasant woman, in no distress, lying in bed comfortably. HEENT: Anicteric, PERLLA, OP clear. CARDIAC: RRR, normal s1/s2, no m/r/g. LUNG: CTAB, no increased work of breathing ABD: Soft, non-tender, non-distended, normoactive BS EXT: Warm, well perfused, no lower extremity edema, erythema or tenderness. NEURO: A&Ox3, alert and interactive thought, CN II-XII intact. Strength full throughout. Sensation to light touch intact. SKIN: No significant rashes. <PERTINENT RESULTS> ADMISSION LABS: -= ___ 05: 30PM BLOOD WBC-2.9* RBC-4.03 Hgb-10.5* Hct-31.9* MCV-79* MCH-26.1 MCHC-32.9 RDW-25.4* RDWSD-70.9* Plt ___ ___ 05: 30PM BLOOD Neuts-54.0 ___ Monos-21.1* Eos-0.0* Baso-0.3 NRBC-1.0* Im ___ AbsNeut-1.56* AbsLymp-0.69* AbsMono-0.61 AbsEos-0.00* AbsBaso-0.01 ___ 05: 30PM BLOOD Glucose-99 UreaN-7 Creat-0.6 Na-145 K-3.0* Cl-107 HCO3-27 AnGap-11 ___ 05: 30PM BLOOD Calcium-9.7 Phos-2.8 Mg-1.8 DISCHARGE LABS: -= ___ 05: 33AM BLOOD WBC-6.0 RBC-3.75* Hgb-9.6* Hct-29.6* MCV-79* MCH-25.6* MCHC-32.4 RDW-25.7* RDWSD-71.3* Plt ___ ___ 05: 33AM BLOOD Glucose-81 UreaN-4* Creat-0.7 Na-141 K-4.0 Cl-105 HCO3-26 AnGap-10 ___ 05: 33AM BLOOD Calcium-9.3 Phos-2.2* Mg-1.9 MICROBIO: -= ___ urine culture: MIXED BACTERIAL FLORA ( >= 3 COLONY TYPES), CONSISTENT WITH SKIN AND/OR GENITAL CONTAMINATION. ___ blood culture: final, no growth C. difficile PCR (Final ___: NEGATIVE. (Reference Range-Negative). ___ 12: 20 pm STOOL CONSISTENCY: NOT APPLICABLE Source: Stool. FECAL CULTURE (Final ___: NO SALMONELLA OR SHIGELLA FOUND. CAMPYLOBACTER CULTURE (Final ___: NO CAMPYLOBACTER FOUND. OVA + PARASITES (Pending): FECAL CULTURE - R/O VIBRIO (Final ___: NO VIBRIO FOUND. FECAL CULTURE - R/O YERSINIA (Final ___: NO YERSINIA FOUND. FECAL CULTURE - R/O E.COLI 0157: H7 (Final ___: No E. coli O157: H7 found. Cryptosporidium/Giardia (DFA) (Final ___: NO CRYPTOSPORIDIUM OR GIARDIA SEEN. IMAGING AND STUDIES: -== None <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Lidocaine Viscous 2% 15 mL PO TID: PRN throat pain 2. Ondansetron 8 mg PO Q8H: PRN nausea/vomiting 3. Prochlorperazine 10 mg PO Q6H: PRN nausea/vomiting 4. Potassium Chloride 20 mEq PO DAILY 5. Nicotine Patch 7 mg/day TD DAILY <DISCHARGE MEDICATIONS> 1. Cyanocobalamin ___ mcg PO DAILY RX *cyanocobalamin (vitamin B-12) 2,500 mcg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills: *3 2. Lansoprazole Oral Disintegrating Tab 30 mg PO DAILY RX *lansoprazole 30 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills: *3 3. Maalox/Diphenhydramine/Lidocaine ___ mL PO QID: PRN throat pain 4. Multivitamins W/minerals 1 TAB PO DAILY RX *multivitamin,tx-minerals 1 tablet(s) by mouth daily Disp #*30 Tablet Refills: *3 5. Potassium Chloride (Powder) 20 mEq PO DAILY RX *potassium chloride 20 mEq 1 packet(s) by mouth daily Disp #*30 Packet Refills: *3 6. Lidocaine Viscous 2% 15 mL PO TID: PRN throat pain 7. Nicotine Patch 7 mg/day TD DAILY 8. Ondansetron 8 mg PO Q8H: PRN nausea/vomiting 9. Prochlorperazine 10 mg PO Q6H: PRN nausea/vomiting <DISCHARGE DISPOSITION> Home With Service Facility: ___ <DISCHARGE DIAGNOSIS> Primary diagnoses: Radiation Esophagitis stage IIIA squamous cell carcinoma of lung Severe Malnutrition Secondary diagnoses: B12 deficiency Chronic hypokalemia Diarrhea Tobacco abuse <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Ms. ___, It was a pleasure caring for you at ___ ___. WHY WAS I IN THE HOSPITAL? - You were having pain with swallowing and difficulty eating enough food. - You were having diarrhea. WHAT HAPPENED TO ME IN THE HOSPITAL? - You received medication that decreased throat discomfort. - You were seen by speech and swallow specialists who made recommendations for your diet. You received a soft liquid diet initially, which was advanced to regular solid foods as tolerated. - Studies were done on your stool to make sure that your diarrhea wasn't caused by an infection. WHAT SHOULD I DO AFTER I LEAVE THE HOSPITAL? - Continue to take all your medicines and keep your appointments. We wish you the best! Sincerely, Your ___ Team ","SUMMARY: ============= Ms. ___ is a ___ woman with stage IIIA squamous cell carcinoma of lung undergoing chemoradiation completed on ___, history of multiple strokes and prior colon cancer s/p hemicolectomy who presents with odynophagia x several weeks, attributed to radiation esophagitis. ACUTE ISSUES: ==================== # Odynophagia/Dysphagia #Radiation Esophagitis Managed with oral liquid lidocaine formulation, which improved patient's ability to tolerate PO. Speech and language pathology consutled, recommended soft ground diet and thin liquids, which was advanced to regular solids. Nutrition consulted as well. If symptoms fail to improve with liquid lidocaine and with a time course consistent with radiation esophagitis, will need further workup as outpatient, such as barium swallow or EGD. Patient was started on lansoprazole for any contribution of GERD, should continue to assess need for PPI as an outpatient. # Hypernatremia Patient with rising Na this admission, up to 149. Likely poor oral intake iso radiation esophagitis. Patient received 1L D5W with improvement of Na to 141 on day of discharge. She was encouraged to maintain liquids throughout the day. # Severe Malnutrition Patient with poor PO intake and weight loss. Nutrition was consulted, and per their recommendations she received Carnation supplements with soy milk with meals, as well as Ensure Clear with meals and multivitamins. PO intake was encouraged. SW was consulted due to concern about her having adequate resources at home (but she denies having issues with resources). ___ assessed her and recommended home, where she already has a walker. OOB with assistance was encouraged during the admission. # Vitamin B12 deficiency B12 was noted to be low this admission, so the patient received cyanocobalamin 1000 mcg IM on ___ and was started on PO cyanocobalamin daily. MMA was obtained, which was pending at time of discharge. CBC was obtained daily. # Stage IIIA Squamous Cell Lung Carcinoma Undergoing concurrent chemoradiation. Will follow up with Dr. ___ as outpatient. CHRONIC ISSUES: ================= # Hypokalemia, chronic Hypokalemia has been chronic. Etiology unclear as patient is not on diuretics. Other etiologies include kidney dysfunction such as rental tubular acidosis. Reportedly does not take potassium as often as necessary at home d/t difficulty swallowing pill. Urine electrolytes notable for >20 K which seems inappropriate in setting of hypokalemia. Potassium powder was trialed during the admission. # Diarrhea, stable Patient reports loose stool since radiation. On admission did report blood in stool that is streaky and superficial; patient denied tarry stools or frank blood. The most concerning etiology would be recurrence of colorectal carcinoma (s/p hemicolectomy), although more likely causes include diverticulosis flare or hemorrhoidal bleeding. Cdiff negative. Hb stable throughout this admission. # Tobacco Abuse: Managed inpatient with nicotine patch. TRANSITIONAL ISSUES: =========================== [] Ensure that patient is eating and drinking without difficulty [] Continue to assess for presence of blood in stools [] Should repeat CBC and BMP at next PCP visit to ensure stable Hb and Na/K [] Previously on potassium tablets, but discharged on potassium powder given odynophagia, will need to follow up with ability to tolerate this. [] Patient was started on lansoprazole for any contribution of GERD, should continue to assess need for PPI as an outpatient. [] Found to have B12 deficiency anemia during this admission, received cyanocobalamin 1000 mcg IM on ___ and was started on PO cyanocobalamin daily, which she should continue. [] Follow up on lab tests that were pending at time of discharge: campylobacter stool culture, stool ova + parasites, fecal culture r/o Yersinia, methylmalonic acid. [] Patient was scheduled for outpatient CT chest ___, unable to complete as an inpatient, will need to be rescheduled by her oncology team ========================== CODE: Full Code (confirmed) EMERGENCY CONTACT HCP: ___ (daughter) ___ ",2703,880
10003372-DS-2,"<SEX> F <SERVICE> UROLOGY <ALLERGIES> Celexa <ATTENDING> ___. <CHIEF COMPLAINT> Adrenal Mass <MAJOR SURGICAL OR INVASIVE PROCEDURE> 1. Laparoscopic right adrenalectomy with removal of large adrenal mass (12cm). 2. Percutaneous liver biopsy. <HISTORY OF PRESENT ILLNESS> ___ yo F with right 10 cm nonfunctional adrenal mass. <PAST MEDICAL HISTORY> Past medical history of hypertension, denies history of MI or stroke. 3 vaginal deliveries, appendectomy <SOCIAL HISTORY> ___ <FAMILY HISTORY> Family history is negative for adrenal issues <PHYSICAL EXAM> WdWn, NAD, AVSS Interactive, cooperative Abdomen soft, appropriately tender along incisions Incisions otherwise c/d/i Extremities w/out edema or pitting and there is no reported calf pain to deep palpation <PERTINENT RESULTS> ___ 12: 50PM BLOOD WBC-6.4 RBC-2.72*# Hgb-7.6*# Hct-23.8*# MCV-88 MCH-27.9 MCHC-31.9* RDW-15.8* RDWSD-50.2* Plt ___ ___ 12: 50PM BLOOD Glucose-91 UreaN-7 Creat-0.6 Na-137 K-4.1 Cl-103 HCO3-23 AnGap-11 ___ 12: 50PM BLOOD Calcium-7.7* Mg-1.7 <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. lisinopril-hydrochlorothiazide ___ mg oral DAILY 2. Omeprazole 20 mg PO DAILY 3. raloxifene 60 mg oral DAILY 4. Simvastatin 20 mg PO QPM 5. Citracal + D3 (calcium phos) (calcium phosphate-vitamin D3) 250 mg calcium- 500 unit oral DAILY 6. Vitamin D 1000 UNIT PO DAILY 7. Centrum Silver Women (multivit-min-iron-FA-lutein) 8 mg iron-400 mcg-300 mcg oral DAILY <DISCHARGE MEDICATIONS> 1. Acetaminophen 650 mg PO Q6H: PRN Pain - Mild 2. Ibuprofen 600 mg PO Q8H: PRN Pain - Mild RX *ibuprofen 600 mg ONE tablet(s) by mouth Q8hrs Disp #*25 Tablet Refills: *0 3. OxyCODONE (Immediate Release) 2.5-5 mg PO Q4H: PRN Pain - Moderate RX *oxycodone 5 mg HALF to ONE FULL tablet by mouth Q4hrs Disp #*30 Tablet Refills: *0 4. Senna 8.6 mg PO BID Duration: 4 Doses RX *sennosides [Senokot] 8.6 mg ONE tab by mouth ___ x daily Disp #*30 Tablet Refills: *0 5. Centrum Silver Women (multivit-min-iron-FA-lutein) 8 mg iron-400 mcg-300 mcg oral DAILY 6. Citracal + D3 (calcium phos) (calcium phosphate-vitamin D3) 250 mg calcium- 500 unit oral DAILY 7. lisinopril-hydrochlorothiazide ___ mg oral DAILY 8. Omeprazole 20 mg PO DAILY 9. raloxifene 60 mg oral DAILY 10. Simvastatin 20 mg PO QPM 11. Vitamin D 1000 UNIT PO DAILY <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> PREOPERATIVE DIAGNOSIS: Right adrenal mass. POSTOPERATIVE DIAGNOSIS: Right adrenal mass with possible liver fibrosis. <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> -Please also refer to the provided handout that details instructions and expectations for your post-operative phase as made available by your urologist. -Resume your pre-admission/home medications except as noted. ALWAYS call to inform, review and discuss any medication changes and your post-operative course with your primary care doctor. -___ reduce the strain/pressure on your abdomen and incision sites; remember to log roll onto your side and then use your hands to push yourself upright while taking advantage of the momentum of putting your legs/feet to the ground. --There may be bandage strips called steristrips which have been applied to reinforce wound closure. Allow these bandage strips to fall off on their own over time but PLEASE REMOVE ANY REMAINING GAUZE DRESSINGS WITHIN 2 DAYS OF DISCHARGE. You may get the steristrips wet. -UNLESS OTHERWISE NOTED; AVOID aspirin or aspirin containing products and supplements that may have blood-thinning effects (like Fish Oil, Vitamin E, etc.). This will be noted in your medication reconciliation. IF PRESCRIBED (see the MEDICATION RECONCILIATION): -IBUPROFEN (the ingredient of Advil, Motrin, etc.) may be taken even though you may also be taking Tylenol/Acetaminophen. You may alternate these medications for pain control. For pain control, try TYLENOL (acetaminophen) FIRST, then ibuprofen, and then take the narcotic pain medication as prescribed if additional pain relief is needed. -Ibuprofen should always be taken with food. Please discontinue taking and notify your doctor should you develop blood in your stool (dark, tarry stools) -Call your Urologist's office to schedule/confirm your follow-up appointment in 4 weeks AND if you have any questions. -Do not eat constipating foods for ___ weeks, drink plenty of fluids to keep hydrated -No vigorous physical activity or sports for 4 weeks or until otherwise advised. Light household chores/activity and leisurely walking/activity is OK and should be continued. Do NOT be a couch potato -Tylenol should be your first-line pain medication. A narcotic pain medication has been prescribed for breakthrough pain ___. -Max daily Tylenol (acetaminophen) dose is THREE to FOUR grams from ALL sources -AVOID lifting/pushing/pulling items heavier than 10 pounds (or 3 kilos; about a gallon of milk) or participate in high intensity physical activity (which includes intercourse) until you are cleared by your Urologist in follow-up. -No DRIVING for THREE WEEKS or until you are cleared by your Urologist -You may shower normally but do NOT immerse your incisions or bathe -Do not drive or drink alcohol while taking narcotics and do not operate dangerous machinery -You may be given prescriptions for a stool softener and/or a gentle laxative. These are over-the-counter medications that may be health care spending account reimbursable. -Colace (docusate sodium) may have been prescribed to avoid post-surgical constipation or constipation related to use of narcotic pain medications. Discontinue if loose stool or diarrhea develops. Colace is a stool-softener, NOT a laxative. -Senokot (or any gentle laxative) may have been prescribed to further minimize your risk of constipation. -If you have fevers > 101.5 F, vomiting, or increased redness, swelling, or discharge from your incision, call your doctor or go to the nearest emergency room. ","Ms. ___ was admitted to Urology with right adrenal mass and underwent laparoscopic right adrenalectomy with percutaneous liver biopsy. No concerning intraoperative events occurred; please see dictated operative note for details. The patient received perioperative antibiotic prophylaxis. The patient was transferred to the floor from the PACU in stable condition. On POD0, pain was well controlled on PCA, hydrated for urine output >30cc/hour, provided with pneumoboots and incentive spirometry for prophylaxis, and ambulated once. On POD1, the patient was restarted on home medications, basic metabolic panel and complete blood count were checked, pain control was transitioned from PCA to oral analgesics, diet was advanced to a clears/toast and crackers diet. Urethral Foley catheter was removed without difficulty and on POD2, diet was advanced as tolerated. The remainder of the hospital course was relatively unremarkable. The patient was discharged in stable condition, eating well, ambulating independently, voiding without difficulty, and with pain control on oral analgesics. On exam, incision was clean, dry, and intact, with no evidence of hematoma collection or infection. The patient was given explicit instructions to follow-up in clinic in four weeks. ",1700,262
10003385-DS-7,"<SEX> M <SERVICE> MEDICINE <ALLERGIES> ___ / ___ <ATTENDING> ___ <CHIEF COMPLAINT> perianal pain <MAJOR SURGICAL OR INVASIVE PROCEDURE> None <HISTORY OF PRESENT ILLNESS> Patient is a ___ man with history of hypertension who presents with perianal pain and purulent discharge. Patient states that he has had longstanding problems with ""hemorrhoids"". He reports that for the past ___ years, he has had intermittent sensation of ""swelling"" and ""rectal pain"" with defecation. This lasted for a few weeks followed by drainage of pus from the rectal areas, followed by some asymptomatic months. However for the past month, he has felt significant pain and irritation, worse with sitting. He also see bloody drainage occasionally from the anal area. In the past, he was seen at ___ ED in ___ for possibly possibly thrombosed painful internal hemmorhoid. He reports he has tried Anusol HC suppository without relief. He works using computers and therefore is quite sedentary at work. He was recently seen by his PCP ___ ___ due to worsening pain and purulent discharge. His doctor prescribed him augmentin and mupriocin, as well as derm referral. HIV and RPR negative at that time. The patient states that the symptoms have not improved. He denies any history of receptive anal intercourse, Crohn's disease, ulcerative colitis, fevers, chills, abdominal pain, dysuria, hematuria, diarrhea. Patient denies any similar pustules in his inguinal region or armpits. No family history of Crohn's disease. Patient reports exquisite pain with defecation. In the ED, initial VS were: 99.9 96 148/102 16 100% RA ED physical exam was recorded as multiple pustules along the left buttock crease ED labs were notable for WBC 13.7 CT pelvis showed soft tissue thickening in the perianal region and extending along the left buttock, without fluid collection. Patient was given 1g Tylenol and vancomycin 1gm Transfer VS were 98.0 67 141/91 18 100% RA REVIEW OF SYSTEMS: A ten point ROS was conducted and was negative except as above in the HPI. <PAST MEDICAL HISTORY> HYPERTENSION SICKLE CELL TRAIT ASTHMA HEMORRHOIDS OBESITY KELOID H/O TOBACCO ABUSE H/O ACL TEAR H/O BACK PAIN <SOCIAL HISTORY> ___ <FAMILY HISTORY> -Mother: ___ -Grandmother: Lung Cancer (still alive) <PHYSICAL EXAM> ADMISSION & DISCHARGE EXAM: Gen: NAD, lying in bed Eyes: EOMI, sclerae anicteric ENT: MMM, OP clear Cardiovasc: RRR, no MRG, full pulses, no edema Resp: normal effort, no accessory muscle use, lungs CTA ___. GI: soft, NT, ND, BS+ MSK: No significant kyphosis. No palpable synovitis. Skin: Multiple nodular/pustular lesions on the left ___ region extending to the gluteal folds. Some of these are erythematous and draining pus. On the right perianal region at 6 o clock, there is also an area of condylomatous lesions, with no pus. No anal fissures observed. No external hemorrhoid observed. There are keloid lesions in the pubic area Neuro: AAOx3. No facial droop. <PERTINENT RESULTS> ___ 12: 10AM URINE HOURS-RANDOM ___ 12: 10AM URINE UHOLD-HOLD ___ 12: 10AM URINE COLOR-Straw APPEAR-Clear SP ___ ___ 12: 10AM URINE BLOOD-NEG NITRITE-NEG PROTEIN-TR GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-6.5 LEUK-NEG ___ 12: 10AM URINE RBC-0 WBC-0 BACTERIA-NONE YEAST-NONE EPI-0 ___ 12: 10AM URINE MUCOUS-RARE ___ 11: 24PM estGFR-Using this CT Soft tissue thickening in the perianal region and extending along the left buttock, without fluid collection. <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Lisinopril 40 mg PO DAILY <DISCHARGE MEDICATIONS> 1. Lisinopril 40 mg PO DAILY <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> ___ lesions, chronic HTN <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Mr. ___, You were admitted for ongoing pain due to the lesions in the ___ area. You have an appointment with Dermatology tomorrow AM - it is very important you keep this appointment so these lesions can be evaluated. Please complete the antibiotics Dr. ___ for you last week. No other changes were made to your medications. We wish you the best, ___ Team ","Mr. ___ is a ___ man with history of hypertension who presents with perianal pain and purulent discharge. He has had a history of multiple ___ lesions for ___ years (pustules with some drainage and warts) and discussed this with his PCP for the first time last week. He was prescribed a course of augmentin, which he nearly completed, and referred to Dermatology urgently for consideration of biopsy and further evaluation. Given the weather, his outpatient appointment was canceled so presented to the ED and was admitted. He had no worsening symptoms from the ___ years of his chronic lesions, with the exception of pain relieved with ibuprofen. He denied any fevers, chills, or sweats. His exam did not reveal s/s cellulitis and CT was negative for an abscess. His dermatology appt was rescheduled for the following morning, so he was discharged a few hours after admission in stable condition with instructions to keep his Dermatology appointment. No changes were made to his medications. ",1156,205
10003400-DS-13,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> Hematuria with supratherapeutic INR <MAJOR SURGICAL OR INVASIVE PROCEDURE> None <HISTORY OF PRESENT ILLNESS> This is a ___ ___ Female with a PMH significant for chronic persistent atrial fibrillation (on anticoagulation), essential hypertension, obesity, IgG multiple myeloma (started C28 of Lenalidomide ___ who presents from clinic with recent hematuria and evidence of a supratherapeutic INR. . The patient presented for a routine ___ clinic visit on ___ and was found to have an INR of 10.7 and there was concern for gross hematuria for several days. She was instructed to take Vitamin K 5 mg PO x 1 an hold her Coumadin, and she was to proceed to the ___ ED. On ___ her INR was 2.6. . Of note, the patient also has a recent history of neck pain since ___ which has been managed by her PCP. There was no inciting event or trauma. She described vague posterior neck pain that is intermittent and achy, worse with flexion and relieved with rest. She denies weakness, numbness or tingling in her upper extremities. She was prescribed warm compresses and Tramadol 50 mg PO Q6H for pain control. Since starting the Tramadol, she had noted episodes of dizziness and lightheadedness with ambulation. She felt the need to support herself with railing and started utilizing a cane more frequently. She denies lower extremity weakness or paresthesias. Her only medication changes was the Tramadol. She has no chest pain or trouble breathing. She denies nausea, emesis or abdominal pain. She has no headaches, vision changes. She denies trauma or recent falls. No true syncope events or LOC were noted. She denies vertiginous symptoms, tinnitus or hearing loss. Overall, with discontinuation of the Tramadol, her symptoms improved - thus her PCP felt this was the precipitant of her ___ complaints. . In the ___ ED, initial VS 97.3 ___ 16 99% RA. Laboratory studies were notable for a WBC 3.9 (ANC > 1500), HCT 34.8%, PLT 322. INR was 9.6. Creatinine 1.0. Troponin < 0.01. Lactate 2.1. A U/A showed 21 WBCs, 4 RBCs with moderate bacteria. An EKG demonstrated A.fib @ 127, LAD/NI and ___. A CXR was without focal consolidation or effusion. She received Ceftriaxone 1 gram IV x 1 and Lopressor 5 mg IV x 1 followed by Metoprolol tartrate 100 mg PO x 1 in the ED given evidence of rapid ventricular response to the ___. . On arrival to the floor, she is mentating well and has minimal complaints. <PAST MEDICAL HISTORY> Atrial Fibrillation: Persistent, Chronic, on Coumadin Multiple Myeloma: described below HTN Obesity Fibroids s/p TAH ONCOLOGIC HISTORY: Presented with anemia in ___. Further testing demonstrated an ___ of approximately 3.3 g/dL, IgG was 5800 mg/dL. Eventually, the patient was referred to Hematology, IgG increased to 7100 mg/dL at the start of treatment. Bone marrow biopsy revealed 60% of her bone marrow occupied by plasma cells, cytogenetics demonstrated translocation of chromosomes 11 and 14, also monosomy 13. Skeletal survey was negative. Initial beta 2 microglobulin was 4.08. ___ - C1 ___ ___ - pneumonia, leukopenia admission to ___ ___ - severe back pain, L3 vertebral compression fracture ___ - resumed Revlimid at 15 mg with Dexamethasone 20 mg weekly; started Zometa every 3 months ___ - more pronounced leukopenia ___ - C19 ___ was down to 0.6 g/dL), reduced Revlimid to 10 mg daily because of neutropenia ___ - back to Revlimid 15 mg given ___ increase to 0.8 g/dL ___ - C27 ___ ___ - started Biaxin ___ - C31 ___ # Afib: found incidentally in ___ # htn # s/p CCY # s/p TAH for fibroids <SOCIAL HISTORY> ___ <FAMILY HISTORY> Her parents died in their ___ or ___ of ""old age."" Her parents and multiple siblings have hypertension. There is no family history of significant arrhythmia or premature coronary disease. <PHYSICAL EXAM> PHYSICAL EXAM on admission: VITALS: 97.6 112 131/84 18 100% RA GENERAL: Appears in no acute distress. Alert and interactive. Well nourished appearing female. HEENT: Normocephalic, atraumatic. EOMI. PERRL. Nares clear. Mucous membranes moist. NECK: supple without lymphadenopathy. JVD not elevated. Thyroid barely palpable. ___: Irregularly irregular rhythm, without murmurs, rubs or gallops. S1 and S2 normal. RESP: Decreased breath sounds at bases with faint inspiratory crackles at bases. No wheezing, rhonchi. Stable inspiratory effort. ABD: soft, ___, with normoactive bowel sounds. No palpable masses or peritoneal signs. EXTR: no cyanosis, clubbing or edema, 2+ peripheral pulses NEURO: CN ___ intact throughout. Alert and oriented x 3. DTRs 2+ throughout, strength ___ bilaterally, sensation grossly intact. Gait deferred. Physical Exam on discharge: AFebrile ___ ___ ___ sat 99% on RA Gen: NAD, lying in bed HEENT: moist mucosa CV: irregularly irregular, normal rate, no murmur Pulm: few crackles at bases, no wheezes, good air movement Abd: NT, ND, soft Ext: no peripheral edema Skin: no skin lesions noted <PERTINENT RESULTS> ___ 05: 34AM BLOOD ___ ___ Plt ___ ___ 05: 34AM BLOOD ___ ___ ___ 05: 34AM BLOOD ___ ___ ___ 06: 15AM BLOOD ___ ___ ___ 10: 25PM BLOOD ___ ___ ___ 05: 34AM BLOOD ___ ___ 11: 40PM URINE ___ Sp ___ ___ 11: 40PM URINE ___ ___ ___ ___ 11: 40PM URINE ___ ___ CXR: The lungs are well expanded and clear. Mild cephalization of the pulmonary vessels is unchanged. The cardiac silhouette is enlarged. The mediastinal silhouette and hilar contours are normal. No pleural effusion or pneumothorax is present. IMPRESSION: Moderate, unchanged cardiomegaly. No edema. <MEDICATIONS ON ADMISSION> Preadmission medications listed are correct and complete. Information was obtained from Patient. 1. ___ 10 *NF* (potassium chloride) 10 mEq Oral DAILY 2. Warfarin 5 mg PO DAILY16 except ___ pills on ___ and ___ when INR is low 3. Amlodipine 2.5 mg PO DAILY 4. Vitamin D 1000 UNIT PO DAILY 5. Furosemide 40 mg PO DAILY 6. Lisinopril 20 mg PO DAILY 7. Metoprolol Tartrate 100 mg PO TID 8. Lenalidomide 15 mg PO DAILY 9. Clarithromycin 250 mg PO DAILY 10. Zometa *NF* (zoledronic acid;<br>zoledronic ___ 4 mg/5 mL Injection every 3 months 11. Dexamethasone 20 mg PO 1X/WEEK (MO) <DISCHARGE MEDICATIONS> 1. Amlodipine 2.5 mg PO DAILY 2. Clarithromycin 250 mg PO DAILY 3. Furosemide 40 mg PO DAILY 4. Lisinopril 20 mg PO DAILY 5. Metoprolol Tartrate 100 mg PO TID 6. Vitamin D 1000 UNIT PO DAILY 7. Lenalidomide 15 mg PO DAILY 8. ___ 10 *NF* (potassium chloride) 10 mEq ORAL DAILY 9. Dexamethasone 20 mg PO 1X/WEEK (MO) 10. Zoledronic Acid *NF* (zoledronic acid;<br>zoledronic ___ 4 mg/5 mL INJECTION EVERY 3 MONTHS 11. Warfarin 5 mg PO DAILY16 <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Primary Diagnosis: Elevated INR Secondary Diagnosis: Atrial Fibrillation CHADS Score 2 Multiple Myeloma <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> It was a pleasure taking care of you at ___ ___. You were admitted to the hospital for an elevated INR that is now coming down to normal. You had no signs of bleeding and your blood pressure and heart rate were normal once we restarted your home dose of metoprolol. Your INR is normal at 2.4 and the goal is to keep it between ___. You will have your INR drawn on ___ and it will continue to be managed by ___. We feel that you are ready for discharge and can continue to have your other medical conditions managed by your outpatient provider. Tonight, please take 2.5mg (one half of your normal dose). Please resume you normal dose of 5mg tomorrow and ___. Close follow up for your coumadin and INR is very important. Please stop taking your tramadol at home, because we believe this was increasing your INR to dangerous levels. Please have urinalysis performed on a urine sample at next primary care visit, and follow up with Urology is blood is found in the urine. While you were here, there was no blood in your urine, but you reportedly did in the past. Weigh yourself every morning, call your primary care provider if weight goes up more than 3 lbs. ","___ with a PMH significant for chronic persistent atrial fibrillation (on anticoagulation), HTN, obesity, IgG multiple myeloma (started C28 of Lenalidomide ___ who presents from clinic with reported recent hematuria and evidence of a supratherapeutic INR in the setting of anticoagulation. # Supratherapeutic INR/Coagulopathy - Likely due to use of tramadol over past 2 weeks for neck pain. INR was 2.6 on ___. Coumadin managed by the ___. INR noted to be 10.7 in clinic on ___ (previously 2.6 in ___. Of note patient started on clarithromycin to increase the potency of her chemotherapy regimen in ___ and has not had INR issues in the past with this drug. She seems compliant with her medications. She had no clinical evidence of bleeding. Her U/A has 4 RBCs and she has no gross hematuria. No neurologic deficits or mental clouding to suggest ICH or bleeding. - no acute indication for FFP given no active bleeding concerns - received Vitamin K 5 mg PO x 1 with improvement in INR - held coumadin in hospital and recommended coumadin 2.5mg po qHS on ___ followed by 5mg po for ___ per ___ ___ at ___ where patient followed. Patient will have INR drawn on ___. # AFib: Chronic, persistent, w/ episodic RVR. Clinic visits noted HR has been in the ___ bpm range at baseline per Atrius records. Has previously utilized Digoxin for rate control, but now remains on Metoprolol for ___ blockade. In the ED, had evidence of A.fib with persistent RVR - she had skipped afternoon dosing of Metoprolol. On arrival to floor, HR stabilized with oral Metoprolol home dosing. - rate control: continued home Metoprolol tartrate 100 mg PO TID - rhythm control: deferred - anticoagulation: held given supratherapeutic INR # Asymptomatic Bacteruira - Reports no dysuria or hematuria. U/A on admission demonstrating 21 WBCs and moderate bacteria without epithelial cells; no ___ or nitrites. Received IV Ceftriaxone 1 g in the ED prior to admission. Her picture is more consistent with asymptomatic bacteruria. Afebrile. Leukopenic without neutropenia. - Did not continue antibiotics - no signs of infection - f/u urine cx : NGTD for 24+ hr # IgG Multiple Myeloma- Presented with anemia in ___. Further testing demonstrated an ___ of approximately 3.3 g/dL, IgG was 5800 mg/dL. Eventually, the patient was referred to Hematology, IgG increased to 7100 mg/dL at the start of treatment. Bone marrow biopsy revealed 60% of her bone marrow occupied by plasma cells, cytogenetics demonstrated translocation of chromosomes 11 and 14, also monosomy 13. Skeletal survey was negative. Now on cycle 28 (as of ___ of Lenalidomide with weekly Dexamethasone and Biaxin per Oncology. ___ > 1500 on admission. - discussed patient with ___ attending Dr. ___ - continued C28 of Lenalidomide 15 mg PO daily (discuss with pharmacy) - continued Biaxin and held Dexamethasone dosing - bone metabolism - will continue Zometa every ___ (due ___ - trended ___: ___ 1500+ # HTN - Stable on home regimen. - continued home Lisinopril 20 mg PO daily - continued home Amlodipine 2.5 mg PO daily - continued home Metoprolol tartrate 100 mg PO TID - continued home Lasix 40 mg PO daily # Microscopic hematuria: In the setting of high INR. Please repeat UA on follow up. Referral to urology recommended if persists. # FEN/GI - Cardiac healthy diet, IVF and electrolyte repletion prn # COMMUNICATION - ___ (husband) - ___ # CODE STATUS - FULL CODE (confirmed with patient) # Dispo: D/C'd to home with husband; ___ did not recommend any home services. Transitional Issues: - Follow up microhematuria with U/A via PCP - ___ INR with appropriate coumadin adjustment via ___ ___ ",2283,943
10003400-DS-15,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> afib with rvr <MAJOR SURGICAL OR INVASIVE PROCEDURE> None <HISTORY OF PRESENT ILLNESS> Mrs ___ is a ___ with obesity, atrial fibrillation on coumadin, CKD III (recent baseline 0.88-1.1), UPJ obstruction s/p stent placement ___ c/b persistent Klebsiella bacteruria, chronic multiple myeloma, and adenocarcinoma of anal canal dx ___ who presents with atrial fibrillation with rapid ventricular response. Pt was seen by PCP ___, ___, for pre-op visit re: cystoscopy and right ureteral stent exchange. She presented with complaints of fatigue, inability to stand due to pain in legs, and bilateral leg swelling. Metoprolol had been hold at nursing home due to intermittent hypotension. EKG in office showed AF with RVR in 140s and she was sent to the ED. In the ED, initial VS were 98.3 157 115/81 18 Exam significant for Labs significant for Cr 1.2, (baseline .9), phos 1.7, WBC 3.8, Hb 9.6, INR of 6.5, and troponin of 0.02. Imaging significant for normal CXR. Initially received 5 mg IV metoprolol tartrate, 50 mg metoprolol tartrate PO, and 1L NS. Due to persistent tachycardia to the 130s, she received an additional 5 mg IV metoprolol x2 then diltiazem 10 mg IV. Transfer VS were 98.6 ___ 16 100% RA. On arrival to the floor, patient reports that she has been feeling tired, lightheaded and dizzy for several weeks. She has also had bilateral leg pain both at rest and exacerbated with weight bearing. She has also had decreased PO intake and describes dry mouth. She also describes dysuria, but no frequency or flank pain. She denies fevers and night sweats, but admits to feeling cold. REVIEW OF SYSTEMS: Denies fever, night sweats, headache, vision changes, rhinorrhea, congestion, sore throat, cough, shortness of breath, chest pain, abdominal pain, nausea, vomiting, diarrhea, constipation, BRBPR, melena, hematochezia, or hematuria. All other 10-system review negative in detail <PAST MEDICAL HISTORY> Hypertension Atrial fibrillation on coumadin Obesity Myeloma Osteoarthritis of right knee UPJ obstruction s/p stent placement ___ c/b persistent Klebsiella bacteruria Anal adenocarcinoma (dx ___ without evidence of metastatic dz ? Perirectal cyst drainage in ___ <SOCIAL HISTORY> ___ <FAMILY HISTORY> Her parents died in their ___ or ___ of ""old age."" Her parents and multiple siblings have hypertension. There is no family history of significant arrhythmia or premature coronary disease. <PHYSICAL EXAM> ADMISSION EXAM: VS: 98.9 112 18 112/61 100RA Tele: irreg irreg 100s GENERAL: NAD HEENT: AT/NC, EOMI, PERRL, anicteric sclerae, pink conjunctivae, patent nares, poor dentition, dry oral mucosa NECK: nontender supple neck, no LAD, no JVD CARDIAC: irregulary irregularm no murmurs, gallops, or rubs. no carotid bruits LUNG: CTAB, no wheezes, rales, rhonchi, breathing comfortably without use of accessory muscles ABDOMEN: nondistended, +BS, nontender in all quadrants, no rebound/guarding, no hepatosplenomegaly, no CVA tenderness EXTREMITIES: No cyanosis or clubbing; Diffuse anasarca, BLE > BLE. 2+ pitting edema in BLE to knee. Bilateral knees edematous, but non erythematous. PULSES: 2+ DP pulses bilaterally NEURO: CN II-XII intact (with the exception of mild left side of mouth droop). Strength: RUE flexor/extensors ___ LUE rlexor/extensors ___ RLE knee extensor ___ LLE knee extensor ___ Unable to elicit bilateral patellar reflexes; Downward babinkski bilat SKIN: warm and well perfused, no excoriations or lesions, no rashes DISCHARGE EXAM: VS Tm 98 18 ___ 100RA Tele: irreg 100s, excursions to 130s IO: 24h 1140/inc + 5 BMs (small) GENERAL: NAD HEENT: AT/NC, EOMI, anicteric sclerae, pink conjunctivae, patent nares, poor dentition NECK: nontender supple neck, no LAD, no JVD CHEST: right-sided portacath accessed, bandage c/d/i, no induration/ttp CARDIAC: irregulary irregular, no murmurs, gallops, or rubs. no carotid bruits LUNG: CTAB, no wheezes, rales, rhonchi, breathing comfortably without use of accessory muscles ABDOMEN: nondistended, +BS, nontender in all quadrants, no rebound/guarding, no hepatosplenomegaly EXTREMITIES: No cyanosis or clubbing; Diffuse anasarca, BLE > BUE. 2+ pitting edema in BLE to knee, improved since admission. Bilateral knees edematous, but non erythematous. PULSES: 2+ DP pulses bilaterally <PERTINENT RESULTS> ADMISSION LABS: --------------- ___ 01: 30PM BLOOD WBC-3.8*# RBC-3.39* Hgb-9.6* Hct-29.4* MCV-87 MCH-28.3 MCHC-32.6 RDW-19.4* Plt ___ ___ 01: 30PM BLOOD Neuts-77.1* Lymphs-14.1* Monos-8.4 Eos-0.4 Baso-0.1 ___ 01: 30PM BLOOD ___ PTT-35.9 ___ ___ 01: 30PM BLOOD Glucose-105* UreaN-18 Creat-1.2* Na-137 K-4.1 Cl-100 HCO3-23 AnGap-18 ___ 01: 30PM BLOOD cTropnT-0.02* ___ 01: 30PM BLOOD Albumin-3.0* Calcium-8.1* Phos-1.7* Mg-1.9 ___ 01: 56PM BLOOD Lactate-2.6* PERTINENT LABS: --------------- ___ 01: 30PM BLOOD CK(CPK)-77 ___ 09: 10PM BLOOD cTropnT-0.01 ___ 04: 46AM BLOOD Cortsol-30.5* ___ 09: 24PM BLOOD Lactate-1.2 ___ 10: 59PM URINE Color-DkAmb Appear-Cloudy Sp ___ ___ 10: 59PM URINE Blood-MOD Nitrite-NEG Protein-600 Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.0 Leuks-LG ___ 10: 59PM URINE RBC-67* WBC->182* Bacteri-MANY Yeast-MOD Epi-7 ___ 10: 33AM URINE Color-Yellow Appear-Cloudy Sp ___ ___ 10: 33AM URINE Blood-MOD Nitrite-NEG Protein-600 Glucose-NEG Ketone-TR Bilirub-NEG Urobiln-NEG pH-6.0 Leuks-LG ___ 10: 33AM URINE RBC-46* WBC->182* Bacteri-MOD Yeast-FEW Epi-25 MICROBIOLOGY: ------------- BLOOD CULTURE ___: Negative URINE CULTURE ___: YEAST ___, org/ml URINE CULTURE ___: YEAST ___, org/ml STOOL C. DIF TOXIN ___: POSITIVE URINE CULTURE ___: YEAST ___, org/ml DISCHARGE LABS: --------------- ___ 05: 55AM BLOOD WBC-3.5* RBC-2.81* Hgb-8.1* Hct-24.6* MCV-88 MCH-28.7 MCHC-32.7 RDW-19.8* Plt ___ ___ 05: 55AM BLOOD Glucose-159* UreaN-21* Creat-0.9 Na-138 K-4.1 Cl-109* HCO3-22 AnGap-11 ___ 05: 55AM BLOOD Calcium-7.7* Phos-2.7 Mg-2.0 STUDIES: -------- ___ CXR: IMPRESSION: No acute cardiopulmonary abnormality. <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Docusate Sodium 100 mg PO BID 2. Polyethylene Glycol 17 g PO DAILY 3. Metamucil (psyllium;<br>psyllium husk;<br>psyllium husk (with sugar);<br>psyllium seed (sugar)) 3.4 gram/12 gram oral Daily 4. Senna 8.6 mg PO BID 5. Diltiazem Extended-Release 120 mg PO DAILY 6. Furosemide 80 mg PO DAILY 7. Metoprolol Tartrate 100 mg PO TID 8. Potassium Chloride 20 mEq PO DAILY 9. Vitamin D 1000 UNIT PO DAILY 10. Lenalidomide 15 mg PO DAILY 11. Dexamethasone 20 mg PO ASDIR 12. Warfarin 3 mg PO DAILY16 <DISCHARGE MEDICATIONS> 1. Diltiazem Extended-Release 120 mg PO DAILY 2. Furosemide 40 mg PO DAILY 3. Metoprolol Tartrate 100 mg PO TID Hold for HR<55 or SBP<90 4. Vitamin D 1000 UNIT PO DAILY 5. Fluconazole 200 mg PO Q24H Duration: 7 Days Last day = ___ 6. Vancomycin Oral Liquid ___ mg PO Q6H Day 14 = ___ 7. Docusate Sodium 100 mg PO BID Hold for loose stools 8. Metamucil (psyllium;<br>psyllium husk;<br>psyllium husk (with sugar);<br>psyllium seed (sugar)) 3.4 gram/12 gram oral Daily Hold for loose stools. 9. Polyethylene Glycol 17 g PO DAILY Hold for loose stools 10. Potassium Chloride 20 mEq PO DAILY 11. Senna 8.6 mg PO BID Hold for loose stools. <DISCHARGE DISPOSITION> Extended Care Facility: ___ <DISCHARGE DIAGNOSIS> Primary diagnoses: -atrial fibrillation with rapid ventricular response -c.difficile infection, severe Secondary diagnoses: -multiple myeloma -rectal adenocarcinoma -pancytopenia <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Out of Bed with assistance to chair or wheelchair. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear ___, ___ was a pleasure taking care of you at the ___ ___. You were admitted for a fast heart rate. We treated this with intravenous medications, and then restarted your home medications. You were also found to have an infection of your colon called C.difficile. You will need to continue antibiotics by mouth for this. Your INR (measure of how thin your blood is from warfarin) is still elevated. Your rehab will measure this and restart warfarin when appropriate. Please remember to weigh yourself every morning, and speak to your MD if your weight rises by more than 3lbs. On behalf of your ___ team, We wish you a speedy recovery! ","___ PMHx obesity, atrial fibrillation on coumadin, CKD III (baseline 1.4) and chronic multiple myeloma and adenocarcinoma of anal canal (dx'ed ___ presenting for AFib with RVR. ACUTE ISSUES: ------------- # Atrial fibrillation with RVR: Pt presented initially with RVR in the 140s. Most likely in the setting of B-blocker and CCB being held due to hypotension. C. diff infection (see below) most likely contributing to hypotension. Pt received IV metoprolol and IV diltiazem in ED and was started on PO metoprolol/diltiazem on floor. She was also fluid resuscitated. Patient discharged with control of afib with RVR with PO metop and diltiazem at home doses. INR was supratherapeutic and coumadin was held (see below). # Hypotension: Per nursing home, she had intermittent hypotension requiring discontinuation of her metoprolol and diltiazem. Most likely secondary to decreased PO intake/loose stools from C.diff infection. Adrenal insufficiency secondary to chronic steroid use in the setting of infection was ruled out with AM cortisol (30). # Funguria, bacteruria: Pt initially reported dysuria and UA x2 showed large leuks/bacteria/yeast. Despite being contaminated, due to symptoms of dysuria, she was initially treated with IV CTX. Urine cultures eventually grew only yeast, prompting discontinuation of CTX. She was no longer symptomatic at this time, and she had no CVA tenderness or systemic symptoms of infection. She had a foley place initially for urine output monitoring, however, this was removed. Funguria will be treated with fluconazole for total 7 days of therapy. # C.difficile infection: Although no recent history of antibiotics, patient immunosuppressed and at rehabilitation facility. She was initially started on PO metronidazole on ___, but this was changed to PO vanc, given that she is immunosuppresed and falls into the severe category. ___, ___. # Coagulopathy: INR on admission was 6.5. Most likely secondary to decreased PO ntake and exacerbated antibiotics. No active signs of bleeding. Once INR reached 7.8, she was given 2.5 mg PO vitamin K. She received additional 2.5 mg PO vitamin K on ___. Coumadin was held on discharge. # Acute on chronic CKD (stage 3): Cr 1.2 (baseline 0.8-1.1). Most likely secondary to decreased PO intake and decreased cardiac output from afib with RVR. Creatinine improved with IVF. # Lower extremity edema: Multi-factorial. Most likely venous stasis vs diastolic heart failure, especially in the setting of afib with RVR, vs hypoalbuminemia. Pa/lateral film in ED showed no cardiomegaly or pulmonary vascualar congestion to suggest decompensated systolic heart failure. Pt on furosemide at home. Albumin was 3.0. Furosemide held on admission due to ___. Edema was managed with pneumatic boots. Furosemide was restarted at 40 mg on discharge. # UPJ obstruction s/p stent placement ___ c/b persistent Klebsiella bacteruria: Pt scheduled for stent replacement soon. She had no CVA tenderness on exam and creatinine was stable after IVF. Pt was scheduled to have stent replaced on ___, but procedure was cancelled due to supratherapeutic INR. Per Urology, pt's INR needs to be <3.0 and she will need this procedure in the next ___ months. # Troponinemia: Most likely strain from RVR vs decreased clearance in the setting of ___. Peaked at 0.02 before downtrending. # Hyperlactatemia: Lactate 2.6 on admission. Most likely secondary to dehydration versus ineffective cardiac output from RVR. Peaked at 2.6 before downtrending. CHRONIC ISSUES: --------------- # Weakness: She had generalized total body weakness, with the lower extremities worse than upper extremities. Also with the left ___ greater than right ___. No documented previous CVA to which asymmetry can be attributed. Most likely deconditioning and myopathy from dexamethasone, versus myositis or cerebrovascular event, both thought unlikely. CK was within normal limits. ___ worked with patient and she was discharged back to rehab. # Leg pain: Most likely osteoarthritis. She does not have diabetes to suggest neuropathy. She continued home oxycodone 10 mg qHS. # Pancytopenia: Patient with stable neutropenia, anemia, thrombocytopenia improved from prior, thought to be secondary to lenalidomide as well as anemia of chronic disease. # Anal adenocarcinoma: Diagnosed recently in ___. T2N0M0. Staging scans showed local disease without suspicious regional LAD, and no distant mets. Baseline CEA 20. Has plans for colorectal surgeon Dr. ___ diverting ostomy. S/p port placement in ___. Plans for chemo/radiation. Updated oncologist. # Anorectal pain: Her bowel regimen included docusate, colace and miralax, as well as being advised to increase and regulate her fiber intake. She was also given nitroglycerin 0.02% cream, 2% lidocaine ointment, Tuck's ointment and perineum care recommendations from wound care nursing. Bowel regimen was held in the setting of loose stools. # IgG myeloma: Patient with longstanding IgG MM, followed by ___ Oncology for which she is on lenolidamide days ___ of 28 days and dexamethasone 1x/week on weeks when she takes lenolidamide. The patient completed her last 3 weeks of Revlamid ___. Also received Zometa ___. Lenolidamide/dexamethasone was held during admission due to infection. TRANSITIONAL ISSUES: -------------------- - C.diff infection, Severe: Needs PO vancomycin 125mg PO QID until ___ for total 14 day treatment course. - Funguria: Three urine cultures grew >100,000 cfu/ml of yeast. She was started on fluconazole treatment, per her Urologist. D1 = ___, D7 = ___. - Ureteral stent replacement: Was scheduled for replacement on ___, but cancelled due to supratherapeutic INR. Her stent can be replaced when her INR is therapeutic (2.0 - 3.0). When therapeutic, please call her Urologist Dr. ___ to schedule a stent replacement. She will also see him on ___. - Supratherapeutic INR: Will need daily INR checks to follow INR until therapeutic so Coumadin may be restarted. If uptrending x72hours, consider 2.5mg PO vitamin K (in the absence of normal gut flora due to C. diff infection). - Diastolic heart failure: Patient restarted on lower dose of furosemide 40 mg. Uptitrate as necessary based on volume status and kidney function. - Myeloma: Revlamid/dexamethasone held during admission and on discharge. Please call her Oncologist Dr. ___ to discuss restarting on ___. - Rectal adenocarcinoma: Stool softeners should be held until frequency and consistency of BM normalizes. # Emergency Contact/HCP: ___ (son) ___ and ___ (son) ___ # CODE: FULL, confirmed ",2761,1644
10003400-DS-16,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> ALTERED MENTAL STATUS <MAJOR SURGICAL OR INVASIVE PROCEDURE> NONE <HISTORY OF PRESENT ILLNESS> Ms. ___ is a ___ year-old woman a ___ significant for AFib on coumadin, UPJ obstruction s/p stent placement in ___ c/b chronic Klebsiella bacturia, IgG myeloma on lenolidamide, and recently diagnosed adenocarcinoma of the anal canal who presents with altered mental status. Of note, patient is currently unable to relay any of her medical information (only response to questions is ""I don't know""). As such, much of medical information is obtained from medical records. Per ED note, the patient was brought in from ___. Her family reports that that she has had AMS for the last ___ days. to the point that she does not recognize her family members and does not know where she is. Upon arrival to ___ ED, initial VS 97.7 91 111/68 16 100%. Labs notable for Chem-7 wnl, P2.0, LFTS wnl, Alb 2.8, CBC with pancytopenia 2.8>9.1<140, coags with INR 3.6. UA positive with large leuk, neg nitrites, 137 WBC, few bacteria. CXR without cardiopulmonary process. Pateint was administered 500cc LR, ceftriaxone 1g x1. She is now admitted to medicine for further management. Vitals prior to transfer 98 88 140/80 18 100% RA. On the floor, initial VS 97.7 110/57 72 18 98%RA. The patient in lying in bed NAD but her only response to questions are ""I don't know."" <PAST MEDICAL HISTORY> Hypertension Atrial fibrillation on coumadin Obesity Myeloma Osteoarthritis of right knee UPJ obstruction s/p stent placement ___ c/b persistent Klebsiella bacteruria Anal adenocarcinoma (dx ___ ? Perirectal cyst drainage in 1980s <SOCIAL HISTORY> ___ <FAMILY HISTORY> Her parents died in their ___ or ___ of ""old age."" Her parents and multiple siblings have hypertension. Sibling with Alzheimer's disease. No family history of significant arrhythmia or premature coronary disease. <PHYSICAL EXAM> ADMISSION PHYSICAL EXAM: Vitals: 97.7 110/57 72 18 98%RA GENERAL: Elderly woman, lying in bed, NAD HEENT: AT/NC, EOMI, PERRL, anicteric sclera, pink conjunctiva, MMM NECK: nontender supple neck, no LAD, no JVD CARDIAC: Irregularly irregular, +S1/S2, no murmurs, gallops, or rubs LUNG: CTAB, no wheezes, rales, rhonchi, breathing comfortably without use of accessory muscles ABDOMEN: nondistended, +BS, nontender in all quadrants, no rebound/guarding, no hepatosplenomegaly. Anus with friable mucosa. EXTREMITIES: 2 piting edema up through shins bilaterally, no cyanosis or clubbing PULSES: 2+ DP pulses bilaterally NEURO: CN II-XII and motor grossly intact intact SKIN: warm and well perfused, no excoriations or lesions, no rashes DISCHARGE PHYSICAL EXAM: Vitals: 99.0 (99.0) 119/71 (100-120/50-80) 85 (60-90) 18 100%RA I/O: 1140/inc Weight: 86.7 kg GENERAL: elderly woman lying in bed in NAD. HEENT: AT/NC, EOMI, PERRL, anicteric sclera CARDIAC: irregularly irregular, +S1/S2, no murmurs LUNG: CTAB, no wheezes, mild crackles, breathing comfortably ABDOMEN: non-distended, +BS, non-tender in all quadrants, no rebound/guarding EXTREMITIES: 2+ piting edema to shins bilaterally NEURO: CN II-XII grossly intact, AA+O X 3. did not know day of the week. uncooperative with other cognitive questions SKIN: warm and well perfused, no rashes <PERTINENT RESULTS> ADMISSION LABS -============ ___ 05: 30PM WBC-2.8* RBC-3.31* HGB-9.1* HCT-28.6* MCV-87 MCH-27.4 MCHC-31.6 RDW-20.8* ___ 05: 30PM NEUTS-71.7* LYMPHS-17.9* MONOS-8.5 EOS-1.6 BASOS-0.2 ___ 05: 30PM PLT COUNT-140* ___ 05: 30PM ___ PTT-35.1 ___ ___ 05: 30PM ALT(SGPT)-16 AST(SGOT)-20 ALK PHOS-83 TOT BILI-0.6 ___ 05: 30PM LIPASE-24 ___ 05: 30PM GLUCOSE-99 UREA N-6 CREAT-0.6 SODIUM-141 POTASSIUM-3.3 CHLORIDE-104 TOTAL CO2-31 ANION GAP-9 ___ 04: 40PM URINE BLOOD-SM NITRITE-NEG PROTEIN-30 GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-8.0 LEUK-LG ___ 04: 40PM URINE RBC-12* WBC-137* BACTERIA-FEW YEAST-NONE EPI-1 PERTINANT LABS -- ___ 05: 01AM BLOOD ___ ___ 05: 47AM BLOOD ___ PTT-33.4 ___ ___ 05: 47AM BLOOD VitB12-471 ___ 05: 47AM BLOOD TSH-2.6 DISCHARGE LABS -- ___ 05: 19AM BLOOD WBC-3.1* RBC-2.90* Hgb-8.1* Hct-25.4* MCV-88 MCH-28.1 MCHC-32.0 RDW-20.5* Plt ___ ___ 05: 19AM BLOOD ___ PTT-35.6 ___ ___ 05: 19AM BLOOD Glucose-95 UreaN-5* Creat-0.6 Na-142 K-3.6 Cl-108 HCO3-27 AnGap-11 ___ 05: 19AM BLOOD Calcium-7.8* Phos-1.8* Mg-1.9 IMAGING -- CXR (___): No evidence of acute cardiopulmonary disease. Head CT w/o contrast (___): 1. No acute intracranial abnormality. 2. Please note MRI of the brain is more sensitive for the evaluation of acute infarct. 3. Atrophy and probable small vessel ischemic changes as described. 4. 15 mm right posterior neck probable dermal inclusion cyst as described. Recommend clinical correlation and correlation with direct examination. MICROBIOLOGY -- URINE CULTURE (Final ___: MIXED BACTERIAL FLORA ( >= 3 COLONY TYPES), CONSISTENT WITH SKIN AND/OR GENITAL CONTAMINATION. BLOOD CULTURE x 2: NGTD <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Diltiazem Extended-Release 120 mg PO DAILY 2. Furosemide 40 mg PO DAILY 3. Metoprolol Tartrate 100 mg PO TID 4. Vitamin D 1000 UNIT PO DAILY 5. Docusate Sodium 100 mg PO BID 6. Metamucil (psyllium;<br>psyllium husk;<br>psyllium husk (with sugar);<br>psyllium seed (sugar)) 3.4 gram/12 gram oral Daily 7. Polyethylene Glycol 17 g PO DAILY 8. Potassium Chloride 20 mEq PO DAILY 9. Senna 8.6 mg PO BID <DISCHARGE MEDICATIONS> 1. Diltiazem Extended-Release 120 mg PO DAILY 2. Docusate Sodium 100 mg PO BID 3. Furosemide 40 mg PO DAILY 4. Metamucil (psyllium;<br>psyllium husk;<br>psyllium husk (with sugar);<br>psyllium seed (sugar)) 3.4 gram/12 gram oral Daily 5. Metoprolol Tartrate 100 mg PO TID Hold for HR<55 or SBP<90 6. Polyethylene Glycol 17 g PO DAILY 7. Senna 8.6 mg PO BID 8. Vitamin D 1000 UNIT PO DAILY 9. Warfarin 1 mg PO DAILY16 10. Potassium Chloride 20 mEq PO DAILY <DISCHARGE DISPOSITION> Extended Care Facility: ___ <DISCHARGE DIAGNOSIS> Primary Diagnosis: Subacute Encephalopathy Secondary Diagnosis: Atrial Fibrillation, Anal Adenocarcinoma, Hypertension, CKD Stage 3 <DISCHARGE CONDITION> Mental Status: Clear and Coherent. Level of Consciousness: Alert and interactive - usually. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Ms. ___, It was a pleasure taking care of you at ___. You were admitted for confusion. You were initially put on antibiotics, but your urine culture did not how infection and these medications were stopped. Other tests including blood tests and a CAT scan of your brain were reassuring. Your mental status remained at baseline throughout your hospitalization and you will need further testing as an outpatient to further define your cognition. Please follow-up with the appointments listed below and take your medications as instructed below. Best wishes, Your ___ Team ","___ with AFib on coumadin, UPJ obstruction s/p stent placement in ___ c/b chronic Klebsiella bacturia, IgG myeloma on lenolidamide, and recently diagnosed adenocarcinoma of the anal canal who presents with altered mental status. # Subacute congitive decline: Patient presenting from assisted living facility with several days of progressive AMS. On admission was A+O X 1 without focal deficits but quickly improved to orientation x3. Differential included infectious etiology (ie UTI), mild dementia per family report or subacute hemorrhage given supratherapeutic INRs. NCHCT obtained on ___ and showed no acute intracranial abnormality. Initially covered with ABX for possible to be UTI (see below) but ABX stopped with urine culture unrevealing. TSH and B12 WNL. Given hx of rectal adenocarcinoma, considered potential brain metastasis, however with no localizing symptoms and low burden malignancy so head MRI was deferred. Please arrange neurocognitive work-up to exclude dementia vs depression/pseudodementia as outpatient given mental status largely notable for apathy and pt being withdrawn with relatively good attention and orientation which makes an acute encephalopathy less likely. . # Pyuria: Patient has a history of chronic Klebsiella bacteriuria as a complication of UPJ obstruction s/p stent placement in ___. Seen previously by ID who recommended not treating unless symptoms. Given that she presented with altered mental status, she was started on ceftriaxone. However, urine culture on ___ returned with mixed flora and CTX stopped. . # Anal adenocarcinoma: Diagnosed recently in ___. T2N0M0. Staging scans showed local disease without suspicious regional LAD, and no distant mets. Baseline CEA 20. Has plans for colorectal surgeon Dr. ___ diverting ostomy. Home bowel regimen of metamucil, senna, colace was continued. . # AFib: CHADS = 2. Patient was rate-controlled during hospitalization. INR 3.6 on admission. Home warfarin was held given supratherapeutic INR. Rate-control agents with home diltiazem and metoprolol was also continued. Warfarin restarted at lower dose on ___. . # Hypertension: Normotensive. Home BB/CCB and furosemide were continued. . # CKD Stage 3: Baseline Cr 0.8-1.1, currently 0.6. . # IgG Myeloma: Patient with longstanding IgG MM, followed by ___ Oncology. . TRANSITIONAL ISSUES: ======================== -will benefit from neurocognitive evaluation to further elucidate possibility of dementia -would also assess for pseudodementia/depression with psychiatry evaluation -will need to discuss with outpatient oncologist re: Revalmid therapy -pt requires motivation from staff for participation in ___ activities. Please promote OOB to chair for all meals and encourage PO intake. -f/u with colorectal surgeon (Dr. ___ for mgmt of anal adenocarcinoma -full code -contact ___ (son) ___ and ___ (son) ___ ",2300,670
10003400-DS-17,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> rectal pain <MAJOR SURGICAL OR INVASIVE PROCEDURE> none <HISTORY OF PRESENT ILLNESS> Mrs. ___ is a ___ w/ anal mucinous adenocarcinoma not yet on chemo, AFib on coumadin, UPJ obstruction s/p stent placement in ___ c/b chronic Klebsiella bacturia, IgG myeloma on lenolidamide, currently residing at ___, who is referred from clinic by her primary oncologist for rectal pain and expedited management of her rectal ca. She had reportedly mentioned worsening rectal pain over the past several days as well as bright red blood on the tissue paper. She denies melanotic stools. She had labs checked at the outpatient office today which showed Hct of 29.3, which is roughly baseline. Because of her lack of follow through but interest to pursue surgery, she was directly admitted for pain control and surgical evaluation. ED: VS ___ HR 106-124, BP 107/76-136/82, RR 15, 100% RA. Received 5 mg IV morphine. Initial labs in ___ ED showed Hct of 15, but was 27.7 when rechecked. Before the recheck, GI was consulted for a possible GI bleed and plan was to admit to ICU. She received 5 mg IV Vit K. However in absence of frank melanotic stools with a H/H that was baseline just several hours prior to admission, the low Hg was suspected to be erroroneous and on recheck Hct 27.7. She was evaluated by colorectal surgery who recommended ""admission to medicine for appropriate oncologic evaluation and pain management. We recommend she be evaluated by radiation oncology for short course pre-op radiation, followed by proctectomy and end colostomy."" REVIEW OF SYSTEMS: 10 point ROS reviewed in detail and negative except for what is mentioned above in HPI <PAST MEDICAL HISTORY> PAST ONCOLOGIC HISTORY: #ANAL ADENOCA: Per Dr. ___: Admitted to ___ ___ for BRBPR. Found to have anal adenocarcinoma, T2N0 based on MRI and CT. Seen by Dr ___ in the hospital from surgery but has been noncompliant with f/u with her despite multiple outreaches from her office. #MM: ___ woman who presented with anemia in ___. Further testing demonstrated an M-spike of approximately 3.3 g/dL, IgG was 5800 mg/dL. Eventually, the patient was referred to Hematology, IgG increased to 7100mg/dL at the start of treatment. Initial Hematology consult was ___. Bone marrow biopsy revealed 60% of her bone marrow occupied by plasma cells, cytogenetics demonstrated translocation of chromosomes 11 and 14, also monosomy 13. Skeletal survey was negative. Initial beta 2 microglobulin was 4.08, she started cycle 1 of Revlimid and dexamethasone on ___, Revlimid at 25 mg. She was admitted to ___ on ___, with pneumonia, she was also coagulopathic and quite leukopenic. She was discharged on ___. On ___, she presented with severe back pain, and she has sustained a compression fracture of L3 vertebra. Her white blood cell count was still low, the Revlimid was held, and restarted on ___ at a lower dose of 15 mg, in combination with weekly dexamethasone at 20 mg. She was started on Zometa. The patient did well on this lower dose of Revlimid with a nice improvement in her IgG and M-spike, M-spike going down to 1.0 g/dL by ___, and her IgG going into the normal range at the same time, she continued on Revlimid 15 mg every days ___, with weekly dexamethasone at 20 mg, repeated every month, with Zometa every 3 months, for quite some time, although by ___, the patient was becoming more leukopenic. At the start of cycle 19 of Revlimid and dexamethasone, in ___, the M-spike was down to 0.6 g/dL, and the Revlimid was reduced to 10 mg per day because of severe neutropenia. Unfortunately by ___ timeframe, the M-spike started to creep up, to 0.8 g/dL fairly consistently through the ___, and by ___, at her ___ cycle of Revlimid and dexamethasone, the M-spike increased to 0.9 g/dL. She was increased to Rev 15 mg and her counts are holding. She reports she missed a month of Rev due to her hospitalization in ___ Cycle #27 Rev 15mg -Dex ___ Clinic appt start Biaxin ___ Cycle #28 Rev-Dex ___ Clinic appt reviewed labs M-spike 0.8g/dL ___ Cycle #29 Rev-Dex ___ Admitted for hematuria, elevated INR attributed to Ultram-warfarin interaction ___ Clinic appt Zometa, on cycle #29 ___ Cycle #30 Rev-Dex ___ Cycle #31-- decided to continue without a clinic appt, she was having a great time visiting family in ___ ___ Cycle #31 day #19 ___ Cycle #32 ___ Cycle #33 and Zometa ___ Cycle #34 start on ___ end ___. ___ Cycle #35 start ___ end ___. M-spike 0.9g/dL ___ Cycle #36, start ___ or ___, Zometa, end ___. M-spike 0.8g/dL ___ Cycle ___ M-spike 0.9g/dL. Now ___ years on Rev-dex (first cycle was ___ Cycle ___ M-spike 0.9g/dL IgG stable. Start Rev ___ ___ finish ___ See me in clinic before cycle #39 start ___ finish ___ See me in clinic, Zometa, cycle #40 will start ___ ( I am out of office ___ ___ Admitted ___ obstructive uropathy and enterococcal UTI discharged ___ to rehab ___ ___ discharged ___ Touched base by phone, hold Revlimid until next follow up ___ Cycle #41 start ___ end ___ Stent change scheduled ___ Cycle #42 planned start ___ Zometa, Previously followed in hem/onc by Dr ___ today to establish care with me. ___ Cycle 44 ___ Cycle 45, zometa ___ Cycle 46 ___ Cycle 47, zometa ___ Cycle 48 Rev ___ Cycle 49 rev, zometa ___ Cycle 50 rev ___ Cycle 51 rev ___ Anal cancer - adeno diagnosed PAST MEDICAL HISTORY: Hypertension Atrial fibrillation on coumadin Obesity Myeloma Osteoarthritis of right knee UPJ obstruction s/p stent placement ___ c/b persistent Klebsiella bacteruria Anal adenocarcinoma (dx ___ ? Perirectal cyst drainage in ___ PSH: ___ - EUA, biopsy of ___ lesion ___ - cystoscopy and R ureteral stent exchange ___ - lap CCY Hysterectomy ___ - unknown ___ procedure <SOCIAL HISTORY> ___ <FAMILY HISTORY> Her parents died in their ___ or ___ of ""old age."" Her parents and multiple siblings have hypertension. Sibling with Alzheimer's disease. No family history of significant arrhythmia or premature coronary disease. <PHYSICAL EXAM> ADMIT PHYSICAL EXAM: General: NAD elderly frail female resting in bed comfortably sleeping VITAL SIGNS: ___ 120/80 95 20 99% RA HEENT: MMM, no OP lesions, no cervical or supraclavicular adenopathy CV: ___, NL S1S2 no S3S4 No MRG PULM: CTAB, No ___ ABD: BS+, soft, NTND, no palpable masses or HSM LIMBS: WWP, 2+ pitting ___ to the proximal leg, no tremors SKIN: No rashes on the extremities NEURO: Grossly normal, oriented to person/place/date/time but had some difficulty with months of year backwards, easily distractable, though process logical RECTAL: PER COLORECTAL SURGERY: ""Rectal: large plaque-like lesion arising from right superolateral portion of anus, extending nearly circumferentially around the anus and into the anal canal; internal extension of the lesion palpable approximately 3cm internally; able to digitally pass lesion without e/o obstruction; small amount of red blood on glove after exam"" DISCHARGE PHYSICAL EXAM: VITAL SIGNS: 98.2 130/78 104 18 98%RA HEENT: MMM, no OP lesions, no cervical or supraclavicular adenopathy CV: irregular irregular nl rate, NL S1S2 no S3S4 No MRG PULM: CTAB, No ___ ABD: BS+, soft, NTND, no palpable masses or HSM LIMBS: WWP, no lower extremity edema, no tremors. SKIN: No rashes on the extremities NEURO: ___ strength throughout no tremor/asterixis,aware of person, place, year but not full date. answers appropriately and follows commands. sensation intact to light touch. Rectal: ulcerated circumferential anorectal mass w/ oozing <PERTINENT RESULTS> ADMISSION LABS: ___ 01: 45PM BLOOD WBC-4.3 RBC-1.73*# Hgb-5.0*# Hct-15.0*# MCV-87 MCH-28.7 MCHC-33.0 RDW-19.1* Plt ___ ___ 01: 45PM BLOOD Neuts-66.5 ___ Monos-14.5* Eos-0.3 Baso-0.1 ___ 01: 45PM BLOOD ___ PTT-32.0 ___ ___ 01: 45PM BLOOD Glucose-90 UreaN-20 Creat-0.7 Na-140 K-3.7 Cl-107 HCO3-25 AnGap-12 ___ 01: 45PM BLOOD ALT-24 AST-21 AlkPhos-81 TotBili-0.5 ___ 01: 45PM BLOOD Albumin-2.9* DISCHARGE LABS: ___ 06: 09AM BLOOD WBC-3.7* RBC-2.90* Hgb-8.6* Hct-26.1* MCV-90 MCH-29.7 MCHC-32.9 RDW-20.2* Plt ___ ___ 06: 09AM BLOOD Glucose-140* UreaN-12 Creat-0.7 Na-141 K-4.1 Cl-110* HCO3-24 AnGap-11 ___ 06: 09AM BLOOD ALT-14 AST-13 AlkPhos-78 TotBili-0.2 ___ 06: 09AM BLOOD Calcium-7.9* Phos-1.9* Mg-1.9 IMAGING: MRI pelvis ___: IMPRESSION: Interval growth of the previously demonstrated distal rectal tumor, with inferior anal extension and mucinous differentiation, now extending further beyond of the right posterior external anal sphincter and into the subcutaneous tissues of the right buttock. The rectal tumor extends beyond the muscularis propria into the mesorectal fat posteriorly on the left, abutting the levator ani muscle and mesorectal fascia without obvious involvement. This constitutes tumor stage T3. No identified definitively pathologic lymphadenopathy. CXR ___: Slight worsening of mild pulmonary vascular congestion in the setting of stable moderate cardiomegaly. No evidence of pneumonia. <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Diltiazem Extended-Release 120 mg PO DAILY 2. Furosemide 20 mg PO DAILY 3. Metamucil (psyllium;<br>psyllium husk;<br>psyllium husk (with sugar);<br>psyllium seed (sugar)) 3.4 gram/12 gram oral Daily 4. Senna 8.6 mg PO DAILY: PRN constipation 5. Vitamin D 1000 UNIT PO DAILY 6. Warfarin 2.5 mg PO DAILY16 7. Potassium Chloride 20 mEq PO DAILY 8. OxycoDONE (Immediate Release) 10 mg PO Q6H: PRN severe pain 9. Bisacodyl ___AILY: PRN constipation 10. Acetaminophen 650 mg PO Q6H: PRN pain 11. Fleet Enema ___AILY: PRN constipation if bisacodyl ineffective 12. OxycoDONE (Immediate Release) 10 mg PO QHS 13. Calcium 600 with Vitamin D3 (calcium carbonate-vitamin D3) 600 mg(1,500mg) -400 unit oral BID 14. Metoprolol Succinate XL 100 mg PO BID 15. Lenalidomide 15 mg PO DAILY myeloma 16. Ascorbic Acid ___ mg PO DAILY 17. Zinc Sulfate 220 mg PO DAILY 18. Citalopram 10 mg PO DAILY 19. Dexamethasone 4 mg PO 1X/WEEK (TH) on ___ while on revlimid <DISCHARGE MEDICATIONS> 1. Acetaminophen 650 mg PO Q6H: PRN pain 2. Bisacodyl ___AILY: PRN constipation 3. Citalopram 10 mg PO DAILY 4. Dexamethasone 4 mg PO 1X/WEEK (TH) on ___ while on revlimid 5. Metoprolol Succinate XL 100 mg PO BID 6. OxycoDONE (Immediate Release) 10 mg PO Q6H: PRN severe pain RX *oxycodone 10 mg 1 tablet(s) by mouth every 6 hours Disp #*60 Tablet Refills: *0 7. OxycoDONE (Immediate Release) 10 mg PO QHS RX *oxycodone 15 mg 1 tablet(s) by mouth at bedtime Disp #*60 Tablet Refills: *0 8. Senna 8.6 mg PO DAILY: PRN constipation 9. Vitamin D 1000 UNIT PO DAILY 10. Aquaphor Ointment 1 Appl TP QID: PRN apply daily and then prn after each bowel movement 11. Ascorbic Acid ___ mg PO DAILY 12. Calcium 600 with Vitamin D3 (calcium carbonate-vitamin D3) 600 mg(1,500mg) -400 unit oral BID 13. Diltiazem Extended-Release 120 mg PO DAILY 14. Docusate Sodium 200 mg PO BID 15. Metamucil Fiber Singles (psyllium husk (aspartame)) 3.4 gm ORAL DAILY 16. Omeprazole 20 mg PO DAILY 17. Polyethylene Glycol 17 g PO DAILY: PRN constipation please give if no bowel movement in 24 hr period 18. Metamucil (psyllium;<br>psyllium husk;<br>psyllium husk (with sugar);<br>psyllium seed (sugar)) 3.4 gram/12 gram oral Daily 19. Potassium Chloride 20 mEq PO DAILY 20. Zinc Sulfate 220 mg PO DAILY 21. Multivitamins ___ 1 TAB PO DAILY <DISCHARGE DISPOSITION> Extended Care Facility: ___ <DISCHARGE DIAGNOSIS> Rectal cancer Rectal bleeding Rectal pain Blood loss anemia Hypophosphatemia (low phosphate) <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Ms ___ it was a pleasure caring for you during your stay at ___. You were hospitalized with worsening pain due to the rectal mass. You also had some rectal bleeding. You completed 5 radiation treatments to the rectum with plans for surgical removal of the mass. Your coumadin was stopped both due to bleeding and in anticipation of surgery. Your lasix was also stopped due to low phosphate. This can be resumed after surgery if needed. You also received a blood transfusion for anemia. ","Mrs. ___ is a ___ w/ anal mucinous adenocarcinoma not yet treated, AFib, UPJ obstruction s/p stent placement in ___ c/b chronic Klebsiella bacturia, IgG myeloma on lenolidamide, currently residing at ___ since ___, who is admitted from clinic by her primary oncologist, Dr. ___ rectal pain and expedited treatment. Also w/ blood loss anemia on admission. #Anal Mucinous Adenocarcinoma Diagnosed in ___. Restaging ___ shows T4 disease extending beyond the anal verge, progressing through external muscle of anal sphincter, progression from 3 months ago. -- plan for 5 fractions per Drs. ___ on thurs ___ w/ first session ___ cancelled due to machine malfunction, resumed ___ and completed ___. -- pt evaluated by Dr. ___/ colorectal surgery with plans for surgical resection proctectomy and end colostomy on ___, one week following completion of radiation. -- pt received ostomy teaching during her stay #Rectal Pain - ___ above -- cont metamucil, senna, colace, prn miralax/bisacodyl -- pain control w/ oxycodone prn and tylenol #Rectal bleeding - persistent hematochezia ___ mass/oozing. no large vol bleeding. stopped lovenox. Anticipate ongoing oozing until surgery but improved w/ radiation and stopping anticoagulation. #Blood loss anemia/ACD - Recent Ferritin and TIBC suggest anemia of chronic inflammation but recent rectal bleeding and low HCT on admission concerning for acute blood loss. HCT 15 in ED on admission likely spurious as Hgb was 9 at ___ earlier that day and on repeat in ED HCT 27. - Normal TSH and b12 - Hgb gradually downtrending ___ bleeding. Was given 1U PRBC on ___ for Hgb 8.6 in anticipation of slow oozing over next week prior to surgery #Hypophosphatemia - poor PO vs GI loss while on bowel regimen vs lasix effect. remained low despite PO phos x 3 days so stopped lasix. PTH secondarily elevated. vitD borderline low will increase to 2000U. Phos 1.9 day of discharge repleted with 500mg #AFib #HTN CHADS2Vasc at least4, coumadin reversed in ED out of initial concern for GI bleed, was transitioned to lovenox. - plan was to cont lovenox perioperatively as needs bridge prior to surgery-- however held in setting of worsening rectal bleeding, risk of bleeding in short term felt to outweigh risk of stroke. off lovenox since ___ -- cont home dilt and metoprolol, decreased dilt dose as BP in low 100s-120s # Neutropenia - resolved. likely ___ revlamid, we are holding revlamid perioperatively for now per primary oncologist. No fevers #CKDIII - renal function is good on arrival but reportedly carries this diagnosis, likely prior myeloma kidney -- avoid nephrotoxins #IgG Myeloma IgG kappa, ISS stage II, Durie-Salmon stage II (IgG greater than 5 g). ___. On Rev-Dex, stable History of vertebral compression fracture ___. Last skeletal survey in ___ neg. -- holding revlamid while hospitalized and perioperative per outpt onc but cont qthurs 20mg po dex -- Zometa given in ___. ",3616,752
10003400-DS-18,"<SEX> F <SERVICE> SURGERY <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> <CHIEF COMPLAINT> Rectal pain Reason for MICU transfer: Hypotension <MAJOR SURGICAL OR INVASIVE PROCEDURE> ___: 1. Closure of abdominoperineal resection defect with a right vertical rectus abdominis muscular cutaneous flap. 2. Ventral hernia repair of pre-existing hernia using Ventralex mesh. 3. End colostomy ___ Flap debridement, local flap advancement closure Intubation <HISTORY OF PRESENT ILLNESS> This is a ___ year old woman with a history of afib, HTN, multiple myeloma and anal adenocarcinoma T4 diagnosed ___ with delayed treatment until progression ___ s/p radiation therapy and admitted for planned abdominal/perineal resection with small bowel resection with end colostomy, fiducial seed placement and perineal closure. There were extensive adhesions and it was converted to an open procedure totalling 8 hrs. During that time she had 1L estimated blood loss. 6 hrs in, her pressures dropped to 60's systolic and she received 4 units PRBC, 2 units FFP, albumin, and 6 liters LR. She nevertheless required phenylephrine and levophed. There was no significant bleeding at closure. She had a perineal flap with subcutaneous JP drain on the right, end ostomy, and pelvic JP drain on the left. In the PACU she remained intubated and continued to be hypotensive and received 2 units platelets and 2 units FFP. Esmolol gtt was attempted to control RVR to 140's without success and was stopped. EKG showed afib with RVR and no evidence of ischemia. Labs were notable for crit 32->22 post op, platelets dropped to 39 and INR rose 1.2->2.4. She was transferred to the FICU where she had no overt signs of bleeding/oozing but remained hypotensive requiring vasopressin addition. A massive transfusion protocol was initiated, intraosseous line placed while awaiting a trauma line. She was transfused 5 untis of blood, ___ with appropriate bump in platelets and improvement in INR. Phenylephrine was stopped and pressures were maintained with LR 4L. Urine output dropped to <5cc/hr and lactate uptrended to 8 with pH 7.15. ROS: Unable to obtain <PAST MEDICAL HISTORY> PAST ONCOLOGIC HISTORY: #ANAL ADENOCA: Per Dr. ___: Admitted to ___ ___ for BRBPR. Found to have anal adenocarcinoma, T2N0 based on MRI and CT. Seen by Dr ___ in the hospital from surgery but has been noncompliant with f/u with her despite multiple outreaches from her office. #MM: ___ woman who presented with anemia in ___. Further testing demonstrated an M-spike of approximately 3.3 g/dL, IgG was 5800 mg/dL. Eventually, the patient was referred to Hematology, IgG increased to 7100mg/dL at the start of treatment. Initial Hematology consult was ___. Bone marrow biopsy revealed 60% of her bone marrow occupied by plasma cells, cytogenetics demonstrated translocation of chromosomes 11 and 14, also monosomy 13. Skeletal survey was negative. Initial beta 2 microglobulin was 4.08, she started cycle 1 of Revlimid and dexamethasone on ___, Revlimid at 25 mg. She was admitted to ___ on ___, with pneumonia, she was also coagulopathic and quite leukopenic. She was discharged on ___. On ___, she presented with severe back pain, and she has sustained a compression fracture of L3 vertebra. Her white blood cell count was still low, the Revlimid was held, and restarted on ___ at a lower dose of 15 mg, in combination with weekly dexamethasone at 20 mg. She was started on Zometa. The patient did well on this lower dose of Revlimid with a nice improvement in her IgG and M-spike, M-spike going down to 1.0 g/dL by ___, and her IgG going into the normal range at the same time, she continued on Revlimid 15 mg every days ___, with weekly dexamethasone at 20 mg, repeated every month, with Zometa every 3 months, for quite some time, although by ___, the patient was becoming more leukopenic. At the start of cycle 19 of Revlimid and dexamethasone, in ___, the M-spike was down to 0.6 g/dL, and the Revlimid was reduced to 10 mg per day because of severe neutropenia. Unfortunately by ___ timeframe, the M-spike started to creep up, to 0.8 g/dL fairly consistently through the ___, and by ___, at her ___ cycle of Revlimid and dexamethasone, the M-spike increased to 0.9 g/dL. She was increased to Rev 15 mg and her counts are holding. She reports she missed a month of Rev due to her hospitalization in ___ Cycle #27 Rev 15mg -Dex ___ Clinic appt start Biaxin ___ Cycle #28 Rev-Dex ___ Clinic appt reviewed labs M-spike 0.8g/dL ___ Cycle #29 Rev-Dex ___ Admitted for hematuria, elevated INR attributed to Ultram-warfarin interaction ___ Clinic appt Zometa, on cycle #29 ___ Cycle #30 Rev-Dex ___ Cycle #31-- decided to continue without a clinic appt, she was having a great time visiting family in ___ ___ Cycle #31 day #19 ___ Cycle #32 ___ Cycle #33 and Zometa ___ Cycle #34 start on ___ end ___. ___ Cycle #35 start ___ end ___. M-spike 0.9g/dL ___ Cycle #36, start ___, Zometa, end ___. M-spike 0.8g/dL ___ Cycle ___ M-spike 0.9g/dL. Now ___ years on Rev-dex (first cycle was ___ Cycle ___ M-spike 0.9g/dL IgG stable. Start Rev ___ ___ finish ___ See me in clinic before cycle #39 start ___ finish ___ See me in clinic, Zometa, cycle #40 will start ___ ( I am out of office ___ ___ Admitted ___ obstructive uropathy and enterococcal UTI discharged ___ to rehab ___ ___ discharged ___ Touched base by phone, hold Revlimid until next follow up ___ Cycle #41 start ___ end ___ Stent change scheduled ___ Cycle #42 planned start ___ Zometa, Previously followed in hem/onc by Dr ___ today to establish care with me. ___ Cycle 44 ___ Cycle 45, zometa ___ Cycle 46 ___ Cycle 47, zometa ___ Cycle 48 Rev ___ Cycle 49 rev, zometa ___ Cycle 50 rev ___ Cycle 51 rev ___ Anal cancer - adeno diagnosed PAST MEDICAL HISTORY: Hypertension Atrial fibrillation on coumadin Obesity Myeloma Osteoarthritis of right knee UPJ obstruction s/p stent placement ___ c/b persistent Klebsiella bacteruria Anal adenocarcinoma (dx ___ ? Perirectal cyst drainage in ___ PSH: ___ - EUA, biopsy of ___ lesion ___ - cystoscopy and R ureteral stent exchange ___ - lap CCY Hysterectomy ___ - unknown ___ procedure <SOCIAL HISTORY> ___ <FAMILY HISTORY> Her parents died in their ___ or ___ of ""old age."" Her parents and multiple siblings have hypertension. Sibling with Alzheimer's disease. No family history of significant arrhythmia or premature coronary disease. <PHYSICAL EXAM> Physical exam on admission: -============ Vitals- T: 96.2 BP 60's-110's/30___s-80's HR 110-140's satting 100% on the vent GENERAL: intubated, sedated HEENT: Sclera anicteric NECK: Trauma line left IJ, bruising at insertion site LUNGS: Good air movement bilaterally with transmitted upper airway sounds CV: Irregular, tachycardic, no S3/S4 appreciated, thready peripheral pulses with delayed cap refill, cool ABD: soft, mildly distended, midline wound vac, ostomy intact and dry with dry trochanter sites. LLQ JP draining serosang. Right JP drain serosang. EXT: Anasarcic, cool, thready pulses. Left ___ finger laxity c/w fracture, right shin with IO c/d/i SKIN: Bruising without petechia, pitting edema Physical exam on discharge: -============ <PERTINENT RESULTS> Labs on admission: -====== ___ 06: 20PM BLOOD WBC-2.5* RBC-3.24* Hgb-10.0* Hct-30.3* MCV-94 MCH-30.9 MCHC-33.0 RDW-19.8* Plt Ct-92* ___ 09: 27PM BLOOD Hypochr-NORMAL Anisocy-2+ Poiklo-1+ Macrocy-1+ Microcy-1+ Polychr-1+ Ovalocy-1+ Schisto-OCCASIONAL Burr-OCCASIONAL ___ 10: 32AM BLOOD Neuts-72.4* Lymphs-12.8* Monos-8.7 Eos-5.5* Baso-0.5 ___ 06: 20PM BLOOD Plt Smr-LOW Plt Ct-92* ___ 10: 32AM BLOOD Plt ___ ___ 07: 05PM BLOOD ___ PTT-60.4* ___ ___ 10: 35PM BLOOD ___ ___ 06: 20PM BLOOD Glucose-96 UreaN-9 Creat-0.7 Na-142 K-3.7 Cl-111* HCO3-26 AnGap-9 ___ 09: 27PM BLOOD ALT-6 AST-15 LD(LDH)-142 CK(CPK)-74 AlkPhos-28* TotBili-1.4 ___ 06: 20PM BLOOD Calcium-8.2* Phos-2.5* Mg-1.9 ___ 05: 35PM BLOOD Type-ART pO2-248* pCO2-44 pH-7.29* calTCO2-22 Base XS--4 ___ 05: 35PM BLOOD Glucose-138* Lactate-2.3* Na-137 K-4.0 Cl-114* ___ 05: 35PM BLOOD Hgb-8.7* calcHCT-26 ___ 05: 35PM BLOOD freeCa-1.37* Reports: -====== ___: KUB IMPRESSION: No evidence of unanticipated foreign body. ___: Chest IMPRESSION: ET tube tip is 4.7 cm above the carinal. NG tube tip is 2 proximal, at the gastroesophageal junction and should be advanced. Right internal jugular line tip is in the right atrium. The cardiomediastinal silhouette is substantially increased potentially due to very low lung volumes with bibasal consolidations. Nodular opacity in the right lower lobe is not well seen on the previous examination, might represent summation of shadows and should be reassessed on subsequent imaging. The findings might in fact represent a combination of low lung volumes and mild pulmonary edema. ___: Hand XR IMPRESSION: There is no evidence of fracture or dislocation. No osteopenia is present. Mild deformity at the distal interphalangeal joint of the second finger is present associated with soft tissue swelling but no evidence of erosions is present. First carpometacarpal joint osteophytes are present, overall finding that are most likely consistent with osteoarthritis. ___ RUQ U/S: 1. Normal liver echogenicity. 2. Mild right hydronephrosis with prominent extrarenal pelvis and right ureteric stent. ___ CXR: Dobbhoff tube tip is in the stomach. Right central venous line tip is at the level of the right atrium. No change in large bilateral pleural effusions and vascular congestion demonstrated. Left PICC line tip is at the level of lower SVC. ___ CT head: No acute intracranial process. If further imaging evaluation is indicated, MRI would be more sensitive than CT. ___ LUE ultrasound: 1. Non-occlusive thrombus in the left internal jugular vein. 2. Occlusive thrombus around the PICC line in one of the left brachial veins. No evidence of thrombus around the portion of the PICC line within the subclavian vein Microbiology: -====== ___ 3: 00 pm SWAB DEEP PERINEAL AEROBIC/ANAEROBIC CULTURE. GRAM STAIN (Final ___: 3+ ___ per 1000X FIELD): POLYMORPHONUCLEAR LEUKOCYTES. NO MICROORGANISMS SEEN. WOUND CULTURE (Preliminary): MIXED BACTERIAL FLORA. This culture contains mixed bacterial types (>=3) so an abbreviated workup is performed. Any growth of P.aeruginosa, S.aureus and beta hemolytic streptococci will be reported. IF THESE BACTERIA ARE NOT REPORTED BELOW, THEY ARE NOT PRESENT in this culture.. PSEUDOMONAS AERUGINOSA. SPARSE GROWTH. SENSITIVITIES: MIC expressed in MCG/ML _________________________________________________________ PSEUDOMONAS AERUGINOSA | CEFEPIME-------------- 2 S CEFTAZIDIME----------- 16 I CIPROFLOXACIN---------<=0.25 S GENTAMICIN------------ <=1 S MEROPENEM-------------<=0.25 S PIPERACILLIN/TAZO----- <=4 S TOBRAMYCIN------------ <=1 S ANAEROBIC CULTURE (Final ___: UNABLE TO R/O OTHER PATHOGENS DUE TO OVERGROWTH OF SWARMING PROTEUS SPP.. Labs on discharge: -====== <MEDICATIONS ON ADMISSION> The Preadmission Medication list may be inaccurate and requires futher investigation. 1. Docusate Sodium 200 mg PO BID 2. Omeprazole 20 mg PO DAILY 3. Citalopram 10 mg PO DAILY 4. Dexamethasone 4 mg PO 1X/WEEK (TH) 5. Psyllium Wafer 1 WAF PO DAILY 6. OxycoDONE (Immediate Release) 10 mg PO Q6H: PRN pain 7. Diltiazem Extended-Release 120 mg PO DAILY 8. Metoprolol Succinate XL 100 mg PO DAILY 9. OxycoDONE (Immediate Release) 15 mg PO QHS 10. Polyethylene Glycol 17 g PO DAILY <DISCHARGE MEDICATIONS> 1. Acetaminophen (Liquid) 1000 mg PO TID do not take more than 4,000mg in a single day. Wean as tolerated. 2. Diltiazem 30 mg PO QID 3. Heparin Flush (10 units/ml) 5 mL IV DAILY and PRN, line flush 4. Artificial Tears ___ DROP BOTH EYES PRN Dry eyes 5. Heparin Flush (100 units/ml) 5 mL IV PRN DE-ACCESSING port 6. Metoprolol Tartrate 50 mg PO Q6H 7. TraMADOL (Ultram) 25 mg PO Q6H: PRN pain 8. Miconazole Powder 2% 1 Appl TP TID: PRN breast skin irritation 9. QUEtiapine Fumarate 12.5 mg PO QHS 10. Citalopram 10 mg PO DAILY 11. Dexamethasone 4 mg PO 1X/WEEK (TH) 12. Diltiazem Extended-Release 120 mg PO DAILY 13. Docusate Sodium 200 mg PO BID 14. Metoprolol Succinate XL 100 mg PO DAILY 15. Omeprazole 20 mg PO DAILY 16. OxycoDONE (Immediate Release) 15 mg PO QHS 17. Polyethylene Glycol 17 g PO DAILY 18. Psyllium Wafer 1 WAF PO DAILY <DISCHARGE DISPOSITION> Extended Care Facility: ___ <DISCHARGE DIAGNOSIS> Locally advanced, distal anorectal cancer status post short-course radiation therapy. <DISCHARGE CONDITION> Mental Status: Confused - always. Level of Consciousness: Lethargic but arousable. Activity Status: Bedbound. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> You were admitted to the hospital after an open abdominoperineal resection and perineal closure with flap for surgical management of your advanced anal adenocarcinoma. You are still recovering from this procedure and will need additional time for healing at a longterm care facility. Please monitor your bowel function closely. You may or may not have had a bowel movement prior to your discharge which is acceptable, however it is important that you have a bowel movement in the next ___ days. After anesthesia it is not uncommon for patients to have some decrease in bowel function but you should not have prolonged constipation. Some loose stool and passing of small amounts of dark, old appearing blood are expected. However, if you notice that you are passing bright red blood with bowel movements or having loose stool without improvement please call the office or go to the emergency room if the symptoms are severe. If you are taking narcotic pain medications there is a risk that you will have some constipation. Please take an over the counter stool softener such as Colace, and if the symptoms do not improve call the office. If you have any of the following symptoms please call the office for advice or go to the emergency room if severe: increasing abdominal distension, increasing abdominal pain, nausea, vomiting, inability to tolerate food or liquids, prolonged loose stool, or extended constipation. You have a long vertical incision on your abdomen that is closed with staples. This incision can be left open to air or covered with a dry sterile gauze dressing if the staples become irritated from clothing. The staples will stay in place until your first post-operative visit at which time they can be removed in the clinic, most likely by the office nurse. Please monitor the incision for signs and symptoms of infection including: increasing redness at the incision, opening of the incision, increased pain at the incision line, draining of white/green/yellow/foul smelling drainage, or if you develop a fever. Please call the office if you develop these symptoms or go to the emergency room if the symptoms are severe. You may shower, let the warm water run over the incision line and pat the area dry with a towel, do not rub. No heavy lifting for at least 6 weeks after surgery unless instructed otherwise by your surgical team. You may gradually increase your activity as tolerated but clear heavy exercise with your surgical team. You will be prescribed a small amount of the pain medication. Please take this medication exactly as prescribed. You may take Tylenol as recommended for pain. Please do not take more than 4000mg of Tylenol daily. Do not drink alcohol while taking narcotic pain medication or Tylenol. Please do not drive a car while taking narcotic pain medication. Thank you for allowing us to participate in your care! Our hope is that you will have a quick return to your life and usual activities. Good luck! Ileostomy Takedown You were admitted to the hospital after an ileostomy takedown. You have recovered from this procedure well and you are now ready to return home. You have tolerated a regular diet, passing gas and your pain is controlled with pain medications by mouth. You may return home to finish your recovery. Please monitor your bowel function closely. You may or may not have had a bowel movement prior to your discharge which is acceptable, however it is important that you have a bowel movement in the next ___ days. After anesthesia it is not uncommon for patients to have some decrease in bowel function but your should not have prolonged constipation. Some loose stool and passing of small amounts of dark, old appearing blood are expected however, if you notice that you are passing bright red blood with bowel your please seek medical attention. If you are passing loose stool without improvement please call the office or go to the emergency room if the symptoms are severe. If you are taking narcotic pain medications there is a risk that you will have some constipation. Please take an over the counter stool softener such as Colace, and if the symptoms does not improve call the office. It is also not uncommon after an ileostomy takedown to have frequent loose stools until you are taking more regular food however this should improve. The muscles of the sphincters have not been used in quite some time and you may experience urgency or small amounts of incontinence however this should improve. If you do not show improvement in these symptoms within ___ days please call the office for advice. Occasionally, patients will need to take a medication to slow their bowel movements as their bodies adjust to the new normal without an ileostomy, you should consult with our office for advice. If you have any of the following symptoms please call the office for advice or go to the emergency room if severe: increasing abdominal distension, increasing abdominal pain, nausea, vomiting, inability to tolerate food or liquids, prolonged loose stool, or constipation. You have a small wound where the old ileostomy once was. This should be covered with a dry sterile gauze dressing. The wound no longer requires packing with gauze packing strip. Please monitor the incision for signs and symptoms of infection including: increasing redness at the incision, opening of the incision, increased pain at the incision line, draining of white/green/yellow/foul smelling drainage, or if you develop a fever. Please call the office if you develop these symptoms or go to the emergency room if the symptoms are severe. You may shower, let the warm water run over the wound line and pat the area dry with a towel, do not rub. Please apply a new gauze dressing after showering. No heavy lifting for at least 6 weeks after surgery unless instructed otherwise by your surgical team. You may gradually increase your activity as tolerated but clear heavy exercise with your surgical team. You will be prescribed a small amount of the pain medication. Please take this medication exactly as prescribed. You may take Tylenol as recommended for pain. Please do not take more than 3000mg of Tylenol daily. Do not drink alcohol while taking narcotic pain medication or Tylenol. Please do not drive a car while taking narcotic pain medication. Thank you for allowing us to participate in your care! Our hope is that you will have a quick return to your life and usual activities. Good luck! ","FICU course: ___ F with history of multiple melanoma on revlimid, afib, ureteropelvic obstruction s/p stent ___ c/b persistent Klebsiella bacteruria, anal adenocarcinoma with delayed treatment s/p radiation ___, s/p planned abdominal/perineal resection with small bowel resection with end colostomy, fiducial seed placement and perineal closure, transferred to FICU for hypotension. Course complicated by AMS due to delirium, A fib with RVR, and pseudomonal infection. She was transferred to the floor on ___. Floor course was remarkable for wound dehiscence, continued afib with occasional RVR and ongoing delirium. # Hypotension: Most likely due to volume loss (8hr procedure with persistent oozing) compounded by third spacing from SIRS DIC response with hypoalbuminemia and anesthesia with delayed renal clearance and finaly RVR with poor filling time. Estimated blood loss was 1L though poorly quantified given the extent of the procedure. Intraop she received 6L crystalloid, 4 PRBC, and albumin (by report though unable to find in OMR), and her post op crit nevertheless dropped from 32 to 22. Post op bleeding possible with DIC (INR 1.2->2.4) and thrombocytopenia nadir 39, though there are no outward signs of blood loss- hemostasis was noted at closure, the incisions have been dry with no significant drains putting out appropriate though dark serosanguanous fluid. Patient required pressor support with phenylephrine, noepinephrine, and vasopressin post-operatively. Patient was empirically covered with vanc/zosyn briefly, though this was discontinued given no clear source of infection. Patient experienced recurrent hypotension on ___ after returning from OR on ___. This was felt to be due to intra-operative blood loss and fluid shifts. She received 1U PRBCs on ___ intra-operatively and again on ___ due to drop in H/H. BP improved with IVF bolus, blood transfusions, and improved control of A fib with RVR. # DIC: INR rose 1.2-> 2.4, platelets dipped to 39 with occasionaly schistos. This is likely from the procedure, no evidence of infection, and it appears to have responded to FFP with stable fibrinogen not requiring cryo. No evidence of petichiae, no appreciable oozing from lines and wounds. SQ heparin was discontinued, then restarted on ___ once platelets > 50. Thrombocytopenia improved during ICU course. It gradually resolved and normalized by ___. # Afib: Previously on warfarin and rate controlled with dilt, bridged with lovenox and dilt recently decreased to 120 due to soft systolics during previous admission. Patient was controlled with dilt gtt and was also briefly on amiodarone. Patient was then transitioned to PO metoprolol and diltiazem for ongoing rate control. # Anal Mucinous Adenocarcinoma Diagnosed in ___. Restaging ___ showed T4 disease extending beyond the anal verge, progressing through external muscle of anal sphincter, progression from 3 months ago. Per report she is status post 5 fractions XRT per Drs. ___, completed ___. Patient underwent abdominal/perineal resection with small bowel resection with end colostomy, fiducial seed placement and perineal closure on ___. Underwent flap debridement, local flap advancement closure on ___. She was started on ancef on ___ per plastic surgery, to be continued until all JP drains removed. She was also started on flagyl post-operatively ___. Deep wound culture from OR on ___ grew Pseudomonas, sparse growth, for which she was started on cefepime on ___. She was switched to IV cipro based on sensitivities and antibiotics were discontinued on ___. The Right side JP was removed on ___ as well since the opening of wound exposed the JP to air and was not able to hold suction. The Left side JPs were left in place. #wound: midline wound dehisced, requiring wet to dry dressing changes daily. It is in the proximity of the ostomy and application of wound vac would be very difficult to manage at this location. we continued with wet to dry dresssing allowing it to heal via second intention. #thromboses: patient with new LUE swelling on ___, found to have thrombosis associated with PICC on U/S. Also has non-occlussive L IJ thrombosis, likely secondary to prior trauma line. Discontinued PICC ___ and patient was not anticoagulated, after discussion with surgery and heme/onc the decision was not to anti-coagulate due to ongoing wound complications and poor overall prognosis. #AMS: most likely secondary to ICU delirium with waxing and waning mental status. Mental status improved significantly during ICU course and patient was placed on seroquel qhS PRN. This was continued while on the floor. Her mentation did not improve much and has ongoing delirium. # Lactic acidosis: Combination of tissue disruption from surgery and hypoperfusion from above. Lactate improved with improved BP. #nutrition: patient with low albumin and pre-albumin levels with poor nutrtional status likely contributing to poor wound healing. She was restarted on TFs post-operatively when cleared by surgery. She was seen by ___ who recommended soft solids and thin liquids, along with supplemental tube feeds. A dobhoff was placed and bridled in the ICU. We continued TF at goal after she was transferred to the floor. She tolerated the TF without issues. # left ___ finger fracture: no op. ",5035,1230
10003400-DS-19,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> Sacral ulcer <MAJOR SURGICAL OR INVASIVE PROCEDURE> Uretropelvic junction stent replacement Intubation PICC line placement Right Chest tube placement <HISTORY OF PRESENT ILLNESS> Ms. ___ is a ___ year-old woman a PMH significant for AFib on coumadin, UPJ obstruction s/p stent placement in ___ c/b chronic Klebsiella bacturia, IgG myeloma on lenolidamide, and adenocarcinoma of the anal canal (followed by Dr. ___ admitted to ___ for evaluation of anemia (Hgb 8.6) with course complicated by atrial fibrillation with RVR requiring ICU admission for dilt gtt, Acute of chronic kidney injury osteomyelitis from sacral decubitus ucler who was transferred to ___ for debridement of sacral ulcer. In the ED she developed afib with RVR with hypotension where she briefly required a dilt gtt. She was then transferred to the floor. Hospital course thus far has included an MRI without osteomyelitis, abdominal distension w/ NGT placement draining bilious contents, CBI and urology procedure for evaluation of hematuria. She underwent cystoscopy ___ to exchange ureteral stent and found purulence behind stent. There was no etiology of hematuria seen. She was started on vanc and zosyn and kept on fluconazole started pre-procedure. Culture significant for ___ albicans and MDR pseudomonas SN to Gentamicin which was held ___ ___. Following cystoscopy, were unable to extubate and couldn't get off pressors. Per report, black colored liquid was coming out of NGT. Required FICU transfer FICU Course Significant for: Extubation and starting on tube feeding. Was restabilized and discharged from the FICU where CT Torso revealed New retroperitoneal soft tissue mass encasing the aorta and common iliac vessels in comparison to the ___ examination. The mass abuts the second and third portion of the duodenum and pancreatic head. Suspected involvement of the pancreatic head and distal CBD with new intra and extrahepatic bile duct dilation. Encasement of both ureters, with new left and worsened right moderate hydronephrosis in comparison to the ___ Transferred to ___ where course was complicated by hypotension and worsening of anemia in the setting of gross hematuria. Her VS were 85/Doppler and HR of high ___. She received one unit prbc at the time of initial assessment and 2nd unit being hung. Prior to transfer: hung 2nd unit prbc (first at about 3). -Obtained ABG. -Guiac positive On arrival to the CCU, pt in respiratory distress with shallow breathing. Intermittently responsive, able to follow some commands. Felt ""ok"" but increasingly somnolent. <PAST MEDICAL HISTORY> PAST ONCOLOGIC HISTORY: #ANAL ADENOCA: Per Dr. ___: Admitted to ___ ___ for BRBPR. Found to have anal adenocarcinoma, T2N0 based on MRI and CT. Seen by Dr ___ in the hospital from surgery but has been noncompliant with f/u with her despite multiple outreaches from her office. #MM: ___ woman who presented with anemia in ___. Further testing demonstrated an M-spike of approximately 3.3 g/dL, IgG was 5800 mg/dL. Eventually, the patient was referred to Hematology, IgG increased to 7100mg/dL at the start of treatment. Initial Hematology consult was ___. Bone marrow biopsy revealed 60% of her bone marrow occupied by plasma cells, cytogenetics demonstrated translocation of chromosomes 11 and 14, also monosomy 13. Skeletal survey was negative. Initial beta 2 microglobulin was 4.08, she started cycle 1 of Revlimid and dexamethasone on ___, Revlimid at 25 mg. She was admitted to ___ on ___, with pneumonia, she was also coagulopathic and quite leukopenic. She was discharged on ___. On ___, she presented with severe back pain, and she has sustained a compression fracture of L3 vertebra. Her white blood cell count was still low, the Revlimid was held, and restarted on ___ at a lower dose of 15 mg, in combination with weekly dexamethasone at 20 mg. She was started on Zometa. The patient did well on this lower dose of Revlimid with a nice improvement in her IgG and M-spike, M-spike going down to 1.0 g/dL by ___, and her IgG going into the normal range at the same time, she continued on Revlimid 15 mg every days ___, with weekly dexamethasone at 20 mg, repeated every month, with Zometa every 3 months, for quite some time, although by ___, the patient was becoming more leukopenic. At the start of cycle 19 of Revlimid and dexamethasone, in ___, the M-spike was down to 0.6 g/dL, and the Revlimid was reduced to 10 mg per day because of severe neutropenia. Unfortunately by ___ timeframe, the M-spike started to creep up, to 0.8 g/dL fairly consistently through the ___, and by ___, at her ___ cycle of Revlimid and dexamethasone, the M-spike increased to 0.9 g/dL. She was increased to Rev 15 mg and her counts are holding. She reports she missed a month of Rev due to her hospitalization in ___ Cycle #27 Rev 15mg -Dex ___ Clinic appt start Biaxin ___ Cycle #28 Rev-Dex ___ Clinic appt reviewed labs M-spike 0.8g/dL ___ Cycle #29 Rev-Dex ___ Admitted for hematuria, elevated INR attributed to Ultram-warfarin interaction ___ Clinic appt Zometa, on cycle #29 ___ Cycle #30 Rev-Dex ___ Cycle #31-- decided to continue without a clinic appt, she was having a great time visiting family in ___ ___ Cycle #31 day #19 ___ Cycle #32 ___ Cycle #33 and Zometa ___ Cycle #34 start on ___ end ___. ___ Cycle #35 start ___ end ___. M-spike 0.9g/dL ___ Cycle #36, start ___ or ___, Zometa, end ___. M-spike 0.8g/dL ___ Cycle ___ M-spike 0.9g/dL. Now ___ years on Rev-dex (first cycle was ___ Cycle ___ M-spike 0.9g/dL IgG stable. Start Rev ___ ___ finish ___ See me in clinic before cycle #39 start ___ finish ___ See me in clinic, Zometa, cycle #40 will start ___ ( I am out of office ___ ___ Admitted ___ obstructive uropathy and enterococcal UTI discharged ___ to rehab ___ ___ discharged ___ Touched base by phone, hold Revlimid until next follow up ___ Cycle #41 start ___ end ___ Stent change scheduled ___ Cycle #42 planned start ___ Zometa, Previously followed in hem/onc by Dr ___ today to establish care with me. ___ Cycle 44 ___ Cycle 45, zometa ___ Cycle 46 ___ Cycle 47, zometa ___ Cycle 48 Rev ___ Cycle 49 rev, zometa ___ Cycle 50 rev ___ Cycle 51 rev ___ Anal cancer - adeno diagnosed PAST MEDICAL HISTORY: Hypertension Atrial fibrillation on coumadin Obesity Myeloma Osteoarthritis of right knee UPJ obstruction s/p stent placement ___ c/b persistent Klebsiella bacteruria Anal adenocarcinoma (dx ___ ? Perirectal cyst drainage in 1980s PSH: ___ - EUA, biopsy of ___ lesion ___ - cystoscopy and R ureteral stent exchange ___ - lap CCY Hysterectomy ___ - unknown ___ procedure <SOCIAL HISTORY> ___ <FAMILY HISTORY> Her parents died in their ___ or ___ of ""old age."" Her parents and multiple siblings have hypertension. Sibling with Alzheimer's disease. No family history of significant arrhythmia or premature coronary disease. <PHYSICAL EXAM> Admission <PHYSICAL EXAM> Vitals: 97.8 120/77 118 20 100RA GENERAL: Elderly woman, lying in bed, NAD HEENT: AT/NC, EOMI, PERRL, anicteric sclera, pink conjunctiva, MMM NECK: nontender supple neck, no LAD, no JVD CARDIAC: Irregularly irregular, +S1/S2, no murmurs, gallops, or rubs LUNG: CTAB, no wheezes, rales, rhonchi, breathing comfortably without use of accessory muscles ABDOMEN: nondistended, +BS, nontender in all quadrants, no rebound/guarding, no hepatosplenomegaly. Anus with friable mucosa. Ostomy in place EXTREMITIES: 2 piting edema up through shins bilaterally, no cyanosis or clubbing PULSES: 2+ DP pulses bilaterally NEURO: CN II-XII and motor grossly intact intact SKIN: warm and well perfused, no excoriations or lesions, no rashes Discharge <PHYSICAL EXAM> deceased <PERTINENT RESULTS> Admission Labs: --------------- ___ 04: 38AM BLOOD WBC-4.3 RBC-2.88* Hgb-8.6* Hct-25.9* MCV-90 MCH-29.9 MCHC-33.2 RDW-15.9* RDWSD-52.1* Plt ___ ___ 04: 38AM BLOOD Neuts-53 Bands-0 Lymphs-14* Monos-25* Eos-3 Baso-0 ___ Metas-2* Myelos-3* AbsNeut-2.28 AbsLymp-0.60* AbsMono-1.08* AbsEos-0.13 AbsBaso-0.00* ___ 04: 38AM BLOOD Hypochr-2+ Anisocy-NORMAL Poiklo-NORMAL Macrocy-NORMAL Microcy-NORMAL Polychr-NORMAL ___ 04: 38AM BLOOD ___ PTT-27.0 ___ ___ 04: 38AM BLOOD Glucose-101* UreaN-35* Creat-2.0*# Na-134 K-4.9 Cl-98 HCO3-27 AnGap-14 ___ 04: 38AM BLOOD ALT-6 AST-18 LD(LDH)-182 AlkPhos-75 TotBili-0.4 ___ 04: 38AM BLOOD Albumin-2.4* Calcium-8.1* Phos-3.6 Mg-2.1 ___ 04: 38AM BLOOD Vanco-14.6 IMAGES: ------- ___ CXR Port-A-Cath catheter tip is at the level of the right ventricular outflow tract. The double tube has been removed. There is substantial distension of the stomach that might potentially benefit from the NG tube insertion. What appears to be a E ureteral stent is partially imaged. Bilateral pleural effusions, right more than left are present. Vascular congestion is noted, borderline with mild interstitial pulmonary edema. ___ KUB 1. A right double J stent projects over the expected location of the right renal pelvis and bladder. The stent is unchanged in position since ___. 2. The stomach is distended with air. ___ TTE The left atrium is moderately dilated. Left ventricular wall thicknesses and cavity size are normal. Regional left ventricular wall motion is normal. Overall left ventricular systolic function is low normal (LVEF 50-55%). The estimated cardiac index is normal (>=2.5L/min/m2). Tissue Doppler imaging suggests a normal left ventricular filling pressure (PCWP<12mmHg). The right ventricular cavity is mildly dilated with normal free wall contractility. The aortic valve leaflets (3) are mildly thickened but aortic stenosis is not present. Trace aortic regurgitation is seen. The mitral valve leaflets are structurally normal. There is no mitral valve prolapse. Mild to moderate (___) mitral regurgitation is seen. There is mild to moderate pulmonary artery systolic hypertension. There is no pericardial effusion. Compared with the prior study (images reviewed) of ___, the findings are similar. ___ Renal US 1. Moderate hydronephrosis and cortical thinning on the right. Mild hydronephrosis on the left. These findings are unchanged from CT ___. 2. A large pleural effusion is unchanged from ___. ___ CXR As compared to the previous radiograph, the right sided J-stent is unchanged. The previously severe gastric over distension has further increased in severity and is now massive. ___ CXR As compared to ___, the patient has received a new nasogastric tube. The tube is located in the middle parts of the stomach. The previous overinflation of the stomach is no longer present. The lung volumes remain low. Moderate cardiomegaly. Moderate bilateral areas of atelectasis and mild to moderate right pleural effusion. ___ MRI Sacrum PND - preliminary read is no osteomylelitis Discharge Labs: N/A --------------- <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Acetaminophen (Liquid) 1000 mg PO TID 2. Diltiazem 30 mg PO QID 3. Heparin Flush (10 units/ml) 5 mL IV DAILY and PRN, line flush 4. Artificial Tears ___ DROP BOTH EYES PRN Dry eyes 5. Heparin Flush (100 units/ml) 5 mL IV PRN DE-ACCESSING port 6. TraMADOL (Ultram) 25 mg PO Q6H: PRN pain 7. Dexamethasone 4 mg PO 1X/WEEK (TH) 8. Calcium Carbonate 500 mg PO BID: PRN heart burn 9. Collagenase Ointment 1 Appl TP DAILY 10. Escitalopram Oxalate 5 mg PO DAILY 11. Metoprolol Succinate XL 200 mg PO DAILY 12. Mirtazapine 7.5 mg PO QHS 13. Pantoprazole 40 mg PO Q24H 14. Furosemide 80 mg PO DAILY <DISCHARGE MEDICATIONS> N/A <DISCHARGE DISPOSITION> Expired <DISCHARGE DIAGNOSIS> Patient Expired <DISCHARGE CONDITION> Patient Expired <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Patient Expired ","Ms. ___ is a ___ year-old woman a PMH significant for AFib on coumadin, UPJ obstruction s/p stent placement in ___ c/b chronic Klebsiella bacturia, IgG myeloma on lenolidamide, and adenocarcinoma of the anal canal (followed by Dr. ___ admitted to ___ for evaluation of anemia (Hgb 8.6) with course complicated by atrial fibrillation with RVR requiring ICU admission for dilt gtt, Acute of chronic kidney injury, ?osteomyelitis from sacral decubitus ulcer now transferred to ___ for debridement of sacral ulcer. Became hypotensive and quite anemic on the floor with H/H of ___ and was transferred to the MICU ___. She peacefully passed away with her family and family pastor present in the room at ___ on ___. #Hypercarbic respiratory failure: The pt consistently required nasal cannula up to 6 L while on the floor. This was thought to be due to volume overload and increased work of breathing. While in the CCU pt became more lethargic and an ABG showed hypercarbic respiratory failure. She was intubated by anesthesia. CXR showed large bilateral pleural effusions and she was grossly anasarcic. IP placed a right chest tube to drain the effusion which showed that it was malignant with cytology showing adenocarcinoma. She was extubated successfully on ___ and was weaned down to room air thereafter. She was able to be comfortable on room air for the rest of her admission. # Encephalopathy: although the pt's mental status had noticed to be declining on the floor, she was still able to answer appropriately. After extubation, the pt was noted to be very lethargic and minimally responsive. EEG was done which showed triphasic waves consistent with an encephalopathy. The pt was trialed on Ativan and Keppra. Her mental status remained very poor in spite of continued Keppra. Neuro signed off after head imaging was unrevealing. Mental status continued to wax and wane through the rest of her time. # Stage IV surgical dehiscence: Patient had correction of abdominoperineal resection defect with a right vertical rectus abdominis muscular cutaneous flap in ___ following resection of anal cancer. She presented to the hospital with stage IV, MRSA + sacral ulcer with concern for osteomyelitis, as wound probes to bone. CT scan with no mention of sacral osteomyelitis. GI deferred to plastics as they did flap surgery. Plastics does not recommend surgical intervention at this time. MRI shows no signs of osteomyelitis. This wound remained stable during her hospital course. # ___: Baseline Creatinine 0.8. Creatinine on admission was 2.1 in setting of diuresis but also possible hypotension from afib with RVR. Pt is grossly volume overloaded with hypoalbumenemia. Concern for prerenal vs. intrinsic with possible multiple myeloma involvement vs obstructive. Creatinine remains above 2.0 today. Renal consulted and believed that her ___ was predominantly secondary to obstruction. After stent exchange by urology ___, renal function improved with a Cr to 1.5 with IV fluids and remained stable. # Gastric Distension: Patient developed nausea and 1 episode of vomiting ___ with increasing distention. And xray ___ showed significant gastric distension. NG tube was placed and >1L was drawn off. Patient's reported symptomatic improvement. Patient continued to have ostomy output throughout episode. No mass appreciated on exam though obese abdomen. Patient not on narcotic medication. On ___, NG tube was clamped without recurrence of distention, patient denies nausea or distension. Unable to get CT abd due to poor kidney function, but got OSH CT read by our radiologists. It was notable for new retroperitoneal mass encasing aorta throughout abdomen. It is touching and possibly invading ___ and ___ portion of duodenum, potentially explaining gastric obstruction symptoms. Invades pancreatic head, explaining ductal dilatation. Also surrounding common iliac vessels, and both ureters (hydronephrosis worse since ___. Speech and swallow was consulted who said the pt should be strict NPO. Tube feeds were started. # Tube feeds: On ___ Ms. ___ was no longer tolerating her tube feeds due to very high residuals. Tube feeds were stopped and she was given nutrition with D5NS at 75/hr. ___ attempted to place the Dobhoff tube post-pyloric but they were unable to pass the tube through the pylorus and noted contrast barely trickles through ___ obstruction. In family meetings the family was informed that the feeding tube could not be advanced, and that other options such as TPN would likely harm the pt more than help her because of her risk for bloodstream infection and metabolic derangements. # Metastatic anal adenocarcinoma: large retroperitoneal mass compressing the abdomen and constricting the aorta at the level of the iliacs noted on CT from OSH, thought to be metastasis from her known anal adenocarcinoma. Per onc, not a candidate for chemotherapy, so likely not worth biopsying even though definitive diagnosis would not otherwise be reached. Recommend getting palliative care involved and having goals of care discussion with family. First family meeting was ___ and son, ___, wanted us to do everything we could to help Ms. ___. This continued to be a theme during her hospital stay, and several meetings were held with the family to discuss goals of care. On ___ it was decided to switch to focusing on her comfort only. # Volume overload: Likely from diastolic heart failure but will need to rule out hypoalbuminemic state, and cirrhosis. Patient with gross volume overload with 2+ ___ edema, bilateral effusions and CT with anasarca on abdominal imaging. TTE unchanged from previous with EF 55% and no gross valvular dysfunction. TSH elevated, T4 WNLs. Patient given albumin ___ with good response. However, patient still significantly overloaded. On ___ she was anuric and hypotensive despite having significant lower extremity and abdominal edema. She was transferred to the MICU on this day. While in the MICU she was stabilized and pressors were downtitrated. Poor response to Lasix alone but given Lasix and Chlorothiazide with good UOP. # Hematuria: Unclear cause but patient was on anticoagulation. Concern would be primarily for tumor infiltration. Hematuria intermittent, but seems to recur during transport. Potential mechanical irritation. Patient continues to pass dime sized clots. Stent exchange done ___ by urology, with improvement in her hematuria. Hematuria with clots returned on ___. Urology recommended CBI which was started ___. She had CBI intermittently throughout her stay to relieve foley obstructions. # Normocytic Anemia: Hgb at ___ 8.6. No evidence of bleeding. She does have stage III CKD. MCV within normal range and iron studies not particularly suggestive of iron deficiency anemia with ferritin of 781. Folate level of 7.4 and B12 of 411. Concern could possibly be for chronic low grade bleed from gut or hematuria. (transfused evening of ___. Hgb remained stable in the 7's until ___ when H/H dropped to ___. This same day she triggered for hypotension of 86/Doppler. As she was anuric at this time there was concern of intraabdominal bleeding and was one of the indications for MICU transfer. Pt had episode of gross hematuria requiring CBI and pRBC transfusion for BP control. Pt required Vasopressin and Phenylephrine while in the MICU but was able to be weaned off. She required intermittent pRBC transfusions during her time in the MICU. # AFib on coumadin: CHADS 2 of 3. Hemodynamically unstable with RVR upon arrival, but controlled with diltiazem and metoprolol. She remained in AFib during her hospital stay. Due to her hematuria and dropping H/H, blood pressure medications and ultimately SQH were discontinued on ___. Pt put on an esmolol gtt as she had afib with RVR into the 130s on her first day in the ICU. She was taken off the esmolol drip and thereafter controlled with IV metoprolol and achieved good control on PO metoprolol with heart rates in the ___. # Hypertension: Currently normotensive. See above for issues with hypotension and reason for MICU transfer ___. # IgG Myeloma: Patient with longstanding IgG MM, followed by ___ Oncology. Currently not on revlimid or dexamethasone. Kappa:lamba increase, but can be seen in kidney disease. Atrius oncology followed patient throughout hospital stay. ==================== TRANSITIONAL ISSUES: ==================== - Family Bereavement Counseling ",3295,1914
10003412-DS-16,"<SEX> M <SERVICE> NEUROSURGERY <ALLERGIES> Chloroquine <ATTENDING> ___ <CHIEF COMPLAINT> L2 fracture, back pain <MAJOR SURGICAL OR INVASIVE PROCEDURE> ___: L2 corpectomy (retroperitoneal approach) and revision of posterior L1-L3 fusion <HISTORY OF PRESENT ILLNESS> Mr. ___ is a ___ Ph.D. researcher at ___ who was in ___ for research projects in ___. He had to jump out of a second-floor window secondary to a terrorist attack and broke his leg and fractured his L2 vertebrae. He initially received care for this in ___. The patient continued to have back pain and after exhausting medical treatment, remained symptomatic. The decision was made to proceed with L2 corpectomy with a revision of posterior instrumentation and fusion. <PAST MEDICAL HISTORY> Mitral valve prolapse headaches GERD Past Surgical: ___: L ankle ORIF ___ L1-L3 fusion <SOCIAL HISTORY> ___ <FAMILY HISTORY> NC <PHYSICAL EXAM> UPON DISCHARGE: Afebrile Vital sigs stable No apparent distress Heart rate regular Respirations non-labored Abdomen, soft, non-tender, non-distended Back incision clean, dry and intact with staples place ___ strength throughout Sensation intact throughout <PERTINENT RESULTS> ___: Portable abdomen xray IMPRESSION: Diffuse dilatation of the large bowel in a pattern most consistent with ileus. No pneumoperitoneum or pneumatosis. ___: Ultrasound Bilateral ___ veins IMPRESSION: No evidence of deep venous thrombosis in the right or left lower extremity veins. ___: CTA Chest IMPRESSION: 1. No evidence of pulmonary embolism or aortic abnormality. 2. Bilateral small nonhemorrhagic pleural effusions and adjacent bibasilar atelectasis. ___: Xray abdomen IMPRESSION: 1. Interval improvement of colonic ileus. 2. Left loculated pleural effusion, better assessed on CT chest from the same day. ___ Lumbosacral spine xray IMPRESSION: Postsurgical changes. No acute fracture. ___ KUB ** <MEDICATIONS ON ADMISSION> Gabapentin 300mg PO TID lansoprazole 15mg PO daily oxycodone prn tramadol prn Cialis 20mg q72 hours <DISCHARGE MEDICATIONS> 1. OxyCODONE (Immediate Release) ___ mg PO Q4H: PRN pain RX *oxycodone 5 mg ___ tablet(s) by mouth Every four (4) hours as needed Disp #*60 Tablet Refills: *0 2. Gabapentin 600 mg PO TID RX *gabapentin 600 mg 1 tablet(s) by mouth three times a day Disp #*42 Tablet Refills: *0 3. Calcium Carbonate 1000 mg PO QID: PRN indisgestion 4. Acetaminophen 650 mg PO Q6H 5. Docusate Sodium 100 mg PO BID RX *docusate sodium 100 mg 1 tablet(s) by mouth Twice daily Disp #*28 Tablet Refills: *0 6. Tizanidine 2 mg PO TID: PRN muscle spasm RX *tizanidine 2 mg 1 tablet(s) by mouth Three times daily as needed Disp #*42 Tablet Refills: *0 7. Cyanocobalamin 1000 mcg PO DAILY 8. FoLIC Acid ___ mcg PO DAILY 9. lansoprazole 15 mg oral DAILY 10. Multivitamins 1 TAB PO DAILY 11. Vitamin D ___ UNIT PO DAILY <DISCHARGE DISPOSITION> Extended Care Facility: ___ <DISCHARGE DIAGNOSIS> L2 fracture, back pain <DISCHARGE CONDITION> Stable <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Surgery -Your dressing was removed on the second day after surgery. The wound may remain uncovered. -Your incision is closed with staples. You will need to have staple removal. -Do not apply any lotions or creams to the site. -Please keep your incision dry until removal of your staples. -Please avoid swimming for two weeks after staple removal. -Call your surgeon if there are any signs of infection like redness, fever, or drainage. Activity -You must wear your brace at all times when out of bed. You may apply your brace sitting at the edge of the bed. You do not need to sleep with it on. -We recommend that you avoid heavy lifting, running, climbing, or other strenuous exercise until your follow-up appointment. -You make take leisurely walks and slowly increase your activity at your own pace. ___ try to do too much all at once. -No driving while taking any narcotic or sedating medication. -No contact sports until cleared by your neurosurgeon. -Do NOT smoke. Smoking can affect your healing and fusion. Medications -Please do NOT take any blood thinning medication (Aspirin, Ibuprofen, Plavix, Coumadin) until cleared by the neurosurgeon. -Do not take any anti-inflammatory medications such as Motrin, Advil, Aspirin, and Ibuprofen etc until cleared by your neurosurgeon. -You may use Acetaminophen (Tylenol) for minor discomfort if you are not otherwise restricted from taking this medication. -It is important to increase fluid intake while taking pain medications. We also recommend a stool softener like Colace. Pain medications can cause constipation. When to Call Your Doctor at ___ for: -Severe pain, swelling, redness or drainage from the incision site. -Fever greater than 101.5 degrees Fahrenheit -New weakness or changes in sensation in your arms or legs. ","On ___, the patient was admitted for elective L2 corpectomy (retroperitoneal approach) and revision of posterior L1-L3 fusion. He underwent this procedure with Dr. ___ was subsequently transferred out of the OR to the PACU for post-anesthesia care and monitoring. On ___ Patient was neurologically stable. He continued to complain of uncontrolled back pain so pain regimen was adjusted. On ___, the patient continued with back pain which he states was mildly improved. He complained of abdominal pain and distention and KUB showed large bowel ileus. His bowel regimen was increased and he received enema with no immediate BM,but large amount of flatus. The patient underwent workup for tachycardia, EKG showed sinus tach and Trops were negative. LENIs were negative for any DVTs and tachycardia improved to 110 after pain improved. On ___, overnight the patient's oxygen saturation dipped down to 80% while sleeping, and he was therefore placed on 1L NC. In the morning, his neurological and motor exam was stable. When working with ___ he had tachyacardia with a heart rate of 100 that increased to 140 when he rose from sitting to standin. He also had a correlating O2 drop to the ___. A CTA was ordered and was negative for PE, though it revealed some atelectasis. A follow-up KUB was ordered for investigation of resolution of ileus, as he had a BM overnight. It showed interval improvement of colonic ileus. On ___, the patient remained neurologically stable. While trying to reposition himself in bed he reports he ""snapped"" his low back and has new posterior right sided lumbar pain. He denies numbness, tingling in his lower extremities. He is full strength bilaterally. A repeat AP/LAT xray are stable. Per CPS his diazepam was d/c'd and he was started on Tizanidine. Diet changed to full liquids. On ___ the patient remained neurologically stable, and was awaiting a rehab bed. He continued to endorse right lower back pain, although continued on pain medication as needed. On ___ the patient remained neurologically and hemodynamically stable. The patient was awaiting a rehab bed. On ___, the patient remained neurologically and hemodynamically stable. Patient complaining of diarrhea with intermittent abdominal pain. Ordered repeat KUB to evaluate previous ileus which showed resolving ileus. Diet was advanced as patient tolerates. At the time of discharge on ___ the patient's pain was well controlled with oral medications, incisions were clean/dry/intact, and the patient was voiding/moving bowels spontaneously. The patient will follow up with Dr. ___ routine. The patient expressed readiness for discharge. ",1267,579
10003502-DS-3,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> Nifedipine Er / Amitriptyline / Prilosec Otc / Terazosin / Amlodipine / Atenolol / Oxybutynin / Hydrochlorothiazide <ATTENDING> ___ <CHIEF COMPLAINT> failure to thrive <MAJOR SURGICAL OR INVASIVE PROCEDURE> None <HISTORY OF PRESENT ILLNESS> Ms. ___ is an ___ year old ___ speaking woman sent in by her PCP for further management of multiple issues, chiefly gait instability, headaches, and poor PO intake. . At baseline, Ms. ___ ambulates with a walker. She does report several falls over the last year, last more than one month prior to today's visit. She denies any loss of consciousness of prodromal symptoms such as chest discomfort or palpitations. No focal weakness, sensory loss, or tremor. . Of note, she has not been eating well due to a poor appetite. She denies any abdominal pain, nausea, vomiting, diarrhea, melena or hematochezia. No other bleeding. Her only other new medication has been restarting lisinopril within the last month. . Her headaches have been an issue for her over the last year. She describes these as originating from her right ear and extending over her scalp. They are intermittent and somewhat responsive to tylenol. No associated visual complaints, n/v, jaw or tongue claudication. She thinks the headaches are related to her chronic right ear problems (extensively worked up by ENT). . In the ED, initial vs were: 97.2 55 166/47 18 97. Patient c/o headaches x ___ year. Guiac negative. CXR unremarkable, EKG showed sinus brady unchanged from before. No orthostatics checked. Patient was given 500cc of saline. Vitals prior to transfer 96.3 57 174/52 18, 100% 2L NC. . On the floor, her headache is ___ in intensity. She has no other major complaints. <PAST MEDICAL HISTORY> HTN Hyperlipidemia CAD Headaches Nephrolithiasis Cataracts Otitis media Syncope ?sick sinus syndrome s/p CCY <SOCIAL HISTORY> ___ <FAMILY HISTORY> Mother deceased at age ___ from breast cancer. Father deceased at age ___. Son deceased at age ___ from heart attack. <PHYSICAL EXAM> Vitals 97.3 54 146/58 18 100% on RA HEENT NC/AT, PEARL, EOMI, dry MM. Right TM with small amount of white ?exudate, left TM with ?perforation Neck Supple, no JVD Pulm Lungs clear bilaterally, no rales or wheezing CV Bradycardic S1 S2 soft systolic murmur at apex Abd Soft nontender +bowel sounds. Guiac negative in ER. Extrem Warm no edema palpable distal pulses Derm Skin warm, no rash Neuro Alert, answering appropriately, attentive. CN ___, strength, and sensation to light touch intact. No tremor, no cogwheeling. No dysmetria. Initially patient refused to stand up because feeling dizzy. Next AM, gait revealed short steps, no shuffling w/ walker, negative Romberg's <PERTINENT RESULTS> Labs on admission: ___ 08: 00PM GLUCOSE-103* UREA N-16 CREAT-1.0 SODIUM-127* POTASSIUM-4.7 CHLORIDE-92* TOTAL CO2-26 ANION GAP-14 ___ 08: 00PM TOT PROT-5.8* ALBUMIN-3.9 GLOBULIN-1.9* CALCIUM-10.7* ___ 12: 05PM WBC-5.0 RBC-3.72* HGB-9.9* HCT-30.2* MCV-81* MCH-26.7* MCHC-33.0 RDW-16.2* ___ 12: 05PM NEUTS-73.2* ___ MONOS-6.6 EOS-0.8 BASOS-0.3 ___ 12: 05PM PLT COUNT-161 ___ 12: 05PM TSH-2.0 ___ 12: 05PM VIT B12-468 ___ 12: 05PM CALCIUM-10.4* PHOSPHATE-2.6* MAGNESIUM-1.8 ___ 12: 05PM ALT(SGPT)-13 AST(SGOT)-17 ALK PHOS-59 TOT BILI-0.4 ___ 02: 44PM URINE U-PEP-NEGATIVE F ___ 01: 26PM URINE BLOOD-NEG NITRITE-NEG PROTEIN-NEG GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-7.0 LEUK-NEG Micro: URINE CULTURE (Final ___: <10,000 organisms/ml. Reports: CXR: IMPRESSION: No acute cardiopulmonary abnormality. ECG: Sinus bradycardia. The P-R interval is prolonged. Left axis deviation. There is non-specific intraventricular conduction delay. There are Q waves in the lateral leads consistent with prior myocardial infarction. Left ventricular hypertrophy with associated ST-T wave changes, although ischemia or myocardial infarction cannot be excluded. Compared to the previous tracing right bundle-branch block is no longer present. Repeat Ecg: Sinus bradycardia with prominent sinus arrhythmia. The P-R interval is prolonged. Left axis deviation. Non-specific intraventricular conduction delay. There are Q waves in the lateral leads consistent with prior myocardial infarction. Left ventricular hypertrophy with associated ST-T wave changes, although ischemia or myocardial infarction cannot be excluded. Compared to the previous tracing there is no significant change. <MEDICATIONS ON ADMISSION> Hydrochlorothiazide 12.5 mg on ___, and ___ only. Oxybutynin 5 mg at night, Protonix 40 mg daily, simvastatin 10 mg daily, aspirin 81 mg daily, Colace 400 mg daily, multivitamin with iron daily. <DISCHARGE MEDICATIONS> 1. Pantoprazole 40 mg Tablet, Delayed Release (E.C.) Sig: One (1) Tablet, Delayed Release (E.C.) PO Q24H (every 24 hours). 2. Simvastatin 10 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 3. Aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable PO DAILY (Daily). 4. Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day): Hold for loose stools. 5. Multivitamin Tablet Sig: One (1) Tablet PO DAILY (Daily). 6. Oxybutynin Chloride 5 mg Tab,Sust Rel Osmotic Push 24hr Sig: One (1) Tab,Sust Rel Osmotic Push 24hr PO once a day. <DISCHARGE DISPOSITION> Home With Service Facility: ___ <DISCHARGE DIAGNOSIS> PRIMARY DIAGNOSIS: 1. Dehydration 2. Gait instability 3. Failure to thrive 4. Noncardiac chest pain SECONDARY DIAGNOSES: Hypertension Hyperlipidemia Coronary artery disease Chronic headaches Nephrolithiasis Cataracts <DISCHARGE CONDITION> Mental Status: Clear and coherent Level of Consciousness: Alert and interactive Activity Status: Ambulatory - requires assistance or aid (walker or cane) <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> You were admitted to the hospital on ___ with balance difficulty and dehydration. You were given intravenous fluids with improvement. You were seen by the physical therapists who recommended that you continue working with physical therapy at home in order to work on your strength and balance. You were also having chest pain, but this resolved with maalox and your heart tests were normal. STOP taking hydrochlorothiazide. None of your other medications were changed. ","Ms. ___ is a ___ year old woman with history of falls, chronic headaches, and poor oral intake who is admitted for failure to thrive. . * Gait instability This is probably multifactorial. Dehydration was a significant factor upon admission. Her hyponatremia, likely hypovolemic in etiology, may also have been relevant to her overall sense of weakness. Though she was admitted with concern for possible Parkinsons, she does not have any clear exam findings to suggest this such as tremor or cogwheeling. NPH is worth considering, but seems less likely. There may be a vestibular component of her gait instability as well, especially given her multiple ENT procedures. She has outpatient neurology follow-up scheduled. A cardiac contribution was considered given her history of prior syncope with question of sick sinus syndrome. After fluid resuscitation, patient no longer orthostatic and Na trending up. She was evaluated by physical therapy who felt that it was safe for her to go home with physical therapy. . * Hyponatremia By history, likely hypovolemic in etiology and improving on discharge. HCTZ could be contributory, and was held on discharge as patient appeared euvolemic with good BP control off the HCTZ. Patient stated her appetite was better on discharge (possible hyponatremia was contributing). . * Bradycardia Prior cardiac workup raised question of sick sinus syndrome, and patient had bradycardic rate, <2 second pauses on tele. TSH was within normal limits. Outpatient cardiology follow-up is scheduled with Dr. ___. . # Noncardiac Chest pain On evening of admission, patient c/o left sided stabbing pain under her rib, worse when she pressed on it and also following a meal. No N/V/SOB/diaphoresis/radiation. She was ruled out for MI with serial unchanged ECGs, two sets negative CE. Her pain resolved with maalox and tylenol and did not return. . * Headaches Appears to be consistent with her chronic headache syndrome, thought to be cervical in etiology by neurology. History less suggestive of other etiologies such as migraine, tension, or even temporal arteritis (but ESR was 3). Continued soft cervical collar at night per neuro recs. Pain resolved with tylenol. . * Anemia Seen by ___ as an outpatient, felt to be related to CRI and some degree of iron deficiency. Gets regular epo and iron infusions. No history of recent gross bleeding. B12, folate, retic, RBC morph, SPEP/UPEP all wnl. No guaiac positive stools during hospitalization. . * Hypertension In setting of dehydration, held ACEI and HCTZ. HCTZ held on discharge as above. SBP's in 130's at time of discharge. In outpatient setting might consider adding amlodipine. She did not have a true allergy to CCBs, only peripheral edema. . * CAD. Continued ASA and statin. Not on BB as outpatient, and continued to hold as she was mildly bradycardic. ",1812,658
10003502-DS-4,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> Nifedipine Er / Amitriptyline / Prilosec Otc / Terazosin / Amlodipine / Atenolol / Oxybutynin / Hydrochlorothiazide <ATTENDING> ___. <CHIEF COMPLAINT> presyncope s/p fall <MAJOR SURGICAL OR INVASIVE PROCEDURE> none <HISTORY OF PRESENT ILLNESS> Ms. ___ is an ___ year old ___ speaking woman who presents after a fall. History was obtained through ___ interpreter. The patient reports feeling unwell 1 day PTA, with no specific complaints, but with general fatigue, baseline chronic headache. She describes bending over to pick up a napkin. Upon standing up, she felt dizzy and like she was about to fall backwards. She quickly plopped down on her behind to prevent herself from falling. At that point, she felt her heart racing and had some difficulty catching her breath. She found she was unable to get up, and her husband ___ help her. They called EMS. . At baseline, Ms. ___ ambulates with a walker. She does report several falls over the last year, but much less frequently since using walker. She denies any loss of consciousness of prodromal symptoms such as chest discomfort or palpitations. No focal weakness, sensory loss, or tremor. Patient also c/o leg swelling, worse over past 2 months, left greater than right. Her legs look normal in the AM, but become swollen as the day progresses. She was told to try compression stockings, but needs a Rx. She has not gained any weight, and she sleeps lying flat. . Of note, she has started taking HCTZ again in the past few days on her own, since she thought it might help with her leg swelling. She drinks ___ glasses water/day and c/o urinary frequency with occasional incontinence because of not making it to BR in time. She feels she is eating well, but cannot gain any weight. Drinking Ensures. <PAST MEDICAL HISTORY> HTN Hyperlipidemia CAD s/p MI in ___ Headaches Nephrolithiasis Cataracts Otitis media Syncope ?sick sinus syndrome s/p CCY <SOCIAL HISTORY> ___ <FAMILY HISTORY> Mother deceased at age ___ from breast cancer. Father deceased at age ___. Son deceased at age ___ from heart attack. <PHYSICAL EXAM> Vitals 97.1 52 130/58 18 100% on RA HEENT NC/AT Neck Supple, no JVD Pulm Lungs clear bilaterally, no rales or wheezing CV Bradycardic S1 S2 soft systolic murmur at apex Abd Soft nontender +bowel sounds. Extrem Warm, palpable distal pulses, 1+ pedal edema Derm Skin warm, no rash Neuro Alert, answering appropriately, attentive. CN ___, strength, and sensation to light touch intact. No tremor, no cogwheeling. No dysmetria. Babinkski downgoing. <PERTINENT RESULTS> ADMISSION LABS: ___ 06: 20PM BLOOD WBC-5.1 RBC-3.17* Hgb-9.4* Hct-27.8* MCV-88 MCH-29.7 MCHC-34.0 RDW-14.2 Plt ___ ___ 06: 20PM BLOOD Neuts-73.5* ___ Monos-5.1 Eos-2.3 Baso-0.3 ___ 06: 20PM BLOOD Plt ___ ___ 06: 20PM BLOOD Glucose-95 UreaN-28* Creat-1.0 Na-128* K-4.5 Cl-95* HCO3-24 AnGap-14 ___ 06: 40AM BLOOD TotProt-5.2* Calcium-10.3 Phos-3.2 Mg-1.8 ___ 12: 55AM BLOOD Albumin-3.7 ___ 06: 20PM BLOOD Osmolal-278 . CARDIAC BIOMARKERS ___ 06: 20PM BLOOD CK(CPK)-92 ___ 12: 55AM BLOOD CK(CPK)-85 ___ 06: 40AM BLOOD CK(CPK)-76 ___ 06: 20PM BLOOD cTropnT-0.02* ___ 12: 55AM BLOOD CK-MB-NotDone cTropnT-0.02* ___ 06: 40AM BLOOD CK-MB-NotDone cTropnT-<0.01 . DISCHARGE LABS: ___ 06: 40AM BLOOD Glucose-80 UreaN-21* Creat-0.9 Na-135 K-4.3 Cl-100 HCO3-28 AnGap-11 . SPEP PENDING URINE CX PENDING . IMAGING L-SPINE PLAIN FILMS: Minimal anterolisthesis of L4 upon L5 and minimal retrolisthesis of L1 upon L2, of indetermiante age. Recommend clinical correlation for point tenderness. No acute fracture seen. Degenerative changes of the lumbar spine. . CXR: Right lower lobe granuloma is stable since ___. Flattening of the diaphragms and hyperinflation of the lungs is compatible with COPD. The aorta is calcified and tortuous. Heart is borderline in size. Degenerative changes of the spine are noted. <MEDICATIONS ON ADMISSION> HCTZ (D/Ced but now taking again) Amitryptiline 10 mg PO QHS (restarted for headaches in ___ Pantoprazole 40 mg PO Q24H Simvastatin 10 mg PO DAILY Aspirin 81 mg PO DAILY (Daily) Docusate Sodium 100 mg PO BID Multivitamin PO DAILY Lisinopril 10 mg PO daily diclofenac fluticasone nasal spray <DISCHARGE MEDICATIONS> 1. Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO once a day. 2. Senna 8.6 mg Tablet Sig: Two (2) Tablet PO once a day as needed for constipation. 3. Pantoprazole 40 mg Tablet, Delayed Release (E.C.) Sig: One (1) Tablet, Delayed Release (E.C.) PO Q24H (every 24 hours). 4. Simvastatin 10 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 5. Multivitamin Tablet Sig: One (1) Tablet PO DAILY (Daily). 6. Lisinopril 10 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 7. Fluticasone 50 mcg/Actuation Spray, Suspension Sig: One (1) Spray Nasal DAILY (Daily). 8. Amitriptyline 10 mg Tablet Sig: One (1) Tablet PO at bedtime. 9. Aspirin 81 mg Tablet Sig: One (1) Tablet PO once a day. 10. compression stockings 2 pairs compression stockings 11. Acetaminophen 325 mg Tablet Sig: One (1) Tablet PO once a day as needed for pain. <DISCHARGE DISPOSITION> Home With Service Facility: ___ <DISCHARGE DIAGNOSIS> primary: presyncope hyponatremia . secondary: sick sinus syndrome coronary artery disease <DISCHARGE CONDITION> Mental Status: Clear and coherent Level of Consciousness: Alert and interactive Activity Status: Ambulatory - requires assistance or aid (walker or cane) <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> It was a pleasure taking care of you. You were admitted for an episode of dizziness and falling. You had been taking HCTZ, a diuretic which can lead to dehydration and low sodium levels in your blood. Your sodium level was low, and improved before you left the hospital. You were treated with intravenous fluids and the HCTZ was stopped. You did well with physical therapy and your heart rate and blood pressure were normal. . You also had leg swelling. This is caused by chronic venous insufficiency, which means that the valves in your veins get leaky over time and cause blood to pool in your legs. The treatment for this is elevating your legs and wearing compression stockings. . The following changes were made to your medications - STOP taking HCTZ ","___ yo ___ speaking F with CAD, chronic ear infection who presents with presyncope and fall at home. . # Presyncope: Likely orthostasis in setting of HCTZ use and possible mild dehydration. Hyponatremia may have also contributed. Patient ruled out for MI. Neurological exam had no focal deficits. There was no evidence of infection, however urine cx was pending at discharge. Patient has bradycardia ___ SSS, but this is a chronic issue and patient is asymptomatic with bradycardia on the floor, and responded appropriately to exercise. No events on tele. Patient was not orthostatic after receiving gentle IVF. Physical therapy consult cleared patient for independent ambulation with walker. HCTZ was discontinued. Patient will have her BP monitored off this medication by her PCP, and may require a replacement medication. Amitrityline was another candidate for causing confusion and falls, however patient has noted benefit from this in terms of headaches. If falls continue, could consider stopping Amitrityline as well. . # Hyponatremia: Patient has h/o hyponatremia in setting of HCTZ, possibly with mild SIADH component as well (since Na did not completely normalize when taken off of HCTZ). Patient had brain MRI as outpatient which showed only moderate microvascular disease, which is unlikely to explain hyponatremia. Patient does have evidence of COPD on CXR, but no other intrathoracic pathology to cause SIADH. Urine osm were intermediate, so no clear SIADH picture. Patient did start taking HCTZ taking on her own over the last few days for leg swelling. This likely accounted for worsened hyponatremia at admission. After holding the HCTZ, giving IVF, and encouraging POs, sodium was in normal range. Patient was instructed not to take HCTZ, and to instead use compression stockings for leg edema. . # Lower extremity edema: This was very consistent with chronic venous insufficiency. Patient describes swelling that only occurs over the course of the day, and improves with rest and elevation. She has not been wearing compression stockings. Otherwise patient had no evidence of volume overload on exam. She is at risk for CHF given CAD and past MI, and should continue to weight herself daily. . # Sick sinus syndrome: Followed by Dr ___ as outpatient. No need for pacemaker given appropriate response to exercise. This episode is highly unlikely to be cardiac in etiology. Sinus bradycardia on tele. Asymptomatic. . # L gluteal pain: No fracture noted on L-spine films. Likely soft tissue trauma from fall. . # Hypercalcemia: Borderline and chronic, with mildly elevated PTH in past. This degree is very unlikely to be causing symptoms. . # Anemia: Hct 28 in baseline range. . # HTN: continue lisinopril. . # Hyperlipidemia: continue statin . #: Headaches: chronic, likely related to chronic ear infections/mastoiditis. . # Otitis media: Right ear chronically infected. Per report, has used ear dropts. Patient does not complain of worsening pain/symptoms in her ear. ",1835,680
10003502-DS-5,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> nifedipine / Amitriptyline / Prilosec OTC / Terazosin / Amlodipine / Atenolol / Oxybutynin / Hydrochlorothiazide <ATTENDING> ___. <CHIEF COMPLAINT> Nausea, Vomiting <MAJOR SURGICAL OR INVASIVE PROCEDURE> None <HISTORY OF PRESENT ILLNESS> ___ year old ___ speaking female with HTN, CAD s/p MI, HL, and vascular cognitive impairment who presents with nausea and vomiting. . She reports feeling well yesterday. At 2: 30AM this morning, she awoke with the acute onset of nausea and vomiting. She describes nonbloody nonbilious vomit x3. Her family called EMS and she had another episode in the ED. Denies abd pain, diarrhea, constipation, or blood in stool/vomit. Denies dysuria. She has had no recent changes in her appetite and yesterday she states that was in her normal state of health. Denies recent changes in food intake (although did eat fish soup that was three days old yesterday). . In the ED, initial vitals were 97.3 64 159/84 16 100%. She was given zofran and no IVF. Labs were notable for a lipase of 88, alk phos 108, Hct 35.4 (from baseline of ___, troponin <0.01, Ca ___. Most recent vitals 98.3 74 115/47 16 98%RA. . On the floor, the patient denies nausea, abdominal pain. She does have a mild stuffy nose that she states is chronic. She denies cough, SOB, myalgias or fatigue. <PAST MEDICAL HISTORY> HTN Hyperlipidemia CAD s/p MI in ___ Headaches Nephrolithiasis Cataracts Otitis media Syncope ?sick sinus syndrome s/p CCY <SOCIAL HISTORY> ___ <FAMILY HISTORY> Mother deceased at age ___ from breast cancer. Father deceased at age ___. Son deceased at age ___ from heart attack. <PHYSICAL EXAM> Admission Exam: Vitals: 100.0 152/60 78 18 99% RA; patient not orthostatic GA: AOx3, NAD HEENT: PERRLA. MMM. no LAD. no JVD. neck supple. Cards: PMI palpable at ___ IC space. No RVH. RRR S1/S2 heard. no murmurs/gallops/rubs. Pulm: Mild crackles in bases bilaterally. Otherwise clear with good air movement. Abd: soft, NT, +BS. no g/rt. neg HSM. neg ___ sign. Extremities: wwp, no edema. DPs, PTs 2+. Neuro/Psych: CNs II-XII intact. ___ strength in U/L extremities. DTRs 2+ ___ (biceps, achilles, patellar). sensation intact to LT, pain, temperature, vibration, proprioception. cerebellar fxn intact (FTN, HTS). gait WNL. Discharge Exam: Vitals: 97.1 134/50 64 16 97% RA GA: AOx3, NAD HEENT: PERRLA. MMM. no LAD. no JVD. neck supple. Cards: PMI palpable at ___ IC space. No RVH. RRR S1/S2 heard. no murmurs/gallops/rubs. Pulm: Mild crackles in bases bilaterally. Otherwise clear with good air movement. Abd: soft, NT, +BS. no g/rt. neg HSM. neg ___ sign. Extremities: wwp, no edema. DPs, PTs 2+. <PERTINENT RESULTS> Admission Labs: ___ 06: 25AM GLUCOSE-116* UREA N-39* CREAT-1.1 SODIUM-138 POTASSIUM-3.8 CHLORIDE-99 TOTAL CO2-28 ANION GAP-15 ___ 06: 25AM ALT(SGPT)-14 AST(SGOT)-28 ALK PHOS-108* TOT BILI-0.4 ___ 06: 25AM LIPASE-88* ___ 06: 25AM ALBUMIN-4.7 CALCIUM-10.6* PHOSPHATE-3.0 MAGNESIUM-2.2 ___ 06: 25AM WBC-10.4# RBC-4.47# HGB-11.8* HCT-35.4* MCV-79*# MCH-26.3*# MCHC-33.2 RDW-15.6* ___ 06: 25AM NEUTS-93.2* LYMPHS-4.3* MONOS-2.1 EOS-0.5 BASOS-0 Discharge Labs: ___ 08: 05AM BLOOD WBC-3.5* RBC-3.54* Hgb-9.3* Hct-28.1* MCV-79* MCH-26.3* MCHC-33.2 RDW-15.6* Plt ___ ___ 08: 05AM BLOOD Glucose-84 UreaN-23* Creat-0.9 Na-138 K-3.7 Cl-109* HCO3-22 AnGap-11 ___ 08: 05AM BLOOD ALT-16 AST-29 LD(LDH)-167 AlkPhos-69 TotBili-0.2 ___ 08: 05AM BLOOD Lipase-31 ___ 08: 05AM BLOOD Calcium-9.1 Phos-2.2* Mg-2.0 Microbiology: ___ 10: 30AM URINE BLOOD-NEG NITRITE-NEG PROTEIN-NEG GLUCOSE-NEG KETONE-TR BILIRUBIN-NEG UROBILNGN-NEG PH-5.0 LEUK-NEG ___ 6: 50 pm Influenza A/B by ___ Source: Nasopharyngeal swab. **FINAL REPORT ___ DIRECT INFLUENZA A ANTIGEN TEST (Final ___: Negative for Influenza A. DIRECT INFLUENZA B ANTIGEN TEST (Final ___: Negative for Influenza B. ___ 7: 18 pm STOOL CONSISTENCY: WATERY Source: Stool. **FINAL REPORT ___ FECAL CULTURE (Final ___: NO SALMONELLA OR SHIGELLA FOUND. CAMPYLOBACTER CULTURE (Final ___: NO CAMPYLOBACTER FOUND. Imaging: CXR: FINDINGS: There is no pneumonia. There is no pleural effusion or pneumothorax. There is mild cardiomegaly with a left ventricular configuration. A right lower lobe granuloma is stable since ___. The thoracic aorta is tortuous. Hilar silhouettes are within normal limits. IMPRESSION: 1. No pneumonia. 2. Stable mild cardiomegaly with a left ventricular configuration. <MEDICATIONS ON ADMISSION> AMITRIPTYLINE - 20 mg Tablet QHS FLUTICASONE - 50 mcg Spray, Suspension - 2 sprays each nostril qpm FUROSEMIDE - 20 mg Tablet - 1 Tablet(s) by mouth qam LISINOPRIL - 40 mg Tablet - 1 Tablet(s) by mouth qam PANTOPRAZOLE [PROTONIX] - 40 mg Tablet, Delayed Release (E.C.) - one Tablet(s) by mouth once a day POTASSIUM CHLORIDE - 10 mEq Tab Sust.Rel. Particle/Crystal - 1 Tab(s) by mouth qam SIMVASTATIN - 10 mg Tablet - 1 Tablet(s) by mouth once a day ACETAMINOPHEN - 325 mg Tablet - 2 Tablet(s) by mouth twice a day as needed for neck pain avoid regular use ASPIRIN - 81 mg Tablet, Delayed Release daily DOCUSATE SODIUM - 400 mg Capsule daily MULTIVITAMIN WITH IRON-MINERAL daily ___ ___ (laxative) <DISCHARGE MEDICATIONS> 1. amitriptyline 10 mg Tablet Sig: Two (2) Tablet PO HS (at bedtime) as needed for sleep. 2. fluticasone 50 mcg/Actuation Spray, Suspension Sig: Two (2) Spray Nasal DAILY (Daily). 3. Lasix 20 mg Tablet Sig: One (1) Tablet PO once a day. 4. lisinopril 40 mg Tablet Sig: One (1) Tablet PO once a day. 5. pantoprazole 40 mg Tablet, Delayed Release (E.C.) Sig: One (1) Tablet, Delayed Release (E.C.) PO once a day. 6. potassium chloride 10 mEq Capsule, Sustained Release Sig: One (1) Capsule, Sustained Release PO once a day. 7. simvastatin 10 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 8. acetaminophen 325 mg Tablet Sig: Two (2) Tablet PO BID;prn as needed for pain, fever. 9. aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable PO DAILY (Daily). 10. docusate sodium 100 mg Capsule Sig: Four (4) Capsule PO once a day. 11. multivitamin,tx-minerals Tablet Sig: One (1) Tablet PO DAILY (Daily). 12. Zofran 4 mg Tablet Sig: One (1) Tablet PO once a day as needed for nausea. Disp: *2 Tablet(s)* Refills: *0* <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Gastroenteritis <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Ms. ___, It was a pleasure to take care of you in the hospital. You came in with nausea and vomiting and this subsided while you were in the hospital. We checked you for influenza and pancreatitis but both were negative. We think that you likely had a viral gastroenteritis. . We did not make any changes to your medications. You should make sure that you eat if you can and drink lots of fluids. . Please return to the emergency room if your symptoms worsen. . Please followup with Dr. ___ as listed below. ","___ year old ___ speaking female with HTN, CAD s/p MI, HL, and vascular cognitive impairment who presented with nausea and vomiting. . #. Nausea/Vomiting: The patient likely had a viral gastroenteritis and she continued to have mild nausea with some vomiting while inpatient. She was cleared by physical therapy and was able to tolerate POs before discharge. . She was also tested for influenza while here given some nasal congestion with the above symptoms. Pre test suspicion for this was low given that she did not have myalgias or other systemic symtpoms. The test was negative. . We also considered mild pancreatitis given an elevation in her lipase upon admission. This decreased on the second day of admission and remained normal and the patient tolerated POs well before discharge. Therefore, pancreatitis was thought to be unlikely. #. Chronic Pain/Vascular Parkinsonism: Continued Amitriptyline. . #. HTN: Continued Lisinopril, Lasix. #. Dyslipidemia: Continued Simvastatin . #. s/p MI in ___: Continued aspirin, lisinopril and simvastatin. . #. Sick sinus syndrome: Followed by Dr. ___, pacemaker felt to be unnecessary given appropriate response of asymptomatic bradycardia to exertion. . #. Chronic anemia: Thought to be secondary to renal failure. Followed by Dr. ___ in Infectious ___, and treated with biweekly injections of Aranesp 200 micrograms. . # Chronic nasal congestion: Continued Fluticasone ",2355,324
10003502-DS-7,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> nifedipine / Amitriptyline / Prilosec OTC / Terazosin / Amlodipine / Atenolol / Oxybutynin / Hydrochlorothiazide / spironolactone <ATTENDING> ___ <CHIEF COMPLAINT> Nausea <MAJOR SURGICAL OR INVASIVE PROCEDURE> None <HISTORY OF PRESENT ILLNESS> Ms. ___ is an ___ with atrial fibrillation/flutter on dabigatran, coronary artery disease, diastolic heart failure (LVEF 60% in ___, hypertension/hyperlipidemia, and vascular dementia who presents with nausea and headache. She is ___ only, and collateral information is obtained from her sister ___. According to her sister, she was in her usual state of health until days to a week prior to admission, when she developed nausea, initially without vomiting, with onset of frequent nonbloody, nonbilious emesis on the night prior to admission. She also experienced intermittent diffuse headaches, consistent with chronic of unclear etiology, over the same period. At least as far as her sister is aware, she has not experienced fevers/chills, chest pain/palpitations, cough, nasal congestion/rhinorrhea, sore throat, shortness of breath at rest/on exertion, difficulty lying flat, abdominal pain, loose stools, hematuria/dysuria, or myalgias. She has not been exposed to sick contacts or made any dietary changes. Her sister does indicate that her appetite has been poor for some time, leading to unintentional weight loss (""lots"") over a ___ period. She experiences chronic intermittent peripheral edema. Of note, she was admitted most recently from ___ for episodic asymptomatic bradycardia to ___ attributed to atrial flutter with variable (2: 1 to 8: 1) block. Home diltiazem was held, given degree of intrinsic nodal disease, and amlodipine was initiated along with preexisting lisinopril for blood pressure control, with pressures of 150s-160s systolic by the time of discharge. More recently, ___ found a 2-lb weight gain (133 lbs, up from 131 lbs at baseline) in association with bilateral pitting edema, right > left, on ___, at which time patient denied shortness of breath. Spironolactone was initiated by her PCP ___ ___ for symptomatic diastolic heart failure, including peripheral edema and pleural effusions, but was discontinued within weeks due to hyponatremia; she reportedly has become hyponatremic on other diuretics in the past. She has no home oxygen requirement. In the ED, initial vital signs were as follows: 97.2 112 170/76 15 100% 3L. Admission labs were notable for Hct of 33.7 (consistent with baseline), platelets of 142 (consistent with baseline), and proBNP of 3220 (no priors available). CXR revealed bilateral pleural effusions, cardiomegaly and mild edema suggesting fluid overload, and possible underlying consolidation. She received acetaminophen 650mg x1, ceftriaxone 1g x1, azithromycin 500mg x1, and furosemide 40mg x1, with 1100cc UOP. Vital signs at transfer were as follows: 98.4 70 165/83 18 100%. On arrival to the floor, patient reports that she is not in pain. Further discussion is difficult due to language barrier. <PAST MEDICAL HISTORY> Hypertension/hyperlipidemia Coronary artery disease complicated by myocardial infarction Atrial fibrillation/flutter Diastolic heart failure (LVEF 60% in ___ Vascular dementia Headaches Nephrolithiasis Cataracts Otitis media Syncope/possible sick sinus syndrome Status post cholecystectomy Gastroesophageal reflux Hyponatremia Anemia Lumbar radiculopathy <SOCIAL HISTORY> ___ <FAMILY HISTORY> Mother deceased at ___ yo from breast cancer. Father deceased at ___ yo. Son deceased at ___ yo from heart attack. <PHYSICAL EXAM> On admission: VS 97.4 140/P 62 18 96 GEN Alert, oriented, no acute distress HEENT NCAT MMM EOMI sclera anicteric, OP clear, left-sided hearing loss NECK supple, no JVD, no LAD PULM Good aeration, CTAB no wheezes, rales, ronchi CV RRR normal S1/S2, no mrg ABD soft NT ND normoactive bowel sounds, no r/g EXT WWP 2+ pulses palpable bilaterally, trace pitting edema bilaterally NEURO CNs2-12 intact, motor function grossly normal SKIN no ulcers or lesions DISCHARGE: I/O: 200po/incontinent of urine NAD, AAO speaking ___ mucosa moist and pink RRR, no m/r/g CTAB BS+, soft, NT, ND no ___ pretibial edema <PERTINENT RESULTS> ___ 10: 15AM BLOOD WBC-6.4 RBC-3.64* Hgb-11.1* Hct-33.7* MCV-93 MCH-30.6 MCHC-33.1 RDW-14.1 Plt ___ ___ 08: 09AM BLOOD WBC-4.9 RBC-3.45* Hgb-10.6* Hct-31.5* MCV-91 MCH-30.6 MCHC-33.6 RDW-14.2 Plt ___ ___ 09: 35AM BLOOD WBC-5.6 RBC-3.99* Hgb-11.3* Hct-35.7* MCV-89 MCH-28.3 MCHC-31.6 RDW-13.6 Plt ___ ___ 07: 33AM BLOOD WBC-5.6 RBC-3.60* Hgb-10.5* Hct-33.1* MCV-92 MCH-29.3 MCHC-31.9 RDW-14.1 Plt ___ ___ 08: 10AM BLOOD WBC-5.6 RBC-3.55* Hgb-10.6* Hct-32.5* MCV-92 MCH-29.9 MCHC-32.7 RDW-14.1 Plt ___ ___ 10: 15AM BLOOD Neuts-84.3* Lymphs-10.6* Monos-3.4 Eos-1.4 Baso-0.4 ___ 10: 15AM BLOOD Glucose-113* UreaN-19 Creat-1.0 Na-135 K-4.2 Cl-99 HCO3-25 AnGap-15 ___ 08: 09AM BLOOD Glucose-88 UreaN-18 Creat-1.0 Na-138 K-4.0 Cl-101 HCO3-32 AnGap-9 ___ 09: 35AM BLOOD Glucose-104* UreaN-18 Creat-1.0 Na-141 K-3.8 Cl-99 HCO3-27 AnGap-19 ___ 07: 33AM BLOOD Glucose-98 UreaN-23* Creat-1.2* Na-141 K-4.2 Cl-101 HCO3-32 AnGap-12 ___ 08: 10AM BLOOD Glucose-102* UreaN-26* Creat-1.2* Na-138 K-3.9 Cl-100 HCO3-32 AnGap-10 ___ 10: 15AM BLOOD CK-MB-5 cTropnT-0.07* proBNP-3220* ___ 08: 09AM BLOOD CK-MB-5 cTropnT-0.11* ___ 04: 20PM BLOOD CK-MB-4 cTropnT-0.09* ___ 01: 03AM BLOOD CK-MB-4 cTropnT-0.09* ___ 09: 35AM BLOOD cTropnT-0.06* ___ 09: 35AM BLOOD cTropnT-0.06* ___ 04: 20PM URINE Blood-NEG Nitrite-NEG Protein-NEG Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-5.5 Leuks-NEG ___ 05: 35PM URINE Blood-NEG Nitrite-NEG Protein-NEG Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-5.0 Leuks-NEG TTE ___: The left atrium is mildly dilated. There is moderate symmetric left ventricular hypertrophy. The left ventricular cavity size is normal. Regional left ventricular wall motion is normal. Overall left ventricular systolic function is normal (LVEF>55%). Right ventricular chamber size and free wall motion are normal. The aortic valve leaflets are moderately thickened. There is mild aortic valve stenosis (valve area 1.2-1.9cm2). Mild (1+) aortic regurgitation is seen. The mitral valve leaflets are mildly thickened. Moderate (2+) mitral regurgitation is seen, but may be underestimated due to Coanda effect and acoustic shadowing from the mitral annulus calcification. The estimated pulmonary artery systolic pressure is normal. There is a small pericardial effusion. IMPRESSION: Moderate symmetric LVH with normal global and regional biventricular systolic function. Mild aortic stenosis. Mild aortic regurgitation. At least moderate mitral regurgitation. <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Aspirin 81 mg PO DAILY 2. Dabigatran Etexilate 75 mg PO BID 3. Fluticasone Propionate NASAL 2 SPRY NU QPM 4. Lidocaine 5% Patch 1 PTCH TD DAILY RLE pain 5. Lisinopril 40 mg PO DAILY 6. Multivitamins W/minerals 1 TAB PO DAILY 7. Pantoprazole 40 mg PO Q24H 8. Pravastatin 10 mg PO DAILY 9. Docusate Sodium 100 mg PO HS ___ hold for loose stool 10. Acetaminophen 1000 mg PO Q8H: PRN pain Please ___ before giving for fever 11. Docusate Sodium 100 mg PO DAILY: PRN constipation 12. Senna 1 TAB PO DAILY: PRN constipation <DISCHARGE MEDICATIONS> 1. Acetaminophen 500 mg PO Q6H: PRN pain 2. Aspirin 325 mg PO DAILY RX *aspirin 81 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills: *3 3. Docusate Sodium 100 mg PO BID 4. Fluticasone Propionate NASAL 2 SPRY NU QPM 5. Lidocaine 5% Patch 1 PTCH TD DAILY RLE pain 6. Lisinopril 40 mg PO DAILY 7. Multivitamins W/minerals 1 TAB PO DAILY 8. Pantoprazole 40 mg PO Q24H 9. Senna 1 TAB PO DAILY: PRN constipation 10. Atorvastatin 80 mg PO DAILY RX *atorvastatin 80 mg 1 tablet(s) by mouth daily at night Disp #*30 Tablet Refills: *3 11. Isosorbide Mononitrate (Extended Release) 60 mg PO DAILY RX *isosorbide mononitrate 60 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills: *3 12. Dabigatran Etexilate 75 mg PO BID 13. Furosemide 20 mg PO DAILY RX *furosemide 20 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills: *3 <DISCHARGE DISPOSITION> Home With Service Facility: ___ <DISCHARGE DIAGNOSIS> Primary: Acute diastolic CHF exacerbation NSTEMI Hypertension <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> It was a pleasure caring for you at ___ ___. You were admitted for a headache and for nausea. You were found to have too much fluid in your body (heart failure) and this was causing stress to your heart. We treated you with diuretics and with medications to improve the blood flow to your heart. Your blood pressure was also found to be too high so we added a new blood pressure medication. ","Hospitalization Summary: Ms. ___ is an ___ yo ___ F with atrial fibrillation/flutter on dabigatran, coronary artery disease, diastolic heart failure (LVEF 60% in ___, hypertension/hyperlipidemia, and vascular dementia who presented with nausea and headache and was found to be in acute-on-chronic diastolic heart failure in the setting of NSTEMI. Active Issues: #NSTEMI: Although viral infection was suspected initially on the basis of history of nausea/vomiting obtained from her sister, revised history of nausea without vomiting in the absence of sick contacts obtained from the patient via interpreter raised concern for acute coronary syndrome, with nausea representing anginal equivalent. While admission EKG was negative for acute ischemic changes, subsequent EKG on hospital day 2 demonstrated new T wave inversions in II, III, aVF, and V3-V6 in association with rising troponinemia of 0.07 to 0.11. She received 81mg aspirin x4 and atorvastatin 80mg, and home Pradaxa was held in favor of a heparin drip. She was transferred from medicine to ___ for further management. On ___, troponins peaked at 0.11 and then downtrended. MBs were flat. BNP was elevated to 3220 and it was thought the the primary pathology was CHF causing heart strain and troponin leak. Heparin gtt was discontinued after 48 hrs and dabigatran was restarted. Aspirin was increased to 325 mg qday and statin to atorvastatin 80 mg qday. #Acute-on-chronic diastolic heart failure: She was found to be in acute-on-chronic heart failure on admission, with clinical signs of volume overload, moderate bilateral pleural effusions and mild pulmonary edema on admission CXR, and elevated proBNP = 3220. Although transiently hypoxic with 3-L supplemental oxygen requirement in the ED, she was on room air by the time of arrival to the floor, with approximately 2-L urine output to 40mg IV Lasix in the ED. She was diuresed with 20- 40 mg IV lasix daily thereafter. She was to be discharged on ___ but had an episode of DOE while ambulating to the bathroom. CXR showed CHF and she was kept for further diuresis. Diuretic regimen on discharge was 20mg QD. She has close f/u with PCP 1 week after discharge for volume status assessment and further titration of diuretics as necessary. In addition she will be discharged with 21 hours of service and ___ with instruction for daily weights and communication with PCP if weights increase. Inactive Issues: #Atrial fibrillation/flutter: She has a history of atrial fibrillation and flutter, including recent admission for bradycardia attributed to atrial flutter with variable block. Admission EKG revealed normal sinus rhythm, and she remained in sinus rhythm on telemetry. Home dabigatran was administerd initially, but subsequently held as above in the setting of NSTEMI. Dabigatran 75 mg BID was restarted prior to discharge. #Hypertension: Home lisinopril was continued. She remained hypertensive in-house and due to multiple drug allergies, imdur 60 mg was started in addition. She continued with isolated hypertension in the very early morning but was normotensive throughout the day after medication administration so no further changes were made. #Hyperlipidemia: Home pravastatin was held in favor of atorvastatin as above. #Anemia/thrombocytopenia: Hematocrit and platelets were 33.7 and 142, respectively, on admission, consistent with recent baseline. She remained hemodynamically stable without signs of active bleeding. #Gastroesophageal reflux: Home pantoprazole was continued. Transitional Issues: - monitoring of volume status and titration of diuretic according to weights/kidney function - atorvastatin was increased to 80 mg and aspirin to 325 mg, which can be downtitrated per cardiology ",2878,881
10003502-DS-8,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> nifedipine / Amitriptyline / Prilosec OTC / Terazosin / Amlodipine / Atenolol / Oxybutynin / Hydrochlorothiazide / spironolactone <ATTENDING> ___ <CHIEF COMPLAINT> ?syncope <MAJOR SURGICAL OR INVASIVE PROCEDURE> None <HISTORY OF PRESENT ILLNESS> ___, ___ only, with atrial fibrillation/flutter on dabigatran, coronary artery disease, diastolic heart failure (LVEF 60% in ___, hypertension, hyperlipidemia, ?SSS, and vascular dementia who was discharged yesterday from the ___ service after an admission for headache and nausea/vomiting found to have CHF with demand ischemia (trop 0.11 peak). She was discharged with 4 new medications (imdur 60 for blood pressure, atorvastatin 80 and aspirin 325 for CAD, lasix 20 for CHF) which she picked up at her pharmacy. Per report from her sister: ___ hour after pt was discharged home, she had an episode of unresponsiveness at 5: 30p last eve that lasted approximately 7 minutes. Sister describes pt appearance during this episode as having her tongue hanging out and had urinary incontinence. Her mentation returned to baseline after approximately 7 minutes. Per the patient (with a translator): she does not remember passing out. States she felt ""unwell"" but cannot tell me more. Does not remember if she took her medications or not (new or otherwise) but did have them picked up from the pharmacy. Does not remember a prodrome or the actual event of ""syncope"". No cp/sob/palps, currently no complaints and is hungry. In the ED, initial vitals were: 98.2 65 130/53 28 98% RA. <PAST MEDICAL HISTORY> Hypertension/hyperlipidemia Coronary artery disease complicated by myocardial infarction Atrial fibrillation/flutter Diastolic heart failure (LVEF 60% in ___ Vascular dementia Headaches Nephrolithiasis Cataracts Otitis media Syncope/possible sick sinus syndrome Status post cholecystectomy Gastroesophageal reflux Hyponatremia Anemia Lumbar radiculopathy <SOCIAL HISTORY> ___ <FAMILY HISTORY> Mother deceased at ___ yo from breast cancer. Father deceased at ___ yo. Son deceased at ___ yo from heart attack. <PHYSICAL EXAM> PHYSICAL EXAMINATION: VS: 97.5 161/67 62 20 96%RA GEN Alert, oriented, no acute distress HEENT NCAT MMM EOMI sclera anicteric, OP clear, left-sided hearing loss NECK supple, no JVD, no LAD PULM Good aeration, CTAB no wheezes, rales, ronchi CV RRR normal S1/S2, no mrg ABD soft NT ND normoactive bowel sounds, no r/g EXT WWP 2+ pulses palpable bilaterally, trace pitting edema bilaterally NEURO CNs2-12 intact, motor function grossly normal SKIN no ulcers or lesions <PERTINENT RESULTS> ___ 08: 10AM BLOOD WBC-5.6 RBC-3.55* Hgb-10.6* Hct-32.5* MCV-92 MCH-29.9 MCHC-32.7 RDW-14.1 Plt ___ ___ 12: 17PM BLOOD WBC-6.7 RBC-3.79* Hgb-11.2* Hct-34.3* MCV-91 MCH-29.5 MCHC-32.7 RDW-13.7 Plt ___ ___ 08: 10AM BLOOD Glucose-102* UreaN-26* Creat-1.2* Na-138 K-3.9 Cl-100 HCO3-32 AnGap-10 ___ 12: 17PM BLOOD Glucose-175* UreaN-27* Creat-1.3* Na-137 K-4.7 Cl-98 HCO3-26 AnGap-18 ___ 05: 56AM BLOOD Glucose-90 UreaN-25* Creat-1.2* Na-140 K-4.0 Cl-102 HCO3-30 AnGap-12 ___ 12: 17PM BLOOD ___ 12: 17PM BLOOD cTropnT-0.07* ___ 08: 10AM BLOOD Calcium-10.2 Phos-3.6 Mg-2.2 CXR ___: IMPRESSION: Persistent small bilateral effusions, larger on the left which have decreased in size. Decreased pulmonary vascular congestion. No evidence of superimposed acute cardiopulmonary process. CT Head ___: IMPRESSION: No evidence of acute intracranial process. <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Acetaminophen 500 mg PO Q6H: PRN pain 2. Aspirin 325 mg PO DAILY 3. Docusate Sodium 100 mg PO BID 4. Fluticasone Propionate NASAL 2 SPRY NU QPM 5. Lidocaine 5% Patch 1 PTCH TD DAILY RLE pain 6. Lisinopril 40 mg PO DAILY 7. Multivitamins W/minerals 1 TAB PO DAILY 8. Pantoprazole 40 mg PO Q24H 9. Senna 1 TAB PO DAILY: PRN constipation 10. Atorvastatin 80 mg PO DAILY 11. Isosorbide Mononitrate (Extended Release) 60 mg PO DAILY 12. Dabigatran Etexilate 75 mg PO BID 13. Furosemide 20 mg PO DAILY <DISCHARGE MEDICATIONS> 1. Acetaminophen 500 mg PO Q6H: PRN pain 2. Aspirin 325 mg PO DAILY 3. Atorvastatin 80 mg PO DAILY 4. Dabigatran Etexilate 75 mg PO BID 5. Docusate Sodium 100 mg PO BID 6. Fluticasone Propionate NASAL 2 SPRY NU QPM 7. Furosemide 20 mg PO DAILY 8. Isosorbide Mononitrate (Extended Release) 60 mg PO DAILY 9. Lidocaine 5% Patch 1 PTCH TD DAILY RLE pain 10. Lisinopril 40 mg PO HS 11. Multivitamins W/minerals 1 TAB PO DAILY 12. Pantoprazole 40 mg PO Q24H 13. Senna 1 TAB PO DAILY: PRN constipation <DISCHARGE DISPOSITION> Extended Care Facility: ___ <DISCHARGE DIAGNOSIS> Acute: syncope Chronic: coronary artery disease, Chronic diastolic congestive heart failure, atrial fibrillation/flutter, possible sick sinus syndrome <DISCHARGE CONDITION> Mental Status: Confused - sometimes. ___ speaking only. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> You were admitted for a fainting spell. We are not sure what caused this episode, however it is possible that your heart is not beating properly. We were unable to capture any of these episodes on our monitors, so we are sending you to a ___ facility that can monitor your heart rate in case these episodes happen again. ","___ hx atrial fibrillation/flutter on dabigatran, coronary artery disease, diastolic heart failure (LVEF 60% in ___, hypertension, hyperlipidemia, ?SSS, and vascular dementia who presents 12 hours post-discharge with possible syncope. #Syncope: unclear etiology, tele with aflutter and 4:1 conduction earlier now with sinus and occasional sinus pauses. Has had recent admissions for similar episodes of ""feeling unwell"" with and without syncope, attributed to her intrinsic nodal disease. EKG unchanged, enzymes flat. ?whether her syncopal event was a sinus conversion pause. Due to the recurrent and progressive nature of her symptoms, and her lack of support at home and concern that the next event could be terminal, she was discharged to a LTAC with plan to continue on telemetry for ___ weeks to capture any event. #CHF: euvolemic upon admission and discharge. Continued aspirin, lisinopril, lasix 20mg qday. Might need further titration of her diuretics pending volume status. #CAD: continued aspirin, atorvastatin, imdur. No chest pain. EKG without changes, enzymes flat. #HTN: started imdur on last admission. Noted that when taken both at the same time in the AM she had BPs in the 100s transiently; this was changed to lisinopril HS and imdur AM. #Afib/flutter: not symptomatic. No rate control due to intrinsic nodal disease. On dabigatran 75 BID. Transitional Issues: - evaluation for any syncopal event and review of telemetry - daily weights and volume assessment ",1704,355
10003502-DS-9,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> nifedipine / Amitriptyline / Prilosec OTC / Terazosin / Amlodipine / Atenolol / Oxybutynin / Hydrochlorothiazide / spironolactone / furosemide <ATTENDING> ___. <CHIEF COMPLAINT> Fall, bradycardia. <MAJOR SURGICAL OR INVASIVE PROCEDURE> None. <HISTORY OF PRESENT ILLNESS> ___ YO F w/ PMH significant for CAD, mild AS, afib/flutter on dabigatran, HFpEF, HTN, HLD, chronic hyponatremia, who presents after a fall at her nursing home. Pt unable to provide history, but per nursing home and OSH notes, in early AM on ___, pt fell and was discovered by nursing home RN. RN at that time noted that pt was confused and lethargic. HR at that time per report was in the ___. EMS was activated and pt brought to OSH ER. En route, EMS report indicates that heart rates were labile, but there are no EKG strips and unclear if pt received any cardiac medications. At OSH ER, pt's EKG revealed bradycardia to 20 with ventricular escape and no signs of atrial activity. The pt was then given 1 mg of atropine with no effect and then transcutaneously paced for 1 hour. She was then noted to have HRs in the ___ and atrial activity. She was then transferred to ___ for possible PPM. Here at ___, noted to be intermittently lethargic and poorly responsive. CT head and neck negative. EP was consulted for possible PPM and initially recommended admission to ___, deferred PPM for the time being. She continued to be intermittently bradycardic to the ___ in the ED, but given that she has a history of previous bradycardia and has been asymptomatic with her episodes, she was felt to be stable for the floor. However, after this she had increasing respiratory distress requiring a NRB. Due to this she was admitted to the CCU. Received Lasix 60mg IV x1. Of note, pt's HCP reports that she had been more altered over the last week in the setting of higher doses of seroquel that the nursing home had started for increased agitation. In the ED initial vitals were: 98.3, HR 90, 142/73, 18, 93% RA EKG: Labs/studies notable for: Na 140, K 4.6, Cl 98 HCO3 35 BUN 58 Cr 1.2 glu 125, WBC 7 Hct 34.8 AST 219 ALT 178 Trop 0.05 ___: 14.8 PTT: 42.4 INR: 1.4 AGap=12 BNP 2900 Lactate 1.5. ABG: ___ On arrival to the CCU: Awake but not answering questions. Pt does not speak ___, per report. On NRB. <PAST MEDICAL HISTORY> 1. CARDIAC RISK FACTORS - Hypertension - Dyslipidemia 2. CARDIAC HISTORY - CAD (100% LAD occlusion). MI ___ year ago. Unclear history of PCI. - Afib/flutter on dabigatran - Mild aortic stenosis 3. OTHER PAST MEDICAL HISTORY - Chronic hyponatremia - Dementia <SOCIAL HISTORY> ___ <FAMILY HISTORY> Mother deceased at ___ yo from breast cancer. Father deceased at ___ yo. Son deceased at ___ yo from heart attack. <PHYSICAL EXAM> ADMISSION PHYSICAL EXAM: VS: T 97.6 BP 132/103 HR 80 RR 21 O2 SAT 100% NRB GENERAL: Ill appearing. Not answering questions. HEENT: Normocephalic atraumatic. Sclera anicteric. PERRL. EOMI. Conjunctiva were pink. No pallor or cyanosis of the oral mucosa. No xanthelasma. NECK: Supple. JVP unable to assess due to restlessness. CARDIAC: PMI located in ___ intercostal space, midclavicular line. Irregularly irregular. Normal S1, S2. II/VI systolic murmur at R sternal border. LUNGS: No chest wall deformities or tenderness. Tachypneic but withoug increased work of breathing. Faint crackles. ABDOMEN: Soft, non-tender, non-distended. No hepatomegaly. No splenomegaly. EXTREMITIES: Warm, well perfused. No clubbing, cyanosis, or peripheral edema. SKIN: No significant skin lesions or rashes. PULSES: Distal pulses palpable and symmetric. DISCHARGE PHYSICAL VS: T 97.6 BP 144/75 HR 54 RR 22 O2 SAT 92% 2 L NC GENERAL: Skinny, somewhat anxious. Oriented to self only. HEENT: Normocephalic atraumatic. Sclera anicteric. PERRL. EOMI. Conjunctiva were pink. No pallor or cyanosis of the oral mucosa. No xanthelasma. NECK: Supple. JVP unable to assess due to restlessness. CARDIAC: PMI located in ___ intercostal space, midclavicular line. Irregularly irregular. Normal S1, S2. II/VI systolic murmur at R sternal border. LUNGS: No chest wall deformities or tenderness. Tachypneic no signs respiratory distress. Lungs clear to auscultation bilaterally. ABDOMEN: Soft, non-tender, non-distended. No hepatomegaly. No splenomegaly. EXTREMITIES: Warm, well perfused. No clubbing, cyanosis, or peripheral edema. SKIN: No significant skin lesions or rashes. PULSES: Distal pulses palpable and symmetric. <PERTINENT RESULTS> ADMISSION LABS: ___ 12: 45PM BLOOD WBC-10.0 RBC-3.55* Hgb-10.5* Hct-34.8 MCV-98 MCH-29.6 MCHC-30.2* RDW-13.1 RDWSD-46.9* Plt ___ ___ 12: 45PM BLOOD Neuts-87.3* Lymphs-5.0* Monos-7.0 Eos-0.0* Baso-0.2 Im ___ AbsNeut-8.76* AbsLymp-0.50* AbsMono-0.70 AbsEos-0.00* AbsBaso-0.02 ___ 12: 45PM BLOOD ___ PTT-42.4* ___ ___ 12: 45PM BLOOD Glucose-125* UreaN-58* Creat-1.2* Na-140 K-4.6 Cl-98 HCO3-35* AnGap-12 ___ 12: 45PM BLOOD proBNP-2915* ___ 12: 45PM BLOOD cTropnT-0.05* ___ 05: 51AM BLOOD CK-MB-9 cTropnT-0.13* ___ 05: 51AM BLOOD Calcium-10.1 Phos-4.6* Mg-2.5 ___ 08: 10PM BLOOD ___ pO2-23* pCO2-79* pH-7.29* calTCO2-40* Base XS-6 ___ 12: 52PM BLOOD Lactate-1.5 PERTINENT RESULTS: ___ 12: 45PM BLOOD cTropnT-0.05* ___ 05: 51AM BLOOD CK-MB-9 cTropnT-0.13* ___ 12: 52PM BLOOD Lactate-1.5 ___ 11: 47PM BLOOD Lactate-1.0 ___ 06: 04AM BLOOD Lactate-2.9* DISCHARGE LABS: ___ 05: 51AM BLOOD WBC-7.8 RBC-3.90 Hgb-11.3 Hct-37.7 MCV-97 MCH-29.0 MCHC-30.0* RDW-13.2 RDWSD-46.2 Plt ___ ___ 05: 51AM BLOOD ___ PTT-36.7* ___ ___ 05: 51AM BLOOD Glucose-89 UreaN-56* Creat-1.2* Na-141 K-4.1 Cl-97 HCO3-31 AnGap-17 ___ 05: 51AM BLOOD CK-MB-9 cTropnT-0.13* IMAGING: CHEST XRAY ___: Large right and moderate left pleural effusions and severe bibasilar atelectasis are unchanged. Cardiac silhouette is obscured. No pneumothorax. Pulmonary edema is mild, obscured radiographically by overlying abnormalities. MICROBIOLOGY: None. <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Artificial Tears ___ DROP BOTH EYES BID 2. Aspirin 81 mg PO DAILY 3. Dabigatran Etexilate 75 mg PO BID 4. Vitamin D ___ UNIT PO EVERY 3 WEEKS 5. Escitalopram Oxalate 15 mg PO DAILY 6. Losartan Potassium 37.5 mg PO DAILY 7. QUEtiapine Fumarate 12.5 mg PO QHS 8. Senna 17.2 mg PO QHS 9. Sodium Chloride Nasal ___ SPRY NU BID: PRN congestion 10. Torsemide 60 mg PO DAILY 11. OxyCODONE (Immediate Release) 2.5 mg PO QAM 12. LORazepam 0.5 mg PO Q6H: PRN anxiety 13. Acetaminophen 650 mg PO Q6H: PRN Pain - Mild <DISCHARGE MEDICATIONS> 1. Acetaminophen 650 mg PO Q6H: PRN Pain - Mild 2. Artificial Tears ___ DROP BOTH EYES BID 3. Dabigatran Etexilate 75 mg PO BID 4. Escitalopram Oxalate 15 mg PO DAILY 5. LORazepam 0.5 mg PO Q6H: PRN anxiety 6. Losartan Potassium 37.5 mg PO DAILY 7. OxyCODONE (Immediate Release) 2.5 mg PO QAM 8. QUEtiapine Fumarate 12.5 mg PO QHS 9. Senna 17.2 mg PO QHS 10. Sodium Chloride Nasal ___ SPRY NU BID: PRN congestion 11. Torsemide 60 mg PO DAILY 12. Vitamin D ___ UNIT PO EVERY 3 WEEKS <DISCHARGE DISPOSITION> Extended Care Facility: ___ <DISCHARGE DIAGNOSIS> Bradycardia <DISCHARGE CONDITION> Mental Status: Confused - always. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Ms. ___, It was a pleasure taking care of you at ___. Why was I here? - You originally went to another hospital because you fell and hit your head. - You were found to have a very slow heart rate and transferred here to ___ for further management What was done while I was in the hospital? - A CT scan of your head and neck at the outside hospital was done and was normal. - You were transferred here with an external pacemaker to bring your heart rate up but we eventually decided to withdraw this device. - You were seen by our electrophysiologists, who did not decided to put in a pacemaker at this time. What should I do when I get home? - Take your old medications as prescribed. All the best, Your ___ team ","Ms. ___ is ___ year old female with a past medical history significant for CAD, mild AS, afib/flutter on dabigatran, HTN, HLD, chronic hyponatremia, who presented to ___ on transfer from OSH after a fall and headstrike when subsequently found to be bradycardic to the ___. She was transferred here externally paced and was seen by our EP physicians. After discussion with patient's healthcare proxy, it was decided not to purse pacemaker placement and to withdraw external pacemaker. She initially became profoundly bradycardic from ___ beats per minute but stabilized to the ___ overnight. She was made DNR/DNI/DNH and sent back to senior living facility hemodynamically stable. Of note CT head at outside facility was negative. TRANSITIONAL ISSUES ==================== - Per discussion with patient's sister, ___, patient was made DNH in addition to her DNR/DNI. She will need a new MOLST signed by her sister and the doctors at ___ ___ - She will also need a palliative care consult with possible escalation to hospice care as needed. ",2688,230
10003637-DS-17,"<SEX> M <SERVICE> SURGERY <ALLERGIES> lisinopril <ATTENDING> ___ ___ Complaint: Perirectal abscess <MAJOR SURGICAL OR INVASIVE PROCEDURE> Incision and drainage of perirectal abscess with placement of Malecot drain <HISTORY OF PRESENT ILLNESS> ___ w hx HTN, HLD, CAD s/p MI (___), s/p ___ placement for R lateral fistula in ano (___) p/w R sided perianal pain x 4 days. At time of EUA in ___, patient was noted to have fistula in ano from R lateral position to posterior midline through which ___ was placed. Another external opening in the R posterolateral location was found to be blind ending and a ___ drain placed to facilitate postoperative drainage. Drain fell out as planned and patient never followed up for definitive treatment. Reports that roughly every other week he develops R sided perianal pain that is alleviated by spontaneous drainage of purulent fluid. States that 4 days ago began developing worsening pain and has not had any spontaneous drainage on this occasion. Came to ED for evaluation. Surgery consult obtained. On surgery eval, patient c/o severe R sided perianal pain. Reports associated constipation with last BM 5 days ago. Also w urinary retention/hesitancy. Denies fever, chills, chest pain, shortness of breath, nausea, vomiting, blood per rectum. <PAST MEDICAL HISTORY> Illness: HTN, HLD, CAD c/b MI s/p PCI/stent (___), Hx perirectal abscess s/p I&D (___) PSH: I&D perirectal abscess (___), EUA, ___ placement (___) Medications: ASA 81', metoprolol succinate ER 25' <ALLERGIES> NKDA <SOCIAL HISTORY> ___ <FAMILY HISTORY> Noncontributory <PHYSICAL EXAM> VS: 98.5 81 140/80 146 100% RA GEN: WD, WN in NAD HEENT: NCAT, anicteric CV: RRR PULM: non-labored, no respiratory distress ABD: soft, NT, ND, no mass, no hernia RECTAL: abscess site appears to be clean and draining via malecot. <PERTINENT RESULTS> ___ 06: 50AM BLOOD WBC-10.9*# RBC-3.79* Hgb-11.9* Hct-35.8* MCV-95 MCH-31.4 MCHC-33.2 RDW-12.7 RDWSD-43.8 Plt ___ ___ 06: 20AM BLOOD WBC-3.7*# RBC-4.05* Hgb-12.6* Hct-37.6* MCV-93 MCH-31.1 MCHC-33.5 RDW-12.3 RDWSD-42.4 Plt ___ ___ 02: 05PM BLOOD WBC-14.1* RBC-4.76 Hgb-14.7 Hct-43.9 MCV-92 MCH-30.9 MCHC-33.5 RDW-12.5 RDWSD-42.5 Plt ___ ___ 02: 05PM BLOOD Neuts-81.5* Lymphs-8.1* Monos-9.4 Eos-0.1* Baso-0.3 Im ___ AbsNeut-11.52* AbsLymp-1.14* AbsMono-1.32* AbsEos-0.01* AbsBaso-0.04 ___ 06: 50AM BLOOD Plt ___ ___ 06: 20AM BLOOD Plt ___ ___ 02: 05PM BLOOD Plt ___ ___ 02: 05PM BLOOD Glucose-102* UreaN-15 Creat-0.7 Na-136 K-3.9 Cl-100 HCO3-23 AnGap-17 ___ 02: 05PM BLOOD estGFR-Using this ___ 06: 50AM BLOOD ALT-29 AST-32 AlkPhos-130 TotBili-0.4 ___ 02: 05PM BLOOD HoldBLu-HOLD ___ 02: 05PM BLOOD LtGrnHD-HOLD ___ 02: 17PM BLOOD Lactate-1.1 <MEDICATIONS ON ADMISSION> Aspirin 81 mg PO DAILY Metoprolol Succinate ER 25mg Qday <DISCHARGE MEDICATIONS> 1. Acetaminophen 650 mg PO Q6H: PRN pain, fever 2. Aspirin 81 mg PO DAILY 3. Metoprolol Tartrate 12.5 mg PO BID 4. OxycoDONE (Immediate Release) ___ mg PO Q4H: PRN pain RX *oxycodone [Oxecta] 5 mg 1 tablet(s) by mouth every four (4) hours Disp #*30 Tablet Refills: *0 <DISCHARGE DISPOSITION> Home With Service Facility: ___ <DISCHARGE DIAGNOSIS> Perirectal abscess <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> An abscess is a pocket of fluid near the rectum that becomes infected. The fluid usually occurs at the site of the anal glands that we all have. The fluid can become infected and require drainage. Once they are drained, they start to feel better very quickly. Most heal completely. Thirty to fifty percent of abscesses either fail to heal over the next ___ weeks or recur at some point in your lifetime. The gland that started the infection may form a fistula, which is a small tunnel connecting the anal gland to the skin of the buttocks outside the anus. Keeping your follow-up appointment is important because it allows us to determine if you develop a fistula. Wound Care You have a malecot drain that is sutured securely on your buttocks in order to drain the abscess. This drain should be flushed every day for hygiene. The dressings that are in place may be removed the following morning or at the first bowel movement. Any packing can be removed at that time or while sitting in the tub. You should expect bloody, foul drainage for several days. This is not a sterile area, and no fancy dressings are required. Dressings mostly act to prevent staining of your undergarments. Feminine mini ___ pads may be easiest to use, and simple gauze pads are also OK. Limiting the use of tape may aid in your comfort. You should begin warm soaks in the bathtub ___ tub after you remove the packing. These soaks may be helpful at relaxing the anal muscle spasms and thus decrease your pain. They may be done for ___ minutes at a time up to every four hours, but at least twice per day. The warm soaks also allow for irrigation of the abscess cavity, which will help speed healing. When in the tub, gentle finger pressure can be applied to the skin around the abscess opening to make sure that it is still completely drained. Cleansing after bowel movements must be performed gently. Baby wipes can be helpful at getting clean with little trauma. Flushable adult wipes are also available. Avoid any medicated wipes as these may contain witch ___ or alcohol. They will cause discomfort. Wiping can be avoided all together if one goes directly to the warm soaks after a bowel movement. Nothing needs to be added to the water. Bubbles, oils, or Epsom salts may be added if this improves your comfort or sense of cleaning. The water should not be so hot as to risk a burn injury. Bowel Regimen It is often difficult to move your bowels after anal surgery. Pain and narcotic pain medications are constipating. It is important to keep the bowels moving. The stool only becomes harder if you do not move them for days. You should eat a regular healthy diet. You should take an over-the counter stool softener (Colace [sodium docusate] 100 mg twice daily or Surfak [docusate calcium] 240 mg once daily) to keep the stools soft. It must be taken with ___ glasses of liquid throughout the day. You should also take one teaspoon dose of a fiber supplement (psyllium, Metamucil, Citrucel, Benefiber) daily to keep the bowels soft and moving. Fluids are also required for these to help. Gentle stimulant laxatives (milk of magnesia, dulcolax, senna) should be taken only if you have not moved your bowels for one or two days. At times, all three of these (stool softener, fiber, and laxative) may be required to help the bowels. It is important not to take so much that you have diarrhea. Activity No driving or working until off narcotic pain medications. Otherwise, you may return to work when you feel that you are able. Avoid activity that can cause direct trauma to the area. Your activity is limited mostly by your discomfort. Pain Medication Pain should improve every day after the drainage of the abscess. No pains should be getting worse. Increased pain at the time of bowel movements is expected. Pain can be controlled with Tylenol, ibuprofen, or a prescription pain medication. No topical ointments or topical antibiotics are required. If you were given a prescription for antibiotic pills, please take them as directed. NOTIFY THE DOCTOR IF ANY OF THE FOLLOWING OCCUR: Fever greater than 101 degrees, swelling in the area, or increased pain, as these can be signs of infection. Heavy drainage is common from these wounds. Inability to move your bowels despite the previous laxative recommendation Inability to urinate. Pain and surgery can make it hard to void. Sometimes sitting in warm soaks helps to get started. Heavy bleeding. ","On ___, Mr. ___ underwent an I & D of his perirectal abscess in the OR under general anesthesia. Almost 1L of pus was aspirated from the abscess. The prior ___ that had been in place since ___ was removed and a Malecot was placed. He tolerated the procedure well and was extubated in the recovery room. On ___, he was febrile to 101.6 and received acetaminophen 1g IV. He had a CXR ordered which showed no acute pneumonia. He also had blood cultures sent which are still pending as of ___. The gram stain shower gram positive cocci in pairs and clusters. The wound culture contained mixed bacterial types. He was started on Unasyn on ___ but after his abscess was drained, the Unasyn was stopped. He was discharged home with services on ___ with visitation from ___ on how to flush his Malecot. His Unasyn was also stopped before he went home. He was tolerating a regular diet, pain controlled and he was passing gas. ",2150,217
10003637-DS-18,"<SEX> M <SERVICE> SURGERY <ALLERGIES> lisinopril <ATTENDING> ___. <CHIEF COMPLAINT> perianal fistula and abscess <MAJOR SURGICAL OR INVASIVE PROCEDURE> Examination under anesthesia, incision and drainage of abscess, placement of Malecot drain <HISTORY OF PRESENT ILLNESS> ___ with PMH significant for fistula in ano with rectal abscess s/p 3 OR drainages, CAD, CHF, hx of stroke and ___ s/p CABG & pacemaker who presents with rectal pain. The patient states that he has been having worsening rectal pain for the past week. Patient first noticed pain on ___ and described as mild. He did his typical routine of warm shower which in the past has worked for rectal pain with mild abscess. On ___ he was admitted to ___ with cough c/w pulmonary edema and was treated with lasix. He was discharged on ___ with continuing worsening rectal pain. On presentation, he describes his pain as ___, with warm baths helping the pain. He had taken no medications to improve his pain. He felt a palpable mass on his inner right buttock and feels it has gotten larger. He had been bedridden with pain for several days. His last bowel movement was the morning of presentation. His last urine output was also that morning. He endorsed trouble passing stool and urine since this morning (even if he were to try he is unable). He endorsed that all 3 times he has required OR intervention, he has had these same set of symptoms. He denied fever, chills, abdominal pain, nausea, vomitting, diarrhea, constipation, bloody bowel movements, or blood from his rectal mass. In the ED, his temp max was 99.5. Lactate is 2.1. WBC 15.8 and H/H is 10.3/32.3. <PAST MEDICAL HISTORY> Illness: HTN, HLD, CAD c/b MI s/p PCI/stent (___), Hx perirectal abscess s/p I&D (___) ___: I&D perirectal abscess (___), EUA, ___ placement (___) Medications: ASA 81', metoprolol succinate ER 25' <ALLERGIES> NKDA <SOCIAL HISTORY> ___ <FAMILY HISTORY> Noncontributory <PHYSICAL EXAM> Discharge PE: VS: AVSS Gen: well appearing male, NAD HEENT: no lymphadenopathy, moist mucous membranes Lungs: CTAB Heart: rrr Abd: soft, nt, nd Incisions: cdi Extremities: wwp <PERTINENT RESULTS> ___ 11: 43PM ___ PTT-32.4 ___ ___ 05: 30PM URINE HOURS-RANDOM ___ 05: 30PM URINE GR HOLD-HOLD ___ 05: 30PM URINE COLOR-Straw APPEAR-Clear SP ___ ___ 05: 30PM URINE BLOOD-NEG NITRITE-NEG PROTEIN-TR GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-6.0 LEUK-NEG ___ 05: 30PM URINE RBC-0 WBC-1 BACTERIA-NONE YEAST-NONE EPI-0 ___ 05: 30PM URINE HYALINE-1* ___ 05: 30PM URINE MUCOUS-RARE ___ 01: 02PM LACTATE-2.1* ___ 11: 30AM GLUCOSE-103* UREA N-37* CREAT-1.6* SODIUM-135 POTASSIUM-4.1 CHLORIDE-96 TOTAL CO2-22 ANION GAP-21* ___ 11: 30AM estGFR-Using this ___ 11: 30AM WBC-15.8*# RBC-3.37* HGB-10.3* HCT-32.3* MCV-96 MCH-30.6 MCHC-31.9* RDW-14.7 RDWSD-52.4* ___ 11: 30AM NEUTS-78.2* LYMPHS-9.6* MONOS-11.3 EOS-0.3* BASOS-0.2 IM ___ AbsNeut-12.33* AbsLymp-1.51 AbsMono-1.79* AbsEos-0.05 AbsBaso-0.03 ___ 11: 30AM PLT COUNT-183 <MEDICATIONS ON ADMISSION> ATORVASTATIN - atorvastatin 80 mg tablet. 1 tablet(s) by mouth once a day CARVEDILOL - carvedilol 12.5 mg tablet. 1 tablet(s) by mouth twice a day - (Prescribed by Other Provider) DIGOXIN - digoxin 125 mcg tablet. 1 tablet(s) by mouth daily - (Prescribed by Other Provider) LOSARTAN - losartan 25 mg tablet. 1 tablet(s) by mouth daily - (Prescribed by Other Provider) SPIRONOLACTONE - spironolactone 25 mg tablet. 1 tablet(s) by mouth daily - (Prescribed by Other Provider) TORSEMIDE - torsemide 20 mg tablet. 2 tablet(s) by mouth daily - (Prescribed by Other Provider) WARFARIN [COUMADIN] - Coumadin 5 mg tablet. 1 tablet(s) by mouth daily x 5 days per week, 3mg on M and F - (Prescribed by Other Provider) Medications - OTC ASPIRIN [ASPIR-81] - Aspir-81 81 mg tablet,delayed release. 1 tablet(s) by mouth once a day - (Prescribed by Other Provider) IRON - Dosage uncertain - (Prescribed by Other Provider) (Not Taking as Prescribed) <DISCHARGE MEDICATIONS> 1. Aspirin 81 mg PO DAILY 2. sodium chloride 0.9 % 0.9 % mallencot drain irrigation BID RX *sodium chloride [Saline Wound Wash] 0.9 % please irrigate rectal mallenot drain with 60cc of sterile normal saline twice a day Refills: *3 3. Tamsulosin 0.4 mg PO QHS please take for 10 days RX *tamsulosin 0.4 mg 1 capsule(s) by mouth at bedtime Disp #*10 Capsule Refills: *0 4. Atorvastatin 80 mg PO QPM 5. Carvedilol 12.5 mg PO BID 6. Digoxin 0.125 mg PO DAILY 7. Losartan Potassium 25 mg PO DAILY 8. Spironolactone 25 mg PO DAILY 9. Torsemide 20 mg PO DAILY 10. Warfarin 6 mg PO 1X/WEEK (FR) 11. Warfarin 4 mg PO 6X/WEEK (___) <DISCHARGE DISPOSITION> Home With Service Facility: ___ <DISCHARGE DIAGNOSIS> Perianal fistula and abscess <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Mr. ___, You were admitted to the ___ on ___ for a perianal fistula with abscess. You underwent an examination under anesthesia with incision and drainage and placement of a drain. You have recovered from the procedure well and are ready to return home. You were seen by cardiology while you were here prior to your surgery. They recommended that you have close follow up with your cardiologist once you are discharged from the hospital. You required diuresis with Lasix several times during your hospital stay with good improvement in your shortness of breath. Please ensure that you make an appointment with both your PCP and your cardiologist once you are discharged for management of your diuretic regimen. The drain placed in your abscess site should remain until you follow up with Dr. ___ in his clinic. You will receive ___ to help you flush the drain twice daily. ","Patient was taken to the OR on ___ for an examination under anesthesia, drainage of abscess, and placement of Malecot drain for perianal fistula and abscess. He tolerated the procedure well and was transferred to the floor with no issue. Neuro: Pain was well controlled on oxycodone 5 mg q6 hours. CV: Vital signs were routinely monitored during the patient's length of stay. Pulm: The patient was encouraged to ambulate, sit and get out of bed, use the incentive spirometer, and had oxygen saturation levels monitored as indicated. GI: The patient was initially kept NPO after the procedure. The patient was later advanced to and tolerated a regular diet at time of discharge. GU: Patient had a Foley catheter that was removed at time of discharge. Urine output was monitored as indicated. At time of discharge, the patient was voiding without difficulty. ID: The patient's vital signs were monitored for signs of infection and fever. The patient was started on/continued on antibiotics as indicated. Heme: The patient had blood levels checked post operatively during the hospital course to monitor for signs of bleeding. The patient had vital signs, including heart rate and blood pressure, monitored throughout the hospital stay. On ___, the patient was discharged to home. At discharge, he was tolerating a regular diet, passing flatus, stooling, voiding, and ambulating independently. He will follow-up in the clinic in ___ weeks. This information was communicated to the patient directly prior to discharge. ",1808,312
10003637-DS-19,"<SEX> M <SERVICE> MEDICINE <ALLERGIES> lisinopril <ATTENDING> ___. <CHIEF COMPLAINT> Hypotension <MAJOR SURGICAL OR INVASIVE PROCEDURE> None <HISTORY OF PRESENT ILLNESS> ___ hx of ischemic cardiomyopathy sent from ___ clinic when his BP was noted to be systolic ___. Patient reports that at 9am his vision was a little blurry and he felt diffusely weak and tired, the subjective feelings completely resolved prior to admission. He states he had been taking his blood pressure medication regularly and drinking only about one small bottle of water daily. He reports over the last year his blood pressure has been regularly with systolic in the ___. He denies fevers or recent illness. Had perirectal abscess drained in ___, site looked well at evaluation today in clinic. No chest pain, palpitations, or cough. No abd pain/n/v/d/urinary symptoms. In the ED, initial vitals were: HR 82 BP79/42 RR16 SaO298% RA Exam notable for Labs notable for BNP 5890, Cr 2.8, WBC 13.4 Imaging notable for ___ CXR: No acute cardiopulmonary abnormality. Patient was given: 500 cc IVF Decision was made to admit for hypotension and ___ Vitals prior to transfer: HR 73 BP101/57 RR20 SaO2 100% RA On the floor, Patient was resting comfortably in bed and asymptomatic. ROS: (+) Per HPI (-) Denies fever, chills, night sweats. Denies headache, sinus tenderness, rhinorrhea or congestion. Denies cough, shortness of breath. Denies chest pain or tightness, palpitations. Denies nausea, vomiting, diarrhea, constipation or abdominal pain. No recent change in bowel or bladder habits. No dysuria. Denies arthralgias or myalgias. <PAST MEDICAL HISTORY> *Cards: HTN, HLD, CAD c/b MI s/p PCI/stent and CABG, CHF with reduced EF (LVEF 27%), Single lead ICD pacemaker *Neuro: L MCA ischemic stroke *GI: Perirectal abscess s/p I&D (___), Anal fistula, s/p EUA, ___ placement <SOCIAL HISTORY> ___ <FAMILY HISTORY> Noncontributory <PHYSICAL EXAM> ADMISSION EXAM: Vital Signs: T97.9 PO, BP97/50, HR60 RR16 SaO2: 100% RA General: Alert, oriented, no acute distress HEENT: Sclera anicteric, MMM, oropharynx clear, EOMI, PERRL, neck supple, JVP not elevated, no LAD CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Lungs: Clear to auscultation bilaterally, no wheezes, rales, rhonchi Abdomen: Soft, non-tender, non-distended, bowel sounds present, no organomegaly, no rebound or guarding GU: No foley Ext: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema Neuro: CNII-XII intact, ___ strength upper/lower extremities, grossly normal sensation DISCHARGE EXAM: Vital Signs: Tmax 98.2 T97.4 BP 102/67 HR 71 RR 18 O2 100%RA General: No acute distress HEENT: Sclera anicteric, conjunctiva without injection. PERRLA. Oropharynx clear with MMM. Neck supple, no JVP elevation. Lungs: Clear to auscultation bilaterally with no wheezes, rales, rhonchi CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops. Left-sided AICD. Abdomen: Soft, non-tender, non-distended. Bowel sounds present with no renal bruits. No rebound tenderness or guarding, no organomegaly, no pulsatile mass. Ext: Warm, well perfused with no cyanosis of the toes or fingers. No calf tenderness or edema. Skin: Without rashes or lesions on gross exam. Tattoos over the forearm bilaterally. Neuro: Alert and oriented. Face symmetric. Speech is fluent and logical with no evidence of dysarthria. Moves all extremities purposefully. <PERTINENT RESULTS> ADMISSION LABS: ___ 02: 05PM WBC-13.4*# RBC-4.11*# HGB-12.1*# HCT-35.6*# MCV-87 MCH-29.4 MCHC-34.0 RDW-14.0 RDWSD-43.9 ___ 02: 05PM NEUTS-72.3* LYMPHS-13.0* MONOS-12.7 EOS-1.2 BASOS-0.4 IM ___ AbsNeut-9.68* AbsLymp-1.74 AbsMono-1.70* AbsEos-0.16 AbsBaso-0.05 ___ 02: 05PM PLT COUNT-223 ___ 02: 21PM ___ PTT-34.1 ___ ___ 02: 05PM GLUCOSE-143* UREA N-78* CREAT-2.8*# SODIUM-133 POTASSIUM-3.7 CHLORIDE-89* TOTAL CO2-23 ANION GAP-25* ___ 02: 05PM CALCIUM-10.4* PHOSPHATE-4.6* MAGNESIUM-2.4 ___ 02: 05PM CK(CPK)-59 ___ 02: 05PM cTropnT-0.04* ___ 02: 05PM CK-MB-2 proBNP-5890* ___ 07: 30PM URINE HOURS-RANDOM ___ 07: 30PM URINE COLOR-Straw APPEAR-Clear SP ___ ___ 07: 30PM URINE BLOOD-NEG NITRITE-NEG PROTEIN-30 GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-5.5 LEUK-NEG ___ 07: 30PM URINE RBC-<1 WBC-2 BACTERIA-FEW YEAST-NONE EPI-0 ___: 30PM URINE MUCOUS-RARE ___ 07: 30PM URINE HYALINE-13* DISCHARGE LABS: ___ 07: 35AM BLOOD WBC-7.7 RBC-3.84* Hgb-11.3* Hct-33.8* MCV-88 MCH-29.4 MCHC-33.4 RDW-14.1 RDWSD-44.8 Plt ___ ___ 07: 35AM BLOOD Plt ___ ___ 07: 35AM BLOOD ___ PTT-34.7 ___ ___ 07: 35AM BLOOD Glucose-105* UreaN-91* Creat-2.6* Na-134 K-3.5 Cl-91* HCO3-25 AnGap-22* ___ 03: 14PM BLOOD Glucose-96 UreaN-84* Creat-1.8* Na-134 K-3.4 Cl-95* HCO3-22 AnGap-20 ___ 07: 35AM BLOOD CK-MB-4 cTropnT-0.03* ___ 07: 35AM BLOOD Calcium-9.6 Phos-5.1* Mg-2.6 ___ 03: 14PM BLOOD Digoxin-0.2* DIAGNOSTICS: ECHO (CHA ___ CONCLUSIONS 1. LV ejection fraction is 27%. 2. The apical portion of the anterior wall and the LV apex are akinetic. 3. The left atrium is mildly dilated. 4. There is mild-to-moderate mitral regurgitation. 5. Estimated RV systolic pressure is moderately elevated at 55 mmHg. 6. Compared to the previous echo of ___, there is no significant change. CXR ___ FINDINGS: Patient is status post median sternotomy and CABG. Left-sided AICD is noted with single lead terminating in the right ventricle. Heart size is normal. Mediastinal and hilar contours are normal. Lungs are clear. No pleural effusion or pneumothorax. No acute osseous abnormalities are detected. IMPRESSION: No acute cardiopulmonary abnormality. <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Aspirin 81 mg PO DAILY 2. Warfarin 4 mg PO DAILY16 3. Atorvastatin 80 mg PO QPM 4. Carvedilol 12.5 mg PO BID 5. Digoxin 0.125 mg PO DAILY 6. Ferrous Sulfate uncertain mg PO DAILY 7. Losartan Potassium 25 mg PO DAILY 8. Spironolactone 25 mg PO DAILY 9. Torsemide 20 mg PO BID <DISCHARGE MEDICATIONS> 1. Aspirin 81 mg PO DAILY 2. Atorvastatin 80 mg PO QPM 3. Digoxin 0.125 mg PO DAILY 4. Ferrous Sulfate uncertain mg PO DAILY 5. Warfarin 4 mg PO DAILY16 6. HELD- Carvedilol 12.5 mg PO BID This medication was held. Do not restart Carvedilol until following up with your primary care doctor 7. HELD- Losartan Potassium 25 mg PO DAILY This medication was held. Do not restart Losartan Potassium until following up with your primary care doctor 8. HELD- Spironolactone 25 mg PO DAILY This medication was held. Do not restart Spironolactone until following up with your primary care doctor 9. HELD- Torsemide 20 mg PO BID This medication was held. Do not restart Torsemide until following up with your primary care doctor <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> PRIMARY DIAGNOSIS ------------------- Hypotension ___ Secondary Diagnosis Congestive Heart Failure <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Mr. ___, You were admitted to the hospital when it was discovered that you had low blood pressures and evidence of kidney injury after having reduced fluid intake while still taking your antihypertensives. You were evaluated with bloodwork and imaging, and given intravenous fluids. Your blood pressure medications were held and we have not restarted these on discharge from the hospital. Please follow-up with your primary care doctor with ___ visit in the next week before resuming your home antihypertensives. Please continue to drink 1.5L of fluids per day. It was a pleasure to be involved with your care! -___ Team ","___ M with h/o ischemic cardiomyopathy (s/p PCI/stent, CABG, ICD pacemaker) c/b systolic CHF (LVEF 27%), L MCA stroke, and perirectal abscess who presents with hypotension and new ___ in the setting fluid restriction while taking multiple diuretics and anti-hypertensives. #Hypotension: Pt presented with a baseline SBP in ___ over past year, was fluid restricting given history of pulmonary edema, presented with SBP in 60-70s in ED. After 500cc fluid bolus, SBP returned to baseline and pt was asymptomatic. Patient was not orthostatic. Bolused additional 1L NS. Hypotension seemed likely attributable to self fluid restriction in the setting of multiple diuretic and anti-hypertensive medications. Losartan, Spironolactone, Carvedilol and Torsemide were held on discharge. Patient was instructed to schedule primary care to have follow-up of his laboratory values. ___: Rise in pt's Cr to 2.8 from baseline of 1.1 with associated BUN/Cr >20. UA was unremarkable. Pt was maintaining UOP, w/ no history to suggest post-renal obstruction. Elevated pro-BNP suggestive of ventricular overload c/w history of ischemic cardiomyopathy, possible cardiorenal contribution to ___. Overall findings were pre-renal ___, likely ___ decreased effective circulating volume in the setting of hypotension and fluid restriction in pt with underlying ischemic cardiomyopathy. He responded well to 1.5L IVFs, with a creatinine of 1.8 at time of discharge. He was instructed to improve his PO intake to 1.5L per day (has hx of CHF exacerbations). Antihypertensives were held at time of discharge. #Hyperphosphatemia: Phos to 5.1 on ___. Likely ___ renal insufficiency. He was given a low phosphate diet for one day. #Normocytic Anemia: H/H down to 11.3/33.8 on ___ AM. Had low suspicion for hemolysis or acute blood loss. Was thought to be likely dilutional after fluids and was consistent with pt's normal range. RESOLVED ISSUES: #Leukocytosis: Patient presented with transient leukocytosis, which downtrended to wnl ___ AM, likely ___ acute stress reaction. CXR/UA was not concerning for infection. Further infectious workup was not pursued. CHRONIC ISSUES: #Ischemic Cardiomyopathy: s/p L ICD placement. No evidence of volume overload on exam ___. Losartan, Spironolactone, Torsemide, Carvedilol in were held in the setting of hypotension and ___, and also held on discharge. #Hypertension: Losartan, Spironolactone, Torsemide, Carvedilol were held as above. #Hyperlipidemia: atorvastatin was continued without issue. #History of MCA stroke: continued home warfarin without issue. TRANSITIONAL ISSUES: -patient was instructed to drink 1.5 L of fluid per day -patient's home antihypertensives were held at time of discharge. -patient was instructed to follow-up with his PCP within one week -patient may benefit from a repeat Na, K, Cl, bicarb, BUN, Cr at time of follow-up -consideration of when to restart home antihypertensives can be considered at follow-up. ",2473,765
10003637-DS-20,"<SEX> M <SERVICE> MEDICINE <ALLERGIES> lisinopril <ATTENDING> ___ <MAJOR SURGICAL OR INVASIVE PROCEDURE> ___: Right heart catheterization ___: Anal exam under anesthesia with anal fistuolotomy ___: Bronchoscopy with EBUS and lymph node biopsies attach <PERTINENT RESULTS> ADMISSION LABS: -== ___ 05: 49PM BLOOD WBC-9.0 RBC-3.71* Hgb-11.3* Hct-34.3* MCV-93 MCH-30.5 MCHC-32.9 RDW-16.9* RDWSD-56.8* Plt ___ ___ 05: 49PM BLOOD Glucose-112* UreaN-69* Creat-1.9* Na-140 K-4.5 Cl-102 HCO3-24 AnGap-14 ___ 05: 49PM BLOOD Calcium-10.1 Phos-3.3 Mg-2.3 Iron-65 PERTINENT INTERVAL LABS: -======= ___ 05: 49PM BLOOD calTIBC-300 Ferritn-246 TRF-231 MICRO: ====== ___ 11: 12 am BRONCHOALVEOLAR LAVAGE RIGHT LOWER LOBE. GRAM STAIN (Final ___: 1+ (<1 per 1000X FIELD): POLYMORPHONUCLEAR LEUKOCYTES. 3+ ___ per 1000X FIELD): GRAM NEGATIVE ROD(S). 1+ (<1 per 1000X FIELD): GRAM POSITIVE COCCI. ___ CLUSTERS. This is a concentrated smear made by cytospin method, please refer to hematology for a quantitative white blood cell count, if applicable. SMEAR REVIEWED; RESULTS CONFIRMED. RESPIRATORY CULTURE (Final ___: 10,000-100,000 CFU/mL Commensal Respiratory Flora. ACID FAST SMEAR (Final ___: NO ACID FAST BACILLI SEEN ON CONCENTRATED SMEAR. FUNGAL CULTURE (Preliminary): NO FUNGUS ISOLATED. POTASSIUM HYDROXIDE PREPARATION (Final ___: Test cancelled by laboratory. PATIENT CREDITED. This is a low yield procedure based on our ___ studies. if pulmonary Histoplasmosis, Coccidioidomycosis, Blastomycosis, Aspergillosis or Mucormycosis is strongly suspected, contact the Microbiology Laboratory (___). ACID FAST CULTURE (Pending): ___ 11: 44 am TISSUE MEDIASTINAL LYMPH NODE. GRAM STAIN (Final ___: 1+ (<1 per 1000X FIELD): POLYMORPHONUCLEAR LEUKOCYTES. NO MICROORGANISMS SEEN. TISSUE (Preliminary): RESULTS PENDING. ANAEROBIC CULTURE (Preliminary): ACID FAST SMEAR (Final ___: NO ACID FAST BACILLI SEEN ON DIRECT SMEAR. ACID FAST CULTURE (Preliminary): FUNGAL CULTURE (Preliminary): NO FUNGUS ISOLATED. POTASSIUM HYDROXIDE PREPARATION (Preliminary): STUDIES: ======== ___: CT chest w/o contrast Mediastinal and hilar lymphadenopathy could be reactive ___ nature or sequela of the evident prior granulomatous infection, however, a lymphoproliferative disorder such as lymphoma cannot be excluded. A PET-CT scan is recommended for further assessment. Moderate cardiomegaly with associated extensive coronary artery atherosclerotic disease and CABG postsurgical changes. Moderate pulmonary edema. ___: Right heart cath - Normal right heart filling pressure. Mildly elevated left heart filling pressure. - Mild pulmonary hypertension (mPA 24mmHg) with hemodynamic features consistent with predominant post-capillary PH (TPG 8, DPG 3, PVR 1.35 ___. - Normal systemic blood pressure and SVR. - Normal cardiac output/index as estimated by both the indirect Fick method and by thermodilution. DISCHARGE LABS: -== ___ 07: 33AM BLOOD WBC-8.8 RBC-2.92* Hgb-9.0* Hct-28.1* MCV-96 MCH-30.8 MCHC-32.0 RDW-17.9* RDWSD-62.1* Plt ___ ___ 07: 33AM BLOOD Glucose-102* UreaN-53* Creat-2.1* Na-139 K-4.4 Cl-101 HCO3-22 AnGap-16 ___ 07: 33AM BLOOD Calcium-9.2 Phos-3.4 Mg-2.0 <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Sacubitril-Valsartan (97mg-103mg) 1 TAB PO BID 2. Allopurinol ___ mg PO DAILY 3. Atorvastatin 80 mg PO QPM 4. CARVedilol 12.5 mg PO BID 5. CARVedilol 6.25 mg PO QPM 6. Digoxin 0.125 mg PO DAILY 7. Omeprazole 40 mg PO BID 8. Spironolactone 25 mg PO DAILY 9. Torsemide 60 mg PO BID 10. Apixaban 5 mg PO BID 11. Aspirin 81 mg PO DAILY <DISCHARGE MEDICATIONS> 1. Allopurinol ___ mg PO DAILY 2. Apixaban 5 mg PO BID 3. Aspirin 81 mg PO DAILY 4. Atorvastatin 80 mg PO QPM 5. CARVedilol 12.5 mg PO BID 6. CARVedilol 6.25 mg PO QPM 7. Digoxin 0.125 mg PO DAILY 8. Omeprazole 40 mg PO BID 9. Sacubitril-Valsartan (97mg-103mg) 1 TAB PO BID 10. Spironolactone 25 mg PO DAILY 11. Torsemide 60 mg PO BID <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Chronic heart failure with reduced ejection fraction Paroxysmal atrial fibrillation Perianal fistula Mediastinal/hilar lymphadenopathy <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Mr. ___, You were admitted to the hospital for heparin (a blood thinner similar to the apixaban you take at home) while getting multiple procedures done. Please see below for more information on your hospitalization. It was a pleasure participating ___ your care! What happened while you were ___ the hospital? - We held your apixaban and started you on a heparin drip for continued anticoagulation for your atrial fibrillation - You underwent multiple procedures while you were hospitalized; this includes a right heart catheterization, an anal fistulotomy, and a bronchoscopy with lymph node biopsies - We gave you a little extra diuretics while you were ___ the hospital to help keep fluid off you. What should you do after leaving the hospital? - Please take your medications as listed below and follow up at the listed appointments. We have made NO changes to your medications. - You have an appointment with the lung doctors ___ ___. They will go over the results of your biopsy then. - Your weight at discharge is 195.8 lbs. Please weigh yourself today at home and use this as your new baseline. - Please weigh yourself every day ___ the morning. Call your doctor if your weight goes up or down by more than 3 lbs ___ one day or 5 lb ___ one week We wish you the best! - Your ___ Healthcare Team ","PATIENT SUMMARY: ================ Mr. ___ is a ___ with CAD/MI s/p PCIs and CABG ___, HFrEF (EF 28%) s/p ___ ICD ___ and cardiomems ___, pAF on apixaban, HTN, DLD, prior L MCA CVA, CKD, and recurrent perirectal abscesses who presented as direct admit from home for heparin gtt bridge for planned procedures including RHC and anal fistulotomy. Chest CT was also performed which demonstrated enlarged lymph nodes, now s/p bronchoscopy with biopsies. He was actively diuresed for slight volume overload until euvolemic and then discharged on his home diuretic regimen. # CORONARIES: Unknown; needs repeat stress ___ RHC: RA 5, PA ___ (24), PCWP 16 CO 5.89 CI 2.92 SVR 1005 # PUMP: TTE ___ showed ___. IVS 1.0, PW 1.0. LVEDD 6.1, LVEF ___. RV normal size/function. No AS/AR. 1+ MR. ___+ TR. Mild pHTN. # RHYTHM: NSR w/ non-specific intraventricular delay TRANSITIONAL ISSUES: ==================== Discharge Weight: 195.8 lbs Discharge Creatinine: 2.1 Discharge diuretic: Home torsemide 60mg BID [ ] Tooth extraction: According to OMFS, it is appropriate to continue apixaban prior to outpatient extraction. If his primary dentist has concerns, he can be referred to our oral surgeons by calling ___. Recommend not holding apixaban for given his prior stroke. [ ] Stress testing: Recommend another CPET (cardiopulmonary stress test) now that he is euvolemic and optimized. [ ] Interventional pulmonology: Pt will follow up with IP ___ 2 weeks, where he will review the results from his bronchoscopy/biopsy. [ ] Cardiology: Outpatient notes had said his spironolactone was increased from 25mg to 50mg PO daily but patient only reports taking 25mg per day. He was continued on 25mg daily of spironolactone while inpatient. ACTIVE ISSUES: ============== # Chronic HFrEF s/p ICD and cardiomems (EF ___ History of dilated ischemic cardiomyopathy, ___ Class II, EDW previously documented as 185-187lbs, but likely closer to 190-195lbs given relatively dry RHC at this weight. On presentation he was well compensated. RHC was performed while inpatient which had largely normal pressures and it was discovered that his cardiomems was not calibrated correctly and still is reporting falsely elevated numbers. He had a few days off diuretics due to NPO status for procedures and mild hypotension, then restarted on his home dosing at discharge. He previously had a CPET that demonstrated poor function. This should be repeated now that he is optimized to reassess his need for LVAD/transplant. - PRELOAD: Torsemide 60mg PO BID - AFTERLOAD: Entresto 97-103mg PO BID, Carvedilol 12.5/18.75mg PO BID - NHBK: Spironolactone 25mg PO daily, Carvedilol as above - Ionotrope: Digoxin 0.125mcg PO daily - ICD: s/p ___ ICD placement ___ ___ - Transplant/VAD: undergoing workup # Transplant workup Evaluation for advanced therapies for VAD/transplant started ___. - Dental/OMFS were consulted for teeth removal. He was found to have no acute dental infections requiring intervention. Therefore, extractions were not performed during this admission. Dental/OMFS recommended pursuing extraction of mobile tooth #9 as an outpatient with an outpatient dentist with no need to hold apixaban. If there are concerns from his primary dentist, he can be referred to our outpatient ___ clinic for extraction. - Underwent right heart catheterization on ___ which demonstrated only mildly elevated filling pressures including a mildly elevated PASP, which is significantly improved from prior. Vasodilator study was not performed given low pulmonary pressures. - CT chest was performed as part of workup, found asymmetric pulmonary edema (R>L) and enlarged mediastinal/hilar lymph nodes. Given these findings, IP was consulted and he underwent bronchoscopy w/ EBUS and lymph node biopsies on ___. Per pulmonology, unclear etiology of the lymph nodes. Initially thought to be just pulmonary edema but RHC showed he was fairly euvolemic. Other possibilities include prior granulomatous disease or, less likely, lymphoma. # Perianal fistula Initially presented ___ s/p multiple exams under anesthesia, I&D, most recently ___ abscess was drained and malecot catheter placed. Evaluated by ___ ___ ___ clinic after referral from cardiology for pre-transplant evaluation. They noted no evidence of abscess but recommended exam under anesthesia with management of fistula ___ ano. He underwent anal fistulotomy with colorectal surgery on ___. The procedure was without complications and he had a cutting ___ placed that will remain until outpatient follow up. - Outpatient CRS follow up on ___. At that visit they will schedule further follow up with Dr. ___. CHRONIC ISSUES: ============== # CAD c/b MI s/p PCI and subsequent CABG - Continued ASA 81mg - Continued atorvastatin 80mg # Paroxysmal atrial fibrillation # Hx CVA - Continued ASA 81, atorvastatin 80 - Continued carvedilol, digoxin per above - Resumed home apixaban 5mg BID # History of GI bleed - Continued omeprazole # ___ on CKD stage ___ B/l 1.3-1.6. Cr 1.9 on admission, had been up to 2.2 as outpatient. Fluctuated throughout admission, 2.1 on discharge, which may be new baseline. ",1787,1288
10003731-DS-2,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> Penicillins / Bactrim / Doxycycline / Sulfa(Sulfonamide Antibiotics) <ATTENDING> ___. <CHIEF COMPLAINT> cellulitis <MAJOR SURGICAL OR INVASIVE PROCEDURE> needle aspiration of subcutaneous hematoma <HISTORY OF PRESENT ILLNESS> ___ with A. fib on rivaroxaban, hypertension, and venous stasis presents with 7 days of increasing erythema on the left leg. One week ago, patient was walking down stairs and struck her left shin on a metal plant holder. Two days ago she noticed some erythema in her lower left leg and went to an urgent care and was placed on clindamycin. Over the last couple days the erythema had increased and she was seen by her PCP on ___ and again on ___. At that time, erythema was noted to expand beyond the marked edges, and she was advised to be admitted for IV antibiotics, but she declined. On the day of presentation, patient's erythema extended even further which prompted her to come to the emergency department. Patient denies any fevers, chest pain, shortness of breath, nausea or vomiting. There has not been any purulent drainage from the leg. In the ED intial vitals were: T 98.3 HR 88 BP 157/86 RR 16 Sat 99%. Labs were significant for lactate of 2, K of 3.4, Cr 1.1, BUN 21, INR 1.3, PTT 40. Patient was given tylenol and IV vancomycin 1 gram x1. Blood cultured were drawn and pending. On the floor, patient states that her leg pain is improved and she has no other acute complaints at this time. Review of Systems: (+) per HPI. 10-point ROS conducted and otherwise negative. <PAST MEDICAL HISTORY> venous insufficiency in lower extremities Paroxysmal a-fib on rivaroxaban for anticoagulation CKD w/ baseline creatinine 1.2 - eGFR 45-50 HTN obesity Depression GERD HSV rosacea sleep disorder PCOS H. pylori by EGD biopsy in ___ <SOCIAL HISTORY> ___ <FAMILY HISTORY> Sister: DVTs Father: a-fib. CVA Mother: vascular disease <PHYSICAL EXAM> On Admission: Vitals - 98.2 160/80 76 18 97%RA GENERAL: NAD. Well-appearing. Very pleasant. HEENT: AT/NC, EOMI, PERRL CARDIAC: irregularly irregular rhythma, ___ SEM heard best at LUSB LUNG: CTAB, no wheezes, rales, rhonchi, breathing comfortably without use of accessory muscles ABDOMEN: nondistended, +BS, nontender in all quadrants, obese PULSES: 2+ DP pulses bilaterally NEURO: CN II-XII intact. No focal deficits SKIN: Large area of erythema extending across left anterior shin and ___ surface of left foot. Area of erythema is extending beyond previously marked lines. This area is warm to touch and tender to palpation. No areas of fluctuance or purulence. No calf tenderness. Right leg w/o any significant skin changes. On Discharge: 97.5 142/84 70 18 100%RA GENERAL: NAD. Well-appearing. HEENT: AT/NC CARDIAC: rrr, no murmurs LUNG: CTAB, no wheezes, rales, rhonchi, breathing comfortably without use of accessory muscles ABDOMEN: nondistended, +BS, nontender in all quadrants, obese PULSES: 2+ DP pulses bilaterally NEURO: CN II-XII intact. No focal deficits SKIN: erythema improving w/in pen marks. Small fluid collection ant shin <PERTINENT RESULTS> On Admission: ___ 08: 40AM GLUCOSE-102* UREA N-15 CREAT-0.9 SODIUM-144 POTASSIUM-3.6 CHLORIDE-101 TOTAL CO2-32 ANION GAP-15 ___ 08: 40AM WBC-6.8 RBC-4.48 HGB-14.2 HCT-42.0 MCV-94 MCH-31.6 MCHC-33.7 RDW-12.4 ___ 08: 40AM PLT COUNT-279 ___ 08: 40AM ___ PTT-38.4* ___ ___ 09: 00PM LACTATE-2.0 ___ 08: 46PM GLUCOSE-133* UREA N-21* CREAT-1.1 SODIUM-140 POTASSIUM-3.4 CHLORIDE-99 TOTAL CO2-31 ANION GAP-13 ___ 08: 46PM WBC-8.7 RBC-4.51 HGB-14.1 HCT-43.6 MCV-97 MCH-31.2 MCHC-32.3 RDW-13.0 ___ 08: 46PM NEUTS-69.8 ___ MONOS-4.7 EOS-1.6 BASOS-1.2 ___ 08: 46PM PLT COUNT-317 ___ 08: 46PM ___ PTT-40.0* ___ On Discharge: ___ 08: 15AM BLOOD WBC-5.6 RBC-4.40 Hgb-14.4 Hct-42.3 MCV-96 MCH-32.6* MCHC-34.0 RDW-12.6 Plt ___ ___ 08: 15AM BLOOD Glucose-114* UreaN-13 Creat-0.8 Na-143 K-4.1 Cl-106 HCO3-27 AnGap-14 Imaging: lower extremity ultrasound ___: 1. No evidence of deep venous thrombosis in the left lower extremity veins. 2. Subcutaneous edema in the area of redness in the mid to distal left shin. Microbiology: Left Shin Fluid Aspiration ___ 1: 57 pm SWAB Source: left shin ABSCESS. **FINAL REPORT ___ GRAM STAIN (Final ___: NO POLYMORPHONUCLEAR LEUKOCYTES SEEN. NO MICROORGANISMS SEEN. WOUND CULTURE (Final ___: NO GROWTH. ANAEROBIC CULTURE (Final ___: NO GROWTH. Blood Culture ___ x 2: no growth <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Adderall XR (dextroamphetamine-amphetamine) 40 mg oral daily 2. Hydrochlorothiazide 25 mg PO DAILY 3. LaMOTrigine 300 mg PO HS 4. Losartan Potassium 50 mg PO DAILY 5. Metoprolol Tartrate 25 mg PO BID 6. Rivaroxaban 20 mg PO DAILY 7. Acetaminophen 325-650 mg PO Q6H: PRN pain 8. Multivitamins 1 TAB PO DAILY 9. Docusate Sodium 100 mg PO BID <DISCHARGE MEDICATIONS> 1. Linezolid ___ mg PO Q12H Duration: 10 Days RX *linezolid [Zyvox] 600 mg 1 tablet(s) by mouth twice a day Disp #*20 Tablet Refills: *0 2. Acetaminophen 325-650 mg PO Q6H: PRN pain 3. Docusate Sodium 100 mg PO BID 4. Hydrochlorothiazide 25 mg PO DAILY 5. LaMOTrigine 300 mg PO HS 6. Losartan Potassium 50 mg PO DAILY 7. Metoprolol Tartrate 25 mg PO BID 8. Multivitamins 1 TAB PO DAILY 9. Rivaroxaban 20 mg PO DAILY 10. Adderall XR (dextroamphetamine-amphetamine) 40 mg ORAL DAILY <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> cellulitis <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Ms. ___, It was a pleasure meeting you during your hospitalization at ___. You were admitted with cellulitis for IV antibiotics. Your infection improved with IV vancomycin. You will be discharged on linezolid to continue to treat the infection. While taking this antibiotic, you will need to follow a low tyramine diet. Please take your medication as prescribed and follow up with your doctor. Sincerely, Your ___ Team ","Ms. ___ is a ___ year old woman with A. fib on rivaroxaban, hypertension, and venous stasis who presented with left leg cellulitis that had not improved on PO clindamycin, admitted for IV antibiotics. ACTIVE ISSUE: # Cellulitis: She presented with a large area of erythema extending across her left anterior shin and ___ surface of left foot. The area of erythema extended beyond previously marked lines. It was warm to the touch and tender to palpation. She had one area of fluctuance noted on her anterior shin which was aspirated and found to be a hematoma; fluid culture of the aspirated fluid was negative for growth. DVT was ruled out with ultrasound. She was treated with vancomycin and her symptoms and erythema improved. Given her multiple medication allergies and previous failure on clindamycin, she was discharged on linezolid to complete treatment of her cellulitis outpatient. CHRONIC/INACTIVE ISSUES: # Paroxysmal Afib: continued metoprolol and rivaroxaban. Rate controlled. # HTN: continued home losartan, metoprolol, and HCTZ # Depression/sleep disorder: continued aderral, lamotrigine and risperidone TRANSITIONAL ISSUES: - Code: Full (confirmed with patient) - Emergency Contact: HCP ___ (friend) ___. Alternative: ___ (brother) ___ ",1961,299
10003757-DS-14,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> Sulfa (Sulfonamide Antibiotics) / nitrofurantoin <ATTENDING> ___. <CHIEF COMPLAINT> Fall from wheelchair <MAJOR SURGICAL OR INVASIVE PROCEDURE> None <HISTORY OF PRESENT ILLNESS> ___ female with a history of peripheral vascular disease, hypertension, coronary artery disease, emphysema, pelvic fracture s/p hip replacement presents to the ED after a fall and a head CT from OSH showing ___ for neurosurgery evaluation. Patient was in her usual state of health until today when she fell from her wheelchair at home. Patient has a laceration to her forehead. Per report from outside hospital, patient was getting up from her wheelchair when she tripped and fell forward hitting her head. Patient denies any chest pain and there is no nausea or vomiting <PAST MEDICAL HISTORY> Past medical history: - Peripheral vascular disease - Hypertension - Coronary artery disease - Emphysema - Pelvic fracture Past surgical history: - Right hip replacement <SOCIAL HISTORY> ___ <FAMILY HISTORY> NC <PHYSICAL EXAM> ADMISSION: Vital signs: reviewed General: alert and oriented x3, cooperative, speaks in full sentences HEENT: EOMI PERLA, left periorbital ecchymosis, left forehead laceration sutured by ED team. Neck supple. Pulmonary: clear to auscultation bilaterally Cardiovascular: regular rate and rhythm, no murmurs Abdomen: soft, nontedner, nondistended. Extremities: warm and well perfussed. Normal ___ 2+ DISCHARGE Vitals: 97.5 122/58R Lying 87 18 95 Ra Gen: Calm, alert, NAD HEENT: Ecchymosis surrounding the left eye, improving, no conjunctival hemorrhage CV: RRR, ___ harsh systolic murmur with radiation to the carotids Resp: Lungs clear to auscultation bilaterally, no w/r/r Abd: Soft, NTND Ext: warm, no edema, L calf > R calf MSK: ecchymosis of L shoulder, mild ttp and with movement, large hematoma on lateral L hip/buttock Neuro: alert, oriented to self and place, not date <PERTINENT RESULTS> ADMISSION: ___ 10: 30PM BLOOD WBC-23.6* RBC-2.90* Hgb-9.4* Hct-29.5* MCV-102* MCH-32.4* MCHC-31.9* RDW-15.0 RDWSD-55.3* Plt ___ ___ 10: 30PM BLOOD Neuts-79.6* Lymphs-8.2* Monos-10.3 Eos-0.6* Baso-0.5 Im ___ AbsNeut-18.76* AbsLymp-1.92 AbsMono-2.42* AbsEos-0.15 AbsBaso-0.12* ___ 10: 30PM BLOOD ___ PTT-25.3 ___ ___ 10: 30PM BLOOD Glucose-134* UreaN-16 Creat-0.5 Na-136 K-4.7 Cl-98 HCO3-26 AnGap-12 ___ 10: 44AM BLOOD Calcium-8.0* Phos-3.4 Mg-1.6 DISCHARGE: ___ 05: 57AM BLOOD WBC-9.9 RBC-2.42* Hgb-7.7* Hct-24.8* MCV-103* MCH-31.8 MCHC-31.0* RDW-17.2* RDWSD-61.1* Plt ___ MICRO: ___ BLOOD CULTURE Blood Culture, Routine-PENDING EMERGENCY WARD ___ BLOOD CULTURE Blood Culture, Routine-PENDING ___ 1: 52 am URINE **FINAL REPORT ___ URINE CULTURE (Final ___: ESCHERICHIA COLI. >100,000 CFU/mL. Cefazolin interpretative criteria are based on a dosage regimen of 2g every 8h. SENSITIVITIES: MIC expressed in MCG/ML _________________________________________________________ ESCHERICHIA COLI | AMPICILLIN------------ 8 S AMPICILLIN/SULBACTAM-- 4 S CEFAZOLIN------------- <=4 S CEFEPIME-------------- <=1 S CEFTAZIDIME----------- <=1 S CEFTRIAXONE----------- <=1 S CIPROFLOXACIN---------<=0.25 S GENTAMICIN------------ <=1 S MEROPENEM-------------<=0.25 S NITROFURANTOIN-------- <=16 S PIPERACILLIN/TAZO----- <=4 S TOBRAMYCIN------------ <=1 S TRIMETHOPRIM/SULFA---- <=1 S IMAGING ___ CT C/A/P: 1. Severe T12 compression fracture with slight retropulsion of the superior T2 endplate, indeterminate age. 2. Multiple fractures of posterior and lateral ___ ribs, some of which demonstrate developing callus, suggesting subacute chronicity. 3. Acute appearing right L1 transverse process fracture, and probable T10 and T11 spinous process fractures. 4. Status post aortic bifemoral bypass with complete occlusion of right bypass graft. 5. 3.5 cm fluid collection encasing the left bypass graft in the left lower quadrant, likely representing a seroma. 6. Apparent filling defect in the left common femoral vein, likely mixing artifact. However, ultrasound is recommended to evaluate for possible DVT. 7. UIP pattern of pulmonary fibrosis in the bilateral lung bases. 8. Diverticulosis without evidence of acute diverticulitis. 9. 4.2 cm abdominal aortic aneurysm at the level of the aortic hiatus. ___ L ___: IMPRESSION: No evidence of deep venous thrombosis in the left lower extremity veins. ___ CT head: 1. Mild left frontal subarachnoid hemorrhage. No prior studies available for comparison. 2. Presumed arachnoid cyst in the left middle cranial fossa. ___ TTE: The left atrial volume index is normal. There is no evidence for an atrial septal defect by 2D/color Doppler. The estimated right atrial pressure is ___ mmHg. There is mild (non-obstructive) hypertrophy of the basal septum with a normal cavity size. There is normal regional left ventricular systolic function. Global left ventricular systolic function is normal. The visually estimated left ventricular ejection fraction is 60%. Left ventricular cardiac index is normal (>2.5L/min/m2) No ventricular septal defect is seen. There is no resting left ventricular outflow tract gradient. Normal right ventricular cavity size with normal free wall motion. The aortic sinus diameter is normal with normal ascending aorta diameter. The aortic arch diameter is normal. There are simple atheroma in the abdominal aorta. The aortic valve leaflets (3) are mildly thickened. There is moderate aortic valve stenosis (valve area 1.0-1.5 cm2). There is no aortic regurgitation. The mitral leaflets are mildly thickened with no mitral valve prolapse. There is moderate mitral annular calcification. There is no mitral valve stenosis. There is mild [1+] mitral regurgitation. Due to acoustic shadowing, the severity of mitral regurgitation could be UNDERestimated. The tricuspid valve leaflets appear structurally normal. There is trivial tricuspid regurgitation. The estimated pulmonary artery systolic pressure is normal. There is no pericardial effusion. IMPRESSION: Adequate image quality. Moderate low gradient aortic stenosis. Normal biventricular systolic function. ___ XR shoulder/humerus: 1. No fracture or dislocation. 2. Multiple focal lucencies in the left humeral shaft could reflect osteopenia but raise concern for multiple myeloma or diffuse metastatic disease, which could be further evaluated with MRI, SPEP, and UPEP. 3. Moderate to severe degenerative changes of the acromioclavicular glenohumeral joints. <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Aspirin 81 mg PO DAILY 2. Atenolol 25 mg PO DAILY 3. Atorvastatin 40 mg PO QPM 4. Calcium 500 + D (calcium carbonate-vitamin D3) 500 mg(1,250mg) -200 unit oral DAILY 5. Docusate Sodium 100 mg PO BID 6. Donepezil 5 mg PO QHS 7. Bisacodyl ___AILY: PRN constipation 8. DULoxetine 60 mg PO DAILY 9. Florastor (Saccharomyces boulardii) 250 mg oral BID 10. Gabapentin 100 mg PO QHS 11. Lisinopril 10 mg PO DAILY 12. Loratadine 10 mg PO DAILY 13. Milk of Magnesia 30 mL PO PRN constipation 14. Multivitamins 1 TAB PO DAILY 15. Nitroglycerin SL 0.4 mg SL Q5MIN: PRN chest pain 16. Omeprazole 20 mg PO BID 17. Senna 17.2 mg PO BID 18. TraMADol 100 mg PO TID 19. Acetaminophen 1000 mg PO Q8H 20. Acetaminophen 650 mg PO Q6H: PRN Pain - Mild 21. Ondansetron 4 mg PO Q8H: PRN nausea <DISCHARGE MEDICATIONS> 1. Cefpodoxime Proxetil 400 mg PO Q12H Duration: 2 Doses Give on ___. Metoprolol Succinate XL 25 mg PO DAILY 3. TraMADol 50 mg PO TID: PRN Pain - Moderate 4. Acetaminophen 1000 mg PO Q8H 5. Aspirin 81 mg PO DAILY 6. Atorvastatin 40 mg PO QPM 7. Bisacodyl ___AILY: PRN constipation 8. Calcium 500 + D (calcium carbonate-vitamin D3) 500 mg(1,250mg) -200 unit oral DAILY 9. Docusate Sodium 100 mg PO BID 10. Donepezil 5 mg PO QHS 11. DULoxetine 60 mg PO DAILY 12. Florastor (Saccharomyces boulardii) 250 mg oral BID 13. Loratadine 10 mg PO DAILY 14. Milk of Magnesia 30 mL PO PRN constipation 15. Multivitamins 1 TAB PO DAILY 16. Nitroglycerin SL 0.4 mg SL Q5MIN: PRN chest pain 17. Omeprazole 20 mg PO BID 18. Ondansetron 4 mg PO Q8H: PRN nausea 19. Senna 17.2 mg PO BID 20. HELD- Gabapentin 100 mg PO QHS This medication was held. Do not restart Gabapentin until talking with your PCP 21. HELD- Lisinopril 10 mg PO DAILY This medication was held. Do not restart Lisinopril until talking with your PCP ___: Extended Care Facility: ___ <DISCHARGE DIAGNOSIS> Small left frontal SAH T12 compression fracture Urinary tract infection Acute right L1 transverse process fracture and T10/T11 spinous process fractures. <DISCHARGE CONDITION> Mental Status: Confused - sometimes. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Ms. ___, You were admitted to the hospital after you fell and hit your head. You had a bleed in your brain but did not need surgery. You were found to have a small fracture in one of the small bones in your back but this was thought to have been present before you fell. You will follow up with spine doctors after ___ leave the hospital for this. You also hit your arm and hip but did not have any broken bones. You were found to have a urinary tract infection and treated with antibiotics. This may have contributed to your fall. You also were found to have low blood pressure when you stand up, so your blood pressure medications stopped. You can discuss restarting them with your primary care doctor. You were found to be anemic (to have low blood counts) and got a blood transfusion. Your blood counts were stable after this. You may need further evaluation of your anemia by your primary care doctor unless this has already been done. It was a pleasure participating in your care. We wish you all the best in the future! Sincerely, Your ___ team ","___ is an ___ with history of dementia, PAD, HTN, CAD, COPD, prior pelvic fracture s/p hip replacement who presented to an OSH with an unwitnessed fall and was transferred to ___ due to CT head showing SAH. Transferred to the medicine service for encephalopathy. # Encephalopathy, toxic/metabolic: Patient was acutely altered on admission with waxing and waning mental status consistent with delirium on baseline of mild dementia. Found to have symptomatic UTI which was a like contributor as well as pain/trauma from her fall. She was started on antibiotics and improved back to baseline. # Small left frontal traumatic SAH: Sustained in her fall. She had repeat head CT that showed stability. She was evaluated by neurosurgery who felt no surgical intervention was needed. Her home aspirin and prophylactic subcutaneous heparin were started on ___. Her goal blood pressure was under 160 and was maintained throughout her hospitalization. Per neurosurgery she did not need seizure prophylaxis and did not need neurosurgery follow up as an outpatient. Sutures were placed for her head laceration and can be removed on ___. # T12 compression fracture # L1 transverse fracture: Per orthospine, likely chronic and unrelated to recent fall. She worked with ___ who recommended rehab. She is weight bearing as tolerated and ROM as tolerated. She should follow up with spine clinic 2 weeks after discharge. Pain control was with lidocaine patch and Tylenol. Her home tramadol was restarted on discharge at reduced dose. # Fall: She suffered an unwitnessed fall and had poor memory of the event. She is on a number of medications that could pre-dispose to falls including multiple antihypertensives (and had positive orthostatics in-house) and sedating/pain mediations. Symptomatic UTI likely contributer as well. A TTE revealed moderate AS. Telemetry revealed rare short runs of self-terminating SVT. Low suspicion overall for cardiac cause of her fall. Her antihypertensives were held with acceptable blood pressures throughout (SBPs < 160). Her tramadol and gabapentin (which had been newly started/uptitrated) were also held. Tramadol was restarted at a lower dose on the day of discharge and well tolerated. # Urinary tract infection: patient with urinary frequency and pansensitive E coli in her urine culture. She was treated with ceftriaxone starting ___ and discharged with one day of cefpodoxime to complete a ___nemia: She was found to be anemic on admission around 7s with a small drop to 6.4 for which she received 1U pRBC with appropriate increase. Her H/H remained stable thereafter. Per her family she has chronic anemia. She may have element of MDS as she has borderline thrombocytopenia as well. She has a hip/buttock hematoma that remained stable. Iron studies showed an elevated ferritin and normal Fe, consistent with ACD. TRANSITIONAL ISSUES: [] Patient discharged on cefpodoxime for 400 mg q12h for one day to complete a 5 day course of antibiotics for UTI [] Patient with sutures in place; can be removed ___ [] Patient found to be anemic with unknown baseline; if not previously evaluated could consider further work up [] Xray of the L humerus revealed: ""Multiple focal lucencies in the left humeral shaft could reflect osteopenia but raise concern for multiple myeloma or diffuse metastatic disease, which could be further evaluated with MRI, SPEP, and UPEP."" [] Patients antihypertensives (atenolol and lisinopril) were stopped on admission due to fall and orthostatic hypotension. If she develops hypertension, can consider restarting. [] Patient started on metoprolol succinate 25 mg daily for cardiac protection as atenolol was stopped [] Patient's tramadol was decreased to 50 mg TID PRN [] Patient's gabapentin was held on discharge **The patient was seen and examined today and is stable for discharge. Greater than 30 minutes were spent on discharge coordination and counseling.** ",2890,887
10004113-DS-2,"<SEX> M <SERVICE> NEUROSURGERY <ALLERGIES> Penicillins <ATTENDING> ___. <CHIEF COMPLAINT> Seizures, Headaches, left frontal cavernous Malformation <MAJOR SURGICAL OR INVASIVE PROCEDURE> ___ craniotomy for RSX of Cavernous malformation <HISTORY OF PRESENT ILLNESS> Mr. ___ is a very pleasant ___ Caucasian male who was diagnosed with a left inferolateral frontal lobe cavernous malformation approximately ___ years ago in around ___. He has had an episode where he had twitching of the right side of his tongue, some dysarthria and that resulted into more extensive simple partial seizures. Now, this past ___, he again had a similar episode where he had twitching of the right side of his tongue and he had difficulty speaking. He is currently taking Keppra 1000 mg once a day at night. A recent CT shows some hyperdensity within the lesion that is indicative of recent hemorrhage. Given the fact that he has continuous seizures despite management of antiepileptic drugs and the vicinity of the small cavernoma to the brain surface, we think it is reasonable to remove it surgically. We will set him up for surgical resection to a preresection Wand Brain Lab MRI prior. He reviewed the risks and benefits of this operation and he is okay with preceding. <PAST MEDICAL HISTORY> Left frontal cavernous malformation w/seizures & headaches <SOCIAL HISTORY> ___ <FAMILY HISTORY> NC <PHYSICAL EXAM> On Discharge: alert, oriented x3. PERRL. Face symmetric. Tongue midline. EOM intact. Strength ___ throughout. Sensation intact to light touch. No pronator drift. Incision c/d/I with staples - no erythema. Mild L facial swelling <PERTINENT RESULTS> MR HEAD W/ CONTRAST Study Date of ___ 5: 16 AM IMPRESSION: 1. Unchanged appearance of a left temporal operculum 1.0 cm lesion compatible with a cavernoma with associated large developmental venous anomaly. 2. Unchanged appearance of a right posterior parasagittal 0.8 cm meningioma. <MEDICATIONS ON ADMISSION> Keppra 1gm Daily, lorazepam (PRN seizures), isotretinoin <DISCHARGE MEDICATIONS> 1. Acetaminophen-Caff-Butalbital ___ TAB PO Q6H: PRN Headache no not take >4g acetaminophen in 24 hours from any source RX *butalbital-acetaminophen-caff 50 mg-325 mg-40 mg ___ capsule(s) by mouth every 6 hours as needed Disp #*30 Capsule Refills: *0 2. Docusate Sodium 100 mg PO BID 3. LevETIRAcetam 500 mg PO QAM RX *levetiracetam [Keppra] 500 mg 1 tablet(s) by mouth every morning Disp #*30 Tablet Refills: *0 4. LevETIRAcetam 1000 mg PO QHS 5. OxyCODONE (Immediate Release) ___ mg PO Q4H: PRN Pain - Moderate RX *oxycodone 5 mg 1 tablet(s) by mouth every 4 hours as needed Disp #*30 Tablet Refills: *0 6. Senna 8.6 mg PO BID: PRN Constipation <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> cavernous malformation <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Discharge Instructions Brain Tumor Surgery - You underwent surgery to remove a Cavernous Malformation from your brain. - Please keep your incision dry until your staples are removed. - You may shower at this time but keep your incision dry. - It is best to keep your incision open to air but it is ok to cover it when outside. - Call your surgeon if there are any signs of infection like redness, fever, or drainage. Activity - We recommend that you avoid heavy lifting, running, climbing, or other strenuous exercise until your follow-up appointment. - You make take leisurely walks and slowly increase your activity at your own pace once you are symptom free at rest. ___ try to do too much all at once. - No driving while taking any narcotic or sedating medication. - If you experienced a seizure while admitted, you are NOT allowed to drive by law. - No contact sports until cleared by your neurosurgeon. You should avoid contact sports for 6 months. Medications - Please do NOT take any blood thinning medication (Aspirin, Ibuprofen, Plavix, Coumadin) until cleared by the neurosurgeon. - You have been discharged on Keppra (Levetiracetam). This medication helps to prevent seizures. Please continue this medication as indicated on your discharge instruction. It is important that you take this medication consistently and on time. - You may use Acetaminophen (Tylenol) for minor discomfort if you are not otherwise restricted from taking this medication. What You ___ Experience: - You may experience headaches and incisional pain. - You may also experience some post-operative swelling around your face and eyes. This is normal after surgery and most noticeable on the second and third day of surgery. You apply ice or a cool or warm washcloth to your eyes to help with the swelling. The swelling will be its worse in the morning after laying flat from sleeping but decrease when up. - You may experience soreness with chewing. This is normal from the surgery and will improve with time. Softer foods may be easier during this time. - Feeling more tired or restlessness is also common. - Constipation is common. Be sure to drink plenty of fluids and eat a high-fiber diet. If you are taking narcotics (prescription pain medications), try an over-the-counter stool softener. When to Call Your Doctor at ___ for: - Severe pain, swelling, redness or drainage from the incision site. - Fever greater than 101.5 degrees Fahrenheit - Nausea and/or vomiting - Extreme sleepiness and not being able to stay awake - Severe headaches not relieved by pain relievers - Seizures - Any new problems with your vision or ability to speak - Weakness or changes in sensation in your face, arms, or leg Call ___ and go to the nearest Emergency Room if you experience any of the following: - Sudden numbness or weakness in the face, arm, or leg - Sudden confusion or trouble speaking or understanding - Sudden trouble walking, dizziness, or loss of balance or coordination - Sudden severe headaches with no known reason ","___ Caucasian male who was diagnosed with a left inferolateral frontal lobe cavernous malformation approximately ___ years ago, with recent recurrent seizure activity, who presents for elective left craniotomy for Cav Mal resection. #Inferolateral frontal lobe cavernous malformation: The patient was taken to the OR on ___ for a left craniotomy for frontal lobe cavernous malformation resection with Dr. ___. The procedure was uncomplicated, the patient was extubated and recovered in the PACU. He was closely monitored and then was transferred to the step down unit when stable. He remained neurologically intact. No postop imaging was indicated. Keppra was increased to 500 mg qAM and 1000 mg q ___. Foley was removed and he was urinating without retention. His diet was advanced and well tolerated, he was ambulating, and pain was well controlled with PO medications. He was discharged home on POD#2. ",1458,198
10004235-DS-22,"<SEX> M <SERVICE> SURGERY <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> Choledochal cyst with gallbladder carcinoma. <MAJOR SURGICAL OR INVASIVE PROCEDURE> ___ 1. Laparoscopic robot-assisted cholecystectomy, complete resection of common bile duct, hilar lymph node dissection, Roux-en-Y hepaticojejunostomy. 2. Laparoscopic partial hepatectomy. 3. Placement of fiducials for radiation. <HISTORY OF PRESENT ILLNESS> ___ man who presented with cholangitis to the ICU, at which time a long distal biliary stricture was identified and an ERCP stent was placed. The patient was found to have extrahepatic biliary ductal dilatation at the pancreatic head with a long, anomalous pancreaticobiliary junction and a very dilated cystic duct. The gallbladder and cystic duct appeared to contain intraluminal mass, although cytology has been negative for carcinoma. The patient is now taken to the operating room for minimally invasive, robotic-assisted resection of the gallbladder extrahepatic bile duct. <PAST MEDICAL HISTORY> Autism HTN ?Gout <SOCIAL HISTORY> ___ <FAMILY HISTORY> No known history of sudden cardiac death. <PERTINENT RESULTS> ___ 04: 47AM BLOOD WBC-9.5 RBC-4.01* Hgb-10.9* Hct-34.2* MCV-85 MCH-27.2 MCHC-31.9* RDW-14.4 RDWSD-44.7 Plt ___ ___ 04: 47AM BLOOD ___ PTT-27.7 ___ ___ 04: 47AM BLOOD Glucose-114* UreaN-11 Creat-1.2 Na-140 K-3.7 Cl-105 HCO3-22 AnGap-17 ___ 09: 00PM BLOOD ALT-120* AST-140* AlkPhos-91 TotBili-0.8 ___ 04: 47AM BLOOD ALT-77* AST-59* AlkPhos-214* TotBili-1.3 <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Colchicine 0.6-1.2 mg PO BID: PRN pain 2. Diazepam 5 mg PO QHS: PRN insomnia 3. Pantoprazole 40 mg PO Q24H 4. Warfarin 5 mg PO DAILY16 5. Metoprolol Succinate XL 200 mg PO DAILY <DISCHARGE MEDICATIONS> 1. Metoprolol Succinate XL 200 mg PO DAILY 2. Pantoprazole 40 mg PO Q24H 3. Warfarin 5 mg PO DAILY16 4. Docusate Sodium 100 mg PO BID RX *docusate sodium 100 mg 1 capsule(s) by mouth twice a day Disp #*30 Capsule Refills: *0 5. OxycoDONE (Immediate Release) ___ mg PO Q4H: PRN pain RX *oxycodone 5 mg 1 tablet(s) by mouth every four (4) hours Disp #*30 Tablet Refills: *0 6. Colchicine 0.6-1.2 mg PO BID: PRN pain 7. Diazepam 5 mg PO QHS: PRN insomnia 8. Rolling Walker Diagnosis: postop weakness Length of need: 3 months Supply: 1 Refill: none <DISCHARGE DISPOSITION> Home With Service Facility: ___ <DISCHARGE DIAGNOSIS> choledochal cyst and gallbladder mass h/o Afib <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Please call Dr ___ office at ___ if you develop fever (temperature of 101 or greater), shaking chills, nausea, vomiting, jaundice, diarrhea, constipation, inability to tolerate food or medications, abdomen distension, you have swelling in your ankles, the incision has fluid leaking, bleeding or redness around the incision site or any other concerning symptoms. Keep incision covered if out in sun to prevent sunburn/scarring. No lifting more than 10 pounds. No straining You may shower, allow water to run over the incision and pat the aresa dry. No lotion or powder near the incision. No tub baths or swimming Continue all home medications as you have been prescribed ","On ___, he underwent laparoscopic robot-assisted cholecystectomy, with complete resection of common bile duct, hilar lymph node dissection, Roux-en-Y hepaticojejunostomy, laparoscopic partial hepatectomy and placement of fiducials for radiation for choledochal cyst with gallbladder carcinoma. Surgeons were Drs ___ and ___. Please refer to operative notes for details. Immediately postop, the patient pulled out his NG. This was not replaced. He was kept npo until postop day 2 when sips were started. Over subsequent days, diet was advanced and tolerated. He was passing flatus and had 2 BMs on ___. JP drain output was non-bilious and decreased to 15cc/day. The JP was removed on ___. LFTs increased mildly as expected postop. The incision was intact without redness/drainage. Vital signs were notable for sinus tachycardia responice to IV metoprolol. This was later changed to his home dose of extended release metoprolol. Warfarin at home dose (5mg) was resumed for h/o afib. His PCP was contact to resume care of coumadin management. He was oob to chair with assist of one. ___ cleared him for home with rolling walker. He was ambulatory and appeared comfortable. He refused pain medication and was given intermittent doses of tylenol. He as ready for discharge on postop 5. Nightingale ___ was arranged. ",1043,320
10004235-DS-23,"<SEX> M <SERVICE> SURGERY <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> Fever <MAJOR SURGICAL OR INVASIVE PROCEDURE> none <HISTORY OF PRESENT ILLNESS> ___ w choledochal cyst and GB mass s/p recent robotic CCY, CBD excision, ___, liver bed resection, fiducial placement ___ p/w fevers. His hospital course was uneventful, except that he pulled his NG tube on POD0. He recovered well and was discharged to home two days ago. The JP drain was removed the day of his discharge due to low output. His father notes that the patient had a fever of 102.8 with tachycardia today, otherwise he was doing well, had good lunch, was passing gas and moving his bowel since his discharge. The called the transplant surgery clinic and was given instruction to be admitted for further work up. ROS: (+) per HPI (-) Denies pain, night sweats, unexplained weight loss, fatigue/malaise/lethargy, changes in appetite, trouble with sleep, pruritis, jaundice, rashes, bleeding, easy bruising, headache, dizziness, vertigo, syncope, weakness, paresthesias, nausea, vomiting, hematemesis, bloating, cramping, melena, BRBPR, dysphagia, chest pain, shortness of breath, cough, edema, urinary frequency, urgency. <PAST MEDICAL HISTORY> Autism HTN ?Gout choledochalcyst,Gallbladder adenocarcinoma 1. Laparoscopic robot-assisted cholecystectomy, complete resection of common bile duct, hilar lymph node dissection, Roux-en-Y hepaticojejunostomy. 2. Laparoscopic partial hepatectomy. 3. Placement of fiducials for radiation <SOCIAL HISTORY> ___ <FAMILY HISTORY> No known history of sudden cardiac death. <PHYSICAL EXAM> Vitals: 98.5 117 136/90 97RA GEN: A&O, NAD HEENT: No scleral icterus, mucus membranes moist CV: irregular, tachycardia, No M/G/R PULM: Clear to auscultation b/l, No W/R/R ABD: Soft, nondistended, nontender, no rebound or guarding, normoactive bowel sounds, no palpable masses, incisions healing well, no erythema or drainage Ext: No ___ edema, ___ warm and well perfused Laboratory: pending Imaging: pending <PERTINENT RESULTS> ___ 04: 47AM BLOOD WBC-9.5 RBC-4.01* Hgb-10.9* Hct-34.2* MCV-85 MCH-27.2 MCHC-31.9* RDW-14.4 RDWSD-44.7 Plt ___ ___ 11: 55PM BLOOD WBC-15.1*# RBC-3.57* Hgb-9.7* Hct-30.0* MCV-84 MCH-27.2 MCHC-32.3 RDW-14.8 RDWSD-45.4 Plt ___ ___ 05: 37AM BLOOD WBC-15.0* RBC-3.59* Hgb-9.6* Hct-30.1* MCV-84 MCH-26.7 MCHC-31.9* RDW-14.8 RDWSD-45.1 Plt ___ ___ 05: 37AM BLOOD ___ ___ 05: 37AM BLOOD Glucose-112* UreaN-10 Creat-1.2 Na-137 K-3.6 Cl-102 HCO3-20* AnGap-19 ___ 06: 10AM BLOOD ALT-79* AST-57* AlkPhos-260* TotBili-1.3 ___ 05: 37AM BLOOD ALT-74* AST-55* AlkPhos-264* TotBili-1.2 All BLOOD CULTURE URINE All INPATIENT ___ BLOOD CULTURE Blood Culture, Routine-PENDING INPATIENT ___ URINE URINE CULTURE-FINAL INPATIENT ___ BLOOD CULTURE Blood Culture, Routine-PENDING INPATIENT <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Metoprolol Succinate XL 200 mg PO DAILY 2. Pantoprazole 40 mg PO Q24H 3. Warfarin 5 mg PO DAILY 4. Docusate Sodium 100 mg PO BID 5. Colchicine 0.6-1.2 mg PO ASDIR 6. Diazepam 5 mg PO DAILY: PRN anxiety <DISCHARGE MEDICATIONS> 1. Docusate Sodium 100 mg PO BID 2. Pantoprazole 40 mg PO Q24H 3. Warfarin 5 mg PO DAILY 4. Acetaminophen 650 mg PO Q8H: PRN pain/headache 5. Ciprofloxacin HCl 500 mg PO Q12H fever of unknown origin Duration: 7 Doses RX *ciprofloxacin HCl 500 mg 1 tablet(s) by mouth twice a day Disp #*14 Tablet Refills: *0 6. Colchicine 0.6-1.2 mg PO ASDIR 7. Diazepam 5 mg PO DAILY: PRN anxiety 8. Metoprolol Succinate XL 200 mg PO DAILY 9. Ursodiol 300 mg PO BID RX *ursodiol 300 mg 1 capsule(s) by mouth twice a day Disp #*60 Capsule Refills: *2 <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Fever <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Please call Dr ___ office at ___ if you develop fever (temperature of 101 or greater), shaking chills, nausea, vomiting, jaundice, diarrhea, constipation, inability to tolerate food or medications, abdomen distension, you have swelling in your ankles, the incision has fluid leaking, bleeding or redness around the incision site or any other concerning symptoms. You have been prescribed Ciprofloxacin (antibiotic) for 7 days Keep incision covered if out in sun to prevent sunburn/scarring. No lifting more than 10 pounds. No straining You may shower, allow water to run over the incision and pat the aresa dry. No lotion or powder near the incision. No tub baths or swimming Continue all home medications as you have been prescribed. Please follow up with your PCP for INR check on _____________ ","___ y.o.M s/p recent lap/robotic CCY, CBD excision, GB fossa excision w/ fever at home to 102 and cough per patient's father. He was admitted to the ___ service and pan cultured. IV antibiotics were started (Vanco/zosyn). He remained with low grade temps overnight to 100.7 during the following day. PE was negative and CT w/o discrete fluid collection. Blood and urine cultures were pending. He felt well the following day and was eating well. Labs were unremarkable except for persistent elevated WBC to 15, LFTS with alk phos 264 and t.bili 1.5. He was started on Ursodiol. Given that he felt well and remained with only low grade temps, he was discharged to home on Cipro 500mg bid for 7 days. He will f/u with Dr. ___ on ___. Nightingale ___ was resumed. ",1530,196
10004296-DS-11,"<SEX> F <SERVICE> OBSTETRICS/GYNECOLOGY <ALLERGIES> Sulfamethoxazole / Penicillins <ATTENDING> ___. <CHIEF COMPLAINT> arrest of descent, gHTN, incisional cellulitis with wound abscess <MAJOR SURGICAL OR INVASIVE PROCEDURE> primary low transverse cesarean section <HISTORY OF PRESENT ILLNESS> Patient is a ___ year-old G3P0 with EDC = ___ (EGA = 37w1d on ___ with elevated blood pressures in the office as high as 140/70 over the past week. Repeat BP in OB triage = 142/70, 141/72, 139/85. PIH labs on ___ showed: CBC 15.6 > 10.6 / 30.3 < 312 ALT 21 Cr 0.5 Uric Acid 5.0 UP: C 0.1 She currently denies headache, visual changes, epigastric or RUQ pain. Denies ctx, VB, LOF. +FM <PAST MEDICAL HISTORY> MEDICAL HISTORY Allergies (Last Verified ___ by ___: Penicillins Sulfamethoxazole --------------- --------------- --------------- --------------- Active Medication list as of ___: Medications - Prescription ALBUTEROL SULFATE [PROAIR HFA] - ProAir HFA 90 mcg/actuation aerosol inhaler. 2 puffs every four (4) hours PRN BUDESONIDE-FORMOTEROL [SYMBICORT] - Symbicort 160 mcg-4.5 mcg/actuation HFA aerosol inhaler. 2 puffs inh twice a day PNV WITH CALCIUM ___ [PRENATAL VITAMINS LOW IRON] - Dosage uncertain - (Prescribed by Other Provider) Medications - OTC DOCUSATE SODIUM - docusate sodium 100 mg capsule. 1 capsule(s) by mouth once per day, as needed, for constipation --------------- --------------- --------------- --------------- Problems (Last Verified ___ by ___, MD): ASTHMA, EXTRINSIC W/ ACUTE EXACERBATION 493.02 ECZEMATOUS DERMATITIS H/O TOBACCO USE 305.1 Surgical History (Last Verified ___ by ___, MD): Surgical History updated, no known surgical history. Family History (Last Verified ___ by ___, MD): Relative Status Age Problem Comments Other ASTHMA V17.5 F/H GI MALIGNANCY V16.0 <SOCIAL HISTORY> ___ <FAMILY HISTORY> NC <PHYSICAL EXAM> VSS Gen: NAD Lungs: CTA CV: RRR Abd: 2cm opening on right side of incision with packing, erythema improved from prior, no pus Ext: 1+ pitting edema bilaterally with no calf tenderness <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Prenatal Vitamins 1 TAB PO DAILY 2. Docusate Sodium 100 mg PO DAILY: PRN constipation 3. Symbicort (budesonide-formoterol) 160-4.5 mcg/actuation inhalation 2 puffs bid 4. ProAir HFA (albuterol sulfate) 90 mcg/actuation 2 puffs Q4H: PRN wheezing <DISCHARGE MEDICATIONS> 1. Albuterol Inhaler 2 PUFF IH Q4H: PRN asthma 2. Docusate Sodium 100 mg PO BID: PRN Constipation RX *docusate sodium [Colace] 100 mg 1 capsule(s) by mouth twice a day Disp #*40 Capsule Refills: *1 3. Ibuprofen 600 mg PO Q6H: PRN Pain RX *ibuprofen 600 mg 1 tablet(s) by mouth every 6 hours Disp #*30 Tablet Refills: *0 4. Symbicort (budesonide-formoterol) 160-4.5 mcg/actuation inhalation BID 5. Clindamycin 450 mg PO Q6H Duration: 10 Days RX *clindamycin HCl 150 mg 3 capsule(s) by mouth every 6 hrs Disp #*108 Capsule Refills: *0 6. Ferrous Sulfate 325 mg PO BID RX *ferrous sulfate 140 mg (45 mg iron) 1 tablet(s) by mouth twice a day Disp #*60 Tablet Refills: *1 7. HYDROmorphone (Dilaudid) ___ mg PO Q4H: PRN pain RX *hydromorphone [Dilaudid] 2 mg ___ tablet(s) by mouth q4hrs Disp #*30 Tablet Refills: *0 8. Labetalol 300 mg PO BID RX *labetalol 300 mg 1 tablet(s) by mouth twice a day Disp #*40 Tablet Refills: *0 9. Prenatal Vitamins 1 TAB PO DAILY 10. ProAir HFA (albuterol sulfate) 90 mcg/actuation 2 PUFFS Q4H: PRN wheezing <DISCHARGE DISPOSITION> Home With Service Facility: ___ <DISCHARGE DIAGNOSIS> primary low transverse cesarean section gestational hypertension asthma arrest of descent endometritis, cellulitis, wound infection <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> pelvic rest x 6 weeks until postpartum visit no heavy lifting or driving x 2 weeks keep incision clean and dry ","The patient is a ___ G3, P0 at 37 weeks 4 days admitted for induction of labor due to gestational hypertension. After a prolonged induction, the patient progressed to fully dilated and +2 station. However, after 5 hours fully dilated and ___ hours pushing, there was no descent of the fetal head and significant caput was noted. The patient was recommended to undergo delivery via cesarean section. She experienced a PPH with EBL 1200cc from cervical extension, but remained stable postpartum. In terms of her gestational hypertension, she had normal labs. She was started on labetalol 200mg BID on ___, which was increased to 300mg BID on ___ for elevated pressures. During her postpartum course she developed an incisional cellulitis with wound abscess. She was noted to have erythema and induration on right side of incision and extending to mons. She was started on IV gent/clinda -> PO clindamycin started ___ ___, 10d course. She incision was opened at bedside ___ and she underwent BID wet to dry dressing changes. She had a wound culture with mixed flora, a negative urine culture, and blood cultures with no growth. Patient also experienced bilateral lower extremity edema during her stay that she found very bothersome. She received Lasix 20mg PO x1, with improvement of symptoms. She was also maintained on Lovenox 40mg daily. She was discharged on ___ in stable condition with plan for outpatient ___ for BID dressing changes and blood pressure monitoring. ",1284,330
10004322-DS-21,"<SEX> M <SERVICE> MEDICINE <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> multiple falls at group home <MAJOR SURGICAL OR INVASIVE PROCEDURE> None <HISTORY OF PRESENT ILLNESS> Mr. ___ is a ___ year old male with a h/o psychosis admitted for falls over the past two days. Patient himself claims that people have been pushing him to the ground and beating him up. He denies blacking out or having palpitations or dizziness before the fall. Importantly, conversations with supervisor of the group home ___ ___ reveal that he has had some mechanical falls, but they were likely not result of being pushed. Per ___, Mr. ___ has been more lethargic than usual. Also, she says that Mr. ___ administers his own medication without supervision and may not have been compliant in the past few weeks. Of note, pt did report ""urine hurting"" in the ED, which he later denied. He also complained of tooth pain on bottom jaw where he has a chronically split tooth and cavity. Also lower bilateral abdominal pain. No back pain. Some recent constipation with last bowel movement 2 days ago. Frequently strains. No blood. No other focal symptoms. In the ED, initial VS were 106/65 hr 100 rr 18 sat 97/ra. He received 2LNS. Head CT, CXR, pelvis and lumbar spine films in the ED were negative. <PAST MEDICAL HISTORY> Psychosis Diabetes COPD <SOCIAL HISTORY> ___ <FAMILY HISTORY> Unknown to patient. <PHYSICAL EXAM> ADMISSION PHYSICAL EXAM: VS: 98.1 117/62 97 18 96RA GENERAL: disheveled male, appears stated age, NAD, odd affect HEENT: Middle lower jaw with cracked tooth that is tender to palpation. No pus or swelling at the area. No areas of bruising/hematoma of chin/jaw. PERRL, EOMI, MMM LUNGS - CTA bilat, no r/rh/wh, good air movement HEART - RRR, no MRG, nl S1-S2 ABDOMEN - Soft, mild tenderness to palpation of lower abdomen (right and lower), +BS EXTREMITIES - no c/c/e, 2+ peripheral pulses NEURO - A&Ox1, CNs II-XII grossly intact, muscle strength ___ throughout, sensation grossly intact throughout, gait not assessed DISCHARGE PHYSICAL EXAM: PHYSICAL EXAM: VS: 98.4 135/70 78 16 98RA GENERAL: disheveled male, appears stated age, NAD, odd affect HEENT: Middle lower jaw with cracked tooth that is tender to palpation. No pus or swelling at the area. No areas of bruising/hematoma of chin/jaw. MMM LUNGS - CTAB HEART - RRR, no MRG, nl S1-S2 ABDOMEN - Soft, NTND +BS EXTREMITIES - no c/c/e, 2+ peripheral pulses NEURO - A&Ox1, CNs II-XII grossly intact, muscle strength ___ throughout, sensation grossly intact throughout, gait not assessed <PERTINENT RESULTS> ADMISSION LABS: ___ 03: 40PM BLOOD WBC-17.7* RBC-4.73 Hgb-13.7* Hct-40.2 MCV-85 MCH-29.0 MCHC-34.2 RDW-14.0 Plt ___ ___ 03: 40PM BLOOD Neuts-85.7* Lymphs-8.9* Monos-5.2 Eos-0 Baso-0.3 ___ 03: 40PM BLOOD Glucose-274* UreaN-22* Creat-1.0 Na-134 K-4.4 Cl-96 HCO3-24 AnGap-18 ___ 03: 40PM BLOOD ALT-23 AST-28 AlkPhos-159* TotBili-0.5 ___ 03: 40PM BLOOD Lipase-32 ___ 03: 40PM BLOOD cTropnT-<0.01 ___ 06: 10AM BLOOD CK-MB-1 cTropnT-<0.01 ___ 06: 10AM BLOOD Calcium-9.1 Phos-3.8 Mg-2.0 ___ 03: 40PM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG Bnzodzp-NEG Barbitr-NEG Tricycl-NEG ___ 05: 37PM BLOOD Lactate-2.4* --========= DISCHARGE LABS: ___ 06: 00AM BLOOD WBC-10.3 RBC-4.14* Hgb-12.1* Hct-35.3* MCV-85 MCH-29.2 MCHC-34.2 RDW-14.3 Plt ___ ___ 06: 00AM BLOOD Glucose-122* UreaN-16 Creat-0.9 Na-138 K-3.8 Cl-100 HCO3-28 AnGap-14 ___ 06: 00AM BLOOD Calcium-9.6 Phos-5.0* Mg-2.2 --========= URINE: ___ 10: 00PM URINE Color-Yellow Appear-Clear Sp ___ ___ 10: 00PM URINE Blood-NEG Nitrite-NEG Protein-30 Glucose-1000 Ketone-NEG Bilirub-NEG Urobiln-NEG pH-5.5 Leuks-NEG ___ 10: 00PM URINE RBC-0 WBC-2 Bacteri-FEW Yeast-NONE Epi-<1 URINE CULTURE (Final ___: MIXED BACTERIAL FLORA ( >= 3 COLONY TYPES), CONSISTENT WITH SKIN AND/OR GENITAL CONTAMINATION. --========= Blood cultures: negative for 48hours --========= IMAGING from ___: CXR: Supine AP portable view of the chest provided. Lung volumes are low. No definite consolidation or supine evidence of effusion or pneumothorax. The cardiomediastinal silhouette appears grossly within normal limits. No definite displaced rib fracture is seen. X-Ray Pelvis/Lumbar Spine: No fracture or malalignment in the lumbar spine. Intact appearance of the bony pelvis Non-Contrast Head CT: There is no evidence of acute hemorrhage, edema, mass, mass effect, or acute territorial infarction. The ventricles and sulci are mildly prominent consistent with age-related atrophy. There are mild periventricular and subcortical white matter hypodensities consistent with the sequela of chronic small vessel ischemic disease. The visualized paranasal sinuses and mastoid air cells are well aerated. No fracture. IMPRESSION: No acute intracranial process EKG: sinus, NA/NI, no acute ischemia --========= <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Docusate Sodium 100 mg PO BID 2. Clozapine 200 mg PO BID 3. Clozapine 75 mg PO HS in addition to 200mg BID 4. Ranitidine 150 mg PO BID 5. MetFORMIN (Glucophage) 1000 mg PO BID 6. Aspirin 81 mg PO DAILY 7. Lisinopril 5 mg PO DAILY hold for SBP < 100 8. Gemfibrozil 600 mg PO BID 9. Acetaminophen 650 mg PO Q6H: PRN pain 10. Fluticasone Propionate 110mcg 2 PUFF IH BID 11. Tiotropium Bromide 1 CAP IH DAILY 12. Glargine 70 Units Breakfast <DISCHARGE MEDICATIONS> 1. Acetaminophen 650 mg PO Q6H: PRN pain 2. Aspirin 81 mg PO DAILY 3. Clozapine 200 mg PO BID 4. Clozapine 75 mg PO HS in addition to 200mg BID 5. Docusate Sodium 100 mg PO BID 6. Fluticasone Propionate 110mcg 2 PUFF IH BID 7. Gemfibrozil 600 mg PO BID 8. Glargine 55 Units Breakfast Insulin SC Sliding Scale using HUM Insulin 9. Lisinopril 5 mg PO DAILY hold for SBP < 100 10. Ranitidine 150 mg PO BID 11. Tiotropium Bromide 1 CAP IH DAILY 12. MetFORMIN (Glucophage) 1000 mg PO BID <DISCHARGE DISPOSITION> Home With Service Facility: ___ <DISCHARGE DIAGNOSIS> Primary: mechanical fall Secondary: psychosis, diabetes, COPD. <DISCHARGE CONDITION> Mental Status: Confused - sometimes. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Mr. ___, It was our pleasure to care for you at ___. You were admitted for a fall and question of confusion. Your mental status improved during your hospitalization and you were treated with your home antipsychotic medications. We had our physical therapists see you in the hospital and they determined that you would benefit from continued physical therapy assesment and care in your group home. ","___ with h/o psychosis admitted because of multiple falls, also vague complaints of abdominal discomfort and burning with urination. # S/P Mechanical Fall: Patient is poor historian and reports being pushed. Collateral info from group home, supports behavioral changes and mechanical fall. Story surrounding fall not consistent with syncope. Furthermore trops negative x2, EKG without changes. Telemetry monitoring without events. No episodes of fall while inpatient. He was able to walk with ___ with use of a cane. ___ recommended further therapy in his group home. # Psychosis: Per collateral info, prior to admission he was more lethargic than usual. There was question of medication compliance as he administers his own meds independently. He was continued on his home medications (CLozapine) and was interactive and appropriate during his admission. Mental status returned to baseline (per collateral information). #Dysuria: On presentation, he gave an inconsistent history of discomfort with urination. UA not convincing of UTI and urine culture only with genital flora contamination. He was not treated with antibiotics. No longer complained of pain with urination. CHRONIC ISSUES: # Diabetes: He is typically on metformin and Lantus 70 units qam. He was started on Lantus 50 units qam and titrated up only to Lantus 55units daily with good effect. He was discharged home on 55units qam to prevent possibility of hypoglycemia. He was also restarted on metformin. #COPD: stable, he continued his home meds (fluticasone and tiotropium inhaler) # He was continued on the following home meds: -ranitidine 150mg BID -Aspirin 81mg po daily -Lisinopril 5mg po daily -Gemfibrozil 600 mg PO BID TRANSITIONAL ISSUES: -He was discharged back home to the ___ Home -Full Code -___ for ___ ",2119,407
10004322-DS-22,"<SEX> M <SERVICE> MEDICINE <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> WEAKNESS <MAJOR SURGICAL OR INVASIVE PROCEDURE> N/A <HISTORY OF PRESENT ILLNESS> ___ is a ___ year-old M (poor historian) with a PMH of psychosis, mechanical falls with negative syncope w/u in ___, T2DM (last HbA1c unknown, on metformin and insulin), and COPD (last FEV1 unknown), who presents with a 2-week history of weakness and cough with sputum production. He was in his usual state of health until 2 weeks ago, when he began to feel weak and short of breath. Of note, he has had similar episodes in the past that last for several days and said directly that ""this feels like pneumonia to me."" This was associated with a frequent cough productive of yellow-green sputum and anorexia with poor PO intake. He denies hemoptysis, fevers, chills, and night sweats. He denies orthopnea and PND. He denies nausea, vomiting, diarrhea, constipation, hematochezia, melena, dysuria, and hematuria. Yesterday, he experienced worsening lightheadedness and he had frequent episodes of tripping. He denies falls, LOC, or head strike with these episodes. This morning, he had an episode of chest pain that was midsternal, sharp, and pleuritic without radiation into the arm or neck or worsened SOB. Concurrently, he was too weak to rise from his chair. Last FSG 138. Given his weakness and worsening respiratory status, he presented to the ED. ___ ED -------- + Initial Vitals: 97.5 91 126/81 17 100% RA + Exam was notable for: Dry MM, R tonsillar fullness. No focality to pulmonary exam. + Labs were significant for: BUN 33, Cr 1.5, AGAP 21 WBC 13, Hgb 12.4, Plt 341 Trop <0.01 + Imaging: - CT head showed no acute process. - CXR showed streaky posteroinferior left lobe opacity may reflect atelectasis, though infection cannot be entirely excluded. - EKG showed NSR, rate 90. + Interventions: 1L IVF, azithromycin 500mg IV x1, CTX 1g x1. + Vitals Prior to Transfer: 97.9 84 132/78 17 99% RA Currently, he continues to have a cough with intermittent sputum production. His appetite has returned and he was eating dinner at the time of the exam. He denies any other complaints. <PAST MEDICAL HISTORY> 1. Paranoid schizophrenia, well-controlled on Clozaril - Previous auditory and visual hallucinations, none ""for awhile"" per patient 2. Mechanical falls with negative syncope workup (___) 3. T2DM (last HbA1c 7.1 in ___ 4. COPD (last FEV1 unknown) <SOCIAL HISTORY> ___ <FAMILY HISTORY> Unknown to patient. <PHYSICAL EXAM> ADMISSION PHYSICAL EXAM VS: T 97.7 BP 137/80 HR 98 RR 20 SaO2 100% RA Wt 78.88kg GEN: Man appearing older than stated age, alert, lying in bed watching TV, no acute distress. HEENT: Dry MM, anicteric sclerae, no conjunctival pallor. +R tonsillar fullness. NECK: Supple without LAD. PULM: Globally decreased breath sounds with intermittent expiratory wheeze, no rhonchi or rales, symmetric air movement, no increased work of breathing. COR: RRR (+)S1/S2 no m/r/g ABD: Soft, non-tender, non-distended, +bowel sounds. EXTREM: Warm, well-perfused, no edema. +2 ___ pulses. NEURO: A&Ox3. CN II-XII grossly intact, motor function grossly normal. Diminished sensation in bilateral distal ___ (although difficult to pinpoint given intermittent compliance with the exam). DISCHARGE PHYSICAL EXAM VS: 97.2 141/86 83 18 97 RA Orthostatics ___: 154/77 82 (lying) 143/78 90 (sitting) 120/86 97 (standing) GEN: Elderly gentleman lying in bed, arousable but falls asleep quickly, NAD. HEENT: Chapped lips, anicteric sclerae. Multiple missing teeth of front lower jaw. NECK: Supple without LAD. PULM: Breath sounds clearer than ___ bilaterally but general poor air movement decreased, intermittent expiratory wheeze, no increased work of breathing. No egophony. COR: RRR (+)S1/S2 no m/r/g, heart sounds distant. ABD: Soft, non-tender, non-distended, +bowel sounds. EXTREM: Warm, well-perfused, no edema. +2 ___ pulses. No e/o diabetic foot ulcers. NEURO: Refused to answer orientation Qs this AM. Gait deferred. <PERTINENT RESULTS> ADMISSION LABS ------------------ ___ 12: 30PM BLOOD WBC-13.0* RBC-4.26* Hgb-12.4* Hct-36.5* MCV-86 MCH-29.1 MCHC-34.0 RDW-13.8 RDWSD-42.5 Plt ___ ___ 12: 30PM BLOOD Neuts-77.3* Lymphs-16.1* Monos-5.3 Eos-0.5* Baso-0.2 Im ___ AbsNeut-10.01* AbsLymp-2.08 AbsMono-0.69 AbsEos-0.06 AbsBaso-0.03 ___ 12: 30PM BLOOD Glucose-139* UreaN-33* Creat-1.5* Na-136 K-4.2 Cl-97 HCO3-22 AnGap-21* OTHER LABS ------------------ ___ 06: 55AM BLOOD Cortsol-13.0 ___ 06: 33AM BLOOD Triglyc-379* HDL-25 CHOL/HD-8.8 LDLcalc-120 ___ 07: 25AM BLOOD WBC-7.2 RBC-3.77* Hgb-10.9* Hct-32.7* MCV-87 MCH-28.9 MCHC-33.3 RDW-13.9 RDWSD-43.2 Plt ___ ___ 06: 33AM BLOOD %HbA1c-7.1* eAG-157* ___ 06: 33AM BLOOD Triglyc-379* HDL-25 CHOL/HD-8.8 LDLcalc-120 ___ 06: 33AM BLOOD HBsAg-Negative HBsAb-Negative IgM HBc-Negative ___ 06: 33AM BLOOD HIV Ab-Negative ___ 06: 33AM BLOOD HCV Ab-Negative ___ 10: 07AM BLOOD ___ pO2-195* pCO2-33* pH-7.43 calTCO2-23 Base XS-0 ___ 12: 30PM BLOOD cTropnT-<0.01 DISCHARGE LABS ___ 06: 13AM BLOOD WBC-9.3 RBC-4.19* Hgb-11.9* Hct-36.5* MCV-87 MCH-28.4 MCHC-32.6 RDW-13.7 RDWSD-43.2 Plt ___ ___ 06: 13AM BLOOD Glucose-114* UreaN-16 Creat-1.1 Na-137 K-4.3 Cl-99 HCO3-21* AnGap-21* IMAGING --------- + CXR (___) Streaky left lobe opacity may reflect atelectasis, though infection cannot be entirely excluded. + CT Head (___) No acute intracranial abnormalities. Specifically, no evidence of intra-axial or extra-axial hemorrhage. + EKG (___) NSR, rate 90 <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Acetaminophen 650 mg PO Q6H: PRN pain 2. Aspirin 81 mg PO DAILY 3. Clozapine 200 mg PO BID 4. Clozapine 75 mg PO HS 5. Docusate Sodium 100 mg PO BID 6. Fluticasone Propionate 110mcg 2 PUFF IH BID 7. Gemfibrozil 600 mg PO BID 8. Lisinopril 5 mg PO DAILY 9. Ranitidine 150 mg PO BID 10. Tiotropium Bromide 1 CAP IH DAILY 11. MetFORMIN (Glucophage) 1000 mg PO BID 12. Detemir 32 Units Breakfast The Preadmission Medication list is accurate and complete. 1. Acetaminophen 650 mg PO Q6H: PRN pain 2. Aspirin 81 mg PO DAILY 3. Clozapine 200 mg PO BID 4. Clozapine 75 mg PO HS 5. Docusate Sodium 100 mg PO BID 6. Fluticasone Propionate 110mcg 2 PUFF IH BID 7. Gemfibrozil 600 mg PO BID 8. Lisinopril 5 mg PO DAILY 9. Ranitidine 150 mg PO BID 10. Tiotropium Bromide 1 CAP IH DAILY 11. MetFORMIN (Glucophage) 1000 mg PO BID 12. Detemir 32 Units Breakfast <DISCHARGE MEDICATIONS> 1. Fludrocortisone Acetate 0.1 mg PO DAILY hypotension 2. Acetaminophen 650 mg PO Q6H: PRN pain 3. Aspirin 81 mg PO DAILY 4. Clozapine 200 mg PO BID 5. Clozapine 75 mg PO HS 6. Docusate Sodium 100 mg PO BID 7. Fluticasone Propionate 110mcg 2 PUFF IH BID 8. Gemfibrozil 600 mg PO BID 9. Detemir 32 Units Breakfast 10. MetFORMIN (Glucophage) 1000 mg PO BID 11. Ranitidine 150 mg PO BID 12. Tiotropium Bromide 1 CAP IH DAILY <DISCHARGE DISPOSITION> Extended Care Facility: ___ <DISCHARGE DIAGNOSIS> PRIMARY DIAGNOSES: COMMUNITY-ACQUIRED PNEUMONIA DEHYDRATION ACUTE KIDNEY INJURY ORTHOSTATIC HYPOTENSION SECONDARY DIAGNOSES: TYPE II DIABETES MELLITUS HYPERTENSION HYPERLIPIDEMIA CHRONIC OBSTRUCTIVE PULMONARY DISEASE PARANOID SCHIZOPHRENIA CORONARY ARTERY DISEASE GASTROESOPHAGEAL REFLUX DISORDER <DISCHARGE CONDITION> Mental Status: Confused - sometimes. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Mr. ___, You were admitted to the hospital for weakness and cough. We found that you had a pneumonia (infection of the lungs) and gave you antibiotics. We also found that you were very dehydrated and gave you IV fluids. Our physical therapists also evaluated you and decided you were strong enough to go home. You will need to continue your antibiotics until _____. It is very important not to stop your antibiotics early as this can lead to repeated or worse infections. Please make sure to drink enough water (at least 8 cups a day) and eat three meals a day. It was a pleasure taking care of you, and we hope you continue to feel better. Sincerely, Your Team at ___ ","___ is a ___ year-old M (poor historian) with a PMH of psychosis, mechanical falls with negative syncope w/u in ___, T2DM (last HbA1c 7.1 in ___, on metformin and insulin), and COPD (last FEV1 unknown), who presents with a 2-week history of weakness and cough with sputum production concerning for CAP as well as orthostatic hypotension. # Cough: Likely CAP given leukocytosis (13k), malaise, sputum production, and LLL infiltrate on CXR. Never met SIRS criteria during hospitalization. He always saturated well on RA with no evidence of increased work of breathing. SputumCx indeterminate, urine legionella negative. He received a 5-day course of antibiotics with ceftriaxone/azithromycin (___). On discharge, he was feeling significantly better with no complaints of cough. # Dizziness/Weakness: The patient presented with orthostatic hypotension thought secondary hypovolemia in the setting of poor PO intake, given positive orthostatics and BUN/Cr > 20:1 suggestive of dehydration. Patient relies on cane at home. ECG NSR, trops neg. CT Head with no acute process. Electrolytes WNL. Despite brisk fluid resuscitation and now likely euvolemic status, orthostatics remain positive and he has a persistent unsteady gait. Underlying etiology unclear, possibly autonomic dysfunction ___ DM versus medication (on clozapine). Per outpatient psychiatrist Dr. ___ has been on the same dose of clozapine for ___ years. Adrenal insufficiency unlikely as ___ AM cortisol level 13.0. ___ evaluated him on ___ and recommended rehab. On discharge, his orthostatic vital signs remained positive and he continued to require assistance with walking. He was initiated on fludrocortisone 0.1mg QD on ___ with some symptom relief. # ___: Likely due to hypovolemia in the setting of poor PO intake given BUN/Cr > 20:1. Last baseline 0.95 in ___. We gave him IVF as above with resolution of his ___ to Cr 0.9. On discharge, his BUN/Cr were ___. # Prior IVDU: Patient reports prior history of heroin use and ""other drugs."" He gave consent for HIV testing. HIV, HepB, HepC were all negative. CHRONIC ISSUES: =============== # Psychosis: Continued clozapine. # Diabetes: RISS, held home metformin. Repeat HbA1c 7.2. FSGs 120s-180s here. No evidence of diabetic foot ulcers. # COPD: Continued home fluticasone and tiotropium inhaler. # GERD: Continued home ranitidine. # CAD: Continued home ASA. # HTN: Held home lisinopril given orthostatic hypotension. # HL: Continued home gemfibrozil. Total Chol 221 Triglycerides 379* elevated. HDL low at 25. Chol/HD 8.8, LDL calc 120. TRANSITIONAL ISSUES =================== # Fludrocortisone: The patient was initiated on Fluricil on ___ at 0.1mg daily. This can be uptitrated at a rate of 0.1mg per week to a maximum of 0.3mg daily. # Transthoracic echo: The patient was scheduled for an outpatient echo. ECHO office will call patient to make appointment. He should follow up with a cardiologist to review the results. # Nutrition: The patient arrived with evidence of dehydration. Please ensure that he is reminded to drink water and other fluids throughout the day, especially if he is feeling ill. # Former IVDU: HIV, HepC, HepB found to be negative on this admission. No evidence of active IVDU. # ? Diabetic neuropathy: The patient intermittently reported reduced sensation and proprioception in bilateral distal extremities. His HbA1c was 7.2 on admission, which is mildly elevated. His orthostatic hypotension may also be an effect of autonomic neuropathy. His primary care physician should reevaluate this at their next appointment. # Orthostatic hypotension: He will be scheduled for an outpatient follow-up appointment with neurology to evaluate for potential causes of autonomic neuropathy. If negative, his psychiatrist should consider redosing of his clozapine to minimize potential side effects. His primary care physician should continue to work closely with him to ensure his diabetes mellitus is being treated adequately. # Blood cultures: Negative since ___, final result pending at discharge. If any growth observed, the patient will be notified. # Lipid panel: Total Chol 221 Triglycerides 379* elevated. HDL low at 25. Chol/HD 8.8, LDL calc 120. He should have a repeat lipid panel performed with his primary care physician and consider alternative agents/dosing to better manage his low HDL and high triglycerides. =========================== # CODE STATUS: Full (unconfirmed) # CONTACT: ___ ___ or ___ ",2730,1105
10004322-DS-23,"<SEX> M <SERVICE> MEDICINE <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___ <CHIEF COMPLAINT> Altered Mental Status <MAJOR SURGICAL OR INVASIVE PROCEDURE> None <HISTORY OF PRESENT ILLNESS> ___ is a ___ year old male with history of schizophrenia with most recent ED visit ___, COPD, DM, mechanical falls most recently in ___ and s/p negative syncope workup in ___, history of urinary retention s/p indwelling foley in ___, admission in ___ for sepsis from pneumonia, presenting with complaints of fever and altered mental status. ___ presented to the ED from his group home after reportedly being febrile yesterday. The group home care staff changed his foley yesterday and noted that he his mental status was altered this morning. Seen in ___ on ___ by Dr. ___ for evaluation of need for chronic foley which was placed in late ___ after ___ presented to the ED after a fall and was found to be in ___ (prior to this, he had no problems voiding) and have obstructive uropathy. Noted to have a hypersensitive bladder with normal compliance, terminal detrusor overactivity, no obstruction, and was able to empty bladder completely despite over activity. The plan was to leave the foley catheter out and monitor PVRs ___ times daily with foley re-insertion if PVR>400-450cc and to continue tamsulosin. In the ED, initial vital signs were: T99.1 HR112 BP91/58 RR16 SaO2 95% on RA - Exam notable for: lethargy, arousable only to pain, oriented x1 - Labs were notable for: 1) Chem 10 - 134|94|28 ---------<159 4.2|20|1.5 2) CBC - 27.3>10.5/32.5<376 Diff - 85.6%, 4.5%, Monos 8.7% 3) LFTs - ALP 167 (ALT 5, AST 14, Tbili 0.5, Alb 3.8) 4) U/A - hazy appearance with large leuks (WBC>182), small amount of blood (RBC>10), Few bacteria, Negative Nitrites, 30 Proteins 5) FluAPCR and FluBPCR - negative 6) Lactate - 1.6 7) Blood cx - pnd 8) Urine cx - pnd - Studies performed include: 1) CT C-spine w/o contrast: No acute fracture or malalignment of the cervical spine. 2) NCHCT: No acute intracranial process 3) CXR: No acute cardiopulmonary process. No focal consolidation to suggest pneumonia. - Patient was given: 1) IV NS 2) Ceftriaxone 2 gm - Vitals on transfer: ___, 99.2F, HR111(106-113), BP135/67 (91-135/55-67), RR25 (___), SaO2 100% on RA Upon arrival to the floor, the patient was somnolent but arousable, oriented to name only. History could not be completed as patient could not answer questions. REVIEW OF SYSTEMS: (+) per HPI (-) chills, night sweats, headache, vision changes, rhinorrhea, congestion, sore throat, cough, shortness of breath, chest pain, abdominal pain, nausea, vomiting, diarrhea, constipation, BRBPR, melena, hematochezia, dysuria, hematuria. <PAST MEDICAL HISTORY> 1. Paranoid schizophrenia, well-controlled on Clozaril - Previous auditory and visual hallucinations, none ""for awhile"" per patient 2. Mechanical falls with negative syncope workup (___) 3. T2DM (last HbA1c 7.1 in ___ 4. COPD (last FEV1 unknown) 5. GERD/Reflux Esophagitis 6. CAD 7. HTN 8. Hyperlipidemia <SOCIAL HISTORY> ___ <FAMILY HISTORY> Unknown to patient <PHYSICAL EXAM> ADMISSION PHYSICAL EXAM: -======= VS: 98.9, 109bpm, BP129/66, RR18, SaO2 96% on RA GENERAL: A&Ox1 (name only), somnolent, responsive to voice and gentle touch but quickly falls asleep, unable to answer questions comprehensibly HEENT: Normocephalic, atraumatic. Pupils equal (3mm), round, and unreactive bilaterally. No conjunctival pallor or injection, sclera anicteric and without injection. Moist mucous membranes, good dentition. Oropharynx is clear. NECK: Thyroid is normal in size and texture, no nodules. No cervical lymphadenopathy. CARDIAC: Regular rhythm, normal rate, no murmurs/rubs/gallops. No JVD. LUNGS: Clear to auscultation bilaterally w/appropriate breath sounds appreciated in all fields. No wheezes, rhonchi or rales. BACK: Skin. no spinous process tenderness. no CVA tenderness. ABDOMEN: Normal bowels sounds, non distended, non-tender to deep palpation in all four quadrants though difficult to assess given patient's altered sensorium. Tympanic to percussion. No organomegaly. well-healed mid-line incision measuring ___ inches EXTREMITIES: No clubbing, cyanosis, or edema, no sign of atrophy/hypertrophy. Pulses DP/Radial 2+ bilaterally. SKIN: No evidence of ulcers, rash or lesions suspicious for malignancy NEUROLOGIC: could not complete due to lack of patient cooperation DISCHARGE PHYSICAL EXAM: -======= VS: 98.0PO, Tmax 98.1, 156/79 (149-156/79-87), 83 (71-85), 18, SaO2 95% on RA GENERAL: A&Ox2 (name and place), able to engage in conversation and keep eyes open HEENT: Normocephalic, atraumatic. Pupils equal (3mm), round, and unreactive bilaterally. No conjunctival pallor or injection, sclera anicteric and without injection. Moist mucous membranes, good dentition. Oropharynx is clear. NECK: Thyroid is normal in size and texture, no nodules. No cervical lymphadenopathy. CARDIAC: Regular rhythm, normal rate, no murmurs/rubs/gallops. No JVD. LUNGS: Clear to auscultation bilaterally w/appropriate breath sounds appreciated in all fields. No wheezes, rhonchi or rales. BACK: Skin. no spinous process tenderness. no CVA tenderness. ABDOMEN: Normal bowels sounds, soft, non-tender/non-distended. Tympanic to percussion. No organomegaly. well-healed mid-line incision measuring ___ inches EXTREMITIES: No clubbing, cyanosis, or edema, no sign of atrophy/hypertrophy. Pulses DP/Radial 2+ bilaterally. SKIN: No evidence of ulcers, rash or lesions suspicious for malignancy NEUROLOGIC: could not complete due to lack of patient cooperation <PERTINENT RESULTS> ADMISSION LABS: -== ___ 12: 54PM PLT SMR-NORMAL PLT COUNT-376 ___ 12: 54PM HYPOCHROM-NORMAL ANISOCYT-NORMAL POIKILOCY-OCCASIONAL MACROCYT-NORMAL MICROCYT-NORMAL POLYCHROM-NORMAL OVALOCYT-OCCASIONAL ___ 12: 54PM NEUTS-85.6* LYMPHS-4.5* MONOS-8.7 EOS-0.0* BASOS-0.2 IM ___ AbsNeut-23.37*# AbsLymp-1.23 AbsMono-2.36* AbsEos-0.00* AbsBaso-0.05 ___ 12: 54PM WBC-27.3*# RBC-3.75* HGB-10.5* HCT-32.5* MCV-87 MCH-28.0 MCHC-32.3 RDW-14.2 RDWSD-44.6 ___ 12: 54PM ALBUMIN-3.8 ___ 12: 54PM ALT(SGPT)-5 AST(SGOT)-14 ALK PHOS-167* TOT BILI-0.5 ___ 12: 54PM estGFR-Using this ___ 12: 54PM GLUCOSE-159* UREA N-28* CREAT-1.5* SODIUM-134 POTASSIUM-4.2 CHLORIDE-94* TOTAL CO2-20* ANION GAP-24* ___ 01: 19PM LACTATE-1.6 ___ 01: 53PM OTHER BODY FLUID FluAPCR-NEGATIVE FluBPCR-NEGATIVE ___ 03: 00PM URINE MUCOUS-RARE ___ 03: 00PM URINE HYALINE-4* ___ 03: 00PM URINE RBC-10* WBC->182* BACTERIA-FEW YEAST-NONE EPI-<1 ___ 03: 00PM URINE BLOOD-SM NITRITE-NEG PROTEIN-30 GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-5.5 LEUK-LG ___ 03: 00PM URINE COLOR-Yellow APPEAR-Hazy SP ___ ___ 03: 00PM URINE bnzodzpn-NEG barbitrt-NEG opiates-NEG oxycodn-NEG ___ 03: 00PM URINE UHOLD-HOLD ___ 03: 00PM URINE HOURS-RANDOM ___ 09: 32PM PLT COUNT-334 ___ 09: 32PM WBC-19.8* RBC-3.39* HGB-9.4* HCT-29.7* MCV-88 MCH-27.7 MCHC-31.6* RDW-14.5 RDWSD-46.8* ___ 09: 32PM GLUCOSE-123* UREA N-24* CREAT-1.2 SODIUM-139 POTASSIUM-3.7 CHLORIDE-101 TOTAL CO2-21* ANION GAP-21* DISCHARGE/PERTINENT LABS: -======== ___ 07: 05AM BLOOD WBC-8.9 RBC-3.32* Hgb-9.2* Hct-27.7* MCV-83 MCH-27.7 MCHC-33.2 RDW-13.9 RDWSD-42.4 Plt ___ ___ 07: 05AM BLOOD Glucose-118* UreaN-6 Creat-0.6 Na-140 K-3.5 Cl-101 HCO3-24 AnGap-19 ___ 07: 00AM BLOOD ___ PTT-35.2 ___ ___ 07: 00AM BLOOD ALT-6 AST-14 LD(LDH)-176 AlkPhos-127 TotBili-0.4 ___ 07: 05AM BLOOD Calcium-8.5 Phos-2.5* Mg-1.7 MICROBIOLOGY: -= ___ 3: 00 pm URINE **FINAL REPORT ___ URINE CULTURE (Final ___: ESCHERICHIA COLI. 10,000-100,000 CFU/mL. Fosfomycin Susceptibility testing requested by ___. ___ ___ (___) ON ___. FOSFOMYCIN = 24MM = SUSCEPTIBLE. FOSFOMYCIN sensitivity testing performed by ___ ___. SENSITIVITIES: MIC expressed in MCG/ML _________________________________________________________ ESCHERICHIA COLI | AMIKACIN-------------- 8 S AMPICILLIN------------ =>32 R AMPICILLIN/SULBACTAM-- =>32 R CEFAZOLIN------------- =>64 R CEFTAZIDIME----------- <=1 S CEFTRIAXONE----------- =>64 R CIPROFLOXACIN--------- =>4 R GENTAMICIN------------ =>16 R MEROPENEM-------------<=0.25 S NITROFURANTOIN-------- <=16 S TOBRAMYCIN------------ =>16 R TRIMETHOPRIM/SULFA---- =>16 R IMAGING: ======== ___ Imaging ABDOMEN (SUPINE & ERECT) Nonobstructive bowel gas pattern in the stomach, small bowel and colon. No evidence of pneumoperitoneum. ___ Imaging CHEST (SINGLE VIEW) No acute cardiopulmonary process. No focal consolidation to suggest pneumonia. ___-SPINE W/O CONTRAST No acute fracture or malalignment of the cervical spine. ___ Imaging CT HEAD W/O CONTRAST No acute intracranial process. <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Fludrocortisone Acetate 0.1 mg PO DAILY hypotension 2. Acetaminophen 650 mg PO Q6H: PRN Pain - Mild 3. Aspirin 81 mg PO DAILY 4. Clozapine 200 mg PO BID 5. Clozapine 75 mg PO QHS 6. Docusate Sodium 100 mg PO BID 7. Fluticasone Propionate 110mcg 2 PUFF IH BID 8. Gemfibrozil 600 mg PO BID 9. Levemir (insulin detemir) 32 units subcutaneous BREAKFAST 10. MetFORMIN (Glucophage) 1000 mg PO BID 11. Ranitidine 150 mg PO BID 12. Tiotropium Bromide 1 CAP IH DAILY <DISCHARGE MEDICATIONS> 1. Clozapine 100 mg PO QHS 2. Acetaminophen 650 mg PO Q6H: PRN Pain - Mild 3. Aspirin 81 mg PO DAILY 4. Docusate Sodium 100 mg PO BID 5. Fludrocortisone Acetate 0.1 mg PO DAILY hypotension 6. Fluticasone Propionate 110mcg 2 PUFF IH BID 7. Gemfibrozil 600 mg PO BID 8. Levemir (insulin detemir) 32 units subcutaneous BREAKFAST 9. MetFORMIN (Glucophage) 1000 mg PO BID 10. Ranitidine 150 mg PO BID 11. Tiotropium Bromide 1 CAP IH DAILY 12. HELD- Clozapine 200 mg PO BID This medication was held. Do not restart Clozapine until until you see your psychiatrist <DISCHARGE DISPOSITION> Extended Care Facility: ___ <DISCHARGE DIAGNOSIS> PRIMARY DIAGNOSES: -= Toxic Metabolic Encephalopathy Catheter-associated UTI Acute Kidney Injury SECONDARY DIAGNOSES: -=== Paranoid Schizophrenia Type 2 Diabetes COPD <DISCHARGE CONDITION> Mental Status: Confused - sometimes. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Mr. ___, It was a pleasure taking care of you. You were admitted to the ___ because you were confused and had a fever. You were found to have a urinary tract infection and you were started on IV antibiotics and your mental status improved significantly. Your Clozaril was also stopped and restarted at a lower dose because of your confusion. You should follow-up with your PCP and outpatient psychiatrist within ___ weeks of discharge. Wishing you a speedy recovery, ___ Care Team ","Mr. ___ is a ___ man with history of paranoid schizophrenia, COPD, Type 2 DM, urinary retention s/p indwelling foley catheter placement in ___, who presented from his group home with report of 1 day of fever prior to admission and altered mental status on the day of presentation to the ED (___). # Altered mental status/catheter associated urinary tract infection: Patient hemodynamically stable on admission, but drowsy and not oriented. Afebrile, but WBC count of 27. Urinalysis consistent with infection in the setting of indwelling foley catheter. Head and neck imaging without acute abnormalities. He was without headaches, photophobia, or neck stiffness to suggest meningoencephalitis. Patient initially started on ceftriaxone; however, urine culture revealed ESBL E. coli resistant to ceftriaxone. Patient switched to meropenem, which he received from ___ to ___. Patient was switched to fosfomycin (1 dose) on discharge to complete a full antibiotic course. Foley catheter was replaced. # Acute kidney injury: Patient also noted to have acute kidney injury with Cr 1.5, likely prerenal in etiology, that resolved with IV fluids. Cr on discharge 1.0. # Paranoid schizophrenia: Patient's clozapine was held on admission, given altered mental status. He was seen by the psychiatry service for assistance with management. Clozapine was resumed at the suggestion of psychiatry at 100mg PO QHS, with plan for outpatient uptitration by primary psychiatrist. # Normocytic anemia: He was found to have Hgb of 8.8-10.5 as compared to most recent baseline of 11.8. He was without signs of overt bleeding. There was low suspicion for hemolysis in the setting of normal TBili and lack of schistocytes on manual smear. # Abdominal pain: He experienced transient abdominal pain with benign abdomen, possibly related to urinary tract infection, though not specifically suprapubic. KUB was without signs of obstruction or perforation. Abdominal pain resolved prior to discharge. # T2DM He received long-acting insulin with sliding scale as needed. Home metformin was held throughout admission and resumed at discharge. # COPD Home fluticasone and tiotropium inhaler were held throughout admission and resumed at discharge. # GERD/Reflux esophagitis He received omeprazole in place of home ranitidine in the inpatient setting. # CAD Home ASA was continued. # Hyperlipidemia Home gemfibrozil was held throughout admission and resumed at discharge. # Orthostatic hypotension Home fludrocortisone was continued. TRANSITIONAL ISSUES: ==================== # Patient's clozapine was stopped on admission and restarted at 100mg PO QHS by recommendation from psychiatry. Patient should follow up with outpatient psychiatrist for uptitration. # Patient was found to have anemia with Hgb of 9.2. He should have a follow-up CBC with differential within 1 week and should be worked-up for iron-deficiency or other causes anemia if not improved; downtrending monocyte count, likely elevated on admission in the setting of infection, also should be ensured. # Follow-up of coagulation studies to ensure downtrending INR (elevated to 1.4 on this admission likely in the setting of infection and poor PO intake, without overt signs of DIC) also advised. # Patient found to have 10 RBC on urinalysis on this admission, likely in the setting of urinary tract infection; please assess for resolution of hematuria following resolution of urinary tract infection, though may be confounded if ongoing foley catheter needed. # Patient should follow up with urology for foley catheter care and to assess whether ongoing foley catheter is needed. Appointment was made for ___. # CODE: Full # CONTACT: ___ (___) ",3527,834
10004365-DS-7,"<SEX> F <SERVICE> OBSTETRICS/GYNECOLOGY <ALLERGIES> Sulfasalazine <ATTENDING> ___. <CHIEF COMPLAINT> Pelvic pain, ruptured ectopic pregnancy <MAJOR SURGICAL OR INVASIVE PROCEDURE> L/s as above. <HISTORY OF PRESENT ILLNESS> 37 g2po (tab1) presents as transfer from ___ for early pregnancy, ___ constant LLQ. Pt s/p RSO. U/s demonstrated enlarged hyperstimulated left ovary w/ nl flow. S/p IVF, VOR ___, UT ___ embryos transferred. <PAST MEDICAL HISTORY> GYN: IF, ovarian cysts PMH: None PSH: L/S, RSO, for ovarian cyst, ___ MEDS: none ALL: sulfa -hives <SOCIAL HISTORY> ___ <FAMILY HISTORY> Noncontributory <PHYSICAL EXAM> VSS at ED. BP 100/60, P70. Appeared in no distress.COR RRR, PULM CTAB, abd mildly distended, moderately tender, no rbnd, no guarding. Ext w/o edema. <PERTINENT RESULTS> Hct 29% (down from 37%). Labs otherwise unremarkable. TV u/s, preliminary read: Left adnexal mass likely hematoma adjacent to the massive left ovary (hyperstimulated). Single viable intrauterine gestation (7wks), a second intrauterine ___ is nonviable. <MEDICATIONS ON ADMISSION> None <DISCHARGE MEDICATIONS> 1. Polysaccharide Iron Complex ___ mg Capsule Sig: One (1) Capsule PO BID (2 times a day). Disp: *60 Capsule(s)* Refills: *2* 2. Acetaminophen 325 mg Tablet Sig: Two (2) Tablet PO Q6H (every 6 hours) as needed. Disp: *0 Tablet(s)* Refills: *0* 3. Oxycodone-Acetaminophen ___ mg Tablet Sig: One (1) Tablet PO Q4H (every 4 hours) as needed. Disp: *30 Tablet(s)* Refills: *0* <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Ruptured heterotopic pregnancy with concomittant intrauterine pregnancy. <DISCHARGE CONDITION> Excellent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Activity as tolerated; Niferex 2x day; Tylenol as needed. ","PREOP DX: Pelvic pain, possible ruptured heterotopic pregnancy vs ruptured adnexal cyst POST OP DX: Ruptured left tubal ectopic pregnancy PROCEDURE: Operative l/s, removal of EP, left salpngectomy ___ ASST: ___: Gen FINDINGS: 1- 150 cc hemoperitoneum 2- 150 cc clot 3- Left FT - ruptured an bleeding at ventral surface ampulla with surrounding clot and presumed gestational tissue. 4 - Enlarged hyperstimulated left ovary w/ normal and vascularized appearance before, during and at the end of case 5 - Surgically absent right FT and ovary 6 - Adhesions of large bowel to LLQ side wall 7 -Enlarged uterus c/w 7 wks GA IVF: ___ cc; 500 cc Hespan U/O:330 cc EBL:350 COMPLICATIONS: none SPECIMEN: Left FT, EP, clot DISPO: Stable to PACU INPATIENT NOTE - ___ SUMMARY Pt seen at ___ontrolled, DTV, no specific complaints. VSS w/ BP 100-110/ 50-60, p70. Exam w/ clear lungs, regular HR, abd mildly distended, mildly tender, incision C/d/i though ecchymosis noted at ___ port site. Labs notalble for : HCT 5 AM 19.7 9 AM 22.4 1PM 21.1 6PM 20 Diet advanced once Hct determined to be stable. TV u/s to be done bedside by residents to assess IU pregnancy viabilit ",559,346
10004401-DS-22,"<SEX> M <SERVICE> MEDICINE <ALLERGIES> Penicillins / Erythromycin Base / Streptomycin / Citric Acid / Atenolol <ATTENDING> ___. <CHIEF COMPLAINT> ___ <MAJOR SURGICAL OR INVASIVE PROCEDURE> Esophagogastroduodenoscopy <HISTORY OF PRESENT ILLNESS> This is an ___ year old man with past medical history significant for CAD s/p bare metal stents x2 in ___, systolic dysfunction (EF 35%), chronic atrial fibrillation on warfarin, VF arrest status pos pacemaker and ICD placement, and rectal cancer s/p resection who presented with melena. Ten days prior to presentation, he began to notice that the stools in his ostomy bag were dark. The color was not frankly black, but darker than usual. He denied nausea, vomiting, hematemesis, pain after meals, epigastric pain, abdominal pain, constipation, or diarrhea. He did aknowledge chronic dysphagia that had been persistent for many years. He also denied syncope, lightheadedness, shortness of breath, and chest pain. On the day of admission, he presented to his PCP's office with the complaint of black stools, and those stools were found to be grossly guaiac positive. Hence, he was admitted for further work-up. Of note, the patient had a colonoscopy approximately eight days prior to presentation for follow-up of his colon cancer. This study was essentially normal. On the presentation to the ED the patient continued to deny complaints and was hemodynamically stable. He received pantoprazole 40 mg IV and had IV access established with two large bore IV's. He was then admitted to the floor. <b><u>Review of Systems: </b></U> He claims a ___ weight loss over the last week, but denies watery stools or increased urine output. He has mild dyspnea on exertion that has increased over the last month. He denies chest pain, SOB, diaphresis, night sweats, fevers, chills. <PAST MEDICAL HISTORY> -CAD s/p bare metal stent x2 in ___ -Hypertension -Systolic dysfunction (EF 35%) -Dual chamber pacemaker -h/o VF s/p ICD for secondary prevention -Chronic atrial fibrillation -Rectal cancer s/p neoadjuvant chemotherapy, resection and adjuvant chemotherapy for positive LNs found at surgery -BPH -h/o stroke in ___ with residual R hand dysthesia -Cervical spondylosis -Sleep apnea on CPAP <SOCIAL HISTORY> ___ <FAMILY HISTORY> Father died of an MI in his ___, Mother died of a PE in her ___, twin sister died of colitis age ___, no family h/o colon, breast, uterine, or ovarian CA <PHYSICAL EXAM> On presentation: VS: Tc: 97.3 Tm: 98.8 BP: 122-138/64-72 ___ RR: 20 95%RA Gen: NAD HEENT: PERRL, EOMI, OP clear, dry mucous membranes, no apparent JVD Cor: distant heart sounds, RRR, nl S1S2, no murmurs, rubs, gallops Pulm: CTAB anteriorly and posteriorly Abd: well-healed abdominal scars, no erythema or irritation by ostomy site, no ostomy output, normoactive BS, NT, ND, No HSM Ext: chronic venous stasis changes, no edema, warm On discharge vital signs were T 99.4, BP 120/70, HR 69, RR 20, 96% on RA. Exam not notably changed from presentation and was basically benign. <PERTINENT RESULTS> <b><u>LABORATORY RESULTS</B></U> On Presentation: WBC-4.3 RBC-2.94*# Hgb-8.4*# Hct-26.1*# MCV-89 Plt ___ ----Neuts-68.1 Lymphs-16.9* Monos-12.9* Eos-1.6 Baso-0.3 ___ PTT-31.0 ___ Glucose-161* UreaN-26* Creat-1.4* Na-138 K-4.0 Cl-101 HCO3-27 On discharge: WBC-3.0* RBC-2.83* Hgb-8.1* Hct-25.2* MCV-89 Plt ___ PTT-31.0 ___ Glucose-103 UreaN-13 Creat-1.0 Na-137 K-4.3 Cl-108 HCO3-21* AnGap-12 Other Results: Hct Trend: 26.1-23.3-23.5-25.7-25.5-25.5-28.9-25.2 <B><U>OTHER STUDIES</B></U> EGD ___: Impression: Erythema and erosion in the stomach body compatible with erosive gastritis Erythema in the first part of the duodenum compatible with mild duodenitis Polyp in the fundus Otherwise normal EGD to third part of the duodenum <MEDICATIONS ON ADMISSION> Clopidogrel 75 daily Aspirin 325 daily Warfarin (goal INR ___ Furosemide 40 daily Lisinopril 5 daily Metoprolol succinate 25 daily Amitryptiline <DISCHARGE MEDICATIONS> 1. Lisinopril 5 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 2. Metoprolol Succinate 25 mg Tablet Sustained Release 24 hr Sig: One (1) Tablet Sustained Release 24 hr PO DAILY (Daily). 3. Furosemide 20 mg Tablet Sig: One (1) Tablet PO QPM. 4. Pantoprazole 40 mg Tablet, Delayed Release (E.C.) Sig: One (1) Tablet, Delayed Release (E.C.) PO twice a day for 4 weeks: Please take until you see Dr. ___. Disp: *60 Tablet, Delayed Release (E.C.)(s)* Refills: *0* 5. Amitriptyline 25 mg Tablet Sig: Two (2) Tablet PO HS (at bedtime). 6. Aspirin 81 mg Tablet, Delayed Release (E.C.) Sig: One (1) Tablet, Delayed Release (E.C.) PO once a day. 7. Warfarin 2 mg Tablet Sig: One (1) Tablet PO twice a week ___ and ___: Please restart warfarin on previous dosage schedule. . 8. Outpatient Lab Work INR check on ___. 9. Warfarin 2 mg Tablet Sig: Two (2) Tablet PO 5X/week (TWThSaSu): Resume warfarin on preivous schedule. 10. Furosemide 40 mg Tablet Sig: One (1) Tablet PO QAM. <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Primary Diagnosis: -------------------- Acute blood loss anemia Gastritis with bleeding in setting of multiple anti-coagulants . Secondary Diagnoses: -------------------- Coronary Artery Disease Chronic Systolic Heart Failure Hypertension <DISCHARGE CONDITION> Good, tolerating PO's, with asymptomatic anemia and Hct stable >24 hours. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> You were admitted to the hospital because you were bleeding into your gastrointestinal tract so that blood was showing up in your colostomy bag. The GI specialists passed a camera into your stomach (endoscopy) and saw some irritation of the lining of your stomach called gastritis. We will medically manage this by giving you the acid blocking medicine (proton pump inhibitor) and by decreasing the number of medications you are on that encourage bleeding. You will follow up in the GI clinic as well. As your blood counts were stable we are now discharging you to complete your recovery at home. Your medications have been changed. Your CLOPIDOGREL (PLAVIX) has been stopped; this was discussed with your cardiologist who agreed; as you are now far enough out from your stent placement that this medication is not necessary. You have also been started on the proton pump inhibitor for blocking stomach acid. This medication is called PANTOPRAZOLE (PROTONIX). Please continue to take all other medications as prescribed. We recommend you avoid alcohol for the next few weeks as your stomach lining heals. Please keep all scheduled follow-up appointments as these are important to help manage your health. You will also need to have your INR rechecked next week as you were off this medication in the hospital and your dose will need to be re-titrated. Please call your doctor or go to the Emergency Room if you have fever>101, chest pain, shortness of breath, further black or red material in your ostomy bag, intractable nausea/vomiting, lightheadedness, fainting, or other concerning changes to your health. Regarding your heart failure, you should weigh yourself every morning and contact your doctor if your weight changes > 3 lbs over the course of 24 hours. Please limit your salt intake to 2 gms/day. ","___ yo man with chronic atrial fibrillation on coumadin, CAD s/p stents on plavix and aspirin, and history of rectal cancer s/p resection and ostomy reconstruction, presents with anemia and dark stools. 1) Anemia/GI bleed: On presentation the patient was anemic with melena, but he was hemodynamically stable and relatively asymptomatic. Hematocrit on presentation was 26.1 so he was not immediately transfused, but he did have large bore IV's inserted and received fluid boluses. He was also started on BID PPI therapy and his anticoagulants (aspirin, clopidogrel, and warfarin) were held. His second hematocrit had dropped to 23.3, but as there was not a great deal of stool or blood in his ostomy bag this was presumed to be more consistent with dilution than continued brisk bleeding. Still, at that time transfusion was offered, but the patient was quite reluctant and as he continued to be hemodynamically stable and asymptomatic transfusion was held. As the day progressed hematocrit rose back to 25 and remained stable throughout the rest of his hospitalization. Gastroenterology was consulted on the day after presentation and planned to take the patient for EGD after allowing the INR to fall for a day. Unfortunately, the INR remained elevated, but at that point gastroenterology elected to proceed with EGD with a plan not to do any interventions unless their was overt, active bleeding. On EGD the patient had gastritis and duodenitis but no ulcers or obvious other sources of bleeding. ___, no intervention was performed and the patient was discharged on BID PPI and with a reduced anticoagulant regimen to follow up in GI clinic. Stools at discharge were non-melenic. Hematocrit was greater than 25. 2) CAD s/p BMS ___: The patient has history of coronary artery disease and had bare metal stents placed in ___. Nevertheless, he never had chest pain or other signs of active ischemia. His aspirin and clopidogrel were held on presentation due to concern for active bleeding. At discharge he was restarted on warfarin and aspirin but as it was greater than one year out from his stent placement it was considered safe to hold clopidogrel at discharge in order to decrease the number of anticoagulants the patient was taking. The patient's cardiologist, Dr ___, was made aware of this decision and thought it was reasonable. 3)Systolic Heart Failure: The patient has an EF of 35% by previous echocardiograms but never showed signs of acute volume overload or evidenced dyspnea in the hospital. Initially, his aspirin, beta blocker, ACE inhibitor, and diuretic were held in the context of potentially active bleeding and concern about hemodynamic stability. These were all restarted prior to discharge. 4)HTN: The patient has a history of hypertension but was never frankly hypertensive in the hospital. His anti-hypertensives were initially held in the hospital and then restarted as described in the previous problem point. 5)Chronic atrial fibrillation: The patient is on metoprolol for rate control and warfarin for stroke prevention. His rate remained relatively well controlled even when metoprolol was being held. His warfarin was held on presentation but restarted after his procedure. His INR never became subtherapeutic. He will follow up with his PCP for further INR monitoring. As the patient was systemically anticoagulated no further DVT prophylaxis was given. He was on BID PPI for GI bleed. He tolerated a full diet prior to discharge. He was full code. ",2024,790
10004401-DS-23,"<SEX> M <SERVICE> MEDICINE <ALLERGIES> Penicillins / Erythromycin Base / Streptomycin / Citric Acid / Atenolol <ATTENDING> ___. <CHIEF COMPLAINT> Hand cramping. <MAJOR SURGICAL OR INVASIVE PROCEDURE> EGD <HISTORY OF PRESENT ILLNESS> ___ yo man with ischemic cardiomyopathy, HTN, A fib on coumadin, h/o gastritis who was admitted for anemia and guaiac positive stools. Of note, his PMD in early ___ had noted worsening anemia and had stopped ASA and coumadin x 1 week and started omeprazole. Also for evaluation of this bili was checked and mildly elevated at 2.3, direct 0.9, hapto 111. His hct remained stable with negative stool guaiacs at that time so asa and coumadin were restarted. Of note, has also gone to his cardiologist who started torsemide (dose reduced 1 week ago). The pt initially presented to the ED with muscle spasms, cramps bilateral hands and lower extremities for the past week, worse at night but bothersome to the point that he has had difficulty driving due to pain. He states the pain is relieved by running it under warm water. He did not take pain meds for the pain and has never had anything like this before. He did not take the torsemide today, and has no muscle cramps today (currently pain free). He notes melena for the past few days at home, which is unusual, but no bright red blood in ostomy output, he denies abdominal pain, nausea, vomitting, constipation, diarrhea, cp, sob, palpitations, sob, cough, fevers, chills, dysuria, hematuria. He notes ___ edema for the past ___ weeks despite stable wieght (168) and bleeding from cracks in dry skin on his hands. In the ED: VS: 99.1 71 110/43 16 99% on RA. ROS: 10 point review of systems negative except as noted above. <PAST MEDICAL HISTORY> -CAD s/p bare metal stent x2 in ___ -Hypertension -Ischemic cardiomyopathy Systolic dysfunction (EF 35%-40% ___ -Dual chamber pacemaker -h/o VF s/p ICD for secondary prevention -Chronic atrial fibrillation -Rectal cancer s/p neoadjuvant chemotherapy, resection and adjuvant chemotherapy for positive LNs found at surgery -BPH -h/o stroke in ___ with residual R hand dysthesia -Cervical spondylosis -Sleep apnea, only uses CPAP intermittently -h/o gastritis ___ year ago -insomnia, has been using chamomile tea and melatonin with minimal relief <SOCIAL HISTORY> ___ <FAMILY HISTORY> Father died of an MI in his ___, Mother died of a PE in her ___, twin sister died of colitis age ___, no family h/o colon, breast, uterine, or ovarian CA <PHYSICAL EXAM> VS: T 96.6 HR 72 BP 110/59 RR 19 Sat 100% RA Gen: Well appearing elderly man in NAD Eye: extra-occular movements intact, pupils equal round, reactive to light, sclera anicteric, not injected, no exudates ENT: mucus membranes moist, no ulcerations or exudates Neck: no thyromegally, JVD: 7cm Cardiovascular: regular rate and rhythm, normal s1, s2, III/VI HSM at apex, no rubs or gallops Respiratory: Clear to auscultation bilaterally, no wheezes, rales or rhonchi Abd: Soft, non tender, non distended, no heptosplenomegally, bowel sounds present, ostomy bag in place, draining dark stool Extremities: 2+ PE to mid calf bilaterally, no cyanosis, clubbing, joint swelling Neurological: Alert and oriented x3, CN II-XII intact, normal attention, sensation normal, speech fluent Integument: Dry skin on hands with scattered fissurees, otherwise warm, moist, no rash or ulceration Psychiatric: appropriate, pleasant, not anxious Hematologic: no cervical or supraclavicular LAD <PERTINENT RESULTS> CBC: 4.4 > 8.5/27.9 < 215 (baseline hct ___ Chem: 133 | 99 | 34 < 139 5.4 | 24 | 1.5 Ca 9.1, Mg 2.5, Phos 3.5 INR 1.8 PTT 35 BNP 2825 ALT 35 AST 64 LD 352 ALK PHOS 121 TOT BILI 1.3 DIR BILI 0.6 INDIR BIL 0.7 ECG: V paced (69), no acute st-t changes, unchanged from prior. CT Chest/Abd: ___ 1. Stable appearance of the liver, with a stable small enhancing focus in the left lobe, which may reflect a hemangioma, but is incompletely characterized. No new lesion identified. 2. Status post abdominoperineal resection of the rectum, with end-colostomy in the left lower quadrant, without evidence of recurrent disease. 3. Stable perastomal hernia containing loops of small bowel without obstruction. 4. Cholelithiasis. EGD ___: Erythema and erosion in the stomach body compatible with erosive gastritis. Erythema in the first part of the duodenum compatible with mild duodenitis. Polyp in the fundus. Otherwise normal EGD to third part of the duodenum. <MEDICATIONS ON ADMISSION> MVI daily ASA 81mg daily Torsemide 20mg BID Klor-Con 20mEQ daily Omepraole 20mg daily Toprol XL 25mg daily Lisinopril 5mg daily Amitryptiline 50mg qhs coumadin: 1mg mwf, 2mg sstr melatonin 2mg hs prn insomnia <DISCHARGE MEDICATIONS> 1. Outpatient Lab Work INR prior to EGD with gastroenterology. to be run STAT for procedure. 2. Metoprolol Succinate 25 mg Tablet Sustained Release 24 hr Sig: One (1) Tablet Sustained Release 24 hr PO DAILY (Daily). 3. Lisinopril 5 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 4. Amitriptyline 25 mg Tablet Sig: Two (2) Tablet PO HS (at bedtime). 5. Furosemide 20 mg Tablet Sig: One (1) Tablet PO BID (2 times a day). 6. Omeprazole 40 mg Capsule, Delayed Release(E.C.) Sig: One (1) Capsule, Delayed Release(E.C.) PO twice a day. Disp: *60 Capsule, Delayed Release(E.C.)(s)* Refills: *2* <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Primary Diagnosis: 285.1 ANEMIA, ACUTE BLOOD LOSS Secondary Diagnosis: 427.31 ATRIAL FIBRILLATION Secondary Diagnosis: 414.01 CAD, NATIVE VESSEL Secondary Diagnosis: 578.9 BLEEDING, GASTROINTESTINAL NOS Secondary Diagnosis: 428.20 HEART FAILURE, (A3) CHRONIC SYSTOLIC Secondary Diagnosis: 401.1 HYPERTENSION, BENIGN Secondary Diagnosis: 530.11 GASTROESOPHAGEAL REFLUX DISEASE (GERD) Secondary Diagnosis: 585.3 CHRONIC KIDNEY DISEASE, STAGE III (___) Secondary Diagnosis: 153.9 MALIGNANT NEOPLASM, COLON <DISCHARGE CONDITION> Mental Status: Clear and coherent Level of Consciousness: Alert and interactive Activity Status: Ambulatory - Independent <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> As we discussed you were admitted with a bleed in your stomach or proximal small intestine. The bleeding has stopped, but we would recommend that you discontinue your aspirin and coumadin until you follow up with your outpaient doctors. We have made plans for you to see Dr. ___. You will need to arrive 1 hour before the appointment time and eat nothing after midnight prior to arrival. You will also need to come that morning to the lab at ___ and have your blood work drawn prior to the procedure. Please provide them with the prescription for this included in your discharge paperwork. We have also increased the dose of your Prilosec(omeprazole) to a higher dose twice a day. Dr. ___ will let you know whether to continue at this dose or not. ******************** We have changed your torsemide back to lasix so please weigh yourself every morning, call your cardiologist if weight goes up more than 3 lbs. We recommend that you see your cardiologist or primary care doctor in the next week as this medication may need to be adjusted and you will have to have your blood electrolytes drawn with the next lasix dose. We have also asked our staff to reschedule your appointment with Dr. ___. ","___ with h/o CHF p/w GI bleeding. . Primary Diagnosis: 285.1 ANEMIA, ACUTE BLOOD LOSS Secondary Diagnosis: 578.9 BLEEDING, GASTROINTESTINAL NOS EGD demonstrated Angioectasia in the Distal duodenal bulb and stomach body with no active bleeding, but signs of recent bleeding. ASA was held and INR was already below theraputic range at 1.7. No intervention was done to the angioectasias b/c of elevated INR. The patient's HCT fell to 25.8. He was given 1 U RBC's with appropriate increase in HCT. He will return on ___ to have an elective EGD with likley cauterization of the angioectasia with Dr. ___. INR to be drawn the ___ before the procedure. To continue to hold ASA and coumadin until further notice. PPI increased. . Secondary Diagnosis: 414.01 CAD, NATIVE VESSEL BB continued. ASA held as above. . Secondary Diagnosis: 428.20 HEART FAILURE, (A3) CHRONIC SYSTOLIC Patient having cramps on torsemide, changed back to lasix 20 bid. instructed to continue daily weights. Lytes in 1 week. . Secondary Diagnosis: 401.1 HYPERTENSION, BENIGN on BB/ACEI . Secondary Diagnosis: 530.11 GASTROESOPHAGEAL REFLUX DISEASE (GERD) PPI as above. . Secondary Diagnosis: 585.3 CHRONIC KIDNEY DISEASE, STAGE III (___) stable ",2025,351
10004401-DS-24,"<SEX> M <SERVICE> MEDICINE <ALLERGIES> Penicillins / Erythromycin Base / Streptomycin / Citric Acid / Atenolol <ATTENDING> ___. <CHIEF COMPLAINT> melana <MAJOR SURGICAL OR INVASIVE PROCEDURE> EGD <HISTORY OF PRESENT ILLNESS> ___ with h/o CHF and GIB. Patient was discharged 1 day PTA for GI bleeding. See the discharge summary for that admission for details. In brief, the patient had angioectasia that required cauterization after his INR was 1.5 or less which was done today. The procedure was uncomplicated, but they noted a significant amount of fresh blood in his stomach and his HCT was 25. He was admitted for observation. Of note, the patient was having symptoms of shortness of breath later today before the procedure when walking up there stairs. This was not present after discharge. No CP, palp, melena, hematemsis, or abd pain. ROS: a complete ROS was obtained and negative except for those mentioned above. <PAST MEDICAL HISTORY> -CAD s/p bare metal stent x2 in ___ -Hypertension -Ischemic cardiomyopathy Systolic dysfunction (EF 35%-40% ___ -Dual chamber pacemaker -h/o VF s/p ICD for secondary prevention -Chronic atrial fibrillation -Rectal cancer s/p neoadjuvant chemotherapy, resection and adjuvant chemotherapy for positive LNs found at surgery -BPH -h/o stroke in ___ with residual R hand dysthesia -Cervical spondylosis -Sleep apnea, only uses CPAP intermittently -h/o gastritis ___ year ago -insomnia, has been using chamomile tea and melatonin with minimal relief <SOCIAL HISTORY> ___ <FAMILY HISTORY> Father died of an MI in his ___, Mother died of a PE in her ___, twin sister died of colitis age ___, no family h/o colon, breast, uterine, or ovarian CA <PHYSICAL EXAM> 96.6 98/58 70 20 98RA NAD, awake, alert, oriented x 3 OP clear, conjunctiva w/o pallor RRR, nml S1 S2, has II/VI holosystolic murmer at apex lungs clear bilaterally abd soft NT, ostomy wnl ___ warm, well perfused with 1+ ___ edema bilaterally strength and sensation intact throughout <PERTINENT RESULTS> ___ 02: 05PM HCT-25.5* ___ 10: 15AM SODIUM-132* POTASSIUM-4.6 CHLORIDE-100 TOTAL CO2-24 ANION GAP-13 ___ 10: 15AM CALCIUM-8.5 PHOSPHATE-3.6 MAGNESIUM-2.2 ___ 10: 15AM ___ <MEDICATIONS ON ADMISSION> 2. Metoprolol Succinate 25 mg Tablet Sustained Release 24 hr Sig: One (1) Tablet Sustained Release 24 hr PO DAILY (Daily). 3. Lisinopril 5 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 4. Amitriptyline 25 mg Tablet Sig: Two (2) Tablet PO HS (at bedtime). 5. Furosemide 20 mg Tablet Sig: One (1) Tablet PO BID (2 times a day). 6. Omeprazole 40 mg Capsule, Delayed Release(E.C.) Sig: One (1) Capsule, Delayed Release(E.C.) PO twice a day. Disp: *60 Capsule, Delayed Release(E.C.)(s)* Refills: *2* <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Primary Diagnosis: 285.1 ANEMIA, ACUTE BLOOD LOSS Secondary Diagnosis: 427.31 ATRIAL FIBRILLATION Secondary Diagnosis: 414.01 CAD, NATIVE VESSEL Secondary Diagnosis: 578.9 BLEEDING, GASTROINTESTINAL NOS Secondary Diagnosis: 401.1 HYPERTENSION, BENIGN Secondary Diagnosis: 530.11 GASTROESOPHAGEAL REFLUX DISEASE (GERD) Secondary Diagnosis: 585.3 CHRONIC KIDNEY DISEASE, STAGE III (___) Secondary Diagnosis: 153.9 MALIGNANT NEOPLASM, COLON Secondary Diagnosis: 428.23 HEART FAILURE, (A2) ACUTE ON CHRONIC SYSTOLIC <DISCHARGE CONDITION> Mental Status: Clear and coherent Level of Consciousness: Alert and interactive Activity Status: Ambulatory - Independent <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> As we discussed, you were admitted for bleeding in your stomach. An intervention was performed to stop that bleeding and your blood counts have been stable. As before, please be aware of the signs and symptoms of bleeding and call your doctor or return to the ER if these occur. Please continue the omeprazole at the higher dose. We have also increased the dose of your lasix to 40 in the morning and 20 at night. Please weigh yourself every morning, call MD if weight goes up more than 3 lbs. Please do not take your aspirin or coumadin until directed by your doctor. ","___ with h/o CHF p/w GI bleeding. . Primary Diagnosis: 285.1 ANEMIA, ACUTE BLOOD LOSS Secondary Diagnosis: 578.9 BLEEDING, GASTROINTESTINAL NOS The patient was electively admitted for an EGD(see HPI) that demonstrated there had been active bleeding in the stomach. Cauterization of the angioectasia was performed with achievement of hemostasis. The patient was given 1 U RBC's for symptomatic anemia with appropriate HCT increased to 30. He was discharged the following day without any evidence of bleeding. He will continue PPI bid, holding ASA/Coumadin until f/u with PCP in the middle of next week to have his HCT checked. . Secondary Diagnosis: 414.01 CAD, NATIVE VESSEL BB continued. ASA held as above. . Secondary Diagnosis: 428.20 HEART FAILURE, (A3) CHRONIC SYSTOLIC Patient was discharged on lasix, but by exam he appears a bit more volume up. ___ have been from blood, IVF, and holding diuretics on last admission. Gave 1 dose IV lasix with blood with good effect. He was discharged on lasix 40 qAM and 20qPM(a previous dosing for him) with f/u lytes in 5 days. . Secondary Diagnosis: 401.1 HYPERTENSION, BENIGN on BB/ACEI . Secondary Diagnosis: 530.11 GASTROESOPHAGEAL REFLUX DISEASE (GERD) PPI as above. . Secondary Diagnosis: 585.3 CHRONIC KIDNEY DISEASE, STAGE III (___) stable ",1177,365
10004401-DS-26,"<SEX> M <SERVICE> MEDICINE <ALLERGIES> Penicillins / Erythromycin Base / Streptomycin / Citric Acid / Atenolol / Torsemide <ATTENDING> ___. <CHIEF COMPLAINT> fatigue <MAJOR SURGICAL OR INVASIVE PROCEDURE> Upper Endoscopy <HISTORY OF PRESENT ILLNESS> ___ year old gentleman with PMH including CAD s/p stenting of OM in ___ following cardiac arrest, s/p dual chamber ICD, dilated cardiomyopathy with last LVEF of 40% (___), atrial tachycardia/fibrillation on coumadin, rectal cancer s/p chemo radiation and surgery in ___, colostomy, s/p stroke in ___ with right hand dysthesia who was reffered by his PCP due to progressive fatigue and ___ Hct. . Patient endorses mild dyspnea on exertion, says he can walk upto 100 feet with walker and up ___ steps w/o stopping. He is comfortable at rest. He has been chronically fatigue, but is moreso over the last ___ months without any acute deterioration. He denies any dark stools or BRBPR, hematemesis, chest pain, palpitations. He does endorse stable orthopnea X2, nocturiaX 4, w/o PND. he has chronic leg swelliung w/o recent change. He was evaluated by his PCP, who sent him to the ED due to concern for slowly ___ hematocrit. . he has history of prior GI bleed ___ angiectasia in the duodenum ___ which was cauterized by EGD, . In the ED, initial vs were: T 98.8 P 68 BP 104/44 R18 O2 96%sat. Guiac was negative. Labs notable for hematocrit of 24.7, with baseline hct ___. Patient was transfered to the ward for further care. . On the floor, patient is w/o complaints . Review of sytems: (+) Per HPI . Patient had some dry cough recently for two-three weeks which reolsved a few days ago. He denies URT complaints or febrile illness. (-) Denies fever, chills, night sweats. Denies headache, sinus tenderness, rhinorrhea or congestion. Denied chest pain or tightness, palpitations. Denied nausea, vomiting, diarrhea, constipation or abdominal pain. No recent change in bowel or bladder habits. No dysuria. Denied arthralgias or myalgias. . <PAST MEDICAL HISTORY> - history of ventricular tachycardia - dilated cardiomyopathy with EF 35-40% - CAD s/p stenting of the OM in ___ following cardiac arrest; s/p dual chamber ICD in ___ - chronic systolic CHF - atrial tachycardia - atrial fibrillation - rectal cancer s/p chemo radiation and surgery in ___ - GI bleed ___ angiectasia in the duodenum ___ - CVA in ___ with right hand dysthesia - prior mechanical falls - depression . <SOCIAL HISTORY> ___ <FAMILY HISTORY> Father: died in ___ from MI. Mother: died in ___ from PE. Twin sister: died of colitis at age ___. No family history of colon, breast, uterine, or ovarian cancer. <PHYSICAL EXAM> <PHYSICAL EXAM> Vitals: T: 96.0 BP: 104/55 P: 69 R: 25. O2% 95%2L General: Alert, oriented, no acute distress HEENT: Sclera anicteric, MMM, oropharynx clear Neck: supple, JVD to Jaw with pos HJR, no LAD Lungs: Some central ronchi which clear with cough, no crackles Clear no wheezes CV: RRR, S1, Split S2, soft SM at apex and LLSB w/o radiation, no rubs/gallops Abdomen: soft, non-tender, non-distended, bowel sounds present, no rebound tenderness or guarding, liver edge palpated 3cm under rib line. No ascitis. Colostomy LLQ. Ext: WWP, severe stasis dermaitis bil ___, no signs of DVT. Bil +3 pitting edema. Neuro: no gross deficit <PERTINENT RESULTS> Admission Labs: . ___ 04: 57PM BLOOD WBC-5.4 RBC-3.39* Hgb-7.9* Hct-25.8* MCV-76* MCH-23.2* MCHC-30.5* RDW-20.9* Plt ___ ___ 04: 30PM BLOOD Neuts-63 Bands-0 ___ Monos-15* Eos-1 Baso-1 ___ Myelos-0 ___ 04: 57PM BLOOD ___ ___ 04: 30PM BLOOD Ret Aut-3.6* ___ 04: 30PM BLOOD Glucose-102* UreaN-32* Creat-1.7* Na-130* K-5.1 Cl-98 HCO3-22 AnGap-15 ___ 04: 30PM BLOOD ALT-23 AST-75* LD(LDH)-483* CK(CPK)-103 AlkPhos-127 TotBili-1.9* DirBili-0.8* IndBili-1.1 ___ 04: 30PM BLOOD CK-MB-2 cTropnT-0.03* proBNP-4846* ___ 04: 57PM BLOOD Iron-38* ___ 04: 57PM BLOOD calTIBC-467 VitB12-1816* Folate->20 Ferritn-74 TRF-359 . ___ 03: 51PM URINE Color-Yellow Appear-Clear Sp ___ ___ 03: 51PM URINE Blood-NEG Nitrite-NEG Protein-NEG Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-8* pH-7.0 Leuks-NEG Micro: ___ BLOOD CULTURE Blood Culture, Routine-PENDING INPATIENT ___ BLOOD CULTURE Blood Culture, Routine-PENDING INPATIENT . Celiac Serology: ___ 07: 55AM BLOOD IgA-130 ___ 07: 55AM BLOOD tTG-IgA-2 antiDGP-0 . Discharge labs: . . ___ 07: 00AM BLOOD WBC-4.4 RBC-3.89* Hgb-9.3* Hct-30.4* MCV-78* MCH-24.0* MCHC-30.8* RDW-20.8* Plt ___ ___ 07: 00AM BLOOD Glucose-91 UreaN-24* Creat-1.1 Na-134 K-3.7 Cl-98 HCO3-23 AnGap-17 ___ 07: 00AM BLOOD LD(LDH)-307* TotBili-3.6* DirBili-1.2* IndBili-2.4 ___ 07: 00AM BLOOD Calcium-8.5 Phos-2.8 Mg-1.9 ___ 07: 00AM BLOOD Hapto-153 . Images: . EKG ___: A-V paced rhythm with ventricular premature beat. Since the previous tracing of ___ no significant change. . CXR ___ unchanged w/lead tips in the expected location of the right atrium and right ventricle. Cardiomegaly is again noted with mild pulmonary vascular congestion. Trace pleural effusions cannot be excluded. There is no definite sign of pneumonia or pneumothorax. Bony structures appear grossly intact. There is a mild dextroscoliosis of the T-spine. IMPRESSION: Cardiomegaly. Mild congestion. . GI endoscopy: . . Echo: ___: LVEF= 40 %.moderate mitral regurgitation. Mild global left ventricular hypokinesis. Moderate right ventricular dilation, <MEDICATIONS ON ADMISSION> - lisinopril 2.5mg PO daily - warfarin PO 1mg TTSS, ___ MWF - CPAP - prescribed but doesn't use it - toprol XL 25mg PO daily - triamcinolone cream applied topically BID to legs - omeprazole 40mg PO BID - lasix 60mg PO BID - spironolactone 25mg PO daily - KCL ___ daily . <ALLERGIES> - penicillin - streptomycin - erythromycin - auriomycin - atenolol <DISCHARGE MEDICATIONS> 1. Toprol XL 25 mg Tablet Sustained Release 24 hr Sig: One (1) Tablet Sustained Release 24 hr PO once a day. 2. triamcinolone acetonide 0.025 % Cream Sig: One (1) Appl Topical BID (2 times a day). 3. omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) Capsule, Delayed Release(E.C.) PO once a day. Disp: *30 Capsule, Delayed Release(E.C.)(s)* Refills: *0* 4. spironolactone 25 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 5. lisinopril 5 mg Tablet Sig: 0.5 Tablet PO DAILY (Daily). 6. warfarin 2 mg Tablet Sig: One (1) Tablet PO 3X/WEEK (___). 7. warfarin 1 mg Tablet Sig: One (1) Tablet PO 4X/WEEK (___). 8. potassium chloride 20 mEq Tab Sust.Rel. Particle/Crystal Sig: One (1) Tab Sust.Rel. Particle/Crystal PO ONCE (Once) for 1 doses. 9. furosemide 20 mg Tablet Sig: Three (3) Tablet PO BID (2 times a day). 10. iron 325 mg (65 mg Iron) Capsule, Sustained Release Sig: One (1) Capsule, Sustained Release PO once a day. Disp: *30 Capsule, Sustained Release(s)* Refills: *0* 11. Vitamin C 500 mg Tablet Sig: One (1) Tablet PO once a day: take with iron tablet. Disp: *30 Tablet(s)* Refills: *2* 12. Colace 100 mg Capsule Sig: One (1) Capsule PO twice a day: continue while taking iron; hold for loose stools. Disp: *60 Capsule(s)* Refills: *2* 13. senna 8.6 mg Capsule Sig: One (1) Capsule PO twice a day: take while on iron tablets; hold for loose stools. Disp: *60 Capsule(s)* Refills: *2* 14. Outpatient Lab Work Please check CBC at PCP's appointment on ___. <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> anemia iron deficiency suspected hemolysis heart failure exacerbation <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> You were admitted due to fatigue and shortness of breath. You were found to have anemia (low number of read blood cells) and worsening heart failure. We suspected bleeding from the intestine. You underwent upper endoscopy which did not demonstrate a source of bleeding in the upper part of your intestinal tract. You will need to undergo lower endoscopy (colonoscopy) to look for bleeding from the lower intestine. You were treated with medication to increase the amount of urine and decrease the accumulation of fluid in your body. You were also given blood units to treat your anemia. . The following changes were made to your medications: . # Omeprazole 40 mg tablet was changed to omeprazole 20 mg tablet. Please take one tablet ONCE daily. . # Iron 325mg tablet was added. Please take one tablet once daily. Please take with vitamin C and colace/senna stool softeners to avoid constipation. . Weigh yourself every morning, call MD if weight goes up more than 3 lbs. ","___ year old gentleman with PMH including CAD s/p stenting, dual chamber ICD, CHF LVEF of 40% mod MR, TR (___), atrial tach/fib on coumadin, s/p chemo + Rad + left coloectomy for rectal CA, h/o upper GIB from duodenal ectazia who was reffered by his PCP due to progressive fatigue and ___ Hct. . # Anemia: Mr. ___ had slowly ___ Hct prior to his admission w/o overt bleeding. On admission found to have microcytic anemia with Hct 24.7 and Retic. Index of 1.1%. Thought to be multifactorial d/t iron deficiency, CRF, Chronic disease. Concern for hemolysis was also raised (See ""Jaundice"" below). B12 and Folate were not deficient. Iron was low with Ferrittin at low end of normal range. He was hemodynamically stable throught his stay. Despite guiac negative stools history was concerning for potential sources of GI bleed including s/p UGIB from duodenal ectasia and s/p rectal cancer. He underwent EGD which was normal. The patient declined colonoscopy at this time. Celiac serology was negative. He recieved a total of 3 units of PRBC. Hct at discharge was 30.4 His coumadin was continued as he did not have signs of major bleeding. Omeprazole dose was reduced from 40mg BID to 20mg QD per normal EGD. Iron supplementation was started. He will require close monitoring of his Hct in the out-patient setting and further anemia workup including outpatient colonoscopy, UPEP, SPEP as well as hematology consultation for possible hemolysis. . # CHF exacerbation. Mr. ___ has dilated cardiomyopathy with EF 40% per echo ___. He was clinically fluid overoladed on admission, likely ___ to decompensated HF in the setting of anemia. He was kept on his home doses of PO furosamide and recieved adittional IV furosamide dosing as well as PRBC for his anemia. Lisinopril, spironolacton and Metoprolol were continued. He had good urine output with this and his fluid status significantly improved to euvolumia at discharge. He will continue to follow-up with his outpatient cardiologist. . # Jaundice: The patient was noticed to be Jaundiced and was found to have hyperbilirubinemia. Urobiilnogen + spoke against obstructive process. Raised LDH++ was concerning for hemolysis, but haptoglobin was normal and direct and indirect coombs testing was negative, no schistocytes were noted on smear. He does have chronic transamintis which is thought to be due to congested liver ___ to right heart failure. Worsening of liver congestion in the setting of decompensated heart failure may be the underlying cause of Jaundice. ___ syndrome is unlikely as he has no history of prior episodes of Jaundice. Trending of LFT's and further work-up should continue in the out-patient setting. Hematology consultation was arranged for work-up of possible hemolysis. . # Acute on chronic renal failure: Admission Cr 1.7 up from 1.3 at baseline, likely pre-renal failure in the setting of decompensated heart failure. Cr subsequently trended down to base-line with treatment of HF. Renal functions should be followed up in the out-patient setting. # Fever: Mr. ___ had a ___ temprature spike during a blood transfusion. Work-up for transfusion reaction was not concerning. Blood cultures were so far negative. He did have a cough but CXR was not concerning for pneumonia. UA was negative. He subsequently remained afebrile and had no leukocytosis. . # Atrial Fibrillation: patient is paced by dual chamber ICD. Rate control with BB and anticoagulatation with Warfaine were continued. His INR on discharge was 1.7. He will continue INR monitoring and warfarin dose adjustment in the out-patient setting. . # CAD: Patient is s/p stenting of the OM in ___ following cardiac arrest; His home medication regimen does not include aspirin and statin. He will continue follow up with his out-patient cardiologist. Initiation of aspirin and statin for seondary prevention should be considered. ",2704,953
10004401-DS-27,"<SEX> M <SERVICE> SURGERY <ALLERGIES> Penicillins / Erythromycin Base / Streptomycin / Citric Acid / Atenolol / Torsemide <ATTENDING> ___. <CHIEF COMPLAINT> Fall down stairs <MAJOR SURGICAL OR INVASIVE PROCEDURE> Chest tube placement (___) Intubation (___) Failed extubation and reintubation (___) Trach and PEG (___) <HISTORY OF PRESENT ILLNESS> Mr. ___ is an ___ yo M with history of atrial fibrillation on coumadin, ventricular tachycardia, and systolic CHF (ejection fraction 35-40%), and baseline rhythm complete heart block status post pacer placements who presents after a fall down stairs with loss of consciousness. At around 2am the morning of admission, Mr. ___ got up from bed and went into the kitchen to drink scotch. He drank ___ cup."" Immediately after, he attempted to go down the stairs to the bedroom and this was the last thing he remembered before being in the ED. Per wife, she heard ""thumps"" and immediately went to the stairs, where she found the patient unconscious with blood behind his head. He was completely still and she denies any shaking, tongue biting, or incontinence. She immediately called ___. Upon EMT arriving, the patient became somewhat interactive. . The patient denies feeling shortness of breath, chest pain, or lightheaded before the fall. He does not recall tripping. He did not feel any different than usual yesterday evening and denies any recent viral illness. Of note, two days before admission the patient did have one episode of light headedness after getting out of bed in the morning, requiring him to lean against the wall. He felt much better after drinking orange juice and felt completely improved after lunch that day. He now complains of chest pain since the fall. . Mr. ___ denies fever, chills, night sweats, headache, vision changes, sore throat, abdominal pain, nausea, vomiting, diarrhea, constipation, hematochezia, dysuria, hematuria. <PAST MEDICAL HISTORY> PMH: ventricular tachycardia, dilated cardiomyopathy with EF 35-40%,- CAD s/p stenting; chronic systolic CHF, atrial tachycardia, atrial fibrillation, rectal cancer s/p chemo radiation and surgery in ___, GI bleed ___ angiectasia in the duodenum ___, CVA in ___ with right hand dysthesia, prior mechanical falls, depression PSH: CAD s/p stenting of the OM in ___ following cardiac arrest, - s/p dual chamber ICD in ___ <SOCIAL HISTORY> ___ <FAMILY HISTORY> Father died in ___ from MI. Mother died in ___ from PE. No family history of colon, breast, uterine, or ovarian cancer. No family history of seizures. <PHYSICAL EXAM> Admission Physical Exam VS: T 98 BP 118/56 HR 66 RR 32 O2 Sat 95% 3L GENERAL: Man laying still in bed. NAD. Sleeping but easily arousable. HEENT: NC/AT, PERRLA, EOMI, sclerae anicteric, MMM, OP clear. NECK: Supple, no thyromegaly, JVP 11cm. no carotid bruits. LUNGS: No increased work of breathing. Diffuse wheezes and rhonci with crackles at the bases. HEART: RRR, III/VI holosystolic murmer at the lower right sternal border. Chest is tender to palpation. ABDOMEN: Soft/NT/ND, no masses or HSM, no rebound/guarding. EXTREMITIES: WWP, no c/c/e, 2+ peripheral pulses. SKIN: No rashes or lesions. LYMPH: No cervical LAD. NEURO: Awake, A&Ox3, CNs II-XII intact, muscle strength ___ throughout but patient has pain in moving them. sensation intact at distal extremities. <PERTINENT RESULTS> CXR (___) - There is moderate cardiomegaly, mild vascular congestion, slightly increased compared to ___. Severe pulmonary artery dilatation indicating pulmonary arterial hypertension has worsened. Transvenous pacemaker/defibrillator leads end in the right atrium and right ventricle respectively. There is no pleural effusion and no pneumothorax. No displaced fractures. CT head (___) - No acute intracranial process. CT cspine (___) - No fractures and no malalignment. Moderate denerative changes. CT A/P (___) - No acute process of the abdomen and pelvis including no evidence of retroperitoneal hematoma. No splenic injury and no left lower rib fractures. Small left pleural effusion. Tiny small right pneumothorax and focus of mediastinal air which could be explained by attempted line placement. Echo (___) - Poor image quality. The left atrium is moderately dilated. The right atrium is markedly dilated. No atrial septal defect is seen by 2D or color Doppler. There is mild symmetric left ventricular hypertrophy. The left ventricular cavity size is normal. Due to suboptimal technical quality, a focal wall motion abnormality cannot be fully excluded. Overall left ventricular systolic function is probably mildly depressed (LVEF= 40-45 %). There is no ventricular septal defect. The right ventricular cavity is dilated The ascending aorta is mildly dilated. The aortic valve leaflets (3) are mildly thickened but aortic stenosis is not present. No aortic regurgitation is seen. The mitral valve leaflets are mildly thickened. There is mild bileaflet mitral valve prolapse. An eccentric, posteriorly directed jet of mild to moderate (___) mitral regurgitation is seen. The tricuspid valve leaflets are mildly thickened. At least mild pulmonary hypertension is detected.There is no pericardial effusion. CTA chest (___) - Acute fractures of the left first through tenth ribs, with some fracture displacement, with subjacent moderate-sized left pleural fluid collection,likely containing blood layering in the dependent portion. There is left lower lobe collapse, and mild left upper lobe atelectasis. No pneumothorax. No pulmonary embolus detected to the subsegmental levels. No dissection. Equivocal right ___ rib injuries. The right lung is clear. CT torso (___) - No evidence of active bleeding in the chest or abdomen. Innumerable left-sided rib fractures and questionable, right rib fractures as previously described. In addition, there is a non-displaced fracture of the left clavicle near the sternoclavicular junction. There is a lytic lesion in the distal left clavicle adjacent to the aromioclavicular joint which appears new from a radiograph in ___ and is concerning for a metastatic focus. Decreased attenuation in the T4 vertebral body on the right may represent a second lytic lesion. Continued atelectasis involving the left lower lobe with left pleural effusion, not significantly increased from prior and other, additionally described, chronic findings in the abdomen, unchanged. L shoulder R|XR (___) - There is an acute fracture involving the left distal clavicle extending into the AC joint. This was not present on the prior study from ___. There is also severe degenerative changes of the left humeral head with spurring. There is a left-sided pacemaker. Moreover, there is increased density to the left lung which may be due to hemorrhage or pleural effusion which has increased since the Chest CT scan <MEDICATIONS ON ADMISSION> CITALOPRAM -10 mg Tablet - 1 Tablet(s) by mouth once a day FUROSEMIDE - 40 mg Tablet - 1(One) Tablet(s) by mouth twice a day GABAPENTIN - 100 mg Capsule - one Capsule(s) by mouth ___ at bedtime LISINOPRIL - 2.5 mg Tablet - one Tablet(s) by mouth once a day METOPROLOL SUCCINATE - 25 mg Tablet Extended Release 24 hr - one Tablet(s) by mouth once a day PANTOPRAZOLE - 40 mg Tablet, Delayed Release (E.C.) - 1 Tablet(s) by mouth once a day PHYSICAL THERAPY-LEFT SHOULDER PAIN - - Evaluate and treat . POTASSIUM CHLORIDE [KLOR-CON M20] - 20 mEq Tablet, ER Particles/Crystals - 1 Tab(s) by mouth ___ SPIRONOLACTONE - 25 mg Tablet - 1 Tablet(s) by mouth ___ TEDS STOCKINGS - 1 PAIR - WEAR ___ TO PREVENT ANKLE SWELLING WARFARIN - (med list update) - 2.5 mg Tablet - one Tablet(s) by mouth 2 tabs on MWF, ___ as directed by MD FERROUS SULFATE - 325 mg Tablet - 1 Tablet(s) by mouth once a day MULTIVITAMIN - Tablet - 1 Tablet(s) by mouth once a day PRAMOXINE-ZINC ACETATE [ITCH RELIEF] - 0.5 %-0.5 % Lotion - BID <DISCHARGE MEDICATIONS> 1. citalopram 20 mg Tablet Sig: 0.5 Tablet ___. 2. gabapentin 300 mg Capsule Sig: One (1) Capsule ___ Q12H (every 12 hours). 3. carvedilol 3.125 mg Tablet Sig: One (1) Tablet ___ BID (2 times a day). 4. lansoprazole 30 mg Tablet,Rapid Dissolve, ___ Sig: One (1) Tablet,Rapid Dissolve, ___ ___. 5. ferrous sulfate 300 mg (60 mg iron) Tablet Sig: One (1) Tablet ___. 6. acetaminophen 325 mg Tablet Sig: Two (2) Tablet ___ Q6H (every 6 hours) as needed for fever, pain. 7. heparin, porcine (PF) 10 unit/mL Syringe Sig: Two (2) ML Intravenous PRN (as needed) as needed for line flush. 8. folic acid 1 mg Tablet Sig: One (1) Tablet ___. 9. oxycodone 5 mg/5 mL Solution Sig: Five (5) mL ___ Q4H (every 4 hours) as needed for pain. 10. docusate sodium 50 mg/5 mL Liquid Sig: One (1) ___ BID (2 times a day). 11. albuterol sulfate 90 mcg/Actuation HFA Aerosol Inhaler Sig: ___ Puffs Inhalation Q2H (every 2 hours) as needed for wheezing. 12. ipratropium bromide 17 mcg/Actuation HFA Aerosol Inhaler Sig: Four (4) Puff Inhalation Q4H (every 4 hours). 13. prednisone 20 mg Tablet Sig: One (1) Tablet ___ once a day: please wean to 10mg qday on ___ and then discontinue on ___. <DISCHARGE DISPOSITION> Extended Care Facility: ___ <DISCHARGE DIAGNOSIS> Multiple bilateral rib fractures Respiratory failure Left clavicular fracture <DISCHARGE CONDITION> Mental Status: Confused - sometimes. Level of Consciousness: Alert and interactive. Activity Status: Out of Bed with assistance to chair or wheelchair. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Please call your doctor or nurse practitioner or return to the Emergency Department for any of the following: *You experience new chest pain, pressure, squeezing or tightness. *New or worsening cough, shortness of breath, or wheeze. *If you are vomiting and cannot keep down fluids or your medications. *You are getting dehydrated due to continued vomiting, diarrhea, or other reasons. Signs of dehydration include dry mouth, rapid heartbeat, or feeling dizzy or faint when standing. *You see blood or dark/black material when you vomit or have a bowel movement. *You experience burning when you urinate, have blood in your urine, or experience a discharge. *Your pain is not improving within ___ hours or is not gone within 24 hours. Call or return immediately if your pain is getting worse or changes location or moving to your chest or back. *You are NOT being restarted on your home medication of COUMADIN which you take for atrial fibrillation. Once you are discharged from rehab please follow-up with your primary care provider to discuss restarting this medication. *You have shaking chills, or fever greater than 101.5 degrees Fahrenheit or 38 degrees Celsius. *Any change in your symptoms, or any new symptoms that concern you. ","___: Initial trauma workup in the ED including CXR, CT head, CT c-spine, CT abdomen/pelvis did not show significant trauma and the patient was admitted to medicine for workup for syncope. On the SIRS team, the patient was noted to have an increasing oxygen requirement and was initially diuresed for a potential CHF exacerbation. ___: CTA to r/o PE and showed left-sided pleural effusion concerning for a hemothorax in the context of the down-trending hct 30 on initial presentation ___ 26 ___ (___) between w/increasing hypoxia. ___: Repeat CT torso showed ___ left-sided rib fractures, up to 3 questionable right rib fractures, atelectasis vs scarring at the posterior right lung base, and stable left pleural effusion. Received 2 units FFP and 1 unit PRBC ___: Increasing O2 requirement with PO2 in the low 90's on ___ NC. 1 additional unit PRBC, diuresing with Lasix 40mg IV x3 with the transfusions. IV Morphine and pain regimen was up-titrated for splinting. Repeat CXR showed large left pleural effusion and Thoracic surgery and IP were consulted for the concern of hemothorax. IP placed a pigtail catheter, which drained 750cc of red blood on insertion, and the patient developed hypotension to the 80's systolic from a prior range of SBP 90's-120's. Triggered for hypotension and received 250cc bolus. PO2 was noted to be 98% on 6L NC with decreasing UOP. ___: He was transferred to the MICU for hypoxia. The Trauma Surgery service was consulted and assumed care of the patient. He was transferred to the Trauma ICU. He was placed on a facemask. The Acute Pain Service was consulted and an epidural was placed for improved pain control. On imaging a white out of the right lung was placed and the patient became increasingly hypoxemic and dyspneic. He was intubated and bronch with copious secrections throughout the left lung. Left lung pneumonia was demonstrated on CT chest. He was treated with vanco and cefepime. ___: A right subclavian central line was placed and his pigtail catheter was discontinued. Bronch was repeated with additional BAL. Ciprofloxacin was added to antibiotic regimen. ___: Bronch was repeated this time with thin secretions. He remained on pressors. ___: He was tranfused one unit of PRBC and started on solumedrol. He was extubated but immediately failed and was reintubated. His epidural was discontinued. ___: Patient underwent bedside trach and PEG. Upper GI endoscopy done at the time was negative for any abnormal findings. ___: Patient remained on ventilator. ___: He was weaned to trach mask and remained stable off the vent all day. He was put back on the vent on CPAP settings at night. BAL demonstrated MSSA and his antibiotics were narrowed to just vanco/cipro. Home antihypertensives and lasix were restarted. ___: He tolerated trach mask all day. Steroid taper was started. Started prednisone taper with plans to taper by 10mg every 48hours. Remaining antibiotics were dc'ed. ___: Tube feedings were adjusted to correct sodium levels. He was initially hypernatremic to 154. His tube feeds were changed from Novasource Renal to Replete with Fiber at 70cc/hr with 250cc q4hr free water flushes. His lasix was held and he was put on D5W at 100cc/hr. His sodium decreased to 148 on the morning of ___ and he was felt to be stable for discharge. His free water flushes were continued and his D5W was dc'ed. ",2787,826
10004401-DS-28,"<SEX> M <SERVICE> MEDICINE <ALLERGIES> Penicillins / Erythromycin Base / Streptomycin / Citric Acid / Atenolol / Torsemide / Heparin Agents <ATTENDING> ___ ___ Complaint: Bloody sputum for 5 days, post-bronchoscopy respiratory distress <MAJOR SURGICAL OR INVASIVE PROCEDURE> ___: Bronchoscopy - only suction trauma visualized, no source of bleeding found. <HISTORY OF PRESENT ILLNESS> Mr. ___ is a very pleasant ___ y/o male with a h/o colon cancer s/p resection and radiation, CAD s/p stents, systolic CHF with EF 40-45%, dilated cardiomyopathy, afib, h/o cardiac arrest and complete heart block now with pacer/AICD, and history of GI bleed secondary to duodenal telangiectasia who is here from rehab following evaluation of blood in his respiratory secretions. . Mr. ___ had a lengthy, complex, and recent admission to the TICU which is summarized in brief. He had a fall on ___, leading to multiple rib fractures. He had L ___ rib frx, R ___ rib frx, L hemothorax decompressed by pigtail catheter, and a L distal clavicle fracture. He was given a tracheostomy and PEG tube after failed extubation and reintubation. . In rehab, the patient was noted to have blood tinged secretions via his trach. A bronschoscopy was performed and reportedly saw bleeding inside of his trachea with poor visualization. He was transfused 2 unit pRBC and was transferred to ___. Here, the patient reports no resp distress. His wife stated that the pt has been stable with no change in his respiration. . He underwent a bronchoscopy with our ___ group on ___, which did not find an etiology of the bleed. Only suction trauma was seen. Of note, he was receiving intermittent lasix and IVF for hypernatremia prior to bronchoscopy. Post-procedure, he was noted to be mildly tachypnic with RR ___ and was satting 88% on 15L NC. As such, he was transferred to the medical ICU for closer monitoring. Of note, he is typically on 50% FIO2 with his trach mask. <PAST MEDICAL HISTORY> rectal cancer s/p removal and radiation ijn ___ CAD s/p stents Complete heart block (now with pacer) afib h/o cardiac arrest (now with AICD) systolic CHF (EF 40-45%) fall with multiple rib fractures (___) GI bleed <SOCIAL HISTORY> ___ <FAMILY HISTORY> Father died in ___ from MI. Mother died in ___ from PE. No family history of colon, breast, uterine, or ovarian cancer. No family history of seizures. <PHYSICAL EXAM> VS: T 101, BP: 111/49, HR: 70, RR: 19, O2: 95% on 50% FiO2 General: NAD, resting comfortably and sleeping, arousable with mild stimuli from sleep, no labored breathing HEENT: NC, AT, no blood at trach opening or in oropharynx, MMM Neck: no JVD, no LAD Lungs: rhonchi throughout, diminished sounds at the bases Heart: RRR, no M/R/G Abdomen: soft, nontender, nondistended, normoactive bowel sounds, PEG and ostomy in place, ostomy has brown stool Skin: dry, hyperpigmentation of distal ___ bilaterally; LUE seems to be more swollen than RUE Ext: bilateral lower extremities wrapped in dressing NEURO: Coherent but sluggish, has episodic confusion. Can verbalize some words through mask. CN II-XII intact, no motor or sensory deficits on screening exam. At discharge: same as above except Gen: Arousable to verbal stimuli HEENT: clear/tan secretions at trach site Ext: LUE with swelling <PERTINENT RESULTS> ___ 02: 15PM BLOOD WBC-10.4 RBC-3.05* Hgb-9.1* Hct-28.8* MCV-95 MCH-29.9 MCHC-31.6 RDW-19.7* Plt ___ ___ 03: 00AM BLOOD WBC-3.8* RBC-2.68* Hgb-8.0* Hct-25.5* MCV-95 MCH-29.7 MCHC-31.2 RDW-17.1* Plt ___ ___ 02: 15PM BLOOD Neuts-80.6* Bands-0 Lymphs-8.4* Monos-9.6 Eos-0.6 Baso-0.6 ___ 02: 15PM BLOOD Hypochr-2+ Anisocy-2+ Poiklo-1+ Macrocy-2+ Microcy-NORMAL Polychr-NORMAL Ovalocy-OCCASIONAL Burr-OCCASIONAL Stipple-OCCASIONAL ___ 02: 15PM BLOOD ___ PTT-30.5 ___ ___ 05: 37AM BLOOD ___ PTT-29.6 ___ ___ 02: 15PM BLOOD Glucose-138* UreaN-63* Creat-1.1 Na-150* K-4.8 Cl-108 HCO3-33* AnGap-14 ___ 03: 00AM BLOOD Glucose-130* UreaN-36* Creat-0.9 Na-141 K-5.1 Cl-105 HCO3-32 AnGap-9 ___ 02: 15PM BLOOD ALT-43* AST-38 AlkPhos-151* TotBili-1.0 ___ 02: 15PM BLOOD Lipase-523* ___ 02: 15PM BLOOD proBNP-7598* ___ 03: 00AM BLOOD Calcium-8.2* Phos-2.8 Mg-2.4 ___ 04: 36PM BLOOD Type-ART Rates-/32 FiO2-100 pO2-60* pCO2-48* pH-7.47* calTCO2-36* Base XS-9 Intubat-NOT INTUBA Comment-TRACH MASK ___ 02: 22PM BLOOD Lactate-1.1 . Microbiology: ___ Blood Cx: No growth ___ Urine Cx: No growth ___ Sputum Cx: Staph aureus coag +, sensitive to levofloxacin ___ MRSA nasal screen: negative . Imaging: ___ LUE doppler: No evidence of deep venous thrombosis in the left upper extremity. ___ CXR: Slightly rotated positioning. A tracheostomy tube is in place. A left-sided dual-lead pacemaker is in place, with lead tips over right atrium and right ventricle. There is moderately severe cardiomegaly, with left lower lobe collapse and/or consolidation. There is upper zone redistribution and diffuse vascular blurring, suggestive of mild CHF. There is focal patchy opacity in the left mid zone, which could reflect atelectasis or a pneumonic infiltrate. There is a small left and possible minimal right effusion. Minimal atelectasis right base. The hila are enlarged. <MEDICATIONS ON ADMISSION> acetaminophen 975mg PO Q8H carvedilol 3.125mg PO BID Citalopram 20mg PO daily docusate 100mg PO BID ferrous sulfate 300mg PO daily fluconazole 100mg PO Q12H folic acid 1 mg po daily lasix 40mg PO daily gabapentin 300mg PO Q12H heparin 5000U SC Q12H lisinopril 2.5mg PO daily MVI daily omeprazole 20mg PO daily protein supplement daily albuterol inhaler 4 puffs Q2H prn wheezing simethicone 80mg PO Q8Hprn oxycodone ___ po q4h prn <DISCHARGE MEDICATIONS> 1. acetaminophen 650 mg Tablet Sig: One (1) Tablet PO every eight (8) hours as needed for pain. 2. acetaminophen 325 mg Tablet Sig: One (1) Tablet PO every eight (8) hours as needed for pain. 3. carvedilol 3.125 mg Tablet Sig: One (1) Tablet PO BID (2 times a day). 4. citalopram 20 mg Tablet Sig: One (1) Tablet PO once a day. 5. docusate sodium 50 mg/5 mL Liquid Sig: Ten (10) milliliters PO BID (2 times a day). 6. ferrous sulfate 325 mg (65 mg iron) Tablet Sig: One (1) Tablet PO once a day. 7. folic acid 1 mg Tablet Sig: One (1) Tablet PO once a day. 8. Lasix 40 mg Tablet Sig: One (1) Tablet PO once a day. 9. gabapentin 300 mg Capsule Sig: One (1) Capsule PO Q12H (every 12 hours). 10. lisinopril 2.5 mg Tablet Sig: One (1) Tablet PO once a day. 11. multivitamin Tablet Sig: One (1) Tablet PO once a day. 12. omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) Capsule, Delayed Release(E.C.) PO once a day. 13. protein supplement Packet Sig: One (1) PO once a day. 14. albuterol sulfate 90 mcg/Actuation HFA Aerosol Inhaler Sig: Four (4) Puff Inhalation q2hr as needed for SOB. 15. simethicone 80 mg Tablet Sig: One (1) Tablet PO every eight (8) hours. 16. oxycodone 5 mg/5 mL Solution Sig: ___ PO Q4H (every 4 hours) as needed for tracheal pain. 17. levofloxacin 750 mg Tablet Sig: One (1) Tablet PO DAILY (Daily) for 2 days: Pt needs one dose on ___ and one dose on ___ (in order to complete 8day course, day 1 was ___. <DISCHARGE DISPOSITION> Extended Care Facility: ___ <DISCHARGE DIAGNOSIS> Respiratory distress, now improved. Tracheostomy requiring ventilation Pneumonia <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Lethargic but arousable. Activity Status: Out of Bed with assistance to chair or wheelchair. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> You initially came from your rehab after receiving a bronchoscopy to evaluate your bloody sputum that you had had for 5 days. You received another bronchoscopy on ___, which did not show any obvious source of bleeding. Afterwards, you had a fast breathing rate and low oxygen saturation, so you were monitored in the ICU. You received antibiotics for suspected pneumonia and were on a ventilator machine at night. Your breathing and overall status has improved, and you can be discharged to your rehab in order to begin regaining your strength. You were found to have an antibody against heparin products and should avoid getting any further heparin products. The following changes were made to your medications: New: Levofloxacin 750mg daily, for 2 more days (dose on ___ and ___ Discontinued: Fluconazole, Heparin Weigh yourself every morning, call MD if weight goes up more than 3 lbs. ","Mr. ___ is a ___ y/o male with colon cancer s/p resection and radiation, CAD s/p stents, systolic CHF with EF 40-45%, dilated cardiomyopathy, afib, h/o cardiac arrest and complete heart block now with pacer/AICD, and history of GI bleed secondary to duodenal telangiectasia who is here from rehab for hemoptysis. Of note, he had lengthy TICU hospitalization for L ___ rib fractures, R ___ rib fractures, a L hemothorax, a L dist clavicle fracture, and he is s/p trach and peg. . # Hemoptysis: Mr. ___ was noted to have blood tinged secretions via his trach. An OSH bronschoscopy was performed and reportedly saw bleeding inside the trachea with poor visualization. He was transfused 2 units of pRBC and transferred to ___. Here, he reported no resp distress. He is status post bronchoscopy with our pulmonary team on ___, which did not find an etiology of the bleed. Only suction trauma was seen, and this may be the primary etiology of his bloody tracheal secretions. While the cause of his hemoptysis remains uncertain, his hematocrits have remained stable and there are no signs of continuing hemoptysis or active bleeding. Chemical DVT ppx was held at time of discharge after he was HIT positive and given risk of bleeding with suction trauma. . # Respiratory distress: His respiratory distress has currentlyimproved. Post bronchoscopy, he was noted to be mildly tachypnic with RR ___ and was 88% on 15L NC. A CXR showed worsening pulmonary edema, and he received lasix with improvement in PACU. He was transferred to the MICU for closer monitoring. Of note, he was receiving intermittent lasix and an IVF bolus prior to bronchoscopy. He is typically on 50% FIO2 with his trach mask. He was weaned from the ventilator, and was continued on albuterol MDIs. He was also treated with vancomycin and cefepime for HCAP, until his sputum Cx grew coag-positive staph sensitive to levofloxacin. He was started on an 8-day course of levofloxacin 750mg qday, of which the last dose will be on ___. Lasix 40mg PO daily was restarted on day of discharge. This should be titrated as needed. -We recommend keeping the patient on the ventilator (MMV) overnight to decrease his work of breathing. . # Fever: The patient p/w low grade fever/temperature post bronchoscopy. His fever curve was trended, and cultures were sent. His urine and blood cultures showed no growth, while his sputum culture grew coag-positive staph as mentioned above. He was continued on levofloxacin. . # Anemia: His anemia was stable after 2u pRBC prior to transfer, and his hematocrits remained stable. There was no further need for transfusion. . # Asymetric swelling of LUE: His LUE was cooler than the RUE and more swollen than the right, but still had good pulses. Although his wife stated that his LUE has always been swollen, a doppler of the LUE was obtained which showed no evidence of DVT. The swelling appears to have reduced, although it still remains more swollen than the RUE. . # Acute on chronic systolic CHF (40-45%): The initial physical exam showed leg edema and his chest x-ray suggest mild CHF. He was given 20mg of lasix in the PACU, and further diuresis was not undertaken in the ICU. He was started on Lasix 40mg PO daily (Previous home dose) on day of discharge. This should continue to be monitored. He was given free water flushes through his G tube for hypernatremia, which resolved during his stay. . # Low platelet count: His platelets fell from 273 on admission to 107 prior to discharge. This drop was consistent with heparin-induced thrombocytopenia, for which his heparin was discontinued. This was confirmed as his heparin antibody from ___ was positive. His PLT count on ___ is 111. He was put on pneumoboots for DVT prophylaxis given risk of bleeding with suction. -He should not be given heparin. . # Hypernatremia: As above, he was given free water flushes for correction of his hypernatremia, which appears to have resolved. Free water flushes were continued at time of discharge. . # Oral candidiasis: PO fluconazole was stopped prior to discharge. . Only evidence of bleed is suection trauma in L maintstem bronchus, needs to come back in 6 week from ___ for rpt bronch ",2563,1038
10004401-DS-29,"<SEX> M <SERVICE> MEDICINE <ALLERGIES> Penicillins / Erythromycin Base / Streptomycin / Citric Acid / Atenolol / Torsemide / Heparin Agents <ATTENDING> ___. <CHIEF COMPLAINT> Respiratory Distress, Hypotension <MAJOR SURGICAL OR INVASIVE PROCEDURE> Right internal jugular (CVL) (discontinued) Arterial line (discontinued) PICC (placed ___ <HISTORY OF PRESENT ILLNESS> ___ year old male with multiple co-morbidities, including rectal cancer s/p resection and radiation in ___, coronary artery disease s/p stents, systolic CHF, dilated cardiomyopathy, atrial fibrillation, history of cardiac arrest and complete heart blood s/p AICD/pacemaker, recent trach/peg who presented with respiratory distress, fevers and hypotension. The patient desaturated one day before admission to 85% at ___ although improved to 92% with suctioning out copious amounts of thick yellow, brown secretions. Per his wife and daughter, he had been doing well with the trach, often having it capped in the last week - up until ___ days ago when he needed to be on the vent more frequently. He reportedly had a fever to ___ yesterday and 102.0 today at rehab and had a CXR performed there showing LLL pneumonia; he was treated with Vancomycin 1 gram X1 there. . On arrival to the ___ ___, the patient was being bagged by EMS upon arrival, hypotensive to SBP80s, not tachypneic, never febrile, satting stably on his trach settings. He was mentating well, complaining only of buttocks pain (stable) and answering questions appropriately. CXR ___ similar to priors and he was treated with Levofloxacin and Cefepime. Given persistent hypotension SBP80s and decreased UOP ___ hours) despite 1.5L IVF, a RIJ CVL was placed and levophed started at 0.06. He also had a midline IV from before and 18 gauge PIV. His troponin was 0.11 so he was also given aspirin 325mg. VS on transfer to MICU: Afebrile, HR70, BP86/40, RR16, 95% on PEEP5, FiO2 60%, TV500. . Upon arrival to the MICU, the patient was resting comfortably in bed. . Review of systems: (+) Per HPI (-) Denies headache, sinus tenderness, congestion. Denies chest pain, chest pressure, palpitations, or weakness. Denies nausea, vomiting, diarrhea, constipation, abdominal pain, or changes in bowel habits. <PAST MEDICAL HISTORY> - Rectal cancer s/p excision and XRT (___) - CAD s/p stents - Complete heart block s/p pacemaker - h/o cardiac arrest (now with AICD) - Afib - Systolic CHF (EF 40-45%) - s/p Fall with multiple rib fractures (___) - h/o GI bleed <SOCIAL HISTORY> ___ <FAMILY HISTORY> Father died in ___ from MI. Mother died in ___ from PE. No family history of colon, breast, uterine, or ovarian cancer. No family history of seizures. <PHYSICAL EXAM> Admission Exam: Vitals: T: Afebrile BP: 105/47 P: 61 R: 13 O2: 100% General: oriented, no acute distress, sleepy HEENT: Sclera anicteric, MMM, oropharynx clear Neck: Supple, RIJ CVL Lungs: Diffusely rhonchorous, rales; no wheezes CV: RRR, ___ holosystolic murmur heard best over apex with dulling of S1 and S2 over apex. Otherwise S1 S2 clear and of good quality over rest of precordium. Abdomen: Soft, non-tender, non-distended, bowel sounds present, no rebound tenderness or guarding; ostomy bag in place GU: three way irrigation foley Ext: warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema; dry stasis changes on bilateral lower extremities Discharge Exam: VS 98.9 73 133/69 24 95% trach collar 50%F1O2 General Appearance: No acute distress, breathing comfortably on trach collar. HEENT: PERRL, Conjunctiva pale, Normocephalic, Poor dentition Cardiovascular: RRR, ___ holosystolic murmur heard best over Respiratory: mild rhonchi throughout all lung fields with occasional expiratory wheezes Abdominal: Soft, non-tender, colostomy, PEG, + BS Extremities: Bilateral ___ edema L>R, Chronic skin changes over bilateral ___ suggestive of chronic venous stasis, right knee tender to palpation Skin: Warm, well perfused Neurologic: Attentive, Follows simple commands, Responds to: Verbal stimuli, Movement: Purposeful, Tone: Normal, localizes pain. Able to point out letters on chart for communicating, appropriate <PERTINENT RESULTS> Blood Counts ___ 08: 00AM BLOOD WBC-28.2*# RBC-2.71* Hgb-7.9* Hct-24.0* MCV-88 MCH-29.1 MCHC-33.1 RDW-16.6* Plt ___ ___ 02: 30PM BLOOD WBC-11.6* RBC-3.00* Hgb-8.8* Hct-26.6* MCV-89 MCH-29.3 MCHC-33.1 RDW-16.6* Plt ___ ___ 02: 53AM BLOOD WBC-8.0 RBC-2.81* Hgb-8.3* Hct-25.0* MCV-89 MCH-29.4 MCHC-33.0 RDW-16.1* Plt Ct-80* Electrolytes ___ 08: 00AM BLOOD Glucose-139* UreaN-45* Creat-1.5* Na-136 K-5.0 Cl-99 HCO3-29 AnGap-13 ___ 02: 57AM BLOOD Glucose-106* UreaN-50* Creat-1.3* Na-138 K-4.4 Cl-107 HCO3-25 AnGap-10 ___ 02: 53AM BLOOD Glucose-144* UreaN-48* Creat-1.2 Na-139 K-4.3 Cl-103 HCO3-29 AnGap-11 <MEDICATIONS ON ADMISSION> Medications (per D/C summary and ___ records): * Acetaminophen 650mg q8 hours PRN pain * Acetaminophen 325mg q8 hours PRN pain * Lidocaine patch X2 * Trazodone 25mg qHS * Carvedilol 3.125mg twice daily * Citalopram 20mg daily * Docusate 10mL twice daily * Ferrous sulfate 325mg elixir daily * Folate 1mg daily * Lasix 40mg daily * Gabapentin 300mg twice daily * Lisinopril 2.5mg daily * Multivitamin daily * Omeprazole 20mg * Protein supplements daily * Albuterol HFA inhaler * Simethicone 80mg every 8 hours * Oxycodone 5 every four hours PRN tracheal pain, dressing changes * Miconazole powrder qHS * Levofloxacin 750mg daily, completed course ___ * Gentamicin nebulizer 80mg q12 hours nebulizer <DISCHARGE MEDICATIONS> 1. acetaminophen 325 mg Tablet Sig: Two (2) Tablet PO Q4H (every 4 hours) as needed for pain. 2. lidocaine 5 %(700 mg/patch) Adhesive Patch, Medicated Sig: One (1) Adhesive Patch, Medicated Topical DAILY (Daily): 12 hours on, 12 hours off. 3. trazodone 50 mg Tablet Sig: 0.5 Tablet PO HS (at bedtime) as needed for insomnia. 4. citalopram 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 5. docusate sodium 50 mg/5 mL Liquid Sig: Ten (10) mL PO BID (2 times a day). 6. ferrous sulfate 300 mg (60 mg iron)/5 mL Liquid Sig: One (1) dose PO DAILY (Daily). 7. folic acid 1 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 8. multivitamin Tablet Sig: One (1) Tablet PO DAILY (Daily). 9. omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) Capsule, Delayed Release(E.C.) PO DAILY (Daily). 10. albuterol sulfate 90 mcg/Actuation HFA Aerosol Inhaler Sig: Two (2) Puff Inhalation Q4H (every 4 hours) as needed for sob, wheeze. 11. simethicone 80 mg Tablet, Chewable Sig: One (1) Tablet, Chewable PO TID (3 times a day). 12. miconazole nitrate 2 % Powder Sig: One (1) Appl Topical HS (at bedtime). 13. oxycodone 5 mg Tablet Sig: ___ Tablets PO every four (4) hours as needed for pain: Hold for Sedation or RR<12. 14. aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable PO DAILY (Daily). 15. Lasix 40 mg Tablet Sig: One (1) Tablet PO once a day. 16. Please change and care for lines per nursing routine 17. carvedilol 6.25 mg Tablet Sig: One (1) Tablet PO twice a day. 18. vancomycin 750 mg Recon Soln Sig: One (1) solution Intravenous twice a day for 24 days. <DISCHARGE DISPOSITION> Extended Care Facility: ___ <DISCHARGE DIAGNOSIS> PRIMARY Healthcare Associated Pneumonia Staph Bacteremia SECONDARY Systolic CHF Atrial Fibrillation <DISCHARGE CONDITION> Mental Status: Confused - sometimes. Level of Consciousness: Lethargic but arousable. Activity Status: Bedbound. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Mr. ___-- It was a pleasure treating you at ___. You were admitted with difficulty breathing and low blood pressure. You were found to have a pneumonia and an infection in your blood. You were treated with antibiotics and improved. You will need to continue your antibiotics for 2 weeks total. The following changes to your medications were made: - STARTED vancomycin (continue until ___ - STARTED aspirin - STOPPED inhaled gentamycin ","HOSPITAL COURSE ___ PMHx rectal cancer s/p resection and XRT w ostomy, systolic CHF (LVEF40-45%), recent trach/peg who presented with respiratory distress, found to have a pnuemonia, with blood and sputum cultures growing out MRSA, now improved to baseline respiratory status being discharged to ___ on 2 week course of IV antibioitics . ACTIVE # Healthcare Associated Pnuemonia and MRSA Bacteremia - Patient presented with increasing O2 requirements, leukocytosis and hypotension; CXR demonstrated LLL PNA; accompanying elevated Lactate, High SvO2 (93%), hypotension and tachycardia suggested sepsis; blood and sputum cultures grew out MRSA. Patient was initially fluid resuscitated and briefly required vasopressors. He was treated with vancomycin (initially with cefepime and levofloxacin as well, which were stopped based upon culture data). Patient respiratory status improved, and patient was able to be weaned off vent to trach collar. Given MRSA bacteremia, patient had PICC line changed and underwent TTE that did not demonstrate signs of valvular lesions; patient was planned for 2 week course with IV vancomycin. . # Sacral decubitus ulcer: Significant, likely stage IV. Appropriate wound care was provided and his pain regimen was increased to Oxycodone to ___ mg q4 PRN for pain which successfully curbed decubitus pain. . # Coronary artery disease: Stable, continued carvedilol; held lisinopril given hypotension and will need to be restarted; started ASA (had been held previously given history of GI bleeds). . # Afib: CHADS4, but off anticoagulation ___ hemothorax ___. Discussed with primary cardiologist who recommended considering restarting coumadin as outpatient. INACTIVE # Anemia - Continued iron supplementation . # Systolic CHF: EF 40-45%, continued lasix . Transitional Issues: - Patient is full code - Will need primary care doctors to discuss ___ as outpatient - Continue vancomycin for 2 weeks total course ",2445,463
10004401-DS-30,"<SEX> M <SERVICE> MEDICINE <ALLERGIES> Penicillins / Erythromycin Base / Streptomycin / Citric Acid / Atenolol / Torsemide / Heparin Agents <ATTENDING> ___. <CHIEF COMPLAINT> Bleeding from colostomy and foley <MAJOR SURGICAL OR INVASIVE PROCEDURE> none <HISTORY OF PRESENT ILLNESS> ___ year old male with multiple co-morbidities including rectal cancer s/p resection and radiation in ___ now with colostomy, coronary artery disease s/p stents, systolic CHF, dilated cardiomyopathy, atrial fibrillation not on coumadin, cardiac arrest and complete heart block s/p AICD/pacemaker, recent trach/peg after prolonged hospitalization for rib fractures/flail chest s/p fall who presents with large amount of bleeding from colostomy and Foley. The patient also endorsed increased shortness of breath, weakness and fatigue. The patient had been recently admitted ___ to the ___ MICU for pneumonia and MRSA bacteremia/sepsis and had been discharged on Vancomycin and baby aspirin (for his atrial fibrillation and coronary artery disease). . In the ___ ED, initial vital signs were: Afebrile, HR70, BP107/53, RR24, 91% on trach vent. Given his tender abdomen, there was initial concern for an intrabdominal event. ACS/General Surgery was consulted and CT abdomen/pelvis was performed. As the imaging was negative, there were no acute surgical concerns; ACS recommended tagged RBC if he continued to bleed. GI was also consulted and recommended two units pRBC for Hct 22, IV PPI initiation. The patient also underwent PEG lavage which was clear but was passing small amounts of maroon colored stools. There was also initial concern for DIC but labs not suggestive of this (the patient has history of heparin induced thrombocytopenia but platelets normal). The patient has had hematuria in the past, with three-way foley in place. . Upon arrival to the MICU, the patient was resting comfortably in bed with trach/PEG, endorsing fatigue and abdominal pain. Per the patient's wife, the patient looked good on discharge two days ago but seemed under the weather on arrival to ___ ___. When she saw him at 6pm yesterday evening, he was stable without signs of bleeding. . Review of systems: (+) Per HPI (-) Denies fever, headache, cough, shortness of breath, or wheezing. Denies chest pain, chest pressure, palpitations, or weakness. Denies nausea, vomiting. <PAST MEDICAL HISTORY> - Rectal cancer s/p excision and XRT (___) - CAD s/p stents (?___) - CVA in ___ with residual right hand dysthesia - Complete heart block s/p pacemaker - h/o cardiac arrest (now with AICD) - GI bleed secondary to angiectasias in the duodenum (___) s/p cauterization via EGD - Atrial fibrillation - Systolic CHF (EF 40-45%) - s/p Fall with multiple rib fractures (___) - MICU admission ___ for hemoptysis, bleeding from trach - Abdominoperineal resection ___ w/ ___ <SOCIAL HISTORY> ___ <FAMILY HISTORY> Father died in ___ from ___. Mother died in ___ from PE. No family history of colon, breast, uterine, or ovarian cancer. No family history of seizures <PHYSICAL EXAM> ADMISSION: Vitals: T: 98.9 BP: 115/54 P: 71 R: 16 O2: 99% (FiO2 35%, Tv 450, RR12, PEEP5) General: Alert, oriented, no acute distress, pale, breathing comfortably via trach HEENT: PERRL, pale conjunctiva, normocephalic, poor dentition, clear oropharynx Neck: Soft, supple, trach in place with minimal secretions Lungs: Mild rhonchi in all lung fields, no wheezing/rales; mild bibasilar crackels CV: Regular rate and rhythm, normal S1 + S2, no rubs or gallops, ___ holosystolic murmur Abdomen: Soft, non-tender, non-distended, positive bowel sounds, no rebound tenderness or guarding, maroon streaked stool in colostomy GU: Three way foley with dark pink urine in collection bag Ext: Warm, well perfused, +pulses, bilateral upper extremity edema, L>R; bilateral anterior shin hemosiderin changes . DISCHARGE: VS: 98.7 70 111/49 17 96% (Pressure Support 12, PEEP 5, FiO2 35%) General: Comfortable, no acute distress HEENT: PERRL, EOMI, MMM, poor dentition Cardiovascular: RRR, II/VI systolic murmur Respiratory / Chest: CTA bilaterally, no wheezes/rales/ronchi Abdominal: Soft, nontender/nondistended, naBS, ostomy c/d/i Extremities: WWP, 2+ lower extremity edema, 2+ upper extremity edema L>R (chronic), ___ pulses Neurologic: Attentive, moving all extremities <PERTINENT RESULTS> Blood Counts ___ 10: 15PM BLOOD WBC-8.1 RBC-2.55* Hgb-7.3* Hct-22.4* MCV-88 MCH-28.7 MCHC-32.6 RDW-16.3* Plt ___ ___ 01: 56AM BLOOD WBC-8.0 RBC-3.06* Hgb-9.2*# Hct-26.3* MCV-86 MCH-29.9 MCHC-34.8 RDW-16.5* Plt ___ ___ 04: 39AM BLOOD WBC-6.9 RBC-3.06* Hgb-8.9* Hct-26.6* MCV-87 MCH-29.0 MCHC-33.5 RDW-16.6* Plt ___ Chemistry ___ 10: 15PM BLOOD Glucose-108* UreaN-49* Creat-1.1 Na-139 K-4.0 Cl-103 HCO3-29 AnGap-11 ABx ___ 06: 51AM BLOOD Vanco-24.2* . IMAGING: ___ CXR: IMPRESSION: Blunting of the left costophrenic angle and left base opacities consistent with left pleural effusion with overlying atelectasis, underlying consolidation cannot be entirely excluded. Cardiomegaly and prominent right hilum again seen. Mild pulmonary vascular congestion, improved. . CT ABD and PELVIS: 1. Ascites is new since most recent exams dating back to ___, likely correlating with diffuse anasarca. 2. Slight increase in size of 9-mm enhancing left liver lobe lesion which is incompletely characterized on this exam. This might be a flash filling hemangioma or focal nodular hyperplasia. No other acute intra-abdominal process. If more definitive characterization is desired, multiphasic CT of the liver could be considered. . <MEDICATIONS ON ADMISSION> * Acetaminophen 325 mg Tablet Sig: Two (2) Tablet PO Q4H PRN * Lidocaine 5 %(700 mg/patch) daily * Trazodone 25 mg Tablet qHS * Citalopram 20 mg daily * Docusate 10mL twice daily * Ferrous sulfate 300mg daily * Folic acid 1mg daily * Multivitamin daily * Omeprazole 20 mg daily * Albuterol inhaler 2 puffs q4 hours PRN * Simethicone 80mg three times daily * Miconazole nitrate 2% powder qHS * Oxycodone ___ q4 hours PRN * Aspirin 81mg daily * Lasix 40mg daily * Carvedilol 6.25mg twice daily * Vancomycin 750mg twice daily X 13 more days <DISCHARGE MEDICATIONS> 1. acetaminophen 325 mg Tablet Sig: Two (2) Tablet PO Q4H (every 4 hours) as needed for pain. 2. lidocaine 5 %(700 mg/patch) Adhesive Patch, Medicated Sig: One (1) Adhesive Patch, Medicated Topical DAILY (Daily): 12 hours on and 12 hours off. 3. trazodone 50 mg Tablet Sig: 0.5 Tablet PO HS (at bedtime) as needed for insomnia. 4. citalopram 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 5. docusate sodium 50 mg/5 mL Liquid Sig: One (1) PO BID (2 times a day): Hold for loose stools. 6. ferrous sulfate 300 mg (60 mg iron)/5 mL Liquid Sig: One (1) PO DAILY (Daily). 7. folic acid 1 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 8. multivitamin Tablet Sig: One (1) Tablet PO DAILY (Daily). 9. omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) Capsule, Delayed Release(E.C.) PO DAILY (Daily). 10. albuterol sulfate 90 mcg/Actuation HFA Aerosol Inhaler Sig: Two (2) Puff Inhalation Q4H (every 4 hours) as needed for sob, wheeze. 11. simethicone 80 mg Tablet, Chewable Sig: One (1) Tablet, Chewable PO TID (3 times a day). 12. miconazole nitrate 2 % Powder Sig: One (1) Appl Topical HS (at bedtime). 13. oxycodone 5 mg Tablet Sig: ___ Tablets PO Q4H (every 4 hours) as needed for pain: PLease evaluate pt and hold for RR<12, sedation or if the patient appears loopy. 14. Lasix 40 mg Tablet Sig: One (1) Tablet PO once a day. 15. vancomycin 500 mg Recon Soln Sig: One (1) Recon Soln Intravenous Q 12H (Every 12 Hours) for 11 days: 500mg started on ___, please get trough morning of ___. 16. psyllium Packet Sig: One (1) Packet PO TID (3 times a day) as needed for low ostomy output: low ostomy output. 17. sucralfate 1 gram Tablet Sig: One (1) Tablet PO QID (4 times a day). 18. carvedilol 6.25 mg Tablet Sig: One (1) Tablet PO BID (2 times a day). <DISCHARGE DISPOSITION> Extended Care Facility: ___ <DISCHARGE DIAGNOSIS> Primary Diagnosis: GI bleed . Secondary Diagnosis: CAD A-fib s/p cardiac arrest and AICD pacemaker <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Out of Bed with assistance to chair or wheelchair. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> You are being dishcarged from ___ ___. You were re-admitted to the hospital for bleeding from your ostomy as well as your Foley catheter. We felt this was because your aspiring was continued. We held your aspirin, gave you one unit of blood and you have been doing well since. You will go back to the ___ and will have follow up with GI and Cardiology for further management of these issues. The following medication was STOPPED: Aspirin 81mg Daily . Please continue to HOLD lisinopril 2.5mg PO Daily Weigh yourself every morning, call MD if weight goes up more than 3 lbs. ","HOSPITAL COURSE ___ M PMHx CAD s/p stenting, systolic CHF (EF40-45%), atrial fibrillation, recent hospitalization for MRSA bacteremia of respiratory source, who represented from ___ with hematuria and blood in colostomy bag, thought to be secondary to recent initiation of ASA, now resolved after holding ASA, hemodynamically stable x multiple days, being discharged to ___. . ACTIVE # Blood in Ostomy: Patient w/ history of UGIB secondary to angiectasias in the duodenum who presented w/ trace blood in his ostomy; patient remaining hemodynamically stable w/ PEG lavage negative; Trace blood in his colostomy bag suggests lower GI bleed; given temporal relationship to initiation of ASA, this was felt to most likely be an exacerbation of underlying issue; bleeding resolved with holding of ASA. He received 2 units of pRBC on the day of admission. His hemoglobin/hematocrit was thereafter stable. Patient/family have declined scoping at this time but may be amenable to this as an outpatient (of note, colonoscopy in ___ was normal). Continued patient's home omeprazole; held ASA (see below). His cardiologist was notified because the patient is now no longer on aspirin or coumadin, but bleeding risk strongly outweighs stroke risk at this time. Patient will need to readdress issue of colonoscopy as an outpatient with outpatient providers. Scheduled follow up with Dr. ___ on ___. Please call Dr. ___ office to see if can get EGD sooner. . # Hematuria: Patient with a history of hematuria of uncertain etiology who presents w recurrence of bleeding, thought to be secondary recent initiation of ASA; holding of ASA resolved bleeding issue; patient will need to have outpatient follow-up with urology for discussion of cystoscopy; (appt was not yet scheduled). PATIENT WITH FIRM FOLEY CATHETER WITH 30CC balloon. Sending extra replacements with the patient. Please be aware if removing. . # MRSA bacteremia: Pt w recent admission notable for MRSA bacteremia w/o TTE evidence of valvular involvement; continued vancomycin treatment course (last day is ___ level was supratherapeutic during this hospitalization; adjusted dosing to 500mg BID. Patient will need Vancomycin trough on morning of ___ and adjust dose as necessary. . # Chronic Diastolic CHF: Patient w EF 55-60% (___) appearing fluid overloaded on admission; restarted patient's home diuresis with good urine output. Continued home carvedilol. Continued to hold lisinopril (had been held during recent admission) given normotensive without. Could consider restarting as outpatient if he became hypertensive. . # Sacral decubitus ulcer: Stage IV, significant. Appropriate wound care. Continued oxycodone, lidocaine. Patient became loopy receiving oxycodone 5mg Q4H. Is written for ___ Q4H:PRN for pain, but will need to be assessed prior to medication to make sure not continuing to get loopy. Please assess at ___ and continue to turn the patient regularly minimizing weight bearing to that area. . # Atrial fibrillation: CHADS4 but off anticoagulation/antiplatelet secondary to history of GI bleeds, hemothorax in ___. Given bleeding on this admission he will likely be a poor candidate for ASA in the future. Alerted outpatient cardiologist Dr. ___ this issue. He has follow up with Dr. ___ on ___ and we will contact him as well on the day of discharge. . TRANSITIONAL - PATIENT WITH FIRM FOLEY CATHETER WITH 30CC balloon. Sending extra replacements with the patient. Please be aware if removing. - Scheduled for follow-up with cardiologist - Scheduled follow up with gastroenterologist, please call to see if can get EGD sooner than schedule appt. - If has continued hematuria, will need urology follow up for cystoscopy. - Continue vancomycin for MRSA bactermia until ___, next traough needs to be morning of ___. Goal level ___. - Wean off vent to trach mask, plan to diurese to dry weight to aid in weaning process - Holding lisinopril given stable, BP, but can restart if becomes hypertensive. ",2640,919
10004401-DS-31,"<SEX> M <SERVICE> MEDICINE <ALLERGIES> Penicillins / Erythromycin Base / Streptomycin / Citric Acid / Atenolol / Torsemide / Heparin Agents <ATTENDING> ___. <CHIEF COMPLAINT> Bacteremia <MAJOR SURGICAL OR INVASIVE PROCEDURE> Transesophagealechocardiogram <HISTORY OF PRESENT ILLNESS> ___ year old male with h/o CAD s/p stenting, systolic CHF (EF40-45%), atrial fibrillation, h/o cardiac arrest with heart block s/p AICD/pacemaker, trach/PEG, recent MRSA bacteremia, and recent MICU admission for hematuria and GI bleed who presents with fevers and baceteria. He was recently admitted ___ for pneumonia and MRSA bacteremia and sepsis. Discharged on IV vancomycin which he has been on since. He was then readmitted ___ to ___ for hematuria and blood from his colostomy bag felt to be secondary to recent aspirin initiation. He was discharged to ___ ___. He has had persistent fevers with Tm 101.5 and positive MRSA blood cultures at rehab. Denies cough, cold symptoms, nausea, or vomiting. Has had diarrhea over the last several days. Denies CP or SOB. His family reports that he was doing poorly a few days ago but has turned around in the past few days. Denies increasing secretions and he is vent-dependent. In the ED, initial vitals were 98.8 70 120/52 96%. He is being admitted to the MICU for an endocarditis workup given history of positive blood cultures. Currently, he reports feeling tired but otherwise okay. Complains of pain in his back and his legs. Review of systems: (+) Per HPI (-) Denies chills, night sweats, recent weight loss or gain. Denies headache, sinus tenderness, rhinorrhea or congestion. Denies cough, shortness of breath, or wheezing. Denies chest pain, chest pressure, palpitations, or weakness. Denies nausea, vomiting, constipation, abdominal pain, or changes in bowel habits. Denies dysuria, frequency, or urgency. Denies arthralgias or myalgias. Denies rashes or skin changes. <PAST MEDICAL HISTORY> Rectal cancer s/p excision and XRT (___) CAD s/p stents (?___) CVA in ___ with residual right hand dysthesia Complete heart block s/p pacemaker H/o cardiac arrest (now with AICD) GI bleed secondary to angiectasias in the duodenum (___) s/p cauterization via EGD Atrial fibrillation, not on coumadin Systolic CHF (EF 40-45%) S/p Fall with multiple rib fractures (___) MICU admission ___ for hemoptysis, bleeding from trach Abdominoperineal resection ___ w/ ___ <SOCIAL HISTORY> ___ <FAMILY HISTORY> Father died in ___ from MI. Mother died in ___ from PE. No family history of colon, breast, uterine, or ovarian cancer. No family history of seizures. <PHYSICAL EXAM> On Admission: Vitals: 97.7 70 108/49 18 100% AC 500x12, PEEP 5, FiO2 35% General: Alert, oriented, no acute distress HEENT: Sclera anicteric, MMM, oropharynx clear, trach in place with clear/white secretions Neck: supple, no LAD Lungs: Coarse rales at bases, no wheezes CV: Regular rate and rhythm, normal S1 + S2, III/VI systolic murmur at apex Abdomen: soft, non-tender, distended, ostomy in place, bowel sounds present, no rebound tenderness or guarding GU: Foley in place Skin: 3cm sacral decub without surrounding erythema. PICC in place on right arm, only mild redness at insertion. Ext: Warm, well perfused with 2+ pitting edema, ulcerations on bilateral shins On discharge: General: Alert, oriented, no acute distress HEENT: Sclera anicteric, MMM, oropharynx clear, trach in place Neck: Supple, no LAD Lungs: Coarse rales at bases, no wheezes CV: Regular rate and rhythm, normal S1 + S2, III/VI systolic murmur at apex Abdomen: Soft, non-tender, distended, ostomy in place, bowel sounds present, no rebound tenderness or guarding GU: Foley in place Skin: 3cm sacral decub without surrounding erythema. PICC in place on left. Ext: Significant ulcerations on bilateral shins, some pain and swelling of both knees that is stable <PERTINENT RESULTS> Admission Labs: ___ 04: 15PM WBC-8.9 RBC-2.79* HGB-8.0* HCT-24.2* MCV-87 MCH-28.8 MCHC-33.3 RDW-15.8* ___ 04: 15PM NEUTS-80.3* LYMPHS-9.0* MONOS-9.9 EOS-0.5 BASOS-0.2 ___ 04: 15PM PLT COUNT-168 ___ 04: 15PM ___ PTT-30.4 ___ ___ 04: 15PM LIPASE-69* ___ 04: 15PM ALT(SGPT)-26 AST(SGOT)-96* ALK PHOS-266* TOT BILI-1.1 ___ 04: 15PM GLUCOSE-127* UREA N-70* CREAT-1.7* SODIUM-134 POTASSIUM-4.3 CHLORIDE-99 TOTAL CO2-27 ANION GAP-12 ___ 05: 00PM COMMENTS-GREEN TOP ___ 4: 15 pm BLOOD CULTURE Blood Culture, Routine (Final ___: STAPH AUREUS COAG +. FINAL SENSITIVITIES. SENSITIVITIES: MIC expressed in MCG/ML STAPH AUREUS COAG + CLINDAMYCIN----------- =>8 R ERYTHROMYCIN---------- =>8 R GENTAMICIN------------ <=0.5 S LEVOFLOXACIN---------- =>8 R OXACILLIN------------- =>4 R RIFAMPIN-------------- <=0.5 S TETRACYCLINE---------- 2 S TRIMETHOPRIM/SULFA---- <=0.5 S VANCOMYCIN------------ <=0.5 S ___ 4: 15 pm URINE Site: CATHETER URINE CULTURE (Final ___: PSEUDOMONAS AERUGINOSA. >100,000 ORGANISMS/ML.. Piperacillin/Tazobactam sensitivity testing performed by ___ ___. SENSITIVITIES: MIC expressed in MCG/ML PSEUDOMONAS AERUGINOSA | CEFEPIME-------------- 16 I CEFTAZIDIME----------- 32 R CIPROFLOXACIN--------- =>4 R GENTAMICIN------------ 8 I MEROPENEM------------- =>16 R PIPERACILLIN/TAZO----- R TOBRAMYCIN------------ <=1 S ___ 4: 00 pm SWAB Source: decubitus ulcer. GRAM STAIN (Final ___: NO POLYMORPHONUCLEAR LEUKOCYTES SEEN. 1+ (<1 per 1000X FIELD): GRAM NEGATIVE ROD(S). WOUND CULTURE (Final ___: PSEUDOMONAS AERUGINOSA. SPARSE GROWTH. Piperacillin/Tazobactam sensitivity testing performed by ___ ___. ENTEROCOCCUS SP.. SPARSE GROWTH. SENSITIVITIES: MIC expressed in MCG/ML PSEUDOMONAS AERUGINOSA | ENTEROCOCCUS SP. | | AMPICILLIN------------ <=2 S CEFEPIME-------------- 32 R CEFTAZIDIME----------- =>64 R CIPROFLOXACIN--------- =>4 R GENTAMICIN------------ 8 I LINEZOLID------------- 1 S MEROPENEM------------- 8 I PENICILLIN G---------- 8 S PIPERACILLIN/TAZO----- R TOBRAMYCIN------------ <=1 S VANCOMYCIN------------ =>32 R ___ 2: 51 pm URINE Source: Catheter. URINE CULTURE (Final ___: PSEUDOMONAS AERUGINOSA. >100,000 ORGANISMS/ML.. Piperacillin/Tazobactam sensitivity testing performed by ___ ___. KLEBSIELLA PNEUMONIAE. 10,000-100,000 ORGANISMS/ML.. Piperacillin/tazobactam sensitivity testing available on request. SENSITIVITIES: MIC expressed in MCG/ML PSEUDOMONAS AERUGINOSA | KLEBSIELLA PNEUMONIAE | | AMPICILLIN/SULBACTAM-- 16 I CEFAZOLIN------------- =>64 R CEFEPIME-------------- 16 I 2 S CEFTAZIDIME----------- 16 I =>64 R CEFTRIAXONE----------- 16 R CIPROFLOXACIN--------- =>4 R =>4 R GENTAMICIN------------ 8 I <=1 S MEROPENEM------------- 8 I <=0.25 S NITROFURANTOIN-------- =>512 R PIPERACILLIN/TAZO----- R TOBRAMYCIN------------ <=1 S =>16 R TRIMETHOPRIM/SULFA---- <=1 S ___ 3: 54 am BLOOD CULTURE Source: Line-midline. Blood Culture, Routine (Final ___: NO GROWTH. ___ 3: 00 am BLOOD CULTURE FROM MIDLINE. Blood Culture, Routine (Final ___: NO GROWTH. ___ 3: 51 am BLOOD CULTURE: Pending ___ 3: 51 am BLOOD CULTURE: Pending Studies: CXR ___: No significant change from ___ radiograph, with cardiomegaly, pulmonary vascular congestion and bilateral pleural effusions again noted. Left lower lobe opacity is compatible with atelectasis and/or pneumonia. TTE ___: The left atrium is moderately dilated. The left atrium is elongated. The right atrium is moderately dilated. There is mild symmetric left ventricular hypertrophy with normal cavity size. The right ventricular cavity is moderately dilated There is abnormal septal motion/position consistent with right ventricular pressure/volume overload. The ascending aorta is mildly dilated. The aortic valve leaflets (3) are mildly thickened but aortic stenosis is not present. No masses or vegetations are seen on the aortic valve. Trace aortic regurgitation is seen. The mitral valve leaflets are mildly thickened. No mass or vegetation is seen on the mitral valve. An eccentric, posteriorly directed jet of Moderate (2+) mitral regurgitation is seen. Due to the eccentric nature of the regurgitant jet, its severity may be significantly underestimated (Coanda effect). Moderate [2+] tricuspid regurgitation is seen. There is mild pulmonary artery systolic hypertension. There is no pericardial effusion. Compared with the prior study dated ___ (images reviewed), the degree of pulmonary pressures is much lower (likely underestimated as the IVC was not well visualized). No vegetations or abscesses visualized. TEE ___: No vegetations seen on the cardiac leaflets. No mass or vegetation seen on the cardiac wires. Simple atheroma aortic arch. At least moderate in severity eccentric mitral regurgitation. Moderate tricuspid regurgitation. Mild to moderate pulmonary artery systolic hypertension. BLE Ultrasound ___: Limited study demonstrates no evidence of right or left lower extremity DVT. CXR ___: As compared to the previous radiograph, the position of the tracheostomy tube and of the pacemaker wires is unchanged. Unchanged moderate cardiomegaly with bilateral areas of atelectasis and substantial enlargement of the vascular structures at the lung hilus. Unchanged moderate pulmonary edema. No newly appeared focal parenchymal opacities. WBC scan ___: 1. Splenomegaly. 2. No focal source of infection localized. Bilateral UE ultrasound ___: No evidence of upper extremity deep venous thrombosis. Labs prior to discharge: ___ 02: 57AM BLOOD WBC-7.1 RBC-2.89* Hgb-8.1* Hct-24.9* MCV-86 MCH-28.0 MCHC-32.5 RDW-15.8* Plt ___ ___ 02: 57AM BLOOD Neuts-75.9* Lymphs-11.7* Monos-10.6 Eos-1.2 Baso-0.5 ___ 02: 57AM BLOOD Glucose-154* UreaN-49* Creat-1.4* Na-135 K-3.5 Cl-96 HCO3-29 AnGap-14 ___ 02: 57AM BLOOD Calcium-8.2* Phos-3.3 Mg-2.1 ___ 11: 06AM BLOOD Tobra-1.9* ___ 09: 00PM BLOOD Tobra-2.5* ___ 04: 03AM BLOOD Vanco-21.5* ___ 07: 50PM BLOOD Vanco-21.7* ___ 02: 07PM BLOOD ___ Temp-37.4 Rates-/35 Tidal V-309 PEEP-5 FiO2-50 pO2-48* pCO2-42 pH-7.48* calTCO2-32* Base XS-6 Intubat-INTUBATED Vent-SPONTANEOU <MEDICATIONS ON ADMISSION> Acetaminophen 650mg po q4h prn pain Lidocaine patch 5% TD daily Trazodone 25mg po qhs prn insomnia Citalopram 20mg po daily Docusate 50mg po bid Ferrous sulfate 300mg po daily Folic acid 1mg po daily Multivitamin 1 tab po daily Omeprazole 20mg po daily Albuterol sulfate 90mcg q4h prn SOB/wheeze Simethicone 80mg po tid Miconazole nitrate 2% application qhs Oxycodone ___ po q4h prn pain Lasix 40mg po daily Vancomycin 500mg IV q12h Psyllium one packet po tid Sucralfate 1gram po qid Carvedilol 6.25mg po bid <DISCHARGE MEDICATIONS> 1. acetaminophen 650 mg/20.3 mL Solution Sig: Six Hundred Fifty (650) mg PO Q6H (every 6 hours) as needed for pain, fever. 2. lidocaine 5 %(700 mg/patch) Adhesive Patch, Medicated Sig: One (1) Adhesive Patch, Medicated Topical DAILY (Daily). 3. trazodone 50 mg Tablet Sig: ___ Tablet PO at bedtime as needed for insomnia. 4. citalopram 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 5. docusate sodium 50 mg/5 mL Liquid Sig: One Hundred (100) mg PO twice a day: Hold for loose stools. 6. ferrous sulfate 300 mg (60 mg iron)/5 mL Liquid Sig: Three Hundred (300) mg PO once a day. 7. folic acid 1 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 8. multivitamin Tablet Sig: One (1) Tablet PO DAILY (Daily). 9. omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) Capsule, Delayed Release(E.C.) PO once a day. 10. albuterol sulfate 90 mcg/Actuation HFA Aerosol Inhaler Sig: ___ Puffs Inhalation Q4H (every 4 hours) as needed for sob, wheeze. 11. simethicone 80 mg Tablet, Chewable Sig: One (1) Tablet, Chewable PO TID (3 times a day). 12. miconazole nitrate 2 % Powder Sig: One (1) Appl Topical HS (at bedtime) as needed for rash. 13. oxycodone 5 mg Tablet Sig: One (1) Tablet PO Q4H (every 4 hours) as needed for pain. 14. fentanyl 12 mcg/hr Patch 72 hr Sig: One (1) Patch 72 hr Transdermal Q72H (every 72 hours). 15. psyllium Packet Sig: One (1) Packet PO TID (3 times a day). 16. sucralfate 1 gram Tablet Sig: One (1) Tablet PO QID (4 times a day). 17. carvedilol 6.25 mg Tablet Sig: One (1) Tablet PO BID (2 times a day): Hold for SBP<100, HR<55. 18. cefepime 1 gram Recon Soln Sig: One (1) gram Injection Q24H (every 24 hours) for 2 days: Last day ___. 19. vancomycin in D5W 1 gram/200 mL Piggyback Sig: One (1) gram Intravenous q48h: Until ___. 20. furosemide 10 mg/mL Solution Sig: Eighty (80) mg Injection Q6H (every 6 hours). 21. metolazone 2.5 mg Tablet Sig: One (1) Tablet PO BID (2 times a day): 30 minutes prior to Lasix dose. 22. omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) Capsule, Delayed Release(E.C.) PO once a day. 23. tobramycin sulfate 40 mg/mL Solution Sig: Three Hundred Twenty (320) mg Injection ONCE (Once) for 1 doses: Give one dose of 320mg when trough level < 1.0. <DISCHARGE DISPOSITION> Extended Care Facility: ___ <DISCHARGE DIAGNOSIS> Primary Diagnosis: MRSA bacteremia Klebsiella and pseudomonas UTI Chronic diastolic congestive heart failure Respiratory failure Secondary Diagnosis: Coronary Artery Disease Atrial fibrillation <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Lethargic but arousable. Activity Status: Bedbound. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> You were admitted to the hospital due to persistent fevers and a bacterial infection in your blood. You underwent multiple studies to evaluate the source of your infection. It does not appear that your heart valves or your pacemaker are infected. You were treated with antibiotics for your bloodstream infection, as well as urinary and wound infections. We also tried to give you diuretics to help your breathing. Changes to your medications: Increased docusate to 100mg po bid Increased albuterol to ___ puffs q4h prn SOB/wheeze Start fentanyl patch 12mcg/hr TD q72h Start cefepime 1g IV q24h for 2 more days, last day ___ Change vancomycin to 1g q48h, last day ___ Change furosemide to 80mg IV q6h Add metolazone to 2.5mg po bid, 30 mins prior to lasix dose Add tobramycin, needs one more dose of 320mg when trough ___ You should be weighed every day and the providers at rehab should be notified if your weight goes up by more than 3 pounds. ","Primary Reason for Hospitalization: Mr. ___ is a ___ year old male with h/o CAD s/p stenting, systolic CHF (EF40-45%), atrial fibrillation, h/o cardiac arrest with heart block s/p AICD/pacemaker, trach/PEG, and recent ICU admission with GI bleed, hematuria, and MRSA bacteremia, who presented from rehab with fevers and persistent MRSA bacteremia while on vancomycin. #. MRSA Bacteremia: The source of the patient's persistent bacteremia was not found. He grew MRSA from multiple blood cultures at rehab and also on initial presentation despite appropriate vancomycin troughs. Multiple sources of persistent seeding were considered. He had a TTE and TEE which were both negative for vegetations and did not show any involvement of his pacer leads. A tagged WBC scan was performed to look for occult focus of infection which was negative. An upper extremity ultrasound was also performed to look for possible infected clot but was negative. His PICC line which had been recently replaced at ___ was removed. A new one was not placed until he had negative blood cultures. He was continued on vancomycin and dosing was changed to 1g q48h. Further blood cultures were negative. Ultimately it was felt he likely has an endovascular source but it was not found during this hospitalization. He should be continued on IV vancomycin for 6 weeks from the date of his last positive blood culture, with last day ___. #. Pseudomonas and Klebsiella UTI: Given that he has an indwelling foley it was suspected that this might be colonization however his cultures were positive even after changing his foley. He was found to have pseudomonas in his urine as well as wound culture. It was multidrug resistant pseudomonas and he was treated with tobramycin for a seven day course. He needs one more dose of tobramycin 320mg IV x 1 when trough < 1. He also grew multidrug resistant klebsiella in his urine and was started on a 7 day course of cefepime with last day ___. #. Fevers: He had fevers on admission felt to be related to his MRSA bacteremia. Other cultures returned positive as above. He also had a knee arthrocentesis which was not consistent with septic arthritis. His PICC was changed after a 24 hour line holiday. He was ruled out for C diff. #. Acute renal failure: BUN/creatinine elevated to 70/1.7 on admission felt to be related to ongoing infection and poor forward floor from chronic systolic CHF. His creatinine slowly improved with diuresis. #. Chronic respiratory failure: He was continued on mechanical ventilation during this admission and was unable to be weaned to trach mask for any length of time. This was felt to be related to chronic respiratory fatigue in addition to substantial pulmonary edema. Diuresis was difficult due to his large obligate fluid intake, but was eventually acheived with lasix 80mg IV q6h plus metolazone 2.5mg po bid. His metolazone may need to be decreased over the next several days if he is overdiuresed as he was on average 1L negative on this regimen for the few days prior to discharge. On the day of discharge, he was on pressure support ___, PEEP 5, FiO2 50% with TV in the 300's. #. Anemia: His hematocrit remained stable in the low 20's during this admission. #. Chronic Diastolic CHF: Has EF 55%. He was continued on his home carvedilol. His lisinopril has been on hold indefinitely and was not restarted due to renal failure. He was diuresed with IV lasix and metolazone as above and will need his creatinine and electrolytes monitored closely with ongoing diuresis. #. Sacral decubitus ulcer: Stage IV. He was started on a fentanyl patch and continued on prn oxycodone for pain control. #. Atrial fibrillation: His heart rate and blood pressure remained stable during this admission. He is off anticoagulation due to h/o GI bleeding and hemothorax. He was continued on carvedilol. #. Wound care: He was evaluated by the wound care team who recommended the following: 1. Follow pressure ulcer guidelines. First Step for fluid management. Turn q 2 hours. 2. Cleanse wounds with commercial wound cleanser. Pat dry. 3. Apply Aquacel ag to sacrum wound, cover with 4x4's and soft sorb dressing, secure with Medipore tape. Change daily. 4. BLE ulcerations - cover with Adaptic dressing, place 4x4 and wrap with Kerlix. Secure with paper tape. 5. No tape on skin. 6. Mid upper back ulcer - Apply Mepilex 4x4 and change q3 days. 7. Mid lower back ulcer - apply DuoDerm wound gel to bed to assist with autolytic debridement of yellow slough. Cover with Mepilex 4x4 dressing, and change q 3 days. 8. Apply Critic Aid clear skin barrier ointment to scrotal tissue to protect from fluid exposure daily. Elevate scrotum to assess with edema. 9. Waffles bilateral feet. 10. Apply aloe vesta ointment to dry intact skin daily. 11. Support nutrition and hydration. TRANSITIONAL ISSUES: - Monitor I/O's closely and check electrolytes closely given large doses of lasix and metolazone. ___ need to back off on metalazone if signs of overdiuresis. However, would continue to aim for -500cc daily I/O balance. - Needs tobramycin trough drawn ___ AM. Give tobramycin 320mg IV x 1 when trough is <1.0. - Continue vancomycin until ___ for MRSA bacteremia. Should have trough measured intermittently to assess for appropriate dosing. - Needs 2 more days of cefepime treatment - Continue ventilator weaning and trach collar trials if possible. Diuresis should help with this. - Please draw weekly labs: CBC/diff, chem-7, LFTs and fax to Infectious disease R.Ns. at ___. All questions regarding outpatient antibiotics should be directed to the infectious disease R.Ns. at ___ or to on call MD in when clinic is closed ",4374,1393
10004401-DS-32,"<SEX> M <SERVICE> MEDICINE <ALLERGIES> Penicillins / Erythromycin Base / Streptomycin / Citric Acid / Atenolol / Torsemide / Heparin Agents <ATTENDING> ___ ___ Complaint: fevers, vomiting, AMS <MAJOR SURGICAL OR INVASIVE PROCEDURE> None <HISTORY OF PRESENT ILLNESS> <HISTORY OF PRESENT ILLNESS> Mr. ___ is an ___ male with history of CAD s/p stenting, CHF (EF 55%), Afib, prior cardiac arrest and heart block s/p pacer/AICD placement, chronic trach, and recent MRSA bacteremia on vancomycin who presents from rehab with a one day history of fevers and vomiting, as well as AMS. Patient has had several recent admissions, including admission from ___ for PNA and MRSA bacteremia/sepsis. Was discharged to rehab on vanco, readmitted ___ for hematuria and GI bleed (blood in ostomy bag), and again readmitted ___ with persistent fevers and positive MRSA blood cultures. Source of MRSA bacteremia was unclear, and work-up during that time included TTE/TEE negative for vegetations on valves and cardiac pacer leads, and negative tagged WBC scan. PICC was removed and replaced. Patient discharged on planned 6 week course of vanco through ___. Hospital course also notable for pseudomonas and klebsiella UTI, treated with 7 day courses of cefepime and tobramycin. Patient had Foley changed during that admission. Was discharged back to ___ ___. . Since discharge, has been noted to have worsening renal function requiring nephrology consult, and in this setting his diuretic regimen was held. Also had increasing SOB requiring pulmonary consult, with change in vent settings from pressure support to AC mode. Has had recurrent GI bleed requiring transfusion of 2 units pRBCs on ___, and has been continued on PPI, sucralfate, and iron supplementation. Per report, usually responds to wife, but was less responsive over past ___ days. On day of admission had several episodes of vomiting, and per wife was febrile to 101. Sent to ED for further evaluation. . In the ED, initial VS were: 98.2 69 106/51 20 95% assist control. Labs notable for leukocytosis (WBC 14.2) with neutrophil predominance, Hct 26.3 (stable), Na 127, Cr 3.5 (baseline 1.4), lactate 1.2. UA suggestive of recurrent UTI. CXR showed moderate pulmonary edema with bilateral pleural effusions, and was similar to recent prior studies. Given LUE edema, ultrasound obtained which was negative for DVT. Patient received vancomycin and cefepime. Also got ASA given elevated trop of 0.2. ECG showed paced rhythm. Patient had 1L NS hung prior to transfer. VS prior to transfer 100.0 70, 112/82, 15, 99%. . On arrival to the MICU, patient nods yes when asked if he is in pain, but he cannot localize the pain. Appears comfortable when resting in bed, though uncomfortable when examined. . <PAST MEDICAL HISTORY> Rectal cancer s/p excision and XRT (___) CAD s/p stents (?___) CVA in ___ with residual right hand dysthesia Complete heart block s/p pacemaker H/o cardiac arrest (now with AICD) GI bleed secondary to angiectasias in the duodenum (___) s/p cauterization via EGD Atrial fibrillation, not on coumadin Systolic CHF (EF 40-45%) S/p Fall with multiple rib fractures (___) MICU admission ___ for hemoptysis, bleeding from trach Abdominoperineal resection ___ w/ ___ <SOCIAL HISTORY> ___ <FAMILY HISTORY> Father died in ___ from MI. Mother died in ___ from PE. No family history of colon, breast, uterine, or ovarian cancer. No family history of seizures. <PHYSICAL EXAM> ADMISSION EXAM: General: easily arousable to voice, frequently falls to sleep, oriented to person and place, unable to assess if oriented to time (could not interpret patient's answer), appears comfortable at rest HEENT: PERRL, EOMI, sclera anicteric, dry MM, oropharynx clear Neck: supple, JVP 8-9cm, trach in place CV: RRR, normal S1 + S2, II/VI holosystolic murmur loudest at apex and radiating to axilla Lungs: bilateral rhonchi with scattered crackles, no wheezing Abdomen: bowel sounds present, soft, mildly distended, diffuse mild tenderness to palpation, suprapubic tenderness, ostomy bag in place GU: foley in place Ext: slighty cool, 2+ pulses, venous stasis changes, 2+ edema to knees bilaterally DISCHARGE EXAM HEENT: PERRL, EOMI, sclera anicteric, dry MM, oropharynx clear Neck: supple, JVP 8-9cm, trach in place CV: RRR, normal S1 + S2, II/VI holosystolic murmur loudest at apex and radiating to axilla Lungs: bilateral rhonchi with scattered crackles, no wheezing Abdomen: bowel sounds present, soft, mildly distended, diffuse mild tenderness to palpation, suprapubic tenderness, ostomy bag in place GU: foley in place Ext: slighty cool, 2+ pulses, venous stasis changes, 2+ edema to knees bilaterally <PERTINENT RESULTS> ADMISSION LABS ___ 06: 25PM BLOOD WBC-14.2*# RBC-3.15* Hgb-8.9* Hct-26.3* MCV-83 MCH-28.2 MCHC-33.8 RDW-15.4 Plt ___ ___ 06: 25PM BLOOD Neuts-82.8* Lymphs-6.4* Monos-10.2 Eos-0.3 Baso-0.4 ___ 06: 25PM BLOOD ___ PTT-35.8* ___ ___ 06: 25PM BLOOD Glucose-108* UreaN-117* Creat-3.5*# Na-127* K-4.5 Cl-85* HCO3-28 AnGap-19 ___ 06: 25PM BLOOD ALT-52* AST-65* AlkPhos-258* TotBili-1.7* ___ 02: 26AM BLOOD Albumin-2.8* Calcium-8.4 Phos-3.5 Mg-2.2 DISCHARGE LABS ___ 03: 32AM BLOOD WBC-4.9 RBC-2.90* Hgb-8.2* Hct-25.5* MCV-88 MCH-28.2 MCHC-32.0 RDW-16.2* Plt ___ ___ 12: 11AM BLOOD ___ PTT-36.1* ___ ___ 03: 32AM BLOOD Glucose-74 UreaN-96* Creat-2.7* Na-140 K-3.7 Cl-102 HCO3-23 AnGap-19 ___ 03: 02AM BLOOD CK(CPK)-21* ___ 03: 32AM BLOOD Calcium-8.4 Phos-4.9* Mg-2.0 MICROBIOLOGY ___ BLood Culture STAPH AUREUS COAG + | CLINDAMYCIN----------- =>8 R DAPTOMYCIN------------ S ERYTHROMYCIN---------- =>8 R GENTAMICIN------------ <=0.5 S LEVOFLOXACIN---------- =>8 R OXACILLIN------------- =>4 R RIFAMPIN-------------- <=0.5 S TETRACYCLINE---------- 2 S TRIMETHOPRIM/SULFA---- <=0.5 S VANCOMYCIN------------ <=0.5 S ___ Urine Culture URINE CULTURE (Final ___: ENTEROCOCCUS SP.. >100,000 ORGANISMS/ML.. Sensitivity testing performed by Sensititre. Daptomycin = 1 MCG /ML. YEAST. 10,000-100,000 ORGANISMS/ML.. SENSITIVITIES: MIC expressed in MCG/ML _________________________________________________________ ENTEROCOCCUS SP. | AMPICILLIN------------ 1 S DAPTOMYCIN------------ S LINEZOLID------------- 1 S TETRACYCLINE---------- =>32 R VANCOMYCIN------------ >256 R ___ Sputum culture ___ 7: 00 pm SPUTUM Source: Endotracheal. **FINAL REPORT ___ GRAM STAIN (Final ___: THIS IS A CORRECTED REPORT ___ AT 3: 00 ___. Reported to and read back by ___. >25 PMNs and <10 epithelial cells/100X field. 4+ (>10 per 1000X FIELD): GRAM NEGATIVE ROD(S). ___ PREVIOUSLY REPORTED AS. <10 PMNs and >10 epithelial cells/100X field. 4+ (>10 per 1000X FIELD): GRAM NEGATIVE ROD(S). RESPIRATORY CULTURE (Final ___: Commensal Respiratory Flora Absent. PSEUDOMONAS AERUGINOSA. HEAVY GROWTH. Piperacillin/Tazobactam sensitivity testing performed by ___ ___. KLEBSIELLA PNEUMONIAE. SPARSE GROWTH. Piperacillin/tazobactam sensitivity testing available on request. SENSITIVITIES: MIC expressed in MCG/ML _________________________________________________________ PSEUDOMONAS AERUGINOSA | KLEBSIELLA PNEUMONIAE | | AMPICILLIN/SULBACTAM-- =>32 R CEFAZOLIN------------- =>64 R CEFEPIME-------------- 16 I <=1 S CEFTAZIDIME----------- 32 R =>64 R CEFTRIAXONE----------- 16 R CIPROFLOXACIN--------- =>4 R =>4 R GENTAMICIN------------ 8 I 2 S MEROPENEM------------- 8 I <=0.25 S PIPERACILLIN/TAZO----- R TOBRAMYCIN------------ <=1 S =>16 R TRIMETHOPRIM/SULFA---- <=1 S ___ Sputum Time Taken Not Noted Log-In Date/Time: ___ 2: 50 am SPUTUM **FINAL REPORT ___ GRAM STAIN (Final ___: >25 PMNs and <10 epithelial cells/100X field. NO MICROORGANISMS SEEN. RESPIRATORY CULTURE (Final ___: RARE GROWTH Commensal Respiratory Flora. STAPH AUREUS COAG +. RARE GROWTH. Oxacillin RESISTANT Staphylococci MUST be reported as also RESISTANT to other penicillins, cephalosporins, carbacephems, carbapenems, and beta-lactamase inhibitor combinations. Rifampin should not be used alone for therapy. This isolate is presumed to be resistant to clindamycin based on the detection of inducible resistance . YEAST. SPARSE GROWTH. SENSITIVITIES: MIC expressed in MCG/ML _________________________________________________________ STAPH AUREUS COAG + | CLINDAMYCIN----------- R ERYTHROMYCIN---------- =>8 R GENTAMICIN------------ <=0.5 S LEVOFLOXACIN---------- =>8 R OXACILLIN------------- =>4 R RIFAMPIN-------------- <=0.5 S TETRACYCLINE---------- <=1 S TRIMETHOPRIM/SULFA---- <=0.5 S VANCOMYCIN------------ <=0.5 S ___ Urine Culture ___ 12: 29 pm URINE Source: Catheter. **FINAL REPORT ___ URINE CULTURE (Final ___: YEAST. 10,000-100,000 ORGANISMS/ML.. ___ RUQ US RIGHT UPPER QUADRANT ULTRASOUND: The liver is normal in echotexture without focal lesions. There is no intrahepatic or extrahepatic biliary ductal dilatation. The normal CBD measures 5 mm in diameter. Again noted is a large gallstone, measuring 2.7 cm, in the non-fully distended gallbladder. The gallbladder wall is mildly thickened measuring up to 5 mm, nonspecific. There is normal hepatopetal portal venous flow. The enlarged spleen measures up to 16.6 cm. The visualized IVC, aorta and pancreas are grossly unremarkable. Trace ascites is noted. IMPRESSION: 1. Known cholelithiasis. 2. Mildly thickened gallbladder wall, unchanged and non-specific, could be seen in right heart failure, hypoalbuminemia or other liver disease. No ultrasound findings to suggest acute cholecystitis. 3. Splenomegaly. ___ LUE US IMPRESSION: No DVT left upper extremity with a left basilic PICC in place. ___ G-tube check REASON FOR EXAMINATION: Evaluation of the percutaneous gastrostomy tube with bleeding and leakage throughout the tube. AP radiograph of the abdomen after injection of contrast material through the percutaneous gastrostomy is noted. The contrast material is demonstrated in the stomach as well as in the duodenum and jejunum. No definitive evidence of extravasation is noted. If clinically warranted, correlation with cross-sectional imaging might be considered. Wound Care recomendations: Recommendations: 1. Follow pressure ulcer guidelines. Atmos Air. Turn q 2 hours. 2. Cleanse wounds with commercial wound cleanser. Pat dry. 3. Apply Aquacel ag to sacrum wound, cover with 4x4's and Soft sorb dressing, secure with Medipore tape. Change daily. 4. LLE anterior excoriation - cover with Adaptic dressing, place 4x4,and wrap with Kerlix. Secure with paper tape. Change daily. 5. No tape on skin. 6. Left Trochanter - apply Mepilex 4x4 to site, and change q3 days. 7. Cleanse scrotum and perineum area with Aloe Vesta foam cleanser daily. Pat dry. 8. Apply Critic Aid clear skin barrier ointment to scrotal tissue to protect from fluid exposure daily. Elevate scrotum to assist with edema. 9. Waffles bilateral feet. 10. Apply Aquaphor ointment to dry intact skin daily from pharmacy daily. Ostomy Care: LLQ, ___, red, flush, os at center, mucocutaneous junction intact, peristomal skin intact with large parastomal hernia. Pouched with ___ Sura one piece drainable, ___ # ___, ___ # ___. No-sting barrier wipe, ___ # ___, ___ # ___. Nursing staff to change pouch q ___ and ___ while her. <MEDICATIONS ON ADMISSION> Acetylcysteine 100mg TID intratracheal Carvedilol 6.25mg BID Citalopram 20mg daily Docusate sodium 100mg BID Ferrous sulfate elixir 325mg daily Folic acid 1mg daily Lidocaine patch daily MVI daily Omeprazole 20mg daily Simethicone 80mg BID Sucralfate 1gm TID Fentanyl 12mcg patch Q72hrs Acetaminophen 650mg Q6H prn pain Albuterol inhaler 2 puffs Q4H prn SOB Psyllium 1 teaspoon TID Oxycodone 5mg Q4H prn pain <DISCHARGE MEDICATIONS> OxycoDONE (Immediate Release) ___ mg PO/NG Q4H: PRN pain hold for sedation or RR <12 Citrate ___ mcg IV Q4H: PRN dressing changes Albuterol Inhaler 6 PUFF IH Q4H: PRN shortness of breath, wheezing Pantoprazole 40 mg IV Q12H Daptomycin 540 mg IV Q48H Acetaminophen (Liquid) 650 mg PO/NG Q6H: PRN pain Fentanyl Patch 12 mcg/hr TP Q72H last changed ___ @ 12: 45 Sucralfate 1 gm PO/NG TID Simethicone 80 mg PO/NG TID Multivitamins 1 TAB PO/NG DAILY Lidocaine 5% Patch 1 PTCH TD DAILY FoLIC Acid 1 mg PO/NG DAILY Ferrous Sulfate (Liquid) 300 mg PO/NG DAILY Docusate Sodium (Liquid) 100 mg PO/NG BID Citalopram 20 mg PO/NG DAILY Carvedilol 6.25 mg PO/NG BID MVI daily Psyllium 1 teaspoon TID Acetylcysteine 100mg TID intratracheal Pt was administered the flu vaccine ___ <DISCHARGE DISPOSITION> Extended Care Facility: ___ <DISCHARGE DIAGNOSIS> MRSA bacteremia with likely pacemaker colonization, multiple decubitus ulcers, ventilator dependence, acute kidney injury, gastrointestinal bleeding, urinary tract infection, chronic congestive heart failure. <DISCHARGE CONDITION> fair <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Mr. ___, It was a pleasure taking care of you in the intensive care unit. As you know, the blood stream infection is probably chronic and it would basically be impossible to cure of you that. We believe that your pacemaker is colonized with the bacteria, and it would be impossible to remove it. You also have a urinary tract infection, and you were bleeding somewhere in your intestines. Fortunately the bleeding stopped. You also have a chronic heart failure, which you are aware. Your kidney insufficiency may resolve, but it may not. You were also administered the flu vaccine while you were here. ","___ male with extensive cardiac PMH, recent MRSA bacteremia, trach on chronic mechanical ventilation, and chronic foley catheter with recent pseudomonal/klebsiella UTI, who presents now from rehab with fever, leukocytosis, vomiting, and AMS in setting enterococcus and yeast UTI, ___, MRSA bacteremia, hematochezia, and Stage 4 sacral decubitus ulcer. . ACUTE ISSUES #. MRSA Bacteremia: Pt had recurrent MRSA bacteremia in the settting of vancomycin treatment. We are particularly concerned about endocarditis from ICD given the refractory nature. However, removal of instrumentation is not an option per patietn and family wishes. Source of infection include sacral decubitous ulcer, UTI, ventilation. Pt does not have leukocytosis or fever. Chronic colonization likely. Complete bacterial clearance is unlikely in this setting. OUTPATIENT ISSUES - START Daptomycin indefinitely - PICC line in place, routine care . #. GIB: Pt presented with HCT drop and Bright red blood through ostomy. He received a total of 3 units pRBC blood transfusion. We temporarily stopped tube feeding the setting of GIB, and discontinued his aspirin. His HCT has been stable in the past 48 hours without transfusion. GI has been consulted, and did not feel that the benefit of osteostomy-scope outweighs its risk. OUTPATIENT ISSUES - CONTINUE tube feeding as scheduled - STOP aspirin and anti-platelets forever. - START pantoprazole 40 mg iv bid - CONTINUE ferrous sulfate, sucrafate . #. ___: Pt presented with elevated Cr to 3.5 on admission with anuria. There was muddy brown cast on urine sedimentation, concerning for ATN in the setting of sepsis and tobramycin exposure. We gave him gentle fluid challenge, and his urine output recovered shortly afterwards. His creatinine decreased to 2.7 on the day of discharge. This may or may not ever go back down to his previous baseline. Regardless, he's not anuric and patient and family have refused initiation of dialysis. OUTPATIENT ISSUES - AVOID nephrotoxic medication - DISCONTINUE Lisinopril . #. Hematuria and UTI: Pt has indwelling foley catheter and presented with hematuria and positive UA. Urine culture was notable for VRE, fungus. We treated him with meropenem and fluconazole while he was in the MICU. He received bladder irrigation for hematuria. His hematuria resolved on the day of discharge. Pt was asymptomatic from his UTI. We felt it is impossible to completely treat his UTI. We decided to withdrawal treatment for now to minimize the hepatic and renal drug intoxication. . #. Decubitus ulcer: Pt has a Stage 4 decubitus ulcer over sacrum and left thigh. The pain from decubitous ulcer is his major concern while he was here. He was seen by wound care. They advise supportive care. OUTPATIENT ISSUES - Pleae CHANGE BODY POSITION every 2 hours - Please provide adequate pain management with lidocaine patch, fentanyl, oxycodone. . #. Positive sputum culture: Pt has trach tube. His sputum culture grew multiresistant klebsiella and pseudomonas. Pt remained afebrile, no leukocytosis, left shift or increased sputum production. We felt the complete irradiation was unlikey given his current clinical status and suspect he has permanent colonization. . CHRONIC ISSUES #. Chronic dCHF: Pt has diastolic CHF. We continued his beta-blocker for the need of rate control. We held his lisinopril in an hope of protecting his current kidney function. We held his aspirin in the setting of GI bleeding. We felt that active treatment for his CHF is less of a priority. OUTPATIENT ISSUES - DISCONTINUED Aspirin and all antiplatelet drugs - DISCONTINUED Lisinopril . #. Atrial fibrillation: Pt is AV paced on telemetry. Not on anticoagulation given history of GI bleeding. Rate controlled with carvedilol. OUTPATIENT ISSUES - Per our EP recommendation, they can disable the defibrillator function, while still keep AV pacing, if there is a need in the change of goal of care. . # Depression: Continue citalopram. . TRANSITIONAL ISSUES Pt declared a code status of DNR/DNI. Extensive discussion has occurred between family and care provider team on goal of care. In general, our understanding is that family would like continued conservative treatment, with no invasive procedure, including the use of pressors. We have conveyed clearly to the family that clinical improvement is unlikely in the current situation. Pt's family expressed concerns that patient has not been getting enough comfort care (ie skin, wound, pain). . The wife has expressed continued frustration with being transferred back and forth from rehab to the hospital. We assured her that the care provided to him at rehab is very good. In general, we'd try to limit the number of unecessary hospitalizations. We explained to the family, with the son present in the room, that the patient's condition is stable, but ultimately is declining. We explicity told them that things are probably as good as they'll ever be, and that in the future he will have a slow and steady decline. We are limited in interventions that can be done here in hospital and have conveyed that to his family. . . ",3997,1183
10004401-DS-33,"<SEX> M <SERVICE> MEDICINE <ALLERGIES> Penicillins / Erythromycin Base / Streptomycin / Citric Acid / Atenolol / Torsemide / Heparin Agents <ATTENDING> ___ <CHIEF COMPLAINT> Bacteremia/ Bleeding from G tube site <MAJOR SURGICAL OR INVASIVE PROCEDURE> Endoscopy x3: Performed by Dr. ___ on ___ and ___ <HISTORY OF PRESENT ILLNESS> ___ year old male per omr with history of CAD s/p stenting, CHF (EF 55%), Afib, prior cardiac arrest and heart block s/p pacer/AICD placement, chronic trach, and recent MRSA bacteremia transitioned from vancomycin to daptomycin presenting from rehab facility with continued bacteremia and bleeding around G-tube site. . Briefly patient was doing well until ___ when he suffered a fall that caused multiple fractures. He was hospitalized and intubated and subsequently trached. He was transferred to rehab where he spent a good deal of time with multiple readmissions for various infections and chronic GI Bleeds. In ___ was admitted to ___ for PNA and found to have MRSa bacteremia. Was dicharged on Vancomycin. Was readmitted later that month for a GI bleed. ___ was deferred ___ to family wishes and comorbidites. He was discharged again to ___. Surveilece cultures remained positive and he was readmitted for infectious work up. TTE, TEE and tagged WBC scan were all negative for ocult infectious source. On that admission he was diagnosed with concurrent Pseudomonas and Klebsiella UTI and treated with Meropenam. Given his persistent MRSA bacteremia he was switched from Vancomycin to daptomycin. . Over the last several days he has been febrile with intermittent AMS. Blood cultures are persistently positive. Per notes form his PCP and discussions with the family, he is being admitted for evaluation for ICD lead explantation and for managment of fevers. . With regards to the bleedign at the G-tube site, the nursing staff at the rehabilitation facility noted oozing of blood from around the G-tube site. There was no bleeding at the lumen of the site. The patient remained normotensive. He remained normal mental status. The G-tube was clear and patent. There were no exacerbating or relieving factors. There was no known preceding trauma to the G-tube. . In the ED, initial VS were: 88 130/70 99% 15L . FAST positive but hemodynamic stable CT abd non-con: simple fluid in the abdomen and pelvis, but no evidence for hematoma. left ventral wall hernia containing non-obstructed loops of bowel. . On arrival to the MICU, he was alert and cooperative and following commands. <PAST MEDICAL HISTORY> Rectal cancer s/p excision and XRT (___) CAD s/p stents (?___) CVA in ___ with residual right hand dysthesia Complete heart block s/p pacemaker H/o cardiac arrest (now with AICD) GI bleed secondary to angiectasias in the duodenum (___) s/p cauterization via EGD Atrial fibrillation, not on coumadin Systolic CHF (EF 40-45%) S/p Fall with multiple rib fractures (___) MICU admission ___ for hemoptysis, bleeding from trach Abdominoperineal resection ___ ___/ ___ <SOCIAL HISTORY> ___ <FAMILY HISTORY> Father died in ___ from ___. Mother died in ___ from PE. No family history of colon, breast, uterine, or ovarian cancer. No family history of seizures. <PHYSICAL EXAM> Admission Exam: General: Alert, no acute distress HEENT: Trached NC AT Neck: trach in place CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Lungs: Coarse bilateral breath sounds Abdomen: soft, non-tender, non-distended, bowel sounds present Ostomy in place GU: Foley in place Ext: WWP 3+ pitting edema to theknees with bilateral venous stasis changes. <PERTINENT RESULTS> ___ 04: 15PM ___ PTT-38.5* ___ ___ 04: 15PM PLT COUNT-110* ___ 04: 15PM NEUTS-82.7* LYMPHS-10.0* MONOS-6.5 EOS-0.5 BASOS-0.2 ___ 04: 15PM WBC-17.4*# RBC-3.50* HGB-9.7* HCT-30.0* MCV-86 MCH-27.6 MCHC-32.2 RDW-17.0* ___ 04: 15PM CALCIUM-8.4 PHOSPHATE-3.3# MAGNESIUM-1.9 ___ 04: 15PM estGFR-Using this ___ 04: 15PM GLUCOSE-130* UREA N-88* CREAT-1.9* SODIUM-141 POTASSIUM-3.9 CHLORIDE-104 TOTAL CO2-25 ANION GAP-16 ___ 04: 24PM GLUCOSE-123* LACTATE-2.1* NA+-140 K+-3.7 CL--105 TCO2-26 ___ 04: 24PM COMMENTS-GREEN TOP ___ 07: 14PM TYPE-ART PO2-60* PCO2-34* PH-7.51* TOTAL CO2-28 BASE XS-3 ___ 07: 42PM URINE WBCCLUMP-MOD MUCOUS-OCC ___ 07: 42PM URINE AMORPH-OCC ___ 07: 42PM URINE RBC-47* WBC->182* BACTERIA-MANY YEAST-FEW EPI-0 ___ 07: 42PM URINE BLOOD-LG NITRITE-NEG PROTEIN-30 GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-5.0 LEUK-LG ___ 07: 42PM URINE COLOR-Red APPEAR-Cloudy SP ___ . CT ABDDOMEN AND PELVIS Study Date of ___ 5: 01 ___ MPRESSION: . 1. Diffuse anasarca with small to moderate amount of ascites within the abdomen and pelvis, but no evidence for hemorrhage. 2. Moderate bilateral pleural effusions which have increased since the most recent examination. Small pericardial effusion, increased. 3. Cholelithiasis without evidence for cholecystitis. 4. Parastomal hernia containing nonobstructed, nondilated loops of small bowel. 5. Prostatic hypertrophy. 6. 15-mm hyperdense left upper pole renal lesion which is unchanged and may represent a hemorrhagic cyst. This can be further assessed with MRI if clinically indicated (as prior renal ultrasound from ___ did not demonstrate any abnormality within this area). . The study and the report were reviewed by the staff radiologist. . . EKG: AV paced at 70 . AP CHEST 1: 43 P.M. ON ___. HISTORY: New right subclavian line. IMPRESSION: AP chest compared to ___ through ___ at 10: 45 a.m.: Tip of the new right subclavian line ends low in the SVC. There is no change in the small-to-moderate right pleural effusion and no pneumothorax or mediastinal widening to suggest complications of line insertion. Severe cardiomegaly is longstanding. Pulmonary vascular engorgement and bibasilar atelectasis are unchanged. Tracheostomy tube is midline. Transvenous right atrial and right ventricular pacer defibrillator leads are in their expected locations, unchanged. No pneumothorax. . ___ 1: 18 am BLOOD CULTURE Site: ARM Source: Venipuncture. Blood Culture, Routine (Preliminary): STAPH AUREUS COAG +. FINAL SENSITIVITIES. Oxacillin RESISTANT Staphylococci MUST be reported as also RESISTANT to other penicillins, cephalosporins, carbacephems, carbapenems, and beta-lactamase inhibitor combinations. Rifampin should not be used alone for therapy. Consultations with ID are recommended for all blood cultures positive for Staphylococcus aureus and ___ species. VANCOMYCIN Sensitivity testing confirmed by Sensititre. SENSITIVITIES: MIC expressed in MCG/ML _________________________________________________________ STAPH AUREUS COAG + | CLINDAMYCIN----------- =>8 R ERYTHROMYCIN---------- =>8 R GENTAMICIN------------ 1 S LEVOFLOXACIN---------- =>8 R OXACILLIN------------- =>4 R RIFAMPIN-------------- <=0.5 S TETRACYCLINE---------- 2 S TRIMETHOPRIM/SULFA---- <=0.5 S VANCOMYCIN------------ 2 S Anaerobic Bottle Gram Stain (Final ___: Reported to and read back by ___. ___ ON ___ AT 0515. GRAM POSITIVE COCCI IN PAIRS AND CLUSTERS. . ___ 3: 45 am URINE Source: Catheter. URINE CULTURE (Preliminary): KLEBSIELLA PNEUMONIAE. >100,000 ORGANISMS/ML.. Piperacillin/tazobactam sensitivity testing available on request. Cefazolin interpretative criteria are based on a dosage regimen of 2g every 8h. PSEUDOMONAS AERUGINOSA. 10,000-100,000 ORGANISMS/ML.. SENSITIVITIES: MIC expressed in MCG/ML _________________________________________________________ KLEBSIELLA PNEUMONIAE | PSEUDOMONAS AERUGINOSA | | AMPICILLIN/SULBACTAM-- =>32 R CEFAZOLIN------------- =>64 R CEFEPIME-------------- <=1 S 16 I CEFTAZIDIME----------- =>64 R 4 S CEFTRIAXONE----------- 16 R CIPROFLOXACIN--------- =>4 R =>4 R GENTAMICIN------------ <=1 S 8 I MEROPENEM-------------<=0.25 S =>16 R NITROFURANTOIN-------- =>512 R TOBRAMYCIN------------ =>16 R <=1 S TRIMETHOPRIM/SULFA---- <=1 S <MEDICATIONS ON ADMISSION> Tylenol ___ q4h PRN Acetylcysteine 100mg TID Citalopram 20 mg QD Daptomycin 500mg Q 48h Docusate 100mg BID Ferrous Sulfate 325mg QD Lidocaine patch Metoprolol 12.5mg BIDSimethicone 80mg TID Sucralfate 1 Gram TID with meals Fentanyl patch 12 mcg Q 3Days (Last applied ___ Albuterol inhaler 2 puffs Q 6hours Oxycodone 5mg QHS COMPAZINE 5MG q 8 HOURS Psyllium seed 1 tsp TID <DISCHARGE DISPOSITION> Expired Facility: ___ <DISCHARGE DIAGNOSIS> Anemia due to upper GI bleed Bacteremia Urinary tract infection <DISCHARGE CONDITION> Deceased <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> N/A ","___ YOM with MMP most notable of which inclue persistent MRSA bacteremia of unknown source, recurrent MDR UTI's, PNA, chronic renal failure presented with fevers, MRSA bacteremia, UTI and UGIB. . # Brief Hospital course: Patient was initially admitted for infectious w/u due to fevers, and was found to have MRSA bacteremia (chronic, likely ___ seeding of ICD), and Klebsiella/Pseudomonas UTI. These were treated with IV vancomycin and meropenem. He subsequently developed bleeding at his G-tube site as well as increased dark output from ostomy bag. His hct trend was: 30 (___) -> 28 (___) -> 25 (___) -> 22 (___). He was transfused 1 unit pRBC. Hct ___ was 18 and bleeding persisted. GI and surgery were consulted. He was given reglan, and started on ppi iv bid. GI performed 3 EGDs that large amounts of blood and an ulcer with visible vessel around peg insertion site; An initial attempt at clipping the ulcer caused bright red blood, confirming that this was likely the cause of the patient's recent bleed. 10cc of epinephrine were injected around the ulcer. 2 clips were applied around the ulcer with hemostasis successfully achieved. The PEG was removed. Because of his chronic MRSA bacteremia (thought likely ___ ICD seeding), TPN was not an option and family felt that a feeding tube would cause him too much discomfort. The palliative care team was consulted for assistance with the family's decision-making regarding goals of care. The family ultimately felt that his current quality of life was not consistent with what he would have wanted based on remarks he had made in the past. They elected to change his goals of care to comfort-measures only. On HD#9 he passed away with family at bedside. Family declined autopsy. ",2539,405
10004422-DS-19,"<SEX> M <SERVICE> CARDIOTHORACIC <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> elective cardiac catheterization <MAJOR SURGICAL OR INVASIVE PROCEDURE> Coronary artery bypass grafting x4: Left internal mammary artery to left anterior descending artery, and reverse saphenous vein graft to the obtuse marginal artery, and sequential reverse saphenous vein graft to the left posterior descending artery and the left posterior left ventricle branch artery. <HISTORY OF PRESENT ILLNESS> ___ yo M with h/o CAD s/p LAD POBA in ___, DES to RCA in ___ and ___, HTN, HLD, presented for elective cardiac catheterization for unstable angina. Per report, patient had 2 episodes of chest tightness while playing golf in ___. These episodes last about 15 minutes without associated nausea, diaphoresis, or shortness of breath. He was seen by Dr. ___ in ___ and was recommended to have ETT Mibi. Patient had it done at ___ ___. He reports some soreness (but not cramps or pain) in his legs when he climb stairs but not when he walk on flat ground. He denies orthopnea, PND, ___ edema, DOE. Patient had cardiac catheterization today on ___. Patient was given 600 mg Plavix x 1 today. He was found to have 2 vessel disease with 90% stenosis at the ostium of the left main and about 80% stenosis in the RCA. Cardiac surgery was onsulted for surgical revascularization. <PAST MEDICAL HISTORY> 1. CARDIAC RISK FACTORS: - Diabetes, + Dyslipidemia, +Hypertension 2. CARDIAC HISTORY: - CABG: None -PACING/ICD: none - PERCUTANEOUS CORONARY INTERVENTIONS: -- CAD s/p LAD angioplasty/POBA in ___, DES to RCA in ___ and ___ 3. OTHER PAST MEDICAL HISTORY: - Dupuytren's contracture left hand, s/p selective fasciectomy and skin graft ___ <SOCIAL HISTORY> ___ <FAMILY HISTORY> Patient was adopted. <PHYSICAL EXAM> Physical Exam on Admission VS: T98, BP 102/80, HR 58, RR 17, O2Sat 100% RA GENERAL: NAD. Oriented x3. Mood, affect appropriate. HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no pallor or cyanosis of the oral mucosa. No xanthelasma. NECK: Supple without elevated JVP CARDIAC: PMI located in ___ intercostal space, midclavicular line. RR, normal S1, S2. No m/r/g. No thrills, lifts. No S3 or S4. LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp were unlabored, no accessory muscle use. CTAB, no crackles, wheezes or rhonchi. ABDOMEN: Soft, NTND. No HSM or tenderness. Abd aorta not enlarged by palpation. No abdominal bruits. EXTREMITIES: No c/c/e. No femoral bruits bilaterally. Right access site without thrill, mass, oozing. 1+ DP pulses bilaterally SKIN: No stasis dermatitis, ulcers, scars, or xanthomas. <PERTINENT RESULTS> TEE ___ PRE BYPASS No spontaneous echo contrast or thrombus is seen in the body of the left atrium/left atrial appendage or the body of the right atrium/right atrial appendage. No atrial septal defect is seen by 2D or color Doppler. Left ventricular wall thickness, cavity size, and global systolic function are normal (LVEF>55%). Right ventricular chamber size and free wall motion are normal. There are simple atheroma in the aortic arch. There are simple atheroma in the descending thoracic aorta. The aortic valve leaflets (3) are mildly thickened but aortic stenosis is not present. Trace aortic regurgitation is seen. The mitral valve leaflets are mildly thickened. Physiologic mitral regurgitation is seen (within normal limits). There is no pericardial effusion. Just prior to initiation of bypass, inferolateral ST elevations were noted on ECG and TEE revealed dyskinesis of the inferior septum and inferior as well as inferolateral hypokinesis. Dr. ___ was notified in person of the results in the operating room at the time of the study. POST CPB The patient was initially AV paced. There is normal biventricular systolic function. Valvular function is unchanged from the prebypass study. The thoracic aorta is intact after decannulation <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Atenolol 25 mg PO DAILY 2. Vytorin ___ *NF* (ezetimibe-simvastatin) ___ mg Oral daily 3. Lisinopril 10 mg PO DAILY 4. Vitamin D Dose is Unknown PO DAILY 5. Aspirin 325 mg PO DAILY 6. Ascorbic Acid ___ mg PO PRN supplement <DISCHARGE MEDICATIONS> 1. Aspirin EC 81 mg PO DAILY 2. Metoprolol Tartrate 25 mg PO BID RX *metoprolol tartrate 25 mg one tablet(s) by mouth twice a day Disp #*30 Tablet Refills: *2 3. Acetaminophen 650 mg PO Q4H: PRN pain, fever 4. Amiodarone 200 mg PO DAILY RX *amiodarone 200 mg one tablet(s) by mouth daily Disp #*30 Tablet Refills: *2 5. Ascorbic Acid ___ mg PO PRN supplement 6. Vitamin D 400 UNIT PO DAILY 7. Vytorin ___ *NF* (ezetimibe-simvastatin) ___ mg Oral daily <DISCHARGE DISPOSITION> Home With Service Facility: ___ <DISCHARGE DIAGNOSIS> Coronary artery disease. <DISCHARGE CONDITION> Alert and oriented x3 nonfocal Ambulating, gait steady Sternal pain managed with oral analgesics <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Please shower daily including washing incisions gently with mild soap, no baths or swimming, and look at your incisions Please NO lotions, cream, powder, or ointments to incisions Each morning you should weigh yourself and then in the evening take your temperature, these should be written down on the chart No driving for approximately one month until follow up with surgeon No lifting more than 10 pounds for 10 weeks Please call with any questions or concerns ___ Females: Please wear bra to reduce pulling on incision, avoid rubbing on lower edge ","Mr. ___ is a ___ year old man with h/o CAD s/p LAD POBA in ___, DES to RCA in ___ and ___, HTN, HLD, presented for elective cardiac catheterization for unstable angina, found to have left main disease admitted for surgical revascularization. The patient was brought to the operating room on ___ where the patient underwent CABGx4 (___-LAD, ___-OM,___-rPDA-rPLD sequence). Patient was only 3 days off plavix. Overall the patient tolerated the procedure well and post-operatively was transferred to the CVICU in stable condition for recovery and invasive monitoring. He arrived on Neo with increased CT drainage for the firt few hours and received plts, protamine and 2 units of cells. The bleeding resolved. He remained intubated overnight due to hemodynamic instability. He extubated the morning of POD#1. He was found to be alert and oriented x 2 and breathing comfortably. The patient was neurologically intact but mildly confused. He remained hypotensive, requiring volume and a-pacing. Over the next ___ hrs he became more confused he pulled out his central line and chest tubes without incident. He has a history of alcohol use and was placed on CIWA scale. He remained in the unit for several days due to his confusion. He eventully improved and was transferred to the floor. Beta blocker was initiated and the patient was gently diuresed toward the preoperative weight. Pacing wires were discontinued without complication. The patient was evaluated by the physical therapy service for assistance with strength and mobility. On post-op #7 he fell on the floor afterwards he complained of left shoulder pain, but a follow-up radiograph revealed no fracture. By the time of discharge on post-operative day eight the patient was ambulating freely, the wound was healing and pain was controlled with oral analgesics. The patient was discharged to home in good condition with appropriate follow up instructions. ",1550,408
10004606-DS-20,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> seizures, abdominal pain <MAJOR SURGICAL OR INVASIVE PROCEDURE> mechanical intubation <HISTORY OF PRESENT ILLNESS> Ms. ___ is a ___ woman with HTN who presents with seizure. Around ___ on ___, daughter received a text from her cousin that the patient was vomiting. The patien't daughter then got back from work in the morning of ___ when she found her mother sleeping on her R side facing opposite direction. She then did a full turn out of bed and fell on the floor face first. Per the daughter, the patient had positive head strike on the night stand on her way down to the floor. Daughter turned her over and saw pt's bottom jaw retracted and top part of mouth sticking out, eyes open, arms straight out stiffly. Tongue was starting to come out, and pt was ""banging up against the bed."" After ___ min, convulsions stopped, and pt developed heavy breathing/snoring. Her eyes kind of cracked open but she was not responsive to daughter. EMS came and brought her outside, but head was flopping around as they were transporting her. When they got close to ___, pt started to ""come to"" and kept taking off the O2 mask. Seemed to go ""in and out"" of consciousness per daughter. She would get intermittently agitated, pupils were dilated, and she would have episodes of intermittent staring where she did not seem to be registering things. No further shaking. Reportedly got 2mg IV Ativan at ___ and transferred to ___. Once she arrived at ___, the patient was complaining of abdominal pain. CT abd/pelvis showed acute pancreatitis. Patient was then intubated given her agitation and need for diagnostic procedures. LP was completed. Nicardipine gtt was initated at OSH for SBP >220. She is now admitted to the neuro ICU, remains intubated on nicardipine gtt for further workup and management. Of note, about 1mo ago, pt was sitting with daughter's cousin. There was a yell, so daughter went to go find her mother. At that time, pt was sitting up with a ""deer caught in headlights look."" Cousin who witnessed the episode said that she sat upright, then started falling backwards and became stiff. Was shaking. Lasted a few seconds, then came out of it. After the episode, she said she was thirsty and did not remember the episode happening at all. Per son at bedside, she did have a seizure ___ years ago without any clear cause. She was living in ___ alone at that time. She was taking a lot of Klonopin, vicodin, and Percocet along with antidepressants, so unclear if this was a trigger. He does not know any further information about the seizure. Also unclear if she ever had strokes before. She had fallen ___ months ago in ___, but son does not think she had any brain hemorrhages from that. She came back to ___ about 5 months ago to live with her daughter. Since that time, she has only been taking lisinopril. No other pain medications. Patient's daughter denies any further drug use over the past 5 months. <PAST MEDICAL HISTORY> HTN, DVTs -internal bleed from small intestine - tubes tied - plantar wart removed - procedure in groin - colonoscopies <SOCIAL HISTORY> ___ <FAMILY HISTORY> no history of seizures or strokes <PHYSICAL EXAM> ===ADMISSION EXAM=== General: agitated, refusing to participate in exam HEENT: contusions on forehead with a few scrapes ___: tachycardic Pulmonary: breathing comfortably on RA Abdomen: Soft, NT, ND Extremities: Warm, no edema Neurologic Examination: - Mental status: awake, agitated, oriented to ___ and ___. Able to name ""thumb"" and ""watch"" and ""green."" Speech is clear and not dysarthric. No gibberish. - Cranial Nerves: PERRL 6->5mm brisk. BTT bilaterally. Face appears symmetric. Looks around the room fully. Unable to perform more dedicated CN exam ___ pt's agitation - Motor: moves all extremities spontaneously and equally - Reflexes: unable to obtain, pt moving too much and is not relaxing - Sensory: withdraws to light touch in all extremities - Coordination: no ataxia when reaching for bed rails or trying to pull out foley catheter - Gait: unable to assess DISCHARGE EXAM VS: 98.8 PO 100 / 56 53 18 97 RA GENERAL: Pleasant elderly woman, sitting up in bed, appears comfortable in no acute distress. Persistent paranoid delusions. HEENT: Sclerae anicteric, EOMI, moist mucous membranes LUNGS: Clear to auscultation bilaterally, no wheezes, rales, or rhonchi. Good inspiratory effort. HEART: Regular rate and rhythm, normal S1 and S2, no murmurs, rubs, gallops, or thrills ABDOMEN: Normal bowel sounds. Soft, non-distended. Mild improving tenderness and hyperesthesia around lap port incision sites. No organomegaly. No rebound tenderness or guarding. EXTREMITIES: Warm and well perfused. No clubbing, cyanosis, or lower extremity edema. NEURO: A&Ox3, moving all 4 extremities with purpose <PERTINENT RESULTS> ADMISSION LABS ___ 12: 00PM BLOOD WBC-15.7* RBC-5.35* Hgb-16.2* Hct-48.4* MCV-91 MCH-30.3 MCHC-33.5 RDW-13.6 RDWSD-45.3 Plt ___ ___ 12: 00PM BLOOD Neuts-91.3* Lymphs-3.8* Monos-4.1* Eos-0.1* Baso-0.2 Im ___ AbsNeut-14.36* AbsLymp-0.59* AbsMono-0.65 AbsEos-0.01* AbsBaso-0.03 ___ 12: 00PM BLOOD ___ PTT-29.7 ___ ___ 12: 00PM BLOOD Glucose-228* UreaN-13 Creat-1.3* Na-132* K-8.4* Cl-93* HCO3-21* AnGap-18* ___ 06: 30PM BLOOD ALT-523* AST-333* AlkPhos-252* TotBili-1.7* ___ 06: 30PM BLOOD Lipase-1222* ___ 06: 30PM BLOOD Calcium-9.6 Phos-2.7 Mg-1.7 ___ 12: 00PM BLOOD Osmolal-287 ___ 12: 00PM BLOOD TSH-3.5 ___ 12: 00PM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG Bnzodzp-NEG Barbitr-NEG Tricycl-NEG ___ 12: 11PM BLOOD Lactate-3.4* K-4.5 PERTINENT LABS ___ 01: 55PM BLOOD Lactate-1.1 ___ 01: 45PM BLOOD WBC-10.5* RBC-3.25* Hgb-9.8* Hct-30.3* MCV-93 MCH-30.2 MCHC-32.3 RDW-14.4 RDWSD-49.2* Plt ___ ___ 05: 25AM BLOOD WBC-7.0 RBC-3.04* Hgb-9.1* Hct-28.1* MCV-92 MCH-29.9 MCHC-32.4 RDW-14.3 RDWSD-48.3* Plt ___ ___ 04: 45PM BLOOD Glucose-93 UreaN-5* Creat-0.7 Na-139 K-3.6 Cl-100 HCO3-24 AnGap-15 ___ 09: 45AM BLOOD Glucose-144* UreaN-8 Creat-0.9 Na-138 K-3.7 Cl-100 HCO3-22 AnGap-16 ___ 01: 36AM BLOOD ALT-177* AST-50* AlkPhos-110* Amylase-149* TotBili-0.6 ___ 02: 32AM BLOOD ALT-139* AST-38 AlkPhos-131* Amylase-302* TotBili-0.9 ___ 03: 58AM BLOOD Lipase-442* ___ 01: 36AM BLOOD Lipase-67* ___ 02: 32AM BLOOD Lipase-40 DISCHARGE LABS ___ 05: 41AM BLOOD WBC-7.0 RBC-2.81* Hgb-8.7* Hct-26.8* MCV-95 MCH-31.0 MCHC-32.5 RDW-14.0 RDWSD-48.2* Plt ___ ___ 05: 41AM BLOOD Glucose-98 UreaN-7 Creat-0.9 Na-140 K-4.4 Cl-101 HCO3-28 AnGap-11 IMAGING/STUDIES CT A/P: ___- 1. Mild to moderate intra and extrahepatic biliary ductal dilatation with probable calculus in the distal common bile duct indicative of choledocholithiasis. If needed, MRCP can provide further confirmation and assessment. 2. Edematous pancreas with peripancreatic fat stranding and fluid most suggestive of acute interstitial edematous pancreatitis. In the setting of probable choledocholithiasis, constellation of findings likely indicate gallstone pancreatitis. Correlation with serum amylase and lipase levels are recommended. 3. Cholelithiasis. Pericholecystic fluid and stranding may be secondary to pancreatitis. 4. Extensive atherosclerotic disease with severe stenosis of the SMA and right renal artery with resultant atrophy of the right kidney. 5. Bilateral nodular adrenal glands which are incompletely characterized. 6. 0.5 cm pulmonary nodule in the right upper lobe. Please see recommendations section. MRI Brain w/ and w/o: ___: 1. Motion limited exam. 2. No evidence for acute infarction. 3. Nonmasslike FLAIR signal abnormality within the right posteriorperiventricular white matter, with discontiguous foci of cystic encephalomalacia and no evidence for blood products. These may represent sequela of prior infarction, demyelination, infection, or other insult. 4. Small chronic infarcts in the left cerebellar hemisphere. Punctate cortical FLAIR hyperintensity in the right frontal lobe may also represent a chronic infarct. 5. Small area of FLAIR hyperintensity and contrast enhancement in the right occipital cortex, with associated chronic blood products, and with questionable involvement of the adjacent sulci. This may represent a chronic infarct with hemorrhagic transformation or sequela of amyloid angiopathy. 6. Small chronic microhemorrhage in the right posterior internal capsule, most likely hypertensive. 7. 6 mm round structure in the region of the left petroclival confluence, with diagnostic considerations including a cholesterol granuloma, another type of lesion, or an aberrant blood vessel. Partial left mastoid air cell opacification. <DISCHARGE INSTRUCTIONS> DISCHARGE WORKSHEET INSTRUCTIONS: Dear Ms. ___, It was a pleasure caring for you at ___ ___! WHY WERE YOU ADMITTED? You were admitted to the hospital because you had seizures. WHAT HAPPENED IN THE HOSPITAL? Your seizures were controlled with medication. You were found to have abdominal pain caused by inflammation in your gallbladder and pancreas. Your gallbladder was removed and this helped the inflammation. We think that your seizures were caused by the inflammation in your gallbladder and pancreas. You were also found to have hypertension caused by a partial blockage to the artery for your right kidney. You were started on new medications to treat your blood pressure and your blood pressure improved. WHAT SHOULD YOU DO AT HOME? You should continue the new medications for your seizures and blood pressure and follow up with the surgeons and neurologist at your next scheduled appointment. You also have a primary care physician appointment scheduled for you to follow up and establish care. You will have to discuss with the new PCP about cardiologist referral for your peripheral vascular disease that was treated with aspirin, Plavix, and procedures in your lower extremity arteries in ___ last year. As you know, your Plavix was stopped due to GI bleeding that occurred in ___ last year. You need a new cardiologist to continue to manage your antiplatelet agents. Because you had a seizure, please do not drive a car until you are cleared by your Neurologist. Please work on switching your insurance to ___ so that you can continue to get care here. Thank you for allowing us be involved in your care, we wish you all the best! Your ___ Team ","================ PATIENT SUMMARY: ================ ___ year old woman who presented with generalized tonic-clonic seizure in the setting of gallstone pancreatitis who was found to have right side renal artery stenosis. Seizures were controlled with keppra and patient underwent cholecystectomy and patients blood pressure was well controlled with medical management. ============= ACUTE ISSUES: ============= #Generalized tonic clonic seizures: Patient presented after a witnessed generalized tonic-clonic seizures. She presented to the emergency room and seizures were initially controlled with ativan in the emergency room. Neurology followed the patient during this hospitalization for workup of seizures. Patient was found to have gallstone induced pancreatitis which is believed to have caused seizures in a patient with underlying susceptibility given history of CVA. She underwent cholecystectomy. Infectious workup was negative. LP was preformed which was bland. MRI demonstrated existing infarcts, but no evidence of acute infarction or intracranial process. The patient was maintained on Keppra 1500 BID and had no further seizures during hospitalization. Neurology recommends that the patient continue keppra 1500 BID indefinitely until potential modification by outpatient neurology in 6 months. If there is concern for mild encephalopathy and gait unsteadiness, Keppra could be decreased to 1250 mg twice daily prior to follow-up. She was started on atorvastatin and aspirin for primary prevention of CVA. #Renal artery stenosis: Patient was found to have right sided renal artery stenosis on CT during hospitalization. Systolic blood pressure were initially 170 systolic. Her blood pressure was controlled with nicardipine drip. Vascular surgery evaluated the patient and recommended no surgical intervention. She was medically managed with oral antihypertensive regime and blood pressure was successfully controlled to the 100-160s systolic. she should continue lisinopril, amlodapine and labetalol as an outpatient. #Gallstone pancreatitis Patient was found to have choledocolithiasis induced pancreatitis. She underwent cholecystectomy and had an uneventful postoperative course. Pain was well controlled with oral oxycodone in the postoperative period. The patient will follow with acute care surgery two weeks after discharge. =============== CHRONIC ISSUES: =============== #GERD: Home famotidine was continued ==================== TRANSITIONAL ISSUES: ==================== [ ] Please recheck patient blood pressure and adjust blood pressure medications accordingly as an outpatient [ ] Neurology recommends that the patient continue keppra 1500 BID indefinitely until potential modification by outpatient neurology in 6 months. If there is concern for mild encephalopathy and gait unsteadiness, Keppra could be decreased to 1250 mg twice daily prior to follow-up. She was started on atorvastatin and aspirin for primary prevention of CVA. [ ] Follow up with surgery for post-operative check after cholecystectomy [ ] Follow up with new PCP to establish care and also for cardiology referral for her known peripheral vascular disease for which she was on aspirin and Plavix, but were stopped for GI bleeding in ___. [ ] given recent seizure, patient should not drive until cleared by her Neurologist FULL CODE HCP daughter ___ ___ ___ on Admission: The Preadmission Medication list is accurate and complete. 1. Lisinopril 20 mg PO BID 2. Famotidine 20 mg PO BID 3. Acetaminophen 500 mg PO Q12H:PRN Pain - Mild Discharge Medications: 1. amLODIPine 10 mg PO DAILY hypertension RX *amlodipine [Norvasc] 10 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 2. Aspirin 81 mg PO DAILY RX *aspirin 81 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 3. Atorvastatin 40 mg PO QPM RX *atorvastatin 40 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 4. Labetalol 400 mg PO BID Hypertension RX *labetalol 200 mg 2 tablet(s) by mouth twice a day Disp #*60 Tablet Refills:*0 5. LevETIRAcetam 1500 mg PO Q12H RX *levetiracetam 1,000 mg 1.5 tablet(s) by mouth every twelve (12) hours Disp #*90 Tablet Refills:*0 6. OxyCODONE (Immediate Release) 10 mg PO Q4H:PRN Pain - Severe RX *oxycodone 5 mg 1 tablet(s) by mouth every six (6) hours Disp #*8 Tablet Refills:*0 7. Acetaminophen 650 mg PO Q6H:PRN Pain - Mild 8. Lisinopril 40 mg PO DAILY RX *lisinopril 40 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 9. Famotidine 20 mg PO BID Discharge Disposition: Home Discharge Diagnosis: ================= Primary diagnosis ================= Generalized tonic-Clonic Seizures cholecystitis =================== Secondary diagnosis =================== Right Renal Artery Stenosis Hypertension Gallstone Pancreatitis Encephalopathy Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Followup Instructions: ___",2908,1197
10004606-DS-21,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> Weakness <MAJOR SURGICAL OR INVASIVE PROCEDURE> None <HISTORY OF PRESENT ILLNESS> Ms. ___ is a ___ female with past medical history notable for hypertension, prior small intestinal bleed (sounds like distal upper AVM), recent hospitalization for seizures in the setting of gallstone pancreatitis status post cholecystectomy who was discharged on ___ who presents to the hospital with several days of weakness. She reports that initially following discharge she was feeling well. She reports that after several days at home she started to feel increasingly fatigued. She reports that she felt similar to when she was bleeding in ___ and required the upper GI which found a likely AVM. She reports the records from that hospitalization or at ___ in ___. She reports that at that time her bowel movements were normal. She reports that on the evening prior to admission she developed diarrhea with black stools. She reports that this is the exact same happened last time she had the upper GI bleed. She reports that she continue to feel further fatigue. She touch base with her primary care doctor who referred her into the emergency department for further evaluation. She also reports that while at home she had a decreased appetite. Per her daughter she started to look increasingly pale. She became lightheaded and dizzy in the shower on several occasions. She also reports that she had urinary symptoms from around the time she got home. She reports that over the last 6 days she has had increased lower abdominal pain, burning on urination, pressure. She reports that she feels like it got so bad she decreased her p.o. intake to reduce the amount that she would have to urinate. She also reports that she had some blood in the urine. In the emergency department she was seen and evaluated. Her initial vital signs were unremarkable. She was afebrile with a heart rate of 81, blood pressure 157/94, respiratory rate of 18. Her H&H was notable for 11.3/35.3 which is up from her discharge hemoglobin and hematocrit of 8.7/26.8. She had a UA that was checked which unfortunately contained 9 epithelial cells. It did have positive nitrates, large leukocyte esterase, greater than 184 white blood cells as well as few bacteria. She received 1 g of IV ceftriaxone, 2 L of normal saline, and was admitted to the medical service for further evaluation and management. She was also evaluated by the surgery service while in the emergency department he felt like if she had anything was likely a slow GI bleed and would not require acute surgical intervention and would recommend admission to medicine for a GI workup. ROS: Pertinent positives and negatives as noted in the HPI. All other systems were reviewed and are negative. <PAST MEDICAL HISTORY> Gallstone pancreatitis status post cholecystectomy ___ Seizures in the setting of the above gallstone pancreatitis Hypertension due to renal artery stenosis, difficult to control Prior history of upper GI bleed from a likely AVM Prior history of DVT no longer on anticoagulation <SOCIAL HISTORY> ___ <FAMILY HISTORY> ___ and found to be not relevant to this illness/reason for hospitalization. She specifically denies any family history of seizures or strokes. <PHYSICAL EXAM> ADMISSION EXAM -------------- VITALS: 98.4 PO 147 / 72 60 18 100 RA GENERAL: Alert and in no apparent distress, laying in bed EYES: Anicteric, pupils equally round ENT: Ears and nose without visible erythema, masses, or trauma. Oropharynx without visible lesion, erythema or exudate CV: Heart regular, no murmur. No JVD. RESP: Lungs clear to auscultation with good air movement bilaterally. Breathing is non-labored GI: Abdomen soft, non-distended, tender to palpation over the suprapubic region. Laparoscopic cholecystectomy incisions healing well. Bowel sounds present. No HSM. No CVA tenderness GU: No suprapubic fullness but significant tenderness to palpation MSK: Neck supple, moves all extremities, strength grossly full and symmetric bilaterally in all limbs SKIN: No rashes or ulcerations noted NEURO: Alert, oriented, face symmetric, gaze conjugate with EOMI, speech fluent, moves all limbs, sensation to light touch grossly intact throughout PSYCH: pleasant, appropriate affect DISCHARGE EXAM -------------- VS: Reviewed GENERAL: Alert and in no apparent distress, laying in bed EYES: Anicteric, pupils equally round CV: Heart regular, no murmur. RESP: Lungs clear to auscultation with good air movement bilaterally. Breathing is non-labored GI: Abdomen soft, non-distended, tender to palpation over the suprapubic region. Laparoscopic cholecystectomy incisions healing well. Bowel sounds present. GU: No suprapubic fullness but significant tenderness to palpation PSYCH: pleasant, appropriate affect <PERTINENT RESULTS> ADMISSION LABS -------------- ___ 03: 46PM BLOOD WBC-10.6*# RBC-3.78*# Hgb-11.5# Hct-35.3# MCV-93 MCH-30.4 MCHC-32.6 RDW-14.0 RDWSD-47.6* Plt ___ ___ 03: 46PM BLOOD Neuts-71.9* Lymphs-17.5* Monos-6.9 Eos-2.6 Baso-0.7 Im ___ AbsNeut-7.65* AbsLymp-1.86 AbsMono-0.73 AbsEos-0.28 AbsBaso-0.07 ___ 02: 22PM BLOOD Glucose-108* UreaN-12 Creat-1.0 Na-145 K-4.8 Cl-104 HCO3-24 AnGap-17 ___ 02: 22PM BLOOD ALT-18 AST-17 AlkPhos-121* TotBili-0.5 MICROBIOLOGY ------------ ___ 4: 55 pm URINE **FINAL REPORT ___ URINE CULTURE (Final ___: MIXED BACTERIAL FLORA ( >= 3 COLONY TYPES), CONSISTENT WITH SKIN AND/OR GENITAL CONTAMINATION. ESCHERICHIA COLI. >100,000 CFU/mL. PRESUMPTIVE IDENTIFICATION. PREDOMINATING ORGANISM. INTERPRET RESULTS WITH CAUTION. Cefazolin interpretative criteria are based on a dosage regimen of 2g every 8h. SENSITIVITIES: MIC expressed in MCG/ML _________________________________________________________ ESCHERICHIA COLI | AMPICILLIN------------ <=2 S AMPICILLIN/SULBACTAM-- <=2 S CEFAZOLIN------------- <=4 S CEFEPIME-------------- <=1 S CEFTAZIDIME----------- <=1 S CEFTRIAXONE----------- <=1 S CIPROFLOXACIN---------<=0.25 S GENTAMICIN------------ <=1 S MEROPENEM-------------<=0.25 S NITROFURANTOIN-------- <=16 S PIPERACILLIN/TAZO----- <=4 S TOBRAMYCIN------------ <=1 S TRIMETHOPRIM/SULFA---- <=1 S DISCHARGE LABS -------------- ___ 08: 10AM BLOOD WBC-5.6 RBC-2.92* Hgb-8.9* Hct-27.2* MCV-93 MCH-30.5 MCHC-32.7 RDW-13.3 RDWSD-45.4 Plt ___ ___ 08: 10AM BLOOD Glucose-101* UreaN-11 Creat-1.0 Na-142 K-4.6 Cl-101 HCO3-30 AnGap-11 ___ 07: 10AM BLOOD ALT-16 AST-17 AlkPhos-91 TotBili-0.4 ___ 07: 45AM BLOOD Calcium-9.7 Phos-3.8 Mg-1.7 ___ 03: 46PM BLOOD calTIBC-411 Ferritn-___-___ ___ 02: 35PM BLOOD Lactate-1.8 KUB: IMPRESSION: Normal bowel gas pattern. <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. amLODIPine 10 mg PO DAILY hypertension 2. Atorvastatin 40 mg PO QPM 3. LevETIRAcetam 1500 mg PO Q12H 4. Acetaminophen 650 mg PO Q6H: PRN Pain - Mild 5. Lisinopril 40 mg PO DAILY 6. Famotidine 20 mg PO BID 7. Aspirin 81 mg PO DAILY 8. OxyCODONE (Immediate Release) 10 mg PO Q4H: PRN Pain - Severe 9. Labetalol 400 mg PO BID Hypertension <DISCHARGE MEDICATIONS> 1. Docusate Sodium 100 mg PO BID RX *docusate sodium [Colace] 100 mg 1 capsule(s) by mouth twice a day Disp #*30 Capsule Refills: *0 2. Ondansetron 4 mg PO Q8H RX *ondansetron 4 mg 1 tablet(s) by mouth every eight (8) hours Disp #*30 Tablet Refills: *0 3. OxyCODONE (Immediate Release) 10 mg PO Q4H: PRN Pain - Severe RX *oxycodone 5 mg 1 capsule(s) by mouth every eight (8) hours Disp #*6 Capsule Refills: *0 4. Pantoprazole 40 mg PO Q12H RX *pantoprazole 40 mg 1 tablet(s) by mouth twice a day Disp #*60 Tablet Refills: *0 5. Polyethylene Glycol 17 g PO DAILY RX *polyethylene glycol 3350 [Miralax] 17 gram 1 powder(s) by mouth once a day Disp #*30 Packet Refills: *0 6. Acetaminophen 650 mg PO Q6H: PRN Pain - Mild 7. amLODIPine 10 mg PO DAILY hypertension 8. Aspirin 81 mg PO DAILY 9. Atorvastatin 40 mg PO QPM 10. Famotidine 20 mg PO BID 11. Labetalol 400 mg PO BID Hypertension 12. LevETIRAcetam 1500 mg PO Q12H 13. Lisinopril 40 mg PO DAILY <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Urinary tract infection Gastritis/peptic ulcer <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Ms. ___, It was a pleasure caring for you during your recent admission at ___. You came for further evaluation of weakness, pain when urinating and black stools. It is important that you continue to take your medications as prescribed and follow up with the appointments listed below. Please follow up with your PCP ___. Please arrange to have you labs checked. Good luck! ","___ female with past medical history notable for hypertension, prior small intestinal bleed (sounds like distal upper AVM), recent hospitalization for seizures in the setting of gallstone pancreatitis status post cholecystectomy who was discharged on ___ who presents to the hospital with several days of weakness. # Possible upper GI bleed # Gastritis: Patient reported several episodes of black stools, but none during admission. Hemoglobin downtrended over the course of admission. Awaiting records from ___ in ___. GI following patient, but did not plan on EGD/colonoscopy. H. pylori antigen was sent. She was placed on PO pantoprazole, as well as home famotidine and simethicone, given complaints of indigestion, as well as antiemetics. # Urinary tract infection: Patient reported approximately five days of urinary tract symptoms with pain on urination, burning on urination, and suprapubic fullness. Pan-sensitive E.coli on urine specimen, placed on ceftriaxone and switched to ciprofloxacin for 7-day course. She was also placed on three day course of pyridium. # Weakness: suspect related to UTI and possible slow GI bleed, see above. ___ consulted. She progressed and was able to be discharged home. #Constipation Patient noted to constipated likely ___ to opioids and decreased mobility. KUB without obstruction. She received bowel regimen. She had a bowel movement prior to discharge. # HTN due to # RAS: Patient has renal artery stenosis as documented on her prior admission. She has difficult to control blood pressures. She was stabilized on a regimen during her prior hospitalization. Continued home antihypertensive regimen of amlodipine, labetalol, lisinopril. # Seizure Disorder: Patient had generalized tonic-clonic seizure during her prior hospitalization in the setting of her gallstone pancreatitis. She was seen by neurology during her prior hospitalization and is now on antiseizure medication with outpatient follow-up. She was continued on her home Keppra. # GERD: continued on home famotidine and added PO pantoprazole. I updated her son and daughter with the plan of care. TRANSITIONS OF CARE ------------------- # Follow-up: patient will follow up with her PCP. ",2545,483
10004606-DS-23,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> Presyncope, Fall <MAJOR SURGICAL OR INVASIVE PROCEDURE> EGD ___ Capsule endoscopy ___ Colonoscopy ___ <HISTORY OF PRESENT ILLNESS> ___ with history of CVA, seizures, upper GI AVM's with chronic anemia, HTN, presents after presyncopal fall. On ___ she was at home and went to linen closet to grab something. Then felt presyncopal, dizzy, warm feeling, and fell backwards, hitting her head first against a bedroom door which gave way, and then against the floor. No LOC. Daughter came to her aid. She did not want to go to the hospital. The next day she went to ___. CT head and CT C-spine negative for acute bleed or fracture. Today she went to her GI appointment and was referred to ___. Last ___ she reported a seizure episode where her arms were shaking and she was in a daze. This lasted for a few minutes. Consistent with prior seizures episodes. In the ___, initial VS were: - 98.3 77 147/45 19 100% RA - Exam: diffuse mild abd tenderness, scant brown stool in rectal vault +guaiac, - Labs: Hgb 7.4, Creatinine 1.1, Lactate 1.3, urine WBC 35, lg leuk, hazy, few bac - Imaging: CXR clear. CT A/P no acute process. On interview she reports acute on chronic ""soreness"" in neck, back, hips, for which she takes oxycodone at home. Otherwise no acute complaints. REVIEW OF SYSTEMS: +tinnitus; all other positives per HPI otherwise 10 point ROS reviewed and negative except as per HPI <PAST MEDICAL HISTORY> - Hypertension - Renal Artery Stenosis - Seizures - CVA - Gallstone pancreatitis - Iron deficiency anemia - AVM's in stomach and duodenum - Lumbar radiculopathy - Chronic opioid use, with pain contract - Hypothyroidism - Hyperlipidemia - COPD - Neuropathic pain - GERD - DVT <SOCIAL HISTORY> ___ <FAMILY HISTORY> Mother had dementia. Father had asbestosis and mesothelioma. <PHYSICAL EXAM> ADMISSION PHYSICAL -= VS: 98.3 130 / 55 58 18 99 ra GENERAL: NAD HEENT: PERRL, EOMI, no nystagmus, tongue moist NECK: +L carotid bruit HEART: RRR, S1, S2, no murmurs LUNGS: LCAB ABDOMEN: s, lower abdominal tenderness GU: suprapubic tenderness EXTREMITIES: no edema NEURO: A&Ox3, moving all 4 extremities with purpose, RLE weakness DISCHARGE PHYSICAL -= ___ ___ Temp: 97.9 PO BP: 162/62 HR: 56 RR: 18 O2 sat: 97% O2 delivery: Ra GENERAL: NAD, sitting in bed NECK: +bilateral carotid bruits HEART: RRR, S1, S2, no murmurs PULM: CTABL ABDOMEN: soft, mildly distended without tenderness, +BS EXTREMITIES: warm, 1+ ___ pulses bilaterally, no edema NEURO: A&Ox3, no facial asymmetry, moving all 4 extremities with purpose <PERTINENT RESULTS> ADMISSION LABS -= ___ 05: 50PM BLOOD WBC-5.5 RBC-2.49* Hgb-7.4* Hct-22.3* MCV-90 MCH-29.7 MCHC-33.2 RDW-15.3 RDWSD-50.4* Plt ___ ___ 05: 50PM BLOOD Neuts-47.5 ___ Monos-8.9 Eos-7.5* Baso-0.5 Im ___ AbsNeut-2.60 AbsLymp-1.94 AbsMono-0.49 AbsEos-0.41 AbsBaso-0.03 ___ 05: 50PM BLOOD ___ PTT-34.2 ___ ___ 05: 50PM BLOOD Glucose-101* UreaN-12 Creat-1.1 Na-138 K-4.2 Cl-99 HCO3-24 AnGap-15 ___ 05: 50PM BLOOD ALT-14 AST-13 AlkPhos-43 TotBili-0.3 ___ 05: 50PM BLOOD Lipase-22 ___ 05: 50PM BLOOD proBNP-78 ___ 05: 50PM BLOOD cTropnT-<0.01 ___ 05: 50PM BLOOD Albumin-4.8 Calcium-9.6 Phos-3.7 Mg-1.8 PERTINENT INTERVAL LABS -====== ___ 09: 10AM BLOOD Calcium-9.4 Phos-4.1 Mg-1.8 Iron-16* ___ 09: 10AM BLOOD calTIBC-382 VitB12-318 Folate-14 Ferritn-14 TRF-294 ___ 06: 48AM BLOOD TSH-3.6 ___ 06: 48AM BLOOD Free T4-0.9* DISCHARGE LABS -= ___ 05: 35AM BLOOD WBC-5.0 RBC-3.62* Hgb-10.7* Hct-34.0 MCV-94 MCH-29.6 MCHC-31.5* RDW-15.5 RDWSD-53.1* Plt ___ ___ 05: 35AM BLOOD Glucose-91 UreaN-20 Creat-1.1 Na-144 K-4.5 Cl-104 HCO3-24 AnGap-16 ___ 05: 35AM BLOOD Calcium-9.6 Phos-5.0* Mg-2.0 MICROBIOLOGY ============ Urine Culture ___: MIXED BACTERIAL FLORA ( >= 3 COLONY TYPES), CONSISTENT WITH SKIN AND/OR GENITAL CONTAMINATION IMAGING AND STUDIES -== ___ CXR AP upright and lateral views of the chest provided. There is no focal consolidation, effusion, or pneumothorax. The cardiomediastinal silhouette is normal. Imaged osseous structures are intact. No free air below the right hemidiaphragm is seen. ___ CT ABD/PEVLIS W CON 1. Colonic diverticulosis without evidence of diverticulitis. No signs of colitis or bowel obstruction. Normal appendix. 2. Status post cholecystectomy with stable mild prominence of the intrahepatic and extrahepatic biliary tree. 3. Extensive aortoiliac atherosclerotic calcification with stents in the bilateral external iliac arteries which appear patent. 4. Atrophic right kidney. 5. Trace free pelvic fluid, nonspecific. ___ ECHO (TTE) The left atrial volume index is normal. The estimated right atrial pressure is ___ mmHg. Left ventricular wall thickness, cavity size and regional/global systolic function are normal (LVEF >55%). There is no left ventricular outflow obstruction at rest or with Valsalva. There is no ventricular septal defect. Right ventricular chamber size and free wall motion are normal. The aortic valve leaflets (3) are mildly thickened but aortic stenosis is not present. No aortic regurgitation is seen. The mitral valve appears structurally normal with trivial mitral regurgitation. There is no mitral valve prolapse. The estimated pulmonary artery systolic pressure is normal. There is no pericardial effusion. IMPRESSION: Normal biventricular cavity size and global/regional systolic function. No pathological valvular flow identified. No structural cause for syncope identified. ___ CAROTID ULTRASOUND Moderate-to-marked predominantly heterogeneous soft plaque within the bilateral carotid arteries most profound within the mid ICAs, right greater than left, resulting in hemodynamically significant stenosis estimated to be 80-99% bilaterally. ___ EGD Mucosa suggestive of ___ Esophagus Erosion in pylorus Angioectasias in stomach and second part of duodenum (Thermal Therapy applied) Capsule released in duodenum ___ COLONOSCOPY Aborted due to high residue material ___ pMIBI FINDINGS: There was soft tissue attenuation. Left ventricular cavity size is within normal limits. Rest and stress perfusion images reveal uniform tracer uptake throughout the left ventricular myocardium. Gated images reveal normal wall motion. The calculated left ventricular ejection fraction is 71%. IMPRESSION: 1. No evidence of myocardial perfusion defect. 2. Normal left ventricular cavity size with normal systolic function. ___ KUB Endoscopy capsule in the proximal descending colon. ___ KUB Endoscopy pill capsule has migrated since ___, now possibly in the sigmoid colon. <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. amLODIPine 10 mg PO DAILY hypertension 2. Atorvastatin 40 mg PO QPM 3. LevETIRAcetam 1500 mg PO Q12H 4. Lisinopril 40 mg PO DAILY 5. Simethicone 40-80 mg PO QID: PRN abd pain 6. Famotidine 20 mg PO BID 7. Ondansetron 4 mg PO Q8H: PRN nausea 8. Pantoprazole 40 mg PO Q12H 9. Aspirin 81 mg PO DAILY 10. Ferrous Sulfate 325 mg PO BID 11. Ascorbic Acid ___ mg PO BID 12. OxyCODONE (Immediate Release) 5 mg PO Q12H: PRN BREAKTHROUGH PAIN 13. Labetalol 200 mg PO BID 14. Gabapentin 300 mg PO TID The Preadmission Medication list is accurate and complete. 1. amLODIPine 10 mg PO DAILY hypertension 2. Atorvastatin 40 mg PO QPM 3. LevETIRAcetam 1500 mg PO Q12H 4. Lisinopril 40 mg PO DAILY 5. Simethicone 40-80 mg PO QID: PRN abd pain 6. Famotidine 20 mg PO BID 7. Ondansetron 4 mg PO Q8H: PRN nausea 8. Pantoprazole 40 mg PO Q12H 9. Aspirin 81 mg PO DAILY 10. Ferrous Sulfate 325 mg PO BID 11. Ascorbic Acid ___ mg PO BID 12. OxyCODONE (Immediate Release) 5 mg PO Q12H: PRN BREAKTHROUGH PAIN 13. Labetalol 200 mg PO BID 14. Gabapentin 300 mg PO TID <DISCHARGE MEDICATIONS> 1. Bisacodyl 10 mg PO/PR DAILY: PRN constipation RX *bisacodyl 5 mg 2 tablet(s) by mouth daily Disp #*30 Tablet Refills: *0 2. Chlorthalidone 12.5 mg PO DAILY RX *chlorthalidone 25 mg 0.5 (One half) tablet(s) by mouth daily Disp #*30 Tablet Refills: *0 3. Docusate Sodium 100 mg PO BID constipation RX *docusate sodium 100 mg 1 capsule(s) by mouth twice daily Disp #*30 Capsule Refills: *0 4. Multivitamins W/minerals 1 TAB PO DAILY RX *multivitamin,tx-minerals 1 tablet(s) by mouth once a day Disp #*30 Tablet Refills: *0 5. Polyethylene Glycol 17 g PO DAILY constipation RX *polyethylene glycol 3350 [PEG___] 17 gram/dose 17 g by mouth daily Refills: *0 6. Senna 8.6 mg PO BID RX *sennosides [senna] 8.6 mg 1 by mouth twice a day Disp #*30 Tablet Refills: *0 7. Atorvastatin 80 mg PO QPM RX *atorvastatin 80 mg 1 tablet(s) by mouth at nightime Disp #*30 Tablet Refills: *0 8. amLODIPine 10 mg PO DAILY hypertension 9. Ascorbic Acid ___ mg PO BID 10. Aspirin 81 mg PO DAILY 11. Famotidine 20 mg PO BID 12. Ferrous Sulfate 325 mg PO BID 13. Gabapentin 300 mg PO TID 14. LevETIRAcetam 1500 mg PO Q12H 15. Lisinopril 40 mg PO DAILY 16. Ondansetron 4 mg PO Q8H: PRN nausea 17. OxyCODONE (Immediate Release) 5 mg PO Q12H: PRN BREAKTHROUGH PAIN 18. Pantoprazole 40 mg PO Q12H 19. Simethicone 40-80 mg PO QID: PRN abd pain 20.Rolling Walker Please provide rolling walker. Dx: Seizure Disorder (ICD-9: 780.39) Prognosis: Good ___: 13 Months <DISCHARGE DISPOSITION> Home With Service Facility: ___ <DISCHARGE DIAGNOSIS> Primary Diagnoses - Acute on chronic upper GI bleed Severe, bilateral coronary artery stenosis Seizure disorder Orthostatic hypotension Secondary Diagnoses -== Bipolar Disorder Hepatitis B <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear ___, ___ was a pleasure taking care of you in the hospital. WHY DID YOU COME TO THE HOSPITAL? -You felt lightheaded and suffered a fall WHAT HAPPENED TO YOU DURING YOUR HOSPITAL STAY? -You were given blood to increase your blood counts -Your bloody bowel movements were evaluated and treated by the gastroenterologists -You were evaluated for seizures by the neurologists and was started on a medication to prevent seizures -You were found to have severe blockages in both arteries supplying blood to brain and need to follow-up with the vascular surgeons in vascular surgery clinic to discuss surgical correction of these blockages -Your heart was evaluated by the cardiologists who do not recommend any further testing at this time WHAT SHOULD YOU DO WHEN YOU LEAVE THE HOSPITAL? please take all of your medications as prescribed, details below Please keep all of your appointments as scheduled -Please keep track of whether you have passed the capsule in your bowel movement. If you have not passed the capsule in 2 days since discharge, you should be seen in clinic by your PCP. Please call your PCP right away if you have any symptoms such as constipation, vomiting, anorexia, and if you are not passing any gas. We wish you the very best! Your ___ Care Team ","___ with history of CVA, seizures, upper GI AVM's with chronic anemia, HTN, peripheral vasculopathy, who presented after presyncopal fall. ACUTE ISSUES ============ # Acute on Chronic Blood Loss Anemia # Upper GI Bleed Presented with ongoing intermittent melena and known gastric and duodenal AVMs per prior EGD's s/p single balloon enteroscopy with APC to small bowel AVMs. Stool guaiac positive in ___. Required 2u pRBCs during her hospitalization. EGD showed several duodenal/gastric AVMs that were cauterized, as well as likely ___ esophagus. Patient was iron deficient and was given 2 125mg IV infusions of ferric gluconate. Patient was continued on PPI prophylaxis. # Seizures Patient reported that her last seizure 1 week prior to admission and involved extremity shaking and AMS that lasted several minutes, consistent with previous episodes. Neurology was consulted for optimization of her AEDs. EEG was performed and the patient was continued on Keppra with plans for outpatient followup in neurology clinic. She had no seizures in house. # Severe, Bilateral Carotid Artery Stenosis Carotid US done as part of pre-syncope work-up revealed severe bilateral carotid artery stenosis (80-99%). She was seen by vascular surgery in house, who recommended no urgent treatment. This could certainly contribute to pre-syncope, however vascular surgery will followup with patient for CEA consideration. # Presyncope Presented 4 days after presyncopal episode at home with fall and head trauma. CT head and c-spine were negative at OSH. Signs and symptoms not consistent with prior seizures. Initial ddx included CNS process (TIA, carotid stenosis), cardiac (had old RBBB on EKG, and new LBBB on this admission), orthostasis (had previously documented orthostatic hypotension), vasovagal event, peripheral vertigo (has tinnitus), or symptomatic anemia. # Concern for Cardiac Conduction Disease Noted patient has HRs usually in ___, even when standing and lightheaded. There was concern that she was not adequately augmenting her cardiac output with exertion due to conduction disease and this blunted response was contributing to her pre-syncope. Also noted to initially have RBBB on EKG, but then LBBB on EKG done later in the same day (in ___ on presentation). Unusual and concerning for conduction disease, so cardiology was consulted and beta-blocker (home med) was held. pMIBI revealed no overt ischemia and ambulatory telemetry revealed that patients heart rates increased to ___. Cardiology felt that this was an appropriate response and the patient did not require further electrophysiologic evaluation during this hospitalization. # Hypertension Patient has history of hypertension (renal artery stenosis) with orthostatic hypotension. Antihypertensives were held in the setting of GI bleed but were restarted once her GI bleed was addressed. She was continued on home doses of blood pressure medications and was also started on chlorthalidone 12.5mg daily for better control. # Chronic Back and Neck Pain Has narcotics contract w PCP for oxycodone 5mg BID since ___. Review of MassPMP indicates pt also prescribed vicodin in OSH ___ three days prior to presentation. Likely that pain is exacerbated by recent fall, so increased pain regimen while in-house. CHRONIC ISSUES ============== # Neuropathic pain: continued gabapentin 300mg TID. # GERD: continued PPI and famotidine. # Chronic nausea: continued ondansetron PRN. TRANSITIONAL ISSUES =================== []Ensure passage of capsule, on discharge KUB ___ noted to be in sigmoid colon/rectum. Consider repeat KUB to assess if concerned. Per GI, very unlikely to cause obstruction once in colon. []Labetalol/Beta-Blockade: Recommend avoiding all beta-blockade given heart rates in the ___. Patient's labetalol was discontinued to avoid negative chronotrope effect []Chlorthalidone: titrate dose as needed for adequate blood pressure control []ASA 81: discharged on ASA 81 given stroke risk in the setting of severe carotid disease, if GI bleed recurs, risk/benefit should be discussed with patient (okay to hold per inpatient cardiology recommendations but neurology would recommend continuing) []Atorvastatin: increased to 80mg (although less data in secondary prevention) due to severe vascular disease ___ esophagus: Noted on EGD. Will have follow up endoscopy with plan for biopsy in ___ []Labs: Repeat CBC at clinic visit to ensure stability, discharge Hgb 9.9 []Vascular Followup: Has appointment with Dr. ___ ___ for CEA evaluation []Neurology Followup: Has appointment for further management of anti-seizure medications # Contact/HCP: ___ (daughter) ___ # Code status: Full, presumed ",3416,1081
10004638-DS-20,"<SEX> F <SERVICE> OBSTETRICS/GYNECOLOGY <ALLERGIES> Phenothiazines / Epinephrine / ppi / Nitrous Oxide <ATTENDING> ___ <CHIEF COMPLAINT> urinary frequency and urgency <MAJOR SURGICAL OR INVASIVE PROCEDURE> robotic sacrocolpopexy Tension free vaginal tape Cystoscopy <HISTORY OF PRESENT ILLNESS> Ms. ___ presented for evaluation of urinary complaints and after review of records and cystocopy was diagnosed with a stage III cystocele and stage I vaginal prolapse, both of which were symptomatic. She also had severe vaginal atrophy despite being on Vagifem. Treatment options were reviewed for prolapse including no treatment, pessary, and surgery. She elected for surgical repair. All risks and benefits were reviewed with the patient and consent forms were signed. <PAST MEDICAL HISTORY> PAST MEDICAL HISTORY: 1. Breast cancer survivor, diagnosed in ___, status post mastectomy, chemotherapy, and tamoxifen treatment. 2. Anxiety. 3. Arthritis. 4. Acid reflux. 5. Low back pain. 6. Osteopenia. 7. Vaginal prolapse. PAST SURGICAL HISTORY: 1. Modified radical mastectomy with reconstruction in ___. 2. Vaginal hysterectomy and bilateral salpingo-oophorectomy in ___ for prolapse, Dr. ___ at ___. PAST OB HISTORY: Twelve number of pregnancies, three number of vaginal deliveries, two number of living children, two number of miscarriages, birth weight of largest baby delivered vaginally 7 pounds 2 ounces, positive for forceps-assisted vaginal delivery, negative for vacuum-assisted vaginal delivery. Menopause: Surgical menopause in ___. <SOCIAL HISTORY> ___ <FAMILY HISTORY> Mother, heart disease and mitral valve prolapse; father, esophageal cancer; maternal grandfather, asthma; paternal grandmother, stomach cancer. <PHYSICAL EXAM> On postoperative check: VS 97.6 106/70 72 18 100% on 1.5L NC OR/PACU I/O 100PO + 2550 IVF / 420UOP + EBL 100 A+O, NARD RRR, CTAB Abd soft, obese, no TTP, +BS, no R/G Robot port sites with surrounding ecchymosis (all ~2cm in diameter) Dermabond intact, well approximated without erythema/exudate Pad with minimal VB Foley with CYU Ext NT, pboots on <PERTINENT RESULTS> ___ 07: 32AM BLOOD WBC-5.3 RBC-3.73* Hgb-10.9* Hct-33.1* MCV-89 MCH-29.1 MCHC-32.8 RDW-13.0 Plt ___ <MEDICATIONS ON ADMISSION> clonazepam 0.5 TID prn, ibandronate 150 q month, naratriptan 2.5 prn h/a, simvastatin 40', sucralfate 1g TID, ASA (held), vagifem, vitamins allergies: phenothyazides, compazine (anaphy) <DISCHARGE MEDICATIONS> 1. clonazepam 0.5 mg Tablet Sig: One (1) Tablet PO TID (3 times a day) as needed for pt request. 2. simvastatin 40 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 3. sucralfate 1 gram Tablet Sig: One (1) Tablet PO TID (3 times a day). 4. ibuprofen 600 mg Tablet Sig: One (1) Tablet PO Q6H (every 6 hours) as needed for pain. Disp: *40 Tablet(s)* Refills: *0* 5. oxycodone-acetaminophen ___ mg Tablet Sig: ___ Tablets PO Q6H (every 6 hours) as needed for pain: do not exceed 12 tabs in any 24 hr period. do not take if dizzy or lightheaded. Disp: *20 Tablet(s)* Refills: *0* 6. acetaminophen 500 mg Tablet Sig: ___ Tablets PO Q6H (every 6 hours) as needed for pain or pt request. 7. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day) as needed for constipation. Disp: *60 Capsule(s)* Refills: *0* <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> pelvic organ prolapse stress urinary incontinence <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> - Please call your doctor if you experience fever > 100.4, chills, nausea and vomiting, worsening or severe abdominal pain, heavy vaginal bleeding, chest pain, trouble breathing, or if you have any other questions or concerns. - Please call if you have redness and warmth around the incisions, if your incisions are draining pus-like or foul smelling discharge, or if your incisions reopen. - No driving while taking narcotic pain medication as it can make you drowsy. - No heavy lifting or strenuous exercise for 6 weeks to allow your incision to heal adequately. - Nothing per vagina (no tampons, intercourse, douching for 6 weeks. - Please keep your follow-up appointments as outlined below. ","Ms. ___ underwent an uncomplicated robotic sacrocolpopexy, TVT, and cystoscopy for stage 3 pelvic organ prolapse and stress urinary incontinence; please see the operative report for full details. Her postoperative course was uncomplicated. She was discharged on postoperative day 1 in good condition after passing her trial of void and meeting all postoperative milestones. ",1227,80
10004638-DS-21,"<SEX> F <SERVICE> OBSTETRICS/GYNECOLOGY <ALLERGIES> Phenothiazines / Epinephrine / ppi / Nitrous Oxide / Benadryl / Protonix <ATTENDING> ___ <CHIEF COMPLAINT> rectocele <MAJOR SURGICAL OR INVASIVE PROCEDURE> posterior repair <HISTORY OF PRESENT ILLNESS> She is a ___ patient who presents with ___ rectocele after having a sacral colpopexy and supracervical hysterectomy in ___ for uterine prolapse and cystocele. At that time, she had no rectocele at all. She has symptoms of bulge and pressure in the vagina that has gotten worse over the past few months. She also complains of feeling of incomplete emptying. She states that after she goes to the bathroom, she could go back and urinate some more. She had some frequency, urgency symptoms, which had resolved postoperatively. She also has resolved diarrhea after being started on Zenpep. She is followed by Dr. ___ and her fecal incontinence has resolved as well as resolved diarrhea. <PAST MEDICAL HISTORY> <PAST MEDICAL HISTORY> She is a breast cancer survivor, anxiety, arthritis, acid reflux, low back pain, and osteopenia. Past Surgical History: Modified radical mastectomy with reconstruction in ___, vaginal hysterectomy, BSO in ___ for prolapse, Dr. ___ lysis of adhesions, ___ sacral colpopexy, cystoscopy, and TVT in ___. Past OB History: She has had three vaginal deliveries. <SOCIAL HISTORY> ___ <FAMILY HISTORY> <FAMILY HISTORY> Positive for heart disease. Mitral valve prolapse in the mother. Father with esophageal cancer. <PHYSICAL EXAM> On admission: General: Well developed, well groomed, thin. Psych: Oriented x3, affect is normal. Skin: Warm and dry. Heart: No peripheral edema or varicosities. Lungs: Normal respiratory effort. Abdomen: Soft, nontender, not distended. No masses, guarding, or rebound. No hernias. Genitourinary: Vulva: Normal hair pattern, no lesions. Urethral Meatus: No caruncle, no prolapse. Urethral meatus nontender, no masses or exudate. Bladder: Moderately atrophic. She is on vaginal estrogen with Vagifem in particular. Caliber and resting tone are normal. There is a stage III rectocele. The anterior wall and apex were extremely well supported. The bladder is nonpalpable and nontender. Cervix is absent as of the uterus and adnexa. No masses in the anus or perineum. <PERTINENT RESULTS> No labs during this hospitalization. <MEDICATIONS ON ADMISSION> BETAMETHASONE DIPROPIONATE - 0.05 % Cream - apply to affected area(s) daily as directed CLONAZEPAM - 0.5 mg Tablet - 1 (One) Tablet(s) by mouth three times a day as needed for prn ESTRADIOL [VAGIFEM] - 10 mcg Tablet - 2 twice per week for maintenence IBANDRONATE [BONIVA] - 150 mg Tablet - 1 Tablet(s) by mouth every month LIPASE-PROTEASE-AMYLASE [ZENPEP] - 20,000 unit-68,000 unit-109,000 unit Capsule, Delayed Release(E.C.) - 2 Capsule(s) by mouth with meals one with snacks SIMVASTATIN - 40 mg Tablet - 1 Tablet(s) by mouth once a day SUCRALFATE - 1 gram Tablet - 1 Tablet(s) by mouth up to four times per day SUMATRIPTAN SUCCINATE - 100 mg Tablet - 1 Tablet(s) by mouth first sign of headahce can repeat in two hours if needed ASPIRIN - (Prescribed by Other Provider) - 81 mg Tablet, Chewable - 1 (One) Tablet(s) by mouth once a day CALCIUM CARBONATE-VITAMIN D3 [CALTRATE-600 PLUS VITAMIN D3] GLUCOSAMINE ___ 2KCL-CHONDROIT [GLUCOSAMINE SULF-CHONDROITIN] MICONAZOLE NITRATE - (BID TO AFFECTED AREA) MULTI VIT W MN-FA-LYCO-LUT-ALA <DISCHARGE MEDICATIONS> 1. Clonazepam 0.5 mg PO TID: PRN anxiety 2. Ibuprofen 600 mg PO Q6H: PRN Pain RX *ibuprofen 600 mg 1 tablet(s) by mouth q8 hours Disp #*30 Tablet Refills: *2 3. Sucralfate 1 gm PO TID 4. Zenpep *NF* (lipase-protease-amylase) 20,000-68,000 -109,000 unit Oral with meals Reason for Ordering: Wish to maintain preadmission medication while hospitalized, as there is no acceptable substitute drug product available on formulary. 2 tab with meals 5. Simvastatin 40 mg PO DAILY <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> rectocele <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> General instructions: * Take your medications as prescribed. * Do not drive while taking narcotics. * Take a stool softener such as colace while taking narcotics to prevent constipation * Do not combine narcotic and sedative medications or alcohol * Do not take more than 4000mg acetaminophen (APAP) in 24 hrs * No strenuous activity until your post-op appointment * Nothing in the vagina (no tampons, no douching, no sex), no heavy lifting of objects >10lbs for 6 weeks. * You may eat a regular diet Call your doctor for: * fever > 100.4 * severe abdominal pain * difficulty urinating * vaginal bleeding requiring >1 pad/hr * abnormal vaginal discharge * redness or drainage from incision * nausea/vomiting where you are unable to keep down fluids/food or your medication To reach medical records to get the records from this hospitalization sent to your doctor at home, call ___. ","Ms ___ underwent an uncomplicated posterior repair for stage III rectocele; see operative report for details. She had an uncomplicated recovery and was discharged home on postoperative day #1 in good condition: ambulating and urinating without difficulty, tolerating a regular diet, and with adequate pain control using PO medication. ",1413,65
10004648-DS-13,"<SEX> F <SERVICE> OBSTETRICS/GYNECOLOGY <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> presumed ectopic pregnancy <MAJOR SURGICAL OR INVASIVE PROCEDURE> none <HISTORY OF PRESENT ILLNESS> ___ G1 with LMP ___ with presumed ectopic (never seen on ultrasound) presents to ED with severe abdominal pain after treatment with MTX on ___. She was having some mild abdominal pain responsive to Tylenol but this morning her pain became ___ and unresponsive to Tylenol. She describes the pain as located across her low abdomen, left > right. It was ""unbearable"" and she had trouble walking although wasn't lightheaded, just overwhelmed with pain. In the ambulance ride, she received 50mcg fentanyl and 4mg zofran IV. Her pain is now ___. She also notes vaginal bleeding, ~3 pads per day. No clots. ___ TVUS (prelim): Focal thickening of the endometrium, portion with vascular flow -> consistent with ongoing SAB. Cystic structure in left ovary most likely corpus luteum. <PAST MEDICAL HISTORY> PGynHx: Notes severe dysmenorrhea, normally takes Aleve. Previously on OCPs. PMHx: denies PSHx: denies <SOCIAL HISTORY> ___ <FAMILY HISTORY> NC <PHYSICAL EXAM> VS on arrival: 97.4 58 106/55 100% RA General: NAD Cardiac: RRR Pulm: CTA Abdomen: Soft, no focal tenderness with NO rebound or guarding. +BS Bimanual: Mildly enlarged AV uterus without tenderness or CMT. Some left adnexal fullness without discrete tenderness (pt notes diffuse ""tenderness"") Ext: NT, NE Labs: HCG 1845 CBC 7.8>41.7<221 Blood type O+ <PERTINENT RESULTS> ___ 11: 57AM BLOOD WBC-7.8# RBC-4.77 Hgb-13.3 Hct-41.7 MCV-88 MCH-27.9 MCHC-31.9 RDW-14.0 Plt ___ ___ 11: 57AM BLOOD ___ PTT-28.0 ___ ___ 11: 57AM BLOOD Glucose-87 UreaN-11 Creat-0.8 Na-136 K-4.4 Cl-105 HCO3-25 AnGap-10 ___ 11: 57AM BLOOD Mg-2.0 ___ 11: 57AM BLOOD HCG-1845 <MEDICATIONS ON ADMISSION> none <DISCHARGE MEDICATIONS> 1. Percocet 7.5-325 mg Tablet Sig: ___ Tablets PO every ___ hours. Disp: *30 Tablet(s)* Refills: *0* <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> PRESUMED ECTOPIC PREGNANCY <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Ms. ___, You were admitted with abdominal pain in the setting of suspected ectopic pregnancy. This was thought to be due to either ongoing miscarriage or aborting tubal ectopic. There was no evidence of a ruptured ectopic pregnancy. To reach medical records to get the records from this hospitalization sent to your doctor at home, call ___. Call your doctor for: * fever > 100.4 * severe abdominal pain * difficulty urinating * vaginal bleeding requiring >1 pad/hr * abnormal vaginal discharge * nausea/vomiting where you are unable to keep down fluids/food or your medication ","Ms. ___ is a ___ year old G1 with LMP at end of ___ and a presumed ectopic who presents with severe abdominal pain after methotrexate administration. On arrival in the ED, she was hemodynamically stable with a hematocrit of 41 and benign abdominal exam. Ultrasound showed a small amount of material in the lower uterine segment, no adenxal masses or free fluid. She was admitted for observation in the absence of any signs of ruptured ectopic. She did well overnight, only requiring tylenol for analgesia. She remained hemodynamically stable without change in abdominal exam. She was discharged to home on HD 2 in good condition. ",838,143
10004719-DS-15,"<SEX> F <SERVICE> SURGERY <ALLERGIES> Percocet <ATTENDING> ___. <CHIEF COMPLAINT> Right leg/foot pain <MAJOR SURGICAL OR INVASIVE PROCEDURE> ___ Right lower extremity angiogram, angioJet mechanical thrombectomy of occluded bypass graft, balloon angioplasty of outflow stenosis. ___ Right lower extremity angiogram, angioJet mechanical thrombectomy of occluded bypass graft, balloon angioplasty of outflow stenosis. <HISTORY OF PRESENT ILLNESS> ___ w Rt AK pop to ___ bypass with NRGSV for a thrombosed popliteal aneurysm in ___ present with worsening new onset right foot claudication. <PAST MEDICAL HISTORY> PMH: DVT R pop v (___), asthma, Rt pop artery thrombus with negative hypercoagulable workup PSH: Rt AK pop to ___ bypass with NRGSV ___ <PHYSICAL EXAM> <PHYSICAL EXAM> Alert and oriented x 3 VS: BP 104/54 HR 72 RR 16 Resp: Lungs clear Abd: Soft, non tender Ext: Pulses: palp throughout. Feet warm, well perfused. No open areas Left groin puncture site: Dressing clean dry and intact. Soft, no hematoma or ecchymosis. <PERTINENT RESULTS> ___ 05: 45AM BLOOD WBC-9.0 RBC-3.91 Hgb-11.5 Hct-34.2 MCV-88 MCH-29.4 MCHC-33.6 RDW-12.9 RDWSD-40.8 Plt ___ ___ 05: 45AM BLOOD Plt ___ ___ 05: 45AM BLOOD Glucose-108* UreaN-10 Creat-0.8 Na-141 K-3.7 Cl-107 HCO3-26 AnGap-12 ___ 05: 45AM BLOOD Calcium-9.2 Phos-3.1 Mg-2.0 Arterial Duplex: Findings. Doppler evaluation was performed of both lower extremity arterial systems at rest. On the right the tibial waveforms are monophasic and there is no audible Waveforms are flat. The left all waveforms are triphasic. The ankle-brachial index is 1.3. Impression severe ischemia right lower extremity <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Clobetasol Propionate 0.05% Soln 1 Appl TP BID 2. Fluocinolone Acetonide 0.01% Solution 1 Appl TP Q24H PRN 3. metroNIDAZOLE 0.75 topical BID 4. ALPRAZolam 0.5 mg PO TID: PRN anxiety 5. Lovastatin 10 mg ORAL DAILY 6. Montelukast 10 mg PO DAILY 7. Fluticasone-Salmeterol Diskus (500/50) 2 INH IH DAILY 8. Pantoprazole 40 mg PO Q24H 9. Aspirin 81 mg PO DAILY 10. Loratadine 10 mg PO BID <DISCHARGE MEDICATIONS> 1. Rivaroxaban 15 mg PO/NG BID FOR THE NEXT 3 WEEKS ONLY. RX *rivaroxaban [___] 15 mg 1 tablet(s) by mouth twice daily Disp #*42 Tablet Refills: *0 2. Clopidogrel 75 mg PO DAILY For the next ___ days. RX *clopidogrel 75 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills: *0 3. metroNIDAZOLE 0.75 topical BID 4. Fluocinolone Acetonide 0.01% Solution 1 Appl TP Q24H PRN 5. Clobetasol Propionate 0.05% Soln 1 Appl TP BID 6. ALPRAZolam 0.5 mg PO TID: PRN anxiety 7. Aspirin 81 mg PO DAILY 8. Fluticasone-Salmeterol Diskus (500/50) 2 INH IH DAILY 9. Loratadine 10 mg PO BID 10. Montelukast 10 mg PO DAILY 11. Pantoprazole 40 mg PO Q24H 12. Rivaroxaban 20 mg PO DAILY Start ___ after loading dose of 15 mg twice daily. RX *rivaroxaban [___] 20 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills: *3 13. Lovastatin 10 mg ORAL DAILY <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Peripheral Arterial Disease Right Posterior Tibial Deep Vein Thrombosis <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Ms. ___, It was a pleasure taking care of you at ___ ___. You were admitted to the hospital with right leg pain that we found was secondary to a blockage in your bypass graft. We also noted a clot in a vein in your calf. We did a peripheral angiogram to open up the graft with special catheter and balloons. To do the procedure, a small puncture was made in one of your arteries. The puncture site heals on its own: there are no stitches to remove. You tolerated the procedure well and are now ready to be discharged from the hospital. Please follow the recommendations below to ensure a speedy and uneventful recovery. Peripheral Angiography Puncture Site Care For one week: -Do not take a tub bath, go swimming or use a Jacuzzi or hot tub. -Use only mild soap and water to gently clean the area around the puncture site. -Gently pat the puncture site dry after showering. -Do not use powders, lotions, or ointments in the area of the puncture site. You may remove the bandage and shower the day after the procedure. You may leave the bandage off. You may have a small bruise around the puncture site. This is normal and will go away one-two weeks. Activity For the first 48 hours: -Do not drive for 48 hours after the procedure For the first week: -Do not lift, push , pull or carry anything heavier than 10 pounds -Do not do any exercises or activity that causes you to hold your breath or bear down with abdominal muscles. Take care not to put strain on your abdominal muscles when coughing, sneezing, or moving your bowels. After one week: -You may go back to all your regular activities, including sexual activity. We suggest you begin your exercise program at half of your usual routine for the first few days. You may then gradually work back to your full routine. Medications: Before you leave the hospital, you will be given a list of all the medicine you should take at home. If a medication that you normally take is not on the list or a medication that you do not take is on the list please discuss it with the team! ","___ sp Rt AK pop to ___ bypass with NRGSV ___ for arterial thrombosis presents with worsening right leg pain that occurred over predictable distances and acute change over past 24 hours with fullness in her right leg. Her motor and sensation are intact with no signs of limb threat. A heparin infusion was started. Arterial duplex showed occluded right popliteal to posterior tibial artery bypass. She was taken to the OR for right lower extremity angiogram, angioJet mechanical thrombectomy of occluded bypass graft, balloon angioplasty of outflow stenosis. A tpa catheter was left in place overnight. She return the next day for right lower extremity angiogram, angioJet mechanical thrombectomy of occluded bypass graft and balloon angioplasty of outflow stenosis. At that session, we were able to remove residual thrombus in the native right popliteal artery and bypass with good outflow to the foot via the anterior tibial, and peroneal arteries. At this point she was pain free with a palpable graft AT and DP pulse. The next morning, we discontinued the heparin infusion and started xarelto. She was ambulatory ad lib, voiding qs and tolerating a regular diet. She was discharged to home. We will see her again in followup in one month with surveillance duplex. ",1597,286
10004720-DS-11,"<SEX> M <SERVICE> MEDICINE <ALLERGIES> Penicillins / Haldol <ATTENDING> ___ ___ Complaint: s/p cardiac arrest <MAJOR SURGICAL OR INVASIVE PROCEDURE> chest thoracostomy tube placement intubation central venous catheter placement <HISTORY OF PRESENT ILLNESS> ___ with PMHx significant for schizophrenia, hypertension and anemia who p/w from nursing home with cardiac arrest. Per EMS, he choked while sitting in his chair eating, found slumped over in chair without e/o trauma, turned blue. Found cyanotic without pulses. Heimelich productive of large food bolus. ROSC ___ s/p CPR and epi x2 and intubated w/ IO placed. In ___, became bradycardic transitioning to Asystole 1330. Given Epi, further CPR, obtained ROSC. His SBP of ___, started on levo. In ED initial VS: T 34.9 HR 83 BP 111/63 RR 14 100% ra Exam: Tube in place, some secretions suctioned, No e/o trauma or prolonged down time, Psoriatic plaques, 2mm minimally responsive pupils, Unresponsive, No spontaneous limb movements Labs were notable for: wbc 16.1, hgb 12.4, plt 635, Na 134, K 4.2, cr 0.3, TnT 0.47, AP 164, normal ALT/AST, INR 1.4, ABG ___, lactate 2.6->1.3 Imaging notable for: NCCTH w/o hemorrhage, CXR w/ possible LLL PNA. EKG 88 NS NA No STTW changes concerning for ischemia Patient was given: RIJ placed, given rocuronium 80 mg, norepinephrine gtt, midazolam gtt, fentanyl gtt Consults: Post-arrest response team recommended TTM at 35 degrees for 24 hours w/ EEG in ICU. TTM was initiated. He developed a CTX after the RIJ was placed that required chest tube placement. VS prior to transfer: T 34.9 HR 87 BP 137/76 RR 20 99% RA On arrival to the MICU: Patient is intubated and sedated, chest tube in place. <PAST MEDICAL HISTORY> Basal cell carcinoma Schizophrenia Anemia Cataracts Constipation Hyponatremia Tobacco abuse Osteoporosis Psoriasis Actinic keratosis Dupuytrens Squamous cell carcinoma Hypertension Allergic rhinitis <SOCIAL HISTORY> ___ <FAMILY HISTORY> Mother: deceased, old age Father: prostate cancer <PHYSICAL EXAM> ADMISSION PHYSICAL EXAM -=========== VITALS: Reviewed in metavision. GENERAL: Intubated and sedated HEENT: Sclera anicteric, PERRLA, ETT in place NECK: supple, right CVL LUNGS: Clear to auscultation bilaterally, no wheezes, rales, rhonchi CV: Regular rate and rhythm, normal S1 S2, no murmurs, rubs, gallops ABD: soft, non-tender, non-distended, bowel sounds present, no rebound tenderness or guarding, no organomegaly EXT: Cool, well perfused, 2+ pulses, no edema SKIN: Artic sun in place <PERTINENT RESULTS> LABS ON ADMISSION -========= ___ 06: 38PM TYPE-CENTRAL VE PO2-40* PCO2-31* PH-7.45 TOTAL CO2-22 BASE XS-0 ___ 06: 38PM LACTATE-1.5 ___ 06: 38PM O2 SAT-72 ___ 06: 10PM GLUCOSE-182* UREA N-13 CREAT-0.3* SODIUM-134 POTASSIUM-4.2 CHLORIDE-97 TOTAL CO2-20* ANION GAP-17* ___ 06: 10PM ALT(SGPT)-14 AST(SGOT)-31 CK(CPK)-279 ALK PHOS-164* TOT BILI-0.6 ___ 06: 10PM ALBUMIN-3.0* CALCIUM-8.5 PHOSPHATE-2.8 ___ 06: 10PM NEUTS-86.9* LYMPHS-5.1* MONOS-6.7 EOS-0.1* BASOS-0.2 IM ___ AbsNeut-14.01* AbsLymp-0.83* AbsMono-1.08* AbsEos-0.01* AbsBaso-0.04 ___ 06: 10PM ___ PTT-29.3 ___ PERTIENT LABS -== Trops ___ 06: 10PM BLOOD cTropnT-0.47* ___ 12: 30AM BLOOD CK-MB-41* MB Indx-13.4* cTropnT-0.41* ___ 07: 32AM BLOOD CK-MB-29* MB Indx-12.0* cTropnT-0.30* ___ 02: 29PM BLOOD CK-MB-27* MB Indx-13.6* cTropnT-0.22* MICRO =========== BCx ___ pending GRAM STAIN (Final ___: >25 PMNs and >10 epithelial cells/100X field. ___ MRSA SCREEN (Final ___: No MRSA isolated. IMAGING -= ___ MRI Head Diffusion abnormalities along the cortex of both cerebral hemispheres predominantly in the parieto-occipital lobes are suggestive of early ischemic brain injury. ___ LENIs 1. Limited examination, but no evidence of deep vein thrombosis in the right upper extremity. 2. Probable hematoma in the upper inner arm as described. Correlate with physical examination for chronicity, and advise clinical follow-up to ensure resolution over time. ___ TTE The left atrial volume index is normal. Normal left ventricular wall thickness, cavity size, and regional/global systolic function (biplane LVEF = 64 %). Tissue Doppler imaging suggests a normal left ventricular filling pressure (PCWP<12mmHg). Right ventricular chamber size and free wall motion are normal. The diameters of aorta at the sinus, ascending and arch levels are normal. The aortic valve leaflets (?#) appear structurally normal with good leaflet excursion. There is no aortic valve stenosis. No aortic regurgitation is seen. The mitral valve appears structurally normal with trivial mitral regurgitation. The estimated pulmonary artery systolic pressure is high normal. There is no pericardial effusion. IMPRESSION: Normal biventricular cavity sizes with preserved regional and global biventricular systolic function. No valvular pathology or pathologic flow identified. No pericardial effusion. ___ EEG This is an abnormal ICU continuous video EEG monitoring study due to the presence of a burst suppression pattern, indicative of a severe ecphalopathy. By the late afternoon, overall amplitudes began to diminish, and more prolonged background attenuation was seen, with plentiful artifact. By the end of the recording, definitive activity of cerebral origin was not clearly seen. These findings are indicative of worsening of the severe encephalopathy, which could be related to medication effects, toxic/metabolic disturbances or progression of neurologic injury. There were no clear epileptiform discharges or electrographic seizures in this recording. ___ Shoulder ___ views Displaced humeral head fracture corresponding to given history, with exact relation of fracture fragments difficult to identify given limited included two views. ___ CXR AP portable supine view of the chest. The endotracheal tube is positioned with its tip 3.8 cm above the carina. There is a vague opacity in the right lower lung which could reflect a focus of pneumonia though attention on followup advised. There is mild retrocardiac opacity likely atelectasis. No large effusion or pneumothorax is seen. The cardiomediastinal silhouette appears grossly unremarkable. There is a dextroscoliotic curvature of the thoracic spine. No acute bony abnormalities. <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. amLODIPine 5 mg PO DAILY 2. Calcium Carbonate 500 mg PO BID 3. Citalopram 10 mg PO DAILY 4. Apixaban 5 mg PO BID 5. OLANZapine 20 mg PO DAILY 6. Divalproex (DELayed Release) 500 mg PO TID 7. Ketoconazole Shampoo 1 Appl TP ASDIR 8. Docusate Sodium 100 mg PO DAILY 9. Hydrocortisone Cream 2.5% 1 Appl TP BID <DISCHARGE MEDICATIONS> Expired <DISCHARGE DISPOSITION> Expired <DISCHARGE DIAGNOSIS> Expired <DISCHARGE CONDITION> Expired <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> N/A ","Mr ___ was admitted to the MICU at ___ for post-cardiac arrest management. He received 5 rounds of CPR prior to ROSC. Unfortunately, despite obtaining ROSC, he suffered a devastating brain injury likely ___ anoxia. This was confirmed on MRI as well as with consult from the neurology team. After speaking with his HCP, we agreed to progress to CMO. He was extubated and expired on ___. ",1995,90
10004733-DS-16,"<SEX> M <SERVICE> NEUROLOGY <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___ <CHIEF COMPLAINT> Headache/Nausea/Vomiting <MAJOR SURGICAL OR INVASIVE PROCEDURE> EGD/Colonoscopy ___ - normal Kidney biopsy ___ - consistent with hypertensive nephropathy <HISTORY OF PRESENT ILLNESS> ___ with no significant PMHx (had not seen physician ___ > ___ years) who was admitted to ___ with hypertensive emergency and ___ on ___ with systolic BP 230s-250s ___ ER and transferred to ___ for further management of hypercarbic respiratory failure. Per report, patient had been having intermittent nausea/vomiting and headaches for which he was taking Advil 800 mg daily for approximately ___ weeks prior to admission. He was taking testosterone which he obtained over the internet during this period (total of 3 doses during the month of ___, but no other meds other than the advil noted above. Due to these ongoing symptoms, patient went to see his PCP for initial visit ~2 weeks prior to admission. At the PCP visit his BP was noted to be 210 systolic. He had minimal symptoms and was started on 25mg HCTZ at that time and advised to return to the PCP's office ___ 2 weeks for re-evaluation and for lab work. Patient reportedly lost ~20 lbs over next 2 weeks. At ___ visit with his PCP his BP was still elevated and he was noted to have creatinine of 3.4 on lab work. He was then sent to the ED at ___. On arrival to ED, BPs were ___ the 230s-250s/130s-160. Patient was not having any chest pain other symptoms other than those noted above on admission to ___ ___. Patient was started on nitro gtt and admitted to ICU for management of malignant hypertension and ___. He has been on nitro gtt since admission, and also has intermittently been on clonidine, vasotec, hydralazine, and metoprolol. MRI/MRA brain done on ___ showed diffuse T2 prolongation of white matter involving mesencephalon, pons and cerebellum. MRI ___ showed scatter regions of acute infarcts ___ the deep brain ___ hemispheres bilaterally. Patient's mental status remained altered throughout hospitalization. Per girlfriend/HCP, his mental status was worse when BPs were lower ___ the 140-160 range - specifically he appeared less ""lucid,"" had difficulty with orientation. ___ addition, he was agitated at times which was out of character. He was seen by neurology on ___ who recommended continued blood pressure control and repeat MRI ___ ___ weeks, gave diagnosis of variant posterior leukoencephalopathy syndrome/PRES variant. Patient was seen by psychiatry who felt that his mental status changes were most likely secondary to long-standing uncontrolled hypertension. Patient was started on Zyprexa. Lumbar puncture was done on ___, culture was negative, EBV pcr from CSF was negative, ___ and IgG were negative. Lyme PCR and RPR were negative. TSH was wnl. ___ addition, patient was noted to have negative initial troponin I which subsequently increased to 0.176. Patient was seen by cardiology who felt trop leak was secondary to ___ and hypertension. Echo done on ___ had LVEF 60%, concentric LV hypertrophy c/w hypertensive changes, normal RV. He was also seen by nephrology for proteinuria and ___. Nephrology felt patient had hypertensive nephropathy. They recommended ace-inhibitor, and beta-blocker. They also recommended ___ and ANCA to be sent to rule out other causes of kidney injury. ANCA was negative, unclear ___ was sent. Renal ultrasound was done which showed right-sided renal cyst, otherwise normal. Regarding his respiratory status, on ___, patient was intubated for hypercarbic respiratory failure. Was extubated on ___. On he was reintubated that evening and extubated on ___. On morning of ___ he was re-intubated for hypercarbia and concern for airway protection. Patient became hypotensive during intubation, thus nitro gtt was dc'd, and all other hypertensive meds were held. Also, patient became febrile on ___, Blood cultures from ___ with GPCs ___ clusters. Sputum from ___ grew proteus mirabilis sensitive to unasyn, cefazolin and cefepime. Patient also became febrile overnight on ___ to 103.2, patient was pan-cultured and started on vanc/zosyn. On arrival to the ___ ICU, initial vitals were: T: 99.4 BP: 167/101 P: 87 R: 22 O2: 100% on vent - CPAP, 40% FiO2, 5 PEEP, pressure support 10. Patient was intubated and sedated - unable to respond to commands. Unable to obtain ROS due to sedation. <PAST MEDICAL HISTORY> Hypertension <SOCIAL HISTORY> ___ <FAMILY HISTORY> Unknown, patient is adopted. <PHYSICAL EXAM> On Admission: VS T: 99.4 BP: 167/101 P: 87 R: 22 O2: 100% on vent - CPAP, 40% FiO2, 5 PEEP, pressure support 10 General: Intubated, sedated HEENT: NC/AT, sclera anicteric, ET tube ___ place Neck: supple, JVP not elevated, no LAD Lungs: Clear to auscultation bilaterally, no wheezes, rales, ronchi CV: Regular rate and rhythm, normal S1 + S2, no r/m/g Abdomen: soft, non-tender, non-distended, bowel sounds present, no rebound tenderness or guarding, no organomegaly GU: Foley ___ place with clear yellow urin Ext: warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema Neuro: MS - intubated, alert, regards to voice, does not follow commands CN - PERRL 4 to 2 bilaterally, patient can track examiner across room horizontally, can look down, but does not look up to voice, patient is too alert to dolls, possible mild L ptosis, intact gag/cough Motor - increased tone throughout with spasticity ___ LUE>RUE, greater spontaneous movement of LUE/LLE compared to RUE/RLE. Strength at least 4+ ___ b/l deltoids/biceps/triceps, Strength at least 4- ___ LLE IP/quad/hams. Strength at least 3 ___ RLE IP/quad/hams. Reflexes symmetrically 3+ throughout at biceps/brachioradialis/patella, symmetrically 2+ at achilles. No ankle clonus. Toes equivocal on L, down on R. Sensory - patient withdraws all extremities to vigorous non-noxious tactile stimuli. Coordination - no dysmetria with pushing away examiners hand with UE bilaterally > > > > > > > > > > > > > > >>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>> On Discharge: General: Awake, cooperative, NAD. HEENT: NC/AT, no scleral icterus, MMM, clear oropharynx Neck: Supple, no nuchal rigidity. No carotid bruits Pulmonary: Lungs CTA bilaterally Cardiac: RRR Abdomen: soft, NT/ND Extremities: No C/C/E bilaterally, 2+ radial, DP pulses bilaterally. Skin: no rashes or lesions Neurologic: -Mental Status: Alert, oriented to hospital, year, name, patient incorrectly said month was ___ (currently ___. Able to relate history without difficulty - can recall events of last few days. Language is fluent with intact comprehension. Normal prosody. There were no paraphasic errors. Pt. was able to name both high and low frequency objects. Able to read without difficulty. Speech was mildly dysarthric. Able to follow both midline and appendicular commands. Continues to report some visual halluciations, aware that they are hallucinations - last was 2d prior to discharge. -Cranial Nerves: I: Olfaction not tested. II: PERRL 3 to 2mm and brisk. VFF to confrontation. Funduscopic exam revealed no papilledema. III, IV, VI: EOMI without nystagmus. Normal saccades. V: Facial sensation intact to light touch. VII: Face symmetric VIII: Hearing intact to finger-rub bilaterally. No evidence of hyperacusis. IX, X: Palate elevates symmetrically. XI: ___ strength ___ trapezii and SCM bilaterally. XII: Tongue protrudes ___ midline and has symmetric strengh. -Motor: Normal bulk, tone throughout. No pronator drift. No adventitious movements. No asterixis. Very slight orbiting around the RUE. Delt Bic Tri WrE FFl FE IO IP Quad Ham TA ___ L 5 ___ ___ 5 5 5 5 5 5 R 5 ___ ___ 5 5 5 5 5 5 -Sensory: No deficits to light touch, pinprick, cold sensation, vibratory sense, proprioception throughout. No extinction to DSS. -DTRs: Bi Tri ___ Pat Ach L 2 2 2 2 2 R 2 2 2 2 2 Plantar response was flexor bilaterally. -Coordination: No dysmetria on FNF or HKS bilaterally. Action tremor with R arm greater than left. -Gait: deferred DISCHARGE PHYSICAL THERAPY EXAM: Hemodynamic Response/Aerobic Capacity Position HR BP RR O2 RPE Rest Supine 94 130/98 16 98%RA Sit ___ 20 99%RA Activity Sit p amb 104 132/96 20 98%RA Recovery Sit 92 132/102 16 98%RA Total Distance Walked: 250ft w/ 1 rest break Functional Status Rolling: I Use of rail: No Sup/Sidelying to Sit: I Head of Bed Elevated: No Sit to Stand: S to ___ Ambulation: S-CGA w/ ___ without AD Stairs: deferred - pt does not negotiate at home Other Activity: n/a Specify: Sit to stand with use of BUE, able to complete on 1 attempt ***Abbreviation Key*** I=Independent S=Supervision ___ Guard ___ Walker SW=Standard Walker SC=Straight Cane AC=Axillary Crutches Gait: Ambulated 250ft w/ ___ and S-CGA with cues for decreased cadence. Steady w/ direction change. Mild R knee hyperextension ___ stance, decreased RLE stance time and LLE step length. Required 1 rest break secondary to fatigue. Balance: I static/dynamic sitting balance without BUE support; able to reach outside of BOS with BUE and return to midline without assist. S static stance w/ ___ for BUE support. CGA progressing to S w/ ___ for BUE support. Pain: denies pain at rest and with mobility Limiting Symptoms: fatigue Other Tests and Measures: ___ Performance Orientated Mobility Assessment: - Balance Tests - 1. Sitting Balance: 1 2. Arises: 1 3. Attempts to Arise: 2 4. Immediate Standing Balance: 1 5. Standing Balance: 1 6. Nudged: 2 7. Eyes Closed: 1 8. Turing 360 Degrees: 1 9. Sitting Down: 1 Balance Score: ___ - Gait Tests - 10. Initiation of Gait: 1 11. Step Length and Height: 4 12. Step Symmetry: 0 13. Step Continuity: 1 14. Path: 1 15. Trunk: 0 16. Walking Stance: 1 Gait Score: ___ Gait + Balance Total Score: ___ <PERTINENT RESULTS> On Admission: Labs: ___ 01: 01PM BLOOD WBC-7.4 RBC-3.37* Hgb-10.0* Hct-30.9* MCV-92 MCH-29.6 MCHC-32.3 RDW-16.2* Plt ___ ___ 01: 01PM BLOOD Neuts-81.8* Lymphs-8.8* Monos-5.3 Eos-3.8 Baso-0.3 ___ 01: 01PM BLOOD ___ PTT-34.1 ___ ___ 10: 02PM BLOOD ACA IgG-6.2 ACA IgM-8.2 ___ 01: 01PM BLOOD Glucose-86 UreaN-44* Creat-3.4* Na-146* K-3.7 Cl-109* HCO3-24 AnGap-17 ___ 04: 00AM BLOOD ALT-46* AST-53* LD(LDH)-184 AlkPhos-113 TotBili-1.1 ___ 01: 01PM BLOOD Calcium-9.5 Phos-3.5 Mg-2.2 ___ 10: 02PM BLOOD CRP-135.1* ___ 10: 02PM BLOOD C3-156 C4-45* Imaging: CHEST (PORTABLE AP) ___: IMPRESSION: The lung volumes are low. The patient is intubated, the endotracheal tube projects approximately 2.6 cm above the carinal. The patient also has a nasogastric tube, the tip is not visualized on the image. Finally, the patient has a right internal jugular vein catheter. The course of the catheter is unremarkable, the tip of the catheter projects over the upper to mid SVC. Moderate cardiomegaly with retrocardiac atelectasis and, potentially, a small left pleural effusion. The patient is ___ mild pulmonary edema. ___ addition, there is a rounded opacity at the lateral and lower aspect 's of the right hilus, potentially representing atelectasis. However, short term radiographic followup should be performed to exclude developing pneumonia or aspiration. There is no evidence of pneumothorax. CT CHEST W/O CONTRAST ___: IMPRESSION: All of the pulmonary abnormalities could be due to atelectasis bilateral lower lobe, including collapse without bronchial obstruction. Lesions ___ the posterior segment of the right upper lobe and particularly the lingula should be re-evaluated with chest CT, contrast enhanced if clinically feasible, when aeration improves elsewhere. Pulmonary hypertension. Cardiomegaly. No pulmonary edema or pleural effusion. CT HEAD W/O CONTRAST ___: IMPRESSION: 1. Comparison across modalities to recent MRI is difficult. However, there is no significant change since outside CT of ___. Again there is nonspecific diffuse hypodensity of the white matter. Possible hypodense area ___ the left cerebellar hemisphere. 2. Diffuse distribution is somewhat atypical for PRES although PRES can be seen ___ a non- posterior distribution. Repeat MRI may be helpful for further evaluation. 3. New aerosolized secretions ___ the sphenoid sinuses, opacification of the left mastoid air cells and fluid ___ the left middle ear cavity. Please correlate clinically for acute sinusitis. EEG ___: IMPRESSION: This is an abnormal continuous ICU monitoring study because of frequent blunted epileptiform discharges ___ bilateral occipital regions. These, only on rare occasions, have a high voltage sharp morphology, ___ the bilateral posterior quadrants, phase reversing ___ a broad field isoelectric at O1 and O2 or at times with shifting laterality between each posterior quadrant. At times, these occur ___ brief runs at ___ Hz lasting up to five seconds ___ the first half of the recording but do not evolve ___ frequency, morphology, or location to meet criteria for seizure. ___ the latter half of the recording, the frequency of the brief runs decrease to 0.5-0.75 Hz and predominantly have only a blunted morphology. These sharp waves indicate potentially epileptogenic foci ___ both occipital regions. Additionally, there is a continuous pattern of severe diffuse background slowing fluctuating with a discontinuous burst suppression pattern throughout the entire recording. These findings are indicative of severe diffuse cerebral dysfunction which is non-specific as to etiology. The fluctuations of the continuous and discontinuous background pattern could indicate either fluctuation ___ severity of the severe diffuse cerebral dysfunction or effects of sedating medications. EKG ___: Sinus rhythm. Left atrial abnormality. Prior anteroseptal and lateral myocardial infarction. Slight ST segment elevation ___ leads V1-V2 with ST segment depression and T wave inversion ___ leads I and aVL. ST segment flattening and slight depression ___ leads II and aVF. The ST-T wave changes raise the question of active anterolateral ischemic process. No previous tracing available for comparison. Clinical correlation is suggested. TRANSTHORACIC ECHOCARDIOGRAM ___: Suboptimal image quality. The left atrium is mildly dilated. No thrombus/mass is seen ___ the body of the left atrium. No atrial septal defect or patent foramen ovale is seen by 2D, color Doppler or saline contrast at rest. The estimated right atrial pressure is at least 15 mmHg. There is mild symmetric left ventricular hypertrophy with normal cavity size and regional/global systolic function (LVEF>55%). No masses or thrombi are seen ___ the left ventricle. There is no ventricular septal defect. The right ventricular cavity is moderately dilated with normal free wall contractility. No masses or vegetations are seen on the aortic valve, but cannot be fully excluded due to suboptimal image quality. There is no aortic valve stenosis. No aortic regurgitation is seen. The mitral valve leaflets are mildly thickened. No mass or vegetation is seen on the mitral valve. Trivial mitral regurgitation is seen. The tricuspid valve leaflets are mildly thickened. Tricuspid regurgitation is present but cannot be quantified. There is moderate pulmonary artery systolic hypertension. There is a trivial/physiologic pericardial effusion. There are no echocardiographic signs of tamponade. MRA MRA BRAIN/NECK W/O CONTRAST ___: IMPRESSION: Study somewhat suboptimal; circle of ___ not completely included. Allowing for technical limitations, no flow-limiting stenosis or aneurysm more than 3mm of the circle ___ or vessels of the neck. Consider repeat evaluation with better quality images when feasible. ___ EEG IMPRESSION: This is an abnormal continuous ICU EEG monitoring study because of occasional blunted epileptiform discharges ___ the bilateral posterior quadrants, phase reversing ___ a broad field isoelectric at O1 and O2 or at times with shifting laterality between each posterior quadrant. On rare occasions, these discharges occur ___ brief ___ second runs at 0.25-0.5 Hz but do not evolve ___ frequency, morphology, or location to meet criteria for seizure. These blunted epileptiform discharges indicate potentially epileptogenic foci ___ both occipital regions. There is moderate to severe diffuse background slowing, which is nonspecific as to etiology. Compared to the previous days recording, the bilateral posterior quadrant epileptiform discharges have decreased ___ frequency, and there is mild improvement ___ the background. ___ CXR IMPRESSION: Examination is centered at the diaphragm, excluding the lung apices. Moderate cardiomegaly is stable, but mild interstitial edema may have improved. There is no evidence of pneumothorax or pleural effusion along the imaged pleural surfaces. Left PIC line ends close to the superior cavoatrial junction, repositioned from the azygos vein. Feeding tube has been withdrawn to the upper stomach. The side ports may not all be beyond the gastroesophageal junction. ___ MRI (radiology read) IMPRESSION: Several acute small subcortical infarcts are identified since the previous MRI examination. There is been some decrease ___ hyperintensities ___ the basal ganglia, brainstem and cerebellum and cerebral convexity regions. Extensive changes still remain. ___ Renal U/S Limited exam demonstrating no hydronephrosis of the left kidney. Right kidney was not imaged due to patient noncompliance Microbiology: ___ 1: 34 pm SPUTUM Source: Endotracheal. GRAM STAIN (Final ___: >25 PMNs and <10 epithelial cells/100X field. 4+ (>10 per 1000X FIELD): GRAM POSITIVE COCCI. ___ PAIRS AND CLUSTERS AND ___ SHORT CHAINS. 1+ (<1 per 1000X FIELD): MULTIPLE ORGANISMS CONSISTENT WITH OROPHARYNGEAL FLORA. RESPIRATORY CULTURE (Preliminary): Commensal Respiratory Flora Absent. PROTEUS MIRABILIS. SPARSE GROWTH. STAPH AUREUS COAG +. MODERATE GROWTH. SENSITIVITIES: MIC expressed ___ MCG/ML _________________________________________________________ PROTEUS MIRABILIS | AMPICILLIN------------ <=2 S AMPICILLIN/SULBACTAM-- <=2 S CEFAZOLIN------------- 8 R CEFEPIME-------------- <=1 S CEFTAZIDIME----------- <=1 S CEFTRIAXONE----------- <=1 S CIPROFLOXACIN---------<=0.25 S GENTAMICIN------------ <=1 S MEROPENEM-------------<=0.25 S PIPERACILLIN/TAZO----- <=4 S TOBRAMYCIN------------ <=1 S TRIMETHOPRIM/SULFA---- <=1 S FUNGAL CULTURE (Preliminary): YEAST. ___ 2: 13 pm URINE Source: Catheter. **FINAL REPORT ___ URINE CULTURE (Final ___: NO GROWTH. ___ 2: 13 pm BLOOD CULTURE Source: Catheter #1. Blood Culture, Routine (Pending): ___ 10: 02 pm SEROLOGY/BLOOD Source: Line-CVL. **FINAL REPORT ___ RAPID PLASMA REAGIN TEST (Final ___: NONREACTIVE. Reference Range: Non-Reactive. ___ 4: 00 am URINE Source: Catheter. **FINAL REPORT ___ URINE CULTURE (Final ___: NO GROWTH. <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Hydrochlorothiazide 25 mg PO DAILY <DISCHARGE MEDICATIONS> 1. Amlodipine 10 mg PO DAILY RX *amlodipine 10 mg 1 tablet(s) by mouth at bedtime Disp #*30 Tablet Refills: *3 2. Atorvastatin 80 mg PO DAILY RX *atorvastatin 80 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills: *3 3. Clonidine Patch 0.3 mg/24 hr 1 PTCH TD QSUN RX *clonidine [Catapres-TTS-1] 0.1 mg/24 hour 3 patches qWeek Disp #*6 Patch Refills: *0 4. Pantoprazole 80 mg PO Q24H RX *pantoprazole 40 mg 2 tablet(s) by mouth daily Disp #*60 Tablet Refills: *3 5. Carvedilol 37.5 mg PO BID RX *carvedilol 12.5 mg 3 tablet(s) by mouth twice a day Disp #*180 Tablet Refills: *3 6. Aspirin 81 mg PO DAILY RX *aspirin 81 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills: *3 7. Lisinopril 30 mg PO DAILY RX *lisinopril 30 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills: *3 8. TraZODone 50 mg PO HS RX *trazodone 50 mg 1 tablet(s) by mouth at bedtime Disp #*30 Tablet Refills: *3 9. standard wheelchair <DISCHARGE DISPOSITION> Home With Service Facility: ___ <DISCHARGE DIAGNOSIS> PRES <DISCHARGE CONDITION> Mental Status: Confused - sometimes. Level of Consciousness: Alert and interactive. Activity Status: Out of Bed with assistance to chair or wheelchair. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Mr. ___, You were admitted with a hypertensive urgency with blood pressures as high as 240/110. This caused nausea/vomiting and headache and damage to your brain called posterior reversible leukoencephalopathy syndrome (PRES) on your Brain MRI. You also had multiple small strokes scattered throughout your brain on a repeat brain MRI. You initially required intubation for trouble breathing. You were transferred to one of our ICUs from another hospital for further management after it became difficult to extubate you. On admission, you had right sided weakness that improved over time. You were ultimately extubated and could breath on your own. Your blood pressure required multiple medications for management throughout the admission but we eventually kept your blood pressure controlled between ___ on multiple blood pressure medications. You had a low red blood cell count (anemia) during the admission which we thought was likely because of the stress placed on your body (anemia of chronic disease). You had a scope of your upper and lower gut to look for other sources of bleeds but these were normal. You had a bacterial infection ___ your blood and a pneumonia that required treatment with IV Vancomycin and IV Zosyn for 12 days. Your kidneys also showed damage from your likely long standing high blood pressure. Our renal service evaluated you and a kidney biopsy was done to confirm this diagnosis. You have been evaluated by our physical therapists. They recommend discharge home with home physical therapy. ___ addition to the follow up appointments listed below, you will also require follow-up with a neurologist. Please obtain a referral from your primary care doctor. ","___ who had not sought medical attention for 25 to ___ years with h/o IVDA and alcoholism who presents with hypertensive urgency with SBP 230-250, N/V, HA, ultimately developing PRES and multiple lacunar infarcts with bleeding all thought to be ___ his hypertension. His medical course was complicated by hypercarbic respiratory failure possible ___ intermittent AMS vs HTN-associated pulmonary edema, persistently difficulty to control HTN, HTN-associated CKD, and chronic anemia ultimately felt to be anemia of chronic disease. He was discharged on multiple medications for blood pressure control, ASA, and atorvastatin. Evaluation by ___ on ___: home w/ home ___ & home OT and 24hr assist from family following 0 ___ visits. Will d/c with rx for standard wheelchair. Hospital course # Neuro - At OSH - MRI/MRV was done ___ and showed no MRV abnormality but did show diffuse FLAIR hyperintensity through the cerebral white matter, brainstem (worst ___ pons) and bilateral cerebellar white matter. Repeat MRI ___ showed multiple bilateral cerebral white matter acute punctate infarcts (bright on DWI and dark on ADC) with associated GRE signal abnormality suggestive of bleed. After concern for acute stroke on MRI on ___, he was started on ASA 81 and Atorvastatin. He reportedly had R sided weakness for multiple days prior to transfer but has been sedated on a propofol drip for intubation. On arrival, he had a clear R hemiparesis and possible L facial weakness. By the time of extubation and transfer to the floor Neurology service from the MICU, these symptoms had resolved. His mental status was notable for intermittent disorientation to month, year, and location. He had multiple anxiety episodes (which reportedly occurred frequently prior to admission as well) - these episodes improved with olanzapine which wasn't required for the 24 hours prior to discharge. He was started on qHS trazodone for insomnia and night time agitation. It may be worthwhile to repeat his MRI as an outpatient for prognostication purposes, though his exam is now clearly improved. #Respiratory - Patient has been intubated 3x at OSH, each time for hypercarbic respiratory failure. There is also question of patient have altered mental status which contributed to difficulty weaning from vent and need for intubation for airway protection. He was successfully extubated after arrival to the FICU on ___. # CV - Patient with HAs, vision changes, elevated BP and CKD on admission to OSH. Patient was kept on nitro gtt, IV hydral, IV metop, clonidine and IV enalapril during hospitalization at ___ ___. Initially maintained on nitro gtt. Gradual control of BPs (given history of strokes and given likely history of chronic HTN) was achieved with SBPs ___ the 120s to 150s with clonidine 0.3 mg qDay (patch - changed qWk), carvedilol, lisinopril, and amlodipine. Clonidine can be weaned by 0.1 mg qWk over the next three weeks to off. Further HTN management will be directed by the renal service on an outpatient basis. # Renal: Patient with elevated creatinine and proteinuria on admission to OSH. Seen by nephrology at ___ who gave diagnosis of hypertensive nephropathy. Recommended BP control and initiation of Ace-inhibitor. Renal U/S at OSH was normal except for R renal cyst. Urine sediment reportedly bland. UA here unremarkable. Cr remains elevated and stable. Kidney biopsy performed ___. Preliminary results revealed endocapillary proliferation and some endothelial damage. There is evidence of chronic disease, arterial wall thickening, some GN. Most likely ___ chronic kidney disease. Creatinine 2.6 on ___ creatinine 2.8 on ___. OSH evaluation for pheo, thyroid abn, cortisol abn were unremarkable. Renin and aldosterone pending at the time of discharge. Renal dopplers limited by patient cooperation but overall unremarkable. # ID - Patient grew GPCs ___ clusters ___ 2 bottles from cultures from ___. Patient only had PIVs ___ place until ___. Vanc sensitive. TTE without evidence of vegetation. Plan for vancomycin; will need two week course starting from date of first negative blood culture (last day ___. Also on ___, was found to have CXR c/f aspiration PNA. Completed 10 day course of IV Zosyn for this. # Heme: Patient acutely developed an anemia with Hg drop from ~11 to ___ over 24 hours, but then stable afterwards. Low reticulocyte count with elevated ferritin and haptoglobin were consistent with anemia of chronic disease. Given history of positive guaics (which resolved when the patient was put on a PPI), GI was consulted. EGD/Colonoscopy were unremarkable. Any further evidence of persistently guiaic positive stools should prompt capsule study. Renal felt that chronic renal disease could be contributing to anemia but EPO would not be recommended for the patient unless his anemia was long standing and until his BP was well controlled. ",5684,1115
10004749-DS-21,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> abdominal pain and diarrhea <MAJOR SURGICAL OR INVASIVE PROCEDURE> none <HISTORY OF PRESENT ILLNESS> The patient is a ___ year old female with a history of GERD and prior C.diff infecion ___ years ago who presents with right lower quadrant abdominal pain. . She reports that the pain started when she awoke this morning. It is localized to the mid abdomen with radiation to the RLQ. She had some associated nausea without vomiting. The abdominal pain very similar to the pain with her previous C.diff colitis. She presented to her ___ clinic, where there was concern for appendicitis. She was also given Acetaminophen 975 mg PO. . After arriving in the ED, she began to have diarrhea, about ___ episodes. The pain was briefly relieved with defecation. She was incontinent of stool at times. There was no bright red blood per rectum or melena. She has felt slightly feverish, but did not check her temperature. Her appetite has been poor today. She denies any vaginal bleeding or discharge. . Prior to this morning, she was feeling at her baseline without any symptoms. She denies any recent antibiotics. Last week, she was on a cruise to ___. She did not have any diarrhea or GI symptoms on the trip. She did not drink any unbottled water or local food. . Initial vitals in ED triage were T 99.7, HR 110, BP 145/84, RR 16, and SpO2 98% on RA. Exam was notable to RLQ tenderness. Pelvic exam showed no CMT or adnexal tenderness. Her CBC was notable for WBC 17.6 with N 86.4%. Her chemistry panel showed Cr 0.7, K 3.4, bicarb 21, and anion gap 14. LFTs were unremarkable except for Lipase 61. UCG was negative and UA appeared contaminated with WBC 6 and few bacteria, but Epi 18. CT abd/pelvis showed several loops of small bowel in the right lower quadrant and pelvis with wall edema, minimal surrounding fat stranding, and trace free fluid. The appendix was minimally hyperemic but only 5-6 mm in diameter, and unlikely to represent acute appendicitis. . She was given NS ___ ml IV. Stool samples were sent for C.diff and bacterial culture. Antibiotics were held pending culture results. She received Morphine x3 and Dilaudid 0.5 mg IV x2. She continued to have abdominal pain and was admitted to medicine for pain control and further workup of her enteritis. . Vitals prior to floor transfer were T 99.2, HR 89, BP 119/74, RR 14, and SPO2 99% on RA. On reaching the floor, she reported continued abdominal pain in the periumbilical area with radiation to the RLQ. She reported baseline loose stool, but that the current diarrhea is abnormal for her. . REVIEW OF SYSTEMS: (+) Per HPI. Mild sore throat and hoarse voice, which she thinks is from not drinking anything in the ED. Some slight chills and mild fatigue. Recent sunburn while on cruise. (-) No fevers. No weight loss. No headache, rhinorrhea, or nasal congestion. No vertigo, presyncope, syncope, vision changes, hearing changes, focal weakness, or paresthesias. No chest pain, pressure, palpitations, SOB, cough, or hemoptysis. No dysphagia or odynophagia. No melena or BRBPR. No hematuria, dysuria, frequency, urgency, incontinence, or discharge. No back, neck, joint, or muscle pain. No rashes or concerning skin lesions. No easy bleeding or bruising. No depression or anxiety. Review of systems was otherwise negative. <PAST MEDICAL HISTORY> # Asthma -- mild intermittent, rare Albuterol use # Chronic Sinusitis -- improved after ENT surgery ___ years ago # GERD -- high dose Omeprazole # C.diff Colitis (___) # Migraines -- few per year # Overweight <SOCIAL HISTORY> ___ <FAMILY HISTORY> No famil history of inflammatory bowel disease or GI malignancy. # Mother: Healthy # Father: Died at age ___ from asthma exacerbation # Siblings: Brother who is well <PHYSICAL EXAM> ADMISSION: VS: T 98.7, BP 132/81, HR 98, RR 16, SpO2 97% on RA, Wt 153 lbs, Ht 62 in Gen: Young female in NAD. Oriented x3. Pleasant, bright affect. HEENT: Sclera anicteric. PERRL, EOMI. MMM, OP benign. Neck: JVP not elevated. No concerning cervical lymphadenopathy. CV: RRR with normal S1, S2. No M/R/G. Chest: Respiration unlabored, no accessory muscle use. CTAB without crackles, wheezes or rhonchi. Abd: Active bowel sounds. Soft, ND. No organomegaly or masses. Tender to palpation in RLQ and periumbilical area. Some rebound tenderness, minimal voluntary guarding. Ext: WWP. Digital cap refill <2 sec. No C/C/E. Distal pulses intact radial 2+, DP 2+, ___ 2+. Skin: No rashes or lesions noted in area of discomfort. Neuro: CN II-XII grossly intact. Moving all four limbs. Normal speech. DISCHARGE: VS: 97.9 115/60 88 18 99%RA Gen: Young female in NAD. Oriented x3. Pleasant, bright affect. HEENT: Sclera anicteric. MM moist, OP benign. Neck: JVP not elevated. No concerning cervical lymphadenopathy. CV: RRR with normal S1, S2. No M/R/G. Chest: Respiration unlabored, no accessory muscle use. CTAB without crackles, wheezes, or rhonchi. Abd: Active bowel sounds. Soft, ND. No organomegaly or masses. Tender to palpation in RLQ and periumbilical area but improved from yesterday. no rebound or guarding. psoas, obturatory, and ___ signs negative Ext: WWP. Digital cap refill <2 sec. No C/C/E. Distal pulses intact radial 2+, DP 2+, ___ 2+. Skin: No rashes or lesions noted in area of discomfort. Neuro: CN II-XII grossly intact. Moving all four limbs. Normal speech. <PERTINENT RESULTS> ADMISSION; ___ 06: 10PM BLOOD WBC-17.6*# RBC-4.55# Hgb-14.0 Hct-42.2 MCV-93 MCH-30.9 MCHC-33.3 RDW-12.7 Plt ___ ___ 06: 10PM BLOOD Neuts-86.4* Lymphs-8.4* Monos-4.2 Eos-0.5 Baso-0.5 ___ 06: 10PM BLOOD Plt ___ ___ 08: 10AM BLOOD ___ PTT-27.2 ___ ___ 06: 10PM BLOOD Glucose-88 UreaN-16 Creat-0.7 Na-139 K-3.4 Cl-104 HCO3-21* AnGap-17 ___ 06: 10PM BLOOD ALT-19 AST-21 AlkPhos-60 TotBili-0.4 ___ 06: 10PM BLOOD Albumin-4.6 Calcium-9.5 Phos-2.9 Mg-1.9 OTHER PERTINENT: ___ 08: 10AM BLOOD WBC-7.3# RBC-4.04* Hgb-12.4 Hct-38.1 MCV-94 MCH-30.8 MCHC-32.6 RDW-13.0 Plt ___ ___ 08: 10AM BLOOD Glucose-90 UreaN-14 Creat-0.6 Na-141 K-4.1 Cl-111* HCO3-20* AnGap-14 ___ 08: 10AM BLOOD Calcium-8.6 Phos-2.4* Mg-1.8 ___ 05: 04PM URINE Color-Yellow Appear-Hazy Sp ___ ___ 05: 04PM URINE Blood-NEG Nitrite-NEG Protein-NEG Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-5.5 Leuks-MOD ___ 05: 04PM URINE RBC-1 WBC-6* Bacteri-FEW Yeast-NONE Epi-18 MICRO: ___ 5: 04 pm STOOL CONSISTENCY: WATERY Source: Stool. **FINAL REPORT ___ C. difficile DNA amplification assay (Final ___: Negative for toxigenic C. difficile by the Illumigene DNA amplification assay. (Reference Range-Negative). FECAL CULTURE (Final ___: NO SALMONELLA OR SHIGELLA FOUND. CAMPYLOBACTER CULTURE (Final ___: NO CAMPYLOBACTER FOUND. OVA + PARASITES (Final ___: NO OVA AND PARASITES SEEN. This test does not reliably detect Cryptosporidium, Cyclospora or Microsporidium. While most cases of Giardia are detected by routine O+P, the Giardia antigen test may enhance detection when organisms are rare. FECAL CULTURE - R/O YERSINIA (Final ___: NO YERSINIA FOUND. DISCHARGE: ___ 07: 59AM BLOOD WBC-8.7 RBC-3.89* Hgb-12.1 Hct-36.4 MCV-94 MCH-31.1 MCHC-33.3 RDW-12.9 Plt ___ ___ 07: 59AM BLOOD Glucose-93 UreaN-5* Creat-0.7 Na-138 K-4.2 Cl-108 HCO3-22 AnGap-12 ___ 07: 59AM BLOOD Calcium-8.9 Phos-2.7 Mg-2.0 IMAGING: ___ CT ABD/PELVIS: IMPRESSION: 1. Enteritis involving several loops of small bowel located in the right lower quadrant of the abdomen and within the pelvis. Differential diagnosis includes infectious, inflammatory, and ischemic etiology. 2. The appendix is 5-6 mm in diameter, and given the diffuse inflammatory findings, appendicitis is not likely the cause of the patient's symptoms. ___ CXR: FINDINGS: The lung volumes are normal. No pleural effusions. No parenchymal abnormalities. Normal size of the cardiac silhouette. <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Omeprazole 40 mg PO BID 2. Albuterol Inhaler ___ PUFF IH Q4-6H: PRN SOB 3. Fluoxetine 20 mg PO DAILY 4. Lorazepam 0.5-1 mg PO BID: PRN anxiety 5. acetaminophn-isometh-dichloral *NF* 325-65-100 mg Oral Q1H: PRN migraine up to maximum of 5 tabs in 12 hours 6. Microgestin Fe ___ (28) *NF* (norethindrone-e.estradiol-iron) 1.5-30 mg-mcg Oral DAILY <DISCHARGE MEDICATIONS> 1. Fluoxetine 20 mg PO DAILY 2. Microgestin Fe ___ (28) *NF* (norethindrone-e.estradiol-iron) 1.5-30 mg-mcg Oral DAILY 3. Omeprazole 40 mg PO BID 4. Acetaminophen 1000 mg PO Q8H 5. DiCYCLOmine 20 mg PO QID RX *dicyclomine 20 mg 1 tablet(s) by mouth four times a day Disp #*10 Tablet Refills: *0 6. OxycoDONE (Immediate Release) ___ mg PO Q4H: PRN pain do not take if drowsy or driving. Take only if pain persists despite taking acetaminophen. RX *oxycodone 5 mg ___ tablet(s) by mouth every four (4) hours Disp #*15 Tablet Refills: *0 7. Albuterol Inhaler ___ PUFF IH Q4-6H: PRN SOB 8. Lorazepam 0.5-1 mg PO BID: PRN anxiety 9. Ondansetron 4 mg PO Q8H: PRN nausea RX *ondansetron 4 mg 1 tablet,disintegrating(s) by mouth every eight (8) hours Disp #*10 Tablet Refills: *0 10. Ciprofloxacin HCl 500 mg PO Q12H Duration: 3 Doses take through end of ___ RX *ciprofloxacin [Cipro] 500 mg 1 tablet(s) by mouth every twelve (12) hours Disp #*3 Tablet Refills: *0 <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> gastroenteritis <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Ms. ___, It was a pleasure taking care of you at the ___ ___. You were admitted with diarrhea and abdominal pain. We treated you with antibiotics, fluids and pain medications, and your symptoms improved. You were able to eat and drink by the time of discharge. You will need to continue treatment with antibiotics for a further 1 day. We also gave you medications to contorl pain and cramping. Please followup with your primary care practitioner. ","The patient is a ___ year old female with a history of GERD and prior C.diff infecion ___ years ago who presents with right lower quadrant abdominal pain and watery diarrhea. ACTIVE ISSUES: # Enteritis/Abdominal Pain: Most likely represents a viral enteritis given her associated URI symptoms of voice hoarseness and sinus congestion, though her recent cruise to ___ raises traveler's diarrhea as also possible but unlikely due to late presentation. Appendicitis was considered very unlikely based on imaging and prominence of diarrhea. Fortunately C-diff PCR is negative. Campylobacter and otther stool studies also negative. IBD very unlikely given the acute presentation and lack of alarm or systemic symptoms. She receivedI IV fluids, bismuth, and an empiric 3-day course of po ciprofloxacin. Her pain was managed with tylenol, opioids, and dicyclomine for cramping. She was tolerating a light diet prior to time of discharge. # Leukocytosis: Resolved after IV fluids overnight after admission. She had elevated WBC 17.6 with N 86.4% on admission. Most likely this is multifactorial from enteritis along with hypovolemia and hemoconcentration. Resolved with fluids alone without any initial empiric antibiotic coverage. CHRONIC ISSUES: # GERD: She takes Omeprazole 40 mg PO BID for GERD symptoms. Given her Cdiff history, tapering her PPI as an outpatient would be reasonable to consider. Continued Omeprazole 40 mg PO BID for now # Anxiety: Continued home fluoxetine. TRANSITIONAL ISSUES: - consider tapering omeprazole as outpatient if able given history of c-diiff ",3098,364
10004764-DS-13,"<SEX> M <SERVICE> CARDIOTHORACIC <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___ <CHIEF COMPLAINT> Chest pain <MAJOR SURGICAL OR INVASIVE PROCEDURE> ___ Urgent coronary artery bypass graft x3, left internal mammary artery to left anterior descending artery, saphenous vein graft to diagonal and distal right coronary arteries. 2. Endoscopic harvesting of long saphenous vein. <HISTORY OF PRESENT ILLNESS> ___ old male hx of CAD, underwent PCI ___ ago BMS to left circ and balloon angioplasty to diagonal branch. At that time was note to have RCA and LAD disease. He reports that over the past few months he has been having worsening chest discomfort, described as burning sensation mid chest that radiates down both arms. He has pain with exertion, relieved with rest. Yesterday he developed chest pain and took SL nitro,pain reslved. He was seen by his PCP today who referred him to ___. His EKG was unremarkable, troponin 0.22. He underwent cardiac cath today which revealed significant multivessel disease. He was transferred to ___ for CABG evaluation. <PAST MEDICAL HISTORY> <PAST MEDICAL HISTORY> CAD, HTN, Hypercholesterolemia Past Surgical History: PCI ___ s/p T+A <SOCIAL HISTORY> ___ <FAMILY HISTORY> unremarkable <PHYSICAL EXAM> ___: Skin: Dry [x] intact [x] HEENT: PERRLA [x] EOMI [x] Neck: Supple [x] Full ROM [x] Chest: Lungs clear bilaterally [x] Heart: RRR [x] Irregular [] Murmur [] grade ______ Abdomen: Soft [x] non-distended [x] non-tender [x] bowel sounds +[x] Extremities: Warm [x] well-perfused [x] Edema [] _____ Varicosities: None [x] Neuro: Grossly intact [x] Pulses: Femoral Right: 2+ Left: 2+ DP Right: 1+ Left: 1+ ___ Right: 1+ Left: 1+ Radial Right: cath site Left: 2+ Carotid Bruit: Right: no Left: no <PERTINENT RESULTS> Cardiac Catheterization: Date: ___ Place: ___ LM 90% stenosis LAD ___ 90% stenosis Circ: 100% stenosis, existing stent unknown, instent stenosis, no thrombosis RCA: mid ___ 60% stenosis, mid 70% Left heart cath revealed: EF 65% grade 2 MR, aortic valve Ok Cardiac Echocardiogram: ___ ECHOCARDIOGRAPHY REPORT ___ ___ MRN: ___ TEE (Complete) Done ___ at 9: 24: 37 AM FINAL Referring Physician ___ ___ of Cardiothoracic Surg ___ ___ ___ Status: Inpatient DOB: ___ Age (years): ___ M Hgt (in): 70 BP (mm Hg): 127/60 Wgt (lb): 143 HR (bpm): 68 BSA (m2): 1.81 m2 Indication: Intraoperative TEE for CABG Diagnosis: I25.9, I34.0 ___ Information Date/Time: ___ at 09: 24 ___ MD: ___, MD ___ Type: TEE (Complete) Sonographer: ___, MD Doppler: Full Doppler and color Doppler ___ Location: Anesthesia West OR cardiac Contrast: None Tech Quality: Adequate Machine: Echocardiographic Measurements Results Measurements Normal Range Left Ventricle - Septal Wall Thickness: *1.2 cm 0.6 - 1.1 cm Left Ventricle - Inferolateral Thickness: 1.1 cm 0.6 - 1.1 cm Left Ventricle - Ejection Fraction: 60% to 65% >= 55% Findings LEFT ATRIUM: Dilated LA. RIGHT ATRIUM/INTERATRIAL SEPTUM: Dilated RA. LEFT VENTRICLE: Normal LV wall thickness, cavity size, and global systolic function (LVEF>55%). Normal regional LV systolic function. RIGHT VENTRICLE: Normal RV chamber size and free wall motion. AORTA: Normal ascending aorta diameter. Normal aortic arch diameter. Focal calcifications in aortic arch. Normal descending aorta diameter. Simple atheroma in descending aorta. Focal calcifications in descending aorta. AORTIC VALVE: Normal aortic valve leaflets (3). No AS. No AR. MITRAL VALVE: Mildly thickened mitral valve leaflets. No MS. ___ (1+) MR. ___ VALVE: Normal tricuspid valve leaflets with trivial TR. No TS. PULMONIC VALVE/PULMONARY ARTERY: Pulmonic valve not visualized. No PS. Physiologic PR. PERICARDIUM: Very small pericardial effusion. ___ COMMENTS: Written informed consent was obtained from the ___. The ___ was under ___ anesthesia throughout the procedure. No TEE related complications. The ___ appears to be in sinus rhythm. Results were personally reviewed with the MD caring for the ___. See Conclusions for post-bypass data Conclusions PRE-BYPASS: The left atrium is dilated. The right atrium is dilated. Left ventricular wall thickness, cavity size, and global systolic function are normal (LVEF>55%). Regional left ventricular wall motion is normal. Right ventricular chamber size and free wall motion are normal. The aortic valve leaflets (3) appear structurally normal with good leaflet excursion and no aortic stenosis or aortic regurgitation. The mitral valve leaflets are mildly thickened. There is billowing of the anterior mitral leaflet. Mild (1+) mitral regurgitation is seen. Trace tricuspid regurgitation is seen. There is a very small pericardial effusion. POST-BYPASS: The ___ is in sinus rhythm and receiving a phenylephrine infusion. Biventricular function remains preserved. There are no regional wall motion abnormalities. Valvular function is unchanged. The thoracic aorta is intact following decannulation. <MEDICATIONS ON ADMISSION> ASA 81mg daily atenolol 25mg daily atorvastatin 80mg daily <DISCHARGE MEDICATIONS> 1. Acetaminophen 1000 mg PO/PR QID: PRN pain or temperature >38.0 2. Amiodarone 200 mg PO BID take 200mg twice daily for one week, then decrease to 200mg daily ongoing RX *amiodarone 200 mg one tablet(s) by mouth twice daily Disp #*120 Tablet Refills: *2 3. Metoprolol Succinate XL 150 mg PO DAILY RX *metoprolol succinate 50 mg three tablet(s) by mouth daily Disp #*90 Tablet Refills: *2 4. OxyCODONE (Immediate Release) ___ mg PO Q4H: PRN Pain: moderate/severe RX *oxycodone 5 mg ___ tablet(s) by mouth every four hours Disp #*40 Tablet Refills: *0 5. Aspirin 81 mg PO DAILY 6. Atorvastatin 80 mg PO QPM <DISCHARGE DISPOSITION> Home With Service Facility: ___ <DISCHARGE DIAGNOSIS> Coronary Artery Disease Hypertension HTN, Hypercholesterolemia <DISCHARGE CONDITION> Alert and oriented x3 nonfocal Ambulating with steady gait Incisional pain managed with oral analgesics Incisions: Sternal - healing well, no erythema or drainage Leg Right/Left - healing well, no erythema or drainage. Edema trace <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Please shower daily including washing incisions gently with mild soap, no baths or swimming until cleared by surgeon. Look at your incisions daily for redness or drainage Please NO lotions, cream, powder, or ointments to incisions Each morning you should weigh yourself and then in the evening take your temperature, these should be written down on the chart No driving for approximately one month and while taking narcotics, will be discussed at follow up appointment with surgeon when you will be able to drive No lifting more than 10 pounds for 10 weeks Females: Please wear bra to reduce pulling on incision, avoid rubbing on lower edge **Please call cardiac surgery office with any questions or concerns ___. Answering service will contact on call person during off hours** ","Mr. ___ was transferred to ___ on ___. On ___ he underwent a coronary artery bypass grafting times three. Please see operative note for full details. He tolerated the procedure well and was transferred to the CVICU in stable condition for recovery and invasive monitoring. He was weaned from sedation, awoke neurologically intact, and was extubated on post-operative day one. He weaned from inotropic and vasopressor support. Beta blocker was initiated and he was diuresed toward his preoperative weight. Mr. ___ remained hemodynamically stable and was transferred to the telemetry floor for further recovery. Chest tubes and epicardial wires were removed per protocol. He was evaluated by the physical therapy service for assistance with strength and mobility. On the evening of post-operative day two he had about two hours of atrial fibrillation and therefore was placed on oral amiodarone. His beta blockade was up-titrated as tolerated. By the time of discharge on post-operative day four he was ambulating freely, his wounds were healing well, and his pain was controlled with oral analgesics. He was discharged to home in good condition with appropriate follow up instructions. ",1892,242
10004955-DS-12,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> Patient recorded as having No Known Allergies to Drugs <ATTENDING> ___. <CHIEF COMPLAINT> left hip fracture <MAJOR SURGICAL OR INVASIVE PROCEDURE> None. <HISTORY OF PRESENT ILLNESS> ___ with hx of HTN and Meningioma presents from ___ with a fractured right hip while on vacation in ___. The patient states that she suffered a mechincal fall while on vacation 8 days ago. The pt states she underwent a surgical intervention (ORIF) in ___ and has been treat there since that time. The patient states she has been unable to bear weight since that time. The pt denies fevers, chills, increased lower extremity swelling, chest pain or pleuritic pain. . Upon arrival to the ED intial vitals 98.5 131/74 106 18 98% RA. Exam notable for ecchymosis on left ___. Labs notable for BC of 11.6, Hct 27.2 (baseline mid to high ___. itals prior to transfer to the floor 98.8 97 120/57 16 97RA. . Upon arrival to the floor the patient has no complaints. Denies chest pain, pleuritic pain, shortness of breath or increased leg swelling. <PAST MEDICAL HISTORY> # Meningioma - Dx ___ with change in mental status - s/p craniotomy ___ with Dr. ___. Remains on Dilantin for life. Followed annually by Dr. ___. MRI ___ ___ evidence of recurrence. Bone density being monitored. # Hyperparathyroidism: s/p parathyroid adenoma removal (___) with Dr. ___ has ___ with Dr. ___. Has annual followup with Dr. ___. # Hypothyroidism # Right nephrolithotomy for treatment of renal staghorn calculus. ___, hx of recurrent kidney stones, previously seen by Dr. ___. CT scan ___ residual stones were noted. # Hypertension with Renal insufficiency - Cr 1.6. # Psoriasis scalp-well controlled with Neutrogena T/Gel once or twice weekly. # Mild to moderate mitral regurgitation- repeat echocardiogram ___ MR. # Cholelithiasis-asymptomatic # Squamous cell carcinoma -anterior chest wall. No recurrence. Followed by Dr. ___ at ___ dermatology <SOCIAL HISTORY> ___ <FAMILY HISTORY> Non-Contributory. No known early CAD. <PHYSICAL EXAM> Vitals: 98.8 97 120/57 16 97%RA Gen: NAD, AOX3 HEENT: PERRLA, EOMI, MMM, sclera anicteric, not injected, no exudates Neck: no thyromegally, JVD: Cardiovascular: RRR normal s1, s2, no murmurs, rubs or gallops. No loud P2 or appreciable RV heave. Respiratory: Clear to auscultation bilaterally, no wheezes, rales or rhonchi Abd: Soft, non-tender, non distended, no heptosplenomegally, bowel sounds present, guaiac negative Extremities: Left hip with ecchymoses. Surgical site with dressing c/d/i. Bilateral ___ stockings. ___ to palpation on skin bilaerally. No appreciable cords. Neurological: CN II-XII intact, normal attention, sensation normal, Integument: Warm, moist, no rash or ulceration Psychiatric: appropriate, pleasant, not anxious <PERTINENT RESULTS> ___ 08: 45PM BLOOD WBC-11.6* RBC-3.00*# Hgb-9.3*# Hct-27.2*# MCV-91 MCH-31.1 MCHC-34.3 RDW-18.3* Plt ___ ___ 06: 00AM BLOOD WBC-7.7 RBC-2.88* Hgb-8.8* Hct-25.9* MCV-90 MCH-30.5 MCHC-33.9 RDW-18.1* Plt ___ ___ 08: 45PM BLOOD ___ PTT-22.1 ___ ___ 08: 45PM BLOOD Glucose-95 UreaN-23* Creat-1.1 Na-146* K-3.6 Cl-109* HCO3-27 AnGap-14 ___ 05: 50AM BLOOD Iron-41 ___ 05: 50AM BLOOD calTIBC-187* VitB12-470 Folate-8.7 Ferritn-98 TRF-144* ___ 06: 40PM URINE Blood-NEG Nitrite-NEG Protein-25 Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-7.0 Leuks-MOD ___ 06: 40PM URINE RBC-0 ___ Bacteri-MOD Yeast-NONE ___ Discharge: ___ 06: 00AM BLOOD WBC-7.7 RBC-2.88* Hgb-8.8* Hct-25.9* MCV-90 MCH-30.5 MCHC-33.9 RDW-18.1* Plt ___ ___ 06: 00AM BLOOD Plt ___ ___ 06: 00AM BLOOD Glucose-79 UreaN-19 Creat-1.0 Na-142 K-3.7 Cl-108 HCO3-24 AnGap-14 hip XR (prelim read): No e/o acute fx or hardware complication/failure. Increased bony bridging compared to ___. <MEDICATIONS ON ADMISSION> Phoslo 667mg 2 capsules TID Levothyroxine 112mcg PO Daily Lisinopril 5mg PO Daily Phenytoin 100mg PO TID ASA 81mg PO Daily Calcium Citrate 250mg PO Daily Vitamin D 400mg <DISCHARGE MEDICATIONS> 1. Levothyroxine 112 mcg Tablet Sig: One (1) Tablet PO DAILY (Daily). 2. Lisinopril 5 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 3. Phenytoin Sodium Extended 100 mg Capsule Sig: One (1) Capsule PO Q8H (every 8 hours). 4. Aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable PO DAILY (Daily). 5. Calcium Citrate 250 mg Tablet Sig: One (1) Tablet PO once a day. 6. Cholecalciferol (Vitamin D3) 400 unit Tablet Sig: One (1) Tablet PO DAILY (Daily). 7. Calcium Acetate 667 mg Capsule Sig: Two (2) Capsule PO BID (2 times a day). 8. Enoxaparin 30 mg/0.3 mL Syringe Sig: One (1) injection Subcutaneous Q12H (every 12 hours). 9. Acetaminophen 325 mg Tablet Sig: Two (2) Tablet PO Q6H (every 6 hours). 10. Oxycodone 5 mg Tablet Sig: One (1) Tablet PO every eight (8) hours as needed for pain. 11. Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day). 12. Senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a day) as needed for constipation. <DISCHARGE DISPOSITION> Extended Care Facility: ___ <DISCHARGE DIAGNOSIS> Primary Diagnosis: 1. hip fracture <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Out of Bed with assistance to chair or wheelchair. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> You were seen at ___ after a hip fracture and repair. You were evaluated by our orthopedic surgeons, who requested X-rays and then recommended that you undergo intensive physical rehabilitation. You were found to have a low red blood cell count compared to two months ago. We suspect that this was because of your fall and surgery, as it appears that you have a blood collection in your leg. We feel that this is stable and you should continue to watch this; if you see signs of increased swelling in your leg, please call your doctor. The following medications were changed during this hospitalization: ADDED tylenol for pain control ADDED oxycodone for pain control ADDED docusate for constipation ADDED senna for constipation ","The patient was admitted after returning from ___, as she was still having severe hip pain with movement. X-rays suggested no hardware malfunction. The Orthopedics service was consulted, who evaluated the patient and recommended rehabilitation with physical therapy. The patient was also noted to have anemia with a hematocrit drop to 27 from the mid-30s approximately 1.5 months ago. This was likely due to her fracture, as a hematoma was noted on the side of the hip without evidence of expansion during the hospitalization. Her hematocrit remained stable. and was 25 at the time of discharge. Additionally, she was found to have pyuria on urinalysis; however, the patient denied dysuria. For this reason, antibiotic treatment was deferred, although this should continue to be followded as an outpatient. ",1900,168
10004963-DS-3,"<SEX> F <SERVICE> NEUROSURGERY <ALLERGIES> Aspirin / ibuprofen <ATTENDING> ___. <CHIEF COMPLAINT> Back and left leg pain <MAJOR SURGICAL OR INVASIVE PROCEDURE> L4-5 microdiscectomy <HISTORY OF PRESENT ILLNESS> THis is a ___ year old female with known herniated discs at L4-5 and L5-S1. This was first detected about ___ years ago. She initially did physical therapy which helped significantly, and she has been relatively pain free since that time. HOwever, this past week she spontaneously developed severe pack pain, radiating down her Left leg. She was seen at ___ earlier today, and was found to have persistent herniated disks at these levels. Transferred to ___ ER for further evaluation. She denies weakness, but pain to her L buttocks radiating down the posterior thigh and calf. She also reports numbness to the top of her left foot. <PAST MEDICAL HISTORY> A.D.D <SOCIAL HISTORY> ___ <FAMILY HISTORY> NC <PHYSICAL EXAM> PHYSICAL EXAM: O: T: 98.1 BP: 92/68 HR: 83 R: 18 O2Sats: 100% Gen: WD/WN, comfortable, NAD. Lying on bed with cane Neck: Supple. Extrem: Warm and well-perfused. Neuro: Mental status: Awake and alert, cooperative with exam, normal affect. Orientation: Oriented to person, place, and date. Motor: D B T WE WF IP Q H AT ___ G Sensation: Intact to light touch, propioception, pinprick and vibration bilaterally. Reflexes: Br Pa Ac Right ___ Left ___ Propioception intact Toes downgoing bilaterally Rectal exam normal sphincter control <PERTINENT RESULTS> MRI lumbar spine ___ Shows L4-5 herniated disc with compression of L L5 nerve root. <MEDICATIONS ON ADMISSION> 1. Concerta 27mg Daily 2. Immitrex PRN 3. Codeine 4. Colace <DISCHARGE MEDICATIONS> 1. Concerta 27 mg Tablet Extended Rel 24 hr Sig: One (1) Tablet Extended Rel 24 hr PO Daily (). 2. oxycodone-acetaminophen ___ mg Tablet Sig: ___ Tablets PO Q4H (every 4 hours) as needed for pain. Disp: *60 Tablet(s)* Refills: *0* 3. sulfamethoxazole-trimethoprim 800-160 mg Tablet Sig: One (1) Tablet PO BID (2 times a day) for 3 days. Disp: *6 Tablet(s)* Refills: *0* <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> L L4-5 herniated disc <DISCHARGE CONDITION> AOx3. Activity as tolerated. No lifting greater than 10 pounds. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> - Do not smoke - Keep wound clean / No tub baths or pools until seen in follow up/ remove dressing POD#2 / begin daily showers POD#4 - If you have steri-strips in place  keep dry x 72 hours. They will fall off on their own or be taken off in the office - No pulling up, lifting> 10 lbs., excessive bending or twisting for two weeks. - Limit your use of stairs to ___ times per day - Have a family member check your incision daily for signs of infection - If you are required to wear one, wear cervical collar or back brace as instructed - You may shower briefly without the collar / back brace unless instructed otherwise - Take pain medication as instructed; you may find it best if taken in the a.m. when you wake for morning stiffness and before bed for sleeping discomfort - Do not take any anti-inflammatory medications such as Motrin, Advil, aspirin, Ibuprofen etc. for 3 months. - Increase your intake of fluids and fiber as pain medicine (narcotics) can cause constipation - Clearance to drive and return to work will be addressed at your post-operative office visit CALL YOUR SURGEON IMMEDIATELY IF YOU EXPERIENCE ANY OF THE FOLLOWING: - Pain that is continually increasing or not relieved by pain medicine - Any weakness, numbness, tingling in your extremities - Any signs of infection at the wound site: redness, swelling, tenderness, drainage - Fever greater than or equal to 101 F - Any change in your bowel or bladder habits ",Pt was admitted to neurosurgery service for further evaluation and pain control. She was intially started on decadron to help with pain control and this offered no relief and she was unable to ambulate. Her physical exam showed trace ___ weakness and it was decided she would benefit from decompression. She was taken to the OR on ___ for L4-5 discectomy. She tolerated this procedure very well with no complications. Post operatively she was transferred back to the floor. On post op exam her leg pain had improved and she only complained of surgical site pain. Her strength was full on examination. She was able to ambulate without difficulty and she will be discharged home on ___ in stable condition. ,984,144
10005001-DS-6,"<SEX> F <SERVICE> OBSTETRICS/GYNECOLOGY <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___ <CHIEF COMPLAINT> Abdominal bloating <MAJOR SURGICAL OR INVASIVE PROCEDURE> Right salpingo-oophorectomy Left cystectomy <HISTORY OF PRESENT ILLNESS> Ms. ___ is a ___ gravida 0 woman who complains of abdominal bloating. She has a long gynecological history significant for uterine fibroids, endometriosis, and endometriomas. While she first started having symptoms of abdominal bloating, menorrhagia, severe menstrual cramping, urinary frequency, nocturia, and constipation in ___, her multiple gynecological diagnoses were not made until she received her first pelvic ultrasound in ___. After multiple myomectomies with Dr. ___ patient was followed biannually, then annually, and finally as needed for symptoms. In ___, ___ noticed abdominal bloating, which she described as a sensation of heaviness in her lower abdomen. A pelvic ultrasound in ___ showed an unchanged fibroid uterus, an unchanged 5.6cm left-sided endometrioma, and a new nodular 7.5cm right-sided endometrioma up to 5mm in wall thickness, concerning for malignant transformation. The patient presents today for surgical evaluation of her imaging findings. ROS was negative for F/C, CP, SOB, abdominal pain, N/V, C/D, changes in bowel or bladder habits, or intermenstrual bleeding. ROS was positive for mild dysmenorrhea, relieved by OTC NSAIDs. <PAST MEDICAL HISTORY> Past OB/GYN: The patient has regular menses. She has never had a pregnancy. Her last Pap smear was in ___, which was normal. She does have a history of genital warts. The patient has a long history of uterine fibroids, endometriosis, endometriomas. She is in a monogamous relationship with a female partner and uses a Mirena IUD. PMH: Allergic rhinitis Depression Uterine fibroids Endometriosis Endometriomas Pseudocholinesterase deficiency PSH: Medial collateral ligament release  ___ Abdominal MMY <SOCIAL HISTORY> ___ <FAMILY HISTORY> Her mother had hypertension and died of colon cancer. Her father has hypertension and prostate cancer. <PHYSICAL EXAM> DISCHARGE EXAM: VS: Gen: This is a well-developed, well-nourished woman in no apparent distress. HEENT: Mucus membranes moist. Oropharynx clear. CV: Regular rate and rhythm. Normal S1 and S2 without murmurs, rubs, or gallops. Pulm: Clear to auscultation bilaterally Abd: Normoactive bowel sounds. Soft, nondistended, nontender. No hepatosplenomegaly. Well-healed ___ scar from her previous MMY. Incision intact. Pelvic: Normal female external genitalia. No rashes or lesions. Bartholin, urethral, and Skene's glands were normal. The vaginal vault contained normal-appearing vaginal discharge. The cervix was nulliparous, without cervical motion tenderness. Uterus was mobile and adnexa were difficult to appreciate given the patients habitus. Ext: 2+ peripheral pulses. No clubbing, cyanosis, or edema. Neuro: Awake, alert, and oriented to person, place, and time. Gross motor and sensory functions intact. <MEDICATIONS ON ADMISSION> Duloxetine 60mg PO QD Lorazapam 0.5mg PO QD as needed <DISCHARGE MEDICATIONS> 1. ibuprofen 600 mg Tablet Sig: One (1) Tablet PO Q6H (every 6 hours) as needed for pain. Disp: *30 Tablet(s)* Refills: *2* 2. oxycodone-acetaminophen ___ mg Tablet Sig: ___ Tablets PO Q4H (every 4 hours) as needed for pain. Disp: *40 Tablet(s)* Refills: *0* 3. duloxetine 30 mg Capsule, Delayed Release(E.C.) Sig: Two (2) Capsule, Delayed Release(E.C.) PO DAILY (Daily). 4. calcium carbonate 200 mg calcium (500 mg) Tablet, Chewable Sig: One (1) Tablet, Chewable PO QID (4 times a day) as needed for dyspepsia. 5. Colace 100 mg Capsule Sig: One (1) Capsule PO twice a day as needed for constipation. Disp: *60 Capsule(s)* Refills: *2* <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Primary diagnosis: Endometriomas Secondary diagnoses: Fibroid uterus, endometriosis <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> General instructions: * Take your medications as prescribed. * Do not drive while taking narcotics. * Do not combine narcotic and sedative medications or alcohol * Do not take more than 4000mg acetaminophen (APAP) in 24 hrs * No strenuous activity until your post-op appointment * Nothing in the vagina (no tampons, no douching, no sex), no heavy lifting of objects >10lbs for 6 weeks. * You may eat a regular diet Incision care: * You may shower and allow soapy water to run over incision; no scrubbing of incision. No bath tubs for 6 weeks. * If you have steri-strips, leave them on. They will fall off on their own or be removed during your followup visit. * If you have staples, they will be removed at your follow-up visit. To reach medical records to get the records from this hospitalization sent to your doctor at home, call ___. ","Ms. ___ is a ___ gravida 0 with a history of uterine fibroids, endometriosis, and endometriomas who complains of worsening abdominal bloating and was found to have a 7.5 cm right endometrioma concerning for malignancy. She was taken to the OR for right salpingo-oophorectomy and left cystectomy with possible total abdominal hysterectomy and cancer staging. Intraoperatively, she was found to have an unchanged fibroid uterus, evidence of endometriosis, and bilateral endometriomas. A right salpingo-oophorectomy and left cystectomy were performed. Frozen pathology sections were found to contain only benign columnar epithelium, and therefore the patient was closed. Cystoscopy showed bilateral ureteral jets of indigo ___ dye, suggestive of intact ureters at the end of the procedure. Please refer to the operative note for full details. Postoperatively, the patient did well, tolerating a regular diet and oral pain medications by POD1. On POD1, her Foley catheter was removed. She was discharged to home in good condition on post-operative day 2. ",1302,244
10005001-DS-7,"<SEX> F <SERVICE> OBSTETRICS/GYNECOLOGY <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___ <CHIEF COMPLAINT> symptomatic fibroid uterus, left ovarian cyst <MAJOR SURGICAL OR INVASIVE PROCEDURE> exploratory laparotomy, lysis of adhesions, multiple myomectomy, left ovarian cystectomy <HISTORY OF PRESENT ILLNESS> Ms. ___ is a ___ gravida 0 with a long history of recurrent ovarian cyst and endometriosis who on ___, underwent a right salpingo-oophorectomy, left ovarian cystectomy for endometriomas. In ___, she had a multiple myomectomies for symptomatic fibroid uterus. The patient presents today for followup of unknown left adnexal cyst. The patient notes that she has no abdominal pain. She is simply experiencing increased bloatedness and pelvic pressure. New symptoms, she has developed stress urinary incontinence with sneezing. We discussed that this certainly can be related to this large adnexal cyst in addition to her overweightedness. On ___, she had an ultrasound, which showed an anteverted uterus that measured 14.3 x 6.7 x 9.2 cm, slightly smaller than previous measurement on ___, where it measured 15.2 x 7.4 x 10.4 cm. Multiple masses were consistent with uterine fibroids. The dominant fibroid was seen at the fundus and measured 3.3 x 3.3 x 3.5 cm. The endometrium was distorted due to fibroids and not well evaluated. An IUD was demonstrated within the endometrial cavity. The patient is status post right oophorectomy, previously seen 10.7 cm left adnexal cyst again visualized and now measuring slightly larger at 10.8 x 10 cm. It predominantly was thin walled; however, there was one area with the appearance of an incomplete septation. This either represented a hydrosalpinx or peritoneal inclusion cyst, less likely a cystadenoma. There was no free pelvic fluid. These findings were discussed with the patient. <PAST MEDICAL HISTORY> Past OB/GYN: The patient has regular menses. She has never had a pregnancy. She does have a history of genital warts. The patient has a long history of uterine fibroids, endometriosis, endometriomas. She is in a monogamous relationship with a female partner. PMH: ___ rhinitis Depression Uterine fibroids Endometriosis Endometriomas Pseudocholinesterase deficiency PSH: Medial collateral ligament release  ___ Abdominal MMY <SOCIAL HISTORY> ___ <FAMILY HISTORY> Her mother had hypertension and died of colon cancer. Her father has hypertension and prostate cancer. <PHYSICAL EXAM> Discharge <PHYSICAL EXAM> AVSS Gen NAD CV RRR P CTAB Abd soft, nondistended, appropriately tender to palpation, incision c/d/I Ext WWP <PERTINENT RESULTS> ___ 07: 25AM WBC-5.9 RBC-4.30 HGB-13.4 HCT-40.5 MCV-94 MCH-31.2 MCHC-33.1 RDW-11.9 RDWSD-41.6 ___ 07: 25AM PLT COUNT-268 <MEDICATIONS ON ADMISSION> Duloxetine 60mg QD <DISCHARGE MEDICATIONS> 1. DULoxetine 60 mg PO DAILY 2. Ibuprofen 600 mg PO Q6H: PRN pain RX *ibuprofen 600 mg 1 tablet(s) by mouth every six (6) hours Disp #*50 Tablet Refills: *0 3. OxyCODONE (Immediate Release) ___ mg PO Q4H: PRN severe pain RX *oxycodone 5 mg ___ tablet(s) by mouth every four (4) hours Disp #*40 Tablet Refills: *0 4. Docusate Sodium 100 mg PO BID RX *docusate sodium [Colace] 100 mg 1 capsule(s) by mouth twice a day Disp #*60 Capsule Refills: *3 <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> fibroid uterus, ovarian cyst <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Ms. ___, You were admitted to the gynecology service after your procedure. You have recovered well and the team believes you are ready to be discharged home. Please call Dr. ___ office with any questions or concerns. Please follow the instructions below. General instructions: * Take your medications as prescribed. * Do not drive while taking narcotics. * Take a stool softener such as colace while taking narcotics to prevent constipation. * Do not combine narcotic and sedative medications or alcohol. * Do not take more than 4000mg acetaminophen (APAP) in 24 hrs. * No strenuous activity until your post-op appointment. * No heavy lifting of objects >10 lbs for 6 weeks. * You may eat a regular diet. * You may walk up and down stairs. Incision care: * You may shower and allow soapy water to run over incision; no scrubbing of incision. No tub baths for 6 weeks. * If you have steri-strips, leave them on. They will fall off on their own or be removed during your followup visit. * If you have staples, they will be removed at your follow-up visit. Call your doctor for: * fever > 100.4F * severe abdominal pain * difficulty urinating * vaginal bleeding requiring >1 pad/hr * abnormal vaginal discharge * redness or drainage from incision * nausea/vomiting where you are unable to keep down fluids/food or your medication To reach medical records to get the records from this hospitalization sent to your doctor at home, call ___. ","On ___, Ms. ___ was admitted to the gynecology service after undergoing an exploratory laparotomy, lysis of adhesions, left ovarian cystectomy, abdominal myomectomy for symptomatic fibroid uterus and left ovarian cyst. Please see the operative report for full details. Her post-operative course was uncomplicated. Immediately post-op, her pain was controlled with IV dilaudid and toradol. On post-operative day 1, her urine output was adequate so her foley was removed and she voided spontaneously. Her diet was advanced without difficulty and she was transitioned to PO oxycodone, Tylenol and ibuprofen (pain meds). By post-operative day 2, she was tolerating a regular diet, voiding spontaneously, ambulating independently, and pain was controlled with oral medications. She was then discharged home in stable condition with outpatient follow-up scheduled. ",1324,183
10005001-DS-8,"<SEX> F <SERVICE> OBSTETRICS/GYNECOLOGY <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> Malignant transformation of endometriosis - final pathology report pending. <MAJOR SURGICAL OR INVASIVE PROCEDURE> exploratory laparotomy, total abdominal hysterectomy, left salingo-oophrectomy, omentectomy, para-aortic lymph node biopsy, liver resection, cystoscopy <HISTORY OF PRESENT ILLNESS> Ms. ___ is a ___ G0 with a history of fibroids and endometriosis who presents today for consultation regarding a large left adnexal mass identified on imaging. In ___ she underwent an abdominal myomectomy with left ovarian cystectomy for 27 fibroids and a 15-cm endometrioma. She reports recovering well until around ___, when she started to experience epigastric discomfort and occasional shortness of breath. She underwent CTA of the chest to evaluate for PE, which was negative and there was no lymphadenopathy or suspicious nodule seen. In ___, she got the heaviest period she has had since her Mirena IUD was placed. She underwent endometrial biopsy on ___, which showed chronic endometritis. She was already taking doxycycline for a positive Lyme titer while awaiting confirmatory testing, but continued to have vaginal bleeding. Her followup Lyme testing was negative. She continued to feel quite fatigued and noted abdominal pain epigastrically as well as in the LLQ, back pain, and decreased appetite and constipation which got progressively more bothersome during ___. She ultimately went to the ED on ___ where she underwent CT scan of the abdomen and pelvis, which showed a large 10-cm left complex adnexal cystic mass with septations and irregular solid components. Additionally, there were multiple subcapsular hepatic lesions and peritoneal implants, as well as retroperitoneal lymphadenopathy. Findings were concerning for a metastatic primary ovarian neoplasm, such as cystadenocarcinoma, versus atypical distribution of endometriotic implants. On ___ patient underwent an MRI of the abdomen and pelvis lower thorax showed clear lung bases no focal consolidations no pleural or pericardial effusion. Liver showed multiple nonenhancing cystic subcapsular implants likely representing hemorrhage. The largest right arises from the right lobe of the liver and measured 4.1 x 2.8 cm. There was no associated enhancement likely represent adherent clot. There were no suspicious enhancing lesions intrinsic to the hepatic parenchyma. Again, in regard to the pelvis, there was a large cystic multiloculated left adnexal structure measuring up to 10.8 x 10.1 cm. The septations were thin without significant enhancement or nodular components. The loculations demonstrated fluid-filled areas correction fluid-filled levels also likely representing hemorrhage. Within one of the loculations, there was a dark spot sign a finding that could be consistent with endometriosis. A smaller right adnexal cystic structure was seen measuring 3.5 x 3.0 cm. Uterus was enlarged with multiple small fibroids and IUD was seen within the endometrial cavity at. There was a trace free fluid within the pelvis multiple cystic anterior peritoneal implants were visualized with fluid-filled levels likely representing hemorrhage. There was peripheral enhancement, which may be reactive in nature. One of these peritoneal implants appeared to have significant surrounding fat stranding. A left periaortic retroperitoneal lesion had a similar appearance. Multiple subcentimeter periaortic lymph nodes were nonspecific. There was no inguinal or pelvic lymphadenopathy. She saw Dr. ___ in the office on ___ and received a 1-month dose of Lupron. She was referred to ___ Oncology for further evaluation given atypical imaging findings. Of note, she had a CA125 checked on ___, which was 108, decreased from 209 in ___. CEA was 0.9 on ___. Today she reports abdominal bloating, constipation, decreased appetite and increased abdominal girth. She noted decreased vaginal spotting since her Lupron shot, but it has been persistent. She also reports continued fatigue and occasional nausea. She denies chest pain, shortness of breath, diarrhea or dysuria. <PAST MEDICAL HISTORY> GYN HX: G0 - LMP ___, only minor spotting while IUD in place except when bleeding began in ___ - Currently sexually active with female partner - ___ history of abnormal Pap smears; last Pap ___ - Denies history of pelvic infections or sexually transmitted infections - Known history of fibroids and ovarian cysts - Known endometriosis PMH: - allergic rhinitis - depression - pseudocholinesterase deficiency - Denies hypertension, diabetes, asthma, thromboembolic disease PSH: - ___ knee surgery - ___ abdominal myomectomy - ___ RSO, L ov cystectomy -> Path: endometriotic cyst with focal metaplastic/reactive changes - ___ abdominal myomectomy, LOA, L ovarian cystectomy -> Path: leiomyomata with degenerative changes, endometriotic cyst <SOCIAL HISTORY> ___ <FAMILY HISTORY> FHx: - Father living, hx of bladder, prostate, skin, and throat cancer (non-smoker) - Mother died age ___ of colon cancer, also had DM and glaucoma - Brother is healthy - Niece with cystic fibrosis - No known family history of breast, uterine, ovarian, or cervical <PHYSICAL EXAM> On day of discharge: Afebrile, vitals stable No acute distress CV: regular rate and rhythm Pulm: clear to auscultation bilaterally Abd: soft, appropriately tender, nondistended, incision clean/dry/intact, no rebound/guarding ___: nontender, nonedematous <MEDICATIONS ON ADMISSION> duloxetine 60mg daily <DISCHARGE MEDICATIONS> 1. Acetaminophen 1000 mg PO Q6H: PRN Pain - Mild do not exceed 4000mg in 24 hours RX *acetaminophen 500 mg 2 tablet(s) by mouth every 6 hours Disp #*60 Tablet Refills: *2 2. Docusate Sodium 100 mg PO BID RX *docusate sodium 100 mg 1 capsule(s) by mouth twice daily Disp #*60 Capsule Refills: *2 3. Enoxaparin Sodium 30 mg SC Q12H Start: ___, First Dose: Next Routine Administration Time Take this medication for a total of 28 days after your surgery, ending ___. RX *enoxaparin 30 mg/0.3 mL 30 mg SC twice a day Disp #*50 Syringe Refills: *0 4. Ferrous GLUCONATE 324 mg PO DAILY RX *ferrous gluconate 324 mg (36 mg iron) 1 tablet(s) by mouth daily Disp #*30 Tablet Refills: *2 5. Ibuprofen 600 mg PO Q6H: PRN Pain - Moderate take with food RX *ibuprofen 600 mg 1 tablet(s) by mouth every 6 hours Disp #*60 Tablet Refills: *1 6. OxyCODONE (Immediate Release) ___ mg PO Q4H: PRN Pain - Severe do not drive or drink alcohol, causes sedation RX *oxycodone 5 mg ___ tablet(s) by mouth every 4 hours Disp #*50 Tablet Refills: *0 7. DULoxetine 60 mg PO DAILY <DISCHARGE DISPOSITION> Home With Service Facility: ___ <DISCHARGE DIAGNOSIS> malignant transformation of endometriosis <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Ms. ___, . You were admitted to the gynecologic oncology service after undergoing the procedures listed below. You have recovered well after your operation, and the team feels that you are safe to be discharged home. Please follow these instructions: . Abdominal instructions: * Take your medications as prescribed. We recommend you take non-narcotics (i.e. Tylenol, ibuprofen) regularly for the first few days post-operatively, and use the narcotic as needed. As you start to feel better and need less medication, you should decrease/stop the narcotic first. * Do not drive while taking narcotics. * Do not combine narcotic and sedative medications or alcohol. * Do not take more than 4000mg acetaminophen (tylenol) in 24 hrs. * No strenuous activity until your post-op appointment. * Nothing in the vagina (no tampons, no douching, no sex) for 12 weeks. * No heavy lifting of objects >10 lbs for 6 weeks. * You may eat a regular diet. * It is safe to walk up stairs. . Incision care: * You may shower and allow soapy water to run over incision; no scrubbing of incision. No bath tubs for 6 weeks. * If you have staples, they will be removed at your follow-up visit. . To reach medical records to get the records from this hospitalization sent to your doctor at home, call ___. . Call your doctor at ___ for: * fever > 100.4 * severe abdominal pain * difficulty urinating * vaginal bleeding requiring >1 pad/hr * abnormal vaginal discharge * redness or drainage from incision * nausea/vomiting where you are unable to keep down fluids/food or your medication * chest pain or difficulty breathing * onset of any concerning symptoms ","Ms. ___ was admitted to the gynecologic oncology service after undergoing exploratory laparaotomy, total abdominal hysterectomy, left salpingo-oophorectomy, omentectomy, para-aortic lymph node biopsy, liver resection and cystoscopy for malignant transformation of endometriosis. Please see the operative report for full details. Her post-operative course is detailed as follows. Immediately postoperatively, her pain was controlled with an epidural and Dilaudid PCA with toradol. Her diet was gradually advanced without difficulty and she was transitioned to oral oxycodone, Tylenol and ibuprofen. On post-operative day #2, her urine output was adequate so her Foley catheter was removed and she voided spontaneously. By post-operative day 5, she was tolerating a regular diet, voiding spontaneously, ambulating independently, and pain was controlled with oral medications. She was then discharged home in stable condition with outpatient follow-up scheduled. ",2096,201
10005012-DS-21,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> Patient recorded as having No Known Allergies to Drugs <ATTENDING> ___. <CHIEF COMPLAINT> Admitted at OSH for SOB <MAJOR SURGICAL OR INVASIVE PROCEDURE> None <HISTORY OF PRESENT ILLNESS> Mrs. ___ is a very nice and confused ___ year-old woman with CAD, HTN, CHF, dyslipidemia, depression, panic attacks and renal cell carcinoma who is transfered to the ___ from ___ after having a osteolytic lession in T7-T8. Patient presented on ___ with SOB and delirium from her nursing home. She was satting 80% on RA in the nursing home and CXR was compatible with CHF and possible PNA (film not available). She received levofloxacin 500 mg PO Daily without improvemt. On ___ a CXR showed bilateral lower lobe infiltrates and she was started on doxycycline without improvement either. Her oxygen saturations dropped and she was tachycardic with what it is reproted as AFib. She was transfered to the ___ for management on ___. . She was admitted to the ICU and diuresed 5 L for possible CHF. She was weaned of the oxygen and had a respiratory alcalosis with metabolic alkalosis with a small A-a gradient, which was thought to be due to her COPD. Patient was also diagnosed with atrial fibrilation in this last hospitalization. It was made the decision to cotninue ASA & Plavix and not anticoagulate due to prior bad experiences with coumadin (unclear). She was diuresed and betablocked. IT was suggested to stard difoxin 50 mg BID and consider cardizem. BNP 1279.1 . She had a CT scan for evaluation of her RCC? and showed a lytic lesion in T7-T8 and was transfered to the ___ for further care. . Upon further history from the daughter she states that since she was originally diagnosed with pneumonia she has not been the same. She has been wax and waining. Her anxiety is increased, she has short-term memory problems, is disoriented. Her activity level has also decreased up to the point in which she is almost bed-bound. <PAST MEDICAL HISTORY> ONCOLOGIC HISTORY: Renal cell CA: Presentation with diverticulitis. Had finding on CT scan of L lower renal pole tumor. Had nephrectomy and path showed conventional type renal cell carcinoma with predominantly granular/eosinophilic cell type, Grade ___, 3.0 cm, with extension into perinephric fat. 1 of 2 LN positive (renal hilum node). Margins uninvolved. Had concomitant segmental resection of the transverse colon due to narrowing on colonoscopy. PAST MEDICAL HISTORY: Chronic Obstructive Pulmonary Disease: O2 dependent with Co2 retention; baseline Co2 ~60 per OSH records Congestive Heart Failure with EF of 49% Renal Cell carcinoma as above T7-T8 lytic lesion Lumonary nodules thought to be metastatic disease Delirium Hypertension Hypercholesterolemia CRI (baseline 1.3) s/p partial colectomy ___ diverticulitis s/p hysterectomy s/p rectal dyslpacia Transverse cholectomy- for non focal diverticulitis MI s/p stent placement ___ yrs ago to the RCA in a 99% stenotic lesion Panic attacks Depression Afib <SOCIAL HISTORY> ___ <FAMILY HISTORY> Mother- expired age ___ stomach ca Father- expired age ___ leukemia Brother- ___ old age Son- ___ YO diagnosed with Alzheimers Son age ~___ ___ dementia as well <PHYSICAL EXAM> VITAL SIGNS - Temp 98.1 F, BP 126/56 mmHg, HR 85 BPM, RR 18 X', O2-sat 95% 2L NC <br> GENERAL - well-appearing woman in NAD, comfortable, appropriate HEENT - NC/AT, PERRLA, EOMI, sclerae anicteric, MMM, OP clear NECK - supple, no thyromegaly, no JVD, no carotid bruits LUNGS - CTA bilat, no r/rh/wh, good air movement, resp unlabored, no accessory muscle use HEART - PMI non-displaced, RRR, no RG, nl S1-S2, SEM in RUSB ___ ABDOMEN - NABS, soft/NT/ND, no masses or HSM, no rebound/guarding. EXTREMITIES - WWP, no c/c/e, 2+ peripheral pulses (radials, DPs), right knee is with patela towards the inner part with full range of motion SKIN - no rashes or lesions other than bruises that match with prior blood draws LYMPH - no cervical, axillary, or inguinal LAD NEURO - awake, A&Ox1 (persoN), CNs II-XII grossly intact, muscle strength ___ throughout, sensation grossly intact throughout to pain, touch, propioception and temperature, DTRs normal in upper extremities and decreased in lower extremities, cerebellar exam intact, her minimental was terribly failed and did not complete due to lack of completion, but she did not recall any 3 words at 5 minutes, was not able to write and only said one of the minus 7s. <PERTINENT RESULTS> Labs: On Admission: ___ 08: 00PM GLUCOSE-159* UREA N-20 CREAT-1.3* SODIUM-138 POTASSIUM-3.7 CHLORIDE-92* TOTAL CO2-34* ANION GAP-16 ___ 08: 00PM ALT(SGPT)-9 AST(SGOT)-20 LD(LDH)-246 ALK PHOS-104 TOT BILI-0.4 ___ 08: 00PM ALBUMIN-3.6 CALCIUM-8.8 PHOSPHATE-3.9 MAGNESIUM-2.0 ___ 08: 00PM VIT B12-666 FOLATE-8.3 ___ 08: 00PM TSH-1.1 ___ 08: 00PM WBC-7.3 RBC-3.83* HGB-12.5 HCT-38.5 MCV-101* MCH-32.6* MCHC-32.4 RDW-15.0 ___ 05: 48PM URINE HOURS-RANDOM UREA N-357 CREAT-40 SODIUM-39 ___ 05: 48PM URINE OSMOLAL-239 ___ 05: 48PM URINE COLOR-Yellow APPEAR-Clear SP ___ ___ 05: 48PM URINE BLOOD-MOD NITRITE-NEG PROTEIN-NEG GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-7.0 LEUK-TR ___ 05: 48PM URINE RBC-13* WBC-11* BACTERIA-NONE YEAST-NONE EPI-<1 ___ 05: 48PM URINE HYALINE-1* Interval Labs: ___ 06: 05AM BLOOD CEA-4.4* ___ AFP-1.2 CA125-401* ___ 06: 05AM BLOOD CA ___ -PND ___ Urine cx negative ___ Blood cx negative ___ 07: 30PM BLOOD Osmolal-277 ___ 07: 13AM URINE Osmolal-467 ___ 07: 13AM URINE Hours-RANDOM Creat-37 Na-81 Discharge Labs: ___ 06: 25AM BLOOD WBC-11.0 RBC-3.99* Hgb-13.0 Hct-39.9 MCV-100* MCH-32.5* MCHC-32.5 RDW-14.9 Plt ___ ___ 06: 25AM BLOOD Glucose-116* UreaN-37* Creat-1.2* Na-130* K-5.5* Cl-94* HCO3-27 AnGap-15 ___ 10: 40AM BLOOD Na-131* K-4.4 Cl-95* Imaging: MRI of spine ___: Multilevel cervical spondylotic changes are seen from C3 through C6. No definite metastatic lesion is seen in the cervical spine. Within the thoracic spine, there are metastatic lesions involving the posterior vertebral body and the posterior elements at T7 and T8. There is substantial epidural disease at T7 which encases and displaces the cord anteriorly with mild compression. There is no abnormal cord signal at this time. There is a metastatic lesion involving the T5 vertebral body on the right. Bilateral pleural effusions are seen. Evaluation of the lumbar spine demonstrates multilevel spondylosis. No definite metastatic lesions seen. Left kidney is not visualized and may have been surgically removed. Please clinically correlate. IMPRESSION: Metastatic disease at T5, T7 and T8. There is epidural tumor at T7 which encases the cord and causes mild cord compression. TTE ___: The left atrium is mildly dilated. No atrial septal defect is seen by 2D or color Doppler. There is mild symmetric left ventricular hypertrophy. There is mild regional left ventricular systolic dysfunction with basal inferior and infero-lateral akinesis (EF 55%). No masses or thrombi are seen in the left ventricle. There is no ventricular septal defect. Right ventricular chamber size and free wall motion are normal. The aortic valve leaflets (3) are mildly thickened but aortic stenosis is not present. Moderate (2+) aortic regurgitation is seen. The mitral valve leaflets are mildly thickened. Moderate to severe (3+) mitral regurgitation is seen. The tricuspid valve leaflets are mildly thickened. There is mild pulmonary artery systolic hypertension. There is a trivial/physiologic pericardial effusion. MRI head/brain ___: No evidence of metastatic disease in the brain. No acute cranial process is seen. CT abd/pelvis ___ (prelim): No evidence of local disease recurrence or distant metastasis. large stool in the rectosigmoid region. <MEDICATIONS ON ADMISSION> Acetaminophen 650mg q4h PRN Acidophilus 2 caps BID Atrovent inh 2 puffs BID Mucinex ___ BID Prilosec 20mg daily CharcoCaps 260-520mg q4h PRN Lidoderm patch daily Fleet enema daily PRN Milk of magnesia 30ml daily PRN Loperamide 4mg PRN Aspirin 81mg daily Plavix 75mg daily Ativan 1mg BID + TID: PRN Duonebs q4h PRN Vicodin ___ tab q4h PRN Premarin cream daily PRN Lasix 20 mg PO Daily Hyomax-SL 0.125mg q6h PRN Colace 200mg daily Zocor 40mg daily Saliva substitute solution q4h PRN Pulmicort 0.25mg/2ml nebs q6h PRN Compazine 10mg PO q8h PRN Bisacodyl 10mg PR PRN Morphine sulfate ER 15 mg PO daily Lopressor 25mg TID Valtrex ___ daily Cymbalta 60mg daily Belladonna-phenobarbital 1 tab TID + TID: PRN Mirtazapine 15mg QHS Trazodone 25mg HS prn Oxycodone 5mg QAM <DISCHARGE MEDICATIONS> 1. Ipratropium Bromide 0.02 % Solution Sig: One (1) Inhalation Q6H (every 6 hours). 2. Aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable PO DAILY (Daily). 3. Omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) Capsule, Delayed Release(E.C.) PO DAILY (Daily). 4. Clopidogrel 75 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 5. Lorazepam 1 mg Tablet Sig: One (1) Tablet PO BID (2 times a day). 6. Furosemide 40 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 7. Simvastatin 40 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 8. Metoprolol Tartrate 50 mg Tablet Sig: One (1) Tablet PO BID (2 times a day). 9. Duloxetine 60 mg Capsule, Delayed Release(E.C.) Sig: One (1) Capsule, Delayed Release(E.C.) PO once a day. 10. Albuterol Sulfate 2.5 mg /3 mL (0.083 %) Solution for Nebulization Sig: One (1) Inhalation Q6H (every 6 hours) as needed for shortness of breath or wheezing. 11. Magnesium Hydroxide 400 mg/5 mL Suspension Sig: Thirty (30) ML PO Q6H (every 6 hours) as needed for constipation. 12. Lisinopril 5 mg Tablet Sig: 0.5 Tablet PO DAILY (Daily). 13. Insulin Lispro 100 unit/mL Solution Sig: One (1) Subcutaneous ASDIR (AS DIRECTED): see attached sliding scale. 14. Heparin (Porcine) 5,000 unit/mL Solution Sig: One (1) Injection TID (3 times a day). 15. Morphine 15 mg Tablet Sig: One (1) Tablet PO every six (6) hours as needed for pain. 16. Dexamethasone 4 mg Tablet Sig: Two (2) Tablet PO three times a day: 8mg tid through ___. 17. Trimethoprim-Sulfamethoxazole 160-800 mg Tablet Sig: One (1) Tablet PO QMOWEFR (___): while on dexamethasone. 18. Senna 8.6 mg Tablet Sig: Two (2) Tablet PO BID (2 times a day). 19. Bisacodyl 5 mg Tablet, Delayed Release (E.C.) Sig: Two (2) Tablet, Delayed Release (E.C.) PO DAILY (Daily) as needed for constipation. 20. Acetaminophen 325 mg Tablet Sig: ___ Tablets PO Q6H (every 6 hours) as needed for fever or pain. 21. Thiamine HCl 100 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 22. Folic Acid 1 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 23. Prochlorperazine Maleate 10 mg Tablet Sig: One (1) Tablet PO every eight (8) hours as needed for nausea. 24. Haloperidol 1 mg Tablet Sig: One (1) Tablet PO HS (at bedtime). 25. Docusate Sodium 100 mg Capsule Sig: Two (2) Capsule PO BID (2 times a day). 26. Polyethylene Glycol 3350 100 % Powder Sig: Seventeen (17) g PO DAILY (Daily). 27. Dexamethasone 4 mg Tablet Sig: Two (2) Tablet PO twice a day: To start ___ and to be continued through ___. 28. Dexamethasone 4 mg Tablet Sig: Two (2) Tablet PO once a day: To begin ___ and continue through ___. 29. Dexamethasone 4 mg Tablet Sig: One (1) Tablet PO once a day: To start ___ and continue through ___. 30. Dexamethasone 2 mg Tablet Sig: One (1) Tablet PO once a day: To begin ___ and continue through ___ then should be discontinued. <DISCHARGE DISPOSITION> Extended Care Facility: ___ <DISCHARGE DIAGNOSIS> Primary: Spinal metastasis with unclear primary tumor Altered mental status Secondary: History of renal cell carcinoma Chronic diastolic heart failure Coronary artery disease Dementia <DISCHARGE CONDITION> Stable <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> You were admitted to ___ due to a tumor that was found in your spine and near your spinal cord on an MRI. We are not clear if this is from your prior kidney cancer, or is a new cancer. However, after discussion with yourself and your daughter, it was decided to treat this with radiation, but not to pursue aggressive treatment options at this time. Please take all medications as prescribed. We have made many minor changes to your medications, and the major changes are as follows: - Changed mirtazipine to haloperidol at night to help relaxation. - Started dexamethasone, a steroid to decrease swelling in your spine. You will also take bactrim, an antibiotic, while on this medication to prevent infection. - Started lisinopril for blood pressure. - Increased lasix to 40mg daily for heart failure. - Changed metoprolol to 50mg BID for blood pressure. - Stopped your valtrex as it is unclear that this is needed. If you experience fevers, chills, worsening confusion, dizziness, chest pain, trouble breathing, back pain, or any other concerning symptoms, please seek medical attention or return to the hospital immediately. ","1. AMS: Per discussion with daughter, patient has had progressive dementia for months, although daughter was not present to comment on deviation from baseline. Her superimposed delirium and agitation were likely from benzo withdrawal, as she was not initially continued on her outpatient standing lorazepam (med list wasn't yet available). With addition of this, and 1mg PO haldol at night, she continued to be confused, although was much more calm and had no further agitation. Her delirium was also managed with pain control (she had very little pain during the admission, though) and frequent reorientation and reassurance. Infectious workup was negative. She had a brain MRI to rule out CVA or metastatic disease, and this was negative. 2. Lytic spine lesion: Seen in T5, T7, T8. Also seen was a mass surrounding the spinal cord with mild anterior spinal cord compression, although with a normal neuro exam. She underwent 3 sessions of XRT during this admission, and will continue XRT on ___ and ___ at 2pm to complete a total of 5 sessions. It remains unclear if her lesions are metastatic renal carcinoma or a new primary, as her renal cell cancer was last treated ___ years ago. CT abdomen/pelvis was done to search for a primary, or find a site amenable to biopsy as XRT made vertebral biopsy not possible. Tumor markers were also sent, but not suggestive of a specific diagnosis. After discussion with the patient's daughter ___ (to whom the patient deferred all medical decisions due to her confusion), it was decided that no further workup for a primary site would be performed. Also, it was decided that there would be no further attempts at treating the patient's malignancy at this time. The patient was on dexamethasone, along with insulin sliding scale and bactrim for prophylaxis, during this admission. She was discharged on a dexamethasone taper, and the bactrim and insulin can be stopped once she is off steroids. Please continue the taper through ___ as outlined explicitly in her discharge medication list. Taper may be modified further upon follow up with radiation-oncology. 3. Disposition: The patient is to return to her prior skilled nursing facility. Her other multiple chronic medical problems remained stable and her prior medication regimen was continued. Regarding goals of care, the patient's daughter was clear that her mother would not want aggressive cancer treatments. She will complete her current radiation course and there is no plan for further treatment of her malignancy. However, she would be amenable to rehospitalization and reconsideration of treatment options if an acute problem were to develop. Patient's code status is DNR/DNI. ",3879,564
10005024-DS-4,"<SEX> M <SERVICE> MEDICINE <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> Abdominal pain <MAJOR SURGICAL OR INVASIVE PROCEDURE> -Flexible sigmoidoscopy ___ -Colonic stent placement ___ <HISTORY OF PRESENT ILLNESS> Mr. ___ is a ___ with history of HCV, etOH use, and hypertension who presents upon transfer from ___ with abdominal pain and found to have likely metastatic colon cancer on CT imaging. The patient reports that he has had dark, liquid bowel movements for the past several weeks. He also reports crampy lower abdominal pain for the past several days which has been worsening. His symptoms have been associated with weight loss; the patient reports 40-lbs over just a few weeks. Lately, the patient has also noticed some lightheadedness with rising with unsteadiness while walking. At ___, the patient was noted to have a hematocrit of 34% and sodium of 118. A CT abdomen showed a rectosigmoid mass with likely metastases to the liver and lungs. Given concern for a RLL infiltrate, he was given antibiotics for a community-acquired pneumonia. Upon transfer to ___ ED, he was found to have a further reduced hematocrit after IV fluids. <PAST MEDICAL HISTORY> Hypertension Alcohol dependence Hepatitis C infection <SOCIAL HISTORY> ___ <FAMILY HISTORY> Mother without significant illnesses. Father with heart condition. <PHYSICAL EXAM> ADMISSION: Vitals: 97.4 134/95 104 22 71.2kg General: Disheveled appearing, drowsy. No acute distress. HEENT: Sclera anicteric. Pale conjunctiva. Pupils equal and reactive to light. Poor dentition. Oropharynx clear. Dry mucous membranes. NECK: Supple. Heart: Tachycardic. Regular rate and rhythm. Normal S1, S2. No murmurs. Lungs: Decreased breath sounds at the bases bilaterally. No wheezes, crackles, or rhonchi. Abdomen: +BS, soft, nondistended. Tender to palpation diffusely. +Hepatomegaly. Genitourinary: No foley. Extremities: Warm and well perfused. Pulses 2+. No peripheral edema. DISCHARGE: Vitals: none GENERAL: Pale appearing not moving. Not arousable to sternal rub HEENT: No pupilary or corneal reflex. Pale conjunctiva CARDIAC: no heart sounds PULMONARY: No breath sounds EXTREMITIES: Cool, no pulses. NEURO: no corneal, pupilary, gag reflexes. No withdrawal to painful stimulus. <PERTINENT RESULTS> ADMISSION LABS: -= ___ 01: 30AM BLOOD WBC-8.0 RBC-3.83* Hgb-10.8* Hct-31.0* MCV-81* MCH-28.1 MCHC-34.7 RDW-15.3 Plt ___ ___ 06: 19AM BLOOD ___ PTT-30.5 ___ ___ 01: 30AM BLOOD Glucose-93 UreaN-7 Creat-0.4* Na-123* K-3.5 Cl-90* HCO3-19* AnGap-18 ___ 01: 30AM BLOOD ALT-30 AST-64* AlkPhos-364* TotBili-0.7 ___ 01: 30AM BLOOD Albumin-3.1* Calcium-8.2* Phos-2.6* Mg-1.9 IMAGING: ======== CT ABD PLV w/oral Contrast (___) IMPRESSION: 1. Interval (since ___ placement of a colonic stent, 2. Circumscribed 10.4 x 7.4mm anterior pelvic fluid collection containing small locules of gas, likely an abscess from sigmoid tumor perforation. This is amenable to drainage. 2a. Moderate/large amount of free air, and small amount of free fluid within the peritoneum. 3. Extensive lymphadenopathy in the retroperitoneum and porta hepatis, which results in narrowing of the origin of the left renal vein. Encasement of the splenic vein-SMV confluence and bilateral renal arteries is also demonstrated, without significant intraluminal narrowing in these vessels. Normally enhancing kidneys on today's study. 4. Innumerable hepatic metastases. 5. Innumerable pulmonary metastases, lungs only partially imaged. 6. Moderately-sized bilateral non-hemorrhagic pleural effusions. ___ Flexible sigmoidoscopy A circumferential mass was encountered at the rectosigmoid junction around 15 cm from the anal verge highly suspcious for primary colorectal cancer. The colonoscope was unable to traverse the stricture which was estimated at around 9mm in diameter.The mass was very friable. (biopsy) Otherwise normal sigmoidoscopy to distal sigmoid colon. Sigmoidoscopy ___: Contents: Solid green stool was found in the rectum. No fresh or old blood was noted. A metal stent was found in the rectum. There is mild tumor ingrowth into the mid-portion of the stent. This area is friable with some bleeding from passage of the endoscope - likely source of bleeding. Impression: Stent in the rectum Stool in the rectum Otherwise normal sigmoidoscopy to splenic flexure Recommendations: Stool softners and laxatives as d/w inpatient team. Oral iron CXR ___: IMPRESSION: There is no clear radiographic change over the past 11 days. Bilateral pleural effusions moderate on the right small on the left and callus pulmonary nodules are unchanged. Extent of central adenopathy is better revealed by the chest CT scan. Confluent opacification at the base of the right lung is probably atelectasis, pleural mild pneumonia is difficult to exclude. In all other locations there no findings that would raise the possibility of pneumonia. ___ ___: FINDINGS: There is normal compressibility, flow and augmentation of the bilateral common femoral, proximal, mid, distal femoral, and popliteal veins. Normal color flow and compressibility are demonstrated in the posterior tibial and peroneal veins. There is normal respiratory variation in the common femoral veins bilaterally. No evidence of medial popliteal fossa (___) cyst. IMPRESSION: No evidence of deep venous thrombosis in the bilaterallower extremity veins. EKG ___: Narrow complex tachycardia. Probably sinus tachycardia. Compared to the previous tracing of ___ the rate has increased. CXR ___: FINDINGS: Numerous nodular opacities compatible the patient's metastatic disease are again appreciated. In addition, there is worsening pulmonary edema as well as a worsening right lower lobe infiltrate which could represent pneumonia in the correct clinical setting. A right pleural effusion is also increased in size. IMPRESSION: Worsening combination of pleural effusion, pulmonary edema and possibly pneumonia particularly in the right lower lobe. CTA CHEST W/ CONTRAST ___: IMPRESSION: 1. Partially limited evaluation of the subsegmental pulmonary arteries, however no evidence of central, lobar, or segmental pulmonary embolism. 2. Since ___, increase in size and number of innumerable pulmonary metastases, as well as enlargement of bilateral pleural effusions, large on the right and moderate on the left. 3. Partially imaged upper abdomen demonstrates diffuse intrahepatic metastasis and considerable upper abdominal lymphadenopathy. KUB ___: IMPRESSION: 1. Rectal stent overlying the sacrum. 2. No bowel obstruction. 3. Likely interval decrease of small right pleural effusion. CT ABDOMEN PELVIS W/ CONTRAST ___: IMPRESSION: 1. Interval (since ___ placement of a colonic stent, 2. Circumscribed 10.4 x 7.4mm anterior pelvic fluid collection containing small locules of gas, likely an abscess from sigmoid tumor perforation. This is amenable to drainage. 2a. Moderate/large amount of free air, and small amount of free fluid within the peritoneum. 3. Extensive lymphadenopathy in the retroperitoneum and porta hepatis, which results in narrowing of the origin of the left renal vein. Encasement of the splenic vein-SMV confluence and bilateral renal arteries is also demonstrated, without significant intraluminal narrowing in these vessels. Normally enhancing kidneys on today's study. 4. Innumerable hepatic metastases. 5. Innumerable pulmonary metastases, lungs only partially imaged. 6. Moderately-sized bilateral non-hemorrhagic pleural effusions PATHOLOGY: ========== ___ GI mucosa PATHOLOGIC DIAGNOSIS: Sigmoid mass biopsy: Adenocarcinoma, low grade <MEDICATIONS ON ADMISSION> none <DISCHARGE MEDICATIONS> none <DISCHARGE DISPOSITION> Expired <DISCHARGE DIAGNOSIS> Primary: ======= Metastatic colon (adenocarcinoma) cancer Colonic perforation Hospital associated pneumonia Septicemia Secondary: ========== Anemia Hypertension Hyponatremia Hepatitis C <DISCHARGE CONDITION> expired <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear loved ones of Mr. ___, It was as pleasure taking part in his care during your hospitalization at ___. He wastransferred from ___ ___ after a CT scan was concerning for colon cancer. A biopsy revealed colon cancer with metastases to his liver and his lung. He had a stent placed in his colon to relieve his abdominal pain. He wasseen by the Oncologists who felt he was not a candidate for chemotherapy given his weakness/poor functional status. Over his hospitalization he had pneumonia, which was treated with antibiotics. He developed worsening abdominal pain and was found to have a perforated colon from the stent that was placed. It was a pleasure taking part in his care! ","Mr. ___ was a ___ with history of HCV and EtOH abuse who presented with abdominal pain and melena with imaging concerning for metastatic colon cancer. ACUTE ISSUES: ============= # Metastatic colon cancer: Patient presented with weight loss for several months with anemia and abdominal pain. Patient without prior preventative health care. Imaging from outside hospital demonstrated rectosigmoid mass with metastases to the liver and lungs. Patient underwent flexible sigmoidoscopy with biopsy demonstrating adenocarcinoma. Given near complete obstruction Advanced Endoscopy placed a palliative stent. He developed diffuse abdominal pain on ___ CT abd showed colonic stent perforation. He was not deemed a surgical candidate due to his widely metastatic disease. He wished to become CMO/DNR/DNI, and expired peacefully on ___. Family was notified and declined autopsy. # Abdominal Stent Perforation: Experienced diffuse abdominal pain on ___, CT abdomen showed perforation ___ stent. He was not felt to be a good surgical candidate due to metastatic cancer and poor functional status. He wished to become CMO. Vancomycin, Ceftriaxone, and Metronidazole were prescribed to improve his abdominal pain and discomfort. # Hyponatremia, chronic: Patient presented with sodium of 118 at outside hospital The patient was given IV fluids until stable sodium level reached at 127. SIADH was thought to be a significant component of his hyponatremia, given his extensive metastatic disease to his lungs. # Septicemia: Met sepsis criteria on ___. Thought to be due to either hospital-associated pneumonia or GI translocation in the setting of stent perforation. He was treated with antibiotics until his family was able to visit, then discontinued. # Hospital-Associated Pneumonia: He developed increased sputum production and shortness of breath, and a chest x-ray was suggestive of right lower lobe pneumonia. He was treated with vancomycin and ceftriaxone. CHRONIC ISSUES: =============== # Microcytic anemia: Patient found to have anemia with MCV 79. Iron studies demonstrated anemia of chronic disease and also likely iron deficient in setting of chronic bleeding from GI malignancy. He was started on iron supplementation. # Transaminitis: Likely secondary to metastatic liver involvement vs. EtOH use given elevated AST:ALT ratio. # Alcohol abuse: Patient reports chronic use of alcohol, multiple beers and at least two shots of brandy daily. Has continued to drink despite lack of appetite prior to hospitalization. During his admission, he had no evidence of withdrawal. # Melena: Patient had melena after stent placement. Sigmoidoscopy on ___ showed tumor infiltration into the stent with friable, bleeding tissue, which was the likely source of his bleeding. # Hypertension: Held home lisinopril in the setting of low blood pressures. # Hepatitis C: untreated. ",2200,614
10005123-DS-17,"<SEX> M <SERVICE> MEDICINE <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> post TIPS monitoring <MAJOR SURGICAL OR INVASIVE PROCEDURE> TIPS ___ <HISTORY OF PRESENT ILLNESS> Mr. ___ is a ___ male with congenital hepatic fibrosis complicated by portal hypertension and variceal bleeding who presents to the medicine floor s/p TIPS procedure for TIPS monitoring. The patient recently presented to the ED on ___ with severe variceal bleeding requiring blood/plasma transfusion as well as endoscopic banding of his esophageal/gastric varices. He ultimately elected to undergo a TIPS placement by ___ on ___. Per sign out, the TIPS procedure was quite complicated, lasting a total of 6 hours. The HVPG was reduced to 10. His esophageal/gastric were not embolized though he did receive tPA for his portal vein thrombosis. <PAST MEDICAL HISTORY> - Congenital hepatic fibrosis -- Portal hypertension -- Gastric and esophageal varices s/p band ligation - Hyperlipidemia <SOCIAL HISTORY> ___ <FAMILY HISTORY> non contributory to this admission <PHYSICAL EXAM> VS: 24 HR Data (last updated ___ @ 1213) Temp: 97.9 (Tm 98.5), BP: 133/78 (129-146/75-78), HR: 71 (71-82), RR: 16 (___), O2 sat: 98% (95-98), O2 delivery: RA, Wt: 203.7 lb/92.4 kg GENERAL: well appearing man in no acute distress HEENT: anicteric sclera, right neck access site bandaged & clean. no active bleeding HEART: RRR, no murmurs, rubs, gallops LUNGS: clear bilaterally ABDOMEN: soft, mildly distended, non-tender to palpation but subjective discomfort, RUQ dressing c/d/I without surrounding erythema, drainage, bleeding EXTREMITIES: wwp, no edema NEURO: A&Ox3, moving all 4 extremities with purpose, no asterixis. Able to say months of the year backwards. <PERTINENT RESULTS> ___ 06: 47AM BLOOD WBC-4.2 RBC-3.93* Hgb-11.0* Hct-33.8* MCV-86 MCH-28.0 MCHC-32.5 RDW-15.2 RDWSD-47.3* Plt Ct-29* ___ 06: 47AM BLOOD Glucose-109* UreaN-15 Creat-1.0 Na-141 K-3.8 Cl-104 HCO3-23 AnGap-14 ___ 06: 47AM BLOOD ALT-824* AST-556* LD(LDH)-289* AlkPhos-360* TotBili-1.8* <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Nadolol 40 mg PO DAILY 2. Pravastatin 40 mg PO QPM <DISCHARGE MEDICATIONS> 1. Lactulose 30 mL PO DAILY RX *lactulose 10 gram/15 mL (15 mL) 30 ml by mouth once a day Disp #*1 Bottle Refills: *2 2. Nadolol 40 mg PO DAILY 3. Pravastatin 40 mg PO QPM 4.Outpatient Lab Work DX: Elevated Liver Enzymes ICD-10: R94.5 Tests: AST, ALT, ALP, Total Bili, Direct Bili Please fax results to ___ at ___. <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> PRIMARY: Congenital hepatic fibrosis Portal hypertension Cirrhosis SECONDARY: History of esophageal and gastric varices <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Mr. ___, It was a pleasure taking care of you at the ___ ___! WHY WAS I IN THE HOSPITAL? -========= - You were admitted because you had a TIPS procedure and needed routine monitoring afterwards WHAT HAPPENED IN THE HOSPITAL? -- - You had a TIPS procedure performed - Post-procedure, your mental status, liver/kidney tests, and blood counts were monitored - You received a medicine to help you have regular bowel movements WHAT SHOULD I DO WHEN I GO HOME? --== - Be sure to take all your medications and attend all of your appointments listed below. - Take your lactulose enough times daily to have two bowel movements every day. - If you notice black or bloody stool or if you are vomiting blood, please go to the ER right away - Interventional Radiology will call you with an appointment in ___ weeks. Thank you for allowing us to be involved in your care, we wish you all the best! Your ___ Healthcare Team ","Mr. ___ is a ___ male with congenital hepatic fibrosis complicated by portal hypertension and variceal bleeding who presents to the medicine floor for post TIPS monitoring. Mild ___ post-op s/p 25gm albumin; otherwise uncomplicated course. Surgical wounds stable; dressing clean and dry. Patient able to tolerate PO without issue. No evidence of hepatic encephalopathy prior to discharge. No further planned intervention by ___ this hospitalization; they will see him in follow-up in ___ weeks. TRANSITIONAL ISSUES: ==================== [ ] please obtain repeat LFTs on ___ with results faxed to ___ (f: ___ [ ] consider repeat hepatitis A and B serologies to ensure immunization (non immune as of ___ in ___ records) [ ] consider repeat AFP as last AFP in BID system is from ___ [ ] please consider stopping lactulose that was continued on discharge depending on post-op course regarding HE ACTIVE ISSUES ============= # Congenital Hepatic Fibrosis c/b portal hypertension: # S/p TIPS ___: As above, patient presented in ___ with variceal bleeding requiring transfusions and banding of his esophageal/gastric varices, now s/p elective TIPS placement on ___ with ___ (10 x 6 and 10 x 8 R TIPS placed). He has no history of HE or ascites. Per ___ team, the TIPS procedure was complicated, lasting 6 hours. His post-TIPS HVPG is between ___ mmHg (pre-tips HVPG not documented). His varices were not embolized though he did receive tPA for his portal vein thrombosis. Tentatively may need another procedure in the near future. He was discharged on lactulose with instructions to titrate to two BMs daily. Consider stopping this at his follow-up appointment. Post-op, his vitals have remained stable. His neck and abdominal access sites appear to be healing appropriately. His LFTs are up but expected post-op changes, downtrending by discharge. Telemetry and foley were dc'd. Patient has been able to urinate and has had multiple bowel movements with lactulose. His MELD-NA post-op on ___ was 16. Pain control with acetaminophen + hot/cold packs. He post-op course was uncomplicated except for a mild ___ discussed below which resolved with albumin. Discharge MELD-NA: 11 Discharge HgB: 11 ___ SCR 1.1 --> 1.4 ---> 1.0 Most likely related to NPO prior to procedure and prolonged operation. HRS very unlikely has patient has no ascites or hepatic hydrothorax (on exam or history of). Urine lytes were unremarkable with UNa <20 which is an appropriate response to pre-renal dehydration. UA and sediment unremarkable. Discharge Creatinine: 1.0 # Thrombocytopenia: Plts in the ___, at baseline. Secondary to cirrhosis, splenomegaly. SQH was held ___ thrombocytopenia. Patient had no e/o bleeding or petichiae during his hospital course. Discharge platelets: 29 CHRONIC ISSUES ============== # Hyperlipidemia: Continued Pravastatin 40 mg QHS ",1127,689
10005123-DS-18,"<SEX> M <SERVICE> MEDICINE <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___ ___ Surgical or Invasive Procedure: ___: Redo TIPS ___: Redo TIPS attach <PERTINENT RESULTS> ADMISSION LABS: ___ 07: 30AM BLOOD WBC-4.2 RBC-4.29* Hgb-12.1* Hct-37.9* MCV-88 MCH-28.2 MCHC-31.9* RDW-14.7 RDWSD-47.1* Plt Ct-63* ___ 07: 30AM BLOOD ___ ___ 07: 30AM BLOOD Plt Ct-63* ___ 06: 11PM BLOOD ___ ___ 07: 30AM BLOOD UreaN-21* Creat-1.0 Na-142 K-4.6 Cl-109* HCO3-22 AnGap-11 ___ 07: 30AM BLOOD ALT-75* AST-88* AlkPhos-487* TotBili-1.0 ___ 06: 11PM BLOOD Albumin-4.0 Calcium-8.7 Phos-2.7 Mg-1.9 DISCHARGE LABS: ___ 04: 54AM BLOOD WBC-5.1 RBC-3.97* Hgb-11.2* Hct-35.4* MCV-89 MCH-28.2 MCHC-31.6* RDW-14.7 RDWSD-48.1* Plt Ct-71* ___ 12: 07PM BLOOD PTT-83.3* ___ 04: 54AM BLOOD Plt Ct-71* ___ 03: 22PM BLOOD ___ 04: 54AM BLOOD Glucose-95 UreaN-24* Creat-1.0 Na-140 K-4.4 Cl-109* HCO3-19* AnGap-12 ___ 04: 54AM BLOOD ALT-501* AST-660* LD(LDH)-696* AlkPhos-428* TotBili-2.7* ___ 04: 54AM BLOOD Albumin-3.6 Calcium-8.3* Phos-3.0 Mg-1.9 MICRO: n/a IMAGING: ___ REDO TIPS Successful right internal jugular access with direct transjugular intrahepatic portosystemic shunt revision with extension of the TIPS cranially. New direct TIPS aspiration thrombectomy. Thrombolysis catheter placement through the right IJ sheath for overnight thrombolysis ___BD & PELVIS W & W/O 1. Interval redo TIPS procedure, with persistent thrombus in the TIPS shunt. The new TIPS shunt lies parallel to the superior most aspect of the pre-existing stent, with its upper portion approximately 1 cm below the cavoatrial junction. The tPA infusion catheter localizes in the lower right atrium, with the lowest radiopaque marker overlying the lower cavoatrial junction. 2. There is increased burden of nonocclusive thrombus in the main portal vein. 3. Interval development of trace ascites. 4. Stable cirrhosis with secondary changes representing the sequela of portal hypertension including perisplenic, perigastric and periesophageal varices, and splenomegaly. ___ REDO TIPS Successful revision of occluded TIPS and thrombosed portal vein with a postprocedural portosystemic gradient of 11 mm Hg. Technically successful coronary variceal embolization and sclerotherapy. <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Nadolol 40 mg PO DAILY 2. Pravastatin 40 mg PO QPM 3. Pantoprazole 40 mg PO Q24H <DISCHARGE MEDICATIONS> 1. Enoxaparin Sodium 90 mg SC Q12H 2. Nadolol 40 mg PO DAILY 3. Pantoprazole 40 mg PO Q24H 4. Pravastatin 40 mg PO QPM <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> PRIMARY DIANGOSIS: Hypoxic respiratory failure Congenital Hepatic Fibrosis c/b portal hypertension and variceal bleeding TIPS occlusion Portal vein thrombosis occlusion SECONDARY DIAGNOSIS: Transaminitis Thrombocytopenia Hyperlipidemia <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Mr. ___, WHY WAS I ADMITTED TO THE HOSPITAL? You were admitted because you had a blood clot in your TIPS and your oxygen was low. WHAT WAS DONE WHILE I WAS HERE? We opened up the vessels/TIPS. We started you on a blood thinner. We watched your breathing closely. WHAT SHOULD I DO NOW? You should take your medications as instructed. You should go to your doctor's appointments as below. We wish you the best! -Your ___ Care Team ","___ male with congenital hepatic fibrosis complicated by portal hypertension and variceal bleeding s/p TIPS ___ who presented to the MICU s/p TIPS revision with thrombolysis complicated by hypoxia. ACUTE ISSUES ======================= #Hypoxic respiratory failure: Patient developed new oxygen requirement after ___ TIPS revision. Unclear if VTE or atelectasis or just some orthodeoxia but responded to oxygen and remained on room air for the majority of his ICU course. # Congenital Hepatic Fibrosis c/b portal hypertension and variceal bleeding: # S/p TIPS ___ and revision ___ Pt with congenital hepatic fibrosis c/b portal HTN and variceal bleeding. TIPS revision complicated by hypoxia. He had a right IJ sheath with lysis catheter placed. He underwent CTV with persistent thrombus in TIPS shunt. Now s/p revision of occuled TIPS and thrombosed portal vein with a postprocedural portosystemic gradient of 11 mm Hg. He also had successful coronary variceal embolization and sclerotherapy. He was placed on a heparin drip post TIPS and transitioned to lovenox on discharge. - GIB/VARICES: EGD ___ which showed scarring at GE junction, proximal grade 2 EVs s/p esophageal band ligation x4 and large gastric varices. Pt also presented to an outside ED in ___ with acute UGIB/variceal bleed. Not able to be banded/embolized; considered for future procedure. On nadolol at home which was continued while inpatient. - ASCITES: no history of ascites, not on diuretics, he was not overloaded on exam. #Transminitis Likely due to liver disease and TIPS procedure # Thrombocytopenia Likely ___ to liver disease and sequestration CHRONIC ISSUES ======================= # Hyperlipidemia: - Continued Pravastatin 40 mg QHS TRANSITIONAL ISSUES: ======================= [ ] please recheck LFTs in 1 week to ensure downtrending [ ] check CBC within 1 week as on anticoagulation and patient has bleeding history [ ] f/u US of TIPS shunt in 1 week [ ] continue lovenox for one month [ ] follow up with ___ in 1 month #CODE STATUS: Presumed FULL #CONTACT: ___ - wife - ___ ",1147,513
10005236-DS-5,"<SEX> M <SERVICE> SURGERY <ALLERGIES> morphine / Demerol <ATTENDING> ___. <CHIEF COMPLAINT> Asymptomatic Carotid Stenosis <MAJOR SURGICAL OR INVASIVE PROCEDURE> Left Carotid Endarterectomy <HISTORY OF PRESENT ILLNESS> Mr. ___ presents to clinic today for carotid duplex for known carotid stenosis. Mr. ___ was seen at ___ ___ at the end of ___ where he was noted to have a greater than 80% stenosis of the left ICA and a 60% stenosis of the right ICA. He is completely asymptomatic and has remained so in the interim. Dr. ___ wanted to repeat the study in our own lab to confirm these findings. There have been no new medical issues, and medications were reconciled in OMR. <SOCIAL HISTORY> ___ <FAMILY HISTORY> Father CAD/PVD; Diabetes - Type II Mother chf [OTHER] Sister ___ Physical ___: Pre-op: Blood pressure is 112/53. Heart rate is 74. Respiratory rate is 18. Height is 6'. Stated weight is 210 lbs. Pain is ___. General: Mr. ___ is a ___ and well-nourished elderly male in no acute distress. Neuro: He is alert and oriented x3, pleasant, and cooperative. The rest of the physical exam is unchanged. On Discharge: T = 98.6 HR = 68 BP = 122/68 RR = 18 SaO2 = 99 on RA GEN: NAD RESP: CTA/B CV: RRR, no bruit heard Pulse Exam: palpable radial pulses bilaterally <PERTINENT RESULTS> ___ 07: 30PM GLUCOSE-138* UREA N-19 CREAT-0.8 SODIUM-143 POTASSIUM-4.5 CHLORIDE-109* TOTAL CO2-26 ANION GAP-13 ___ 07: 30PM CALCIUM-8.6 PHOSPHATE-3.1 MAGNESIUM-1.5* ___: 30PM WBC-12.7* RBC-4.21* HGB-12.3*# HCT-38.6*# MCV-92 MCH-29.1 MCHC-31.7 RDW-13.5 ___ 07: 30PM PLT COUNT-257 <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Albuterol Inhaler ___ PUFF IH Q4H: PRN wheez 2. glimepiride *NF* 0.5 mg Oral QD 3. Hydrochlorothiazide 12.5 mg PO QMOWEFR 4. Lisinopril 2.5 mg PO DAILY 5. MetFORMIN (Glucophage) 1000 mg PO BID 6. Metoprolol Succinate XL 25 mg PO DAILY 7. Omeprazole 20 mg PO DAILY 8. Viagra *NF* (sildenafil) 50 mg Oral PRN One hr before sex 9. Simvastatin 40 mg PO DAILY 10. Tiotropium Bromide 1 CAP IH DAILY <DISCHARGE MEDICATIONS> 1. Albuterol Inhaler ___ PUFF IH Q4H: PRN wheez 2. Hydrochlorothiazide 12.5 mg PO QMOWEFR 3. Lisinopril 2.5 mg PO DAILY 4. MetFORMIN (Glucophage) 1000 mg PO BID 5. Metoprolol Succinate XL 25 mg PO DAILY 6. Simvastatin 40 mg PO DAILY 7. Tiotropium Bromide 1 CAP IH DAILY 8. Omeprazole 20 mg PO DAILY 9. glimepiride *NF* 0.5 mg ORAL QD 10. Viagra *NF* (sildenafil) 50 mg Oral PRN 11. OxycoDONE (Immediate Release) 5 mg PO Q4H: PRN pain RX *oxycodone 5 mg ___ tablet(s) by mouth every ___ hours Disp #*50 Tablet Refills: *0 12. Aspirin 81 mg PO DAILY RX *aspirin 81 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills: *2 <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> status post left carotid endarterectomy <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Division of Vascular and Endovascular Surgery Carotid Endarterectomy Surgery Discharge Instructions WHAT TO EXPECT: 1. Surgical Incision: -It is normal to have some swelling and feel a firm ridge along the incision -Your incision may be slightly red and raised, it may feel irritated from the staples 2. You may have a sore throat and/or mild hoarseness -Try warm tea, throat lozenges or cool/cold beverages 3. You may have a mild headache, especially on the side of your surgery -Try ibuprofen, acetaminophen, or your discharge pain medication -If headache worsens, is associated with visual changes or lasts longer than 2 hours- call vascular surgeons office 4. It is normal to feel tired, this will last for ___ weeks -You should get up out of bed every day and gradually increase your activity each day -You may walk and you may go up and down stairs -Increase your activities as you can tolerate- do not do too much right away! 5. It is normal to have a decreased appetite, your appetite will return with time -You will probably lose your taste for food and lose some weight -Eat small frequent meals -It is important to eat nutritious food options (high fiber, lean meats, vegetables/fruits, low fat, low cholesterol) to maintain your strength and assist in wound healing -To avoid constipation: eat a high fiber diet and use stool softener while taking pain medication MEDICATION: -Take all of your medications as prescribed in your discharge ACTIVITIES: -No driving until post-op visit and you are no longer taking pain medications -No excessive head turning, lifting, pushing or pulling (greater than 5 lbs) until your post op visit -You may shower (no direct spray on incision, let the soapy water run over incision, rinse and pat dry) -Your incision may be left uncovered, unless you have small amounts of drainage from the wound, then place a dry dressing over the area CALL THE OFFICE FOR: ___ -Changes in vision (loss of vision, blurring, double vision, half vision) -Slurring of speech or difficulty finding correct words to use -Severe headache or worsening headache not controlled by pain medication -A sudden change in the ability to move or use your arm or leg or the ability to feel your arm or leg -Trouble swallowing, breathing, or talking -Temperature greater than 101.5F for 24 hours -Bleeding, new or increased drainage from incision or white, yellow or green drainage from incisions ","The patient was admitted to the Vascular Surgical Service for evaluation and treatment. On ___, the patient underwent Left carotid Endarterectomy, which went well without complication (reader referred to the Operative Note for details). After a brief, uneventful stay in the PACU, the patient arrived on the floor NPO, on IV fluids and antibiotics, with a foley catheter, and on dilaudid for pain control. He did well overnight and was advanced to a regular diet, which he tolerated well. His foley was removed and he voided. His pain was well controlled. After an uneventful recovery, he was discharged home on ___ in stable condition. ",1585,140
10005236-DS-6,"<SEX> M <SERVICE> ORTHOPAEDICS <ALLERGIES> morphine / Demerol <ATTENDING> ___. <CHIEF COMPLAINT> Right femoral neck fracture <MAJOR SURGICAL OR INVASIVE PROCEDURE> Closed reduction, internal fixation with cannulated screws of Right femoral neck fracture <HISTORY OF PRESENT ILLNESS> ___ M presents with right femoral neck fracture s/p mechanical fall. He fell on his right side earlier this morning, with immediate right hip pain and inability to ambulate. He denies pain elsewhere. He ambulates without assistance at baseline, but reports he does not walk as much as he used to due to antecedent bilateral hip pain. He is fairly active and enjoys fishing regularly. <PAST MEDICAL HISTORY> PMH/PSH: DM HTN COPD Claudication Carotid stenosis S/p L carotid endarterectomy ___ <SOCIAL HISTORY> ___ <FAMILY HISTORY> Father CAD/PVD; Diabetes - Type II Mother chf [OTHER] Sister ___ Physical ___: Right lower extremity: - Skin intact - Fires ___ - SILT S/S/SP/DP/T distributions - 1+ ___ pulses, WWP <DISCHARGE INSTRUCTIONS> INSTRUCTIONS AFTER ORTHOPAEDIC SURGERY: - You were in the hospital for orthopedic surgery. It is normal to feel tired or ""washed out"" after surgery, and this feeling should improve over the first few days to week. - Resume your regular activities as tolerated, but please follow your weight bearing precautions strictly at all times. ACTIVITY AND WEIGHT BEARING: - Touchdown weight bearing RLE MEDICATIONS: - Please take all medications as prescribed by your physicians at discharge. - Continue all home medications unless specifically instructed to stop by your surgeon. - Do not drink alcohol, drive a motor vehicle, or operate machinery while taking narcotic pain relievers. - Narcotic pain relievers can cause constipation, so you should drink eight 8oz glasses of water daily and take a stool softener (colace) to prevent this side effect. ANTICOAGULATION: - Please take Lovenox 40mg daily for 4 weeks WOUND CARE: - You may shower. No baths or swimming for at least 4 weeks. - Any stitches or staples that need to be removed will be taken out at your 2-week follow up appointment. - No dressing is needed if wound continues to be non-draining. Physical Therapy: Activity: Activity: Out of bed w/ assist Right lower extremity: Touchdown weight bearing Left lower extremity: Full weight bearing Encourage turning, deep breathing and coughing qhour when awake. Treatments Frequency: DSD as needed. Sutures/staples removed at clinic. Elevation as tolerated. ","The patient presented to the emergency department and was evaluated by the orthopedic surgery team. The patient was found to have right femoral neck fracture and was admitted to the orthopedic surgery service. The patient was taken to the operating room on ___ for closed reduction and cannulated screw fixation, which the patient tolerated well. For full details of the procedure please see the separately dictated operative report. The patient was taken from the OR to the PACU in stable condition and after satisfactory recovery from anesthesia was transferred to the floor. The patient was initially given IV fluids and IV pain medications, and progressed to a regular diet and oral medications by POD#1. The patient was given ___ antibiotics and anticoagulation per routine. The patient's home medications were continued throughout this hospitalization. The patient worked with ___ who determined that discharge to rehab was appropriate. The ___ hospital course was otherwise unremarkable. At the time of discharge the patient's pain was well controlled with oral medications, incisions were clean/dry/intact, and the patient was voiding/moving bowels spontaneously. The patient is NVI distally in the right extremity, and will be discharged on lovenox for DVT prophylaxis. The patient will follow up with Dr. ___ routine. A thorough discussion was had with the patient regarding the diagnosis and expected post-discharge course including reasons to call the office or return to the hospital, and all questions were answered. The patient was also given written instructions concerning precautionary instructions and the appropriate follow-up care. The patient expressed readiness for discharge. Discharge Medications: 1. Acetaminophen 650 mg PO Q6H 2. Calcium Carbonate 500 mg PO QID:PRN indigestion 3. Docusate Sodium 100 mg PO BID 4. Enoxaparin Sodium 40 mg SC QPM Duration: 4 Weeks Start: Today - ___, First Dose: Next Routine Administration Time RX *enoxaparin 40 mg/0.4 mL 40 mg SC QPM Disp #*28 Syringe Refills:*0 5. Lisinopril 2.5 mg PO DAILY 6. Metoprolol Succinate XL 25 mg PO DAILY 7. OxycoDONE (Immediate Release) 2.5-5 mg PO Q4H:PRN pain RX *oxycodone 5 mg ___ tablet(s) by mouth Q4H: PRN Disp #*60 Tablet Refills:*0 8. Senna 8.6 mg PO BID Discharge Disposition: Extended Care Facility: ___ ___ Diagnosis: Right femoral neck fracture Discharge Condition: AOX3, OOB with assistance of ___, overall stable Followup Instructions: ___",588,571
10005308-DS-20,"<SEX> F <SERVICE> ORTHOPAEDICS <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> right ankle fracture dislocation <MAJOR SURGICAL OR INVASIVE PROCEDURE> right ankle surgical fixation <HISTORY OF PRESENT ILLNESS> ___ healthy female who sustained a right ankle injury following a mechanical slip and fall down stairs. She states she was packing to fly home tomorrow morning when she was going to load up her suitcase down stairs, slipped on the last step, twisting and injuring her ankle. Denied head strike or loss of consciousness. She is not currently on anticoagulation. She denies any numbness or paresthesias in the right foot. She denies any previous injury to the right ankle. Notably she is currently in town visiting her son. She lives in ___ currently. She is here with her husband and son. <PAST MEDICAL HISTORY> none <SOCIAL HISTORY> ___ <FAMILY HISTORY> noncontributory <PHYSICAL EXAM> Right lower exam -splint c/d/I -grossly moves exposed toes -silt in exposed toes -toes WWP <MEDICATIONS ON ADMISSION> none <DISCHARGE MEDICATIONS> 1. Acetaminophen 1000 mg PO Q6H 2. Docusate Sodium 100 mg PO BID 3. Enoxaparin Sodium 40 mg SC QHS RX *enoxaparin 40 mg/0.4 mL ___t bedtime Disp #*28 Syringe Refills: *0 4. OxyCODONE (Immediate Release) ___ mg PO Q4H: PRN Pain don't drink or drive while taking RX *oxycodone 5 mg ___ tablet(s) by mouth every four (4) hours PRN Disp #*30 Tablet Refills: *0 5. Senna 8.6 mg PO BID <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> right ankle fracture <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> <DISCHARGE INSTRUCTIONS> INSTRUCTIONS AFTER ORTHOPAEDIC SURGERY: - You were in the hospital for orthopedic surgery. It is normal to feel tired or ""washed out"" after surgery, and this feeling should improve over the first few days to week. - Resume your regular activities as tolerated, but please follow your weight bearing precautions strictly at all times. ACTIVITY AND WEIGHT BEARING: -Nonweightbearing right lower extremity in splint MEDICATIONS: 1) Take Tylenol ___ every 6 hours around the clock. This is an over the counter medication. 2) Add oxycodone as needed for increased pain. Aim to wean off this medication in 1 week or sooner. This is an example on how to wean down: Take 1 tablet every 3 hours as needed x 1 day, then 1 tablet every 4 hours as needed x 1 day, then 1 tablet every 6 hours as needed x 1 day, then 1 tablet every 8 hours as needed x 2 days, then 1 tablet every 12 hours as needed x 1 day, then 1 tablet every before bedtime as needed x 1 day. Then continue with Tylenol for pain. 3) Do not stop the Tylenol until you are off of the narcotic medication. 4) Per state regulations, we are limited in the amount of narcotics we can prescribe. If you require more, you must contact the office to set up an appointment because we cannot refill this type of pain medication over the phone. 5) Narcotic pain relievers can cause constipation, so you should drink eight 8oz glasses of water daily and continue following the bowel regimen as stated on your medication prescription list. These meds (senna, colace, miralax) are over the counter and may be obtained at any pharmacy. 6) Do not drink alcohol, drive a motor vehicle, or operate machinery while taking narcotic pain relievers. 7) Please take all medications as prescribed by your physicians at discharge. 8) Continue all home medications unless specifically instructed to stop by your surgeon. ANTICOAGULATION: - Please take Lovenox daily for 4 weeks WOUND CARE: - You may shower. No baths or swimming for at least 4 weeks. - Any stitches or staples that need to be removed will be taken out at your 2-week follow up appointment. - Incision may be left open to air unless actively draining. If draining, you may apply a gauze dressing secured with paper tape. - If you have a splint in place, splint must be left on until follow up appointment unless otherwise instructed. Do NOT get splint wet. DANGER SIGNS: Please call your PCP or surgeon's office and/or return to the emergency department if you experience any of the following: - Increasing pain that is not controlled with pain medications - Increasing redness, swelling, drainage, or other concerning changes in your incision - Persistent or increasing numbness, tingling, or loss of sensation - Fever ___ 101.4 - Shaking chills - Chest pain - Shortness of breath - Nausea or vomiting with an inability to keep food, liquid, medications down - Any other medical concerns THIS PATIENT IS EXPECTED TO REQUIRE ___ DAYS OF REHAB ","The patient presented to the emergency department and was evaluated by the orthopedic surgery team. The patient was found to have a right ankle fracture dislocation and was admitted to the orthopedic surgery service. The patient was taken to the operating room on ___ for open reduction internal fixation of right ankle fracture, which the patient tolerated well. For full details of the procedure please see the separately dictated operative report. The patient was taken from the OR to the PACU in stable condition and after satisfactory recovery from anesthesia was transferred to the floor. The patient was initially given IV fluids and IV pain medications, and progressed to a regular diet and oral medications by POD#1. The patient was given ___ antibiotics and anticoagulation per routine. The patient's home medications were continued throughout this hospitalization. The patient worked with ___ who determined that discharge to home was appropriate. The ___ hospital course was otherwise unremarkable. At the time of discharge the patient's pain was well controlled with oral medications, incisions were clean/dry/intact, and the patient was voiding/moving bowels spontaneously. The patient is nonweightbearing in the right lower extremity in a splint, and will be discharged on Lovenox for DVT prophylaxis. The patient will follow up with Dr. ___ routine. Alternatively, since she is from ___ she may choose to follow-up with an orthopedic provider ___. She was instructed to follow-up in 2 weeks. A thorough discussion was had with the patient regarding the diagnosis and expected post-discharge course including reasons to call the office or return to the hospital, and all questions were answered. The patient was also given written instructions concerning precautionary instructions and the appropriate follow-up care. The patient expressed readiness for discharge. ",1182,356
10005348-DS-10,"<SEX> M <SERVICE> CARDIOTHORACIC <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> Pulmonary nodule <MAJOR SURGICAL OR INVASIVE PROCEDURE> ___ 1. Video-assisted thoracoscopy left lower lobe wedge resection. 2. Video-assisted thoracoscopy left lower lobectomy. 3. Mediastinal lymph node dissection. <HISTORY OF PRESENT ILLNESS> Mr. ___ is a ___ man who was referred by ___ ___, NP, at ___, for evaluation of a pulmonary nodule. He has a LLL nodule first noted on CT chest in ___, which was stable in size at about 1 cm through ___. A CT chest without contrast performed one week ago, on ___ noted an increase in size to 17.6 by 15.8 by 16.2 mm. As a result, he was referred here for further evaluation. He reports some mild generalized fatigue, but is able to play 18 holes of golf without a cart. He also notes 15 pounds of unintentional weight loss (with good appetite) in the past two months. Mild nonproductive cough and intermitant mild hoarse voice over past year. <PAST MEDICAL HISTORY> CAD - s/p stents x4, most recently ___ yrs ago, no recent anginal symptoms Prostate CA - s/p radical prostetectomy at age ___ Inguinal hernia - s/p repair ___ at ___ Pulmonary nodules Aortic stenosis Middle cerebral artery stenosis Anemia HTN AV Block (Mobitz II) HLD Impaired glucose tolerance EtOH dependence (not currently drinking) Osteoarthritis (L hand/wrist) Trigger finger Cervical disc disease Lumbar disc disease Depressive disorder Glaucoma (angle recession) Peripheral neuropathy Hoarseness <SOCIAL HISTORY> ___ <FAMILY HISTORY> Father - CAD Physical ___: BP: 136/75. Heart Rate: 69. Weight: 152.9. Height: 72.25. BMI: 20.6. Temperature: 98.6. Resp. Rate: 16. Pain Score: 0. O2 Saturation%: 98. GENERAL [x] WN/WD [x] NAD [x] AAO [ ] abnormal findings: HEENT [x] NC/AT [x] EOMI [x] PERRL/A [x] Anicteric [x] OP/NP mucosa normal [x] Tongue midline [x] Palate symmetric [x] Neck supple/NT/without mass [x] Trachea midline [ ] Abnormal findings: RESPIRATORY [x] CTA b/l [ ] Abnormal findings: CARDIOVASCULAR [x] RRR [ ] No m/r/g [x] No edema [x] Abnormal findings: Loud systolic murmur over RUSB GI [x] Soft [x] NT [x] ND [x] No mass/HSM [ ] Abnormal findings: GU [x] Deferred [ ] Nl genitalia [ ] Nl pelvic/testicular exam [ ] Nl DRE [ ] Abnormal findings: NEURO [x] Strength intact/symmetric [x] Sensation intact/ symmetric [x] Reflexes nl [x] No facial asymmetry [x] Cognition intact [x] Cranial nerves intact [ ] Abnormal findings: MS [x] No clubbing [x] No cyanosis [x] No edema [x] Gait nl [x] No tenderness [x] Tone/align/ROM nl [x] Palpation nl [x] Nails nl [ ] Abnormal findings: LYMPH NODES [x] Cervical nl [x] Supraclavicular nl [x] Axillary nl [x] Inguinal nl [ ] Abnormal findings: SKIN [x] No rashes/lesions/ulcers [x] No induration/nodules/tightening [ ] Abnormal findings: PSYCHIATRIC [x] Nl judgment/insight [x] Nl memory [x] Nl mood/affect [ ] Abnormal findings: <PERTINENT RESULTS> Discharge Labs ___ 05: 50AM BLOOD WBC-5.7 RBC-3.51* Hgb-10.5* Hct-31.6* MCV-90 MCH-30.0 MCHC-33.4 RDW-13.3 Plt ___ ___ 05: 50AM BLOOD Glucose-103* UreaN-11 Creat-0.8 Na-134 K-3.7 Cl-98 HCO___ AnGap-12 ___ 05: 50AM BLOOD Calcium-8.5 Phos-2.6* Mg-1.9 Imaging ___ CXR : Small left pneumothorax has developed following removal of the basal and medial pleural tube. There is no appreciable left pleural effusion, but there is a small region of consolidation in the left lower lobe, which could be area of focal bleeding. Right basal atelectasis is new. Heart size normal. <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Brimonidine Tartrate 0.15% Ophth. 1 DROP LEFT EYE BID 2. Dorzolamide 2%/Timolol 0.5% Ophth. 1 DROP LEFT EYE BID 3. Atorvastatin 80 mg PO DAILY 4. Latanoprost 0.005% Ophth. Soln. 1 DROP LEFT EYE HS 5. Pantoprazole 40 mg PO Q24H 6. Aspirin 325 mg PO DAILY 7. Citalopram 20 mg PO DAILY 8. Cyanocobalamin 1000 mcg IM/SC MONTHLY <DISCHARGE MEDICATIONS> 1. Pantoprazole 40 mg PO Q24H 2. Docusate Sodium 100 mg PO BID RX *docusate sodium 100 mg 1 tablet(s) by mouth twice a day Disp #*30 Tablet Refills: *0 3. Atorvastatin 80 mg PO DAILY 4. Aspirin 325 mg PO DAILY 5. Citalopram 20 mg PO DAILY 6. brimonidine *NF* 0.2 % OS bid 7. Latanoprost 0.005% Ophth. Soln. 1 DROP LEFT EYE HS 8. Dorzolamide 2%/Timolol 0.5% Ophth. 1 DROP LEFT EYE BID 9. Senna 1 TAB PO BID RX *sennosides [senna] 8.6 mg 1 tablet by mouth twice a day Disp #*30 Tablet Refills: *0 10. Acetaminophen 650 mg PO Q6H 11. Cyanocobalamin 1000 mcg IM/SC MONTHLY 12. TraMADOL (Ultram) 50 mg PO QID RX *tramadol 50 mg 1 tablet(s) by mouth four times a day Disp #*60 Tablet Refills: *1 13. Metoprolol Tartrate 50 mg PO BID RX *metoprolol tartrate 50 mg 1 tablet(s) by mouth twice a day Disp #*60 Tablet Refills: *0 <DISCHARGE DISPOSITION> Home With Service Facility: ___ <DISCHARGE DIAGNOSIS> Left lower lobe pulmonary nodule Urinary retention Orthostatic hypotension Atrial fibrillation <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> * You were admitted to the hospital for lung surgery and you've recovered well. You are now ready for discharge. * Continue to use your incentive spirometer 10 times an hour while awake. * Check your incisions daily and report any increased redness or drainage. Cover the area with a gauze pad if it is draining. * Your chest tube dressing may be removed in 48 hours. If it starts to drain, cover it with a clean dry dressing and change it as needed to keep site clean and dry. * You will continue to need pain medication once you are home but you can wean it over a few weeks as the discomfort resolves. Make sure that you have regular bowel movements while on narcotic pain medications as they are constipating which can cause more problems. Use a stool softener or gentle laxative to stay regular. * No driving while taking narcotic pain medication. * Take Tylenol ___ mg every 6 hours in between your narcotic. * Continue to stay well hydrated and eat well to heal your incisions * Shower daily. Wash incision with mild soap & water, rinse, pat dry * No tub bathing, swimming or hot tubs until incision healed * No lotions or creams to incision site * Walk ___ times a day and gradually increase your activity as you can tolerate. Call Dr. ___ ___ if you experience: -Fevers > 101 or chills -Increased shortness of breath, chest pain or any other symptoms that concern you. ","Mr. ___ was admitted to the thoracic surgery service for a left lower lobe pulmonary nodule. He was taken to the OR and underwent an uncomplicated VATS LLL lobectomy with placement of a chest tube. He tolerated the procedure without complications and recovered uneventfully in the PACU before being transferred to the floor in stable condition. (Please see the associated operative report for specific procedural details.) Post-operatively his pain was controlled with a PCA and IV pain medication with a transition to PO pain meds once tolerating POs. His diet was advanced slowly and without difficulty. His chest tube was removed on POD#2 without incident and his oxygen saturations were > 95% on room air. He was able to use his incentive spirometer effectively. Unfortunately he failed one voiding trial which required replacement of his Foley catheter for an additional day. His second voiding trial was successful and Flomax was also started. He had some confusion with the use of Dilaudid but improved with Ultram and Tylenol. Upon standing up for a chest xray he had some dizziness and orthostatic signs were checked. Lying, his BP was 114/70 with a heart rate of 78 and standing it was 80/42 with a heart rate of 88. He was initially treated with IV fluids and increasing his oral intake of liquids. Despite doing that his orthostasis persisted and an EKG demonstrated atrial fibrillation at a rate of 114. This was also associated with hypokalemia, hypophosphatemia and hypomagnesemia. After repleting his electrolytes and starting metoprolol, he converted back into sinus rhythm. Of note, he had been on Lopressor as recent as ___ but after discussing the situation with his wife, she monitored him closely and noticed that his heart rate was in the 50's therefore stopped the lopressor. There is no prior record of atrial fibrillation noted in his record. ",2029,410
10005348-DS-11,"<SEX> M <SERVICE> CARDIOTHORACIC <ALLERGIES> Hydromorphone <ATTENDING> ___ <CHIEF COMPLAINT> Dizziness <MAJOR SURGICAL OR INVASIVE PROCEDURE> ___ - Cardiac catheterization ___ - Aortic valve replacement <HISTORY OF PRESENT ILLNESS> Mr. ___ is a ___ year old man with a history of aortic stenosist, coronary artery disease status psot multiple stents, iron deficiency anemia, and lung cancer status post left lower lobe resection. He was hospitalized at ___ in ___ with chest pain and congestive heart failure. He He ruled out for myocardial infarction. An echocardiogram demonstrated worsening aortic stenosis with a calculated aortic valve area of 0.9 cm2. He reported frequent episodes of dizziness. He denied chest pain or dyspnea but has not been doing very much activity. Given the progression of his aortic stenosis, he was referred to ___ for surgical consultation. A preoperative cardiac catheterization demonstrated stenosis of two diagonal branches. The GI service was consulted due to acute on chronic anemia. <PAST MEDICAL HISTORY> Aortic Stenosis Cervical Disc Disease Coronary Artery Disease - LAD stents ___ and most recently in ___ with DES to LAD and POBA of jailed D2 Glaucoma Heart Block Mobitz II Hoarseness Hyperlipidemia Hypertension Impaired Glucose Tolerance Inguinal Hernia Iron Deficiency Anemia Lumbar Disc Disease Lung Cancer Middle Cerebral Artery Stenosis Osteoarthritis Peripheral Neuropathy Prostate Cancer Pulmonary Nodules Trigger Finger Surgery History: Bilroth Procedure, ___ Inguinal Hernia Repair, ___ Left lower lobe resection via VATS, ___ Lumbar Disc Surgery, ___ Radical Prostatectomy, ___ <SOCIAL HISTORY> ___ <FAMILY HISTORY> Father - died of myocardial infarction at age ___ Brother - ___ brothers with stents <PHYSICAL EXAM> HR: 53 SB BP right: 140/66 left: 144/66 RR: 18 O2 sat: 100% on RA Height: 73"" Weight: 155 lbs General: WDWN, NAD Skin: Dry [x] intact [x] HEENT: PERRLA [x] EOMI [x] Neck: Supple [x] Full ROM [x], no LAD or JVD Chest: Lungs clear bilaterally [x] Heart: RRR [x] Irregular [] Murmur [] grade IV/VI LLSB radiates across entire chest Abdomen: Soft [x] non-distended [x] non-tender [x] bowel sounds + [x] Extremities: Warm [x], well-perfused [x] Edema: none Varicosities: None [x] Neuro: Grossly intact [x] Pulses: Femoral Right: 2+ Left: 2+ DP Right: 2+ Left: 2+ ___ Right: 2+ Left: 2+ Radial Right: TR band Left: 2+ Carotid Bruit: + vs murmur <PERTINENT RESULTS> Cardiac Catheterization ___ at ___ Coronary angiography of this right dominant system demonstrated mild disease of the LMCA, mild diffuse CAD of the LAD - previously placed mid LAD stents are widely patent. Discrete 70% ostial stenosis of small jailed D1; 60% discrete ostial stenosis of large D2. Left Circumflex with mild diffuse disease, previously placed OM2 stent is widely patent. RCA with mild disease. Carotid Ultrasound ___ at ___ Right ICA <40% stenosis. Left ICA <40% stenosis. ___ 08: 05AM BLOOD WBC-7.2 RBC-2.61* Hgb-8.3* Hct-24.2* MCV-93 MCH-31.7 MCHC-34.3 RDW-15.4 Plt ___ ___ 08: 05AM BLOOD ___ ___ 08: 05AM BLOOD Glucose-108* UreaN-13 Creat-0.8 Na-136 K-4.2 Cl-103 HCO3-25 AnGap-12 ___ ___ M ___ ___ Radiology Report CHEST (PA & LAT) Study Date of ___ 10: 19 AM ___ ___ ___ 10: 19 AM CHEST (PA & LAT) Clip # ___ Reason: eval for pleural effusions Final Report EXAMINATION: CHEST (PA AND LAT) INDICATION: ___ year old man s/p CABG/AVR // eval for pleural effusions eval for pleural effusions IMPRESSION: In comparison with the study of ___, and there is again enlargement of the cardiac silhouette there bilateral pleural effusions and compressive atelectasis, more prominent on the left. Otherwise, little change. TEE: ___: Conclusions PRE-BYPASS: The left atrium is moderately dilated. No spontaneous echo contrast or thrombus is seen in the body of the left atrium or left atrial appendage. No atrial septal defect is seen by 2D or color Doppler. Left ventricular wall thicknesses and cavity size are normal. Overall left ventricular systolic function is low normal (LVEF 50-55%). Right ventricular chamber size and free wall motion are normal. The ascending, transverse and descending thoracic aorta are normal in diameter and free of atherosclerotic plaque to XX cm from the incisors. There are simple atheroma in the aortic root. There are simple atheroma in the ascending aorta. There are three aortic valve leaflets. The aortic valve leaflets are severely thickened/deformed. There is very severe aortic valve stenosis (Vmax ___ or mean gradient >=60mmHg; valve area <1.0cm2). Mild (1+) aortic regurgitation is seen. The mitral valve leaflets are moderately thickened. Mild (1+) mitral regurgitation is seen. There is no pericardial effusion. POST CPB: 1. Preserved bi-ventricular function 2. A tri-leaflet bioprosthetic valve is seen in the aortic position. Well seated and stable with good leaflet excursion. Trce perivalvular aortic regurgitaation between the right and non-voronary cusps. 3. No other change 3. No appreciable gradient across the valve <MEDICATIONS ON ADMISSION> Aspirin 325 mg tablet once a day Brimonidine 0.2 % eye drops, 1 drop OS twice a day Citalopram 20 mg tablet once a day Colace 100 mg capsule Qhs Dorzolamide 2 % eye drops, 1 drop left eye three times a day Ferrous Sulfate Folic Acid 1 mg tablet once a day Furosemide 20 mg tablet once a day Latanoprost 0.005 % eye drops, 1 drop OS QPM Metoprolol Tartrate 25 mg tablet twice a day Multivitamin 1 tablet once a day Nitroglycerin 0.4 mg SL tablet prn chest pain Potassium Chloride 10 mEq once a day Preservision Areds Simvastatin 20 mg tablet once a day Sulfasalazine 500 mg tablet twice a day Vitmain C <DISCHARGE MEDICATIONS> 1. Acetaminophen 650 mg PO/PR Q4H: PRN temperature >38.0 2. Aspirin EC 81 mg PO DAILY 3. Atorvastatin 40 mg PO QPM 4. Brimonidine Tartrate 0.15% Ophth. 1 DROP LEFT EYE Q8H 5. Citalopram 20 mg PO DAILY 6. Docusate Sodium 100 mg PO BID 7. Dorzolamide 2% Ophth. Soln. 1 DROP LEFT EYE TID 8. FoLIC Acid 1 mg PO DAILY 9. Furosemide 40 mg PO DAILY Duration: 7 Days 10. Latanoprost 0.005% Ophth. Soln. 1 DROP BOTH EYES QHS 11. Metoprolol Tartrate 37.5 mg PO TID 12. OxycoDONE (Immediate Release) ___ mg PO Q6H: PRN pain RX *oxycodone 5 mg ___ tablet(s) by mouth every six (6) hours Disp #*60 Tablet Refills: *0 13. Potassium Chloride 20 mEq PO BID 14. SulfaSALAzine_ 500 mg PO BID 15. TraMADOL (Ultram) 50 mg PO Q6H: PRN pain RX *tramadol 50 mg 1 tablet(s) by mouth every six (6) hours Disp #*50 Tablet Refills: *0 16. Warfarin 2 mg PO DAILY16 titrate for INR goal ___ <DISCHARGE DISPOSITION> Extended Care Facility: ___ ___ Diagnosis: Aortic Stenosis Cervical Disc Disease Coronary Artery Disease - LAD stents ___ and most recently in ___ with DES to LAD and POBA of jailed D2 Glaucoma Heart Block Mobitz II Hoarseness Hyperlipidemia Hypertension Impaired Glucose Tolerance Inguinal Hernia Iron Deficiency Anemia Lumbar Disc Disease Lung Cancer Middle Cerebral Artery Stenosis Osteoarthritis Peripheral Neuropathy Prostate Cancer Pulmonary Nodules Trigger Finger Surgery History: ___ Procedure, ___ Inguinal Hernia Repair, ___ Left lower lobe resection via VATS, ___ Lumbar Disc Surgery, ___ Radical Prostatectomy, ___ <DISCHARGE CONDITION> Alert and oriented x3 nonfocal Ambulating, gait steady Sternal pain managed with oral analgesics Sternal Incision - healing well, no erythema or drainage <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Please shower daily including washing incisions gently with mild soap, no baths or swimming, and look at your incisions Please NO lotions, cream, powder, or ointments to incisions Each morning you should weigh yourself and then in the evening take your temperature, these should be written down on the chart No driving for approximately one month and while taking narcotics, will be discussed at follow up appointment with surgeon when you will be able to drive No lifting more than 10 pounds for 10 weeks Please call with any questions or concerns ___ **Please call cardiac surgery office with any questions or concerns ___. Answering service will contact on call person during off hours** ","He was admitted on ___ for cardiac catheterization. Given his history of recent acute on chronic anemia, he was seen by the GI service. He was cleared for surgery will follow up as an outpatient for a colonscopy. He was taken to the operating room on ___. He underwent aortic valve replacement and ____. Please see operative note for full details. He tolerated the procedure well and was transferred to the CVICU in stable condition for recovery and invasive monitoring. He weaned from sedation, awoke neurologically intact and was extubated on POD 1. He was weaned from inotropic and vasopressor support. Beta blocker was initiated and he was diuresed toward his preoperative weight. He remained hemodynamically stable and was transferred to the telemetry floor for further recovery. He was evaluated by the physical therapy service for assistance with strength and mobility. By the time of discharge on POD 6 he needed assistance with ambulation, the wound was healing, and pain was controlled with oral analgesics. He was discharged to ___ on POD#6 in good condition with appropriate follow up instructions. Had intermittent atrial fibrillation and was anticoagulated with coumadin. ",2333,248
10005368-DS-9,"<SEX> M <SERVICE> CARDIOTHORACIC <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> Gastroesophageal reflux disease <MAJOR SURGICAL OR INVASIVE PROCEDURE> Laparoscopic ___ fundoplication <HISTORY OF PRESENT ILLNESS> The patient is a ___ gentleman whom I have been asked to see by Dr. ___ evaluation of gastroesophageal reflux disease. The patient has a history of irritable bowel syndrome with symptoms of abdominal pain and diarrhea, although this has largely improved over the past several years. His current symptoms include regurgitation of food, primarily with coughing as well as occasional substernal chest pain. His primary complaint is dysphagia as well as odynophagia on eating solid food. The patient has seen an ENT physician, ___ ___ also underwent a pH testing off of PPIs. This test performed in ___ shows ___ score of 25.9. <PAST MEDICAL HISTORY> The patient has no significant past medical history other than irritable bowel syndrome. <PHYSICAL EXAM> Gen: NAD, A&Ox3 Cardiac: RRR, no m/r/g Pulm: CTAB Abd: Soft, NTND Extremeties: warm and well perfused Incisions: covered with dermabond no evidence of infection, no bleeding or drainage <PERTINENT RESULTS> Esophageal study ___ While standing, the patient was given a small amount of thin barium contrast to ingest. Barium passed freely through the gastroesophageal junction and into the stomach. There was only a small amount of residual contrast in the distal esophagus which cleared with tertiary contractions. The patient was next laid horizontally and was given more contrast to ingest while in the right anterior oblique position. No reflux was seen. The patient was rolled into a number differentpositions to visualize the fundoplication and there is no evidence of loosening. IMPRESSION: Normal postoperative appearance of ___ fundoplication. <MEDICATIONS ON ADMISSION> Dexilant 60mg daily albuterol ___ puff ___ prn lorazepam 0.5mg QID: prn oxybutynin ER 5mg QID valacyclovir 500mg daily Vitamin B12 daily Loratidine 10mg daily Lysine 1000mg 3 times per week <DISCHARGE MEDICATIONS> 1. Ondansetron 4 mg IV ONCE: PRN for nausea 2. OxycoDONE (Immediate Release) ___ mg PO Q4H: PRN pain <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Gastroesophageal reflux disease <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Call Dr. ___ ___ if you experience: -Fevers > 101 or chills -Difficult or painful swallowing -Nausea, vomiting (take antinausea medication) -Increased shortness of breath Pain -Acetaminophen as needed for pain along with your narcotic -Take stool softners with narcotics -No driving while taking narcotics Activity -Shower daily. Wash incision with mild soap and water, rinse, pat dry -No tub bathing, swimming or hot tubs until incision healed -No lotions or creams to incision -Walk ___ times a day for ___ minutes increase to a Goal of 30 minutes daily Diet: Full liquid diet for ___ days. Increase to soft solids as tolerates Eat small frequent meals. Sit in chair for all meals. Remain sitting up for ___ minutes after all meals NO CARBONATED DRINKS ",Mr. ___ was admitted on ___ to undergo a laparoscopic ___ fundoplication for his GERD. The procedure was uncomplicated and he tolerated it well. He was extubated and stable in the OR. His stat CXR in the PACU revealved a small R apical pneumothorax however he was asymptomatic and repeat CXR 4 hours later revealed reinflation of the lung. He never dropped his sat's or had difficulty breathing. Post-operatively he has had some acute urinary retention for which he has a urinary foley catheter replaced. Barium swallow on POD #1 showed no extravasation and his diet was advanced without problem. He discharged to home on ___. ,809,144
10005565-DS-3,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> Patient recorded as having No Known Allergies to Drugs <ATTENDING> ___. <CHIEF COMPLAINT> Syncope <MAJOR SURGICAL OR INVASIVE PROCEDURE> none <HISTORY OF PRESENT ILLNESS> Ms. ___ is a ___ yo F w/hx of CAD s/p MI, gout, hypothyroidism who presented to the ED with syncope. She had seen her PCP today and was standing outside the office when she fainted. She first felt a feeling of regurgitation and a bitter taste in her mouth, then felt lightheaded and then passed out.She awoke and vomited once. Her pulse was found to be in the ___ and she was brought to the ED. The same type of incident occured a few years ago but she does not remember what hospital she was admitted to. She takes atenolol, however it makes her dizzy and she is inconsistent with taking it.She denies any recent medication changes. She does say she has been more fatigued in the last ___ weeks. She was passed out for a few minutes and as per witness reports she did not shake, bite her tongue, experience fecal/urinary incontinence or experience any motor/sensory abnormalities after waking up.She denies any associated chest pain, palpitations, or headache. She feels like her exercise tolerance has improved in the last couple of months and denies any chest pain or abnormal shortness of breath on exertion. . On review of systems, she denies any prior history of stroke, TIA, deep venous thrombosis, pulmonary embolism, bleeding at the time of surgery, She someitimes has left upper back and left arm pain but says it is related to her gout, cough, hemoptysis, black stools or red stools. She denies recent fevers, chills or rigors. She denies exertional buttock or calf pain. All of the other review of systems were negative. . Cardiac review of systems is notable for absence of chest pain, dyspnea on exertion, paroxysmal nocturnal dyspnea, orthopnea, ankle edema, palpitations, syncope or presyncope. . In the ED, initial vitals were 97.5 37 120/66 16 99%. She triggered on arrival for bradycardia of 37. She was asymptomatic and normotensive. Pacer pads were placed but not used. She was not given Atropine. She underwent head CT which was normal and CXR which was normal. Vitals prior to transfer: afebrile HR 44 BP 102/54 RR 13 99% RA. <PAST MEDICAL HISTORY> PAST MEDICAL HISTORY: 1. CARDIAC RISK FACTORS: HTN 2. CARDIAC HISTORY: Catherization ___ years ago at the ___, according to patient she was told it was normal and nothing was done. 3. OTHER PAST MEDICAL HISTORY: Gout Hypothyroidism CAD HLD . <SOCIAL HISTORY> ___ <FAMILY HISTORY> No family history of early MI, arrhythmia, cardiomyopathies, or sudden cardiac death; otherwise non-contributory. <PHYSICAL EXAM> VS: T=97.4 BP=127/71 HR=44 RR=18 O2 sat=96% RA GENERAL: WDWN female in NAD. Oriented x3. Mood, affect appropriate. HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no pallor or cyanosis of the oral mucosa. No xanthalesma. NECK: Supple, non elevated JVP CARDIAC: PMI located in ___ intercostal space, midclavicular line. RR, soft S1, S2. No m/r/g. No thrills, lifts. No S3 or S4. LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp were unlabored, no accessory muscle use. CTAB, no crackles, wheezes or rhonchi. ABDOMEN: Soft, NTND. No HSM or tenderness. Abd aorta not enlarged by palpation. No abdominial bruits. EXTREMITIES: No c/c/e. No femoral bruits. SKIN: No stasis dermatitis, ulcers, scars, or xanthomas. PULSES: Right: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ ___ 2+ Left: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ ___ 2+ <PERTINENT RESULTS> Admission Labs ___ 03: 00PM GLUCOSE-124* UREA N-14 CREAT-0.6 SODIUM-140 POTASSIUM-3.8 CHLORIDE-100 TOTAL CO2-29 ANION GAP-15 ___ 03: 00PM estGFR-Using this ___ 03: 00PM cTropnT-< 0.01 ___ 03: 00PM CALCIUM-9.3 PHOSPHATE-2.7 MAGNESIUM-2.2 ___ 03: 00PM TSH-2.6 ___ 03: 00PM WBC-10.5 RBC-4.22 HGB-13.0 HCT-37.7 MCV-89 MCH-30.9 MCHC-34.6 RDW-14.2 ___ 03: 00PM NEUTS-81.8* LYMPHS-12.0* MONOS-4.1 EOS-1.4 BASOS-0.6 ___ 03: 00PM PLT COUNT-307 . Discharge Labs ___ 07: 15AM BLOOD WBC-6.9 RBC-4.22 Hgb-12.6 Hct-38.0 MCV-90 MCH-29.9 MCHC-33.2 RDW-14.3 Plt ___ ___ 03: 00PM BLOOD WBC-10.5 RBC-4.22 Hgb-13.0 Hct-37.7 MCV-89 MCH-30.9 MCHC-34.6 RDW-14.2 Plt ___ ___ 03: 00PM BLOOD Neuts-81.8* Lymphs-12.0* Monos-4.1 Eos-1.4 Baso-0.6 ___ 07: 15AM BLOOD Plt ___ ___ 03: 00PM BLOOD Plt ___ ___ 07: 15AM BLOOD Glucose-94 UreaN-12 Creat-0.6 Na-143 K-3.3 Cl-104 HCO3-32 AnGap-10 ___ 03: 00PM BLOOD estGFR-Using this ___ 03: 00PM BLOOD cTropnT-< 0.01 ___ 07: 15AM BLOOD Calcium-9.2 Phos-3.6 Mg-2.2 ___ 03: 00PM BLOOD Calcium-9.3 Phos-2.7 Mg-2.2 ___ 03: 00PM BLOOD TSH-2.6 . Reports CHEST (PORTABLE AP) Clip # ___ Reason: eval for infiltrate UNDERLYING MEDICAL CONDITION: ___ year old woman with bradycardia REASON FOR THIS EXAMINATION: eval for infiltrate Final Report HISTORY: Bradycardia, evaluate for bradycardia. COMPARISON: ___. CHEST, SINGLE AP VIEW: The heart is top normal in size, with a mildly tortuous aorta. The lungs are clear without consolidation or edema. No pleural effusion or pneumothorax is identified. IMPRESSION: No acute cardiopulmonary abnormality. The study and the report were reviewed by the staff radiologist. . CT HEAD W/O CONTRAST Clip # ___ Reason: eval for ICH UNDERLYING MEDICAL CONDITION: ___ year old woman with syncope REASON FOR THIS EXAMINATION: eval for ICH CONTRAINDICATIONS FOR IV CONTRAST: None. Provisional Findings Impression: ___ WED ___ 6: 02 ___ No acute intracranial process. Final Report HISTORY: ___ female with syncope. Question intracranial hemorrhage. COMPARISON: None. TECHNIQUE: Contiguous axial images through the brain were acquired without intravenous contrast. FINDINGS: The gray-white matter differentiation is preserved. There is no evidence of hemorrhage, mass, mass effect, shift of midline structures, or infarction. The ventricles and sulci are normal in size and configuration. Periventricular hypodensity adjacent to the frontal horn of the right lateral ventricle likely represents the sequelae of chronic ischemic microvascular disease. The calvarium is intact. The visualized paranasal sinuses are clear. Mild atherosclerotic calcification is noted within the cavernous carotid arteries bilaterally. IMPRESSION: No acute intracranial process. <MEDICATIONS ON ADMISSION> Atenolol 50mg PO daily Levothyroxine 100 mcg Tab Oral daily Hydrochlorothiazide 25 mg Tab Oral daily Amlodipine 10 mg Tab Oral daily Crestor 20 mg Tab Oral daily Allopurinol ___ mg Tab Oral daily Colchicine 0.6 mg Tab Oral daily . <DISCHARGE MEDICATIONS> 1. Rosuvastatin 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 2. Allopurinol ___ mg Tablet Sig: Three (3) Tablet PO DAILY (Daily). 3. Hydrochlorothiazide 12.5 mg Capsule Sig: Two (2) Capsule PO DAILY (Daily). 4. Levothyroxine 100 mcg Tablet Sig: One (1) Tablet PO DAILY (Daily). <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Bradycardia Syncope . Secondary Diagnosis HTN Hypothyroidism Gout <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> It was a pleasure to care for you as your doctor. . You were brought to the hospital because of losing consciousness and low heart rate. We carried out several exams and decided you needed no intervention at this time. You probably passed out because of low heart rate and a natural response to reflux of food called vagal response. . We have discontinued some of your blood pressure medications on this admission because your blood pressures were well controlled. Please take your blood pressures at home and contact your primary care physician on future management of your blood pressure. . We made the following changes to your home medication list: STOP Atenolol due to low heart rate STOP Amlodipine due to low blood pressure Please talk to your primary doctor next week regarding your blood pressure and your medications. We continued the rest of your medications you were taking before being admitted to the hospital. Please follow up with the outpatient appointments below: ","Ms. ___ is a ___ yo F w/hx of CAD s/p MI, gout, hypothyroidism who presented to the ED with syncope and bradycardia in the ___. . #Syncope- The patient experienced some reflux of the food she had eaten and then felt lightheaded and passed out. She was found to have sinus bradycardia on presentation to the E.D. High on the differential is symptomatic bradycardia causing syncope.Per the patient she has a history of 1 episode of low HR causing her to past out a few years ago. The last EKG we have of her is in ___ when she was NSR in the ___. She denies having palpitations or experiencing lightheadedness on a regular basis, however she does say her atenolol makes her lightheaded. Vasovagal syncope given regurgitation of her food, and perhaps increased abdominal pressure, before passing out was also high on the differential. She also has a hx. of hypothyroidism which can cause bradycardia. Lower on the differential was seizure because of no typical clincial symptoms and PE because she denied any SOB and was never found to be tachycardic. Her heart rate was in the 40's and the tele showed sinus bradycardia. She was asymptomatic.However of note she does say she has been more fatigued than usual in the last week or two. We monitored on tele.-sinus bradycardia on ___-50.Held nodal blocking agents including atenolol and amlodipine during the admission and on discharge.She was hemodynamically stable.Checked TSH-2.6.Walked the patient and see if her heart rate increases above 60/minand ####.Restarted HCTZ home dose on discharge, however will discontinue atenolol and amlodipine given baseline bradycardia and controlled hypertension with systolic blood pressures from 100-110.Will need reassessment of blood pressure medications as outpatient. . # Hypothyroidism- Continued home dose synthroid .Checked TSH-2.6 . #Gout- Was not active, had no joint pains.Held colchicine given no clinically active disease. Continued Allopurinol home dose . # HTN -Was not hypertensive during the admission, SBP's running in the 100- 120's Her atenolol was discontinued given her baseline bradycardia and her amlodipine was disconinued given her low blood pressures. She was discharged only on her home dose 25mg/day Hydrochlorthiazide. She will need outpatient follow up for titration of blood pressure medications. _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ ________________________________________________________________ Outpatient follow up -Patient's Blood pressure on admission was between 105-130/60-80. Her atenolol was discontinued given her baseline bradycardia and her amlodipine was disconinued given her low blood pressures. She was discharged only on her home dose 25mg/day Hydrochlorthiazide. She will need outpatient follow up for titration of blood pressure medications. -Please consider outpatient cardiac stress test ",2433,697
10005605-DS-21,"<SEX> F <SERVICE> SURGERY <ALLERGIES> Tetracycline / Flagyl <ATTENDING> ___. <CHIEF COMPLAINT> diverticular abscess <MAJOR SURGICAL OR INVASIVE PROCEDURE> none <HISTORY OF PRESENT ILLNESS> Ms. ___ is a ___ woman, who presented with ___ abdominal pain since ___ in LLQ. Patient has not had much nausea except for a single episode last ___ when she vomited foodstuff and a small amount of bile. She is still having bowel movements and passing flatus, but her pain was much increased from her simple uncomplicated ""diverticular flare"" that she has had ___ x year. She has never had an abscess or hospitalization for her prior episodes and has not had abx. CT done thru PCP today which showed an abscess in her colon. Sent here for admission. Unasyn given x 1. Had colonoscopy ___ which showed 2 polyps, moderate diverticulosis. <PAST MEDICAL HISTORY> Symptomatic Cholelithiasis Biliary obstruction s/p ERCP Anemia <SOCIAL HISTORY> ___ <FAMILY HISTORY> Diverticulitis <PHYSICAL EXAM> Temp: 97.2 HR: 79 BP: 110/61 Resp: 18 O(2)Sat: 100 Normal Constitutional: Comfortable HEENT: Normocephalic, atraumatic, Pupils equal, round and reactive to light, Extraocular muscles intact Oropharynx within normal limits Chest: Clear to auscultation Cardiovascular: Regular Rate and Rhythm, Normal first and second heart sounds Abdominal: Soft, mild LLQ tenderness w/o r/g. Nl BS. Extr/Back: No cyanosis, clubbing or edema Skin: Warm and dry Neuro: Speech fluent <PERTINENT RESULTS> ___ 08: 25PM BLOOD WBC-11.8*# RBC-3.99* Hgb-12.4 Hct-33.9* MCV-85 MCH-31.1 MCHC-36.7* RDW-12.3 Plt ___ ___ 08: 25PM BLOOD Neuts-75.6* ___ Monos-3.4 Eos-0.7 Baso-0.4 ___ 08: 25PM BLOOD Plt ___ ___ 08: 25PM BLOOD Glucose-108* UreaN-33* Creat-2.0* Na-136 K-3.6 Cl-95* HCO3-25 AnGap-20 ___ 08: 30PM BLOOD Lactate-1.3 ___ BLOOD CULTURE Blood Culture, Routine-PENDING ___ BLOOD CULTURE Blood Culture, Routine-PENDING ___ 09: 36PM URINE Color-Yellow Appear-Clear Sp ___ ___ 09: 36PM URINE Blood-NEG Nitrite-POS Protein-100 Glucose-NEG Ketone-15 Bilirub-LG Urobiln-1 pH-5.0 Leuks-TR ___ 09: 36PM URINE RBC-2 WBC-8* Bacteri-FEW Yeast-NONE Epi-6 TransE-<1 ___ 09: 36PM URINE CastGr-1* CastHy-78* ___ 09: 36PM URINE Mucous-OCC ___ 07: 45AM BLOOD WBC-7.0 RBC-3.41* Hgb-10.7* Hct-29.1* MCV-85 MCH-31.2 MCHC-36.6* RDW-12.4 Plt ___ ___ 07: 45AM BLOOD Plt ___ ___ 07: 45AM BLOOD ___ PTT-28.5 ___ ___ 07: 45AM BLOOD Glucose-90 UreaN-32* Creat-1.5* Na-140 K-3.7 Cl-102 HCO3-27 AnGap-15 ___ 07: 45AM BLOOD Calcium-9.4 Phos-4.6* Mg-2.1 CT abd/pelv in ATRIUS 1. Sigmoid diverticulitis with 4.3 x 4.7cm intraluminal abscess versus adjacent pelvic abscess. IV contrast would be helpful to differentiate, which was not administered due to elevated creatinine. Follow-up CT recommended to exclude an underlying mass. 2. 3 mm noncalcified nodule in left lung base. Chest CT advised. <MEDICATIONS ON ADMISSION> ___, Calci-Chew, multivitamin, lisinopril-hydrochlorothiazid <DISCHARGE MEDICATIONS> 1. lisinopril 10 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 2. hydrochlorothiazide 12.5 mg Capsule Sig: One (1) Capsule PO DAILY (Daily). 3. Augmentin 875-125 mg Tablet Sig: One (1) Tablet PO twice a day for 6 days. Disp: *12 Tablet(s)* Refills: *0* <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> diverticular abscess <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> You were admitted to the ACS service for a diverticular abscess. Please resume all regular home medications. Please take any new medications as prescribed. If you have pain, you may take acetaminophen (Tylenol) as directed, but do not exceed 4000 mg in one day. Please get plenty of rest, continue to walk several times per day, and drink adequate amounts of fluids. Please also follow-up with your PCP. ","Ms. ___ is a ___ year old female who has a history of diverticulosis and has been having abdominal pain for 4 days. Outpatient CT performed on ___ showed diverticulitis with a 4.3 x 4.7 cm collection. She was referred to the emergency department for further evaluation. Upon ED presentation, pt's abdomen was soft with normoactive bowel sounds, with mild LLQ tenderness w/o rebound tenderness or guarding. Labs were notable for a slightly increased white count, chronic renal insufficiency, and a UTI. Pt was given Unasyn. Given concern for worsening diverticular disease, diverticular abscess, pt was seen by surgery and admitted to ___ service. Pt was made NPO, given IVF, IV abx, to good effect. Symptomatic resolution seen, tolerating regular diet. Given improving clinical picture, patient discharged on 7-day course of Augmentin on ___. ",1276,196
10005605-DS-22,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> Tetracycline / Flagyl <ATTENDING> ___. <CHIEF COMPLAINT> lower abd pain <MAJOR SURGICAL OR INVASIVE PROCEDURE> None <HISTORY OF PRESENT ILLNESS> ___ y/o F with HTN, CKD stage III, h/o diverticulitis and diverticular abscess, presented originally to the ___ ED on ___ with 3 days of LLQ pain and constipation. She received a CT abd/pelvis, which showed acute diverticulitis with no evidence of perforation or fluid collection. There was also a large amt of stool seen in the colon with an abrupt transition point seen in the caliber of the bowel within the distal sigmoid colon, multiple prominent left pelvic lymph nodes, noted to be concerning for a underlying colonic mass. The patient was observed overnight on ___ and discharged on ___ with stool softeners (colace and Miralax) and oral antibiotics (cipro 500 mg BID and clindamycin 300 mg q6h for 10 days). She had a bowel movement prior to discharge from ED. Since then, she has not had any additional bowel movements. She was at work today when she developed sudden ___ pain in her abd. Due to this, she decided to come to the ED. She usually has bowel movements daily but states that since she had been taking Zofran (was recently d/c'd from ___ ED in ___ for an episode of vertigo), she noted worsening constipation. Denies any fever/chills but has had nausea today with no vomiting. In the ED, initial vitals were: 98.7 74 174/93 18 98% RA. Labs showed normal WBC of 7.3 with 76.8% neutrophils. Electrolytes were wnl, lactate 1.3. UA was negative for UTI. UCx and BCx were drawn. Rectal exam was performed, which showed minimal stool in vault. Patient was not given any medications in the ED. On arrival to the floor, the patient's pain had largely resolved, remaining at ___ without any pain meds. She denies CP, SOB, HA. She denies weight loss and endorses a several pound weight gain. Has been tolerating PO without problems but noted some fullness yesterday. Of note, she has had a colonoscopy in ___, which showed mod-severe diverticulosis. Also seen were two 4-5 mm sessile polyps, one in the cecum and one at 65 cm from the anorectal verge. Path revealed Langerhans cell histiocytoma (eosinophilic granuloma). <PAST MEDICAL HISTORY> - HTN - CKD stage III - Anemia - H/o diverticular abscess ___ - Symptomatic cholelithiasis s/p cholecystectomy ___ - DVT in R soleal vein in context of multiple fx ___ after being hit by car (US ___ and ___ showed stability) - Tibial plateau fx in L knee after being hit by car ___ <SOCIAL HISTORY> ___ <FAMILY HISTORY> Mother - lung cancer ___ uncle - lung cancer ___ aunt - colon cancer <PHYSICAL EXAM> ADMISSION EXAM -== Vitals: 97.5 148/66 75 18 97% RA ___ pain General: Alert, oriented, no acute distress HEENT: Sclera anicteric, MMM, oropharynx clear, EOMI, PERRL Neck: Supple, JVP not elevated, no LAD CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Lungs: Clear to auscultation bilaterally, no wheezes, rales, rhonchi Abdomen: Soft, mildly tender to palpation in lower abd, non-distended, bowel sounds present, no organomegaly, no rebound or guarding GU: No foley Ext: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema Neuro: moves all extremities well DISCHARGE EXAM -= Vitals: T: 97.5 HR: 75 BP: 148/66 RR: 18 SaO2: 97% RA General: Alert, sitting up in bed, interactive, no acute distress HEENT: Sclera anicteric, MMM, oropharynx clear, EOMI, PERRL 3->2 directly and consensually Neck: Supple, JVP not elevated, no LAD CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Lungs: Clear to auscultation bilaterally, no wheezes, rales, rhonchi Abdomen: Soft, non-distended. Tender to palpation in left lower quadrant, bowel sounds present, no organomegaly, no rebound or guarding GU: No foley Ext: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema Neuro: AOx3, memory ___ immediate and delayed, speech fluent. CNII-XII intact, ___ strength upper/lower extremities, grossly normal sensation in face, upper and lower extremities, gait narrow based and stable <PERTINENT RESULTS> ADMISSION LABS -= ___ 11: 30AM BLOOD WBC-7.3 RBC-4.42 Hgb-13.6 Hct-39.4 MCV-89 MCH-30.8 MCHC-34.5 RDW-12.8 Plt ___ ___ 11: 30AM BLOOD Neuts-76.8* Lymphs-16.2* Monos-4.1 Eos-2.0 Baso-1.0 ___ 11: 30AM BLOOD Glucose-104* UreaN-23* Creat-1.1 Na-139 K-3.9 Cl-102 HCO3-23 AnGap-18 ___ 11: 41AM BLOOD Lactate-1.3 DISCHARGE LABS -= ___ 08: 15AM BLOOD WBC-5.1 RBC-3.88* Hgb-12.0 Hct-34.6* MCV-89 MCH-30.8 MCHC-34.6 RDW-13.0 Plt ___ ___ 08: 15AM BLOOD Glucose-109* UreaN-19 Creat-1.1 Na-140 K-4.2 Cl-104 HCO3-23 AnGap-17 ___ 08: 15AM BLOOD Glucose-109* UreaN-19 Creat-1.1 Na-140 K-4.2 Cl-104 HCO3-23 AnGap-17 ___ 08: 15AM BLOOD Calcium-9.7 Phos-3.7 Mg-2.2 MICROBIOLOGY ============ **FINAL REPORT ___ URINE CULTURE (Final ___: NO GROWTH. BCX PENDING <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Amlodipine 5 mg PO DAILY 2. Multivitamins 1 TAB PO DAILY 3. Ondansetron 4 mg PO QID: PRN dizziness 4. Meclizine 25 mg PO Q8H: PRN dizziness 5. Clindamycin 300 mg PO Q6H 6. Ciprofloxacin HCl 500 mg PO Q12H 7. Docusate Sodium 100 mg PO BID 8. Polyethylene Glycol 17 g PO DAILY <DISCHARGE MEDICATIONS> 1. Amlodipine 5 mg PO DAILY 2. Ciprofloxacin HCl 500 mg PO Q12H Last day of antibiotics ___. Clindamycin 300 mg PO Q6H Last day of antibiotics ___. Docusate Sodium 100 mg PO BID 5. Multivitamins 1 TAB PO DAILY 6. Polyethylene Glycol 17 g PO DAILY <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> PRIMARY DIAGNOSIS - # Diverticulitis # Constipation SECONDARY DIAGNOSIS -== # Hypertension <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Ms. ___, It was a pleasure taking care of you during your hospitalization at ___. You were admitted to the hospital because you were having worsening abdominal pain and constipation. We have given you stool softeners and laxatives while you were in the hospital, and this resolved. In addition, we continued you on antibiotics (ciprofloxacin and clindamycin) for diverticulitis that was previously seen on ___ ___. You should continue taking these antibiotics as previously instructed to complete a 10-day total course of antibiotics. There were some abnormalities that were seen on your CT scan. We recommend that you schedule for a colonoscopy in ___ weeks to evaluate for a possible mass in your colon that could be contibuting to your constipation. We wish you the best, Your ___ Care Team ","BRIEF SUMMARY ============== ___ y/o F with HTN, CKD stage III, h/o diverticulitis and diverticular abscess, presented originally to the ___ ED on ___, found to have diverticulitis and constipation and discharged on cipro/clinda, now returns with another episode of lower abd pain, most likely consistent with known diagnoses. ACTIVE ISSUES ============= # Acute, uncomplicated diverticulitis - The patient was recently found to have diverticulitis, diagnosed on CT abd/pelvis on ___ and represented on ___ with similar abdominal pain. While patient does have a history of diverticulitis and diverticular abscess, this current episode can be considered uncomplicated. The patient was afebrile, with normal WBC at 7.3 and normal lactate. On arrival to the floor, pain had diminished from ___ to ___ with no additional pain medication while in-house and the patient had a completely benign abdominal exam with no concerns for perforation. She was discharged on ___ from the ___ ED with a 10-day total course of ciprofloxacin/clindamycin (has Flagyl allergy), which she had been compliant with. She was continued on this regimen during her brief hospitalization and discharged to complete this 10-day course, with last dose ___. She tolerated a regular low residue diet in the hospital and did not require any additional pain medication, so she was discharged on ___. # Constipation - The patient presented to the ED on ___ with bowel pain and reports of not having had a bowel movement since her discharge from the ___ ED on ___. She had a large amount of stool seen in the sigmoid colon on CT abd/pelvis on ___ but no stool in the vault on rectal exam on examination. Etiologies included medication-induced, as the patient had been taking Zofran at home for dizziness, which could have contributed to constipation. Furthermore, there could be an obstructive underlying mass (ddx colonic source vs. gyn source) given pelvic lymphadenopathy seen on CT abd/pelvis. Last colonoscopy was performed ___, which showed sessile polpys that were biopsied and revealed Langerhans cell histiocytoma (eosinophilic granuloma). The patient was given colace and Miralax for relief of constipation and she had two large bowel movements prior to discharge on ___ with relief of abdominal pain. To further investigate whether there is an underlying mass, the patient will need a repeat outpatient colonoscopy in ___ weeks after her acute episode of diverticulitis has resolved. She was discharged on colace/Miralax. CHRONIC ISSUES ============== # Stage III CKD - Creatinine of 1.1 on admission, stable. # HTN - stable. Continued home amlodipine. TRANSITIONAL ISSUES ==================== # Patient will need a repeat colonoscopy in ___ weeks to evaluate for possible colonic mass given presence of pelvic lymph nodes and transition point seen in the sigmoid colon. Both patient and PCP are aware. # Patient will complete 10-day oral antibiotic therapy for diverticulitis (ciprofloxacin and clindamycin) as previously instructed. Last dose will be ___. # CODE: Full # CONTACT: ___ (sister) - ___ (H), ___ (C) ",2011,697
10005749-DS-15,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___ <CHIEF COMPLAINT> Lower extremity edema <MAJOR SURGICAL OR INVASIVE PROCEDURE> Peripherally inserted central venous catheter <HISTORY OF PRESENT ILLNESS> ___ y.o female with pmhx. of polycystic disease s/p bilateral native nephrectomies in ___ and then deceased donor renal transplant in ___ on Cellcept, Cyclosporine, and Prednisone, afib on ASA, type 2 DM, HTN had complicated recent hospital course (___) with recurrent pneumonia, exudative pleural effusion and infected hepatic cyst requiring ___ drainage c/b septic physiology requiring high volume rescuscitation and vasopressors, complicated by hyperkalemia and worsening renal function, who presented today to ___ clinic for second opinion regarding her increasing creatinine. At ___ clinic she was noted to have significant lower extremity edema and pulse of 120 and was directly admitted to ___. . Of note she was discharged from her last admission at ___ on ___ and has completed 1 month course of Cipro and Flagyl for infected hepatic cyst. She had significant volume overload after her large volume resuscitation for sepsis and ultimately discharged on lasix 20mg daily howvever this was stopped on ___. In addition her ___ to be held. She did recieve an abdominal CT scan with IV contrast on ___ for reevaluation of her hepatic abscess which revealed intervel decerase in the size of tghe fluid collection in the right hepatic lobe. On ___ her BUN/creat was ___ which was elevated from baseline (___). On ___ she was admitted again to ___ for hyperkalemia and acute renal injury. Her potassium was 6.4 and BUN/Creat ___. She was discharged on ___ with her Lasix continuing to be held, her Cipro/flagyl continued for hepatic cyst for 10 more days ___ drain removed during this admission) and immunosuppressives continued. . Currently the patient denies any pain. She has been experiencing orthopnea and lower extremity edema for ___ weeks. She usually weighs approxiamately 120Ibs and now weighs 140Ibs. She denies any recent CT studies. She denies any chest pain,cough, fevers, chills, palpitations, dizziness, syncope, lower extremity pain or dyspnea on exertion. She is ambulatory dependent on a walker at baseline. She does endorse decreased urinary output in the last 3 weeks but denies any hematuria, dysuria, back/abdominal pain, nausea, vomiting, decreased appeptite or confusion. . . ROS: per HPI, denies fever, chills, night sweats, headache, vision changes, rhinorrhea, congestion, sore throat, cough, shortness of breath, chest pain, abdominal pain, nausea, vomiting, diarrhea, constipation, BRBPR, melena, hematochezia, dysuria, hematuria. <PAST MEDICAL HISTORY> ESRD due to ___ s/p deceased donor renal transplant ___ Bilateral naitive nephrectomies in ___ Hx of recieving HD via LUE AVF for ___ year prior to transplant HTN DMt type 2 Hyperlipidemia Recurrent UTI Gallstone pancreatitis s/p sphincterotomy <SOCIAL HISTORY> ___ <FAMILY HISTORY> Older sister s/p kidney trasnplant Daughter also has ___ <PHYSICAL EXAM> ADMISSION EXAM GENERAL: Well appearing ___ yo M/F who appears stated age. Comfortable, appropriate and in good humor, oriented X 3 HEENT: Sclera icteric. PERRL, EOMI. NECK: Supple with 10cm JVP CARDIAC: PMI located in ___ intercostal space, midclavicular line. RRR, S1 S2 clear and of good quality without murmurs, rubs or gallops. No S3 or S4 appreciated. LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp were unlabored, no accessory muscle use, moving air well and symmetrically. CTAB, insp b/l crackles, no wheezes or rhonchi. ABDOMEN: NonDistended and Soft, ___ to palpation. Dullness to percussion over dependent areas but tympanic anteriorly. No HSM or tenderness. EXTREMITIES: Warm and well perfused, no clubbing or cyanosis. 2+ ___ bilaterally to knees. <PERTINENT RESULTS> ADMISSION LABS ___ 07: 15PM BLOOD ___ ___ Plt ___ ___ 07: 15PM BLOOD ___ ___ ___ 07: 15PM BLOOD ___ ___ ___ 07: 15PM BLOOD ___ ___ ___ 07: 15PM BLOOD ___ LD(LDH)-299* ___ ___ ___ 01: 10PM BLOOD ___ ___ 04: 52AM BLOOD ___ ___ 04: 52AM BLOOD ___ . DISCHARGE LABS ___ 05: 12AM BLOOD ___ ___ Plt ___ ___ 05: 12AM BLOOD ___ ___ ___ 05: 12AM BLOOD ___ ___ ___ 05: 12AM BLOOD ___ . URINE STUDIES ___ 09: 49PM URINE ___ Sp ___ ___ 09: 49PM URINE ___ ___ ___ 09: 49PM URINE ___ ___ ___ 09: 49PM URINE ___ ___ 09: 49PM URINE ___ ___ 09: 49PM URINE ___ ___ . MICROBIOLOGY URINE CULTURE (Final ___: YEAST. ___ ORGANISMS/ML.. . CLOSTRIDIUM DIFFICILE TOXIN A & B TEST (Final ___: Feces negative for C.difficile toxin A & B by EIA. (Reference ___. . ___ 4: 31 pm STOOL CONSISTENCY: NOT APPLICABLE Source: Stool. **FINAL REPORT ___ MICROSPORIDIA STAIN (Final ___: NO MICROSPORIDIUM SEEN. CYCLOSPORA STAIN (Final ___: NO CYCLOSPORA SEEN. FECAL CULTURE (Final ___: NO ENTERIC GRAM NEGATIVE RODS FOUND. NO SALMONELLA OR SHIGELLA FOUND. CAMPYLOBACTER CULTURE (Final ___: NO CAMPYLOBACTER FOUND. OVA + PARASITES (Final ___: NO OVA AND PARASITES SEEN. This test does not reliably detect Cryptosporidium, Cyclospora or Microsporidium. While most cases of Giardia are detected by routine O+P, the Giardia antigen test may enhance detection when organisms are rare. FECAL CULTURE - R/O VIBRIO (Final ___: NO VIBRIO FOUND. FECAL CULTURE - R/O YERSINIA (Final ___: NO YERSINIA FOUND. FECAL CULTURE - R/O E.COLI 0157: H7 (Final ___: NO E.COLI 0157: H7 FOUND. Cryptosporidium/Giardia (DFA) (Final ___: NO CRYPTOSPORIDIUM OR GIARDIA SEEN. CLOSTRIDIUM DIFFICILE TOXIN A & B TEST (Final ___: Feces negative for C.difficile toxin A & B by EIA. (Reference ___. . CMV Viral Load (Final ___: CMV DNA not detected. Performed by PCR. Detection Range: 600 - 100,000 copies/ml. FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES. This test has been validated by the Microbiology laboratory at ___. . PARVOVIRUS B19 DNA, QL REAL Not Detected Not Detected TIME PCR . BK Virus DNA, Quantitative ___ PCR BK Virus, QN PCR No DNA Detected <500 copies/mL STUDIES EKG ___ Atrial fibrillation with a rapid ventricular response. ___ wave changes. Low voltage in the limb leads. No previous tracing available for comparison. . TTE ___ The left atrium is mildly dilated. Left ventricular wall thicknesses and cavity size are normal. Overall left ventricular systolic function is severely depressed (LVEF= ___. [Intrinsic left ventricular systolic function is likely more depressed given the severity of valvular regurgitation.] Right ventricular chamber size is normal. with mild global free wall hypokinesis. The aortic valve leaflets (3) are mildly thickened but aortic stenosis is not present. Trace aortic regurgitation is seen. The mitral valve leaflets are mildly thickened. Moderate to severe (3+) mitral regurgitation is seen. Moderate to severe [3+] tricuspid regurgitation is seen. There is moderate pulmonary artery systolic hypertension. [In the setting of at least moderate to severe tricuspid regurgitation, the estimated pulmonary artery systolic pressure may be underestimated due to a very high right atrial pressure.] Significant pulmonic regurgitation is seen. There is a small pericardial effusion. There is an anterior space which most likely represents a prominent fat pad. IMPRESSION: Severely depressed LV systolic dysfunction with anterior/anteroseptal akinesis and hypokinesis of all segments bar basal inferior/inferolateral segments. Dilated and depressed right ventricle. Moderate to severe mitral regurgitation likely due to leaflet tethering. Moderate to severe tricuspid regurgitation. At least moderate pulmonary hypertension. . Chest Xray ___ Moderate bilateral pleural effusions layer dependently. Cardiac silhouette has a peculiar shape, and a larger than expected component to the right of midline. Whether this is due to cardiomegaly or pericardial effusion is indeterminate. There is no particular distention of either pulmonary or mediastinal vasculature to suggest one or the other. Bibasilar atelectasis is relatively mild, and there is no pulmonary edema. Aortic contour is normal. . ___ When compared to the study of ___, there is continued enlargement of the cardiac silhouette with evidence of elevated pulmonary venous pressure. The right heart border is now sharply seen, as is the hemidiaphragm, consistent with substantial decrease in pleural effusion. However, this could represent a more erect position of the patient rather than significant fluid decrease. There is opacification at the left base consistent with a small effusion on this side. <MEDICATIONS ON ADMISSION> Metoprolol Tartrate 12.5 mg TID Glipizide 5mg Qd Prednisione 5mg Qdaily Lorazepam 0.25mg Q12 H PRN agitation Cyclosporine 50mg BID Mycophenolate Mofetil 500mg BID Ciprofloxacin 500mg BID Flagyl 500mg TID MVI <DISCHARGE MEDICATIONS> 1. prednisone 5 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 2. lorazepam 0.5 mg Tablet Sig: One (1) Tablet PO Q8H (every 8 hours) as needed for insomnia/anxiety . Disp: *20 Tablet(s)* Refills: *0* 3. metoprolol succinate 50 mg Tablet Extended Release 24 hr Sig: Three (3) Tablet Extended Release 24 hr PO BID (2 times a day). Disp: *180 Tablet Extended Release 24 hr(s)* Refills: *0* 4. mycophenolate mofetil 250 mg Capsule Sig: One (1) Capsule PO BID (2 times a day). 5. multivitamin Capsule Sig: One (1) Capsule PO once a day. 6. Coumadin 5 mg Tablet Sig: One (1) Tablet PO once a day. Disp: *30 Tablet(s)* Refills: *2* 7. Diltzac ER 120 mg Capsule, Extended Release Sig: One (1) Capsule, Extended Release PO once a day. Disp: *30 Capsule, Extended Release(s)* Refills: *2* 8. cyclosporine modified 25 mg Capsule Sig: Two (2) Capsule PO Q12H (every 12 hours). 9. furosemide 40 mg Tablet Sig: One (1) Tablet PO BID (2 times a day). Disp: *60 Tablet(s)* Refills: *2* 10. Outpatient Lab Work Please have your labs drawn on ___ and have the results faxed to ___. Please have chemistry panel, CBC, cyclosporine level and INR drawn. <DISCHARGE DISPOSITION> Home With Service Facility: ___ ___: PRIMARY DIAGNOSIS Acute on chronic systolic congestive heart failure Acute on chronic renal failure Atrial Fibrillation with rapid ventricular response . SECONDARY DIAGNOSIS Status post kidney transplant Hyperlipidemia Diabetes Hypertension <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Ms. ___, It was a pleasure participating in your care while you were admitted to ___. As you know you were admitted because you were having increased swelling in your legs and difficulty breathing. You had an EKG which showed your heart was in an abnormal rhythm and going fast. You were given medications to improve your heart rate. You also had an ultrasound of your heart called an ECHO which showed your heart was not pumping well and one of your heart valves was leaky. You were given medication to remove extra fluid. You will need a repeat echo as an outpatient. We Made the following changes to your medications 1. START Metoprolol Succinate 150 mg twice a day 2. START Diltazem 120 mg once a day 3. STOP Ciprofloxacin 4. STOP Flagyl 5. Start Coumadin a blood thinner 6. We decreased your Cell Cept to 250mg twice a day 7. STOP Glipizide. . Please continue to take the rest of your home medications as you were before coming to the hospital. . You will be followed by the ___ clinic at ___ associates at ___. Please contact ___ to establish when you need lab draws for monitoring of your INR (measurement of blood thickness). . Please have your labs drawn on ___ and have the results faxed to ___ which is the ___. Please have chemistry panel, CBC, cyclosporine level and INR drawn. ","___ y.o female with pmhx. of polycystic disease s/p bilateral native nephrectomies in ___ and then deceased donor renal transplant in ___ on Cellcept, Cyclosporine, and Prednisone, afib on ASA, type 2 DM, HTN had complicated recent hospital course (___) with recurrent pneumonia, exudative pleural effusion and infected hepatic cyst requiring ___ drainage c/b septic physiology requiring high volume resuscitation and vasopressors, complicated by hyperkalemia and worsening renal function, who presented to ___ clinic for second opinion regarding her increasing creatinine being admitted for volume overload and tachycardia. . #Acute systolic heart failure- Patient was admitted with significant lower extremity edema, elevated JVD and pleural effusions. A TTE showed a EF of ___ anterior/anteroseptal akinesis and hypokinesis as well as moderate to severe mitral regurgitation. She was diuresed with bolus doses of IV lasix (40 mg BID) approximately ___ L per day for 4 days. Her weight on admission was 64.8 kg and 59 kg on discharge. She was transitioned to oral lasix 40 mg BID. Cardiology was consulted a felt presentation was not complete consistent with ischemic cardiomyopathy and possibly reflective of a tachymyopathy. She will however need further imaging with a MIBI or possible catheterization as an outpatient. She will also need a repeat TTE to evaluate valve and ventricular function now that she is no longer volume overloaded. She would likely also benefit from initiation as an ACEi as an outpatient when renal function improves. . ___ creatinine was 1.8 on admission from a baseline of 1.2. This was felt to likely reflect poor cardiac forward flow leading to hypoperfusion. Patient was diuresed as above with improvement in her creatinine to 1.6. Patient will ___ with transplant nephrology. . #Hepatic Cyst- Patient is status post drainage of cyst and drain removal ___. Per Infectious Disease at ___ patient was supposed to take 10 more days of Ciprofloxacin and Flagyl. However these antibiotics were discontinued at the time of admission as the patient had no signs of infection. She remained afebrile with no signs of infection throughout the remainder of her hospital course. . #Atrial Fibrilliation- Patient was noted to be in atrial fibrillation with rates as high as the 150s. Patient was asymptomatic without chest pain or palpitations. TSH was within normal limits. In consultation with cardiology she was started on metoprolol tartrate which was titrated upward to 150 mg twice a day. This was converted to metoprolol succinate 150 mg BID. Rates remained elevated to the ___ and she was started on diltiazem with improved rate control. The patient was only on aspirin on admission. However she was initiated on warfarin at the time of discharge. The decision was made not to undertake bridging therapy. Patient will ___ in the ___ ___ clinic for INR monitoring and warfarin dose adjustment. . #Kidney Transplant- Patient was continued on her home immunosuppresives, including Cyclosporine, Cell Cept and steroids. His BK virus PCR was negative. Cyclosporine levels were appropriate. . #Thrombocytopenia- Patients platelets were noted to decrease from admission platelet count of 140's to the 80's with recovery to the 100s. In the differential is HIT and splenic sequestration. Heme onc consult has recommended HIT ab and various viral PCR's. The HIT antibody was negative. CMV viral load was negative. Parvovirus titers were negative and EBV titers were pending at the time of discharge. Reticulocyte count was appropriate. Vitamin B12, folate and iron levels were within normal limits. Infectious ___ including blood and urine cultures were negative. There was no evidence of bleeding. The patient will need close monitoring of her platelet count as an outpatient. Patient will also need a US to rule out splenomegaly. . #DM- Patient was maintained on an insulin sliding scale. Oral hypoglycemics were restarted on discharge. . TRANSITIONAL ISSUES - Patient will ___ with transplant nephrology, cardiology and with a new ___ PCP - ___ INR monitoring and dose adjustment was transitioned to ___ clinic - EBV titers were pending at the time of discharge - Patient will need an US to evaluate for splenomegaly, repeat TTE and stress MIBI - Patient will need to have her creatinine and platelet count monitoring - Patient was full code throughout this admission ",3166,1003
10005749-DS-16,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___ <CHIEF COMPLAINT> pleuritic chest pain <MAJOR SURGICAL OR INVASIVE PROCEDURE> none <HISTORY OF PRESENT ILLNESS> ___ s/p renal transplant in ___ (unable to obtain IV dye), afib on coumadin recently sub-therapeutic, who presents with ___ days of pleuritic chest pain under her left breast. She denied any pain at rest, dyspnea or lower extremity pain or swelling. She was seen at ___ on ___ where she reported a recent car trip to ___ in the middle of last week ___ach way). Her INR was found to be 1.2. She also notes recent exercise which she thinks may have contributed to the pain. She currently feels at baseline, with no pain. No recent fevers/chills. No chest pain or abdominal pain. No shortness of breath. - Initial vitals: 98.4 88 145/72 99% RA - Labs were notable for UA neg for infection. INR was 1.2. Chem7 was notable Cr of 1.4, Trop negative. Alb 3.1, AP 133. CBC: 7.9 / 10.1 / - Studies performed include CXR showing stable small to moderate bilateral pleural effusions and stable mild cardiomegaly and pulmonary artery enlargement. Bilateral LENIS were negative - Patient was given 1mg warfarin On the floor patient feels well, no pleuritic pain, no shortness of breath. Review of Systems: (+) per HPI (-) fever, chills, night sweats, headache, vision changes, rhinorrhea, congestion, sore throat, cough, shortness of breath, chest pain, abdominal pain, nausea, vomiting, diarrhea, constipation, BRBPR, melena, hematochezia, dysuria, hematuria. <PAST MEDICAL HISTORY> ATRIAL FIBRILLATION CHRONIC KIDNEY DISEASE DIABETES TYPE II HYPERLIPIDEMIA HYPERTENSION GALLSTONE PANCREATITIS S/P SPHINCTEROTOMY S/P RENAL TRANSPANT SYSTOLIC CONGESTIVE HEART FAILURE EF ___ SHINGLES - FOREHEAD DIABETES MELLITUS MITRAL REGURGITATION URINARY TRACT INFECTION RENAL TRANSPLANT ___ BILATERAL NEPHRECTOMIES ___ SPHINCTEROTOMY BREAST AUGMENTATION <SOCIAL HISTORY> ___ <FAMILY HISTORY> Sister RENAL TRANSPLANT Daughter POLYCYSTIC KIDNEYS <PHYSICAL EXAM> Physical exam on admission: --=== Vitals: 99.1 162/97 96 16 99% RA blood sugar 371 General: comfortable, in NAD HEENT: MMM, PERRL, oropharynx clear Neck: supple CV: RRR, normal s1 and s2 Lungs: CTAB Abdomen: soft, nontender, nondistended Ext: warm, well perfused, no ___ edema Neuro: alert and oriented x 3, moving all extremities with purpose. CN II-XI intact Physical exam on discharge: --=== Vitals: 98.5 (101.0) 158/99 86 16 99% RA General: comfortable, in NAD HEENT: MMM, PERRL, oropharynx clear Neck: supple CV: RRR, normal s1 and s2 Lungs: CTAB Abdomen: soft, mild ttp over transplanted kidney in RLQ, no RUQ tenderness, nondistended Ext: warm, well perfused, no ___ edema Neuro: alert and oriented x 3, moving all extremities with purpose. CN II-XI intact <PERTINENT RESULTS> Labs on admission: -======== ___ 12: 24PM BLOOD WBC-9.8 RBC-3.44* Hgb-10.5* Hct-30.2* MCV-88 MCH-30.5 MCHC-34.8 RDW-12.7 RDWSD-40.1 Plt ___ ___ 12: 24PM BLOOD Neuts-88.4* Lymphs-7.1* Monos-3.8* Eos-0.2* Baso-0.1 Im ___ AbsNeut-8.70* AbsLymp-0.70* AbsMono-0.37 AbsEos-0.02* AbsBaso-0.01 ___ 12: 24PM BLOOD ___ ___ 12: 24PM BLOOD Plt ___ ___ 12: 24PM BLOOD UreaN-21* Creat-1.2* Na-132* K-4.4 Cl-97 HCO3-24 AnGap-15 ___ 12: 24PM BLOOD ALT-15 AST-20 ___ 12: 24PM BLOOD Lipase-35 ___ 12: 24PM BLOOD Calcium-9.1 ___ 03: 30PM BLOOD Albumin-3.1* Calcium-9.0 Phos-2.6*# Mg-1.8 ___ 02: 43PM BLOOD D-Dimer-___* ___ 03: 35PM BLOOD Lactate-1.8 Reports: -======== IMPRESSION: 1. Multiple liver cysts and tortuous anechoic structures in the central liver which may represent additional cysts and/or saccular dilation of bile ducts, several with either intraductal stones or parenchymal calcifications. MRCP is suggested for further delineation and to exclude a common hepatic duct stone or other central cause of apparent biliary dilation, versus intrinsic biliary dilation such as could be due to ___'s disease or cholangiohepatitis. 2. Trace perihepatic ascites and small left pleural effusion. RECOMMENDATION(S): MRCP is recommended for further evaluation. V/Q Scan IMPRESSION: Low likelihood ratio for acute pulmonary embolism. By electronically signing this report, I, the attending physician, attest that I have reviewed the images associated with the above examination(s) and agree with the findings as documented above. Microbiology: -======== URINE CULTURE (Final ___: NO GROWTH. Blood Culture, Routine: Pending x3 Labs on discharge: -======== ___ 07: 15AM BLOOD WBC-5.3 RBC-2.89* Hgb-8.6* Hct-25.1* MCV-87 MCH-29.8 MCHC-34.3 RDW-12.6 RDWSD-40.1 Plt ___ ___ 07: 15AM BLOOD Glucose-151* UreaN-19 Creat-1.4* Na-135 K-3.5 Cl-101 HCO3-23 AnGap-15 ___ 07: 15AM BLOOD Calcium-8.6 Phos-3.3 Mg-1.6 ___ 07: 15AM BLOOD ___ PTT-87.9* ___ <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. PredniSONE 5 mg PO DAILY 2. Mycophenolate Mofetil 250 mg PO BID 3. Multivitamins 1 TAB PO DAILY 4. Metoprolol Succinate XL 100 mg PO BID 5. Losartan Potassium 25 mg PO DAILY 6. Lorazepam 0.5 mg PO QHS: PRN anxiety 7. GlipiZIDE XL 5 mg PO DAILY 8. Furosemide 20 mg PO DAILY: PRN leg swelling 9. Ferrous Sulfate 325 mg PO EVERY OTHER DAY 10. Diltiazem Extended-Release 120 mg PO DAILY 11. Atorvastatin 10 mg PO QHS 12. Ezetimibe 10 mg PO DAILY 13. CycloSPORINE (Neoral) MODIFIED 25 mg PO Q12H 14. Warfarin 1 mg PO DAILY16 15. Calcium 600 + D(3) (calcium carbonate-vitamin D3) 600 mg(1,500mg) -400 unit oral 2 tablets once a day <DISCHARGE MEDICATIONS> 1. CycloSPORINE (Neoral) MODIFIED 25 mg PO Q12H 2. Diltiazem Extended-Release 120 mg PO DAILY 3. Ezetimibe 10 mg PO DAILY 4. Ferrous Sulfate 325 mg PO EVERY OTHER DAY 5. Furosemide 20 mg PO DAILY: PRN leg swelling 6. Lorazepam 0.5 mg PO QHS: PRN anxiety 7. Metoprolol Succinate XL 100 mg PO BID 8. Losartan Potassium 25 mg PO DAILY 9. Multivitamins 1 TAB PO DAILY 10. Mycophenolate Mofetil 250 mg PO BID 11. PredniSONE 5 mg PO DAILY 12. Levofloxacin 750 mg PO Q48H RX *levofloxacin 750 mg 1 tablet(s) by mouth every other day Disp #*3 Tablet Refills: *0 13. Atorvastatin 10 mg PO QHS 14. Calcium 600 + D(3) (calcium carbonate-vitamin D3) 600 mg(1,500mg) -400 unit oral 2 tablets once a day 15. GlipiZIDE XL 5 mg PO DAILY 16. Warfarin 1 mg PO DAILY16 <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Primary: Fevers Chest pain Commmunity acquired pneumonia Secondary: status post renal transplant atrial fibrillation <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Ms. ___, It has been a pleasure taking part in your care during your hospitalization at ___. You were admitted for left sided chest pain, and there was concern for a possible blood clot in your lungs. A study was performed that showed that it is unlikely that there was a clot in your lung. However, you had high fevers, and there was concern for infection given that you take immune suppressive medications. An ultrasound showed cysts in your liver, and bile duct dilation, which will need to get followed up with an outpatient gastroenterologist. You were treated empirically with broad antibiotics and these were changed to levofloxacin to treat for community acquired pneumonia. Please monitor your INR very closely given that it may fluctuate with your antibiotics. Please follow up with the appointments as scheduled below. Please continue to take your medications, and take your coumadin daily unless instructed otherwise by your doctor. Again, it has been a pleasure taking part in your care, and we wish you the best. Sincerely, - Your ___ care team ","___ s/p renal transplant in ___ (unable to obtain IV dye), on immunosuppresion, s/p bilateral nephrectomies, afib on coumadin recently sub-therapeutic, who presents with ___ days of pleuritic chest pain under her left breast after 12 hours driving which resolved upon presentation. CP was of unclear cause. VQ scan was low probability. Patient notes some exercise recently and thinks this may have caused her pain. cardiac enzymes negative, EKG reassuring for ACS. patient was subtherapeutic on coumadin and has CHADS2 score of 3, and was treated with heparin gtt. Patient had fevers of unknown etiology, blood cultures were drawn which were pending at time of discharge. The patient remained afebrile for 24 hours and was treated for presumed community acquired pneumonia given her subjective symptoms of pleuritic chest pain and pleural effusion on admission CXR. # FEVERS - Pt admitted for chest pain but spiked low grade fevers during admission. Initially placed on empiric vancomycin and zosyn, but continued spiking fevers without apparent source. CXR showed minor pulmonary effusion on the R side. No localizing infectious symptoms, and fever resolved. Has reportedly had history of liver cyts which were again demonstrated on RUQ US without RUQ tenderness to palpation, thus not believed to be the source of intermittent fevers. The patient remained afebrile for 24 hours and was treated for presumed community acquired pneumonia given her subjective symptoms of pleuritic chest pain and pleural effusion on admission CXR without obvious localizing infectious signs, clear V/Q scan, and negative urine and blood cultures at the time of discharge. # CP: The patient had an admission EKG and troponins reassuring for ACS, but reported pleuritic chest pain on admission. Given a sub-therapeutic INR the patient was begun on a heparin drip, and with a recent history of travel and elevated d-dimer a V/Q scan was ordered which showed low probability of a pullmonary embolism. The patient's chest pain resolved completely by hospital day 2. Given that her only subjective complaint on admission was pleuritic chest pain, it was believed that her pain likely stemmed from a parapneumonic effusion and the patient was treated for community acquired pneumonia. TRANSITIONAL ISSUES: # AFIB - ensure patient taking coumadin 2 mg. Follow up INR on ___ # Liver cysts and sacular intrahepatic bile duct dilation - Noted on RUQ US to assess for possible fever source. Radiology recommended MRCP for further evaluation. Pls consider GI referral if needed. (note: pt with transplanted kidney) # Please monitor INR closely given concurrent levofloxacin administration # Code Status: Full code # Emergency Contact/HCP: ___ (husband) ___ ",2439,599
10005749-DS-17,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> High blood sugars, labs showing acute on chronic kidney injury <MAJOR SURGICAL OR INVASIVE PROCEDURE> None <HISTORY OF PRESENT ILLNESS> Ms. ___ is a ___ with a h/o renal transplant, CHF, AFib on Coumadin, DM who presented to the ED on ___ with hyperglycemia (600s) and worsening kidney function on routine tests at PCP. On ___, her blood glucose was 665, and her Hgb A1c was found to be 12.7. Her creatinine was 2.1, up from 1.4 in ___ (most recent value). Had been taking her home Glipizide as prescribed. She had been urinating frequently and had a cold a few days prior to admission, but otherwise had no symptomatic complaints. <PAST MEDICAL HISTORY> ATRIAL FIBRILLATION CHRONIC KIDNEY DISEASE DIABETES TYPE II HYPERLIPIDEMIA HYPERTENSION GALLSTONE PANCREATITIS S/P SPHINCTEROTOMY S/P RENAL TRANSPANT SYSTOLIC CONGESTIVE HEART FAILURE EF ___ SHINGLES - FOREHEAD DIABETES MELLITUS MITRAL REGURGITATION URINARY TRACT INFECTION RENAL TRANSPLANT ___ BILATERAL NEPHRECTOMIES ___ SPHINCTEROTOMY BREAST AUGMENTATION <SOCIAL HISTORY> ___ <FAMILY HISTORY> Sister RENAL TRANSPLANT Daughter POLYCYSTIC KIDNEYS <PHYSICAL EXAM> PHYSICAL EXAM upon admission: Vitals: 97.4 PO, 160 / 55, 71, 20, 97 Ra Intake: 480, outs not recorded General: alert, oriented, no acute distress HEENT: sclera anicteric, slightly dry mucus membranes, oropharynx clear Neck: supple, JVP not elevated, no LAD Lungs: clear to auscultation bilaterally, no wheezes, rales, rhonchi CV: Irregularly irregular rhythm, normal S1 + S2, no murmurs, rubs, gallops Abdomen: soft, non-tender, non-distended, bowel sounds present, no rebound tenderness or guarding, no organomegaly GU: no foley Ext: warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema Neuro: CNs2-12 intact, motor function grossly normal PHYSICAL EXAM upon discharge: Vitals: 97.4 PO, 160 / 55, 71, 20, 97 Ra Intake: 480, outs not recorded General: alert, oriented, no acute distress HEENT: sclera anicteric, slightly dry mucus membranes, oropharynx clear Neck: supple, JVP not elevated, no LAD Lungs: clear to auscultation bilaterally, no wheezes, rales, rhonchi CV: Irregularly irregular rhythm, normal S1 + S2, no murmurs, rubs, gallops Abdomen: soft, non-tender, non-distended, bowel sounds present, no rebound tenderness or guarding, no organomegaly GU: no foley Ext: warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema Neuro: CNs2-12 intact, motor function grossly normal <PERTINENT RESULTS> LABS UPON ADMISSION ___ 05: 42PM BLOOD UreaN-46* Creat-2.1* Na-127* K-4.0 Cl-86* HCO3-22 AnGap-23* ___ 05: 42PM BLOOD Glucose-665* ___ 05: 42PM BLOOD WBC-7.9 RBC-3.54* Hgb-9.8* Hct-29.1* MCV-82 MCH-27.7 MCHC-33.7 RDW-14.1 RDWSD-41.6 Plt ___ ___ 05: 42PM BLOOD %HbA1c-12.7* eAG-318* ___ 12: 15PM BLOOD Glucose-548* UreaN-47* Creat-1.9* Na-122* K-3.8 Cl-85* HCO3-21* AnGap-20 ___ 12: 15PM BLOOD WBC-11.2* RBC-3.64* Hgb-10.1* Hct-30.0* MCV-82 MCH-27.7 MCHC-33.7 RDW-14.1 RDWSD-41.8 Plt ___ ___ 12: 15PM BLOOD Neuts-90.2* Lymphs-6.1* Monos-2.1* Eos-0.2* Baso-0.2 Im ___ AbsNeut-10.14* AbsLymp-0.68* AbsMono-0.24 AbsEos-0.02* AbsBaso-0.02 LABS UPON DISCHARGE: ___ 11: 19AM BLOOD Glucose-221* UreaN-42* Creat-1.8* Na-130* K-3.1* Cl-91* HCO3-22 AnGap-20 ___ 05: 56PM BLOOD Glucose-356* UreaN-43* Creat-1.9* Na-126* K-4.0 Cl-89* HCO3-23 AnGap-18 ___ 11: 19AM BLOOD WBC-11.4* RBC-3.64* Hgb-10.1* Hct-30.1* MCV-83 MCH-27.7 MCHC-33.6 RDW-14.1 RDWSD-41.7 Plt ___ ___ 11: 19AM BLOOD ___ PTT-35.5 ___ IMAGING: RENAL US ___ IMPRESSION: 1. Patent renal transplant vasculature. 2. Borderline to minimally elevated intrarenal resistive indices measuring up to 0.79 in the interpolar region. CXR ___ IMPRESSION: Persistent small left and trace right pleural effusions and cardiomegaly. No pulmonary edema. <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. PredniSONE 5 mg PO DAILY 2. Losartan Potassium 25 mg PO DAILY 3. LORazepam 0.5 mg PO QHS: PRN anxiety 4. Metoprolol Succinate XL 100 mg PO BID 5. Diltiazem Extended-Release 120 mg PO DAILY 6. Ezetimibe 10 mg PO DAILY 7. Warfarin 1 mg PO EVERY OTHER DAY 8. Atorvastatin 10 mg PO QPM 9. CycloSPORINE (Neoral) MODIFIED 25 mg PO Q12H 10. Mycophenolate Mofetil 250 mg PO BID 11. Ferrous Sulfate 325 mg PO EVERY OTHER DAY 12. Furosemide 60 mg PO BID 13. Multivitamins 1 TAB PO DAILY 14. GlipiZIDE XL 5 mg PO DAILY 15. Calcium 600 + D(3) (calcium carbonate-vitamin D3) 600 mg(1,500mg) -400 unit oral DAILY 16. Warfarin 0.5 mg PO EVERY OTHER DAY <DISCHARGE MEDICATIONS> 1. Cefpodoxime Proxetil 100 mg PO Q12H Duration: 10 Days RX *cefpodoxime 100 mg 1 tablet(s) by mouth twice per day Disp #*18 Tablet Refills: *0 2. NPH 10 Units Breakfast Insulin SC Sliding Scale using HUM Insulin 3. Atorvastatin 10 mg PO QPM 4. Calcium 600 + D(3) (calcium carbonate-vitamin D3) 600 mg(1,500mg) -400 unit oral DAILY 5. CycloSPORINE (Neoral) MODIFIED 25 mg PO Q12H 6. Diltiazem Extended-Release 120 mg PO DAILY 7. Ezetimibe 10 mg PO DAILY 8. Ferrous Sulfate 325 mg PO EVERY OTHER DAY 9. LORazepam 0.5 mg PO QHS: PRN anxiety 10. Metoprolol Succinate XL 100 mg PO BID 11. Multivitamins 1 TAB PO DAILY 12. Mycophenolate Mofetil 250 mg PO BID 13. PredniSONE 5 mg PO DAILY 14. Warfarin 1 mg PO EVERY OTHER DAY 15. Warfarin 0.5 mg PO EVERY OTHER DAY 16. HELD- Furosemide 60 mg PO BID This medication was held. Do not restart Furosemide until you see your PCP or your kidney doctor 17. HELD- Losartan Potassium 25 mg PO DAILY This medication was held. Do not restart Losartan Potassium until you see your PCP or kidney doctor 18.Outpatient Lab Work Chem 10, ___ fax to: ___, MD ___, MD ___ <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> PRIMARY DIAGNOSIS: HYPERGLYCEMIA Acute kidney injury on chronic kidney injury Complicated urinary tract infection Hyponatremia Hypokalemia SECONDARY DIAGNOSIS: Atrial fibrillation Renal transplant Congestive heart failure Anxiety Hypertension <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Ms. ___, You came to the hospital because you had very high blood sugar and bloodwork showing that your kidneys were not working as well. While you were in the hospital, you were given insulin and intravenous fluids. Your Lasix and Losartan medications were held because you were very dehydrated. Your electrolyte levels were abnormal, which were repleted. You were also found to have a urinary tract infection, which was treated with antibiotics. Since your blood sugars were so high, it is very important that you take insulin every day, as prescribed. When you leave the hospital, you will also need to continue taking antibiotics (cefpodoxime 100 mg PO twice per day for 10 days) with last dose on ___. NEW MEDICATIONS: Insulin NPH 10 units at breakfast Insulin sliding scale Humalog (see discharge medications)(we have provided you with a chart that) Cefpodoxime 100 mg PO twice a day through ___ STOPPED MEDICATIONS: Glipizide Furosemide (Lasix) Losartan MAKE AN APPOINTMENT WITH YOUR NEPHROLOGIST FOR WITHIN ONE WEEK - Dr. ___ AN APPOINTMENT WITH YOUR PRIMARY CARE DOCTOR - Call ___ PLEASE ATTEND YOUR ___ APPOINTMENT Please get your labs checked next ___. It was a pleasure taking care of you. Your ___ Team ","___ with a history of renal transplant, CHF, AFib on Coumadin, DM who was admitted on ___ after she was found to have hyperglycemia (600s) and worsening renal function on routine lab tests at PCP (Cr 2.1 on ___, up from most recent 1.4 on ___. # Hyperglycemia / T2DM: Pt presented with significant hyperglycemia with ___ and elevated serum osms (but not meeting criteria for HHS). Treated with insulin in ED and developed low K. Given her significantly elevated glucose and HbA1c, the patient requires insulin therapy for glucose control. ___ was consulted and recommended the following regimen: NPH 10 Units fixed dose in the morning and Humalog sliding scale at meals (see discharge paperwork for scale). Her electrolyte abnormalities resolved with repletion and intravenous fluids. Her home glipizide was held. # Acute on chronic kidney disease s/p renal transplant: She presented with Cr 2.1, though her Cr has been baseline 1.2-1.3 for many years. Her acute presentation is likely due to hypovolemia in setting of hyperglycemia and gradual decline in kidney function. She was given intravenous fluids, and her creatinine was followed closely. Her Lasix and Losartan were held during admission due to her dehydration and ___. Her home cyclosporine, prednisone, and MMF were continued. Cr was not back to baseline upon discharge. Losartan and Lasix held at discharge. # UTI: She was also found to have a urinalysis suggestive of UTI, culture pending. This infection likely developed in setting of acute on chronic hyperglycemia. Endorsed urinary sx. She was treated with ceftriaxone 1g IV once daily and transitioned to cefpoxodime 500mg twice a day for a 7 day course (last dose ___. Urine cultures were pending at the time of discharge. #Extensive discussions were had with patient and husband regarding discharge plan. We requested that the patient stay overnight given the elevated Cr, pending urine cultures, electrolyte abnormalities, and need for additional fluid repletion and patient education. Patient insisted on discharge and agreed to help ensure very close follow-up. CHRONIC: # A-fib Continued home warfarin at 0.5 and 1mg alternating (note was just changed on ___ per ___ clinic because INR was high. Continued diltiazem, metoprolol and digoxin. # CHF ECHO ___ with normal regional/global systolic function. Mild-to-moderate mitral regurgitation. Moderate pulmonary hypertension. EF >55%. Per hx and exam, she was volume down. Lasix was held. # Anxiety Continued home lorazepam # HTN Losartan held in setting of ___. Furosemide held in setting of ___. # HLD Continued home atorvastatin and zetia. **TRANSITIONAL ISSUES** NEW MEDICATIONS: Insulin NPH 10 units at breakfast Insulin sliding scale Humalog (see discharge medications) Cefpodoxime 100 mg PO BID, end date ___ STOPPED MEDICATIONS: Glipizide Furosemide (Lasix) Losartan -Pt needs close f/u with PCP, ___, and ___. PCP is ___. Discussed with patient and family -Pt should have repeat labs on ___, chem 10 and INR. If her creatinine is improved and she does not appear hypovolemic, please restart her losartan and furosemide. ",2503,764
10005808-DS-15,"<SEX> M <SERVICE> NEUROLOGY <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___ <CHIEF COMPLAINT> limb weakness and tingling <MAJOR SURGICAL OR INVASIVE PROCEDURE> Lumbar Puncture <HISTORY OF PRESENT ILLNESS> Mr. ___ is a ___ year old right handed gentleman with no significant past medical history presenting with a three week history of bilateral hand paresthesias and weakness, bilateral leg paresthesias and weakness, bilateral calf pain and a resolved three day episode of R facial droop with ptosis. Mr. ___ was in his normal state of health until the week of ___ when he fell ill with a cold. He continued to go to work and only noted a runny nose, congestion, and a cough. He denies any fever, chills, nausea, vomiting, diarrhea illness, difficutly breathing, myalgias, or extreme fatigue. These symptoms lasted for a week. On ___, the pt woke up with tingling in his fingers and palms. He denies ever having this before and tried all day to alleviate the sensation without success. This continued for three days and evolved on ___ to include pain and weakness in his calves, all of which prompted him to call his PCP and go in for an urgent appointment. He was seen by an NP who found his temperature to be 99.2. Per report, she felt his symptoms were suggestive of bilateral Carpel Tunnel Syndrome and sent Lyme serologies, diabetes screening tests, and thyroid function tests. He was also noted to be hypertensive with a SBP greater than 175 on this visit. On follow up with his PCP on ___, he noticed that he had difficulty whistling. His wife also felt his R eyelid was droopy, that he was blinking less than usual, and his smile was assymetric on the R. His PCP informed him of the negative Lyme, diabetes, and thyroid tests, but was concerned for stroke in the setting of his BP of 182/120 and thus sent him to the ___ in ___. At the ___, he had a negative CT, EKG and ""blood work"". He was diagnosed with Bell's Palsy, informed that his calf pain was a mystery and given Prednisone. The next day, he had follow up with an Angels? ___ NP who agreed with the ___'s ___ diagnosis and felt that he was having a ""leg muscle problem"". The ___, he felt the pain in his leg had intensified to a burning sensation, non radiating with increased weakness, paresthesias, and difficulty walking. He went back to the ___ where he was evaluated for DVT with a ""blood test"" and the negative result persuaded them not to do an ultrasound. By this time, he felt his facial palsy was completely resolved. ___, he felt the tingling in his hands had evolved to ""stinging"" pain (___), weakness and numbness with continued tingling. He felt that he was dropping things all the time and could not open bottles or button his shirts. His calf pain also continued and was worsening, thus his PCP gave him an U/s that was negative and suggested a muscle biopsy, ABI, and EMG. The following week, ___, his wife noticed that he appeared drunk when he walked and had to hold on to the wall with each step to prevent from falling. On ___, he had an ABI and an EMG read as negative, but while at work, hes legs gave out and he had a fall complicated by subsequent left hamstring strain. Neurology follow up was scheduled for ___ and given his history and progressively worsening symptoms, he was directly admitted from clinic to the floor. On neuro ROS, the pt denies loss of vision, blurred vision, diplopia, dysphagia, vertigo, or hearing difficulty. Denies difficulties comprehending speech. No bowel or bladder incontinence or retention. Denies back pain. On general review of systems, the pt denies recent fever or chills. No night sweats or recent weight loss or gain. Denies shortness of breath. Denies chest pain or tightness, palpitations. Denies nausea, vomiting, diarrhea, constipation or abdominal pain. No recent change in bowel or bladder habits. No dysuria. Denies arthralgias or myalgias. Denies rash. Denies tick bite, exposure to toxic chemicals, new medications, or recent procedure. <PAST MEDICAL HISTORY> Hiatal hernia in ___ Occasional heartburn <SOCIAL HISTORY> ___ <FAMILY HISTORY> He has no family history of autoimmune disease or neurological disease. Positive FH of diabetes, CVD, HTN, and high cholesterol. <PHYSICAL EXAM> Admission Physical Examination: <PHYSICAL EXAM> Vitals: T: 97.8F P: 68 R: 14 BP: 127/86 SaO2: 98% RA General: Awake, cooperative, NAD. HEENT: NC/AT, no scleral icterus noted, MMM, no lesions noted in oropharynx Neck: Supple. No nuchal rigidity Pulmonary: Lungs CTA bilaterally without R/R/W Cardiac: RRR, nl. S1S2, no M/R/G noted Abdomen: soft, NT/ND, normoactive bowel sounds, no masses or organomegaly noted. Extremities: No edema. 2+ radial, DP pulses bilaterally . Neurologic: -Mental Status: He is alert, oriented x 3 and could describe historical facts accurately. He is attentive, able to name ___ backward. His language is fluent with intact repetition and comprehension. Naming of high and low frequency items is intact. He accurately follows commands and memory is intact with ___ words remembered at 30sec and 5 min. -Cranial Nerves: I: Olfaction not tested. II: PERRL 3 to 2mm and brisk. VFF to confrontation. Funduscopic exam revealed a sharp disck on the right, but the patient's eye watering prevented visualization of the left. III, IV, VI: EOMI without nystagmus. Normal saccades. V: Facial sensation intact to light touch. VII: No facial droop, facial musculature symmetric. VIII: Hearing intact to finger-rub bilaterally. IX, X: Palate elevates symmetrically. XI: ___ strength in trapezii and SCM bilaterally. XII: Tongue protrudes in midline. -Motor: Normal bulk with slight decreased tone in wrist, elbows, and ___. Slight pronator drift bilaterally. No adventitious movements, such as tremor, noted. No asterixis noted. -Sensory: Deficits pinprick on hands and wrists bilaterally up to elbows. Deficits in the legs starting above the knee to the feet, cold sensation intact. Light touch intact. Intact vibratory sense, but decreased proprioception at toes. No extinction to DSS. -DTRs: ___ throughout. Plantar response was mute. -Coordination: No intention tremor, no dysdiadochokinesia noted. No dysmetria on FNF but abnormal HKS bilaterally. RAM slowed on R side. -Gait: Shuffled, narrow-based, with assistance. Unable to support weight without support. -Romberg positive. Discharge <PHYSICAL EXAM> Improved from admission as follows: CNs: Mild right to left facial asymmetry with right sided weakness. Motor: Full strength in his upper extremities. In the lower extremity his adductors and left hamstring and toe extensors are breakable. His right side is full strength. Reflexes: Still absent in his ___, but present in his UE L>R (2 and 1 at left bi and tri, and 1 and 0 on the right bi and tri). Sensation: He has a sensory level to pinprick at B/l ankles, the knuckles on the left and below the knuckles on the right. Coordination: He still has impaired proprioception at his toes, but not ankles and fingers. Gait: still requires assistance of walker, but improved to one assist only. <PERTINENT RESULTS> ___ 02: 59PM %HbA1c-5.7 eAG-117 ___ 05: 11PM CEREBROSPINAL FLUID (CSF) WBC-0 RBC-0 POLYS-48 ___ ___ 05: 11PM CEREBROSPINAL FLUID (CSF) PROTEIN-72* GLUCOSE-60 ___ 06: 20PM SED RATE-4 ___ 06: 20PM PLT COUNT-256 ___ 06: 20PM NEUTS-66.1 ___ MONOS-4.0 EOS-3.2 BASOS-0.7 ___ 06: 20PM WBC-9.8 RBC-5.03 HGB-15.3 HCT-43.7 MCV-87 MCH-30.3 MCHC-34.9 RDW-13.9 ___ 06: 20PM PEP-NO SPECIFI IgA-386 ___ 06: 20PM CRP-4.8 ___ 06: 20PM ___ * TITER-1: 80 ___ 06: 20PM TSH-2.3 ___ 06: 20PM VIT B12-410 ___ 06: 20PM TOT PROT-6.1* CALCIUM-9.3 PHOSPHATE-2.5* MAGNESIUM-1.9 ___ 06: 20PM ALT(SGPT)-31 AST(SGOT)-21 ALK PHOS-48 TOT BILI-0.4 ___ 06: 20PM GLUCOSE-105* UREA N-18 CREAT-0.8 SODIUM-142 POTASSIUM-3.9 CHLORIDE-105 TOTAL CO2-24 ANION GAP-17 ___ 08: 41PM URINE BLOOD-NEG NITRITE-NEG PROTEIN-NEG GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-8.0 LEUK-NEG ___ 08: 41PM URINE COLOR-Straw APPEAR-Clear SP ___ ___ 08: 41PM URINE U-PEP-NO PROTEIN . Imaging Studies: . 1. Chest PA and Lateral (___) FINDINGS: Normal lung volumes. Normal size of the cardiac silhouette. Normal hilar and mediastinal contours. No evidence of pneumonia, pleural effusion, or pulmonary edema. . 2. MR ___ Spine Without ___ FINDINGS: Lumbar vertebrae appear normal in height and alignment. There is diffusely and mildly heterogeneous marrow signal intensity seen involving the vertebral bodies, which may represent heterogeneous fatty infiltration, marrow reconversion secondary to anemia or may also be seen in marrow infiltrative disorders. The spinal cord terminates at the upper L1 level. Conus medullaris and cauda equina have normal morphologies and signal intensities. Pre- and paravertebral soft tissues are unremarkable. At T12-L1, L1-L2, L2-L3, there is no disc herniation, spinal canal or neural foraminal narrowing. Small anterior osteophytes are noted at multiple levels with mixed ___ changes at the ___ aspect of T12. At L3-L4, there is mild diffuse disc bulge, but no significant spinal canal or neural foraminal narrowing. At L4-L5, there is disc bulge with posterior annular tear and shallow protrusion with no significant spinal canal or left neural foraminal narrowing; mild right foraminal narrowing. Mild bilateral facet joint effusions are noted. At L5-S1, there is no disc herniation, spinal canal or neural foraminal narrowing. . IMPRESSION: 1. Diffusely and mildly heterogeneous bone marrow signal intensity may reflect heterogeneous fatty marrow infiltration/marrow reconversion. Please correlate with hematology labs for anemia/infiltrative disorders. . 2. Mild degenerative changes in the lumbar spine involving the discs and facets without significant spinal canal or neural foraminal narrowing. . 3. Prominent epidural fat is noted circumferentially in the lumbosacral region effacing the CSF space and deforming the thecal sac. <MEDICATIONS ON ADMISSION> Prilosec OTC once a month Metoprolol XR 75mg (since ___ Percocet 5mg (since ___ <DISCHARGE MEDICATIONS> 1. gabapentin 300 mg Capsule Sig: Two (2) Capsule PO TID (3 times a day) for 1 months. Disp: *180 Capsule(s)* Refills: *1* 2. metoprolol succinate 50 mg Tablet Extended Release 24 hr Sig: 1.5 Tablet Extended Release 24 hrs PO DAILY (Daily). 3. omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) Capsule, Delayed Release(E.C.) PO DAILY (Daily). <DISCHARGE DISPOSITION> Home With Service Facility: ___ <DISCHARGE DIAGNOSIS> Acute Inflammatory Polyneuropathy (AIDP) <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Neuro: Mild right to left facial asymmetry with right sided weakness. Full strength in his upper extremities. In the lower extremity his adductors and left hamstring and toe extensors are breakable. His right side is full strength. His reflexes are still absent in his ___, but present in his UE L>R (2 and 1 at left bi and tri, and 1 and 0 on the right bi and tri). He has a sensory level to pinprick at B/l ankles, the knuckles on the left and below the knuckles on the right. He still has impaired proprioception at his toes, but not ankles and fingers. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Mr. ___, You were admitted to the ___ due to limb numbness and weakness. You had a lumbar puncture that showed high protein and low cells. You were diagnosed with an acute inflammatory demyelinating process (AIDP, also known as ___ or variant). You were started on treatment with IVIG which you tolerated well. Your symptoms have improved with the daily IVIG and physical therapy. You will be discharged to home and will continue physical therapy. Please follow up with your PCP ___ within the next 2 weeks. On admission, you were taking the following medications: Prilosec OTC once a month Metoprolol XR 75mg (since ___ Percocet 5mg (since ___ Please STOP: Percoset Please START: Gabapentin 600 mg TID while continuing to have pain. ","Mr. ___ is a ___ yo generally healthy gentleman who presented with subacute, progressive limb weakness and paresthesias in a peripheral distribution following an upper respiratory illness. His pattern of weakness were consistent with a variant of Acute Inflammatory Demyelinating Polyradiculopathy (AIDP or ___. The patient received a lumbar puncture which demonstrated albuminocytologic dissociation providing further evidence for AIDP. He was started on IVIG and received 5 doses. He improved on a daily basis and tolerated the IVIG well. He was seen by ___ throughout and his pain was controlled with Gabapentin. His respiratory effort was also monitored with NIF's and vital capacities daily and was never concerning. Mr ___ was discharged in good condition. ___ felt he would do well at home with a walker and home ___. He was sent with a prescription for Gabapentin and a follow-up appointment with Dr. ___. ",3210,193
10005812-DS-10,"<SEX> F <SERVICE> OBSTETRICS/GYNECOLOGY <ALLERGIES> Patient recorded as having No Known Allergies to Drugs <ATTENDING> ___. <CHIEF COMPLAINT> Premature Preterm Rupture of Membranes <MAJOR SURGICAL OR INVASIVE PROCEDURE> D+E <HISTORY OF PRESENT ILLNESS> ___ G3P1 at ___ presented to the ED with leaking of fluid and N/V x 1d. N/V started last night after eating at ___, had emesis x 1, sudden onset. Woke this morning with persistent nausea, emesis x 1 today. Had ""gush of fluid"" after emesis last night with persistent leaking of clear fluid throughout the day; she has needed to wear a pad. Mild lower abd cramping also started today. Denies F/C, cough, dysuria, changes in bowel habits, sick contacts, vaginal bleeding. Continues to feel flutters of FM. U/S in ED demonstrated cervical funneling with an open internal os. An MRI also confirmed this, with no evidence of appendicitis. <PAST MEDICAL HISTORY> PNC: - ___: ___ - labs: unknown - screening: per pt, FFS wnl POBHX: G3 ___ - LTCS x 1, term, ___ arrest of dilation 5cm - SAB x 1 PGYNHX: - menstrual cycle: regular - Paps: denies hx abnl; no hx cervical procedures - STIs: denies PMH: - pseudotumor cerebri PSH: - LTCS - ACL reconstruction <SOCIAL HISTORY> ___ <FAMILY HISTORY> NC <PHYSICAL EXAM> VS: 98.4 110 127/74 16 100RA GENERAL: NAD CARDIO: RRR PULM: CTAB ABDOMEN: soft, very mild TTP b/l LQ R>L, no R/G, mildly gravid EXTREMITIES: NT b/l SSE: +pooling, +nitrazine with membranes seen at os, which appears 2-3cm dilated bedside TAUS: adeq fluid, +FM, FHR 168bpm (M-mode) <PERTINENT RESULTS> ___ 09: 50PM WBC-25.4* RBC-4.02* HGB-12.2 HCT-35.2* MCV-88 MCH-30.4 MCHC-34.6 RDW-14.1 ___ 09: 50PM PLT COUNT-304 ___ 09: 50PM NEUTS-84.0* LYMPHS-12.0* MONOS-3.3 EOS-0.4 BASOS-0.3 ___ 09: 50PM ALT(SGPT)-21 AST(SGOT)-17 ALK PHOS-99 TOT BILI-0.4 ___ 09: 50PM LIPASE-17 ___ 09: 50PM GLUCOSE-110* UREA N-5* CREAT-0.6 SODIUM-137 POTASSIUM-3.8 CHLORIDE-104 TOTAL CO2-20* ANION GAP-17 ___ 10: 31PM ___ PTT-28.4 ___ ___ 10: 31PM ___ ___ 09: 40PM URINE COLOR-Straw APPEAR-Clear SP ___ ___ 09: 40PM URINE BLOOD-NEG NITRITE-NEG PROTEIN-NEG GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-7.0 LEUK-SM ___ 09: 40PM URINE ___ BACTERIA-RARE YEAST-NONE EPI-0 ___ 05: 52AM WBC-24.8* RBC-3.77* HGB-11.8* HCT-34.0* MCV-90 MCH-31.3 MCHC-34.8 RDW-13.1 ___ 05: 52AM PLT COUNT-283 ___ 05: 52AM ___ PTT-25.4 ___ ___ 05: 52AM ___ URINE CULTURE (Final ___: MIXED BACTERIAL FLORA ( >= 3 COLONY TYPES), CONSISTENT WITH SKIN AND/OR GENITAL CONTAMINATION. ___ 5: 55 am SWAB Fluid should not be sent in swab transport media. Submit fluids in a capped syringe (no needle), red top tube, or sterile cup. SWAB OF VAGINAL -AMNIOTIC FLUID. **FINAL REPORT ___ GRAM STAIN (Final ___: 1+ (<1 per 1000X FIELD): POLYMORPHONUCLEAR LEUKOCYTES. 3+ ___ per 1000X FIELD): GRAM NEGATIVE ROD(S). 2+ ___ per 1000X FIELD): GRAM POSITIVE ROD(S). FLUID CULTURE (Final ___: Due to mixed bacterial types (>=3) an abbreviated workup is performed; P.aeruginosa, S.aureus and beta strep. are reported if present. Susceptibility will be performed on P.aeruginosa and S.aureus if sparse growth or greater.. HAEMOPHILUS SP. SPARSE GROWTH. <MEDICATIONS ON ADMISSION> PNV <DISCHARGE MEDICATIONS> 1. Motrin 600 mg Tablet Sig: One (1) Tablet PO every six (6) hours as needed for pain. Disp: *60 Tablet(s)* Refills: *0* 2. Percocet ___ mg Tablet Sig: ___ Tablets PO every ___ hours as needed for pain. Disp: *20 Tablet(s)* Refills: *0* 3. Doxycycline Monohydrate 100 mg Tablet Sig: One (1) Tablet PO twice a day for 7 days. Disp: *14 Tablet(s)* Refills: *0* <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> s/p D+E for pprom at 20 wks <DISCHARGE CONDITION> stable <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Pelvic rest for 6 weeks ","Mrs. ___ was transferred from the ED to L+D, where she was initially expectantly managed for her PPROM. She was started on ampicillin, gentamicin, and clindamycin. However, it became apparent that she had developed chorioamnionitis (foul-smelling green-tinged amniotic fluid as well as fundal tenderness and an elevated white count). She was counseled regarding the prognosis and the significant risks to herself, and she agreed to undergo dilatation and evacuation of the fetus. Dr. ___ this procedure on ___. It was uncomplicated; op-note available in OMR. The patient was transferred to the Gynecology service post-operatively where she was continued on triple antibiotic therapy. She did well on this and remained afebrile on post-op day #1, when she was discharged home on oral doxycycline. She saw social work as well during her stay. ",1350,197
10005817-DS-11,"<SEX> M <SERVICE> CARDIOTHORACIC <ALLERGIES> Penicillins <ATTENDING> ___ <CHIEF COMPLAINT> Chest pain <MAJOR SURGICAL OR INVASIVE PROCEDURE> ___: 1. Urgent pump assisted coronary artery bypass graft x3: Left internal mammary artery to left anterior descending artery, saphenous vein graft to diagonal and obtuse marginal arteries. 2. Endoscopic harvesting of the long saphenous vein. <HISTORY OF PRESENT ILLNESS> ___ year old man w/pmh of CAD with LAD stent, CHF (EF 35-40%), COPD, presented to ___ ___ with 4 days of worsening dyspnea with ___ edema after being found in tripod position with RA sat of 90% by EMS. He was initially treated for COPD exacerbation, but ruled in for NSTEMI. He was kept in ICU for bipap support and was stable for cardiac catheterization today which showed multivessel disease, including instent LAD stenosis. He is hemodynamically stable in NSR and is being transferred to ___ for revascularization evaluation. Of note, his last dose of plavix was ___. <PAST MEDICAL HISTORY> Coronary artery disease w/LAD stent Chronic obstructive pulmonary disease hypertension Congestive heart failure Diabetes mellitus Rectal Cancer ___ - treated w Chemo/ Rad followed by a surgical procedure to remove residual tumor via the rectum Post traumatic stress disorder (pt is ___ veteran) <SOCIAL HISTORY> ___ <FAMILY HISTORY> No premature coronary artery disease <PHYSICAL EXAM> Admission PE (OSH VS ___: temp ___, HR 87, RR 24, BP 132/56, sat 97%) Ht: 5'9'' Wt: 210 lbs Pulse: 62 RR: 20 Resp: O2 sat: 95% 1 liter NC B/P ___ Height: Weight: 91.1 kg General: no distress Skin: Warm [x] Dry [] intact [x] HEENT: NCAT [x] PERRLA [x] EOMI [x] Neck: Supple [x] Full ROM [x] Chest: Lungs clear bilaterally [x] Heart: RRR [x] Irregular [] Murmur [] grade ______ Abdomen: Soft [x] non-distended [x] non-tender [x] bowel sounds + [] Extremities: Warm [x], well-perfused [] Edema [x] 1+ pedal edema_____ Varicosities: None [x] Neuro: Grossly intact [x] Pulses: Femoral Right: 2+ Left: 2+ DP Right: 1+ Left: 1+ Radial Right: bandaged Left: 2+ Carotid Bruit Right: none Left: none <PERTINENT RESULTS> ___ 10: 35AM BLOOD Hct-26.8* ___ 04: 11AM BLOOD WBC-6.2 RBC-2.49* Hgb-7.9* Hct-23.8* MCV-95 MCH-31.5 MCHC-33.0 RDW-14.4 Plt ___ ___ 05: 27AM BLOOD ___ ___ 04: 11AM BLOOD Glucose-79 UreaN-15 Creat-1.1 Na-138 K-3.8 Cl-104 HCO3-27 AnGap-11 ___ ECHOCARDIOGRAPHY REPORT ___ ___ MRN: ___ TEE (Complete) Done ___ at 11: 21: 33 AM PRELIMINARY Referring Physician ___ ___ of Cardiothoracic Surg ___ ___ Status: Inpatient DOB: ___ Age (years): ___ M Hgt (in): BP (mm Hg): / Wgt (lb): HR (bpm): BSA (m2): Indication: Introperative monitoring for CABG ICD-9 Codes: 428.0, 786.05, 410.91, 424.0 Test Information Date/Time: ___ at 11: 21 ___ MD: ___, MD Test Type: TEE (Complete) 3D imaging. Sonographer: ___, MD Doppler: Full Doppler and color Doppler Test Location: Anesthesia West OR cardiac Contrast: None Tech Quality: Adequate Tape #: ___-: Machine: 4 Echocardiographic Measurements Results Measurements Normal Range Left Ventricle - Ejection Fraction: 30% to 40% >= 55% Aorta - Annulus: 2.1 cm <= 3.0 cm Aorta - Sinus Level: 2.6 cm <= 3.6 cm Aorta - Sinotubular Ridge: 2.1 cm <= 3.0 cm Aorta - Ascending: 3.0 cm <= 3.4 cm Findings Multiplanar reconstructions were generated and confirmed on an independent workstation. LEFT ATRIUM: Dilated ___. No spontaneous echo contrast in the body of the ___. No spontaneous echo contrast or thrombus in the body of the ___. Good (>20 cm/s) ___ ejection velocity. All four pulmonary veins identified and enter the left atrium. RIGHT ATRIUM/INTERATRIAL SEPTUM: Normal RA size. A catheter or pacing wire is seen in the RA. No ASD by 2D or color Doppler. LEFT VENTRICLE: Normal LV wall thickness and cavity size. Moderate regional LV systolic dysfunction. Moderate-severe global left ventricular hypokinesis. Mildly depressed LVEF. RIGHT VENTRICLE: Normal RV chamber size and free wall motion. Normal RV systolic function. AORTA: Focal calcifications in aortic root. Mildly dilated descending aorta. Simple atheroma in descending aorta. Focal calcifications in descending aorta. AORTIC VALVE: Normal aortic valve leaflets (3). No AR. MITRAL VALVE: Mildly thickened mitral valve leaflets. Mild (1+) MR. ___ VALVE: Normal tricuspid valve leaflets with trivial TR. PULMONIC VALVE/PULMONARY ARTERY: Pulmonic valve not well seen. Physiologic (normal) PR. PERICARDIUM: Small pericardial effusion. GENERAL COMMENTS: Written informed consent was obtained from the ___. A TEE was performed in the location listed above. I certify I was present in compliance with ___ regulations. The ___ was under general anesthesia throughout the procedure. The TEE probe was passed with assistance from the anesthesioology staff using a laryngoscope. No TEE related complications. The ___ appears to be in sinus rhythm. Cardiology Fellow involved with the ___ care was notified by e-mail. Houseofficer caring for the ___ was notified of the results by e-mail. REGIONAL LEFT VENTRICULAR WALL MOTION: N = Normal, H = Hypokinetic, A = Akinetic, D = Dyskinetic Conclusions PRE-BYPASS: The left atrium is dilated. No spontaneous echo contrast is seen in the body of the left atrium or left atrial appendage. No spontaneous echo contrast or thrombus is seen in the body of the left atrium or left atrial appendage. No atrial septal defect is seen by 2D or color Doppler. Left ventricular wall thicknesses and cavity size are normal. There is moderate regional left ventricular systolic dysfunction with mid to distal moderate anterior and ___ wall hypoknesis. There is moderate to severe global left ventricular hypokinesis (LVEF = 35-40%). Overall left ventricular systolic function is mildly depressed (LVEF= 35-40 %). Right ventricular chamber size and free wall motion are normal. with normal free wall contractility. The descending thoracic aorta is mildly dilated. There are simple atheroma in the descending thoracic aorta. The aortic valve leaflets (3) appear structurally normal with good leaflet excursion. No aortic regurgitation is seen. The mitral valve leaflets are mildly thickened. Mild (1+) mitral regurgitation is seen. There is a small pericardial effusion. POST CPB: The EF looks slightly improved from prebypass. EF 40-45%. The Anterior and anterio-lateral wall appear less hypokinetic but still at baseline. No change in MR. ___ valve and aorta are unchanged from baseline. I certify that I was present for this procedure in compliance with ___ regulations. Interpretation assigned to ___, MD, Interpreting physician  ___ ___. All rights reserved. <MEDICATIONS ON ADMISSION> lisinopril 5mg po daily metformin 1000mg po BID pioglitazone 45mg po daily glipizide 5mg po daily lipitor 80mg po daily ASA EC 325mg po daily metoprolol succinate ER 100mg po daily niacin 50mg po qHS vitamin D 1000 units po daily Vitamin B12 100mcg po daily seroquel XR 50mg po daily Meds at OSH: seroquel 50mg po daily plavix 600mg po daily heparin IV Azithromycin 500mg IV q24h (___) albuterol PRN ASA 325mg po daily lasix 40mg IV daily lisinopril 5mg po daily methylprednisolone 125mcg IV q6h (___) to prednisone 60mg po daily metoprolol 25mg po q8hr protonix 40mg IV q24h (___) Lantus insulin +SSI Plavix - 600mg on ___, last dose: 75mg on ___ <DISCHARGE MEDICATIONS> 1. Acetaminophen 650 mg PO Q4H: PRN pain 2. Amiodarone 400 mg PO BID x 7 days, then decrease to 200 mg BID x 7 days, then decrease to 200 mg daily RX *amiodarone 200 mg 2 tablet(s) by mouth twice a day Disp #*90 Tablet Refills: *0 3. Aspirin EC 81 mg PO DAILY RX *aspirin [Adult Low Dose Aspirin] 81 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills: *1 4. Atorvastatin 80 mg PO DAILY RX *atorvastatin 80 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills: *1 5. Carvedilol 6.25 mg PO BID RX *carvedilol 6.25 mg 1 tablet(s) by mouth twice a day Disp #*60 Tablet Refills: *1 6. Docusate Sodium 100 mg PO BID RX *docusate sodium 100 mg 1 tablet(s) by mouth twice a day Disp #*60 Tablet Refills: *1 7. GlipiZIDE XL 5 mg PO DAILY RX *glipizide 5 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills: *1 8. Lisinopril 5 mg PO DAILY RX *lisinopril 5 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills: *1 9. MetFORMIN (Glucophage) 500 mg PO BID RX *metformin 500 mg 1 tablet(s) by mouth twice a day Disp #*60 Tablet Refills: *1 10. OxycoDONE (Immediate Release) ___ mg PO Q4H: PRN pain RX *oxycodone 5 mg ___ tablet(s) by mouth q4h prn Disp #*50 Tablet Refills: *0 11. QUEtiapine Fumarate 50 mg PO QHS 12. Furosemide 40 mg PO DAILY x 10 days RX *furosemide 40 mg 1 tablet(s) by mouth daily Disp #*10 Tablet Refills: *0 13. Potassium Chloride 20 mEq PO DAILY Duration: 10 Days RX *potassium chloride 10 mEq 1 tablet(s) by mouth daily Disp #*10 Tablet Refills: *0 <DISCHARGE DISPOSITION> Home With Service Facility: ___ <DISCHARGE DIAGNOSIS> Coronary artery disease w/LAD stent Chronic obstructive pulmonary disease hypertension Congestive heart failure Diabetes mellitus Rectal Cancer ___ - treated w Chemo/ Rad followed by a surgical procedure to remove residual tumor via the rectum Post traumatic stress disorder (pt is ___ veteran) <DISCHARGE CONDITION> Alert and oriented x3 nonfocal Ambulating with steady gait Incisional pain managed with oral analgesia Incisions: Sternal - healing well, no erythema or drainage Leg Left - healing well, no erythema or drainage. ___ ___ Edema <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> 1) Please shower daily including washing incisions gently with mild soap, no baths or swimming until cleared by surgeon. Look at your incisions daily for redness or drainage. 2) Please NO lotions, cream, powder, or ointments to incisions. 3) Each morning you should weigh yourself and then in the evening take your temperature, these should be written down on the chart provided. 4) No driving for approximately one month and while taking narcotics. Driving will be discussed at follow up appointment with surgeon when you will likely be cleared to drive. 5) No lifting more than 10 pounds for 10 weeks 6) Please call with any questions or concerns ___ *Females: Please wear bra to reduce pulling on incision, avoid rubbing on lower edge **Please call cardiac surgery office with any questions or concerns ___. Answering service will contact on call person during off hours** ","Mr. ___ was admitted to the ___ on ___ via transfer from ___ for surgical management of his coronary artery disease. He was worked-up by the cardiac surgical service in the usual preoperative manner. He waited for Plavix washout, requiring Nitroglycerin drip for his stenosis preop. Bedside PFTs were done. He had an episode of Epistaxis on HD# 4. His hematocrit was=25 and he was transfused one pack red blood cells. His Hep drip was held at that time. On HD# 5 he was taken to the operating room and underwent 1. Urgent pump assisted coronary artery bypass graft x3: Left internal mammary artery to left anterior descending artery, saphenous vein graft to diagonal and obtuse marginal arteries. 2. Endoscopic harvesting of the long saphenous vein with ___. He tolerated the procedure well and was transferred to the CVICU for further invasive monitoring. He awoke neurologically intact and weaned to extubate. His postop hypertension was controlled with Nicardipine drip. He weaned off the drip with Hydralazine and Beta-blocker. Statin/ASA and diuresis were initiated. All lines and tubes were discontinued per protocol withoout incident. On pod#1 he transferred to the step down unit for further recovery. Physical Therapy was consulted for evaluation of strength and mobility. While on the step down unit his rhythm went into rapid atrial fibrillation. Initially the rate was difficult to control requiring Amio bolus x 2 and drip per protocol along with IV Beta-blocker and Diltiazem. Ultimately he converted into normal sinus rhythm. No anticoagulation per ___ he went back into AF. His home meds were reinstated as tolerated. The remainder of his hospital course was essentially unremarkable. He continued to progress and was cleared for discharge to home with ___ on pod#5. All follow up appointments were advised. ",3001,408
10005817-DS-12,"<SEX> M <SERVICE> MEDICINE <ALLERGIES> Penicillins <ATTENDING> ___. <CHIEF COMPLAINT> weakness, hypoxia secondary to superior vena cava syndrome <MAJOR SURGICAL OR INVASIVE PROCEDURE> intubation ___ Left femoral line placement ___ R femoral line placement Left chest tube placement Radiation Therapy Left PICC placement <HISTORY OF PRESENT ILLNESS> ___ h/o COPD, CAD s/p CABG, pAfib on xarelto, CKD, HTN, HLD, L supraclaviular mass dx as neuroendocrine tumor, who presented to ___ on ___ for dehydration and failure to thrive. He did report scapular pain and dyspnea on exertion x 4 weeks starting about 2 months prior to presentation. Outpatient CT showed mediastinal lymphadenopathy and a supraclavicular mass. Biopsy on ___ showed poorly differentiated neuroendocrine tumor. Initial plan was to start chemotherapy of etoposide and carbaplantiunum x 3 days, as well as additioning to PET scan to ___, however patient was unable to tolerate lying flat and PET scan was not performed. The patient was sent by his outpatient oncologist to ___ on ___ for failure to thrive and hypotension with SBPs in the ___. CT scan on ___ showed mediastinal adenopathy and SVC compromise and rec'd radiation but this was not done due to clinical decompensation. However, once the disease is staged, if the patient has no sign of metastatic disease, than chemotherapy would be curative. During his time at ___, his hospital course was notable for increased upper extremity swelling, facial swelling, and increased hypoxia. RUE ultrasound was negative for DVT. He had an increasing oxygen requirement from 2L to 7L. Given concern for airway compromise, the patient was transferred to the ___ ICU on ___. Due to lack of surgical backup at ___, the patient was not intubated at ___ and subsequently transferred here for further airway evaluation. Of note, the patient had a recent admission at ___ on ___ for pneumonia, at which time he was treated with levaquin. Vital signs at the time of transfer were 97.6 80 160/76 19 96% on high flow NC 8L. Physical exam notable for facial flushing, able to speak in full sentences, RUE swelling. Labs prior to transfer notable for a WBC of 12.6, H/H ___, platelets WNL. VBG 7.40/___. Cr 1.7. Lactate 3.8 -> 2.2. Procalcitonin <0.05 (undetectable). On arrival to the MICU, the patient was hemodynamically stable with pulse of 76 are blood pressure of 127/64. He had an increased work of breathing using his abdominal muscles. He was sitting upright, unable to tolerate laying flat. <PAST MEDICAL HISTORY> - Coronary artery disease w/LAD stent; now s/p CABG x3: Left internal mammary artery to left anterior descending artery, saphenous vein graft to diagonal and obtuse marginal arteries - Chronic obstructive pulmonary disease - hypertension - Congestive heart failure EF 40-45%. - Diabetes mellitus - Rectal Cancer ___ - treated w Chemo/ Rad followed by a surgical procedure to remove residual tumor via the rectum - Post traumatic stress disorder (pt is ___ veteran) - atrial fibrillation - CKD <SOCIAL HISTORY> ___ <FAMILY HISTORY> FAMILY HISTORY: No premature coronary artery disease, or neuroendocrine carcinomas <PHYSICAL EXAM> MICU ADMISSION -=========== Vitals: T 97.7 HR 76 BP 127/64 R 20 93% 6L NC GENERAL: fatigued, no acute distress HEENT: Sclera anicteric, noted ___ swelling with rightsided facial fullness. Difficult to visualize posterior oropharynx ___: Regular without murmurs RESP: Increased work of breathing with abnormal muscles. No stridor. RLL crackles ABD: Non-tender, non-distended EXT: Warm, no edema ___, Mild edema RUE NEURO: CN II-XII intact. Strength ___ UE and ___ b/l DEATH EXAM ___ - ___) -=========== Pupils non-reactive to light No cardiac sounds auscultated No respiratory effort seen Telemetry without cardiac electrical activity <PERTINENT RESULTS> ADMISSION LABS: -- ___ 10: 30PM WBC-12.1*# RBC-3.67*# HGB-10.9*# HCT-33.4* MCV-91 MCH-29.7 MCHC-32.6 RDW-14.0 RDWSD-46.3 ___ 10: 30PM PLT COUNT-359# ___ 10: 30PM GLUCOSE-190* UREA N-48* CREAT-1.6* SODIUM-138 POTASSIUM-4.5 CHLORIDE-101 TOTAL CO2-23 ANION GAP-19 ___ 10: 51PM freeCa-1.11* ___ 10: 30PM CALCIUM-9.0 PHOSPHATE-3.1 MAGNESIUM-2.4 URIC ACID-8.3* ___ 10: 51PM LACTATE-2.3* DISCHARGE LABS: -- ___ 01: 02PM BLOOD WBC-9.8 RBC-3.06* Hgb-8.9* Hct-26.2* MCV-86 MCH-29.1 MCHC-34.0 RDW-14.6 RDWSD-44.7 Plt ___ ___ 05: 00AM BLOOD ___ PTT-67.6* ___ ___ 11: 14AM BLOOD Glucose-161* UreaN-102* Creat-2.7* Na-131* K-3.9 Cl-89* HCO3-28 AnGap-18 ___ 05: 00AM BLOOD ALT-27 AST-55* LD(LDH)-925* AlkPhos-93 TotBili-0.4 ___ 11: 14AM BLOOD Calcium-7.0* Phos-6.0* Mg-1.8 MICROBIOLOGY: -- ___ FLUID RECEIVED IN BLOOD CULTURE BOTTLES Fluid Culture in Bottles-PRELIMINARY INPATIENT ___ PLEURAL FLUID GRAM STAIN-FINAL; FLUID CULTURE-FINAL; ANAEROBIC CULTURE-PRELIMINARY INPATIENT ___ URINE URINE CULTURE-FINAL INPATIENT ___ BLOOD CULTURE Blood Culture, Routine-PENDING INPATIENT ___ SPUTUM GRAM STAIN-FINAL; RESPIRATORY CULTURE-FINAL {YEAST} INPATIENT ___ URINE URINE CULTURE-FINAL INPATIENT ___ BLOOD CULTURE Blood Culture, Routine-FINAL INPATIENT ___ STOOL C. difficile DNA amplification assay-FINAL INPATIENT ___ BRONCHOALVEOLAR LAVAGE GRAM STAIN-FINAL; RESPIRATORY CULTURE-FINAL {YEAST}; POTASSIUM HYDROXIDE PREPARATION-FINAL; FUNGAL CULTURE-PRELIMINARY {YEAST} INPATIENT ___ MRSA SCREEN MRSA SCREEN-FINAL {STAPH AUREUS COAG +} INPATIENT ___ PLEURAL FLUID GRAM STAIN-FINAL; FLUID CULTURE-FINAL; ANAEROBIC CULTURE-FINAL PATHOLOGY: --= PLEURAL FLUID, LATERALITY NOT SPECIFIED: POSITIVE FOR MALIGNANT CELLS. Consistent with metastatic poorly-differentiated non-small cell neuroendocrine carcinoma. A few small groups of and scattered single atypical epithelioid cells are seen on the cell block preparation. Immunohistochemical stains show the atypical cells to be focally, weakly positive for synaptophysin, and CK5/6. No immunoreactive cells for chromogranin are seen. The patient's prior slides of lymph node biopsy (___) were not available for comparison. Drs. ___ and ___ were informed of the diagnosis via e-mail by Dr. ___ on ___ STUDIES: --= + TTE ___: The left atrium is mildly dilated. There is mild symmetric left ventricular hypertrophy. The left ventricular cavity size is normal. Due to suboptimal technical quality, a focal wall motion abnormality cannot be fully excluded. Overall left ventricular systolic function is normal (LVEF = 65%). Right ventricular chamber size and free wall motion are normal. The diameters of aorta at the sinus, ascending and arch levels are normal. The aortic valve is not well seen. There is no aortic valve stenosis. No aortic regurgitation is seen. The mitral valve leaflets are mildly thickened. Trivial mitral regurgitation is seen. The left ventricular inflow pattern suggests impaired relaxation. There is mild pulmonary artery systolic hypertension. There is a small pericardial effusion. There are no echocardiographic signs of tamponade. <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Atorvastatin 80 mg PO QPM 2. Carvedilol 12.5 mg PO BID 3. Diltiazem Extended-Release 240 mg PO DAILY 4. Docusate Sodium 100 mg PO BID 5. Fenofibrate 160 mg PO DAILY 6. Levothyroxine Sodium 50 mcg PO DAILY 7. Multivitamins 1 TAB PO DAILY 8. Rivaroxaban 15 mg PO DAILY 9. SAXagliptin 2.5 mg oral DAILY 10. GlipiZIDE XL 10 mg PO QAM 11. GlipiZIDE XL 5 mg PO QPM 12. LamoTRIgine 100 mg PO DAILY 13. Omeprazole 20 mg PO DAILY 14. HYDROcodone-Acetaminophen (5mg-325mg) 1 TAB PO Q6H: PRN Pain - Moderate 15. QUEtiapine Fumarate 25 mg PO QHS 16. Fentanyl Patch 75 mcg/h TD Q72H 17. Midodrine 5 mg PO TID <DISCHARGE MEDICATIONS> patient expired <DISCHARGE DISPOSITION> Expired <DISCHARGE DIAGNOSIS> - Superior Vena Cava Syndrome - Poorly differentiated neuroendocrine tumor - Acute Hypoxemic Respiratory failure - Healthcare associated pneumonia - Malignant Pleural Effusions - Acute tubular necrosis - Tumor lysis syndrome - New onset atrial fibrillation/flutter with rapid ventricular response. <DISCHARGE CONDITION> Patient expired <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Patient expired ","Mr. ___ is a ___ year-old man with recently-diagnosed metastatic poorly-differentiated high-grade neuroendocrine carcinoma (likely of pulmonary origin), with bulky retroperitoneal/common iliac/mediastinal lymphadenopathy concerning for metastatic disease, who was admitted to ___ on ___ with progressive dyspnea and hypoxemia thought to be at least partially related to ___ syndrome from an enlarging chest/neck mass, which was treated with external radiotherapy. Hospital course was been complicated by hypoxemic respiratory failure requiring prolonged mechanical intubation, sepsis ___ obstructive pneumonia, acute kidney injury ___ acute tubular necrosis, malignant pleural effusions requiring bilateral chest tube placement and hemodynamically unstable atrial fibrillation. Mr. ___ was followed closely by numerous consulting services (Heme-Onc, Pulmonary, Radiation Oncology, Nephrology, Infectious Disease). He developed progressive multi-system organ failure despite aggressive supportive care. Given his progressive decline and based on family wishes, his care was transitioned to a comfort focus and he was extubated with family at the bedside in accordance with his goals of care. He expired soon thereafter with official time of death being ___ @ 18:36. Autopsy was deferred. ",2395,258
10005866-DS-15,"<SEX> M <SERVICE> SURGERY <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> Abd pain <MAJOR SURGICAL OR INVASIVE PROCEDURE> ___: ex-lap and LOA ___: hematoma evacuation ___: Incision opened and VAC placed <HISTORY OF PRESENT ILLNESS> ___ with HCV, ETOH cirrhosis (MELD 13, MELD-Na 18)p/w 5 days of nausea, vomiting, abdominal pain and melena. His symptoms started 5 days ago and he has not been able to maintain adequate PO intake since. His pain was initially diffuse but is now localized to the RLQ. Denies fevers or chills. No prior similar episodes in the past. The patient is followed by Dr. ___ at ___. Per patient report his liver disease has been stable in the past ___ years and his ascites has been well controlled with medical therapy (last paracenthesis over one year ago per pt report). Last EGD on file done in ___, significant for 2 bleeding gastric ulcers and one duodenal ulcer. <PAST MEDICAL HISTORY> HCV, cirrhosis,lumbar and sacral osteoarthritis, FTT, gastric and duodenal ulcers <SOCIAL HISTORY> ___ <FAMILY HISTORY> Non-Contributory <PHYSICAL EXAM> Temp: 98.5; P: 89; BP: 109/69; RR: 18; O2: 100% RA General: alert, OrientedX3; in no acute distress HEENT: atraumatic, normocephalic; oral mucosa moist Resp: clear breath sounds bilaterally CV: RRR; no murmurs, rubs, or gallops Abd: soft, protuberant, mid-line vac intact Vac measurement: 5cm long x2cm wide x1cm deep; low suction, -75mm Hg Extr: atraumatic, skin intact <PERTINENT RESULTS> ___ 05: 00AM BLOOD WBC-7.2 RBC-2.11* Hgb-7.2* Hct-22.2* MCV-105* MCH-34.1* MCHC-32.4 RDW-19.5* RDWSD-73.1* Plt ___ ___ 07: 30AM BLOOD WBC-7.3 RBC-3.44* Hgb-11.9* Hct-35.3* MCV-103* MCH-34.6* MCHC-33.7 RDW-14.8 RDWSD-55.3* Plt ___ ___ 05: 20AM BLOOD ___ PTT-41.5* ___ ___ 05: 00AM BLOOD Glucose-86 UreaN-10 Creat-0.5 Na-131* K-3.8 Cl-103 HCO3-22 AnGap-10 ___ 04: 40AM BLOOD ALT-14 AST-38 AlkPhos-83 TotBili-3.4* ___ 07: 30AM BLOOD Lipase-126* ___ 05: 00AM BLOOD Albumin-2.2* Calcium-7.2* Phos-2.4* Mg-1.7 ___ CT ABD & PELVIS WITH CO IMPRESSION: 1. Large right rectus sheath hematoma measuring 9 x 5.9 x 8.5 cm with evidence of active extravasation. Given patient's history of cirrhosis and portal hypertension and venous collaterals, it is unclear whether the source of this hematoma is arterial or venous. 2. Moderate right-sided pleural effusion. 3. Cirrhotic appearing liver, extensive esophageal, perigastric, and perisplenic varices, and large volume ascites. ___ PARACENTESIS DIAG/THERA IMPRESSION: Technically successful ultrasound-guided diagnostic and therapeutic paracentesis removing 0.8 L of serosanguineous ascitic fluid. <MEDICATIONS ON ADMISSION> Spironolactone 50 mg daily Furosemide 20 mg daily Lactulose 20 GM/30 ML solution 30 mLs by mouth 3 (three) times daily. Lidocaine 5 % patch MVI Potassium chloride ___ MEQ tablet1 tablet by mouth daily. <DISCHARGE MEDICATIONS> 1. Furosemide 20 mg PO DAILY 2. Lactulose 30 mL PO TID Titrate to ___ bowel movements daily 3. Spironolactone 50 mg PO DAILY 4. Famotidine 20 mg PO Q12H 5. OxycoDONE (Immediate Release) ___ mg PO Q4H: PRN pain 6. Lidocaine 5% Patch 1 PTCH TD QAM 7. Multivitamins 1 TAB PO DAILY 8. Potassium Chloride 10 mEq PO DAILY Hold for K > 5 <DISCHARGE DISPOSITION> Extended Care Facility: ___ ___ Diagnosis: ETOH Cirrhosis Small bowel obstruction Rectus sheath hematoma Pneumonia <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Please contact Dr. ___ office at ___ if the patient develops fever > 101, chills, bleeding from the wound, nausea, vomiting, diarrhea, constipation, inability to tolerate food, fluids or medications, increased abdominal pain, jaundice ; yellowing of the skin or eyes, VAC fails to hold suction or any other concerns No lifting more than 10 pounds VAC dressing change to abdominal wound q 3 days using black foam and 75 mmHG continuous suction. If VAC fails, wound may be temporarily dressed with a NS damp to dry dressing. ","Mr. ___ is a ___ year old male with a history of HCV cirrhosis who presented to ___ on ___ with the chief complaint of abdominal pain; evaluation in the ED by surgery revealed localized abdominal pain, with clinical and radiological signs of an acute abdomen with concern for an internal hernia. The patient was taken to the OR for a lysis of adhesions and relief of obstruction due to multiple adhesions into the pelvis causing an internal loop obstruction. The patient tolerated the procedure well, please refer to the operative report for further details. Post-procedure the patient was extubated in PACU due to prolonged sedation, which went unremarkably. He did receive 24 hours of cefazolin after surgery, in addition to 5% albumin for a total of 500cc for volume support. On POD1: The patient was kept NPO, with a NG tube in place. He electrolytes were closely monitored and repleted as necessary. His pain was further managed with IV and PO pain medications. POD2: a NGT clamp trial was performed, and the patient was started on glutamine supplementation. His electrolytes were continued to be closely monitored and repleted. There was a concern for a RUE DVT due to difficult CVL placement in the OR; however, a repeat RUE/neck US showed no evidence of a DVT. POD3: the patient underwent a KUB, which did not show signs of obstruction or ileus. NGT was dc'd, and the patient was kept NPO. He electrolytes were repleted as per protocol. His foley catheter was removed at mid-night, and the patient voided spontaneously. POD4: the patient complained of a cough with intermittent sputum production, he was given a PRN nebulizer therapy and a PA/LAT cxr was consistent with clearing of a prior mucous plug. The patient was started on a clear liquid diet, and his IVF were stopped once he was taking in a good amount PO. His home Lasix dose was continued as well. The patient's expected post-operative pain and transient electrolyte abnormalities were followed and corrected. POD5: overnight the patient complained of ___ erythema, along with fluctuance and increased pain/tenderness. An Abd/Pelv CT scan without contrast revealed a large right rectus sheath hematoma measuring 9 x 5.9 x 8.5 cm with evidence of active extravasation; given those findings, several wound staples were removed at bed-side with the plan to take to OR as soon as possible. The patient received a ___ in the interim due to continuous oozing from his abdominal wound. A foley was placed due to urinary retention. The patient was taken to the OR and a rectus sheath hematoma was evacuated, and any active bleeders were treated with argon beam laser. A wound vac was placed in the OR for wound management. Post-op the patient's medications were resumed, and he was started on a clear liquid diet. POD6: the patient tolerated his clear diet well and was advanced to a regular diet, while his IVF were dc'd. His diuretics were restarted and he was given 1U of FFP due to a high INR and anticipation of a paracentesis. The patient's levaquin for presumed pneumonia was changed to vanc, cefepime for broader coverage; in addition, he underwent a nasal MRSA screen which was negative, along with sputum cx which grew commensal flora. The patient under paracentesis due to abdominal distention, where 0.8L were removed, and cell count was not consistent with SBP. The patient received 12.5 grams of albumin for repletion. POD7: the patient was restarted on his lactulose, his foley dc'd, and a vac placed. POD8: the patient was managed for his routine pain control, electrolyte repletion, along with ambulation. POD9: a physical therapy consult was placed, and the patient resumed his PO levaquin to complete a 7-day course. POD10-11: an occupation therapy consult was placed, and the patient was discharged to rehab. The patient's vac was changed on ___ its measurements are 5cmX2cmX1cm deep, and the vac is set on min suction at -75 mmHg At the time of discharge, the patient was comfortable with the discharge plan and recommendations. ",1306,924
10005866-DS-16,"<SEX> M <SERVICE> MEDICINE <ALLERGIES> Tylenol / Neurontin <ATTENDING> ___ <CHIEF COMPLAINT> RUQ abdominal pain, vomiting, diarrhea <MAJOR SURGICAL OR INVASIVE PROCEDURE> -diagnostic para ___ <HISTORY OF PRESENT ILLNESS> Mr ___ is a ___ year old man with cirrhosis (EtOH/HCV untreated, genotype 3)Child Class C, complicated by esophageal varices, ascites, and encephalopathy, chronic abdominal pain and multiple prior abdominal surgeries, presenting with 3 days of more severe RUQ pain, vomiting, and diarrhea. After a several month stay in rehab in ___ following his last ___ hospitalization in ___, the patient has been doing well at home. In his usual state of health, he has chronic RUQ abdominal pain, and is followed by his PCP and hepatologist; patient states that his pain has been attributed to possibly scar tissue from his several abdominal surgeries. He was previously on fentanyl patch for this but is now on oxycodone 10mg QID. ___ checked ___. Last filled oxycodone 10mg 30 day supply (120 pills) ___. He has Child's class C cirrhosis but overall his ascites and hepatic encephalopathy are well controlled with Lasix/spironolactone and lactulose. Prior paracentesis was ""Several years ago."" He developed his present symptoms 3 days ago, with the subacute onset of worsening RUQ pain (stabbing, constant with waves of more severe pain, worse with vomiting, no change with eating/position/movement). For the past 3 days he has also had ___ episodes per day of vomiting (clear/yellow fluid, no blood or coffee-ground emesis), and has been unable to tolerate food, or fluids, and thinks he has also vomited pills (although has been trying to stay compliant with his regimen). He has also been having multiple episodes per day of watery/yellow fluid diarrhea (no blood or melena). His ROS is positive for chills/sweats, and fatigue. His abdominal distention is moderate but stable. But he denies fevers, myalgia/arthralgias, HA, URI symptoms, visual complaint, chest pain/pressure, dyspnea, cough, rash, bruising, lower extremity edema. No recent travel, sick contacts, or recent raw/uncooked/spoiled food. He presented to the ED for further evaluation. In the ED, initial vitals were: Temp. 98.0, HR 82, BP 157/82, RR 22, 100% RA - Exam notable for: RUQ tenderness to palpitation, abdomen distended but soft --Bedside abdominal ultrasound showed small volume of ascites without a pocket amenable to paracentesis. - Labs notable for: --WBC 5.4, Hgb 14.0, plt 181 --Na 130, K 4.8, HCO3 15, creatinine 0.8, glucose 144, BUN 9 --ALT 32, AST 127, alk phos 145, Tbili 4.7, albumin 2.8 --lactate 2.6, repeat lactate 1.7 --INR 1.4, PTT 38.7 - Imaging was notable for: CT abdomen ___: 1. Cirrhosis with evidence of portal hypertension with moderate volume ascites partially loculated in the right upper quadrant, extensive portosystemic varices. ***Partially occlusive thrombus in the main portal vein. *** 2. Small bowel distention without obstruction may reflect ileus. Mild thickening of the proximal colon may reflect portal colopathy. 3. Trace right pleural effusion with chronic appearing atelectasis in the right lower lung. 4. Extensive atherosclerotic disease of the aorta. Liver US ___: 1. There is a new nonocclusive thrombus within the main portal vein with extension into the left and right portal vein branches. There is normal hepatopetal flow within the main portable vein and evidence of sluggish flow within the left and right portal vein branches. 2. Large volume ascites. 3. Worsening splenomegaly measuring 13.7 cm today, previously measuring 12 cm ___. 4. New 1.6 cm focus within the right hepatic lobe is incompletely characterized. Follow-up MR for further evaluation is recommended. - Patient was given: --morphine 4mg IV x2 --ondansetron 4mg IV --1L normal saline --started on heparin drip Upon arrival to the floor, patient reports continued abdominal pain in the RUQ, and being very thirsty and a little hungry. REVIEW OF SYSTEMS: (+) Per HPI (-) 10 point ROS reviewed and negative unless stated above in HPI <PAST MEDICAL HISTORY> - Hepatitis C (genotype 3) - Cirrhosis, Child's Class C due EtOH and HCV d/b hepatic encephalopathy, portal hypertension with ascites and esophageal varices, portal hypertensive gastropathy - Gastric & Duodenal ulcers - Insomnia - Umbilical hernia - Sacral osteoarthritis Past Surgical History: - Umbilical hernia repair (___) -SBO requiring Ex lap & repair of ruptured umbilical hernia with lysis of adhesions (___) - Abdominal Hematoma evacuation (___) - Abdominal incision opened, wound vac placed (___) <SOCIAL HISTORY> ___ <FAMILY HISTORY> Sister and brother both with ""collapsed lungs."" No family history of liver disease. <PHYSICAL EXAM> ADMISSION PHYSICAL EXAM: -- VITAL SIGNS: BP 115 / 77 hr 64 RR18 SPO2 98 Ra GENERAL: chronically ill appearing man, resting in bed in moderate discomfort. Able to move around in bed without obvious increase in pain. Alert, fully conversant, very pleasant. HEENT: NCAT. Dry oral mucosa. No scleral icterus. Conjunctivae white. No JVD. NECK: full ROM, no masses CARDIAC: RRR, no murmurs, no lower extremity edema LUNGS: CTAB, unlabored breathing on ambient air ABDOMEN: moderately distended, but soft. Moderately tender in RUQ. Umbilical hernia site intact, non-tender. Dull to percussion, no fluid wave. Normal bowel sounds. Collateral vessels faintly visible in abdominal wall EXTREMITIES: warm, no edema. No asterixis NEUROLOGIC: alert, fully oriented. CN exam normal. Strength/sensation intact. Gait not tested. No asterixis or tremor. SKIN: no rashes, no jaundice DISCHARGE PHYSICAL EXAM: -- VS: 98.1 PO 106 / 68 R Lying 68 18 96 Ra GENERAL: chronically ill appearing man, resting in bed in moderate discomfort. HEENT: NCAT. MMM. No scleral icterus CARDIAC: RRR, no murmurs, no lower extremity edema LUNGS: CTAB, unlabored breathing on ambient air ABDOMEN: moderately distended, but soft. Moderately tender in RUQ. Umbilical hernia site intact, non-tender. Normal bowel sounds. Collateral vessels faintly visible in abdominal wall EXTREMITIES: warm, no edema. No asterixis NEUROLOGIC: alert, fully oriented. CN exam normal. Strength/sensation intact. Gait not tested. No asterixis or tremor. SKIN: no rashes, no jaundice <PERTINENT RESULTS> ADMISSION LABS: -========= ___ 09: 36AM BLOOD WBC-5.4 RBC-3.97* Hgb-14.0 Hct-42.2 MCV-106* MCH-35.3* MCHC-33.2 RDW-14.2 RDWSD-56.4* Plt ___ ___ 09: 36AM BLOOD Neuts-65.3 ___ Monos-10.4 Eos-1.9 Baso-1.7* Im ___ AbsNeut-3.51 AbsLymp-1.08* AbsMono-0.56 AbsEos-0.10 AbsBaso-0.09* ___ 11: 21AM BLOOD ___ PTT-38.7* ___ ___ 09: 36AM BLOOD Glucose-144* UreaN-9 Creat-0.8 Na-130* K-4.8 Cl-101 HCO3-15* AnGap-19 ___ 09: 36AM BLOOD ALT-32 AST-127* AlkPhos-145* TotBili-4.7* ___ 09: 36AM BLOOD Albumin-2.8* ___ 05: 00AM BLOOD Calcium-7.7* Phos-2.9 Mg-1.4* ___ 09: 44AM BLOOD Lactate-2.6* DISCHARGE LABS: -========= ___ 04: 46AM BLOOD WBC-5.1 RBC-3.46* Hgb-12.3* Hct-37.0* MCV-107* MCH-35.5* MCHC-33.2 RDW-14.2 RDWSD-55.5* Plt ___ ___ 04: 46AM BLOOD ___ PTT-36.8* ___ ___ 04: 46AM BLOOD Glucose-93 UreaN-9 Creat-0.9 Na-133 K-4.2 Cl-99 HCO3-26 AnGap-12 ___ 04: 46AM BLOOD ALT-21 AST-63* AlkPhos-159* TotBili-2.3* ___ 04: 46AM BLOOD Albumin-2.4* Calcium-8.0* Phos-3.6 Mg-1.6 PERTINENT RESULTS: -========= ___ 01: 55PM ASCITES TNC-64* RBC-650* Polys-1* Lymphs-48* Monos-6* Mesothe-2* Macroph-43* Other-0 ___ 01: 55PM ASCITES TotPro-1.7 Glucose-103 LD(LDH)-104 Albumin-0.7 Cholest-19 ___ 08: 58PM STOOL NoroGI-NEGATIVE NoroGII-NEGATIVE MICROBIOLOGY: -========= ___ 1: 55 pm FLUID RECEIVED IN BLOOD CULTURE BOTTLES PERITONEAL FLUID. Fluid Culture in Bottles (Preliminary): NO GROWTH. ___ 1: 48 pm PERITONEAL FLUID PERITONEAL FLUID. **FINAL REPORT ___ GRAM STAIN (Final ___: 1+ (<1 per 1000X FIELD): POLYMORPHONUCLEAR LEUKOCYTES. NO MICROORGANISMS SEEN. This is a concentrated smear made by cytospin method, please refer to hematology for a quantitative white blood cell count. IMAGING: -========= ___ IMPRESSION: 1. Cirrhosis with new partially occlusive thrombus within the main portal vein. 2. Large volume ascites. 3. Worsening splenomegaly measuring 13.7 cm today, previously measuring 12 cm ___. 4. New 1.6 cm focus within the right hepatic lobe is incompletely characterized. Follow-up MR for further evaluation is recommended. ___ IMPRESSION: Tiny right pleural effusion, otherwise unremarkable exam. ___ IMPRESSION: 1. Cirrhosis with evidence of portal hypertension with moderate volume ascites partially loculated in the right upper quadrant, extensive portosystemic varices. Partially occlusive thrombus in the main portal vein. 2. Small bowel distention without obstruction may reflect ileus. Mild thickening of the proximal colon may reflect portal colopathy. 3. Trace right pleural effusion with chronic appearing atelectasis in the right lower lung. 4. Extensive atherosclerotic disease of the aorta. <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Furosemide 20 mg PO DAILY 2. Lactulose 30 mL PO TID 3. Spironolactone 50 mg PO DAILY 4. Famotidine 20 mg PO Q12H 5. OxycoDONE (Immediate Release) 10 mg PO Q6H: PRN Pain - Moderate 6. Multivitamins 1 TAB PO DAILY 7. Potassium Chloride 10 mEq PO DAILY 8. Sulfameth/Trimethoprim SS 1 TAB PO DAILY 9. Calcium 600 + D(3) (calcium carbonate-vitamin D3) 600 mg(1,500mg) -400 unit oral DAILY 10. Polyethylene Glycol 17 g PO DAILY: PRN constipation <DISCHARGE MEDICATIONS> 1. Calcium 600 + D(3) (calcium carbonate-vitamin D3) 600 mg(1,500mg) -400 unit oral DAILY 2. Famotidine 20 mg PO Q12H 3. Furosemide 20 mg PO DAILY 4. Lactulose 30 mL PO TID 5. Multivitamins 1 TAB PO DAILY 6. OxycoDONE (Immediate Release) 10 mg PO Q6H: PRN Pain - Moderate RX *oxycodone 10 mg 1 tablet(s) by mouth every six (6) hours Disp #*8 Tablet Refills: *0 7. Polyethylene Glycol 17 g PO DAILY: PRN constipation 8. Potassium Chloride 10 mEq PO DAILY Hold for K > 9. Spironolactone 50 mg PO DAILY 10. Sulfameth/Trimethoprim SS 1 TAB PO DAILY <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Primary Diagnosis: -====== -viral gastroenteritis Secondary Diagnosis: -===== -ETOH/HCV Cirrhosis <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Mr ___, It was a pleasure being involved in your care. Why you were here: -You came in for nausea/vomiting/diarrhea. What we did while you were here : -We gave you some fluids through your IV because you were dehydrated. We believe that you had a viral illness, which cleared on its own. -We also took some fluid out of your abdomen to make sure you were not having an infection, and this was negative for any infection. Your next steps: -please take all your medications as indicated below -please keep all of your appointments We wish you well, Your ___ Care Team ","___ year old man with cirrhosis (EtOH/HCV untreated, genotype 3) Child Class C, complicated by esophageal varices, ascites, and encephalopathy, chronic abdominal pain and multiple prior abdominal surgeries, presenting with 3 days of acute on chronic RUQ pain, vomiting, and diarrhea likely ___ viral gastroenteritis. C.diff negative, norovorius negative. Diagnostic para w/ no e/o SBP. Stool Cx pending at time of discharge. Patient was given IV fluids with spontaneous resolution (though persistent chronic RUQ pain). Hospital course complicated by new non-occlusive PVT, lactate slightly elevated on initial presentation normalized with IVF less c/f ischemia. Outpatient hepatologist (Dr. ___ was contacted who recommended against anticoagulation given non-occlusive, and concerns with patient compliance. Otherwise no changes to home medications. ====================== ACUTE ISSUES ====================== #Abdominal pain, vomiting, diarrhea: presented with 3 days of acute on chronic RUQ pain, vomiting, and diarrhea likely ___ viral gastroenteritis. C.diff negative, norovorius negative. Diagnostic para w/ no e/o SBP. Stool Cx pending at time of discharge. Patient was given IV fluids with spontaneous resolution (though persistent chronic RUQ pain). Of note RUQ U/S and CT A/P w/ e/o non-occlusive PVT, though unlikely explanation for presentation as non-occlusive w/ down-trending lactate. #Partially occlusive portal vein thrombosis: iso decompensated cirrhosis; RUQ ultrasound and CT abdomen with contrast demonstrated partially occlusive portal vein thrombus, new since ___ ultrasound. Lactate slightly elevated on initial presentation normalized with IVF less c/f ischemia. Outpatient hepatologist (Dr. ___ was contacted who recommended against anticoagulation given non-occlusive, and concerns with patient compliance. #Hyponatremia : Admitted w/ serum sodium 130. Per history, multiple days of low fluid intake, diarrhea, vomiting, while continuing to take diuretics suggested he was intravascularly depleted. Resolved s/p 1L IVF, and resolution of gastroenteritis w/ improved PO intake. Home diuretics restarted upon discharge. #Cirrhosis: Child's Class C, complicated by ascites, hepatic encephalopathy, prior SBP, esophageal varices. -volume: home Lasix/spironolactone initially held iso n/v/d, resumed upon discharge. -hepatic encephalopathy - cont home lactulose after resolution of diarrhea -SBP ppx - cont home Bactrim -esophageal varices - last EGD in ___ no evidence of bleeding on this presentation; Transitional Issues: ========================== -On RUQ U/S: There is a 1.6 cm echogenic focus within the mid right hepatic lobe, peripherally, for which follow-up MR for further evaluation is recommended. -Patient w/ new non-occlusive PVT. Would recommend f/u CT in 3 months to eval for progression of PVT thrombus. -Stool cultures pending at time of discharge, please follow up # CODE: full # CONTACT: sister/HCP ___ ___ ",3298,684
10005866-DS-20,"<SEX> M <SERVICE> MEDICINE <ALLERGIES> Neurontin <ATTENDING> ___. <CHIEF COMPLAINT> Abdominal pain <MAJOR SURGICAL OR INVASIVE PROCEDURE> ___ Exploratory laparotomy ___ EGD ___ EGD nasojejeunal placed and bridled (removed ___ CT-guided placement of an ___ pigtail catheter into the lesser sac collection. (removed ___ PICC placement. <HISTORY OF PRESENT ILLNESS> ___ man with multiple recent admissions for waxing and waning abdominal pain, history of EtOH/hep C cirrhosis, now presents with 24 hours of acutely worsening epigastric pain associated with multiple episodes of emesis and dark stools. Patient states that his abdominal pain was at its baseline yesterday at which point he noticed an acute worsening of his pain that he describes as sharp and in his upper abdomen. He also had several episodes of emesis, reporting his vomit as being dark brown in character. Decided to re-present to ED for reevaluation of abdominal pain given acute worsening status. Most recently presented to the ED over the weekend where he got a CT abdomen pelvis that did not show any acute interval changes compared to prior scans. Was discharged home with expectant management, transplant surgery was not consulted at that time. Now, underwent repeat CT scan showing free air and fluid in the lesser sac concerning for gastric perforation. Transplant surgery is consulted for surgical management of this disease. ROS: (+) per HPI <PAST MEDICAL HISTORY> - Hepatitis C (genotype 3) - Cirrhosis, Child's Class C due EtOH and HCV d/b hepatic encephalopathy, portal hypertension with ascites and esophageal varices, portal hypertensive gastropathy - Gastric & Duodenal ulcers - Insomnia - Umbilical hernia - Sacral osteoarthritis Past Surgical History: - Umbilical hernia repair (___) -SBO requiring Ex lap & repair of ruptured umbilical hernia with lysis of adhesions (___) - Abdominal Hematoma evacuation (___) - Abdominal incision opened, wound vac placed (___) <SOCIAL HISTORY> ___ <FAMILY HISTORY> Sister and brother both with ""collapsed lungs."" No family history of liver disease. <PHYSICAL EXAM> Admission <PHYSICAL EXAM> -======== Vitals: T 97.8 HR 96 BP 145/79 RR 20 100 RA GEN: A&O, uncomfortable appearing HEENT: No scleral icterus, mucus membranes moist CV: RRR PULM: No respiratory distress ABD: Firm, tender to percussion in the epigastric region, guarding present, moderately distended, no fluid wave DRE: Deferred Neuro: CSM grossly intact x 4 Ext: No ___ edema, UE and ___ warm and well perfused bilat Discharge <PHYSICAL EXAM> -======== VS: 97.5 95/56 65 18 99 Ra GENERAL: cachectic appearing older male, sitting up in bed, more conversant and interactive today. HEENT: anicteric sclera, temporal muscle wasting Neck: supple HEART: irregular rhythm, no m/r/g LUNGS: CTAB on anterior exam ABDOMEN: protuberant but soft, +BS, tenderness to palpation in right upper quadrant, midline surgical incision with staples removed, well healed, dressing over RLQ with drain place draining dark brown serosanguineous fluid EXTREMITIES: no lower extremity edema, no clubbing or cyanosis SKIN: no jaundice, warm and dry NEURO: alert, oriented, no asterixis, moving all extremities <PERTINENT RESULTS> Admission Labs: ___ 02: 35AM -=== WBC-15.9*# RBC-3.39* Hgb-11.7* Hct-35.5* MCV-105* MCH-34.5* MCHC-33.0 RDW-14.7 RDWSD-56.3* Plt ___ PTT-29.5 ___ Glucose-122* UreaN-15 Creat-0.5 Na-134* K-4.3 Cl-97 HCO3-22 AnGap-15 ALT-24 AST-63* AlkPhos-92 TotBili-2.5* Lipase-24 Calcium-6.8* Phos-3.7 Mg-1.7 Triglyc-36 Microbiology ============ Blood Culture, Routine (Final ___: NO GROWTH. HELICOBACTER PYLORI ANTIBODY TEST (Final ___: NEGATIVE BY EIA.(Reference Range-Negative). ___ 7: 44 pm PERITONEAL FLUID PERITONEAL FLUID. GRAM STAIN (Final ___: NO POLYMORPHONUCLEAR LEUKOCYTES SEEN. NO MICROORGANISMS SEEN. FLUID CULTURE (Final ___: NO GROWTH. ANAEROBIC CULTURE (Preliminary): NO GROWTH. Imaging: ========= CT Abdomen Pelvis ___ IMPRESSION: 1. Free air and increased fluid within the lesser sac concerning for perforated viscus, which could be from the stomach based on location. 2. Mildly dilated small bowel bowel a transition point. This could represent ileus versus partial small bowel obstruction. No initial in of the bowel or pneumatosis. 3. Cirrhotic liver with findings of portal hypertension including varices and ascites. Upper GI Contrast Study: ___ IMPRESSION: Leak of contrast from the posterior antrum of the stomach. CXR: ___ COMPARISON: ___ IMPRESSION: Pulmonary edema has slightly worsened. Cardiomediastinal silhouette is stable. Left-sided PICC line is unchanged the NG tube projects below the left hemidiaphragm. Small bilateral effusions left greater than right are unchanged. No pneumothorax is seen CT Abdomen Pelvis ___ IMPRESSION: 1. A 8.5 x 5.9 cm loculated fluid collection with rim enhancement in the lesser sac is identified. Compared to ___, the fluid collection demonstrates thicker and more discrete wall. 2. Small ascites and peritonitis is similar to before. 3. Liver cirrhosis with mild splenomegaly and portosystemic shunt. 4. Small bilateral pleural effusions. CT Abdomen for Interventional Procedure: ___ IMPRESSION: Successful CT-guided placement of an ___ pigtail catheter into the lesser sac collection. Samples were sent for microbiology evaluation. Abdominal Ultrasound ___: IMPRESSION: No fluid pocket amenable to percutaneous sampling. A diagnostic paracentesis was not performed. Transfer Labs: ___ 06: 32AM -== WBC-5.0 RBC-2.99* Hgb-9.7* Hct-31.0* MCV-104* MCH-32.4* MCHC-31.3* RDW-17.1* RDWSD-64.6* Plt ___ PTT-28.8 ___ Glucose-108* UreaN-15 Creat-0.5 Na-137 K-4.5 Cl-106 HCO3-24 AnGap-7* ALT-18 AST-58* AlkPhos-194* TotBili-1.2 Albumin-2.2* Calcium-7.3* Phos-2.6* Mg-1.8 Discharge Labs: ___ 05: 55AM -== WBC-4.2 RBC-2.72* Hgb-9.0* Hct-28.7* MCV-106* MCH-33.1* MCHC-31.4* RDW-16.6* RDWSD-65.1* Plt ___ Glucose-97 UreaN-14 Creat-0.5 Na-136 K-4.8 Cl-105 HCO3-21* AnGap-10 ALT-19 AST-59* AlkPhos-198* TotBili-1.2 Albumin-2.1* Calcium-7.3* Phos-2.6* Mg-1.8 <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Famotidine 20 mg PO BID 2. Furosemide 20 mg PO DAILY 3. Lactulose 30 mL PO QID 4. Spironolactone 50 mg PO DAILY 5. Sulfameth/Trimethoprim SS 1 TAB PO DAILY SBP prophylaxis 6. Polyethylene Glycol 17 g PO DAILY 7. Bisacodyl ___AILY: PRN constipation 8. Calcium 600 + D(3) (calcium carbonate-vitamin D3) 600 mg(1,500mg) -400 unit oral DAILY 9. Multivitamins 1 TAB PO DAILY 10. Potassium Chloride 20 mEq PO DAILY 11. Simethicone 40-80 mg PO TID: PRN gas pain 12. Thiamine 100 mg PO DAILY 13. OxyCODONE (Immediate Release) 10 mg PO Q4H: PRN Pain - Moderate <DISCHARGE MEDICATIONS> 1. Acetaminophen 500 mg NG Q6H 2. Lidocaine 5% Patch 1 PTCH TD QAM apply to abdomen remove in pm 3. OxyCODONE SR (OxyconTIN) 20 mg PO TID abdominal pain RX *oxycodone 5 mg/5 mL 20 mL by mouth three times a day Refills: *0 4. Simethicone 40-80 mg PO TID: PRN gas pain 5. Sucralfate 1 gm PO QID 6. Sulfameth/Trimethoprim DS 1 TAB PO/NG DAILY 7. OxyCODONE (Immediate Release) 10 mg PO Q2H: PRN BREAKTHROUGH PAIN RX *oxycodone 5 mg/5 mL 10 mL by mouth every 2 hours Refills: *0 8. Bisacodyl ___AILY: PRN constipation 9. Calcium 600 + D(3) (calcium carbonate-vitamin D3) 600 mg(1,500mg) -400 unit oral DAILY 10. Lactulose 30 mL PO TID 11. Multivitamins 1 TAB PO DAILY 12. Polyethylene Glycol 17 g PO DAILY 13. Thiamine 100 mg PO DAILY <DISCHARGE DISPOSITION> Extended Care Facility: ___ <DISCHARGE DIAGNOSIS> PRIMARY DIAGNOSES: Gastric perforation, frozen abdomen. Duodenal ulcer Esophagitis SECONDARY DIAGNOSES: portal hypertensive gastropathy anemia malnutrition Cirrhosis <DISCHARGE CONDITION> Mental Status: Confused - sometimes. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Mr. ___, WHY WAS I ADMITTED TO THE HOSPITAL? - You were having pain in your abdomen. WHAT HAPPENED WHILE I WAS IN THE HOSPITAL? - You were found to have a hole in your intestine (perforated ulcer), that could not be repaired due to scarred down tissue in your abdomen (frozen abdomen) - You were given antibiotics to prevent infection - You had a temporary drain placed in your abdomen to drain an infection, and this was removed. - You initially were given a feeding tube to bypass the hole, but as it healed from the inside, you were able to eat regular food. - Because you were so sick and there was no cure for your advance liver disease and holes in your stomach and intestines, you chose hospice care. WHAT SHOULD I DO WHEN I GO HOME -Take medications to help your pain -Eat for comfort Thank you for letting us be a part of your care! Your ___ Team ","Summary: --------- Mr ___ is a ___ man with alcoholic and hepatitis C cirrhosis who presented with abdominal pain, and was found to have a perforated inoperable duodenal and stomach ulcer. Active Issues: -------------- # DUODENAL AND GASTRIC ULCERS with # ___ GUIDED DRAINAGE OF LESSER SAC COLLECTION: The patient presented to the ___ Emergency Department with abdominal pain. There was evidence of perforated ulcer on both CT abdomen and upper GI series (posterior antral leak to lesser sac). Initially he was kept NPO with IV hydration and placed on broad-spectrum antibiotics with pip-tazo and fluconazole from ___. He underwent EGD on ___ with the following finding: large ulcer measuring approximately 5-6cm was seen in the first part of the duodenum. There was likely perforation around the edge of the ulcer measuring 2-3cm -This appeared contained. The perforation was too large for endoscopic intervention. There was also moderate to severe esophagitis in the distal esophagus with portal hypertensive gastropathy seen. H. pylori was negative. He was put on the maximum dose of PPI. A NG was in place. He underwent exploratory laparotomy by Dr. ___, but was found to have a frozen abdomen thus unable to see perforated stomach. Postop, he was transferred to the SICU for management as he was hypotensive and hematocrit had decreased. He was given albumin and 4 units of PRBC. Hct stabilized, but on ___, he had brief episode of SVT with rate of 160 without blood pressure drop; afib with intermittent RVR that was treated with metoprolol IV x 2 with decrease in BP. The patient required pressors and amiodarone was started (please see #Afib below). He transferred out of the SICU and was started on TPN. Afib was managed with metoprolol. Metoprolol dose was increased and he was given intermittent doses of Lasix for volume control and pulmonary edema seen on CXR. His diet was initially advanced to clears then full liquids. However, he did not tolerate advancement to a regular diet. He experienced a lot of abdominal pain. Diet was changed to just sips of clears and pain was managed with a Dilaudid PCA. His diet was eventually changed to tube feeds and then regular diet as per an initial goals of care discussion. An abdominal CT ___ an 8cm loculated fluid collection in lesser sac. He then underwent ___ placement of a drain in the fluid collection. Microbiology evaluation of the fluid collection did not grow any organisms, so antibiotics were discontinued on ___. ___ continued to follow the drain until output was < 5cc for 2 consecutive days, at which point the drain was pulled. Diet was advanced slowly for comfort, with supplemental nutrition from nasogastric tube feeds. After a goals of care meeting on ___, Pt endorsed a desire to transition towards measures that would improve his comfort. In light of this, his NGT was pulled ___ and he was permitted a regular PO diet, which he tolerated well. Patient was continued on sucralfate for continued gastric coating and comfort. PPI and other unnecessary medicines were held. # GOALS OF CARE DISCUSSION: Pt with poor prognosis due to his perforated viscus, surgically frozen abdomen, and non-transplant candidacy. A goals of care meeting was held on ___ with the patient and his friend, as well as newly-chosen HCP, ___. At this meeting, Pt acknowledged the severity of his illness and endorsed a willingness to transition his course more towards comfort-focused care. Medicines that would not contribute to his comfort were discontinued. Unnecessary tubes and lines, including his NGT and PICC line, were removed prior to discharge. Patient was discharged to a ___ facility for housing and further titration of his care. # ETOH/HCV CIRRHOSIS with # ASCITES and # NEED FOR SBP PPX: Previously complicated by hepatic encephalopathy, ascites, grade I esophageal varices. Pt without significant hepatic encephalopathy or large ascites during his hospital stay; he was initially put on oral diuretics to minimize the ascites and risk of wound dehiscence, but these were held in the setting of significant weight loss while on tube feeds and overall hypo- to euvolemic appearance on exam. Patient was continued on Bactrim for SBP prophylaxis. He was continued on lactulose to keep his mental status clear. Given goals of care discussion as above, vitamins such as thiamine and multivitamin were discontinued. # ATRIAL FIBRILLATION: Had one episode of Afib on ___, for which he was amiodarone loaded and started on amio gtt. He was stable on PO metoprolol in-house, though sometimes limited due to soft blood pressures. He had a CHADS-VASC of 0. Given his goals of care discussion at discharge, PO metoprolol was discontinued. Anticoagulation was deferred given recent surgery as well as goals of care discussion as above. # NUTRITION: Initially requiring TPN, then tube feeds by ___. He continued to lose muscle mass despite optimal nutrition on TF's. After goals of care discussion ___, patient was provided with a regular diet - which he tolerated well. TRANSITIONAL ISSUES: -------------------- # CODE STATUS: DNR/DNI, CMO, Do not Hospitalize # CONTACT: Friend/HCP, ___ (___) [ ] GOALS OF CARE: - Pt transitioned to DNR/DNI and comfort measures only, given his poor prognosis and lack of surgical alternatives for his medical conditions. [ ] PAIN MANAGEMENT: - If patient is requiring more than 3 daily doses of oxycodone for breakthrough pain, consider uptitrating his TID oxyconTIN for further long-lasting pain relief. [ ] MEDICATION CHANGES: - Added: Oxycodone 10mg PO q2h:PRN breakthrough pain, acetaminophen 500mg Q6H, Bactrim DS 1 tab daily, lidocaine patch, oxyconTIN 20mg PO TID, sucralfate 1gm PO QID, polyethylene glycol 17g daily - Changed: Lactulose (QID -> TID), Bactrim (1 SS tab -> 1 DS tab for SBP Ppx) - Stopped: Metoprolol, Vitamins, furosemide, lansoprazole ",2646,1378
10005909-DS-20,"<SEX> F <SERVICE> SURGERY <ALLERGIES> amoxicillin <ATTENDING> ___. <CHIEF COMPLAINT> ___ Syndrome <MAJOR SURGICAL OR INVASIVE PROCEDURE> ___ Thrombolysis, mechanical thrombectomy ___ IVC filter placement Repeat mechanical thrombectomy, angiojet Common iliac wall stent x2 <HISTORY OF PRESENT ILLNESS> Ms. ___ is a ___ with hx of hypothyroidism presenting with left leg swelling and pain. She was in her usual state of health until last night when she noted progressive left leg swelling and pain. Over the night she developed worsening pain in her left groin pain radiating down her leg which prompted her to present to ___ for further evaluation in the morning. On venous duplex, she was found to extensive left leg DVT. She was started on a heparin gtt with a loading bolus and transferred to ___ for further management. She denies recent long periods of immobility, travel history, or history of DVT. No recent surgery or leg trauma. Denies shortness or breath or leg weakness, parasthesias or loss of sensation. No known hypercoaguability disorder. Her mother notes a possible GSV aneurysm which was resected after a pregnancy many years ago. Her father had a DVT after a prolonged ICU course. Vascular surgery was consulted for further management. <PAST MEDICAL HISTORY> Hypothyroidism, depression <SOCIAL HISTORY> ___ <FAMILY HISTORY> No family history of hypercoagulability disorders. Father had history of DVT while hospitalized in the ICU. <PHYSICAL EXAM> Physical Exam on Discharge: Vitals: 99 100 122/74 24 100%RA GEN: AOx3, NAD HEENT: No scleral icterus, mucus membranes moist CV: RRR, No M/G/R PULM: Clear to auscultation b/l, No W/R/R ABD: Soft, nondistended, nontender, no rebound or guarding, normoactive bowel sounds, no palpable masses Ext: LLE mildly swollen, wrapped with ace wrap, no RLE swelling, no evidence of phlegmasia, strength and sensation equal Pulses: R: p/p/p/p L: p/p/p/p <PERTINENT RESULTS> ___ 07: 14AM BLOOD WBC-13.1* RBC-2.88* Hgb-8.5* Hct-26.6* MCV-92 MCH-29.5 MCHC-32.0 RDW-13.5 RDWSD-45.2 Plt ___ ___ 07: 14AM BLOOD Plt ___ ___ 07: 14AM BLOOD ___ PTT-84.5* ___ ___ 07: 14AM BLOOD Glucose-92 UreaN-6 Creat-0.6 Na-140 K-3.3 Cl-104 HCO3-25 AnGap-14 ___ 07: 14AM BLOOD Calcium-8.2* Phos-2.6* Mg-1.9 ___ 07: 14AM BLOOD <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. DULoxetine 120 mg PO DAILY 2. Levothyroxine Sodium 75 mcg PO DAILY 3. ClonazePAM 0.5 mg PO BID <DISCHARGE MEDICATIONS> 1. Docusate Sodium 100 mg PO BID 2. OxyCODONE (Immediate Release) ___ mg PO Q4H: PRN Pain - Moderate RX *oxycodone 5 mg 1 tablet(s) by mouth every four hours Disp #*30 Tablet Refills: *0 3. Rivaroxaban 15 mg PO BID for first three weeks only RX *rivaroxaban [___] 15 mg 1 tablet(s) by mouth twice a day Disp #*42 Tablet Refills: *0 4. Rivaroxaban 20 mg PO DAILY after first 3 weeks RX *rivaroxaban [___] 20 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills: *2 5. ClonazePAM 0.5 mg PO BID 6. DULoxetine 120 mg PO DAILY 7. Levothyroxine Sodium 75 mcg PO DAILY <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> ___ syndrome - DVT in LLE <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Lower Extremity Angioplasty/Stent Discharge Instructions MEDICATION: - Take Aspirin 325mg (enteric coated) once daily - If instructed, take Plavix (Clopidogrel) 75mg once daily - Continue all other medications you were taking before surgery, unless otherwise directed - You make take Tylenol or prescribed pain medications for any post procedure pain or discomfort WHAT TO EXPECT: It is normal to have slight swelling of the legs: - Elevate your leg above the level of your heart with pillows every ___ hours throughout the day and night - Avoid prolonged periods of standing or sitting without your legs elevated - It is normal to feel tired and have a decreased appetite, your appetite will return with time - Drink plenty of fluids and eat small frequent meals - It is important to eat nutritious food options (high fiber, lean meats, vegetables/fruits, low fat, low cholesterol) to maintain your strength and assist in wound healing - To avoid constipation: eat a high fiber diet and use stool softener while taking pain medication ACTIVITIES: - When you go home, you may walk and use stairs - You may shower (let the soapy water run over groin incision, rinse and pat dry) - Your incision may be left uncovered, unless you have small amounts of drainage from the wound, then place a dry dressing or band aid over the area - No heavy lifting, pushing or pulling (greater than 5 lbs) for 1 week (to allow groin puncture to heal) - After 1 week, you may resume sexual activity - After 1 week, gradually increase your activities and distance walked as you can tolerate - No driving until you are no longer taking pain medications CALL THE OFFICE FOR: ___ - Numbness, coldness or pain in lower extremities - Temperature greater than 101.5F for 24 hours - New or increased drainage from incision or white, yellow or green drainage from incisions - Bleeding from groin puncture site SUDDEN, SEVERE BLEEDING OR SWELLING (Groin puncture site) - Lie down, keep leg straight and have someone apply firm pressure to area for 10 minutes. If bleeding stops, call vascular office ___. If bleeding does not stop, call ___ for transfer to closest Emergency Room. ","The patient was admitted on ___ for left lower extremity swelling. CTA demonstrated right iliac artery compression of the left iliac vein, and the patient was started on heparin. The patient was brought to the operating room on ___ and underwent IVC filter placement and catheter-directed thrombolysis, which was the patient had no evidence of hematoma and was transferred to the PACU for recovery, where she remained hemodynamically stable. Hematocrit q6hrs remained stable, and the patient complained of mild back pain, which improved with pain management. The patient was closely monitored in the ICU and remained stable. She was brought back to the OR on ___ for mechanical thrombectomy and placement of left CIV wall stent. The procedure was without complications. The patient did well intraoperatively and was transferred back to the ICU, where she continued to recover. On ___, her diet was advanced and foley was d/c'ed. She was discharged to home on POD#2 in stable condition with rivaroxaban 15mg BID for first 3 weeks, followed by 20mg daily. Follow-up has been arranged with Dr. ___ in clinic with surveillance with LLE duplex in 3 wks. At the time of discharge the patient's pain was well controlled with oral medications, thrombectomy incisions were clean/dry/intact, and the patient was voiding/moving bowels spontaneously. The patient will follow up with a LLE duplex and Dr. ___ in three weeks. She will be discharged on xarelto. A thorough discussion was had with the patient regarding the diagnosis and expected post-discharge course including reasons to call the office or return to the hospital, and all questions were answered. The patient was also given written instructions concerning precautionary instructions and the appropriate follow-up care. The patient expressed readiness for discharge. ",1503,380
10005991-DS-13,"<SEX> M <SERVICE> MEDICINE <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> Abdominal pain <MAJOR SURGICAL OR INVASIVE PROCEDURE> EGD with biopsies <HISTORY OF PRESENT ILLNESS> PCP: Dr. ___ ___ year-old man with abdominal pain that started the morning of admission. The episodes last ___ minutes, 8 out of 10 in severity, sharp in quality, diffuse, but most severe in upper abdomen, and occurred 4 times prior to presentation. He had black, loose stools x 4 episodes on morning of ___ with stool urgency, but no stool incontinence. He had nausea without vomiting. He drinks ___ beers each weekend, but has been cutting down. He used Ibuprofen 600mg once one week prior to admission for a headache. Otherwise, the patient has loose stools once or twice weekly, but not black-colored. Denies constipation. No current fever or chills. His diet typically consists of pizza, burritos, and beer. Currently states that his pain is 7 out of 10 in the umbilical area. Denies ever having alcohol withdrawal symptoms. Review of Systems: (+) Per HPI (-) Denies night sweats, weight change, visual changes, oral ulcers, bleeding nose or gums, chest pain, shortness of breath, palpitations, orthopnea, PND, lower extremity edema, cough, hemoptysis, dysuria, hematuria, easy bruising, skin rash, myalgias, joint pain, back pain, numbness, weakness, dizziness, vertigo, headache, confusion, or depression. All other review of systems negative. <PAST MEDICAL HISTORY> Anxiety, sees a psychiatrist, Dr. ___ <SOCIAL HISTORY> ___ <FAMILY HISTORY> Mother with history of heart attack. Father healthy. <PHYSICAL EXAM> VS: 96.3, 138/88, 49, 20, 99% on room air Pain 7 out of 10 in umbilical area GEN: NAD HEENT: EOMI, anicteric sclerae, MMM, no oral lesions NECK: Supple CHEST: CTAB CV: RRR, normal S1 and S2, no murmurs ABD: Soft, nontender, nondistended, bowel sounds present SKIN: No rashes or other lesions EXT: No lower extremity edema NEURO: Alert, oriented x3, CN ___ intact, sensory intact throughout, strength ___ BUE/BLE, fluent speech, normal coordination PSYCH: Calm, appropriate <PERTINENT RESULTS> Admission Labs: ___ 09: 40AM WBC-11.6* Hgb-17.1 Hct-48.4 MCV-85 RDW-13.7 Plt-331 Glu-111* BUN-20 Cr-1.0 Na-140 K-4.4 Cl-105 HCO3-22 ALT-36 AST-46* AlkPhos-74 Amylase-36 TotBili-0.5 Lipase-27 H. Pylori antibody: Negative CXR ___: No acute process CT Abdomen and Pelvis ___: No acute intra-abdominal pathology to explain the patient's pain. Specifically, normal appendix. EGD: Erythema in the antrum compatible with gastritis (biopsy normal); erythema in the duodenal bulb compatible with duodenitis Discharge Labs: ___ 07: 20PM WBC-4.3# RBC-4.80 Hgb-13.9*# Hct-40.0 MCV-83 Plt ___ ___ 07: 25AM Hct-39.1* <MEDICATIONS ON ADMISSION> Sertraline 150 mg PO daily Lorazepam 1 mg PO BID prn anxiety Zolpidem 10 mg PO QHS prn insomnia <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Gastritis Duodenitis <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> You were admitted to the hospital with abdominal pain and black stools concerning for bleeding from your GI tract. You underwent a procedure called an EGD which found inflammation in your stomach (gastritis) and in the first part of your small intestine (duodenitis). For this you are being prescribed an acid suppressing medication which you will need to take twice a day for a month. You will also need to follow-up with ___ in Gastroenterology. Due to ongoing abdominal pain you are being prescribed a medication called Ultram. However, this medication can interact with medications you are already taking and is not a good long-term option. You are being given a one day supply of this medication, and will need to discuss your pain control further with your primary care physician ___. It is very important that you stop drinking, as this can worsen the inflammation in your stomach. It is also important that you avoid medications such as Ibuprofen, Motrin, Advil, Naproxen, and Alleve, as these can also worsen the inflammation. You can use Tylenol as needed for pain. ","___ year-old man with heavy alcohol use and poor diet presents with severe abdominal pain and black loose stools (guaiac positive) concerning for a GI bleed. # Gastrointestinal bleed: Guaiac positive in ED, with a decrease in his Hct from 48 to 40. Patient had no further bowel movements while in the hospital, and subsequent Hct was stable at 39. He underwent EGD which was notable for duodenitis and gastritis, biopsies of which were within normal limits. H.pylori antibody was negative. It was felt his duodenitis and gastritis were secondary to heavy alcohol use, and patient was advised to abstain from alcohol. He was started on a twice daily proton pump inhibitor, which he should continue until follow-up with ___ gastroenterology. The patient continued to complain of pain following his EGD, and was advised to avoid NSAIDs given the gastritis noted on EGD. He was prescribed Tylenol and a limited supply of Ultram and advised to follow-up with his PCP if his pain persists. He tolerated a full regular diet prior to discharge with no change in his level of pain. # Anxiety disorder: Mood remained stable on Sertraline and Lorazepam. ",1152,255
10005991-DS-14,"<SEX> M <SERVICE> MEDICINE <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> Abdominal Pain, distension <MAJOR SURGICAL OR INVASIVE PROCEDURE> Esophagogastroduodenoscopy Colonoscopy <HISTORY OF PRESENT ILLNESS> Mr. ___ is a ___ y/o M with past medical history significant for Anxiety, and abdominal pain. Of note he had recent hospitilization in early ___ for abdominal pain, was evaluated by GI who was consulted for concern for upper GI bleed, an EGD was performed which showed gastritis and duodenitis with normal biopsies. It was believed at that time that his gastritis and duodenitis were due to heavy alcohol use. He was started on a PPI twice daily. He was negative for H. Pylori. . Today he is s/p EGD and colonoscopy for further evaluation of abdominal pain. He had an MRCP two days ago, which was essentially negative. After his colonoscopy patient continued to have abdominal pain, gas, distension and was admitted for further monitoring overnight. . Per history patient said that he has been daily with mainly epigastric pain, has not had any N/V recently. Pain is aggravated by eating, and alcohol intake (patient still reports drinking ___ drinks/week). Denies any recent Fevers/Chills, hematochezia, melena. He reports on average ___ BM's per day, with diarrhea on and off. He was not taking a PPI prior to admission due to insurance issues with ""prior authorization"". . On the floor patient's vitals were 97.8, 148/81, 62, 20, 97%RA. After his colonoscopy/EGD today patient currently reports that he has ___ pain, mainly in the LLQ, RLQ, and constant, non-radiating. He reports passing gas, has not had BM yet. Has taken clear liquids, does not currently report nausea (had 1 episode of emesis after his procedure today). . . Review of sytems: (+) Per HPI (-) Denies fever, chills, night sweats, recent weight loss or gain. Denies headache, sinus tenderness, rhinorrhea or congestion. Denied cough, shortness of breath. Denied chest pain or tightness, palpitations. No recent change in bowel or bladder habits. No dysuria. Denied arthralgias or myalgias. <PAST MEDICAL HISTORY> -Anxiety, sees a psychiatrist, Dr. ___, Duodenitis -s/p bilateral inguinal hernia repair as child, denies other surgeries <SOCIAL HISTORY> ___ <FAMILY HISTORY> -Mother with history of heart attack (believed to be in her ___, patient denies other medical issues. -Father healthy. -Uncle with ___ Lymphoma -Denies family history of GI issues <PHYSICAL EXAM> Vitals: 97.8, 148/81, 62, 20, 97%RA General: Alert, oriented, no acute distress HEENT: Sclera anicteric, MMM, oropharynx clear Neck: supple, JVP not elevated, no LAD Lungs: Clear to auscultation bilaterally, no wheezes, rales, ronchi CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Abdomen: soft, obese, ttp in RLQ, LLQ, no rebound or gaurding, no organomegaly GU: no foley Ext: warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema Neuro: CNs2-12 intact, motor function grossly normal <PERTINENT RESULTS> Labs during Observation: ___ 06: 05AM BLOOD WBC-6.4 RBC-4.68 Hgb-13.6* Hct-39.4* MCV-84 MCH-29.1 MCHC-34.5 RDW-13.5 Plt ___ ___ 06: 05AM BLOOD Glucose-87 UreaN-15 Creat-1.1 Na-136 K-4.2 Cl-103 HCO3-24 AnGap-13 ___ 06: 05AM BLOOD Calcium-9.1 Phos-3.3 Mg-2.6 . ___ EGD: Impression: Grade 1 esophagitis in the lower third of the esophagus Erythema and congestion in the antrum compatible with gastritis (biopsy) Granularity, erythema, congestion and nodularity in the duodenal bulb compatible with duodenitis (biopsy). Otherwise normal EGD to third part of the duodenum. . ___ Colonoscopy: Impression: Polyps in the rectum and transverse colon (polypectomy, polypectomy, endoclip, epinephrine injection). Diverticulosis of the sigmoid colon. Otherwise normal colonoscopy to cecum. <DISCHARGE INSTRUCTIONS> Dear Mr. ___, It was a pleasure taking care of you at ___. You were admitted to the hospital for observation after your EGD and Colononscopy for abdominal pain. Your pain improved overnight with pain medications, and with a medication to control gas. MEDICATION CHANGES: START Pantoprazole 40mg tab two times a day (Dr. ___ has requested prior authorization for this, if you can not obtain then please take omeprazole instead) START Oxycodone 5mg as needed for abdominal pain every 4 to 6 hours. Do not operate machinery, or drive while taking this medication. Can cause drowsiness. Avoid taking aspirin,ibuprofen, motrin, or other anti-inflammatory medications known as (NSAIDS) Recommendations to help with heartburn: Avoid chocolate, peppermint, alcohol, caffeine, onions, aspirin. Elevate the head of the bed 3 inches. Go to bed with an empty stomach. Please follow-up with your PCP and GI as below. ","Mr. ___ is a ___ year old male with past medical history significant for anxiety with noted gastritis, duodenitis per previous EGD in ___, who presented s/p Colonoscopy/EGD with abdominal pain, distension and kept overnight for observation. . #Abdominal Pain/Gastritis/Duodenitis: Patient s/p EGD/Colonoscopy. Likely source of abdominal pain is from distension, gas from colonoscopy. Patient discussed with GI, low risk for perforation. Patient remained afebrile throughout stay. He did not exhibit any signs of nausea/vomiting. He had a previous MRCP on ___ without evidence of pancreatitis, or cholestasis. Patient was started on pantoprazole BID which he will continue as an outpatient. He was given simethicone to help with his distension, and pain control with oxycodone 5mg PRN and tylenol. He was started on a regular diet and tolerated this well prior to discharge. Patient has scheduled follow-up with his GI doctor within the next month. . #Anxiety: Patient followed by psychiatrist as outpatient. He was continued on his lorazepam and zoloft home dose. . #Insomnia: Patient continued on home zolpidem. . TRANSITIONAL ISSUES: 1) Patient to follow up with his GI doctor in ___ month 2) Patient has scheduled follow up with PCP ___ on ___: Sertraline 150 mg PO daily Lorazepam 1 mg PO BID prn anxiety Zolpidem 10 mg PO QHS prn insomnia Discharge Medications: 1. pantoprazole 40 mg Tablet, Delayed Release (E.C.) Sig: One (1) Tablet, Delayed Release (E.C.) PO twice a day. 2. zolpidem 10 mg Tablet Sig: One (1) Tablet PO at bedtime as needed for insomnia. 3. lorazepam 1 mg Tablet Sig: One (1) Tablet PO twice a day as needed for anxiety. 4. sertraline 50 mg Tablet Sig: Three (3) Tablet PO DAILY (Daily). 5. oxycodone 5 mg Tablet Sig: One (1) Tablet PO every ___ hours as needed for pain for 5 doses. Disp:*5 Tablet(s)* Refills:*0* Discharge Disposition: Home Discharge Diagnosis: Primary Diagnosis: Gastritis, Duodenitis Secondary Diagnosis: Anxiety Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Followup Instructions: ___",1311,575
10006029-DS-15,"<SEX> M <SERVICE> MEDICINE <ALLERGIES> ___ <ATTENDING> ___ <CHIEF COMPLAINT> anbormal lfts <MAJOR SURGICAL OR INVASIVE PROCEDURE> ERCP ___ <HISTORY OF PRESENT ILLNESS> PRIMARY ONCOLOGIST: Dr ___ ___: Metastatic clear cell renal cell carcinoma TREATMENT: ___, randomized to sunitinib 50 mg PO daily x 4 weeks followed by 2 weeks off. Dose reduced sunitinib to 37.5 mg daily. Cycle 25, Week 1. CHIEF COMPLAINT: Abnormal LFTs HISTORY OF PRESENT ILLNESS: Mr. ___ is a pleasant ___ w/ ID-T2DM, HTN, DL, BPH, and metastatic clear cell RCC, s/p radical L nephrectomy in ___, found to have pulmonary, mediastinal, and hilar mets ___, now on ___, randomized to sunitinib, dose-reduced, currently 2 weeks off sunitinib per protocol, who is directly admitted from clinic for abnormal LFTs found on routine lab screening. He feels tired but has no localizing symptoms. He did not have any F/C, no abd pain, no N/V. Appeared mildly lethargic today after he took his Ativan today for anxiety related coming into ___. His family reported ___ episodes of confusion since his last clinic visit. He states he's had greasy foods lately without any n/v, no abd pain. He drinks a couple beers a week during his weeks off sunitinib. No new meds. No apap/nsaids. No recent travel. No camping. REVIEW OF SYSTEMS: 10 point ROS reviewed in detail and negative except for what is mentioned above in HPI <PAST MEDICAL HISTORY> PAST ONCOLOGIC HISTORY (per OMR): -___: presented with acute onset of gross hematuria accompanied with some mild flank pain. During his workup, he was found to have a 4.8 cm mass on a CAT scan dated ___, specifically the scan describes a left renal mass with internal enhancement measuring 4.1 x 4.8 cm in size in the mid and upper pole of the left kidney. Also described was the fat-containing left inguinal hernia and left perinephric stranding. There was no adenopathy or other suspicious lesions. There is also an old sclerotic right ilial lesion and left sacral lesion. -___: underwent a laparoscopic hand assisted radical right nephrectomy by Dr. ___ pathology showed a renal cell carcinoma, clear cell type, ___ grade II/IV measuring 4 cm extending but not invading through the renal capsule or Gerota's fascia margins were questionably positive at the renal vein and otherwise negative. On review of pathology here at ___, the margins are described as negative including the renal vein margin. A background of global glomerulosclerosis is described. Overall, this was a T3bNxMx lesion. Postoperative imaging on ___ which was a CT torso showed no evidence of recurrent or metastatic disease. -___: CT chest showed interval increase in prominence of mediastinal lymph nodes and minimal interval increase in multiple b/l pulmonary nodules, concerning for progression -___: Fine needle aspirate of 11R and 11L lymph nodes, which was consistent with metastatic RCC -___: CT Torso - mediastinal and hilar nodes and pulmonary lesions increased in size. No definite intra-abdominal sites of disease -___: C1D1 ___, randomized to sunitinib -___: Multiple grade ___ adverse events including thrombocytopenia (grade 2; platelet 52,000), leukopenia (grade 2; WBC 2.9), elevated lipase (grade 1), elevated amylase (grade 1; elevated at baseline), elevated ALT (grade 1), and hypothyroidism (grade 1). Mild symptoms with treatment. Continued sunitinib at 50mg daily per protocol. -___: CT Torso: Response of mediastinal lymphadenopathy, bilateral hilar lymphadenopathy, and numerous parenchymal metastases. Stable disease by RECIST (decrease 19.1% from baseline). -___: Sunitinib reduced to 37.5 mg daily due to erythematous rash and blistering on palms and sole of right foot. -___: CT Torso: Decrease in pulmonary and mediastinal lesions. Stable disease by RECIST 1.1 (decrease 22.5% from baseline). -___: CT Torso: Partial response by RECIST 1.1 (decrease 39.8% from baseline). -___: CT Torso: Partial response by RECIST 1.1 (decrease 46.3% from baseline). -___: CT Torso: Partial response by RECIST 1.1 (decrease 40.3% from baseline). -___: CT Torso: Partial response by RECIST 1.1 (decrease 42.6% from baseline). -___: CT Torso: Partial response by RECIST 1.1 (decrease 47.7% from baseline). -___: CT torso: Ongoing partial response comments: No significant change compared to prior scan. No new lesions. -___: CT Torso: PR by RECIST 1.1 -___: CT Torso: PR by RECIST 1.1: -54.22% change from baseline and -10.29% change from last scan. -___: CT Torso: partial response: -57.79% from baseline, -7.79% from nadir -___: CT Torso shows continued partial response, no significant change compared to prior PAST MEDICAL HISTORY (per OMR): 1. Clear cell kidney cancer as above. 2. Benign prostatic hypertrophy. 3. Diabetes mellitus. 4. Hypertension. 5. Hyperlipidemia. 6. History of anxiety. <SOCIAL HISTORY> ___ <FAMILY HISTORY> Mother: Died of rectal/colon cancer. Father: No cancers, history of diabetes. Other: He has a sister with ovarian cancer diagnosed at age ___ and a brother with liver cancer at age ___ and another brother with hairy cell leukemia, which is in remission. <PHYSICAL EXAM> VITAL SIGNS: 97.5 PO 160 / 89 R Sitting 71 18 99 ra General: NAD, Resting in bed comfortably with daughter at bedside ___: MMM, no OP lesions, no cervical/supraclavicular adenopathy, no icterus CV: RR, NL S1S2 no S3S4 No MRG PULM: CTAB, No C/W/R, No respiratory distress ABD: BS+, soft, NTND, no palpable masses or HSM LIMBS: WWP, trace b/l pitting edema at the distal ___, no tremors SKIN: No rashes on the extremities NEURO: Grossly normal, speech clear, AOx3 ACCESS: No port <PERTINENT RESULTS> ___ 06: 55AM BLOOD WBC-3.9* RBC-3.12* Hgb-10.5* Hct-33.5* MCV-107* MCH-33.7* MCHC-31.3* RDW-16.8* RDWSD-65.9* Plt ___ ___ 07: 25AM BLOOD WBC-3.0* RBC-3.03* Hgb-10.2* Hct-32.2* MCV-106* MCH-33.7* MCHC-31.7* RDW-16.9* RDWSD-66.0* Plt ___ ___ 11: 30AM BLOOD WBC-3.6* RBC-3.21* Hgb-10.8* Hct-34.9* MCV-109* MCH-33.6* MCHC-30.9* RDW-17.0* RDWSD-68.3* Plt ___ ___ 06: 55AM BLOOD Glucose-121* UreaN-14 Creat-1.2 Na-147 K-4.5 Cl-106 HCO3-27 AnGap-14 ___ 07: 25AM BLOOD Glucose-204* UreaN-18 Creat-1.3* Na-140 K-4.3 Cl-103 HCO3-25 AnGap-12 ___ 11: 30AM BLOOD UreaN-19 Creat-1.4* Na-139 K-5.3 Cl-101 ___ 06: 55AM BLOOD ALT-101* AST-47* LD(___)-239 AlkPhos-188* TotBili-1.5 DirBili-0.7* IndBili-0.8 ___ 09: 45PM BLOOD ALT-123* AST-57* LD(LDH)-274* CK(CPK)-106 AlkPhos-241* TotBili-2.3* ___ 11: 30AM BLOOD ALT-133* AST-71* LD(___)-289* AlkPhos-259* Amylase-210* TotBili-3.0* DirBili-1.8* IndBili-1.2 ___ 09: 45PM BLOOD cTropnT-<0.01 ___ 11: 30AM BLOOD Lipase-252* ___ 06: 55AM BLOOD Lipase-63* ___ 06: 55AM BLOOD Albumin-3.7 Calcium-9.3 Phos-3.7 Mg-2.0 ___ 09: 45PM BLOOD calTIBC-306 VitB12-356 Folate->20 ___ Ferritn-597* TRF-235 ___ 09: 45PM BLOOD Triglyc-207* HDL-30* CHOL/HD-4.7 LDLcalc-70 ___ 11: 30AM BLOOD Free T4-1.2 ___ 09: 45PM BLOOD HBsAg-NEG HBsAb-NEG HBcAb-NEG ___ 09: 45PM BLOOD Smooth-NEGATIVE ___ 09: 45PM BLOOD ___ ___ 09: 45PM BLOOD IgG-666* IgA-165 IgM-120 ___ 09: 45PM BLOOD HCV Ab-NEG ___ 09: 46PM BLOOD Lactate-0.7 ___ 11: 30AM BLOOD FREE T3-Test ___ 11: 30AM BLOOD Free T4-1.2 <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. amLODIPine 10 mg PO DAILY 2. Atenolol 100 mg PO DAILY 3. cariprazine 1.5 mg oral DAILY 4. Fenofibrate 48 mg PO DAILY 5. FLUoxetine 20 mg PO DAILY 6. Gabapentin 100 mg PO DAILY 7. GlipiZIDE 2.5 mg PO BID 8. Lantus Solostar U-100 Insulin (insulin glargine) ___ units subcutaneous QPM 9. Levothyroxine Sodium 100 mcg PO DAILY 10. LORazepam 0.5 mg PO DAILY: PRN anxiety 11. Ondansetron 4 mg PO Q8H: PRN nausea 12. Prochlorperazine 5 mg PO Q8H: PRN nausea 13. Simvastatin 40 mg PO QPM 14. Tamsulosin 0.4 mg PO QHS 15. Ascorbic Acid ___ mg PO DAILY 16. Vitamin D 5000 UNIT PO DAILY 17. Omeprazole 20 mg PO DAILY 18. Artificial Tears Preserv. Free ___ DROP BOTH EYES PRN dry eyes 19. Lisinopril 40 mg PO DAILY <DISCHARGE MEDICATIONS> 1. Enoxaparin Sodium 120 mg SC DAILY Start: Future Date - ___, First Dose: First Routine Administration Time RX *enoxaparin 120 mg/0.8 mL 120 mg sc daily Disp #*30 Syringe Refills: *0 2. amLODIPine 10 mg PO DAILY 3. Artificial Tears Preserv. Free ___ DROP BOTH EYES PRN dry eyes 4. Ascorbic Acid ___ mg PO DAILY 5. Atenolol 100 mg PO DAILY 6. cariprazine 1.5 mg oral DAILY 7. FLUoxetine 20 mg PO DAILY 8. Gabapentin 100 mg PO DAILY 9. GlipiZIDE 2.5 mg PO BID 10. Lantus Solostar U-100 Insulin (insulin glargine) ___ units subcutaneous QPM 11. Levothyroxine Sodium 100 mcg PO DAILY 12. Lisinopril 40 mg PO DAILY 13. LORazepam 0.5 mg PO DAILY: PRN anxiety 14. Omeprazole 20 mg PO DAILY 15. Ondansetron 4 mg PO Q8H: PRN nausea 16. Prochlorperazine 5 mg PO Q8H: PRN nausea 17. Tamsulosin 0.4 mg PO QHS 18. Vitamin D 5000 UNIT PO DAILY 19. HELD- Fenofibrate 48 mg PO DAILY This medication was held. Do not restart Fenofibrate until discussed with your oncologist 20. HELD- Simvastatin 40 mg PO QPM This medication was held. Do not restart Simvastatin until discussed with your oncologist <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Biliary Stricture Portal Vein Thrombus <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear ___ ___ were admitted to the hospital because ___ had abnormal liver enzymes. MRI of your liver (MRCP) revealed a narrowing in your bile duct, also known as a stricture. ___ had an ERCP (endoscopy and a camera into your bile duct) which confirmed a stricture. These improved after ___ had an ERCP. ___ had a plastic stent placed in your bile duct and ___ tolerated this well. Your liver enzymes are already improving. ERCP team will call ___ to schedule another ERCP in 4 weeks or so to possibly remove the stent. ___ will follow up on the biopsy results with your oncology team. ___ were also found to have a clot in one of your veins (portal vein) which will need to be treated with a blood thinner. ___ will start this ___. Call your oncology team if there are any issues or questions. Regards, Your ___ team ","IMAGING: RUQ US ___: 1. Biliary sludge without evidence of gallbladder-wall thickening or intrahepatic biliary dilatation. 2. No evidence of focal liver lesions MRCP ___: 1. Moderate intra and extrahepatic biliary ductal dilatation with duct penetrating sign suggestive of inflammatory rather than neoplastic stricture. Correlation with ERCP may be considered. No evidence of choledocholithiasis or definite obstructing mass. 2. Short-segment (11 mm) eccentric filling defect within the main portal vein, suspicious for nonocclusive thrombus. 3. Sludge within the gallbladder lumen. 4. Status post left nephrectomy with stable soft tissue within the left nephrectomy bed. 5. Multiple pancreatic cystic lesions, likely small side branch IPMNs, measuring up to 10 mm. ASSESSMENT AND PLAN: ___ w/ ID-T2DM, HTN, DL, BPH, and metastatic clear cell RCC, s/p radical L nephrectomy in ___, found to have pulmonary, mediastinal, and hilar mets ___, now on ___, randomized to sunitinib, dose-reduced, currently 2 weeks off sunitinib per protocol, who is directly admitted from clinic for abnormal LFTs found on routine lab screening. # Elevated LFTs Non-specific elevations. US did not reveal any focal lesions nor any biliary dilatation nor stones. Lipase elevated at 252 but in absence of any abd pain, unlikely pancreatitis. Unlikely sunitinib effect per oncology. Pt did appear to be lethargic per oncologist but is AOx3 and no asterixis, but cannot rule out some element of encephalopathy. Found on MRCP to have moderate intra/extrahepatic biliary ductal dilatation suggestive of stricture. Hepto wnl and anemia stable, so unlikely hemolysis. SPEP largely wnl. ERCP on ___ revealed stricture in bile duct and had plastic biliary stent placed. He tolerated procedure well. Had no infectious symptoms nor any signs of post-ercp pancreatitis. He was advanced to full diet and instructed to f/u with oncology for the results of the brushings done during ERCP. Their team will coordinate a repeat ERCP in 4 wks. # Portal Vein THrombus MRCP revealed a small non-occlusive filling defect within the main portal vein suspicious for thrombus. Due to risk of progression, patient was started on once daily dosing lovenox at 1.5 mg/kg. Due to sphincterotomy during the ERCP, patient was instructed to wait 5 days after ercp to start the lovenox. He was provided teaching on how to inject and warning signs while he was here. # Pancreatic cysts Found on MRCP, per radiology, felt to be to be small side branch Intraductal papillary mucinous neoplasm. - f/u in ___ year # ___ CT scans from ___ revealed partial response to sunitinib. - sunitinib is currently on hold - will f/u w/ Dr ___ # Macrocytic Anemia Chronic and at baseline. TSH WNL as well as VIt B12, Folate, spep, and ferritin/TIBC. # Depressed mood/anxiety - hold cariprazine ___ lfts - cont fluoxetine # T2DM: cont home insulin, glipizide # HTN: cont amlodipine, atenolol, lisinopril # DL: hold statin/fibrate # CKD: cr baseline # Hypothyroidism: cont levothyroxine (TSH WNL) # BPH: cont flomax FEN: Regular low fat diabetic diet DVT PROPHYLAXIS: HSQ ACCESS: PIV CODE STATUS: Full code, presumed PCP: ___, MD DISPO: Home w/o services BILLING: 45 min spent coordinating care for discharge ________________ ___, D.O. Heme/Onc Hospitalist p: ___ ",3278,872
10006029-DS-16,"<SEX> M <SERVICE> MEDICINE <ALLERGIES> ___ <ATTENDING> ___. <CHIEF COMPLAINT> Fatigue <MAJOR SURGICAL OR INVASIVE PROCEDURE> ___: ERCP and EUS <HISTORY OF PRESENT ILLNESS> Mr. ___ is a ___ male with IDDM, HTN, BPH, and clear cell RCC s/p radical L nephrectomy (___) metastatic to the lungs, mediastinum, and hilum currently on chemotherapy (experimental trial; on sunitinib), with recent admission (___) for biliary stricture s/p ERCP with plastic stent placement (CBD brushing cytology non-diagnostic) and non-occlusive portal vein thrombus started on enoxaparin who presented to the ED with fever, jaundice, and confusion. The CBD brushing cytology from his prior admission was non-diagnostic. His imaging was reviewed at multidisciplinary pancreas conference and no mass lesion was visualized in the head of the pancreas but there was some peripancreatic stranding around the head of the pancreas noted. There was some concern for a potential primary pancreatobiliary tumor (rather than rare RCC metastasis to pancreas), so he was planned for a repeat ERCP and EUS in ___ weeks (planned for the week of ___ off sunatinib). He last followed up in ___ clinic with Dr. ___ on ___. He was complaining of a week of increased fatigue, nausea, and poor PO intake. His sunatinib was held due to concern for side effects. Over the past week since then, he has had worsening jaundice and fatigue. Last night, he developed chills, restlessness, mild confusion, and fevers to 101, which prompted his wife to bring him to ___. He was transferred from there to the ___ ED. Right now, he feels ok, just a little tired. He feels like his thinking is foggy. No fevers/chills since he presented to the hospital. No nausea, vomiting, abdominal pain. He has had loose stools, which he associates with the sunatinib. No bloody, black, or ___ stools. His urine has been ""tea colored."" He has had poor appetite. No chest pain, shortness of breath, or palpitations. ED COURSE: VS: Tmax 98.6, HR ___, BP 100s-110s/60s, RR 16, SpO2 98-100% on RA Labs: WBC 3.4, AST/ALT 71/97, AP 214, Tbili 7.6, lipase 148, lactate 1.4 Exam: jaundiced, abdomen benign, guaiac negative brown stool Imaging: RUQ US: persistent left intrahepatic biliary dilation, persistent GB sludge Interventions: None ROS: Pertinent positives and negatives as noted in the HPI. All other systems were reviewed and are negative. <PAST MEDICAL HISTORY> PAST ONCOLOGIC HISTORY (per OMR): -___: presented with acute onset of gross hematuria accompanied with some mild flank pain. During his workup, he was found to have a 4.8 cm mass on a CAT scan dated ___, specifically the scan describes a left renal mass with internal enhancement measuring 4.1 x 4.8 cm in size in the mid and upper pole of the left kidney. Also described was the fat-containing left inguinal hernia and left perinephric stranding. There was no adenopathy or other suspicious lesions. There is also an old sclerotic right ilial lesion and left sacral lesion. -___: underwent a laparoscopic hand assisted radical right nephrectomy by Dr. ___ pathology showed a renal cell carcinoma, clear cell type, ___ grade II/IV measuring 4 cm extending but not invading through the renal capsule or Gerota's fascia margins were questionably positive at the renal vein and otherwise negative. On review of pathology here at ___, the margins are described as negative including the renal vein margin. A background of global glomerulosclerosis is described. Overall, this was a T3bNxMx lesion. Postoperative imaging on ___ which was a CT torso showed no evidence of recurrent or metastatic disease. -___: CT chest showed interval increase in prominence of mediastinal lymph nodes and minimal interval increase in multiple b/l pulmonary nodules, concerning for progression -___: Fine needle aspirate of 11R and 11L lymph nodes, which was consistent with metastatic RCC -___: CT Torso - mediastinal and hilar nodes and pulmonary lesions increased in size. No definite intra-abdominal sites of disease -___: C1D1 ___, randomized to sunitinib -___: Multiple grade ___ adverse events including thrombocytopenia (grade 2; platelet 52,000), leukopenia (grade 2; WBC 2.9), elevated lipase (grade 1), elevated amylase (grade 1; elevated at baseline), elevated ALT (grade 1), and hypothyroidism (grade 1). Mild symptoms with treatment. Continued sunitinib at 50mg daily per protocol. -___: CT Torso: Response of mediastinal lymphadenopathy, bilateral hilar lymphadenopathy, and numerous parenchymal metastases. Stable disease by RECIST (decrease 19.1% from baseline). -___: Sunitinib reduced to 37.5 mg daily due to erythematous rash and blistering on palms and sole of right foot. -___: CT Torso: Decrease in pulmonary and mediastinal lesions. Stable disease by RECIST 1.1 (decrease 22.5% from baseline). -___: CT Torso: Partial response by RECIST 1.1 (decrease 39.8% from baseline). -___: CT Torso: Partial response by RECIST 1.1 (decrease 46.3% from baseline). -___: CT Torso: Partial response by RECIST 1.1 (decrease 40.3% from baseline). -___: CT Torso: Partial response by RECIST 1.1 (decrease 42.6% from baseline). -___: CT Torso: Partial response by RECIST 1.1 (decrease 47.7% from baseline). -___: CT torso: Ongoing partial response comments: No significant change compared to prior scan. No new lesions. -___: CT Torso: PR by RECIST 1.1 -___: CT Torso: PR by RECIST 1.1: -54.22% change from baseline and -10.29% change from last scan. -___: CT Torso: partial response: -57.79% from baseline, -7.79% from nadir -___: CT Torso shows continued partial response, no significant change compared to prior PAST MEDICAL HISTORY (per OMR): 1. Clear cell kidney cancer as above. 2. Benign prostatic hypertrophy. 3. Diabetes mellitus. 4. Hypertension. 5. Hyperlipidemia. 6. History of anxiety. <SOCIAL HISTORY> ___ <FAMILY HISTORY> Colorectal cancer - mother ___ cancer - sister (dx at age ___ Liver cancer - brother ___ cell leukemia - brother ___ - father Physical ___: ADMISSION EXAM: VITALS: T 97.6, HR 68, BP 115/76, RR 16, SpO2 98% on RA ___: Alert, NAD, breathing room air comfortably EYES: Icteric sclera, PERRL ENT: MMM, sublingual jaundice, OP clear CV: NR/RR, no m/r/g RESP: CTAB, no wheezes, crackles, or rhonchi GI: Abdomen soft, non-distended, non-tender to palpation. Bowel sounds present. No HSM. MSK: Neck supple, moves all extremities, strength grossly full and symmetric bilaterally in all limbs SKIN: Jaundiced NEURO: Alert, oriented to hospital, city, date; able to recite the days of the week backwards, face symmetric, gaze conjugate with EOMI, speech fluent, moves all limbs PSYCH: pleasant, appropriate affect DISCHARGE EXAM: T 97.9, HR 70, BP 143/79, RR 18, SpO2 97% on RA ___: Alert, NAD, breathing room air comfortably EYES: Icteric sclera ENT: MMM, OP clear CV: NR/RR, no m/r/g RESP: CTAB, no wheezes, crackles, or rhonchi GI: Abdomen soft, non-distended, non-tender to palpation. Bowel sounds present. MSK: Neck supple, moves all extremities, strength grossly full and symmetric bilaterally in all limbs SKIN: Jaundiced (but improved) NEURO: Alert, oriented, face symmetric, gaze conjugate with EOMI, speech fluent, moves all limbs PSYCH: pleasant, appropriate affect <PERTINENT RESULTS> ADMISSION LABS: ___ 05: 43AM BLOOD WBC-3.4* RBC-2.48* Hgb-8.4* Hct-24.9* MCV-100* MCH-33.9* MCHC-33.7 RDW-16.8* RDWSD-61.6* Plt ___ ___ 05: 43AM BLOOD Glucose-95 UreaN-24* Creat-1.5* Na-138 K-4.4 Cl-106 HCO3-18* AnGap-14 ___ 05: 55AM BLOOD Albumin-2.5* Calcium-8.1* Phos-3.5 Mg-1.9 Iron-18* ___ 05: 43AM BLOOD Albumin-2.8* ___ 05: 55AM BLOOD calTIBC-160* Hapto-230* Ferritn-990* TRF-123* ___ 05: 43AM BLOOD ALT-97* AST-71* AlkPhos-214* TotBili-7.6* DirBili-5.6* IndBili-2.0 MICRO: BCx ___: NGTD Blood culture (___): STREPTOCOCCUS ANGINOSUS (___) GROUP | CEFTRIAXONE----------- 0.5 S CLINDAMYCIN-----------<=0.25 S ERYTHROMYCIN----------<=0.12 S PENICILLIN G----------<=0.06 S VANCOMYCIN------------ 0.5 S PATHOLOGY/CYTOLOGY: Biliary mass biopsy (___): Minute fragment of highly atypical cells with sclerotic stroma consistent with adenocarcinoma Common bile duct stricture brushings (___): POSITIVE FOR MALIGNANT CELLS. - Adenocarcinoma. IMAGING: RUQ US (___): IMPRESSION: 1. Persistent mild left intrahepatic biliary dilation in presence of a partially visualized CBD stent raises concern for stent malfunction. Compared to the prior ultrasound, the degree of intrahepatic biliary dilation has not changed significantly. 2. Persistent gallbladder sludge. ERCP ___: removal of the old stent and placement of a new stent over a 2cm malignant-appearing stricture of the distal CBD. Cytology brushings were sampled. EUS ___: 1.8 x 1.1 cm ill-defined hypoechoic area around the distal CBD. FNB was performed x3 CT torso ___: IMPRESSION: Non obstructive pneumonia, left upper lobe. Minimal residual pulmonary edema and pleural effusions attributable to heart failure. Atherosclerotic coronary calcification. Left PICC line ends just above the superior cavoatrial junction. IMPRESSION: 1. No evidence of local recurrence or metastatic disease in the abdomen and pelvis. 2. Mild intrahepatic and extrahepatic biliary ductal dilatation, with CBD stent in place. 3. Known nonocclusive main portal vein thrombus appears increased in size, though difficult to directly compare to MR due to differences in imaging technique. ERCP ___: Biliary plastic stent removed with a snare. A metal stent was placed over 2cm long malignant appearing stricture in the distal CBD. TTE ___: IMPRESSION: Adequate image quality. Mild symmetric left ventricular hypertrophy with normal cavity size and regional/global left ventricular systolic function. No 2D echocardiographic evidence for endocarditis. If clinically suggested, the absence of a discrete vegetation on echocardiography does not exclude the diagnosis of endocarditis. <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Enoxaparin Sodium 120 mg SC DAILY Start: ___, First Dose: Next Routine Administration Time 2. amLODIPine 10 mg PO DAILY 3. Ascorbic Acid ___ mg PO DAILY 4. Atenolol 100 mg PO DAILY 5. cariprazine 1.5 mg oral DAILY 6. FLUoxetine 20 mg PO DAILY 7. Gabapentin 100 mg PO BID 8. GlipiZIDE 2.5 mg PO BID 9. Glargine 16 Units Bedtime 10. Levothyroxine Sodium 100 mcg PO DAILY 11. Lisinopril 40 mg PO DAILY 12. LORazepam 0.5 mg PO DAILY: PRN anxiety 13. Omeprazole 20 mg PO DAILY 14. Ondansetron 4 mg PO Q8H: PRN nausea 15. Prochlorperazine 5 mg PO Q8H: PRN nausea 16. Tamsulosin 0.4 mg PO QHS 17. Vitamin D 5000 UNIT PO DAILY 18. Multivitamins 1 TAB PO DAILY 19. Fenofibrate 48 mg PO DAILY <DISCHARGE MEDICATIONS> 1. CefTRIAXone 2 gm IV Q24H RX *ceftriaxone in dextrose,iso-os 2 gram/50 mL 2 gm IV once a day Disp #*9 Intravenous Bag Refills: *0 2. MetroNIDAZOLE 500 mg PO Q8H RX *metronidazole 500 mg 1 tablet(s) by mouth every eight (8) hours Disp #*27 Tablet Refills: *0 3. Glargine 16 Units Bedtime 4. amLODIPine 10 mg PO DAILY 5. Ascorbic Acid ___ mg PO DAILY 6. Atenolol 100 mg PO DAILY 7. cariprazine 1.5 mg oral DAILY 8. Enoxaparin Sodium 120 mg SC DAILY Start: ___, First Dose: Next Routine Administration Time 9. Fenofibrate 48 mg PO DAILY 10. FLUoxetine 20 mg PO DAILY 11. Gabapentin 100 mg PO BID 12. GlipiZIDE 2.5 mg PO BID 13. Levothyroxine Sodium 100 mcg PO DAILY 14. Lisinopril 40 mg PO DAILY 15. LORazepam 0.5 mg PO DAILY: PRN anxiety 16. Multivitamins 1 TAB PO DAILY 17. Omeprazole 20 mg PO DAILY 18. Ondansetron 4 mg PO Q8H: PRN nausea 19. Prochlorperazine 5 mg PO Q8H: PRN nausea 20. Tamsulosin 0.4 mg PO QHS 21. Vitamin D 5000 UNIT PO DAILY <DISCHARGE DISPOSITION> Home With Service Facility: ___ ___ Diagnosis: Cholangitis Bacteremia Adenocarcinoma <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Mr. ___, You were admitted to the hospital after you were found to have a blockage of your bile ducts causing a serious infection called cholangitis. You were also found to have bacteria in your blood stream. You underwent an ERCP with a plastic stent placed. After the procedure your bilirubin continued to rise and you underwent a second ERCP to place a metal stent. For your serious infection you were started on IV antibiotics and will need to continue this for two weeks. This blockage in the bile duct was caused by a stricture. Samples of the stricture were taken and found to be cancer (adenocarcinoma). You were seen by the oncology team and have follow up with them in a few days to talk about treatment options. It was a pleasure caring for you, Your ___ Team ","SUMMARY/ASSESSMENT: Mr. ___ is a ___ male with IDDM, HTN, BPH, and metastatic clear cell RCC s/p radical L nephrectomy (___) on chemotherapy (sunitinib), with recent admission (___) for biliary stricture s/p ERCP with plastic stent placement (CBD brushing cytology non-diagnostic) and non-occlusive portal vein thrombus started on enoxaparin who presented to the ED with fever, jaundice, and confusion, found to have persistent intrahepatic biliary dilation and gallbladder sludge on ___ US s/p ERCP x2 with placement of plastic, then metal biliary stent and EUS with pathology from FNB of CBD mass consistent with new pancreatobiliary adenocardinoma. ACUTE/ACTIVE PROBLEMS: # Cholangitis # Strep spp. (likely Enterococcus) bacteremia # Adenocarcinoma pancreaticobiliary origin He presented with fever, jaundice, and mental status changes. RUQ US also showed persistent left intrahepatic biliary dilation and gallbladder sludge despite the presence of CBD stent, suggesting that the stent was non-functioning/occluded or there was some other source of obstruction. The CBD brushing cytology from his prior ERCP was non-diagnostic. He had no apparent mass in the head of the pancreas on imaging but there remained some concern for a primary pancreatobiliary tumor so he was planned to have a repeat ERCP and EUS the week he was admitted. Blood culture at ___ is growing Strep spp. He was treated with Unasyn for cholangitis as well as Strep bacteremia. BCx here grew Strep anginosus. He had an ERCP on ___ with removal of the old stent and placement of a new stent over a 2cm malignant-appearing stricture of the distal CBD. Cytology brushings were sampled. EUS was completed on which they visualized a 1.8 x 1.1 cm ill-defined hypoechoic area around the distal CBD. FNB was performed x3. Pathology was consistent with adenocarcinoma. After the plastic stent placement, his LFTs did not improve and bilirubin continued to rise. A repeat ERCP was done on ___ with removal of the plastic stent and placement of a metal stent. After this, his LFTs started to improve. His Unasyn was changed to ceftriaxone and metronidazole for ease of dosing to complete a 2 week course ___ - ___. A PICC was placed prior to discharge. TTE did not show evidence of endocarditis. # ___ on CKD Cr peaked at 1.8 from baseline 1.2. Most likely this was prerenal in the setting of cholangitis. It improved after ERCP, antibiotics, and fluid resuscitation. # PVT He was found to have a non-occlusive portal vein thrombus on MRCP during his recent hospital admission and was started on enoxaparin. HIs home enoxaparin was initially held for ERCP, then resumed. # Macrocytic anemia Macrocytic anemia is chronic. Baseline H/H appears to be ___, so he is lower than baseline. He had no signs of bleeding. Recent TSH, folate, B12, ferritin, and TIBC were wnl. Bilirubin is predominantly direct, so less likely hemolysis. Other hemolysis labs were not consistent with hemolysis. Acute on chronic anemia is perhaps ___ bone marrow suppression from sepsis. He was given 1 unit pRBCs for Hgb 7.6. # Metastatic clear cell RCC on chemotherapy He is followed at ___ by Dr. ___. He was diagnosed in ___ in workup of gross hematuria and flank pain. He underwent a laparoscopic radical right nephrectomy in ___. He was found to have metastases to the lungs, mediastinal lymph nodes, and hilar lymph nodes in ___. In ___ he was enrolled in an experimental trial and started on sunatinib. His most recent CT showed clinical response. He is currently in his regularly scheduled two weeks off on sunatinib. He had a surveillance CT on ___ which showed no evidence of local recurrence of metastatic disease in the abdomen/pelvis. # LUL pneumonia He was found to have LUL opacity on CT chest ordered for surveillance. He was also complaining of cough. He was on Unasyn while inpatient, then transitioned to ceftriaxone and metronidazole for 2 weeks total, which should cover him for pneumonia. # HTN Initially his home atenolol dose was halved due to concern for cholangitis/impending sepsis. His home amlodipine 10 mg and lisinopril 40 mg daily were also initially held. These were resumed prior to or at discharge. # Insulin-dependent DM type II At home he takes glargine 16 units qhs if his FSBG is <170 and he takes 18 units qhs if his FBSG is >170. While inpatient, he was given glaring 8 units qhs as he was not taking much PO as well as lispro SSI. CHRONIC/STABLE PROBLEMS: # Hypothyroidism - continued home levothyroxine # Depression and anxiety - continued home fluoxetine; held home cariprazine as it is non-formulary Mr. ___ is clinically stable for discharge. The total time spent today on discharge planning, counseling and coordination of care was greater than 30 minutes. ",3693,1204
10006029-DS-17,"<SEX> M <SERVICE> MEDICINE <ALLERGIES> ___ <ATTENDING> ___ <CHIEF COMPLAINT> Hypotension, ___ on CKD <MAJOR SURGICAL OR INVASIVE PROCEDURE> none <HISTORY OF PRESENT ILLNESS> Mr. ___ is a ___ male with history metastatic RCC, locally advanced cholangiocarcinoma s/p six months of gemcitabine and cisplatin, and recent diagnosis of pancreatic acinar cell carcinoma receiving liposomal irinotecan and ___ who presents with hypotension and acute on chronic renal failure. He reports that he checks his blood pressure using a machine at home every morning. His BP this morning was 79/44 about 15 minutes after taking amlodipine, atenolol, and lisinopril. This was associated with dizziness. Later in the morning repeat check was 110/70. He notes decreased appetite. He had one loose small bowel movement yesterday but otherwise no diarrhea. He presented to clinic for follow-up His vitals were Temp 97.3, BP 125/58, HR 72, RR 16, and O2 sat 100% RA. Labs were notable for Cr 2.7 from baseline Cr 1.7-1.8. He was given 2L NS and referred for direct admission to 11 ___. On arrival to the floor, patient reports shortness of breath with exertion, mild nausea without vomiting, and tingling in his hands. He denies fevers/chills, night sweats, headache, vision changes, weakness, cough, hemoptysis, chest pain, palpitations, abdominal pain, nausea/vomiting, hematemesis, hematochezia/melena, dysuria, hematuria, and new rashes. REVIEW OF SYSTEMS: A complete 10-point review of systems was performed and was negative unless otherwise noted in the HPI. PAST ONCOLOGIC HISTORY: - ___: Presented with acute onset of gross hematuria accompanied with some mild flank pain. During his workup, he was found to have a 4.8 cm mass on a CAT scan dated ___, specifically the scan describes a left renal mass with internal enhancement measuring 4.1 x 4.8 cm in size in the mid and upper pole of the left kidney. Also described was the fat-containing left inguinal hernia and left perinephric stranding. There was no adenopathy or other suspicious lesions. There is also an old sclerotic right ilial lesion and left sacral lesion. - ___: Underwent a laparoscopic hand assisted radical right nephrectomy by Dr. ___ pathology showed a renal cell carcinoma, clear cell type, ___ grade II/IV measuring 4 cm extending but not invading through the renal capsule or Gerota's fascia margins were questionably positive at the renal vein and otherwise negative. On review of pathology here at ___, the margins are described as negative including the renal vein margin. A background of global glomerulosclerosis is described. Overall, this was a T3bNxMx lesion. Postoperative imaging on ___ which was a CT torso showed no evidence of recurrent or metastatic disease. - ___: CT chest showed interval increase in prominence of mediastinal lymph nodes and minimal interval increase in multiple b/l pulmonary nodules, concerning for progression - ___: Fine needle aspirate of 11R and 11L lymph nodes, which was consistent with metastatic RCC - ___: CT Torso - mediastinal and hilar nodes and pulmonary lesions increased in size. No definite intra-abdominal sites of disease - ___: C1D1 ___, randomized to sunitinib - ___: Multiple grade ___ adverse events including thrombocytopenia (grade 2; platelet 52,000), leukopenia (grade 2; WBC 2.9), elevated lipase (grade 1), elevated amylase (grade 1; elevated at baseline), elevated ALT (grade 1), and hypothyroidism (grade 1). Mild symptoms with treatment. Continued sunitinib at 50mg daily per protocol. - ___: CT Torso: Response of mediastinal lymphadenopathy, bilateral hilar lymphadenopathy, and numerous parenchymal metastases. Stable disease by RECIST (decrease 19.1% from baseline). - ___: Sunitinib reduced to 37.5 mg daily due to erythematous rash and blistering on palms and sole of right foot. - ___: CT Torso: Decrease in pulmonary and mediastinal lesions. Stable disease by RECIST 1.1 (decrease 22.5% from baseline). - ___: CT Torso: Partial response by RECIST 1.1 (decrease 39.8% from baseline). - ___: CT Torso: Partial response by RECIST 1.1 (decrease 46.3% from baseline). - ___: CT Torso: Partial response by RECIST 1.1 (decrease 40.3% from baseline). - ___: CT Torso: Partial response by RECIST 1.1 (decrease 42.6% from baseline). - ___: CT Torso: Partial response by RECIST 1.1 (decrease 47.7% from baseline). - ___: CT torso: Ongoing partial response comments: No significant change compared to prior scan. No new lesions. - ___: CT Torso: PR by RECIST 1.1 - ___: CT Torso: PR by RECIST 1.1: -54.22% change from baseline and -10.29% change from last scan. -___: CT Torso: Partial response: -57.79% from baseline, -7.79% from nadir - ___: CT Torso shows continued partial response, no significant change compared to prior - ___: C25D1 held, admitted for biliary stricture - ___: Resumed cycle 25 day 1 - ___: Admitted for biliary stricture and cholangitis, diagnosed with pancreatobiliary adenocarcinoma and taken off study. ERCP x2 with placement of plastic, then metal biliary stent. EUS/biopsy of CBD mass showed new pancreatobiliary adenocardinoma. - ___: C1D1 Gemcitabine 1000mg/m2 Cisplatin 25 mg/m2 D1,___: C2D1 Gemcitabine 1000mg/m2 Cisplatin 25 mg/m2 D1,___: C3D1 Gemcitabine 1000mg/m2 Cisplatin 25 mg/m2 D1,___: CT torso showed stable disease - ___: C4D1 Gemcitabine 1000mg/m2 Cisplatin 25 mg/m2 D1,___: C5D1 Gemcitabine 1000mg/m2 Cisplatin 25 mg/m2 D1,___: MR liver showed ongoing inoperable disease but stable - ___: C6D1 Gemcitabine 1000mg/m2 Cisplatin 25 mg/m2 D1,15 dose modified for low counts - ___: CT torso showed stable disease - ___: C7D1 Gemcitabine 1000mg/m2 Cisplatin 25 mg/m2 D1,15 - ___: C8D1 Gemcitabine 1000mg/m2 Cisplatin 18.75 mg/m2 D1,15 reduced for CKD - ___: CT torso showed possible liver lesion and pancreatic lesion. Biopsy of liver lesion suggests poorly differentiated carcinoma. Biopsy of pancreas lesion suggests acinar cell carcinoma. - ___: C1D1 nanoliposomal irinotecan / ___ / leucovorin ___ I) <PAST MEDICAL HISTORY> PAST ONCOLOGIC HISTORY (per OMR): -___: presented with acute onset of gross hematuria accompanied with some mild flank pain. During his workup, he was found to have a 4.8 cm mass on a CAT scan dated ___, specifically the scan describes a left renal mass with internal enhancement measuring 4.1 x 4.8 cm in size in the mid and upper pole of the left kidney. Also described was the fat-containing left inguinal hernia and left perinephric stranding. There was no adenopathy or other suspicious lesions. There is also an old sclerotic right ilial lesion and left sacral lesion. -___: underwent a laparoscopic hand assisted radical right nephrectomy by Dr. ___ pathology showed a renal cell carcinoma, clear cell type, ___ grade II/IV measuring 4 cm extending but not invading through the renal capsule or Gerota's fascia margins were questionably positive at the renal vein and otherwise negative. On review of pathology here at ___, the margins are described as negative including the renal vein margin. A background of global glomerulosclerosis is described. Overall, this was a T3bNxMx lesion. Postoperative imaging on ___ which was a CT torso showed no evidence of recurrent or metastatic disease. -___: CT chest showed interval increase in prominence of mediastinal lymph nodes and minimal interval increase in multiple b/l pulmonary nodules, concerning for progression -___: Fine needle aspirate of 11R and 11L lymph nodes, which was consistent with metastatic RCC -___: CT Torso - mediastinal and hilar nodes and pulmonary lesions increased in size. No definite intra-abdominal sites of disease -___: C1D1 ___, randomized to sunitinib -___: Multiple grade ___ adverse events including thrombocytopenia (grade 2; platelet 52,000), leukopenia (grade 2; WBC 2.9), elevated lipase (grade 1), elevated amylase (grade 1; elevated at baseline), elevated ALT (grade 1), and hypothyroidism (grade 1). Mild symptoms with treatment. Continued sunitinib at 50mg daily per protocol. -___: CT Torso: Response of mediastinal lymphadenopathy, bilateral hilar lymphadenopathy, and numerous parenchymal metastases. Stable disease by RECIST (decrease 19.1% from baseline). -___: Sunitinib reduced to 37.5 mg daily due to erythematous rash and blistering on palms and sole of right foot. -___: CT Torso: Decrease in pulmonary and mediastinal lesions. Stable disease by RECIST 1.1 (decrease 22.5% from baseline). -___: CT Torso: Partial response by RECIST 1.1 (decrease 39.8% from baseline). -___: CT Torso: Partial response by RECIST 1.1 (decrease 46.3% from baseline). -___: CT Torso: Partial response by RECIST 1.1 (decrease 40.3% from baseline). -___: CT Torso: Partial response by RECIST 1.1 (decrease 42.6% from baseline). -___: CT Torso: Partial response by RECIST 1.1 (decrease 47.7% from baseline). -___: CT torso: Ongoing partial response comments: No significant change compared to prior scan. No new lesions. -___: CT Torso: PR by RECIST 1.1 -___: CT Torso: PR by RECIST 1.1: -54.22% change from baseline and -10.29% change from last scan. -___: CT Torso: partial response: -57.79% from baseline, -7.79% from nadir -___: CT Torso shows continued partial response, no significant change compared to prior PAST MEDICAL HISTORY (per OMR): 1. Clear cell kidney cancer as above. 2. Benign prostatic hypertrophy. 3. Diabetes mellitus. 4. Hypertension. 5. Hyperlipidemia. 6. History of anxiety. <SOCIAL HISTORY> ___ <FAMILY HISTORY> Colorectal cancer - mother ___ cancer - sister (dx at age ___ Liver cancer - brother ___ cell leukemia - brother ___ - father Physical ___: ADMISSION PHYSICAL EXAM: VS: Temp 97.9, BP 150/74, HR 71, RR 20, O2 sat 100% RA. GENERAL: Pleasant man, in no distress, lying in bed comfortably. HEENT: Anicteric, PERLL, OP clear. CARDIAC: RRR, normal s1/s2, no m/r/g. LUNG: Appears in no respiratory distress, clear to auscultation bilaterally, no crackles, wheezes, or rhonchi. ABD: Soft, non-tender, non-distended, normal bowel sounds. EXT: Warm, well perfused, no lower extremity edema. NEURO: A&Ox3, good attention and linear thought, CN II-XII intact. Gross strength and sensation intact. SKIN: No significant rashes. ACCESS: Right chest wall port without erythema. DISCHARGE PHYSICAL EXAM: VS: ___ 1623 Temp: 98.1 PO BP: 148/78 HR: 76 RR: 18 O2 sat: 97% O2 delivery: RA GENERAL: Pleasant man, in no distress, lying in bed comfortably. HEENT: Anicteric, PERLL, OP clear. CARDIAC: RRR, normal s1/s2, no m/r/g. LUNG: Appears in no respiratory distress, clear to auscultation bilaterally, no crackles, wheezes, or rhonchi. ABD: Soft, non-tender, non-distended, normal bowel sounds. EXT: Warm, well perfused, no lower extremity edema. NEURO: A&Ox3, good attention and linear thought, CN II-XII intact. Gross strength and sensation intact. SKIN: No significant rashes. ACCESS: Right chest wall port without erythema. <PERTINENT RESULTS> ADMISSION LABS: ___ 12: 45PM BLOOD WBC-5.6 RBC-3.04* Hgb-9.1* Hct-28.6* MCV-94 MCH-29.9 MCHC-31.8* RDW-14.6 RDWSD-49.4* Plt ___ ___ 12: 45PM BLOOD Neuts-72.3* Lymphs-17.0* Monos-8.0 Eos-2.0 Baso-0.2 Im ___ AbsNeut-4.05 AbsLymp-0.95* AbsMono-0.45 AbsEos-0.11 AbsBaso-0.01 ___ 12: 45PM BLOOD Plt ___ ___ 12: 45PM BLOOD UreaN-48* Creat-2.7* Na-135 K-4.7 Cl-102 HCO3-18* AnGap-15 ___ 12: 45PM BLOOD ALT-24 AST-31 LD(LDH)-667* AlkPhos-173* TotBili-0.4 ___ 12: 45PM BLOOD Albumin-3.9 Calcium-9.4 Phos-3.1 Mg-2.1 ___ 05: 54AM BLOOD Hapto-271* ___ 10: 41PM URINE Color-Straw Appear-Clear Sp ___ ___ 10: 41PM URINE Blood-NEG Nitrite-NEG Protein-NEG Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.0 Leuks-NEG ___ 10: 41PM URINE Hours-RANDOM Creat-78 Na-34 DISCHARGE LABS: ___ 05: 47AM BLOOD WBC-5.2 RBC-2.74* Hgb-8.3* Hct-26.1* MCV-95 MCH-30.3 MCHC-31.8* RDW-14.6 RDWSD-49.2* Plt ___ ___ 05: 47AM BLOOD Plt ___ ___ 05: 47AM BLOOD Glucose-120* UreaN-26* Creat-1.7* Na-141 K-4.9 Cl-106 HCO3-23 AnGap-12 ___ 05: 47AM BLOOD Calcium-9.0 Phos-3.9 Mg-2.0 PERTINENT STUDIES: Radiology Report RENAL U.S. Study Date of ___ 8: 18 AM COMPARISON: CT abdomen and pelvis ___ FINDINGS: The left kidney is surgically absent. A cortical defect is re-demonstrated in the interpolar region of the right kidney. There is a 1.3 cm exophytic simple cyst arising from the lower pole of the right kidney, stable from the prior CT. There is no hydronephrosis or stones bilaterally. Normal cortical echogenicity and corticomedullary differentiation are seen bilaterally. Right kidney: 11.5 cm The bladder is moderately well distended and normal in appearance. IMPRESSION: No hydronephrosis. Normal cortical echogenicity and corticomedullary differentiation within the remaining right kidney. Radiology Report CHEST (PORTABLE AP) Study Date of ___ 7: 22 ___ COMPARISON: CT is available from ___. FINDINGS: Port terminates in the mid superior vena cava. Cardiac, mediastinal and hilar contours appear stable. There is no pleural effusion or pneumothorax. Lungs appear clear. IMPRESSION: No evidence of acute cardiopulmonary process. MICROBIOLOGY: ___ 10: 41 pm URINE Source: ___. **FINAL REPORT ___ URINE CULTURE (Final ___: NO GROWTH. <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. amLODIPine 10 mg PO DAILY 2. Ascorbic Acid ___ mg PO DAILY 3. Atenolol 50 mg PO DAILY 4. Levothyroxine Sodium 100 mcg PO DAILY 5. LORazepam 0.5 mg PO DAILY: PRN anxiety/insomnia 6. Multivitamins 1 TAB PO DAILY 7. Omeprazole 20 mg PO DAILY 8. Ondansetron 8 mg PO Q8H: PRN nausea/vomiting 9. Prochlorperazine 5 mg PO Q8H: PRN nausea/vomiting 10. Tamsulosin 0.4 mg PO QHS 11. Vitamin D 5000 UNIT PO DAILY 12. GlipiZIDE 2.5 mg PO BID 13. Lisinopril 10 mg PO DAILY 14. Fenofibrate 48 mg PO DAILY 15. Amoxicillin ___ mg PO PREOP 16. Citalopram 20 mg PO DAILY 17. Glargine 16 Units Bedtime 18. Rivaroxaban 10 mg PO DAILY 19. Acetaminophen ___ mg PO Q8H: PRN Pain - Mild/Fever 20. Cyanocobalamin 1000 mcg PO DAILY <DISCHARGE MEDICATIONS> 1. Acetaminophen ___ mg PO Q8H: PRN Pain - Mild/Fever 2. Ascorbic Acid ___ mg PO DAILY 3. Citalopram 20 mg PO DAILY 4. Cyanocobalamin 1000 mcg PO DAILY 5. Fenofibrate 48 mg PO DAILY 6. Glargine 16 Units Bedtime 7. Levothyroxine Sodium 100 mcg PO DAILY 8. LORazepam 0.5 mg PO DAILY: PRN anxiety/insomnia 9. Multivitamins 1 TAB PO DAILY 10. Omeprazole 20 mg PO DAILY 11. Ondansetron 8 mg PO Q8H: PRN nausea/vomiting 12. Prochlorperazine 5 mg PO Q8H: PRN nausea/vomiting 13. Rivaroxaban 10 mg PO DAILY 14. Tamsulosin 0.4 mg PO QHS 15. Vitamin D 5000 UNIT PO DAILY 16. HELD- amLODIPine 10 mg PO DAILY This medication was held. Do not restart amLODIPine until you discuss with your primary care doctor. 17. HELD- Atenolol 50 mg PO DAILY This medication was held. Do not restart Atenolol until you discuss with your primary care doctor. 18. HELD- GlipiZIDE 2.5 mg PO BID This medication was held. Do not restart GlipiZIDE until you follow up with your PCP. 19. HELD- Lisinopril 10 mg PO DAILY This medication was held. Do not restart Lisinopril until you discuss with your primary care doctor. <DISCHARGE DISPOSITION> Home With Service Facility: ___ <DISCHARGE DIAGNOSIS> Acute Issues: ========== Hypotension Acute on chronic CKD Secondary Issues: - Hypertension CKD <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> -===== DISCHARGE INSTRUCTIONS -===== Dear Mr. ___, It was a pleasure caring for you at ___ ___. WHY WAS I IN THE HOSPITAL? - You were admitted for low blood pressures WHAT HAPPENED TO ME IN THE HOSPITAL? - We gave you fluids through an IV, and we held your blood pressure medications. Your blood pressures eventually improved to normal range. - We monitored your kidney function which improved with fluids and holding your blood pressure medications. WHAT SHOULD I DO AFTER I LEAVE THE HOSPITAL? - Continue to take all your medicines and keep your appointments. - Do not take any of your blood pressure medications until you discuss with your primary care doctor. We wish you the best! Sincerely, Your ___ Team ","Brief hospital summary: ======================= Mr. ___ is a ___ male with history metastatic RCC, locally advanced cholangiocarcinoma s/p six months of gemcitabine and cisplatin, and recent diagnosis of pancreatic acinar cell carcinoma receiving liposomal irinotecan and ___ who presents with hypotension and acute on chronic renal failure. Hypotension and ___ resolved with IVFs and holding BP medications. He was discharged in stable condition. Transitional issues: ============== [] Hgb on discharge 8.3. [] Held home lisinopril, atenolol, and amlodipine given concern for dehydration and hypotension. BPs improved during course of hospital stay. [] Please titrate BP medications on outpatient basis as clinically indicated [] Cr on discharge 1.7 (baseline appears to be 1.4-1.7). Please recheck BMP within one week of discharge to trend Cr. [] Glipizide held on discharge due to increase risk of hypoglycemia. Would consider d/c vs restart based on renal function Acute issues: ========== # Hypotension: Likely combination of poor PO intake and dehydration in setting of poor appetite and nausea from new chemotherapy regimen while continuing multiple home BP medications. Given IVF and held BP medications with resolution of hypotension. Orthostatics prior to discharge unremarkable. # ___ on CKD: Likely prerenal in setting of poor PO intake. FeNa <1% consistent with diagnosis. Held lisinopril which we will continue to hold upon discharge. Renal ultrasound without evidence of hydronephrosis. # Anemia: Likely secondary to chemotherapy and malignancy. Hemolysis labs reassuring. No clinical evidence of bleeding. Hgb on discharge 8.3. Chronic issues: =============== # Fatigue: Likely from anemia and chemotherapy side effect. Stable during course of hospitalization # Pancreatic Acinar Cell Carcinoma: # Cholangiocarcinoma: # Secondary Neoplasm of Liver: Currently on palliative liposomal ___. Follow-up with Dr. ___ # Metastatic Renal Cell Carcinoma: # Secondary Neoplasm of Lung: He is on a treatment hold due to the management of his cholangiocarcinoma and now pancreatic cancer. # Portal Vein Thrombus: continued home rivaroxaban # BPH: continued home Flomax # Hypothyroidism: continued home levothyroxine # Diabetes: continued home lantus, started humalog ISS, and held home glipizide while in house and on discharge. # Anxiety: continued home citalopram ",4796,546
10006029-DS-18,"<SEX> M <SERVICE> MEDICINE <ALLERGIES> mirtazapine <ATTENDING> ___. <CHIEF COMPLAINT> Nausea and vomiting <MAJOR SURGICAL OR INVASIVE PROCEDURE> None <HISTORY OF PRESENT ILLNESS> Mr. ___ is a pleasant ___ w/ ID-T2DM, HTN, DL, BPH, and three concurrent cancers (1) metastatic clear cell RCC, s/p radical L nephrectomy in ___, found to have pulmonary, mediastinal, and hilar mets ___ (now off sunitinib w/o disease progression), (2) metastatic cholangiocarcinoma s/p 6 months gem/cisplatin, who subsequently had new (3) acinar cell carcinoma of the pancreas, now on ___ I regimen of liposomal irinotecan and ___, last dose ___, p/w nausea/vomiting that started last evening. Patient was interviewed with his daughter at bedside and she helped provide collateral. They note that he has had n/v the past few weeks, especially with chemo. He had poor appetite as well since chemo. The vomiting seemed to be intermittent, sometimes able to tolerate PO. Last night he developed abdominal pain and vomiting. He had regular bowel movements last night. This morning he had diarrhea but no further episodes of vomiting and his abdominal pain improved and nausea improved. He had special K cereal with skim milk today and tolerated it well. He called into his ___ clinic where he was seen this am. There he had 2L NS and obtained a KUB which suggested SBO. He is only a little tender in the epigastrium on exam. He was then admitted to 12R to the oncology service. <PAST MEDICAL HISTORY> PAST ONCOLOGIC HISTORY (per OMR): -___: presented with acute onset of gross hematuria accompanied with some mild flank pain. During his workup, he was found to have a 4.8 cm mass on a CAT scan dated ___, specifically the scan describes a left renal mass with internal enhancement measuring 4.1 x 4.8 cm in size in the mid and upper pole of the left kidney. Also described was the fat-containing left inguinal hernia and left perinephric stranding. There was no adenopathy or other suspicious lesions. There is also an old sclerotic right ilial lesion and left sacral lesion. -___: underwent a laparoscopic hand assisted radical right nephrectomy by Dr. ___ pathology showed a renal cell carcinoma, clear cell type, ___ grade II/IV measuring 4 cm extending but not invading through the renal capsule or Gerota's fascia margins were questionably positive at the renal vein and otherwise negative. On review of pathology here at ___, the margins are described as negative including the renal vein margin. A background of global glomerulosclerosis is described. Overall, this was a T3bNxMx lesion. Postoperative imaging on ___ which was a CT torso showed no evidence of recurrent or metastatic disease. -___: CT chest showed interval increase in prominence of mediastinal lymph nodes and minimal interval increase in multiple b/l pulmonary nodules, concerning for progression -___: Fine needle aspirate of 11R and 11L lymph nodes, which was consistent with metastatic RCC -___: CT Torso - mediastinal and hilar nodes and pulmonary lesions increased in size. No definite intra-abdominal sites of disease -___: C1D1 ___, randomized to sunitinib -___: Multiple grade ___ adverse events including thrombocytopenia (grade 2; platelet 52,000), leukopenia (grade 2; WBC 2.9), elevated lipase (grade 1), elevated amylase (grade 1; elevated at baseline), elevated ALT (grade 1), and hypothyroidism (grade 1). Mild symptoms with treatment. Continued sunitinib at 50mg daily per protocol. -___: CT Torso: Response of mediastinal lymphadenopathy, bilateral hilar lymphadenopathy, and numerous parenchymal metastases. Stable disease by RECIST (decrease 19.1% from baseline). -___: Sunitinib reduced to 37.5 mg daily due to erythematous rash and blistering on palms and sole of right foot. -___: CT Torso: Decrease in pulmonary and mediastinal lesions. Stable disease by RECIST 1.1 (decrease 22.5% from baseline). -___: CT Torso: Partial response by RECIST 1.1 (decrease 39.8% from baseline). -___: CT Torso: Partial response by RECIST 1.1 (decrease 46.3% from baseline). -___: CT Torso: Partial response by RECIST 1.1 (decrease 40.3% from baseline). -___: CT Torso: Partial response by RECIST 1.1 (decrease 42.6% from baseline). -___: CT Torso: Partial response by RECIST 1.1 (decrease 47.7% from baseline). -___: CT torso: Ongoing partial response comments: No significant change compared to prior scan. No new lesions. -___: CT Torso: PR by RECIST 1.1 -___: CT Torso: PR by RECIST 1.1: -54.22% change from baseline and -10.29% change from last scan. -___: CT Torso: partial response: -57.79% from baseline, -7.79% from nadir -___: CT Torso shows continued partial response, no significant change compared to prior PAST MEDICAL HISTORY (per OMR): 1. Clear cell kidney cancer as above. 2. Benign prostatic hypertrophy. 3. Diabetes mellitus. 4. Hypertension. 5. Hyperlipidemia. 6. History of anxiety. <SOCIAL HISTORY> ___ <FAMILY HISTORY> Colorectal cancer - mother ___ cancer - sister (dx at age ___ Liver cancer - brother ___ cell leukemia - brother ___ - father Physical ___: ADMISSION EXAM: VITAL SIGNS: 98.4 PO 112 / 71 89 18 97 Ra General: NAD, Resting in bed comfortably with daughter at bedside ___: + xerostomia, + healing dried cold sore the L lower lip CV: RR, NL S1S2 no S3S4 No MRG PULM: CTAB, No C/W/R, No respiratory distress ABD: scant bowel sounds, mostly tympanic, soft, minimally tender in epigastrium, no peritoneal signs, no significant distention LIMBS: WWP, no ___, no tremors SKIN: No notable rashes on trunk nor extremities NEURO: Face symmetric, speech clear and fluent, strength b/l ___ intact PSYCH: Thought process logical, linear, future oriented ACCESS: R Chest port site intact w/o overlying erythema, accessed and dressing C/D/I DISCHARGE EXAM: ___ 0910 Temp: 97.4 PO BP: 136/89 HR: 102 RR: 18 O2 sat: 95% O2 delivery: RA FSBG: 269 ___ 0918 Pain Score: ___ GENERAL: appears uncomfortable, weaker and pale. EYES: Anicteric ENT: MMM, no lesions noted CV: RRR, no murmur. Right chest port. RESP: anterior exam, quiet lungs, normal respiratory effort. GI: Abdomen soft, mild distention, G-tube in place. MSK: no edema or swelling NEURO: sleepy, but awakens with gentle touch, face symmetric, speech fluent, moves all limbs, answers all questions, fully oriented. PSYCH: Pleasant, appropriate affect <PERTINENT RESULTS> ADMISSION LABS: ___ 01: 15PM BLOOD WBC-3.5* RBC-2.83* Hgb-8.4* Hct-26.9* MCV-95 MCH-29.7 MCHC-31.2* RDW-17.2* RDWSD-58.1* Plt ___ ___ 01: 15PM BLOOD Neuts-74* Lymphs-12* Monos-13 Eos-0* ___ Metas-1* AbsNeut-2.59 AbsLymp-0.42* AbsMono-0.46 AbsEos-0.00* AbsBaso-0.00* ___ 05: 41AM BLOOD ___ PTT-25.9 ___ ___ 01: 15PM BLOOD UreaN-26* Creat-1.8* Na-132* K-4.4 Cl-95* HCO3-22 AnGap-15 ___ 01: 15PM BLOOD ALT-20 AST-28 LD(___)-861* AlkPhos-150* TotBili-0.4 ___ 01: 15PM BLOOD Albumin-3.3* Calcium-9.1 Phos-3.9 Mg-2.2 -====== DISCHARGE LABS: ___ 06: 25AM BLOOD WBC-19.0* RBC-3.27* Hgb-9.4* Hct-31.4* MCV-96 MCH-28.7 MCHC-29.9* RDW-17.6* RDWSD-59.2* Plt ___ ___ 06: 25AM BLOOD Glucose-176* UreaN-35* Creat-1.5* Na-141 K-4.8 Cl-100 HCO3-22 AnGap-19* ___ 06: 25AM BLOOD ALT-24 AST-79* LD(LDH)-1713* AlkPhos-184* TotBili-0.8 ___ 06: 25AM BLOOD Calcium-9.0 Phos-4.0 Mg-2.1 -====== MICROBIOLOGY: ___ 3: 07 am STOOL CONSISTENCY: LOOSE Source: Stool. **FINAL REPORT ___ C. difficile PCR (Final ___: NEGATIVE. ___ 3: 07 am STOOL CONSISTENCY: LOOSE Source: Stool. FECAL CULTURE - R/O E.COLI 0157: H7 (Pending): -====== ABDOMINAL X-RAY ___: FINDINGS: There are multiple centrally located distended loops of small bowel, concerning for small bowel obstruction. There is no free intraperitoneal air. Osseous structures are unremarkable. Re-demonstrated is a common bile duct extent in grossly unchanged position compared to the prior study given differences in techniques. Two small linear hyperdensities noted over the midline adjacent to the biliary stent, likely surgical clips. IMPRESSION: Imaging findings concerning for small-bowel obstruction. Further evaluation with CT abdomen and pelvis, with iv contrast, is recommended. CT ABDOMEN/PELVIS WITH ORAL CONTRAST ___: 1. Interval increase in size of pancreatic head mass, now measuring up to 8.0 cm, previously 6.0 cm. 2. Numerous metastatic lesions throughout the liver, increased in size and number. 3. Interval worsening of retroperitoneal lymphadenopathy. 4. Wall thickening of an approximately 20 cm segment of distal and terminal ileum with adjacent fat stranding, compatible with infectious or inflammatory ileitis. No small bowel obstruction. Oral contrast is seen to the rectum. 5. New 3 mm pulmonary nodule in the left lower lobe. <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Acetaminophen ___ mg PO Q8H: PRN Pain - Mild/Fever 2. Citalopram 20 mg PO DAILY 3. Levothyroxine Sodium 100 mcg PO DAILY 4. LORazepam 0.5 mg PO DAILY: PRN anxiety/insomnia 5. Multivitamins 1 TAB PO DAILY 6. Omeprazole 20 mg PO DAILY 7. Prochlorperazine 5 mg PO Q8H: PRN nausea/vomiting 8. Rivaroxaban 10 mg PO DAILY 9. Tamsulosin 0.4 mg PO QHS 10. Vitamin D 5000 UNIT PO DAILY 11. Ascorbic Acid ___ mg PO DAILY 12. Cyanocobalamin 1000 mcg PO DAILY 13. Fenofibrate 48 mg PO DAILY 14. Ondansetron 8 mg PO Q8H: PRN nausea/vomiting 15. GlipiZIDE 2.5 mg PO BID 16. Abreva (docosanol) 10 % topical ___ times daily prn cold sore <DISCHARGE MEDICATIONS> 1. Dexamethasone 4 mg PO DAILY RX *dexamethasone 4 mg 1 tablet(s) by mouth once a day Disp #*5 Tablet Refills: *0 2. Morphine Sulfate (Concentrated Oral Solution) 20 mg/mL ___ mg PO Q2H: PRN Breakthrough pain RX *morphine concentrate 100 mg/5 mL (20 mg/mL) 0.25-0.75 ml by mouth q2h Refills: *0 3. OLANZapine (Disintegrating Tablet) 5 mg PO BID: PRN nausea not addressed by ondansetron RX *olanzapine 5 mg 1 tablet(s) by mouth twice a day Disp #*10 Tablet Refills: *0 4. Abreva (docosanol) 10 % topical ___ times daily prn cold sore 5. Acetaminophen ___ mg PO Q8H: PRN Pain - Mild/Fever 6. Ascorbic Acid ___ mg PO DAILY 7. Citalopram 20 mg PO DAILY 8. Cyanocobalamin 1000 mcg PO DAILY 9. Fenofibrate 48 mg PO DAILY 10. Levothyroxine Sodium 100 mcg PO DAILY 11. LORazepam 0.5 mg PO DAILY: PRN anxiety/insomnia 12. Multivitamins 1 TAB PO DAILY 13. Omeprazole 20 mg PO DAILY 14. Ondansetron 8 mg PO Q8H: PRN nausea/vomiting 15. Prochlorperazine 5 mg PO Q8H: PRN nausea/vomiting 16. Rivaroxaban 10 mg PO DAILY 17. Tamsulosin 0.4 mg PO QHS 18. HELD- GlipiZIDE 2.5 mg PO BID This medication was held. Do not restart GlipiZIDE until someone tells you to <DISCHARGE DISPOSITION> Home With Service Facility: ___ ___ Diagnosis: Abdominal pain Nausea with vomiting Diarrhea Ileitis Metastatic cholangiocarcinoma Acinar cell pancreatic cancer Metastatic renal cell carcinoma <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Mr. ___, You were hospitalized with abdominal pain. Despite the fact that you initially improved, you subsequently worsened and the symptoms were all related to progressive cancer. We talked about the meaning of this with you and your family and you are opting to go home with hospice care. We put a gastric tube in to help alleviate any symptoms of obstruction. You should keep the gastric tube hooked up to low suction overnight and when you are not doing anything during the day. When you are active, and for ___ minutes after taking oral medications, you should clamp the tube. You were continued on most of your oral medications that you take at home. Over time, you may decide to discontinue these medications if they are not necessary for your comfort (for instance, your vitamin supplements), and can discuss this with your hospice team. The hospice team will help you manage your symptoms at home. We wish you the best of luck going forward. Thanks, Your ___ Team ","Mr. ___ is a ___ year old male with type 2 diabetes, hypertension, hyperlipidemia, BPH, and three concurrent cancers: (1) metastatic clear cell renal cell carcinoma, s/p radical L nephrectomy in ___, found to have pulmonary, mediastinal, and hilar metastases ___ (now off sunitinib without disease progression), (2) metastatic cholangiocarcinoma s/p 6 months gem/cisplatin, who subsequently had new (3) acinar cell carcinoma of the pancreas, now on ___ I regimen of liposomal irinotecan and ___, last dose ___, who went to ___ clinic with nausea, vomiting, abdominal pain and was found to have possible SBO on KUB. This led to direct admission for workup. CT abdomen/pelvis with oral contrast showed no evidence of bowel obstruction, but showed findings of ileitis, as well as increasing pancreatic mass size and new hepatic lesions all concerning for progression of his cancer. While hospitalized, he developed recurrent symptoms of nausea, vomiting after an initial improvement, and then developed signs and symptoms of frank obstruction likely related to his pancreatic mass or peritoneal carcinomatosis. No further imaging was pursued. An NG tube was placed for decompression and he had significant improved symptoms. He subsequently underwent palliative venting G-tube is a transition to hospice. ACUTE/ACTIVE PROBLEMS: # Abdominal pain # Nausea and vomiting, with malignant obstruction, in setting of progressive acinar cell cancer, and large pancreatic mass # Acinar cell pancreatic cancer He has been off sutinib as his other cancers are being managed and his pulm/hepatic mets have been stable. He is not yet due for restaging imaging. He is due for ___, LV, liposomal irinotecan. His oncologists are Dr ___ ___ Dr ___ seen on ___. CT abdomen/pelvis showed increased size of pancreatic head mass (from 6.0 to 8.0 cm), numerous metastatic liver lesions (increased in size and number), interval worsening of retroperitoneal lymphadenopathy, and new 3 mm pulmonary nodule in the left lower lobe. He had been having nausea and vomiting likely related to chemo for several weeks, but then developed diarrhea, vomiting, and abdominal pain the night prior to presentation. His symptoms have resolved. He had 2 watery bowel movements after admission. KUB had showed multiple centrally located distended loops of small bowel, concerning for small bowel obstruction. He has not had prior bowel obstruction. Since he has only 1 kidney with a Cr of 1.6, initial CT was done without IV contrast. CT abdomen/pelvis with oral contrast showed no evidence of bowel obstruction, but showed wall thickening of distal and terminal ileum with adjacent fat stranding, compatible with infectious or inflammatory ileitis. Since he was afebrile with improved symptoms, empiric antibiotics were not started. C. difficile was negative as was ecoli. He was initially treated with bowel rest and IV fluids, then diet was advanced. The CT scan also showed increasing size of pancreatic mass, enlarging and new hepatic lesions, new left lung nodule, worsening retroperitoneal lymphadenopathy, all concerning for progression of disease. Given this new complication of his pancreatic cancer, family meeting was held on ___, with a decision to pursue hospice care at home given no other therapeutic options. His prognosis was given as weeks. He was transitioned to liquid concentrated morphine for pain, as well as lorazepam for anxiety, and dexamethasone for nausea. Oral medications were given after his PEG was placed, with clear instructions on how to take them. This included dexamethasone, concentrated morphine, and olanzapine. Other home medications were continued at this time, with decisions to stop these medications going forward to occur with hospice services and Dr. ___, patient's oncologist. MOLST form was completed. # Acute on chronic anemia: Baseline hemoglobin is ___. Hemoglobin was low at 6.7 on ___, so he was transfused 1 unit PRBCs with improvement to 8.3. He had no obvious signs of acute blood loss anemia and stool has not appeared grossly bloody or signs of melena evident. His blood count remained stable. Labs were not checked after goals of care were changed. CHRONIC/STABLE PROBLEMS: # Chronic kidney disease: Creatinine is 1.4-1.6 at baseline. He had recent ___ with Cr of 2.2 on ___ and 1.8 on admission, likely due to dehydration. Renal function returned to baseline after getting IV fluids then rose after he likely developed recurrent dehydration. As stated above labs were not rechecked after goals of care change. # History of Portal Vein Thrombus: He was continued on home Rivaroxaban 10mg daily, except for initially being held while NPO. This was continued for now, but should be stopped if decided not consistent with comfort going forward. # Severe protein-calorie malnutrition: He has low albumin and reported low oral intake due to nausea, vomiting, and abdominal pain, which has been ongoing off/on for weeks, likely due to chemo and his known cancers. Consulted nutrition who recommended low fiber diet with Ensure Clear early in hospitalization, but given transition to hospice, he was recommended to have diet as tolerated. # Type 2 diabetes: His glargine was initially decreased while NPO on IV D5LR, then stopped and treated with sliding scale insulin only and Glipizide was held. On discharge, glipizide was continued. TRANSITIONS OF CARE ------------------- # Follow-up: patient is being discharged to hospice. Dr. ___ ___ be the physician responsible for decisions going forward. # Code status: DNR/DNI, comfort-focused care ",3521,1232
10006053-DS-10,"<SEX> M <SERVICE> MEDICINE <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> <CHIEF COMPLAINT> GIB Reason for MICU transfer: active GIB <MAJOR SURGICAL OR INVASIVE PROCEDURE> EGD with banding TIPS <HISTORY OF PRESENT ILLNESS> Mr. ___ is a ___ y/o man with h/o EtOH cirrhosis, currently drinking, c/b recurrent ascites requiring weekly taps, encephalopathy, and esophageal varices who presented to OSH intoxicated with BRBPR and hematemesis yesterday. Initially stabilized with 2 units pRBCs. hct 24, plt 96, INR 1.8. Alcohol level 0.195. GI performed EGD under concious sedation and saw fresh blood in stomach and esophagus, banded 3 varices. Ocreotide and protonix drips started. RUQ showed only ascites and cirrhotic liver, PV not mentioned. After endoscope, started having active hematemasis and was then intubated. Repeat EGD saw again lots of blood but did not believe varices had new bleeding. Injected sodium tetradisusulfate into the varix. GI recommended transfer. As patient prepped for transfer, he started having active bleeding from multiple orfices including mouth, rectum, and nose. Started on 2 additional pressors to include vasopressin, levophen, and neo and ___ was placed. NGT 800 cc prior to ___. Additional pRBC, platelets and FFP were given for total of 15 units pRBC, 10 units FFP, 6 units platelets. On arrival to the MICU, initials vitals were AF 114 110/62 32 100% on ventilator set at Vt 480 RR 24 FiO2 80% PEEP 12. He was actively bleeding at the mouth. Intial ABG showed pH 7.04/53/137, lactate 11.9. hct 24, plt 71, INR 1.9, Fibrinogen 72. Given 1 unit cryo. GI and ___ were consulted and came to bedside for evaluation. <PAST MEDICAL HISTORY> EtOH cirrhosis alcohol abuse h/o hypokalemia and hypomag <SOCIAL HISTORY> ___ <FAMILY HISTORY> non-contributory <PHYSICAL EXAM> ADMISSION EXAM -== GENERAL: intubated, sedated HEENT: Sclera icteric, MMM, oropharynx clear, blood at oropharynx, ___ tube in place NECK: supple, no LAD LUNGS: Clear to auscultation bilaterally, no wheezes, rales, rhonchi CV: tachycardic, normal S1 S2, no murmurs, rubs, gallops ABD: soft, distended, caput madusae visible, bowel sounds present EXT: Warm, well perfused, 2+ pulses, trace edema bilaterally NEURO: intubated and sedated DEATH NOTE =========== Cardiac sounds absent. Lung sounds absent without chest rise. Neuro exam without withdrawal to painful stimuli and absent corneal reflexes. <PERTINENT RESULTS> ADMISSION LABS -== ___ 11: 36PM BLOOD WBC-9.7 RBC-2.57* Hgb-7.8* Hct-24.0* MCV-94 MCH-30.2 MCHC-32.3 RDW-14.9 Plt Ct-71* ___ 11: 36PM BLOOD Neuts-82.6* Lymphs-7.4* Monos-8.6 Eos-1.2 Baso-0.2 ___ 11: 36PM BLOOD ___ PTT-71.7* ___ ___ 11: 36PM BLOOD Fibrino-72* ___ 11: 36PM BLOOD Glucose-201* UreaN-12 Creat-1.7* Na-147* K-6.3* Cl-110* HCO3-14* AnGap-29* ___ 11: 36PM BLOOD ALT-115* AST-729* LD(LDH)-1168* CK(CPK)-1391* AlkPhos-36* Amylase-117* TotBili-2.0* DirBili-0.5* IndBili-1.5 ___ 11: 36PM BLOOD CK-MB-42* MB Indx-3.0 cTropnT-0.02* ___ 11: 36PM BLOOD Albumin-2.0* Calcium-8.2* Phos-9.3* Mg-1.8 ___ 08: 41AM BLOOD Hapto-<5* ___ 11: 36PM BLOOD TSH-0.96 ___ 11: 55PM BLOOD ___ Temp-35.6 pO2-137* pCO2-53* pH-7.04* calTCO2-15* Base XS--17 ___ 11: 55PM BLOOD Glucose-179* Lactate-11.9* K-6.1* ___ 11: 55PM BLOOD freeCa-0.71* IMAGING STUDIES -== CXR ___: Tube is projecting over the mid mediastinum and might potentially represent ___ tube. Heart size and mediastinum are grossly within normal limits. The ET tube tip is approximately 4.5 cm above the carina. Left basal consolidation is most likely associated with pleural effusion. Right lung is essentially clear. TIPS ___: IMPRESSION: Successful intrahepatic portosystemic shunt placement with decrease in porto-systemic pressure gradient from 24 to 6 mm Hg. Removal of 5 L of ascites. Placement of a left internal jugular triple-lumen catheter. Placement of a right internal jugular trauma line (triple lumen). RECOMMENDATION: If esophageal bleeding continues, consider further treatment with ___ embolization of esophageal varices. ___ LIVER OR GALLBLADDER US - 1. Patent TIPS shunt. 2. Cirrhotic appearing liver with right pleural effusion and moderate ascites. ___ CHEST (PORTABLE AP) - As compared to the previous radiograph, the patient has received a ___ device. The endotracheal tube as well as the left and right central venous access lines are constant. Mildly increasing bilateral pleural effusions and signs of mild-to-moderate fluid overload. Moderate cardiomegaly is constant. No pneumothorax. <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. This patient is not taking any preadmission medications <DISCHARGE MEDICATIONS> Not applicable. <DISCHARGE DISPOSITION> Expired <DISCHARGE DIAGNOSIS> Not applicable. <DISCHARGE CONDITION> Not applicable. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Not applicable. ","___ with h/o EtOH cirrhosis, currently drinking, c/b recurrent ascites requiring weekly taps, encephalopathy, and esophageal varices who presented to an outside hospital intoxicated with BRBPR and hematemesis requiring transfusion and EGD with significant esophageal variceal bleeding requiring ___ pressure balloon placement. On arrival, his bleeding temporarily stabilized and then subsequently resumed with impending DIC and multiorgan failure. Unfortunately he expired despite our resuscitation efforts. ",1571,99
10006131-DS-14,"<SEX> M <SERVICE> MEDICINE <ALLERGIES> Patient recorded as having No Known Allergies to Drugs <ATTENDING> ___. <CHIEF COMPLAINT> ASA overdose <MAJOR SURGICAL OR INVASIVE PROCEDURE> HD <HISTORY OF PRESENT ILLNESS> Initial history and physical is as per ICU team . This is a ___ year-old male with a history of previous suicide attempt who is transferred to ___ from ___ after presenting there following aspirin overdose. He took 200 pills of ASA 325mg in a suicide attempt and then called his brother. He was taken to ___. ASA level on presentation to OSH was 21.7 and then rose to 51. Bicarb gtt was initiated. Reports that this was a suicide attempt sparked by the poor economy, rising gas prices, etc. He currently denies SI/HI and states that he wants to live. . In the ED, initial vital were T: 98.2 BP: 139/107 HR: 103 RR: 20 O2sat: 98%RA. Urine and serum tox screens were negative. Repeat aspirin level here was 105. Creatinine was elevated to 1.3. VBG was 7.43/35/48. Bicarb drip was continued. Renal was consulted who recommended hemodialysis and HD line was placed by renal team upon presentation to the FICU. . ROS: + Tinnitus. He currently denies fevers/chills. He is diaphoretic and feels antsy. He denies LH/dizziness. No changes in vision. No CP/SOB, no cough. No abdominal pain/N/V. No dysuria/urinary frequentcy. No rahses. <PAST MEDICAL HISTORY> Previous suicide attempt appox ___ yrs ago <SOCIAL HISTORY> ___ <FAMILY HISTORY> Non contributory <PHYSICAL EXAM> Tmax: 36.1 C (96.9 F)Tcurrent: 35.9 C (96.7 F) HR: 96 (96 - 132) bpm BP: 103/41(53) {93/41(53) - 146/89(98)} mmHg RR: 27 (19 - 27) insp/min SpO2: 97% Heart rhythm: SR (Sinus Rhythm)Height: 67 Inch GEN: Diaphoretic, jittery, anxious HEENT: EOMI, PERRL, sclera anicteric, no epistaxis or rhinorrhea, MMM, OP Clear NECK: No JVD, carotid pulses brisk, no bruits, no cervical lymphadenopathy, trachea midline COR: Sinus tachycardia, no M/G/R, normal S1 S2, radial pulses +2 PULM: Lungs clear anteriorly, no W/R/R ABD: Soft, NT, ND, +BS, no HSM, no masses EXT: No C/C/E, no palpable cords NEURO: alert, oriented to person, place, and time. CN II  XII grossly intact. Moves all 4 extremities. Strength and sensation to soft touch grossly intact. SKIN: No jaundice, cyanosis, or gross dermatitis. No ecchymoses. <PERTINENT RESULTS> On admission: ___ 09: 45PM BLOOD WBC-8.1 RBC-5.30 Hgb-16.6 Hct-46.1 MCV-87 MCH-31.4 MCHC-36.1* RDW-13.9 Plt ___ ___ 09: 45PM BLOOD Glucose-126* UreaN-14 Creat-1.3* Na-141 K-4.2 Cl-101 HCO3-22 AnGap-22 ___ 09: 45PM BLOOD ALT-29 AST-26 LD(LDH)-193 CK(CPK)-182* AlkPhos-70 TotBili-0.2 ___ 09: 45PM BLOOD Albumin-4.9* Calcium-9.1 Phos-3.7 Mg-2.4 ___ 09: 45PM BLOOD ASA-105* Ethanol-NEG Acetmnp-NEG Bnzodzp-NEG Barbitr-NEG Tricycl-NEG ___ 03: 03AM BLOOD HCV Ab-NEGATIVE <MEDICATIONS ON ADMISSION> None <DISCHARGE MEDICATIONS> 1. Nicotine 14 mg/24 hr Patch 24 hr Sig: One (1) Patch 24 hr Transdermal DAILY (Daily). 2. Polyethylene Glycol 3350 100 % Powder Sig: One (1) dose PO daily prn as needed for constipation. 3. Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day). 4. Senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a day) as needed. 5. Multivitamin Tablet Sig: One (1) Tablet PO DAILY (Daily). <DISCHARGE DISPOSITION> Extended Care <DISCHARGE DIAGNOSIS> Aspirin Overdose, suicide attempt <DISCHARGE CONDITION> Good <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> -Transfer to inpatient psychiatric unit for further care -Follow up with PCP after discharge. ","This is a ___ year-old male without significant PMH who presents following suicide attempt with aspirin overdose. . # Aspirin overdose/suicide attempt: Pt had no signs or symptoms of bleed and remain afebrile from time of admission until transfer out of the unit. ASA level on admission was 105 and trended down to 15 at time of transfer to the floor. Pt initially had AG met acidosis with compensatory resp alkalosis. He was initially placed on a bicarb gtt but this was d/c'd ___. Toxicology and renal were consulted and pt had HD line placed followed by HD on ___. HD line is to be removed by renal on ___. Psych was consulted and recommended inpatient psychiatry unit placement. He was watched a 1:1 sitter on the floor. At time of transfer to the inpatieent floor, he denied any SI or other thoughts of hurting himself. He remaineed medically stable and will be transferred to ___ 4 for further psychiactric care. . # ARF: Cr was 1.6 at admission. ASA can cause interstitial nephritis, papillary necrosis, proteinuria. Creatinine now down to 1.0 from 1.3 on admission, within normal range . # FEN: Regular diet. . # Code: FULL. # Dispo: transfer to inpatient psychiatry unit ",1176,286
10006131-DS-15,"<SEX> M <SERVICE> PSYCHIATRY <ALLERGIES> Patient recorded as having No Known Allergies to Drugs <ATTENDING> ___. <CHIEF COMPLAINT> ""I am depressed, I tried to OD on Aspirin when I was drunk"" <MAJOR SURGICAL OR INVASIVE PROCEDURE> activated charcoal for ASA overdose, hemodialysis as well <HISTORY OF PRESENT ILLNESS> Pt is a ___ y.o. man transferreed from ___ where he was taken after SA by OD on ASA. Pt is unable to give significant details re: events of yesterday, but reports he drank ___ beers and ___ shots of vodka, then took 200 325mg ASA. He then called his brother. Brother called ___ and pt was taken to OSH. Transferred here for higher level of care. Treated with bicarb drip and hemodialysis. Medical team anticipates transfer to floor once ASA level below 20. Pt reports he has been significantly depressed recently. States his sxs include poor sleep, low energy, depressed mood, anhedonia, restlessness and anxiety. States he has been struggling with depression for past ___ years, but his sxs have been worse x last 2 months since getting out of jail. States he has been thinking of suicide ""on and off"" since then. States ""everything just hit me yesterday"" while he was drinking and he took the pills. States he isn't sure why he called his brother after taking the pills. States he took the pills with intent to die and he wishes he had not survived the SA. Pt's depression and SA occur in the context of heavy EtOH intake. States for the past several years, he has been drinking about 8 beers/day. Lately has been drinking more. Reports drinking ""my whole life"" and states his longest period of sobriety was 2 months while he was in jail. Pt states ""I know I'm an alcoholic."" Denies morning drinking. States he got ""the shakes"" for the first time ""a couple of weeks ago."" Sxs also occur in the context of severe psychosocial stressors, including financial problems and pending charges for credit card fraud. States he engaged in fraudulent activity to pay for EtOH. Reports court date on ___. <PAST MEDICAL HISTORY> Pt reports 2 previous SAs. One ___ yrs ago, last ___ years ago. All in context of heavy EtOH intake. Hospitalized ___ yrs ago in ___ and ___ years ago in ___. Reports he saw psychiatrist and therapist briefly after last hosp d/c, but stopped ""once I felt better for a little while."" Previously on Wellbutrin following hops d/c, but stopped once prescription ran out. Past Med Hx: Denies <SOCIAL HISTORY> ___ <FAMILY HISTORY> my whole family is alcoholic; sister with previous SA <PHYSICAL EXAM> within normal limits with stable vital signs. not suggestive of withdrawal from Etoh <PERTINENT RESULTS> ___ 04: 55PM ALT(SGPT)-23 AST(SGOT)-21 ALK PHOS-68 TOT BILI-0.4 ___ 04: 55PM VIT B12-395 FOLATE-12.0 ___ 04: 55PM TSH-0.81 ___ 06: 25AM GLUCOSE-82 UREA N-15 CREAT-0.9 SODIUM-139 POTASSIUM-3.9 CHLORIDE-104 TOTAL CO2-27 ANION GAP-12 ___ 06: 25AM CALCIUM-8.6 PHOSPHATE-2.7 MAGNESIUM-2.0 ___ 06: 25AM WBC-5.7 RBC-4.75 HGB-14.6 HCT-42.9 MCV-90 MCH-30.8 MCHC-34.1 RDW-13.5 ___ 06: 25AM PLT COUNT-204 ___ 02: 18PM ASA-9 ___ 01: 56PM GLUCOSE-103 UREA N-15 CREAT-0.9 SODIUM-138 POTASSIUM-3.8 CHLORIDE-104 TOTAL CO2-25 ANION GAP-13 ___ 01: 56PM CALCIUM-8.1* PHOSPHATE-2.3* MAGNESIUM-1.9 <MEDICATIONS ON ADMISSION> none <DISCHARGE MEDICATIONS> Well Butrin SR 100 mg BID <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> I- Etoh dependence, substance induced depression, r/o MDD II-defer III-none IV- financial stressors, pending court date/legal troubles V-GAF 50 <DISCHARGE CONDITION> stable mood and affect, no SI, intent, or plan. forward thinking and motivated to change Etoh dependent lifestyle <DISCHARGE INSTRUCTIONS> please keep all follow-up appointments provided, take all medications as written; If you feel unsafe or suicidal in future please call ___ and/or come to ED if in emergency ___ MD ___ Completed by: ___","Legal: ___ Psych: Reported prior response to Well-Butrin so waited for CIWA=0 for 24 hrs to r/o underlying Etoh withdrawal state before beginning therapy at 100 mg BID. Pt tolerated with no side effects, initial improvements to energy level noted. By time of discharge, pt mood improved greatly, no SI, no active intent or plans, no VH, AH, or HI. Pt optimistic and forward thinking about ""beating my alcohol habit, I feel motivated to take care of it definitively now, high past time that I did this"". Pt said he would attend AA as part of his strategy Behavioral: Pt remained upbeat and pleasant throughout his stay, felt to be a positive influence on other patients. Pt was never verbally or physically abusive during his stay in the unit. never required redirection, seclusion, CO, chemical or physical restraints. Group: Very upbeat and pleasant in groups, brought good attitude and strongly participated per multiple group leader observations. Was felt to be a good influence for his fellow patients in offering positive insights. Family: Has some supports from brother and sister; plans for discharge communicated to pt's sister, ___. Aftercare/Dispo plan: Pt had no PCP, ___, or psychiatrist on admission; further complicating matters was his lack of insurance. In spite of the difficulties thus encountered in arranging for aftercare, ___ was able to provide the following arrangements for the pt- intake at ___ which is walk in clinic between ___ M-F;this center will provide for both Etoh counseling and PCP establishment of care. Pt applying for Mass Health, will get prescription(s) from ___ in the interim. Medical: Withdrawal unlikely but as precaution, Valium prns per CIWA placed as order. CIWA=o throughout and no prns needed so CIWA D/Cd ___. no other medical issues or concerns arose during admission aside from pt concern over facial rash (says he has hx seborrhea and takes desonide .05% cream for it) which responded to well to 0.05% desonide cream. VSS at time of discharge. ",1089,435
10006196-DS-11,"<SEX> F <SERVICE> OBSTETRICS/GYNECOLOGY <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> vaginal bleeding <MAJOR SURGICAL OR INVASIVE PROCEDURE> none <HISTORY OF PRESENT ILLNESS> ___ G1P0 at 25w0d with known posterior previa who presents with first episode of spotting in this pregnancy. No ctx, LOF. +FM. <PAST MEDICAL HISTORY> ___ ___ tri us Labs Rh+/Abs-/RI/RPRNR/HBsAg-/HIV-/GBS unknown Genetics LR ERA FFS normal, complete posterior previa GLT not yet done Issues 1. post previa on FFS OBHx: G1 GynHx: hx LGSIL ___, no f/u. PMH: denies PSH: denies <SOCIAL HISTORY> ___ <FAMILY HISTORY> non-contributory <PHYSICAL EXAM> (on admission) VITALS: T 98.6, HR 108, BP 113/71 GENERAL: A&O, comfortable ABDOMEN: soft, gravid, nontender GU: no bleeding on pad EXT: no calf tenderness TOCO no ctx FHT 150/mod var/+accels/-decels On discharge: afebrile, VSS Gen: NAD Abd: soft, nontender, gravid ___: without edema <PERTINENT RESULTS> n/a <MEDICATIONS ON ADMISSION> prenatal vitamins <DISCHARGE MEDICATIONS> 1. Prenatal Vitamins 1 TAB PO DAILY 2. Ranitidine 150 mg PO BID: PRN heartburn <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> posterior placenta previa, spotting <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Ms. ___, You were admitted to the antepartum service after having some spotting, which has since resolved. You received a complete course of steroids and had reassuring monitoring during your stay. You had an ultrasound done which showed a persistent placenta previa covering the cervix. Your doctors feel ___ are safe to go home with outpatient followup. Please call your doctor right away if you notice any additional vaginal bleeding or start having contractions. Your zantac prescription has been sent to the ___ on ___ ___. ","___ y/o G1P0 with posterior previa diagnosed at 20 weeks admitted to the antepartum service at 25w0d with small spotting. On admission, she was hemodynamically stable with no further bleeding. Speculum exam was deferred given her spotting had resolved. Fetal testing was reassuring. She was admitted to the antepartum service for observation. She had an ultrasound in the CMFM which revealed persistent complete previa. She was given two doses of betamethasone and had no active bleeding so she was discharged home in good condition on hospital day 2 with bleeding precautions and outpatient followup. ",546,131
10006269-DS-16,"<SEX> M <SERVICE> MEDICINE <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <MAJOR SURGICAL OR INVASIVE PROCEDURE> EGD Colonoscopy Biopsy during colonoscopy Lumbar puncture attach <PERTINENT RESULTS> ADMISSION LABS: ___ 11: 00AM WBC-10.0 RBC-4.66 HGB-8.4* HCT-30.9* MCV-66* MCH-18.0* MCHC-27.2* RDW-20.1* RDWSD-45.3 ___ 11: 00AM NEUTS-85.1* LYMPHS-6.6* MONOS-7.7 EOS-0.0* BASOS-0.2 IM ___ AbsNeut-8.47* AbsLymp-0.66* AbsMono-0.77 AbsEos-0.00* AbsBaso-0.02 ___ 11: 00AM PLT COUNT-225 ___ 11: 00AM GLUCOSE-111* UREA N-15 CREAT-1.0 SODIUM-128* POTASSIUM-4.6 CHLORIDE-95* TOTAL CO2-18* ANION GAP-15 ___ 11: 00AM ALT(SGPT)-13 AST(SGOT)-20 ALK PHOS-80 TOT BILI-1.0 ___ 11: 00AM ALBUMIN-4.9 ___ 07: 20AM BLOOD Hypochr-1+* Anisocy-1+* Macrocy-1+* Microcy-1+* Polychr-1+* Tear Dr-1+* RBC Mor-SLIDE REVI ___ 11: 42AM BLOOD Ret Aut-3.1* Abs Ret-0.13* ___ 07: 20AM BLOOD calTIBC-371 VitB12-293 Folate-8 Ferritn-5.6* TRF-285 ___ 11: 42AM BLOOD Hapto-208* ___ 07: 20AM BLOOD TSH-1.1 ___ 07: 20AM BLOOD 25VitD-17* ___ 03: 30AM BLOOD IgA-162 ___ 03: 40PM CEREBROSPINAL FLUID (CSF) TNC-146* RBC-7* POLYS-1 ___ MONOS-12 BASOS-1 OTHER-0 ___ 03: 40PM CEREBROSPINAL FLUID (CSF) TNC-141* RBC-2 POLYS-1 ___ MONOS-3 OTHER-0 ___ 03: 40PM CEREBROSPINAL FLUID (CSF) PROTEIN-100* GLUCOSE-57 ___ 11: 00AM Lyme Ab-NEG ___ 04: 45PM BLOOD Trep Ab-NEG ___ 07: 20AM BLOOD HIV Ab-NEG ___ 03: 05PM BLOOD Parst S-NEGATIVE MICRO: ___ 3: 40 pm CSF;SPINAL FLUID Site: LUMBAR PUNCTURE TUBE #3. GRAM STAIN (Final ___: NO POLYMORPHONUCLEAR LEUKOCYTES SEEN. NO MICROORGANISMS SEEN. FLUID CULTURE (Final ___: NO GROWTH. HSV CSF HSV2 + low positive IMAGING: CT head w/o acute intracranial process Discharge Labs: ___ 06: 00AM BLOOD WBC-5.6 RBC-3.79* Hgb-7.2* Hct-27.1* MCV-72* MCH-19.0* MCHC-26.6* RDW-22.1* RDWSD-56.4* Plt ___ ___ 06: 00AM BLOOD Glucose-80 UreaN-12 Creat-0.8 Na-143 K-3.9 Cl-111* HCO3-21* AnGap-11 ___ 06: 00AM BLOOD Calcium-8.2* Phos-4.5 Mg-1.7 ___ 05: 45AM BLOOD Hapto-126 ___ 07: 20AM BLOOD TSH-1.1 ___ 05: 50AM BLOOD CEA-1.9 ___ 03: 30AM BLOOD IgA-162 Colonoscopy: Circumferential mass of malignant appearance was found in the distal rectum completely encircling the rectal verge. There were local ulcerations in the 12 o'clock position. Multiple cold forceps biopsies were performed for histology in the rectal mass. EGD: Normal erythema in the whole esophagus. Erythema in the antrum with gastritis. Erythema in the duodenum compatible with duodenitis. <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. TraZODone 50 mg PO QHS: PRN insomnia 2. Citalopram 20 mg PO DAILY 3. Lisinopril 20 mg PO DAILY 4. Metoprolol Succinate XL 50 mg PO DAILY <DISCHARGE MEDICATIONS> 1. Acetaminophen 1000 mg PO Q6H: PRN Pain - Mild/Fever 2. Doxycycline Hyclate 100 mg PO Q12H RX *doxycycline hyclate 100 mg 1 capsule(s) by mouth twice a day Disp #*12 Capsule Refills: *0 3. Pantoprazole 40 mg PO DAILY RX *pantoprazole 40 mg 1 tablet(s) by mouth once a day Disp #*30 Tablet Refills: *0 4. ValACYclovir 1000 mg PO TID RX *valacyclovir [Valtrex] 1,000 mg 1 tablet(s) by mouth three times a day Disp #*18 Tablet Refills: *0 5. Citalopram 20 mg PO DAILY 6. Lisinopril 20 mg PO DAILY 7. Metoprolol Succinate XL 50 mg PO DAILY 8. TraZODone 50 mg PO QHS: PRN insomnia <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Viral meningitis ___ HSV Iron deficiency anemia Rectal cancer <DISCHARGE CONDITION> Stable for outpatient follow up <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear ___, You came to the hospital with severe headache and fevers. You were found to have a viral meningitis with testing showing herpes simplex virus to be the cause. Please continue taking Valtrex and doxycycline until ___ to treat this infection. When you were in the hospital, you were found to have iron deficiency anemia. You were seen by the Gastroenterologists. You underwent an EGD and a colonoscopy. The EGD showed a little stomach irritation. Avoid ibuprofen, higher dose aspirin, and naproxen. Take pantoprazole to help with the irritation. There was no cancer found in the stomach. The colonoscopy showed a rectal cancer. Please follow up as instructed with gastroenterology for a better pathology sample and with the multi-disciplinary colorectal cancer team as instructed. Your appointment with the multi-disciplinary team has already been set up. Call the ___ clinic to set up an appointment with them, in order for them to get a better sample of the tumor. This is needed for the pathologists and oncologists. If you do not hear from the office within 48 hours, call them at: ___. We wish you the best in your recovery. -- Your medical team ","Hospital Medicine Attending Progress Note Time patient seen and examined today HPI on Admission: Mr. ___ is a ___ male with a PMHX of partial aortic dissection, HTN, who presents w/ HA & fever x2d concerning for meningitis. Patient reports that 3 days ago, he developed malaise and terrible headache: constant, dull, diffuse. The following day, headache was relenting ___ pain. Also had fever of 102 and took tylenol/ibuprofen without relief of symptoms. He reports nausea and decreased PO intake. Denies vision changes, sensitivity to light, syncope, URI sx, chest pain, shortness of breath, abd pain, diarrhea/constipation, sick contacts. Has mild neck stiffness as well. He lives in ___, does a lot of yardwork. Has had exposure to ticks, mosquitoes, but none he memorably recalls recently. No recent travel hx. No rash. He was feeling entirely well prior to onset of these symptoms. Given terrible headache and fever, he presented to the ED. Hospital Course to Date: The pt was admitted for acute onset headache and fever. LP showed a cell count of 141 with lymphocytic predominance and elevated protein to 100. He was initially started on bacterial meningitis coverage, then narrowed to acyclovir based on negative CSF stain and cultures. Doxycycline was added to cover potential lyme meningitis. The pt's CSF came back positive for HSV PCR. Per ID recommendations from ___: ""Would recommend continuing on Acyclovir for now but when safe for discharge can change to Valtrex 1 gram po three times per day to complete 14 day course. In setting of only low positive HSV 2 PCR and extensive outdoor activity would also complete 14 day course of doxycycline even though lyme is less likely."" The pt improved dramatically. His headache resolved. Throughout his hospitalization, he had no confusion or neurologic deficits. He was transitioned to oral acyclovir the day before discharge and discharged on PO acyclovir + PO doxycycline for a total 14 day course. Of note, the pt was incidentally found to have an abnormally low Hb on admission. He required 1u PRBC transfusion ___. He denies any known bleeding. GI was consulted and recommended EGD + colonoscopy, performed ___. EGD showed diffuse erythema of the mucosa with no bleeding noted in the antrum, consistent with gastritis. Colonoscopy showed a circumferential mass of malignant appearance in the distal rectum completely encircling the rectal verge. There were local ulcerations in the 12:00 position. Colorectal surgery was consulted. They recommended follow up at the colorectal cancer clinic. Follow up was arranged prior to discharge and the pt was aware of the diagnosis and need for follow up. The clinic and colorectal surgery asked for a baseline CEA which was normal. They asked for a staging MRI pelvis which did not show any spread of the presumed cancer. Pathology was sent by GI. Initial pathology showed superficial fragments of tubulovillous adenoma. This was pending at the time of discharge, though initial reports had shown the same diagnosis, so the pt was instructed to follow up with GI. The GI phone number was shared with the patient and he was instructed to call them directly if he did not hear from the clinic within 24 hours. The pt received a total of 2u PRBCs this hospitalization. Hb was 7.2 on the morning of discharge and the pt received 1u PRBCs (the second unit this stay) on the day of discharge after the Hb of 7.2 in order to ensure that his Hb did not drop below 7.0 at home. Close follow up was arranged prior to discharge. The pt had no active bleeding at the time of discharge. Return to ER precautions such as dizziness and increased bleeding were reviewed with the patient. The pt's BP meds were held on admission but restarted prior to discharge. ",1712,848
10006277-DS-18,"<SEX> M <SERVICE> MEDICINE <ALLERGIES> Patient recorded as having No Known Allergies to Drugs <ATTENDING> ___. <CHIEF COMPLAINT> ___ <MAJOR SURGICAL OR INVASIVE PROCEDURE> none <HISTORY OF PRESENT ILLNESS> Pt is an ___ yo male w/ h/o afib on ___ transferred from ___ with ___. His symptoms began one month ago, when he could not remember the day or the time. Two days ago, he fell out of a chair to the floor and was unable to pick himself up. He has no history of head injury or loss of consciousness. He phoned a neighbor who found him on the ground and he was brought to an OSH hospital. At ___ his vital signs were stable, BPs ranged from 100-120 systolic, HR ___, maintaining O2 sats on 2LNC. Laboratory data notable for absense of leukocytosis, normal renal function, INR 4.3. A RLE ultrasound was negative for DVT given Right knee swelling. A XR of the knee showed DJD with effusion. CXR showed interstitial edema. Head CT and MRI which showed small R frontal and R temporal SDHs and a small R occipital intraperitoneal hemorrhage. He was given 2 units of FFP and Vitamin K to reverse his supratherapeutic INR (4.3) on coumadin and sent to ___ for evlauation and management by neurosurgery managment. In the ED vital signs were 97.4 187/100 74 20 2L NC ROS obtained was positive for generalized weakness. He denied headache. CXR was obtained which showed signs of volume overload and insterstitial lung disease. He was given 40mg IV lasix and transferred to the ICU. On the floor, he was tired and unable to provide a history or review of systems. <PAST MEDICAL HISTORY> Atrial fibrillation HTN h/o anemia h/o osteoarthritis <SOCIAL HISTORY> ___ <FAMILY HISTORY> reviewed and no pertinent ___ <PHYSICAL EXAM> VITAL SIGNS: T=98.1 BP=136/77 HR=74 ___ O2=94% ___ NC GENERAL: Asleep, arousable to voice. NAD. Alternating periods of apnea and rapid breathing. HEENT: Normocephalic, atraumatic. conjunctival pallor. No scleral icterus. Dry MM. CARDIAC: irregular rhythm, normal rate. Normal S1, S2. ___ systolic murmur at RUSB radiating to axilla. ___ blowing holosystolic murmur at apex radiating to axilla ___ LUNGS: Clear anteriorly ABDOMEN: NABS. Soft, NT, ND. No HSM EXTREMITIES: R knee edema. SKIN: No rashes/lesions, ecchymoses. NEURO: Deferred given complete neuro exam by neurosurgery an hr ago. As per NS: Neurological Exam: Mental status: Awake, year - ___, month - ___, hospital - ___. Fluent speech with some phonemic paraphasias Difficulty naming hammock, stethoscope. Cranial Nerves: I: Not tested II: PERRL, 4-->2mm with light. III, IV, VI: EOMI. no nystagmus. V, VII: facial sensation intact, facial strength IX, X: Palatal elevation symmetrical. XII: Tongue midline without fasciculations. Motor: Normal bulk. Normal tone. No pronator drift. Delt Tri Bi IP Ham PF C5 C7 C6 RT: 4 5- ___ 5 LEFT: 4+ 5- 4+ ___ Sensation: intact to pinprick, light touch. Toes downgoing bilaterally <PERTINENT RESULTS> Admission Labs ___: BLOOD: WBC-8.3 Hgb-11.6* Hct-35.4* MCV-75* Plt ___ Neuts-75.1* Lymphs-16.2* Monos-6.9 Eos-1.3 Baso-0.5 ___ PTT-32.0 ___ Glucose-110* UreaN-17 Creat-0.9 Na-138 K-5.0 Cl-101 HCO3-26 AnGap-16 Calcium-8.9 Phos-3.3 Mg-2.1 URINE: Color-Yellow Appear-Clear Sp ___ Blood-SM Nitrite-NEG Protein- Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-4* pH-6.5 Leuks-NEG ___ Bacteri-OCC Yeast-NONE ___ ABG ___ pO2-199* pCO2-32* pH-7.54* calTCO2-28 Base XS-5 AADO2-484 URINE ___ Color-Yellow Appear-Hazy Sp ___ Blood-MOD Nitrite-NEG Protein-100 Glucose-NEG Ketone-NEG Bilirub-SM Urobiln-8* pH-6.5 Leuks-MOD MICROBIOLOGY: URINE Cx ___ & ___: ENTEROCOCCUS SP. AMPICILLIN------------ <=2 S NITROFURANTOIN-------- <=16 S TETRACYCLINE---------- =>16 R VANCOMYCIN------------ <=1 S BLOOD Cx ___: No growth to date IMAGING: CXR ___: Stable cardiomegaly and moderate pulmonary edema with a small right pleural effusion. A chest x-ray following diuresis is recommended CT head ___: 1. No significant interval change in bilateral subdural hematomas, as well as a rounded hemorrhagic focus within the right occipital lobe, which may also be extraaxial. 2. Punctate foci of layering hemorrhage within the occipital horns of lateral ventricles, unchanged. 3. No new hemorrhage identified CT C-spine ___: 1. No fracture identified. 2. Severe multilevel degenerative changes, with a grade 1 anterolisthesis of C5 on 6, of indeterminate chronicity. However, clinical correlation is suggested. If there is a high clinical concern for ligamentous or cord injury, an MRI is suggested ECHO ___: Mild left ventricular hypertrophy with mildly depressed global systolic function. Severe diastolic dysfunction. Severe aortic stenosis. Severe pulmonary artery systolic hypertension CT head ___: 1. No significant change in the subdural hemorrhages, noted, in the right frontal, right parietal and the left tentorial as well as along the cerebral convexity based on both sides compared to the most recent study. Follow up as clinically indicated. CT Spine ___: 1. No acute fracture within the limitation of severe osteopenia. 2. Large lesion at S2 level, expanding and indenting S2, likely large sacral Tarlov cyst. Underlying soft tissue component can not be excluded and a MRI may be helpful in further evaluation. 3. Degenerative changes as described above. 4. Scattered areas of ground-glass opacity in bilateral lungs as well as areas of atelectasis and small right pleural effusion. Dedicated chest CT can be obtained for further evaluation if clinically warranted. 5. Tortuous and dilated left iliac artery, 2.1cm max.inadequately assessed. Color doppler study may be helpful CT head ___: No significant interval change from ___. MRI brain ___: No acute infarcts seen. Previously noted bilateral subdurals and subarachnoid hemorrhage as well as right sided intraventricular blood products are identified. No significant new abnormalities are seen DISCHARGE LABS ___: WBC-9.5 Hgb-11.8* Hct-37.3* MCV-76* Plt ___ PTT-26.7 ___ Glucose-103 UreaN-19 Creat-0.7 Na-135 K-5.6* Cl-100 HCO3-23 AnGap-18 (moderately hemolyzed sample) Calcium-8.5 Phos-3.5 Mg-2.0 <MEDICATIONS ON ADMISSION> Metoprolol succinate 25mg daily Coumadin 3mg daily Lasix 20mg daily <DISCHARGE MEDICATIONS> 1. Levetiracetam 250 mg Tablet Sig: Three (3) Tablet PO BID (2 times a day): please take this medication until your appointment with neurosurgery. 2. Acetaminophen 325 mg Tablet Sig: ___ Tablets PO Q6H (every 6 hours) as needed for fever, pain. 3. Metoprolol Succinate 50 mg Tablet Sustained Release 24 hr Sig: One (1) Tablet Sustained Release 24 hr PO DAILY (Daily). 4. Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day) as needed for constipation. 5. Senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a day) as needed for constipation. 6. Ampicillin 250 mg Capsule Sig: Two (2) Capsule PO Q6H (every 6 hours) for 10 days. 7. Sodium Chloride 0.9% Flush 3 mL IV Q8H: PRN line flush Peripheral line: Flush with 3 mL Normal Saline every 8 hours and PRN. <DISCHARGE DISPOSITION> Extended Care Facility: ___ <DISCHARGE DIAGNOSIS> Primary: Subdural hematomas, Urinary Tract Infection Secondary: Atrial fibrillation <DISCHARGE CONDITION> Improved, subdural hematomas are stable, neuro exam improved - no longer has left hemineglect <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> You were admitted to the hospital for a bleed in your brain. You were monitored closely in the MICU. The neurosurgery team came and evaluated you and determined there was no need for a surgical intervention at this time. CT scans showed no progression of your bleed. You were transferred to the general medicine floor on ___ and did well. The neurology team also came and evaluated you and requested an MRI which showed no new strokes and the previous bleeds were stable. The following changes were made to your medications 1. Hold Coumadin and other blood thinners until your visit with Neurosurgery in 4 weeks. 2. Start Keppra 750mg by mouth twice daily to prevent seizures until your visit with Neurosurgery 3. Take Ampicillin 500mg by mouth every 6 hours for the next ___ days for a urinary tract infection 4. Tylenol ___ by mouth every 6 hours as needed for pain 5. Increase Metoprolol succinate from 25mg to 50mg by mouth daily 6. Discontinue Lasix 20mg until re-evaluation by your primary care physician. If you experience worsening headache, increased weakness, difficulty speaking or slurring your speech, bowel or bladder incontinence, shortness of breath, chest pain, fevers, chills, or any other concerning symptoms, please call your primary care physician or return to the emergency department. It was a pleasure meeting you and taking part in your care. ","Mr. ___ is an ___ yo male w/ PMHx sig for atrial fibrillation on ___ transferred from ___ with R frontal and temporal DHs and R occipital IPH in the setting of supratheraputic INR, thought to be related from unknown trauma vs hypertension. # Subdural hematomas: The patient was found to have R frontal and temporal subdurals and R occipital IPH in the setting of supratherapeutic INR. This was reversed with Vitamin K and FFP. He was followed by NS, who determined that no surgical intervention was needed at this time and recommended that Keppra be started for seizure prophylaxis. They had initially recommended restarting ASA, but given the extent of his bleeds and discussion with his family, it was decided to hold anticoagulation until further evaluation with NSG in 1 month. The patient continued to have L sided weakness and L hemineglect on transfer to the floor, so Neurology was consulted. A repeat MRI revealed no evidence of acute infarct and stable size of his bleeds. They felt that his bleeds could explain his previous hemineglect. On repeat examination, Neurology felt his hemi neglect had and did not feel further intervention was needed. He is scheduled for NSG follow up in 1 month with repeat CT scan. # Atrial fibrillation: The patient has a h/o afib, for which he was on Coumadin and Toprol 25mg PO daily. He had an episode of afib with RVR on ___, which responded well to Diltiazem 10mg IV. His Toprol dose was increased to 50mg PO daily with good effect. HR on discharge 88. # UTI: The patient had a UCx that showed infection with Enterococcus. The patient was started on a 14 day course of Ampicillin. He has 10 days remaining in his course. # Severe AS/Pulm HTN: The patient had an ECHO, which showed severe aortic stenosis with valve area 0.8-1.0 cm2 and severe pulm HTN. He will need close follow up by his outpatient cardiologist, Dr. ___, ___ ",2460,464
10006368-DS-16,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> atropine eyedrops <ATTENDING> ___. <CHIEF COMPLAINT> post-polypectomy bleed <MAJOR SURGICAL OR INVASIVE PROCEDURE> none <HISTORY OF PRESENT ILLNESS> ___ year old woman without significant past medical history who is s/p colonoscopy and polypectomy on ___, presenting with blood per rectum. On colonoscopy, a sessile 8mm benign-appearing polyp and sessile 2cm multilobular poly were completely removed from the proximal transverse and mid -ascending colon respectively. After the colonoscopy she had two episodes ""like flowing blood"", slept through the night, and then at 8 am on day of presentation had two bloody BMs within 30 minutes where the blood was noticeably darker. She has had occasional dizzininess and weakness recently. In the ED, initial vitals: 97.2 84 114/72 16 94% RA. She was asymptomatic in the ED and no gross rectal bleeding was noted. Guaiac positive with brown/black stools. GI evaluated her and recommended observation for continued bleed and and Hct monitoring q6h. Her admission Hct was 38.9, dropped down to 34.5 over 12 hours. She was admitted due to this Hct drop. At time of admission to medicine, her Hct was 37.8. Vitals prior to transfer: 98.0 72 133/70 16 98%. Currently, the patient reports feeling ""good"" and has not had any bowel movements over night. She was curious why she was admitted after no episodes of rectal bleeding while under observation. ROS: per HPI, denies fever, chills, night sweats, headache, vision changes, rhinorrhea, congestion, sore throat, cough, shortness of breath, chest pain, abdominal pain, nausea, vomiting, diarrhea, constipation, dysuria, hematuria. <PAST MEDICAL HISTORY> Hpylori (started on Pylera ___, not filled script yet), CAD and hypertension. <SOCIAL HISTORY> ___ <FAMILY HISTORY> Father with CAD and an abnormal prostate. Mother died of colon cancer at age ___. Her siblings are all well. <PHYSICAL EXAM> ADMISSION EXAM --------------- 98.0 72 133/70 16 98% Gen: NAD, AOx3 HEENT: normocephalic / atraumatic. Conjunctiva clear, sclera anicteric. PERRL, EOM intact. Pulm: Clear to auscultation bilaterally, anteriorly and posteriorly. Card: RRR. Normal S1/S2. No MRG. Abd: Normoactive bowel sounds. Soft, NT/ND w/o masses or HSM. Ext: No swelling or deformity. Extremities WWP. Mild bilateral nonpitting edema. Skin: Skin warm and w/o rash, pigmented lesions, petechiae, or ecchymoses. DISCHARGE EXAM --------------- Afebrile, vital signs stable Gen: NAD, AOx3 HEENT: normocephalic / atraumatic. Conjunctiva clear, sclera anicteric. PERRL, EOM intact. Pulm: Clear to auscultation bilaterally, anteriorly and posteriorly. Card: RRR. Normal S1/S2. No MRG. Abd: Normoactive bowel sounds. Soft, NT/ND w/o masses or HSM. Ext: No swelling or deformity. Extremities WWP. Mild bilateral non-pitting edema. Skin: Skin warm and w/o rash, pigmented lesions, petechiae, or ecchymoses. <PERTINENT RESULTS> ADMISSION LABS -------------- ___ 12: 55PM BLOOD WBC-6.7 RBC-4.46 Hgb-13.2 Hct-38.9 MCV-87 MCH-29.7 MCHC-34.0 RDW-13.4 Plt ___ ___ 06: 45PM BLOOD Hct-38.0 ___ 01: 50AM BLOOD Hct-34.5* ___ 06: 55AM BLOOD WBC-6.3 RBC-4.43 Hgb-13.4 Hct-37.8 MCV-85 MCH-30.2 MCHC-35.4* RDW-13.4 Plt ___ ___ 12: 55PM BLOOD Neuts-52.1 ___ Monos-4.6 Eos-1.5 Baso-0.7 ___ 06: 55AM BLOOD Neuts-45.9* Lymphs-46.1* Monos-4.2 Eos-3.1 Baso-0.7 ___ 12: 55PM BLOOD Plt ___ ___ 01: 04PM BLOOD ___ PTT-26.6 ___ ___ 06: 55AM BLOOD Plt ___ ___ 12: 55PM BLOOD Glucose-85 UreaN-21* Creat-0.9 Na-142 K-5.7* Cl-106 HCO3-26 AnGap-16 ___ 06: 58PM BLOOD K-3.6 DISCHARGE LABS -------------- same as above, same day discharge and no new labs drawn MICROBIOLOGY ----------- none IMAGING ------- none <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Metoprolol Succinate XL 25 mg PO DAILY 2. Pravastatin 80 mg PO DAILY 3. Valsartan 80 mg PO DAILY hold for SBP < 110 4. Aspirin 81 mg PO DAILY 5. Vitamin D 1000 UNIT PO DAILY 6. Glucosamine *NF* (glucosamine sulfate) 500 mg Oral daily 7. Multivitamins 1 TAB PO DAILY <DISCHARGE MEDICATIONS> 1. Multivitamins 1 TAB PO DAILY 2. Pravastatin 80 mg PO DAILY 3. Valsartan 80 mg PO DAILY 4. Vitamin D 1000 UNIT PO DAILY 5. Glucosamine *NF* (glucosamine sulfate) 500 mg Oral daily 6. Aspirin 81 mg PO DAILY hold for ___ days following discharge 7. Metoprolol Succinate XL 25 mg PO DAILY You were not taking this prior to admission. Please discuss with your PCP whether to resume it. <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> post-polypectomy bleed <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Ms. ___, You were admitted to the hospital with a small amount of bleeding after a colonoscopy. Your blood counts initially went down in the emergency department, but then returned to your normal blood counts. You had no abdominal pain and no evidence of bleeding for 24 hours when admitted to the medical floor. You were able to tolerate a regular diet and were discharged to home. Follow up with your primary care physician and gastroenterology for routine care. ","___ year old woman who underwent colonoscopy with polypectomy two days prior to presentation, admitted with blood in stools and hematocrit drop; resolved upon admission. ACTIVE ISSUES ------------- #. Rectal Bleeding/Hematocrit drop: Patient with likely mild post-polypectomy bleed 1 day following colonoscopy. She was observed in the ED for 24 hours without bleeding, but was admitted to medicine for further monitoring in light of a 4 point HCT drop (39 to 34). On admission to medicine, HCT improved to 37. The patient had no abdominal pain, cramping, or evidence of bleeding. She was able to tolerate a regular diet. She was discharged to home with PCP and gastroenterology ___. INACTIVE ISSUES --------------- #.Hypertension: Blood pressure was stable. She was not taking her prescribed metoprolol succinate or aspirin prior to admission. These were not given in the hospital. Her home dose of valsartan was continued. The patient should follow up with her PCP for further management of her hypertension. #.Hyperlipidemia: PRAVASTATIN 80 mg was continued. #.H. pylori: No upper gastrointestinal symptoms during admission. She had not started her Pylera treatment yet and this was deferred to outpatient so that she may complete her full course withut interruptions. TRANSITIONAL ISSUES ------------------- ___: PCP and ___ follow up appointments were scheduled Code status: Full Contact: daughter ___ ",1604,314
10006431-DS-21,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> latex <ATTENDING> ___ <CHIEF COMPLAINT> Painless jaundice, nausea <MAJOR SURGICAL OR INVASIVE PROCEDURE> EUS <HISTORY OF PRESENT ILLNESS> Ms. ___ is a ___ PMHx HTN and congenital deafness who was initially admitted to ___ on ___ for painless jaundice/biliary obstruction associated with n/v, post-prandial abdominal pain and unintentional weight loss over the past month. History is obtained with assistance of her son who is fluent in ___ sign language. She had an MRCP as an outpatient which showed concern for possible lesion at uncinated process. She was then sent to ___ on ___ for ERCP evaluation; ERCP showed stricture with post-obstructive dilation with severely dilated proximal CBD. These findings were compatible with extrinsic compression of malignant pancreatic lesion at the head/uncinate process of the pancreas. She underwent sphincterotomy with stent placement; brushings showed atypical cells on cytology. She was transferred back to ___ ___. Post-ERCP, the patient has had ongoing obstructive symptoms of n/v, abdominal pain and very limited PO tolerance (barely tolerating a liquid diet). EUS was performed on ___ which was wnl, but her CA ___ level was elevated to 180. She has been afebrile, and labs have shown improvement of her LFTs with AST46, ALT 86, alkphos 376 at admission to 303 today. Tbili 18 at admission to 10.1 today. WBC nml. Transfer is requested for repeat ERCP evaluation and further work-up for malignancy. Upon arrival to the floor, the patient feels overall well and endorses just some mild epigastric and RUQ abdominal soreness. She has been only on liquids for the past 2 weeks without any significant PO intake. ROS: (+) Per HPI (-) Denies fever, chills, night sweats. Denies headache, sinus tenderness, rhinorrhea or congestion. Denies cough, shortness of breath. Denies chest pain or tightness, palpitations. No recent change in bowel or bladder habits. No dysuria. Denies arthralgias or myalgias. <PAST MEDICAL HISTORY> HTN congenital deafness GERD Goiter <SOCIAL HISTORY> ___ <FAMILY HISTORY> Father passed away from complications of gangrenous colitis. Mother with T2DM. Sister with colon CA. Sister deceased, ___. <PHYSICAL EXAM> Vital Signs: 98.3, 158/92, 71, 18, 99% on RA ___: Well-appearing elderly jaundiced female, oriented, no acute distress HEENT: Sclera icteric, MMM, oropharynx clear, EOMI, PERRL, neck supple, JVP not elevated, no LAD CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Lungs: Clear to auscultation bilaterally, no wheezes, rales, rhonchi Abdomen: Soft, obese, nondistended, mild TTP of epigastrium and RUQ, normal bowel sounds GU: No foley Ext: Warm, well perfused, 2+ pulses, trace pitting edema of BLE Neuro: AOX3, moving all extremities spontaneously, nml gait. Can read lips, responding to all commands On discharge: GEN: Lying in bed, in NAD, jaundiced HEENT: EOMI, sclerae anicteric, MMM, OP clear NECK: No LAD, no JVD CARDIAC: RRR, no M/R/G PULM: normal effort, no accessory muscle use, LCAB GI: soft, NT, ND, NABS MSK: No visible joint effusions or deformities. DERM: No visible rash. No jaundice. NEURO: AAOx3. No facial droop, moving all extremities. PSYCH: Full range of affect EXTREMITIES: WWP, trace edema <PERTINENT RESULTS> ___ OSH labs WBC 7.6 Hgb 11.1 (down from 14.8 at admission on ___ Plt 260 MCV 77 Na 142 K 4.1 Cl 107 CO2 28 Cr 0.672 Tbili 10.1 AST 46 ALT 86 AP 303 CEA 112 CA ___ 180.6 On Admission: ___ 06: 50AM BLOOD WBC-8.2 RBC-3.78* Hgb-10.2* Hct-29.4* MCV-78* MCH-27.0 MCHC-34.7 RDW-18.1* RDWSD-48.0* Plt ___ ___ 06: 50AM BLOOD ___ PTT-26.9 ___ ___ 06: 50AM BLOOD Glucose-110* UreaN-6 Creat-0.7 Na-142 K-4.1 Cl-106 HCO3-31 AnGap-9 ___ 06: 50AM BLOOD ALT-69* AST-56* AlkPhos-277* TotBili-8.8* ___ 06: 50AM BLOOD calTIBC-177* Ferritn-755* TRF-136* On Discharge: ___ 06: 44AM BLOOD WBC-9.1 RBC-3.81* Hgb-10.1* Hct-30.4* MCV-80* MCH-26.5 MCHC-33.2 RDW-18.6* RDWSD-50.7* Plt ___ ___ 06: 44AM BLOOD Glucose-144* UreaN-6 Creat-0.5 Na-141 K-3.3 Cl-104 HCO3-29 AnGap-11 ___ 06: 44AM BLOOD ALT-61* AST-51* AlkPhos-257* TotBili-6.1* ___ 06: 44AM BLOOD Calcium-9.1 Phos-2.6* Mg-1.9 ___ 06: 15AM BLOOD IGG SUBCLASSES 1,2,3,4-Test IMAGING & STUDIES - ___ ERCP Findings: Esophagus: Limited exam of the esophagus was normal Stomach: Limited exam of the stomach was normal Duodenum: Limited exam of the duodenum was normal Major Papilla: Normal major papilla was noted. Cannulation: Cannulation of the biliary duct was successful and deep with a sphincterotome using a free-hand technique. Contrast medium was injected resulting in complete opacification. The procedure was not difficult. Biliary Tree/Fluoroscopy Interpretation: The scout film was normal. A single 1.5 cm stricture was seen at the lower third of the common bile duct. There was post-obstructive dilation with severely dilated proximal CBD. with both CBD. These findings are compatible with extrinsic compression of malignant pancreatic lesion at the head/uncinate process of pancreas. A sphincterotomy was performed in the 12 o'clock position using a sphincterotome over an existing guidewire. No evidence of post sphincterotomy bleeding was noted. Cytology samples were obtained for histology using a brush in the lower third of the common bile duct for final diagnosis. Due to obstructive pattern a ___ biliary plastic stent was placed into the distal common bile duct. Post stent deployment a good contrast and bile drainage was noted both endoscopically and fluoroscopically. I supervised the acquisition and interpretation of the fluoroscopy images. The quality of the images was good. Impression: -The scout film was normal. -Normal major papilla was noted. -Cannulation of the biliary duct was successful and deep with a sphincterotome using a free-hand technique. -Contrast medium was injected resulting in complete opacification. -A single 1.5 cm stricture was seen at the lower third of the common bile duct. -There was post-obstructive dilation with severely dilated proximal CBD. -These findings are compatible with extrinsic compression of malignant pancreatic lesion at the head/uncinate process of pancreas. -A sphincterotomy was performed in the 12 o'clock position using a sphincterotome over an existing guidewire. -No evidence of post sphincterotomy bleeding was noted. -Cytology samples were obtained for histology using a brush in the lower third of the common bile duct for final diagnosis. -Due to obstructive pattern a ___ biliary plastic stent was placed into the distal common bile duct. -Post stent deployment a good contrast and bile drainage was noted both endoscopically and fluoroscopically. -Otherwise normal ercp to third part of the duodenum ___: Tissue biopsy pancreas: Adenocarcinoma ___ CT Chest IMPRESSION: No evidence of metastasis. Large goiter, substantially narrows the trachea at the thoracic inlet and could contribute to malacia, though not assessed by this study. Ultrasound recommended to exclude concurrent thyroid nodules. Small bilateral pleural effusions. Severe bibasilar relaxation atelectasis. ___ CT A/P Pancreas Protocol 1. Patient is now status post biliary stenting, with the stent extending from the common hepatic duct to the duodenum. There is associated pneumobilia, the but interval reduction in the intra and extrahepatic biliary dilatation. 2. A approximately 1.6 cm x 1.4 cm x 1.4 cm poorly-defined hypoenhancing lesion is seen at the head of the pancreas. 3. Peripancreatic fluid and fat stranding, particularly surrounding the head of the pancreas, SMA and SMV. This may represent pancreatitis in the appropriate clinical setting. 4. Subcentimeter hypodensity in segment 4B of the liver likely represents a biliary hamartoma versus simple cyst. 5. Multiple bilateral subcentimeter renal hypodensities are too small to characterize but likely represent simple renal cysts. 6. 1.7 cm homogeneously enhancing lesion in the uterus, likely a fibroid. 7. Please see separate report of CT chest performed on the same date. ___ Thyroid US Multinodular goiter. Dominant solid nodules arising from the isthmus and right lower pole measuring 3.2 cm and at least 4.9 cm, respectively, are recommended for biopsy. RECOMMENDATION(S): Thyroid biopsy of the dominant isthmic and right lower pole nodules, as above. <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Lisinopril 20 mg PO DAILY 2. Omeprazole 40 mg PO DAILY 3. Aspirin 81 mg PO DAILY <DISCHARGE MEDICATIONS> 1. Docusate Sodium 100 mg PO BID RX *docusate sodium 100 mg 1 capsule(s) by mouth twice a day Disp #*30 Capsule Refills: *0 2. Polyethylene Glycol 17 g PO DAILY Do not take if you are having loose stools RX *polyethylene glycol 3350 [Miralax] 17 gram 1 powder(s) by mouth daily Disp #*15 Packet Refills: *0 3. Sarna Lotion 1 Appl TP QID: PRN pruritus RX *camphor-menthol [Sarna Anti-Itch] 0.5 %-0.5 % Apply to affected area Four times daily Refills: *0 4. Senna 8.6 mg PO BID Please do not take this if you are having loose stools RX *sennosides [senna] 8.6 mg 1 tablet by mouth twice daily Disp #*30 Tablet Refills: *0 5. Aspirin 81 mg PO DAILY 6. Cholestyramine 4 gm PO DAILY 7. Lisinopril 20 mg PO DAILY 8. Omeprazole 40 mg PO DAILY 9. Ondansetron 4 mg PO Q4H: PRN nausea 10. zaleplon 5 mg oral QHS: PRN <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Primary: Pancreatic adenocarcinoma <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Ms. ___, You were admitted to the hospital because of an inability to tolerate food. This is likely from compression of part of your GI tract by a mass. Fortunately, your symptoms improved during your hospitalization. You underwent imaging to help further characterize what may be going on in your GI tract to cause these symptoms. You are scheduled for follow up with the surgery team to discuss the next steps in your diagnosis and treatment plan. Of note, your CT scan revealed a large goiter. The recommendation was to obtain an ultrasound to determine the presence of nodules. The ultrasound did reveal some nodules that were recommended for biopsy. However, it appears that you have recently undergone a thyroid nodule biopsy. Please continue to follow up with your thyroid specialist as previously scheduled. Please follow up with your primary care doctor as previously scheduled. It was a pleasure to be a part of your care! Your ___ treatment team ","Ms. ___ is a ___ PMHx HTN and congenital deafness who was initially admitted to ___ on ___ for painless jaundice/biliary obstruction associated with n/v, post-prandial abdominal pain and unintentional weight loss s/p ERCP with sphincterotomy and stent placement for CBD dilation, transferred for repeat ERCP evaluation for likely ongoing obstruction. # Pancreatic adenocarcinoma: Resulting in painless jaundice and nausea. She underwent ERCP with sphincterotomy on ___ with plastic stent placement to relieve the obstruction. Her LFTs subsequently downtrended and her nausea improved. CT pancreas notable for 1.6 cm x 1.4 cm x 1.4 cm poorly-defined hypoenhancing lesion is seen at the head of the pancreas. Staging CT of the chest was negative for metastases. She was seen by the surgery team and is scheduled for follow up in the surgery clinic on ___ to discuss the next steps in surgical management. # Goiter: Patient has known goiter and reportedly has an outpatient endocrinologist. Staging CT of the chest noted this large goiter and advised for further evaluation with ultrasound. Ultrasound revealed multinodular goiter. Dominant solid nodules arising from the isthmus and right lower pole measuring 3.2 cm and at least 4.9 cm, respectively, are recommended for biopsy. On discussion of these findings with the patient she revealed that she has in fact recently undergone biopsy of her thyroid and has follow up with her endocrinologist in the near future. # Pruritis: Likely secondary to elevated bilirubin. She found most symptomatic relief with sarna lotion (rather than cholestyramine) and was discharged with a prescription. # HTN: Continued home lisinopril ",2947,380
10006431-DS-22,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> latex <ATTENDING> ___. <CHIEF COMPLAINT> diarrhea <MAJOR SURGICAL OR INVASIVE PROCEDURE> None <HISTORY OF PRESENT ILLNESS> Ms. ___ is a pleasant ___ w/ HTN, DL, congenital deafness, and recently diagnosed borderline resectable pancreatic head adenocarcinoma, on neoadjuvant C1D21 Folfirinox who presents for diarrhea for two days. She had ERCP with stent placement done yesterday. No complications with that. She reports multiple episodes of watery brown non-bloody diarrhea for the past two days. She reports not eating or drinking as much over the past several months. Also some nausea on and off over the same time period. She reports mild gas pain but denies abdominal pain and vomiting. In ED, initial vitals were Temp 97.7, HR 91, BP 102/65, RR 15, O2 sat 98% RA. She received 1L NS. CXR was negative for infection. Vitals prior to transfer were Temp 98.1, HR 77, BP 106/66, RR 16, O2 sat 100% RA. On arrival to the floor, she reports that she is feeling well. She denies fevers/chills, headache, dizziness/lightheadedness, shortness of breath, cough, chest pain, palpitations, abdominal pain, vomiting, constipation, dysuria, and rashes. <PAST MEDICAL HISTORY> HTN congenital deafness GERD Goiter <SOCIAL HISTORY> ___ <FAMILY HISTORY> Father passed away from complications of gangrenous colitis. Mother with T2DM. Sister with colon CA. Sister deceased, ___. <PHYSICAL EXAM> ADMISSION PHYSICAL EXAM: VS: Temp 97.3, BP 125/89, HR 69, RR 18, O2 sat 100% RA. GENERAL: Pleasant woman, in no distress, lying in bed comfortably. HEENT: Anicteric, PERLL, OP clear. CARDIAC: RRR, normal s1/s2, no m/r/g. LUNG: Appears in no respiratory distress, clear to auscultation bilaterally, no crackles, wheezes, or rhonchi. ABD: Normal bowel sounds, soft, nontender, nondistended, no hepatomegaly, no splenomegaly. EXT: Warm, well perfused, no lower extremity edema, erythema or tenderness. NEURO: Alert, oriented, good attention and linear thought, CN II-XII intact. Strength full throughout. SKIN: No significant rashes. <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Lisinopril 20 mg PO DAILY 2. Omeprazole 20 mg PO DAILY 3. Ondansetron 8 mg PO Q8H: PRN nausea/vomiting 4. LORazepam 0.5 mg PO BID: PRN anxiety,nausea 5. Prochlorperazine 10 mg PO Q6H: PRN nausea/vomiting 6. TraMADol 50-100 mg PO Q6H: PRN Pain - Moderate 7. Dexamethasone 4 mg PO BID <DISCHARGE MEDICATIONS> 1. Bismuth Subsalicylate 30 mL PO TID ___ cause black discoloration of stool RX *bismuth subsalicylate [Bismatrol] 525 mg/15 mL 15 ml by mouth three times daily Refills: *0 2. LOPERamide 4 mg PO Q8H RX *loperamide 2 mg 2 tablets by mouth three times daily Disp #*50 Capsule Refills: *1 3. Dexamethasone 4 mg PO BID take for 2 days after chemotherapy 4. Lisinopril 20 mg PO DAILY 5. LORazepam 0.5 mg PO BID: PRN anxiety,nausea RX *lorazepam 0.5 mg 1 tablet by mouth twice daily Disp #*30 Tablet Refills: *1 6. Omeprazole 20 mg PO DAILY 7. Ondansetron 8 mg PO Q8H: PRN nausea/vomiting 8. Prochlorperazine 10 mg PO Q6H: PRN nausea/vomiting 9. TraMADol 50-100 mg PO Q6H: PRN Pain - Moderate <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Diarrhea-likely from Irinotecan. Pancreatic cancer <DISCHARGE CONDITION> stable alert and oriented to time place and person independent ambulation <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear ___, It was a pleasure taking care of you. You were admitted since you developed loose stools. We found out that you had no infections causing the diarrhea. It is likely a adverse reaction from chemotherapy agent. Please take Imodium and Peptobismol as directed until your diarrhea is controlled. Please follow up for your appointment with ___ on ___. Sincerely, ___ MD ","___ is a pleasant ___ w/ HTN, DL, congenital deafness, and recently diagnosed borderline resectable pancreatic head adenocarcinoma, on neoadjuvant C1D21 Folfirinox who presents for diarrhea for two days. Diarrhea- She has 2 loose watery diarrhea everyday mostly at AM. Her stool c diff was negative. She was started on Imodium and the dose was titrated up to 4mg TID but she still continued to have loose watery diarrhea. Her diarrhea is most likely from Irinotecan. She was also started on peptobismol to help her diarrhea Elevated Lipase- She had a mild elevation of lipase levels but this is likely from her having a ERCP on the day prior to admission. She does not have any epigastric abdominal pain or lipase levels high enough to suspect pancreatitis. Her blood and urine cultures were negative during this admission. She was discharged home in a stable condition. ",1147,205
10006431-DS-23,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> latex <ATTENDING> ___. <CHIEF COMPLAINT> Nausea/vomting, diarrhea <MAJOR SURGICAL OR INVASIVE PROCEDURE> None <HISTORY OF PRESENT ILLNESS> Ms. ___ is a ___ female with with HTN, DL, congenital deafness, and borderline resectable pancreatic head adenocarcinoma on neoadjuvant C2D12 Folfirinox who presents with nausea/vomiting, diarrhea, and inability to tolerate POs. Patient reports continued diarrhea as well as nausea/vomiting that has not been controlled with home medications. She was seen in clinic on ___ where she noted diarrhea for one week and was given immodium, Zofran, and 1L NS. She had been taking Pepto Bismal. Stool studies were ordered however patient unable to give a sample and attempted to be done at outside facility but not processed. She continued to have diarrhea and poor PO intake due to nausea and poor appetite. She tried immodium without significant improvement. She wants to stop chemo due to the side effects. Of note, she was recently admitted ___ to ___ with diarrhea. Stool studies were negative. She was started on immodium and pepto bismal. On arrival to the ED, initial vitals were 97.9 80 118/71 16 100% RA. Labs were notable for WBC 3.0, H/H 13.0/39.8, Plt 248, Na 134, K 3.5, BUN/Cr ___, LFTs wnl, INR 1.2, and UA bland. CT abdomen was negative for acute process. Patient was given Zofran 4mg IV x 2 and 1L Ns at 100 cc/hr. Vitals prior to transfer were 98.0 99 117/90 18 99% RA. On arrival to the floor, patient reports that she is feeling better. She is able to drink without nausea. She denies fevers/chills, headache, dizziness/lightheadedness, vision changes, weakness/numbness, shortness of breath, cough, chest pain, palpitations, and dysuria. <PAST MEDICAL HISTORY> PAST ONCOLOGIC HISTORY: ___ has a history of hypertension, congenital deafness, and GERD, and presented in early ___ to ___ with painless jaundice. At the time, she also noted several weeks of nausea, vomiting, postprandial abdominal pain and a 20-pound weight loss. She was referred to ___ where she underwent ERCP. This study identified a stricture in the common bile duct due to external compression. Brushings were atypical. Her CA ___ was elevated at 180 U/mL. She underwent endoscopic ultrasound ___. This study identified a 1.8 x 1.6 cm pancreatic head mass without vascular involvement. Biopsy by ___ showed adenocarcinoma. CT angiogram also showed a 1.6 x 1.4 x 1.4 cm pancreatic head mass with stranding but no definite involvement at the SMA and SMV. There was no evidence of distant metastases. Ms. ___ was diagnosed with borderline resectable PDA and initiated chemotherapy with neoadjuvant FOLFIRINOX ___. C1D15 dose reduced for N/V/D. She underwent biliary stent change and was then hospitalized ___ with persistent diarrhea and leukocytosis. PAST MEDICAL HISTORY: 1. Hypertension 2. Congenital deafness 3. GERD 4. Goiter 5. History of nephrolithiasis 6. Hypercholesterolemia 7. Status post C-section x 2 <SOCIAL HISTORY> ___ <FAMILY HISTORY> The patient's father died of an MI at ___ years. Her mother died with type 2 diabetes mellitus. A sister died with colon cancer at ___ years. Another sister died of ___ disease. She has two sons without health concerns. <PHYSICAL EXAM> ADMISSION PHYSICAL EXAM: VS: Temp 97.2, BP 154/84, HR 99, RR 18, O2 sat 98% RA. ___: Pleasant woman, in no distress, lying in bed comfortably. HEENT: Anicteric, PERLL, OP clear. CARDIAC: RRR, normal s1/s2, no m/r/g. LUNG: Appears in no respiratory distress, clear to auscultation bilaterally, no crackles, wheezes, or rhonchi. ABD: Normal bowel sounds, soft, nontender, nondistended, no hepatomegaly, no splenomegaly. EXT: Warm, well perfused, no lower extremity edema, erythema or tenderness. NEURO: Alert, oriented, good attention and linear thought, CN II-XII intact. Strength full throughout. SKIN: No significant rashes. Discharge PE: 97.7 142 / 80 82 18 97 RA ___: Well appearing, lying in bed in NAD Eyes: PERLL, EOMI, sclera anicteric ENT: MMM, oropharynx clear without exudate or lesions Respiratory: CTAB without crackles, wheeze, rhonchi, though breath sounds reduced at bases. Cardiovascular: RRR, normal S1 and S2, no murmurs, rubs or gallops Gastrointestinal: Soft, nontender, nondistended, +BS, no masses or HSM Extremities: Warm and well perfused, no peripheral edema Skin: warm, no rashes/no jaundice/no skin ulcerations noted Neurological: Alert and oriented x3 <PERTINENT RESULTS> ADMISSION LABS: ___ 10: 35AM URINE COLOR-Straw APPEAR-Clear SP ___ ___ 10: 35AM URINE BLOOD-NEG NITRITE-NEG PROTEIN-30 GLUCOSE-NEG KETONE-40 BILIRUBIN-NEG UROBILNGN-NEG PH-6.5 LEUK-NEG ___ 10: 35AM URINE RBC-0 WBC-0 BACTERIA-NONE YEAST-NONE EPI-1 ___ 04: 29AM GLUCOSE-103* UREA N-10 CREAT-0.5 SODIUM-134 POTASSIUM-3.5 CHLORIDE-99 TOTAL CO2-20* ANION GAP-19 ___ 04: 29AM ALT(SGPT)-29 AST(SGOT)-22 ALK PHOS-60 TOT BILI-0.4 ___ 04: 29AM LIPASE-33 ___ 04: 29AM ALBUMIN-3.0* CALCIUM-8.1* PHOSPHATE-2.3* MAGNESIUM-1.6 ___ 04: 29AM WBC-3.0*# RBC-4.66 HGB-13.0 HCT-39.8 MCV-85 MCH-27.9 MCHC-32.7 RDW-15.0 RDWSD-45.9 ___ 04: 29AM NEUTS-41 BANDS-3 ___ MONOS-21* EOS-2 BASOS-0 ATYPS-1* ___ MYELOS-0 AbsNeut-1.32* AbsLymp-0.99* AbsMono-0.63 AbsEos-0.06 AbsBaso-0.00* ___ 04: 29AM HYPOCHROM-NORMAL ANISOCYT-2+ POIKILOCY-3+ MACROCYT-NORMAL MICROCYT-2+ POLYCHROM-NORMAL OVALOCYT-1+ SCHISTOCY-OCCASIONAL BURR-3+ TEARDROP-OCCASIONAL ___ 04: 29AM ___ PTT-22.7* ___ DISCHARGE LABS: ___ 06: 17AM BLOOD WBC-7.6 RBC-4.35 Hgb-12.0 Hct-36.5 MCV-84 MCH-27.6 MCHC-32.9 RDW-15.4 RDWSD-46.3 Plt ___ ___ 06: 17AM BLOOD Glucose-94 UreaN-8 Creat-0.4 Na-137 K-4.0 Cl-99 HCO3-29 AnGap-13 ___ 06: 17AM BLOOD Calcium-8.9 Phos-3.4 Mg-1.7 MICRO: URINE CULTURE (Final ___: MIXED BACTERIAL FLORA ( >= 3 COLONY TYPES), CONSISTENT WITH SKIN AND/OR GENITAL CONTAMINATION. ___ C diff, stool studies negative IMAGING: ___ CXR IMPRESSION: In comparison with the study of ___, there is little interval change. The cardiac silhouette remains within normal limits with no evidence of vascular congestion or acute focal pneumonia. There is blunting of the left costophrenic angle on the lateral view, suggesting small interval pleural effusion. The right Port-A-Cath again extends to the lower SVC. ___ CT A/P IMPRESSION: 1. No evidence of acute intra-abdominal process. 2. Pancreatic head hypodensity is unchanged and associated peripancreatic soft tissue density is less conspicuous, potentially due to interval improvement or differences in technique. 3. Left pelvic vein engorgement and left gonadal vein enlargement are nonspecific findings but may be seen in the setting of pelvic congestion syndrome. <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. LORazepam 0.5 mg PO BID: PRN anxiety,nausea 2. Omeprazole 20 mg PO DAILY 3. Ondansetron 8 mg PO Q8H: PRN nausea/vomiting 4. TraMADol 50-100 mg PO Q6H: PRN Pain - Moderate 5. Bismuth Subsalicylate 30 mL PO TID: PRN diarrhea/nausea/abdominal pain 6. LOPERamide 4 mg PO TID: PRN diarrhea 7. Dexamethasone 4 mg PO BID 8. Lisinopril 20 mg PO DAILY 9. Prochlorperazine 10 mg PO Q6H: PRN nausea/vomiting 10. ___ ___ UNIT PO QID <DISCHARGE MEDICATIONS> 1. Docusate Sodium 100 mg PO BID: PRN constipation RX *docusate sodium 100 mg 1 tablet(s) by mouth twice a day Disp #*60 Tablet Refills: *0 2. Senna 8.6 mg PO BID: PRN constipation RX *sennosides [senna] 8.6 mg 1 tablet by mouth twice a day Disp #*60 Tablet Refills: *0 3. Dexamethasone 2 mg PO DAILY Duration: 7 Days RX *dexamethasone 2 mg 1 tablet(s) by mouth once a day Disp #*7 Tablet Refills: *0 4. Bismuth Subsalicylate 30 mL PO TID: PRN diarrhea/nausea/abdominal pain 5. Lisinopril 20 mg PO DAILY 6. LOPERamide 4 mg PO TID: PRN diarrhea 7. LORazepam 0.5 mg PO BID: PRN anxiety,nausea 8. ___ ___ UNIT PO QID 9. Omeprazole 20 mg PO DAILY 10. Ondansetron 8 mg PO Q8H: PRN nausea/vomiting 11. Prochlorperazine 10 mg PO Q6H: PRN nausea/vomiting 12. TraMADol 50-100 mg PO Q6H: PRN Pain - Moderate <DISCHARGE DISPOSITION> Home With Service Facility: ___ ___ Diagnosis: Primary: Chemotherapy-related nausea Secondary: Pancreatic adenocarcinoma <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Ms. ___, You were admitted to ___ for nausea/vomiting/diarrhea and inability to tolerate food after your recent chemotherapy. You were given medicine which resolved your diarrhea and helped with nausea. Since you continued to have difficulty eating, you were started on a course of steroids. Please follow up with your oncologist to determine your ongoing chemotherapy plans. It was a pleasure caring for you, Your ___ Healthcare Team ","___ female with with HTN, congenital deafness, and borderline resectable pancreatic head adenocarcinoma on neoadjuvant C2D12 Folfirinox who presents with nausea/vomiting, diarrhea, and inability to tolerate POs. # Diarrhea/Nausea/Vomiting: Most likely due to side effects of FOLFIRINOX. Abdominal CT without acute process and exam benign. Similar symptoms in past after chemotherapy. Less likely infection especially given negative stool studies. C. diff negative so after consultation with outpatient oncologist, treated with typical antidiarrheal regimen of loperamide and lomotil with resolution of diarrhea. Beginning to improve, mildly increased PO intake but solid foods still limited. Diarrhea largely resolved. After discussion with patient and outpatient oncologist was started on Decadron 2 mg PO daily to help improve appetite/reduce nausea in order to allow adequate PO intake for safe discharge. - Continue 2mg dexamethasone daily, likely will stop after 7 day course if continued improvement - Continue anti-emetic regimen - Continue PPI #Cough: Having cough intermittently productive of yellow sputum. Lung exam reassuring, CXR shows no evidence of pneumonia, afebrile without leukocytosis. -Monitor off antibiotics, if symptoms worsening consider repeat chest imaging -Cont IS -Encourage ambulation # Pancreatic Cancer/neutropenia: s/p FOLFIRINOX cycle 2 on ___. GI sx likely ___ further plans for administration of this drug. Neutropenic with ANC ___, likely ___ recent chemotx, no fevers to date, WBC now improved with ANC >2800. Will follow with Dr. ___. - Continue tramadol for pain # HTN: - Lisinopril was held initially, restarted on discharge # Anxiety: She reports having anxiety about leaving the hospital as after multiple recent discharges she quickly went to a local ED. She was counseled extensively that she had made gradual improvement and there was no further treatment recommended in the hospital at this time. -Consider outpatient social work or palliative care referral to help with anxiety and symptom management. ",2771,452
10006431-DS-24,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> latex <ATTENDING> ___ <CHIEF COMPLAINT> abd pain <MAJOR SURGICAL OR INVASIVE PROCEDURE> ___: EUS was performed using a linear echoendoscope at ___ MHz frequency. Celiac Plexus Neurolysis was performed. The take-off of the celiac artery was identified. A 22-gauge EUS needle was primed with saline and advanced adjacent to the Aorta, just superior to the celiac artery take-off. The celiac plexus was visualized. This was aspirated to assess for vascular injection. No blood was noted. Bupivacaine 0.25% x 10 cc was injected bilaterally. Dehydrated 98% alcohol x 10 cc was injected. The needle was then withdrawn. <HISTORY OF PRESENT ILLNESS> ---========== ONCOLOGY HOSPITALIST ADMISSION NOTE ___ ---========== PRIMARY ONCOLOGIST: ___ PRIMARY DIAGNOSIS: Metastatic pancreatic cancer TREATMENT REGIMEN: C7D1 Gemcitabine ___ CC: ___ pain HISTORY OF PRESENTING ILLNESS: ___ is a ___ year old woman with metastatic pancreatic cancer on palliative gemcitabine who is admitted with one week of progressive epigastric abdominal pain. Patient is deaf and uses ASL; interview conducted with the aid of her son translating. Patient developed insidious onset of progressive epigastric abdominal pain after chemotherapy on ___. Her pain progressed, and was associated with nausea, dry heaves, and poor po intake. Olanzapine was prescribed for her worsening nausea on ___, which made her very sleepy. By ___ she was not tolerating po intake with emesis x2 and her pain was up to ___. She discusse with her oncologist, and presented to the ___ ED. There, her lipase was 2800. CT a/p reportedly showed 'large infiltrative pancreatic head tumor along with tumor infiltrate and/or pancreatitis in the lesser sac and about the celiac axis'. She was transferred to ___ ED. In the ED, initial VS were pain 10, T 99.6, HR 94, BP 115/75, RR 16, O2 97%RA. Initial labs notable for Na 137, K 4.4, HCO3 24, Cr 0.5, Ca 9.6, Mg 2.0, P 2.9, ALT 14, AST 14, ALP 138, TBili 0.6, Alb 3.3, Lipase 508, INR 1.2, lactate 1.2. Patient was given IV lR along with IV Zofran and IV morphine. VS prior to transfer were T 98.4, HR 80, BP 121/57, RR 16, O2 98%RA. On arrival to the floor, patient reports progressive epigastric pain, up to ___ with occaisional radiation into RUQ and LUQ. It is worse with any po intake. Minimal relief with home oxycodone and tramadol. She has mild intermittent abdominal pain but nothing like this. She has associated poor appetite and nausea. No fevers or chills. No dysphagia or odynophagia. No UTRI symptoms. No SOB, cough, or chest pian. No dysuria, although has had low UOP. No BM in last two days and no diarrhea. No new joint pains, rashes, or leg swelling. REVIEW OF SYSTEMS: A complete 10-point review of systems was performed and was negative unless otherwise noted in the HPI. <PAST MEDICAL HISTORY> PAST ONCOLOGIC HISTORY: ___ has a history of hypertension, congenital deafness, and GERD, and presented in ___ to ___ with painless jaundice. At the time, she also noted several weeks of nausea, vomiting, postprandial abdominal pain and a 20-pound weight loss. She was referred to ___ where she underwent ERCP. This study identified a stricture in the common bile duct due to external compression. Brushings were atypical. Her CA ___ was elevated at 180 U/mL. She underwent endoscopic ultrasound ___, which identified a 1.8 x 1.6 cm pancreatic head mass without vascular involvement. Biopsy by ___ showed adenocarcinoma. CT angiogram also showed a 1.6 x 1.4 x 1.4 cm pancreatic head mass with stranding but no definite involvement at the SMA and SMV. There was no evidence of distant metastases. Ms. ___ was diagnosed with borderline resectable PDA and initiated chemotherapy with neoadjuvant FOLFIRINOX ___. C1D15 was dose reduced for N/V/D. She was hospitalized ___ with diarrhea, nausea, anorexia, and neutropenia. Her C2D15 treatment was held. With cycle 3 she transitioned to mFOLFOX. She completed five infusion and was taken to the OR ___. Liver metastases were identified intraoperatively, and plans for resection were aborted. She initiated palliative chemotherapy with gemcitabine ___. The dose was reduced to 750mg/m2 on C1D8 due to neutropenia. With cycle 2 she transitioned to day 1 and 15 schedule. Following six cycles there was further progression, and she was referred for combination gemcitabine/nab-paclitaxel. PAST MEDICAL HISTORY: 1. Hypertension. 2. Congenital deafness. 3. GERD. 4. Goiter. 5. History of nephrolithiasis. 6. Hypercholesterolemia. 7. Status post C-section x 2. <SOCIAL HISTORY> ___ <FAMILY HISTORY> The patient's father died of an MI at ___ years. Her mother died with type 2 diabetes mellitus. A sister died with colon cancer at ___ years. Another sister died of ___ disease. She has two sons without health concerns. <PHYSICAL EXAM> VITAL SIGNS: 97.9 PO 108 / 66 Lying 70 18 95 RA ___: NAD HEENT: MMM CV: RR, NL S1S2 no S3S4, no MRG PULM: CTAB, respirations unlabored ABD: BS+, S, less TTP epigastric area LIMBS: No ___ SKIN: No rashes on extremities NEURO: Grossly WNL <PERTINENT RESULTS> ___ 05: 19AM BLOOD WBC-12.0* RBC-3.41* Hgb-9.6* Hct-30.0* MCV-88 MCH-28.2 MCHC-32.0 RDW-14.7 RDWSD-46.3 Plt ___ ___ 05: 19AM BLOOD Glucose-69* UreaN-4* Creat-0.4 Na-135 K-3.6 Cl-98 HCO3-25 AnGap-12 ___ 05: 19AM BLOOD ALT-9 AST-14 LD(LDH)-127 AlkPhos-109* TotBili-0.5 ___ 04: 46AM BLOOD Lipase-293* ___ 05: 19AM BLOOD Albumin-2.7* Calcium-8.5 Phos-2.1* Mg-1.7 ___ 04: 46AM BLOOD Triglyc-73 <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Lisinopril 20 mg PO DAILY 2. OLANZapine 5 mg PO BID: PRN nausea 3. Omeprazole 20 mg PO DAILY 4. Ondansetron 8 mg PO Q8H: PRN nausea 5. OxyCODONE (Immediate Release) 5 mg PO Q4H: PRN Pain - Moderate 6. Prochlorperazine 10 mg PO Q6H: PRN nausea 7. TraMADol 50-100 mg PO Q6H: PRN Pain - Moderate 8. Acetaminophen 1000 mg PO Q6H: PRN Pain - Mild <DISCHARGE MEDICATIONS> 1. Lidocaine 5% Patch ___ PTCH TD QAM to LUQ area RX *lidocaine 5 % ___ patches daily to LUQ daily, 12 hrs on, 12 hrs off Disp #*30 Patch Refills: *0 2. Magnesium Citrate 300 mL PO ONCE Duration: 1 Dose RX *magnesium citrate 300 ml by mouth q3 days Refills: *0 3. Milk of Magnesia 30 mL PO Q6H: PRN constipation RX *magnesium hydroxide [Milk of Magnesia] 400 mg/5 mL 30 ml by mouth q6h prn Refills: *0 4. Multivitamins W/minerals 1 TAB PO DAILY 5. OxyCODONE SR (OxyconTIN) 10 mg PO Q12H RX *oxycodone 10 mg 1 tablet(s) by mouth q12 Disp #*60 Tablet Refills: *0 6. Polyethylene Glycol 17 g PO DAILY constipation RX *polyethylene glycol 3350 17 gram 1 powder(s) by mouth daily Disp #*30 Packet Refills: *0 7. Senna 17.2 mg PO BID constipation RX *sennosides [senna] 8.6 mg 17.2 mg by mouth twice a day Disp #*120 Tablet Refills: *0 8. Ondansetron ODT ___ mg PO Q8H: PRN nausea RX *ondansetron 4 mg ___ tablet(s) by mouth every eight (8) hours Disp #*60 Tablet Refills: *0 9. Acetaminophen 1000 mg PO Q6H: PRN Pain - Mild 10. OLANZapine 5 mg PO BID: PRN nausea 11. Omeprazole 20 mg PO DAILY 12. OxyCODONE (Immediate Release) 5 mg PO Q4H: PRN Pain - Moderate <DISCHARGE DISPOSITION> Home With Service Facility: ___ ___ Diagnosis: Acute Pancreatitis Pancreatic Cancer <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear ___, ___ was a pleasure caring for ___ in the hospital. ___ were admitted because of worsening abdominal pain. ___ had a celiac plexus block and were started on oxycontin with improvement of your pain. ___ will need to continue a low fat diet. ___ were seen by the nutritionist who recommended eating small frequent meals. Please eat high protein, nutrient-dense diets that include fruits, vegetables, whole grains, low fat dairy, and other lean protein sources. Abstinence from alcohol and greasy or fried foods is important in helping to prevent malnutrition and pain. Best, Your ___ Team ","IMAGING: ___BDOMEN (___) - Image loaded into PACS. Read in chart: "" Large infiltrative pancreatic head tumor. There is tumor infiltrate and/or pancreatitis in the lesser sac and about the celiac axis/SMA. Attenuation of the portal vein and splenic vein due to tumor. Multiple liver metastases. Large amount stool in the right colon "" ASSESSMENT AND PLAN: ___ w/ metastatic pancreatic cancer on palliative gemcitabine who is admitted with one week of progressive epigastric abdominal pain # Pancreatitis # Abdominal pain: Patient with one week of progressive worsening of epigastric abdominal pain/nausea. Found to have elevated lipase and OSH imaging suggestive of acute inflammation c/w pancreatitis flare (although difficult to interpret given her pancreatic cancer). No elevation in LFT's to suggest acute obstruction. Pain has been largely insidious since diagnosis of pancreatic ca so possibly acute pancreatitis but largely pain is due to the tumor hence celiac plexus block ___. Symptoms cont to improve slowly. - low fat diet - appreciate Pal care c/l for sx control - started on oxycontin 10 mg bid w/ modicum of improvement of her sx - cont oxycodone prn (uses rarely) # Metastatic pancreatic cancer: Initially thought locally advanced and went to OR for Whipple after neoadjuvant chemotherapy, unfortunately found to have metastatic liver disease intraoperatively. Recently progressive after 6C palliative gemcitabine. Plan has been to initiate nab-paclitaxel for C7D15 however she noted several times she is not interested in receiving any more chemo until she regains her strength. - chemo on hold for this week - f/u Onc arranged - f/u w/ palliative care being arranged # Hypertension: now hypotensive, hence dc'd home acei w/ SBP ___ # GERD: cont PPI CODE: DNR/DNI COMMUNICATION: Patient EMERGENCY CONTACT HCP: Health care proxy chosen: Yes Name of health care proxy: ___ Cell phone: ___ phone) DISPO: Home w/ ___ BILLING: >30 min spent coordinating care for discharge ______________ ___, D.O. Heme/Onc Hospitalist ___ ",2432,473
10006431-DS-25,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> latex <ATTENDING> ___. <CHIEF COMPLAINT> Nausea, anorexia, abdominal pain <MAJOR SURGICAL OR INVASIVE PROCEDURE> None <HISTORY OF PRESENT ILLNESS> ___ PMH of Deafness (uses ASL), GERD, HTN, Metastatic Pancreatic Cancer (mets to liver, recently on palliative gemcitabine), CBD obstruction (s/p sphincerotomy and metal stent placement) who recently was admitted for pain control and possible pancreatitis (s/p celiac plexus block and increased pain regimen), now returns with nausea, vomiting, abdominal pain and decreased PO intake Pt was last discharged on ___ after being admitted for possible pancreatitis vs pain ___ progression of malignancy. She had celiac nerve plexus block and had oxycontin initiated. As a result pain was improved and patient was discharged with outpatient oncology followup OF note, patient is deaf and uses ASL to communicate for complex decision making, but was able to communicate by writing and with lip reading for purposes of this interview. Pt noted that since discharge she has had intermittent abdominal pain which is epigastric and radiating to the back, which comes on in spasms, with sharp stabbing sensation. She noted that her pain may be slightly improved compared to prior though. However, she is more concerned with nausea/vomiting at home with yellow colored vomitus and lack of po intake ___ decreased appetite. Denied fever, chills, sore throat, dysuria, rash, significant diarrhea. In the ED, initial vitals: 98.1 107 122/87 18 99% RA. Labs revealed WBC of 23 (recent baseline was 12), Hgb 11.9 (baseline 9.5), plt 585 (baseline 268). Chem wnl, LFTs unchanged since last admission. Lipase 123 down from 500 on last admit. Lactate normal. She was given IVF, Zofran, and dilaudid. She noted that she felt unsafe going home as did not feel remarkably improved so was admitted to oncology for further care. REVIEW OF SYSTEMS: A complete 10-point review of systems was performed and was negative unless otherwise noted in the HPI. <PAST MEDICAL HISTORY> PAST ONCOLOGIC HISTORY: As per OMR ""presented in ___ to ___ with painless jaundice. At the time, she also noted several weeks of nausea, vomiting, postprandial abdominal pain and a 20-pound weight loss. She was referred to ___ where she underwent ERCP. This study identified a stricture in the common bile duct due to external compression. Brushings were atypical. Her CA ___ was elevated at 180 U/mL. She underwent endoscopic ultrasound ___, which identified a 1.8 x 1.6 cm pancreatic head mass without vascular involvement. Biopsy by ___ showed adenocarcinoma. CT angiogram also showed a 1.6 x 1.4 x 1.4 cm pancreatic head mass with stranding but no definite involvement at the ___ and ___. There was no evidence of distant metastases. Ms. ___ was diagnosed with borderline resectable PDA and initiated chemotherapy with neoadjuvant FOLFIRINOX ___. C1D15 was dose reduced for N/V/D. She was hospitalized ___ with diarrhea, nausea, anorexia, and neutropenia. Her C2D15 treatment was held. With cycle 3 she transitioned to mFOLFOX. She completed five infusion and was taken to the OR ___. Liver metastases were identified intraoperatively, and plans for resection were aborted. She initiated palliative chemotherapy with gemcitabine ___. The dose was reduced to 750mg/m2 on C1D8 due to neutropenia. With cycle 2 she transitioned to day 1 and 15 schedule. Following six cycles there was further progression, and she was referred for combination gemcitabine/nab-paclitaxel"" PAST MEDICAL HISTORY: 1. Hypertension. 2. Congenital deafness. 3. GERD. 4. Goiter. 5. History of nephrolithiasis. 6. Hypercholesterolemia. 7. Status post C-section x 2. 8. CBD obstruction s/p sphincerotomy and metal stent placement via ERCP <SOCIAL HISTORY> ___ <FAMILY HISTORY> The patient's father died of an MI at ___ years. Her mother died with type 2 diabetes mellitus. A sister died with colon cancer at ___ years. Another sister died of ___ disease. She has two sons without health concerns. <PHYSICAL EXAM> Vitals: 98.3 134/84 104 18 98RA ___: Sitting in bed, appears comfortable, no acute distress EYES: PERRLA HEENT: Moist mucous membranes, oropharynx clear NECK: Supple LUNGS: Clear to auscultation bilaterally no wheezes rales or rhonchi, normal respiratory rate CV: Regular rate and rhythm without any murmurs rubs or gallops ABD: Slight epigastric tenderness to moderate palpation, nondistended, normoactive bowel sounds, no ascites EXT: Normal bulk/tone, no deformity SKIN: Warm/dry, no rash NEURO: Alert and oriented 3, fluent speech but has difficulty with correct pronunciation as is deaf, but reads lips and writes to communicate ACCESS: chest port with dressing c/d/i <PERTINENT RESULTS> ___ 02: 10PM WBC-23.0*# RBC-4.30# HGB-11.9 HCT-37.1 MCV-86 MCH-27.7 MCHC-32.1 RDW-16.1* RDWSD-48.4* ___ 02: 10PM PLT COUNT-585*# ___ 02: 10PM cTropnT-0.05* ___ 02: 10PM ALT(SGPT)-10 AST(SGOT)-18 ALK PHOS-153* TOT BILI-0.5 ___ 02: 10PM LIPASE-123* ___ 02: 10PM GLUCOSE-132* UREA N-10 CREAT-0.4 SODIUM-138 POTASSIUM-4.3 CHLORIDE-97 TOTAL CO2-23 ANION GAP-18* ___ 02: 53PM LACTATE-1.7 <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Acetaminophen 1000 mg PO Q6H: PRN Pain - Mild 2. Ondansetron ODT ___ mg PO Q8H: PRN nausea 3. OxyCODONE (Immediate Release) 5 mg PO Q4H: PRN Pain - Moderate 4. Omeprazole 20 mg PO DAILY 5. Lidocaine 5% Patch ___ PTCH TD QAM to LUQ area 6. Milk of Magnesia 30 mL PO Q6H: PRN constipation 7. OxyCODONE SR (OxyconTIN) 10 mg PO Q12H 8. Polyethylene Glycol 17 g PO DAILY constipation 9. Senna 17.2 mg PO BID constipation 10. OLANZapine 5 mg PO BID: PRN nausea 11. Magnesium Citrate 300 mL PO ONCE 12. Multivitamins W/minerals 1 TAB PO DAILY <DISCHARGE MEDICATIONS> 1. Baclofen 5 mg PO Q8H: PRN Back Pain RX *baclofen 10 mg 0.5 (One half) tablet(s) by mouth every eight (8) hours Disp #*90 Tablet Refills: *2 2. lidocaine 5 % topical QAM RX *lidocaine [Lidoderm] 5 % apply to left upper abdomen qam Disp #*30 Patch Refills: *3 RX *lidocaine 5 % apply to left upper abdomen qam Disp #*30 Patch Refills: *2 3. OxyCODONE (Immediate Release) ___ mg PO Q4H: PRN Pain - Moderate RX *oxycodone 5 mg ___ tablet(s) by mouth every four (4) hours Disp #*60 Tablet Refills: *0 4. OxyCODONE SR (OxyconTIN) 10 mg PO Q8H abdominal pain 5. Lidocaine 5% Patch ___ PTCH TD QAM to LUQ area 6. Magnesium Citrate 300 mL PO ONCE 7. Milk of Magnesia 30 mL PO Q6H: PRN constipation 8. Multivitamins W/minerals 1 TAB PO DAILY 9. OLANZapine 5 mg PO BID: PRN nausea 10. Omeprazole 20 mg PO DAILY 11. Ondansetron ODT ___ mg PO Q8H: PRN nausea 12. Polyethylene Glycol 17 g PO DAILY constipation 13. Senna 17.2 mg PO BID constipation <DISCHARGE DISPOSITION> Home With Service Facility: ___ ___ Diagnosis: Metastatic pancreatic cancer <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Please take your medications as prescribed. ","Ms ___ is a pleasant ___ year-old female with deafness admitted with recurrent abdominal pain, nausea, and poor appetite attributed to her pancreatic cancer. Her anti-nausea and pain medications were adjusted to achieve better symptom control, including increase of her oxycontin dose from bid to tid, and adding baclofen to address some element of back spasm. Her appetite remained minimal, but she was able to tolerate fluids throughout her stay. She met with Dr ___ our ___ Care service and discussed options for home hospice, though at the time of discharge she remains uncertain whether she may pursue palliative chemotherapy instead. Her ___ agency has the ability to deliver hospice care and will continue to offer information on this option after she arrives home. Throughout her admission she was seen at least daily with the assistance of our ASL interpreter. ",2092,166
10006457-DS-13,"<SEX> F <SERVICE> SURGERY <ALLERGIES> Morphine Sulfate / Codeine / Dilaudid (PF) <ATTENDING> ___. <CHIEF COMPLAINT> Dizziness, fatigue, and possible syncopal episode x 2 weeks. <MAJOR SURGICAL OR INVASIVE PROCEDURE> Carotid endarterectomy (CEA) <HISTORY OF PRESENT ILLNESS> ___ is a ___ right handed woman with PMH of HTN, HL, DM II c/b peripheral neuropathy, current smoking, an episode of pericarditis, family history of early MI, and poor previous medical care (has not seen a physician in over ___ years), who initially presented with HTN (SBP 190-210) and nonspecific symptoms of postural lightheadedness, bilateral hand numbness and tingling, left retro-orbital headaches, some transient visual blurring, and a possible syncopal episode. <PAST MEDICAL HISTORY> PmHX: DMII - ___ years, complicated with neuropathy and retinopathy. pericarditis HTN Hyperlipidemia abd pain, s/p x-lap ___, unrevealing; appendectomy ETT ___ with small anterior defect (likely artifact). EF 73%. Nephrolithiasis ALL: Codeine, morphine, dilaudid - all cause nausea, vomiting, itching <SOCIAL HISTORY> ___ <FAMILY HISTORY> No family history of neurologic disease including stroke, seizures, movement disorders, demyelinating diseases, or migraines. # Mother: ___ # Father: Fatal MI at age ___. # Siblings: Three sisters and one brother, all well. <PHYSICAL EXAM> PER OMR on ___ T 98.8 BP 115/74 (110-150s) HR 79 RR 18 O2 100% RA Blood glucose ranging from 200-252 General: Awake, cooperative, NAD. HEENT: NC/AT Neck: Supple, soft bruit in left neck, high by the angle of jaw. Pulmonary: CTABL Cardiac: RRR, III/VI murmur in mitral area Abdomen: soft, nontender, nondistended Extremities: no edema, warm to palpation Skin: no rashes or lesions noted. Neurologic: -Mental Status: Alert, oriented to self, ___ and ___. -Cranial Nerves: I: Olfaction not tested. II: PERRL briskly, L>R by <1mm. VFF to confrontation. III, IV, VI: Some difficulty with smooth pursuit but EOMI without nystagmus. Normal saccades. V: Facial sensation intact to light touch. VII: R NLF, symmetric activation VIII: Hearing intact to finger-rub bilaterally. IX, X: Palate elevates symmetrically. XI: ___ strength in trapezii and SCM bilaterally. XII: Tongue protrudes in midline. - Motor: Normal bulk, tone throughout. Mild atrophy of small muscles of hand/feet. +R pronator drift. No adventitious movements, such as tremor, noted. No asterixis noted. Delt Bic Tri WrE FFl FE IO IP Quad Ham TA ___ L 5 ___ ___ 4+ 5 4+ 5 5 4 4 R 4+ 5 4+ ___ 4+ 4+ 5 4 5 5 4 4 -Sensory: No deficits to light touch throughout. Decreased vibration at the toes bilaterally. Decreased pinprick to just below the knees bilaterally. Decreased proprioception at the toes > fingers. -DTRs: Bi Tri ___ Pat Ach L 1 1 1 1 0 R 1 1 1 1 0 Plantar response was tonically extensor. -Coordination: Mild dysmetria on FNF on R, worse when eyes closed ?related to proprioceptive loss. Somewhat slow/clumsier on R hand with finger tapping and rapid alternating movement. -Gait: +Romberg. Somewhat unsteady gait but not broad based. <PERTINENT RESULTS> ADMISSION LABS ___ 07: 53PM BLOOD WBC-8.5 RBC-4.82 Hgb-14.7 Hct-42.0 MCV-87 MCH-30.5 MCHC-35.1* RDW-12.3 Plt ___ ___ 07: 53PM BLOOD Neuts-63.0 ___ Monos-3.9 Eos-2.1 Baso-1.1 ___ 06: 10AM BLOOD ___ PTT-29.5 ___ ___ 07: 53PM BLOOD Glucose-152* UreaN-17 Creat-0.8 Na-138 K-3.7 Cl-98 HCO3-28 AnGap-16 PERTINENT LABS ___ 07: 53PM BLOOD ALT-19 AST-24 CK(CPK)-212* AlkPhos-81 TotBili-1.1 ___ 07: 53PM BLOOD Calcium-9.9 Phos-3.3 Mg-1.6 ___ 07: 53PM BLOOD Lipase-53 ___ 07: 53PM BLOOD CK-MB-5 cTropnT-<0.01 ___ 06: 10AM BLOOD CK-MB-3 cTropnT-<0.01 ___ 06: 10AM BLOOD VitB12-PND ___ 06: 10AM BLOOD %HbA1c-9.3* eAG-220* ___ 06: 10AM BLOOD Triglyc-PND HDL-PND LDLmeas-PND DISCHARGE LABS WBC RBC Hgb Hct MCV MCH MCHC RDW Plt ___ 9.6 4.13* 12.3 35.7* 87 29.7 34.3 12.6 256 Glucose UreaN Creat Na K Cl HCO3 AnGap ___ 05: 15 173 9 0.6 138 3.9 ___ Calcium Phos Mg ___ 8.6 3.9 2.0 MICRO __________________________________________________________ ___ 6: 10 am SEROLOGY/BLOOD CHEM # ___ ___. RAPID PLASMA REAGIN TEST (Pending): NON-REACTIVE __________________________________________________________ ___ 9: 00 pm URINE 802S. URINE CULTURE (Pending): MIXED BACTERIAL FLORA ( >= 3 COLONY TYPES), CONSISTENT WITH SKIN AND/OR GENITAL CONTAMINATION. __________________________________________________________ ___ 8: 32 pm BLOOD CULTURE Blood Culture, Routine (Pending): NO GROWTH. __________________________________________________________ ___ 7: 53 pm BLOOD CULTURE Blood Culture, Routine (Pending): NO GROWTH. STUDIES ___: CTA NECK W&W/OC & RECONS IMPRESSION: Increase in size of hypodensities in the left basal ganglia and left frontal lobe compared to the previous MR, which could represent evolution of the infarct; however, new infarcts are also possible. Consider MRI to evaluate for acute or progressive infarct if clinically indicated. The left common carotid artery is widely patent status post endarterectomy. Patent right carotid arterie, vertebral arteries and major branches. ___: MR HEAD W/O CONTRAST IMPRESSION: Multiple, predominantly left infarctions as above, with interval increase in the size of infarctions seen previously, as well as multiple new foci of infarction, including a right paramedian focus. A small amount of interval susceptibility artifact in the confluent left frontal infarction suggests minimal interval intracranial blood. ___: MR HEAD W/O CONTRAST IMPRESSION: Redemonstration of numerous bilateral cerebral foci of abnormally slow diffusion consistent with infarction, overall unchanged from the most recent comparison. A small amount of left frontal hypointensity on gradient-echo imaging suggesting blood products seen on the most recent examination is no longer apparent. <MEDICATIONS ON ADMISSION> None. <DISCHARGE MEDICATIONS> 1. Senna 1 TAB PO BID: PRN constipation 2. Acetaminophen 1000 mg PO Q6H: PRN pain 3. Aspirin EC 325 mg PO DAILY 4. Atorvastatin 80 mg PO DAILY RX *atorvastatin 80 mg 1 tablet(s) by mouth once a day Disp #*60 Tablet Refills: *1 5. Heparin 5000 UNIT SC TID 6. Metoprolol Tartrate 12.5 mg PO TID RX *metoprolol tartrate 25 mg Half tablet(s) by mouth once a day Disp #*30 Tablet Refills: *1 7. GlipiZIDE 5 mg PO DAILY RX *glipizide 5 mg 1 tablet(s) by mouth once a day Disp #*30 Tablet Refills: *0 8. MetFORMIN (Glucophage) 1000 mg PO BID RX *metformin [Glucophage] 1,000 mg 1 tablet(s) by mouth twice a day Disp #*60 Tablet Refills: *1 9. Insulin SC Sliding Scale Fingerstick QID Insulin SC Sliding Scale using HUM Insulin RX *insulin lispro [Humalog] 100 unit/mL As per attached schedule Up to 10 Units QID per sliding scale Disp #*2 Cartridge Refills: *0 10. Nicotine Patch 7 mg TD DAILY 11. Docusate Sodium 100 mg PO BID: PRN constipation 12. Acetaminophen-Caff-Butalbital ___ TAB PO Q8H: PRN headache Duration: 1 Weeks RX *butalbital-acetaminophen-caff [Fioricet] 50 mg-325 mg-40 mg ___ tablet(s) by mouth three times a day Disp #*30 Tablet Refills: *0 <DISCHARGE DISPOSITION> Extended Care Facility: ___ <DISCHARGE DIAGNOSIS> Left-sided carotid stenosis s/p Left Carotid Endarterectomy (___) <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires supervision because of some motor weakness on the right upper extremity. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Please monitor your blood glucose levels frequently and alter insulin dose according to the attached Insulin Sliding Scale guidleines. WHAT TO EXPECT: 1. Surgical Incision: -It is normal to have some swelling and feel a firm ridge along the incision -Your incision may be slightly red and raised, it may feel irritated from the staples 2. You may have a sore throat and/or mild hoarseness -Try warm tea, throat lozenges or cool/cold beverages 3. You may have a mild headache, especially on the side of your surgery -Try ibuprofen, acetaminophen, or your discharge pain medication -If headache worsens, is associated with visual changes or lasts longer than 2 hours- call vascular surgeons office 4. It is normal to feel tired, this will last for ___ weeks -You should get up out of bed every day and gradually increase your activity each day -You may walk and you may go up and down stairs -Increase your activities as you can tolerate- do not do too much right away! 5. It is normal to have a decreased appetite, your appetite will return with time -You will probably lose your taste for food and lose some weight -Eat small frequent meals -It is important to eat nutritious food options (high fiber, lean meats, vegetables/fruits, low fat, low cholesterol) to maintain your strength and assist in wound healing -To avoid constipation: eat a high fiber diet and use stool softener while taking pain medication MEDICATION: -Take all of your medications as prescribed in your discharge ACTIVITIES: -No driving until post-op visit and you are no longer taking pain medications -No excessive head turning, lifting, pushing or pulling (greater than 5 lbs) until your post op visit -You may shower (no direct spray on incision, let the soapy water run over incision, rinse and pat dry) -Your incision may be left uncovered, unless you have small amounts of drainage from the wound, then place a dry dressing over the area CALL THE OFFICE FOR: ___ -Changes in vision (loss of vision, blurring, double vision, half vision) -Slurring of speech or difficulty finding correct words to use -Severe headache or worsening headache not controlled by pain medication -A sudden change in the ability to move or use your arm or leg or the ability to feel your arm or leg -Trouble swallowing, breathing, or talking -Temperature greater than 101.5F for 24 hours -Bleeding, new or increased drainage from incision or white, yellow or green drainage from incisions ","___ woman h/o HTN, DMII c/b neuropathy and retinopathy, daily tobacco abuse, alcohol dependence, presented with postural lightheadedness, visual obscurations, bilateral hand tingling and numbness. She also had fluctuating inattentiveness. Was initially admitted to medicine, but MRI showed scattered punctate left hemisphere deep ___ infarctions as well as one in the splenium of the CC. MRA shows what looks like critical stenosis of the left carotid bifurcation ___: - Patient presented to ED with dizziness and subtle left-sided weakness with high BP (194/95). In the ED, she remained quite hypertensive (SBP 190-210), and all parts of neurological examination were normal except for a mild distal symmetric peripheral neuropathy in a stocking distribution. Overnight, her blood pressures were improved, remaining in the 130-140s, with blood sugars in the 200-250 range. She spiked one low grade fever to 100.2 while in house, but this spontaneously resolved. On my examination, she had a delayed reaction time and was quite indifferent and dysprosodic. There was a paucity of emotionality and facial expressions. She had no aphasia or dysarthria, and followed commands well. There was no neglect. The remainder of the examination was unremarkable. ___: With the nonspecific findings on examination, the patient was admitted to the medicine service for a presumed hypertensive emergency. She was started on a baby aspirin. An MRI was recommended, and identified multiple small areas of restricted diffusion in the left hemisphere and splenium all consistent with a shower of emboli from a proximal embolic source. An MRA done at that time showed the presence of a stenosed left carotid bifurcation. Labs showed hyperglycemia and an elevated A1c to 9.3, consistent with poorly controlled DM. Her lipid panel returned showing an elevated TC (277), elevated LDL (169) and normal HDL(46). Her UA showed a urinary tract infection, and so she was started on ceftriaxone. Upon discovery of the stroke, the patient has been transferred to the neurology stroke service for continued work up and care. Echo on ___ showed: IMPRESSION: Mild symmetric left ventricular hypertrophy with preserved regional and global biventricular systolic function (LVEF >55%). No valvular pathology or pathologic flow identified. No structural cardiac cause of syncope identified. Carotid Duplex on ___ showed: IMPRESSION: Significant stenosis at the origin of the left internal carotid artery, estimated between 80 and 99%. On the right, there is also significant stenosis at the origin of the ICA, with estimated 40-59% narrowing. ___: In light of discovering significant stenosis at the origin of the left internal carotid artery, estimated between 80 and 99%, urgent vascular surgery consult was initiated and heparin gtt was started (goal 50-70, PTT q6h). - Will stop ASA 325mg daily while on heparin drip - HOB down and allow BP autoregulation. - Continue atorvastatin 40mg daily - Supportive care with insulin sliding scale, PRN tylenol, CIWA scale, nicotine patch, etc. - Continue ceftriaxone for UTI - ___ consult - Placed SW consults in light of poor previous medical care, new diagnosis. The patient underwent emergent left CEA on ___ (see operative note for details). The patient tolerated the procedure well, was extubated in the OR and was taken to the recovery room in stable condition. Overnight on ___, the patient experienced confusion and weakness of the right upper extremity; anisocria was seen on examination. Neurology was consulted who recommended avoidance of hypotension with goal SBP 120-160, continue aspirin/statin and repeat MRI of head to look for additional infarcts. A CTA of the head and neck was performed on ___ that showed increase in size of hypodensities in the left basal ganglia and left frontal lobe compared to the previous MR with possibility of new infarcts. This was followed by a MR1 Head that confirmed the presence of multiple, predominantly left infarctions as above, with interval increase in the size of infarctions, as well as multiple new foci of infarction, including a right paramedian focus. There was also concern for a left frontal hypointensity on gradient-echo imaging suggesting blood products. The next day on ___ the patient complained of headache so Neurology was consulted again who recommended obtaining a repeat CT brain to document stability of the left frontal lobe petechial hemorrhage. The patient's aspirin and SQH were held and an MRI Head w/o contrast was performed on ___. The repeat MRI confirmed resolution of hemorrhage seen the previous day. That same day the patient underwent a speech/swallowing evaluation the next day following which her diet was progressed. ___ were on board throughout the ___ hospital stay. On ___, the patient's motor function appeared to be stable (barring some fluctuation due to difficulty with cooperating) and there was improvement in speech so the goal was to achieve normotension with a SBP <150, avoid hypotension, continue aspirin/statin, re-start heparin SQ TID for DVT prophylaxis, diabetic diet/heart healthy diet, and insulin sliding scale for goal normoglycemia. ___ was consulted, given the patient's uncontrolled blood sugar levels and HBA1C of 9%, following which she was started on oral hyperglycemics and Humalog sliding scale. Over ___, the patient has continued to make excellent progress. Her medical issues are well under control and after soliciting re-evaluation from Neurology and ___ ___ she was deemed stable for discharge to an acute rehab facility of her family's choice in ___. There the patient will continue to receive extensive ___ and speech therapy and will follow up with Vascualr Surgery, Neurology and ___ ___ in the coming weeks. ",2841,1281
10006513-DS-13,"<SEX> M <SERVICE> UROLOGY <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> nephrolithiasis, acute kidney injury <MAJOR SURGICAL OR INVASIVE PROCEDURE> Cystoscopy, left ureteral stent placement. <HISTORY OF PRESENT ILLNESS> ___ yo diabetic male, found to have at least 2 separate left ureteral stones, 4 mm at left UVJ and 6 mm at proximal ureter. His UA is unremarkable and he is without fevers. His creatinine is elevated to 1.4 on arrival and 1.5 on recheck after fluids. Discussed this with the patient, and ultimately recommended cystoscopy and placement of left ureteral stent for decompression given his elevated creatinine. <PAST MEDICAL HISTORY> Problems (Last Verified - None on file): DIABETES TYPE II NEPHROLITHIASIS Surgical History (Last Verified - None on file): No Surgical History currently on file. <SOCIAL HISTORY> ___ <FAMILY HISTORY> No Family History currently on file. <PHYSICAL EXAM> WdWn male, NAD, AVSS Interactive, cooperative Abdomen soft, Nt/Nd Lower extremities w/out edema or pitting and no report of calf pain <PERTINENT RESULTS> ___ 10: 36PM BLOOD WBC-10.1* RBC-5.54 Hgb-14.2 Hct-44.0 MCV-79* MCH-25.6* MCHC-32.3 RDW-12.9 RDWSD-36.7 Plt ___ ___ 10: 36PM BLOOD Neuts-64.3 ___ Monos-6.9 Eos-2.9 Baso-0.4 Im ___ AbsNeut-6.50* AbsLymp-2.49 AbsMono-0.70 AbsEos-0.29 AbsBaso-0.04 ___ 06: 28AM BLOOD Glucose-193* UreaN-13 Creat-1.4* Na-143 K-4.9 Cl-107 HCO3-24 AnGap-12 ___ 05: 39AM BLOOD Glucose-91 UreaN-15 Creat-1.5* Na-139 K-4.8 Cl-102 HCO3-24 AnGap-13 ___ 10: 36PM BLOOD Glucose-260* UreaN-18 Creat-1.4* Na-135 K-4.6 Cl-99 HCO3-18* AnGap-18 ___ 10: 36PM BLOOD ALT-23 AST-14 AlkPhos-93 TotBili-0.2 ___ 06: 28AM BLOOD Calcium-8.8 Mg-2.0 ___ 10: 36PM BLOOD Albumin-4.0 ___ 03: 16AM BLOOD Lactate-1.6 ___ 12: 35AM URINE Color-Yellow Appear-Clear Sp ___ ___ 12: 35AM URINE Blood-SM* Nitrite-NEG Protein-TR* Glucose-1000* Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.0 Leuks-NEG ___ 12: 35AM URINE RBC-14* WBC-3 Bacteri-FEW* Yeast-NONE Epi-<1 ___ 12: 35AM URINE Mucous-RARE* ___ 01: 05PM OTHER BODY FLUID STONE ANALYSIS-PND ___ 12: 35 am URINE **FINAL REPORT ___ URINE CULTURE (Final ___: ESCHERICHIA COLI. 10,000-100,000 CFU/mL. PRESUMPTIVE IDENTIFICATION. Cefazolin interpretative criteria are based on a dosage regimen of 2g every 8h. SENSITIVITIES: MIC expressed in MCG/ML _________________________________________________________ ESCHERICHIA COLI | AMPICILLIN------------ 4 S AMPICILLIN/SULBACTAM-- <=2 S CEFAZOLIN------------- <=4 S CEFEPIME-------------- <=1 S CEFTAZIDIME----------- <=1 S CEFTRIAXONE----------- <=1 S CIPROFLOXACIN---------<=0.25 S GENTAMICIN------------ <=1 S MEROPENEM-------------<=0.25 S NITROFURANTOIN-------- <=16 S PIPERACILLIN/TAZO----- <=4 S TOBRAMYCIN------------ <=1 S TRIMETHOPRIM/SULFA---- <=1 S <MEDICATIONS ON ADMISSION> The Preadmission Medication list may be inaccurate and requires futher investigation. 1. MetFORMIN (Glucophage) 1000 mg PO BID 2. GlipiZIDE 20 mg PO DAILY 3. Januvia (SITagliptin) 100 mg oral DAILY <DISCHARGE MEDICATIONS> 1. Acetaminophen 650 mg PO Q6H: PRN Pain - Mild 2. Cephalexin 250 mg PO Q6H Duration: 7 Days RX *cephalexin 250 mg ONE tablet(s) by mouth Q6hrs Disp #*28 Tablet Refills: *0 3. Docusate Sodium 100 mg PO BID RX *docusate sodium 100 mg ONE capsule(s) by mouth twice a day Disp #*60 Capsule Refills: *0 4. OxyCODONE (Immediate Release) 5 mg PO Q4H: PRN Pain - Moderate RX *oxycodone 5 mg ONE tablet(s) by mouth Q4hrs Disp #*10 Tablet Refills: *0 5. Pravastatin 80 mg PO DAILY 6. Sodium Bicarbonate 650 mg PO TID RX *sodium bicarbonate 650 mg ONE tablet(s) by mouth three times a day Disp #*28 Tablet Refills: *0 7. Tamsulosin 0.4 mg PO QHS RX *tamsulosin 0.4 mg ONE capsule(s) by mouth DAILY Disp #*30 Capsule Refills: *0 8. amLODIPine 10 mg PO DAILY 9. Aspirin 81 mg PO DAILY 10. GlipiZIDE 20 mg PO DAILY 11. Januvia (SITagliptin) 100 mg oral DAILY 12. MetFORMIN (Glucophage) 1000 mg PO BID 13.Outpatient Lab Work Please have repeat lab work (Chem 7) through your PCP ___ ___ days after discharge (to check your kidney function). Call to arrange when you get home today. <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> nephrolithiasis; Obstructing left ureteral stones acute kidney injury urinary tract infection (E.Coli) <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> -You can expect to see occasional blood in your urine and to possibly experience some urgency and frequency over the next month; this may be related to the passage of stone fragments or the indwelling ureteral stent. -The kidney stone may or may not have been removed AND/or there may fragments/others still in the process of passing. -You may experience some pain associated with spasm of your ureter.; This is normal. Take the narcotic pain medication as prescribed if additional pain relief is needed. -Ureteral stents MUST be removed or exchanged and therefore it is IMPERATIVE that you follow-up as directed. -Do not lift anything heavier than a phone book (10 pounds) -You may continue to periodically see small amounts of blood in your urine--this is normal and will gradually improve -Resume your pre-admission/home medications EXCEPT as noted. You should ALWAYS call to inform, review and discuss any medication changes and your post-operative course with your primary care doctor. -For pain control, try TYLENOL FIRST, then ibuprofen, and then take the narcotic pain medication as prescribed if additional pain relief is needed. -You may be given prescriptions for a stool softener and/or a gentle laxative. These are over-the-counter medications that may be health care spending account reimbursable. -Colace (docusate sodium) may have been prescribed to avoid post-surgical constipation or constipation related to use of narcotic pain medications. Discontinue if loose stool or diarrhea develops. Colace is a stool-softener, NOT a laxative. -Senokot (or any gentle laxative) may have been prescribed to further minimize your risk of constipation. -Do not eat constipating foods for ___ weeks, drink plenty of fluids to keep hydrated ","Mr. ___ is known to Dr. ___ previous treatment of uric acid renal stones. He has had ___ days of vomiting and left flank pain and came to the emergency room last night. CT scan revealed proximal and distal left ureteral stones. His creatinine was elevated from baseline of ___. Based on his constellation of symptoms and the acute kidney injury, we decided to bring him to the operating room today for left ureteral stent placement. He was taken urgently for obstructing left ureteral stones with acute kidney injury and underwent cystoscopy, left ureteral stent placement. He tolerated the procedure well and recovered in the PACU before transfer to the general surgical floor. See the dictated operative note for full details. Overnight, the patient was hydrated with intravenous fluids and received appropriate perioperative prophylactic antibiotics. Intravenous fluids and Flomax were given to help facilitate passage of stones but toradol was held given his acute kidney injury. On POD1 his creatinine bumped to 1.6 from 1.4. At discharge on POD1, patients pain was controlled with oral pain medications, tolerating regular diet, ambulating without assistance, and voiding without difficulty. He was explicitly advised to follow up for future procedures to include ureteral stent removal/exchange, definitive stone management. He was discharged with antibiotics and sodium bicarb tablets and advised to have a recheck of his lab work in ___ days after discharge. ",1952,301
10006513-DS-14,"<SEX> M <SERVICE> MEDICINE <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> Fever, left ankle and knee pain <MAJOR SURGICAL OR INVASIVE PROCEDURE> None <HISTORY OF PRESENT ILLNESS> ___ ___ speaking man with history of gout and diabetes presenting with two days of left ankle and knee pain and subjective fevers. He has previously had gout in his ankles. He reports fevers to 101 at home. He denies trauma to the area, dysuria, penile discharge and rash. He denies IV drug use. He has been taking large doses of NSAIDs for pain over last 2 days. In the ED: - Initial vital signs were notable for: T97.2 HT119 BP126/82 RR17 SpO2 98% RA - Exam notable for: tachycardia, warm and swollen left ankle and left knee without redness, able to range both joints however the knee hurts when ranged. - Labs were notable for: Cr 1.8->1.5 Cl 109 HCO3 21->20 WBC 11.0 (7.12 absolute PMNs) BUN 32 CRP 253 - Studies performed include: Joint fluid: slightly cloudy yellow fluid WBC ___ RBC 17 Poly 97% Lymph ___ Mono ___ Macro 2 Crystal Moderate, Needle I/E, Negatively birefringent GRAM STAIN 2+ ___ per 1000X FIELD): /POLYMORPHONUCLEAR LEUKOCYTES NO MICROORGANISMS SEEN Left Ankle Mortise XRay: IMPRESSION: 1. No acute fracture dislocation. 2. Degenerative changes most prominent the medial malleolus and tibiofibular joint, which may reflect sequela from prior injury. 3. Moderate plantar calcaneal spur. Left Knee XRay IMPRESSION: No acute fractures. Moderate left knee joint effusion. - Patient was given: ___ 22: 40 IV Morphine Sulfate 4 mg ___ 00: 01 IVF NS 1000 mL ___ 02: 09 PO Acetaminophen 1000 mg ___ 02: 09 PO Pravastatin 80 mg ___ 07: 26 PO/NG amLODIPine 10 mg ___ 07: 26 PO/NG Aspirin 81 mg ___ 07: 26 PO/NG Lisinopril 20 mg ___ 07: 26 PO PredniSONE 40 mg ___ 09: 45 IV Morphine Sulfate 4 mg ___ 09: 45 IV Morphine Sulfate 4 mg ___ 14: 25 PO Acetaminophen 1000 mg - Consults: None Upon arrival to the floor, patient appears comfortable. Endorses ___ pain in his L knee and ___ pain in his left ankle, described as burning. Pain first started ___ days ago, was at its worst last night. Denies any recent injury to his knee or ankle. Reports history of gout with similar symptoms to previous gout attacks, although has not had it in his knee before only his ankles. Patient also reports history of nephrolithiasis w prior procedures for stone removal. Took 500mg Motrin TID at home, however he was told to avoid NSAIDs because of his ___, and says ice also helps. Denies fever at this time, felt fever-ish at home yesterday but did not take his temp. Otherwise denies chest pain, shortness of breath, abdominal pain, dysuria, constipation/diarrhea. REVIEW OF SYSTEMS: Complete ROS obtained and is otherwise negative. <PAST MEDICAL HISTORY> Type II Diabetes Nephrolithiasis ___ Gout <SOCIAL HISTORY> ___ <FAMILY HISTORY> Non-contributory <PHYSICAL EXAM> ADMISSION PHYSICAL EXAM: VITALS: T 98.0 BP 116/78 HR 94 RR 16 98% RA GENERAL: Alert and interactive. In no acute distress. HEENT: NCAT. PERRL, EOMI. Sclera anicteric and without injection. MMM. Ears with small tophi on earlobes NECK: No cervical lymphadenopathy. No JVD. CARDIAC: Regular rhythm, normal rate. Audible S1 and S2. No murmurs/rubs/gallops. LUNGS: Clear to auscultation bilaterally. No wheezes, rhonchi or rales. No increased work of breathing. BACK: No CVA tenderness. ABDOMEN: Large, non distended, non-tender to palpation in all four quadrants. No organomegaly. EXTREMITIES: L knee is warm and swollen compared to R, TTP, no erythema or skin changes, active ROM ___. L ankle also warm and swollen, no erythema or skin changes, decent ROM. No clubbing or cyanosis. Pulses DP/Radial 2+ bilaterally. SKIN: Warm. Cap refill <2s. No rash. NEUROLOGIC: CN2-12 intact. ___ strength throughout. Normal sensation. Gait is normal. AOx3. DISCHARGE PHYSICAL EXAM 24 HR Data (last updated ___ @ 1157) Temp: 98.7 (Tm 98.7), BP: 131/77 (116-143/77-96), HR: 103 (88-103), RR: 21 (___), O2 sat: 96% (96-98), O2 delivery: Ra, Wt: 211.4 lb/95.89 kg GENERAL: Alert and interactive. In no acute distress. HEENT: NCAT. PERRL, EOMI. Sclera anicteric and without injection. MMM. Ears with small tophi on earlobes NECK: No cervical lymphadenopathy. No JVD. CARDIAC: Regular rhythm, normal rate. Audible S1 and S2. No murmurs/rubs/gallops. LUNGS: Clear to auscultation bilaterally. No wheezes, rhonchi or rales. No increased work of breathing. BACK: No CVA tenderness. ABDOMEN: Large, non distended, non-tender to palpation in all four quadrants. No organomegaly. EXTREMITIES: L knee is warm and swollen compared to R, TTP, no erythema or skin changes. L ankle also warm and swollen, no erythema or skin changes. No clubbing or cyanosis. Pulses DP/Radial 2+ bilaterally. SKIN: Warm. Cap refill <2s. No rash. NEUROLOGIC: CN2-12 intact. ___ strength throughout. Normal sensation. Gait is normal. AOx3. <PERTINENT RESULTS> ADMISSION LABS: -== ___ 09: 15PM BLOOD WBC-11.0* RBC-5.76 Hgb-14.6 Hct-46.9 MCV-81* MCH-25.3* MCHC-31.1* RDW-13.5 RDWSD-39.7 Plt ___ ___ 09: 15PM BLOOD Neuts-64.8 ___ Monos-8.6 Eos-1.4 Baso-0.5 Im ___ AbsNeut-7.12* AbsLymp-2.67 AbsMono-0.94* AbsEos-0.15 AbsBaso-0.05 ___ 09: 15PM BLOOD Glucose-165* UreaN-32* Creat-1.8* Na-140 K-5.0 Cl-102 HCO3-21* AnGap-17 ___ 09: 15PM BLOOD CRP-253.0* ___ 05: 54AM BLOOD UricAcd-8.5* ___ 11: 58PM JOINT FLUID ___ RBC-17 Polys-97* ___ Macro-2 ___ 11: 58PM JOINT FLUID Crystal-MOD Shape-NEEDLE Locatio-I/E Birefri-NEG Comment-c/w calciu DISCHARGE LABS: -== ___ 05: 46AM BLOOD Glucose-125* UreaN-26* Creat-1.2 Na-141 K-4.7 Cl-103 HCO3-23 AnGap-15 MICROBIOLOGY: - ___ 11: 58 pm JOINT FLUID RIGHT KNEE. GRAM STAIN (Final ___: 2+ ___ per 1000X FIELD): POLYMORPHONUCLEAR LEUKOCYTES. NO MICROORGANISMS SEEN. FLUID CULTURE (Preliminary): NO GROWTH. IMAGING: ======== ___ Ankle X-Ray IMPRESSION: 1. No acute fracture dislocation. 2. Degenerative changes most prominent the medial malleolus and tibiofibular joint, which may reflect sequela from prior injury. 3. Moderate plantar calcaneal spur. ___ L Knee X-Ray IMPRESSION: No acute fractures. Moderate left knee joint effusion. <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. GlipiZIDE 20 mg PO DAILY 2. Januvia (SITagliptin) 100 mg oral DAILY 3. MetFORMIN (Glucophage) 1000 mg PO BID 4. amLODIPine 10 mg PO DAILY 5. Aspirin 81 mg PO DAILY 6. Atorvastatin 40 mg PO QPM 7. Vitamin D ___ UNIT PO DAILY 8. Lisinopril 40 mg PO DAILY 9. liraglutide 1.8 mg subcutaneous DAILY <DISCHARGE MEDICATIONS> 1. Acetaminophen 650 mg PO Q6H: PRN Pain - Mild/Fever 2. PredniSONE 40 mg PO DAILY Duration: 3 Doses RX *prednisone 20 mg 2 tablet(s) by mouth once a day Disp #*6 Tablet Refills: *0 3. amLODIPine 10 mg PO DAILY 4. Aspirin 81 mg PO DAILY 5. Atorvastatin 40 mg PO QPM 6. GlipiZIDE 20 mg PO DAILY 7. Januvia (SITagliptin) 100 mg oral DAILY 8. liraglutide 1.8 mg subcutaneous DAILY 9. Lisinopril 40 mg PO DAILY 10. MetFORMIN (Glucophage) 1000 mg PO BID 11. Vitamin D ___ UNIT PO DAILY <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Acute Gout Flare ___ ___ Type 2 Diabetes <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Mr. ___, It was a pleasure taking care of you at the ___ ___. Why did you come to the hospital? You had severe pain in your left knee and ankle that was found to be due to gout. What did you receive in the hospital? You received steroids to treat the gout flare, as well as IV fluids and pain medication. What should you do once you leave the hospital? - Try to drink >3L/day of fluids - Please take your medications as prescribed and go to your future appointments which are listed below. - Check your blood sugar daily while on steroids and call your primary care physician if your sugar is > 300 We wish you all the best! - Your ___ Care Team ","BRIEF HOSPTIAL COURSE: ====================== ___ ___ speaking man with history of gout and uric acid nephrolithiasis (followed by urology) and T2DM who presented with two days of left ankle and knee pain consistent with acute gout flare, treated with prednisone, IVF, and morphine for pain management. TRANSITIONAL ISSUES: ==================== [] Consider allopurinol for gout prevention when acute flare resolved #Gout Flare Initial exam was notable for warm and swollen left ankle and left knee without redness, able to range both joints however knee was painful with ROM. Studies performed in the ED included L knee and ankle XR that were unremarkable. Arthrocentesis was performed with synovial fluid analysis showing needle shaped negatively birefringent crystals consistent with gout. He was started on a 5 day course of prednisone 40mg. He also received IVF and morphine in the ED. Once on the floor he was continued on the prednisone and had appropriate PO fluid intake. He was discharged with remaining 3d course of prednisone. ___ on ___: Cr initially 1.8 in ED BUN 32, up from baseline 1.2-1.3. Likely ___ dehydration and possibly NSAID use at home. He was given IV fluid in the ED with improvement to 1.5. His creatinine was checked again ___ prior to discharge home. CHRONIC ISSUES: =============== #Type II Diabetes: On sliding scale insulin while inpatient. Home medications restarted at discharge. Instructed to call PCP if finger sticks at home > 300 while on prednisone. ",2575,355
10006580-DS-21,"<SEX> F <SERVICE> SURGERY <ALLERGIES> ACE Inhibitors / sertraline <ATTENDING> ___. <CHIEF COMPLAINT> Carotid body tumor <MAJOR SURGICAL OR INVASIVE PROCEDURE> Excision of right carotid body tumor <HISTORY OF PRESENT ILLNESS> This is a woman with a 3-cm right carotid body tumor who underwent coil embolization of the feeding external carotid branches yesterday and presents now for resection. <PAST MEDICAL HISTORY> PMHx: carotid body tumor, HTN, depression, dizziness, DM, HLD, arthritis, obesity, hip/lower leg fx, R wrist fx PSHx: gastric bypass, repair L hip/lower leg/R arm <SOCIAL HISTORY> ___ <FAMILY HISTORY> not illicited <PHYSICAL EXAM> Discharge physical exam: AVSS A&Ox3 HEENT: CN2-12 intact, appropriate, face symmetric, neck soft and without hematoma, drain removed prior to d/c Abd soft NTND Ext warm, b/l p/p/p/p, ___ strength symmetric <PERTINENT RESULTS> ___ 05: 51PM GLUCOSE-141* UREA N-9 CREAT-0.4 SODIUM-128* POTASSIUM-3.3 CHLORIDE-92* TOTAL CO2-23 ANION GAP-16 ___ 05: 51PM estGFR-Using this ___ 05: 51PM CALCIUM-7.5* MAGNESIUM-1.3* ___ 05: 51PM HCT-27.3* ___ 05: 51PM ___ PTT-46.3* ___ <MEDICATIONS ON ADMISSION> The Preadmission Medication list may be inaccurate and requires futher investigation. 1. Fluticasone Propionate NASAL Dose is Unknown NU Frequency is Unknown 2. Gabapentin 100 mg PO BID: PRN pain 3. MetFORMIN (Glucophage) 850 mg PO BID 4. Omeprazole 20 mg PO DAILY 5. Pravastatin 40 mg PO QPM 6. Ranitidine 300 mg PO BID 7. Sucralfate 1 gm PO QID 8. Aspirin 81 mg PO DAILY 9. Vitamin D Dose is Unknown PO Frequency is Unknown 10. Cyanocobalamin Dose is Unknown PO Frequency is Unknown 11. Multivitamins 1 TAB PO DAILY 12. NPH 40 Units Breakfast <DISCHARGE MEDICATIONS> 1. Aspirin 81 mg PO DAILY 2. MetFORMIN (Glucophage) 850 mg PO BID 3. Omeprazole 20 mg PO DAILY 4. Ranitidine 300 mg PO BID 5. Sucralfate 1 gm PO QID 6. Acetaminophen 650 mg PO Q4H: PRN pain, fever 7. Docusate Sodium 100 mg PO BID 8. OxycoDONE (Immediate Release) ___ mg PO Q4H: PRN pain RX *oxycodone 5 mg 1 tablet(s) by mouth q4hrs Disp #*20 Tablet Refills: *0 9. Senna 8.6 mg PO BID: PRN constipation 10. Cyanocobalamin 50 mcg PO DAILY 11. Fluticasone Propionate NASAL 1 SPRY NU DAILY 12. Gabapentin 100 mg PO BID: PRN pain 13. Multivitamins 1 TAB PO DAILY 14. Pravastatin 40 mg PO QPM 15. Vitamin D 1000 UNIT PO DAILY 16. NPH 40 Units Breakfast <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Carotid body tumor <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Division of Vascular and Endovascular Surgery Carotid Body Surgery Discharge Instructions WHAT TO EXPECT: 1. Surgical Incision: -It is normal to have some swelling and feel a firm ridge along the incision -Your incision may be slightly red and raised, it may feel irritated from the staples 2. You may have a sore throat and/or mild hoarseness -Try warm tea, throat lozenges or cool/cold beverages 3. You may have a mild headache, especially on the side of your surgery -Try ibuprofen, acetaminophen, or your discharge pain medication -If headache worsens, is associated with visual changes or lasts longer than 2 hours- call vascular surgeons office 4. It is normal to feel tired, this will last for ___ weeks -You should get up out of bed every day and gradually increase your activity each day -You may walk and you may go up and down stairs -Increase your activities as you can tolerate- do not do too much right away! 5. It is normal to have a decreased appetite, your appetite will return with time -You will probably lose your taste for food and lose some weight -Eat small frequent meals -It is important to eat nutritious food options (high fiber, lean meats, vegetables/fruits, low fat, low cholesterol) to maintain your strength and assist in wound healing -To avoid constipation: eat a high fiber diet and use stool softener while taking pain medication MEDICATION: -Take all of your medications as prescribed in your discharge ACTIVITIES: -No driving until post-op visit and you are no longer taking pain medications -No excessive head turning, lifting, pushing or pulling (greater than 5 lbs) until your post op visit -You may shower (no direct spray on incision, let the soapy water run over incision, rinse and pat dry) -Your incision may be left uncovered, unless you have small amounts of drainage from the wound, then place a dry dressing over the area CALL THE OFFICE FOR: ___ -Changes in vision (loss of vision, blurring, double vision, half vision) -Slurring of speech or difficulty finding correct words to use -Severe headache or worsening headache not controlled by pain medication -A sudden change in the ability to move or use your arm or leg or the ability to feel your arm or leg -Trouble swallowing, breathing, or talking -Temperature greater than 101.5F for 24 hours -Bleeding, new or increased drainage from incision or white, yellow or green drainage from incisions ","Mrs. ___ is a ___ year old female with a right carotid body tumor who was admitted to the ___ ___ on ___. The patient was taken to the endovascular suite and underwent angioembolization of her tumor. For details of the procedure, please see the surgeon's operative note. Pt tolerated the procedure well without complications and was brought to the post-anesthesia care unit in stable condition. She subsequently underwent resection of right carotid body tumor, with preservation of the internal and external carotid arteries and facial nerve monitoring on ___. After a brief stay, pt was transferred to the vascular surgery floor where she remained through the rest of the hospitalization. Post-operatively, she did well without any groin swelling nor facial or other neuro deficits. She remained neurologically intact throughout her hospitalization. She had a right JP drain below her incision to monitor drainage which initially was sanguineous but soon became sero-sanguineous. By POD 4 the draining volume had decreased to less than 30mL per day and the drain was removed. She was able to tolerate a regular diet, get out of bed and ambulate without assistance, void without issues, and pain was controlled on oral medications alone. She was deemed ready for discharge, and was given the appropriate discharge and follow-up instructions. ",1443,272
10006640-DS-3,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> Bactrim / adhesive tape / chlorhexidine / lactose / seasonal <ATTENDING> ___. <CHIEF COMPLAINT> Post-procedure monitoring <MAJOR SURGICAL OR INVASIVE PROCEDURE> Right hepatic artery embolization (___) <HISTORY OF PRESENT ILLNESS> Ms. ___ is a ___ woman with a past medical history of IBS, LPR, eczema, thyroid nodules, severe menstrual cramps on OCP since age ___, insulin resistance, fibromyalgia, interstitial cystitis, and depression/anxiety, who who was found to have large hepatic adenoma now admitted for monitoring after embolization. Patient was found to have a very large 21 cm hepatic adenoma with satellite adenomas in the beginning of ___. She was referred to the multidisciplinary liver clinic who recommended that she have an embolization by interventional radiology and stop all estrogen based therapy. She underwent the embolization today with interventional radiology they did an embolization of the right lobe via the right radial access. After the procedure she was noted to have some mild chest tightness that they thought was likely diaphragmatic irritation. She was also noted to have a mild rash on her upper chest that had not been noted prior to the procedure. She got a dose of IV Benadryl. Her heart rate at the time was 80 and her systolic blood pressure was 147. She got a dose of Toradol a dose of Decadron and was admitted to the floor for further monitoring. On arrival to the floor: Pt reports her rash has resolved. She continues to report ___ CP which radites to epigastrum with periodic waves. Not clearly worse by exertion. No associated SOB, palpations. She reports stable fibromyalgia pain of multiple joints as well. Notably she recently underwent an hysterectomy approx 1 month prior and 14 point review of systems reviewed with patient and negative except HPI <PAST MEDICAL HISTORY> asthma obesity IBS GERD interstitial cystitis on yearly bladder infusion therapy glucose resistance fibromyalgia GERD/LPR ADHD anxiety/depression Lactose intolerance Thyroid nodules eczema/hidradinitis suppuritiva migraines jaundiced as a baby, went home normally <SOCIAL HISTORY> ___ <FAMILY HISTORY> Positive for UC. Maternal great aunt with liver cancer. Second cousins with liver cancer. PAternal side without liver disease. HTN, DM run in the family. Someone has bladder cancer. <PHYSICAL EXAM> ADMISSION EXAM: VS: ___ 1721 Temp: 97.5 PO BP: 169/98 HR: 82 RR: 18 O2 sat: 94% O2 delivery: ra General Appearance: pleasant, comfortable, no acute distress Eyes: PERLL, EOMI, no conjuctival injection, anicteric ENT: no sinus tenderness, MMM, oropharynx without exudate or lesions, no supraclavicular or cervical lymphadenopathy, no JVD, no carotid bruits, no thyromegaly or palpable thyroid nodules Respiratory: CTA b/l with good air movement throughout Cardiovascular: RR, S1 and S2 wnl, no murmurs, rubs or gallops. Gastrointestinal: Mild epigastric TTP which reproduces pts chest pain. Otherwise Nd, +b/s, soft, no masses or HSM. 3 well-healed port sites from prior/recent hysterectomy Extremities: no cyanosis, clubbing or edema Skin: warm, no rashes/no jaundice/no skin ulcerations noted Neurological: Alert, oriented to self, time, date, reason for hospitalization. Cn II-XII intact. Psychiatric: pleasant, appropriate affect, at times anxious appearing GU: no catheter in place DISCHARGE EXAM: VS: ___ 0802 Temp: 97.8 PO BP: 150/84 R Lying HR: 85 RR: 22 O2 sat: 95% O2 delivery: RA FSBG: 115 General Appearance: NAD, appears well Eyes: PERRL ENT: mmm, OP clear Respiratory: CTAB Cardiovascular: NR/RR, no m/r/g Gastrointestinal: Soft, obese, non-distended, epigastric TTP without guarding or rebound tenderness, normoactive bowel sounds Extremities: no cyanosis, clubbing or edema, good peripheral pulses Skin: warm, no rashes/no jaundice/no skin ulcerations noted Neurological: Alert, oriented, CN grossly intact, grossly nonfocal Psychiatric: pleasant, normal affect <PERTINENT RESULTS> ADMISSION LABS: ___ 07: 30AM BLOOD WBC-7.7 RBC-4.65 Hgb-13.3 Hct-42.2 MCV-91 MCH-28.6 MCHC-31.5* RDW-14.7 RDWSD-48.8* Plt ___ ___ 07: 30AM BLOOD ___ ___ 01: 10PM BLOOD Glucose-123* UreaN-8 Creat-0.6 Na-140 K-4.6 Cl-100 HCO3-22 AnGap-18 ___ 01: 10PM BLOOD Calcium-9.9 Phos-3.8 Mg-2.0 ___ 01: 10PM BLOOD ALT-194* AST-92* AlkPhos-973* TotBili-0.3 ___ 01: 10PM BLOOD cTropnT-<0.01 DISCHARGE LABS: ___ 10: 37AM BLOOD WBC-8.1 RBC-4.59 Hgb-13.2 Hct-40.9 MCV-89 MCH-28.8 MCHC-32.3 RDW-14.6 RDWSD-47.3* Plt ___ ___ 10: 37AM BLOOD Glucose-121* UreaN-8 Creat-0.6 Na-136 K-4.0 Cl-95* HCO3-26 AnGap-15 ___ 06: 55AM BLOOD ALT-1429* AST-___* LD(LDH)-2091* AlkPhos-1362* TotBili-0.4 ___ 06: 55AM BLOOD Albumin-4.4 STUDIES/REPORTS: Embolization: FINDINGS: 1. Conventional hepatic arterial anatomy . 2. Pre-embolization arteriogram showing an area of blush in the right lobe corresponding to the large known right hepatic adenoma. 3. Cone-beam CT showing supply to the vast majority of the adenoma from the branches to segments 5, 7 and 8 4. Post-embolization showing stasis in the embolized branches of the right hepatic artery. IMPRESSION: Successful left trans radial approach trans-arterial bland embolization of the large, right lobe hepatic adenoma. <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Amitriptyline 10 mg PO QHS 2. ClonazePAM 1 mg PO BID: PRN Anxiety 3. darifenacin 15 mg oral BID 4. DULoxetine ___ 30 mg PO DAILY 5. Gabapentin 600 mg PO BID 6. MetFORMIN (Glucophage) 1000 mg PO BID 7. phentermine 37.5 mg oral QAM 8. Ranitidine 150 mg PO BID 9. TraZODone 50 mg PO QHS: PRN Insomnia 10. Cetirizine 10 mg PO DAILY Allergies <DISCHARGE MEDICATIONS> 1. Acetaminophen 650 mg PO Q4H: PRN Pain - Mild/Fever 2. OxyCODONE (Immediate Release) ___ mg PO Q6H: PRN Pain - Severe RX *oxycodone 5 mg ___ tablet(s) by mouth every six (6) hours Disp #*16 Tablet Refills: *0 3. Amitriptyline 10 mg PO QHS 4. Cetirizine 10 mg PO DAILY Allergies 5. ClonazePAM 1 mg PO BID: PRN Anxiety 6. darifenacin 15 mg oral BID 7. DULoxetine ___ 30 mg PO DAILY 8. Gabapentin 600 mg PO BID 9. MetFORMIN (Glucophage) 1000 mg PO BID 10. phentermine 37.5 mg oral QAM 11. Ranitidine 150 mg PO BID 12. TraZODone 50 mg PO QHS: PRN Insomnia <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Hepatic adenomas s/p right hepatic artery embolization <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Ms. ___, You were admitted to the hospital for monitoring after embolization for hepatic adenomas. You will be discharged with a limited supply of oxycodone but your pain should improve with time. You will follow up with interventional radiology in clinic in about 1 week - they will call you to make an appointment. Best wishes for your continued healing. Take care, Your ___ Care Team ","Ms. ___ is a ___ with a past medical history of IBS, LPR, eczema, thyroid nodules, severe menstrual cramps on OCP since age ___, insulin resistance, fibromyalgia, interstitial cystitis, and depression/anxiety, who who was found to have large hepatic adenoma now admitted for monitoring after embolization. Acute problems: ============== # Hepatic adenoma status post embolization She was monitored overnight after the procedure without significant events. Her pain was treated with oxycodone and IV morphine for breakthrough pain. She was discharged with a few days worth of oxycodone and instructed to taper down as she is able and as the pain improves. She will follow up in ___ clinic in about a week to determine if she needs another procedure. # Chest pain EKG without concerning findings and troponin negative. Likely from diaphragmatic irritation from large embolization. # DM: Held metformin. Blood glucose controlled on sliding scale insulin. # Elevated liver labs: AP Elevated to 973 from 647 in ___. GGT at that time 129 ALT 194 (41) AST 92 (30) also elevated compared to ___. LFTs predictably increased further after embolization. Pt has already undergone considerable serologic workup (AMA, Anti-SMooth muscle, ___, AFP) 1 month prior so will hold on further workup for now. TRANSITIONAL ISSUE: [ ] Consider repeating LFTs at follow up ___ appointment in 1 week to ensure they are trending down after embolization. Chronic issues: ============== #Fibromylagia: Home duloxetine, gabapntin #IBS: Home amitriptyline, #Anxiety: Home clonazepam #Obesity: Hold Phenteremine #GERD: Home ranitidine #Insomnia: Home trazodone >30 minutes spent on discharge ",2092,402
10006692-DS-5,"<SEX> M <SERVICE> MEDICINE <ALLERGIES> Penicillins <ATTENDING> ___. <CHIEF COMPLAINT> CHIEF COMPLAINT: Headache, RLE cellulitis <MAJOR SURGICAL OR INVASIVE PROCEDURE> None <HISTORY OF PRESENT ILLNESS> HISTORY OF PRESENT ILLNESS: Pt is a ___ year old ___ speaking M w/ PMH of CAD s/p CABG, HTN and HLD presenting to the ED with hypertension recorded at home, found to have RLE cellulitis. Per pt, on the day prior to admission, he began to experience RLE leg pain that was described as more discomfort. This was followed one hour later by an acute onset of headache, chills, shivering/shaking and felt feverish. Pt felt warm to the touch but Temp taken at home was not elevated. Pt took Excedrin at the time of symptom onset, checked his BP at home which showed a reading of 211/110. Pt took 2 doses of Captopril 25mg tablets, and came into the ___ ED for further evaluation. Of note, pt reports that he has had well controlled BP on a beta blocker (trade name: ___ 25mg x1 a day, a Bblocker not available in the US), with baseline BPs in the 120s/50s per home readings. Pt had been fasting for ___ in the day-light hours, but of note, he has been fasting for ___ but states he has been taking his BP meds, as well as his Aspirin 81mg and Lipitor 40mg. In the ED, initial vitals were: 97.7 98 ___ - Labs were significant for Labs were significant for initial Wbc of 9.6 which increased to 17.8 (initial Diff 93.2%N), low Phos at 1.4, low Mg of 1.5 but otherwise normal Mg and lactate of 1.6. Pt received ___, CT head, and Chest CXR were negative for acute process. - The patient was given 500NS bolus, 125ml/hr maintenance. Cefazolin, Vanc, Ceftriaxone, Tylenol and , IV Mag, IV Phos + 3 packets NeutraPhos, Potassium Chloride 40 mEq - EKG was notable for 1mm STD V3-V4 and TWI when BP was in 200's systolic. First trop neg and second value .02. Repeat ECG after control of BP shows sub-1mm STD in V3-V4. Trop resolved. - Cards was consulted who believed patient had demand ischemia in setting of febrile cellulitis and hypertensive emergency which resolved. They had no suspicion of plaque rupture and no need for anticoagulation. While in the ED he spiked to T100.5 HR 81 BP 103/50 RR 24 SpO2 96% RA. Pt continued to improve on IV Abx therapy, with vitals prior to transfer T 97.8 HR 73 BP 106/53 RR 24 SpO2 97% RA. Upon arrival to the floor, pt was afebrile with stable VS: T99.4, HR 68 BP 124/59 RR 18 and Spo2 of 99% on RA. Pt was comfortable sitting in bed, with no pain in the LLE, resolution of his headache symptoms and no chills or shakes. Pt did endorse feeling subjectively warm, and endorsed 2x episodes of diarrhea. REVIEW OF SYSTEMS: (+) Per HPI (-) Denies recent weight loss or gain. Denies sinus tenderness, rhinorrhea or congestion. Denies cough, shortness of breath. Denies chest pain or tightness, palpitations. Denies nausea, vomiting, diarrhea, constipation or abdominal pain. No recent change in bowel or bladder habits. No dysuria. Denies arthralgias or myalgias. <PAST MEDICAL HISTORY> HLD HTN CAD s/p CABG <SOCIAL HISTORY> ___ <FAMILY HISTORY> Denies family history of CAD <PHYSICAL EXAM> PHYSICAL EXAM: Vitals: VS: T99.4, HR 68 BP 124/59 RR 18 and Spo2 of 99% on RA General: Alert, oriented, sitting upright in bed, in no acute distress HEENT: Sclera anicteric, MMM, oropharynx clear, EOMI, PERRL Neck: Supple, JVP not elevated, no LAD CV: Systolic murmur, regular rate and rhythm, audible S1 S2 Lungs: Clear to auscultation bilaterally, no wheezes, rales, rhonchi Abdomen: Soft, non-tender, non-distended, bowel sounds present, no organomegaly, no rebound or guarding GU: No foley Ext: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema. Full ROM of RLE at knee and ankle. Skin: Warm, smooth, erythematous area extending from ankle to upper calf just below knee. Area marked. Warm to touch, with minimal tenderness to palpation Neuro: CNII-XII intact, ___ strength upper/lower extremities, grossly normal sensation, 2+ reflexes bilaterally, gait deferred. <PERTINENT RESULTS> Admission ========== ___ 05: 10PM GLUCOSE-106* UREA N-15 CREAT-1.0 SODIUM-134 POTASSIUM-4.1 CHLORIDE-102 TOTAL CO2-20* ANION GAP-16 ___ 05: 10PM CALCIUM-8.7 PHOSPHATE-3.2# MAGNESIUM-2.0 ___ 01: 00PM cTropnT-<0.01 ___ 06: 45AM cTropnT-0.02* ___ 10: 30AM ALT(SGPT)-28 AST(SGOT)-30 LD(LDH)-146 CK(CPK)-50 ALK PHOS-47 TOT BILI-2.4* DIR BILI-0.2 INDIR BIL-2.2 ___ 10: 30AM WBC-17.8*# RBC-4.95 HGB-14.4 HCT-41.6 MCV-84 MCH-29.1 MCHC-34.6 RDW-12.9 RDWSD-39.2 ___ 01: 09AM URINE HOURS-RANDOM ___ 01: 09AM URINE UHOLD-HOLD ___ 01: 09AM URINE COLOR-Yellow APPEAR-Clear SP ___ ___ 01: 09AM URINE BLOOD-NEG NITRITE-NEG PROTEIN-NEG GLUCOSE-NEG KETONE-10 BILIRUBIN-NEG UROBILNGN-NEG PH-5.5 LEUK-NEG Discharge =========== ___ 07: 17AM BLOOD Glucose-94 UreaN-12 Creat-0.9 Na-135 K-3.8 Cl-102 HCO3-22 AnGap-15 ___ 07: 17AM BLOOD Calcium-8.4 Phos-1.5*# Mg-1.8 ___ 07: 17AM BLOOD ALT-28 AST-37 AlkPhos-49 TotBili-1.4 ___ 07: 17AM BLOOD WBC-11.9* RBC-4.73 Hgb-13.9 Hct-40.0 MCV-85 MCH-29.4 MCHC-34.8 RDW-13.2 RDWSD-40.7 Plt ___ Imaging ========== Chest Xray ___ IMPRESSION: No acute cardiopulmonary abnormality. CT Head ___ IMPRESSION: Mild involutional change. No evidence of hemorrhage. ___ ___ IMPRESSION: No evidence of deep venous thrombosis in the right lower extremity veins. The peroneal veins are not visualized. <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Atorvastatin 40 mg PO QPM 2. nebivolol 25 ng oral DAILY 3. Aspirin 81 mg PO DAILY <DISCHARGE MEDICATIONS> 1. Atorvastatin 40 mg PO QPM 2. Acetaminophen 325-650 mg PO Q6H: PRN fever RX *acetaminophen 500 mg 1 tablet(s) by mouth every 6 hours Disp #*20 Tablet Refills: *0 3. Cephalexin 500 mg PO Q6H RX *cephalexin 500 mg 1 tablet(s) by mouth every 6 hours Disp #*33 Tablet Refills: *0 4. Aspirin 81 mg PO DAILY 5. nebivolol 25 ng oral DAILY <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Primary Diagnosis Cellulitis Hypertensive emergency <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Mr. ___, It was our pleasure caring for you in ___ ___. You came to the hospital because you were feeling unwell and had high blood pressure. You were found to have a skin infection and we gave you antibiotics and you improved. Your blood pressure improved as well. You were doing better so you were able to go home. ","This is a ___ year old ___ male recently immigrated to ___ with past medical history of CAD s/p CABG presenting ___ with headache, chills, and subjective fever in setting of fasting for ___, as well as hypertension on check at home, in ED found to have RLE cellulitis and hypertensive emergency (SBP 211mmHg with EKG changes concerning for demand ischemia), with quick normalization of blood pressures on oral regimen (and normalization of EKG changes), treated with antibiotics with significant improvement, discharged home with scheduled appointment to establish care at ___. # Acute Cellulitis right leg: patient presented after acute onset of RLE pain, swelling and progressively worsening erythema; exam consistent with acute cellulitis; otherwise notable for leukocytosis WBC 17.9, afebrile. He was started on Cefazolin 2G IV Q8H with rapid improvement, receding from the area marked in the ED, WBC downtrending to 11.9. He was transitioned to PO Cephalexin 2GM Q8H prior to discharge with an expected ___nding on ___. # Malignant Hypertensive / Accelerated Hypertension - patient admitted with SBP 211mmHg; during that time he had nonspecific ST/Twave changes noted and troponin peaking at 0.02. His blood pressures rapidly improved with oral metoprolol. Repeat EKG improved, troponins downtrended. Underlying etiology felt to relate to possible missed doses of home antihypertensive. On day of discharge BP ranged 110s-120s/60s-70s. Patient on nabivolol from ___ (not available here), declined transition to blood pressure agent sold here, but willing to discuss when establishing with PCP. # Hyponatremia / Hypokalemia / Hypophosphatemia / Hypomagnesemia - Na of 132, K of 3.4, Phos 1.0 and Mg 1.5 on presentation, all thought to related to insensible losses from infection as well as ongoing fasting during ___. He was repleted with improvement. Counseled patient that due to his acute illness, team advised against additional fasting which could pose a risk to his health. #CAD s/p 3 vessel CABG - as above, he had evidence of cardiac strain in setting of hypertension that resolved with blood pressure control; while inpatient he was given metoprolol (as nabivolol is not available here), home Aspirin and Atorvastatin. See above re: blood pressure management medications. Transitional ------------- - In setting of fasting for ___, he was noted to have some electrolyte deficiencies - he was counseled that, given his illness, would avoid fasting - To complete a 10 day course of antibiotics end date ___ - Noted to have mild thrombocytopenia during this admission, stable; could consider outpatient workup ",2081,620
10006716-DS-6,"<SEX> M <SERVICE> UROLOGY <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> Prostate cancer, obstructive symptoms <MAJOR SURGICAL OR INVASIVE PROCEDURE> TURP, bipolar <HISTORY OF PRESENT ILLNESS> ___, who was seen in preparation today for his upcoming TUR prostate scheduled for ___. His TUR prostate is part of his ongoing treatment program set up for his stage T3A and B adenocarcinoma of the prostate, associated with high residual urine volumes in the 400s. He has been on Lupron therapy since ___ and his residual urine volume today is 234 mL. Indeed rectal exam reveals a tumor outside the capsule. A history and physical was done and I went over the operation with the patient and his wife including the fact that part of his obstructive problem is lack of dynamic voiding due to scarring and infiltration of the tumor into the bladder neck area. Therefore, removing the obstruction may not completely free up his voiding such that he may still have an elevated residual urine volume, but it should be better than it is today. In addition, I will leave a small amount of extra tissue at the apex to assure against incontinence as the entire prostatic area may be somewhat rigid and removing all of the prostatic tissue could result in incontinence. Putting all this together, the operation will be done carefully to open it up as much as possible without any incontinence problems. <PAST MEDICAL HISTORY> - history of low-grade colitis diagnosed on colonoscopy at ___ in ___, started on Canasa suppository and was on them for about a month, but has not used them in over ___ years. He saw occasional trace blood in the stool, but nothing regularly. He has not had a colonoscopy since ___ - hypertension. <SOCIAL HISTORY> ___ <FAMILY HISTORY> Father had coronary disease and his mother had ___ disease. Paternal uncle had stomach cancer and his maternal grandfather had stomach cancer. <PHYSICAL EXAM> AFVSS NAD, pleasant and conversive non-labored breathing soft, non-tender, non-distended 3-way catheter in place, draining clear yellow urine WWP grossly non-focal <MEDICATIONS ON ADMISSION> Lisinopril 20 mg daily, hydrochlorothiazide 12.5 daily, Flomax 0.4 mg b.i.d. <DISCHARGE MEDICATIONS> 1. bacitracin zinc 500 unit/gram Ointment Sig: One (1) Appl Topical TID (3 times a day) as needed for penile irritation: apply to tip of penis for pain relief. Disp: *1 tube* Refills: *0* 2. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day) as needed for constipation. Disp: *60 Capsule(s)* Refills: *0* 3. acetaminophen 325 mg Tablet Sig: ___ Tablets PO Q6H (every 6 hours) as needed for pain, fever>100. Disp: *60 Tablet(s)* Refills: *0* 4. Cipro 500 mg Tablet Sig: One (1) Tablet PO twice a day for 10 days: to be taken until catheter removed. Disp: *20 Tablet(s)* Refills: *0* 5. oxycodone 5 mg Tablet Sig: One (1) Tablet PO every ___ hours as needed for pain: for pain not relieved with tylenol or ibuprofen. Disp: *20 Tablet(s)* Refills: *0* <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Prostate cancer, obstructive symptoms <DISCHARGE CONDITION> Stable, Good A/Ox3 Functionally independent <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> INSTRUCTIONS: -Do not lift anything heavier than a phone book (10 pounds) or drive until you are seen by your Urologist in follow-up -You may continue to periodically see small amounts of blood in your urine--this is normal and will gradually improve MEDICATIONS: -Resume all of your pre-admission medications, except HOLD aspirin until you see your urologist in followup AND your foley has been removed (if not already done) -Complete a course of antibiotics (Ciprofloxacin) -You will be discharged home with a medication called PYRIDIUM that will help with the ""burning"" pain you may experience when voiding. This medication may turn your urine bright orange. -Colace has been prescribed to avoid post surgical constipation and constipation related to narcotic pain medication. Discontinue if loose stool or diarrhea develops. Colace is a stool softener, NOT a laxative -Do not eat constipating foods for ___ weeks, drink plenty of fluids to keep hydrated -No vigorous physical activity or sports for 4 weeks or until otherwise advised -Tylenol should be your first line pain medication, a narcotic pain medication has been prescribed for breakthrough pain >4. Replace Tylenol with narcotic pain medication. -Max daily Tylenol (acetaminophen) dose is 4 grams from ALL sources, note that narcotic pain medication also contains Tylenol -Do not drive or drink alcohol while taking narcotics and do not operate dangerous machinery. Also, if the Foley catheter and Leg Bag are in place--Do NOT drive (you may be a passenger). ","Mr. ___ was admitted to Dr. ___ service after bipolar transurethral resection of prostate. No concerning intraoperative events occurred; please see dictated operative note for details. He patient received ___ antibiotic prophylaxis. The patient's postoperative course was uncomplicated. He received intravenous antibiotics and continuous bladder irrigation overnight. On POD1 the CBI was discontinued and Foley catheter was kept in place with plans for follow up the following week in clinic for vodiding trial. His urine was clear and and without clots. He remained afebrile throughout his hospital stay. At discharge, the patient had pain well controlled with oral pain medications, was tolerating regular diet, ambulating without assistance. He was given pyridium and oral pain medications on discharge and a course of antibiotics along with explicit instructions to follow up in clinic with Dr. ___. ",1180,176
10006820-DS-18,"<SEX> M <SERVICE> MEDICINE <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___ <CHIEF COMPLAINT> Left leg swelling <MAJOR SURGICAL OR INVASIVE PROCEDURE> IVC filter placement <HISTORY OF PRESENT ILLNESS> ___ year old man with afib and recent GI bleed who presents with a left lower extremity pain. Today the patient was evaluated for a routine appointment with his cardiologist where he endorsed left lower extremity pain and was found to have a DVT by ultrasound. He was diagnosed with atrial fibrillation with symptomatic RVR in ___. He was placed on metoprolol and dabigitran at the time (CHADS 0, he was placed on anticoagulation due to a possible TIA given transient left sided leg weakness). He has not had symptomatic atrial fibrillation since starting metoprolol in ___. He then developed BRBPR along with some black/tarry stool 6 weeks ago. Denied abdominal pain, constipation/straining, or NSAID use prior to the bleeding. He saw his PCP who ___ hemorrhoid treatment, but the bleeding persisted (bloody stools occurred once daily). He was subsequently admitted to ___ for ongoing GI bleeding. During that hospitalization (4 days total), he received 4 units PRBCs, EGD, colonoscopy, and a failed capsule endoscopy (did not make it to small bowel). ___ showed mild distal esophagitis, hiatal hernia, single tiny possible early ___ lesion and friability of the duodenal bulb. His dabigitran was stopped 2 weeks ago. He did not receive heparin SQ during his hospitalization that he can remember. He tried to walk frequently during that hospitalization. 6 days ago, he noticed the left lower extremity pain and swelling. He has never had a clot before, and denies a family history of VTE. He has been active since the hospitalization with exercise ___ (cardio/weights). Denies shortness of breath, chest pain, or palpitations. His last bloody bowel movement was 4 days ago. In the ED, initial VS were: 98.6 57 99/62 16 100%. Rectal exam guaiac negative. Labs notable for HCT 27, INR 1.0, and WBC 4.3 with 9% eosinophils. Left ___ showed left gastroc vein DVT. He was started on a heparin drip at 20: 40 at 1350 units/hour with no bolus. VS prior to transfer were: 98.1. HR: 61. BP: 97/63 (patient reports lower BPs at baseline- active ___. O2: 97% RA. RR: 14. On arrival to the floor, he is comfortable and relayes his history clearly and consisely. He denies pain or discomfort. No SOB. <PAST MEDICAL HISTORY> - PUD ___ years ago in setting of NSAID use - atrial fibrillation - recent GI bleeding <SOCIAL HISTORY> ___ <FAMILY HISTORY> Lives alone, semi-retired ___. Former smoker. No ETOH or IVDA. Active at baseline. <PHYSICAL EXAM> VITALS: 97.6F 54 sinus 100/56 20 165lb GENERAL: NAD, comfortable HEENT: PERRL, EOMI, MMM NECK: no carotid bruits, no JVD LUNGS: CTAB HEART: RRR, normal S1 S2, no MRG ABDOMEN: Soft, NT, NABS, no organomegaly EXTREMITIES: Subtle left lower extremity non-pitting edema, left varicose veins present, palpable tender cord medial calf just distal to popliteal fossa. Distal pulses intact bilaterally, extremities warm and well perfused. No lower extremity erythema. NEUROLOGIC: A+OX3, ___ strength all extremities, sensation intact throughout <PERTINENT RESULTS> Admission: ___ 05: 00PM BLOOD Neuts-54.0 ___ Monos-5.5 Eos-9.0* Baso-0.7 ___ 05: 00PM BLOOD ___ PTT-30.1 ___ ___ 05: 00PM BLOOD Plt ___ ___ 05: 00PM BLOOD Glucose-88 UreaN-10 Creat-0.8 Na-141 K-4.3 Cl-108 HCO3-25 AnGap-12 Discharge: ___ 08: 50AM BLOOD WBC-4.1 RBC-3.42* Hgb-9.9* Hct-32.3* MCV-94 MCH-29.0 MCHC-30.8* RDW-15.0 Plt ___ ___ 08: 50AM BLOOD Plt ___ ___ 08: 50AM BLOOD Glucose-93 UreaN-11 Creat-0.8 Na-143 K-4.7 Cl-109* HCO3-22 AnGap-17 ___ 08: 50AM BLOOD Calcium-9.1 Phos-3.9 Mg-2.1 Studies: ___ Radiology IVC GRAM/FILTER: pending ___ Cardiovascular ECHO: LVEF 55-60%. Normal regional and global biventricular systolic function. Normal diastolic function. No pathologic valvular abnormalities. Mild biatrial enlargement. ___ Radiology UNILAT LOWER EXT VEINS: 1. Left gastrocnemius vein deep venous thrombosis. 2. Ruptured ___ cyst. <MEDICATIONS ON ADMISSION> Preadmission medications listed are correct and complete. Information was obtained from Patient. 1. Ferrous Sulfate 325 mg PO DAILY 2. Metoprolol Succinate XL 25 mg PO DAILY <DISCHARGE MEDICATIONS> 1. Ferrous Sulfate 325 mg PO DAILY 2. Metoprolol Succinate XL 25 mg PO DAILY <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Left gastroc DVT <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Mr. ___, You were admitted to the hospital because you were found to have a clot in your leg (DVT). Because you had a recent GI bleed when you were on blood thinners (Pradaxa) for your atrial fibrillation, we placed a removable filter (IVC filter) in the vein leading to your heart to protect you from a clot entering the lungs (pulmonary embolus). This filter is temporary and should be removed in 3 months. You have expressed interest in transferring your cardiology care to the ___, so we set up a follow up appointment with a cardiologist here (below) who will remove the filter in the future and help decide whether or not you will need blood thinners in the future for your atrial fibrillation. We also reviewed the records from ___ from the gastroenterologists who performed the colonoscopy, endoscopy, and capsule study. You should follow up with your PCP to get ___ referral for a GI appointment at the ___ so they can explore the possibility of additional studies to find the source of bleeding. You also have to get a referral from your PCP to get ___ follow up appointment for a hematologist here (Dr. ___ or colleagues) who will discuss possible blood testing to determine why you formed a clot in your leg. It is unclear why you formed a clot in your leg, this could be due to your recent hospitalization, but it could also be due to low level inflammation which could be from a variety of causes such as infection or a cancer. You could also be at a genetically higher risk of forming clots. It was a pleasure taking care of you. ","Mr. ___ is a ___ year old man with afib (previously on dabigitran) and recent GI bleed with no source identified on endoscopy or colonoscopy from ___, who presented from clinic with a left lower extremity DVT and is now s/p IVC filter placement. # Left gastroc DVT: He was evaluated during a routine appointment with his cardiologist where on review of systems he endorsed left lower extremity pain and was sent to the ED where he was found to have a left gastroc DVT by ultrasound. It is unclear if unprovoked or provoked. During his recent hospitalization for GI bleed (below) he went without heparin SQ or DVT prophylaxis, but he was ambulating multiple times daily. In the ED was started on heparin drip. Given his recent GI bleed with unclear source, the decision was made to place an IVC filter as anticoagulation would put him at risk of continued bleed. IVC filter was placed on ___, and patient was set up with follow up with Dr. ___ will coordinate the removal of the filter in 3 months. Because he was over ___ and this was his first clot and he has no FH of clots, a hypercoaguable workup was not done in the hospital. Our concern, however, is that he may have an irreversible etiology for his DVT, such as a malignancy, especially in the setting of this GI bleed. He was given instructions to follow up with his PCP who will provide a referral for hematology follow up with Dr. ___ ___ or colleagues to further investigate a possible hypercoagulable state. # Recent GI bleed: Mr. ___ was recently admitted to ___ for a GI bleed while on Pradaxa. During that hospitalization (4 days total), he received 4 units PRBCs, EGD, colonoscopy, and a failed capsule endoscopy (did not make it to small bowel). ___ showed mild distal esophagitis, hiatal hernia, single tiny possible early ___ lesion and friability of the duodenal bulb. There was no obvious source of bleeding found. His dabigitran was discontinued during that admission (approximately two weeks prior to current admission). His last bloody bowel movement was 4 days prior to admission and he remained guaiac negative throughout hospitalization. Two large bore peripheral IVs were placed, an active type and screen was maintained and HCT was checked Q12H, which remained stable. He was started on iron at his prior hospitalization and that was continued. # Atrial fibrillation: He is currently in normal sinus rhythm without any perceptible episodes of afib since ___ when he was started on metoprolol. Metoprolow was continued during hospitalization with holding parameters. His Pradaxa was discontinued on prior hospitalization, but there was ongoing discussion of anticoagulation risks/benefits (CHADS 0 vs 2 with ? TIA) given this recent GI bleed. Likely he should avoid dabigitran, but depending on the opinions of his outpatient gastroenterologist and cardiologist, his case may warrant trial of daily aspirin vs. coumadin in future. # CODE STATUS: FULL confirmed # EMERGENCY CONTACT: friend ___ (patient would like her to be his HCP although needs to fill out paperwork) # Transitional issues: - Patient was scheduled with follow up appointment with PCP to arrange referrals for hematology with Dr. ___ or colleagues for workup of ? unprovoked DVT, cardiology with Dr. ___ IVC filter retrieval, and GI for possible re-scoping to find source of bleeding. - Patient will need IVC filter removal in 3 months from discharge (appointment scheduled with Dr. ___ in 1 month. - Patient will need cancer screening given possibly unprovoked DVT. - Patient will need to discuss with PCP and cardiologist the need for anticoagulation for atrial fibrillation going forward. He was dischared on no form of anticoagulation given recent bleed. ",1731,839
10006825-DS-8,"<SEX> F <SERVICE> PSYCHIATRY <ALLERGIES> Patient recorded as having No Known Allergies to Drugs <ATTENDING> ___. <CHIEF COMPLAINT> ""I've been controlled by a Ouija board."" <MAJOR SURGICAL OR INVASIVE PROCEDURE> None <HISTORY OF PRESENT ILLNESS> Pt says she has been controlled by a Ouija board, it has been making her do bad things like prostituting and leaving her family. She is extremely disorganized and cannot provide a coherent history. Talks a great deal about ___: she has known him since childhood, was his gf previously, has a daughter by him, and is now being pimped and completely controlled by him. She says he follows her everywhere and threatens her. Pt touches on many topics: things that God is helping her. Thinks maybe she has other children she doesn't know about. Thinks maybe she's actually a refugee and wasn't born here. Says ___ current gf is a witch who casts spells. Pt also notes insomnia, says she afraid to sleep b/c she thinks someone may kills her while she sleeps. Also reports ""starving [her]self,"" says she's lost ""a bunch"" of weight but can't quantify. Endorses depressed mood but denies SI or HI currently. <PAST MEDICAL HISTORY> PMH: Pt denies. PPH: Pt reports at least one suicide attempt (""taking pills"") in ___. Pt says she thinks she has been diagnosed with bipolar disorder. Pt's grandmother (___) reports that the pt has been hospitalized several times in the past, with the first time having been in her ___. <SOCIAL HISTORY> ___ <FAMILY HISTORY> FH: Pt's grandmother (___) reports that bipolar disorder runs in the pt's maternal family. Pt also has Uncle with schizophrenia. Drug and ETOH abuse on mom's side of family. <PHYSICAL EXAM> Physical Exam at Admission: Temp: 98.6 HR: 74 BP: 130/88 Resp: 14 O(2)Sat: 100 normal Constitutional: Comfortable HEENT: Normocephalic, atraumatic, Pupils equal, round and reactive to light, Extraocular muscles intact Chest: Clear to auscultation Cardiovascular: Regular Rate and Rhythm, Normal first and second heart sounds Abdominal: Normal Extr/Back: Normal Skin: Normal Neuro: Speech fluent Psych: flight of eyes, calm, cooperative Mental Status Exam at Admission: *APPEARANCE & FACIAL EXPRESSION: Young AA woman, average grooming *POSTURE: Initially lying on the bed. Later sat up on bed ___ as she described it. *BEHAVIOR: Eyes fluttering at half-mast at times. Good eye contact. *ATTITUDE: cooperative *SPEECH: quiet, pressured, difficult to interrupt. *MOOD: ""I feel much better now that I'm tell you all this."" *AFFECT: odd, tearful at times. *THOUGHT FORM: Extremely tangential with some loosening of associations. *THOUGHT CONTENT: delusions re Ouija board, spells being cast on her, idea that she may have other children she doesn't know about. *ABNORMAL PERCEPTIONS: Denies *NEUROVEGETATIVE SYMPTOMS: reports insomnia, poor appetite, starving herself. *SUICIDALITY/HOMICIDALITY: denies SI/HI *INSIGHT AND JUDGMENT: fair/fair *COGNITIVE ASSESSMENT: alert -ORIENTATION: not formally tested, but clearly oriented to self and situation. -ATTENTION: MOYB without error. -MEMORY: ___ at 2 min. Gave ""bunny"" as ___ word in place of ___ -CALCULATIONS: $2.75 = 11 quarters (calculates this out loud as 8 plus three.) -FUND OF KNOWLEDGE (ESTIMATE INTELLIGENCE): Points to Obama t-shirt she is wearing when asked current president. Names ""The ___ ___ as previous president. -PROVERB INTERPRETATION: book/cover = ""Statue of ___"" (mimics upraised arm with torch) -SIMILARITIES/ANALOGIES: bike/train - transportation - but bike is more like exercise <PERTINENT RESULTS> ___ 06: 52PM URINE bnzodzpn-NEG barbitrt-NEG opiates-NEG cocaine-NEG amphetmn-NEG mthdone-NEG ___ 06: 52PM URINE COLOR-Yellow APPEAR-Clear SP ___ ___ 06: 52PM URINE BLOOD-NEG NITRITE-NEG PROTEIN-TR GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-4* PH-7.0 LEUK-NEG ___ 06: 52PM URINE RBC-<1 WBC-1 BACTERIA-FEW YEAST-NONE EPI-4 ___ 09: 45PM GLUCOSE-110* UREA N-14 CREAT-0.9 SODIUM-144 POTASSIUM-3.9 CHLORIDE-106 TOTAL CO2-27 ANION GAP-15 ___ 09: 45PM TSH-0.95 ___ 09: 45PM FREE T4-1.6 ___ 09: 45PM HCG-LESS THAN ___ 09: 45PM ASA-NEG ETHANOL-NEG ACETMNPHN-NEG bnzodzpn-NEG barbitrt-NEG tricyclic-NEG ___ 09: 45PM WBC-9.1 RBC-4.82 HGB-12.0 HCT-36.7 MCV-76* MCH-24.9* MCHC-32.8 RDW-13.5 ___ 09: 45PM NEUTS-62.0 ___ MONOS-4.1 EOS-1.7 BASOS-0.6 ___ 09: 45PM PLT COUNT-412 <MEDICATIONS ON ADMISSION> Patient not currently taking any medications. Patient denies taking any vitamins, dietary supplements, herbs, or OTC medications. Past med trials have included risperidone, sertraline, and ariprizole (obtained from PCP). Per patient she was adamant that she did not like the way that risperidone made her feel. <DISCHARGE MEDICATIONS> 1. Ferrous Sulfate 300 mg (60 mg Iron) Tablet Sig: One (1) Tablet PO DAILY (Daily). Disp: *30 Tablet(s)* Refills: *2* 2. Aripiprazole 15 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). Disp: *30 Tablet(s)* Refills: *0* <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> bipolar affective disorder with psychotic features; r/o schizophrenia and schizoaffective disorer <DISCHARGE CONDITION> Patient is medically stable and safe for discharge. Vitals have been stable and within normal limits. Patient is able to ambulate fully without assistance. Mental Status Exam: Appeareance: pt looks stated age, appropriatly dressed and groomed with good hygiene Behavior: no PMR or PMA Speech: normal rate and volume with good inflection Mood: 'great!' Affect: bright, reactive, apporpriate TP: linear and goal directed TC: no AH/VH/SI/HI, looking forward to discharge and future oriented, no longer dellusional about being controlled by ___ by means of a Ouigi board Insight/judgment: both still limited, though significantly improved since time of discharge <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> You are being discharged to a rooming house. Please keep your scheduled appointments as written below. Importantly, please call ___ (___) the day prior to your appointment with your new therapist ___ in order to confirm your appointment on ___ at 5: 30PM otherwise your appointment will be canceled. Continue to take your medications as prescribed and abstain from drugs and alcohol as they can worsen your condition. ","*Psychiatric: Patient admitted on ___. Presented with paranoid delusions regarding her ex-boyfriend ___, whom she believes had been controlling her with a Ouija board/9 black candles. Patient expressed further concern that she may have multiple other children she doesn't know about. Patient given Lorazepam 1 mg PO Q6H:PRN, but refused anti-psychotic medication initially. On ___, patient agreed to trial of Aripiprazole 10 mg PO daily. On ___, Aripiprazole increased to 15 mg PO daily given limited response to 10 mg dose. Patient showed significant improvement with regard to her thought content. On ___, when asked about whether she thinks ___ could still control her with the Ouija board, she says no because there ""is no board."" Though importantly at this time the patient also demonstrated inappropriate affect in that when she would read section from her autobiography out loud to the treatment team about sexual abuse perpetrated by her father which her and her sister endured during childhood she was smiling and laughing while doing so. On ___ patient's thought process/content normalize and her affect, though odd at times, ceased to be inappropriate. Her thoughts are future-oriented, with plans to live in a rooming house, and to enroll in school. *Behavioral: Patient was in good behavioral control throughout the course of her stay. *Medical: No known medical conditions. Vitals within normal limits and stable throughout course of stay. *Legal: ___ ",1747,303
10006825-DS-9,"<SEX> F <SERVICE> PSYCHIATRY <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> ""People were intimidating me"" <MAJOR SURGICAL OR INVASIVE PROCEDURE> None <HISTORY OF PRESENT ILLNESS> Ms. ___ is a ___ year old woman, with history of bipolar disorder with psychotic features who was seen in the ___ ___ for concerns of paranoia and disorganization. She was found by EMS and brought in to the ___. Patient refused to answer questions on unit stating that it was all in her notes and that she wanted to go to bed. She does feel safe on the unit and doesn't believe anyone here is trying to hurt her. She stated that she was here ""voluntarily"" and can leave when she wants when we discussed legal status. However, she was unwilling to sign any paperwork including the CV this morning as she only wanted to go lay down. Per ___ consult note from ___: ""Patient opened the conversation by referring to herself in the ___ person as ""___"". She stated that her ""inlaw sister"" kicked her out of ""my house"" last night and sister told her to ""have a nice life"". Patient took this to be a threat and since then ""walked all over the place to ___. She then tried to find a bed at multiple shelters however was denied because ""they heard through the grapevine"" that her family did not want her to get a bed. She thinks her family is making threats toward her such as wanting to kill her if she tells this clinician too much information. She believes the phone line is tapped. She said she did not need to further explain the situation to this clinician because this clinician ""already knows"". She then got tired of walking around and called EMS. Patient reported diagnosis of bipolar disorder and PTSD but does not believe she has bipolar disorder. She stated that her therapist ___ at ___ determined that she does not have the disorder and so she has not taken her medications in over a year. Patient denied SI/HI/AVH. She stated she has not slept in over a week and that her energy is high. She has been fasting because she is ""trying to find everything out at once""."" Course in ___: Patient had no behavioral problems in the ___ and did not require restraints. She was medically cleared. ROS: Patient refused to answer questions. <PAST MEDICAL HISTORY> Diagnosed with bipolar with first hospitalization at age ___. About 1 hospitalization per year since then. Last at ___ 1 month ago. Suicide attempt by overdose around age ___ when she gave up custody of eldest daughter to husband. Current therapist ___ at ___; Psychiatrist ___ at ___ in ___. Unknown med trial Per ___ discharge summary ___: ""Pt reports at least one suicide attempt (""taking pills"") in ___. Pt says she thinks she has been diagnosed with bipolar disorder. Pt's grandmother (___) reports that the pt has been hospitalized several times in the past, with the first time having been in her teens."""" Past medical history: Patient denies any medical conditions <SOCIAL HISTORY> Patient reported being born in ___ and being stolen from the hospital and taken to the ___ by her ""inlaw father who was in the army and inlaw mother"". Her biological mother lives in ___ but she cannot contact her because her inlaw family threatened to kill patient if she did. Patient stated having 2 daughters ages ___ and ___ who lives with their father. She went to ___ in ___ and previously worked as a ___. Reported physical and sexual abuse as child. Father would force her to have sex with her sister while he watched. Denied access to weapons. Per ___ discharge summary ___ ""Pt grew up in ___. One older sister. Pt says her father was a ""robber"" and a ""pedophile."" Father was incarcerated for assault on his older daughter. Pt sexually active by age ___ and reports being sexually abused by her father. Pt finished high school and did some work at ___, studying nursing. Has a ___ daughter whose father (___), the pt's pimp, is in legal custody of. Pt says she has known ___ all her life and has been living with him under his control for ""a while."" Prior to admission, patient was living with her a new boyfriend."""" <PHYSICAL EXAM> VS: BP=144/96, HR=95, T=97.8, RR=16, SaO2=94 % on RA * General: NAD. Well-nourished, well-developed. Appears stated age. Dressed in hospital gown, wearing colorful scarf on head. Glasses. Good to fair hygiene. * Gait: normal gait, steady on feet NEUROPSYCHIATRIC EXAMINATION: * Appearance: NAD. Appears stated age. Well kept on examination. * Behavior: Appropriate with good eye contact but not cooperative with interview. * Orientation: refused to answer questions * Mood: ""fine"" * Affect: congruent to stated mood, irritable * Thought Process: could not assess * Thought Content: Some possibly paranoid thoughts about people ""intimidating"" her, however she would not give more details. Does not believe she is in danger in the hospital. * Judgment: Poor. * Insight: Poor. * Speech: Spontaneous. Normal conversational volume, tone, rate, and prosody. COGNITION: Patient refused to participate <PERTINENT RESULTS> ___ 11: 45PM GLUCOSE-101* UREA N-12 CREAT-0.8 SODIUM-141 POTASSIUM-3.6 CHLORIDE-104 TOTAL CO2-27 ANION GAP-14 ___ 11: 45PM estGFR-Using this ___ 11: 45PM ASA-NEG ETHANOL-NEG ACETMNPHN-NEG bnzodzpn-NEG barbitrt-NEG tricyclic-NEG ___ 11: 45PM WBC-10.1* RBC-4.44 HGB-11.2 HCT-35.5 MCV-80* MCH-25.2* MCHC-31.5* RDW-14.6 RDWSD-41.6 ___ 11: 45PM NEUTS-59.8 ___ MONOS-8.9 EOS-0.7* BASOS-0.3 IM ___ AbsNeut-6.05 AbsLymp-3.02 AbsMono-0.90* AbsEos-0.07 AbsBaso-0.03 ___ 11: 45PM PLT COUNT-329 <MEDICATIONS ON ADMISSION> Pt was not taking any medications on admission. <DISCHARGE MEDICATIONS> 1. OLANZapine 5 mg PO DAILY RX *olanzapine 5 mg 1 tablet(s) by mouth QAM Disp #*7 Tablet Refills: *0 2. OLANZapine 10 mg PO QHS RX *olanzapine 10 mg 1 tablet(s) by mouth at bedtime Disp #*7 Tablet Refills: *0 <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Schizoaffective Disorder <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> -please attend your apointments -please take your medications as prescribed ","SAFETY: The pt. was placed on 15 minute checks on admission and remained here on that level of observation throughout. She was unit-restricted. There were no acute safety issues during this hospitalization. LEGAL: ___ PSYCHIATRIC: #Acute mania: schizoaffective disorder vs. bipolar I disorder Ms. ___ presentation of elevated mood, reduced sleep with increased energy, distractability, and mildly pressured speech was considered consistent with acute mania. Her symptoms of disorganized thought process and behavior were consistent with acute psychosis, likely related to her current manic episode. On admission, she refused to take risperidone or zyprexa. She said that she would take latuda. However, she then refused latuda. She ultimately agreed to take zyprexa, and she was started on zyprexa 5mg PO BID. This dose was then increased to zyprexa 5mg PO QAM and 10mg PO QHS. She was also treated with ativan 1mg PO BID, which was then reduced to 1mg PO daily and then stopped. On this medication regimen, she gradually improved. She began sleeping and her psychotic symptoms of paranoid delusions and disorganized thought process resolved. At the time of discharge, she was sleeping well and had become less disorganized. She reported a ""good"" mood and felt like she was back to her baseline. She denied suicidal or homicidal ideation. GENERAL MEDICAL CONDITIONS: None PSYCHOSOCIAL: #) GROUPS/MILIEU: Pt intermittently attended groups. #) COLLATERAL CONTACTS: None #) FAMILY INVOLVEMENT: none #) INTERVENTIONS: INFORMED CONSENT: Pt was informed of the risks and benefits of treatment as well as alternatives, including no treatment. RISK ASSESSMENT: #) Chronic/Static Risk Factors: -chronic mental illness #) Modifiable Risk Factors: -psychosocial stressors -medication non-compliance -single status #) Protective Factors: Outpatient treaters PROGNOSIS: Poor to fair Ms. ___ has a history of medication non-compliance and multiple past hospitalizations. If she is compliant with her medication, she may do fairly well. However, if she stops taking her medications after discharge, she is at a high risk for relapse. Therefore, close outpatient follow-up will be necessary. ",1578,503
10007058-DS-2,"<SEX> M <SERVICE> MEDICINE <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> Chest pain <MAJOR SURGICAL OR INVASIVE PROCEDURE> ___ - Percutaneous coronary intervention with thrombectomy and no stent <HISTORY OF PRESENT ILLNESS> Mr. ___ is a healthy ___ year-old male who presented with back pain and chest pain following a crossfit work-out and was found to have a dissection of the abdominal aorta in addition to new q waves on EKG and a mildly elevated troponin. The patient reports that he had a strenuous work-out the morning of admission. At home, shortly following the work-out, he experienced acute onset back pain across his back below the clavicle. This was associated with a cold sweat. The pain did not subside and when the patient tried to climb his stairs at home, he felt extremely week and thus presented to the ___ at ___. Upon presentation his back pain began to subside but he did begin to experience some mild central chest pain. At the ___, he was hemodynamically stable. An EKG was obtained which demonstrated new inferior q waves and a troponin was measured at 0.04. A CTA was obtained which demonstrated an abdominal aortic dissection of the infrarenal aorta. He was therefore transferred to ___ for further care. Here CT repeated  still no ascending dissection. Overnight echocardiogram poor quality, no obvious WMA. This mornings echo showed slight inferior HK. Cardiac biomarkers rising and pt noted to have Q waves with slight STEs inferiorly. He went to cath and was found to have a RCA lesion. He had a thrombectomy with no stent and has a 50% residual distal RCA stenosis. Admitted to the CCU for further monitoring. Vitals on transfer were: T 98.2, HR 63, BP 123/71, RR 21, 99% RA. On the floor, patient reports that he feels ""great"" with no chest pain, back pain, shoulder pain or SOB. Only complaint is of mild lower abdominal dull pain. <PAST MEDICAL HISTORY> PCP ___ ___ EKG with first-degree heart block sinus bradycardia, pt is asymptomatic, no further actions GERD L4/L5 microdiscectomy Otherwise healthy <SOCIAL HISTORY> ___ <FAMILY HISTORY> Father: angioplasty, afib Mother: afib ___ grandfather may have had MI Otherwise mainly history of cancer (lung) No family history of early MI, arrhythmia, cardiomyopathies, or sudden cardiac death; otherwise non-contributory. <PHYSICAL EXAM> ADMISSION PHYSICAL EXAM: -======= VS: T 98.2, HR 63, BP 123/71, RR 21, 99% RA Gen: Pleasant gentleman, NAD HEENT: MMM NECK: no JVP elevation CV: RRR, no murmurs, rubs, gallops LUNGS: CTAB, no wheezes ABD: soft, +BS, mild tenderness in mid lower quadrant EXT: warm, well-perfused, +pulses SKIN: warm, dry, no rashes or lesions NEURO: A&Ox3, CNII-XII grossly intact DISCHARGE PHYSICAL EXAM: -======= VS: T 98.2, HR 60-70s, BP 120s/70s, RR ___, 97-99% RA Gen: Pleasant gentleman, NAD HEENT: MMM NECK: no JVP elevation CV: RRR, no murmurs, rubs, gallops LUNGS: CTAB, no wheezes ABD: soft, +BS, mild tenderness in mid lower quadrant EXT: warm, well-perfused, +pulses SKIN: warm, dry, no rashes or lesions NEURO: A&Ox3, CNII-XII grossly intact <PERTINENT RESULTS> Admission Labs: -== ___ 06: 15PM BLOOD WBC-11.3* RBC-4.61 Hgb-13.4* Hct-40.5 MCV-88 MCH-29.1 MCHC-33.1 RDW-12.9 RDWSD-41.2 Plt ___ ___ 06: 15PM BLOOD Neuts-76.8* Lymphs-15.5* Monos-7.2 Eos-0.0* Baso-0.2 Im ___ AbsNeut-8.67* AbsLymp-1.75 AbsMono-0.81* AbsEos-0.00* AbsBaso-0.02 ___ 06: 15PM BLOOD ___ PTT-27.9 ___ ___ 06: 15PM BLOOD Glucose-99 UreaN-15 Creat-1.0 Na-137 K-4.1 Cl-102 HCO3-27 AnGap-12 ___ 12: 19AM BLOOD CK(CPK)-2278* ___ 06: 15PM BLOOD CK-MB-52* ___ 12: 19AM BLOOD Calcium-8.8 Phos-2.9 Mg-2.0 Discharge Labs: -== ___ 06: 40AM BLOOD WBC-6.1 RBC-4.14* Hgb-11.9* Hct-37.3* MCV-90 MCH-28.7 MCHC-31.9* RDW-12.8 RDWSD-42.0 Plt ___ ___ 06: 40AM BLOOD ___ PTT-28.4 ___ ___ 06: 40AM BLOOD Glucose-92 UreaN-13 Creat-0.9 Na-138 K-4.1 Cl-101 HCO3-26 AnGap-15 ___ 10: 45AM BLOOD CK(CPK)-713* ___ 06: 40AM BLOOD Calcium-9.3 Phos-4.3 Mg-2.0 ___ 04: 55AM BLOOD %HbA1c-5.2 eAG-103 ___ 11: 26AM BLOOD Triglyc-627* HDL-65 CHOL/HD-2.6 LDLmeas-73 ___ 04: 24AM BLOOD CRP-2.8 Troponin Trend: -== ___ 06: 15PM BLOOD cTropnT-0.21* ___ 12: 19AM BLOOD CK-MB-157* MB Indx-6.9* cTropnT-0.70* ___ 03: 58AM BLOOD CK-MB-178* MB Indx-7.3* cTropnT-1.37* ___ 09: 58AM BLOOD CK-MB-171* MB Indx-6.7* cTropnT-1.82* ___ 04: 24AM BLOOD cTropnT-2.77* ___ 11: 26AM BLOOD CK-MB-3 cTropnT-<0.01 CK Trend: ========= ___ 12: 19AM BLOOD CK(CPK)-2278* ___ 03: 58AM BLOOD CK(CPK)-2432* ___ 09: 58AM BLOOD CK(CPK)-2562* ___ 11: 26AM BLOOD CK(CPK)-74 Micro: ======= RPR: Imaging: ========= CTA ___: 1. Infrarenal abdominal aortic aneurysm as detailed above originating at the level of the ___ and extending into the proximal right common iliac artery. No significant change compared to recent CT. 2. Normal thoracic aorta without dissection. CXR ___: Lungs are fully expanded and clear. Cardiomediastinal and hilar silhouettes and pleural surfaces are normal. EKG (___): NSR, nl axis, no ST changes TTE (___): The left atrium is mildly dilated. No atrial septal defect is seen by 2D or color Doppler. Left ventricular wall thickness, cavity size and regional/global systolic function are normal (LVEF >55%). There is no ventricular septal defect. Right ventricular chamber size and free wall motion are normal. An aortic dissection cannot be excluded. The aortic valve leaflets (3) appear structurally normal with good leaflet excursion and no aortic stenosis or aortic regurgitation. The mitral valve leaflets are structurally normal. Mild (1+) mitral regurgitation is seen. The pulmonary artery systolic pressure could not be determined. There is no pericardial effusion. CARDIAC CATH (___): RCA occluded with thrombus in mid- to distal-vessel. LAD and circumflex free of disease. <MEDICATIONS ON ADMISSION> None. <DISCHARGE MEDICATIONS> 1. TiCAGRELOR 90 mg PO BID RX *ticagrelor [BRILINTA] 90 mg 1 tablet(s) by mouth twice a day Disp #*60 Tablet Refills: *6 2. Atorvastatin 80 mg PO QPM RX *atorvastatin 80 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills: *6 3. Aspirin EC 81 mg PO DAILY RX *aspirin 81 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills: *6 4. Metoprolol Succinate XL 12.5 mg PO DAILY RX *metoprolol succinate 25 mg 0.5 (One half) tablet(s) by mouth daily Disp #*30 Tablet Refills: *6 5. Nitroglycerin SL 0.3 mg SL Q5MIN: PRN chest pain RX *nitroglycerin 0.4 mg 1 tablet(s) sublingually q5min Disp #*15 Tablet Refills: *0 <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Primary diagnosis: - TYPE B AORTIC DISSECTION - ACUTE CORONARY SYNDROME <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Mr. ___, You came to the hospital because you were having chest pain. We found that you were having a heart attack and we broke down a clot from one of your hearts blood vessels to treat that. Other imaging found that the wall of your large blood vessel, the aorta had formed a slit called a dissection. The vascular surgeons and did not think you needed to have a surgical repair at this time. It will be very important for you to keep good control of your blood pressure, and follow-up with the vascular surgeons, your PCP, and your new cardiologist (Drs. ___ and ___. Should you have any chest pain, please use the nitroglycerin pills we have prescribed for you. Take up to three pills, spaced 5 minutes apart. If the pain does not go away after this, call ___. If your pain does go away, call either Dr. ___ Dr. ___ an appointment. Finally, we have started you on several new medications because of your heart attack. These are very important, and must be taken every day. They are: 1) Ticagrelor (Brillinta) 90 mg twice a day. This will be continued for at least 3 months, and potentially as long as 9 months. The duration of this will be decided in follow-up appointments with Dr. ___ 2) Aspirin 81 mg daily, likely for the forseeable future 3) Metoprolol succinate 12.5 mg daily, on an ongoing basis 4) Atorvastatin 80 mg daily, on an ongoing basis It was a pleasure taking care of you! Your ___ Team ","___ y/o previously healthy gentleman presenting with a type B aortic dissection complicated by an NSTEMI in the context of a cross-fit workout. # CORONARIES: 50% distal RCA occlusion, LAD and circumflex clean # PUMP: EF > 55% # RHYTHM: normal #) TYPE B AORTIC DISSECTION: Mr. ___ is a healthy ___ year-old male who presented with back pain and chest pain following a crossfit work-out and was found to have a dissection of the abdominal aorta. The dissection was located just beneath the takeoff of the ___, and terminating at the proximal most aspect of the right common iliac artery. Although he is a male he has no other clear risk factors, including HTN, age, CAD, vasculitis, bicuspid aortic valve, family history, h/o AVR, or cocaine use. We continued tight BP control - SBP<140 with IV/PO BB. He had no evidence on exam or imaging of end-organ or lower extremity ischemia. Therefore, the is no indication for emergent vascular surgery intervention. He will need f/u imaging in 6 months and will follow up with ___. His ESR and CRP were within normal limits and his RPR was not reactive. #) ACUTE CORONARY SYNDROME: He went to cath and was found to have a RCA lesion. He had a thrombectomy with no stent and has a 50% residual distal RCA stenosis. Admitted to the CCU for further monitoring after thrombectomy and we continued heparin 24h after procedure (starting it 4 hours after procedure). The patient is a Killip Class I indicating 6% mortality based on an updated study in JAMA performed at ___ and ___ published in ___. We continued aspirin 81mg daily, ticagrelor 90 BID, atorvastatin 10mg daily. TRANSITIONAL ISSUES: ========================= [] f/u aortic imaging in 6 months ",2606,428
10007134-DS-16,"<SEX> M <SERVICE> SURGERY <ALLERGIES> No Allergies/ADRs on File <ATTENDING> ___ <CHIEF COMPLAINT> Left chest pain <MAJOR SURGICAL OR INVASIVE PROCEDURE> None <HISTORY OF PRESENT ILLNESS> Mr. ___ is a ___ year old man who was sleeping lying on a driveway and was run over by backing out car, causing 3 left ribs fracture. <PAST MEDICAL HISTORY> DM (not treated) ? head aneurysm ___ years ago, seen in ___ <SOCIAL HISTORY> ___ <FAMILY HISTORY> non-contributory <PHYSICAL EXAM> PHYSISCAL EXAM ON ADIMSSION (___) Constitutional: Comfortable, intoxicated HEENT: Pupils equal, round and reactive to light, Normocephalic, atraumatic Ccollar in place Chest: Clear to auscultation, diffuse tenderness, L crepitus Cardiovascular: Regular Rate and Rhythm Abdominal: Soft, Nontender Extr/Back: No cyanosis, clubbing or edema Skin: abrasions to anterior chest wall Neuro: GCS 14 ( -1 for spont eye opening), otherwise intact Psych: Normal mood PHYSISCAL EXAM ON DISCHARGE (___) Constitutional: Comfortable, AAOX3 HEENT: Pupils equal, round and reactive to light, normocephalic Chest: Clear to auscultation, mild diffuse tenderness on anterior chest wall Cardiovascular: Regular Rate and Rhythm, no m/r/g Abdominal: Soft, Nontender, non-distended, no organomegaly Extr/Back: No cyanosis, clubbing or edema Skin: abrasions to anterior chest wall Neuro: GCS 15, strength ___ Psych: Normal mood <PERTINENT RESULTS> LAB RESULTS ___ 08: 45AM BLOOD WBC-7.6 RBC-4.12* Hgb-13.3* Hct-40.4 MCV-98 MCH-32.3* MCHC-32.9 RDW-15.5 RDWSD-55.6* Plt ___ ___ 06: 02AM BLOOD WBC-7.9 RBC-4.02* Hgb-13.1* Hct-38.1* MCV-95 MCH-32.6* MCHC-34.4 RDW-14.7 RDWSD-51.2* Plt ___ ___ 08: 47AM BLOOD WBC-7.2 RBC-4.13* Hgb-13.3* Hct-39.5* MCV-96 MCH-32.2* MCHC-33.7 RDW-14.8 RDWSD-51.8* Plt ___ ___ 05: 35AM BLOOD WBC-7.8 RBC-3.99* Hgb-12.9* Hct-38.7* MCV-97 MCH-32.3* MCHC-33.3 RDW-14.6 RDWSD-52.1* Plt ___ ___ 05: 35AM BLOOD Plt ___ ___ 08: 47AM BLOOD Plt ___ ___ 08: 45AM BLOOD Plt ___ ___ 05: 35AM BLOOD Glucose-159* UreaN-5* Creat-0.6 Na-132* K-3.5 Cl-94* HCO3-26 AnGap-16 ___ 08: 47AM BLOOD Glucose-126* UreaN-8 Creat-0.7 Na-130* K-3.9 Cl-91* HCO3-22 AnGap-21* ___ 06: 02AM BLOOD Glucose-149* UreaN-8 Creat-0.6 Na-132* K-3.7 Cl-92* HCO3-26 AnGap-18 ___ 05: 35AM BLOOD Calcium-8.8 Phos-2.6* Mg-1.8 ___ 08: 47AM BLOOD Calcium-8.9 Phos-1.2* Mg-2.0 ___ 08: 45AM BLOOD Calcium-8.8 Phos-3.8 Mg-1.8 IMAGING CXR (___) IMPRESSION: Small amount of subcutaneous emphysema along the mid left lateral chest wall with concern for nondisplaced fracture of the left sixth and seventh ribs. CT pending CT SPINE (___) 1. No acute traumatic abnormality. 2. Severe paraseptal emphysema. 3. Small left thyroid nodule could be further evaluate dedicated ultrasound, if clinically indicated. CT HEAD (___) IMPRESSION: 1. Left lamina papyracea probable chronic fracture. 2. No intracranial hemorrhage. CT TORSO (___) IMPRESSION: 1. Small left pneumothorax with adjacent anterolateral left fifth through seventh rib fractures and small amount of adjacent subcutaneous emphysema. 2. Small foci of cortical regularity in the anterior right ribs may reflect a nutrient foramen. If pain is present in this location, however, subtle nondisplaced fractures could be considered. 3. Severe paraseptal emphysema with a significant component of centrilobular emphysema. 4. Scattered calcified pulmonary granulomas likely reflect prior granulomatous infection. CXR (___) IMPRESSION: Small left pneumothorax, more fully assessed by recent CT. CXR (___) IMPRESSION: Resolution of pneumothorax. Unchanged left sixth and seventh rib fractures. No other acute cardiopulmonary process. <MEDICATIONS ON ADMISSION> None <DISCHARGE MEDICATIONS> OxyCODONE (Immediate Release) ___ mg PO/NG Q3H: PRN Pain - Moderate Lidocaine 5% Patch 1 PTCH TD QAM Ketorolac 30 mg IV Q8H Docusate Sodium 100 mg PO/NG BID <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Left ___ rib fracture Left small apical pneumothorax <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Mr. ___, You were admitted to ___ for rib fractures and were treated conservatively. You are recovering well and are now ready for discharge. Please follow the instructions below to continue your recovery: * Your injury caused 3 rib fractures which can cause severe pain and subsequently cause you to take shallow breaths because of the pain. * You should take your pain medication as directed to stay ahead of the pain otherwise you won't be able to take deep breaths. If the pain medication is too sedating take half the dose and notify your physician. * Pneumonia is a complication of rib fractures. In order to decrease your risk you must use your incentive spirometer 4 times every hour while awake. This will help expand the small airways in your lungs and assist in coughing up secretions that pool in the lungs. * You will be more comfortable if you use a cough pillow to hold against your chest and guard your rib cage while coughing and deep breathing. * Symptomatic relief with ice packs or heating pads for short periods may ease the pain. * Narcotic pain medication can cause constipation therefore you should take a stool softener twice daily and increase your fluid and fiber intake if possible. * Do NOT smoke * If your doctor allows, non-steroidal ___ drugs are very effective in controlling pain ( ie, Ibuprofen, Motrin, Advil, Aleve, Naprosyn) but they have their own set of side effects so make sure your doctor approves. * Return to the Emergency Room right away for any acute shortness of breath, increased pain or crackling sensation around your ribs (crepitus). ","The patient presented to Emergency Department on ___. Upon arrival to ED the patient was evaluated for anterior chest pain. Several imaging studies were done including CXR, CT scan of Torson, spine and head showing only left ___ ribs fracture and a small apical pneumothorax which did not need placement of a chest tube. He was admitted to the floor for pain control. Neuro: The patient was alert and oriented throughout hospitalization; pain was initially managed with a dilaudid PCA and then transitioned to oral oxycodone, ketorolac and a lidocaine patch. CV: The patient remained stable from a cardiovascular standpoint; vital signs were routinely monitored. Pulmonary: The patient remained stable from a pulmonary standpoint; vital signs were routinely monitored. Good pulmonary toilet, early ambulation and incentive spirometry were encouraged throughout hospitalization. GI/GU/FEN: Patient was always on a regular diet and with bathroom privileges. ID: The patient's fever curves were closely watched for signs of infection, of which there were none. HEME: The patient's blood counts were closely watched for signs of bleeding, of which there were none. Prophylaxis: The patient received subcutaneous heparin and ___ dyne boots were used during this stay and was encouraged to get up and ambulate as early as possible. At the time of discharge, the patient was doing well, afebrile and hemodynamically stable. The patient was tolerating a diet, ambulating, voiding without assistance, and pain was well controlled. The patient received discharge teaching and follow-up instructions with understanding verbalized and agreement with the discharge plan. ",1725,337
10007174-DS-11,"<SEX> M <SERVICE> MEDICINE <ALLERGIES> Penicillins / Sulfa (Sulfonamide Antibiotics) / vancomycin / levofloxacin / acyclovir / Lipitor / lisinopril / amlodipine <ATTENDING> ___. <CHIEF COMPLAINT> abdominal pain and diarrhea <MAJOR SURGICAL OR INVASIVE PROCEDURE> none <HISTORY OF PRESENT ILLNESS> Mr. ___ is a ___ year old man with history of DVT and PE on coumadin, T2DM, HTN, large smoking history, Crohn's, multiple SBOs and abdominal surgeries who presents with right side abdominal pain and diarrhea. 2 weeks prior to admission Mr. ___ was in his usual state of health when he began experiencing watery diarrhea ___ times per day which consisted mostly of water with small pieces of stool as well as what he describes as ""rectal pain"" and diffuse pain across his entire abdomen. His watery diarrhea continued when 4 days prior to admission he began noticing bright red blood on the toilet tissue and occasional blood mixed in with his stool. 2 days prior to admission, Mr. ___ developed sharp episodic non-radiating right side abdominal pain which came every ___ minutes then gradually dissipated. Of note, he admits to experiencing nightsweats, increased satiety, increased belching and increased flatulence for the past 2 weeks, and 50lb weight loss over the past year. He also notes one episode of hematuria 2 weeks ago with the onset of his symptoms, rhinorrhea, and increased urinary frequency of late which is consistent with his past UTIs. He denies any fever, chills, vomiting, sick contacts, recent travel, change in diet, change in his pain with eating, dysuria, shortness of breath, or chest pain. Also of note, Mr. ___ had 7 sessile polyps removed during colonoscopy on ___, and was found to have multiple colonic diverticula at this time. On ___ multiple biopsies were taken without any evidence of colitis. In the ED, initial vitals were: 98.7 74 145/99 18 100% ED Labs: significant for INR 2.6, lipase 108, CRP 2.1, positive UA ED Studies: CT Abdomen and pelvis with contrast - showed no acute intraabdominal process, small bowel containing hernia adjacing to surgical scarring in the RLQ without evidence of obstruction UA - Lg leuk, 68 WBC, few bacteria, trace protein ED Course: The patient was given morphine 5mg x1 and zofran 4mg x1. He was admitted for further workup of abdmominal pain and bloody diarrhea. Vitals prior to transfer were: 98.9 69 125/66 17 100% RA. Upon transfer, Mr. ___ continued to complain of R sided abdominal pain. <PAST MEDICAL HISTORY> -Diabetes mellitus with renal manifestation -Hyperlipidemia -Colon adenomas -Hypertension, essential, benign -PANIC DISORDER W/O AGORAPHOBIA -DEPRESSIVE DISORDER -Pulmonary nodule/lesion, solitary -Crohn's disease -NEUROPATHY, UNSPEC -History of pulmonary embolism -Coronary artery disease -History of obesity -COPD, moderate -___ disease -CKD (chronic kidney disease) stage 1, GFR 90 ml/min or greater -PUD c/b perforation, s/p laparotomy, colostomy and reversal -multiple hernia surgeries -open cholecystectomy <SOCIAL HISTORY> ___ <FAMILY HISTORY> No family GI history Father - had emphysema Mother - had CAD, PVD, and RA Sister - had TTP <PHYSICAL EXAM> ADMISSION PHYSICAL EXAM: Vitals: T 97.8 BP 112/58 HR 58 RR 18 Sat 96%RA Wt 74.7kg General: Alert, oriented, no acute distress HEENT: Sclera anicteric, PERRL, MMM, oropharynx clear of erythema and exudate Neck: supple, no LAD or masses. Lungs: Clear to auscultation bilaterally, no wheezes, rales, rhonchi CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Abdomen: soft, non-distended, Moderately tender at border between RUQ and RLQ. Bowel sounds present in all quadrants, no rebound tenderness or guarding. Multiple large ~1cm external hemorrhoids and erythema on rectal exam. Ext: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema Skin: Dry. Normal texure and temperature. Few echymmoses on right wrist. Neuro: CN II-XII intact. Full ___ strength in UE and ___ bilaterally. Sensation to light touch grossly intact in face, UE, and ___ bilaterally. DISCHARGE PHYSICAL EXAM: Vitals: Tm 98.5 Tc 98.3 BP 127/60 (106-130/45-60) HR 68 (55-68) RR 20 Sat 98%RA General: Alert, oriented, no acute distress HEENT: Sclera anicteric, PERRL, MMM, oropharynx clear of erythema and exudate Neck: supple, no LAD or masses. Lungs: Clear to auscultation bilaterally, no wheezes, rales, rhonchi CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Abdomen: soft, non-distended, Moderately tender at border between RUQ and RLQ. Bowel sounds present in all quadrants, no rebound tenderness or guarding. Multiple large ~1cm external hemorrhoids and erythema on rectal exam. Ext: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema Skin: Dry. Normal texure and temperature. Few echymmoses on right wrist. Neuro: CN II-XII intact. Full ___ strength in UE and ___ bilaterally. Sensation to light touch grossly intact in face, UE, and ___ bilaterally. <PERTINENT RESULTS> ADMISSION LABS ___ 04: 20PM GLUCOSE-91 UREA N-13 CREAT-0.9 SODIUM-142 POTASSIUM-4.4 CHLORIDE-104 TOTAL CO2-26 ANION GAP-16 ___ 04: 20PM WBC-9.8 RBC-5.31 HGB-11.2* HCT-37.9* MCV-71* MCH-21.1* MCHC-29.6* RDW-18.4* RDWSD-44.9 ___ 04: 20PM PLT COUNT-231 ___ 04: 20PM URINE COLOR-Yellow APPEAR-Clear SP ___ ___ 04: 20PM URINE BLOOD-NEG NITRITE-NEG PROTEIN-TR GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-6.0 LEUK-LG ___ 04: 20PM URINE RBC-0 WBC-68* BACTERIA-FEW YEAST-NONE EPI-1 MICROBIOLOGY ___ Blood cx pending Urine culture ___ 4: 39 pm URINE Site: NOT SPECIFIED ADDED TO CHEM ___. **FINAL REPORT ___ URINE CULTURE (Final ___: ESCHERICHIA COLI. 10,000-100,000 ORGANISMS/ML.. PRESUMPTIVE IDENTIFICATION. Cefazolin interpretative criteria are based on a dosage regimen of 2g every 8h. SENSITIVITIES: MIC expressed in MCG/ML _________________________________________________________ ESCHERICHIA COLI | AMPICILLIN------------ <=2 S AMPICILLIN/SULBACTAM-- <=2 S CEFAZOLIN------------- <=4 S CEFEPIME-------------- <=1 S CEFTAZIDIME----------- <=1 S CEFTRIAXONE----------- <=1 S CIPROFLOXACIN---------<=0.25 S GENTAMICIN------------ <=1 S MEROPENEM-------------<=0.25 S NITROFURANTOIN-------- <=16 S PIPERACILLIN/TAZO----- <=4 S TOBRAMYCIN------------ <=1 S TRIMETHOPRIM/SULFA---- <=1 S DISCHARGE LABS ___ 05: 43AM BLOOD WBC-6.5 RBC-4.80 Hgb-10.1* Hct-34.2* MCV-71* MCH-21.0* MCHC-29.5* RDW-18.0* RDWSD-44.7 Plt ___ ___ 05: 43AM BLOOD ___ PTT-38.6* ___ ___ 05: 43AM BLOOD Glucose-112* UreaN-9 Creat-0.9 Na-142 K-4.0 Cl-106 HCO3-27 AnGap-13 ___ 05: 43AM BLOOD Calcium-8.8 Phos-3.4 Mg-1.8 <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Omeprazole 20 mg PO BID 2. MetFORMIN (Glucophage) 1000 mg PO BID 3. GlipiZIDE 10 mg PO DAILY 4. Losartan Potassium 50 mg PO DAILY 5. Metoprolol Tartrate 25 mg PO DAILY 6. Aspirin 81 mg PO DAILY 7. Warfarin 3 mg PO DAILY16 8. Rosuvastatin Calcium 20 mg PO QPM 9. TraZODone 100 mg PO DAILY 10. Lorazepam 1 mg PO Q6H: PRN anxiety <DISCHARGE MEDICATIONS> 1. Aspirin 81 mg PO DAILY 2. Lorazepam 1 mg PO Q6H: PRN anxiety 3. Losartan Potassium 50 mg PO DAILY 4. Metoprolol Tartrate 25 mg PO DAILY 5. Omeprazole 20 mg PO BID 6. Rosuvastatin Calcium 20 mg PO QPM 7. Warfarin 3 mg PO DAILY16 8. Acetaminophen 1000 mg PO Q8H: PRN abdominal pain RX *acetaminophen [Pain Reliever] 500 mg 2 capsule(s) by mouth every 8 hours Disp #*30 Capsule Refills: *0 9. Cefpodoxime Proxetil 400 mg PO Q12H Last dose should be administered ___ RX *cefpodoxime 200 mg 2 tablet(s) by mouth twice daily Disp #*20 Tablet Refills: *0 10. GlipiZIDE 10 mg PO DAILY 11. MetFORMIN (Glucophage) 1000 mg PO BID 12. TraZODone 100 mg PO DAILY 13. Ferrous GLUCONATE 324 mg PO DAILY RX *ferrous gluconate 324 mg (37.5 mg iron) 1 tablet(s) by mouth daily Disp #*30 Tablet Refills: *0 14. Outpatient Lab Work ICD9: V12.51 Please check INR ___. Please fax results to: ___, RN - ___ Please fax results to ___ <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Diarrhea Bleeding Hemorrhoids <DISCHARGE CONDITION> Stable <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Mr. ___, You were admitted to ___ because you had a 2 week course of diarrhea, abdominal pain and nausea. A CT Scan of your abdomen showed a hernia but showed no signs of a small bowel obstruction. We performed a rectal exam and identified multiple external hemorrhoids which likely caused the bleeding you noticed recently with your diarrhea. You were also found to have a urinary tract infection for which we gave you antibiotics that you will continue to take (by mouth) for another 4 days through ___. You were also found to have iron deficiency, for which you will take an iron supplement daily. You should continue to take the Tylenol that we prescribed for your abdominal pain until it resolves, and should apply the hydrocortisone cream for one week we prescribed for your hemorrhoids as needed. Lastly, we recommend that you eat a diet high in fiber to prevent future development or worsening of your hemorrhoids. It is very important that you follow up with your primary care physician and take your medications as prescribed. Please have your INR checked on ___. We wish you the best! Sincerely, Your ___ medical team ","Mr. ___ is a ___ year old man with history of DVT and PE on coumadin, T2DM, HTN, large smoking history, Crohn's, multiple SBOs and abdominal surgeries who presented with right side abdominal pain and diarrhea. #Abdominal pain and diarrhea/brbpr: Likely secondary to external hemorrhoids and infectious enteritis. Mr. ___ reported sharp episodic non-radiating right side abdominal pain which came every ___ minutes then gradually dissipated before returning again. He had one loose, non-bloody bowel movement while in the ED but had no diarrhea during his hospitalization despite reporting a two week history of watery, non-bloody bowel movements ___ times per day which became tinged with blood 4 days prior to admission. CRP was wnl, CT A/P showed a hernia containing bowel but was negative for fat stranding, mesenteric lymphadenopathy, and bowel obstruction. Rectal exam revealed multiple large external hemorrhoids. He was given Tylenol for pain and tolerated a clear liquids diet. He was started on a topical hydrocortisone BID for external hemorrhoids. He was evaluated by the surgical team given his hx of multiple abdominal surgeries and hernia, however no surgical intervention was advised. #Complicated Urinary Tract Infection: On admission Mr. ___ reported increased urinary frequency consistent with past UTIs. UA done in the ED was positive, so he was started on a 7 day course of Ceftriaxone 1g IV in the ED, and completed ___ days of the course during his hospital stay. Urine culture grew pan-sensitive E. coli. He was switched to PO Cefpodoxime for continuation of the remaining 5 days of this antibiotic course upon discharge. Given his history of multiple UTIs, Mr. ___ complicated UTI was believed to be secondary to urinary tract structural abnormality vs. prostatic enlargement. #Microcytic Anemia: Mr. ___ had low H/H with low MCV in the ED that persisted throughout his hospital stay. Iron studies showed iron deficiency anemia. He was started on Ferrous gluconate 324mg daily. His microcytic anemia was believed to be secondary to chronic bleeding from hemorrhoids vs. nutritional deficiency. Slow bleeding from occult GI malignancy is also possible. #Hypomagnesemia: On admission Mr. ___ was found to have low magnesium. He was given Magnesium Oxide, after which his magnesium level normalized. This hypomagnesemia was believed to be secondary to diarrhea in the setting of infectious enteritis vs. colitis. #Weight loss/Fe deficiency anemia: Mr. ___ reported unintentional 50lb weight loss over the past year. PSA sent on admission was within normal limits. Serum TSH level was sent as further workup of his weight loss, and will be followed up after discharge. Further workup for malignancy should be considered in the outpatient setting. #T2DM: Mr. ___ was started on Humalog sliding scale upon admission. His blood glucose remained stable throughout the admission. He will be restarted on his diabetes regimen of Glipizide and Metformin upon discharge. #History of PE and DVT: Mr. ___ was continued on his home dose of warfarin during his hospitalization and his INR remained therapeutic. He should continue this warfarin dosage after discharge, with periodic f/u by PCP to test INR. #Coronary artery disease: Mr. ___ was continued on his home dosages of ASA and Rosuvastatin during this hospitalization given his history of coronary artery disease. #Peptic Ulcer Disease: Continued on his home dosage of Omeprazole during this hospitalization given his history of peptic ulcer disease. #HTN: Continued on his home dosage of Metoprolol tartrate for HTN during this hospitalization with good blood pressure control. #HLD: Continued on his home dosage of Rosuvastatin during this hospitalization. #Insomnia: Continued on his home dosage of Trazodone for insomnia during this hospitalization. #Panic Disorder with Agoraphobia: Continued on his home dosage of Lorazepam PRN for panic disorder during this hospitalization. He did not require any administrations of the Lorazepam during his stay. ==================== TRANSITIONAL ISSUES: ==================== -Continue topical hydrocortisone 0.2% ointment for one week only given risk for thinning of skin with prolonged steroid use. -Continue Cefpodoxime 400mg PO BID to be started on ___ and continue until ___ (Day ___. -Follow-up urine culture sensitivities -Continue Ferrous gluconate 324mg PO q24h for iron deficiency anemia and consider further w/u for etiology. Consider w/u of malignancy in the setting of iron deficiency anemia, night sweats, and weight loss. -Followup TSH after discharge and notify PCP for further workup if necessary. #CODE STATUS: Full code. #CONTACT: ___ (niece) ___ ",2842,1054
10007174-DS-12,"<SEX> M <SERVICE> MEDICINE <ALLERGIES> Penicillins / Sulfa (Sulfonamide Antibiotics) / vancomycin / levofloxacin / acyclovir / Lipitor / lisinopril / amlodipine <ATTENDING> ___. <CHIEF COMPLAINT> LLE pain and redness <MAJOR SURGICAL OR INVASIVE PROCEDURE> none <HISTORY OF PRESENT ILLNESS> Patient is a ___, with a PMHx of NIDDM, PE (on coumadin), CKD, CAD, and s/p fall 1 week ago c/b L knee hemearthrosis who presents with LLE pain, swelling and redness. He states that for the last 5 days, he has been noticing bruising on his L leg, mostly on the medial aspect of his R thigh. However, yesterday he noticed worsening swelling of the distal ___ of his LLE and a warm rash on his L shin. The rash was worse today, prompting presentation. He endorses significant pain in both his L knee and L shin. He denies F/C, abdominal pain, N/V. He has also been having difficulty ambulating ___ pain and has been requiring cane. Of note, patient was recently admitted ___ with abdominal pain, diarrhea, and BRBPR, with course complicated by UTI. GI symptoms were felt to be due to external hemorrhoids and infectious enteritis. UTI was secondary to pan-sensitive E coli for which patient was treated with IV ceftriaxone and discharged on cefpodoxime. Antibiotic course ended on ___. He states that his diarrhea has improved, as has the rectal bleeding. He now states that the diarrhea is only occasional and the bleeding has significantly improved. He was also seen in the ED on ___ with L knee pain after a mechanical fall. Xray at ___ showed no fracture. CT at ___ showed hematome and no occult fracture. He was seen by ortho and ___ who felt that patient was safe for discharge. He was seen by home ___ after discharge. Patient has been seen by ___ at home and was found to have INR ___ yesterday. He was advised to take 1.5mg warfarin instead of regular dose of 3mg daily. In the ED, initial vitals: 97.9 74 130/65 16 100% RA - Labs notable for: WBC 8 with 71.5 PMNs, BNP wnl with Cr 0.8 at baseline, lactate 2.4, H/H 8.8/29.6, INR 3.9 - Pt given: 600mg IV clindamycin, 5mg PO oxycodone, and 5mg IV morphine On arrival to the floor, pt reports that pain continues to be severe with some improvement from IV morphine. The pain in both the L knee and L shin is severe. The pain, overlying erythema, and swelling associated wtih L knee has been stable since fall. He also notes numbness in his L sole that started with the swelling. <PAST MEDICAL HISTORY> -Diabetes mellitus with renal manifestation -MI s/p stent placement in ___ -Hyperlipidemia -Colon adenomas -Hypertension, essential, benign -PANIC DISORDER W/O AGORAPHOBIA -DEPRESSIVE DISORDER -Pulmonary nodule/lesion, solitary -Crohn's disease: patient was told that he once had Crohn's disease based on biopsy, more recent colonoscopy was normal per patient -NEUROPATHY, UNSPEC -History of pulmonary embolism -History of obesity -COPD, moderate -___ disease -CKD (chronic kidney disease) -PUD c/b perforation, s/p laparotomy, colostomy and reversal -multiple hernia surgeries -open cholecystectomy <SOCIAL HISTORY> ___ <FAMILY HISTORY> No family GI history Father - had emphysema Mother - had CAD, PVD, and RA Sister - had TTP <PHYSICAL EXAM> ADMISSION PHYSICAL EXAM: -======== Vitals: 98.2, 133/97, 76, 18, 96/RA General: pleasant gentleman and mild distress secondary to pain HEENT: miotic pupils, reactive to light. MMM. OP clear Neck: supple, no LAD Lungs: CTAB CV: RRR, ___ systolic murmur best heard in RUSB Abdomen: soft, non-tender, non-distended. +BS GU: no foley Ext: LLE with bruising in L medial thigh and scattered throughout distal ___ of extremity. L patella tender to palpation throughout with mild overlying erythema, warmth, and swelling. Active and passive ROM of L knee both significantly limited by pain. Swelling of distal ___ of RLE as well. Large erythematous patch on medial aspect of shin, spreading to front of shin and calf as well. Poorly defined borders. markedly tender to palpation. +warmth. Neuro: AOx3, no gross deficits DISCHARGE PHYSICAL EXAM: -======== Vitals: 98, 109/49, 69, 18, 96/RA General: pleasant gentleman in NAD HEENT: PERRL. MMM. OP clear Neck: supple, no LAD Lungs: CTAB CV: RRR, ___ systolic murmur best heard in RUSB Abdomen: soft, non-tender, non-distended. +BS GU: no foley Ext: LLE with bruising in L medial thigh and scattered throughout distal ___ of extremity in dependent areas. L patella tender to palpation throughout with mild overlying erythema, warmth, and swelling. Active and passive ROM of L knee somewhat limited by pain. Swelling of distal ___ of RLE significantly improved from prior. Moderate sized erythematous patch on medial aspect of shin, spreading to front of shin and calf as well also significantly improved. Associated tenderness to palpation and warmth significantly improved. Neuro: AOx3, no gross deficits, walking independently with cane <PERTINENT RESULTS> ADMISSION LABS: -= ___ 12: 20PM BLOOD WBC-8.0 RBC-4.15* Hgb-8.8* Hct-29.6* MCV-71* MCH-21.2* MCHC-29.7* RDW-18.4* RDWSD-46.7* Plt ___ ___ 12: 20PM BLOOD Neuts-71.5* ___ Monos-5.3 Eos-0.4* Baso-0.4 Im ___ AbsNeut-5.69 AbsLymp-1.76 AbsMono-0.42 AbsEos-0.03* AbsBaso-0.03 ___ 12: 20PM BLOOD ___ PTT-43.5* ___ ___ 12: 20PM BLOOD Glucose-104* UreaN-13 Creat-0.8 Na-141 K-4.6 Cl-105 HCO3-26 AnGap-15 ___ 12: 20PM BLOOD CK(CPK)-55 ___ 08: 05AM BLOOD Calcium-9.0 Phos-3.5 Mg-1.6 ___ 12: 30PM BLOOD Lactate-2.4* ___ 09: 00AM BLOOD Lactate-1.5 INR: ==== ___: 3.9 ___: 3.3 ___: 3.7 MICRO: ======= ___: BCx no growth to date, final pending at discharge DISCHARGE LABS: -== ___ 07: 40AM BLOOD WBC-5.2 RBC-4.08* Hgb-8.5* Hct-28.8* MCV-71* MCH-20.8* MCHC-29.5* RDW-18.6* RDWSD-46.0 Plt ___ ___ 07: 40AM BLOOD ___ PTT-42.4* ___ ___ 07: 40AM BLOOD Glucose-147* UreaN-14 Creat-0.8 Na-139 K-4.2 Cl-102 HCO3-28 AnGap-13 ___ 07: 40AM BLOOD Calcium-8.6 Phos-3.4 Mg-1.9 <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Aspirin 81 mg PO DAILY 2. Lorazepam 1 mg PO Q6H: PRN anxiety 3. Losartan Potassium 50 mg PO DAILY 4. Metoprolol Tartrate 25 mg PO DAILY 5. Omeprazole 20 mg PO BID 6. Rosuvastatin Calcium 20 mg PO QPM 7. Warfarin 3 mg PO DAILY16 8. GlipiZIDE 5 mg PO DAILY 9. MetFORMIN (Glucophage) 1000 mg PO BID 10. TraZODone 100 mg PO QHS 11. Ferrous GLUCONATE 324 mg PO DAILY <DISCHARGE MEDICATIONS> 1. Aspirin 81 mg PO DAILY 2. Ferrous GLUCONATE 324 mg PO DAILY 3. Lorazepam 1 mg PO Q6H: PRN anxiety 4. Losartan Potassium 50 mg PO DAILY 5. Metoprolol Tartrate 25 mg PO DAILY 6. Omeprazole 20 mg PO BID 7. Rosuvastatin Calcium 20 mg PO QPM 8. TraZODone 100 mg PO QHS 9. Warfarin 3 mg PO DAILY16 10. Acetaminophen 650 mg PO Q8H: PRN pain RX *acetaminophen 650 mg 1 tablet(s) by mouth every 8 hours Disp #*20 Tablet Refills: *0 11. Clindamycin 450 mg PO Q8H RX *clindamycin HCl 150 mg 3 capsule(s) by mouth three times a day Disp #*48 Capsule Refills: *0 12. TraMADOL (Ultram) 50 mg PO Q6H: PRN pain RX *tramadol 50 mg 1 tablet(s) by mouth every 6 hours Disp #*20 Tablet Refills: *0 13. GlipiZIDE 5 mg PO DAILY 14. MetFORMIN (Glucophage) 1000 mg PO BID 15. Outpatient Lab Work INR on ___ and ___ ICD-9: 415.1 Please fax results to ___ <DISCHARGE DISPOSITION> Home With Service Facility: ___ <DISCHARGE DIAGNOSIS> Primary: cellulitis hemarthrosis elevated INR Secondary: history of pulmonary embolism s/p fall diabetes <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Mr. ___, You were admitted to ___ with a skin infection on your left lower extremity. This improved significantly with IV antibiotics. You will need to continue oral antibiotics at home. Take this medication three times a day. The last day of antibiotics is ___. Please take these as prescribed. If you develop any worsening pain, swelling, or redness, please call your doctor. Also, if you develop diarrhea or watery stools, please call your doctor. When you came to the hospital, you were also found to have a high INR level. We did not give you your dose of warfarin on ___ because of this. You will need close monitoring of you INR at home until it stabilizes. Because your INR was elevated today at 3.7, please skip your dose tonight. Tomorrow, your ___ will check your INR. Take 1.5mg warfarin (half a tablet) tomorrow. After that, ___ be in touch regarding your warfarin dosage. It has been a pleasure taking care of you, Your ___ Care Team ","Patient is a ___ with a PMHx of NIDDM, PE (on coumadin), CAD s/p fall one week ago complicated by hemarthorsis who presents with left lower extremity cellulitis and elevated INR. He was previously evalauted for knee pain with xray and CT negative for fracture but showed hemarthrosis. His knee pain and swelling was stable on presentation but patient had increased LLE shin swelling, erythema, and warmth consistent with cellulitis. He was started on IV clindamycin with significant improvement. He was transitioned to PO clindamycin prior to discharge. He was also seen by physical therapy who felt that patient was safe for discharge with home ___. #cellulitis: Patient has history of DM but has no evidence of deep infection/ulceration on exam. No signs of sepsis with no leukocytosis, fever, tachycardia, or tachypnea. Patient with allergy to penicillins, sulfa, and vancomycin. Therefore, patient was treated with IV clindamycin. Cellulitis improved significantly and patient was transitioned to PO clindamycin to complete 7 day course, last day ___. Pain was controlled with standing APAP and IV morphine initially and transitioned to PO oxycodone with improvement in pain. Patient was seen by ___ who felt that patient was safe for discharge with home ___. #elevated INR: Patient has history of PE for which he is on warfarin. INR found to be elevated at 3.9 on admission (___). Elevation may be due to recent antibiotic use. Warfarin was held on ___ and restarted on ___ as INR was downtrending at 3.3. On day of discharge, ___, INR was 3.7. He was advised to hold warfarin on ___ and to take 1.5mg on ___. ___ to check INR on ___ and ___ and fax results to ___ anticoagulation management clinic. Patient's INR, warfarin dosing, and transitional instructions were verbally relayed to RN at ___ clinic. #L knee pain and swelling: patient found to have L knee hemearthrosis after fall in the setting of anticoagulation. CT imaging during recent ED visit after fall on ___ showed no occult fracture but presence of hemarthrosis. Pain and swelling continue to be significant but were both improving by time of discharge. Patient was seen by ___ who felt that patient was safe for discharge with home ___. #Anemia: Patient found to have anemia during last hospitalization found to be secondary to iron deficiency. Iron losses may be secondary to hemorrhoids. H/H slightly lower than prior admission, which may be secondary to hemearthrosis. No other significant signs of bleeding. Patient was continued on home ferrous gluconate 324mg daily. #CKD: Cr remained at baseline during admission (0.8-0.9) #History of PE and DVT: Patient is on warfarin, currently supratherapeutic, as detailed above. #T2DM: HgbA1c 7.2% on ___. On glipizide and metformin at home. Patient was maintained on HISS during admission. #Coronary artery disease: Continued home ASA and rosuvastatin #Peptic Ulcer Disease: Continued home omeprazole #HTN: Continued home metoprolol tartrate and losartan #HLD: continued home rosuvastatin. #Insomnia: continued home trazodone PRN #Panic Disorder with Agoraphobia: Continued on his home ativan PRN TRANSITIONAL ISSUES: =================== - continue clindamycin 450mg TID, last day ___ - contiue tramadol 50mg q4-6h PRN pain - follow up with PCP for ___ up of cellulitis and hemarthrosis - INR elevated on presentation at 3.9. Warfarin dose held on ___. INR on ___ 3.7. Patient advised to hold dose on ___ and to take 1.5mg (instead of 3mg) on ___. This plan was communicated verbally to ___ anticoagulation management clinic. - ___ to check INR on ___ and ___. Results to be faxed to ___ ___, RN - ___ # EMERGENCY CONTACT: ___ (niece) ___ # CODE STATUS: Full confirmed ",2646,931
10007326-DS-17,"<SEX> M <SERVICE> MEDICINE <ALLERGIES> Penicillins <ATTENDING> ___. <CHIEF COMPLAINT> Hematemesis <MAJOR SURGICAL OR INVASIVE PROCEDURE> Esophagogastroduodenoscopy (EGD) <HISTORY OF PRESENT ILLNESS> Mr. ___ is a ___ year old male with lactose intolerance who presented to ED with abdominal pain and hematemesis since the night prior to admission. He reports that he ate ___ food and a slice of pizza on ___ at ~5pm. At ~10 pm he reports onset of crampy epigastric pain with occasional epigastric burning pain that was relieved only by laying on his side. He took peptobismol which improved the pain, and had a normal bowel movement. At ~1am he woke up and had an episode of forceful vomiting during which he vomited ___ times, the last time he vomited about ___ cup of bright red blood. He went back to bed and woke up hours later and drank water because he felt dehydrated, and this caused him to vomit again, this time his vomited had dried blood more similar to coffee grounds. At this time he also had a loose, brown, non-bloody bowel movement. Finally, at ~5am he again drank water which prompted a third episode of vomiting coffee ground material. Patient endorses drinking coffee, and having ___ drinks of alcohol approximately twice per week. He denies recent NSAID use, and reports using NSAIDs ___ month about 2 pills each time. In the ED, initial VS were 99.2 122 153/90 16. Received 2L NS with improvement noted in his tachycardia, NG lavage showed bright red blood and clots which did not clear after >300cc output. He additionally received a DRE which was heme negative. NG tube was removed while in the ED. Patient was started on IV PPI and GI was consulted. Patient was transferred to floor pending GI consult. Transfer VS 97.7 89 142/70 16 100%RA One review of systems, he endorsed abdominal pain, nausea, vomiting, hematemesis and diarrhea as detailed in HPI. He denied fever, chills, night sweats, headache, vision changes, rhinorrhea, congestion, cough, shortness of breath, chest pain, constipation, BRBPR, melena, hematochezia, dysuria, hematuria. All other 10-system review negative in detail. On arrival to the floor, patient reports mild ongoing abdominal pain. Denies lightheadedness or palpitations. No additional acute symptoms. <PAST MEDICAL HISTORY> - Lactose intolerance (keeps a lactose free diet) - Tonsillectomy and arytenoidectomy ___ years old) - Wisdom tooth extraction ___ years old) <SOCIAL HISTORY> ___ <FAMILY HISTORY> -Father, aged ___, suffers from Diverticular Disease for ___ years which has been refractory with well maintained diet and hydration. Gallbladder removed for unspecified reasons. -Mother, aged ___, suffers from GERD and ""thyroid problems."" Has had recurrence of breast cancer 3 times with 2x being treated with chemotherapy and radiation and the ___ recurrence being treated with full mastectomy, all in same breast. -Grandmother (maternal) Passed from stomach cancer in early ___ -Grandfather: died from myocardial infarction -2 Brothers, aged ___ and ___, no medical conditions No family history of bleeding disorders. <PHYSICAL EXAM> ADMISSION PHYSICAL EXAM: VS 98.9 130/80 96(up to 120s on tele when ambulatory) 18 97%RA GEN Alert, oriented, no acute distress HEENT NCAT MMM EOMI sclera anicteric, OP clear NECK supple, no JVD, no LAD PULM Good aeration, CTAB no wheezes, rales, ronchi CV RRR normal S1/S2, no mrg ABD soft NT ND normoactive bowel sounds, no r/g EXT WWP 2+ pulses palpable bilaterally, no c/c/e NEURO CNs2-12 intact, motor function grossly normal SKIN no ulcers or lesions DISCHARGE PHYSICAL EXAM Tmax 100.0 Tc 99.0 BP 120/73 (117-160/63-80) HR 83 (83-97) RR 20 (___) O2sat 99%RA (97-99%RA) General: Alert, oriented, cooperative, in no acute distress HEENT: NCAT, MMM, PERRLA, EOMI, anicteric sclerae, OP clear Neck: supple, no JVD, no palpable lymphadenopathy Pulm: Good aeration, CTAB without wheezes, rales, or ronchi Cor: RRR, normal S1, S2, no MRG Abdomen: soft, non-tender, non-distended, no rebound or guarding, no palpable hepatosplenomegaly, positive bowel sounds Extremities: WWP, 2+ radial and dorsalis pedis pulses bilaterally, no C/C/E Skin: No ulcers or lesions noted <PERTINENT RESULTS> ___ 07: 25AM BLOOD WBC-6.1 RBC-4.70 Hgb-14.6 Hct-42.0 MCV-89 MCH-31.0 MCHC-34.7 RDW-12.5 Plt ___ ___ 03: 35PM BLOOD WBC-9.0 RBC-4.39* Hgb-13.8* Hct-39.3* MCV-90 MCH-31.4 MCHC-35.1* RDW-12.4 Plt ___ ___ 10: 00AM BLOOD WBC-13.4* RBC-4.90 Hgb-15.3 Hct-43.5 MCV-89 MCH-31.2 MCHC-35.1* RDW-12.6 Plt ___ ___ 06: 00AM BLOOD WBC-12.2* RBC-5.08 Hgb-16.0 Hct-44.2 MCV-87 MCH-31.6 MCHC-36.2* RDW-12.3 Plt ___ ___ 06: 00AM BLOOD Neuts-90.8* Lymphs-3.8* Monos-4.1 Eos-0.8 Baso-0.4 ___ 06: 00AM BLOOD ___ PTT-27.7 ___ ___ 07: 25AM BLOOD Glucose-94 UreaN-6 Creat-0.8 Na-139 K-3.6 Cl-102 HCO3-27 AnGap-14 ___ 06: 00AM BLOOD Glucose-127* UreaN-15 Creat-0.9 Na-137 K-4.2 Cl-102 HCO3-25 AnGap-14 ___ 06: 00AM GFR = >75 ___ 03: 35PM BLOOD ALT-44* AST-23 LD(LDH)-130 AlkPhos-61 TotBili-1.1 ___ 07: 25AM BLOOD Calcium-8.8 Phos-2.9 Mg-1.9 ___ 03: 35PM BLOOD Albumin-3.9 ___ CHEST (PA & LAT): FINDINGS: PA and lateral radiographs of the chest demonstrate clear lungs without focal consolidation concerning for pneumonia, pleural effusion or pneumothorax. The pulmonary vasculature is not engorged. The cardiac silhouette is normal in size. The mediastinal and hilar contours are within normal limits. There is no evidence of pneumomediastinum. The trachea is midline. The visualized upper abdomen is unremarkable. IMPRESSION: No acute cardiopulmonary pathology, specifically no evidence of pneumomediastinum. ___ 11: 30: 00 AM EGD Report: IMPRESSION: Localized erythema in the gastroesophageal junction possibly consistent with healed erosion or MW tear(biopsy). Erythema in the fundus compatible with gastritis. Mild erythema in the antrum compatible with gastritis (biopsy). Normal mucosa in the whole duodenum. Otherwise normal EGD to third part of the duodenum. RECOMMENDATIONS: Follow up biopsy results from antrum and esophagus. Hematemesis most likely related to ___ tear from retching. Would recommend daily PPI, advancing diet as tolerated, and observation. Continue recs of inpatient consult team. ___ Pathology Tissue: GI BX'S (2 JARS): A. Gastroesophageal junction biopsy: Squamous epithelium, no diagnostic abnormalities recognized. Gastric type mucosa, no intestinal metaplasia identified. B. Antrum biopsy: No diagnostic abnormalities recognized. <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Multivitamins 1 TAB PO DAILY <DISCHARGE MEDICATIONS> 1. Omeprazole 40 mg PO DAILY Duration: 14 Days RX *omeprazole 40 mg 1 capsule(s) by mouth Daily Disp #*14 Capsule Refills: *0 2. Multivitamins 1 TAB PO DAILY <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> ___ Tear Upper GI Bleed <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Mr. ___, You were treated in the hospital for bleeding your GI tract. You underwent endoscopy of your upper GI tract which showed evidence of irritation of the stomach lining. There was an area of irritation where the stomach and esophagus meet which was most likely the source of your bleeding. You have been placed on a medicine to suppress acid production in your stomach. You should continue to take this until your follow up appointment with your new primary care physician in two weeks. You had biopsies taken from your stomach during the endoscopy. The results of your biopsies were normal without diagnostic abnormalities. You can follow up with your primary care physician regarding the results. ","___ male presents with acute onset of abdominal pain, nausea, vomiting, diarrhea and hematemesis. #Hematemesis: He does not have clear risk factors for upper GI bleed. He reports drinking normal amounts of coffee, denies recent or heavy NSAID use, although he does report drinking ___ drinks approximately twice a week. There was no history or symptoms consistent with PUD, GERD, or H. pylori as the presentation appears to have been acute over one to two days. He denies family history of bleeding or clotting disorders. Differential considered included bleeding ulcer ___ tear vs AVM. Given the extent of blood loss with evidence of early hemorrhagic shock including tachycardia on presentation, GI was consulted and performed an urgent EGD for evaluation which showed localized erythema in the gastroesophageal junction consistent with healed erosion or ___ tear, erythema consistent with gastritis in the antrum and fundus, and otherwise wnl to third part of duodenum. History and EGD findings were most consistent with ___ tear. Biopsies from antrum and GE junction returned grossly normal without diagnostic abnormalities. Patient received Pantoprazole 40 mg IV while in ED. He was kept on IV pantoprazole and switched to omeprazole 40 mg PO daily the evening after EGD. His diet was advanced following the procedure, and he tolerated a regular diet well prior to discharge. His vital signs remained normal and stable throughout his hospitalization, and he did not experience any further episodes of vomiting or hematemesis. Per GI recs, we discharged him on a two week course of omeprazole 40 mg PO daily. We set up follow-up with his PCP in two weeks. Patient was advised to avoid fatty foods, caffeine, alcohol, spicy foods and anything that could irritate his stomach. #Hemorrhagic shock - no hypotension He presented with tachycardia and orthostatic symptoms without blood pressure drop (headache, mild dizziness on rising from bed). He received 2L NS in ED with good heart rate response. Upon arrival to floor heart rate was trending back up and increased >120 with standing on several occassions. He underwent urgent EGD which did not reveal active bleeding. He received an additional 1L bolus of NS on transfer to the floor, and was maintained on ___ continuous at 75-125 ml/hr while he diet was advanced to a regular diet. He was maintained on telemetry, which was only notable for several non-sustained, asymptomatic episodes of tachycardia upon standing and walking. His vital signs were monitored throughout and he never developed hypotension, or other signs or symptoms of hypovolemia. Hematocrit was trended 44.2-->43.5-->39.3-->42.0 on ___, ___, and ___ respectively. Two 18 gauge peripheral IVs were maintained throughout his hospitalization, as well as active type and crossmatch. ",2250,620
10007795-DS-13,"<SEX> F <SERVICE> SURGERY <ALLERGIES> Cipro / ciprofloxacin / fluconazole <ATTENDING> ___. <CHIEF COMPLAINT> Acute pancreatitis <MAJOR SURGICAL OR INVASIVE PROCEDURE> ___: Endoscopic ultrasound guided successful cyst gastrostomy with aspiration of 4 liters of fluid and irrigation of adherent necrotic material attached to the wall of the cyst. 4 double-pigtail stents were placed. . ___: Revision of cystogastrostomy. . ___: CT guided ___ F drainage catheter placement into the right flank collection. . ___: CT fluoroscopy-guided upsize and exchange over the wire of a previously placed 14 ___ with a 20 ___ chest tube drainage catheter. <HISTORY OF PRESENT ILLNESS> ___ yo F with alcoholic hepatitis and pancreatitis in ___ found to have pseudocyst and transferred to ___ for EUS guided drainage. Pt has recent admission for ETOH pancreatitis, pneumonia, sepsis and respiratory failure, requiring intubation at OSH. She has been at rehab since discharge for the past month. At rehab she was on TPN, which was weaned and started on an oral diet. However, she developed abdominal pain and was transferred from rehab to ___ on ___ for this pain. Labs there notable for WBC 17, lipase 196. She was treated conservatively with bowel rest, iv dilaudid, and started on TPN. GI was consulted. She was found to have multi-loculated panc pseudocyst on CT imaging. Her lipase and leukocytosis improved. Per discharge summary she was afebrile though pt tells me she had one temp of 100.7 but has not received abx. She is transferred to ___ for EUS guided drainage. Currently, she c/o LUQ, ___, abdominal pain, worse w/ movement, not associated w/ nausea/emesis, and improved w/ dilaudid. She has had low ostomy output. +Flatus. <PAST MEDICAL HISTORY> Per ___ and ___ discharge summary ___. Hypertension. Hypercholesterolemia. Diabetes ___ pancreatitis. Metabolic toxic encephalopathy Depression. Diverticulitis s/p sigmoid resection and end colostomy unable to be reversed b/c severe scarring and fibrosis. Anemia of chronic disease. Breast Ca s/p bl mastectomy and chemotherapy ___ years ago. ETOH abuse. Bowel obstruction. Pancreatic pseudocyst. s/p appendectomy for ruptured appendix. s/p laparoscopy - pelvic pain r/o endomitriosis <SOCIAL HISTORY> ___ <FAMILY HISTORY> Cancer <PHYSICAL EXAM> On admission: T 98.3, BP 130/73, HR 108, RR 18, O2 94% RA Gen-NAD HEENT- OP clear, sclera anicteric CV- Regular rate, no murmurs Pulm- CTAB Abd- +scar, ostomy in place, min TTP at LUQ, no guarding/rebound Ext- wwp, no edema Neuro- A&Ox3 Prior discharge: VS: 98.8, 89, 106/91, 18, 99% RA GEN: Pleasant with NAD, Dobhoff tube in place. CV: RRR, no m/r/g PULM: CTAB ABD: Right flank with ___ F catheter to graviry drainage. Site with dressing and c/d/i. LUQ ostomy patent. EXTR: Warm, no c/c/e <PERTINENT RESULTS> ___ 08: 43AM BLOOD WBC-17.1* RBC-2.86* Hgb-7.6* Hct-24.3* MCV-85 MCH-26.5* MCHC-31.2 RDW-15.7* Plt ___ ___ 04: 08AM BLOOD Neuts-78* Bands-0 Lymphs-3* Monos-15* Eos-1 Baso-1 ___ Metas-1* Myelos-1* ___ 06: 45AM BLOOD Glucose-170* UreaN-10 Creat-0.7 Na-133 K-4.2 Cl-99 HCO3-24 AnGap-14 ___ 07: 10AM BLOOD ALT-16 AST-16 AlkPhos-120* TotBili-0.2 ___ 06: 45AM BLOOD Calcium-8.1* Phos-3.2 Mg-1.7 ___ 2: 33 pm ABSCESS Source: R. flank fluid collection. GRAM STAIN (Final ___: NO POLYMORPHONUCLEAR LEUKOCYTES SEEN. 3+ ___ per 1000X FIELD): BUDDING YEAST WITH PSEUDOHYPHAE. FLUID CULTURE (Final ___: ___ ALBICANS, PRESUMPTIVE IDENTIFICATION. HEAVY GROWTH. ANAEROBIC CULTURE (Final ___: NO ANAEROBES ISOLATED. FUNGAL CULTURE (Preliminary): ___ ALBICANS, PRESUMPTIVE IDENTIFICATION. ID PERFORMED ON CORRESPONDING ROUTINE CULTURE. ___ ABSCESS PANCREATIC PSEUDO CYST. **FINAL REPORT ___ GRAM STAIN (Final ___: NO POLYMORPHONUCLEAR LEUKOCYTES SEEN. 2+ ___ per 1000X FIELD): BUDDING YEAST. WOUND CULTURE (Final ___: ___ ALBICANS, PRESUMPTIVE IDENTIFICATION. SPARSE GROWTH. ANAEROBIC CULTURE (Final ___: NO ANAEROBES ISOLATED. ___ MRCP: IMPRESSION: 1. Multiple large peripancreatic fluid collections, described above. Splenic vein occlusion appears chronic. 2. Hepatic steatosis. 3. Left pleural effusion and bilateral atelectasis. 4. T11 vertebral body compression fracture, likely subacute. ___ CT ABD: IMPRESSION: 1. Multiple rim enhancing peripancreatic fluid collections with ___ largest discrete fluid collections as detailed above, 1 of which contains 3 drains extending into the stomach and enteric contrast material. Smaller rim enhancing fluid collections in the left upper quadrant of the abdomen are too small to drain. Superinfection of these collections is likely the source of the patient's fever. 2. Chronic splenic vein occlusion. 3. Stable small left pleural effusion and bibasilar atelectasis on the left greater than the right. 4. Subacute T11 vertebral body compression fracture. ___ ECHO: IMPRESSION: Normal global and regional left ventricular systolic dysfunction. Borderline right ventricular systolic function. Moderate functional mitral regurgitation. Elevated LV filling pressure and mild pulmonary hypertension. ___ CT ABD: IMPRESSION: 1. Multiple rim enhancing peripancreatic fluid collections with the 2 largest discrete fluid collections as detailed above, 1 of which contains 3 endoscopic drains and a right percutaneous drainage catheter, which is unchanged or slightly increased in size from the prior CT. 2. Smaller rim enhancing fluid collections in the left upper quadrant of the abdomen are decreased in size from the prior CT. 3. Unchanged small left pleural effusion and bibasilar atelectasis on the left greater than the right. <MEDICATIONS ON ADMISSION> Transfer medications: 1. Duloxetine 60 mg PO DAILY 2. Insulin SC Sliding Scale Insulin SC Sliding Scale using REG Insulin 3. Pantoprazole 40 mg IV Q12H 4. Tamoxifen Citrate 20 mg PO DAILY 5. Nicotine Patch 14 mg TD DAILY 6. Multivitamins 1 TAB PO DAILY 7. Gemfibrozil 600 mg PO BID 8. Acetaminophen 650 mg PO Q6H: PRN pain 9. HYDROmorphone (Dilaudid) 0.5-1 mg IV Q3H: PRN pain 10. Heparin 5000 UNIT SC TID <DISCHARGE MEDICATIONS> 1. Nicotine Patch 14 mg TD DAILY 2. Tamoxifen Citrate 20 mg PO DAILY 3. Acetaminophen 650 mg PO Q6H: PRN pain 4. Duloxetine 60 mg PO DAILY 5. Heparin 5000 UNIT SC TID 6. Insulin SC Sliding Scale Fingerstick QACHS, HS Insulin SC Sliding Scale using REG Insulin 7. Gabapentin 300 mg PO TID 8. HYDROmorphone (Dilaudid) ___ mg PO Q3H: PRN pain 9. Morphine SR (MS ___ 15 mg PO Q8H 10. Pantoprazole 40 mg PO Q12H 11. Gemfibrozil 600 mg PO BID 12. Multivitamins 1 TAB PO DAILY <DISCHARGE DISPOSITION> Extended Care Facility: ___ <DISCHARGE DIAGNOSIS> 1. Acute alcoholic necrotizing pancreatitis. 2. Infected pancreatic pseudocyst. 3. Peripancreatic fluid collection <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> You were admitted with acute pancreatitis and pain from a large pseudocyst. You underwent endoscopic ultrasound guided drainage of the pseudocyst x 2 and finished treatment with antibiotics. You have done well and are now safe to return in Nursing Home to complete your recovery with the following instructions: . Please call Dr. ___ office at ___ if you have questions or concerns. . Please resume all regular home medications , unless specifically advised not to take a particular medication. Also, please take any new medications as prescribed. Please get plenty of rest, continue to ambulate several times per day, and drink adequate amounts of fluids. Avoid lifting weights greater than ___ lbs until you follow-up with your surgeon, who will instruct you further regarding activity restrictions. Avoid driving or operating heavy machinery while taking pain medications. Please follow-up with your surgeon and Primary Care Provider (PCP) as advised. . ___ drain care: *Please look at the site every day for signs of infection (increased redness or pain, swelling, odor, yellow or bloody discharge, warm to touch, fever). *If the drain is connected to a collection container, please note color, consistency, and amount of fluid in the drain. Call the doctor, ___, or ___ nurse if the amount increases significantly or changes in character. Be sure to empty the drain frequently. Record the output, if instructed to do so. *Drain will flushed by RNs daily with 10 cc of sterile NS. *Wash the area gently with warm, soapy water or ___ strength hydrogen peroxide followed by saline rinse, pat dry, and place a drain sponge. Change daily and as needed. *Keep the insertion site clean and dry otherwise. *Avoid swimming, baths, hot tubs; do not submerge yourself in water. *Make sure to keep the drain attached securely to your body to prevent pulling or dislocation. . Ostomy care: Please continue current care. ","___ yo F with alcoholic hepatitis and pancreatitis in ___ found to have pseudocyst and transferred to ___ for EUS guided drainage. #PANCREATIC PSEUDOCYST: She underwent MRCP and then was taken for endoscopic ultrasound guided cyst gastrostomy on ___ with aspiration of 4 liters of fluid and irrigation of adherent necrotic material attached to the wall of the cyst. 4 double-pigtail stents were placed. However, after the procedure she continued to have abdominal pain and developed a fever. CT scan showed persistent extensive ___ fluid collections. She underwent repeat EUS guided drainage and removal of stents on ___. This was followed by CT guided drain placement in the right flank fluid collection by ___ on ___. TPN was continued on admission with oral dilaudid and MS ___ for pain control. #PNEUMONIA: The patient developed fever to 102 on ___ following the EUS. Although concerning for abdominal source CXR with pneumonia (and patient with cough x 3 days). Vanc/Zosyn started to cover HCAP and abdominal infection to be completed ___, but these were resumed on ___ given ongoing infectious concerns. #POSSIBLE PSEUDOCYST INFECTION, CANDIDAL INFECTION: Fluid culture from the drain placed in the right fluid collection grew ___ albicans. Possible that relatively immune suppressed given history of ETOH use and cancer. She was given one dose of fluconazole but developed respiratory distress and rash concerning for drug reaction. Infectious disease was consulted. We opted for Micafungin IV coverage given the candidal infection of her pseudocyst material. Her case was discussed with ___ who felt examination for endophthalmitis was not warranted in the absence of ocular symptoms. #Depression: continued Cymbalta. Social work consulted for assistance in coping with prolonged illness. #Diabetes, secondary to pancreatitis: Treated with insulin. #Breast Ca: Noted to have moderate height loss of T11 and pulmonary nodule on OSH imaging. She states she has had chronic changes at T11 for a few years, known to her oncologist. No known history of pulmonary nodule. Her tamoxifen was continued. -- NEEDS ONC F/U FOR OSH PULM NODULE . #Compression fracture: CT noting T11 subacute vertebral body compression fracture. --NEEDS ONC F/U ....... The patient was transferred to HPB Surgery Service on ___: SURGERY DISCHARGE SUMMARY (___) Ms. ___ was transferred to the ___ Surgical Service for further management. She was made NPO with IV fluids, and continued on IV Vancomycin, Zosyn, and Micafungin. Neuro: The patient received PO dilaudid with good effect and adequate pain control. When tolerating PO patient was transitioned to PO pain medication. Chronic pain service was consulted in order to optimize patient's pain control and their recommendations were followed. CV: The patient remained stable from a cardiovascular standpoint; vital signs were routinely monitored. Cardiac Echo was obtained and demonstrated normal global and regional left ventricular systolic dysfunction, borderline right ventricular systolic function (see report for details). Pulmonary: The patient remained stable from a pulmonary standpoint; vital signs were routinely monitored. Good pulmonary toilet, early ambulation and incentive spirometry were encouraged throughout hospitalization. GI/GU/FEN: Initially upon transfer patient was made NPO with IV fluids and TPN. On ___ a Dobhoff nasogastric tube was placed at the bedside, which was then advanced post-pyloric by radiology. Tube feeds were then initiated and titrated up to goal rate, which she tolerated. TPN was discontinued when tube feeds were at goal. She was also advanced to clear liquids which she tolerated. On ___ her 8French drain in the cyst was upsized by interventional radiology to a 20 ___ drain. Drain output was closely monitored. Patient's intake and output were closely monitored, and IV fluid was adjusted when necessary. Electrolytes were routinely followed, and repleted when necessary. ID: The patient's white blood count was monitored and continued to trend downward throughout her hospital course. The infectious disease service continued to follow. Vanc and Zosyn were discontinued on ___ per their recommendations after cyst cultures were positive only for budding yeast. On ___ her Micafungin was also discontinued due to the continued decreasing white blood cell count and the fact that her drain was putting out minimal purulent drainage. The patient remained afebrile with mild elevated WBC prior discharge. WBC will be continued to follow as outpatient. ID was contacted prior patient discharge, and ID agreed with the plan to discharge without antibiotics treatment. PICC line was removed prior discharge. Endocrine: The patient's blood sugar was monitored throughout his stay; insulin dosing was adjusted accordingly. Patient was discharged on sliding scale insulin. Hematology: The patient's complete blood count was examined routinely; no transfusions were required. Prophylaxis: The patient received subcutaneous heparin and venodyne boots were used during this stay; was encouraged to get up and ambulate as early as possible. At the time of discharge, the patient was doing well, afebrile with stable vital signs. The patient was tolerating TF at goal and clears, ambulating, voiding without assistance, and pain was well controlled. The patient received discharge teaching and follow-up instructions with understanding verbalized and agreement with the discharge plan. ",2469,1134
10007795-DS-14,"<SEX> F <SERVICE> SURGERY <ALLERGIES> Cipro / ciprofloxacin / fluconazole <ATTENDING> ___. <CHIEF COMPLAINT> Pancreatic necrosis <MAJOR SURGICAL OR INVASIVE PROCEDURE> ___ - Pancreatic washout and upsizing of pancreatic drain <HISTORY OF PRESENT ILLNESS> ___ with pancreatitis c/b necrosis and pseudocyst s/p multiple drainage procedures and drain placements. Currently has ___ Fr drain in draining thick pancreatic necrotic debris. Concern is that the drain is too small to handle such thick output and should be upsized. <PAST MEDICAL HISTORY> Per ___ and ___ discharge summary ___. Hypertension. Hypercholesterolemia. Diabetes ___ pancreatitis. Metabolic toxic encephalopathy Depression. Diverticulitis s/p sigmoid resection and end colostomy unable to be reversed b/c severe scarring and fibrosis. Anemia of chronic disease. Breast Ca s/p bl mastectomy and chemotherapy ___ years ago. ETOH abuse. Bowel obstruction. Pancreatic pseudocyst. s/p appendectomy for ruptured appendix. s/p laparoscopy - pelvic pain r/o endomitriosis <SOCIAL HISTORY> ___ <FAMILY HISTORY> Cancer <PHYSICAL EXAM> On discharge: afebrile at 99.2, ___ 121/62 18 99% on RA NAD, A+OX3 no scleral icterus RRR CTAB Soft, TTP around drain site, ND, ostomy appears normal and functioning Right pancreatic drain site draining pancreatic debris. Drain is put in ostomy bag to collect debris. 1+ pitting edema b/l Right thigh has some minimal redness, no fluctuance, no induration <PERTINENT RESULTS> ___ 06: 00AM BLOOD WBC-17.6* RBC-2.92* Hgb-7.5* Hct-24.5* MCV-84 MCH-25.5* MCHC-30.4* RDW-15.9* Plt ___ ___ 08: 15AM BLOOD WBC-27.7*# RBC-3.32* Hgb-8.9* Hct-28.7* MCV-86 MCH-26.8* MCHC-31.0 RDW-15.8* Plt ___ ___ 07: 30AM BLOOD WBC-19.0* RBC-2.97* Hgb-7.9* Hct-25.2* MCV-85 MCH-26.7* MCHC-31.5 RDW-16.0* Plt ___ ___ 06: 00AM BLOOD ___ PTT-27.8 ___ ___ 07: 30AM BLOOD Glucose-185* UreaN-5* Creat-0.6 Na-135 K-3.9 Cl-99 HCO3-27 AnGap-13 ___ 06: 00AM BLOOD ALT-13 AST-12 LD(LDH)-109 AlkPhos-152* Amylase-17 TotBili-0.2 ___ 06: 00AM BLOOD Lipase-18 ___ 11: 00 am ABSCESS RETROPERITONEAL FLUID FROM PANCREATIC ABSCESS. GRAM STAIN (Final ___: NO POLYMORPHONUCLEAR LEUKOCYTES SEEN. NO MICROORGANISMS SEEN. WOUND CULTURE (Final ___: ___ ALBICANS, PRESUMPTIVE IDENTIFICATION. SPARSE GROWTH. ANAEROBIC CULTURE (Final ___: NO ANAEROBES ISOLATED. FUNGAL CULTURE (Preliminary): ___ ALBICANS. ___ blood cultures are pending as of this discharge summary <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Nicotine Patch 14 mg TD DAILY 2. Tamoxifen Citrate 20 mg PO DAILY 3. Acetaminophen 650 mg PO Q6H: PRN pain 4. Duloxetine 60 mg PO DAILY 5. Gabapentin 300 mg PO TID 6. HYDROmorphone (Dilaudid) ___ mg PO Q3H: PRN pain 7. Morphine SR (MS ___ 15 mg PO Q8H 8. Pantoprazole 40 mg PO Q12H 9. Gemfibrozil 600 mg PO BID 10. Multivitamins 1 TAB PO DAILY <DISCHARGE MEDICATIONS> 1. Acetaminophen 650 mg PO Q6H: PRN pain 2. Duloxetine 60 mg PO DAILY 3. Gabapentin 300 mg PO TID 4. Gemfibrozil 600 mg PO BID 5. Tamoxifen Citrate 20 mg PO DAILY 6. Nicotine Patch 14 mg TD DAILY 7. Morphine SR (MS ___ 15 mg PO Q8H 8. HYDROmorphone (Dilaudid) ___ mg PO Q3H: PRN pain 9. Multivitamins 1 TAB PO DAILY 10. Sodium Chloride 0.9% Flush 10 mL IV PRN line flush 11. Micafungin 100 mg IV Q24H 12. Pantoprazole 40 mg PO Q12H 13. Heparin 5000 UNIT SC TID to be administered if patient is non-ambulatory <DISCHARGE DISPOSITION> Extended Care Facility: ___ <DISCHARGE DIAGNOSIS> Pancreatitis, pancreatic pseudocyst, pancreatic necrosis <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> You were admitted for debridement and upsizing of your pancreatic drain. You have done well and are now safe to return in Nursing Home to complete your recovery with the following instructions: . Please call Dr. ___ office at ___ if you have questions or concerns. . Please resume all regular home medications , unless specifically advised not to take a particular medication. Also, please take any new medications as prescribed. Please get plenty of rest, continue to ambulate several times per day, and drink adequate amounts of fluids. Avoid lifting weights greater than ___ lbs until you follow-up with your surgeon, who will instruct you further regarding activity restrictions. Avoid driving or operating heavy machinery while taking pain medications. Please follow-up with your surgeon and Primary Care Provider (PCP) as advised. . Pancreatic drain care: *Please look at the site every day for signs of infection (increased redness or pain, swelling, odor, yellow or bloody discharge, warm to touch, fever). * The pancreatic drain is placed in an ostomy bag and left to drain via gravity. The nurses ___ flush the drain (20 cc of NS q8hours) and fluid will drain from the tube and around the incision. This is normal and indicates that the drain is working by keeping the pancreatic tract open. * Call the doctor, ___, or ___ nurse if the amount increases significantly or changes in character. Be sure to empty the drain frequently. Record the output, if instructed to do so. *Wash the area gently with warm, soapy water or ___ strength hydrogen peroxide followed by saline rinse, pat dry, and place a drain sponge. Change daily and as needed. *Keep the insertion site clean and dry otherwise. *Avoid swimming, baths, hot tubs; do not submerge yourself in water. *Make sure to keep the drain attached securely to your body to prevent pulling or dislocation. . Ostomy care: Please continue current care. ",Mrs. ___ was admitted and underwent drain upsizing and pancreatic washout on ___. She did well afterwards with excellent pain control on oral medications. Her post-operative course was uncomplicated. She was pancultured for a low grade temperature. CXR was normal. UA was negative. Her OR cultures grew back ___ and she was started on Micafungin. A PICC line was placed for long term antibiotics. At the time of discharge she is afebrile. She was started on clears and advanced to fulls while supplementing her nutrition with tube feeds at goal. She has taken enough fulls and her tube feeds were stopped. ,1690,131
10007795-DS-15,"<SEX> F <SERVICE> SURGERY <ALLERGIES> ciprofloxacin / fluconazole <ATTENDING> ___. <CHIEF COMPLAINT> Abdominal pain <MAJOR SURGICAL OR INVASIVE PROCEDURE> None <HISTORY OF PRESENT ILLNESS> ___ w/ h/o EtOH pancreatitis c/b multiple infected pseudocysts s/p transgastric endoscopic cyst gastrostomy and percutaneous drainage of R flank fluid collection, p/w new LUQ pain x ___ weeks, increasing over the past week (especially yesterday). She was previously taking 6 mg Dilaudid q8h, but now is up to 8mg q8h. No f/c, no n/v. No diarrhea; +constipation. Her TF were decreased in an attempt to encourage PO intake, but eating caused her pain. She reports she takes 2 Ensures and 1 serving of clear liquid per day. <PAST MEDICAL HISTORY> Per ___ and ___ discharge summary ___. Hypertension. Hypercholesterolemia. Diabetes ___ pancreatitis. Metabolic toxic encephalopathy Depression. Diverticulitis s/p sigmoid resection and end colostomy unable to be reversed b/c severe scarring and fibrosis. Anemia of chronic disease. Breast Ca s/p bl mastectomy and chemotherapy ___ years ago. ETOH abuse. Bowel obstruction. Pancreatic pseudocyst. s/p appendectomy for ruptured appendix. s/p laparoscopy - pelvic pain r/o endomitriosis <SOCIAL HISTORY> ___ <FAMILY HISTORY> Cancer <PHYSICAL EXAM> Prior Discharge: VSS, Afebrile GEN: Pleasant with NAD CV: RRR, no m/r/g PULM: CTAB ABD: Soft, tender for deep palpations around ostomy site. LLQ ostomy with ostomy appliance and brown liquid stool, RUQ ___ drain to gravity drainage into ostomy bag with purulent fluid. EXTR: warm, no c/c/e <PERTINENT RESULTS> ___ 08: 00PM BLOOD WBC-14.1* RBC-4.43# Hgb-12.4# Hct-36.9# MCV-83 MCH-28.1 MCHC-33.7 RDW-16.3* Plt ___ ___ 08: 40AM BLOOD WBC-9.1 RBC-4.34 Hgb-12.1 Hct-37.0 MCV-85 MCH-27.9 MCHC-32.8 RDW-16.2* Plt ___ ___ 08: 00PM BLOOD Glucose-101* UreaN-7 Creat-0.4 Na-138 K-3.8 Cl-103 HCO3-23 AnGap-16 ___ 08: 00PM BLOOD ALT-15 AST-19 AlkPhos-111* TotBili-0.2 ___ 08: 00PM BLOOD Albumin-4.0 Calcium-9.6 Phos-3.0 Mg-1.6 ___ 08: 00PM BLOOD Lipase-14 ___ ABD CT: IMPRESSION: Decrease in peripancreatic and right posterolateral fluid collections compared to ___. No new fluid collections. <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Duloxetine 60 mg PO DAILY 2. Gabapentin 300 mg PO TID 3. Gemfibrozil 600 mg PO BID 4. HYDROmorphone (Dilaudid) 8 mg PO Q3H: PRN pain 5. Pancrelipase 5000 2 CAP PO TID W/MEALS 6. Lorazepam 0.5 mg PO Q8H: PRN anxiety 7. Micafungin 100 mg IV Q24H 8. Ondansetron 4 mg PO Q8H: PRN nausea 9. Pantoprazole 40 mg PO Q24H 10. Prochlorperazine 5 mg PO Q6H: PRN nausea 11. Tamoxifen Citrate 20 mg PO DAILY 12. Docusate Sodium 100 mg PO BID 13. Senna 2 TAB PO QHS <DISCHARGE MEDICATIONS> 1. Docusate Sodium 100 mg PO BID 2. Duloxetine 60 mg PO DAILY 3. Gabapentin 300 mg PO Q8H 4. Gemfibrozil 600 mg PO BID 5. HYDROmorphone (Dilaudid) ___ mg PO Q4H: PRN pain 6. Micafungin 100 mg IV Q24H 7. Milk of Magnesia 30 mL PO Q6H: PRN constipation RX *magnesium hydroxide [Milk of Magnesia] 400 mg/5 mL 20 mL by mouth three times a day: PRN Disp #*200 Fluid Ounce Refills: *3 8. Pancrelipase 5000 2 CAP PO Q 8H 9. Senna 1 TAB PO BID 10. Tamoxifen Citrate 20 mg PO DAILY 11. Florastor (saccharomyces boulardii) 250 mg Oral BID <DISCHARGE DISPOSITION> Home With Service Facility: ___ <DISCHARGE DIAGNOSIS> Infected pancreatic pseudocyst <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> You were admitted to the surgery service at ___ for evaluation of your abdominal pain. You now feel better and are now safe to return home to complete your recovery with the following instructions: . Please ___ Dr. ___ office at ___ if you have any questions or concerns. . Please resume all regular home medications , unless specifically advised not to take a particular medication. Also, please take any new medications as prescribed. Please get plenty of rest, continue to ambulate several times per day, and drink adequate amounts of fluids. Avoid lifting weights greater than ___ lbs until you follow-up with your surgeon, who will instruct you further regarding activity restrictions. Avoid driving or operating heavy machinery while taking pain medications. Please follow-up with your surgeon and Primary Care Provider (PCP) as advised. . RUQ ___ drain: *Please look at the site every day for signs of infection (increased redness or pain, swelling, odor, yellow or bloody discharge, warm to touch, fever). *If the drain is connected to a collection container, please note color, consistency, and amount of fluid in the drain. ___ the doctor, ___, or ___ nurse if the amount increases significantly or changes in character. Be sure to empty the drain frequently. Record the output, if instructed to do so. *Wash the area gently with warm, soapy water or ___ strength hydrogen peroxide followed by saline rinse, pat dry, and place a drain sponge. Change daily and as needed. *Keep the insertion site clean and dry otherwise. *Avoid swimming, baths, hot tubs; do not submerge yourself in water. *Make sure to keep the drain attached securely to your body to prevent pulling or dislocation. . Monitoring Ostomy output/Prevention of Dehydration: *Keep well hydrated. *Replace fluid loss from ostomy daily. *Avoid only drinking plain water. Include Gatorade and/or other vitamin drinks to replace fluid. *Try to maintain ostomy output between 1000mL to 1500mL per day. *If Ostomy output >1 liter, take 4mg of Imodium, repeat 2mg with each episode of loose stool. Do not exceed 16mg/24 hours. . PICC Line: *Please monitor the site regularly, and ___ your MD, nurse practitioner, or ___ Nurse if you notice redness, swelling, tenderness or pain, drainage or bleeding at the insertion site. * ___ your MD or proceed to the Emergency Room immediately if the PICC Line tubing becomes damaged or punctured, or if the line is pulled out partially or completely. DO NOT USE THE PICC LINE IN THESE CIRCUMSTANCES.Please keep the dressing clean and dry. Contact your ___ Nurse if the dressing comes undone or is significantly soiled for further instructions. ","The patient well known for Dr. ___ was admitted to the General Surgical Service for evaluation of increased abdominal pain. On admission, the patient underwent abdominal CT scan which demonstrated multiple multiloculated rim-enhancing fluid collections surrounding the pancreas, but all smaller compare to CT scan from ___, no new collections were identified. Patient remained afebrile with elevated WBC on admission. Patient was made NPO with IV fluids, continued on home dose Micafungin and her pain was well controlled with Dilaudid PCA. On HD # 2, patient's diet was advanced to clears and she was restarted on TF at goal, PCA was converted to PO Dilaudid. Patient was started on aggressive bowel regiment with Colace, Senna and Milk of Magnesia. Patient's abdominal pain improved on clears, and she tolerated tubefeeds at goal. WBC returned to normal on HD # 3. During hospitalization, patient's stoma was evaluated by Ostomy nurse and their recommendations were followed. Patient was discharged home on HD # 4 in stable condition. At the time of discharge, the patient was doing well, afebrile with stable vital signs. The patient was tolerating a regular diet, ambulating, voiding without assistance, and pain was well controlled. The patient received discharge teaching and follow-up instructions with understanding verbalized and agreement with the discharge plan. ",1805,282
10007795-DS-16,"<SEX> F <SERVICE> SURGERY <ALLERGIES> ciprofloxacin / fluconazole <ATTENDING> ___. <CHIEF COMPLAINT> Elevated WBC, malaise <MAJOR SURGICAL OR INVASIVE PROCEDURE> None <HISTORY OF PRESENT ILLNESS> ___ with ETOH hepatitis and pancreatitis episode ___ with prolonged hospitalization at ___ c/b PNA, sepsis, respiratory failure, and pancreatic pseudocyst s/p endoscopic cystogastrostomy ___ and ___ drainage of R flank collection ___ c/b infection of pseudocyst (___), ___ fungemia, & severe necrotizing pancreatitis s/p laparoscopic drainage and debridement ___, on home tube feeds and outpatient micafungin therapy, now presents at the behest of her outpatient caregiver due to an elevated WBC to 18 on routine outpatient labs. She does endorse some malaise, myalgias, and mild SOB for the past ___s a change in character of her drain output from a purulent yellowish color to a purulent brown/tan color, however drain quantity has remained unchanged at about 40cc per day. Has had some non-radiating LLQ pain around her ostomy for the past couple weeks that is dull and not exacerbated by palpation or tube feeds (via dobhoff) and has been stable, but she does feel that oral intake occasionally makes this pain increase. Denies nausea or emesis and continues to pass stool and gas from her ostomy, has lost ___ lbs over the past month. She continues to have intermittent low-grade fevers at home, but no fevers of 101 or higher, no chills or sweats. RUE ___ site is cared for by home RN's and the cap is changed weekly, last changed today, and she has not noticed any swelling or redness or drainage from this site. No pain with urination, urinary frequency, or discharge. No dizziness, lightheadedness, chest pain, cough. Surgery is now consulted regarding her elevated WBC and generalized malaise. <PAST MEDICAL HISTORY> Per ___ and ___ discharge summary ___. Hypertension. Hypercholesterolemia. Diabetes ___ pancreatitis. Metabolic toxic encephalopathy Depression. Diverticulitis s/p sigmoid resection and end colostomy unable to be reversed b/c severe scarring and fibrosis. Anemia of chronic disease. Breast Ca s/p bl mastectomy and chemotherapy ___ years ago. ETOH abuse. Bowel obstruction. Pancreatic pseudocyst. s/p appendectomy for ruptured appendix. s/p laparoscopy - pelvic pain r/o endomitriosis <SOCIAL HISTORY> ___ <FAMILY HISTORY> Cancer <PHYSICAL EXAM> Discharge physical exam: Vital signs afebrile and stable Gen: Alert and oriented, no acute distress CV: RRR Pulm: No respiratory distress Abdomen: Soft, non-distended, mildly tender, ostomy with foul smelling brown stool, R flank drainage with small amount of brown liquid Extremities: warm and well perfused <PERTINENT RESULTS> ___ 09: 20PM URINE COLOR-Yellow APPEAR-Hazy SP ___ ___ 09: 20PM URINE BLOOD-NEG NITRITE-NEG PROTEIN-TR GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-2* PH-5.0 LEUK-LG ___ 09: 20PM URINE RBC-7* WBC-50* BACTERIA-FEW YEAST-NONE EPI-11 TRANS EPI-<1 ___ 09: 20PM URINE MUCOUS-MANY ___ 05: 20PM GLUCOSE-107* UREA N-12 CREAT-0.5 SODIUM-137 POTASSIUM-3.8 CHLORIDE-100 TOTAL CO2-22 ANION GAP-19 ___ 05: 20PM estGFR-Using this ___ 05: 20PM ALT(SGPT)-28 AST(SGOT)-22 ALK PHOS-129* TOT BILI-0.3 ___ 05: 20PM LIPASE-11 ___ 05: 20PM ALBUMIN-4.3 ___ 05: 20PM WBC-20.4*# RBC-4.78 HGB-13.2 HCT-40.1 MCV-84 MCH-27.6 MCHC-32.8 RDW-15.6* ___ 05: 20PM NEUTS-82.5* LYMPHS-9.3* MONOS-6.8 EOS-1.1 BASOS-0.4 ___ 05: 20PM PLT COUNT-295 US from ___: Nonocclusive thrombus extending from the right subclavian vein into the axillary and central portion of the basilic vein. There is no DVT in the distal basilic vein, cephalic vein or paired brachial veins. <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Duloxetine 60 mg PO DAILY 2. Gabapentin 300 mg PO TID 3. Gemfibrozil 600 mg PO BID 4. HYDROmorphone (Dilaudid) 8 mg PO Q3H: PRN pain 5. Pancrelipase 5000 2 CAP PO TID W/MEALS 6. Lorazepam 1 mg PO Q8H: PRN anxiety 7. Micafungin 100 mg IV Q24H 8. Pantoprazole 40 mg PO Q24H 9. Tamoxifen Citrate 20 mg PO DAILY 10. Docusate Sodium 100 mg PO BID 11. Milk of Magnesia 30 mL PO HS: PRN constipation 12. Multivitamins 1 TAB PO DAILY 13. Senna 2 TAB PO HS: PRN constipation <DISCHARGE MEDICATIONS> 1. Docusate Sodium 100 mg PO BID 2. Duloxetine 60 mg PO DAILY 3. Gabapentin 300 mg PO TID 4. Gemfibrozil 600 mg PO BID 5. HYDROmorphone (Dilaudid) 8 mg PO Q3H: PRN pain 6. Lorazepam 1 mg PO Q8H: PRN anxiety 7. Micafungin 100 mg IV Q24H 8. Milk of Magnesia 30 mL PO Q6H: PRN constipation 9. Multivitamins 1 TAB PO DAILY 10. Pancrelipase 5000 2 CAP PO TID W/MEALS 11. Pantoprazole 40 mg PO Q12H 12. Senna 1 TAB PO BID: PRN constipation 13. Tamoxifen Citrate 20 mg PO DAILY 14. Vancomycin Oral Liquid ___ mg PO Q6H <DISCHARGE DISPOSITION> Home With Service Facility: ___ <DISCHARGE DIAGNOSIS> 1. Clostridium difficile colitis 2. Gram positive bacteremia <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> General <DISCHARGE INSTRUCTIONS> Please resume all regular home medications , unless specifically advised not to take a particular medication. Also, please take any new medications as prescribed. Please get plenty of rest, continue to ambulate several times per day, and drink adequate amounts of fluids. Avoid lifting weights greater than ___ lbs until you follow-up with your surgeon, who will instruct you further regarding activity restrictions. Avoid driving or operating heavy machinery while taking pain medications. Please follow-up with your surgeon and Primary Care Provider (PCP) as advised. Drain Care: *Please look at the site every day for signs of infection (increased redness or pain, swelling, odor, yellow or bloody discharge, warm to touch, fever). *Note color, consistency, and amount of fluid in the drain. ___ the doctor, ___, or ___ nurse if the amount increases significantly or changes in character. *Be sure to empty the drain frequently. Record the output, if instructed to do so. *You may shower; wash the area gently with warm, soapy water. *Keep the insertion site clean and dry otherwise. *Avoid swimming, baths, hot tubs; do not submerge yourself in water. *Make sure to keep the drain attached securely to your body to prevent pulling or dislocation. PICC Line: *Please monitor the site regularly, and ___ your MD, nurse practitioner, or ___ Nurse if you notice redness, swelling, tenderness or pain, drainage or bleeding at the insertion site. * ___ your MD or proceed to the Emergency Room immediately if the PICC Line tubing becomes damaged or punctured, or if the line is pulled out partially or completely. DO NOT USE THE PICC LINE IN THESE CIRCUMSTANCES.Please keep the dressing clean and dry. Contact your ___ Nurse if the dressing comes undone or is significantly soiled for further instructions. What to watch out for when you have a Dobhoff Feeding Tube: 1. Blocked tube: If the tube won't flush, try using 15 mL carbonated cola or warm water. If it still will not flush, ___ your nurse or doctor. Always be sure to flush the tube with at least 60 mL water after giving medicine or feedings. 2.Vomiting: ___ doctor if vomiting persists. Vomiting causes the loss of body fluids, salts and nutrients. *Give the feeding in an upright position. *Try smaller, more frequent feedings. Be sure the total amount for the day is the same though. *Infection may cause vomiting. Clean and rinse equipment well between feedings. *Do not let formula in the feeding bag hang longer than 6 hours unrefrigerated. After the formula can is opened, it should be stored in refrigerator until used. 3. Diarrhea: *This is frequent loose, watery stools. *Can be caused by: giving too much feeding at once or running it too quickly, decreased fiber in diet, impacted stool or infection. Some medicines also cause diarrhea. *Avoid hanging formula for longer than 6 hours. *Give more water after each feeding to replace water lost in diarrhea. ___ doctor if diarrhea does not stop after ___ days. 4. Dehydration: *Due to diarrhea, vomiting, fever, sweating. (Loss of water and fluids) *Signs include: decreased or concentrated (dark) urine, crying with no tears, dry skin, fatigue, irritability, dizziness, dry mouth, weight loss, or headache. *Give more water after each feeding to replace the water lost. ___ your doctor. 5. Constipation: ___ be caused by too little fiber in diet, not enough water or side effects of some medicines. *Take extra fruit juice or water between feedings. *If constipation becomes chronic, ___ the doctor. 6. Gas, bloating or cramping: Be sure there is no air in the tubing before attaching the feeding tube. 7.Tube is out of place: If the tube is no longer in your stomach, tape it down and ___ your doctor or home health nurse. Do not use the tube. You will need to have a new tube placed. Monitoring Ostomy output/Prevention of Dehydration: *Keep well hydrated. *Replace fluid loss from ostomy daily. *Avoid only drinking plain water. Include Gatorade and/or other vitamin drinks to replace fluid. *Try to maintain ostomy output between 1000mL to 1500mL per day. ","Ms. ___ was admitted on ___ after being found to have an elevated WBC in combination with malaise and some abdominal pain. She was pan-cultured on admission. Her blood cultures revealed negative cultures in those drawn from peripheral IV's, however in the blood culture from the PICC, viridans strep, coag-neg staph, and micrococcus grew. Her clostridium difficile PCR test at the same time was positive. The infectious disease service was then consulted. They recommended that she be on IV vancomycin for 14 days for her gram positive bacteremia and po vancomycin for 2 months. They planned to follow her in clinic to gradually wean the dose of po vanc. On HOD1, she did note some blood from her R flank drain however this never occurred again during her hospitalization. On ___, IV nurse attempted to place a R sided PICC line however follow chest xray revealed it was curled up in the arm. She then went to interventional radiology for placement of a PICC on ___. The radiology placement was unsuccessful and it prompted for RUE US. US revealed right subclavian vein thrombosis. Patient was started on SC Lovenox. Her antibiotics were changed to Linezolid per ID. Also per ID, her micafungin was stopped on ___. During her hospitalization, her WBC was trended and was normalized at the time of her discharge. Her electrolytes were also monitored and repleted as necessary. At the time of discharge, she was voiding, ambulatory, and mentating well. Her ostomy output was brown and foul smelling. The output from the drain on the R flank was decreasing in quantity and mostly liquid brown. ",2523,359
10007795-DS-17,"<SEX> F <SERVICE> SURGERY <ALLERGIES> ciprofloxacin / fluconazole <ATTENDING> ___. <CHIEF COMPLAINT> dehydration, abdominal pain, and tachycardia <MAJOR SURGICAL OR INVASIVE PROCEDURE> none <HISTORY OF PRESENT ILLNESS> Ms ___ is a ___ with ETOH hepatitis and pancreatitis on ___ with a prolonged hospitalization at ___ c/b PNA, sepsis, respiratory failure, and pancreatic pseudocyst, s/p endoscopic cystogastrostomy ___ and ___ drainage of R flank collection ___ c/b infection of pseudocyst ___ fungemia, & severe necrotizing pancreatitis s/p laparoscopic drainage and debridement ___. She was most recently readmitted to ___ on ___ for increased WBCs and malaise, and a work up was notable for blood cultures from her PICC which grew viridans strep, coag-neg staph, and micrococcus grew and clostridium difficile PCR test at the same time was positive. She was treated with Vancomycin and transitioned to Linezolid and started on Micafungin per ID recomendations. She was ultimately discharged to a rehab on ___ in stable condition. Since discharge, the patient has been doing well, went from rehab to home two weeks prior to presenting and has been tolerating a regular diet. One week prior to presentation, however, she noticed a sharp burning pain at the site of her RLQ drain that she reported was ___ in severity and has persisted. She also noted that during this time, her RLQ drain, which had been working its way out over the past few weeks, had withdrawn back into her wound. Over the past few days, her RLQ pain has persisted and radiates across her epigastrum and along her back and increases to ___ in severity. Given the persistent abdominal and back pain, she presented to clinic today for evaluation. In addition to pain, she endorses poor po intake, dark urine, and feeling dehdraded. She denies emesis or fevers during this time, but does endorse having some nausea and night sweats. She also reports feeling depressed and is upset that she continues to return to the hospital. <PAST MEDICAL HISTORY> Per ___ and ___ discharge summary ___. Hypertension. Hypercholesterolemia. Diabetes ___ pancreatitis. Metabolic toxic encephalopathy Depression. Diverticulitis s/p sigmoid resection and end colostomy unable to be reversed b/c severe scarring and fibrosis. Anemia of chronic disease. Breast Ca s/p bl mastectomy and chemotherapy ___ years ago. ETOH abuse. Bowel obstruction. Pancreatic pseudocyst. s/p appendectomy for ruptured appendix. s/p laparoscopy - pelvic pain r/o endomitriosis <SOCIAL HISTORY> ___ <FAMILY HISTORY> Cancer <PHYSICAL EXAM> <PERTINENT RESULTS> ___ 09: 15PM URINE HOURS-RANDOM ___ 09: 15PM URINE UCG-NEGATIVE ___ 09: 15PM URINE COLOR-Yellow APPEAR-Clear SP ___ ___ 09: 15PM URINE BLOOD-NEG NITRITE-NEG PROTEIN-TR GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-6.0 LEUK-MOD ___ 09: 15PM URINE RBC-4* WBC-14* BACTERIA-FEW YEAST-NONE EPI-4 TRANS EPI-<1 ___ 09: 15PM URINE MUCOUS-RARE ___ 06: 36PM LACTATE-1.1 ___ 06: 30PM GLUCOSE-78 UREA N-13 CREAT-0.5 SODIUM-136 POTASSIUM-3.8 CHLORIDE-99 TOTAL CO2-26 ANION GAP-15 ___ 06: 30PM estGFR-Using this ___ 06: 30PM ALT(SGPT)-12 AST(SGOT)-14 ALK PHOS-116* TOT BILI-0.2 ___ 06: 30PM LIPASE-14 ___ 06: 30PM ALBUMIN-4.2 CALCIUM-9.8 PHOSPHATE-3.3 MAGNESIUM-1.8 ___ 06: 30PM WBC-14.6*# RBC-4.97# HGB-13.7# HCT-42.3# MCV-85 MCH-27.6 MCHC-32.3 RDW-14.2 ___ 06: 30PM NEUTS-81.4* LYMPHS-11.5* MONOS-4.3 EOS-2.2 BASOS-0.5 ___ 06: 30PM PLT COUNT-285 ___ 06: 30PM ___ PTT-31.8 ___ <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Gabapentin 300 mg PO TID 2. Duloxetine 60 mg PO DAILY 3. Gemfibrozil 600 mg PO BID 4. Pancrelipase 5000 3 CAP PO TID W/MEALS 5. Lorazepam 1 mg PO Q8H: PRN anxiety 6. Pantoprazole 40 mg PO Q24H 7. Pregabalin 50 mg PO TID 8. Tamoxifen Citrate 20 mg PO DAILY 9. Docusate Sodium 100 mg PO BID 10. Senna 1 TAB PO BID: PRN constipation 11. Multivitamins 1 TAB PO DAILY <DISCHARGE MEDICATIONS> 1. Docusate Sodium 100 mg PO BID RX *docusate sodium 100 mg 1 capsule(s) by mouth twice a day Disp #*60 Capsule Refills: *0 2. Duloxetine 60 mg PO DAILY 3. Gabapentin 300 mg PO TID 4. Gemfibrozil 600 mg PO BID 5. Lorazepam 1 mg PO Q8H: PRN anxiety 6. Multivitamins 1 TAB PO DAILY 7. Pancrelipase 5000 3 CAP PO TID W/MEALS 8. Pantoprazole 40 mg PO Q24H 9. Senna 1 TAB PO BID: PRN constipation 10. Tamoxifen Citrate 20 mg PO DAILY 11. HYDROmorphone (Dilaudid) ___ mg PO Q4H: PRN pain RX *hydromorphone 4 mg ___ tablet(s) by mouth every four (4) hours Disp #*60 Tablet Refills: *0 12. Pregabalin 50 mg PO TID <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Dehydration <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Please call your doctor or nurse practitioner if you experience the following: *You experience new chest pain, pressure, squeezing or tightness. *New or worsening cough, shortness of breath, or wheeze. *If you are vomiting and cannot keep down fluids or your medications. *You are getting dehydrated due to continued vomiting, diarrhea, or other reasons. Signs of dehydration include dry mouth, rapid heartbeat, or feeling dizzy or faint when standing. *You see blood or dark/black material when you vomit or have a bowel movement. *You experience burning when you urinate, have blood in your urine, or experience a discharge. *Your pain is not improving within ___ hours or is not gone within 24 hours. Call or return immediately if your pain is getting worse or changes location or moving to your chest or back. *You have shaking chills, or fever greater than 101.5 degrees Fahrenheit or 38 degrees Celsius. *Any change in your symptoms, or any new symptoms that concern you. . General <DISCHARGE INSTRUCTIONS> Please resume all regular home medications , unless specifically advised not to take a particular medication. Also, please take any new medications as prescribed. Please get plenty of rest, continue to ambulate several times per day, and drink adequate amounts of fluids. Avoid lifting weights greater than ___ lbs until you follow-up with your surgeon, who will instruct you further regarding activity restrictions. Avoid driving or operating heavy machinery while taking pain medications. Please follow-up with your surgeon and Primary Care Provider (PCP) as advised. Incision Care: *Please call your doctor or nurse practitioner if you have increased pain, swelling, redness, or drainage from the incision site. *Avoid swimming and baths until your follow-up appointment. *You may shower, and wash surgical incisions with a mild soap and warm water. Gently pat the area dry. *Please change your dressing to your right abdomen wound daily and as needed with dry gauze ","The patient was admitted to the General Surgical Service on ___ from clinic where she had presented with left abdominal pain and tachycardia. Her drain had been removed in clinic and silver nitrate was applied due to some bloody drainage at the site. On admission, she was made NPO, put on IV pain medication, and received IV fluid hydration. CT scan of her abdomen showed an interval decrease in size of a prior peripancreatic fluid collection with question of superinfection of the collection. CT also showed question of a new splenic infarct, a high density in the subcutaneous tissue of the right posterolateral drain tract (which was correlated with the application of silver nitrate at that site), and a destructive appearing right iliac lucency concerning for a metastatic focus (given history of breast cancer). Infectious work up was done that was unremarkable - chest x-ray showed mild atelectasis and urinalaysis was negative. Her labs were also within normal limits with no leukocytosis. On HD2, the patient showed improvement in her abdominal pain and was advanced to a regular diet, which she tolerated well with no nausea and vomiting. Her home medications were restarted, and she was transitioned to PO pain control. Her wound remained covered, and her ostomy was viable. At the time of discharge, the patient was doing well, afebrile with stable vital signs. The patient was tolerating a regular diet, ambulating, voiding without assistance, and pain was well controlled. We discussed with her the CT finding of possible metastatic disease for which she was follow up with oncology. The patient received discharge teaching and follow-up instructions with understanding verbalized and agreement with the discharge plan. ",1962,356
10007818-DS-2,"<SEX> M <SERVICE> MEDICINE <ALLERGIES> Penicillins <ATTENDING> ___. <CHIEF COMPLAINT> Volume overload <MAJOR SURGICAL OR INVASIVE PROCEDURE> Paracentesis ___ Paracentesis ___ Paracentesis ___ Paracentesis ___ Paracentesis ___ Paracentesis ___ Cardiac catheterization HD line placement CVL placement A-line placement <HISTORY OF PRESENT ILLNESS> ___ year old with CAD, hypertension, atrial fibrillation not on Coumadin, type 2 DM, and ___ Class C cirrhosis secondary to non-alcoholic steatohepatitis complicated by recurrent ascites, no reported varices, ?GI bleed, and hepatic encephalopathy presenting from clinic with volume overload. Pt was initially seen by Dr. ___ in clinic ___ for consideration of TIPS. He was subsequently sent to transplant clinic for workup of possible transplant given the risk of decompensation secondary to a TIPS procedure. Today, he presented to clinic to see Dr. ___ was noted to be volume overloaded with massive ascites and failure to thrive. He was subsequently admitted directly from clinic to the ET service with plans for aggressive volume management and TIPS. On presentation to the floor, pt reports that over the past few months he has had increasing ascites, and overall general worsening with fatigue and weakness. Since ___ he has been having regular paracenteses, first biweekly and now up to one time per week. His last paracentesis was 4 days ago, and 6 liters were drained. He has had no recent confusion, no nausea or vomiting, no melena. His bowel movements are normal (loose). <PAST MEDICAL HISTORY> Child C cirrhosis ___ nonalcoholic steatohepatitis Atrial fibrillation: off Coumadin after having a supratherapeutic INR and ?blood loss in ___ T2DM on insulin CAD HTN <SOCIAL HISTORY> ___ <FAMILY HISTORY> Unknown <PHYSICAL EXAM> ADMISSION PHYSICAL EXAM VS: T97.5 BP119/69 HR62 RR18 O2100 RA General: lying in bed, appears tired, NAD. HEENT: anicteric sclerae; MMM. Neck: no appreciable JVD. CV: regular rate and rhythm (not in afib), normal S1 and S2 Lungs: CTAx2 with good air movement Abdomen: distended, tense, nontender, +fluid wave Ext: nonedematous; nontender. Neuro: AOx3, no asterixis Skin: no jaundice DISCHARGE PHYSICAL EXAM Patient deceased <PERTINENT RESULTS> ADMISSION LABS ___ 07: 36PM BLOOD WBC-8.6 RBC-3.82* Hgb-11.7* Hct-35.6* MCV-93 MCH-30.6 MCHC-32.9 RDW-15.3 RDWSD-52.3* Plt ___ ___ 07: 36PM BLOOD ___ PTT-38.5* ___ ___ 07: 36PM BLOOD Glucose-230* UreaN-68* Creat-2.0* Na-125* K-5.2* Cl-93* HCO3-21* AnGap-16 ___ 07: 36PM BLOOD ALT-22 AST-45* AlkPhos-84 TotBili-1.2 ___ 07: 36PM BLOOD Albumin-3.6 Calcium-9.6 Phos-3.6 Mg-2.1 PERTINENT INTERMITTENT LABS ___ 03: 10AM BLOOD Lipase-131* ___ 11: 54AM BLOOD CK-MB-1 cTropnT-0.02* ___ 02: 05PM BLOOD CK-MB-1 cTropnT-<0.01 ___ 10: 17PM BLOOD Hapto-22* ___ 07: 21AM BLOOD D-Dimer-GREATER TH ___ 03: 55AM BLOOD Triglyc-174* ___ 03: 10AM BLOOD Triglyc-188* ___ 09: 41AM BLOOD TSH-0.92 ___ 01: 01PM BLOOD PTH-17 ___ 09: 41AM BLOOD T4-2.5* ___ 06: 14AM BLOOD HBsAg-NEGATIVE HBsAb-NEGATIVE HBcAb-NEGATIVE ___ 10: 42AM BLOOD PEP-NO SPECIFI IgG-762 IgA-319 IgM-59 IFE-NO MONOCLO ___ 04: 30AM BLOOD HIV Ab-Negative ___ 06: 14AM BLOOD HCV Ab-NEGATIVE DISCHARGE LABS ___ 03: 10AM BLOOD WBC-12.2* RBC-UNABLE TO Hgb-UNABLE TO Hct-36.0* MCV-UNABLE TO MCH-UNABLE TO MCHC-UNABLE TO RDW-UNABLE TO RDWSD-UNABLE TO Plt Ct-72* ___ 03: 10AM BLOOD ___ ___ 03: 10AM BLOOD Glucose-317* UreaN-49* Creat-2.4* Na-132* K-3.8 Cl-92* HCO3-20* AnGap-24 ___ 03: 10AM BLOOD ALT-29 AST-121* AlkPhos-105 TotBili-34.5* ___ 03: 10AM BLOOD Calcium-8.8 Phos-3.6 Mg-2.7* MICRO: ___ 3: 09 pm PERITONEAL FLUID PERITONEAL FLUID. **FINAL REPORT ___ GRAM STAIN (Final ___: NO POLYMORPHONUCLEAR LEUKOCYTES SEEN. NO MICROORGANISMS SEEN. This is a concentrated smear made by cytospin method, please refer to hematology for a quantitative white blood cell count.. FLUID CULTURE (Final ___: NO GROWTH. ANAEROBIC CULTURE (Final ___: NO GROWTH. ___ 4: 30 am Blood (EBV) **FINAL REPORT ___ ___ VIRUS VCA-IgG AB (Final ___: POSITIVE BY EIA. ___ VIRUS EBNA IgG AB (Final ___: POSITIVE BY EIA. ___ 8: 00 pm BLOOD CULTURE **FINAL REPORT ___ Blood Culture, Routine (Final ___: ESCHERICHIA COLI. FINAL SENSITIVITIES. Cefazolin interpretative criteria are based on a dosage regimen of 2g every 8h. AZTREONAM REQUESTED PER ___ ___ (___) ___. SENSITIVE TO AZTREONAM sensitivity testing performed by ___ ___. SENSITIVITIES: MIC expressed in MCG/ML _________________________________________________________ ESCHERICHIA COLI | AMPICILLIN------------ <=2 S AMPICILLIN/SULBACTAM-- <=2 S CEFAZOLIN------------- <=4 S CEFEPIME-------------- <=1 S CEFTAZIDIME----------- <=1 S CEFTRIAXONE----------- <=1 S CIPROFLOXACIN---------<=0.25 S GENTAMICIN------------ <=1 S MEROPENEM-------------<=0.25 S PIPERACILLIN/TAZO----- <=4 S TOBRAMYCIN------------ <=1 S TRIMETHOPRIM/SULFA---- <=1 S ___ 12: 55 am URINE Site: NOT SPECIFIED **FINAL REPORT ___ URINE CULTURE (Final ___: SERRATIA MARCESCENS. >100,000 ORGANISMS/ML.. This organism may develop resistance to third generation cephalosporins during prolonged therapy. Therefore, isolates that are initially susceptible may become resistant within three to four days after initiation of therapy. For serious infections, repeat culture and sensitivity testing may therefore be warranted if third generation cephalosporins were used. Piperacillin/tazobactam sensitivity testing available on request. AZTREONAM Susceptibility testing requested by ___. ___ ___ ___. SENSITIVE TO AZTREONAM. AZTREONAM sensitivity testing performed by ___. SENSITIVITIES: MIC expressed in MCG/ML _________________________________________________________ SERRATIA MARCESCENS | CEFEPIME-------------- <=1 S CEFTAZIDIME----------- <=1 S CEFTRIAXONE----------- <=1 S CIPROFLOXACIN---------<=0.25 S GENTAMICIN------------ <=1 S MEROPENEM-------------<=0.25 S NITROFURANTOIN-------- 256 R TOBRAMYCIN------------ 2 S TRIMETHOPRIM/SULFA---- <=1 S ___ 2: 19 am SPUTUM Source: Endotracheal. **FINAL REPORT ___ GRAM STAIN (Final ___: ___ PMNs and <10 epithelial cells/100X field. 1+ (<1 per 1000X FIELD): BUDDING YEAST WITH PSEUDOHYPHAE. RESPIRATORY CULTURE (Final ___: Commensal Respiratory Flora Absent. Due to mixed bacterial types ( >= 3 colony types) an abbreviated workup will be performed appropriate to the isolates recovered from this site. YEAST. SPARSE GROWTH. GRAM NEGATIVE ROD(S). RARE GROWTH. STAPH AUREUS COAG +. RARE GROWTH. This isolate is presumed to be resistant to clindamycin based on the detection of inducible resistance . SENSITIVITIES: MIC expressed in MCG/ML _________________________________________________________ STAPH AUREUS COAG + | CLINDAMYCIN----------- R ERYTHROMYCIN---------- R GENTAMICIN------------ <=0.5 S LEVOFLOXACIN---------- =>8 R OXACILLIN-------------<=0.25 S TETRACYCLINE---------- <=1 S TRIMETHOPRIM/SULFA---- <=0.5 S ___ 6: 29 pm BRONCHOALVEOLAR LAVAGE GRAM STAIN (Final ___: 1+ (<1 per 1000X FIELD): POLYMORPHONUCLEAR LEUKOCYTES. 1+ (<1 per 1000X FIELD): BUDDING YEAST. RESPIRATORY CULTURE (Final ___: Commensal Respiratory Flora Absent. YEAST. 10,000-100,000 ORGANISMS/ML.. FUNGAL CULTURE (Preliminary): YEAST. NOCARDIA CULTURE (Preliminary): NO NOCARDIA ISOLATED. ACID FAST SMEAR (Final ___: NO ACID FAST BACILLI SEEN ON CONCENTRATED SMEAR. ACID FAST CULTURE (Preliminary): NO MYCOBACTERIA ISOLATED. DIAGNOSTICS AND IMAGING RUQ w/ Doppler ___: IMPRESSION: Cirrhotic appearing liver with large ascites and splenomegaly. No suspicious masses. Patent hepatic vasculature. Cholelithiasis. Renal US ___: IMPRESSION: 1. No evidence of hydronephrosis. 2. Cirrhosis with large amount of intra-abdominal ascites. CXR ___: IMPRESSION: In comparison with the study of ___, there are again low lung volumes that accentuate the transverse diameter of the heart. Continued increased opacification at the left base, consistent with pleural effusion and compressive basilar atelectasis. Mild indistinctness of pulmonary vessels could reflect some elevated pulmonary venous pressure. The ___ tube appears unchanged CT A/P ___. 24 cm right retroperitoneal hematoma secondary to a right common femoral artery pseudoaneurysm measuring 2.2 cm with a neck of 0.2 cm and another component of the pseudoaneurysm just superiorly measuring 3 cm. 2. Cirrhosis, ascites and splenomegaly. 3. Cholelithiasis. 4. Moderate right pleural effusion and bibasilar atelectasis. ___ Arteriogram 1. Punctate foci of active extravasation from the right L3 and L4 lumbar arteries, treated with Gelfoam and coil embolization, with good angiographic result. 2. The right lateral circumflex artery was in proximity to the known area of bleeding, and was Gel-Foam and coil embolized, with good angiographic result. 3. The previously identified right common femoral artery pseudoaneurysm remains thrombosed, with a tiny area (2-3 mm) of residual pseudoaneurysm, too small to treat. This will likely thrombose on its own. 4. A small 4 mm pseudoaneurysm identified arising from the left SFA on left CFA angiography at the site of the arterial pressure line entry was too small to treat, and appeared thrombosed with ultrasound at the conclusion of the case. ___ CT A/P IMPRESSION: 1. Stable size of large right retroperitoneal hematoma status post coil embolization of right lumbar arteries and right lateral circumflex artery. No evidence of active extravasation. 2. Cirrhosis with sequelae of portal hypertension including splenomegaly, ascites and perigastric varices. 3. No drainable fluid collection identified. No evidence of bowel ischemia. 4. Tiny 6 mm pseudoaneurysm arising from the left superficial femoral artery just distal to its origin. The pseudoaneurysm is superior to the site of active extravasation seen on ___. ___ CT Chest IMPRESSION: 1. Small bilateral pleural effusions with adjacent consolidation, which appears to be predominantly atelectasis. A component of infection may also be present. 2. CT abdomen/pelvis reported separately. ___ CT Head 1. Severely motion limited examination demonstrating no acute large intracranial abnormality. 2. Fluid in the posterior nasopharynx and mastoid air cells bilaterally. ___ CT A/P IMPRESSION: 1. Large right retroperitoneal hematoma is similar in appearance to prior examination given redistribution. No evidence of active bleed. 2. No findings to suggest infection in the abdomen or pelvis. ___ CT Chest IMPRESSION: No evidence of active intrathoracic infection or malignancy. Small bilateral effusions with persistent left left lower lobe collapse and right basal atelectasis with increasing endobronchial secretions in the lower lobes. <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Loratadine 10 mg PO DAILY PRN allergic symptoms 2. Rifaximin 550 mg PO BID 3. Nadolol 10 mg PO DAILY 4. Sodium Polystyrene Sulfonate 15 gm PO 2X/WEEK (___) 5. Methimazole 15 mg PO DAILY 6. Omeprazole 20 mg PO DAILY 7. Fenofibrate 200 mg PO DAILY 8. Aspirin 81 mg PO DAILY 9. Humalog ___ 20 Units Bedtime 10. Vitamin D 1000 UNIT PO DAILY 11. Fish Oil (Omega 3) 1000 mg PO DAILY 12. Multivitamins 1 TAB PO DAILY <DISCHARGE MEDICATIONS> Patient deceased <DISCHARGE DISPOSITION> Expired <DISCHARGE DIAGNOSIS> PRIMARY DIAGNOSES Diuretic refractory ascites Severe malnutrition SECONDARY DIAGNOSES NASH cirrhosis Atrial fibrillation Type 2 Diabetes Coronary Artery Disease Hyperthyroidism Renal insufficiency <DISCHARGE CONDITION> Patient deceased <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Patient Deceased ","___ year old with ___ Class C cirrhosis secondary to NASH presenting from clinic with volume overload, sarcopenia, and question of possible TIPS for refractory ascites. FLOOR COURSE: Patient was admitted with diuretic refractory ascites. He was admitted for paracenteses and evaluation for TIPS and future transplant. The transplant team made the initial decision that the patient is not a TIPS or transplant candidate because of severe malnutrition, and goal became to improve nutritional status and then proceed. The patient's renal function began to worsen, and workup was consistent with hepatorenal syndrome. Nephrology was consulted, and agreed with HRS as the diagnosis, and he was started on midodrine, octreotide and daily albumin. As his renal failure progressed, he required dialysis and had a dialysis line placed ___. His worsening renal function led to the decision to expedite his transplant eligibility. Because he has a history of CAD and is s/p 2 stents from ___, he had to undergo a cardiac catheterization for evaluation of CAD and transplant eligibility. He went for cardiac cath on ___, which found no interventional lesions. However, the day after the procedure he developed a retroperitoneal bleed, which led to transfer to the ICU. MICU COURSE: # Shock: Initially secondary to hemorrhagic shock due to retroperitoneal bleed requiring massive transfusion protocol on arrival to the MICU. He was resuscitated though subsequently had ongoing septic shock physiology requiring pressor support. Etiology of septic shock was secondary to new infections including serratia UTI, E.coli bacteremia, MSSA VAP. Despite completing a course of antibiotics (Vanc/Meropenem) for all of these infections by ___ he had a persistent and rising leukocytosis. Infectious disease was consulted for assistance with workup and management. Micafungin was added for empiric fungal coverage. His HD line (placed in the setting of renal failure as below) was removed. Pus was noted around the insertion site, suggesting a line infection as a possible contributing source. Blood cultures, however, remained negative. Peritoneal fluid was also not suggestive of infection. Note is made of peritoneal fluid from ___, which appears inflammatory, despite correction for RBC count. Cultures were negative, however and subsequent pleural fluid did not suggest spontaneous or secondary bacterial peritonitis. Alternative etiology potentially secondary to persisent gut translocation into the peritoneal space. His leukocytosis downtrended without a clear source of ongoing infection. # Respiratory failure: Mr. ___ was initially intubated in the setting of hemorrhagic shock and metabolic acidosis. His course was then complicated by MSSA VAP. After correction of metabolic acidosis he remained intubated in the setting of altered mental status, volume overload, and impaired lung dynamics in the setting of ascites. Yet, despite clearing of his mental status, improvement of volume status with HD, and large volume paracenteses it was not possible to wean him off of the ventilator. He remained intubated for more than two weeks with a likely contribution from respiratory muscle weakness in the setting of prolonged intubation. He had ongoing thick secretions requiring repeated bronchoscopies for clearance of mucous plugging and LLL collapse. Tracheostomy was discussed with the patient and family. The patient clearly indicated that he did not want a tracheostomy, nor did he want to remain intubated. Rather, he made it clear that he wanted to be extubated to comfort care. He was extubated on the evening of ___ and passed within a few hours. Family was at bedside. # Renal failure: Mr. ___ was noted to have progressively worsening renal function prior to MICU transfer, consistent with hepatorenal syndrome. He was started on midodrine and octreotide as well as albumin. His renal failure progressed requiring dialysis and a dialysis line was placed ___. He continued on CVVH while in the ICU and was ultimately transitioned to intermittent HD. His HD line was removed as noted above in the setting of persistent leukocytosis for a line holiday. A temporary line was replaced given ongoing dialysis needs. He required pressors in the ICU in order to tolerate fluid removal with HD. # MSSA pneumonia: Noted to have MSSA pneumonia from sputum culture on ___. He was initially treated with Vancomycin pending sensitivities. However, he was continued on Vancomycin despite penicillin sensitivity in order to prevent inducible serratia resistance in the setting of serratia UTI, as below. He completed a course of antibiotics on ___, though antibiotics were continued as noted above in the setting of ongoing leukocytosis. # E.coli bacteremia: E.coli noted on blood culture on ___. He was initially treated with Meropenem for GNR bacteremia and completed a 2 week course of meropenem on ___, though antibiotics were continued in the setting of persistent leukocytosis as above and concern for ongoing gut translocation. # Serratia UTI: Noted on urine culture on ___. He was treated with a course of meropenem. # Atrial flutter/fib: MICU course was complicated by recurrent episodes of atrial fibrillation and flutter. This initially occurred in the setting of volume removal with CVVH and responded well to doses of metoprolol or diltiazem. He developed atrial fibrillation with hypotension requiring pressors later in his ICU course during bronchoscopy, requiring amiodarone. He was continued on amiodarone until his he was transitioned to comfort measures. # Ileus: Mr. ___ malnutrition was noted while he was on the floor and prior to MICU transfer. After intubation an NGT was placed and tube feeds were initiated. He had high residuals that precluded goal tube feeding. CT A/P did not reveal obstructive pathology. Concern for potential peritonitis causing ileus, though ileus persisted despite negative peritoneal cultures. Ileus did not improve with reglan. He was started on TPN. A dophoff was placed, advanced post-pyloric by ___. # Decompensated Cirrhosis: Mr. ___ had worsening liver failure with rising bilirubin and MELD score throughout his hospital stay in the setting of multiple complications as noted below. Also with renal failure requiring HD. MICU team and liver attending had ongoing family meetings regarding potential for liver/kidney transplant. As his hospital course progressed it became increasingly clear that he would not recover to be well enough for a transplant. His family struggled to come to terms with this. Ultimately he indicated that he wanted to be extubated to CMO and passed within a few hours. Family was at bedside. ",3473,1429
10007928-DS-2,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> Sulfa(Sulfonamide Antibiotics) / Sulfa(Sulfonamide Antibiotics) <ATTENDING> ___. <CHIEF COMPLAINT> hematemesis <MAJOR SURGICAL OR INVASIVE PROCEDURE> EGD <HISTORY OF PRESENT ILLNESS> ___ year old woman with no PMH presents with 5 days of abdominal pain and nausea, and one day of nausea/hematemesis. . 5 days ago patient experienced ___ loose non bloody bowel movements per day, assocaiated with mild intermittent lower abdominal pain. Three days ago, she noted shaking and felt hot and sweaty, thought she hd a temperature, but did not have a thermometer. This evening around 7: 00 pm she became acutely nauseous and vomiting with BRB. With her second emesis, she vomited > 1 cup BRB. She then had 4 more episodes of hematemesis, < 1 cup. . Denies dizziness, lightheadedness, syncope, chest pain. No recent travel or food experiementation. She does note a tick bite to her right thigh about 1 week ago. She removed it promptly, and did not have any rash. . On arrival to the ED VS were 97.1 98 102/59 15 99% RA. NGT was placed, removed mild BRB and coffee grounds, cleared after 500cc lavage. Guaiac negative brown stool. Hct 40. Called GI, thought likely ___ tear, would consider endoscopy in am. Started on pantoprazole bolus + drip, 2 18g PIVs placed. Given 2L NS. Admitted to ICU for UGIB. . On arrival to the MICU, she feels shaky, but nausea is improved since arrival. <PAST MEDICAL HISTORY> None <SOCIAL HISTORY> ___ <FAMILY HISTORY> Father with type ___ DM and bladder cancer, mother with lung cancer. <PHYSICAL EXAM> ADMISSION EXAM: General: Alert, oriented, no acute distress HEENT: Sclera anicteric, MMM, oropharynx clear, EOMI, PERRL Neck: supple, JVP not elevated, no LAD CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Lungs: Clear to auscultation bilaterally, no wheezes, rales, ronchi Abdomen: soft, non-tender, non-distended, bowel sounds present, no organomegaly GU: no foley Ext: warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema Neuro: CNII-XII intact, ___ strength upper/lower extremities, grossly normal sensation, 2+ reflexes bilaterally, gait deferred, finger-to-nose intact . DISCHARGE EXAM: VS: 98.0, 100-110/60-76, 73-86, 18, 95% on 4L Gen: Well-appearing, alert, and communicative HEENT: MMM Lungs: Minimal crackles anteriorly R>L. Heart: RRR, no murmuirs, no rubs Abd: Soft, nontender, nondistended Ext: Trace pedal edema, edema of right hand, clubbing of fingers. No further rashon legs <PERTINENT RESULTS> ADMISSION LABS: ___ 09: 30PM BLOOD WBC-15.6* RBC-4.54 Hgb-13.8 Hct-40.6 MCV-89 MCH-30.3 MCHC-33.9 RDW-11.8 Plt ___ ___ 09: 30PM BLOOD Neuts-87.7* Lymphs-6.1* Monos-5.6 Eos-0.4 Baso-0.2 ___ 09: 30PM BLOOD ___ PTT-29.8 ___ ___ 09: 30PM BLOOD Glucose-126* UreaN-17 Creat-0.9 Na-128* K-3.6 Cl-89* HCO3-25 AnGap-18 ___ 09: 30PM BLOOD ALT-59* AST-51* AlkPhos-68 TotBili-0.6 . DISCHARGE LABS: ___ 01: 30PM BLOOD WBC-8.3 RBC-4.09* Hgb-12.1 Hct-38.0 MCV-93 MCH-29.6 MCHC-31.9 RDW-12.9 Plt ___ ___ 06: 15AM BLOOD Neuts-79.3* Lymphs-15.4* Monos-4.7 Eos-0.1 Baso-0.5 ___ 04: 25AM BLOOD Hypochr-1+ Anisocy-OCCASIONAL Poiklo-OCCASIONAL Macrocy-OCCASIONAL Microcy-OCCASIONAL Polychr-OCCASIONAL ___ 05: 15PM BLOOD Parst S-NEGATIVE ___ 01: 30PM BLOOD Glucose-94 UreaN-10 Creat-0.6 Na-138 K-4.5 Cl-103 HCO3-27 AnGap-13 ___ 06: 15AM BLOOD ALT-49* AST-59* AlkPhos-63 TotBili-0.4 . MICROBIOLOGY: ___ Urine culture: mixed flora ___ Blood culture: no growth to date ___ Influenza A/B nasopharyngeal swab: negative ___ Lyme serology: pending ___ H. pylori Ab: negative ___ Urine Legionella Ag: negative ___ Blood culture: no growth to date ___ Blood culture: no growth to date ___ Blood culture (mycolytic): no growth to date ___ Stool culture/C. diff: pending . IMAGING: ___ CXR: The lung apices are not depicted. NG tube ends in the gastric antrum in appropriate position. The lungs are clear, the cardiomediastinal silhouette and hila are normal. There is no pleural effusion and no pneumothorax. Partially visualized abdomen shows normal bowel gas pattern. EGD ___: Esophagitis in the lower third of the esophagus Small hiatal hernia Friability and erythema in the antrum and stomach body compatible with gastritis Ulcer in the pylorus Ulcers in the duodenal bulb Otherwise normal EGD to third part of the duodenum Recommendations: Prilosec 40mg BID Advance diet as tolerated. Avoid NSAIDs. Serial hcts. Active type and cross. GI bleeding is unlikely the cause of the patient's current hypotensive episodes and warrents further investigation for a possible infectious cause. Given the clear history of NSAID use, follow up egd is not required but would check a h pylori serology and treat if positive. Would need a test of cure 4 weeks post h pylori serology as well. . ___ CTA chest: 1. No PE. 2. Mild pulmonary edema. 3. Upper lobe peribronchovascular airspace filling could be edema or a manifestation of more severe airspace abnormality in the lower lungs, mostly consolidation, partially atelectasis, due to aspiration, multifocal pneumonia, or less likely hemorrhage. In the setting of a recent transfusions, transfusion reaction may be contributory. 4. Esophageal wall thickening, with diffuse infiltration of the mediastinal fat which may reflect inflammatory change or confluent lymphadenopathy, though the progression from normal mediastinal contours on ___ favors a rapidly evolving inflammatory process. There is no finding to suggest esophageal perforation. . ___ CXR: As compared to the previous radiograph, there is a massive increase in extent and severity of multifocal pneumonia. The resulting very widespread parenchymal opacities are more extensive on the right than on the left and show multiple air bronchograms. In addition, retrocardiac atelectasis has newly appeared, and there is a small right pleural effusion. The opacities are better displayed on the CTA examination, performed yesterday at 9: 41 p.m. Moderate cardiomegaly. <MEDICATIONS ON ADMISSION> None <DISCHARGE MEDICATIONS> 1. MetRONIDAZOLE (FLagyl) 500 mg PO Q8H Duration: 6 Days RX *metronidazole 500 mg Every 8 hours Disp #*18 Tablet Refills: *0 2. Pantoprazole 40 mg PO Q12H RX *pantoprazole 40 mg twice a day Disp #*60 Tablet Refills: *2 3. Levofloxacin 750 mg PO DAILY RX *Levaquin 750 mg daily Disp #*6 Tablet Refills: *0 <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Pneumonia- multifocal Ulcers of the stomach and duodenum (upper small intestine). Diarrhea Gastroenteritis Pulmonary Edema <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> You were treated in the hospital for pneumonia and vomitting up of blood clots that likely developed because of vomitting, diarrhea, and fevers (possibly due to a stomach flu) as well as high doses of aspirin that worsened your stomach and small intestine ulcers. It is important that you complete the course of antibiotics for treatment of your pneumonia. Please take Levofloxacin 750 mg by mouth daily and metronidazole 500 mg by mouth every 8 hours for six more days. As you know, you were given many liters of fluids through your veins while you were in the intensive care unit because you were so sick. You will continue to urinate out this fluid within the next several days. Because you vomitted blood, we took a look at your esophagus, stomach, and upper small intestines with a camera. We saw that you have an ulcer in your stomach and several ulcers of your upper small intestine. To help treat your ulcers, it is important that you start to take Prilosec (omeprazole) 40mg twice a day. It is also important that you avoid all non-steroidal anti-inflammatory drugs, including ibuprofen, alleve, and aspirin. You may take tylenol. You developed new diarrhea in the hospital. This is most likely likely due to antibiotics and should resolve as your gut flora return. You can take yogurt or lactobacillus supplements to accelerate this process. If your diarrhea gets worse or you develop any fevers, please see your doctor. Finally, it is important that you begin to see a primary care doctor regularly. Please follow-up regarding this hospitalization with ___ NP (see appointment below). At that time, you will also be set up with a primary care doctor. We have made the following changes to your medications: START Levofloxacin 750 mg by mouth daily and metronidazole 500 mg by mouth every 8 hours for six more days. START Pantoprazole 40mg by mouth twice a day ","___ year old woman with no known medical history who presented with subjective fevers, abdominal pain, and hematemesis and developed hypoxic respiratory failure. Clinical picture likely consistent with an initial gastroenteritis with emesis likely leading to aspiration pneumonia and hematemesis. # Hematemesis: EGD revealed mild esophagitis, a non-bleeding 7mm ulcer in the pylorus, and several superficial non-bleeding ulcers ranging in size from 3mm to 5mm in the duodenal bulb. This was likely due to aspirin use and recurrent emesis. H. pylori antibody is negative. Her HCT continued to rise and she was transitioned from a pantoprazole gtt to pantoprazole 40mg PO Q12h. # Hypoxemic Respiratory Failure: Patient developed fevers and new hypoxia on ___. She was empirically treated for pneumonia with ceftriaxone. CT chest showed likely multifocal pneumonia which was possible due to aspiration. Given these findings, antibiotics were broadened to vanc/levo/flagyl and ID was consulted. The vanc was discontinued on ___ and the patient was discharged with PO levo and flagyl for likely aspiration pneumonia. Her pulmonary status improved significantly during hosptialization and she was satting 100% on RA at discharge. # Volume overload: the patient received over 12L of IV fluids in the ICU in the setting of hypotension (BP 80/40s with fever, mottled legs, likely sepsis with pulmonary source). After pt stabalized, she was gently diuresed. # Diarrhea/Abdominal Pain: Likely viral gastroenteritis as this resolved during the hospitalization. Stool cultures, including C diff, were negative. # Tick Bite: Recent tick bite removed quickly. Lyme serologies were negative and smear was negative for babesiosis although ANAPLASMA PHAGOCYTOPHILUM was negative. . # Transaminitis: Very mild transaminitis (50s). No RUQ pain, no hyperbilirubinemia. Likely related to viral gastroenteritis/acute infectious process. Transitional issues/INcidental radiographic findings. -Pt will require primary care follow up: has not seen a PCP ___ ___ years. Would follow LFT's as well. -Pt has recently decided to stop smoking. Outpatient support should be provided to support this goal. -Pt still mildly volume overload at discharge. She was mobilizing and self-diuresing effectively and will follow up with PCP closely to see if she would benefit from lasix. -___ WAS NOTED TO HAVE ESOPHAGEAL WALL THICKENING ON CT WITH CONFLUENT LYMPHADENOPATHY THAT FAVORED AN INFLAMMATORY PROCESS. This will likely require further work up ",2439,599
10008077-DS-10,"<SEX> M <SERVICE> SURGERY <ALLERGIES> shellfish derived <ATTENDING> ___. <CHIEF COMPLAINT> Enlargement of pararenal abdominal aortic aneurysm with impingement on the para-visceral segment. <MAJOR SURGICAL OR INVASIVE PROCEDURE> Endovascular repair of abdominal aortic aneurysm using physician-modified fenestrated ___. <HISTORY OF PRESENT ILLNESS> Mr. ___ is a ___ gentleman with history of small bowel obstructions, last occurring in ___, coronary artery disease, hypertension and atrial fibrillation on Coumadin who presents for repair of a pararenal abdominal aortic aneurysm. Mr. ___ has a vascular history to include bilateral popliteal artery aneurysms repaired via above-knee to below-knee popliteal artery bypass. Recently, his aneurysm had grown and had impinged on the para-visceral segment. He was therefore referred to Dr. ___ risks, benefits, and alternatives to open versus endovascular repair were explained to the patient in detail and he elected to pursue physician-modified ___. The risks, benefits and alternatives to this treatment were explained to the patient in detail and he consented to proceed. <PAST MEDICAL HISTORY> PAST MEDICAL HISTORY: - Abdominal aortic aneurysm - Bilateral popliteal artery aneurysms - Small-bowel obstruction. - Atrial fibrillation - (Coumadin) - Coronary artery disease - Hypertension - Arthritis - Gastroesophageal reflux disease PAST SURGICAL HISTORY: - Incarcerated incisional hernia repair with mesh (___) - L3-L4 revision decompression with foraminotomy and discectomy in ___, - Exploratory laparotomy (___). - Lumbar laminectomy L2 through L5 (___) - Left total knee replacement (___) - Multiple trigger finger releases - Coronary artery bypass graft x 3 at ___ (___) - Anterior cervical discectomy at C3 and C4, anterior body fusion (___) - Ligation of popliteal artery aneurysm with AK to BK popliteal artery bypass (___). - Ligation of a right popliteal artery aneurysm with AK to BK popliteal artery bypass (___) - Partial medial meniscectomy left knee (___). - Left shoulder revision arthroscopy with repair of the rotator cuff (___) - Right shoulder revision and arthroscopy with primary repair of the rotator cuff in ___. - Umbilical hernia repair - Right total knee replacement (___) - Partial meniscectomy and debridement arthritis right knee (___) - Ankle arthroscopy and ___ - Appendectomy. <SOCIAL HISTORY> ___ <FAMILY HISTORY> Father: ___ ___, colon cancer. Mother: ___ at ___ years old, coronary artery disease. Sister #1: Deceased at ___ years old, lung carcinoma. Sister #2: Deceased at ___, uterine cancer. <PHYSICAL EXAM> Vitals: T97.7, HR76, 148/84, 20RR, 96%RA General: NAD, comfortable HEENT: NCAT, PERRL, MMM Chest/CV: RRR, no MRG Pulmonary: CTAB ABD: SNT/ND, normoactive BS, no palpable masses Neuro: A/O, CN II-XII intact, steady gait with walker Extremities: palpable DP and ___ pulses, no edema, motor and sensation intact in bilateral lower extremities; no erythema, warmth, or swelling at wound sites on R ___. Minimal back pain and. Resolved Right groin pain. <MEDICATIONS ON ADMISSION> Medications - Prescription DILTIAZEM HCL - diltiazem ER 360 mg capsule,extended release. 1 capsule(s) by mouth q am - (Prescribed by Other Provider) ESOMEPRAZOLE MAGNESIUM [NEXIUM] - Nexium 40 mg capsule,delayed release. 1 capsule(s) by mouth q am - (Prescribed by Other Provider) METOPROLOL SUCCINATE - metoprolol succinate ER 100 mg tablet,extended release 24 hr. 1 tablet(s) by mouth twice a day - (Prescribed by Other Provider) NITROGLYCERIN - nitroglycerin 0.4 mg sublingual tablet. 1 tablet(s) sublingually as directed for chest pain - (Prescribed by Other Provider) PRAVASTATIN - pravastatin 10 mg tablet. 1 tablet(s) by mouth q hs - (Prescribed by Other Provider) RANITIDINE HCL - ranitidine 150 mg capsule. 1 capsule(s) by mouth q hs - (Prescribed by Other Provider) WARFARIN - warfarin 5 mg tablet. 1 tablet(s) by mouth qd on a sliding scale based on INR results - (Prescribed by Other Provider) ZALEPLON - zaleplon 10 mg capsule. 1 capsule(s) by mouth q hs - (Prescribed by Other Provider) Medications - OTC ASPIRIN - aspirin 81 mg tablet,delayed release. 1 tablet(s) by mouth once a day - (Prescribed by Other Provider) <DISCHARGE MEDICATIONS> 1. Acetaminophen 1000 mg PO Q8H 2. Clopidogrel 75 mg PO DAILY RX *clopidogrel 75 mg 1 (One) tablet(s) by mouth once a day Disp #*30 Tablet Refills: *0 3. Diltiazem Extended-Release 360 mg PO DAILY 4. Metoclopramide 10 mg PO QIDACHS 5. Metoprolol Succinate XL 100 mg PO BID 6. Omeprazole 40 mg PO DAILY Alternatively you can take Esomeprazole - Nexium 40mg capsule - 1 capsule by mouth q am 7. Pravastatin 10 mg PO QPM 8. Ranitidine 150 mg PO QHS 9. Warfarin 5 mg PO 5X/WEEK (___) 10. Warfarin 2.5 mg PO 2X/WEEK (MO,TH) <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Abdominal aortic aneurysm status post Fenestrated Endovascular Aneurysm Repair. <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Mr. ___, You were admitted to ___ and underwent a FENESTRATED ENDOVASCULAR ANEURYSM REPAIR. You have now recovered from surgery and are ready to be discharged. Please follow the instructions below to continue your recovery: MEDICATIONS: - Please stop taking your Aspirin while taking Plavix. Resume Aspirin 81mg in one(1) month when you stop taking your Plavix. - Take Plavix 75mg once daily for one month. - Please restart your Coumadin at your usual dose. 5 mg ___, ___, and ___. 2.5 mg ___ and ___. - Continue all other medications you were taking before surgery, unless otherwise directed - You make take Tylenol or prescribed pain medications for any post procedure pain or discomfort WHAT TO EXPECT AT HOME: It is normal to have slight swelling of the legs: - Elevate your leg above the level of your heart (use ___ pillows or a recliner) every ___ hours throughout the day and at night - Avoid prolonged periods of standing or sitting without your legs elevated It is normal to feel tired and have a decreased appetite, your appetite will return with time - Drink plenty of fluids and eat small frequent meals - It is important to eat nutritious food options (high fiber, lean meats, vegetables/fruits, low fat, low cholesterol) to maintain your strength and assist in wound healing - To avoid constipation: eat a high fiber diet and use stool softener while taking pain medication ACTIVITIES: - When you go home, you may walk and go up and down stairs - You may shower (let the soapy water run over groin incision, rinse and pat dry) - Your incision may be left uncovered, unless you have small amounts of drainage from the wound, then place a dry dressing or band aid over the area that is draining, as needed - No heavy lifting, pushing or pulling (greater than 5 lbs) for 1 week (to allow groin puncture to heal) - After 1 week, you may resume sexual activity - After 1 week, gradually increase your activities and distance walked as you can tolerate - No driving until you are no longer taking pain medications CALL THE OFFICE FOR: ___ - Numbness, coldness or pain in lower extremities - Temperature greater than 101.5F for 24 hours - New or increased drainage from incision or white, yellow or green drainage from incisions - Bleeding from groin puncture site FOR SUDDEN, SEVERE BLEEDING OR SWELLING (Groin puncture site or incision) - Lie down, keep leg straight and have someone apply firm pressure to area for 10 minutes. If bleeding stops, call vascular office. If bleeding does not stop, call ___ for transfer to closest Emergency Room. ","Mr. ___ arrived to ___ on ___ for an elective fenestrated endovascular aneurysm repair after enlargement of a pararenal abdominal aortic aneurysm with impingement on the para-visceral segment. The patient presented to pre-operative admission and was evaluated by anesthesia. The patient was taken to the operating room for an endovascular repair of abdominal aortic aneurysm using ___-modified fenestrated ___. Both rentals and SMA were stunted and had bilateral percutaneous access. At the completion of this, the patient had soft groins without any evidence of hematoma or bleeding. Pulses in the feet were checked and all pedal pulses, which had been palpable preoperatively, were still palpable. 40 mg of Protamine were administered and the patient was extubated in the operating room and taken to the PACU for further recovery. There were no adverse events in the operating room; please see the operative note for more details. After a brief stay in PACU, the patient was transferred to the vascular surgery floor where he remained through the rest of the hospitalization. Post-operatively he did well without any groin swelling and neurological exams were intact following his surgery. He was able to tolerate a regular diet, get out of bed and ambulate with assistance. On POD1 he did complain of pain in his back which was later on well controlled with PO Dilaudid. He preferred to stay in ___ that night due to pain control. On POD2, Mr. ___ began complaining of severe back pain and inability to lift his legs secondary to pain in his groins. A CTA of torso was ordered which showed no evidence of endoleak, retroperitoneal hematoma, or groin access complications. Later that day, symptoms subsided and the patient was able to get out of bed to chair and ambulate and reported absence of pain in both groins and minimal back pain. Previous dose of Coumadin was restarted. Mr. ___ was deemed ready for discharge, and was given the appropriate discharge and follow-up instructions. ",2055,425
10008077-DS-11,"<SEX> M <SERVICE> MEDICINE <ALLERGIES> shellfish derived / hydromorphone / oxycodone / trazodone <ATTENDING> ___ <MAJOR SURGICAL OR INVASIVE PROCEDURE> Coronary Angiogram ___ attach <PERTINENT RESULTS> DISCHARGE PHYSICAL EXAMINATION -- VS: reviwed in MetaVision GENERAL: Well developed, well nourished, appears uncomfortable while laying in bed HEENT: Normocephalic, atraumatic. Sclera anicteric. PERRL. EOMI. NECK: Supple. JVP ~9-10cm CARDIAC: irregular rate. No murmurs, rubs, or gallops. LUNGS: No chest wall deformities or tenderness. Respiration is unlabored with no accessory muscle use. LCTA ABDOMEN: Soft, non-tender, non-distended. No palpable hepatomegaly EXTREMITIES: cool extremities, mild lower extremity edema to shins b/l SKIN: No significant lesions or rashes, no hematoma at either radial access sites, normal capillary refill b/l, no extr discoloration PULSES: Distal pulses palpable and symmetric both radial and DP. NEURO: alert, oriented x3, moving all extremities ADMISSION LABS -= ___ 08: 30AM BLOOD WBC-5.9 RBC-5.16 Hgb-11.8* Hct-38.5* MCV-75* MCH-22.9* MCHC-30.6* RDW-21.3* RDWSD-55.6* Plt ___ ___ 09: 52PM BLOOD Glucose-108* UreaN-20 Creat-1.2 Na-137 K-5.6* Cl-105 HCO3-18* AnGap-14 ___ 09: 52PM BLOOD Calcium-8.9 Phos-3.5 Mg-2.0 ___ 09: 52PM BLOOD ALT-15 AST-40 LD(LDH)-450* CK(CPK)-172 AlkPhos-58 TotBili-0.8 ___ 08: 30AM BLOOD ___ PERTINENT STUDIES - ___ 09: 52PM BLOOD CK-MB-13* MB Indx-7.6* cTropnT-0.21* proBNP-840 ___ 04: 19AM BLOOD CK-MB-46* MB Indx-13.2* cTropnT-0.44* ___ 12: 30PM BLOOD CK-MB-55* ___ 06: 28PM BLOOD CK-MB-44* ___ 12: 23AM BLOOD CK-MB-33* ___ 08: 18AM BLOOD CK-MB-21* DISCHARGE LABS -= ___ 08: 18AM BLOOD WBC-6.0 RBC-4.54* Hgb-10.5* Hct-33.8* MCV-74* MCH-23.1* MCHC-31.1* RDW-21.4* RDWSD-56.6* Plt Ct-99* ___ 08: 18AM BLOOD ___ PTT-48.6* ___ ___ 08: 18AM BLOOD Glucose-90 UreaN-18 Creat-1.1 Na-138 K-4.2 Cl-106 HCO3-19* AnGap-13 ___ 08: 18AM BLOOD Calcium-8.8 Phos-2.6* Mg-2.1 IMAGING/OTHER STUDIES -==== Coronary angiography ___ Findings - Three vessel coronary artery disease. - Succesful RCA CTO PCI with 5 DES complicated with proximal RCA/aortic dissection (succesfully stented). Distal edge wire-induced dissection that will most likely heal normally. Recommendations - Maximize medical therapy - DAPT for at least 12 months; 30 months prefered if no bleeding issues. OBS tonight. CTA TTE ___ IMPRESSION: Suboptimal image quality. Mild symmetric left ventricular hypertrophy with normal cavity size and mild regional systolic dysfunction consistent with known CAD. Moderately dilated right ventricle with moderate systolic dysfunction. Mild mitral, tricuspid, and aortic regurgitation. Normal estimated pulmonary artery systolic pressure. Mildly dilated ascending aorta. Tomorrow if Cr stable. Aggresive IVFs tonight. Maximize medical therapy. <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Metoprolol Succinate XL 100 mg PO BID 2. Ranolazine ER 1000 mg PO BID 3. Warfarin 2.5 mg PO 6X/WEEK (___) 4. Warfarin 5 mg PO 1X/WEEK (TH) 5. amLODIPine 5 mg PO DAILY 6. Ranitidine 150 mg PO QHS 7. Pravastatin 20 mg PO QPM 8. Isosorbide Mononitrate (Extended Release) 60 mg PO BID 9. Nitroglycerin SL 0.4 mg SL Q5MIN: PRN chest pain 10. esomeprazole magnesium 40 mg oral DAILY 11. Aspirin 81 mg PO DAILY <DISCHARGE MEDICATIONS> 1. Atorvastatin 80 mg PO QPM 2. Clopidogrel 75 mg PO DAILY 3. amLODIPine 5 mg PO DAILY 4. Aspirin 81 mg PO DAILY 5. esomeprazole magnesium 40 mg oral DAILY 6. Isosorbide Mononitrate (Extended Release) 60 mg PO BID 7. Metoprolol Succinate XL 100 mg PO BID 8. Nitroglycerin SL 0.4 mg SL Q5MIN: PRN chest pain 9. Ranitidine 150 mg PO QHS 10. Ranolazine ER 1000 mg PO BID 11. Warfarin 5 mg PO 1X/WEEK (TH) 12. Warfarin 2.5 mg PO 6X/WEEK (___) <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Primary diagnoses: Coronary Artery disease s/p CABG, RCA CTO s/p ___ 5 Persistent angina Secondary diagnoses: Atrial Fibrillation HTN HLD <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Hi Mr. ___, WHY WERE YOU ADMITTED TO THE HOSPITAL? You were admitted following your cardiac catheterization in which 5 drug coated stents were placed to open a blockage in your right coronary artery. Procedure was complicated by tearing in the right coronary artery which was fixed with a stent. Echo did not show any complications. Instructions regarding care of the access site are included with your discharge information. WHAT SHOULD YOU DO AFTER YOU LEAVE THE HOSPITAL? Please continue your current medications with the following changes: - continue Aspirin 81mg daily for one month, then STOP. You will go back on aspirin after one year when you come off Plavix. - Start Plavix 75mg daily, you should take this for a minimum of one year and ONLY stop when told by a cardiologist specifically. - Stop Pravastatin and start Atorvastain 80 mg daily - Continue to to take Coumadin (Warfarin) per Dr. ___ ___ - Continue all other medications without any change. It is very important to take all of your heart healthy medications. In particular, aspirin and clopidogrel (Plavix) help to keep the stents in the vessels of the heart open and help reduce your risk of having a future heart attack. If you stop these medications or miss ___ dose, you risk causing a blood clot forming in your heart stents which could cause a life threatening heart attack. Please do not stop taking either medication without talking to your heart doctor, even if another doctor tells you to stop the medications. It is strongly recommended that you attend a cardiac rehab program in the near future. A referral form was provided to you that lists the locations of these programs. Please bring this with you to your follow up visit with your cardiologist, and they will inform you when it is safe to begin a program. If you were given any prescriptions on discharge, any future refills will need to be authorized by your outpatient providers, primary care or cardiologist. If you have any urgent questions that are related to your recovery from your hospitalization or are experiencing any symptoms that are concerning to you and you think you may need to return to the hospital, please call the ___ HeartLine at ___ to speak to a cardiologist or cardiac nurse practitioner. It has been a pleasure to have participated in your care and we wish you the best with your health! Your ___ Cardiac Care Team ","Patient Summary: ================ Mr. ___ is ___ male with HTN, HLD, AF on coumadin, CAD s/p CABG ___ (with LIMA-LAD, SVG-OM, and SVG-RCA), AAA s/p endovascular repair, dilated ascending aorta (4.2cm), CKD stage III, who underwent complex PCI with 5 DES to a chronically occluded RCA for persistent stable angina. The procedure was complicated by aortic root/proximal RCA dissection. He was transferred to the CCU for monitoring post procedure and had improvement of his chest pain and stabilization of his blood pressure. Medical therapy was titrated on the floor prior to discharge. #CORONARIES: CABG ___ with LIMA-LAD, SVG-OM, and SVG-RCA, s/p ___ 5 to RCA CTO ___ c/b aortic root/RCA dissection #PUMP: EF 51%, 1+ MR/TR/AR, mod RV dilation #RHYTHM: atrial fibrillation Transitional Issues: ==================== [] Patient reported interest in switching over to a DOAC, though was hesitant to do so without speaking to his outpatient cardiologist. Would consider transition from warfarin to a DOAC. [] He was started on triple therapy due to ___. He should be continued on this for 1 month with plan to discontinue the ASA at that point. In one year, his Plavix should be replaced by ASA [] Should consider cardiac rehab program after discharge [] He was transitioned from pravastatin 20mg to atorvastatin 80mg. ACUTE ISSUES: =============== # CAD s/p CABG # s/p ___ 5 to RCA CTO ___ c/b aortic root/RCA dissection Patient with history of CAD with CABG in ___ (LIMA-LAD, SVG-OM, and SVG-RCA). On his most recent cath, patient was noted to have CTO of mid LAD, LIMA-LAD patent, occluded SVG-OM and RCA, and CTO of the RCA. Due to ongoing chest pain despite 3 antianginal medications, he underwent elective revascularization of his known CTO RCA. During this hospitalization, his coronary angiogram showed severe tortuosity beginning in the mid segment of the RCA, with 70% stenosis with a TIMI flow grade of 0 in the proximal and mid segments, a 100% stenosis in the mid and distal segments, and significant collaterals. During initial access to through R radial catheter was kinked and angiogram showed a small perforation in the brachial artery that was closed with a Fr. guide and a BP cuff. Access was then obtained through L radial, 5 stents total were placed to the RCA. Angiogram during cath showed distal dissection into the RPDA/RPL (wire induced most likely, no intervention performed) with TIMI 3 flow, as well as an aortic root/proximal RCA dissection at the origin requiring ___. Final angiogram showed no residual, stable ___ RCA/ aortic dissection as well as distal RPDA dissection and TIMI 3 flow. Following the procedure, he continued to report chest pain and was started on an IV nitro drip with a brief drop of his blood pressure when he was given morphine. He was admitted to the CCU on the nitro drip and his BP stabilized and his chest pain resolved. His CK-MB was trended and peaked prior to discharge. Focused TTE showed overall preserved left ventricular systolic function and normal right ventricle free wall motion, no pericardial effusion. He was discharged on atorvastatin 80mg, ASA, Plavix, and warfarin with plan to continue triple therapy for 1 month and then continue with Plavix and warfarin. His anti-anginal medications were not changed during this admission. # A fib: He was started on a heparin drip while inpatient and started on warfarin 5mg two days prior to discharge. He was given instructions to take warfarin 5mg the night of discharge and then to resume his home regimen of 2.5 mg x 6 days and 5 mg on ___. He is managed by Dr. ___ has an INR check for ___. He was continued on his home metoprolol 100mg BID. # HTN: His amlodipine was held while his blood pressures were low and was restarted on the day of discharge as his blood pressure improved. He was continued on his home nitrate and metoprolol. # HLD: He was transitioned from pravastatin 20mg to atorvastatin 80mg following his procedure. # CKD stage III Patient with baseline Cre ~1.2-1.3. His Cr remained close to baseline during this admission. #GERD He was continued on his home omeprazole. ",1980,1045
10008245-DS-2,"<SEX> M <SERVICE> MEDICINE <ALLERGIES> phenobarbital / Zonegran / Demerol <ATTENDING> ___. <CHIEF COMPLAINT> Pelvic pain, limp on R <MAJOR SURGICAL OR INVASIVE PROCEDURE> None <HISTORY OF PRESENT ILLNESS> ___ year old male with severe developmental delay, nonverbal, history of seizures, presents as a transfer from ___ for orthopedics evaluation. This morning he began having difficulty walking with apparent limp. No injuries or trauma reported by group home staff. The patient previously has had unexplained injuries including a broken leg, gash in his leg and gash over the eye. All of these incidents were reported to the ___. The patient initially went to ___ where CT scan showed comminuted fracture of the right ilium. At ___ initial labs showed H/H 13.5/40.2 which trended to 11.1/34 after fluids. Patient transiently soft blood pressure in the high ___, responded to single bolus of saline 500 mL. He also had a fever at ___. In the ED, initial VS were: 99.2F, HR 99, 125/77, RR 20, 96% on RA Exam notable for: Hematoma and bruising on the right hip and bilateral elbows. Pain with right straight leg raise. Labs showed: -Negative flu -Unremarkable BMP except for Cl 109 -CK 122 -WBC 6.8, Hb 11.1, Platelets 203 -INR 1.2 -Urinalysis - bland Imaging showed: CXR: Lung volumes still remain quite low. Heterogeneous opacification at the lung bases, particularly the right, could be due to pneumonia, especially aspiration. Upper lungs are clear. No pleural effusion. Consults: -Ortho: Injury is closed; right lower extremity is neurovascularly intact. Follow up in ___ clinic in 2 weeks. Ok for activity as tolerated. Secondary survey negative for pain elsewhere when palpated throughout his extremities and down spine. -SW: Filed ___ report for abuse/neglect of a disabled person. -___: Recommended d/c to rehab. -CM: Multiple rehab referrals placed with no rehab bed offered as of 540pm. Patient received: -Home medications -Ceftriaxone, azithromycin, flagyl Transfer VS were: 98.1F (Tmax 100.6), HR 99, BP 110/80, RR 18, 99% on RA On arrival to the floor, patient unable to provide further history but mother at bedside. She does report that the patient can become aggressive (biting, hitting) with over stimulation. She says he has a high tolerance for pain and does want him getting anything more than Tylenol for now. She is unaware of any fevers at the group home. Denies recent cough or difficulty breathing. <PAST MEDICAL HISTORY> 1. Intellectual disability, non-verbal 2. Asthma 3. Constipation 4. Dysphagia (on regular diet with thin liquids) 5. Epilepsy / Myoclonic seizure disorder 6. Osteoporosis 7. Mood disorder with aggression and psychosis <SOCIAL HISTORY> ___ <FAMILY HISTORY> Father died from complications of alcoholism, also with history of HTN and bladder cancer. Mother with basal cell carcinoma. Brother is healthy. <PHYSICAL EXAM> ADMISSION PHYSICAL EXAM: VS: 98.1F, 116/91, RR91, RR 20, 95%RA GENERAL: NAD, mother holding arms to prevent patient from hitting during exam HEENT: AT/NC, anicteric sclera, MMM NECK: supple, no LAD CV: RRR, S1/S2, no murmurs, gallops, or rubs PULM: CTAB, no wheezes, rales, rhonchi, breathing comfortably without use of accessory muscles GI: abdomen soft, nondistended, nontender in all quadrants, no rebound/guarding, no hepatosplenomegaly EXTREMITIES: no edema, cries in pain with straight leg raise on the right, hematoma on right hip DISCHARGE PHYSICAL EXAM: GENERAL: NAD, caregiver holding arms to prevent patient from hitting during exam. Patient smiling and appeared very comfortable. HEENT: AT/NC, anicteric sclera, MMM NECK: supple, no LAD CV: RRR, S1/S2, no murmurs, gallops, or rubs PULM: CTAB, no wheezes, rales, rhonchi, breathing comfortably without use of accessory muscles GI: abdomen soft, nondistended, nontender in all quadrants, no rebound/guarding, no hepatosplenomegaly EXTREMITIES: no edema, hematoma on right hip improving. <PERTINENT RESULTS> ADMISSION LABS: ___ 06: 01PM BLOOD WBC-6.8 RBC-3.47* Hgb-11.1* Hct-34.3* MCV-99* MCH-32.0 MCHC-32.4 RDW-12.8 RDWSD-45.8 Plt ___ ___ 06: 01PM BLOOD ___ PTT-28.6 ___ ___ 06: 01PM BLOOD Glucose-82 UreaN-11 Creat-0.8 Na-145 K-4.0 Cl-109* HCO3-25 AnGap-11 ___ 03: 40AM BLOOD Calcium-8.9 Phos-4.5 Mg-2.5 DISCHARGE LABS: None IMAGING: Pelvic X-ray: Study is read in conjunction with pelvis CT ___. There has been no change in minimal displacement of the vertically oriented fracture of the lateral right iliac wing. Pelvis and hips are otherwise intact. <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Alendronate Sodium 70 mg PO QMON 2. ClonazePAM 1 mg PO TID 3. Fluvoxamine Maleate 100 mg PO TID 4. Nuedexta (dextromethorphan-quinidine) ___ mg oral TID 5. Boost (food supplemt, lactose-reduced) 0.04 gram- 1 kcal/mL oral DAILY 6. Calcium Carbonate 600 mg PO BID 7. LevoCARNitine 200 mg PO TID 8. Docusate Sodium 100 mg PO BID 9. LevETIRAcetam 1500 mg PO BID 10. Multivitamins 1 TAB PO DAILY 11. Montelukast 10 mg PO DAILY 12. Vitamin D 400 UNIT PO DAILY 13. Acetaminophen 650 mg PO Q6H: PRN Pain - Mild/Fever <DISCHARGE MEDICATIONS> 1. Acetaminophen 650 mg PO Q6H: PRN Pain - Mild/Fever 2. Alendronate Sodium 70 mg PO QMON 3. Boost (food supplemt, lactose-reduced) 0.04 gram- 1 kcal/mL oral DAILY 4. Calcium Carbonate 600 mg PO BID 5. ClonazePAM 1 mg PO TID 6. Docusate Sodium 100 mg PO BID 7. Fluvoxamine Maleate 100 mg PO TID 8. LevETIRAcetam 1500 mg PO BID 9. LevoCARNitine 200 mg PO TID 10. Montelukast 10 mg PO DAILY 11. Multivitamins 1 TAB PO DAILY 12. Nuedexta (dextromethorphan-quinidine) ___ mg oral TID 13. Vitamin D 400 UNIT PO DAILY <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> PRIMARY DIAGNOSES Non-displaced fracture of the Right Ilium Hypernatremia SECONDARY DIAGNOSES Seizure disorder Osteoporosis <DISCHARGE CONDITION> Mental Status: Confused - sometimes. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Mr. ___, It was a pleasure taking part in your care here at ___! Why was I admitted to the hospital? - You were admitted for a fall and were found to have a fracture in your right hip. What was done for me while I was in the hospital? - You were treated medically for your fracture with pain management and underwent physical therapy to help you regain your mobility. - We continued your home medications. What should I do when I leave the hospital? - Attend all your follow-up appointments and take all of your medications as prescribed. - Follow-up at the orthopedics clinic as scheduled below. - Continue to walk with assistance as much as you can to help the healing process. Sincerely, Your ___ Care Team ","SUMMARY: ___ with severe developmental delay, nonverbal, history of seizures, presents with limping and found to have a fracture of the right ilium. No report of fall but has history of them due to unsteady gait. ACUTE ISSUES: =============== #Hip hematoma/Non-displaced fracture of the right ilium: Ortho consult decided to non-surgically treat the patient with pain management and physical therapy. There was an unknown source of trauma however patient has had other injuries in the past at group home that were unexplained, possibly secondary to longstanding spastic gait and impulsivity. Group home stated he is unsteady on feet at baseline and has not had any witnessed syncopal episodes. Pelvic x-rays showed no interval change from prior CT showing minimal displacement of fracture. Hematoma was improving on discharge. He will follow up at the ___ on ___. He was discharged to group home after being cleared by physical therapy. #Hypernatremia: He was intermittently hypernatremic in the setting of poor intake of water. He was able to maintain himself without use of IV fluids and encouraged to drink more water. #Fever: Previously had low grade fevers and had no clear localizing source of infection with urinalysis and culture and flu both negative. Chest x-ray did show heterogeneous opacification at the lung bases, particularly the right was concerning for aspiration pneumonia, but had no cough and hypoxia and was monitored throughout his admission during which he remained well clinically and hemodynamically stable. CHRONIC ISSUES: =============== #Seizure disorder Continued on home keppra and LevoCARNitine #Aggression Continued on home Fluvoxamine and ClonazePAM, which was recently uptitrated to TID) -Nuedexta is NF, mother does not have medications here in the hospital but will ask her to bring it #Osteoporosis Continued on weekly Alendronate, Vit D, and Calcium Carbonate while he was in house. #Constipation Continued home docusate. #Asthma Continued home Montelukast. MEDICATION CHANGES: NONE TRANSITIONAL ISSUES: [] Ensure patient following orthopedics recommendations (follow-up appointment on ___ [] Please get BMP at first follow up: Monitor his Na as he tended to be mildly hypernatremic while he was inpatient, encourage good PO water intake [] Follow-up on pain/mobility at group home: Ensure he walks with one to one assistance as he has required while in patient [] OK to return to adult day care program when able to walk on own without assistance ",1979,540
10008287-DS-17,"<SEX> F <SERVICE> NEUROSURGERY <ALLERGIES> naproxen / latex <ATTENDING> ___. <CHIEF COMPLAINT> cavernous malformation <MAJOR SURGICAL OR INVASIVE PROCEDURE> ___: Left temporal craniectomy for cavernous malformation <HISTORY OF PRESENT ILLNESS> ___ year old female known to the Neurosurgical Service who has been conservatively monitored for known cavernous malformation. Recently, she has had more seizures related to her cavernous malformation slowly bleeding thus elected to now have it resected. <PAST MEDICAL HISTORY> thyroid cancer cavernous malformation seizures <SOCIAL HISTORY> ___ <FAMILY HISTORY> nc <PHYSICAL EXAM> EXAM UPON DISCHARGE: Gen: WD/WN, comfortable, NAD. HEENT: Pupils: PERRL ___ EOMs: Intact Extrem: Warm and well-perfused. Neuro: Mental status: Awake and alert, cooperative with exam, normal affect. Orientation: Oriented to person, place, and date. Language: Speech fluent with good comprehension and repetition. Naming intact. No dysarthria or paraphasic errors. Cranial Nerves: I: Not tested II: Pupils equally round and reactive to light, 2 to 1mm bilaterally. III, IV, VI: Extraocular movements intact bilaterally without nystagmus. V, VII: Facial strength and sensation intact and symmetric. VIII: Hearing intact to voice. XII: Tongue midline without fasciculations. Motor: Normal bulk and tone bilaterally. No abnormal movements, tremors. Strength full power ___ throughout. No pronator drift Sensation: Intact to light touch <PERTINENT RESULTS> ___ CT HEAD W/O CONTRAST IMPRESSION: 1. Status post resection of the left mesial temporal lobe mass, likely a cavernous malformation, with expected postsurgical changes, including involving blood products and bilateral pneumocephalus. 2. No shift of normally midline structures. The basal cisterns are patent. No unexplained intracranial hemorrhage. <MEDICATIONS ON ADMISSION> keppra 750mg BID, Armour 90mg daily <DISCHARGE MEDICATIONS> 1. Acetaminophen-Caff-Butalbital ___ TAB PO Q6H: PRN headache Do not exceed 6 tab/day. Each tablet contains: Acetaminophen 325mg, Butalbital 50mg, Caffeine 40mg RX *butalbital-acetaminophen-caff 50 mg-325 mg-40 mg ___ tablet(s) by mouth every 6 hours as needed Disp #*45 Tablet Refills: *0 2. Bisacodyl 10 mg PO/PR DAILY: PRN constipation 3. Docusate Sodium 100 mg PO BID 4. LevETIRAcetam 750 mg PO BID RX *levetiracetam 750 mg 1 tablet(s) by mouth twice a day Disp #*45 Tablet Refills: *0 5. OxyCODONE (Immediate Release) ___ mg PO Q4H: PRN pain RX *oxycodone 5 mg ___ tablet(s) by mouth every 6 hours as needed Disp #*45 Tablet Refills: *0 6. Senna 17.2 mg PO QHS 7. Thyroid 90 mg PO DAILY <DISCHARGE DISPOSITION> Home With Service Facility: ___ <DISCHARGE DIAGNOSIS> Cavernous Malformation <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Surgery  You underwent a surgery called a craniotomy to have left cavernous malformation resection.  Please keep your sutures along your incision dry until they are removed. It is best to keep your incision open to air but it is ok to cover it when outside. Call your surgeon if there are any signs of infection like redness, fever, or drainage. Activity  We recommend that you avoid heavy lifting, running, climbing, or other strenuous exercise until your follow-up appointment.  You make take leisurely walks and slowly increase your activity at your own pace once you are symptom free at rest. ___ try to do too much all at once.  No driving while taking any narcotic or sedating medication.  If you experienced a seizure while admitted, you are NOT allowed to drive by law.  No contact sports until cleared by your neurosurgeon. You should avoid contact sports for 6 months. Medications  Please do NOT take any blood thinning medication (Aspirin, Ibuprofen, Plavix, Coumadin) until cleared by the neurosurgeon.  You have been discharged on Keppra (Levetiracetam). This medication helps to prevent seizures. Please continue this medication as indicated on your discharge instruction. It is important that you take this medication consistently and on time.  You may use Acetaminophen (Tylenol) for minor discomfort if you are not otherwise restricted from taking this medication. What You ___ Experience:  You may have difficulty paying attention, concentrating, and remembering new information.  Emotional and/or behavioral difficulties are common.  Feeling more tired, restlessness, irritability, and mood swings are also common.  You may also experience some post-operative swelling around your face and eyes. This is normal after surgery and most noticeable on the second and third day of surgery. You apply ice or a cool or warm washcloth to your eyes to help with the swelling. The swelling will be its worse in the morning after laying flat from sleeping but decrease when up.  You may experience soreness with chewing. This is normal from the surgery and will improve with time. Softer foods may be easier during this time.  Constipation is common. Be sure to drink plenty of fluids and eat a high-fiber diet. If you are taking narcotics (prescription pain medications), try an over-the-counter stool softener. Headaches:  Headache is one of the most common symptoms after a brain bleed.  Most headaches are not dangerous but you should call your doctor if the headache gets worse, develop arm or leg weakness, increased sleepiness, and/or have nausea or vomiting with a headache.  Mild pain medications may be helpful with these headaches but avoid taking pain medications on a daily basis unless prescribed by your doctor.  There are other things that can be done to help with your headaches: avoid caffeine, get enough sleep, daily exercise, relaxation/meditation, massage, acupuncture, heat or ice packs. When to Call Your Doctor at ___ for:  Severe pain, swelling, redness or drainage from the incision site.  Fever greater than 101.5 degrees Fahrenheit  Nausea and/or vomiting  Extreme sleepiness and not being able to stay awake  Severe headaches not relieved by pain relievers  Seizures  Any new problems with your vision or ability to speak  Weakness or changes in sensation in your face, arms, or leg Call ___ and go to the nearest Emergency Room if you experience any of the following:  Sudden numbness or weakness in the face, arm, or leg  Sudden confusion or trouble speaking or understanding  Sudden trouble walking, dizziness, or loss of balance or coordination  Sudden severe headaches with no known reason ","Patient was electively admitted for cavernous malformation resection. OR was uneventful and patient was extubated in the OR and brought to the PACU for immediate post-operative care. In the PACU, patient complains of headache and nausea however nausea improving after medications. Patient will remain ICU level of care overnight. On ___, patient is neurologically and hemodynamically stable. Patient complains of intermittent nausea and incisional pain. Medications adjusted. Patient transferred to the floor with physical therapy consult. On ___, patient is neurologically and hemodynamically stable. Patient states nausea is improved and is slowly increasing diet. Case management saw the patient and set the patient up for services at home. Patient to be discharged tomorrow. On ___, the patient remained neurologically and hemodynamically stable. She did not have any issues overnight. She was stable and deemed safe for discharge homw with services and appropriate follow-up. ",1593,191
10008408-DS-14,"<SEX> M <SERVICE> MEDICINE <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> HMED Admission Note ___ cc: L hand swelling <MAJOR SURGICAL OR INVASIVE PROCEDURE> None <HISTORY OF PRESENT ILLNESS> ___ yo M with mental retardation, group home resident who is non-verbal at baseline who presents with L hand swelling and erythema. Pt noted to have L hand swelling and redness today, streaking along L forearm noted. No fever or chills. Pt did not appear uncomfortable. No known trauma or cuts. Pt brought to the ED where vitals were notable for low grade temp to 99.9, no leukoctytosis. Swelling of L hand noted as well as streaking erythema. Ultrasound of L arm did not reveal DVT. Pt given Vancomycin for likely cellulitis and admitted for further care. ROS: pt non-verbal and unable to provide <PAST MEDICAL HISTORY> BPH Mental retardation B12 deficiency Depression Osteoporosis Hyperlipidemia <SOCIAL HISTORY> ___ <FAMILY HISTORY> Unable to provide <PHYSICAL EXAM> Vitals: 97.9 148/60 60 18 99%RA Gen: NAD HEENT: NCAT CV: rrr, no r/m/g Pulm: clear bl Abd: soft, nt/nd, normal bs Ext: LUE with swollen hand, streaking to proximal forearm below elbow, mild warmth. Neuro: alert, nonverbal . On discharge as above except L arm without streaking to proximal forearm. Hematoma at thenar aspect of hand much less red. Erythema receded below the marked boundary. Linear scratch has now closed. No fluid expressed with palpation. <PERTINENT RESULTS> ___ 06: 01PM WBC-5.9 RBC-3.85* HGB-11.6* HCT-35.5* MCV-92 MCH-30.1 MCHC-32.7 RDW-14.7 ___ 06: 01PM PLT COUNT-290 ___ 06: 01PM GLUCOSE-111* UREA N-30* CREAT-1.1 SODIUM-142 POTASSIUM-4.4 CHLORIDE-105 TOTAL CO2-29 ANION GAP-12 ___ 06: 01PM LD(LDH)-239 ___ 06: 01PM CRP-7.0* ___ 06: 02PM LACTATE-1.3 XR Hand: Soft tissue swelling without visualized fracture. U/s vascular LUE: No evidence of deep vein thrombosis in the left upper extremity. <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Polyethylene Glycol 17 g PO DAILY 2. Fluocinonide 0.05% Ointment 1 Appl TP BID 3. Multivitamins 1 TAB PO DAILY 4. Latanoprost 0.005% Ophth. Soln. 1 DROP LEFT EYE QHS 5. Aspirin 81 mg PO DAILY 6. Erythromycin 0.5% Ophth Oint 0.5 in LEFT EYE QHS 7. Simvastatin 40 mg PO QPM 8. Cyanocobalamin 1000 mcg IM/SC Frequency is Unknown 9. Fleet Enema ___AILY: PRN constipation 10. Combigan (brimonidine-timolol) 0.2-0.5 % ophthalmic BID 11. Alendronate Sodium 70 mg PO Frequency is Unknown 12. Acetaminophen 650 mg PO Q6H: PRN pain 13. Vitamin D 1000 UNIT PO DAILY 14. Hydrocortisone Cream 2.5% 1 Appl TP BID 15. Bisacodyl 10 mg PR QHS: PRN constipation 16. Sertraline 100 mg PO DAILY 17. zinc oxide 20 % topical DAILY: PRN skin 18. Calcium Carbonate 1250 mg PO BID <DISCHARGE MEDICATIONS> 1. Acetaminophen 650 mg PO Q6H: PRN pain 2. Calcium Carbonate 1250 mg PO BID 3. Latanoprost 0.005% Ophth. Soln. 1 DROP LEFT EYE QHS 4. Multivitamins 1 TAB PO DAILY 5. Sertraline 100 mg PO DAILY 6. Simvastatin 40 mg PO QPM 7. Vitamin D 1000 UNIT PO DAILY 8. Alendronate Sodium 70 mg PO QSUN 9. Bisacodyl 10 mg PR QHS: PRN constipation 10. Combigan (brimonidine-timolol) 0.2-0.5 % ophthalmic BID 11. Cyanocobalamin 1000 mcg IM/SC ONCE PER MONTH 12. Erythromycin 0.5% Ophth Oint 0.5 in LEFT EYE QHS 13. Fleet Enema ___AILY: PRN constipation 14. Fluocinonide 0.05% Ointment 1 Appl TP BID 15. Polyethylene Glycol 17 g PO DAILY 16. zinc oxide 20 % topical DAILY: PRN skin 17. Cephalexin 500 mg PO Q8H Duration: 7 Days RX *cephalexin 500 mg 1 capsule(s) by mouth three times a day Disp #*18 Capsule Refills: *0 18. Sulfameth/Trimethoprim DS 1 TAB PO BID Duration: 7 Days RX *sulfamethoxazole-trimethoprim [Bactrim DS] 800 mg-160 mg 1 tablet(s) by mouth twice a day Disp #*12 Tablet Refills: *0 19. Hydrocortisone Cream 2.5% 1 Appl TP BID 20. Durable goods Kerlix Bandage Roll 4.5 inch x ___ yard. One roll per day. Please apply to L hand wound. Dispense 30. Zero refills. 21. Durable Goods Xeroform Occlusive Gauze Strip 5 inches x 9 inches. Please apply to L hand wound daily. Please dispense 30 strips. No refills. 22. Durable goods 4 x 4 gauze sponges. Apply one gauze sponge to L wound daily. Please dispense 30 sponges. No refills. <DISCHARGE DISPOSITION> Home With Service Facility: ___ <DISCHARGE DIAGNOSIS> Primary 1. Left hand cellulitis Secondary BPH Mental retardation B12 deficiency Depression Osteoporosis Hyperlipidemia <DISCHARGE CONDITION> Mental Status: Able to sing 'Take me out to the ballgame' but otherwise non verbal. Level of Consciousness: Alert and interactive. Activity Status: Out of Bed with assistance to chair or wheelchair. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> It was a pleasure to care for you. You were admitted with hand cellulitis. You were treated with IV antibiotics (vancomycin and cefazolin) with great improvement. This was then switched to po antibiotics, keflex and bactrim to complete a 10 day course. I wish you the very best! ","___ yo M who is nonverbal at baseline who comes from group home with L hand cellulitis. # Cellulitis He was started on vancomcyin but contiued to have low grade temps and thus cefazolin was added. An X ray was negative for fracture. US was negative for abscess.He was seen by hand surgery who agreed with the management of hand elevation. He was not given a splint since he appeared comfortable. He was switched to oral abx on ___ and observed for more than 24hrs with continued improvement. He was discharged to complete a 10 day course of keflex and bactrim. He can be started on florastor supplementation to prevent cdiff. # Glaucoma -His home meds were continued. . # ASA use: Discussed with his PCP and given his many ecchymoses in the L hand surround the cellulitis and his history of easy bleeding (coags normal) his ASA was held. He does not have a history of CAD per PCP. . # Osteoporosis He was continued on vitamin D and calcium. He received fosamax on ___ prior to admission. . # HLD: His statin was continued. FEN - pureed diet, no thin liquids PPX - sqh Code - FULL code per RN at group home. ",1661,273
10008454-DS-14,"<SEX> F <SERVICE> SURGERY <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> S/P MVC Right leg and chest pain <MAJOR SURGICAL OR INVASIVE PROCEDURE> ___ 1. Irrigation debridement skin to bone right femur. 2. Open reduction internal fixation with intramedullary nail right open femur fracture. <HISTORY OF PRESENT ILLNESS> ___ year old female who unrestrained driver in a high-speed MVC with intrusion to the dashboard noted to have open R femur fx and R rib fx's <PAST MEDICAL HISTORY> PMH none PSH none <SOCIAL HISTORY> ___ <FAMILY HISTORY> non contributory <PHYSICAL EXAM> Constitutional: uncomfortable HEENT: Normocephalic, atraumatic Trachea midline Chest: Clear to auscultation equal breath sound tender along right chest Cardiovascular: Regular Rate and Rhythm, Normal first and second heart sounds Abdominal: Soft, Nontender Extr/Back: Open wound with swelling to right thigh Skin: No rash pulses intact distally Neuro: Speech fluent Psych: Normal mood, Normal mentation Cranial nerves II through XII grossly intact, Motor ___ in all extremities, sensory without focal deficits <PERTINENT RESULTS> ___ 05: 00AM WBC-21.2* RBC-4.83 HGB-14.2 HCT-40.9 MCV-85 MCH-29.5 MCHC-34.8 RDW-13.7 ___ 05: 00AM PLT COUNT-337 ___ 05: 00AM ___ PTT-21.3* ___ ___ 05: 00AM ASA-NEG ETHANOL-NEG ACETMNPHN-NEG bnzodzpn-NEG barbitrt-NEG tricyclic-NEG ___ 05: 07AM GLUCOSE-247* LACTATE-3.3* NA+-140 K+-3.6 CL--102 TCO2-24 ___ 05: 00AM UREA N-15 CREAT-0.9 ___ CXR : Minimally displaced rib fractures, left first through third ribs. ___ CTA Chest : 1. Traumatic focal dissection in the proximal descending aorta with expanding contained thrombus since ___. 2. No central pulmonary embolism. 3. Mild pulmonary edema. 4. Small bilateral pleural effusions and adjacent atelectasis. 5. Stable anterior proximal left rib fractures. 6. Fatty liver. ___ MRI Left knee : 1. No evidence of injury to the menisci, ligaments, or tendons. 2. Medial femoral condyle osseous contusion. 3. Full thickness chondral fissure in the lateral tibial plateau. 4. Diffuse subcutaneous soft tissue and vastus muscle edema. ___ CTA Chest : 1. Focal contained, post-traumatic aortic dissection in the proximal descending aorta is unchanged since previous CT dated ___. 2. Stable fractures involving the anterior ends of first and second ribs on left side. <MEDICATIONS ON ADMISSION> none <DISCHARGE MEDICATIONS> 1. acetaminophen 325 mg Tablet Sig: Two (2) Tablet PO Q4H (every 4 hours) as needed for fever/pain. 2. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day). 3. famotidine 20 mg Tablet Sig: One (1) Tablet PO BID (2 times a day). Disp: *60 Tablet(s)* Refills: *2* 4. senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a day) as needed for constipation. 5. aspirin 325 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 6. hydromorphone 2 mg Tablet Sig: ___ Tablets PO Q3H (every 3 hours) as needed for pain. Disp: *60 Tablet(s)* Refills: *0* 7. labetalol 100 mg Tablet Sig: One (1) Tablet PO BID (2 times a day). Disp: *60 Tablet(s)* Refills: *2* 8. ciprofloxacin 500 mg Tablet Sig: One (1) Tablet PO Q12H (every 12 hours): thru ___. Disp: *4 Tablet(s)* Refills: *0* 9. Coumadin 5 mg Tablet Sig: One (1) Tablet PO once a day: INR ___ to determine future. Disp: *30 Tablet(s)* Refills: *2* <DISCHARGE DISPOSITION> Home With Service Facility: ___ ___ Diagnosis: S/P MVC 1. Open right femur fracture 2. Proximal descending thoracic aortic dissection with contained thrombus 3. Left rib fractures ___. Right first rib fracture <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> * You were admitted to the hospital after your car accident with multiple injuries including a broken right leg, rib fractures and a small tear in your aorta which sealed over. * Your orthopedic surgery went well and your weight bearing status on the right leg is partial weight bearing with crutches. The ___ will take your staples out. * Your injury caused left rib fractures ___ and the right first rib which can cause severe pain and subsequently cause you to take shallow breaths because of the pain. * You should take your pain medication as directed to stay ahead of the pain otherwise you won't be able to take deep breaths. If the pain medication is too sedating take half the dose and notify your physician. * Pneumonia is a complication of rib fractures. In order to decrease your risk you must use your incentive spirometer 4 times every hour while awake. This will help expand the small airways in your lungs and assist in coughing up secretions that pool in the lungs. * You will be more comfortable if you use a cough pillow to hold against your chest and guard your rib cage while coughing and deep breathing. * Symptomatic relief with ice packs or heating pads for short periods may ease the pain. * Narcotic pain medication can cause constipation therefore you should take a stool softener twice daily and increase your fluid and fiber intake if possible. * Do NOT smoke * The aortic dissection was noted on your initial CT scan. You need to have good blood pressure control and also must stay on a blood thinner called Coumadin. You will need to have your blood tested frequently in the beginning of therapy but after you are regulated it should be once a month. Maintain safety precautions while on Coumadin so that you don't bleed. Be careful with sharp objects. Shave your legs with an electric razor to prevent cuts that will bleed excessively. Do not use ibuprofen or any product with Ibuprofen in it as it can increase your bleeding tendency. * Dr. ___ will regulate your Coumadin dose. * Your blood sugars have been on the high side since your admission and you should talk to your PCP about further testing for diabetes. * Return to the Emergency Room right away for any acute shortness of breath, increased pain or crackling sensation around your ribs ( crepitus ), chest pain, or increased leg pain. ","On ___, the patient went to the OR for femur fx repair, she had low O2 sats postoperatively, requiring a non rebreather. On ___, the patient's C-spine was cleared and her diet was slowly advanced. Logroll precautions were d/c'd and patient was started on dilaudid PCA. ON ___, the patient had an acute drop in her HCT down to 23.7, she received a unit of blood and responded appropriately. She continued to have some desaturation with turning/sleeping, but she was able to be transitioned from NRB to NC. On ___, the patient underwent CTA to rule out PE, which showed dissection of the descending aorta. Cardiac surgery was consulted and recommended no surgery, but instead strict blood pressure control. On ___, patient was started on labetalol gtt for better HR and BP control, and this was transitioned to po Lopressor and labetalol gtt was discontinued. Otherwise, patient was doing well, tolerating regular diet. Ortho recommended 50% weight bearing on right leg and full wt bearing on the left leg. The patient was transferred to the floor on ___. Following transfer to the Trauma floor she continued to make good progress. Vascular surgery was consulted regarding her descending thoracic aortic dissection and they recommended Coumadin, aspirin and keeping SBP < 140 mmHg. Her Coumadin was started on ___ at 5mg followed by 7.5 mg on ___ and ___. Her INR on ___ is 1.7 and she will take 5mg daily with an INR check on ___. Dr. ___ PCP ___ dose her Coumadin starting on ___. Her last CTA chest was on ___ which showed no progression of her dissection. Blood pressure control was successful with Lopressor and hydralazine with SBP 95-120/70 and heart rates in the 70's. She will be discharged on Labetolol alone at 100 mg BID and the ___ will follow up with blood pressure checks for the first few days. Her blood sugars have been elevated since admission in the high 100-240 range. She was encouraged to follow up with Dr. ___ ___ further management. From an Orthopedic standpoint she has done well post op. Her incision is healing well and after many Physical Therapy visits she is able to crutch walk safely. Her weight bearing status is partial (50%) on the right leg and full weight bearing on the left. Her staples will be removed by the ___ on ___. After a long recovery she was discharged home on ___ with ___ services for BP checks and Coumadin teaching and monitoring. ",1622,564
10008628-DS-3,"<SEX> F <SERVICE> CARDIOTHORACIC <ALLERGIES> Penicillins / Codeine <ATTENDING> ___. <CHIEF COMPLAINT> Recurrent effusions <MAJOR SURGICAL OR INVASIVE PROCEDURE> ___ Left video-assisted thoracoscopic surgery parietal pleural biopsy, effusion evacuation, and bronchoscopy. <HISTORY OF PRESENT ILLNESS> Mrs. ___ is an ___ woman with a history of breast cancer and newly diagnosed thyroid nodule suspicious for papillary cancer who has now presented with mediastinal lymphadenopathy which has grown very quickly. She has had workup with an EBUS with biopsy of level VII lymph node which showed suspicion for lymphoma. <PAST MEDICAL HISTORY> - HTN - Hypothyroidism - Breast cancer x2, status post lumpectomy x2, status post XRT. <SOCIAL HISTORY> ___ <FAMILY HISTORY> Mother: deceased breast cancer. Father ___: Sister deceased MM, Brother deceased lymphoma ___ Other <PHYSICAL EXAM> PHYSICAL EXAM: Height: Weight: Temp: 96.8 HR: 107 BP: 140/70 RR: 22 O2 Sat: 94% RA GENERAL [x] All findings normal [ ] WN/WD [ ] NAD [ ] AAO [ ] abnormal findings: HEENT [x] All findings normal [ ] NC/AT [ ] EOMI [ ] PERRL/A [ ] Anicteric [ ] OP/NP mucosa normal [ ] Tongue midline [ ] Palate symmetric [ ] Neck supple/NT/without mass [ ] Trachea midline [ ] Thyroid nl size/contour [ ] Abnormal findings: RESPIRATORY [ ] All findings normal [x] CTA/P [x] Excursion normal [x] No fremitus [ ] No egophony [ ] No spine/CVAT [ ] Abnormal findings: Decrease breath CARDIOVASCULAR [x] All findings normal [ ] RRR [ ] No m/r/g [ ] No JVD [ ] PMI nl [ ] No edema [ ] Peripheral pulses nl [ ] No abd/carotid bruit [ ] Abnormal findings: GI [x] All findings normal [ ] Soft [ ] NT [ ] ND [ ] No mass/HSM [ ] No hernia [ ] Abnormal findings: GU [x] Deferred [ ] All findings normal [ ] Nl genitalia [ ] Nl pelvic/testicular exam [ ] Nl DRE [ ] Abnormal findings: NEURO [x] All findings normal [ ] Strength intact/symmetric [ ] Sensation intact/ symmetric [ ] Reflexes nl [ ] No facial asymmetry [ ] Cognition intact [ ] Cranial nerves intact [ ] Abnormal findings: MS [x] All findings normal [ ] No clubbing [ ] No cyanosis [ ] No edema [ ] Gait nl [ ] No tenderness [ ] Tone/align/ROM nl [ ] Palpation nl [ ] Nails nl [ ] Abnormal findings: LYMPH NODES [x] All findings normal [ ] Cervical nl [ ] Supraclavicular nl [ ] Axillary nl [ ] Inguinal nl [ ] Abnormal findings: PSYCHIATRIC [x] All findings normal [x] Nl judgment/insight [x] Nl memory [x] Nl mood/affect <PERTINENT RESULTS> ___ 04: 22PM POTASSIUM-3.4 ___ 04: 22PM MAGNESIUM-1.7 ___ 04: 22PM WBC-6.0 RBC-3.71* HGB-12.0 HCT-35.6* MCV-96 MCH-32.5* MCHC-33.8 RDW-14.0 ___ 04: 22PM PLT COUNT-341 ___ 12: 50PM OTHER BODY FLUID CD23-D CD45-D ___ ___ KAPPA-D CD2-D CD7-D CD10-D CD19-D CD20-D LAMBDA-D CD5-D ___ 12: 50PM OTHER BODY FLUID CD3-D ___ 12: 50PM OTHER BODY FLUID IPT-D <MEDICATIONS ON ADMISSION> Medications - Prescription AMLODIPINE [NORVASC] - (Prescribed by Other Provider) - Dosage uncertain ANASTROZOLE [ARIMIDEX] - 1 mg Tablet - one Tablet(s) by mouth daily LATANOPROST [XALATAN] - (Prescribed by Other Provider) - Dosage uncertain LEVOTHYROXINE - (Prescribed by Other Provider) - Dosage uncertain METOPROLOL SUCCINATE [TOPROL XL] - (Prescribed by Other Provider) - Dosage uncertain PERSERVISION - (Prescribed by Other Provider) - Dosage uncertain TRIAMTERENE-HYDROCHLOROTHIAZID [DYAZIDE] - (Prescribed by Other Provider) - Dosage uncertain <DISCHARGE MEDICATIONS> 1. Levothyroxine 50 mcg Tablet Sig: One (1) Tablet PO DAILY (Daily). 2. Anastrozole 1 mg Tablet Sig: One (1) Tablet PO daily (). 3. Toprol XL 50 mg Tablet Sustained Release 24 hr Sig: One (1) Tablet Sustained Release 24 hr PO once a day. 4. Amlodipine 2.5 mg Tablet Sig: Three (3) Tablet PO once a day. 5. Latanoprost 0.005 % Drops Sig: One (1) Drop Ophthalmic HS (at bedtime). 6. Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day). 7. Hydromorphone 2 mg Tablet Sig: One (1) Tablet PO every six (6) hours as needed for pain for 14 days. Disp: *56 Tablet(s)* Refills: *0* 8. Acetaminophen 325 mg Tablet Sig: ___ Tablets PO Q6H (every 6 hours) as needed for prn pain. <DISCHARGE DISPOSITION> Home With Service Facility: ___ <DISCHARGE DIAGNOSIS> Left pleural effusion <DISCHARGE CONDITION> stable <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Call Dr. ___ ___ if experience: -Fever > 101 or chills -Increased shortness of breath, cough or sputum production -Chest pain -Incision develop drain: steri-strips remove if start to come off. ","Mrs. ___ is an ___ woman with a history of breast cancer and newly diagnosed thyroid nodule suspicious for papillary cancer who has now presented with mediastinal lymphadenopathy which has grown very quickly. She has had workup with an EBUS with biopsy of level VII lymph node which showed suspicion for lymphoma. Patient was brought to the OR for Left video-assisted thoracoscopic surgery parietal pleural biopsy, effusion evacuation, and bronchoscopy. Post-Op: Patient was stable with little pain on exam. CT was placed on suction and diet was advanced as tolerated. POD 1: Patient complained of mild incisional site pain with positive response to Dilaudid. She was started on Colace and maintained oxygen sat at 93-95% on 4L NC. She was subsequently weaned down to 2L NC. She continued to tolerated her diet and IVF were decreased. CXR: In comparison with prior study, there is little change in the appearance of the left chest tube and extensive opacification involving the lower half of the left lung. Dilatation of a gas-filled stomach, for which nasogastric tube might prove helpful. POD 2: Patient re-mained on telemetry w/o events. CT remained to suction with serosanguinous outputs. No leak was observed and no crepitus in the chest wall was appreciable. Patient was weaned to 1.5L NC and reported 1 BM. CXR: Unchanged left lower lobe and middle lobe opacity, consistent with post-surgical changes, or residual lung mass. Pneumonia cannot be ruled out, but is less likely. POD 3: CT placed to water seal. Patient was weaned of 02 and maintained sat's at 93% on RA. Pain was well controlled with Tylenol. Discharge planning was initiated and patient was thought to be fit for discharge home with services. Follow-up CXR showed findings listed below. CXR: Again seen is a left-sided chest tube. There is a new loculated pneumothorax in the left upper lung laterally. POD 4: Patient continued to be stable with good PO-intake, adequate UOP and minimal pain. Given recent CXR patient was kept for a day and Patient CT was clamped at 9:00pm. Repeat CXR showed stable loculation with no new pneumothorax. POD 5: Patient continued to be stable. CT was removed uneventfully and post-pull CXR was ordered. Patient continued to be stable with stable vital prior to discharge. ",1437,534
10008647-DS-18,"<SEX> M <SERVICE> SURGERY <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> Fall <MAJOR SURGICAL OR INVASIVE PROCEDURE> None. <HISTORY OF PRESENT ILLNESS> ___ w/ PMHx notable for HTN and remote head injury 40+ years prior now seen in consultation following a presumed syncopal episode. Pt cannot describe any inciting events leading to the fall and reports becoming aware that he had fallen after his wife awakened him. He reports LOC immediately surrounding the events of the fall, but has had no difficulty with memory, motor/sensation, vision, or speech since. He was taken to ___ where workup there included labs which were normal and a CT head and c-spine which demonstrated bifrontal subacute on chronic SDHs with a small, acute right lateral-posterior component. CT cspine consistent with chronic degenerative changes, but no acute traumatic injury. He was transferred to ___ for further workup and evaluation. <PAST MEDICAL HISTORY> PMHx: HTN, hepatitis B PSHx: L leg/hip surgery distantly while in ___ war, repair of L scalp laceration ~ ___ year ago <SOCIAL HISTORY> ___ <FAMILY HISTORY> brother with colon cancer at young age, otherwise unknown <PHYSICAL EXAM> ADMISSION PHYSICAL EXAM PE: 97.9 88 132/70 16 99% RA Gen: NAD, comfortable, superficial abrasions over left cheek and chin HEENT: EOMI, pupils equal and reactive ___, left neck pain on lateral side which pt reports is chronic and muscular in nature, no deformities noted and no motor/sensory loss; no cspine tenderness, no thoracic or lumbar spine tenderness or deformity; head with abrasions as noted above, otherwise atraumatic CV: RRR R: CTAB Abd: soft, NT/ND, no masses, no surgical incisions, no hernias, no bruising Ext: moves all extremities x4 equally and with full sensation and strength, no bruising or e/o traumatic injury -======== -======== DISCHARGE PHYSICAL EXAMINATION Discharge: 97.6 PO 135 / 76 66 18 96 Ra Gen: NAD, comfortable, superficial abrasions over left cheek and chin HEENT: EOMI, PERRLA CV: RRR R: CTAB Abd: soft, NT/ND, no masses, no surgical incisions, no hernias, no bruising Ext: moves all extremities x4 equally and with full sensation and strength, no bruising or e/o traumatic injury <PERTINENT RESULTS> IMAGING STUDIES ___ CT Cspine: No cervical vertebral fracture or traumatic subluxation. Multilevel degenerative changes with asymmetric multifocal neural foraminal stenosis -======== LABS ___ 07: 21PM BLOOD WBC-8.9 RBC-4.33* Hgb-14.1 Hct-40.2 MCV-93 MCH-32.6* MCHC-35.1 RDW-11.7 RDWSD-40.0 Plt ___ ___ 07: 21PM BLOOD Neuts-52.8 ___ Monos-5.7 Eos-1.6 Baso-0.7 Im ___ AbsNeut-4.69 AbsLymp-3.48 AbsMono-0.51 AbsEos-0.14 AbsBaso-0.06 ___ 07: 21PM BLOOD Glucose-106* UreaN-22* Creat-1.0 Na-139 K-3.8 Cl-104 HCO3-21* AnGap-14 ___ 09: 19AM BLOOD CK(CPK)-49 ___ 02: 12AM BLOOD CK-MB-1 cTropnT-<0.01 <MEDICATIONS ON ADMISSION> HCTZ 25', losartan 100', omeprazole 20' <DISCHARGE MEDICATIONS> 1. Acetaminophen 650 mg PO Q6H: PRN Pain - Mild 2. Docusate Sodium 100 mg PO BID 3. LevETIRAcetam 500 mg PO Q12H Duration: 7 Days RX *levetiracetam 500 mg 1 tablet(s) by mouth every twelve (12) hours Disp #*12 Tablet Refills: *0 4. Polyethylene Glycol 17 g PO DAILY: PRN constipation 5. Hydrochlorothiazide 25 mg PO DAILY 6. Losartan Potassium 100 mg PO DAILY 7. Omeprazole 20 mg PO DAILY <DISCHARGE DISPOSITION> Home With Service Facility: ___ <DISCHARGE DIAGNOSIS> Acute on chronic right and chronic appearing left subdural hematomas <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Ms. ___, You were admitted to the Acute Care Surgery Service on ___nd found to have a bleed in your head. You had a repeat CT scan that showed the bleed was stable. You were evaluated by the neurosurgery team who recommended that you take a medication called Keppra to prevent seizures for the next 7 days. You were seen and evaluated by physical and occupational therapy who cleared you for discharge to home with home physical therapy. You are now doing better, tolerating a regular diet, and ready to be discharged to home to continue your recovery. Please note the following discharge instructions: Please call your doctor or nurse practitioner or return to the Emergency Department for any of the following: *You experience new chest pain, pressure, squeezing or tightness. *New or worsening cough, shortness of breath, or wheeze. *If you are vomiting and cannot keep down fluids or your medications. *You are getting dehydrated due to continued vomiting, diarrhea, or other reasons. Signs of dehydration include dry mouth, rapid heartbeat, or feeling dizzy or faint when standing. *You see blood or dark/black material when you vomit or have a bowel movement. *You experience burning when you urinate, have blood in your urine, or experience a discharge. *Your pain in not improving within ___ hours or is not gone within 24 hours. Call or return immediately if your pain is getting worse or changes location or moving to your chest or back. *You have shaking chills, or fever greater than 101.5 degrees Fahrenheit or 38 degrees Celsius. *Any change in your symptoms, or any new symptoms that concern you. Please resume all regular home medications, unless specifically advised not to take a particular medication. Also, please take any new medications as prescribed. Please get plenty of rest, continue to ambulate several times per day, and drink adequate amounts of fluids. Avoid driving or operating heavy machinery while taking pain medications. --= Signs and symptoms of a concussion may include: -Headache or a feeling of pressure in the head -Temporary loss of consciousness -Confusion or feeling as if in a fog -Amnesia surrounding the traumatic event -Dizziness or ""seeing stars"" -Ringing in the ears -Nausea -Vomiting -Slurred speech -Delayed response to questions -Appearing dazed -Fatigue You may have some symptoms of concussions immediately. Others may be delayed for hours or days after injury, such as: -Concentration and memory complaints -Irritability and other personality changes -Sensitivity to light and noise -Sleep disturbances -Psychological adjustment problems and depression -Disorders of taste and smell ","Ms. ___ is an ___ yo M who was admitted to the Acute Care Trauma surgery service after sustanging a fall with bifrontal subacute on chronic subdural hemorrhages and small acute right lateral component. He was admitted to the acute care surgery service for continuous cardiac monitoring given possible syncope episode. The patient was seen and evaluated by neurosurgery who recommended a repeat CT scan which was stable and seizure prophylaxis with keppra for 7 days. The patient remained hemodynamically stable with no events on continuous telemetry and negative cardiac enzymes. Physical and occupational therapy assessed the patient and recommend discharge to home with continued physical therapy which the patient and daughter agreed. On HD2, the patient was doing well, afebrile with stable vital signs. The patient was tolerating a regular diet, ambulating, voiding without assistance, and pain was well controlled. The patient was discharged home with home ___ services. The patient received discharge teaching and follow-up instructions with understanding verbalized and agreement with the discharge plan. ",1654,211
10008816-DS-5,"<SEX> M <SERVICE> PSYCHIATRY <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> ""I need to get my life on track"" <MAJOR SURGICAL OR INVASIVE PROCEDURE> defer <HISTORY OF PRESENT ILLNESS> ___ Caucasian male with reported history of bipolar disorder, anxiety, ADD, and alcohol dependence self-presented to ED s/p ingestion 1 liter of vodka and 15 seroquel tabs (100mg). Pt denies suicide attempt and says ingestion was an effort to relieve anxiety. Pt was released from jail in ___ and has since struggled to receive psychiatric/substance abuse treatment. He reports drinking ___ liters of vodka daily for the last two weeks and was at this ED on ___ with similar presentation. Last drink was evening of ___ He was supposed to start Arbour/HRI PHP yesterday but felt this level of care was insufficient, given his level of depression and anxiety and inability to stay away from alcohol when not supervised. At pt's initial intake with a psychiatrist at the ___, he was given prescriptions for Seroquel, Prozac, trileptal, and buspirone. Patient reports that during incarceration, he was taking Prozac, Seroquel, mirtazapine, eleval, trileptal, buspar, and trazodone but was released with prescriptions for these medications. When pt presented to the Emergency department yesterday, he reported having visual and auditory hallucinations and difficulty thinking and speaking clearly. Over the course of his stay in the ED, his symptoms improved slightly, and upon examination this evening, his speech and thought had regained some clarity. He continued to feel quite anxious but was calmed by the news of his admission to the inpatient unit. Pt continued to deny any current or previous SI or HI and reported that he was no longer having visual or auditory hallucinations or paranoia. He continues to be very concerned and anxious about his emotional instability, tendency towards alcohol/prescription medical abuse, and lack of social and financial supports but does not know how to get back on track. <PAST MEDICAL HISTORY> Psychiatric Hx: Diagnosed with bipolar disorder, anxiety, ADD, and alcohol dependence. Hospitalized in ___ ED ___, intake at ___/HRI PHP ___, CCS ___ from ___ ___ months ago, and ___ ___. More than 10 detoxes at CAB in ___ and ___. Patient previously in care of psychiatrist Dr. ___ at ___ but has not seen in over a year. Medication/ECT trials: Seroquel, Elavil, Zoloft and Ritalin, concerta, Adderall, vivance and straterra for ADD as child. Self-Injury: Hx of OD on ___ and last night but denies suicide attempt. Access to weapons: Denies. Medical Hx: Abdominal hernia s/p surgery. Left hip fracture s/p surgical rod replacement. <SOCIAL HISTORY> ___ <FAMILY HISTORY> Brother with depression, maternal grandmother and uncle with alcoholism <PHYSICAL EXAM> Per Dr. ___ on admission on ___: PE: General: Well-nourished, in no distress. HEENT: Normocephalic. PERRL, EOMI. Oropharynx clear. Neck: Supple, trachea midline. No adenopathy or thyromegaly. Back: No significant deformity, no focal tenderness. Lungs: Clear to auscultation; no crackles or wheezes. CV: Regular rate and rhythm; no murmurs/rubs/gallops Abdomen: Positive bowel sounds. Firmly distended. Slightly tender to deep palpation in LLQ. No rebound tenderness, guarding, or organomegaly. Extremities: No clubbing, cyanosis, or edema. Skin: Warm and dry, no rash or significant lesions. Neurological: *Cranial Nerves- I: Not tested II: Pupils equally round and reactive to light bilaterally. III, IV, VI: Extraocular movements intact bilaterally without nystagmus. V, VII: Facial strength and sensation intact and symmetric. VIII: Hearing intact to voice. IX, X: Palatal elevation symmetrical. XI: Sternocleidomastoid and trapezius normal bilaterally. XII: Tongue midline without fasciculations. *Motor- Normal bulk and tone bilaterally. Strength full power ___ throughout. No pronator drift. Gait: Wide-based. Limp favoring right leg. Difficulty with heel-toe walk. *Sensation- Intact to light touch. *Coordination- Normal on finger-nose-finger <PERTINENT RESULTS> ___ 02: 13PM URINE HOURS-RANDOM ___ 02: 13PM URINE bnzodzpn-POS barbitrt-NEG opiates-NEG cocaine-NEG amphetmn-NEG mthdone-NEG ___ 06: 35AM GLUCOSE-108* UREA N-14 CREAT-0.7 SODIUM-138 POTASSIUM-3.7 CHLORIDE-104 TOTAL CO2-28 ANION GAP-10 ___ 06: 35AM estGFR-Using this ___ 06: 35AM ALT(SGPT)-18 AST(SGOT)-19 ALK PHOS-90 TOT BILI-0.4 ___ 06: 35AM LIPASE-47 ___ 06: 35AM CALCIUM-8.5 PHOSPHATE-3.4 MAGNESIUM-2.0 ___ 06: 35AM VIT B12-314 FOLATE-10.8 ___ 06: 35AM TSH-2.2 ___ 06: 35AM HBs Ab-POSITIVE ___ 06: 35AM ASA-NEG ETHANOL-NEG ACETMNPHN-NEG bnzodzpn-NEG barbitrt-NEG tricyclic-NEG ___ 06: 35AM HCV Ab-NEGATIVE ___ 06: 35AM WBC-5.9 RBC-3.67* HGB-12.0* HCT-35.6* MCV-97 MCH-32.8* MCHC-33.8 RDW-12.6 ___ 06: 35AM NEUTS-61.5 ___ MONOS-5.7 EOS-2.1 BASOS-1.0 ___ 06: 35AM PLT COUNT-229 <MEDICATIONS ON ADMISSION> Per Dr. ___ evaluation on ___: The Preadmission Medication list is accurate and complete. 1. QUEtiapine Fumarate 100 mg PO QHS 2. Oxcarbazepine 300 mg PO BID 3. Fluoxetine 15 mg PO DAILY <DISCHARGE MEDICATIONS> 1. FoLIC Acid 1 mg PO DAILY RX *folic acid 1 mg 1 (One) tablet(s) by mouth once a day Disp #*30 Tablet Refills: *0 2. Multivitamins 1 TAB PO DAILY RX *multivitamin [Chewable Multi Vitamin] 1 (One) tablet, chewable(s) by mouth once a day Disp #*30 Capsule Refills: *0 3. Thiamine 100 mg PO DAILY RX *thiamine HCl 100 mg 1 (One) tablet(s) by mouth once a day Disp #*30 Tablet Refills: *0 4. naltrexone *NF* 50 mg ORAL DAILY Alcohol dependence Reason for Ordering: Wish to prescribe this medication for alcohol dependence for this patient, as there is no acceptable substitude drug available on formulary. RX *naltrexone 50 mg 1 (One) tablet(s) by mouth once a day Disp #*30 Tablet Refills: *0 5. Oxcarbazepine 300 mg PO BID RX *oxcarbazepine 300 mg 1 (One) tablet(s) by mouth twice a day Disp #*60 Tablet Refills: *0 <DISCHARGE DISPOSITION> Extended Care <DISCHARGE DIAGNOSIS> AXIS I etoh dependence h/o cocaine dependence in remission AXIS II antisocial traits <DISCHARGE CONDITION> Good Stable Pt is dressed casually and makes fair eye contact w/ the team. He is 'fine' in mood and affect is constricted yet appears mood congruent. His speech is normal - fluent, reg rate/vol/tone. He has no perceptual disturbances, thoughts are linear/organized and he lacks delusions/ruminations. Pt has no suicidal/homicidal thoughts. His insight/judgment are currently fair. Pt's cognition is intact. He is alert and oriented x3, recall for short/long-term are fair, he can perform tasks of executive function and is able to abstract think. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Please avoid abusing alcohol and any drugs--whether prescription drugs or illegal drugs--as this can further worsen your medical and psychiatric illnesses. Dear Mr. ___, You were admitted for treatment of etoh dependence and were placed on a valium taper and CIWA protocol for safe withdrawal. During your hospital stay we monitored you for safety and administered multivitamins and other medications. You were safe throughout the duration of your admission and you are now ready for discharge. It is imperative that you remain sober to avoid any future mood disturbance or risk of self-harm. Please f/u with your referrals including ___ House and AA. At ___ House you will be given appropriate psychiatric follow-up. ","#) PSYCHIATRIC 1. Alcohol dependence Pt reported symptoms/hx of high tolerance, withdrawal, extra time spent seeking out (described 'dine and dash' at restaurants to obtain liquor), use despite rec difficulties (parents/friends have estranged themselves ___ pt's substance use), failure to be able to cut back (described immediate relapse after last hospitalization). We initiatiated treatment with Naltrexone and the pt was discharged on 50mg oral qday to help with alcohol cravings. We discussed strategies to help maintain sobriety and pt. attested that the found regular AA attendance with a sponsor most helpful; we have encouraged that participate in AA extensively after discharge in addition to attend the ___ program for sobriety. 2. SIMD The pt has reported being given a diagnosis of bipolar d/o and depression in the past. We discussed this at length with him, and he shared that since age ___ he has been consuming a heavy quantity of alcohol. The pt has experienced both 'manic' and 'depressive' sx in the past but those were in the context of etoh or cocaine intake. Therefore, we did not believe the pt has a primary mood d/o and we encouraged him to gain sobriety and continue to f/u for assessments of his mood. At the pt's insistence, we continued w/ his home med of Trileptal during the admission, but we would again recommend that outpt team consider tapering this down as the pt's diagnosis is solidified. 3. Antisocial Traits The pt exhibits many traits c/w antisocial personality. He has a long h/o criminal activity and per family, lacks any remorse for his actions. Pt is impulsive, reckless, and has caused his friends/family to estrange themselves from his life. #) MEDICAL 1. Alcohol withdrawal Given pt's long history of alcohol dependence, and his previous history of delerium tremens including one grand mal seizure in the past, we treated this pt with a CIWA scale for administering diazepam, and added in a standing diazepam dosage in light of pt's elevations in blood pressure and heart rate. We were able to discontinue to CIWA scale by ___ and started a successful diazepam taper which concluded on ___. 2. Abdominal pain Pt c/o ___ pain on the unit and was consulted on by internal medicine who opined that he had a benign exam, normal ___ x-ray, and no further w/u was necessary. #) SOCIAL/GROUPS/MILIEU 1. Groups The pt attended groups on the unit and was observed to be euthymic. He participated in the education/coping groups and often cited his background in psychology as an area that he felt accomplished in and hoped to find gainful employment someday again. 2. Milieu The pt was cooperative with peers in the milieu. He was observed to be calm and euthymic. There were no problems with aggression or lack of cooperation. 3. Family Contacts The pt's mother spoke with our LICSW and shared that he has a very long h/o continuous etoh use and that he is now estranged from most family and friends. Mother reported that the family would not assist pt w/ housing due to his frequent relapses and criminal behaviors. The family agreed that pt's main problem is etoh dependence. There were no safety concerns reported. Family were contacted on date of d/c to inform them that pt is going to ___ House for rehab. #) LEGAL Pt came in on a conditional voluntary basis. He signed a 3-day notice on ___. #) RISK ASSESSMENT Mr. ___ has a low imminent risk of harm to himself/others at this time. He has not been suicidal nor homicidal throughout this hospital stay or in the immediate time preceeding his admssion. Mr. ___ is currently motivated for sobriety and agrees to transition to an extended care facility for rehab from this hospital. The pt is nevertheless a high chronic risk for relapse on etoh which could inadvertantly lead to serious harm. To mitigate this risk we successfully detoxed him during this admission, prescribed naltrexone to reduce cravings, gave much psychoeducation about the risks of etoh use, and referred him to an extended care facility. At this time the least restrictive setting for care is outpatient. ",2053,899
10008819-DS-12,"<SEX> F <SERVICE> SURGERY <ALLERGIES> Penicillinase <ATTENDING> ___. <CHIEF COMPLAINT> abdominal pain and bulge <MAJOR SURGICAL OR INVASIVE PROCEDURE> Ventral hernia repair <HISTORY OF PRESENT ILLNESS> ___ year old female presenting with longstanding history of having a reducible hernia (at least ___ years). It caused no pain and she was always able to manually reduce it. Last month, she presented to the ED with abdominal discomfort and inability to reduce the hernia. She denies any severe pain at the time, nausea, vomiting, skin changes, obstipation. She did note a decreased in frequency of her bowel movements to every other day. A CT scan demonstrated incarcerated transverse colon within the ventral hernia, with no evidence of obstruction or bowel compromise. She opted for outpatient referral for surgical repair. She has continued to have only mild abdominal discomfort and is unable to reduce the hernia. She is tolerating PO intake, having bowel movements, and otherwise feels well <PAST MEDICAL HISTORY> HTN, ovarian dermoid cyst, fibroids <SOCIAL HISTORY> ___ <FAMILY HISTORY> Father has CAD s/p heart transplant, multiple myeloma, and kidney cancer <PHYSICAL EXAM> VS: T: 97.3 HR: 77 BP: 123/69 RR: 18 O2Sat: 95%RA GEN: AA&O x 3, NAD, calm, cooperative. HEENT: (-)LAD, mucous membranes moist, trachea midline, EOMI CHEST: Clear to auscultation bilaterally, (-) cyanosis. ABDOMEN: soft, diffuse tenderness, incision sites are c/d/i covered with steri-strips. JP drain in place with scant serosanguineous drainage EXTREMITIES: Warm, well perfused, no edema <PERTINENT RESULTS> ___ 02: 44PM BLOOD Hct-41.8 ___ 05: 45AM BLOOD Hct-41.0 <MEDICATIONS ON ADMISSION> Lisinopril 10 mg tablet <DISCHARGE MEDICATIONS> 1. Acetaminophen 650 mg PO Q6H 2. Cyclobenzaprine 10 mg PO TID: PRN pain RX *cyclobenzaprine 10 mg 1 tablet(s) by mouth three times a day Disp #*30 Tablet Refills: *0 3. Docusate Sodium 100 mg PO BID RX *docusate sodium 100 mg 1 capsule(s) by mouth twice a day Disp #*20 Capsule Refills: *0 4. OxyCODONE (Immediate Release) 5 mg PO Q6H: PRN Pain - Moderate RX *oxycodone 5 mg 1 tablet(s) by mouth every six (6) hours Disp #*10 Tablet Refills: *0 5. Lisinopril 20 mg PO DAILY <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> s/p ventral hernia repair <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> It was a pleasure taking care of you here at the ___ ___. You were admitted to our hospital for your abdominal pain. You had a ventral hernia repair on ___. You tolerated the procedure well and have recovered well from some mild post-operative issues, that resolved prior to your discharge. You are now ambulating, stooling, tolerating a regular diet, and your pain is controlled by pain medications by mouth. You are now ready to be discharged to home. Please follow the recommendations below to ensure a speedy and uneventful recovery. ACTIVITY: - Do not drive until you have stopped taking pain medicine and feel you could respond in an emergency. - You may climb stairs. You should continue to walk several times a day. - You may go outside, but avoid traveling long distances until you see your surgeon at your next visit. - You may start some light exercise when you feel comfortable. Slowly increase your activity back to your baseline as tolerated. - Heavy exercise may be started after 6 weeks, but use common sense and go slowly at first. - No heavy lifting (10 pounds or more) until cleared by your surgeon, usually about 6 weeks. - You may resume sexual activity unless your doctor has told you otherwise. HOW YOU MAY FEEL: - You may feel weak or ""washed out"" for 6 weeks. You might want to nap often. Simple tasks may exhaust you. - You may have a sore throat because of a tube that was in your throat during the surgery. YOUR BOWELS: - If needed, you may take a stool softener(such as Colace, one capsule) or gentle laxative (such as milk of magnesia, 1 tbs) twice a day. You can get both of these medicines without a prescription. - If you go 48 hours without a bowel movement, or have pain moving the bowels, call your surgeon. - After some operations, diarrhea can occur. If you get diarrhea, don't take anti-diarrhea medicines. Drink plenty of fluids and see if it goes away. If it does not go away, or is severe and you feel ill, please call your surgeon. PAIN MANAGEMENT: - You are being discharged with a prescription for Cyclobenzaprine for pain control. You may take Tylenol as directed, not to exceed 3500mg in 24 hours. Take regularly for a few days after surgery but you may skip a dose or increase time between doses if you are not having pain until you no longer need it. You may take the oxycodone for moderate and severe pain not controlled by the Tylenol. You may take a stool softener while on narcotics to help prevent the constipation that they may cause. Slowly wean off these medications as tolerated. - Your pain should get better day by day. If you find the pain is getting worse instead of better, please contact your surgeon. If you experience any of the following, please contact your surgeon: - sharp pain or any severe pain that lasts several hours - chest pain, pressure, squeezing, or tightness - cough, shortness of breath, wheezing - pain that is getting worse over time or pain with fever - shaking chills, fever of more than 101 - a drastic change in nature or quality of your pain - nausea and vomiting, inability to tolerate fluids, food, or your medications - if you are getting dehydrated (dry mouth, rapid heart beat, feeling dizzy or faint especially while standing) -any change in your symptoms or any symptoms that concern you Additional: - You are being discharged with a JP drain. Please empty when halfway full and record daily output. MEDICATIONS: - Take all the medicines you were on before the operation just as you did before, unless you have been told differently. - If you have any questions about what medicine to take or not to take, please call your surgeon. - You are going home on metoprolol 12.5mg every 12 hours. Please continue until follow up in clinic. (1 week following discharge). WOUND CARE: -You may shower with any bandage strips that may be covering your wound. Do not scrub and do not soak or swim, and pat the incision dry. If you have steri strips, they will fall off by themselves in ___ weeks. If any are still on in two weeks and the edges are curling up, you may carefully peel them off. *** Your staples will be removed by your surgeon at your follow up appointment. Do not take baths, soak, or swim for 6 weeks after surgery unless told otherwise by your surgical team. -Notify your surgeon is you notice abnormal (foul smelling, bloody, pus, etc) or increased drainage from your incision site, opening of your incision, or increased pain or bruising. Watch for signs of infection such as redness, streaking of your skin, swelling, increased pain, or increased drainage. Please call with any questions or concerns. Thank you for allowing us to participate in your care. We hope you have a quick return to your usual life and activities. -- Your ___ Care Team ","The patient presented to pre-op on ___. Pt was evaluated by anaesthesia and was taken to the operating room for open ventral hernia repair with mesh. There were no adverse events in the operating room; please see the operative note for details. Pt was extubated, taken to the PACU until stable, then transferred to the ward for observation. Neuro: The patient was alert and oriented throughout hospitalization; pain was initially managed with a morphine PCA and IV dilaudid and then transitioned to oral Tylenol and ultram once tolerating a diet. CV: The patient remained stable from a cardiovascular standpoint; vital signs were routinely monitored. Pulmonary: The patient remained stable from a pulmonary standpoint; vital signs were routinely monitored. Good pulmonary toilet, early ambulation and incentive spirometry were encouraged throughout hospitalization. GI/GU/FEN: The patient was initially kept NPO. On ___ the diet was advanced sequentially to a Regular diet, which was well tolerated. Patient's intake and output were closely monitored ID: The patient's fever curves were closely watched for signs of infection, of which there were none. HEME: The patient's blood counts were closely watched for signs of bleeding, of which there were none. Prophylaxis: The patient received subcutaneous heparin and ___ dyne boots were used during this stay and was encouraged to get up and ambulate as early as possible. At the time of discharge, the patient was doing well, afebrile and hemodynamically stable. The patient was tolerating a diet, ambulating, voiding without assistance, and pain was well controlled. The patient received discharge teaching and follow-up instructions with understanding verbalized and agreement with the discharge plan. ",1769,355
10008924-DS-15,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> ___ <ATTENDING> ___. <CHIEF COMPLAINT> liver failure <MAJOR SURGICAL OR INVASIVE PROCEDURE> esophagogastroduodenoscopy (EGD) large volume paracentesis x 2 <HISTORY OF PRESENT ILLNESS> Ms. ___ is a ___ year old female with MELD 24 EtOH cirrhosis complicated by recurrent ascites admitted for liver evaluation. The patient reports that she was first told that she had liver disease in ___ after presenting with abdominal distension. She reports that she had 2 therapeutic paracenteses over the summer, but in the past month has required 3 large volume paracenteses (6L x2 most recently) in the past month. She reports that she has never had formal outpatient hepatology evaluation, and denies any history of encephalopathy, hematemesis, melena/hematochezia. The patient was most recently admitted to ___ on ___ for increased abdominal girth s/p therapeutic paracentesis. During her prior admission to ___. ___, she had negative ceruloplasmin, alpha 1 antitrypsin, and iron levels. During her last admission, the patient was noted to have a leukocytosis to 18 of unclear etiology, although was treated for a UTI earlier this month during an admission to ___ ___ with a quinolone. . Of note, the patient reports a history of heavy EtOH use described as ___ pints/day of vodka, with her last drink on ___. She states that she voluntarily admitted herself to an ___ facility. She denies a history of withdrawal symptoms including seizures. . On arrival to the ___ ED, VS 97.9 70 100/50 18 100%RA. He had an abodminal ulrasound performed, negative diagnostic paracentesis, and was admitted to E-T for further management. . Currently, the patient is reporting increased abdominal girth over the past week with associated abdominal tenderness. Denies any CP/SOB, f/c/s, n/v/d, abd pain, HA, palpitations, or dysuria. Patient does report chronic diarrhea in setting of lactulose use. . Review of systems: As above, otherwise negative. <PAST MEDICAL HISTORY> EtOH cirrhosis complicated by recurrent ascites EtOH abuse/dependence <SOCIAL HISTORY> ___ <FAMILY HISTORY> Negative for family history of liver disease <PHYSICAL EXAM> -- per admitting resident -- Gen: Age appropriate female in NAD HEENT: Perrl, eomi, scleral icterus. MMM, OP clear without lesions, exudate, or erythema. Neck supple without LAD. CV: Nl S1+S2, no m/r/g Pulm: CTAB Abd: Distended, umbilical hernia. TTP bilaterally in subcostal region (chronic per patient). +BS. GU: OB brown positive Ext: No c/c/e (R>L, present since last admission with negative ___ per patient). <PERTINENT RESULTS> ___ 06: 10AM BLOOD WBC-10.5 RBC-2.57* Hgb-8.5* Hct-26.5* MCV-103* MCH-33.0* MCHC-32.1 RDW-15.9* Plt Ct-94* ___ 04: 30AM BLOOD ___ ___ 04: 30AM BLOOD Glucose-105* UreaN-16 Creat-1.1 Na-134 K-3.9 Cl-99 HCO3-27 AnGap-12 ___ 06: 10AM BLOOD ALT-10 AST-62* AlkPhos-125* TotBili-2.5* ___ 06: 10AM BLOOD Albumin-2.8* Calcium-8.7 Phos-4.2 Mg-1.5* ___ 05: 45AM BLOOD calTIBC-105* VitB12-1281* Folate-17.4 Ferritn-140 TRF-81* ___ 06: 00AM BLOOD HBsAg-NEGATIVE HBsAb-NEGATIVE HBcAb-NEGATIVE HAV Ab-NEGATIVE ___ 06: 05AM BLOOD Smooth-POSITIVE * ___ 06: 00AM BLOOD AMA-NEGATIVE ___ 06: 00AM BLOOD ___ ___ 06: 00AM BLOOD AFP-1.5 ___ 06: 05AM BLOOD IgG-1602* IgM-157 ___ 06: 00AM BLOOD HCV Ab-NEGATIVE RUQ U/S: 1. Cirrhosis, splenomegaly, ascites, with reversal of flow in the portal venous system, compatible with portal hypertension. 2. CBD dilated up to 1 cm without evidence of choledocho- or cholelithiasis. 3. Distended gallbladder with gallbladder wall edema in the absence of focal sonographic ___ sign. The gallbladder wall edema may be attributable to third spacing. Overall, findings are inconclusive for acute cholecystitis. 4. Patent hepatic arterial and systemic venous vasculature. . MRCP: 1. Evidence of hepatic cirrhosis with portal hypertension. 2. No intrahepatic or extrahepatic biliary duct dilatation. . CXR: No evidence of acute cardiopulmonary process. . EGD: - Erythema, congestion and abnormal vascularity in the fundus and stomach body compatible with portal hypertensive gastropathy - Linear erythema with erosions in the antrum compatible with erosive gastritis (biopsy) - Large bezoar noted in fundus. No clear underlying mucosal abnormality. - Abnormal mucosa in the duodenum (biopsy) - Erythema with erosion in the duodenal bulb and first part of the duodenum compatible with erosive duodenitis - Otherwise normal EGD to third part of the duodenum . GI biopsy: Gastrointestinal mucosal biopsies: A. Antrum: Antral mucosa with mild vascular congestion, otherwise within normal limits. B. Duodenum: Duodenal mucosa with no diagnostic abnormalities recognized. <MEDICATIONS ON ADMISSION> Folate 1 mg daily Lactulose 30 mL po bid Levofloaxcin 750 mg po daily x5 days (completed today) Nicotine patch 14 mg TD daily KCl 10 meq daily <DISCHARGE MEDICATIONS> 1. Thiamine HCl 100 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). Disp: *30 Tablet(s)* Refills: *0* 2. Folic Acid 1 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). Disp: *30 Tablet(s)* Refills: *0* 3. Lactulose 10 gram/15 mL Syrup Sig: Thirty (30) ML PO TID (3 times a day). Disp: *2700 ML(s)* Refills: *0* 4. Oxycodone 5 mg Tablet Sig: One (1) Tablet PO every twelve (12) hours as needed for pain. Disp: *10 Tablet(s)* Refills: *0* 5. Spironolactone 100 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). Disp: *30 Tablet(s)* Refills: *0* 6. Furosemide 40 mg Tablet Sig: One (1) Tablet PO BID (2 times a day). Disp: *60 Tablet(s)* Refills: *0* 7. Ciprofloxacin 250 mg Tablet Sig: One (1) Tablet PO Q24H (every 24 hours). Disp: *30 Tablet(s)* Refills: *0* 8. Omeprazole 40 mg Capsule, Delayed Release(E.C.) Sig: One (1) Capsule, Delayed Release(E.C.) PO once a day. Disp: *30 Capsule, Delayed Release(E.C.)(s)* Refills: *0* 9. Multivitamin Tablet Sig: One (1) Tablet PO DAILY (Daily). <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Primary Diagnosis: 1. alcoholic cirrhosis with ascites 2. anemia 3. acute renal failure 4. leukocytosis <DISCHARGE CONDITION> Mental Status: Clear and coherent Level of Consciousness: Alert and interactive Activity Status: Ambulatory - Independent <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> You were seen at ___ for liver failure, kidney failure, and ascites. We improved your kidney function with an albumin (protein) infusion and fluids. You received two large volume paracenteses to remove some of your ascites from your abdomen. Additionally, you had low-grade fevers during your hospitalization that was concerning for a possible infection of the fluid in your belly. You were treated with antibiotics for this infection and were started on prophylactic antibiotics to be continued to decrease the chance of recurrence of infection. Additionally, you were found to have developing low blood counts during this hospitalization that was concerning for a bleed in your gastrointestinal tract. You received a blood transfusion and an EGD (endoscopy). The endoscopy revealed no evidence of esophageal varices, but did show that your stomach and intestine were inflamed (gastritis, duodenitis). You were started on a proton-pump inhibitor (omeprazole) to help treat this condition. It is extremely important that you COMPLETELY ABSTAIN from alcohol. Any further alcohol at this point will severely damage your liver and put you at increased risk for complete liver failure and death. Please make your follow up appointments as listed below. The following medications were changed: ADDED ciprofloxacin to decrease the chance of infection in your abdomen ADDED omeprazole to treat your gastritis / duodenitis ADDED furosemide (lasix), a diuretic to help reduce the accumulation of fluid in your abdomen ADDED spironolactone, a diuretic to help reduce the accumulation of fluid in your abdomen ADDED lactulose, a laxative medication that helps to decrease the risk of developing confusion in patients with liver failure ADDED oxycodone to help you with pain control from your abdominal swelling in the short term ADDED thiamine and folate, vitamins to help supplement your diet ","# ARF, EtOH cirrhosis - The patient presented in acute renal failure with Cr 2.3 on admission (0.9 per outside hospital records on ___. She was given an albumin challenge for assessment of pre-renal vs. hepatorenal syndrome, and her creatinine quickly improved. Her diuretics, which had initially been held for renal failure, were restarted; she was unable to have a significant negative diuresis but maintained relatively even I+Os once uptitrated to lasix 40 mg po bid and aldactone 100 mg/d. She required two large volume paracenteses during this admission, in which a total of 6.5 L was removed (2L, 4.5L). As part of workup for cirrhosis, outside records were reviewed, which indicated a normal a1-antitrypsin, ceruloplasmin levels. Iron levels were WNL, although one note mentions a high transferrin saturation and a possible workup for hemachromatosis. On our workup, hepatitis A, B, C serologies were sent and were negative, including HbsAb. ___ neg, IgG/IgM WNL. Anti-SMA was positive at 1:20 titer. At this time we believe the anti-SMA titer is not significant enough to raise strong clinical suspicion for an autoimmune hepatitis, especially given a strong EtOH history and an AST/ALT ratio consistent with this. Further assessment to be done as as an outpatient. # leukocytosis - DDx initially worrisome for cholangitis (given CBD dilation on RUQ U/S) or SBP (although diagnostic para in ED was negative; this was in the setting of ongoing levofloxacin therapy). MRCP was performed and was negative for evidence of dilation or stone in biliary tree. Patient was treated empirically for SBP regardless with five days of high dose CTX and was switched to cipro for ppx. Pt was initially febrile during admission but defervesced with no proven source of infection. Leukocytosis improved during hospitalization (10.8 <-- 17.8 since admission). - UCx ___ shows <10^5 VRE in setting of normal urine dipstick. Repeat UCx ___ negative. All UAs have been negative. Likely represents contaminant, no role for treatment. # EtOH abuse - Patient reports that last drink was over two weeks ago, with no history of withdrawal or seizures. Stressed significance of total alcohol cessation on discharge. Patient was discharged on thiamine, folate, MVI. # anemia - Hct decreased to 22.0 (<-- 26.2 <-- 31.0) earlier in admission. Hct stabilized at ___ after 1u pRBC ___. ___ be partially ___ intravascular volume depletion and subsequent expansion with albumin, but positive stool guaiac on admission was concerning for GI process, especially as patient has never had an endoscopy. Repeat guaiac was negative ___. EGD showed evidence of gastritis / duodenitis but no e/o varices. # gastritis/duodenitis - As seen on EGD. Of note, gastric bezoar was seen on EGD, but as this is unlikely to be playing any role in her current symptoms, no role for further active management. - GI biopsies showed no abnormal findings - started PPI ",2271,714
10008924-DS-16,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> ___ <ATTENDING> ___. <CHIEF COMPLAINT> Transfer from ___ for concern for HRS <MAJOR SURGICAL OR INVASIVE PROCEDURE> Therapeutic paracentesis with removal of 4 liters of ascites Blood transfusions Multiple diagnostic paracenteses <HISTORY OF PRESENT ILLNESS> Ms ___ is a ___ year-old female with pmh of alcoholic cirrhosis and admitted to ___ on ___ with weight gain, increasing abdominal distension, and abdominal pain, found to have ARF thought to be HRS. She recently (___) underwent an umbilical hernia repair during which time 7 L of fliud were removed from her abdomen. She had been drinking a half pint of hard liqour daily, but had been sober for the last month until a week ago when she started drinking again due to familial stress. She identifies the alcohol use as occuring before the weight gain. Her labs were notable for a creatinine of 3.6 (most recent nadir of 0.9-1.0 in early ___, Na of 127, Hct of 20.2, platelets of 57, and WBC of 13.7. . She underwent an ultrasound-guided paracentesis with 4750 cc of blood-tinged fluid removed. She was seen by GI and renal consults who felt she would benefit from transfer to BI. Per the renal consult note she has had intermittent hepatorenal syndrome type I, but during this admission there was concern for Type II HRS so she was started on octreotide, midodrine, and albumin. She was also transfused 2 units of PRBC. She was transferred on vancomycin, however there is nothing in the discharge summary regarding why this was started and she denies any focal infectious symptoms. . Of note, OSH records from ___ with note of abdominal CT with rectus sheath hematoma as well as liver mass and omental masses suspicious for metasteses. She denies any knowledge of intraabdominal or liver masses other than cirrhosis. . Currently she denies symptoms. Denies current abdominal pain, dyspnea, chest pain, fevers. She did have significant nausea and vomiting earlier today, but has felt better since the paracentesis. . Review of Systems: (+) Per HPI (-) Denies fever, chills, night sweats, recent weight loss or gain. Denies headache, sinus tenderness, rhinorrhea or congestion. Denies chest pain or tightness, palpitations. Denies cough, shortness of breath, or wheezes. No dysuria. Denies arthralgias or myalgias. No numbness/tingling in extremities. No feelings of depression or anxiety. All other review of systems negative. <PAST MEDICAL HISTORY> - EtOH cirrhosis complicated by recurrent ascites and hx of hepatic encephalopathy. Known portal gastropathy. - EtOH abuse/dependence. Denies a history of alcohol withdrawal. - Multiple epsisodes of ARF due to prerenal azotemia versus HRS type II - Anemia - s/p umbilical hernia repair on ___ - Psoriasis <SOCIAL HISTORY> ___ <FAMILY HISTORY> Negative for family history of liver disease <PHYSICAL EXAM> Exam on admission ___: VS: T 99.2 BP 95/53 HR 80 RR 18 Sat 97% on RA Admission weight: 53.98 kgs (119.00 lbs) GEN: Middle-aged female lying in bed in NAD. HEENT: sclerae icteric, white coating present on her tongue. CV: RRR, ___ systolic murmur heard best at the LUSB PULM: Breathing comfortably. Crackles present b/l up to the mid lung fields. ABD: +BS, distended, + fluid wave, slightly tender to palpation throughout, no rebound or guarding. Well-healed surgical incision across the lower abdomen. LIMBS: No peripheral edema. SKIN: erythematous, scaling plaques scattered on her arms and legs. Spider angiomas present on her chest. NEURO: Alert and oriented to person, place, and date. No asterixis. <PERTINENT RESULTS> Labs on admission ___: WBC-10.4 RBC-2.91* Hgb-8.9* Hct-27.1* MCV-93# MCH-30.5 MCHC-32.7 RDW-18.8* Plt Ct-51* ___ PTT-40.0* ___ Glucose-115* UreaN-29* Creat-3.7*# Na-128* K-4.5 Cl-97 HCO3-22 AnGap-14 ALT-109* AST-618* LD(___)-246 AlkPhos-195* TotBili-8.0* Albumin-2.1* Calcium-7.9* Phos-5.5* Mg-1.3* Lactate-1.7 Other labs: ___ TSH: 1.7 (normal) Labs on discharge ___ 06: 20AM BLOOD WBC-10.4 RBC-3.25* Hgb-10.2* Hct-32.6* MCV-100* MCH-31.3 MCHC-31.3 RDW-19.1* Plt ___ ___ 06: 20AM BLOOD Neuts-69.8 ___ Monos-5.8 Eos-1.9 Baso-0.9 ___ 05: 20AM BLOOD Hypochr-1+ Anisocy-1+ Poiklo-2+ Macrocy-3+ Microcy-NORMAL Polychr-NORMAL Ovalocy-1+ Target-1+ Burr-1+ Acantho-1+ ___ 06: 20AM BLOOD Plt ___ ___ 05: 50AM BLOOD ___ 06: 20AM BLOOD Glucose-109* UreaN-38* Creat-2.2* Na-136 K-4.8 Cl-104 HCO3-19* AnGap-18 ___ 06: 20AM BLOOD ALT-8 AST-48* LD(LDH)-245 AlkPhos-49 TotBili-3.5* ___ 06: 20AM BLOOD Albumin-4.3 Calcium-9.6 Phos-3.8 Mg-1.7 ___ 05: 30AM BLOOD TSH-1.7 ___ 06: 20AM BLOOD ___ PTT-58.3* ___ Micro: All BCx: no growth ___ Peritoneal culture: no growth (Final) ___ MRSA screen negative ___ Peritoneal cx: no growth ___ C. diff negative ___ Peritoneal cx: NGTD ___ UCx: NGTD ___ BCx: NGTD ___ BCx: pending ___ Peritoneal culture: NGTD ___ UCx: NGTD (UA negative) ___ Throat culture: r/o B strep: pending; viral cx: pending ___ C diff: negative ___: peritoneal fluid: no growth ___: peritoneal fluid: no growth, AFB -pending IMAGING: CXR ___: Heart is upper limits of normal in size and is slightly increased compared to the previous study. A few minimal interstitial opacities are present at the lung bases. No confluent areas of consolidation are observed, and there are no pleural effusions or concerning skeletal findings. Mildly distended loops of bowel in the upper abdomen are incompletely evaluated on this radiograph. Abd US ___: continued reversal of main portal vein flow, consistent with portal hypertension, but it remains patent with no evidence of clot. patent hepatic artery. cirrhosis, large amount of ascites. continued wall thickening of gallbladder, likely due third spacing. no hydronephrosis. CT abdomen/pelvis w/o contrast ___: There is ascites with layering hyperdensity compatible with superimposed intraperitoneal hemorrhage. There is thickening of the left rectus abdominis muscle compatible with rectus hematoma. There are healing right rib fractures and left rib fractures, which may be acute. ___ ECHO: IMPRESSOION: Normal regional and global left ventricular systolic function. EF > 55%. The right ventricle is mildly dilated and hypokinetic with moderate tricuspid regurgitation and at least mild pulmonary hypertension. Mild mitral regurgitation. ___ Abdominal US: There is a moderate amount of free fluid within the abdomen. A site in the right lower quadrant was marked. Reference is made to previous CT dated ___, and the location of the site of collateral vessels was noted. Color Doppler was applied at the site marked for paracentesis, and no vessels were visualized in this region. ___ CXR: Slight worsening of left lower lobe opacity underlying left rib fracture which suggests atelectasis. ___ CXR: In comparison with the study of ___, there is little overall change. Continued low lung volumes with a patchy opacification at the left base. The findings are most consistent with atelectasis, though in view of the clinical history, the possibility of supervening pneumonia cannot be unequivocally excluded. ___ Abd US: 1. Nodular liver in keeping with cirrhosis. 2. Moderate ascites. 3. Splenomegaly with interval increase in size compared to ___. 4. Pulsatile flow in the portal vein, can be seen in CHF and chronic liver disease. 5. Similar appearance to gallbladder compared to multiple prior studies, with wall thickening likely due to third spacing, and irregularity at the fundus likely due to adenomyomatosis. If clincal concern for cholecystitis, HIDA scan may be contributory. ___ CT ___ w/ PO contrast only: 1. Cirrhotic liver with splenomegaly and large ascites. Splenomegaly is again noted to be larger than on ___. Ascites little changed in amount. 2. Ascites currently of simple fluid density, with interval resolution of high density blood since ___. 3. Left rectus sheath hematoma, mildly decreased in size since ___. 4. Distended gallbladder is unchanged in appearance, with wall thickening along the fundus, probably due to adenomyomatosis, and a punctate calcified stone. 5. Small bilateral pleural effusions, with adjacent atelectasis. Aelectasis slightly improved on the right from ___. ___ Diag paracentesis: Removed 2 L fluid, sent for requested studies. ___ paracentesis: Removed 60cc fluid, sent for requested studies. ___ paracentesis: sent for requested studies. <MEDICATIONS ON ADMISSION> 1. Aldactone 50 mg po bid 2. Lasix 20 mg po daily 3. Folic acid 1 mg po daily 4. Thiamine 100 mg po daily 5. Oxycodone prn 6. Lactulose 30 ml prn 7. Corgard 20 mg po daily 8. Prilosec 20 mg po bid 9. K-dur 20 mEq po daily 10. MVI daily 11. Compazine 10 mg po prn <DISCHARGE MEDICATIONS> 1. Omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) Capsule, Delayed Release(E.C.) PO BID (2 times a day). Disp: *60 Capsule, Delayed Release(E.C.)(s)* Refills: *2* 2. Folic Acid 1 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). Disp: *30 Tablet(s)* Refills: *2* 3. Thiamine HCl 100 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). Disp: *30 Tablet(s)* Refills: *2* 4. Multivitamin Tablet Sig: One (1) Tablet PO DAILY (Daily). Disp: *30 Tablet(s)* Refills: *2* 5. Rifaximin 200 mg Tablet Sig: Two (2) Tablet PO TID (3 times a day). Disp: *180 Tablet(s)* Refills: *2* 6. Midodrine 10 mg Tablet Sig: 1.5 Tablets PO three times a day. Disp: *90 Tablet(s)* Refills: *2* 7. Lactulose 10 gram/15 mL Syrup Sig: Fifteen (15) ML PO twice a day: This medication makes you have bowel movements and prevents you from becoming confused. You should increase or decrease this medication to ensure you have ___ bowel movements a day. Disp: *1350 ML(s)* Refills: *2* 8. Outpatient Lab Work Chem 7 and INR Please fax results to Dr. ___ at ___ Please perform on ___ Dx - Acute Renal Failure 9. Sulfamethoxazole-Trimethoprim 800-160 mg Tablet Sig: One (1) Tablet PO 5X/WEEK (___). Disp: *150 Tablet(s)* Refills: *2* 10. Oxycodone 5 mg Tablet Sig: One (1) Tablet PO every twelve (12) hours: please do not drink alcohol or perform activities requiring fast reaction time while taking this medication. ___ cause sedation. Disp: *20 Tablet(s)* Refills: *0* <DISCHARGE DISPOSITION> Home With Service Facility: ___ <DISCHARGE DIAGNOSIS> Alcoholic hepatitis Alcoholic cirrhosis Hepatorenal syndrome Hemoperitoneum Alcohol abuse <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Ms. ___, you were admitted to ___ for evaluation of your worsening abdominal distention. During the procedures to evaluate the fluid in your belly, you had some bleeding. You were given blood with improvement in your blood counts. You also had inflammation of your liver due to alcohol use (alcoholic hepatitis) which occurred on top of your known scarring of the liver (alcoholic cirrhosis), which is what led to the collection of fluid. You had some injury to your kidneys which improved. You had some low grade fevers and were treated for a possible infection of the fluid in your abdomen. Just before you were set to leave, you had a higher fever requiring a longer course of stronger antibiotics. While you have become better in the hospital, continued improvement will be dependent on you. It is VERY important that you do not drink alcohol. You had extensive nutrition counseling in the hospital. You should continue to eat high calorie and high protein meals with supplements such as Ensure. Changes to your medications: 1. STOP Aldactone until your doctors tells ___ it is ok to restart this. 2. STOP Lasix until your doctor tells you it is ok to restart this. 3. STOP Corgard until your doctor tells you it is ok to restart this. 4. STOP K-dur 5. STOP Compazine 6. INCREASE Prilosec to 20mg twice a day 7. DECREASE Lactulose to 15 mL twice a day. This medication makes you have bowel movements and prevents you from becoming confused. You should increase or decrease this medication to ensure you have ___ bowel movements a day. 8. START Rifaximin 400mg three times a day. If you are unable to get this medication or it is too expensive, please tell Dr. ___ your visit with him. 9. START midodrine 10mg three times a day CONTINUE Folic acid, thiamine, multivitamin It was a pleasure taking care of you during your stay! ","___ year-old female with PMHx of alcoholic cirrhosis and admitted to ___ on ___ with weight gain, increasing abdominal distension, and abdominal pain, found to have ARF, thought to be HRS. On admission to ___, due to concern for possible HRS and as no fluid was sent for analysis at OSH she had a diagnostic paracentesis that was very concerning for hemoperitoneum with bloody appearing fluid, RBCs 360,000 (not enough for spun Hct) with WBC 250 (past para RBCs ___, albumin less than assay. CBC in the morning had dropped 6 points so she was transfused an addition 1 U PRBC. CT abdomen performed and suspicious for hemoperitoneum; also notable for rectus sheath hematoma. Transplant surgery consulted, recommended MICU observation and continued transfusion support. She was transfused total of 3 units PRBC, 1 bag platelets, 3 units FFP and DDAVP. # Anemia of acute blood loss/Rectus sheath hematoma/hemoperitoneum: Bleeding from rectus sheath hematoma in setting of coagulopathy in combination with paracentesis may have contributed to blood loss. Notes suggest hematoma was present in ___ at previous hospitalization. Pt was given blood, FFP, DDAVP and platelets in the ICU with improvement and stabilization of hematocrit. Her hct remained stable at 34-35 on the floor without recurrence of hemoperitoneum. She completed 5 days of ceftriaxone for possible SBP (___). Subsequent paracentesis were done in spot marked by radiology in area with few collateral blood vessels. On CT ___, rectus hematoma was slightly smaller and ascites as of simple fluid density, with interval resolution of high density blood since ___ however paracentesis ___ still demonstrated high red cell count, although decreased from admission, indicating resolving hemoperitoneum. # Hypoxia: The patient required ___ liters of oxygen while in the ICU since being given multiple blood products for dropping hematocrit in the setting of renal failure and minimal urine output. CXRs showed atelectasis without PNA. Echo with normal systolic function, mod TR, RV dilation. Hypoxia likely ___ ascites, volume overload and atelectasis. She did not have any episodes of respiratory distress. The patient was taken out of bed. Her hypoxia resolved by the time she arrived on the floor without recurrence during the rest of her hospitalization. # Acute renal failure: Renal team considered pre-renal vs. ATN as etiology of her renal failure. Abdominal US without hydronephrosis. Hepatorenal a possibility, but a diagnosis of exclusion per ICU team. The patient had low UOP on the night of admission and was given lasix 80 mg IV with a fair response. Renal suggested albumin 25g BID in order to increase her oncotic pressure. UOP rose to ___ cc per hour on the day of transfer to the floor. On the floor, she was treated for hepatorenal syndrome and her Cr slowly improved (peak 4.0 --> 1.4). Albumin and octreotide were eventually stopped with continuation of midodrine given SBP 90's. Pt's creatinine increased again to 2.5 with fevers raising concern for worsening HRS in setting of infection. Renal was consulted, and felt that urinary sedimentation was most consistent with ATN although prerenal problems and HRS could contribute. She was Midodrine was continued and octreotide restarted. She again received albumin 25mg IV BID from ___ to ___ for HRS in setting of presumed SBP (see 'fevers' below). Her kidney function improved and Cr was 2.2 on discharge. She will require close outpatient follow up of kidney function and has labs ordered for ___ which will be followed up by her PCP. Her PCP can decide based on her Cr whether she can restart her diuretics. Her INR had also trended up during her hospitalization to 2.4. She was given 5mg p.o vitamin K prior to discharge for reversal and her INR should be followed up by her PCP on her labs of ___. . # Altered mental status: The patient had altered mental status on admission. Possible etiologies included hepatic encephalopathy, uremia, and delirium due to metabolic causes. She was started on rifaxamin in addition to her lactulose. Her mental status improved on the day of transfer to the floor. She continued to have minor asterixis on the day of transfer, but was more alert and oriented. On the floor, her asterixis resolved and she remained AOx3 without recurrence of encephalopathy. She was continued on lactulose and rifaximin. # Alcohol induced hepatitis/hepatic cirrhosis - acute decompensation likely precipitated by relapsed alcohol abuse. Her LFTs improved since admission. Hepatic encephalopathy resolved. EGD ___ with erosive gastritis and portal hypertensive gastropathy but no varices. She was continued on lactulose and rifaximin. Diuretics were held given her renal failure and can be restarted as outpatient. Nadolol held as she was hypotensive and can be started as outpatient although she may not need it as no varices on most recent EGD (done prior admission ___. Of note, splenomegaly increased (13cm-->16cm) on CT from ___ to ___. Should be followed up as outpatient. #Fever- Pt had low grade fevers early in her hospitalization, attributed to alcoholic hepatitis. Cultures negative and fevers resolved. Later in her hospitalization (___), she again developed low grade fevers with Tmax 99.5-100. These were attributed to viral URI. Para negative for SBP ___ by cell count but given fevers, increased WBC in peritoneal fluid, and hemoperitoneum which is risk factor for infection, she began empiric treamtment SBP (started cipro 500mg BID (day 1= ___ with albumin x2. WBC in peritoneal fluid on ___ improved from ___ and cultures negative. On ___, she developed increased fevers with T 101-102 with new leukocytosis with left shift. ID was consulted and felt this was possible superinfection of her known rectus hematoma or hemoperitoneum. Antibiotics were broadened to vanc/flagyl/cefepime (day 1= ___. She was given albumin x2 on ___ and ___ for presumed SBP to prevent HRS. Imaging was negative for pneumonia, loculation in abdomen, or cholecystitis. Cultures were negative. Her fevers improved and leukocystosis and differential normalized. She was discharged on SBP prophylaxis with bactrim as she developed fever during treatment for SBP on cipro. # EtOH abuse. Actively drinking prior to admission. Later in hospitalization, pt denied drinking prior to hospitalization and stated she became ill because she was weak. Pt continued on MVI, folic acid and thiamine. Social work discussed alcohol use with patient. She will require close outpatient follow up for relapse prevention. # Liver mass and omental masses. Noted on a consult note from OSH. Sister has been told of this at OSH. Films from OSH and current studies were obtained and reviewed with radiology. These masses are not apparent on CTs (all without contrast) nor MRI in our system. AFP negative in ___. Pt will require MRI with contrast as outpatient to definitely evaluate this. # Rib fractures - Noted on imaging. Pt denies falls, trauma, abuse. Unclear chronicity. Pt will require outpatient follow up and BMD testing. . # Code: Full code (confirmed with patient ___ ",3404,1662
10008924-DS-17,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> ___ <ATTENDING> ___. <CHIEF COMPLAINT> Transfer with ? splenic laceration <MAJOR SURGICAL OR INVASIVE PROCEDURE> Diagnostic paracentesis Therapeutic paracentesis of 9 Liters of ascitic fluid <HISTORY OF PRESENT ILLNESS> Mrs. ___ is a ___ woman with alcoholic cirrhosis, continued alcohol abuse, intermittent acute renal failure who presented to an outside hospital after her sister found her on the ground after a fall. At the OSH, she underwent trauma evaluation, which demonstrated a ? splenic laceration, so she was transferred to ___. Upon arrival, she reports abdominal fullness and reports feelign cold, but she has no frank abdominal pain. She denies lower extermity edema, shortness of breath, orthopnea. She denies hematemesis, coffee ground emesis or hematochezia or melena. She reports that her right orbit is mildly painful, but this is improving. All other review of systems negative. Of note, there is some mention in the OSH records of low-grade temps, but it is not apparent that attempts at paracentesis were made. <PAST MEDICAL HISTORY> - EtOH cirrhosis complicated by recurrent ascites and hx of hepatic encephalopathy. Known portal gastropathy. - EtOH abuse/dependence. Denies a history of alcohol withdrawal. - Multiple epsisodes of ARF due to prerenal azotemia versus HRS type II - Anemia - s/p umbilical hernia repair on ___ - Psoriasis <SOCIAL HISTORY> ___ <FAMILY HISTORY> Negative for family history of liver disease <PHYSICAL EXAM> Vitals: 98.8, 152/78, 73, 18, 95%RA General: Alert, oriented x3, NAD, R eye with surrounding echymossis, jaundiced, HEENT: NCAT, PERRL, EOMI, + scleral icterus, MM dry, no lesions noted in OP Neck: supple, no significant JVD or carotid bruits appreciated Pulmonary: Decreased BS at both bases, R>L Cardiac: RR, nl S1 S2, no murmurs, rubs or gallops appreciated Abdomen: Distended, positive fluid wave, shifting dullness Extremities: Trace bilateral edema, 2+ radial, DP pulses b/l Neurologic: Alert, oriented x 3. Able to relate history without difficulty. <PERTINENT RESULTS> ___ 07: 15AM WBC-6.5 RBC-3.39* HGB-10.3* HCT-31.2* MCV-92# MCH-30.4 MCHC-33.1 RDW-19.7* ___ 07: 15AM ALBUMIN-3.2* CALCIUM-8.7 PHOSPHATE-3.4 MAGNESIUM-1.1* ___ 07: 15AM ALT(SGPT)-25 AST(SGOT)-98* ALK PHOS-142* TOT BILI-4.6* ___ 07: 15AM GLUCOSE-77 UREA N-19 CREAT-1.8* SODIUM-136 POTASSIUM-3.6 CHLORIDE-104 TOTAL CO2-20* ANION GAP-16 ___ 09: 00AM ___ PTT-53.0* ___ ___ 10: 10AM ASCITES WBC-30* ___ POLYS-5* LYMPHS-54* ___ MESOTHELI-2* MACROPHAG-39* ___ 10: 10AM ASCITES TOT PROT-2.6 GLUCOSE-97 LD(LDH)-67 ALBUMIN-1.4 ___ 12: 35PM HCT-31.2* ___ 10: 05PM BLOOD Hct-30.2* ___ 07: 10AM BLOOD Hct-31.9* ___ 06: 45AM BLOOD Hct-28.9* Imaging: OSH: CT abdomen: massive ascites, wedge-shaped density in the upper aspect of the spleen, splenic laceration cannot be excluded. CT head: soft tissue swelling adjacent to right orbit, no intracranial pathology. CT abd/pelvis ___ at ___: IMPRESSION: 1. Splenic laceration. Unable to evaluate for active extravasation due to lack of IV contrast. 2. Cirrhotic liver with splenomegaly and large ascites. Amount of ascites has increased. 3. Interval decrease in size of left rectus sheath hematoma, almost resolved. 4. Distended gallbladder with appearance of adenomyomatosis at the fundus and possible small gallstone. <MEDICATIONS ON ADMISSION> Folic acid 1 mg po daily Thiamine 100 mg po daily Multivitamin daily Omeprazole 40 mg po daily Nadolol 40 mg po daily Lasix 20 mg po daily Aldactone 25 mg po daily Lactulose 15 mL twice daily, titrating to ___ bowel movements per day Rifaximin 400 mg po tid Bactrim DS 1 tab 5 times per week <DISCHARGE MEDICATIONS> 1. Folic Acid 1 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 2. Thiamine HCl 100 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 3. Multivitamins Tablet, Chewable Sig: One (1) Tablet PO DAILY (Daily). 4. Nadolol 40 mg Tablet Sig: One (1) Tablet PO once a day. 5. Lasix 20 mg Tablet Sig: One (1) Tablet PO once a day. 6. Aldactone 25 mg Tablet Sig: One (1) Tablet PO once a day. 7. Lactulose 10 gram/15 mL Solution Sig: Fifteen (15) ML PO BID (2 times a day): Titrate to ___ bowel movements per day. 8. Rifaximin 200 mg Tablet Sig: Two (2) Tablet PO TID (3 times a day). 9. Sulfamethoxazole-Trimethoprim 800-160 mg Tablet Sig: One (1) Tablet PO 5X/WEEK (___). 10. Omeprazole 40 mg Capsule, Delayed Release(E.C.) Sig: One (1) Capsule, Delayed Release(E.C.) PO once a day. <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Primary: Splenic laceration Secondary: Alcoholic cirrhosis Hyponatremia Chronic kidney disease Chronic anemia <DISCHARGE CONDITION> Mental Status: Patient was oriented to person and place, but was slightly confused about the date. Otherwise she answered questions appropriately. No asterixis. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> You were transferred to ___ due to concern for damage to your spleen. You had fallen and been taken to another hospital where there was concern for bleeding from the spleen. You underwent an abdominal/pelvis CT here which showed the damage to the spleen. Your blood counts were monitored and remained stable. You underwent a diagnostic paracentesis to check for infection in the fluid in your stomach. There was no evidence of infection. The liver doctors saw ___ and recommended draining fluid from your abdomen to improve your abdominal distenion so you underwent a therapeutic paracentesis the day of your discharge. It is very important that you stop drinking alcohol to prevent further damage to your liver. No changes were made to your medications. Continue your medications as previously prescribed. ","Ms ___ is a ___ year-old female with alcoholic cirrhosis who presented to an OSH s/p fall, found to have a splenic laceration and transferred here for further care. # Splenic laceration: Upon arrival she was hemodynamically stable. Radiology was unable to open the imaging on the OSH CD, so a non-contrast abdominal/pelvis CT was completed which showed a moderate-sized splenic laceration (although radiology was unable to tell if it was actively bleeding due to lack of contrast). Her Hct was trended and remained stable in the low 30' to high 20's. Transplant surgery was consulted and recommended conservative management. On discharge her Hct was 28.9. # Alcoholic Cirrhosis: The patient has a history of ESLD with history of encephalopathy and HRS. A diagnostic para was negative for SBP. She had ascites on exam and her diuretics were initially held in anticipation of a large volume paracentesis. She was given 50 gm albumin the day prior to discharge and the day of discharge had a large-volume paracentesis of 9 L of ascitic fluid and received an additional 50 gm of albumin. She will follow up with her hepatologist as an outpatient next week. She was continued on nadolol, a PPI, lactulose, rifaximin, and bactrim (for SBP prophylaxis). # Continued alcohol use: She was monitored on a CIWA scale, however did not display symptoms of withdrawal. She was continued on thiamine, folic acid, and a multivitamin. She was strongly encouraged to stop drinking do to alcohol's negative effects on her health. # Chronic kidney disease: The patient recently had HRS and has chronic renal insufficiency. Her creatinine on admission was 1.8 (the lowest value recorded in OMR for her recently). Her diuretics were held and she received albumin as described above and her Cr trended down to 1.3 the day of discharge. She was asked to restart her diuretics the day after discharge. # Code: She is full code. ",1696,452
10009021-DS-18,"<SEX> M <SERVICE> MEDICINE <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> lip and chin mass <MAJOR SURGICAL OR INVASIVE PROCEDURE> Biopsy of right chin mass ___ <HISTORY OF PRESENT ILLNESS> Mr. ___ is a ___ gentleman followed at ___ with a history of HIV (on HAART; ___ CD4+: 136, CD4%: 5, VL: <75) and hepatitis C who present for management of R chin lesion. Lesion first developed about three months ago and initially looked like a small pimple; it has enlarged more rapidly over the past two months and it is painful, draining yellow fluid. Patient has taken multiple courses of antibiotics and antivirals, including treatment-dose TMP-SMX and Valtrex without improvement. On ___, patient was seen in the ___, where he was told lesion did not look viral but could be skin cancer. On ___, patient was seen in the ___ ___ where his lesion was I&D's. He was started on Keflex and treatment-dose TMP-SMX and referred to Dermatology. He was seen by ___ Dermatology on ___, where the lesion was biopsied. On ___, micro grew MRSA and patient was started on minocycline and vicodin for pain control. Biopsy also showed epidermal necrosis with multinucleated keratinocytes consistent with HSV infection. Fungal culture is still pending. In the ___, initial VS were 99.0 82 123/74 18 100%. Exam showed a 3 x 5 cm yellow crusted lesion extending from the R lip to the R chin without involvement of mucous membranes. Labs were notable for normal electrolytes, normal WBC. The patient was seen by plastic surgery who recommeded admission to medicine for IV antibiotics and raised concern that this rapidly growing lesion could represent malignancy. Received vancomycin 1 gram and was admitted to the medicine service for futher management. On arrival to the floor, vital signs were 98.2 118/74 79 16 99 RA, 78.9 kg. Patient denies fevers, chills, nausea, vomiting, abdominal pain, night sweats, weight loss. There is no family history of skin cancer; patient has a history of anal condyloma/AIN1 but no malignancy. No history of excessive sun exposure. Review of Systems: per HPI. Also specifically denies mouth pain, gum pain, dysphagia, difficulty swallowing. <PAST MEDICAL HISTORY> - Dizziness - HIV - Hepatitis C - HSV - HPV - Hypertension - Rectal mass: anal condylomata, surgically removed ___ (AIN I, low-grade dysplasia) - Shoulder pain - Abnormal LFT's - Anemia - Tinea cruris - Diarrhea - Hip pain (bilateral): previously on narcotics contract - DJD right hip - R hip labral tear, chronic - Dysplastic hips - Knee derangement - Hyperlipidemia - Hypertension - Tobacco use - Presbyopia - Polysubstace abuse (cocaine, crystal meth, MJ) - Depression <SOCIAL HISTORY> ___ <FAMILY HISTORY> Includes breast, lung cancer. No skin cancers. <PHYSICAL EXAM> ADMISSION PHYSICAL EXAM: Vitals- 98.2 118/74 79 16 99 RA General- Alert, oriented, no acute distress HEENT- Sclera anicteric, MMM with minimal white exudate on bilateral buccal mucosa but no erythema or lesions in mouth. 2cm x 2.5 cm hypertrophic lesion on R lower ___ border of lip with satellite 1 x 1 cm lesion on R chin draining serosanguinous fluis, portions ulcerated, tender to palpation. Does not extend into mucosa. Neck- Supple, JVP not elevated, submandibular LAD Lungs- Clear to auscultation bilaterally, no wheezes, rales, ronchi CV- Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Abdomen- soft, non-tender, non-distended, bowel sounds present, no rebound tenderness or guarding, no organomegaly GU- no foley Ext- warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema Neuro- CNs2-12 intact, A+O x 3 DISCHARGE PHYSICAL EXAM: Vitals- Tm98.9 ___ 98-99%RA General- Alert, oriented, no acute distress HEENT- Dressing clean, no drainage noted. 2cm x 2 cm fungating yellow lesion on R lower ___ border of lip with satellite lesion 0.8, biopsied. Minimal exudate. Does not extend into mucosa. Lungs- Clear to auscultation bilaterally, no wheezes, rales, rhonchi CV- Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Abdomen- soft, non-tender, non-distended, bowel sounds present GU- no foley Ext- warm, well perfused, no edema <PERTINENT RESULTS> Admission Labs ___ 04: 50PM BLOOD WBC-4.2 RBC-5.16 Hgb-12.9* Hct-41.1 MCV-80* MCH-25.0* MCHC-31.3 RDW-15.4 Plt ___ ___ 04: 50PM BLOOD Neuts-44.7* ___ Monos-5.5 Eos-7.9* Baso-0.7 ___ 04: 50PM BLOOD Glucose-73 UreaN-11 Creat-0.9 Na-139 K-4.0 Cl-103 HCO3-27 AnGap-13 ___ 08: 05AM BLOOD ALT-83* AST-48* AlkPhos-56 TotBili-0.4 ___ 08: 05AM BLOOD Calcium-9.2 Phos-4.0 Mg-1.9 ___ 04: 50PM BLOOD Neuts-44.7* ___ Monos-5.5 Eos-7.9* Baso-0.7 Pertinent Labs ___ 08: 22AM BLOOD WBC-4.7 Lymph-41 Abs ___ CD3%-84 Abs CD3-1610 CD4%-6 Abs CD4-119* CD8%-74 Abs CD8-1417* CD4/CD8-0.1* ___ 08: 05AM BLOOD ALT-83* AST-48* AlkPhos-56 TotBili-0.4 ___ 06: 02AM BLOOD ALT-125* AST-80* AlkPhos-49 TotBili-1.2 ___ 06: 04AM BLOOD ALT-113* AST-66* AlkPhos-51 TotBili-1.4 ___ 06: 02AM BLOOD Vanco-4.5* Discharge Labs ___ 06: 04AM BLOOD WBC-6.0 RBC-4.30* Hgb-10.8* Hct-34.4* MCV-80* MCH-25.1* MCHC-31.4 RDW-16.0* Plt ___ ___ 06: 04AM BLOOD Glucose-110* UreaN-11 Creat-1.0 Na-140 K-3.7 Cl-105 HCO3-28 AnGap-11 ___ 06: 04AM BLOOD Calcium-9.6 Phos-5.0* Mg-1.7 __________________________________________________________ Time Taken Not Noted Log-In Date/Time: ___ 4: 29 pm SKIN SCRAPINGS **FINAL REPORT ___ VIRAL CULTURE: R/O HERPES SIMPLEX VIRUS (Final ___: HERPES SIMPLEX VIRUS TYPE 2. CONFIRMED BY MONOCLONAL FLUORESCENT ANTIBODY.. VARICELLA-ZOSTER CULTURE (Final ___: NO FURTHER WORK UP. Refer to Herpes simplex viral culture for further information. __________________________________________________________ ___ 8: 22 am IMMUNOLOGY **FINAL REPORT ___ HIV-1 Viral Load/Ultrasensitive (Final ___: 34 copies/ml. Performed using the Cobas Ampliprep / Cobas Taqman HIV-1 Test v2.0. Detection Range: ___ copies/mL. This test is approved for monitoring HIV-1 viral load in known HIV-positive patients. It is not approved for diagnosis of acute HIV infection. In symptomatic acute HIV infection (acute retroviral syndrome), the viral load is usually very high (>>1000 copies/mL). If acute HIV infection is clinically suspected and there is a detectable but low viral load, please contact the laboratory for interpretation. It is recommended that any NEW positive HIV-1 viral load result, in the absence of positive serology, be confirmed by submitting a new sample FOR HIV-1 PCR, in addition to serological testing. __________________________________________________________ ___ 8: 15 am BLOOD CULTURE #2. Blood Culture, Routine (Pending): __________________________________________________________ ___ 8: 05 am BLOOD CULTURE #1. Blood Culture, Routine (Pending): __________________________________________________________ ___ 4: 50 pm BLOOD CULTURE **FINAL REPORT ___ Blood Culture, Routine (Final ___: NO GROWTH. ___ PICC LINE INSERTION In comparison with the earlier study of this date, the PICC line has been re-directed with the tip in the region of the mid portion of the SVC. ___ Skin biopsy right chin mass: PENDING <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Atazanavir 300 mg PO DAILY 2. RiTONAvir 100 mg PO DAILY 3. abacavir-lamivudine 600-300 mg oral daily 4. Minocycline 100 mg PO Q12H 5. TraMADOL (Ultram) 50 mg PO Q6H: PRN pain 6. Sulfameth/Trimethoprim DS 1 TAB PO DAILY 7. Naproxen 500 mg PO Q12H 8. Acetaminophen 1000 mg PO Q6H: PRN pain 9. Amlodipine 5 mg PO DAILY 10. losartan-hydrochlorothiazide 50-12.5 mg oral daily 11. Aspirin 81 mg PO DAILY 12. Cialis (tadalafil) 10 mg oral 1 hour prior to sexual activity as needed 13. Docusate Sodium 100 mg PO BID: PRN constipation 14. Senna 1 TAB PO HS <DISCHARGE MEDICATIONS> 1. Acetaminophen 1000 mg PO Q6H: PRN pain 2. Amlodipine 5 mg PO DAILY 3. Aspirin 81 mg PO DAILY 4. Atazanavir 300 mg PO DAILY 5. Docusate Sodium 100 mg PO BID: PRN constipation 6. Naproxen 500 mg PO Q12H 7. RiTONAvir 100 mg PO DAILY 8. abacavir-lamivudine 600-300 mg oral daily 9. losartan-hydrochlorothiazide 50-12.5 mg oral daily 10. Cialis (tadalafil) 10 mg oral 1 hour prior to sexual activity as needed 11. Foscarnet Sodium 4500 mg IV Q12H RX *foscarnet 24 mg/mL 4500 mg IV q12 h Disp ___ Milligram Refills: *0 12. IV fluids Normal Saline (0.9%) 500ml to be given with each Foscarnet infusion. Dispense- quantity sufficient for 3 week course of foscarnet 13. Sulfameth/Trimethoprim DS 1 TAB PO DAILY 14. TraMADOL (Ultram) 50 mg PO Q6H: PRN pain 15. Senna 1 TAB PO HS 16. Vancomycin 1750 mg IV Q 12H RX *vancomycin 750 mg 750 mg IV every twelve hours Disp #*9 Vial Refills: *0 RX *vancomycin 1 gram 1 gram IV every twelve hours Disp #*9 Vial Refills: *0 <DISCHARGE DISPOSITION> Home With Service Facility: ___ <DISCHARGE DIAGNOSIS> Herpes simplex virus infection Methicillin resistant staphylococcus aureus Human immunodeficiency virus with acquired immune deficiency syndrome <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Mr. ___, You were admitted for IV treatment of your lip and chin ulcer/mass. You were evaluated by dermatology and infectious disease, and your ulcer/mass was thought to be a herpes lesion with a bacterial (MRSA) infection. The mass was biopsied and sent for pathology, which is still pending. You were treated for MRSA with vancomycin, and HSV was treated at first with acyclovir, then switched to foscarnet. You will continue vancomycin through ___ and foscarnet for ___ weeks (exact duration to be determined at outpatient visit). You will need frequent laboratory monitoring of your kidney function while on the foscarnet. Please go to the ___ clinic lab on ___ between ___ AM (before your morning vancomycin infusion) for your lab draw. It was a pleasure caring for you. Sincerely, Your ___ Care Team ","___ M with HIV (on HAART; ___ CD4+: 136, CD4%: 5, VL: <75) and recently diagnosed hepatitis C with a R lip/chin lesion rapidly increasing in size, positive for MRSA and resistant to acyclovir, bactrim, keflex, minocycline. Patient with HIV (CD4 119, VL 34 on this admission) on HAART presented with rapidly enlarging lip/chin lesion/mass over past three months, resistant to bactrim, acyclovir, keflex. It was positive for MRSA without improvement on minocycline. He was admitted for IV vanc, and evaluated by derm and ID and felt to be HSV (possibly verrucous HSV per derm) vs malignancy with MRSA superinfection. He was treated with IV vanc and initially high-dose acyclovir then switched to foscarnet per ID and derm consult recs. Viral culture of lesion was positive for HSV-2. Biopsy of the satellite newer lesion is pending at discharge. A PICC line was placed for IV abx with home ___. He is to continue foscarnet for ___ weeks (exact duration to be determined on outpatient followup) with 500cc normal saline infusion prior to each foscarnet infusion. Electrolytes and renal function to be checked twice weekly while on foscarnet. Vancomycin was increased from 1g Q12H dosing to 1750mg Q12H due to low vanc trough. He is to continue vancomycin through ___ with trough to be checked on ___. Follow up with PCP ___, and ___ clinic were scheduled at discharge. # HIV Infection: Checked with CD4 count ___. Continued on atazanavir, ritonavir, abacavir-lamivudine, Bactrim ppx. # Hepatitis C: Recently diagnosed with LFTs elevated, which were stable/downtrending at discharge. Previously referred to Dr. ___ with no appointments made. He will follow up with ___ clinic for current lip/chin lesion and will subsequently be scheduled for followup for his hepatitis C. CHRONIC ISSUES: # Hip Pain: Bilateral, chronic. managed on tramadol, naproxen and tylenol. # Substance Abuse: History of cocaine and crystal meth abuse (reports none in past 4 months). Uses MJ for pain. Patient should continue counseling at Adcare (1hr x 2d/week) at discharge. # HTN - Continued amlodipine, losartan, HCTZ # Cardiac prophylaxis - Continued aspirin 81 mg daily TRANSITIONAL ISSUES: **Continue foscarnet for ___ weeks (exact duration to be determined on outpatient followup). Please monitor electrolytes twice weekly while on foscarnet. Should have 500cc normal saline infusion prior to each foscarnet infusion. **Continue vancomycin through ___. Trough to be checked ___. **Elevated LFTs which were stable/down trending at discharge. **Pending at discharge: pathology from biopsy of right lip/chin. **Ordered for chem panel, LFTs and vanc trough on ___. **Patient needs to schedule a visit with ID for hepatitis C; has ___ clinic f/u for now regarding current lip/chin lesion on ___. **Biopsy sutures can be removed at derm appointment ___. ",3017,723
10009035-DS-15,"<SEX> M <SERVICE> CARDIOTHORACIC <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> Asymptomatic <MAJOR SURGICAL OR INVASIVE PROCEDURE> Mitral Valve Repair (38mm ring) ___ <HISTORY OF PRESENT ILLNESS> Mr. ___ is a ___ male with no significant past medical history who was found to have a heart murmur on his annual physical exam. An echocardiogram demonstrated severe MR with preserved biventricular function. He denies any dyspnea on exertion, fatigue, palpitations, orthopnea or syncopal episodes. As early intervention can increase the odds of a repair, he has been referred for surgical evaluation. <PAST MEDICAL HISTORY> Mitral Regurgitation hypospadias repair x 2 <SOCIAL HISTORY> ___ <FAMILY HISTORY> Father with hypertension and grandmother with mitral valve replacement approximately ___ years ago <PHYSICAL EXAM> Pulse: 111 Resp: 16 O2 sat: 100%RA B/P Right: 137/89 Left: 142/89 Height: Weight: General: NAD, WGWN Skin: Warm [x] Dry [x] Intact [x] HEENT: NCAT [x] PERRLA [x] EOMI [x] Neck: Supple [x] Full ROM [x] JVD [] Chest: Lungs clear bilaterally [x] Heart: RRR [x] Irregular [x] Murmur [x] Grade _4/6 syst. +thrill_ Abdomen: Soft [x] non-distended [x] non-tender [x] bowel sounds + [x] Extremities: Warm [x], well-perfused [x] Edema [] __none_ Varicosities: None [x] Neuro: Grossly intact [x] Pulses: Femoral Right: 2+ Left: 2+ DP Right: 2+ Left: 2+ ___ Right: 2+ Left: 2+ Radial Right: 2+ Left: 2+ Carotid Bruit - Right: Left: no bruits, radiation of cardiac murmur <PERTINENT RESULTS> Intra-op TEE ___ Conclusions PRE-CPB: The left atrium is markedly dilated. No atrial septal defect is seen by 2D or color Doppler. Left ventricular wall thicknesses are normal. The left ventricular cavity size is normal. Overall left ventricular systolic function is normal (LVEF>55%). Right ventricular chamber size and free wall motion are normal. No thoracic aortic dissection is seen. The aortic valve leaflets (3) appear structurally normal with good leaflet excursion. The mitral valve leaflets are mildly thickened and redundant. Atrialization of the posterior leaflet insertion is seen. There is prolapse of all three scallops of the posterior mitral leaflets with the p2 scallop being most significantly affected. The mitral valve leaflets do not fully coapt. There is both a central and eccentric, anteriorly directed jet of MR. ___ to severe (3+) mitral regurgitation is seen. Due to the eccentric nature of the regurgitant jet, its severity may be significantly underestimated (Coanda effect). Dr ___ was notifed of findings in person at time of study. POST-CPB: The anterior mitral leaflet now spans the entire mitral annulus and the posterior leaflet can be minimally seen, consistent with mitral valve repair. A mitral annular ring is seen. There is no residual MR. ___ systolic function remain preserved. Other valvular function remains unchanged. There is no evidence of dissection. . ___ 06: 20AM BLOOD WBC-8.7 RBC-3.45* Hgb-10.0* Hct-29.3* MCV-85 MCH-28.9 MCHC-34.0 RDW-12.9 Plt ___ ___ 05: 55AM BLOOD WBC-11.3* RBC-3.42* Hgb-10.0* Hct-28.9* MCV-85 MCH-29.1 MCHC-34.5 RDW-12.5 Plt ___ ___ 06: 20AM BLOOD ___ PTT-28.4 ___ ___ 06: 20AM BLOOD Glucose-116* UreaN-17 Creat-1.1 Na-140 K-4.2 Cl-98 HCO3-34* AnGap-12 ___ 05: 55AM BLOOD Glucose-101* UreaN-14 Creat-1.0 Na-140 K-4.5 Cl-99 HCO3-31 AnGap-15 <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. This patient is not taking any preadmission medications <DISCHARGE MEDICATIONS> 1. Acetaminophen 650 mg PO Q4H: PRN pain/fever 2. Aspirin EC 81 mg PO DAILY RX *aspirin [Adult Low Dose Aspirin] 81 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills: *0 3. Furosemide 20 mg PO DAILY Duration: 5 Days RX *furosemide 20 mg 1 tablet(s) by mouth daily Disp #*5 Tablet Refills: *0 4. Ibuprofen 600 mg PO Q8H: PRN pain RX *ibuprofen 600 mg 1 tablet(s) by mouth every six (6) hours Disp #*60 Tablet Refills: *0 5. Lorazepam 0.25 mg PO Q6H: PRN anxiety RX *lorazepam 0.5 mg 0.5 (One half) tab by mouth every six (6) hours Disp #*20 Tablet Refills: *0 6. Metoprolol Tartrate 50 mg PO BID RX *metoprolol tartrate 50 mg 1 tablet(s) by mouth twice a day Disp #*60 Tablet Refills: *0 7. Potassium Chloride 20 mEq PO DAILY Duration: 5 Days RX *potassium chloride [___-Con] 20 mEq 1 packet by mouth daily Disp #*5 Packet Refills: *0 8. TraMADOL (Ultram) 50 mg PO Q4H: PRN pain RX *tramadol 50 mg 1 tablet(s) by mouth every four (4) hours Disp #*60 Tablet Refills: *0 <DISCHARGE DISPOSITION> Home With Service Facility: ___ <DISCHARGE DIAGNOSIS> Mitral Regurgitation hypospadias repair x 2 <DISCHARGE CONDITION> Alert and oriented x3 nonfocal Ambulating, gait steady Sternal pain managed with oral analgesics Sternal Incision - healing well, no erythema or drainage Edema- trace <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Please shower daily including washing incisions gently with mild soap, no baths or swimming, and look at your incisions Please NO lotions, cream, powder, or ointments to incisions Each morning you should weigh yourself and then in the evening take your temperature, these should be written down on the chart No driving for approximately one month and while taking narcotics, will be discussed at follow up appointment with surgeon when you will be able to drive No lifting more than 10 pounds for 10 weeks **Please call cardiac surgery office with any questions or concerns ___. Answering service will contact on call person during off hours** ","The patient was brought to the Operating Room on ___ where the patient underwent Mitral Valve Repair with Dr. ___. Overall the patient tolerated the procedure well and post-operatively was transferred to the CVICU in stable condition for recovery and invasive monitoring. POD 1 found the patient extubated, alert and oriented and breathing comfortably. The patient was neurologically intact and hemodynamically stable, weaned from inotropic and vasopressor support. Beta blocker was initiated and the patient was gently diuresed toward the preoperative weight. The patient was transferred to the telemetry floor for further recovery. Chest tubes and pacing wires were discontinued without complication. He developed some abdominal distention and bowel regimen was increased. He had a bowel movement. The patient was evaluated by the physical therapy service for assistance with strength and mobility. By the time of discharge on POD 4 the patient was ambulating freely, the wound was healing and pain was controlled with oral analgesics. The patient was discharged home w ___ in good condition with appropriate follow up instructions. ",1674,213
10009049-DS-16,"<SEX> M <SERVICE> MEDICINE <ALLERGIES> Penicillins <ATTENDING> ___. <CHIEF COMPLAINT> Chest pain <MAJOR SURGICAL OR INVASIVE PROCEDURE> None <HISTORY OF PRESENT ILLNESS> ___ year old male with hx remote paroxysmal afib presenting as transfer from OSH with c/o cough, n/diarrhea, and chest pain. Patient reports onset of cough/congestion 4d ago. Cough productive of green sputum. Had progressive fatigue, and yesterday had 6 episodes watery diarrhea with nonbloody emesis x1. Denies fevers/chills although did not take temp at home, no recent travel or sick contacts Yesterday evening then developed sharp left sided chest pain, left sided, ___, also involving left shoulder. Pain lasted about 10mins and went away on its own, denies associated aggravating or releiving factors. He presented to ___ where initial EKG showed STE in I, avL. Patient received nitro/morphine x1 with improvement in chest pain, however became bradycardic to the ___ with SBP 73/44, received 0.5mg atropine. Also received ASA 325, ceftriaxone, lovenox ___, toradol and 1L IVF. Plan was for PCI but this was aborted after reviewing subsequent EKGs. Also ceftriaxone x1 and 2L IVF. Trop/MB neg x2, WBC @ 15.3 with 52% bands. He was transferred to our ED for further eval. In the ED, initial vitals: 99 87 126/68 18 96% 3L, Tm 104.9. Iniital labs notable for chem-7 with bicarb 21, Bun/Cr ___ (baseline 1.0). CBC with plt 134, INR 1.3, lactate 2.5. trop neg, LFTs WNL. Patient was given tylenol, vanc/levofloxacin, oseltamivir and toradol x1, and 2L IVF. CXR was done with evidence of bibasilar opacities concerning for rapidly developing pneumonia vs. alveolar hemorrhage. On arrival to the MICU, patient has no complaints. Says he is feeling a little better. Denies dyspnea, chest pain, abdominal pain, no further episodes emesis or diarrhea since yesterday. Denies hemoptysis. <PAST MEDICAL HISTORY> Low back pain Disc disorder of lumbar region PROSTATITIS, UNSPEC H/O SCC left forehead ___ Atopic Dermatitis paroxysmal atrial fibrillation - noticed on ETT in ___, asymptomatic <SOCIAL HISTORY> ___ <FAMILY HISTORY> Unknown/adopted <PHYSICAL EXAM> Admission <PHYSICAL EXAM> -======= Vitals- T: 98.4 BP: 106/64 hr 87 94% 4L General- awake, alert, NAD HEENT- EOMI, PERRLA, OMM no lesions Neck- supple JVP mildly elevated at 30deg to under mandible CV- RRR, split s2 more prominent during inhalation, no murmurs Lungs- rhonchi bilaterally with fair air movement, + egophany LLB Abdomen- mildly distended/hypertympanic, no r/g/r, +BS GU- no foley Ext- WWP no c/c/e Neuro- CN II-XII intact, strength ___ in UE and ___ b/l Dishcarge <PHYSICAL EXAM> -======== Vitals - 97.9, 126/88, HR 72, 18, 97% on RA General- awake, alert, NAD HEENT- EOMI, PERRLA, OMM no lesions Neck- supple JVP mildly elevated at 30deg to under mandible CV- RRR, split s2 more prominent during inhalation, no murmurs Lungs- CTAB, improved egophany LLB Abdomen- mildly distended/hypertympanic, no r/g/r, +BS GU- no foley Ext- WWP no c/c/e Neuro- CN II-XII intact, strength ___ in UE and ___ b/l <PERTINENT RESULTS> ADMISSION LABS -== ___ 05: 05AM BLOOD WBC-6.8 RBC-4.95 Hgb-15.3 Hct-46.1 MCV-93 MCH-30.9 MCHC-33.2 RDW-12.5 Plt ___ ___ 05: 05AM BLOOD ___ PTT-36.9* ___ ___ 05: 05AM BLOOD Glucose-127* UreaN-26* Creat-1.4* Na-137 K-4.0 Cl-101 HCO3-21* AnGap-19 ___ 05: 05AM BLOOD Albumin-3.9 ___ 05: 25AM BLOOD Lactate-2.5* DISCHARGE LABS -== ___ 05: 40AM BLOOD WBC-8.4 RBC-3.55* Hgb-11.0* Hct-32.9* MCV-93 MCH-30.9 MCHC-33.4 RDW-12.9 Plt ___ ___ 05: 40AM BLOOD Glucose-91 UreaN-10 Creat-0.9 Na-145 K-3.4 Cl-106 HCO3-27 AnGap-15 ___ 05: 40AM BLOOD Calcium-7.4* Phos-3.3# Mg-1.9 IMAGING ======= TTE: Normal global and regional biventricular systolic function. No diastolic dysfunction, pulmonary hypertension or pathologic valvular abnormality seen. No pericardial effusion. CXR: Short interval development of bibasilar opacities, which are concerning for a rapidly developing pneumonia versus alveolar hemorrhage. CT CHEST W/CONTRAST (___): 1. Bilateral pleural effusions, moderate on the left side without evidence of empyema. 2. Multifocal airspace disease which is predominant at the lung bases and is likely in keeping with multifocal pneumonia. Multiple mediastinal and hilar reactive lymph nodes are noted. 3. Incidental finding of a 6 mm non-obstructing stone in the upper pole of the left kidney. <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. This patient is not taking any preadmission medications <DISCHARGE MEDICATIONS> 1. Acetaminophen 1000 mg PO Q6H: PRN pain 2. Docusate Sodium 200 mg PO BID RX *docusate sodium [Colace] 100 mg 1 capsule(s) by mouth twice a day Disp #*60 Capsule Refills: *0 3. Guaifenesin ___ mL PO Q6H: PRN cough RX *guaifenesin 100 mg/5 mL 5 mL by mouth every 6 hours Disp #*1 Bottle Refills: *0 4. Levofloxacin 750 mg PO DAILY RX *levofloxacin 750 mg 1 tablet(s) by mouth daily Disp #*4 Tablet Refills: *0 <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Primary: Pneumonia Secondary: Ileus <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Mr ___, It was a pleasure taking care of you during your stay at ___. You were admitted after you were diagnosed with pneumonia. We started you on antibiotics and you improved. You also had issues with moving your bowels which resolved with conervative measures. Please continue a full liquid diet at home (soups, jello, shakes) and advance to regular diet slowly as tolerated. ___ MDs ","BRIEF SUMMARY STATEMENT: Mr. ___ is a ___ year old male with no significant medical history presenting as transfer from OSH with c/o cough, n/d/diarrhea, and chest pain found to have fever and hypoxia. On further work-up, pt. was found to have a multifocal pneumonia. Culture data was unrevealing. Pt. was placed on antibiotics and continued to improve. His O2 requirement resolved and he was discharged with close follow-up. ACTIVE ISSUES ============= # Sepsis and Community Acquired Pneumonia: Mr. ___ presented with tachycardia, temp to 104, and multifocal opacities seen on CXR. He was started on ceftriaxone and levofloxacin in accordance to ___ guidelines for community acquired pneumonia. Respiratory viral panel negative, legionella negative, strep pneumo antigen negative, and cultures were unrevealing. Pt. grew GPCs in clusters in blood ___ bottles) which raised concern for possible MRSA bacteremia from MRSA pneumonia. Pt. has negative MRSA swab and without known MRSA risk factors. TTE was negative for evidence of endocarditis and surveillance blood cultures were negative. Oxygen requirement had resolved by day 2 of admission and he was transferred to the floor. He was transitioned to levofloxacin to complete his course of antibiotics. # Chest Pain: Pt. complained of left sided sharp chest pain made worse with coughing and deep breathing. Most likely pleuritic chest pain from underlying inflammatory pleuritis from pneumonia. Cardiac enzymes neg x2 making cardiac ischemia less likely. No ischemic changes or other notable changes seen on ECG. TTE done on ___ and was grossly normal with LVEF 60-65%. # Abdominal Distension: Initially, pt. presented with diarrhea, CDiff negative. Continued to complain of abdominal distension. KUB showed multiple air filled loops of bowel without air fluid levels consistent with possible ileus. Pt. continued to complain of minimal flatus, abdominal distension made worse with consuming POs, and minimal BMs. Slowly, he began to tolerate PO intake. At time of discharge, pt. was tolerating full liquids without issue. He was encouraged to advance his diet as tolerated. # Anemia: Patient with downtrending Hct throughout this admission. Initial and repeat DIC labs returned negative. Most likely etiology ___ bone marrow suppression due to acute illness with possible suppression ___ medication effect. No signs of active bleeding. # ___: Pt. with evidence ___ on admission. Likely pre-renal etiology in the setting of pneumonia and sepsis. With IVF, pt's creatinine returned to baseline and ___ resolved. CHRONIC ISSUES ============== # BPH: Stable. Continued on flomax TRANSITIONAL ISSUES =================== # Antibiotics: Pt. should continue levofloxacin for an additional 4 days to complete a 10 day course. ",1758,616
10009116-DS-14,"<SEX> M <SERVICE> ORTHOPAEDICS <ALLERGIES> Penicillins <ATTENDING> ___. <CHIEF COMPLAINT> R transscaphoid perilunate fracture dislocation <MAJOR SURGICAL OR INVASIVE PROCEDURE> ___ Dr. ___, MD 1. Open reduction internal fixation right scaphoid fracture. 2. Open reduction internal fixation triquetral fracture. 3. Open release of the right carpal tunnel. 4. Open reduction internal fixation of a wrist perilunate dislocation <HISTORY OF PRESENT ILLNESS> HPI: ___ yo RHD M who was skateboarding on ___ when he was struck from behind on the R side by a car. Pt was taken to ___ where trauma workup was negative except for a R transscaphoid perilunate fracture dislocation. Pt was transferred to ___ ED & orthopaedics was consulted. At time of initial eval pt had median nerve symptom w/ numbness at tingling of fingertips of the first 3 digits w/ associated slight diminished sensation in those digits. Closed reduction was performed under conscious sedation & pt was placed in a splint. Pt median nerve symptoms improved with resolution of paresthesias and only slight diminished sensation over the thumb. Pt was discharged home, and now returns for planned surgical fixation. Pt reports had some tingling in median nerve distribution upon waking this morning, but this has resolved. No other interval changes. ROS otherwise negative. <PAST MEDICAL HISTORY> h/o B ankle fx h/o metacarpal fracture s/p tonsillectomy as a child <SOCIAL HISTORY> ___ <FAMILY HISTORY> Noncontributory <PHYSICAL EXAM> PEX on admission A&O x 3 Calm and comfortable RUE: splint c/d/i Sensation to light touch slightly diminished thumb as compared to other side, otherwise SILT in R M U distibutions EPL FPL EIP EDC FDP fire Digits WWP <PERTINENT RESULTS> N/A <MEDICATIONS ON ADMISSION> 1. oxycodone 5 mg Tablet Sig: ___ Tablets PO Q3H (every 3 hours) as needed for pain. 2. acetaminophen 325 mg Tablet Sig: Two (2) Tablet PO Q4H (every 4 hours). 3. Senna Concentrate 8.6 mg Tablet Sig: One (1) Tablet PO twice a ___: Take while on narcotic to prevent constipation. <DISCHARGE MEDICATIONS> 1. oxycodone 5 mg Tablet Sig: ___ Tablets PO Q3H (every 3 hours) as needed for pain. 2. acetaminophen 325 mg Tablet Sig: Two (2) Tablet PO Q4H (every 4 hours). 3. Senna Concentrate 8.6 mg Tablet Sig: One (1) Tablet PO twice a ___: Take while on narcotic to prevent constipation. <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> R transscaphoid perilunate fracture dislocation s/p ORIF & carpal tunnel release <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> 1. Please return to the emergency department or notify MD if you experience: increasing pain not relieved by medication, increased swelling, decreased sensation, difficulty with movement, fevers >101.5, shaking chills, redness or drainage at the incision site, chest pain, shortness of breath or other symptoms of concern. 2. Please follow up with your PCP regarding this admission and any new medications and refills. 3. Resume your pre-hospitalization medications unless otherwise instructed. 4. You have been given medications for your pain control. As your pain improves, decrease your pain medication by taking fewer tablets and/or increasing the time interval between doses. Do not drink, drive or operate machinery while taking narcotics. Take a stool softener to prevent constipation. 5. Do not drive until cleared to do so by your surgeon or your primary MD. 6. Please keep splint clean and dry 7. WB Status: non-weightbearing right upper extremity 8. Please keep right upper extremity maximally elevated at all times to help w/ swelling and pain 9. Antibiotics: Physical Therapy: Non-weightbearing right upper extremity Treatments Frequency: Please continue splint. Keep clean and dry ","The patient was admitted to the Orthopaedic Service for repair of a R transscaphoid perilunate fracture dislocation & triquetral fracture. The patient was taken to the OR and underwent ORIFR transscaphoid perilunate fracture dislocation & triquetral fracture as well as carpal tunnel release. The patient tolerated all procedures without difficulty and was transferred to the PACU in stable condition. Please see operative report for full details. The patient transferred to the floor in the usual fashion. Postoperatively, pain was controlled with a PCA with a transition to PO pain meds as tolerated. Diet was advanced without complication. Pt noted persitent numbness in the median nerve distribution which was improved w/ strict hand elevation. At time of discharge states has mild slight residual ""pins & needles"" senstion involving the thumb. The hospitalization has otherwise been uneventful and the patient has done well. **** At discharge, vital signs are stable, the patient is alert and oriented, afebrile, tolerating pos, voiding qshift and pain is well controlled. Splint is c/d/i. Pt has very mild decreased senstion to light touch over the R thumb, similar to pre-operative exam. Digits are WWP. Fires EPL/FPL/FDP/EDC. The extremities are neurovascularly intact distally throughout. All incisions are clean, dry and intact without evidence of infection, hematoma or seroma. **** The patient is discharged to home in stable condition. Intructions given. ",963,314
10009129-DS-21,"<SEX> M <SERVICE> ORTHOPAEDICS <ALLERGIES> ibuprofen <ATTENDING> ___. <CHIEF COMPLAINT> L thumb near complete amputation <MAJOR SURGICAL OR INVASIVE PROCEDURE> ___ ___: 1. Irrigation and debridement down to necrotic bone. 2. Primary IP joint arthrodesis with autograft. 3. Repair of the radial digital nerve. 4. Repair of the ulnar digital nerve. 5. Repair of the ulnar digital artery with a 3 cm vein graft from the foot. 6. Full thickness skin graft measuring 5x1.5cm <HISTORY OF PRESENT ILLNESS> Mr. ___ is a ___ year old male with past medical history significant for HCV who presents from outside hospital with a near complete amputation of his left thumb at the interphalangeal joint. Patient states he was using a table saw at work and cut through his thumb. He denies any other injuries. He has no sensation distal to the cut. <PAST MEDICAL HISTORY> Hepatitis C virus <SOCIAL HISTORY> ___ <FAMILY HISTORY> NC <PHYSICAL EXAM> NAD No respiratory distress RRR splint c/d/i, decreased sensation in the distal thumb, some sensation over dorsal nailbed, cap refill ___ <MEDICATIONS ON ADMISSION> Methadone <DISCHARGE MEDICATIONS> 1. Acetaminophen 1000 mg PO Q8H 2. Aspirin 162 mg PO DAILY 3. Docusate Sodium 100 mg PO BID 4. Gabapentin 300 mg PO TID 5. OxyCODONE (Immediate Release) ___ mg PO Q4H: PRN Pain 6. Senna 8.6 mg PO BID 7. Methadone (Concentrated Oral Solution) 10 mg/1 mL 63 mg PO DAILY <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> L thumb near complete amputation <DISCHARGE CONDITION> Stable <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> - You were in the hospital for orthopedic surgery. It is normal to feel tired or ""washed out"" after surgery, and this feeling should improve over the first few days to week. - Resume your regular activities as tolerated, but please follow your weight bearing precautions strictly at all times. ACTIVITY AND WEIGHT BEARING: - Non weight bearing L upper extremity MEDICATIONS: - Please take all medications as prescribed by your physicians at discharge. - Continue all home medications unless specifically instructed to stop by your surgeon. - Do not drink alcohol, drive a motor vehicle, or operate machinery while taking narcotic pain relievers. - Narcotic pain relievers can cause constipation, so you should drink eight 8oz glasses of water daily and take a stool softener (colace) to prevent this side effect. ANTICOAGULATION: - Please take Aspirin 162mg daily for 4 weeks WOUND CARE: - You may shower. No baths or swimming for at least 4 weeks. - Any stitches or staples that need to be removed will be taken out at your 2-week follow up appointment. - Splint must be left on until follow up appointment unless otherwise instructed - Do NOT get splint wet Physical Therapy: NWB LUE Treatments Frequency: Wound monitoring Pin care: The initial dressing may have Xeroform wrapped at the pin site with surrounding gauze. Often, the Xeroform is used in the immediate post-op phase to allow for control of the bleeding. The Xeroform can be removed ___ days after surgery. If the pin sites are clean and dry, keep them open to air. If they are still draining slightly, cover with clean dry gauze until draining stops. If they need to be cleaned, use ___ strength Hydrogen Peroxide with a Q-tip to the site. Call your surgeon's office with any question ","The patient presented to the emergency department and was evaluated by the orthopedic Hand surgery team. The patient was found to have L thumb near complete amputation and was admitted to the orthopedic surgery service. The patient was taken to the operating room on ___ for: 1. Irrigation and debridement down to necrotic bone. 2. Primary IP joint arthrodesis with autograft. 3. Repair of the radial digital nerve. 4. Repair of the ulnar digital nerve. 5. Repair of the ulnar digital artery with a 3 cm vein graft from the foot. 6. Full thickness skin graft measuring 5x1.5cm , which the patient tolerated well. For full details of the procedure please see the separately dictated operative report. The patient was taken from the OR to the PACU in stable condition and was monitored for 24hours there w/ q1h NV exams to his L thumb. After 24h he was transferred to the floor. The patient was initially given IV fluids and IV pain medications including a supraclavicular nerve catheter. He was initially kept NPO in case there was a need to potentially take him back to the OR for a revision. He progressed to a regular diet and oral medications by POD#2. The patient was given ___ antibiotics and anticoagulation per routine and antibiotics were continued while he was in house. The patient's home medications were continued throughout this hospitalization. The patient was discharged home with followup in 1 week. The ___ hospital course was otherwise unremarkable. At the time of discharge the patient's pain was well controlled with oral medications, incisions were clean/dry/intact, and the patient was voiding/moving bowels spontaneously. The patient is NWB on the LUE, and will be discharged on ASA 162mg for DVT prophylaxis. The patient will follow up in Hand Clinic per routine. A thorough discussion was had with the patient regarding the diagnosis and expected post-discharge course including reasons to call the office or return to the hospital, and all questions were answered. The patient was also given written instructions concerning precautionary instructions and the appropriate follow-up care. The patient expressed readiness for discharge. ",852,460
10009142-DS-4,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> s/p fall <MAJOR SURGICAL OR INVASIVE PROCEDURE> None <HISTORY OF PRESENT ILLNESS> ___ h/o HTN, dementia, anemia, gait instability, hypothyroidism, c/o fall today. She notes that last week she fell in the bathroom after slipping on her rug, but today she remembers taking a shower and the next thing she remembers is waking up on the floor of her bathroom naked. She had head pain after that but denies any subsequent or recent CP, SOB, palpitations, lightheadedness, fever, cough, rash, dysuria or other symptoms. After the fall she got up and resumed her usual daily activities but noticed a bump on the back of her head so called EMS. . In the ED, initial vs were: 97.8 76 153/73 16 97% RA. Labs notable for WBC count of 15 with 4 bands. CK mildly elevated at 865, normal creatinine, troponin negative. U/A negative. CXR ok. CT head showed acute left cerebral subdural hematoma with NO midline shift. C-spine without fracture. Neuro exam without any focal deficits. Neurosurgery was consulted and recommended CT head in the early AM to re-eval the bleed but no need to start an ___ follow along. VS: . On the floor, patient reports that she has chronic hip pain from osteoarthritis that is not any worse than usual, but denies vision change, loss of sensation, muscular weakness, increased confusion, difficulty speaking, or headache. . Review of systems: (+) Per HPI (-) Denies fever, night sweats, recent weight loss or gain. Denies sinus tenderness, rhinorrhea or congestion. Denied cough, shortness of breath. Denied chest pain or tightness, palpitations. Denied nausea, vomiting, diarrhea, constipation or abdominal pain. No recent change in bowel or bladder habits. No dysuria. <PAST MEDICAL HISTORY> HTN, Dementia ___ SLUMS, anemia, Vitamin b12 deficiency, high cholesterol, gait abnormality, urge ncontinence, hypothyroidism, osteoarthritis of the bilateral hips, s/p steroid injection in ___ Mild thrombocytopenia and anemia with occasional increased monocyte percentage followed by Heme/ONC and felt to be early MDS vs. normal variant, JAK2 negative <SOCIAL HISTORY> ___ <FAMILY HISTORY> Father had a heart attack and several of his family members had diabetes. Brother had stomach cancer and brother had colon cancer. <PHYSICAL EXAM> Vitals: T: BP: 170/83 P: 100 R: 18 O2: 96% on RA General: Alert, oriented, no acute distress HEENT: Sclera anicteric, MMM, oropharynx clear, PERRL, EOMI Neck: supple, JVP not elevated, no LAD Lungs: Clear to auscultation bilaterally, no wheezes, rales, ronchi CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Abdomen: soft, non-tender, non-distended, bowel sounds present, no rebound tenderness or guarding, no organomegaly Ext: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema Neuro: A&O x3, CN ___ intact. Strength and sensation intact bilaterally and symmetric. Finger to nose intact. Gait deferred. <PERTINENT RESULTS> ___ 04: 45PM BLOOD WBC-15.6*# RBC-3.88* Hgb-12.2 Hct-35.9* MCV-93 MCH-31.4 MCHC-33.9 RDW-13.4 Plt ___ ___ 07: 02AM BLOOD WBC-6.7# RBC-3.34* Hgb-10.6* Hct-29.8* MCV-89 MCH-31.6 MCHC-35.5* RDW-13.6 Plt ___ ___ 04: 45PM BLOOD Neuts-80* Bands-4 Lymphs-5* Monos-8 Eos-1 Baso-0 Atyps-2* ___ Myelos-0 . ___ 04: 45PM BLOOD Hypochr-NORMAL Anisocy-OCCASIONAL Poiklo-NORMAL Macrocy-NORMAL Microcy-NORMAL Polychr-NORMAL . ___ 07: 53PM BLOOD ___ PTT-25.9 ___ ___ 04: 45PM BLOOD Glucose-167* UreaN-40* Creat-1.1 Na-133 K-4.7 Cl-100 HCO3-23 AnGap-15 ___ 07: 02AM BLOOD Glucose-104* UreaN-26* Creat-0.9 Na-136 K-4.5 Cl-105 HCO3-25 AnGap-11 . ___ 04: 45PM BLOOD CK(CPK)-865* ___ 11: 10PM BLOOD CK(CPK)-611* ___ 07: 02AM BLOOD CK(CPK)-429* ___ 04: 45PM BLOOD cTropnT-0.02* ___ 11: 10PM BLOOD cTropnT-0.03* ___ 07: 02AM BLOOD CK-MB-13* MB Indx-3.0 cTropnT-0.02* . ___ 04: 45PM BLOOD Calcium-10.0 Phos-3.9 Mg-1.9 ___ 07: 02AM BLOOD Calcium-8.8 Phos-3.1 Mg-1.9 Cholest-155 . ___ 07: 02AM BLOOD VitB12-1156* ___ 07: 02AM BLOOD Triglyc-76 HDL-65 CHOL/HD-2.4 LDLcalc-75 ___ 07: 02AM BLOOD TSH-1.4 . ___ 06: 00PM URINE Color-Yellow Appear-Clear Sp ___ ___ 06: 00PM URINE Blood-MOD Nitrite-NEG Protein-25 Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-5.0 Leuks-NEG ___ 06: 00PM URINE ___ Bacteri-NONE Yeast-NONE ___ ___ 6: 00 pm URINE Site: CLEAN CATCH **FINAL REPORT ___ URINE CULTURE (Final ___: MIXED BACTERIAL FLORA ( >= 3 COLONY TYPES), CONSISTENT WITH SKIN AND/OR GENITAL CONTAMINATION. CT C-spine FINDINGS: There is no acute cervical fracture or malalignment. The vertebral body heights are well preserved. The prevertebral soft tissues are unremarkable. Thickening fo the transverse ligament noted. Multilevel degenerative changes are moderate with tiny posterior osteophytes but without significant narrowing of the spinal canal. The visualized lung apices are unremarkable. Tiny mucosal thickening is noted at the right maxillary sinus. The remaining visualized paranasal sinuses and mastoid air cells are clear. IMPRESSION: No acute cervical fracture or malalignment. CT head ___ Preliminary Report TECHNIQUE: Non-contrast MDCT images were acquired through the head. Multiplanar reformatted images were obtained for evaluation. FINDINGS: There is a predominantly hyperdense extra-axial crescentic collection along the left cerebral convexity, with maximum thickness of 9 mm (image 2: 14), with a small hypodense component alno noted. Findings are compatible with acute on chronic subdural hematoma. Effacement of the adjacent sulci is mild, and there is no shift of midline structures. The ventricles remain symmetric in configuration. Mild periventricular white matter hypodensities are compatible with mild chronic microvascular ischemic disease. The gray-white matter differentiation is grossly preserved. There is no acute fracture. The visualized paranasal sinuses and mastoid air cells are clear. A small subgaleal hematoma is noted in the left occiput. IMPRESSION: 1. Acute on chronic left cerebral subdural hematoma with maximum thickness of 9 mm. 2. Small subgaleal hematoma in the left occiput. CT head repeat ___ Final Report INDICATION: ___ woman status post fall with subdural hematoma, repeat CT to assess interval change. COMPARISON: CT head without contrast, ___. TECHNIQUE: MDCT images were acquired through the head without intravenous contrast. Saggital and coronal reformats were generated and reviewed. FINDINGS: Again seen is a heterogeneously hypodense left subdural collection extending along the entire left cerebral convexity, maximally measuring 9 mm in breadth (2: 18), unchanged since the prior study. There is interval redistribution of the hyperdense hematoma, with a fluid-fluid level now present. There is mild effacement of the left cerebral hemispheric sulci, without significant shift of midline structures. There is mild compression of the left lateral ventricle, predominantly the left temporal horn, unchanged since the prior study. The gray-white matter differentiation is preserved. No intraparenchymal or intraventricular hemorrhage is detected. A small left occipital scalp contusion (2: 12) is unchanged. No acute bony injury is identified. The mastoid air cells, external auditory canals, and imaged paranasal sinuses are clear. IMPRESSION: 1. Acute-on-chronic subdural hematoma surrounding the entire left cerebral convexity, is unchanged in size since prior study. 2. Mild mass effect on the adjacent sulci persists, without significant shift of midline structures. 3. A small left occipital subgaleal hematoma, which is stable. Chest xray Final Report HISTORY: ___ woman status post fall. Assess for acute process. COMPARISON: None. SINGLE SUPINE CHEST RADIOGRAPH: There is increased opacity projecting over the left lower lung which most likely represent calcified costochondral cartilages. There is no definite airspace consolidation. No pneumothorax or pleural effusion is noted. The cardiomediastinal silhouette is top normal. The hilar contours and pulmonary vasculature are unremarkable. Moderate degenerative changes are noted in the thoracolumbar spine, with multiple clips in the right upper quadrant. IMPRESSION: No acute cardiopulmonary process. <MEDICATIONS ON ADMISSION> Miralax Caclium and D Tylenol ___ mg 2 q 6 Levoxyl 75 mcg cdaily Celebrex ___ mg BID Lidoderm patch Vitamin B6 Lisinopril 20 mg ddaily Vitamin b12 250 mcg daily Betoptic-s 0.25% as directed twice a day Asa 81 mg daily (not recently taking) <DISCHARGE MEDICATIONS> 1. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day). 2. senna 8.6 mg Tablet Sig: One (1) Tablet PO HS (at bedtime). 3. polyethylene glycol 3350 17 gram/dose Powder Sig: One (1) PO DAILY (Daily) as needed for constipation. 4. lidocaine 5 %(700 mg/patch) Adhesive Patch, Medicated Sig: One (1) Adhesive Patch, Medicated Topical DAILY (Daily). 5. multivitamin Tablet Sig: One (1) Tablet PO DAILY (Daily). 6. calcium carbonate 200 mg (500 mg) Tablet, Chewable Sig: One (1) Tablet, Chewable PO TID (3 times a day). 7. cholecalciferol (vitamin D3) 400 unit Tablet Sig: Two (2) Tablet PO DAILY (Daily). 8. levothyroxine 75 mcg Tablet Sig: One (1) Tablet PO DAILY (Daily): take this medication by itself on an empty stomach. 9. cyanocobalamin (vitamin B-12) 250 mcg Tablet Sig: One (1) Tablet PO DAILY (Daily). 10. betaxolol 0.25 % Drops, Suspension Sig: One (1) Drop Ophthalmic BID (2 times a day). 11. Tylenol Extra Strength 500 mg Tablet Sig: Two (2) Tablet PO every six (6) hours: not to exceed 4 grams daily. 12. lisinopril 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily): SBP goal 140-160 in setting of subdural hematoma. 13. oxycodone 5 mg Tablet Sig: one half Tablet PO Q8H (every 8 hours) as needed for arthritis pain. 14. bisacodyl 5 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily) as needed for constipation. 15. bisacodyl 10 mg Suppository Sig: One (1) Rectal HS (at bedtime) as needed for constipation. <DISCHARGE DISPOSITION> Extended Care Facility: ___ <DISCHARGE DIAGNOSIS> Primary: subdural hematoma Secondary: orthostatic hypotension <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> You were admitted to the hospital after falling at home. You hit your head and on imaging with a CT scan it shows that you have a large bruise called a subdural hematoma. It is not increasing in size and will likely resolve without any additional intervention. You will need to follow up with neurosurgery after discharge (Dr. ___ in 1 month with a repeat CT scan of your head to assess any interval changes in the bruise. You will need to avoid taking aspirin or other blood thinner until you see Dr. ___. . Due to the nature of the hematoma in your brain, it is important to keep your blood pressure in the range of 140s-160s. . The following changes were made to your medications: STOPPED Aspirin, this medication will need to be held until you see Dr. ___ Celebrex, this medication may have been causing your dizziness and eye discomfort STARTED Tylenol (acetaminophen) for your arthritis pain STARTED Oxycodone 2.5mg every 8 hours for your arthritis pain, the rehab center should increase this is your pain is not controlled. STARTED Dulcolax, suppositories that need to be used while you are using the oxycodone. CONTINUE miralax, senna, docusate. These are your regular bowel medications. CONTINUE other home medications including: levothyroxine, lisinopril, vitamins, and eye drops. . Please follow up with your doctors as listed below. ","This is an ___ year old female s/p fall with subdural hematoma. . # Subdural Hematoma: Pt had no focal neurologic findings on exam and was observed to be stable on serial exams. ___ diagnosed on admission head CT and followed on repeat study which showed stable findings. Neurosurgery signed off with no indication for acute intervention. Aspirin therapy discontinued on admission with plan to continue to hold any anticoagulation or antiplatelet therapy pending a one month follow up with neurosurgery. Acute mental status change would prompt need for urgent re-evaluation by neurosurgery team and reimaging to assess interval change of subdural hematoma. Currently pt is AOx3, normal neurological exam, and at baseline MS. *Systolic blood pressure goals 140-160s in setting of recent head bleed. *Continue holding all antiplatelet agents, aspirin, or anticoagulation therapies. . # s/p fall: Unclear why patient fell as no clear preceding symptoms and no post-ictal symptoms but clear LOC. DDX includes arrhythmia, vaso-vagal episode after getting out of hot shower into cold bathroom, decreased cerebral perfusion from hypotension due to medications or valvular issue, or possibly just a mechanical fall. Patient does not have memory of the event. Cardiac event unlikely as no chest pain. Only new medication is celebrex (initiated 10 days ago) - rarely associated w CNS symptoms and instability. Pt noted to be orthostatic on admission and after 1 liter IVF hydration her orthostasis resolved. No abnormalities noted on telemetry. Cardiac enzymes flat and did not indicated ACS. Creatinine kinase elevated on admission and downtrended likely ___ down status and fall. Physical therapy evaluated pt and recommended short stay at rehab to regain full baseline function s/p hospitalization. TSH and B12 levels wnl. *Given significant orthostatic hypotension, now resolved, would check BPs in standing position. . # Leukocytosis: Resolved. Felt to be ___ fall, as no infectious symtptoms. U/A negative with negative culture. CXR without PNA. Patient may also have an underlying MDS per ___ records however leukocytosis resolved after HD1. . # Elevated CK: Likely ___ fall, time spent down. Cardiac enzymes currently downtrending. . # Hypertension: In setting of subdural hematoma, systolic BP goal 140-160 which was in goal on home lisinopril dose of 20mg daily. Would follow closely and assure in proper range. *Holding all aspirin/antiplatelet/anticoagulation agents in the setting of head bleed. To be cleared by neurosurgery at 1mo followup. . # Hyperlipidemia: Pt not on ___ statin despite diagnosis of hyperlipidemia. Fasting lipids found to be wnl during stay. No indication to start statin therapy. . # Hypothyroidism: Continued on home levothyroxine. TSH wnl. . # Osteoarthritis: Pt recently started on celebrex after steroid injection 2 weeks ago. Rarely celebrex is associated with CNS disturbances and could lead to fall. She does report dizziness and eye discomfort that started with the intiation of this medication. Celebrex discontinued with resolution of her symptoms. She was continued on home vitamin D and calcium. She was treated with lidocaine patches and high dose standing tylenol. Also started low dose oxycodone 2.5mg Q8hours for her arthritis pain in avoidance of NSAIDs or aspirin. *Plan to assess pain control once engaging in physical therapy and uptitrate oxycodone frequency as needed. . #History of B12 deficiency: B12 level wnl. Continued on home PO B12 supplement. . # Prophylaxis: pneumoboots, no indication for ppi, bowel regimen # Access: peripherals # Code: Full-patient states she has never discussed this before and would like to think about it. # Communication: Patient and ___ (daughter) ___ ",3308,864
10009203-DS-9,"<SEX> M <SERVICE> MEDICINE <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> bloody bowel movement <MAJOR SURGICAL OR INVASIVE PROCEDURE> none <HISTORY OF PRESENT ILLNESS> ___ smoker w/ history of hyperlipidemia, BPH, GERD, DJD, osteoarthritis, and colon polyps presents today with one bloody BM, fever in AM and abdominal pain. Pt's last ___ was in ___ at which point he had some polyps that were benign. The patient woke up in the morning in his usual state of health. He went to work after eating a muffin and drinking a coffee. While at work, he experienced a band of pain along his abdomen, lasting for 45 minutes and was drenched in sweat. Had large blood BM at 11 AM (blood covered stool). Since then has had ___ belly pain in lower quadrants in a horizontal band. In the ED, initial vs at 14: 22 were pain 6 t 98.6 64 133/78 16 99%. He was ound to have elevated WBC (19.2). CT shows colitis, patient given 0.5 mg IV dilaudid, 400mg IV cipro. Transfer VS 98.1po 59 16 126/81 100% RA ___. On arrival to the floor, patient reports continued abdominal pain, but is comfortable. He also reports continuing smoking and having a rash along his right axila. He denies any recent antibiotics, travel, changes in his diet, or sick contacts. REVIEW OF SYSTEMS: Recent headache over the weekend, twice, which is new for him.. Denies fever, chills, night sweats, vision changes, rhinorrhea, congestion, sore throat, cough, shortness of breath, chest pain, constipation, melena, dysuria, hematuria. All other 10-system review negative in detail. <PAST MEDICAL HISTORY> 1. Status post appendectomy. 2. Status post sebaceous cyst excision. 3. Status post arthroscopy, left knee. 4. Status post arthroscopy, right knee. <SOCIAL HISTORY> ___ <FAMILY HISTORY> Positive for lung cancer, CAD, hypertension, and diabetes. No history of crohn disease or ulceraive colitis. <PHYSICAL EXAM> Admission: VS 98.7, 146/89, 56, 18, 98% GEN Alert, oriented, no acute distress HEENT NCAT MMM EOMI sclera anicteric, OP clear NECK supple, no JVD, no LAD PULM Good aeration, CTAB no wheezes, rales, ronchi CV RRR normal S1/S2, no mrg ABD soft tender along left lower quadrant. ND normoactive bowel sounds, no hsm EXT WWP 2+ pulses palpable bilaterally, no c/c/e NEURO CNs2-12 intact, motor function grossly normal SKIN small erythematous papular rash under right axila. Discharge: VS 98.4, 122/80, 65, 18, 96%RA GEN Alert, oriented, no acute distress HEENT NCAT MMM EOMI sclera anicteric, OP clear NECK supple, no JVD, no LAD PULM Good aeration, CTAB no wheezes, rales, ronchi CV RRR normal S1/S2, no mrg ABD soft, mildly tender with soft and deep palpation in LLQ, no masses EXT WWP 2+ pulses palpable bilaterally, no c/c/e NEURO CNs2-12 intact, motor function grossly normal SKIN small erythematous papular rash under right axila. <PERTINENT RESULTS> Admission: ___ 02: 32PM NEUTS-91.6* LYMPHS-5.7* MONOS-2.6 EOS-0 BASOS-0.1 ___ 02: 32PM WBC-19.2*# RBC-5.14 HGB-15.6 HCT-46.2 MCV-90 MCH-30.4 MCHC-33.8 RDW-13.1 ___ 02: 32PM LIPASE-51 ___ 02: 32PM PLT COUNT-346 ___ 02: 32PM ALT(SGPT)-30 AST(SGOT)-29 LD(LDH)-187 ALK PHOS-73 TOT BILI-0.5 ___ 02: 32PM LIPASE-51 ___ 02: 32PM GLUCOSE-120* UREA N-14 CREAT-0.7 SODIUM-137 POTASSIUM-4.5 CHLORIDE-103 TOTAL CO2-27 ANION GAP-12 ___ 02: 40PM LACTATE-1.1 ___ 07: 52PM URINE BLOOD-NEG NITRITE-NEG PROTEIN-TR GLUCOSE-NEG KETONE-10 BILIRUBIN-NEG UROBILNGN-NEG PH-6.5 LEUK-NEG ___ 07: 52PM URINE COLOR-Yellow APPEAR-Clear SP ___ Discharge: ___ 07: 00AM BLOOD WBC-12.2* RBC-4.90 Hgb-14.3 Hct-43.5 MCV-89 MCH-29.2 MCHC-32.9 RDW-12.6 Plt ___ ___ 07: 00AM BLOOD Plt ___ ___ 07: 00AM BLOOD Glucose-95 UreaN-13 Creat-0.7 Na-138 K-4.1 Cl-106 HCO3-25 AnGap-11 ___ 07: 00AM BLOOD Calcium-9.0 Phos-3.1 Mg-2.2 Micro: ___ 9: 00 pm STOOL CONSISTENCY: NOT APPLICABLE Source: Stool. **FINAL REPORT ___ C. difficile DNA amplification assay (Final ___: Negative for toxigenic C. difficile by the Illumigene DNA amplification assay. (Reference Range-Negative). FECAL CULTURE (Final ___: NO SALMONELLA OR SHIGELLA FOUND. CAMPYLOBACTER CULTURE (Final ___: NO CAMPYLOBACTER FOUND. FECAL CULTURE - R/O VIBRIO (Final ___: NO VIBRIO FOUND. FECAL CULTURE - R/O YERSINIA (Final ___: NO YERSINIA FOUND. FECAL CULTURE - R/O E.COLI 0157: H7 (Final ___: NO E.COLI 0157: H7 FOUND. ___ 2: 52 pm BLOOD CULTURE Blood Culture, Routine (Pending): ___BD & PELVIS WITH CO IMPRESSION: 1. Acute colitis involving the descending and sigmoid colon. Etiologies include infectious, inflammatory and less likely ischemic. 2. Enlarged prostate, correlate with PSA. 3. Bilateral small indeterminate adrenal nodules. 4. Mild compression of T11 and T12 vertebral bodies. Cardiovascular Report ECG Study Date of ___ 3: 26: 28 ___ Sinus rhythm. Normal tracing. No previous tracing available for comparison. <MEDICATIONS ON ADMISSION> Preadmission medications listed are correct and complete. Information was obtained from PatientwebOMR. 1. Finasteride 5 mg PO DAILY 2. Tamsulosin 0.4 mg PO HS Hold for SBP<100 <DISCHARGE MEDICATIONS> 1. Finasteride 5 mg PO DAILY 2. Tamsulosin 0.4 mg PO HS Hold for SBP<100 <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Primary: colitis <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Mr. ___, It was a pleasure taking care of you at ___ ___. You were admitted with an episode bloody bowel movement. CT scan showed colitis, which may have be infectious. You were seen by gastroenterology and will follow up with Dr. ___ in clinic. Medication changes: none ","# Colitis: Patient presented with one bloody bowel movement associated with crampy abdominal pain. CT showing acute colitis of descending colon. Differential diagnosis includes infectious (bacterial, viral, parasitic), ischemic, and inflammatory. Ischemic possible given high white count, acute nature and smoking history, however normal lactate. EKG with normal sinus rhythm. Infectious possible with high white count, however patient was afebrile and did not describe diarrhea or vomiting. Further, patient had no travel history, sick contacts or concerning food ingestion. First presentation of inflammatory bowel disease is possible, however less likely given acute nature and disease of only descending colon. Diverticuli seen on previous colonoscopy, however elevated white count and pain is not consistent with diverticular bleeding. The patient was started on ciprofloxacin for possible infectious etiology and given IV fluids. Gastroenterology was consulted due to concern for ischemic etiology. Stool studes were sent and were negative for salmonella, shigella, campylobacter, vibrio and yersinia. C. difficile testing was not done as sample was unsuitable for testing (solid). GI recommended discontinuing ciprofloxacin and outpatient follow up given resolving symptoms with stable hemodynamics and recent colonoscopy. The patient was scheduled for outpatient follow up with gastroenterology. Chronic Issues: # T11/ T12 vetebral compression: Compression seen on CT scan. Patient has no current back pain with normal neurological exam. # Enlarged prostate: BPH, mildly symptomatic with stable PSA, and a relatively recent prostate biopsy, which was negative for malignancy. Patient continued on finasteride and Flomax as prescribed. Transitional Issues: -follow up with GI for possible endoscopy as outpatient -follow up with PCP -___ cultures pending ",1838,379
10009585-DS-9,"<SEX> M <SERVICE> MEDICINE <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___ <CHIEF COMPLAINT> Mechanical fall <MAJOR SURGICAL OR INVASIVE PROCEDURE> Open reduction internal fixation of right hip ___ <HISTORY OF PRESENT ILLNESS> Mr. ___ is a ___ year-old man with history of hypertension and chronic kidney disease presenting after mechanical fall at work. He walked into the meat freezer and tripped on a drain and fell. He did not hit his head or lose consciousness. He complained of ___ left hip pain after the event. He also had left thumb pain after hitting his thumb while using his right hand to break his fall. In the ED, initial VS: T 98.2 HR 79 BP 151/60 RR 16 SaO2 93%. Hip and femur x-ray showed right proximal femur fracture. He had a CT of his head and and c-spine that showed no intracranial hemorrhage and no fracture. Patient received morphine 8 mg, possibly aspirin 81 mg (it is unclear if he actually received this in ED), and 1 L NS. His initial EKG showed ST depressions in V3, V4, and V5. Patient was admitted to medicine to exclude myocardial infarction prior to planned orthopedic surgery. At the time of admission, patient was doing well, complaing of right hip pain. Pain was relieved by morphine in the ED, but it returnned as his analgesics wore off. He reported no chest pain, nausea, vomiting, or diaphoresis. At baseline, he can walk one flight of stairs and stops to rest when he gets to the top. He has never had chest pain, dyspnea on exertion, orthopnea, or paroxysmal nocturnal dyspnea. ROS: Denies fever, chills, night sweats, headache, vision changes, rhinorrhea, congestion, sore throat, cough, shortness of breath, chest pain, abdominal pain, nausea, vomiting, diarrhea, constipation, BRBPR, melena, hematochezia, dysuria, hematuria. <PAST MEDICAL HISTORY> Hypertension Chronic kidney disease Macular degeneration Cateracts S/P hernia repair <SOCIAL HISTORY> ___ <FAMILY HISTORY> Mother had MI at age ___, otherwise non-contributory <PHYSICAL EXAM> Admission: GENERAL - elderly gentleman appearing slightly uncomfortable, with appropriate affect VS - Temp 97.6 F, BP 140/70, HR 78, R 18, O2-sat 97% on RA HEENT - NC/AT, EOMI, sclerae anicteric, MMM, OP clear NECK - supple, no thyromegaly, no JVD, no carotid bruits LUNGS - CTA bilaterally; no wheezes, rales, rhonchi HEART - RRR, S1, S2; no murmurs, rubs, gallops ABDOMEN - Bowel sounds present, soft, non-tender, non-distended EXTREMITIES - warm and well perfused; no clubbing, cyanosis or edema; right leg shortened and externally rotated NEURO - awake, A&Ox3, CNs II-XII grossly intact, muscle strength ___ throughout (not assessed in RLE due to pain), sensation grossly intact in upper and lower extremities, no protanor drift Discharge: VS- T 96-98, BP 92-136/50-64, HR 61-81, SaO2 93-100% on RA I/O- ___ on day of discharge, ___ on prior day Weight: 91 <- 83.5 <- 87.5 <- 86.3 GENERAL- Awake and alert in NAD NECK- Supple, no JVP LUNGS- CTA bilaterally; no wheezes, rales, rhonchi HEART- RRR, S1, S2; no murmurs, rubs, gallops ABDOMEN- Soft, NT/ND, BS present EXTREMITIES - No gross deformity. No obvious deformity of right hip/thigh. 1+ edema R>L. Intact pulses distally. NEURO - A&Ox3, CN II-XII intact, strength ___ although with some pain on right hip movement against resistance. Sensation intact throughout. <PERTINENT RESULTS> ___ 01: 05PM BLOOD WBC-19.7* RBC-3.77* Hgb-12.3* Hct-35.2* MCV-93 MCH-32.5* MCHC-34.9 RDW-13.9 Plt ___ ___ 06: 46AM BLOOD WBC-13.7* RBC-3.27* Hgb-10.4* Hct-29.5* MCV-90 MCH-31.8 MCHC-35.2* RDW-15.5 Plt ___ ___ 06: 52AM BLOOD WBC-14.4* RBC-3.15* Hgb-9.9* Hct-27.8* MCV-88 MCH-31.3 MCHC-35.6* RDW-15.4 Plt ___ ___ 06: 55AM BLOOD WBC-12.9* RBC-4.14*# Hgb-12.4*# Hct-37.0* MCV-89 MCH-29.9 MCHC-33.5 RDW-16.8* Plt ___ ___ 01: 26PM BLOOD Hct-36.7* ___ 01: 05PM BLOOD ___ PTT-24.6 ___ ___ 01: 05PM BLOOD Glucose-117* UreaN-34* Creat-1.6* Na-142 K-4.1 Cl-106 HCO3-22 AnGap-18 ___ 06: 55AM BLOOD Glucose-110* UreaN-59* Creat-2.0* Na-136 K-4.1 Cl-103 HCO3-23 AnGap-14 ___ 01: 05PM BLOOD cTropnT-<0.01 ___ 09: 00AM BLOOD CK-MB-8 cTropnT-0.09* ___ 09: 15PM BLOOD CK-MB-10 MB Indx-1.4 cTropnT-0.11* ___ 07: 05AM BLOOD CK-MB-12* MB Indx-1.7 cTropnT-0.12* ___ 09: 15PM BLOOD Calcium-8.4 Phos-4.0 Mg-2.1 ___ 09: 00AM BLOOD Cholest-134 Triglyc-80 HDL-38 CHOL/HD-3.5 LDLcalc-80 ___ 02: 48AM URINE Color-Yellow Appear-Hazy Sp ___ ___ 02: 48AM URINE Blood-MOD Nitrite-NEG Protein-30 Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-5.0 Leuks-SM ___ 02: 48AM URINE RBC-8* WBC-14* Bacteri-NONE Yeast-NONE Epi-<1 ___ 02: 48AM URINE CastGr-3* ___ 02: 48AM URINE Hours-RANDOM UreaN-830 Creat-133 Na-34 K-66 Cl-50 ___ 2: 48 am URINE Source: ___. PSEUDOMONAS AERUGINOSA. 10,000-100,000 ORGANISMS/ML.. ___ 3: 56: 22 ___ ECG Baseline artifact. Sinus rhythm with ST segment depressions in leads V3-V5 suggestive of myocardial ischemia. No previous tracing available for comparison. ___ Hip X-ray Single AP view of the pelvis and AP and lateral views of the right hip were obtained. There is a comminuted fracture of the very proximal right femoral shaft with varus angulation of the proximal fragment and femoral head. No dislocation is seen. The pubic symphysis and sacroiliac joints are not widened. There is diffuse osteopenia. Degenerative changes are seen in the visualized lower lumbar spine. Multiple pelvic phleboliths are seen. IMPRESSION: Comminuted fracture of the proximal right femoral shaft with varus angulation of the proximal fragment. ___ Hand X-ray AP, oblique, and lateral views of the left hand were obtained. There is diffuse osteopenia, which limits evaluation for subtle fracture. Given this, no acute fracture or dislocation is seen. Mild degenerative change at the first carpometacarpal joint and triscaphe joint are seen. AP, oblique, and navicular views of the left wrist were obtained. No definite acute fracture or dislocation is seen. There is diffuse osteopenia. Mild degenerative changes are noted at the first carpometacarpal and the triscaphe joint. IMPRESSION: Diffuse osteopenia, which makes evaluation for subtle fractures suboptimal, however, given this, no evidence of acute fracture or dislocation. ___ Head CT There is no evidence of acute intra- or extra-axial hemorrhage, edema, mass effect or shift of normally midline structures. Scattered periventricular white matter hypodensities are compatible with chronic small vessel ischemic disease. The gray-white matter interface is otherwise well preserved without evidence of acute major vascular territorial infarct. The ventricles and sulci are proportionally enlarged consistent with age-related involutional changes. Vascular calcifications of the bilateral vertebral arteries and carotid siphons are incidentally noted. The extra-calvarial soft tissues show no evidence of trauma. The bony calvarium and skull base are intact without fractures. The mastoid air cells are well pneumatized. The ethmoid air cells, sphenoid sinus, and left maxillary sinus show evidence of sinus disease. IMPRESSION: 1. No acute intracranial process. 2. Chronic small vessel ischemic disease and age-related global atrophy. 3. Ethmoid air cells, sphenoid sinus, and left maxillary sinus show evidence of sinus disease. ___ C-Spine: There is diffuse osteopenia which limits detection of subtle cervical fractures. No definite cervical fracture or acute malalignment is seen. There is loss of normal cervical lordosis with grade 1 anterolisthesis of C3 on C4 and C4 on C5 with associated facet disease, endplate sclerosis, anterior osteophytes, and small posterior disc-osteophyte complex formation. There is no prevertebral soft tissue swelling. The atlantooccipital and atlantoaxial articulations are well maintained. The vertebral body heights are preserved. There is multilevel degenerative change predominantly in the form of cascading anterior osteophytes with posterior disc-osteophyte complexes, most prominent at C5-C6 showing marginal to moderate encroachment on the central canal. Multilevel facet disease and uncovertebral hypertrophy is also noted. The visualized lung apices are clear with minimal apical thickening or scarring. The thyroid gland is not completely visualized. IMPRESSION: 1. Diffusely osteopenic spine with no definite cervical fracture seen. 2. Grade 1 anterolisthesis of C3 on C4 and C4 on C5 is of indeterminate age, but given adjacent degenerative disease and associated facet disease, may be chronic. 3. Multilevel degenerative changes as detailed above with loss of normal cervical lordosis. CXR ___ Single supine AP portable view of the chest was obtained. The lungs are hyperinflated with flattening of the diaphragms, suggesting chronic obstructive pulmonary disease. No focal consolidation, pleural effusion, or evidence of pneumothorax is seen. The aorta is unfolded and calcified. The cardiac silhouette is top normal. No overt pulmonary edema is seen. The bones are diffusely osteopenic. ___ AP/ Lat Femur in OR Multiple views of the right proximal femur. Status post ORIF of the right femur with an intramedullary nail, hip screw, and interlocking screws. The fracture is in improved alignment. Total intraoperative fluoroscopic imaging time is 108.1 seconds. Please see operative report for further details. ___ Echocardiogram The left atrium is mildly dilated. Left ventricular wall thickness, cavity size, and global systolic function are normal (LVEF>55%). Due to suboptimal technical quality, a focal wall motion abnormality cannot be fully excluded. Right ventricular chamber size and free wall motion are normal. The ascending aorta is mildly dilated. The aortic arch is mildly dilated. The number of aortic valve leaflets cannot be determined. There is no aortic valve stenosis. Trace aortic regurgitation is seen. The estimated pulmonary artery systolic pressure is normal. There is no pericardial effusion. IMPRESSION: Normal global biventricular systolic function. No clinically-significant valvular disease seen. <MEDICATIONS ON ADMISSION> aspirin 81 mg daily Acular 4% as directed both eyes QID atenolol 50 mg daily slunisolide 25 mcg nasally BID Hyzaar 12.5-50 mg 1 tab daily naproxen 250mg PRN nifedipine 90 mg daily potassium chloride slow release 10 mEq daily <DISCHARGE MEDICATIONS> 1. aspirin 325 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 2. Acular LS 0.4 % Drops Sig: One (1) drop Ophthalmic four times a day. 3. flunisolide 25 mcg (0.025 %) Spray, Non-Aerosol Sig: One (1) puff Nasal twice a day. 4. hydrochlorothiazide 12.5 mg Tablet Sig: One (1) Tablet PO once a day. 5. nifedipine 90 mg Tablet Extended Release Sig: One (1) Tablet Extended Release PO DAILY (Daily). 6. atorvastatin 80 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 7. metoprolol tartrate 50 mg Tablet Sig: One (1) Tablet PO BID (2 times a day). 8. enoxaparin 30 mg/0.3 mL Syringe Sig: One (1) Subcutaneous Q24H (every 24 hours) for 10 days: Last dose ___ am. 9. cholecalciferol (vitamin D3) 400 unit Tablet Sig: Two (2) Tablet PO DAILY (Daily). 10. calcium carbonate 200 mg calcium (500 mg) Tablet, Chewable Sig: One (1) Tablet, Chewable PO TID (3 times a day). 11. Plavix 75 mg Tablet Sig: One (1) Tablet PO once a day: START ___. Tablet(s 12. oxycodone-acetaminophen ___ mg Tablet Sig: One (1) Tablet PO twice a day for 5 days. 13. Cipro 250 mg Tablet Sig: One (1) Tablet PO once a day for 6 days: Day ___. 14. docusate sodium 100 mg Tablet Sig: One (1) Tablet PO twice a day as needed for constipation for 7 days. <DISCHARGE DISPOSITION> Extended Care Facility: ___ ___ Diagnosis: Mechanical fall with right subtrochanteric femur fracture Non-ST segment elevation myocardial infarction Coronary artery disease Hypertension Acute on chronic kidney disease (stage 3 at presentation) Acute blood loss anemia Urinary tract infection Macular degeneration Leukocytosis <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Mr. ___, It was our pleasure to take care of you at ___. You were admitted following a mechanical fall in which you broke your hip. During the operation, you suffered a small heart attack. We found on looking at the squeezing function of your hear that there were no lasting defects, although you likely have disease and narrowing in your coronary arteries. We made the following changes to your medications: STOP atenolol STOP Hyzaar STOP Naprosyn STOP KCL CHANGE ASA to 325mg daily from 81mg daily START Hydrochlorothiazide 12.5mg daily START Atorvastatin 80mg daily START Metoprolol 50mg twice daily START Vitamin D 800U daily START Calcium Carbonate 500mg three times daily START Lovenox until ___ for 2 weeks START Ciprofloxacin 250mg daily until ___ START Oxycodone/ Acetaminophen ___ twice daily for 5 days until ___. START Docusate 100mg Twice daily as needed for constipation for 7 days until ___. ","___ year old man with history of hypertension, Chronic Kidney Disease (stage 3), S/P mechanical fall with right subtrochanteric femur fracture transferred to ___ for worsening electrocardiographic ST depressions and rising troponins without chest pain following surgical repair of his hip fracture. # Non-ST-Elevation Myocardial Infarction: Per report, patient had initial small ST depressions on admission EKG in V3-V6, which became progressivly deeper following surgery with peak troponin-T to 0.12 and CKMB 12 (in setting of peak CK 702). Patient was loaded with Plavix and given IV heparin overnight initially with resolution of ST depressions the following day. Throughout the whole event, patient was free of chest pain. A follow up echocardiogram did not detect any wall motion abnormalities and showed an EF of >55%. The option of coronary angiography for risk stratification with ad hoc angioplasty if suitable to prevent re-infarction was broached with the patient, however, he consistently declined it under all circumstances. Accordingly, non-invasive risk stratification (i.e., stress testing) was not pursued, as he would not have agreed to coronary angiography even if the test showed large areas of myocardium at risk with residual ischemia. Patient was continued on aspirin 81 mg daily and prophylactic Lovenox 30mg q24h for total of 2 weeks (___). The decision was made to not use Plavix while the patient was on Lovenox, however, resuming Plavix for at least a month for post-MI secondary prevention should be considered by his primary care physician and new cardiologist. Patient was also started on Metoprolol 50 mg BID (stopping atenolol given his CKD) and atorvastatin 80 mg daily. # Right Subtrochanteric Femur Fracture: Now S/P Open Reduction Internal Fixation ___. Patient had NSTEMI following surgery which was asymptomatic. Patient was relatively pain free throughout the hospitalization and required a total of 2 tabs of oxycodone. Per ortho, patient was allowed to weight bear as tolerated and is to complete a two week course of Lovenox for DVT prophylaxis. # Anemia/bleeding: The patient had a falling Hct after surgery (35.2 at presentation, nadir 27.5). This was felt most likely related to bleeding into his thigh. He also had guaiac (+) stools (but has an MCV of 89) and known external hemorrhoids. Patient was transfused a total of 6 units (1 prior to surgery and 5 post surgery over 4 days) as above with appropriate response. There was no evidence of bleeding based on the hip exam and lack of ecchymosis. Hct was stable at 36.7 on the day of discharge. # Leukocytosis: 19.7K, which fluctuated during the admission and was 12.9 at discharge. Patient was afebrile and without focal infectious findings. Most likely etiology is still stress response following surgery and NSTEMI. A urine culture was preliminary positive for GRAM NEGATIVE ROD(S) 10,000-100,000 ORGANISMS/ML at time of discharge (subsequently returned as Pseudomonas). Patient did have a Foley catheter during the hospitalization and was empirically begun on ciprofloxacin (to which the Pseudomonas was ultimately deemed to be sensitive). # Hypertension: Patient's home regimen was altered, taking off the Hyzaar and adding back HCTZ 12.5 mg daily. Patient was also switched from atenolol to metoprolol 50 mg BID. An ACE-inhibitor can be considered in outpatient setting for renal protection and secondary prevention post-MI when creatinine recovers. # Chronic kidney disease: Unknown baseline, but patient reports his creatinine has been elevated in past. FeNA calculated to be 0.43 indictating likely pre-renal component to the creatinine rise. Creatinine max was 2.3, at discharge he was 2.0. Medications were renally dosed, Hyzaar was held, and NSAIDs avoided. # Transitional: -Plavix 75 mg daily starting ___ with cessation of lovenox. -ACE inhibitor (patient with no known allergy) (or ___ if unable to tolerate an ACE-I) can be considered as an outpatient with stabilization of creatinine. -Urine cultures positive for ___ org/mL at time of discharge but patient asymptomatic. Started treatment with Cipro 250mg daily x 7 days (until ___ ",3744,990
10009628-DS-14,"<SEX> M <SERVICE> CARDIOTHORACIC <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___ <CHIEF COMPLAINT> coronary arttery disease <MAJOR SURGICAL OR INVASIVE PROCEDURE> ___ - Coronary artery bypass graft x5 (left internal mammary artery to the ramus artery and saphenous vein grafts to left anterior descending artery, diagonal, obtuse marginal, posterior descending) <HISTORY OF PRESENT ILLNESS> ___ year old ___ speaking gentleman was found in atrial fibrillation fibrillation following a colonoscopy. He was admitted to ___ and was found to have an elevated troponin. A cardiac catheterization was perfomed which showed severe three vessel disease. Given the severity of his disease, he was transferred to the ___ for surgical management. <PAST MEDICAL HISTORY> insulin dependent diabetes mellitus Hypercholesterolemia Diabetic retinopathy <SOCIAL HISTORY> ___ <FAMILY HISTORY> Father MI < ___ [n]died resp illness. Mother < ___ [n]MI age ___ <PHYSICAL EXAM> Pulse: Resp: 16 O2 sat: B/P Right: 122/60 Left: 122/64 Height: Weight: 145 ___ in NAD Skin: Dry [] intact [x] HEENT: PERRLA [x] EOMI [x] Neck: Supple [x] Full ROM [x] Chest: Lungs clear bilaterally [x] Heart: RRR [] Irregular [x] Murmur [n] grade ______ Abdomen: Soft [x] non-distended [x] non-tender [x] bowel sounds + [x] Extremities: Warm [x], well-perfused [x] Edema [n] _____ Varicosities: None [x] Neuro: Grossly intact [x] Pulses: Femoral Right: 2 Left: 2 DP Right: 2 Left: 2 ___ Right: 2 Left: 2 Radial Right: 2 Left: 2 Carotid Bruit Right: N Left: N <PERTINENT RESULTS> ___ - ECHO PRE BYPASS The left atrium is dilated. No spontaneous echo contrast or thrombus is seen in the body of the left atrium/left atrial appendage or the body of the right atrium/right atrial appendage. No atrial septal defect is seen by 2D or color Doppler. The left ventricular cavity size is normal. Regional left ventricular wall motion is normal. Overall left ventricular systolic function is normal (LVEF>55%). Right ventricular chamber size and free wall motion are normal. There are simple atheroma in the aortic arch. There are simple atheroma in the descending thoracic aorta. The aortic valve leaflets (3) are mildly thickened but aortic stenosis is not present. No aortic regurgitation is seen. The mitral valve leaflets are mildly thickened. Mild (1+) mitral regurgitation is seen. There is no pericardial effusion. Dr. ___ was notified in person of the results in the operating room at the time of the study. POST BYPASS The patient is atrially paced. There is normal biventricular systolic function. The mitral regurgitation is worsened - now moderate, central regurgitation. The thoracic aorta is intact after decannulation ___ 04: 20AM BLOOD WBC-9.1 RBC-2.99* Hgb-9.1* Hct-26.1* MCV-87 MCH-30.5 MCHC-35.0 RDW-13.5 Plt ___ ___ 07: 30PM BLOOD WBC-8.4 RBC-4.58* Hgb-14.0 Hct-39.5* MCV-86 MCH-30.4 MCHC-35.3* RDW-12.2 Plt ___ ___ 05: 39AM BLOOD ___ ___ 04: 20AM BLOOD ___ 05: 22AM BLOOD ___ ___ 05: 25AM BLOOD ___ ___ 01: 48AM BLOOD ___ PTT-26.0 ___ ___ 02: 53AM BLOOD ___ PTT-27.1 ___ ___ 12: 40PM BLOOD ___ PTT-26.6 ___ ___ 05: 39AM BLOOD Na-132* K-4.3 Cl-98 ___ 05: 22AM BLOOD Glucose-59* UreaN-26* Creat-1.0 Na-139 K-3.9 Cl-103 HCO3-33* AnGap-7* ___ 07: 30PM BLOOD Glucose-225* UreaN-14 Creat-0.9 Na-138 K-4.0 Cl-104 HCO3-24 AnGap-14 ___ 07: 30PM BLOOD ALT-23 AST-24 LD(LDH)-199 AlkPhos-85 TotBili-0.3 <MEDICATIONS ON ADMISSION> Lantus 15units daily,metformin 850mg BID,Glipizide 20mg daily,ASA 325mg daily,Lipitor 40mg daily, prn Naproxen <DISCHARGE MEDICATIONS> 1. Outpatient Lab Work serial ___ Coumadin for AFib Goal INR ___ First draw day after discharge Then please do INR checks ___, and ___ for 2 weeks then decrease as directed by Dr. ___ to phone ___ fax ___ 2. hydromorphone 2 mg Tablet Sig: ___ Tablets PO Q4H (every 4 hours) as needed for pain for 4 weeks. Disp: *50 Tablet(s)* Refills: *0* 3. metoprolol tartrate 50 mg Tablet Sig: One (1) Tablet PO TID (3 times a day). Disp: *90 Tablet(s)* Refills: *2* 4. metformin 500 mg Tablet Sig: One (1) Tablet PO twice a day. Disp: *60 Tablet(s)* Refills: *2* 5. atorvastatin 40 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). Disp: *30 Tablet(s)* Refills: *2* 6. tamsulosin 0.4 mg Capsule, Ext Release 24 hr Sig: One (1) Capsule, Ext Release 24 hr PO HS (at bedtime). Disp: *30 Capsule, Ext Release 24 hr(s)* Refills: *2* 7. isosorbide dinitrate 10 mg Tablet Sig: One (1) Tablet PO TID (3 times a day). Disp: *90 Tablet(s)* Refills: *2* 8. amiodarone 200 mg Tablet Sig: as directed Tablet PO BID (2 times a day): 400mg (2 tablets) twice daily for two weeks, then 200mg (one tablet) twiced daily for two weeks , then 200mg(one tablet) daily until instructed to discontinue. Disp: *100 Tablet(s)* Refills: *2* 9. magnesium hydroxide 400 mg/5 mL Suspension Sig: Thirty (30) ML PO HS (at bedtime) as needed for constipation. 10. acetaminophen 325 mg Tablet Sig: Two (2) Tablet PO Q4H (every 4 hours) as needed for fever, pain. 11. aspirin 81 mg Tablet, Delayed Release (E.C.) Sig: One (1) Tablet, Delayed Release (E.C.) PO DAILY (Daily). <DISCHARGE DISPOSITION> Home With Service Facility: ___ ___ Diagnosis: Coronary artery disease IDDM Hypercholesterolemia Diabetic retinopathy <DISCHARGE CONDITION> Alert and oriented x3, nonfocal Ambulating with steady gait Incisional pain managed with oral analgesics Incisions: Sternal - healing well, no erythema or drainage Leg Left - healing well, no erythema or drainage. Edema: trace <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> 1) Please shower daily including washing incisions gently with mild soap, no baths or swimming until cleared by surgeon. Look at your incisions daily for redness or drainage. 2) Please NO lotions, cream, powder, or ointments to incisions. 3) Each morning you should weigh yourself and then in the evening take your temperature, these should be written down on the chart provided. 4) No driving for approximately one month and while taking narcotics. Driving will be discussed at follow up appointment with surgeon when you will likely be cleared to drive. 5) No lifting more than 10 pounds for 10 weeks 6) Please call with any questions or concerns ___ **Please call cardiac surgery office with any questions or concerns ___. Answering service will contact on call person during off hours** ","Mr. ___ was admitted to the ___ on ___ for surgical management of his coronary artery disease. He was worked-up in the usual preoperative manner. A radial duplex ultrasound was obtained as a radial artery graft was desired given his younger age. This revealed significant califications of the bilateral radial arteries and thus the decision was made not to use a radial artery for conduit. On ___, Mr. ___ was taken to the Operating Room where he underwent coronary artery bypass grafting to five vessels. As the greater saphenous vein was very small in the left leg, an extra length was harvested from his right thigh. Please see operative note for details. Postoperatively he was taken to the Intensive Care Unit for monitoring. Over the next several hours, he awoke neurologically intact and was extubated. He was transfused a unit of red blood cells for postoperative anemia. He remained in atrial fibrillation which was treated with Amiodarone. On postoperative day two, he was transferred to the step down unit for further recovery. He was gently diuresed towards his preoperative weight. The Physical Therapy service was consulted for assistance with his postoperative strength and mobility. Anti-coagulation was initiated with Coumadin for atrial fibrillation. He was extremely sensitive to dosing and his INR rose to 5.2, nec3essitating an extra hospital day as the Coumadin was held and the INR fell to 3. Arrangements were made for his anticoagulation to be managed by his primary care physician. Follwoup appointments were given and medications and restrictions discussed. He had converted to sinus rhythm at discharge and Amiodarone will be tapered over the next 4 weeks. ",1941,357
10009657-DS-2,"<SEX> F <SERVICE> SURGERY <ALLERGIES> Patient recorded as having No Known Allergies to Drugs <ATTENDING> ___ <CHIEF COMPLAINT> Fevers, chills, perianal pain <MAJOR SURGICAL OR INVASIVE PROCEDURE> Incision and drainage of rectal abscess <HISTORY OF PRESENT ILLNESS> ___ yo F s/p laser destruction of perineal and perianal condyulomata on ___ by Dr. ___. She had recovered well, and had returned both to work and school. She now returns with complaints of 3 days of intermittant fevers and chills, as well as some new L perianal pain. She reports night sweats as well. She has had a decreased appetite since the surgery and she has had some trouble moving her bowels since then, with her last BM being 3 days ago. She denies nausea or vomiting. She denies any melena or hematochezia. She denies any drainage of bleeding from the perianal region. Her L gluteus is tender when sitting, but she does not note any increase in pain when she moves her bowels. She does reports some dysuria and dark brown urine. <PAST MEDICAL HISTORY> PMH: Depression, anxiety, perineal/perianal condylomata PSH: Microscopically-assisted biopsy and transanal laser destruction of anal, perineal, vulvar, and vaginal condylomata ___ <SOCIAL HISTORY> ___ <FAMILY HISTORY> Non-contributory. <PHYSICAL EXAM> On day of admission: PE: 98.4 94 140/84 10 100RA NAD. A&Ox3. Anicteric. MMM. Supple. RRR. CTAB. Soft. NT. ND. +BS. Normal tone. No masses. No gross or occult blood. Erythema ~2 lateral to anal verge on L, occupying apex of gluteus. Tender to palpation. No induration or fluctuance at area of erythema. No tenderness in the anal canal. No masses, fullness or tenderness on digial rectal exam. No additional condylomata appreciated. Warm and well perfused. No peripheral edema. <PERTINENT RESULTS> ___ 06: 40AM BLOOD WBC-12.1* RBC-3.58* Hgb-11.4* Hct-32.9* MCV-92 MCH-31.8 MCHC-34.6 RDW-12.4 Plt ___ ___ 06: 25AM BLOOD WBC-19.5* RBC-3.55* Hgb-11.2* Hct-32.9* MCV-93 MCH-31.5 MCHC-33.9 RDW-12.6 Plt ___ ___ 07: 15AM BLOOD WBC-22.7* RBC-3.38* Hgb-10.9* Hct-31.1* MCV-92 MCH-32.3* MCHC-35.1* RDW-12.2 Plt ___ ___ 10: 20AM BLOOD WBC-31.3* RBC-4.03* Hgb-13.3 Hct-37.1 MCV-92 MCH-33.1* MCHC-35.9* RDW-12.1 Plt ___ ___ 06: 20PM BLOOD Neuts-69 Bands-21* Lymphs-5* Monos-5 Eos-0 Baso-0 ___ Myelos-0 ___ 10: 20AM BLOOD Glucose-115* UreaN-5* Creat-0.6 Na-137 K-4.1 Cl-103 HCO3-21* AnGap-17 ___ 10: 20AM BLOOD Calcium-8.3* Phos-2.5* Mg-1.7 . CT ABDOMEN W/CONTRAST Study Date of ___ IMPRESSION: Large anal fluid collection, which may represent multiple adjacent collections, or a single large collection with multiple compartments. It is highly suspicious for abscess in this clinical setting and would be amenable to percutaneous drainage. <MEDICATIONS ON ADMISSION> None <DISCHARGE MEDICATIONS> 1. Acetaminophen 500 mg Tablet Sig: ___ Tablets PO Q6H (every 6 hours) as needed for pain: Do not exceed 4000mg in 24hours. 2. Tums 500 mg Tablet, Chewable Sig: ___ Tablet, Chewables PO four times a day as needed for heartburn. 3. Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day) as needed for constipation for 1 months: Take with oxycodone. Disp: *60 Capsule(s)* Refills: *0* 4. Ciprofloxacin 250 mg Tablet Sig: Three (3) Tablet PO Q12H (every 12 hours) for 7 days. Disp: *42 Tablet(s)* Refills: *0* 5. Metronidazole 500 mg Tablet Sig: One (1) Tablet PO TID (3 times a day) for 7 days: Take with food. Disp: *21 Tablet(s)* Refills: *0* 6. Oxycodone 5 mg Tablet Sig: ___ Tablets PO Q4H (every 4 hours) as needed for pain for 2 weeks: Take 2 tabs 30 minutes prior to dressing change and as needed. Disp: *45 Tablet(s)* Refills: *0* 7. Ibuprofen 600 mg Tablet Sig: One (1) Tablet PO Q8H (every 8 hours) as needed for pain for 2 weeks: Take with food . Disp: *45 Tablet(s)* Refills: *0* <DISCHARGE DISPOSITION> Home With Service Facility: ___ <DISCHARGE DIAGNOSIS> Primary: ___ abscess . Secondary: perineal/perianal condylomas, Anxiety, depression <DISCHARGE CONDITION> Stable Tolerating a regular diet Adequate pain control with oral medication <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Please call your doctor or return to the ER for any of the following: * Your pain is not improving within ___ hours or not gone within 24 hours. Call or return immediately if your pain is getting worse or is changing location or moving to your chest or back. *Avoid driving or operating heavy machinery while taking pain medications. * You have shaking chills, or a fever greater than 101.5 (F) degrees or 38(C) degrees. * Any serious change in your symptoms, or any new symptoms that concern you. * Please resume all regular home medications and take any new meds as ordered. * Continue to ambulate several times per day. . Perirectal Abscess wound care: -Pre-medicate yourself with Pain pills about ___ minutes prior to dressing change per Visting nurse. -___ should be changed once a day. -You may shower. Avoid swimming and baths until your follow-up appointment. -Please call the doctor if you have increased pain, swelling, redness, or drainage from the incision sites. ","The patient was admitted from the emergency room on ___. She was empirically started on levo/flagyl. ___ - the patient had a CT confirming a deep multiloculated ___ abscess and was brought to the operating room for an incision and drainage of a ___ abscess. A foley catheter was placed due to difficulty voiding. ___ - the patient underwent a dressing change and second look in the operating room which revealed no undrained or new areas, she continued on antibiotics. The foley catheter was removed at midnight. Voiding adequate amounts. ___ - Tolerating a regular diet. Passing flatus. Ambulating independently. Perirectal wound packing changed at bedside. Two open sites, packed with kerlix gauze. Wound bed beefy red, no purulent exudate noted. Patient pre-medicated prior to dressing change. Tolerated well. WBC decreased 19.5 from 22. ___ - Discharge home with ___ for dressing changes. Continue with oral antibiotics for 7 more days. ",1572,216
10009657-DS-3,"<SEX> F <SERVICE> SURGERY <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> perirectal abscess <MAJOR SURGICAL OR INVASIVE PROCEDURE> Exam under anesthesia Incision and drainage of complex ___ abscess <HISTORY OF PRESENT ILLNESS> Ms. ___ is a ___ woman who underwent incision and drainage of a perirectal abscess approximately ___ years ago. She now presents with recurrent perirectal abscess and on a CAT scan that was obtained in the emergency room before surgery consult; the patient was found to have a horseshoe type of perirectal abscess extending from the patient's left side and around the rectum on the dorsal aspect. The patient was then taken to the OR for examination under anesthesia and incision and drainage of the perirectal abscess. <PAST MEDICAL HISTORY> PMH: Depression, anxiety, perineal/perianal condylomata PSH: Microscopically-assisted biopsy and transanal laser destruction of anal, perineal, vulvar, and vaginal condylomata ___ <SOCIAL HISTORY> ___ <FAMILY HISTORY> Non-contributory. <PHYSICAL EXAM> Discharge Physical Exam VS: 98.9 73 115/76 18 100%ra Gen: alert and oriented x3 NAD CV: RRR Pulm: CTAB Abd: Soft NT ND Rectal: opened abscess cavity with some purulent drainage, packed loosely with plain packing material <PERTINENT RESULTS> ___ 04: 21PM LACTATE-0.9 ___ 02: 25PM WBC-19.1*# RBC-3.82* HGB-11.7* HCT-36.0 MCV-94 MCH-30.6 MCHC-32.5 RDW-11.9 ___ 04: 45AM BLOOD WBC-13.7* RBC-3.59* Hgb-11.2* Hct-33.4* MCV-93 MCH-31.1 MCHC-33.5 RDW-11.6 Plt ___ <MEDICATIONS ON ADMISSION> lamictal 100', dicyclomine 10' <DISCHARGE MEDICATIONS> 1. lamotrigine 100 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 2. oxycodone 5 mg Tablet Sig: ___ Tablets PO Q4H (every 4 hours) as needed for pain. Disp: *40 Tablet(s)* Refills: *0* 3. acetaminophen 325 mg Tablet Sig: Two (2) Tablet PO Q6H (every 6 hours) as needed for pain. Disp: *40 Tablet(s)* Refills: *0* 4. dicyclomine 10 mg Capsule Sig: One (1) Capsule PO once a day. 5. Colace 100 mg Capsule Sig: One (1) Capsule PO twice a day. Disp: *60 Capsule(s)* Refills: *0* <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> ___ abscess <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> You were admitted to the colorectal surgery service after drainage of a complex ___ abscess. You have done well postoperatively and you are now ready to go home. You will have a small wick inside the abscess. This should be removed tomorrow. After it is removed, please start taking ___ baths daily and after bowel movements. Continue to take pain medication as needed and also take stool softeners to prevent constipation. ","Ms. ___ has a history of prior perirectal abscesses, and presented to the ED with symptoms of a recurrent abscess. She was taken to the OR for incision and drainage of this large horseshoe type abscess; for full details please see the dictated operative summary. She tolerated the procedure well; a shortened chest tube was left in the cavity to allow for irrigation overnight. She was brought back to the floor in good condition. She was advanced to a regular diet and pain was controlled on oral medications. She ambulated and voided appropriately. She remained on cipro/flagyl for the duration of her hospital course. Prior to discharge, the tube was removed from the cavity and a loose packing was placed. She will remove the packing in one day and follow up with Dr. ___ in clinic later this week. She is discharged home in good condition on hospital day 2, POD#1. ",833,187
10009657-DS-4,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___ <CHIEF COMPLAINT> N/V/D <MAJOR SURGICAL OR INVASIVE PROCEDURE> none <HISTORY OF PRESENT ILLNESS> ___ woman whose PMH includes laser ablation for perianal condylomata and subsequent hx of complex ischiorectal abscess requiring operative drainage, s/p resection of perianal abscess ___, p/w n/v/d since this AM. Pt reports that the diarrhea is watery, emesis is nonbilious, non-bloody. Denies f/c. Denies cp/sob/ha. Pt reports that she initially had onset of abdominal pain shortly before diarrhea. Reports no rectal pain.She felt very well on the day of presentation and only after participating in cleaning day did she experienced gradual -> severe abdominal pain/supra-pelvic burning -> nausea -> emesis and diarrhea. Earlier outbreak of norovirus at her school where she works but none recently. No clear sick contacts. No foreign travel. No strange foods. No vaginal discharge or bleeding. On examination in the ED, moderate abdominal ttp below the umbilicus with rebound. Per rectum, purulent-appearing mucoid discharge which is occult positive. In ER: (Triage Vitals: 9 96.9 77 101/54 16 100% RA ) Meds Given: ___ 14: 15 Ondansetron 2mg/mL-2mL 1 ___ ___ 15: 38 Ondansetron 2mg/mL-2mL 1 ___ ___ 15: 50 Readi-Cat 2 (Barium Sulfate 2% Suspension) 450 mL Bottle 2 ___ ___ 16: 15 Morphine 5 mg Vial [class 2] Radiology Studies: abdominal CT PAIN SCALE: ___ ________________________________________________________________ REVIEW OF SYSTEMS: CONSTITUTIONAL: [] All Normal [ -] Fever [- ] Chills [ ] Sweats [ ] Fatigue [ ] Malaise [ ]Anorexia [ ]Night sweats [ -] _____ lbs. weight loss/gain over _____ months Eyes [X] All Normal [ ] Blurred vision [ ] Loss of vision [] Diplopia [ ] Photophobia ENT [x] WNL [ ] Dry mouth [ ] Oral ulcers [ ] Bleeding gums [ ] Sore throat [] Sinus pain [ ] Epistaxis [ ] Tinnitus [ ] Decreased hearing [ ] Other: RESPIRATORY: [X] All Normal [ ] Shortness of breath [ ] Dyspnea on exertion [ ] Can't walk 2 flights [ ] Cough [ ] Wheeze [ ] Purulent sputum [ ] Hemoptysis [ ]Pleuritic pain [ ] Other: CARDIAC: [X] All Normal [ ] Palpitations [ ] Edema [ ] PND [ ] Orthopnea [ ] Chest Pain [ ] Dyspnea on exertion [ ] Other: GI: [] All Normal [ +] Nausea [+] Vomiting [+] Abd pain [] Abdominal swelling [+] Diarrhea [ ] Constipation [ ] Hematemesis [- ] Blood in stool [ ] Melena [ ] Dysphagia: [ ] Solids [ ] Liquids [ ] Odynophagia [ ] Anorexia [ ] Reflux [ ] Other: GU: [X] All Normal [ ] Dysuria [ ] Incontinence or retention [ ] Frequency [ ] Hematuria []Discharge []Menorrhagia SKIN: [X] All Normal [ ] Rash [ ] Pruritus MS: [X] All Normal [ ] Joint pain [ ] Jt swelling [ ] Back pain [ ] Bony pain NEURO: [X] All Normal [ ] Headache [ ] Visual changes [ ] Sensory change [ ]Confusion [ ]Numbness of extremities [ ] Seizures [ ] Weakness [ ] Dizziness/Lightheaded [ ]Vertigo [ ] Headache ENDOCRINE: [X] All Normal [ ] Skin changes [ ] Hair changes [ ] Heat or cold intolerance [ ] loss of energy HEME/LYMPH: [] All Normal [+] Easy bruising- chronic [ ] Easy bleeding [ ] Adenopathy PSYCH: [X] All Normal [ ] Mood change []Suicidal Ideation [ ] Other: ALLERGY: [- ]Medication allergies [ ] Seasonal allergies [X]all other systems negative except as noted above <PAST MEDICAL HISTORY> PMH: Depression, anxiety, perineal/perianal condylomata PSH: # Microscopically-assisted biopsy and transanal laser destruction of anal, perineal, vulvar, and vaginal condylomata ___ # perirectal abscess drainage in ___ # perirectal abscess drainage ___ <SOCIAL HISTORY> ___ <FAMILY HISTORY> Maternal grandmother with skin cancer. Paternal aunt with breast cancer. <PHYSICAL EXAM> 1. VS T = 98.9 P = 73 BP = 127/76 RR = 18 O2Sat on _100% on RA GENERAL: Well appearing very pleasant female. Nourishment: good Grooming: good Mentation 2. Eyes: [X] WNL EOMI without nystagmus, Conjunctiva: clear/injection/exudates/icteric 3. ENT [X] WNL [X] Moist [] Endentulous [] Ulcers [] Erythema [] JVD ____ cm [] Dry [] Poor dentition [] Thrush [] Swelling [] Exudate 4. Cardiovascular [X] WNL [X] Regular [] Tachy [X] S1 [X] S2 [] Systolic Murmur /6, Location: [] Irregular []Brady []S3 [] S4 [] Diastolic Murmur /6, Location: [X] Edema RLE None [] Bruit(s), Location: [X] Edema LLE None [] PMI [] Vascular access [X] Peripheral [] Central site: 5. Respiratory [ ] [X] CTA bilaterally [ ] Rales [ ] Diminshed [] Comfortable [ ] Rhonchi [ ] Dullness [ ] Percussion WNL [ ] Wheeze [] Egophony 6. Gastrointestinal [ ] WNL Soft, non tender all quadrants. She reports that her abdomen was tender when examined in the ED but now it is much improved. Rectum: site of ___ abscess drainage non-tender and without erythema 7. Musculoskeletal-Extremities [] WNL [ ] Tone WNL [x ]Upper extremity strength ___ and symmetrical [ ]Other: [ ] Bulk WNL [X] Lower extremity strength ___ and symmetrica [ ] Other: [] Normal gait []No cyanosis [ ] No clubbing [] No joint swelling 8. Neurological [X] WNL [X ] Alert and Oriented x 3 [ ] Romberg: Positive/Negative [ ] CN II-XII intact [ ] Normal attention [ ] FNF/HTS WNL [] Sensation WNL [ ] Delirious/confused [ ] Asterixis Present/Absent [ ] Position sense WNL [ ] Demented [ ] No pronator drift [] Fluent speech 9. Integument [] WNL Warm and dry with multiple tatooes 10. Psychiatric [X] WNL [X] Appropriate [] Flat affect [] Anxious [] Manic [] Intoxicated [] Pleasant [] Depressed [] Agitated [] Psychotic [] Combative 11. Hematologic/Lymphatic [ X] WNL [X] No cervical ___ [] No axillary ___ [] No supraclavicular ___ [] No inguinal ___ [] Thyroid WNL TRACH: []present [X]none PEG: []present [X]none [ ]site C/D/I COLOSTOMY: : []present [X]none [ ]site C/D/I <PERTINENT RESULTS> ___ 04: 00PM URINE HOURS-RANDOM ___ 04: 00PM URINE UCG-NEGATIVE ___ 04: 00PM URINE COLOR-Yellow APPEAR-Clear SP ___ ___ 04: 00PM URINE BLOOD-NEG NITRITE-NEG PROTEIN-30 GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-5.5 LEUK-NEG ___ 04: 00PM URINE RBC-1 WBC-2 BACTERIA-FEW YEAST-NONE EPI-4 ___ 04: 00PM URINE MUCOUS-MANY ___ 02: 29PM LACTATE-3.3* ___ 02: 15PM GLUCOSE-113* UREA N-12 CREAT-0.9 SODIUM-136 POTASSIUM-3.7 CHLORIDE-100 TOTAL CO2-23 ANION GAP-17 ___ 02: 15PM estGFR-Using this ___ 02: 15PM ALT(SGPT)-31 AST(SGOT)-29 ALK PHOS-73 TOT BILI-0.3 ___ 02: 15PM LIPASE-88* ___ 02: 15PM ALBUMIN-4.9 CALCIUM-9.8 PHOSPHATE-3.6 MAGNESIUM-1.7 ___ 02: 15PM WBC-37.1*# RBC-4.99# HGB-15.3# HCT-46.8# MCV-94 MCH-30.6 MCHC-32.6 RDW-12.5 ___ 02: 15PM NEUTS-92.4* LYMPHS-4.5* MONOS-2.4 EOS-0.5 BASOS-0.2 ___ 02: 15PM PLT COUNT-482*# -------------- <MEDICATIONS ON ADMISSION> dicyclomine 10 mg Capsule 1 (One) Capsule(s) by mouth four times a day take before each meal and at bedtime ___ lamotrigine [Lamictal] 100 mg Tablet 1 (One) Tablet(s) by mouth once a day (Prescribed by Other Provider) ___ <DISCHARGE MEDICATIONS> 1. lamotrigine 100 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 2. dicyclomine 10 mg Capsule Sig: One (1) Capsule PO four times a day: before meals and at bedtime. <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Primary diagnosis: viral gastroenteritis Secondary diagnoses: pelvic cyst, needs f/u IBS depression/ anxiety <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> See below. We made no changes in your outpatient medications. ","The patient is a lovely ___ year old female with h/o perirectal abscess x ___ s/p drainage of a perirectal abscess now presenting with abdominal pain, nausea, vomiting, diarrhea. # viral gastroenteritis, likely Norovirus: Clinically stable, quickly improved, able to tolerate po and advance to regular diet within 12 hours of admission. Leukocytosis much improved. No indication for antibiotics. # perirectal abscess: no acute issues, s/p drainage on ___ # IBS: stable, continued dicyclomine . # ovarian cyst: noted on CT scan; obtained pelvic US to further evaluate. It showed simple right ovarian cyst measuring up to 5.2 cm in maximum dimension. Ultrasound followup in one year is recommended. # depression/ anxiety: stable, continued lamictal ",2391,173
10009657-DS-5,"<SEX> F <SERVICE> SURGERY <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___ <CHIEF COMPLAINT> Rectal Pain <MAJOR SURGICAL OR INVASIVE PROCEDURE> Incision and Drainage with ___ Placement for treatment of Perirectal Abscess <HISTORY OF PRESENT ILLNESS> HPI: ___ with IBS and prior I&D of ___ and ischiorectal abscesses in ___ and ___ now p/w worsening rectal pain over the past several days. She was recently seen in ED on ___ with 2 days of worsening rectal pain after anal sex, examination at that time exam was unremarkable and pt was instructed to avoid anal intercourse and discharged home. Patient states that since that time she has had increased rectal pain and swelling, fevers/chills, and night sweats. Feels that this is consistent with her prior presentations of perianal abscesses. She has refrained from all sexual contact since her last ED visit. She also reports some nausea and bloating, but denies vomiting, hematochezia or black stools. She has no pain with defecation and her last BM was yesterday. <PAST MEDICAL HISTORY> PMH: Depression, anxiety, perineal/perianal condylomata PSH: # Microscopically-assisted biopsy and transanal laser destruction of anal, perineal, vulvar, and vaginal condylomata ___ # perirectal abscess drainage in ___ # perirectal abscess drainage ___ <SOCIAL HISTORY> ___ <FAMILY HISTORY> Maternal grandmother with skin cancer. Paternal aunt with breast cancer. <PHYSICAL EXAM> General: Doing well, pain controlled, tolerating medications by mouth, minimal pain A&OX3 No chest pain or shortness of breath Abd: soft, nondistended <PERTINENT RESULTS> ___ 05: 40AM BLOOD WBC-19.3* RBC-3.63* Hgb-11.8* Hct-34.9* MCV-96 MCH-32.6* MCHC-33.8 RDW-11.8 Plt ___ ___ 02: 17PM BLOOD WBC-20.3* RBC-4.22 Hgb-13.5 Hct-41.3 MCV-98 MCH-32.0 MCHC-32.7 RDW-11.5 Plt ___ ___ 02: 17PM BLOOD Neuts-89.3* Lymphs-6.9* Monos-3.5 Eos-0.1 Baso-0.2 ___ 05: 40AM BLOOD Glucose-103* UreaN-6 Creat-0.5 Na-139 K-3.5 Cl-105 HCO3-24 AnGap-14 ___ 02: 17PM BLOOD Glucose-84 UreaN-7 Creat-0.7 Na-138 K-3.8 Cl-103 HCO3-26 AnGap-13 ___ 05: 40AM BLOOD Calcium-8.0* Phos-3.5 Mg-1.5* CT ABD & PELVIS WITH CONTRAST Study Date of ___ 5: 36 ___ IMPRESSION: IMPRESSION: A large perianal fluid collection consistent with abscess does not definitely involve the anal sphincter, but is not well evaluated on CT. If definite determinent of sphincter involvement is required, MR can help with further evaluation. <MEDICATIONS ON ADMISSION> None <DISCHARGE MEDICATIONS> 1. Acetaminophen 1000 mg PO Q8H do not take more than 3000mg of tylenol in 24 hours or drink alcohol while taking 2. Docusate Sodium 100 mg PO BID 3. OxycoDONE (Immediate Release) ___ mg PO Q3H: PRN pain do not drink alcohol or drive a car while taking this medications RX *oxycodone 5 mg ___ tablet(s) by mouth every four (4) hours Disp #*35 Tablet Refills: *0 4. Amoxicillin-Clavulanic Acid ___ mg PO Q12H Duration: 7 Days Please take entire prescription, start first dose evening of ___ RX *amoxicillin-pot clavulanate 875 mg-125 mg 1 Tablet by mouth every twelve (12) hours Disp #*14 Tablet Refills: *0 <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Perirectal Abscess <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> You were admitted to the inpatient Colorectal Surgery Service after I&D of horseshoe perirectal abscess with ___ placement. Please monitor your bowel function closely. You may or may not have had a bowel movement prior to your discharge which is acceptable, however it is important that you have a bowel movement in the next ___ days. If you are taking narcotic pain medications there is a risk that you will have some constipation. Please take an over the counter stool softener such as Colace, and if the symptoms do not improve call the office. If you have any of the following symptoms please call the office for advice or go to the emergency room if severe: increasing abdominal distension, increasing abdominal pain, nausea, vomiting, inability to tolerate food or liquids, prolonged loose stool, or extended constipation. You can shower, let the warm soapy water run over the area and keep as clean and dry as possible. You may preform ___ baths ___ times daily as needed. Please preform these as instructed by the nursing staff. Please eat foods that promote bowel motility such as: prunes, oat meal, apple juice, etc. Please avoid constipation. You have ___ which has been incerted into the abscess and this will help keep the abscess draining and allow it to heal. This can be left open to air and a gauze dressing o pad may be worn in your underwear collect drianage. The ___ will stay in place until your first clinic visit and Dr. ___ will decide if the abscess has resolved enough for it to be removed. Please monitor or rectal area for signs and symptoms of worsening infection including: increasing redness, increased pain, increased draining of white/green/yellow/foul smelling drainage, or if you develop a fever. Please call the office if you develop these symptoms or go to the emergency room if the symptoms are severe. You may shower, let the warm water run over the incision line and pat the area dry with a towel, do not rub. Avoid intercourse until your follow-up with Dr. ___. You may gradually increase your activity as tolerated but clear heavy exercise with your surgeon. You will be prescribed a small amount of the pain medication Oxycodone. Please take this medication exactly as prescribed. You may take Tylenol as recommended for pain. Please do not take more than 3000mg of Tylenol daily. Do not drink alcohol while taking narcotic pain medication or Tylenol. Please do not drive a car while taking narcotic pain medication. Thank you for allowing us to participate in your care! Our hope is that you will have a quick return to your life and usual activities. Good luck! ","Ms. ___ was admitted overnight after I&D of a perirectal abscess. She was doing well on post-operative day one. Her wbs was 19 however, the abscess was drained. She was seen by the surgical attending and discharged home. She was given a week of Augmentin by mouth and pain mediacation. She tolerated a regular diet without issue. ",1580,78
10009657-DS-6,"<SEX> F <SERVICE> SURGERY <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___ <CHIEF COMPLAINT> ___ abscess <MAJOR SURGICAL OR INVASIVE PROCEDURE> ___: Examination under anesthesia, incision and drainage of perirectal abscess. <HISTORY OF PRESENT ILLNESS> ___ with hx of IBS, ___ abscess s/p multiple I&D presenting now with 1 week of rectal pain. Patient states her symptoms of 'pressure' and 'pain' are very similar to that of her previous episodes of ___ abscess. She attempted ___ baths but noted increasing pain over the past three days. She denies fevers or chills. Has noted some drainage from below, denies foul odor, purulence or blood. She denies pelvic or abdominal pain. She has had a colonoscopy, most recently ___ ___ to evaluate for possible IBD and was found to have internal hemorrhoids. <PAST MEDICAL HISTORY> PMH: IBS, Depression, anxiety, perineal/perianal condylomata, perirectal abscess PSH: Microscopically-assisted biopsy and transanal laser destruction of anal, perineal, vulvar, and vaginal condylomata ___ perirectal abscess drainage ___, perirectal abscess drainage ___ ___ placement of horseshoe abscess ___ <SOCIAL HISTORY> ___ <FAMILY HISTORY> Maternal grandmother with skin cancer. Paternal aunt with breast cancer. <PHYSICAL EXAM> --ADMISSION EXAM-- PE: VS: afebrile, VSS General: ___ no acute distress, able to ambulate without difficulty HEENT: mucus membranes moist, nares clear, trachea at midline CV: regular rate, rhythm. No appreciable murmurs, rubs, gallops Pulm: clear to auscultation bilaterally Abd: non-tender, non-distended GU: no ___ masses. left lateral fullness and scarring c/w prior abscess/I&D. Induration and tenderness to palpation of the left anterior anus. 1cm linear opening which does not extend into the anus, unable to express additional fluid or pus. MSK: warm, well perfused Neuro: alert, oriented to person, place, time --DISCHARGE EXAM-- VS: T99.7, HR 75, BP 114/71, RR 16, SaO2 98% General: ___ no acute distress, appears well CV: regular rate, rhythm. No appreciable murmurs, rubs, gallops Pulm: clear to auscultation bilaterally Abd: non-tender, non-distended GU: Malecot drain secured ___ place with stitch with minimal serosanguinous drainage. No erythema or fullness of perianal region. Ext: warm, well perfused Neuro: alert, oriented to person, place, time <PERTINENT RESULTS> --LABS-- ___ 09: 45PM BLOOD WBC-16.3* RBC-4.07* Hgb-13.4 Hct-36.6 MCV-90 MCH-32.9* MCHC-36.7* RDW-12.1 Plt ___ ___ 08: 16AM BLOOD WBC-13.7* RBC-3.75* Hgb-12.2 Hct-33.9* MCV-90 MCH-32.4* MCHC-35.9* RDW-11.8 Plt ___ ___ 09: 45PM BLOOD Glucose-90 UreaN-8 Creat-0.7 Na-138 K-4.0 Cl-105 HCO3-19* AnGap-18 ___ 08: 16AM BLOOD Glucose-100 UreaN-7 Creat-0.7 Na-138 K-3.8 Cl-105 HCO3-25 AnGap-12 --MICROBIOLOGY-- ___ 9: 35 pm URINE N. **FINAL REPORT ___ URINE CULTURE (Final ___: NO GROWTH. ___ 12: 45 am BLOOD CULTURE X2 **FINAL REPORT ___ Blood Culture, Routine (Final ___: NO GROWTH. ___ 6: 07 am ABSCESS PERIRECTAL . **FINAL REPORT ___ GRAM STAIN (Final ___: 1+ (<1 per 1000X FIELD): POLYMORPHONUCLEAR LEUKOCYTES. 1+ (<1 per 1000X FIELD): GRAM POSITIVE COCCI. ___ PAIRS. SMEAR REVIEWED; RESULTS CONFIRMED. FLUID CULTURE (Final ___: NO GROWTH. ANAEROBIC CULTURE (Final ___: NO GROWTH. <MEDICATIONS ON ADMISSION> Birth control <DISCHARGE MEDICATIONS> 1. Acetaminophen 650 mg PO Q6H: PRN pain 2. Ciprofloxacin HCl 500 mg PO Q12H Take for 14 days (___). RX *ciprofloxacin HCl 500 mg 1 tablet(s) by mouth every 12 hours Disp #*28 Tablet Refills: *0 3. MetRONIDAZOLE (FLagyl) 500 mg PO Q8H Take for 14 days (___). RX *metronidazole 500 mg 1 tablet(s) by mouth every 8 hours Disp #*40 Tablet Refills: *0 4. OxycoDONE (Immediate Release) ___ mg PO Q4H: PRN pain RX *oxycodone 5 mg ___ tablet(s) mouth every 4 hours Disp #*40 Tablet Refills: *0 <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Horseshoe perirectal abscess <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Ms. ___, You were admitted to the Colorectal Surgery Service at ___ after undergoing incision and drainage of a perirectal abscess. A Malecot drain was placed to help heal the abscess. You have done well and can be discharged home. You are going home with the drain. Please monitor your bowel function closely. You may or may not have had a bowel movement prior to your discharge which is acceptable, however it is important that you have a bowel movement ___ the next ___ days. If you are taking narcotic pain medications there is a risk that you will have some constipation. Please take an over the counter stool softener such as Colace, and if the symptoms do not improve call the office. If you have any of the following symptoms please call the office for advice or go to the emergency room if severe: increasing abdominal distension, increasing abdominal pain, nausea, vomiting, inability to tolerate food or liquids, prolonged loose stool, or extended constipation. You can shower, let the warm soapy water run over the area and keep as clean and dry as possible. You may perform ___ baths ___ times daily as needed. Please eat foods that promote bowel motility such as: prunes, oat meal, apple juice, etc. Please avoid constipation. You have a Malecot drain which has been inserted into the abscess cavity, and this will help keep the abscess draining and allow it to heal. During the day, you can cap or tie the Malecot. At night, you need to open it to allow it to drain the abscess. The drain will stay ___ place until your first clinic visit and Dr. ___ will decide if the abscess has resolved enough for it to be removed. Please monitor the rectal area for signs and symptoms of worsening infection including: increasing redness, increased pain, increased draining of white/green/yellow/foul smelling drainage, or if you develop a fever. Please call the office if you develop these symptoms or go to the emergency room if the symptoms are severe. You may shower, let the warm water run over the incision line and pat the area dry with a towel, do not rub. Avoid intercourse until your follow-up with Dr. ___. You may gradually increase your activity as tolerated but clear heavy exercise with your surgeon. You will be prescribed a small amount of the pain medication Oxycodone. Please take this medication exactly as prescribed. You may take Tylenol as recommended for pain. Please do not take more than 3000mg of Tylenol daily. Do not drink alcohol while taking narcotic pain medication or Tylenol. Please do not drive a car while taking narcotic pain medication. Thank you for allowing us to participate ___ your care! Our hope is that you will have a quick return to your life and usual activities. Good luck! ","The patient was admitted to the Colorectal Surgery service from the ED for management of a horseshoe perirectal abscess. She was started on antibiotics. She was taken to the OR on ___ for exam under anesthesia and incision and drainage of the abscess. A Malecot drain was placed ___ the abscess cavity at the conclusion of the case. The patient tolerated the procedure well and returned to the floor. Antibiotics were continued post-operatively. Patient was discharged home on POD1. At time of discharge, she was tolerating a regular diet, voiding, passing stool. Pain was well-controlled on oral medication. Patient was afebrile with stable hemodynamics throughout hospital course. Patient was discharged with Malecot drain ___ place, a ten-day course of antibiotics, and instructions for drain care. She will follow up with Dr. ___ ___ clinic. ",1878,177
10010058-DS-11,"<SEX> M <SERVICE> MEDICINE <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> right foot swelling and erythema <MAJOR SURGICAL OR INVASIVE PROCEDURE> None <HISTORY OF PRESENT ILLNESS> ___ ___ man with CAD s/p anterior myocardial infarction many years ago, ischemic CMP (EF ___, s/p single-lead AICD in ___, Atrial Fibrillation on Coumadin presents with pain in his right foot. On ___, the patient's nurse from the ___ ___ called reporting pt had flu like symptoms. A hospitalist called back, and the patient said that he did not need to be seen, and only had a slight cough. On ___, the nurse called once again, indicating that the patient felt worse, and was having green sputum, fever and taking tyleniol. He was seen in HCA, diagnosed clinically with pneumonia, and told the PCP he had been having a cough for 2 weeks, and a fever to 102. HCA hosptialist prescribed Levaquin 500 mg x 1, and was told to continue for 250 mg daily for 9 more days. However, he was seen again by his PCP today, who referred him to the ED. He has a history of foot infections, and says that there has been no recent trauma to his foot. He says his foot pain has been going on for several days down. . In the ED, initial vitals 99.8 62 124/64 18 100. Exam notable for irregular irregular. Labs notable for WBC 11.4, Cr 2.1 (at baseline), K 5.2. BCx x2 sent. CXR with subsegmental atelectasis or linear scarring in the right mid lung field. Otherwise, no acute cardiopulmonary abnormality. The pt received doses of Vancomycin, Cefazolin. ED vital signs on transfer 98.7 98/51 60 14% RA. Received 1 L NS at 75cc/hr. . ROS: + as per HPI, in addition to a yellowish productive cough Denies fever, chills, night sweats, headache, vision changes, rhinorrhea, congestion, sore throat, shortness of breath, chest pain, abdominal pain, nausea, vomiting, diarrhea, constipation, BRBPR, melena, hematochezia, dysuria, hematuria. <PAST MEDICAL HISTORY> # CAD status post silent anterior MI several years ago. # Systolic heart failure, probable ischemic cardiomyopathy with LVEF of ___. # Mild-to-moderate mitral and tricuspid regurgitation # Single-lead AICD in ___. # Atrial fibrillation, on warfarin. # Cataracts. # Depression <SOCIAL HISTORY> ___ <FAMILY HISTORY> Unremembered or not known. <PHYSICAL EXAM> VS - Temp 100.1 F, 108/64 BP , HR 54 , R 18 , O2-sat 100% RA GENERAL - well-appearing man in NAD, comfortable, appropriate HEENT - NC/AT, PERRL, EOMI, sclerae anicteric, MMM, OP clear NECK - supple, no thyromegaly, no JVD, no carotid bruits LUNGS - CTA bilat, no r/rh/wh, good air movement, resp unlabored, no accessory muscle use HEART - irregularly irregular, no MRG, nl S1-S2 ABDOMEN - NABS, soft/NT/ND, no masses or HSM, no rebound/guarding EXTREMITIES - cool left lower extremity, no c/c/e, 2+ peripheral pulses (radials, DPs). + TTP over hallux medial aspect and pain with flexion/extension of toe; erythema extending to distal portion of mid-foot SKIN - right foot from toes ___ and dorsum of foot are erythematous and warm to touch NEURO - awake, A&Ox3, CNs II-XII grossly intact, muscle strength ___ throughout, sensation grossly intact throughout, gait deferred <PERTINENT RESULTS> Labs on Admission: ___ 01: 23PM GLUCOSE-97 UREA N-34* CREAT-2.1* SODIUM-136 POTASSIUM-5.2* CHLORIDE-103 TOTAL CO2-22 ANION GAP-16 ___ 01: 23PM estGFR-Using this ___ 12: 50PM WBC-11.4*# RBC-3.86* HGB-12.0* HCT-35.4* MCV-92 MCH-31.1 MCHC-33.9 RDW-13.2 ___ 12: 50PM NEUTS-85.6* LYMPHS-8.8* MONOS-4.8 EOS-0.4 BASOS-0.4 ___ 12: 50PM PLT COUNT-260# ___ 12: 50PM ___ PTT-38.9* ___ ___ 12: 38PM LACTATE-1.8 Labs on Discharge: ___ 06: 25AM BLOOD WBC-8.9 RBC-3.56* Hgb-11.0* Hct-31.8* MCV-89 MCH-31.0 MCHC-34.6 RDW-12.9 Plt ___ ___ 06: 25AM BLOOD Glucose-93 UreaN-34* Creat-2.1* Na-134 K-4.8 Cl-103 HCO3-25 AnGap-11 Microbiology: ___ Blood Culture, Routine-PENDING x2 Imaging: - CHEST (PA & LAT)Study Date of ___ 1: 06 ___ IMPRESSION: Subsegmental atelectasis or linear scarring in the right mid lung field. Otherwise, no acute cardiopulmonary abnormality. <MEDICATIONS ON ADMISSION> WARFARIN - 2mg Po Daily ASPIRIN - 81 mg DIGOXIN - 250 mcg ROSUVASTATIN 20 mg METOPROLOL SUCCINATE - 50mg LISINOPRIL - 20 mg CITALOPRAM - 20 mg ipratropium bromide [Atrovent] 21 mcg Spray, Non-Aerosol ___ sprays(s) each nostril three times a day as needed for runny nose LEVOFLOXACIN - 250mg (Started ___ for Levaquin 500 mg for first day and then 250 mg daily for nine more days. <DISCHARGE MEDICATIONS> 1. warfarin 2 mg Tablet Sig: One (1) Tablet PO once a day: Please take as directed by your ___ clinic. 2. aspirin 81 mg Tablet Sig: One (1) Tablet PO once a day. 3. digoxin 250 mcg Tablet Sig: One (1) Tablet PO once a day. 4. rosuvastatin 20 mg Tablet Sig: One (1) Tablet PO once a day. 5. metoprolol succinate 50 mg Tablet Sustained Release 24 hr Sig: One (1) Tablet Sustained Release 24 hr PO once a day. 6. lisinopril 20 mg Tablet Sig: One (1) Tablet PO once a day. 7. citalopram 20 mg Tablet Sig: One (1) Tablet PO once a day. 8. ipratropium bromide 0.03 % Spray, Non-Aerosol Sig: ___ sprays Nasal three times a day: ___ sprays(s) each nostril three times a day as needed for runny nose . 9. Medrol (Pak) 4 mg Tablets, Dose Pack Sig: One (1) Tablets, Dose Pack PO once a day for 6 days: Please take as directed per medrol dose PAK instruction. Disp: *1 PAK* Refills: *0* 10. dextromethorphan-guaifenesin ___ mg Capsule Sig: ___ Capsules PO twice a day for 5 days. Disp: *20 Capsule(s)* Refills: *0* <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Primary Diagnosis: - Gout Secondary Diagnosis: - Coronary Artery Disease - Systolic Heart Failure <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Mr. ___, it was a pleasure taking care of you. You were admitted to the hospital because of right foot pain, which you have had in the past, and have had for many years. When you came to the emergency department, we thought that you may have had an infection of your foot, and we started you on antibiotics. After further evaluation, we believe that you have some inflmmation of your toe, by a condition that is called GOUT. Gout causes crystals to form in your joint, making them very painful. We started you on some medication which helps to reduce inflammation, and stopped your antibiotics. When you leave the hospital: - START Medrol Dose PAK as directed - STOP LEVOFLOXACIN 250 mg DAILY - START dextromethorphan-guaifenesin ___ mg Capsule: Take ___ Capsules twice a day for 5 days as needed for cough We did not make any other changes to your medications. It is very important that you RETURN TO THE EMERGENCY DEPARTMENT if the pain in your foot starts to get worse, or if you start to have worsening fevers or chills, as we have stopped your antibiotics. ","___ with CAD, AF on Coumadin, presenting with RLE pain and erythema . # Gout: The presumed diagnosis in the emergency department of the patient's RLE erythema and pain was initially cellulitis; he received IV doses of Vancmycin and Cefazolin in the ED, and was continued on IV Vancomycin on the floor. His WBC count was elevated at 11.4, and subsequently trended down with IV fluids in the setting of antibiotics. However, on examination the next morning, the patient was noted to have pain very specifically in the MTP joint of the right foot, with surrounding areas of erythema that were not tender to palpation. On further questioning, the patient indicated that he has pain in his bilateral MTP joints with pain roughly lasting ___ days twice a year, for nearly ___ years. The patient had a uric acid drawn back in ___ which was elevated at 7.5. The patient was treated with a one time dose of colchicine, but was not continued on this given his renal failure. He was discharged with a Medrol dose PAK to help reduce inflammation, with ___ with his PCP. Gout is also presumed to be the most likely diagnosis given that the patient had developed foot pain in the setting of Levoquin antibiotics for a presumed pneumonia. The patient was given very specific instructions to return to the ED if his pain or erythema were to worsen, given that he was being discharged off antibiotics. # Presumed Pneumonia: The patient's lungs sound CTA, in addition to a CXR which does not show any focal pneumonia. Per report the patient has been febrile at home, but has not been febrile in house. Patient does have a mild leukocytosis that has resolved, but which was presumed secondary to a gout flare. Levofloxacin was DC'ed. # Coronary Artery Disease: Continued on home regimen of ASA, digoxin, statin, and BB., and lisonpril # Systolic Congestive Heart Failure: Patient has an EF of ___. Continued on home regimen of ASA, digoxin, statin, and BB., and lisonpril # CKD: Stable with creatinine at 2.1. # Atrial fibrillation: Patient is rate controlled with digoxin and metoprolol. We continued his warfarin in house. # Pending Studies - ___ Blood Culture, Routine-PENDING x 2 # PCP ___ issues - Assess for improvement in RLE, leading to a presumptive diagnosis of gout ",2145,542
10010058-DS-12,"<SEX> M <SERVICE> MEDICINE <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> acute encephalopathy <MAJOR SURGICAL OR INVASIVE PROCEDURE> none <HISTORY OF PRESENT ILLNESS> Mr ___ is a ___ year-old male with a past medical history of hyperlipidemia, CAD, anterior MI, ischemic cardiomyopathy with LVEF 35%, mild- moderate MR, CKD, and AF with CHB s/p BiVICD implant, here with failure to thrive, lightheadedness, and mild confusion. History is very limited due to patient being deaf and confused. Pt is also ___ speaking however does seem to understand some ___ and is able to read ___ when I write down questions. I was also unable to reach family members by phone. Per ED records, pt has had poor PO intake for weeks, however in the past week it has decreased even more and he has had bilious small amounts of vomit in the AMs. Denies fevers, chills, sweats, cough, shortness of breath. Endorses incontinence x about 1 week. Patient's daughter also endorses mild confusion. In the ED, patient was able to recognize daughters and knows his own name, however was unsure what date it was - which is not his baseline. In the ED, initial vitals were: 98.6 60 96/51 16 100% RA. Labs were notable for trop of 0.15--)0.13-->>0.11, LDH 373, Na 130, creatinine 3.4, bland UA, plts 48. CT head showed no acute process, CXR was nl. Pt was given 2 L NS. On the floor, pt states that he is tired but is unable to answer any other questions, I think due to a combination of confusion and difficulty hearing. When I write my questions on paper, he reads the first part however then becomes confused. He states he is not on any pain. Provides phone numbers for his granddaughter however one of them is not a valid number. Review of systems: unable to obtain due to confusion and HOH <PAST MEDICAL HISTORY> (per chart, unable to confirm with patient): hypertension hyperlipidemia AFib CAD CHF hearing loss CORONARY ARTERY DISEASE GOUT HYPERLIPIDEMIA MEMORY LOSS PACEMAKER CHRONIC KIDNEY DISEASE HYPERTENSION ISCHEMIC CARDIOMYOPATHY <SOCIAL HISTORY> ___ <FAMILY HISTORY> unknown <PHYSICAL EXAM> 97.8 116 / 56 60 16 99 Ra Constitutional: Alert, confused, NAD EYES: Sclera anicteric, EOMI, PERRL ENT: MMD, oropharynx clear, Neck: Supple, no LAD CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Respiratory: Clear to auscultation bilaterally, no wheezes, rales, rhonchi GI: Soft, non-tender, non-distended, bowel sounds present, no organomegaly, no rebound or guarding GU: No foley EXT: Warm, well perfused, no CCE NEURO: unable to assess, responds to questioning but answers are unclear, moves all extermities, CNS grossly intact SKIN: no rashes or lesions <PERTINENT RESULTS> ___ 06: 30PM LD(LDH)-373* TOT BILI-0.6 ___ 06: 30PM cTropnT-0.11* ___ 06: 30PM CK-MB-6 cTropnT-0.13* ___ 06: 30PM HAPTOGLOB-241* ___ 02: 14PM ___ PTT-34.6 ___ ___ 01: 30PM URINE HOURS-RANDOM ___ 01: 30PM URINE UHOLD-HOLD ___ 01: 30PM URINE COLOR-Straw APPEAR-Clear SP ___ ___ 01: 30PM URINE BLOOD-SM NITRITE-NEG PROTEIN-30 GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-6.0 LEUK-NEG ___ 01: 30PM URINE RBC-4* WBC-<1 BACTERIA-FEW YEAST-NONE EPI-0 ___ 01: 30PM URINE AMORPH-RARE ___ 01: 30PM URINE MUCOUS-RARE ___ 12: 45PM GLUCOSE-99 UREA N-140* CREAT-3.4*# SODIUM-130* POTASSIUM-4.1 CHLORIDE-96 TOTAL CO2-13* ANION GAP-25* ___ 12: 45PM estGFR-Using this ___ 12: 45PM ALT(SGPT)-29 AST(SGOT)-44* CK(CPK)-248 ALK PHOS-71 TOT BILI-0.6 ___ 12: 45PM LIPASE-132* ___ 12: 45PM cTropnT-0.15* ___ 12: 45PM CK-MB-6 ___ 12: 45PM ALBUMIN-4.1 ___ 12: 45PM WBC-7.2 RBC-3.78* HGB-11.3* HCT-32.3* MCV-85# MCH-29.9 MCHC-35.0 RDW-15.1 RDWSD-46.9* ___ 12: 45PM NEUTS-74.0* LYMPHS-8.5* MONOS-16.3* EOS-0.4* BASOS-0.1 IM ___ AbsNeut-5.33 AbsLymp-0.61* AbsMono-1.17* AbsEos-0.03* AbsBaso-0.01 ___ 12: 45PM HYPOCHROM-NORMAL ANISOCYT-1+ POIKILOCY-2+ MACROCYT-OCCASIONAL MICROCYT-1+ POLYCHROM-OCCASIONAL OVALOCYT-1+ SCHISTOCY-OCCASIONAL BURR-1+ ELLIPTOCY-OCCASIONAL ___ 12: 45PM PLT COUNT-48*# ___ 12: 45PM RET AUT-1.0 ABS RET-0.04 MICRO: urine cxs pending STUDIES: CT head: No acute intracranial process. CXR: no acute process EKG: paced rhythm with underlying afib, TWI in V1, V2, LVH, LAD ___ 06: 25AM BLOOD WBC-5.7 RBC-3.40* Hgb-10.2* Hct-28.6* MCV-84 MCH-30.0 MCHC-35.7 RDW-15.1 RDWSD-46.4* Plt Ct-47* ___ 06: 25AM BLOOD Plt Ct-47* ___ 06: 25AM BLOOD ___ ___ 06: 25AM BLOOD Glucose-137* UreaN-110* Creat-3.0* Na-137 K-3.2* Cl-106 HCO3-12* AnGap-20 ___ 06: 30PM BLOOD cTropnT-0.11* ___ 06: 30PM BLOOD CK-MB-6 cTropnT-0.13* ___ 12: 45PM BLOOD cTropnT-0.15* ___ 06: 25AM BLOOD TSH-1.3 ___ 06: 25AM BLOOD calTIBC-241* VitB12-862 Folate->20 Ferritn-706* TRF-185* ___ 06: 30PM BLOOD Hapto-241* ___ 06: 25AM BLOOD Digoxin-1.6 ___ 06: 25AM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG Bnzodzp-NEG Barbitr-NEG Tricycl-NEG ___ 06: 25AM BLOOD COPPER (SERUM)-PND C IMPRESSION: 1. Fusiform and saccular aneurysmal dilatation of the infrarenal abdominal aorta measuring up to 3.9 cm extending into both common iliac arteries and the right external iliac artery. Linear areas of calcification within the aneurysm sac at the level of the third portion of the duodenum is suspicious for dissection which is limited in the absence of intravenous contrast. The aneurysm sac exerts mass effect on the third portion of the duodenum which is decompressed. There is no upstream dilatation of the duodenum to suggest obstruction. The distance between the anterior aspect of the aortic aneurysm to the anterior wall peritoneal is approximately 1.5 cm. 2. Colonic diverticulosis without CT evidence of acute diverticulitis. 3. Cholelithiasis without CT evidence of acute cholecystitis. 4. Asymmetric sclerosis and narrowing of the right SI joint likely reflecting prior sacroiliitis. 5. Mild-to-moderate cardiomegaly with at least right and possibly biatrial enlargement. Stable size of a known left ventricular aneurysm with increased interval calcifications since ___. 6. Two 2 mm pulmonary micro nodules in the right lung base. In a patient with no known risk factors for lung cancer, these are presumed to be benign and no follow-up is recommended. In a patient with risk factors for lung cancer, ___ year follow-up is recommended. T abdomen/pelvis: <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Allopurinol ___ mg PO DAILY 2. Apixaban 2.5 mg PO BID 3. Colchicine 0.6 mg PO TID: PRN joint pain 4. Digoxin 0.25 mg PO DAILY 5. ipratropium bromide 0.03 % nasal Other 6. Metoprolol Succinate XL 50 mg PO DAILY 7. Mirtazapine 30 mg PO QHS 8. Rosuvastatin Calcium 20 mg PO QPM 9. Aspirin 81 mg PO DAILY 10. Loratadine 10 mg PO DAILY <DISCHARGE MEDICATIONS> 1. Allopurinol ___ mg PO EVERY OTHER DAY 2. ipratropium bromide 0.03 % nasal Other 3. Loratadine 10 mg PO DAILY 4. Metoprolol Succinate XL 50 mg PO DAILY 5. Rosuvastatin Calcium 20 mg PO QPM 6. HELD- Apixaban 2.5 mg PO BID This medication was held. Do not restart Apixaban until you discuss with your doctor due to your low platlet count 7. HELD- Aspirin 81 mg PO DAILY This medication was held. Do not restart Aspirin until you discuss with your doctor due to your low platelet count 8. HELD- Colchicine 0.6 mg PO TID: PRN joint pain This medication was held. Do not restart Colchicine until you discuss with your doctor 9. HELD- Digoxin 0.25 mg PO DAILY This medication was held. Do not restart Digoxin until you discuss with your doctor 10. HELD- Mirtazapine 30 mg PO QHS This medication was held. Do not restart Mirtazapine until you discuss with your doctor <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> weakness dehydration nausea with vomiting weight loss <DISCHARGE CONDITION> Mental Status: Confused - sometimes. Level of Consciousness: Alert and interactive. Activity Status: Out of Bed with assistance to chair or wheelchair. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> You were admitted for monitoring and further work up of weight loss, nausea, vomiting, dehydration, kidney failure and weakness. For this, you had lab testing and were given IV fluids and had a CT scan. Due to the unexplained dehydration and weight loss as well as weakness, renal failure, electrolyte abnormalities, and concern for falls and fractures due to weakness we recommended that you stay inpatient for further work up and monitoring but you declined. Risks of leaving against medical advice include infection, worsened renal failure, electrolyte abnormalities, undiagnosed cancer and including death. We recommend that you see your PCP ___ for ongoing care. Weigh yourself every morning, call MD if weight goes up more than 3 lbs. ","___ y.o male with h.o HL, CAD, MI, ___ with EF 35%, CKD, afib with CHF s/p biVICD who presented with weight loss, inability to tolerate PO, confusion, weakness found to have acidosis and ___ on CKD. #weight loss #inability to tolerate PO #nausea with vomiting #severe protein calorie malnutrition Symptoms are concerning for underlying malignancy. Pt with signs of dehydration and weight loss. No apparent prior w/u for these symptoms and pt has yet to see PCP. Unknown if prior colonoscopy. CT scan without revealing cause. Nutrition consulted and pt given IVF. However, pt and family after much discussion with ___ ___ present and again with pt's PCP on speaker phone, pt and family elected to leave AMA accepting risks of dehydration, malnutrition, undiagnosed illness, cancer, electrolyte abn, worsening renal function, risk of falls and injury due to weakness. Pt advised to f/u with PCP ___. #acute encephalopathy-likely due to metabolic derangements. Head CT without acute process. Tox screen neg. TSH, LFts, b12/folate WNL. IVF given. Held mirtazapine. ___ on CKD, baseline appears to be Cr 2.4-2.5. Likely prerenal due to above. Pt given some IVF. #thrombocytopenia-b12/folate WNL. Iron studies c/w ACD. Haptoglobin elevated, less likely hemolysis. Outpt f/u given AMA discharge. #anemia-most likely AOCD. Outpt f/u given AMA discharge. #hyponatremia-improved #AGMA-likely due to ___. Lactate WNL. Outpt f /u given AMA discharge. #HTN, HL, afib, CAD, chronic systolic CHF -continued home meds (BB, statin, held dig and eliquis given tpenia. Currently hypovolemic. #gout-no e/o acute flare. Continue appropriately dosed allopurinol. HOld colchicine given CKD. Pt was never able to see ___ as he left AMA before consult. ",2820,465
10010058-DS-13,"<SEX> M <SERVICE> MEDICINE <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> Chest pain <MAJOR SURGICAL OR INVASIVE PROCEDURE> N/A <HISTORY OF PRESENT ILLNESS> Mr. ___ is a ___ year old male with past medical history significant for ischemic cardiomyopathy with LVEF 35%, coronary artery disease ___ silent anterior MI of indeterminate age (presumed to be years ago), permanent AF w/ CHB ___ BiV-ICD implant, mild-moderate MR, CKD, hyperlipidemia who presents to the emergency department today with complaint of chest and epigastric pain. Pain occurred in middle of night and awoke patient from his sleep. Pain is associated with nausea, dyspnea, and diaphoresis. Denies any pain similar to this in the past. Denies any pain in his back, fevers, chills, or emesis. In the ED initial vitals were: T 96.7, HR 57, BP 99/57, RR 18, SpO2 99% RA <PAST MEDICAL HISTORY> (per chart, unable to confirm with patient): hypertension hyperlipidemia AFib CAD CHF hearing loss CORONARY ARTERY DISEASE GOUT HYPERLIPIDEMIA MEMORY LOSS PACEMAKER CHRONIC KIDNEY DISEASE HYPERTENSION ISCHEMIC CARDIOMYOPATHY <SOCIAL HISTORY> ___ <FAMILY HISTORY> Noncontributory to patient's presentation <PHYSICAL EXAM> Admission ___ Temp: 97.7 PO BP: 108/67 R Lying HR: 60 RR: 16 O2 sat: 96% O2 delivery: 2LNC GENERAL: lying in bed, interactive but hard of hearing. HEENT: PERRL. EOMI. No pallor or cyanosis of the oral mucosa. NECK: Supple. JVP 14-15cm CARDIAC: Normal S1, S2. No murmurs, rubs, or gallops. LUNGS: Bibasilar crackles and dullness at bases. ABDOMEN: Soft, non-tender, non-distended. EXTREMITIES: 1+ bilateral edema. WWP. PULSES: 2+ peripheral pulses. Discharge ___ 0710 Temp: 97.5 PO BP: 115/61 R Lying HR: 60 RR: 16 O2 sat: 100% O2 delivery: Ra ___ Total Intake: 1570ml PO Amt: 1570ml ___ Total Output: 650ml Urine Amt: 650ml GENERAL: NAD HEENT: PERRL. MMM. NECK: JVP noted at the clavicle with patient at 30 degrees CARDIAC: Normal S1, S2. Grade ___ systolic murmur LUNGS: Clear to auscultation bilaterally EXTREMITIES: No ___ edema noted. Warm and well perfused. PULSES: 2+ peripheral pulses. <PERTINENT RESULTS> Admission ___ 04: 05AM BLOOD WBC-7.3 RBC-3.39* Hgb-10.4* Hct-31.8* MCV-94 MCH-30.7 MCHC-32.7 RDW-14.5 RDWSD-49.7* Plt ___ ___ 04: 05AM BLOOD Neuts-73.4* Lymphs-14.6* Monos-9.6 Eos-1.6 Baso-0.4 Im ___ AbsNeut-5.36 AbsLymp-1.07* AbsMono-0.70 AbsEos-0.12 AbsBaso-0.03 ___ 04: 05AM BLOOD ___ PTT-39.0* ___ ___ 04: 05AM BLOOD Glucose-118* UreaN-34* Creat-1.8* Na-137 K-4.5 Cl-102 HCO3-20* AnGap-15 ___ 04: 05AM BLOOD ALT-34 AST-48* CK(CPK)-153 AlkPhos-59 TotBili-0.6 ___ 04: 05AM BLOOD CK-MB-6 ___ ___ 04: 05AM BLOOD Albumin-4.0 Calcium-8.8 Phos-3.2 ___ 04: 05AM BLOOD D-Dimer-2200* ___ 07: 40AM BLOOD TSH-2.2 ___ 07: 30AM BLOOD HBsAg-NEG HBsAb-NEG HBcAb-POS* ___ 07: 50AM BLOOD HBV VL-NOT DETECT ___ 07: 30AM BLOOD HCV Ab-NEG Discharge ___ 07: 50AM BLOOD WBC-6.2 RBC-3.24* Hgb-10.2* Hct-31.4* MCV-97 MCH-31.5 MCHC-32.5 RDW-15.6* RDWSD-55.2* Plt ___ ___ 07: 50AM BLOOD Neuts-67.8 Lymphs-16.0* Monos-11.3 Eos-3.9 Baso-0.2 Im ___ AbsNeut-4.21 AbsLymp-0.99* AbsMono-0.70 AbsEos-0.24 AbsBaso-0.01 ___ 07: 50AM BLOOD Plt ___ ___ 07: 50AM BLOOD Glucose-92 UreaN-68* Creat-2.5* Na-140 K-5.8* Cl-100 HCO3-27 AnGap-13 ___ 07: 50AM BLOOD ALT-86* AST-63* LD(LDH)-285* AlkPhos-68 TotBili-0.5 ___ 06: 50AM BLOOD ___ ___ 07: 50AM BLOOD Calcium-9.1 Phos-5.4* Mg-2.7* ___ 06: 17AM BLOOD Hapto-154 Studies ___ RUQ US 1. Cholelithiasis. 2. Mild gallbladder wall edema is significantly improved compared to recent CT from ___. No other evidence of cholecystitis. ___ ECHO The left atrial volume index is SEVERELY increased. The right atrium is moderately enlarged. The estimated right atrial pressure is >15mmHg. There is normal left ventricular wall thickness with a moderately increased/dilated cavity. The apex is aneurysmal. A left ventricular thrombus/mass cannot be excluded. Overall left ventricular systolic function is severely depressed secondary to akinesis of the anterior septum and apex with focal apical dyskinesis, severe hypokinesis with focal basal akinesis of the inferior septum and inferior free wall, and hypokinesis of the anterior ftree wall and lateral wall. Quantitative biplane left ventricular ejection fraction is 27 %. The right ventricular free wall is hypertrophied. Dilated right ventricular cavity with low normal free wall motion. Intrinsic right ventricular systolic function is likely lower due to the severity of tricuspid regurgitation. The aortic sinus diameter is normal for gender with mildly dilated ascending aorta. The aortic arch diameter is normal. The aortic valve leaflets (3) are mildly thickened. There is no aortic valve stenosis. There is moderate [2+] aortic regurgitation. The mitral valve leaflets are mildly thickened with no mitral valve prolapse. There is moderate to severe [3+] mitral regurgitation. The tricuspid valve leaflets appear structurally normal. There is moderate to severe [3+] tricuspid regurgitation. Due to acoustic shadowing, the severity of tricuspid regurgitation may be UNDERestimated. There is mild-moderate pulmonary artery systolic hypetension. In the setting of at least moderate to severe tricuspid regurgitation, the pulmonary artery systolic pressure may be UNDERestimated. There is no pericardial effusion. A left pleural effusion is present. Compared with the prior TTE ___, left ventricular ejection fraction is further reduced, with increased mitral and tricuspid regurgitation. EMR ___ CTA 1. 7 mm penetrating plaque in the distal portion of the aortic arch, without prior imaging for 2 studies acuity. A short-segment focal dissection in the mid aortic arch, appears chronic. 2. Signs of heart failure with cardiomegaly, pulmonary edema, bilateral pleural effusions greater on the right, as well as gallbladder-wall edema. 3. Infrarenal aortic aneurysm and left common iliac aneurysm. Please note that the prior study was done without IV contrast however based on wall calcifications in overall diameter it is grossly unchanged. <DISCHARGE INSTRUCTIONS> Dear Mr ___ You were admitted to ___ because you had a small heart attack. You had extra fluid that caused weight gain. This is called heart failure. While you were here we gave you a medication to help you urinate more and remove fluid. What to do when you go home: * Please weigh yourself every daily. Do this in the morning after you go to the bathroom and before you get dressed. * If your weight goes up by more than 3 lbs in 1 day or more than 5 lbs in 3 days, please call your heart doctor or your primary care doctor and alert them to this change. * We have made changes to your medication list, so please make sure to take your medications as listed below * You will also need to have close follow up with your heart doctor and your primary care doctor. It was a pleasure to take care of you. We wish you the best with your health! Your ___ Cardiac Care Team ","Mr. ___ is a ___ year old male with PMH significant for ischemic cardiomyopathy (LVEF 27% on ___ ECHO), CAD ___ silent anterior MI of indeterminate age), permanent AF w/ CHB ___ BiV-ICD implant (on apixaban), CKD, hyperlipidemia who presented for chest/epigastric pain. He was found to have elevated troponins and decompensated heart failure. He was medically treated for NSTEMI with heparin drip and continuation of home medications including aspirin, statin, and beta blocker. He was diuresed with Lasix drip. He was also managed for ___ during this time, which was improving at time of discharge. While inpatient he had a reaction to likely hydralazine that resulted in a morbilliform drug rash. The drug was discontinued and his rash improved. Corresponding to that rash he had elevated LFTs that were downtrending by time of admission. He was found to have isolated hepatitis B antibody. # CORONARIES: CAD ___ silent anterior MI # PUMP: HFrEF (EF 35%) # RHYTHM: permanent AF and CHB ___ BiV-ICD ACTIVE ISSUES: ============== #Acute decompensated HFrEF (EF 35%) #Ischemic Cardiomyopathy #LBBB ___ CRT-D The patient presented with clinical evidence of volume overload with rales, elevated JVP, mild pulmonary edema on CXR, and congestive gallbladder and ascending colon on CT. BNP >50000. Diuresed on a Lasix drip at 10cc/hr. - Admission weight 51 kg, discharge dry weight 45.4 kg - Preload: 10 mg furosemide daily - Afterload: Imdur 90 mg daily (previous intolerance to ACE + he has hyperkalemia) - Neurohormonal blockade: metoprolol 50 mg XL - Digoxin was discontinued w/ supratherapeutic level, worsening renal failure, and stable cardiac function after diuresis #NSTEMI #CAD with prior silent MI Initial trop elevated with peak to 2.60, without clear new ECG changes. Unclear if initial presentation was Type 1 NSTEMI versus demand in the setting of severe decompensated CHF. He received 48 hour heparin drip, aspirin, and rosuvastatin. After discussion with the patient and family, it was determined that he did not desire any invasive intervention such as cardiac catheterization. He will continue on aspirin, rosuvastatin 20 mg, and metoprolol succinate 50 mg qD at home. ___ on CKD Baseline appears to be ___ and was at baseline at presentation, but increased to a peak of 3.4 with diuresis. It was not clear the etiology of his ___, but possibly prerenal in the setting of his low flow state. No urinalysis sediment evidence of ATN. No post-renal obstruction. Renal function was improving at the time of discharge, with creatinine down to 2.5. We did suspend apixaban for some time, but it was restarted once renal function improved. #Hyperkalemia Persistently hyperkalemic during the admission. Likely a combination of both diet and acute renal failure. Patient was found to have pile of bananas in his room. He likes eating them because they are soft. Patient and patient's family education on low potassium foods. He was not discharged on any potassium elevating agents at the time of discharge. His levels will need to be followed closely as ___ outpatient. # Transaminitis Mild transaminitis of unclear etiology. Initially thought to be due to vascular congestion, but has remained elevated even after diuresis. RUQ without evidence for cholecystitis. Possibly hypersensitivity to hydralazine, as LFTs increased after drug was introduced. Was also Hep B core Ig positive without Ag or Ab positive, which is nonspecific. LFTs were downtrending at time of discharge. Hepatitis B viral load pending at time of discharge. He should receive a fibroscan to follow up for possible cirrhosis secondary to possible chronic disease. # Morbilliform Drug Eruption Patient with erythematous itchy macular rash that started on back and thighs and since spread to abdomen anteriorly. Derm consulted, believes to be drug eruption, but unclear which drug. Patient started on hydralazine, furosemide, isosorbide mononitrite at the same time. Hydralazine was held at is was believed to be likely culprit, and rash improved. He was started on 14 day course of betamethasone steroid cream, per derm. #Ulceration of aortic arch #Aortic dissection Found on CT in ED. Cardiac surgery was consulted and recommended medical management with blood pressure control with systolic blood pressures < 120 mmHg. This should be continued as ___ outpatient. # Anemia Stable between ___ without any further acute drops. No evidence for hemolysis or active bleeding at this time. CHRONIC ISSUES: =============== #AF ___ BiV-ICD: Patient continued home metoprolol, as above, and will be able to continue apixaban for anticoagulation. He has a BiV-ICD in place. Transitional Issues: ==================== [ ] Persistent hyperkalemia while inpatient, please follow at next appointment (lab slip provided on discharge). [ ] Patient with elevated transaminases during admission. Improving on discharge. Please follow with repeat LFTs at PCP ___ [ ] Follow up hepatitis B viral load (to r/o active Hep B infection). Currently pending in OMR. [ ] Due to prior hepatitis B infection, patient may benefit from fibroscan. [ ] Follow weights to ensure proper diuretic dose on furosemide 10 mg qD [ ] Follow blood pressures to ensure adequate afterload reduction (ideally systolic < 120 mmHg), previously intolerant to ACE inhibitors (and hyperkalemic) thus not initiated on discharge [ ] Discuss with patient whether or not to inactivate ICD given DNR/DNI code status Cr: 2.5 Wt: 45.4 kg CODE STATUS: DNR/DNI CONTACT: ___ Relationship: Daughter Phone number: ___ ___ on Admission: The Preadmission Medication list is accurate and complete. 1. Allopurinol ___ mg PO DAILY 2. Metoprolol Succinate XL 50 mg PO DAILY 3. Rosuvastatin Calcium 20 mg PO QPM 4. ipratropium bromide 0.03 % nasal Other 5. Loratadine 10 mg PO DAILY 6. Mirtazapine 45 mg PO QHS 7. Digoxin 0.25 mg PO DAILY 8. Colchicine 0.6 mg PO TID:PRN joint pain 9. Apixaban 2.5 mg PO BID 10. Aspirin 81 mg PO DAILY Discharge Medications: 1. Betamethasone Dipro 0.05% Oint 1 Appl TP BID RX *betamethasone dipropionate 0.05 % Apply to affected areas (not on face, groin, axilla) twice a day Refills:*0 2. Furosemide 10 mg PO DAILY RX *furosemide 20 mg 0.5 (One half) tablet(s) by mouth once a day Disp #*15 Tablet Refills:*3 3. Isosorbide Mononitrate (Extended Release) 90 mg PO DAILY RX *isosorbide mononitrate 30 mg 3 tablet(s) by mouth once a day Disp #*90 Tablet Refills:*3 4. Multivitamins W/minerals 1 TAB PO DAILY RX *multivitamin,tx-minerals [Multi-Vitamin HP/Minerals] 1 capsule(s) by mouth once a day Disp #*30 Capsule Refills:*12 5. Allopurinol ___ mg PO DAILY RX *allopurinol ___ mg 1 tablet(s) by mouth once a day Disp #*30 Tablet Refills:*0 6. Apixaban 2.5 mg PO BID RX *apixaban [Eliquis] 2.5 mg 1 tablet(s) by mouth twice a day Disp #*60 Tablet Refills:*0 7. Aspirin 81 mg PO DAILY RX *aspirin [Adult Low Dose Aspirin] 81 mg 1 tablet(s) by mouth once a day Disp #*30 Tablet Refills:*0 8. ipratropium bromide 0.03 % nasal Other RX *ipratropium bromide 21 mcg (0.03 %) 1 spray nasal once a day Disp #*1 Spray Refills:*0 9. Loratadine 10 mg PO DAILY RX *loratadine [Claritin] 10 mg 1 tablet(s) by mouth once a day Disp #*30 Tablet Refills:*0 10. Metoprolol Succinate XL 50 mg PO DAILY RX *metoprolol succinate 50 mg 1 tablet(s) by mouth once a day Disp #*30 Tablet Refills:*0 11. Mirtazapine 45 mg PO QHS RX *mirtazapine 45 mg 1 tablet(s) by mouth at bedtime Disp #*30 Tablet Refills:*0 12. Rosuvastatin Calcium 20 mg PO QPM RX *rosuvastatin 20 mg 1 tablet(s) by mouth at bedtime Disp #*30 Tablet Refills:*0 13.Outpatient Lab Work ICD 10 N17.9: acute kidney injury R74.0 transaminitis Please obtain CMP, lytes, and LFTs (ALT/ALT/LDH/TBili/Albumin) and provide to outpatient PCP ___ ___ Fax ___. Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: Primary: Acute Decompensated Systolic Heart Failure Non-ST Elevation MI Secondary: Acute Kidney Injury Transaminitis Hyperkalemia Atrial fibrillation Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Followup Instructions: ___",2163,2232
10010058-DS-14,"<SEX> M <SERVICE> MEDICINE <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> Shortness of breath <MAJOR SURGICAL OR INVASIVE PROCEDURE> Coronary angiogram ___ <HISTORY OF PRESENT ILLNESS> ___ w/ hx of HLD, CAD c/b remote anteroseptal MI, ischemic cardiomyopathy HFrEF (EF=27%) mild/mod MR/TR, CKD, and permanent afib w/ CHB s/p BiV ICD who presented with respiratory distress, found to be in cardiogenic shock c/b possible demand STEMI. Per report from family and EMS, patient has been feeling weak and short of breath progressively for the last 2 days. EMS was eventually called on evening of presentation due to worsening dyspnea. EMS evaluation notable for RR between 40 and 60 breaths/min, and mild hypotension. He was placed on BiPAP prior to arrival to the ___ ED. In the ED, initial vitals were T 97.6, BP 99/66, RR 37, O2 96% on BiPAP. Exam notable for tachypnea and diffuse bibasilar pulmonary wheezes, though no peripheral edema. Labs notable for: - K 5.7, BUN/Cr 59/3.3 - Trop 0.15 - proBNP 28,546 - VBG pH 7.27, pCO2 45, lactate 3.6 He was was given 20mg IV Lasix, 150mg IV amiodarone bolus followed by gtt, 600mg PR ASA, and 2mg IV Ca gluconate. Initial EKG showed afib/flutter w/ V-paced complexes HR 115. However subsequent EKGs over the course of 1hr showed the development SVT w/ ST elevations in anteroseptal leads followed by episodes of nonsustained polymorphic VT requiring ICD shocks. CXR showed mild pulmonary vascular congestion and edema. The pt was intubated shortly after arrival for worsening respiratory status. He also became progressively hypotensive to 69/52. A code STEMI was called given the EKGs findings as described. He was taken to the cath lab where coronary angiography revealed 100% ostial LAD and distal LM of unclear chronicity, with R to L collaterals. PCI was deferred given the complexity of lesions. A swan was placed via R fem vein revealing for RA 13, RV 52/2, PA ___ (34), PCWP 24, CI 1.7, CO 3.0. An impella was placed via R fem artery for mechanical support. On arrival to the CCU, the pt was intubated and sedated. <PAST MEDICAL HISTORY> Cardiac History: 1. Ischemic cardiomyopathy (LVEF 27%) 2. Coronary artery disease s/p anterior MI 3. Permanent atrial fibrillation, complete heart block, s/p BiV-ICD 4. Mild-moderate MR 5. HFrEF (EF 27% as of ___ Other PMH: 1. Chronic kidney disease 2. Dyslipidemia 3. Gout <SOCIAL HISTORY> ___ <FAMILY HISTORY> Unable to obtain given intubation <PHYSICAL EXAM> ADMISSION EXAM -= VS: T 97.5, HR 78, BP ___ (91), RR 24, O2 100% on 50% FiO2 ventilated GENERAL: Intubated, sedated NECK: Supple, JVP CARDIAC: RRR, S1/S2, ___ holosystolic murmur, prominent PMI LUNGS: CTAB anteriorly ABDOMEN: Soft, non-tender, non-distended, BS+ EXTREMITIES: Warm, well perfused, no edema, R fem/arterial access sites cleanly dressed w/o surrounding hematoma or induration SKIN: No significant lesions or rashes PULSES: Distal pulses palpable and symmetric NEURO: Sedated DISCHARGE EXAM -= Patient expired <PERTINENT RESULTS> ADMISSION LABS -= ___ 01: 05AM BLOOD WBC-7.4 RBC-4.12* Hgb-12.2* Hct-39.8* MCV-97 MCH-29.6 MCHC-30.7* RDW-14.6 RDWSD-51.8* Plt Ct-88* ___ 01: 05AM BLOOD Neuts-75.6* Lymphs-14.2* Monos-8.7 Eos-0.8* Baso-0.3 Im ___ AbsNeut-5.58 AbsLymp-1.05* AbsMono-0.64 AbsEos-0.06 AbsBaso-0.02 ___ 01: 05AM BLOOD ___ PTT-30.3 ___ ___ 01: 05AM BLOOD Glucose-196* UreaN-59* Creat-3.3* Na-142 K-9.4* Cl-110* HCO3-17* AnGap-15 ___ 01: 05AM BLOOD ALT-<5 AST-105* AlkPhos-60 TotBili-0.4 ___ 01: 05AM BLOOD ___ ___ 01: 05AM BLOOD cTropnT-0.15* ___ 01: 05AM BLOOD Albumin-4.0 Calcium-8.4 Phos-5.4* Mg-2.6 ___ 05: 43AM BLOOD Hapto-103 ___ 01: 11AM BLOOD ___ pO2-37* pCO2-45 pH-7.27* calTCO2-22 Base XS--6 Comment-GREEN TOP ___ 03: 37AM BLOOD Glucose-170* Lactate-2.2* Creat-3.2* Na-142 K-5.3 Cl-115* REPORTS ======= CHEST (PORTABLE AP) Study Date of ___ 1. Mild pulmonary vascular congestion and edema. 2. Stable cardiomegaly. CHEST (PORTABLE AP) Study Date of ___ The endotracheal tube terminates 35 mm above the carina. The enteric tube terminates within the proximal stomach in the side-port of the projects within the proximal stomach. The tip of the Swan-Ganz catheter projects over the right hilum. The Impella projects over the aorta and left ventricle. The left-sided pacemaker terminates in the right ventricle. There cardiomediastinal silhouette is moderately enlarged. There are mild bibasilar opacifications. No pneumothorax. Trace left pleural effusion. Visualized osseous structures unchanged. CORONARY ANGIOGRAPHY ___ FINDINGS: Elevated left heart filling pressure. - Cardiogenic shock. - Mild pulmonary hypertension. - Three vessel coronary artery disease. - Three vessel epicardial CAD suggestive of chronic total occlusion in the LAD vs. subtotal chronic occlusion (functional CTO) with acute occlusion. Collaterals from the RPDA are highly developed and presentation was cardiogenic shock and not chest pain/ST elevations (first ECG) and there is evidence of old anterior MI on TTE and old ECGs. There is a proximal RCA stenosis and mild epicardial disease in the LCx. Cardiogenic shock now s/p succesful Impella CP placement. Recommendations - Family meeting with goals of care including long-term dialysis, rehab and revascularization vs. medical management or even comfort care. CABG vs. high risk PCI evaluation if compatible with goals of care. Impella care per protocolCycle Trop/MBTripple therapy (heparin,ASA/Ticag) for now. TTE ___ The right atrial pressure could not be estimated. There is suboptimal image quality to assess regional left ventricular function. The visually estimated left ventricular ejection fraction is ___. The aortic valve leaflets (3) are mildly thickened. The Impella catheter inlet is positioned close to aortic valve. There is mitral regurgitation (cannot be qualified). Due to acoustic shadowing, the severity of mitral regurgitation could be UNDERestimated. There is tricuspid regurgitation present (could not be qualified). Due to acoustic shadowing, the severity of tricuspid regurgitation may be UNDERestimated. There is a trivial pericardial effusion. IMPRESSION: Focused study. The Impella catheter is positioned too close to the aortic valve. Severely depressed left ventricular systolic function. TTE ___ There is SEVERE global left ventricular hypokinesis. The visually estimated left ventricular ejection fraction is ___. The Impella catheter is correctly positioned with respect to the aortic valve. There is mitral regurgitation (cannot be qualified). There is mild pulmonary artery systolic hypertension. IMPRESSION: Focused study/limited views. Correctly positioned Impella catheter. Depressed left ventricular systolic function. Mitral regurgitation present (not quantified). <MEDICATIONS ON ADMISSION> The Preadmission Medication list may be inaccurate and requires futher investigation. 1. Mirtazapine 45 mg PO QHS 2. Allopurinol ___ mg PO DAILY 3. Colchicine 0.6 mg PO TID: PRN joint pain 4. Metoprolol Succinate XL 50 mg PO DAILY 5. Apixaban 2.5 mg PO BID 6. Rosuvastatin Calcium 20 mg PO QPM 7. Furosemide 10 mg PO DAILY 8. Isosorbide Mononitrate (Extended Release) 30 mg PO DAILY 9. Aspirin 81 mg PO DAILY 10. Loratadine 10 mg PO DAILY 11. Tamsulosin 0.4 mg PO QHS <DISCHARGE MEDICATIONS> Patient deceased <DISCHARGE DISPOSITION> Expired <DISCHARGE DIAGNOSIS> Patient deceased <DISCHARGE CONDITION> Patient deceased <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Patient deceased ","SUMMARY: ======== ___ w/ hx of HLD, CAD c/b remote anteroseptal MI, ischemic cardiomyopathy HFrEF (EF=27%) mild/mod MR/TR, CKD, and permanent afib w/ CHB s/p BiV ICD who presented with respiratory distress, found to be in cardiogenic shock c/b possible demand STEMI. He was intubated shortly after arrival to the ED for respiratory distress. While he was in the ED, his rhythm changed from sinus to a narrow complex tachycardia and ST segment elevations developed over the course of an hour on serial EKGs. He also had polymorphic VT during this time for which amiodarone drip was initiated. Code STEMI was called, he was given ASA and ticagrelor load and he was taken to the cath lab where he was found to have 95% distal LM disease, 100% ___ LAD stenosis with collateralization from RCA distribution, 40% ___, and 70% ostial RCA disease. No intervention was performed due to complexity and unclear goals of care; and impella CP was placed through right femoral access while heparin drip initiated; a Swan-ganz catheter was placed in the R femoral vein, and later on an A-line was placed in the right arm. Goals of care discussion was held, as the patient was previously DNR/DNI and PCI would put him at high risk for needing dialysis given his CKD; there was concern this would not be consistent with his goals as someone who preferred to avoid being in the hospital. The recovery process would additionally likely necessitate a long rehab stint. Meanwhile, he was treated broadly with vancomycin and Cefepime for fever, likely secondary to lung source. Due to his Impella he developed complications of hemolysis and hyperkalemia, so was temporized with IV insulin and dextrose. He was not making significant urine so Lasix was a poor option and dialysis was not within goals of care. Repeat family meeting was held discussing CPR, and it was decided that this would be against the patient's wishes. At that time, patient was made DNR and ICD was disabled. HCP wished to continue with medical management including impella and ventilator support until family was able to visit the patient. Overnight on ___, patient had increasingly downtrending MAPs and began alarming for low flow on the impella. Exam at that point in time was notable for R surgical pupil, L fixed dilated pupil, no corneal reflex, no gag or cough reflex, no withdraw to painful stimuli. Cardiac exam with very faint S1/S2 with weak carotid pulses. Patient was triggering spontaneous breaths on ventilator. Upon discussion with family at that time, the preference was to wait to discontinue life support until arrival of the daughter. After that conversation, patient then developed loss of all arterial pulsations on A-line and lost his pulse on exam. He also was noted to be asystolic on telemetry so all supportive measures were withdrawn. He was pronounced disease at 0405 on ___. Family members were immediately contacted and came to bedside. His HCP declined autopsy. ",2237,664
10010066-DS-6,"<SEX> M <SERVICE> ORTHOPAEDICS <ALLERGIES> Patient recorded as having No Known Allergies to Drugs <ATTENDING> ___ <CHIEF COMPLAINT> Fall off ladder, presents with R foot pain and low back pain <MAJOR SURGICAL OR INVASIVE PROCEDURE> ___: I&D right open calcaneus fracture with VAC placement ___: I&D right open calcaneus fracture with VAC change ___: I&D right open calcaneus fracture with ORIF and Split Thickness Skin Graft to wound. <HISTORY OF PRESENT ILLNESS> Mr. ___ is a ___ year old man who had a fall off a ladder (approx 12 feet)on ___. He was taken to ___ ___ and was found to have a Grade IIIb open right calcaneal fracture. He was then transferred to the ___ for further evaluation and care. <PAST MEDICAL HISTORY> Depression Anxiety Right foot fx (___) treated non-operatively Low back injury (___) treated non-operatively <SOCIAL HISTORY> ___ <FAMILY HISTORY> n/a <PHYSICAL EXAM> Upon admission Alert and oriented Cardiac: Regular rate rhythm Chest: Lungs clear bilaterally Abdomen: Soft non-tender non-distended Extremities: RLE, SILT R foot/toes/plantar surface open fracture with large laceration medial to right ankle/heel <PERTINENT RESULTS> ___ 07: 20PM GENTA-1.2* ___ 07: 20AM GLUCOSE-143* UREA N-10 CREAT-0.9 SODIUM-141 POTASSIUM-4.2 CHLORIDE-106 TOTAL CO2-26 ANION GAP-13 ___ 07: 20AM WBC-6.3 RBC-3.56* HGB-10.9* HCT-32.2* MCV-91 MCH-30.5 MCHC-33.7 RDW-13.6 ___ 07: 20AM PLT COUNT-162 ___ 06: 15PM ___ PTT-25.5 ___ ___: 45PM GLUCOSE-100 UREA N-11 CREAT-0.8 SODIUM-139 POTASSIUM-3.4 CHLORIDE-106 TOTAL CO2-23 ANION GAP-13 ___ 05: 45PM WBC-6.3 RBC-4.15* HGB-12.4* HCT-36.8* MCV-89 MCH-29.9 MCHC-33.8 RDW-13.8 ___ 05: 45PM NEUTS-78.8* LYMPHS-16.4* MONOS-4.1 EOS-0.3 BASOS-0.4 ___ 05: 45PM PLT COUNT-164 ___ 05: 45PM URINE COLOR-Straw APPEAR-Clear SP ___ ___ 05: 45PM URINE BLOOD-NEG NITRITE-NEG PROTEIN-NEG GLUCOSE-NEG KETONE-15 BILIRUBIN-NEG UROBILNGN-NEG PH-7.0 LEUK-NEG <MEDICATIONS ON ADMISSION> Antidepressant - unknown med and dose <DISCHARGE MEDICATIONS> 1. Senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a day) as needed for constipation. Disp: *60 Tablet(s)* Refills: *0* 2. Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day). Disp: *60 Capsule(s)* Refills: *0* 3. Acetaminophen 325 mg Tablet Sig: Two (2) Tablet PO Q6H (every 6 hours). 4. Enoxaparin 30 mg/0.3 mL Syringe Sig: One (1) syringe Subcutaneous Q12H (every 12 hours) for 18 days. Disp: *36 syringes* Refills: *0* 5. Hydromorphone 2 mg Tablet Sig: ___ Tablets PO Q3H (every 3 hours) as needed for pain. Disp: *100 Tablet(s)* Refills: *0* <DISCHARGE DISPOSITION> Home With Service Facility: ___ <DISCHARGE DIAGNOSIS> Fall from ladder Right open calcaneus fracture <DISCHARGE CONDITION> Stable/Good <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Continue to be non-weight bearing on your right leg Continue to take your lovenox injections as instructed Please take all medication as prescribed If you have any increased pain, swelling, and or numbness, not relieved with rest, elevation and or pain medication, or if you have any other concerning symptoms, please call the office or come to the emergency department You have been prescribed a narcotic pain medication. Please take only as directed and do not drive or operate any machinery while taking this medication. There is a 72 hour ___ through ___, 9am to 4pm) response time for prescription refil requests. There will be no prescription refils on ___, ___, or holidays. Please plan accordingly. ","Mr. ___ presented to the ___ on ___ via transfer from ___ with a right open calcaneal fracture. He was admitted, consented, and taken to the operating room. He underwent an I&D with VAC placement of his right calcaneal fracture wound. He tolerated the procedure well, was extubated, transferred to the recovery room and then to the floor. On ___ he returned to the operating room and underwent a repeat I&D of his right calcaneal fracture with VAC change. He tolerated the procedure well, was extubated, transferred to the recovery room and then to the floor. On ___ he returned to the operating room and underwent an I&D of the right calcaneal wound with ORIF by orthopaedics and a split thickness skin graft to his wound by plastic surgery. He tolerated the procedure well, was extubated, transferred to the recovery room and then to the floor. He remained on bedrest per plastic surgery for graft protection. His splint was changed on ___ to provide improved padding. On ___ his VAC was removed by plastic surgery and his antibiotics were stopped. On ___ he was taken off bedrest and worked with physical therapy, though was only allowed to dangle his leg (have it dependent for 15 minutes 3 times a day). On ___ he was able to start physical therapy and was cleared for home with ___. Foley ___ was removed and he voided 500cc prior to discharge. The rest of his hospital stay was uneventful with his lab data and vital signs within normal limits and his pain controlled. He is being discharged today in stable condition. ",1133,330
10010231-DS-21,"<SEX> M <SERVICE> MEDICINE <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> planned admission for HiDAC <MAJOR SURGICAL OR INVASIVE PROCEDURE> None. <HISTORY OF PRESENT ILLNESS> Mr. ___ is a ___ gentleman without any past medical history, and recent diagnosis of acute myeloid leukemia s/p recent admission for 7+3 starting ___, who presents for initiation of HiDAC consolidation therapy. The patient had favorable genetics given t(8;21). Bone marrow biopsy, FISH, and cytogenetics on day 21 indicated complete response to 7+3. Because of this, the plan per outpatient oncology team, was for consolidation with ___ cycles of HiDAC. Patient was recently seen in follow up on ___, during which time, there was a discussion of the potential adverse effect of this regimen, particularly cytopenias requiring close follow-up, as well as cerebellar degeneration. After a discussion of risks, patient signed an informed consent to initiate cycle 1 of HiDAC on ___, with plan to have port placed. Patient says that he has felt will since his recent admission for 7+3 (discharge on ___. He denies fatigue (presenting complaint on recent admission for AML diagnosis) any fevers, chills, night sweats. He denies headache, lightheadedness, chest pain, shortness of breath, URI sx, nausea/vomiting, diarrhea/constipation, or dysuria/urinary incontinence. Review of Systems: (+) Per HPI. Denies fever, chills, night sweats, headache, vision changes, rhinorrhea, congestion, sore throat, cough, shortness of breath, chest pain, abdominal pain, nausea, vomiting, diarrhea, constipation, BRBPR, melena, hematochezia, dysuria, hematuria. <PAST MEDICAL HISTORY> PAST ONCOLOGIC HISTORY: Patient presented to ___ with a 3 week history of weakness associated with dyspnea on exertion and chest pain on ___ and was transferred to ___ for further evaluation by heme/onc when a CBC revealed leukocytosis with blasts. Bone marrow biopsy confirmed acute myeloid leukemia, t(8;21), RUNX1/RUNX1T1 rearrangement. Patient was started on 7+3 on ___. Day 14 bone marrow with aplasia but persistent t(8;21) in 40% of cells per karyotype and RUNX1/RUNX1T1 rearrangement in 16% per FISH. Decision was made not to re-induce. Day 21 bone marrow on ___ was with no morphologic or cytogenetic evidence of residual disease. PAST MEDICAL/SURGICAL HISTORY: He is in excellent health and has had no past problems. <SOCIAL HISTORY> ___ <FAMILY HISTORY> Both mother and father died of old age. He denies any family history of malignancy or blood disorders. <PHYSICAL EXAM> ADMISSION PHYSICAL EXAM -============ Vitals: T 97.9 BP 122/70 HR 72 RR 18 O2Sat 100% RA Gen: Pleasant, calm, appropriately interactive HEENT: No conjunctival pallor. No icterus. MMM. OP clear. NECK: JVP 4 cm above sternal angle at 45 degr. Normal carotid upstroke without bruits. LYMPH: No cervical or supraclav LAD CV: Normocardic, regular. Normal S1,S2. No MRG. LUNGS: No incr WOB. CTAB. No wheezes, rales, or rhonchi. ABD: NABS. Soft, NT, ND. EXT: WWP. No ___ edema. SKIN: No rashes/lesions, petechiae/purpura ecchymoses. NEURO: A&Ox3. LINES: PIV DISCHARGE PHYSICAL EXAM -============ Vitals: T 97.9 BP 122/70 HR 72 RR 18 O2Sat 100% RA Gen: Pleasant, calm, appropriately interactive HEENT: No conjunctival pallor. No icterus. MMM. OP clear. NECK: JVP 4 cm above sternal angle at 45 degr. Normal carotid upstroke without bruits. LYMPH: No cervical or supraclav LAD CV: Normocardic, regular. Normal S1,S2. No MRG. LUNGS: No incr WOB. CTAB. No wheezes, rales, or rhonchi. ABD: NABS. Soft, NT, ND. EXT: WWP. No ___ edema. SKIN: No rashes/lesions, petechiae/purpura ecchymoses. NEURO: A&Ox3. LINES: Port <PERTINENT RESULTS> ADMISSION LABS -- ___ 10: 12AM GLUCOSE-107* UREA N-12 CREAT-0.7 SODIUM-138 POTASSIUM-4.0 CHLORIDE-104 TOTAL CO2-23 ANION GAP-15 ___ 10: 12AM ALT(SGPT)-22 AST(SGOT)-18 LD(LDH)-167 ALK PHOS-68 TOT BILI-0.2 ___ 10: 12AM ALBUMIN-3.9 CALCIUM-9.2 PHOSPHATE-3.5 MAGNESIUM-2.1 URIC ACID-5.6 ___ 10: 12AM WBC-7.4 RBC-3.16* HGB-10.3* HCT-30.6* MCV-97 MCH-32.6* MCHC-33.7 RDW-18.4* RDWSD-63.4* ___ 10: 12AM NEUTS-77* BANDS-0 LYMPHS-9* MONOS-9 EOS-2 BASOS-2* ___ METAS-1* MYELOS-0 AbsNeut-5.70 AbsLymp-0.67* AbsMono-0.67 AbsEos-0.15 AbsBaso-0.15* ___ 10: 12AM HYPOCHROM-NORMAL ANISOCYT-1+ POIKILOCY-1+ MACROCYT-NORMAL MICROCYT-NORMAL POLYCHROM-OCCASIONAL OVALOCYT-1+ BURR-OCCASIONAL TEARDROP-OCCASIONAL ___ 10: 12AM PLT SMR-NORMAL PLT COUNT-340 ___ 10: 12AM ___ PTT-28.4 ___ ___ 10: 12AM ___ MICROBIOLOGY -- N/A IMAGING -- N/A DISCHARGE AND PERTINENT LABS -- ___ 12: 00AM BLOOD WBC-2.9*# RBC-3.12* Hgb-10.0* Hct-30.1* MCV-97 MCH-32.1* MCHC-33.2 RDW-16.9* RDWSD-59.1* Plt ___ ___ 12: 00AM BLOOD Neuts-97.0* Lymphs-1.4* Monos-1.0* Eos-0.0* Baso-0.3 Im ___ AbsNeut-2.81# AbsLymp-0.04* AbsMono-0.03* AbsEos-0.00* AbsBaso-0.01 ___ 12: 00AM BLOOD Plt ___ ___ 12: 00AM BLOOD Glucose-212* UreaN-10 Creat-0.5 Na-135 K-4.0 Cl-100 HCO3-24 AnGap-15 ___ 12: 00AM BLOOD ALT-62* AST-48* LD(___)-154 AlkPhos-47 TotBili-0.5 ___ 12: 00AM BLOOD Albumin-3.9 Calcium-8.8 Phos-2.8 Mg-2.1 <MEDICATIONS ON ADMISSION> None. <DISCHARGE MEDICATIONS> 1. Ondansetron ODT 4 mg PO Q8H: PRN Nausea RX *ondansetron 4 mg 1 tablet(s) by mouth Q8H: prn Disp #*42 Tablet Refills: *0 2. PrednisoLONE Acetate 1% Ophth. Susp. 1 DROP BOTH EYES TID RX *prednisolone acetate 1 % 1 drop ophthalmic three times a day Refills: *0 <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> PRIMARY DIAGNOSES -===== Acute myeloid leukemia <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Mr. ___, It was a pleasure taking care of you! Why you were admitted - For consolidation chemotherapy for your cancer. What we did for you - We continued treatment for your leukemia. You tolerated the chemotherapy very well. - We placed a port to facilitate your future treatments. What you should do when you go home: - Please take your medications as prescribed. - Please attend your follow-up appointment with your primary oncologist, Dr. ___ on ___, ___ at 10: 00 AM. We wish you the best, Your ___ team ","Mr. ___ is a ___ with recent dx of AML t(8;21), RUNX1/RUNX1T1 rearrangement, s/p 7+3 on ___, with day 21 bone marrow biopsy on ___ notable for no morphologic or cytogenetic evidence of residual disease, now admitted for first cycle of HiDAC consolidation therapy (D1: ___ and port placement. #AML: The patient has a recent dx of AML, t(8;21), RUNX1/RUNX1T1 rearrangement and is s/p recent admission for 7+3 on ___. Day 14 bone marrow biopsy showed aplasia, but persistent t(8;21) in 40% of cells per karyotype and RUNX1/RUNX1T1 rearrangement in 16% per FISH, and decision was made at that time not to re-induce. Day 21 bone marrow on ___ was notable for no morphologic or cytogenetic evidence of residual disease, and decision was made to initiate HiDAC consolidation therapy (D1: ___, D3: ___, D5: ___ for a total of 6 doses. On admission on ___, WBC 7.4, H&H 10.3/30.6, plt 340, ANC 5700, ALT/AST ___. Baseline cerebellar exam prior to 1st dose was notable for slight intention tremor on bilateral finger to nose testing. There was no change in cerebellar exam with subsequent doses of chemotherapy and exam was stable at time of discharge. At time of discharge on ___, WBC 2.9, H&H 10.0/30.1, plt 228, ANC 2810. ALT/AST 62/48. Patient also had port placed on ___. TRANSITIONAL ========================= - Patient received first cycle of HiDAC consolidation therapy (D1: ___, D3: ___, D5: ___ for a total of 6 doses. - Patient had port placed on ___. - Patient has outpatient appointment with primary oncologist, Dr. ___ on ___ at 10:00 AM, phone# ___. ",2088,451
10010231-DS-22,"<SEX> M <SERVICE> MEDICINE <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___ <CHIEF COMPLAINT> Fever. <MAJOR SURGICAL OR INVASIVE PROCEDURE> None. <HISTORY OF PRESENT ILLNESS> Mr ___ is a ___ year old man with recently diagnosed AML with RUNX1/RUNX1T1 rearrangement, s/p induction with 7+3 (D1 ___ and s/p HiDAC consolidation (D1: ___, D3: ___, D5: ___, who presented to clinic today for labs and was found to be febrile and neutropenic. From clinic note: ""Called to ___ 7 by nurse for fever to 100.8. On interview, patient is feeling well with the exception of fever, chills, and mild right-sided chest pain. Otherwise, feeling well. He denies shortness of breath, cough, abdominal pain, nausea, vomiting, and diarrhea. Right-sided port is without pain or irritation."" Upon arrival to the floor, he states that his temperature was actually 99.8 last night (although he told the nurse in clinic today that it was 100.8 last night). He woke up feeling slightly sweaty this morning, but states that this was due to using too many blankets overnight. Otherwise, he has been feeling well. He did note a couple days of RUQ pain upon moving or swallowing, but this has since resolved. Finally, he stated that his calves have been slightly sore recently when walking. Otherwise no complaints. No recent travel. Had a friend with a cold last week, otherwise no sick contacts. <PAST MEDICAL HISTORY> PAST ONCOLOGIC HISTORY: Patient presented to ___ with a 3 week history of weakness associated with dyspnea on exertion and chest pain on ___ and was transferred to ___ for further evaluation by heme/onc when a CBC revealed leukocytosis with blasts. Bone marrow biopsy confirmed acute myeloid leukemia, t(8;21), RUNX1/RUNX1T1 rearrangement. Patient was started on 7+3 on ___. Day 14 bone marrow with aplasia but persistent t(8;21) in 40% of cells per karyotype and RUNX1/RUNX1T1 rearrangement in 16% per FISH. Decision was made not to re-induce. Day 21 bone marrow on ___ was with no morphologic or cytogenetic evidence of residual disease. PAST MEDICAL/SURGICAL HISTORY: He is in excellent health and has had no past problems. <SOCIAL HISTORY> ___ <FAMILY HISTORY> Both mother and father died of old age. He denies any family history of malignancy or blood disorders. <PHYSICAL EXAM> ADMISSION PHYSICAL EXAM: -========== Vitals: T98.1 BP 110/64 P 98 RR 21 O2 100% RA Gen: Pleasant, calm, ___ speaking gentleman HEENT: No conjunctival pallor. No icterus. MMM. OP clear. NECK: JVP flat. Normal carotid upstroke without bruits. LYMPH: No cervical or supraclav LAD CV: Normocardic, regular. Normal S1,S2. No MRG. LUNGS: No incr WOB. CTAB. No wheezes, rales, or rhonchi. ABD: NABS. Soft, NT, ND. EXT: WWP. No ___ edema. On L foreleg, few scattered raised patches with superficial scale. No cords/redness in b/l calves. NEURO: A&Ox3. LINES: R POC: c/d/I DISCHARGE PHYSICAL EXAM: -========== Vitals: Tm 98.6 BP ___ P ___ RR 20 O2 95-100% RA Gen: Pleasant, calm, ___ speaking gentleman. HEENT: No icterus. MMM. OP clear. NECK: JVP flat. Normal carotid upstroke without bruits. LYMPH: No cervical or supraclav LAD CV: Normocardic, regular. Normal S1,S2. No MRG. LUNGS: No incr WOB. CTAB. No wheezes, rales, or rhonchi. ABD: NABS. Soft, NT, ND. EXT: WWP. No ___ edema. On L foreleg, few scattered raised patches with superficial scale. No cords/redness in b/l calves. NEURO: A&Ox3. LINES: R POC: c/d/I <PERTINENT RESULTS> ADMISSION LABS: -======= ___ 08: 55AM BLOOD WBC-1.1*# RBC-2.35* Hgb-7.6* Hct-21.7* MCV-92 MCH-32.3* MCHC-35.0 RDW-15.0 RDWSD-50.4* Plt Ct-34* ___ 08: 55AM BLOOD Neuts-3* Bands-0 ___ Monos-67* Eos-0 Baso-0 ___ Myelos-0 AbsNeut-0.03* AbsLymp-0.33* AbsMono-0.74 AbsEos-0.00* AbsBaso-0.00* ___ 08: 55AM BLOOD Glucose-122* UreaN-13 Creat-0.9 Na-135 K-3.7 Cl-100 HCO3-22 AnGap-17 ___ 08: 55AM BLOOD ALT-32 AST-20 AlkPhos-68 TotBili-0.2 ___ 08: 55AM BLOOD CK-MB-<1 cTropnT-<0.01 ___ 08: 55AM BLOOD Calcium-9.0 Phos-2.6* Mg-1.8 ___ 10: 00AM URINE Color-Yellow Appear-Clear Sp ___ ___ 10: 00AM URINE Blood-NEG Nitrite-NEG Protein-30 Glucose-NEG Ketone-TR Bilirub-NEG Urobiln-NEG pH-6.0 Leuks-NEG ___ 10: 00AM URINE RBC-2 WBC-1 Bacteri-NONE Yeast-NONE Epi-<1 ___ 10: 00AM URINE CastHy-5* ___ 10: 00AM URINE Mucous-MOD IMAGING: -======= CXR ___: Comparison to ___. No relevant change is noted. No evidence of pneumonia. Normal size of the cardiac silhouette. Normal hilar and mediastinal contours. No pulmonary edema. No pleural effusions. MICROBIOLOGY: -======= ___ 5: 29 pm Rapid Respiratory Viral Screen & Culture Source: Nasopharyngeal swab. Respiratory Viral Culture (Pending): Respiratory Viral Antigen Screen (Pending): ___ 12: 00 am BLOOD CULTURE Source: Line-PORT. Blood Culture, Routine (Pending): ___ 10: 00 am URINE ___. **FINAL REPORT ___ URINE CULTURE (Final ___: NO GROWTH. ___ 9: 25 am BLOOD CULTURE Blood Culture, Routine (Pending): PERTINENTS LABS: -======= N/a DISCHARGE LABS: -======= ___ 12: 28AM BLOOD WBC-4.4 RBC-2.66* Hgb-8.4* Hct-24.7* MCV-93 MCH-31.6 MCHC-34.0 RDW-16.4* RDWSD-54.5* Plt ___ ___ 12: 28AM BLOOD Neuts-37 Bands-10* ___ Monos-25* Eos-0 Baso-0 Atyps-1* Metas-6* Myelos-0 Blasts-2* NRBC-3* AbsNeut-2.07 AbsLymp-0.88* AbsMono-1.10* AbsEos-0.00* AbsBaso-0.00* ___ 12: 28AM BLOOD Glucose-111* UreaN-10 Creat-0.6 Na-137 K-4.2 Cl-102 HCO3-25 AnGap-14 ___ 12: 28AM BLOOD ALT-41* AST-30 LD(LDH)-181 AlkPhos-79 TotBili-0.2 ___ 12: 28AM BLOOD Albumin-3.8 Calcium-9.0 Phos-4.3 Mg-2.1 <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Ondansetron 4 mg PO Q8H: PRN nausea 2. Acyclovir 400 mg PO Q12H 3. Ciprofloxacin HCl 500 mg PO Q12H 4. Fluconazole 400 mg PO Q24H 5. Montelukast 10 mg PO DAILY <DISCHARGE MEDICATIONS> 1. Ondansetron 4 mg PO Q8H: PRN nausea 2. HELD- Acyclovir 400 mg PO Q12H This medication was held. Do not restart Acyclovir until instructed to do so by your doctor. 3. HELD- Ciprofloxacin HCl 500 mg PO Q12H This medication was held. Do not restart Ciprofloxacin HCl until instructed to do so by your doctor. 4. HELD- Fluconazole 400 mg PO Q24H This medication was held. Do not restart Fluconazole until instructed to do so by your doctor. 5. HELD- Montelukast 10 mg PO DAILY This medication was held. Do not restart Montelukast until instructed to do so by your doctor. <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> PRIMARY: Febrile neutropenia SECONDARY: Acute myelogenous leukemia <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Mr. ___, It was a pleasure taking care of you at ___ ___. Why was I in the hospital? You were in the hospital because you had a fever at home, and your blood counts are very low. What happened to me in the hospital? We gave you antibiotics to fight infection. We did tests of your blood and urine to look for infection, but did not find any. What should I do when I leave the hospital? You should go to your follow up appointment at 8am on ___. You do not need to take any medicines for now. Best wishes, Your ___ team ","Mr ___ is a ___ year old man with recently diagnosed AML with RUNX1/RUNX1T1 rearrangement, s/p induction with 7+3 (D1 ___ and s/p HiDAC consolidation (D1: ___, D3: ___, D5: ___, who presented to clinic for labs and was found to be febrile and neutropenic. # Febrile neutropenia. Pt self-reports fever to 100.8 prior to admission. He had 2 fevers during admission, with last one on ___ (to 100.6). Otherwise no infectious or localizing symptoms. He was well appearing and non-toxic on exam. No hemodynamic instability or other signs to suggest severe infection/sepsis. He received a dose of both Vancomycin and Cefepime in clinic prior to being admitted. Vancomycin was stopped on admission due to his benign clinical status. Cefepime was continued for the duration of admission (Day 1: ___, and stopped upon discharge. UA, UCx, CXR did not show evidence of infection. Blood and Port cultures were obtained and remained negative during admission, with blood cultures still pending at time of discharge. # AML. S/p induction with 7+3 (D1 ___ and s/p 1 cycle of HiDAC consolidation. Has a history of transfusion reaction (hives) in setting of platelet transfusion, without respiratory distress. Last transfusion ___. CBC, chemistry, LFTs monitored daily. He did not require any transfusions, and his counts improved to ANC >1000 prior to discharge (see above). His prophylactic medications were held upon discharge due to his recovering counts, but he was instructed to hold onto these medications as he will need them in the future. # RUQ pain. Unclear etiology of pain, although suspicion for ACS is very low given pain is now resolved and Troponin negative. This did not re-occur during admission. # Calf pain. Pt states he has had b/l calf pain for days-weeks. No palpable cord, redness, warmth on exam to suggest DVT in either leg. No further work-up was implemented. ",2341,458
10010231-DS-23,"<SEX> M <SERVICE> MEDICINE <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> Admit for Cycle 2 HIDAC <MAJOR SURGICAL OR INVASIVE PROCEDURE> None <HISTORY OF PRESENT ILLNESS> ___ yo M with no past medical history and recent diagnosis of acute myeloid leukemia s/p 7+3 admitted for cycle 2 of HiDAC. Communicated with patient using interpretor (in person). Pt feels well. Denies any sort of infectious symptoms. He mentions that he worked as a ___ and in ___. He denies all ROS. <PAST MEDICAL HISTORY> PAST ONCOLOGIC HISTORY: Patient presented to ___ with a 3 week history of weakness associated with dyspnea on exertion and chest pain on ___ and was transferred to ___ for further evaluation by heme/onc when a CBC revealed leukocytosis with blasts. Bone marrow biopsy confirmed acute myeloid leukemia, t(8;21), RUNX1/RUNX1T1 rearrangement. Patient was started on 7+3 on ___. Day 14 bone marrow with aplasia but persistent t(8;21) in 40% of cells per karyotype and RUNX1/RUNX1T1 rearrangement in 16% per FISH. Decision was made not to re-induce. Day 21 bone marrow on ___ was with no morphologic or cytogenetic evidence of residual disease. PAST MEDICAL/SURGICAL HISTORY: He is in excellent health and has had no past problems. <SOCIAL HISTORY> ___ <FAMILY HISTORY> Both mother and father died of old age. He denies any family history of malignancy or blood disorders. <PHYSICAL EXAM> ADMISSION PHYSICAL EXAM: ___: NAD VITAL SIGNS: 97.4 PO ___ 20 98 RA HEENT: MMM, no OP lesions, CV: RRR, NL S1S2 no S3S4 MRG PULM: CTAB. No crackles or wheezes ABD: BS+, soft, NTND, LIMBS: No edema, clubbing, tremors, or asterixis; SKIN: No rashes or skin breakdown NEURO: No focal deficits observed. DISCHARGE PHYSICAL EXAM: T 98.0 BP 116/68 HR 85 RR 18 O2 98%RA ___: Pleasant, well appearing. NAD HEENT: Anicteric. MMM, no OP lesions, CV: RRR, NL S1S2 no S3S4 MRG. PULM: CTAB. No crackles or wheezes GI: BS+, soft, NTND. No HSM. MSK: No edema, clubbing, tremors, or asterixis; Normal bulk SKIN: No rashes or skin breakdown NEURO: CN II-XII intact. AAOx3. FTN intact without dysmetria. No DDK. No truncal ataxia. Tandem gait intact. <PERTINENT RESULTS> ___ 05: 45PM BLOOD WBC-4.0 RBC-2.67* Hgb-8.8* Hct-25.9* MCV-97 MCH-33.0* MCHC-34.0 RDW-19.1* RDWSD-64.4* Plt ___ ___ 12: 00AM BLOOD WBC-4.3 RBC-3.02* Hgb-9.6* Hct-29.6* MCV-98 MCH-31.8 MCHC-32.4 RDW-19.2* RDWSD-66.9* Plt ___ ___ 12: 00AM BLOOD WBC-10.4*# RBC-2.71* Hgb-8.9* Hct-26.7* MCV-99* MCH-32.8* MCHC-33.3 RDW-19.5* RDWSD-68.8* Plt ___ ___ 02: 00AM BLOOD WBC-3.4*# RBC-2.84* Hgb-9.2* Hct-27.8* MCV-98 MCH-32.4* MCHC-33.1 RDW-18.9* RDWSD-67.4* Plt ___ ___ 12: 20AM BLOOD WBC-4.8 RBC-2.66* Hgb-9.8* Hct-28.9* MCV-109*# MCH-36.8*# MCHC-33.9 RDW-14.6 RDWSD-58.0* Plt ___ ___ 05: 45PM BLOOD Glucose-109* UreaN-12 Creat-0.9 Na-139 K-4.0 Cl-103 HCO3-27 AnGap-13 ___ 12: 00AM BLOOD Glucose-157* UreaN-13 Creat-0.7 Na-137 K-4.5 Cl-104 HCO3-24 AnGap-14 ___ 12: 00AM BLOOD Glucose-182* UreaN-15 Creat-0.6 Na-137 K-3.6 Cl-103 HCO3-24 AnGap-14 ___ 02: 00AM BLOOD Glucose-156* UreaN-10 Creat-0.6 Na-135 K-3.8 Cl-102 HCO3-25 AnGap-12 ___ 12: 20AM BLOOD Glucose-131* UreaN-15 Creat-0.8 Na-137 K-3.8 Cl-101 HCO3-25 AnGap-15 ___ 10: 21PM BLOOD Glucose-125* UreaN-12 Creat-0.5 Na-138 K-3.9 Cl-103 HCO3-26 AnGap-13 ___ 05: 45PM BLOOD ALT-51* AST-36 AlkPhos-64 TotBili-0.2 ___ 12: 00AM BLOOD ALT-52* AST-37 AlkPhos-68 TotBili-0.2 ___ 12: 00AM BLOOD ALT-40 AST-25 AlkPhos-73 TotBili-0.3 ___ 02: 00AM BLOOD ALT-39 AST-25 AlkPhos-52 TotBili-0.5 ___ 12: 20AM BLOOD ALT-14 AST-22 AlkPhos-62 TotBili-0.2 <MEDICATIONS ON ADMISSION> None <DISCHARGE MEDICATIONS> None <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Acute myeloid leukemia <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Mr. ___, It was a pleasure taking care of you. You admitted for HiDAC chemotherapy for your AML. You tolerated the infusion well. Please note we have stopped several medications that help prevent infection (acyclovir, fluconazole, and ciprofloxacin). Please discuss with Dr. ___ during your follow up appointments if you should restart these medications. You will need to follow up in clinic to have your blood counts monitored. These appointments have been scheduled as below. It has been a pleasure taking care of you, Sincerely, Your ___ care team ","PRINCIPLE REASON FOR ADMISSION: Mr ___ is a ___ year old man with recently diagnosed AML with t(8,21)/RUNX1/RUNX1T1 rearrangement, s/p induction with 7+3 (D1 ___ and s/p HiDAC consolidation, here for C2 HiDAC. # AML: Favorable genetics given t(8;21). Bone marrow biopsy, FISH, and cytogenetics on day 21 indicate complete response to 7+3. Because of this, he is currently undergoing consolidation with ___ cycles of HiDAC. Admitted for Cycle 2 of HiDAC; ___. Tolerated well without significant complaint. Of note, after discussion with outpatient oncology team will hold off on ppx anti-infectives on discharge (has been on acyclovir, cipro, and fluconazole). He will be seen in clinic on ___ for further re-evaluation. Transitional issues: - ___ eval on ___ for count check and re-eval - Consider restarting ppx anti-infectives. ",1649,221
10010231-DS-24,"<SEX> M <SERVICE> MEDICINE <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> Fever <MAJOR SURGICAL OR INVASIVE PROCEDURE> None <HISTORY OF PRESENT ILLNESS> ___ with recent diagnosis AML on HiDAC (recent admit ___ for second cycle HiDAC consolidation after previously receiving 7+3) presenting as a transfer from ___ with fever in setting of neutropenia. Note that after his first cycle of HiDAC he was admitted ___ with neutropenic fever. Initially on vanc cefepime, cefepime continued for duration of his stay though vanc stopped on admit, no cultures showed documented infection, and it's not clear from ___ summary that any specific source was suspected as it seems he didn't even have any localizing symptoms. Pt reports on my interview today that he has been feeling fine but maybe with slight mild nonproductive cough over the last week (extremely minimal he reports on being pressed further) and this morning around 7 Am noted fever at home to 100.0 and subsequently 100.4 so went to ___. He reports that he had a sharp pleuritic right sided pain at the time of the fever and mild headache, but that these resolved very rapidly when his temperature returned to normal and he hasn't experienced these since. He denies significant sore throat or rhinorrhea neck stiffness, dysuria, diarrhea, or pain anywhere else. No SOB or chest pain specifically and no ___ edema. On review of ___ records from ___, he reported there mild sore throat, mild congestion and subjective fever/chills. Denied sick contacts and stated had flu shot this year. At ___ pt was in SR without EKG changes c/f ischemia. He presented with temp to 100.0. BP there was 146/72, HR 94, RR 18 98.6 temp. 100% RA. Labs with normal serum chem WBC 0.2 hct 19.3 plts 25. trop I was 0.049 (ref range <0.046). UA reassuring. Given vanc/cefepime. was given 324mg aspirin for slightly positive trop, but had no chest pain or ekg changes. Note he was seen in clinic ___ and received 1u plts for plts 11, now 25. Hct was in the 19 range but did not receive blood. ED COURSE at BI: T 98.9 HR 87 136/81 18 100% RA. lactate 1.4. trop neg. WBC 0.3, Hct 19.4, plts 25, chem pending at time of transfer from ED, UA reassuring, flu swab pending. On arrival to the floor interview as above conducted in ___, pt reports he feels quite well with most of the above symptoms completely resolved. All other 10 point ROS except as noted above negative. <PAST MEDICAL HISTORY> Patient presented to ___ with a 3 week history of weakness on ___. ___ revealed leukocytosis with blasts for which he was transferred to ___. Bone marrow biopsy confirmed acute myeloid leukemia, t(8;21), RUNX1/RUNX1T1 rearrangement. Patient was started on 7+3 on ___. Day 14 bone marrow with aplasia but persistent t(8;21) in 40% of cells per karyotype and RUNX1/RUNX1T1 rearrangement in 16% per FISH. Decision was made not to re-induce. Day 21 bone marrow on ___ was with no morphologic or cytogenetic evidence of residual disease. Treatment History: - ___: 7+3 - ___: BMB with ___ - ___: C1D1 HiDAC - ___: C2D1 HiDAC <SOCIAL HISTORY> ___ <FAMILY HISTORY> Both mother and father died of old age. He denies any family history of malignancy or blood disorders. <PHYSICAL EXAM> -======= Admission <PHYSICAL EXAM> -======= VITAL SIGNS: 98.8 122/76 108 16 93% RA ___: NAD HEENT: MMM, no OP lesions, no cervical, supraclavicular, or axillary adenopathy, no thyromegaly. CV: RR, NL S1S2 no S3S4 MRG. PULM: CTAB. GI: BS+, soft, NTND, no masses or hepatosplenomegaly. LIMBS: No edema, clubbing, tremors, or asterixis; no inguinal adenopathy. SKIN: No rashes or skin breakdown port site intact w/o erythema. Pt does have darker brown skin lesions over anterior foreleg on left but states chronic. NEURO: Oriented x3. Cranial nerves II-XII are within normal limits excluding visual acuity which was not assessed, no nystagmus; strength is ___ of the proximal and distal upper and lower extremities; reflexes are 2+ of the biceps, triceps, patellar, and Achilles tendons, toes are down bilaterally; gait is normal, coordination is intact. -======= Discharge <PHYSICAL EXAM> -======= VS: 97.9 118/70 75 18 100RA GEN: NAD HEENT: MMM, no OP lesions, no cervical, supraclavicular, axillary adenopathy, no thyromegaly CV: RR, NL S1S2 no S3S4 MRG PULM: CTAB ABD: BS+, soft, NTND, no masses or hepatosplenomegaly EXT: No edema, clubbing, tremors, or asterixis; no inguinal adenopathy SKIN: No rashes or skin breakdown port site intact w/o erythema; pt does have darker brown skin lesions over anterior foreleg on left but states chronic. NEURO: A&Ox3; Cranial nerves II-XII are within normal limits; Gross strength and sensation intact. <PERTINENT RESULTS> -== Admission Labs: -== ___ 08: 50AM BLOOD WBC-0.2* RBC-2.24* Hgb-7.4* Hct-21.1* MCV-94 MCH-33.0* MCHC-35.1 RDW-15.6* RDWSD-53.3* Plt Ct-11*# ___ 08: 50AM BLOOD Neuts-0 Bands-0 Lymphs-99* Monos-1* Eos-0 Baso-0 ___ Myelos-0 AbsNeut-0.00* AbsLymp-0.20* AbsMono-0.00* AbsEos-0.00* AbsBaso-0.00* ___ 08: 50AM BLOOD UreaN-16 Creat-0.9 Na-138 K-4.1 Cl-103 HCO3-23 AnGap-16 ___ 08: 50AM BLOOD ALT-41* AST-26 AlkPhos-77 TotBili-0.2 ___ 08: 50AM BLOOD Calcium-9.3 Phos-3.5 Mg-1.9 ___ 04: 45PM BLOOD cTropnT-<0.01 ___ 05: 48AM BLOOD cTropnT-<0.01 ___ 04: 45PM BLOOD Lipase-23 ___ 04: 56PM BLOOD Lactate-1.4 -== Discharge Labs: -== ___ 12: 00AM BLOOD WBC-4.1 RBC-2.64* Hgb-8.3* Hct-24.6* MCV-93 MCH-31.4 MCHC-33.7 RDW-14.8 RDWSD-50.4* Plt ___ ___ 12: 00AM BLOOD Neuts-29* Bands-2 Lymphs-16* Monos-42* Eos-0 Baso-0 Atyps-1* Metas-5* Myelos-5* NRBC-3* AbsNeut-1.27* AbsLymp-0.70* AbsMono-1.72* AbsEos-0.00* AbsBaso-0.00* ___ 12: 00AM BLOOD ___ PTT-28.1 ___ ___ 12: 00AM BLOOD Glucose-144* UreaN-13 Creat-0.6 Na-137 K-3.8 Cl-102 HCO3-25 AnGap-14 ___ 12: 00AM BLOOD ALT-70* AST-47* LD(LDH)-200 AlkPhos-89 TotBili-<0.2 ___ 12: 00AM BLOOD Albumin-3.9 Calcium-9.1 Phos-4.3 Mg-2.1 ======== Imaging: ======== CXR ___ at ___ Findings: There has been interval placement of a Mediport on the right side, the tip of which projects over the SVC/right atrial junction. No focal consolidation. No pleural effusion. No pneumothorax. Unchanged cardiomediastinal silhouette. Impression: No acute pulmonary process. - Microbiology: - ___ 4: 11 pm BLOOD CULTURE Source: Line-port. **FINAL REPORT ___ Blood Culture, Routine (Final ___: NO GROWTH. ___ 10: 14 pm Rapid Respiratory Viral Screen & Culture Source: Nasopharyngeal swab. **FINAL REPORT ___ Respiratory Viral Culture (Final ___: No respiratory viruses isolated. Culture screened for Adenovirus, Influenza A & B, Parainfluenza type 1,2 & 3, and Respiratory Syncytial Virus.. Detection of viruses other than those listed above will only be performed on specific request. Please call Virology at ___ within 1 week if additional testing is needed. Respiratory Viral Antigen Screen (Final ___: Negative for Respiratory Viral Antigen. Specimen screened for: Adeno, Parainfluenza 1, 2, 3, Influenza A, B, and RSV by immunofluorescence. Refer to respiratory viral culture and/or Influenza PCR (results listed under ""OTHER"" tab) for further information.. ___ 6: 30 pm BLOOD CULTURE 2 OF 2. **FINAL REPORT ___ Blood Culture, Routine (Final ___: NO GROWTH. ___ 4: 45 pm BLOOD CULTURE **FINAL REPORT ___ Blood Culture, Routine (Final ___: NO GROWTH. ___ 4: 45 pm URINE **FINAL REPORT ___ URINE CULTURE (Final ___: NO GROWTH. <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Acyclovir 400 mg PO Q8H 2. Ciprofloxacin HCl 500 mg PO Q12H 3. Fluconazole 400 mg PO Q24H <DISCHARGE MEDICATIONS> 1. Acyclovir 400 mg PO Q8H <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> - fever and neutropenia - acute myeloid leukemia - pancytopenia <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Mr. ___, It was a pleasure caring for you while you were at ___. You came from ___ with fevers and low blood counts, which has happened to you before when you have gotten chemotherapy. We found no infection but kept you on antibiotics to prevent any infection from taking hold. You never had any symptoms while you were here, and once your counts recovered antibiotics were stopped and you were discharged home. Thank you for allowing us to participate in your care! Best regards, Your ___ Care Team ","Mr. ___ is a ___ male with history AML on HiDAC (recent admit ___ for second cycle HiDAC consolidation after previously receiving 7+3) who presented as a transfer from ___ with fever in setting of neutropenia. # Febrile Neutropenia: The patient was febrile and seen first at ___, where cultures were drawn and a CXR was negative. He was then transferred to ___ where he was again febrile and cultured, then started on vanco/cefepime. Subsequent to this we was afebrile and all cultures were negative with no localizing signs of infection. Vancomycin and cefepime were stopped after ANC>5400 and patient had been afebrile >24h after abx. stopped. Dr. ___ was consulted and stopped his cipro and fluconazole prophylaxis after count recovery, and the patient was fit for discharge. He will be seen in clinic ___ and have planned admission ___. # AML: Favorable genetics given t(8.21) s/p 7+3 and C2D1 HiDAC consolidation was ___. Bone marrow biopsy, FISH, and cytogenetics on day ___ indicate complete response to 7+3. Because of this, he is currently undergoing consolidation with ___ cycles of HiDAC, first cycle c/b admit for neutropenic fever, cytopenias. He presented for a similar picture, neutropenia with ANC<500 and fever. He was treated as above. Ultimately the patient's counts sufficiently recovered to be sent home, and he will return to be seen by Dr. ___ as an outpatient. # Panyctopenia (anemia, thrombocytopenia, neutropenia): Likely all consequence of chemotherapy and underlying malignancy and inflammatory block. His counts recovered by the time of discharge. TRANSITIONAL ISSUES: - continue to trend LFTs while outpatient, slight rise thought to be medication effect - continue to monitor ANC and counts - plan for next HiDAC cycle - Contact: ___son) ___ - Code: Full ",2606,429
10010231-DS-26,"<SEX> M <SERVICE> MEDICINE <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> epigastric abdominal pain <MAJOR SURGICAL OR INVASIVE PROCEDURE> none <HISTORY OF PRESENT ILLNESS> Mr. ___ is a ___ male with history AML s/p 7+3 induction now s/p 3C of HiDAC. Developed FN after C2 of HiDAC with no obvious infectious source found now presenting with abdominal pain. SUBJECTIVE: Patient c/o slight epigastric pain hx of this with previous chemotherapy cycles feels similar to prior. No fevers since last admission, denies chills/rigors/uri sx. pain ___ on pain scale feels ""gas pains"". no recent n/v/d. He denies shortness of breath, cough, chest pain, rashes, and dysuria. <PAST MEDICAL HISTORY> <PAST MEDICAL HISTORY> Patient presented to ___ with a 3 week history of weakness on ___. CBC revealed leukocytosis with blasts for which he was transferred to ___. Bone marrow biopsy confirmed acute myeloid leukemia, t(8;21), RUNX1/RUNX1T1 rearrangement. Patient was started on 7+3 on ___. Day 14 bone marrow with aplasia but persistent t(8;21) in 40% of cells per karyotype and RUNX1/RUNX1T1 rearrangement in 16% per FISH. Decision was made not to re-induce. Day 21 bone marrow on ___ was with no morphologic or cytogenetic evidence of residual disease. Treatment History: - ___: 7+3 - ___: BMB with ___ - ___: C1D1 HiDAC - ___: C2D1 HiDAC - ___: C3D1 HiDAC <SOCIAL HISTORY> ___ <FAMILY HISTORY> Both mother and father died of old age. He denies any family history of malignancy or blood disorders. <PHYSICAL EXAM> ADMISSION PHYSICAL EXAM: VITAL SIGNS: Temp 98.2 BP 123/74 HR 96 RR 16 O2 sat 100% RA. ___: NAD. HEENT: MMM, no OP lesions, no cervical, supraclavicular, axillary adenopathy, no thyromegaly. CV: RR, NL S1S2 no S3S4 MRG. PULM: CTAB. GI: BS+, soft, slight pain on palpation of epigastric region. no masses or hepatosplenomegaly. LIMBS: No edema, clubbing, tremors, or asterixis; no inguinal adenopathy. SKIN: No rashes or skin breakdown port site intact w/o erythema. Pt does have darker brown skin lesions over anterior foreleg on left but states chronic. NEURO: A&Ox3. Cranial nerves II-XII are within normal limits. Gross strength and sensation intact. no nystagmus, rapid hand movements and tandem gait intact. DISCHARGE PHYSICAL EXAM: VITAL SIGNS: TC 98.3 ___ 20 99-100%RA GEN: NAD, awake and alert, non-toxic in appearance. HEENT: MMM, no OP lesions, no cervical, supraclavicular, axillary adenopathy, no thyromegaly. CV: RR, NL S1S2 no S3S4 MRG. PULM: Non-labored. CTAB. GI: BS+, soft. Pain on palpation of epigastric region resolved. No rebound tenderness. No palpable masses or hepatosplenomegaly. LIMBS: No edema, clubbing, tremors, or asterixis; no inguinal adenopathy. SKIN: No rashes or skin breakdown; port site intact w/o erythema, discharge or swelling. Does have darker brown skin lesions over anterior foreleg on left but states chronic. NEURO: A&Ox3. Cranial nerves II-XII are within normal limits. Gross strength and sensation intact. No nystagmus, rapid hand movements and tandem gait intact. <PERTINENT RESULTS> LABS: ___ 09: 45AM PLT SMR-RARE PLT COUNT-9*# ___ 09: 45AM HYPOCHROM-NORMAL ANISOCYT-1+ POIKILOCY-1+ MACROCYT-NORMAL MICROCYT-1+ POLYCHROM-OCCASIONAL OVALOCYT-OCCASIONAL TEARDROP-1+ BITE-OCCASIONAL ___ 09: 45AM NEUTS-4* BANDS-0 LYMPHS-96* MONOS-0 EOS-0 BASOS-0 ___ MYELOS-0 AbsNeut-0.01* AbsLymp-0.19* AbsMono-0.00* AbsEos-0.00* AbsBaso-0.00* ___ 09: 45AM WBC-0.2* RBC-2.37* HGB-7.7* HCT-21.5* MCV-91 MCH-32.5* MCHC-35.8 RDW-14.5 RDWSD-48.2* ___ 09: 45AM CALCIUM-9.3 PHOSPHATE-3.9 MAGNESIUM-2.0 ___ 09: 45AM LIPASE-21 ___ 09: 45AM ALT(SGPT)-62* AST(SGOT)-30 ALK PHOS-82 TOT BILI-0.5 ___ 09: 45AM GLUCOSE-128* UREA N-13 CREAT-0.8 SODIUM-140 POTASSIUM-3.9 CHLORIDE-104 TOTAL CO2-21* ANION GAP-19 ___ 12: 15PM PLT COUNT-46*# ___ 11: 45PM BLOOD WBC-0.4*# RBC-2.49* Hgb-8.2* Hct-22.4* MCV-90 MCH-32.9* MCHC-36.6 RDW-14.6 RDWSD-47.3* Plt Ct-21* ___ 11: 45PM BLOOD Neuts-14* Bands-0 Lymphs-66* Monos-16* Eos-0 Baso-0 Atyps-4* ___ Myelos-0 AbsNeut-0.06* AbsLymp-0.28* AbsMono-0.06* AbsEos-0.00* AbsBaso-0.00* ___ 11: 45PM BLOOD Plt Ct-21* ___ 11: 45PM BLOOD Glucose-121* UreaN-12 Creat-0.7 Na-134 K-4.0 Cl-100 HCO3-24 AnGap-14 ___ 11: 45PM BLOOD ALT-48* AST-23 LD(LDH)-106 AlkPhos-75 TotBili-0.7 ___ 11: 45PM BLOOD Albumin-3.9 Calcium-8.9 Phos-3.8 Mg-2.2 ECG ___ Clinical indication for EKG: R___.31 - Abnormal electrocardiogram [ECG] [EKG] Sinus rhythm. Possible inferior wall myocardial infarction. Somewhat early R wave progression. Compared to the previous tracing of ___ the rate is now somewhat slower. Otherwise, unchanged. <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Acyclovir 400 mg PO Q12H 2. Ciprofloxacin HCl 500 mg PO Q12H 3. Fluconazole 400 mg PO Q24H 4. Montelukast 10 mg PO DAILY 5. Simethicone 40-80 mg PO QID: PRN gas pain <DISCHARGE MEDICATIONS> 1. Pantoprazole 40 mg PO Q24H 2. Acyclovir 400 mg PO Q12H 3. Ciprofloxacin HCl 500 mg PO Q12H 4. Fluconazole 400 mg PO Q24H 5. Montelukast 10 mg PO DAILY 6. Simethicone 40-80 mg PO QID: PRN gas pain <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> AML Abdominal pain likely GERD/Gastritis <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Mr. ___, You were admitted due to dehydration and abdominal upset which improved with IV fluids time and adding a medication for heartburn. You will be discharged home and follow up as stated below. Please do not hesitate to call in the meantime with any questions or concerns. It was a pleasure taking care of you. ","ASSESSMENT AND PLAN: Mr. ___ is a ___ male with history AML s/p 7+3 and C3 HiDAC consolidation presenting with epigastric pain. C3D17 ___ #Epigastric pain: (resolved), described as mild in nature and was minimal on exam, etiology likely GERD vs. gastritis related. Added protonix and simethicone on admission with improvement. Received IVF ___ overnight. No fevers throughout hospital course so no further workup necessitated as etiology of pain unlikely infectious in origin although we had a low threshold for initiating empiric antimicrobial given neutropenia. No nausea, vomiting or diarrhea. Patient eating and drinking well. Lipase WNL. CMV/EBV PCR pending at discharge. #AML: Favorable genetics given t(8.21) s/p 7+3 and now s/p C3 HiDAC consolidation. Bone marrow biopsy, FISH, and cytogenetics on day 21 of 7+3 indicate complete response. Will continue acyclovir, fluconazole and ciprofloxacin. Received neulasta given ___ and expect counts recovery soon. Follow up arranged for lab check on ___ at ___ and ___ with primary team #Panyctopenia (anemia, thrombocytopenia, neutropenia): counts at nadir secondary to recent cycle of HiDAC but showing signs of recovery. No e/o clinical blood loss currently. Likely all consequence of chemotherapy and underlying malignancy and inflammatory block. However, given downtrend of H/H on ___, received 1U of PRBCs on ___. Transfuse for hgb <7 and/or plt <10K. Will RTC to ___ on ___ for lab check as above. Prophylaxes: # Access: POC # Contact: ___ # Disposition: Discharged ___ RTC on ___ at ___ for labs and ___ for provider visit and labs # Code Status: Full ",1980,405
10010231-DS-27,"<SEX> M <SERVICE> MEDICINE <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> HiDAC <MAJOR SURGICAL OR INVASIVE PROCEDURE> none <HISTORY OF PRESENT ILLNESS> Mr. ___ is a ___ male with history AML s/p 7+3 induction now s/p 3C of HiDAC. Developed FN after C2 of HiDAC with no obvious infectious source found now presenting for C4 of HiDAC. <PAST MEDICAL HISTORY> <PAST MEDICAL HISTORY> Patient presented to ___ with a 3 week history of weakness on ___. ___ revealed leukocytosis with blasts for which he was transferred to ___. Bone marrow biopsy confirmed acute myeloid leukemia, t(8;21), RUNX1/RUNX1T1 rearrangement. Patient was started on 7+3 on ___. Day 14 bone marrow with aplasia but persistent t(8;21) in 40% of cells per karyotype and RUNX1/RUNX1T1 rearrangement in 16% per FISH. Decision was made not to re-induce. Day 21 bone marrow on ___ was with no morphologic or cytogenetic evidence of residual disease. Treatment History: - ___: 7+3 - ___: BMB with ___ - ___: C1D1 HiDAC - ___: C2D1 HiDAC - ___: C3D1 HiDAC <SOCIAL HISTORY> ___ <FAMILY HISTORY> Both mother and father died of old age. He denies any family history of malignancy or blood disorders. <PHYSICAL EXAM> ADMISSION PHYSICAL EXAM: VITAL SIGNS: Temp 97.9 BP 130/70 HR 72 RR 16 O2 sat 98% RA. ___: NAD. HEENT: MMM, no OP lesions, no cervical, supraclavicular, axillary adenopathy, no thyromegaly. CV: RR, NL S1S2 no S3S4 MRG. PULM: CTAB. GI: BS+, soft, slight pain on palpation of epigastric region. no masses or hepatosplenomegaly. LIMBS: No edema, clubbing, tremors, or asterixis; no inguinal adenopathy. SKIN: No rashes or skin breakdown port site intact w/o erythema. Pt does have darker brown skin lesions over anterior foreleg on left but states chronic. NEURO: A&Ox3. Cranial nerves II-XII are within normal limits. Gross strength and sensation intact. no nystagmus, rapid hand movements and tandem gait intact. DISCHARGE PHYSICAL EXAM: VITAL SIGNS: 97.8 PO ___ 20 98 RA ___: NAD. HEENT: MMM. CV: RR, NL S1S2 no S3S4 MRG. PULM: CTAB. ABD: soft/nt/nd, no HSM LIMBS: No edema, clubbing, tremors, or asterixis; no inguinal adenopathy. SKIN: No new rashes NEURO: A&Ox3. Cranial nerves II-XII are within normal limits. Gross strength and sensation intact. no nystagmus, rapid hand movements and tandem gait intact. FNF intacdt and negative romberg <PERTINENT RESULTS> ADMISSION LABS: ___ 09: 05AM BLOOD WBC-4.4 RBC-3.23* Hgb-10.8* Hct-32.4* MCV-100* MCH-33.4* MCHC-33.3 RDW-20.2* RDWSD-72.9* Plt ___ ___ 09: 05AM BLOOD Neuts-50.8 ___ Monos-17.3* Eos-0.5* Baso-0.7 Im ___ AbsNeut-2.23 AbsLymp-1.34 AbsMono-0.76 AbsEos-0.02* AbsBaso-0.03 ___ 09: 05AM BLOOD Glucose-112* ___ 09: 05AM BLOOD UreaN-12 Creat-0.7 Na-139 K-4.2 Cl-102 HCO3-25 AnGap-16 ___ 09: 05AM BLOOD ALT-117* AST-64* AlkPhos-83 TotBili-0.4 ___ 09: 05AM BLOOD Calcium-9.5 Phos-3.8 Mg-2.1 DISCHARGE LABS: ___ 12: 00AM BLOOD WBC-3.8* RBC-3.11* Hgb-10.4* Hct-31.0* MCV-100* MCH-33.4* MCHC-33.5 RDW-18.5* RDWSD-67.1* Plt ___ ___ 12: 00AM BLOOD Neuts-97.0* Lymphs-1.9* Monos-0.5* Eos-0.0* Baso-0.3 Im ___ AbsNeut-3.67 AbsLymp-0.07* AbsMono-0.02* AbsEos-0.00* AbsBaso-0.01 ___ 12: 00AM BLOOD Glucose-133* UreaN-15 Creat-0.6 Na-136 K-4.2 Cl-102 HCO3-23 AnGap-15 ___ 12: 00AM BLOOD ALT-104* AST-56* LD(LDH)-172 AlkPhos-65 TotBili-0.8 <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Acyclovir 400 mg PO Q12H 2. Montelukast 10 mg PO DAILY 3. Pantoprazole 40 mg PO Q24H 4. Simethicone 40-80 mg PO QID: PRN gas pains 5. Ciprofloxacin HCl 500 mg PO Q12H 6. Fluconazole 400 mg PO Q24H <DISCHARGE MEDICATIONS> 1. PrednisoLONE Acetate 1% Ophth. Susp. 1 DROP BOTH EYES TID 2. Acyclovir 400 mg PO Q12H RX *acyclovir 400 mg 1 tablet(s) by mouth q 12 hours Disp #*28 Tablet Refills: *0 3. Montelukast 10 mg PO DAILY 4. Pantoprazole 40 mg PO Q24H RX *pantoprazole 40 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills: *0 5. Simethicone 40-80 mg PO QID: PRN gas pains 6. HELD- Ciprofloxacin HCl 500 mg PO Q12H This medication was held. Do not restart Ciprofloxacin HCl until outpatient team tells you to restart 7. HELD- Fluconazole 400 mg PO Q24H This medication was held. Do not restart Fluconazole until outpatient team tells you to restart <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> AML <DISCHARGE CONDITION> Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Mental Status: Clear and coherent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Mr. ___, You were admitted to receive HiDAC chemotherapy. You tolerated this well and will be discharged home. You will follow up in clinic as stated below. Please do not hesitate to call in the meantime with any questions or concerns. It was a pleasure taking care of you. ","Mr. ___ is a ___ male with history AML s/p 7+3 and C3 HiDAC consolidation presenting for C4 C4D6 ___ # AML: Favorable genetics given t(8.21) s/p 7+3 and now s/p C3 HiDAC consolidation. Bone marrow biopsy, FISH, and cytogenetics on day 21 of 7+3 indicate complete response. He received Cytarabine 5940 mg IV Q12H on Days 1, 3 and 5. ___, ___ and ___ mg/m2). Neuro checks prior to each chemotherapy were performed and did nto show signs of cerebellar toxicity. He also received the following: - antiemetics/IVF per protocol - Continue acyclovir, fluc and cipro while neutropenic - neulasta to be given ___ - f/u set for clinic ___ #epigastric pain: mild in nature and minimal on exam, likely GERD/gastritis related. had w/u inhouse last admission, lipase WNL, afebrile. Improved with protonix, simethicone. ",1710,237
10010231-DS-28,"<SEX> M <SERVICE> MEDICINE <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___ <CHIEF COMPLAINT> febrile neutropenia <MAJOR SURGICAL OR INVASIVE PROCEDURE> POC removal ___ <HISTORY OF PRESENT ILLNESS> HPI: ___ with history of AML on HiDAC C4D13 presenting to the ED with fever and submandibular swelling. The patient reports he had a small ""bump"" under his chin for over a week. This morning he awoke and found the bump had dramatically enlarged, became tender to touch, and he developed fevers. He then presented to the hospital. He denies CP, SOB, N/V/D, abdominal pain. In the ED: VS: T 102.9 | HR120 | BP 137/87 | 20 | 100% RA His evam was notable for: Small pustule on R scalp, palpable fluctuant 3cm diameter ? abscess in submandibular region. Labs Notable for WBC 0.1, HGB of 8.4 and plt of 14. Also sodium of 131. He was given: 13: 22 IVF NS 14: 19 PO Acetaminophen 1000 mg 14: 37 IV Vancomycin 16: 21 IV CefePIME 2 g On the floor, he arrived in stable condition, still febrile and confirmed the above story <PAST MEDICAL HISTORY> <PAST MEDICAL HISTORY> Other than his malignancy, he has no medical conditions. Past Onc History: Initial presentation of AML on ___ to ___, transferred to ___ for Leukocyotosis with blastsand Bone marrow confirmed. Bone marrow biopsy confirmed acute myeloid leukemia, t(8;21), RUNX1/RUNX1T1 rearrangement. Patient was started on 7+3 on ___. Day 14 bone marrow with aplasia but persistent t(8;21) in 40% of cells per karyotype and RUNX1/RUNX1T1 rearrangement in 16% per FISH. Decision was made not to re-induce. Day 21 bone marrow on ___ was with no morphologic or cytogenetic evidence of residual disease. Treatment History: - ___: 7+3 - ___: BMB with ___ - ___: C1D1 HiDAC - ___: C2D1 HiDAC - ___: C3D1 HiDAC - ___: C4D1 HiDAC <SOCIAL HISTORY> ___ <FAMILY HISTORY> Both mother and father died of old age. He denies any family history of malignancy or blood disorders. <PHYSICAL EXAM> Admission <PHYSICAL EXAM> Vitals: 98.8 | PO 130/69 | 87 | 18 | 100% RA Gen: Pleasant, calm HEENT: No conjunctival pallor. No icterus. MMM. OP clear. NECK: 2cm fluctuant nodule in left submandibular region with small central lesion. No JVP appreciated. LYMPH: No cervical or supraclav LAD CV: Normocardic, regular. Normal S1,S2. No MRG. LUNGS: No incr WOB. CTAB. No wheezes, rales, or rhonchi. ABD: NABS. Soft, NT, ND. EXT: WWP. No ___ edema. SKIN: No rashes/lesions, petechiae/purpura ecchymoses other than noted above NEURO: A&Ox3. LINES: Left Portacath heparin dependent Discharge <PHYSICAL EXAM> VS: TC 97.7 ___ 94-99%RA Gen: pleasant & conversant, NAD. HEENT: No conjunctival pallor. No icterus. MMM. OP clear. NECK: submandibular swelling and erythema resolved. No fluctuance or tenderness appreciated. CV: Normocardic, regular. Normal S1/S2. No MRG. LUNGS: No increased WOB. CTAB. ABD: +BS, soft, NT/ND EXT: WWP. No ___ edema. SKIN: Except as described above. No other petechiae/purpura ecchymoses. NEURO: A&Ox3, grossly non-focal <PERTINENT RESULTS> ADMISSION LABS: ___ 09: 00AM BLOOD WBC-0.2*# RBC-2.51* Hgb-8.5* Hct-24.4* MCV-97 MCH-33.9* MCHC-34.8 RDW-15.9* RDWSD-56.5* Plt Ct-10*# ___ 09: 00AM BLOOD Neuts-23* Bands-0 Lymphs-75* Monos-0 Eos-1 Baso-1 ___ Myelos-0 AbsNeut-0.05* AbsLymp-0.15* AbsMono-0.00* AbsEos-0.00* AbsBaso-0.00* ___ 09: 00AM BLOOD UreaN-14 Creat-0.7 Na-134 K-4.0 Cl-101 HCO3-24 AnGap-13 ___ 09: 00AM BLOOD ALT-99* AST-41* AlkPhos-85 TotBili-0.4 ___ 09: 00AM BLOOD Calcium-9.0 Phos-2.7 Mg-1.9 Microbiology: ___ 1: 15 pm BLOOD CULTURE positive x2 **FINAL REPORT ___ Blood Culture, Routine (Final ___: STAPH AUREUS COAG +. FINAL SENSITIVITIES. SENSITIVITIES: MIC expressed in MCG/ML ________________________________________________________ STAPH AUREUS COAG + | CLINDAMYCIN-----------<=0.25 S ERYTHROMYCIN----------<=0.25 S GENTAMICIN------------ <=0.5 S LEVOFLOXACIN---------- 0.25 S OXACILLIN-------------<=0.25 S TRIMETHOPRIM/SULFA---- <=0.5 S Aerobic Bottle Gram Stain (Final ___: GRAM POSITIVE COCCI IN CLUSTERS. Reported to and read back by ___ ___ (___), @11: 10 ON ___. IMAGING: ___ CT Neck IMPRESSION: 1. There are a few prominent, though nonenlarged, cervical lymph nodes. 1 of which may correspond to the clinical area of concern, but is not pathologically enlarged or necrotic. No mass or abscess is identified. 2. Mild, nonspecific soft tissue stranding in the subcutaneous tissues inferior to the chin. 3. Moderate mucosal thickening in the left maxillary sinus. ___ CT Neck IMPRESSION: 1. Left greater than right submental subcutaneous edema, consistent with known cellulitis in this area, demonstrates mild progression compared to 3 days earlier on ___. No free fluid or abscess. 2. Multiple small right upper lobe lung nodules measuring up to 5 mm are new compared ___. In the setting of bacteremia, these may represent septic emboli. Atypical infection may also be considered as the patient is neutropenic (Nocardia, etc). 3. Moderate polypoid mucosal thickening in the left maxillary sinus with occlusion of the left ostiomeatal unit and a mucous retention cyst in the right maxillary sinus, similar to prior. Given the small periapical lucency involving ___ 14 or 15, as detailed above, please correlate clinically whether there may be odontogenic etiology of sinus disease. ___ CT Chest IMPRESSION: 1. Numerous bilateral pulmonary nodules appear increased in number at least in the upper lobes since the prior neck CT and favor infectious etiology, likely fungal in the setting of febrile neutropenia. Correlate with clinical assessment. If the patient's symptoms persist despite treatment, consider repeat Chest CT in ___ weeks to reevaluate. 2. Anemia. 3. Minimal colonic diverticulosis. ___ US Neck IMPRESSION: 1. No drainable fluid collection. No abnormal lymph nodes. 2. Mild skin thickening and subcutaneous edema of the submental area, consistent with patient's known cellulitis. ___ MANDIBLE PANOREX IMPRESSION: No periapical lucency. ___ LIVER U/S IMPRESSION: Echogenic liver consistent with steatosis. Other forms of liver disease including steatohepatitis, hepatic fibrosis, or cirrhosis cannot be excluded on this examination. Unchanged from prior. CT CHEST ___ IMPRESSION: Multiple scattered pulmonary nodules are minimally decreased in size as compared to chest CT ___. No new pulmonary nodules identified. DISCHARGE LABS: ___ 08: 15AM BLOOD WBC-2.8* RBC-2.80* Hgb-9.4* Hct-28.3* MCV-101* MCH-33.6* MCHC-33.2 RDW-20.9* RDWSD-76.9* Plt ___ ___ 08: 15AM BLOOD Neuts-42.9 ___ Monos-25.9* Eos-0.4* Baso-0.7 NRBC-1.4* Im ___ AbsNeut-1.21* AbsLymp-0.83* AbsMono-0.73 AbsEos-0.01* AbsBaso-0.02 ___ 08: 15AM BLOOD Hypochr-NORMAL Anisocy-2+ Poiklo-1+ Macrocy-1+ Microcy-NORMAL Polychr-1+ Ovalocy-1+ Schisto-1+ Tear Dr-1+ ___ 08: 15AM BLOOD Plt Smr-NORMAL Plt ___ ___ 08: 15AM BLOOD Glucose-103* UreaN-6 Creat-0.8 Na-140 K-4.2 Cl-103 HCO3-28 AnGap-13 ___ 08: 15AM BLOOD ALT-51* AST-58* LD(LDH)-204 AlkPhos-82 TotBili-0.3 ___ 08: 15AM BLOOD Albumin-3.8 Calcium-9.0 Phos-3.9 Mg-2.1 ___ 08: 15AM BLOOD <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Acyclovir 400 mg PO Q12H 2. Pantoprazole 40 mg PO Q24H 3. Simethicone 40-80 mg PO QID: PRN gas pains 4. PrednisoLONE Acetate 1% Ophth. Susp. 1 DROP BOTH EYES TID 5. Ciprofloxacin HCl 500 mg PO Q12H 6. Fluconazole 400 mg PO Q24H 7. Montelukast 10 mg PO DAILY <DISCHARGE MEDICATIONS> 1. Linezolid ___ mg PO Q12H you will continue this medication until ___ RX *linezolid ___ mg 1 tablet(s) by mouth twice a day Disp #*30 Tablet Refills: *0 2. Voriconazole 200 mg PO Q12H 3. Acyclovir 400 mg PO Q12H 4. Montelukast 10 mg PO DAILY 5. Pantoprazole 40 mg PO Q24H 6. Simethicone 40-80 mg PO QID: PRN gas pains <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Primary Diagnosis: Febrile Neutrapenia MSSA Bacteremia Peripheral Pulmonary Nodules Secondary Diagnosis: AML <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Mr. ___, You were admitted due to fever when your blood counts were very low. You were found to have a blood infection and you were treated with IV antibiotics. Your fever has now resolved so we transitioned you to an oral regimen of antibiotics with plan of completing on ___. Please refer below for your appointment with Dr. ___ ___ was a pleasure taking care of you. Sincerely Your ___ TEAM ","ASSESSMENT/PLAN: Mr. ___ is a ___ year old male with AML s/p C4 of HiDAC (___) who presents with febrile neutropenia found to have MSSA bacteremia and new pulmonary nodules. C4D38 ___ #Febrile Neutropenia: #MSSA bacteremia: Likely source is skin and soft tissue infection from an ingrown hair/folliculitis. MSSA growing from first set of blood cultures on ___, was on vancomycin and meropenem but narrowed to cefazolin x 4 week course from POC removal (___). Patient has completed mandatory 2 weeks course of IV ABX with cefazolin in-house with NTD surveillance cultures. However, given concern for medical contraindication for central line access to provide intravenous antibiotics at home, we recommend changing from cefazolin to linezolid PO as there is no better alternative for patient. Patient transitioned to linezolid on ___ and will continue until ___ -surveillance cultures have been negative to date as above. -CT Neck negative for abscess -TTE no significant findings -ID consulted, recs appreciated--felt more comfortable tx as endovascular infection for extended course, per ___ team will treat 4 week course from POC removal (___) - Chest CT concerning for fungal infection, see below - F/U panorex for abscess - negative - F/U b-glucan/galactomannan - negative on ___, see below for repeat on ___ #Lung Nodules: concerning for fungal infection, found incidentally on neck CT that were new and worsening on repeat imaging. Patient was switched from fluconazole to posaconazole on ___ given these findings. However, due to elevated LFTs, discontinued posaconazole (___) which was thought to be the likely culprit as well as ciprofloxacin. Per ID, patient will require repeat CT chest in 4 weeks to monitor nodules but may obtain earlier per primary oncologist. Repeat CT chest on ___ showed multiple scattered pulmonary nodules that are minimally decreased in size as compared to chest CT ___. Although no new pulmonary nodules were identified, patient now has elevated BD glucan and given his AML, he is at a high risk for fungal PNA so initiated on voriconazole (d1: ___ with plan to follow up radiographically as above. He will likely need a 6WK course. -Beta glucan 61 on ___ (was negative on ___ -Asp galactomannan negative on ___ #Transaminitis: (improving). Thought to be secondary to medication-effect (posaconazole likely culprit which was discontinued on ___. Liver ultrasound on ___ showed echogenic liver consistent with steatosis. Other forms of liver disease including steatohepatitis, hepatic fibrosis, or cirrhosis cannot be excluded on this examination. Hep serologies were unremarkable on ___. Re-consulted ID on ___ in light of worsening transaminitis to consider switch from cefazolin to vancomycin. ID thinks that his transaminitis is potentially from posaconazole which has been discontinued, as above, and would not expect his LFTs to plateau until ___ days after discontinuing the offending agent. We will continue to monitor and trend LFTs closely particularly given initiation of voriconaozle. #AML on HiDAC: s/p 4C of HIDAC. Patient counts now recovered, continue with Acyclovir 400mg BID prophylactically. #Pancytopenia: now recovered although noted some mild downtrending of his WBC and ANC, etiology most likely secondary to chemotherapy. He had a positive hemoocult test on ___ and ___. Repeat CBC/COAGS stable. Coombs negative. Will need GI consult for further work-up -stopped filgrastim ___ -Singulair 10mg daily for history or mild urticarial reaction to plts transfusions #ACCESS: POC removed. No access. #CODE: Presumed Full #Contact: ___ #DISPO: Discharged ___. RTC next week on ___ or ___ ",2725,873
10010264-DS-16,"<SEX> M <SERVICE> MEDICINE <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___ <CHIEF COMPLAINT> Melena, hematemesis <MAJOR SURGICAL OR INVASIVE PROCEDURE> ___: EGD <HISTORY OF PRESENT ILLNESS> Mr. ___ is a ___ year old gentleman with a h/o hip bursitis and hemorrhoids who presents with two days of black stool and hematemesis. On ___, he began having loose, watery diarrhea that was ""jet black"" and several episodes of ""black"" emesis. Yesterday, he had two formed black BMs and no emesis. Last BM was this morning and it remained black. He denies hematochezia. He reports headache, mild lightheadedness, and nausea but denies further emesis. He denies fever/chills, anorexia, abdominal pain, chest pain, and shortness of breath. Of note, ___ has been taking 400-1200mg ibuprofen for the past week for his hip bursitis. ___ went to his PCP ___ ___ and labs were notable for Hct 37.1 (down from 45 in ___. Repeat Hct on ___ was 32, so he was told to go to the ED for evaluation. In the ED, initial VS were T 99.8, HR 99, BP 136/79, RR 18, O2 100% RA. Labs were remarkable for Hct 34.5. He was given pantoprazole 40mg IV and transferred to the medicine floor. <PAST MEDICAL HISTORY> Hip bursitis - bilateral, on ibuprofen Hemorrhoids - diagnosed by ___ in ___ <SOCIAL HISTORY> ___ <FAMILY HISTORY> Sister with ___ disease. <PHYSICAL EXAM> ADMISSION EXAM: Vitals: T 98.2, BP 109/63, HR 67, RR 18, O2 100% RA General: AAOx3, pleasant, sitting comfortably in bed, NAD HEENT: Sclera anicteric, MMM, oropharynx clear Neck: Supple, JVP not elevated, no LAD Lungs: Breathing comfortably without accessory muscle use, clear to auscultation bilaterally, no wheezes, rales, rhonchi CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Abdomen: +BS, soft, non-tender, non-distended, bowel sounds present, no rebound tenderness or guarding, no organomegaly Ext: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema Skin: No rashes or lesions noted Neuro: CN II-XII intact, moving all extremities DISCHARGE EXAM: Vitals: T 98, BP 110/70, HR 72, RR 18, O2 99% RA General: AAOx3, pleasant, sitting comfortably in bed, NAD HEENT: Sclera anicteric, MMM, oropharynx clear Neck: Supple, JVP not elevated, no LAD Lungs: Breathing comfortably without accessory muscle use, clear to auscultation bilaterally, no wheezes, rales, rhonchi CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Abdomen: +BS, soft, non-tender, non-distended, bowel sounds present, no rebound tenderness or guarding, no organomegaly Ext: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema Skin: No rashes or lesions noted Neuro: CN II-XII intact, moving all extremities <PERTINENT RESULTS> ADMISSION LABS: ___ 12: 08PM BLOOD WBC-6.6 RBC-3.54* Hgb-11.5* Hct-34.5* MCV-98 MCH-32.5* MCHC-33.3 RDW-11.9 Plt ___ ___ 12: 08PM BLOOD Neuts-65.2 ___ Monos-5.0 Eos-6.7* Baso-0.9 ___ 12: 08PM BLOOD ___ PTT-29.4 ___ ___ 12: 08PM BLOOD Glucose-100 UreaN-21* Creat-0.8 Na-139 K-4.1 Cl-106 HCO3-26 AnGap-11 DISCHARGE LABS: ___ 01: 15PM BLOOD Hct-33.5* ___ 05: 40AM BLOOD Glucose-93 UreaN-9 Creat-0.6 Na-141 K-4.2 Cl-108 HCO3-24 AnGap-13 ___ 05: 40AM BLOOD Calcium-8.7 Phos-3.1 Mg-2.0 EGD ___: Normal mucosa in the esophagus Mild erythema and erosions in the stomach consistent with gastritis (biopsy) Clean-based gastric ulcer seen in the pyloric channel. Re-bleeding rate within 30 days is less than 5%. Normal mucosa in the duodenum Otherwise normal EGD to third part of the duodenum <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Ibuprofen 400 mg PO Q8H: PRN pain 2. Excedrin Migraine (aspirin-acetaminophen-caffeine) 250-250-65 mg oral prn headache 3. Multivitamins 1 TAB PO DAILY <DISCHARGE MEDICATIONS> 1. Omeprazole 40 mg PO BID RX *omeprazole 40 mg 1 capsule(s) by mouth twice a day Disp #*60 Capsule Refills: *0 2. Multivitamins 1 TAB PO DAILY 3. TraMADOL (Ultram) 50 mg PO Q6H: PRN pain RX *tramadol 50 mg 1 tablet(s) by mouth q6h prn Disp #*40 Tablet Refills: *0 <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Primary diagnosis: Peptic ulcer disease Secondary diagnosis: Hip bursitis <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Mr. ___, It was a pleasure caring for you during your stay at ___. You were admitted for black stools. An endoscopy showed an ulcer in the stomach, which was likely the source of bleeding. There was no evidence of active bleeding and your blood counts remained stable. Please continue to take your medications as prescribed and keep your follow-up appointments. It is very important that you STOP taking ibuprofen, aspirin, and NSAIDs, as this likely caused the ulcer. -Your ___ Team ","___ y/o M with hip bursitis and hemorrhoids who presents with two days of melena and hematemesis in the setting of excessive NSAID use. # Upper GI bleed: EGD was notable for a clean-based ulcer in the pyloric channel, most likely secondary to NSAID use. ___ remained hemodynamically stable throughout hospitalization. His hematocrit dropped slightly on day 2 (34.5 to 31.7), but was stable thereafter. ___ was started on pantoprazole 40mg IV bid, which was transitioned to omeprazole 40mg po on discharge, and all NSAIDs were held. He should continue high dose PPI for 8 weeks, at which point cessation can be considered. H. pylori IgG was negative; gastric biopsies for H. pylori are pending. Follow-up endoscopy is not required in the setting of a shallow pyloric ulcer with a clear cause. ___ has follow-up appointment scheduled with GI on ___. # Hip bursitis: NSAIDs were held in the setting of GI bleed. His bursitis pain was controlled with tylenol and tramadol prn. ___ was instructed to avoid NSAIDs/aspirin as these likely caused his ulcer. Consider steroid injection in the future if needed for pain. TRANSITIONAL ISSUES: [ ] ___ should continue high dose PPI for 8 weeks, at which point cessation can be considered. [ ] Follow-up endoscopy is not required in the setting of a shallow pyloric ulcer with a clear cause. [ ] Please recheck hematocrit at GI appointment on ___. [ ] Pending results: gastric biopsies for H. pylori. [ ] For PCP: ___ must avoid NSAIDs/aspirin. He was started on tramadol for his bursitis pain. Consider steroid injection if needed for bursitis pain. ",1527,389
10010362-DS-11,"<SEX> F <SERVICE> OBSTETRICS/GYNECOLOGY <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___ <CHIEF COMPLAINT> ""s/p cesarean section complicated by PPH requiring transfusion"" <MAJOR SURGICAL OR INVASIVE PROCEDURE> cesarean section <HISTORY OF PRESENT ILLNESS> The patient is a ___ gravida 2, para 0, who presented in early labor on ___ after spontaneous rupture of membranes. She progressed to 8 cm at around 10 a.m. on ___ with expectant management, but cervical dilitation did not progress. The patient agreed to augment her labor with Pitocin. However, she did continue to labor without neuraxial anesthesia. The Pitocin was titrated per protocol, but she did not make any cervical change for several hours. At this point an intrauterine pressure catheter was recommended; the patient declined. She did elect for a combined spinal epidural and afterwards the Pitocin was continued to be titrated per protocol. However, after 12 hours, she was still found to be 8 cm, 100%, and -1 station. Therefore, the recommendation was made to proceed with a primary cesarean section due to arrest. The risks and benefits were discussed with the patient and her partner, all questions were answered, all consents were signed. She had a reassuring fetal status prior to surgery. Total EBL was 800cc. She was transferred to the postpartum floor and then experienced several gushed of bright red blood mixed with clots from her vagina. She was brought back to the Labor floor. <SOCIAL HISTORY> ___ <FAMILY HISTORY> Non-contributory <PHYSICAL EXAM> On examination during PPH, pt had bled out 400cc of blood clots in the bed. U/S showed some lower uterine segment clots. Endometrial stripe appeared adequate. Evacuated 400cc more of blood from lower uterine segment. She received 1000mcg of cytotec and 40 units of pitocin. Pt was transferred back to labor and delivery for continued bleeding. <PERTINENT RESULTS> ___ 12: 15AM BLOOD WBC-15.5* RBC-4.59 Hgb-14.1 Hct-39.4 MCV-86 MCH-30.7 MCHC-35.7* RDW-13.4 Plt ___ ___ 12: 41AM BLOOD WBC-20.4* RBC-3.91* Hgb-12.3 Hct-33.8* MCV-87 MCH-31.4 MCHC-36.4* RDW-13.6 Plt ___ ___ 03: 27AM BLOOD WBC-22.4* RBC-3.50* Hgb-10.9* Hct-30.3* MCV-87 MCH-31.2 MCHC-36.0* RDW-13.7 Plt ___ ___ 07: 31AM BLOOD WBC-15.9* RBC-2.71* Hgb-8.2* Hct-23.2* MCV-86 MCH-30.1 MCHC-35.2* RDW-13.8 Plt ___ ___ 05: 06PM BLOOD WBC-15.1* RBC-3.05* Hgb-9.7* Hct-26.9* MCV-88 MCH-31.7 MCHC-36.0* RDW-14.1 Plt ___ ___ 08: 35AM BLOOD WBC-16.6* RBC-2.90* Hgb-9.0* Hct-25.6* MCV-88 MCH-30.9 MCHC-35.0 RDW-14.2 Plt ___ <MEDICATIONS ON ADMISSION> - Prenatal vitamins <DISCHARGE MEDICATIONS> 1. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day) as needed for Constipation. Disp: *60 Capsule(s)* Refills: *1* 2. oxycodone-acetaminophen ___ mg Tablet Sig: ___ Tablets PO Q3H (every 3 hours) as needed for Pain. Disp: *45 Tablet(s)* Refills: *0* 3. ibuprofen 600 mg Tablet Sig: ___ Tablets PO Q6H (every 6 hours) as needed for Pain. Disp: *60 Tablet(s)* Refills: *1* 4. ferrous sulfate 325 mg (65 mg iron) Capsule, Extended Release Sig: One (1) Capsule, Extended Release PO twice a day. Disp: *60 Capsule, Extended Release(s)* Refills: *2* <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> s/p cesarean section s/p blood transfusion <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> routine postpartum ","Ms. ___ was transferred back to labor and delivery when her bleeding failed to stop with 40 units of pitocin, 1000mcg of cytotec and manual evacuation. Her bleeding however did resolve after she received 0.2mg of IM Methergine. Her HCT was trended and found to nadir at 23.2. She had tachycardia and a low urine output. The decision was the made to transfuse her for symptomatic anemia. She received 2 units of red cells and her hematocrit responded appropriately to 25.6, her urine output and heart rate improved significantly. The rest of her postpartum course was uncomplicated. ",1138,145
10010374-DS-17,"<SEX> F <SERVICE> OBSTETRICS/GYNECOLOGY <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> abdominal pain <MAJOR SURGICAL OR INVASIVE PROCEDURE> none <HISTORY OF PRESENT ILLNESS> ___ year-old Gravida 2 Para 1 at 28 weeks 6 days gestational age who presented with acute onset left lower quadrant pain while laying still in bed. She got up and urinated and it gradually worsened to ___. She had never experienced this kind of pain before. It was twisting and very sharp in nature and constant. Worse with legs extended vs flexed. A couple of hours after the pain started, she started to feel uterine tightening. Denied fever, chills, nausea, vomiting, diarrhea, dysuria, vaginal bleeding, leaking of fluid, hematuria, abnormal vaginal discharge. + Fetal movement. Last intercourse the morning prior. <PAST MEDICAL HISTORY> PRENATAL COURSE - Estimated Due Date: ___ - labs: A+/Ab- - screening: GLT wnl, FFS wnl . OBSTETRIC HISTORY Gravida 2 Para 1 (___) @ ___: Vacuum-assisted vaginal delivery @ 34 ___ wks, spontaneous preterm labor, had been hospitalized during pregnancy @ 30 weeks with vaginal bleeding and received betamethasone. 5#4, male GYNECOLOGIC HISTORY: remote history of chlamydia . PAST MED/SURG HISTORY: benign <SOCIAL HISTORY> ___ <FAMILY HISTORY> non-contributory <PHYSICAL EXAM> (on admission) VS: T 98.3, RR 18, BP 97/66, HR 130->115 GENERAL: crying, lying on her side in fetal position, very uncomfortable, able to speak in full sentences CARDIO: reg rhythm, tachy PULM: CTAB BACK: no CVA tenderness ABDOMEN: soft, gravid, most TTP LLQ just superior to inguinal area (no palpable underlying masses) though tender more superiorly as well, no R/G, no uterine TTP EXTREMITIES: NT b/l SSE: def SVE/BME: L/C/P TOCO: no clear ctx FHT: 150, mod var, AGA, no decels BPP: ___, cephalic, DVP 5.3, EFW 1328g 2#15oz <PERTINENT RESULTS> ___ WBC-9.0 RBC-3.95 Hgb-12.8 Hct-36.4 MCV-92 Plt-404 ___ Neuts-72.8 ___ Monos-6.3 Eos-1.4 Baso-0.4 ___ WBC-9.5 RBC-4.04 Hgb-12.3 Hct-36.4 MCV-90 Plt-417 ___ Neuts-70.0 ___ Monos-5.6 Eos-1.1 Baso-0.4 . ___ ___ PTT-31.1 ___ ___ . ___ Glucose-73 BUN-4 Creat-0.5 Na-134 K-4.2 Cl-102 HCO3-22 ___ Calcium-8.7 Phos-3.7 Mg-2.0 . ___ URINE Blood-NEG Nitrite-NEG Protein-NEG Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-7.0 Leuks-SM . Pelvic Ultrasound: Limited views demonstrate a live single intrauterine gestation with normal cardiac activity. The cervix remains long and closed. Please note that this limited exam does not substitute a full fetal survey. . Attention was then directed to bilateral superiorly displaced ovaries, necessitating use of linear probe. The left ovary measures 2.7 x 2 x 1.5 cm, with normal arterial and venous flow. The right ovary measures 2.2 x 1.4 x 1 cm, with normal venous flow. Arterial flow on the right is not demonstrated. The ovaries appear normal in size and morphology. There is no focal tenderness over the superiorly displaced ovaries. . Targeted ultrasound was performed to the site of symptomology in the lower abdomen, away from the ovaries, demonstrating no focal pathology. . IMPRESSION: 1. Normal size and morphology of bilateral ovaries. Normal vascularity of the left ovary. Limited arterial assessment of the right ovary. 2. Limited exam of single intrauterine gestation with normal cardiac activity and closed cervix. For full assessment of the fetus, continued routine fetal followup is recommended. 3. Tenderness in the lower abdomen is away from superiorly displaced ovaries. No discrete pathology is demonstrated at the site of symptom. <MEDICATIONS ON ADMISSION> prenatal vitamin folic acid <DISCHARGE MEDICATIONS> prenatal vitamin folic acid <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> pregnancy at 29+0 weeks gestation suspected viral gastroenteritis <DISCHARGE CONDITION> stable <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> stay well hydrated ","Ms. ___ received 0.5mg of IV Dilaudid in triage and her pain greatly improved. As above, her pelvic ultrasound was negative for any pathology and her laboratory studies were unrevealing. She did not require any additional analgesics and was admitted to the antepartum floor for close observation and abdominal exams. While there, she had an episode of emesis after eating and began having chills and feeling generally unwell with no abdominal pain, but abdominal discomfort. She remained afebrile with no elevation of white count and had no other focal signs or symptoms. It was thought that she had a mild viral gastritis. Her left lower quadrant pain never returned. She was given zantac, oral zofran and IV hydration and by the afternoon on hospital day #2 was feeling better. . Fetal testing was reassuring by ultrasound and non-stress testing. She had no signs of labor and her cervix remained closed. . She was discharged home on hospital day #2 symptomatically improved. ",1130,210
10010393-DS-5,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> Penicillins / Topamax / Reglan <ATTENDING> ___. <CHIEF COMPLAINT> Urinary retention, pain at intrathecal pump catheter site <MAJOR SURGICAL OR INVASIVE PROCEDURE> None <HISTORY OF PRESENT ILLNESS> This is a ___ year old woman with history of pudendal neuralgia s/p intrathecal pump placement in ___ and with ongoing narcotic use, hypothyroidism and history of an arrhythmia who presents with pain at the site of her intrathecal pain pump catheter and urinary retention, transferred from ___ for rule-out of cord compression. Patient has had several years of pain so disabling that she ""has not been able to get out of bed for ___ years."" She trialed many different pain regimens (see pain management notes from this institution) and ultimately was seen by a pain management physician in ___ for placement of an intrathecal pain pump in ___. Since then, she has been able to get out of bed on at least two occasions, though her pain is only moderately improved. This week she developed new back pain at the site of the pump's insertion and urinary retention. Also with one episode of fecal incontinence in the setting of new nausea, vomiting X ___ yesterday and multiple episodes of watery diarrhea over the past week. No other incontinence during this time. No fevers, chills, chest pain, shortness of breath, melena, BRBPR. Given the pain at the insertion site, she presented to ___ ___ where she was reportedly neurologically stable and a CT with IV contrast was unremarkable. She was bladder scanned there for 800 cc urine, Foley was placed and she put out 1200cc urine. Required 4mg IV dilaudid for pain control. She was then transferred to ___ to rule out cord compression given pain and new urinary retention. Upon arrival to the floor, she complains the light is bothering her eyes. She also details the history above. REVIEW OF SYSTEMS: Per HPI. Denies headache, visual changes, cough, fevers, chills, dyspnea, chest pain, abdominal pain, nausea, vomiting, diarrhea, constipation, dysuria, rash and weakness. <PAST MEDICAL HISTORY> HYPOTHYROIDISM ARRHYTHMIA PUDENDAL IMPINGEMENT SYNDROME s/p INTRATHECAL PUMP PLACEMENT SOMATIZATION DISORDER <SOCIAL HISTORY> ___ <FAMILY HISTORY> No cardiac or cancer history in either parent. Mother and sister with depression. <PHYSICAL EXAM> ADMISSION PHYSICAL EXAM: VITALS: 97.9F 113/68 76 18 96% on RA GENERAL: no acute distress, lying in bed HEENT: NC/AT, no scleral icterus, PERRLA, EOMI NECK: supple CARDIAC: RRR, normal S1/S2, no murmurs PULMONARY: clear to auscultation bilaterally ABDOMEN: normal bowel sounds, soft, non-tender, non-distended EXTREMITIES: Warm, well-perfused, no cyanosis, clubbing or edema. Mild tenderness to palpation over lumbar incision site where pump catheter is. NEUROLOGIC: A&Ox3, CN II-XII grossly normal, strength normal and symmetric in the bilateral UE and ___ DISCHARGE PHYSICAL EXAM: VITALS: 98.3F 116/85 77 18 97% on RA GENERAL: no acute distress, lying in bed HEENT: NC/AT, no scleral icterus, PERRLA, EOMI NECK: supple CARDIAC: RRR, normal S1/S2, no murmurs PULMONARY: clear to auscultation bilaterally ABDOMEN: normal bowel sounds, soft, non-tender, non-distended EXTREMITIES: Warm, well-perfused, no cyanosis, clubbing or edema NEUROLOGIC: A&Ox3, CN II-XII grossly normal, strength normal and symmetric in the bilateral UE and ___ <PERTINENT RESULTS> ADMISSION LABS: ___ 12: 20AM BLOOD WBC-3.2* RBC-3.84* Hgb-11.5 Hct-33.4* MCV-87 MCH-29.9 MCHC-34.4 RDW-12.2 RDWSD-38.7 Plt ___ ___ 12: 20AM BLOOD Neuts-28.9* Lymphs-56.1* Monos-12.5 Eos-1.6 Baso-0.9 AbsNeut-0.93* AbsLymp-1.80 AbsMono-0.40 AbsEos-0.05 AbsBaso-0.03 ___ 12: 20AM BLOOD Glucose-96 UreaN-10 Creat-0.7 Na-142 K-3.9 Cl-107 HCO3-27 AnGap-12 ___ 12: 20AM BLOOD CK(CPK)-80 ___ 12: 49AM URINE Type-RANDOM Color-Yellow Appear-Clear Sp ___ ___ 12: 49AM URINE Blood-NEG Nitrite-NEG Protein-TR Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-1 pH-6.5 Leuks-NEG ___ 12: 49AM URINE RBC-4* WBC-1 Bacteri-FEW Yeast-NONE Epi-0 ___ 12: 49AM URINE Mucous-RARE ___ 12: 14PM STOOL NoroGI-NEGATIVE NoroGII-NEGATIVE DISCHARGE LABS: ___ 05: 52AM BLOOD WBC-2.7* RBC-3.65* Hgb-10.9* Hct-31.7* MCV-87 MCH-29.9 MCHC-34.4 RDW-12.2 RDWSD-38.8 Plt ___ MICROBIOLOGY: **FINAL REPORT ___ URINE CULTURE (Final ___: NO GROWTH. **FINAL REPORT ___ C. difficile DNA amplification assay (Final ___: Negative for toxigenic C. difficile by the Illumigene DNA amplification assay. (Reference Range-Negative). FECAL CULTURE (Final ___: NO SALMONELLA OR SHIGELLA FOUND. CAMPYLOBACTER CULTURE (Final ___: NO CAMPYLOBACTER FOUND. FECAL CULTURE - R/O VIBRIO (Final ___: NO VIBRIO FOUND. FECAL CULTURE - R/O YERSINIA (Final ___: NO YERSINIA FOUND. FECAL CULTURE - R/O E.COLI 0157: H7 (Final ___: NO E.COLI 0157: H7 FOUND. ECG Study Date of ___ 7: 51: 52 AM Clinical indication for EKG: ___.___ - QT interval for medication monitoring Sinus rhythm. Normal tracing. Read by: ___. Intervals Axes Rate PR QRS QT QTc (___) P QRS T 83 ___ 426 54 63 55 IMAGING: SECOND OPINION READ OF CT (___) L-SPINE FINDINGS: There is normal alignment of the lumbar spine. Mild ligamentum flavum thickening is seen at L3-4, L4-5 and L5-S1. No significant spinal canal or neural foraminal stenosis is seen. There is no acute fracture or malalignment. There is an intrathecal catheter which courses from the pump, which is not visualized, through the left subcutaneous soft tissues of the back, between the L2-3 spinous process and into the thecal sac. Two linear hyperdensities are noted within the soft tissues at the level of the L3 spinous process, consistent with surgical sutures. Minimal stranding is noted within the posterior soft tissues, at the level of the L3 spinous process, likely secondary to postsurgical changes. No fluid collection or soft tissue mass is identified along the course of the catheter. The catheter extends from the through the T11- L2 spinal canal. No discontinuity is noted in the visualized catheter. A fluid-filled distended bladder is seen. Multiple sub cm hypodensities are noted in the kidneys, which are too small to characterize and likely represent simple cysts. IMPRESSION: 1. Minimal soft tissue stranding in the posterior soft tissues of the back, at the L2-3 level, consistent with postsurgical changes. No fluid collection or abscess identified along the course of the visualized catheter. <MEDICATIONS ON ADMISSION> The Preadmission Medication list may be inaccurate and requires futher investigation. 1. HYDROmorphone (Dilaudid) 4 mg PO Q8H: PRN PAIN 2. LORazepam 1 mg PO Q4H: PRN anxiety 3. Methadone 5 mg PO TID 4. DULoxetine 60 mg PO BID 5. Pregabalin ___ mg PO DAILY 6. NexIUM (esomeprazole magnesium) 40 mg oral DAILY 7. Levothyroxine Sodium 137 mcg PO DAILY 8. Vitamin D ___ UNIT PO 1X/WEEK (WE) 9. BusPIRone 15 mg PO TID 10. Lidocaine 5% Ointment 1 Appl TP ONCE ASDIR 11. Tizanidine 2 mg PO TID 12. TraZODone 150 mg PO QHS: PRN insomnia 13. Verapamil SR 120 mg PO Q24H 14. Polyethylene Glycol 17 g PO DAILY 15. Ranitidine 300 mg PO QHS 16. Ondansetron 4 mg PO Q8H: PRN nausea 17. Dilaudid (HYDROmorphone) 16 mg oral QAM 18. ziconotide 8.01 mcg/day injection INFUSION <DISCHARGE MEDICATIONS> 1. BusPIRone 15 mg PO TID 2. HYDROmorphone (Dilaudid) 4 mg PO Q8H: PRN PAIN 3. Levothyroxine Sodium 137 mcg PO DAILY 4. LORazepam 1 mg PO Q4H: PRN anxiety 5. Methadone 5 mg PO TID 6. Ondansetron 4 mg PO Q8H: PRN nausea 7. Polyethylene Glycol 17 g PO DAILY 8. Pregabalin ___ mg PO DAILY 9. Ranitidine 300 mg PO QHS 10. Tizanidine 2 mg PO TID 11. TraZODone 150 mg PO QHS: PRN insomnia 12. Verapamil SR 120 mg PO Q24H Do not take this medication if your systolic blood pressure in the morning is below 100. 13. DULoxetine 60 mg PO BID 14. Lidocaine 5% Ointment 1 Appl TP ONCE ASDIR 15. NexIUM (esomeprazole magnesium) 40 mg oral DAILY 16. Vitamin D ___ UNIT PO 1X/WEEK (WE) 17. HYDROmorphone (Dilaudid) (HYDROmorphone) 16 mg ORAL QAM 18. Voltaren (diclofenac sodium) 1 % topical QID: PRN pain RX *diclofenac sodium [Voltaren] 1 % Apply to painful site of lower back 4 times per day Refills: *0 <DISCHARGE DISPOSITION> Home With Service Facility: ___ <DISCHARGE DIAGNOSIS> PRIMARY DIAGNOSES: Acute urinary retention Acute viral gastroenteritis SECONDARY DIAGNOSES: Postsurgical pain of incision site Chronic pudendal impingement syndrome Hypothyroidism Unspecified cardiac arrhythmia <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Ms. ___, You were admitted to ___ for urinary retention and pain over your intrathecal pump catheter incision site. We believe the urinary retention was due to the recent increase in the ziconotide dose running through your pump. We were able to get administrative approval for the company who adjusts your pump settings to come provide their services in the inpatient setting, however they are able to visit you in your home to adjust the settings sooner. You will have additional nursing services to care for your new Foley catheter. Once your ziconotide dose is decreased, the Foley catheter should be removed to allow a trial of urination. If you are still unable to urinate, you should return to the hospital immediately. Our radiologists and pain specialists reviewed the CT images of your lumbar spine and we believe that the pain you are experiencing is due to the superficial placement of the pump catheter, which has some mild inflammatory changes around it. Please continue lidocaine ointment or patches and Voltaren gel to relieve the pain in that area until you can see a pain specialist who can manage this type of intrathecal pump. It was a pleasure taking care of you. Best wishes, Your ___ Care Team ","___ with chronic pudendal impingement syndrome s/p intrathecal pump for ziconotide infusion who was admitted for acute urinary retention and pain at intrathecal pump catheter site. #Acute urinary retention - Timing seems to coincide with recent increase in ziconotide dose on ___. ___ Pain service was consulted and recommended decreasing the ziconotide dose 20%, to previous dose. However, ___ Pain service only has equipment for ___ pumps and were not able to interrogate or adjust the Flowonix Prometra pump, which the patient has. Administrative approval was obtained for Pentec, the company who manages patient's pump in the outpatient setting, to provide services as inpatient. Given delay in ability of pump service agency to provide adjustment in the inpatient setting, patient was discharged with Foley catheter with plan for decrease in ziconotide dose as an outpatient, followed by Foley removal and voiding trial. #Acute pain over intrathecal pump catheter site - Developed over the ___ weeks prior to admission. CT L spine revealed no signs of infection. However, where catheter bends and overlaps the L2 spinous process is quite superficial and had some mild surrounding inflammatory stranding of the soft tissue. Per ___ Pain Service, this inflammation could be causing the pain. Pressure on the site over time from supine position (patient spends most of her time in bed due to debilitating pain) could explain the timing of the pain 6 months after pump was placed. The pain was partially relieved by lidocaine patches. Patient was discharged with lidocaine ointment and Voltaren gel. Dr. ___ at the ___ in ___, who placed the pump, was contacted by phone on ___ regarding this issue, and did not feel the catheter was causing the pain but was willing to see the patient in followup. He recommended that the patient find a local pain specialist in ___ who could manage the pump and the ziconotide but was unable to provide a referral to a specific specialist. ___ Pain was also unable to provide this referral as the Flowonix brand of intrathecal pumps is essentially never used in the ___ of ___. Patient will contact the vendor to request a referral to an appropriate local provider. #Chronic low back pain and pelvic pain: Patient has been debilitated by this pain for several years despite multiple procedures. Her current narcotics are managed by Dr. ___ ___ in ___ and her pump is managed by Dr. ___ ___ in ___. She was continued on her home pain regimen, which was confirmed per phone conversation with Dr. ___ on ___, with the exception of substituting regular release hydromorphone for her extended release hydromorphone due to it being non-formulary at ___. #Orthostatic hypotension: Pt had been having loose stools and decreased PO intake, likely due to a viral gastroenteritis. She was also on higher doses of hydromorphone at the beginning of the hospitalization for acute on chronic pain. The orthostasis resolved with IV fluids, weaning of narcotics, and improvement in her gastroenteritis. Stool studies were negative for infectious source. CHRONIC ISSUES: #HYPOTHYROIDISM: Continued levothyroxine. #HX OF HTN/CARDIAC ARRHYTHMIA: Continued home Verapamil. #PSYCH: Continued home medications. TRANSITIONAL ISSUES: - Patient will require routine Foley care - Voiding trial to be performed after intrathecal ziconotide dose is decreased by 20%. If no void within 8 hours, seek urgent medical attention. - Patient will require ongoing followup with pain specialist and evaluation of intrathecal pump catheter incision site. - Patient had mild leukopenia (WBC 2.8) and anemia (Hgb ___ that was stable during this admission. Consider outpatient workup. - Consider routine periodic monitoring of CK levels while patient is on ziconotide. ",2930,811
10010393-DS-6,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> Penicillins / Topamax / Reglan <ATTENDING> ___. <CHIEF COMPLAINT> Low back pain <MAJOR SURGICAL OR INVASIVE PROCEDURE> None <HISTORY OF PRESENT ILLNESS> ___ year old woman with history of pudendal neuralgia s/p intrathecal pump placement in ___ and with ongoing narcotic use, hypothyroidism and history of an arrhythmia who presents with pain at the site of her intrathecal pain pump catheter and urinary retention, transferred from ___ on ___ for rule-out of cord compression. She was reportedly unable to undergo MRI due to pump. CT L spine revealed no signs of infection. However, where catheter bends and overlaps the L2 spinous process is quite superficial and had some mild surrounding inflammatory stranding of the soft tissue. Per ___ Pain Service, this inflammation could be causing the pain. Pt was seen by Neurology service who felt cord compression unlikely. Ultimately urinary retention was thought to be due to increased ziconotide in pump, and she was discharged with a Foley. She returns now for worsening pain overlying the pump. Of note, the patient's opioids are managed by an outpt provider in ___, and pump is managed by a provider in ___. Her visiting nurse contacted her spine surgeon in ___, who reportedly gave the nurse the order to shut off her pump (unclear reasons). The pump was shut off, resulting in worsening back pain which prompted the pain to come to the ED. She notes she took 5mg methadone as well as smoked marijuana for the pain prior to coming in. She also notes buttock's paresthesias, which are new. She had one reported fall when getting out of her car in the ED but was able to stand back up and walk. Denies any fevers. She continues to have foley in. In the ED, initial vital signs were: 97.7 74 102/57 16 98% RA - Exam was notable for: very uncomfortable female, no visible evidence of infection overlying lumbar incision site; poor effort with motor exam due to pain but grossly intact, perirectal sensation intact, able to increase rectal tone - Labs were notable for: ___ ct 3.5, CRP: 0.4 - Imaging: none - The patient was given: 1g IV dilaudid - Consults: none Upon arrival to the floor, pt continues to have severe lower back pain as well as buttocks paresthesias. She also notes having a migraine HA. <PAST MEDICAL HISTORY> HYPOTHYROIDISM ARRHYTHMIA PUDENDAL IMPINGEMENT SYNDROME s/p INTRATHECAL PUMP PLACEMENT SOMATIZATION DISORDER <SOCIAL HISTORY> ___ <FAMILY HISTORY> No cardiac or cancer history in either parent. Mother and sister with depression. <PHYSICAL EXAM> ADMISSION PHYSICAL EXAM: VITALS: 98.9, 115/76, 94, 20, 100% on RA GENERAL: uncomfortable female, lying on R side in bed HEENT: NC/AT, no scleral icterus, PERRLA, EOMI CARDIAC: RRR, normal S1/S2, no murmurs PULMONARY: clear to auscultation bilaterally ABDOMEN: normal bowel sounds, soft, non-tender, non-distended EXTREMITIES: no edema NEUROLOGIC: TTP to palpation over lumbar incision site where pump catheter is. Rectal tone intact, mild decreased sensation over buttocks to gross touch (R>L) but intact by pinprick, ___ sensation intact, ___ dorsiflexion and plantar flexion, hip flexion limited by pain DISCHARGE PHYSICAL EXAM: VITALS: 98, 122/68, 78, 18, 98% on RA GENERAL: uncomfortable female, lying on R side in bed HEENT: NC/AT, no scleral icterus, PERRLA, EOMI. R tympanic membrane with mild inferior bulge and apparent purulence in middle ear. CARDIAC: RRR, normal S1/S2, no murmurs PULMONARY: clear to auscultation bilaterally ABDOMEN: normal bowel sounds, soft, non-tender, non-distended EXTREMITIES: no edema NEUROLOGIC: TTP to palpation over lumbar incision site where pump catheter is. Gait slow but normal. <PERTINENT RESULTS> RELEVANT LABS: ___ 05: 52AM BLOOD WBC-2.7* RBC-3.65* Hgb-10.9* Hct-31.7* MCV-87 MCH-29.9 MCHC-34.4 RDW-12.2 RDWSD-38.8 Plt ___ ___ 10: 05PM BLOOD Calcium-9.4 Phos-4.6* Mg-1.8 ___ 10: 05PM BLOOD Glucose-94 UreaN-8 Creat-0.6 Na-142 K-3.9 Cl-106 HCO3-28 AnGap-12 ___ 07: 38AM BLOOD WBC-3.3* RBC-4.13 Hgb-12.2 Hct-36.2 MCV-88 MCH-29.5 MCHC-33.7 RDW-12.5 RDWSD-39.8 Plt ___ ___ 07: 38AM BLOOD Glucose-86 UreaN-7 Creat-0.6 Na-141 K-3.7 Cl-104 HCO3-25 AnGap-16 ___ 10: 05PM BLOOD CRP-0.4 ___ 07: 38AM BLOOD Calcium-9.5 Phos-5.4* Mg-1.8 ___ 05: 58PM URINE Blood-NEG Nitrite-NEG Protein-NEG Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.5 Leuks-NEG ___ 05: 58PM URINE Color-Straw Appear-Clear Sp ___ MICROBIOLOGY: ___ BLOOD CULTURE PENDING <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. BusPIRone 15 mg PO TID 2. HYDROmorphone (Dilaudid) 4 mg PO Q8H: PRN PAIN 3. Levothyroxine Sodium 150 mcg PO DAILY 4. LORazepam 1 mg PO Q4H: PRN anxiety 5. Methadone 5 mg PO TID 6. Ondansetron 4 mg PO Q8H: PRN nausea 7. Polyethylene Glycol 17 g PO DAILY 8. Pregabalin ___ mg PO DAILY 9. Ranitidine 300 mg PO QHS 10. Tizanidine 2 mg PO TID 11. TraZODone 100 mg PO QHS: PRN insomnia 12. Verapamil SR 120 mg PO Q24H 13. DULoxetine 120 mg PO DAILY 14. Lidocaine 5% Ointment 1 Appl TP ONCE ASDIR 15. NexIUM (esomeprazole magnesium) 40 mg oral DAILY 16. Voltaren (diclofenac sodium) 1 % topical QID: PRN pain 17. Sumatriptan Succinate 6 mg SC ONCE: PRN HA 18. ARIPiprazole 5 mg PO DAILY 19. Albuterol 0.083% Neb Soln 1 NEB IH BID 20. Elmiron (pentosan polysulfate sodium) 100 mg oral TID 21. Exalgo ER (HYDROmorphone) 16 mg oral DAILY <DISCHARGE MEDICATIONS> 1. Albuterol 0.083% Neb Soln 1 NEB IH BID 2. ARIPiprazole 5 mg PO DAILY 3. BusPIRone 15 mg PO TID 4. DULoxetine 120 mg PO DAILY 5. Levothyroxine Sodium 150 mcg PO DAILY 6. LORazepam 1 mg PO Q4H: PRN anxiety 7. Methadone 7.5 mg PO TID 8. Ondansetron 4 mg PO Q8H: PRN nausea 9. Polyethylene Glycol 17 g PO DAILY 10. Pregabalin ___ mg PO DAILY 11. Ranitidine 300 mg PO QHS 12. Tizanidine 2 mg PO TID 13. TraZODone 100 mg PO QHS: PRN insomnia 14. Verapamil SR 120 mg PO Q24H 15. Azithromycin 250 mg PO Q24H Duration: 4 Days Last day ___ RX *azithromycin 250 mg 1 tablet(s) by mouth daily Disp #*4 Tablet Refills: *0 16. OxycoDONE (Immediate Release) 10 mg PO Q8H: PRN pain RX *oxycodone 10 mg 1 tablet(s) by mouth every eight (8) hours Disp #*21 Tablet Refills: *0 17. Phenazopyridine 100 mg PO TID Duration: 3 Days RX *phenazopyridine [Pyridium] 100 mg 1 tablet(s) by mouth three times a day Disp #*5 Tablet Refills: *0 18. Elmiron (pentosan polysulfate sodium) 100 mg oral TID 19. Exalgo ER (HYDROmorphone) 16 mg oral DAILY 20. Lidocaine 5% Ointment 1 Appl TP ONCE ASDIR 21. NexIUM (esomeprazole magnesium) 40 mg oral DAILY 22. Sumatriptan Succinate 6 mg SC ONCE: PRN HA 23. Voltaren (diclofenac sodium) 1 % topical QID: PRN pain 24. Methylprednisolone 6 mg PO TID Duration: 1 Day RX *methylprednisolone 4 mg 1 tablets(s) by mouth four times a day Disp #*1 Dose Pack Refills: *0 <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Primary Diagnoses: Low back pain Acute urinary retention Otitis media Secondary Diagnoses: Hypertension Migraine Orthostatic hypotension <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Ms. ___, You were admitted to the hospital for worsening back pain. Your exam and blood work were not concerning for any neurological changes. We changed one of your pain medications, increased your methadone dose, and started you on a steroid taper and your symptoms improved. Please complete the steroid taper after discharge and follow up with your pain doctor. We removed your Foley catheter and your urinary retention resolved. While you were here, you were also diagnosed with a middle ear infection of your right ear. Please finish taking 5 days total of azithromycin. Best wishes, Your ___ Team ","___ with chronic pudendal impingement syndrome s/p intrathecal pump for ziconotide infusion with recent admission ___ for acute urinary retention and pain at intrathecal pump catheter site who now presented one day after discharge with continued pain at intrathecal pump. ACUTE ISSUES: #Low back pain - Pt with recent admission for acute pain over intrathecal catheter site for her chronic pudendal impingement syndrome. CT of the lumbar spine at that time revealed no signs of infection. However, where catheter bends and overlaps the L2 spinous process is superficial and had some mild surrounding inflammatory stranding of the soft tissue. Per ___ Pain Service, this inflammation could be causing the pain. Neurology also saw the patient during last admission and there were no concerns for cord compression. She was discharged home on ___ and woke on ___ with worsening pain and buttocks paresthesias, which actually occurred prior to her intrathecal pump being turned off. History of paresthesias and report of falling concerning for acute cord syndrome however she was again seen by the Neurology consult service and exam was not concerning for cord compression. Pain Service was consulted again and increased her methadone to 7.5mg TID, and replaced her short-acting hydromorphone with oxycodone to avoid development of narcotic tolerance. She was started on a methylprednisolone taper with improvement in her pain. She was continued on her other pain medications with the exception of Exalgo, which was substituted with hydromorphone short-acting 4mg q6h (Exalgo is non-formulary at ___. Neurosurgery was consulted and declined to intervene surgically on the pump catheter site; they recommended she follow up with the physician who manages her pump, Dr. ___. ___, a representative from ___, the company which adjusts the patient's intrathecal pump settings, confirmed on day of discharge by phone that she would be visiting the patient at home to empty the pump of ziconotide and replace with saline, per Dr. ___ order. Patient stated she would seek another pain specialist in ___ to manage her Prometra pump. #Acute urinary retention - Noted last hospital admission, felt to be secondary to recent increase in ziconotide dose on ___. Pump was unable to be decreased last hospital admission due to lack of legal permission for pump company to provide inpatient services at ___, and pt was discharged with Foley. Now that pump was turned off, Foley catheter was removed on ___ and patient passed voiding trial. She had no further urinary retention during this admission. #Otitis media - Patient complained of right ear pain and fullness on day of discharge. She had been having symptoms for several days prior to this admission and reported a URI in the few weeks prior to admission. Exam revealed otitis media of the right ear. She was started on azithromycin for a 5-day course given her penicillin allergy. CHRONIC ISSUES: #Orthostatic hypotension - Patient was again noted to have orthostatic lightheadedness intermittently. She received IV fluids with improvement in her BP and symptoms. She was instructed to monitor her BP at home and call her PCP or seek medical attention if her orthostatic symptoms returned. #Migraine: continued on sumatriptan prn. #HYPOTHYROIDISM: continued levothyroxine. #HX OF HTN/CARDIAC ARRHYTHMIA: Continued home Verapamil. #PSYCH: Continue home medications, including buspirone, Ativan, trazadone, duloxetine, abilify, lyrica #Constipation: chronic in setting of opioids. Continued home miralax daily. #GERD: continued home ranitidine and PPI. TRANSITIONAL ISSUES: - Patient discharged with methylprednisolone taper, with last day ___. - Patient discharged with azithromycin for otitis media, with last day ___. - Hydromorphone (short-acting) was stopped and oxycodone 10mg q8h prn pain was started. - Patient had mild leukopenia (WBC 2.8) and anemia (Hgb ___ that was stable during this admission. Consider outpatient workup. - Patient has had chronic orthostatic lightheadedness. Consider adjusting her antihypertensive medications and further outpatient workup. ",2496,926
10010393-DS-7,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> Penicillins / Topamax / Reglan <ATTENDING> ___. <CHIEF COMPLAINT> -=========== HMED Admission H&P -=========== CC: Back pain <MAJOR SURGICAL OR INVASIVE PROCEDURE> None <HISTORY OF PRESENT ILLNESS> Ms. ___ is a ___ year old woman with a history of debilitating pudendal neuralgia who was admitted in ___ and ___ with worsening back pain, who presented to the ED today with subacutely worsening back pain. She had an intrathecal ziconotide pump for placed in ___ in ___ and had presented to ___ in ___ with worsened back pain at the site of the pump as well as urinary retention. Cord compression was ruled out at that time and her ziconotide was stopped (this was suspected as the cause of her urinary retention), and she was also started on prednisone for her pain which was attributed to inflammation around the site of her pump catheter where it passes by the L2 spinous process. She has also been managed on multiple chronic narcotics and other agents for her pain. During the prior admission she was seen by neurology, neurosurgery, and pain service. She reports that initially the steroids were extremely helpful at controlling her pain but that she has been completing a slow taper. The plan had been tapering to 15 mg in ___ and 10 mg in ___, but in recent weeks she has had worsening control of her pain, similar to its prior location and quality. The pain is most severe over the lumbar incision site and is severe to the point of limiting basic daily function - has been using commode d/t difficulty ambulating ___ pain. She is followed closely by her PCP, who increased the steroids back to 40 mg daily and attempted a rapid taper with 4 days of 40mg, 4 days of 30, and 4 days of 20. She noted some slight improvement with the increase to 40 mg but subsequently returned to severe pain when this was reduced to 30 and then 20. She also notes that she no longer sees the doctor in ___ who placed her pump. She reports that her PCP obtained an MRI in recent days, although she is unsure what the results showed. Her PCP recommended presenting to the ED given her worsening pain control. She denies any urinary retention, changes in bowel patterns, weakness, or numbness. Review of systems: Const: no fevers, chills HEENT: + HA x 2 weeks, bilateral, constant non-pulsating ""not migraine"" CV: + intermittent palpitations, no CP Pulm: + occasional dyspnea associated with palpitations, otherwise no dyspnea or cough GI: +RUQ pain for past week intermittently, no n/v, no changes in PO intake, no changes in BMs GU: no retention or urinary changes MSK: no new myalgias/arthralgias except as per HPI Neuro: no new focal weakness or numbness Derm: no new rashes Hem: no new bleeding/bruising Endo: no hot/cold intolerance Psych: no recent mood changes <PAST MEDICAL HISTORY> HYPOTHYROIDISM ARRHYTHMIA PUDENDAL IMPINGEMENT SYNDROME s/p INTRATHECAL PUMP PLACEMENT SOMATIZATION DISORDER <SOCIAL HISTORY> ___ <FAMILY HISTORY> No cardiac or cancer history in either parent. Mother and sister with depression. <PHYSICAL EXAM> Admission <PHYSICAL EXAM> Vital signs: 98 120/72 68 18 99% RA gen: pt in NAD, lying in bed HEENT: nc/at, sclera anicteric, conjunctiva noninjected, PER, EOMI, MMMs CV: RRR no m/r/g Pulm: CTAB No c/r/w Abd/GI: S NT ND BS+, no masses/HSM palpated (except pump) Back: tenderness over lumbar incision site Extr: wwp, distal pulses intact, no edema GU: no Foley Neuro: alert and interactive, strength, sensation, CNs grossly intact, reflexes brisk throughout all 4 extremities Skin: no rashes on limited skin exam Psych/MS: normal range of affect Discharge PE: VS: 98.0 132 / 84 86 18 100 RA Gen: NAD, occasionally tearful, resting on her side HEENT: EOMI, PERRLA, MMM CV: RRR nl s1s2 no m/r/g Resp: CTAB no w/r/r Abd: Soft, NT, ND +BS Ext: no c/c/e Back: pump site c/d/I, no erythema or swelling, diffuse lower back tenderness to even light palpation of skin Neuro: CN II-XII intact, ___ strength throughout Skin: warm, dry no rashes <PERTINENT RESULTS> CBC: 6.0>12.6<227 BMP: ___ UA wnl MRI lumbar spine w/o contrast ___: Impression There has been interval placement of hardware since the prior exam as further discussed above. This results in extensive artifact including regions of signal loss and distortion of the anatomy. Allowing for this limitation, there is persistent changes of mild lumbar spondylosis but no definitive limiting central canal or foraminal stenosis at any level in the lumbar spine. Extrahepatic biliary ductal dilation. MRI thoracic spine w/o contrast ___: Impression Mild chronic T6 and T9 compression fracture deformities. No limiting central canal or foraminal stenosis at any level in the thoracic spine. Extrahepatic biliary duct dilation to 7.5 mm. RUQ ___: IMPRESSION: Unremarkable abdominal ultrasound. No evidence of biliary tree dilation. Normal CBD. <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Albuterol 0.083% Neb Soln 1 NEB IH BID 2. ARIPiprazole 5 mg PO DAILY 3. BusPIRone 15 mg PO TID 4. DULoxetine 120 mg PO DAILY 5. Levothyroxine Sodium 125 mcg PO DAILY 6. LORazepam 1 mg PO Q4H: PRN anxiety 7. Methadone 5 mg PO TID 8. Ondansetron 4 mg PO Q8H: PRN nausea 9. Polyethylene Glycol 17 g PO DAILY 10. Pregabalin ___ mg PO DAILY 11. Ranitidine 300 mg PO QHS 12. Tizanidine 2 mg PO TID 13. TraZODone 100 mg PO QHS: PRN insomnia 14. Verapamil SR 120 mg PO Q24H 15. Elmiron (pentosan polysulfate sodium) 100 mg oral TID 16. Exalgo ER (HYDROmorphone) 16 mg oral DAILY 17. Lidocaine 5% Ointment 1 Appl TP ONCE ASDIR 18. NexIUM (esomeprazole magnesium) 40 mg oral DAILY 19. Sumatriptan Succinate 6 mg SC ONCE: PRN HA 20. Voltaren (diclofenac sodium) 1 % topical QID: PRN pain 21. OxyCODONE--Acetaminophen (5mg-325mg) 2 TAB PO TID 22. Linzess (linaclotide) 290 mcg oral DAILY 23. PredniSONE 20 mg PO DAILY <DISCHARGE MEDICATIONS> 1. Lidocaine 5% Patch 1 PTCH TD QAM RX *lidocaine 5 % Apply one patch to lower back Daily Disp #*30 Patch Refills: *0 2. PredniSONE 40 mg PO DAILY 40 mg daily x 1 week, 30 mg daily x 1 week, 20 mg PO daily x 1 week then 10 mg PO daily x 1 week. Tapered dose - DOWN RX *prednisone 10 mg As directed tablet(s) by mouth Daily Disp #*70 Tablet Refills: *0 3. Albuterol 0.083% Neb Soln 1 NEB IH BID 4. ARIPiprazole 5 mg PO DAILY 5. BusPIRone 15 mg PO TID 6. DULoxetine 120 mg PO DAILY 7. Elmiron (pentosan polysulfate sodium) 100 mg oral TID 8. Exalgo ER (HYDROmorphone) 16 mg oral DAILY 9. Levothyroxine Sodium 125 mcg PO DAILY 10. Lidocaine 5% Ointment 1 Appl TP ONCE ASDIR 11. Linzess (linaclotide) 290 mcg oral DAILY 12. LORazepam 1 mg PO Q4H: PRN anxiety 13. Methadone 5 mg PO TID 14. NexIUM (esomeprazole magnesium) 40 mg oral DAILY 15. Ondansetron 4 mg PO Q8H: PRN nausea 16. OxyCODONE--Acetaminophen (5mg-325mg) 2 TAB PO TID 17. Polyethylene Glycol 17 g PO DAILY 18. Pregabalin ___ mg PO DAILY 19. Ranitidine 300 mg PO QHS 20. Sumatriptan Succinate 6 mg SC ONCE: PRN HA 21. Tizanidine 2 mg PO TID 22. TraZODone 100 mg PO QHS: PRN insomnia 23. Verapamil SR 120 mg PO Q24H 24. Voltaren (diclofenac sodium) 1 % topical QID: PRN pain <DISCHARGE DISPOSITION> Home With Service Facility: ___ <DISCHARGE DIAGNOSIS> Acute on chronic back pain <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> You were admitted with worsening of your chronic back pain. You had a recent MRI of your spine which did not show any significant abnormalities. You were seen by the chronic pain service, you were started on a lidocaine patch. We recommend that you follow-up with a pain physician who specializes in your Prometra pump. ","___ year old woman with pudendal neuralgia status post intrathecal pump catheter placement in ___ treated with ziconotide infusion complicated by urinary retention (pump currently not in use) presenting with worsening of chronic back pain. #Pudendal neuralgia with severe subacute on chronic pain: No significant change in character of pain, no fevers, chills, weakness, numbness, incontinence, retention or other concerning findings. MRI T/L spine on ___ showing no concerning findings, no evidence of infection or significant spinal stenosis. Chronic pain service was consulted. She reports she had significant benefit from her intrathecal pump prior to developing side effect of urinary retention and having it stopped, she is interested in trialing another medication through the pump. On discharge in ___ she was counselled to find a physician to manage the pump but has not done so, recommended that she work on seeing an outpatient doctor who can manage her Prometra intrathecal pump, given name and office information of a local physician who is certified to manage the Prometra pump. Concern that there is significant anxiety and/or possible somatization disorder contributing to symptoms. - Started Lidoderm patch, recommend following up with Dr. ___ to manage her intrathecal pump. - Home ___ - continuing home medication regimen, which is as follows: - methadone 5 tid prn - percocet 10 tid prn - pregabalin 150 AM 300 HS - Exalgo 16 mg daily (in hospital placed on hydromorphone 4 mg PO q6H as Exalgo non-formulary) - tizanidine 2 tid prn - ativan 1 q4h prn - duloxetine 120 - elmiron (will use home med) and miralax for constipation - topical lidocaine PRN - increasing prednisone to 40 mg daily with taper of 10 mg daily. - Recommend that she establish care with a psychiatrist and therapist to help manage her anxiety and psychiatric disorders which are likely contributing significantly to her symptoms. #Abdominal pain #Biliary ductal dilation on MRI She denies any current abdominal pain, n/v, pruritus, jaundice. LFTs normal and RUQ unremarkable without ductal dilation. #History of supraventricular arrhythmia -cont verapimil 120 #HA: History of migraine headaches. - Continue home PRN Imitrex #Other home meds: - cont albuterol PRN for wheezing - cont abilify 5 for mood - cont buspar 15 TID for anxiety - cont synthroid ___ for hypothyroidis - cont PRN zofran for nausea - cont PRN trazodone for insomnia - cont home ranitidine and substitute omeprazole for protonix for GERD # FEN: regular diet # Prophylaxis: Subcutaneous heparin # Access: peripherals # Communication: Patient # Code: Full (discussed with patient) # ___: home with home ___ ",2283,634
10010399-DS-8,"<SEX> F <SERVICE> PLASTIC <ALLERGIES> Iodine; Iodine Containing / Latex <ATTENDING> ___. <CHIEF COMPLAINT> Acquired absence of the right breast, status post nipple sparing mastectomy for breast cancer <MAJOR SURGICAL OR INVASIVE PROCEDURE> Immediate reconstruction of nipple-sparing mastectomy with deep inferior epigastric perforator flap from the contralateral side, harvest of pedicle of the flap, and anastomosis of the thoracodorsal artery and vein (___) <HISTORY OF PRESENT ILLNESS> Patient is a ___ female with a history of having a mammogram finding of newly diagnosed ductal carcinoma on the right breast with a focus of suspicious microinvasion. She has a history of microinvasive carcinoma of the right breast diagnosed first in ___ of which she was found to have been diagnosed with invasive ductal carcinoma with ER negativity and HER-2/neu positivity. She has also been treated with breast conservation surgery as well as postoperative radiotherapy. She is now here for planned mastectomy for breast cancer to be followed by desired immediate breast reconstruction. <PAST MEDICAL HISTORY> PMH: Polio, breast disease, radiation therapy, left knee Bakers cyst PSH: Lumpectomy ___, cholecystectomy ___, tubal ligation ___ <SOCIAL HISTORY> Smokes 1.5 ppd for 30+ years, trying to quit; denies alcohol yes; last used IV drugs ___ years ago <PHYSICAL EXAM> VS: Afebrile, VSS Gen: NAD CV: RRR, no murmurs Resp: CTAB, no crackles or wheezes Breasts: R breast flap viable and intact, incision c/d/i without hematoma, Dopplerable pulse. JP with serosanguinous fluid. Abd: Soft, mildly TTP, +BS. Incision c/d/i without hematoma. Ext: Warm, distal pulses palpable <PERTINENT RESULTS> ___ 04: 14AM BLOOD WBC-12.0*# RBC-3.55* Hgb-11.1* Hct-32.6* MCV-92 MCH-31.2 MCHC-34.0 RDW-13.4 Plt ___ <MEDICATIONS ON ADMISSION> Depakote, fluoxetine, quetiapine, trazodone <DISCHARGE DISPOSITION> Home With Service Facility: ___ <DISCHARGE DIAGNOSIS> Acquired absence of the right breast, status post nipple sparing mastectomy for breast cancer. <DISCHARGE CONDITION> Good <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Return to the ER if: * If you are vomiting and cannot keep in fluids or your medications. * If you have shaking chills, fever greater than 101.5 (F) degrees or 38 (C) degrees, increased redness, swelling or discharge from incision, chest pain, shortness of breath, or anything else that is troubling you. * Any serious change in your symptoms, or any new symptoms that concern you. * Please resume all regular home medications and take any new meds as ordered. * Do not drive or operate heavy machinery while taking any narcotic pain medication. You may have constipation when taking narcotic pain medications (oxycodone, percocet, vicodin, hydrocodone, dilaudid, etc.); you should continue drinking fluids, you may take stool softeners, and should eat foods that are high in fiber. * ___ nursing services will help you with JP drain care. Empty JP drains daily and record daily output. ","The patient was admitted to the plastic surgery service on ___ and had an immediate reconstruction of nipple-sparing mastectomy with deep inferior epigastric perforator flap from the contralateral side, harvest of pedicle of the flap, and anastomosis of the thoracodorsal artery and vein. She tolerated the procedure well. Neuro: The patient received morphine PCA with good effect and adequate pain control. When tolerating oral intake, the patient was transitioned to oral pain medications. CV: The patient was stable from a cardiovascular standpoint; vital signs were routinely monitored. Pulmonary: The patient was stable from a pulmonary standpoint; vital signs were routinely monitored. GI/GU: Post-operatively, the patient was given IV fluids until tolerating oral intake. Her diet was advanced when appropriate, which was tolerated well. She was also started on a bowel regimen to encourage bowel movement. Foley was removed on POD#2. Intake and output were closely monitored. ID: Post-operatively, the patient was started on IV cefazolin. The patient's temperature was closely watched for signs of infection. Prophylaxis: The patient received subcutaneous heparin during this stay, and was encouraged to get up and ambulate as early as possible. At the time of discharge, the patient was doing well, afebrile with stable vital signs, tolerating a regular diet, ambulating, voiding without assistance, and pain was well controlled. ",782,300
10010399-DS-9,"<SEX> F <SERVICE> PLASTIC <ALLERGIES> Iodine; Iodine Containing / Latex <ATTENDING> ___. <CHIEF COMPLAINT> Patient noted redness and firmness of the medial aspect of the right breast which advanced gradually. She has also noted increased pain in this area. <MAJOR SURGICAL OR INVASIVE PROCEDURE> Bedside incision and drainage x 2 <HISTORY OF PRESENT ILLNESS> ___ yo F presents s/p right ___ flap revision and left mastopexy on ___ with right breast erythema and induration. The patient had a right mastectomy and ___ flap reconstruction in ___ by Dr. ___. Her course was unremarkable. She returned on ___ for revisional surgery including scar excision and advancement to the right breast and mastopexy to the left breast. Her initial post-operative course was unremarkable. Starting two days ago, she noted redness and firmness of the medial aspect of the right breast which advanced gradually. She has also noted increased pain in this area. She notes that she has chills at baseline but denies fever, sweats or other systemic symptoms. She presented to an OSH and was transferred to ___ given her recent surgery. <PAST MEDICAL HISTORY> -Right breast cancer s/p mastectomy/radiation and ___ flap, left mastopexy -Depression -Polio as a child -Cholecystectomy ___ -Knee surgery for left knee ___ syct -Tubal ligation ___ <SOCIAL HISTORY> ___ <FAMILY HISTORY> Non-contributory <PHYSICAL EXAM> Vitals: 97.8, 109/66, 14, 75, 97% RA General: Alert, oriented, NAD Breast: Right breast s/p ___ reconstruction with transverse incision. There is erythema, induration and tenderness in a discrete area on the medial aspect of the breast just medial to her transverse incision. There is fluctuance beneath the erythema. There is a small portion of the lateral incision that has some superficial minor dehiscence. The left breast has well healing incisions without pain or erythema. <PERTINENT RESULTS> ___ 07: 22PM LACTATE-1.0 ___ 07: 10PM GLUCOSE-86 UREA N-12 CREAT-0.8 SODIUM-133 POTASSIUM-4.5 CHLORIDE-94* TOTAL CO2-29 ANION GAP-15 ___ 07: 10PM estGFR-Using this ___ 07: 10PM WBC-13.1*# RBC-4.59 HGB-13.6 HCT-40.8 MCV-89 MCH-29.8 MCHC-33.5 RDW-14.0 ___ 07: 10PM NEUTS-73.8* ___ MONOS-4.5 EOS-0.7 BASOS-0.7 ___ 07: 10PM PLT COUNT-227 . Time Taken Not Noted Log-In Date/Time: ___ 12: 58 am SWAB Site: BREAST GRAM STAIN (Final ___: 3+ ___ per 1000X FIELD): POLYMORPHONUCLEAR LEUKOCYTES. NO MICROORGANISMS SEEN. SMEAR REVIEWED; RESULTS CONFIRMED. WOUND CULTURE (Final ___: STAPH AUREUS COAG +. MODERATE GROWTH. SENSITIVITIES: MIC expressed in MCG/ML _________________________________________________________ STAPH AUREUS COAG + | CLINDAMYCIN-----------<=0.25 S ERYTHROMYCIN---------- =>8 R GENTAMICIN------------ <=0.5 S LEVOFLOXACIN---------- 0.25 S OXACILLIN------------- 0.5 S TRIMETHOPRIM/SULFA---- <=0.5 S ANAEROBIC CULTURE (Preliminary): NO ANAEROBES ISOLATED. <MEDICATIONS ON ADMISSION> DIVALPROEX [DEPAKOTE ER] - (Prescribed by Other Provider) - 500 mg Tablet Sustained Release 24 hr - one Tablet(s) by mouth at bedtime FLUOXETINE - (Prescribed by Other Provider) - 20 mg Capsule - 1 (One) Capsule(s) by mouth once a day PROPRANOLOL - (Prescribed by Other Provider) - 80 mg Tablet - 1 (One) Tablet(s) by mouth once a day QUETIAPINE [SEROQUEL] - (Prescribed by Other Provider) - 300 mg Tablet - 1 (One) Tablet(s) by mouth once a day TRAZODONE - (Prescribed by Other Provider) - 150 mg Tablet - 1 (One) Tablet(s) by mouth once a day <DISCHARGE MEDICATIONS> 1. Acetaminophen 325 mg Tablet Sig: ___ Tablets PO Q6H (every 6 hours) as needed for pain, fever: Max 12 tabs/day. Do not exceed 4000mg/4gms per day. 2. Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day). Disp: *45 Capsule(s)* Refills: *2* 3. Divalproex ___ mg Tablet Sustained Release 24 hr Sig: One (1) Tablet Sustained Release 24 hr PO DAILY (Daily). 4. Propranolol 80 mg Capsule,Sustained Action 24 hr Sig: One (1) Capsule,Sustained Action 24 hr PO DAILY (Daily). 5. Quetiapine 150 mg Tablet Sustained Release 24 hr Sig: One (1) Tablet Sustained Release 24 hr PO DAILY (Daily). 6. Trazodone 100 mg Tablet Sig: 1.5 Tablets PO DAILY (Daily). 7. Ibuprofen 400 mg Tablet Sig: One (1) Tablet PO Q8H (every 8 hours) as needed for headache: Do not exceed 2400 mg/day. 8. Fluoxetine 20 mg Capsule Sig: One (1) Capsule PO DAILY (Daily). 9. Hydromorphone 4 mg Tablet Sig: One (1) Tablet PO Q4H (every 4 hours) as needed for pain. Disp: *50 Tablet(s)* Refills: *0* 10. Augmentin 875-125 mg Tablet Sig: One (1) Tablet PO every twelve (12) hours for 7 days. Disp: *14 Tablet(s)* Refills: *1* <DISCHARGE DISPOSITION> Home With Service Facility: ___ <DISCHARGE DIAGNOSIS> Right breast cellulitis/fluid collection <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> You were admitted on ___ for a right breast infection. Please follow these discharge instructions. . Personal Care: . You may unpack your right breast wound and shower and then pack with fresh dressings. . You should pre-medicate with your pain meds ___ minutes prior to dressing change. . Pack your right breast wound with ___ inch iodoform gauze packing and cover with dry sterile gauze once a day. . Once you have packed and covered your wound with fresh dressings, do not uncover and do not touch as you will introduce new bacteria to the wound. . Continue to avoid smoking and the nicotine patch as nicotine impairs healing. You've done great so far!! . Diet/Activity: 1. You may resume your regular diet. 2. DO NOT lift anything heavier than 5 pounds or engage in strenuous activity for two weeks after surgery. . Medications: 1. Resume your regular medications unless instructed otherwise and take any new meds as ordered. 2. You may take your prescribed pain medication for moderate to severe pain. You may switch to Tylenol or Extra Strength Tylenol for mild pain as directed on the packaging. Please note that Percocet and Vicodin have Tylenol as an active ingredient so do not take these meds with additional Tylenol. 4. Take prescription pain medications for pain not relieved by tylenol. 5. Take your antibiotic as prescribed. 6. Take Colace, 100 mg by mouth 2 times per day, while taking the prescription pain medication. You may use a different over-the-counter stool softerner if you wish. 7. Do not drive or operate heavy machinery while taking any narcotic pain medication. You may have constipation when taking narcotic pain medications (oxycodone, percocet, vicodin, hydrocodone, dilaudid, etc.); you should continue drinking fluids, you may take stool softeners, and should eat foods that are high in fiber. . Call the office IMMEDIATELY if you have any of the following: 1. Signs of infection: fever with chills, increased redness, swelling, warmth or tenderness at the surgical site, or unusual drainage from the incision(s). 2. A large amount of bleeding from the incision(s) or drain(s). 3. Fever greater than 101.5 oF 4. Severe pain NOT relieved by your medication. . Return to the ER if: * If you are vomiting and cannot keep in fluids or your medications. * If you have shaking chills, fever greater than 101.5 (F) degrees or 38 (C) degrees, increased redness, swelling or discharge from incision, chest pain, shortness of breath, or anything else that is troubling you. * Any serious change in your symptoms, or any new symptoms that concern you. ","The patient was admitted to the plastic surgery service on ___ and had a bedside incision and drainage x 2 of right breast infected fluid collection. The patient tolerated the procedures well. . Neuro: The patient's pain management was a complicated issue during her stay. Patient was tried on several different pain regimens and essentially reported no relief with any of them but always appeared very comfortable without diaphoresis and without a change in vital signs. She started out with Percocet and then Dilaudid IV rescues but then reported the percocet was not working for her. So on ___, patient was changed to Dilaudid ___ po Q4hPRN. Unfortunately, a subsequent dressing change caused her severe pain and she was quickly transitioned to a dilaudid PCA for overnight on ___. On ___, the PCA was discontinued and the patient was placed back on oral dilaudid. She responded well to Dilaudid .5mg IV x 1 prior to dressing changes and then Dilaudid 4mg po Q4h PRN for around the clock pain management. . CV: The patient was stable from a cardiovascular standpoint; vital signs were routinely monitored. . Pulmonary: The patient was stable from a pulmonary standpoint; vital signs were routinely monitored. . GI/GU: Patient had no issues with voiding or with bowel movements while an inpatient. Intake and output were closely monitored. . ID: A culture was obtained from the right breast wound upon admission and patient was started on Unasyn IV. The wound was cleansed and packed with Iodoform gauze twice daily. The wound began to improve status post the second incision and drainage. The culture grew stap aureus coag positive which was sensitive to everything with the exception of erythromycin. The patient was discharged home with daily packing changes and a 7-day prescription for Augmentin. The patient's temperature was closely watched for signs of infection during her inpatient stay. . Prophylaxis: The patient was encouraged to get up and ambulate as much as possible during her inpatient stay. . At the time of discharge on hospital day #4, the patient was doing well, afebrile with stable vital signs, tolerating a regular diet, ambulating, voiding without assistance, and pain was well controlled. ",2125,475
10010424-DS-9,"<SEX> M <SERVICE> MEDICINE <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> DOE and Chest pressure <MAJOR SURGICAL OR INVASIVE PROCEDURE> Cardiac catheterization <HISTORY OF PRESENT ILLNESS> This is a ___ year old male in his USOH with CAD and previous 4 vessel CABG who presented to an OSH ED on ___ after two days of DOE and palpiations. The palpiatations were initially ___ on with exertion, and he had not lightheadedness or dizziness. He rested the following day, and when he took his son to the train station he noted a similar palpitations. He went to an OSH ED where a stress echo, cardiac enzymes and ECG were negative. He then had a similar episode of DOE when he was climbing stairs at work on ___. He began to feel lightheaded, and noticed a pronouced swelling and choking feeling in his throat. He had not palpiatations at that time. He went to the OSH ED where a ddimer, CXR, and troponin were negative. He was sent home to be followed by his PCP. He presented to clinic today where he was thought to have crescendo angina. He was sent to ___ ED for evaluation for a cardiac catheritization. . In the ED, initial vitals were 97.1 135/76 74 18 100 RA. In the ED he was guiac negative and given plavix 300 mg PO x 1. He was seen by the At___ Cardiologist who recommended plavix 300 mg PO daily, and a cardiac catheritization. . He underwent a Left heart cath with a right groin cath that was notable for the findings listed below. . On arrival to the floor, the patient was feeling well. He had no complaints. His vitals are listed below. . On review of systems, s/he denies any prior history of stroke, TIA, deep venous thrombosis, pulmonary embolism, bleeding at the time of surgery, black stools or red stools. S/he denies recent fevers, chills or rigors. S/he denies exertional buttock or calf pain. All of the other review of systems were negative. . Cardiac review of systems is notable for paroxysmal nocturnal dyspnea, orthopnea, ankle edema, palpitations, syncope or presyncope. . <PAST MEDICAL HISTORY> 1. CARDIAC RISK FACTORS: Diabetes, (+)Dyslipidemia [recent labs noted below], (+)Hypertension 2. CARDIAC HISTORY: -CABG: ___: CABG x 4 bypass grafts 35% Proximal LAD, 85% Mid-LAD, 85% distal LAD, 80% D1, 90% Mid RCA, 80% Cx L lateral. Had vein graft to first OM, and to RCA, mammary to LAD. No post op complications. -PERCUTANEOUS CORONARY INTERVENTIONS: -PACING/ICD: 3. OTHER PAST MEDICAL HISTORY: Hyperlipidemia ___ Chol 136, HDL 48, LDL 76 Urethra hematoma after Bike Trauma Fecal Occult positive Stool (___). No colonoscopy Colonic Poly (___) Adenoma, removed Retinal Tear Vitreous Degeneration Cataract Sensorineural hearing loss GERD CAD Urinary Frequency/Urgency Loss of Height <SOCIAL HISTORY> ___ <FAMILY HISTORY> Brother with ___ Cancer Maternal Grandmother with cerebral hemorrhage Father - CAD/CABG. Mother HTN, ___ CA Brother- ___ CA <PHYSICAL EXAM> VS: T=AF BP=127/69 HR= 72 RR=20 O2 sat= 98 GENERAL: in NAD. Oriented x3. Mood, affect appropriate. HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no pallor or cyanosis of the oral mucosa. No xanthalesma. NECK: Supple CARDIAC: PMI located in ___ intercostal space, midclavicular line. RR, normal S1, S2. No m/r/g. No thrills, lifts. No S3 or S4. LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp were unlabored, no accessory muscle use. CT anteriorly. No crackles, wheezes or rhonchi. ABDOMEN: Soft, NTND. No HSM or tenderness. EXTREMITIES: No c/c/e. Angio seal in place. SKIN: No stasis dermatitis, ulcers, scars, or xanthomas. PULSES: Right: Carotid 2+[No carotid bruits], DP 2+ ___ 2+ Left: Carotid 2+[No carotid bruits],DP 2+ ___ 2+ <PERTINENT RESULTS> Admission Labs: ___ 08: 52PM BLOOD Hct-38.0* Plt ___ ___ 08: 52PM BLOOD ___ PTT-36.1* ___ ___ 08: 52PM BLOOD Glucose-143* UreaN-15 Creat-0.9 Na-137 K-3.9 Cl-105 HCO3-25 AnGap-11 ___ 08: 52PM BLOOD CK(CPK)-72 ___ 06: 30AM BLOOD CK-MB-3 ___ 08: 52PM BLOOD Calcium-8.6 Phos-3.6 Mg-2.2 . Cardiac Catheterization COMMENTS: 1. Coronary angiography in this right-dominant system demonstrated three-vessel disease. The LMCA had no angiographically apparent disease. The LAD was occluded in its mid-portion an had a moderate sized D1 with a highly angulated and tortuous 80% stenosis. The LCx was occluded proximally. The RCA had a 40% proximal stenosis and a 90% mid stenosis. 2. Arterial conduit angiography demonstrated an atretic LIMA-LAD. The SVG-Diag and SVG-OM1 were patent. The SVG-RCA was occluded at its origin. 3. Limited resting hemodynamics revealed mild systemic arterial hypertension with SBP 143mmHg and DBP 80mmHg. 4. Successful PTCA/stenting of the mid RCA with a Promus Rx 3.0x15 mm drug-eluting stent (DES) post-dilated with 3.5 mm then 4.0 mm balloons inflated at 18 atm. Final angiography revealed normal TIMI 3 flow, no angiographically apparent dissection and 0% residual stenosis in the new stent. (see ___ comments) 5. R ___ femoral artery angioseal closure device deployed without complications (see ___ comments) FINAL DIAGNOSIS: 1. Three vessel coronary artery disease. 2. Patent SVG-OM1, SVG-Diag. Occluded SVG-RCA. 3. Atretic LIMA-LAD. 4. Successful PTCA/stenting of the native mid RCA with a Promus Rx 3.0x15 mm drug-eluting stent (DES) post-dilated with a 3.5 mm then 4.0 mm balloon. (see ___ comments) 5. R ___ femoral artery angioseal closure device deployed without complications (see ___ comments) 6. Other territories of potential ischemia include retrograde limb of OM2 and DIAG1. DIAG1 size and anatomy suboptimal for PCI, but if ongoing angina would onsider PCI of OM2 retrograde limb stenosis by going through SVG. 7. ASA indefinitely; plavix (clopidogrel) for a minimal of 12 months. . ECHO: The left atrium is mildly dilated. Left ventricular wall thickness, cavity size and regional/global systolic function are normal (LVEF >55%). Tissue Doppler imaging suggests a normal left ventricular filling pressure (PCWP<12mmHg). Right ventricular chamber size and free wall motion are normal. The diameters of aorta at the sinus, ascending and arch levels are normal. The aortic valve leaflets (3) are mildly thickened but aortic stenosis is not present. The mitral valve leaflets are structurally normal. There is no mitral valve prolapse. Mild (1+) mitral regurgitation is seen. The estimated pulmonary artery systolic pressure is high normal. There is no pericardial effusion. . IMPRESSION: Normal biventricular cavity sizes with preserved global and regional biventricular systolic function. Mild mitral regurgitation with normal valve morphology. No pericardial effusion. . CLINICAL IMPLICATIONS: Based on ___ AHA endocarditis prophylaxis recommendations, the echo findings indicate prophylaxis is NOT recommended. Clinical decisions regarding the need for prophylaxis should be based on clinical and echocardiographic data. . Duplex Arterial US INDICATION: ___ male status post recent right groin catheterization. Now with femoral bruit. Evaluate for pseudoaneurysm. COMPARISON: None. FINDINGS: Ultrasnographic evaluation of the right common femoral vessels was performed. There are normal arterial and venous waveforms seen, without evidence of pseudoaneurysm, fistula, or hematoma. IMPRESSION: Normal right common femoral vessels, without pseudoaneurysm, fistula, or hematoma. <MEDICATIONS ON ADMISSION> Aspirin 325 mg PO daily (___) Lisinopril 2.5 mg PO qAM (___) Niaspan (Niacin) 1000 mg daily (___) Crestor 20 mg PO daily (___) Nitrostat 0.4 mg sublingual q5 min PRN Metorpolol 12.5 mg PO BID (___) Ranitidine 150 mg BID (___) <DISCHARGE MEDICATIONS> 1. ranitidine HCl 150 mg Tablet Sig: One (1) Tablet PO BID (2 times a day). 2. lisinopril 5 mg Tablet Sig: 0.5 Tablet PO DAILY (Daily). 3. clopidogrel 75 mg Tablet Sig: One (1) Tablet PO DAILY (Daily) as needed for CAD: s/p mid RCA DES. Disp: *30 Tablet(s)* Refills: *0* 4. aspirin 325 mg Tablet, Delayed Release (E.C.) Sig: One (1) Tablet, Delayed Release (E.C.) PO DAILY (Daily) as needed for CAD: s/p mid RCA DES. Disp: *30 Tablet, Delayed Release (E.C.)(s)* Refills: *0* 5. rosuvastatin 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 6. niacin 500 mg Capsule, Sustained Release Sig: Two (2) Capsule, Sustained Release PO DAILY (Daily). 7. isosorbide mononitrate 30 mg Tablet Sustained Release 24 hr Sig: One (1) Tablet Sustained Release 24 hr PO DAILY (Daily). Disp: *30 Tablet Sustained Release 24 hr(s)* Refills: *0* 8. nitroglycerin 0.4 mg Tablet, Sublingual Sig: One (1) Tablet, Sublingual Sublingual ASDIR (AS DIRECTED): Please take every five minutes for 3 doses. If your chest pain is not relieved after three doses, please call your physician ___ 911. Disp: *30 Tablet, Sublingual(s)* Refills: *0* 9. metoprolol succinate 25 mg Tablet Sustained Release 24 hr Sig: Three (3) Tablet Sustained Release 24 hr PO once a day. Disp: *90 Tablet Sustained Release 24 hr(s)* Refills: *0* 10. guaifenesin 100 mg/5 mL Syrup Sig: ___ MLs PO Q6H (every 6 hours) as needed for cough for 5 days. <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> Primary Diagnosis: Angina/Coronary Vasospasm <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Mr. ___- ___ were admitted to the hospital for chest pain. ___ underwent a cardiac catheterization which showed that ___ had coronary artery disease and an occluded vein graft from your prior coronary bypass surgery. ___ had a stent placed in your right coronary artery. ___ will need to follow up with your primary care physician and your cardiologist. The following medication changes were made: ADDED: plavix, isosorbide mononitrate, guaifenesin CHANGED: Metoprolol STOPPED: None ","Active Issues: Chest pain: ___ year old male with known s/p CABG/CAD and worsening angina but biomarkers and ECG non consistent with Unstable angina who presented to the ED after his symptoms remained unabated despite medical therapy. He has 3 vessel CAD, with a new DES to mid RCA, with a focal stenosis in the retrograde limb of the SVG to OM1 bypass graft. He also has a LIMA to LAD that is atretic. After his RCA stent was placed he had some chest pain, consistent in character and quality of his previous chest pain which was positional. Due to a recent stent, there was concern about acute thrombosis, but his ECG did not demonstrate profound ST elevation, etiologies for his chest pain after his cath included: Distal embolization from RCA stent, Repolarization abnormalities from reperfusion, versus pericarditis. His cardiac enzymes were cycled again and he was placed on heparin. The following morning he was chest pain free, and an US of the groin did not demonstrate any pseudoaneurysm or abnormality. He also had a headache that was treated with tylenol. . Chronic Medical Problems: For his dyslipidemia, and GERD he was continued on his home medications. ",2876,272
10010429-DS-19,"<SEX> M <SERVICE> CARDIOTHORACIC <ALLERGIES> Patient recorded as having No Known Allergies to Drugs <ATTENDING> ___. <CHIEF COMPLAINT> Syncope <MAJOR SURGICAL OR INVASIVE PROCEDURE> ___ Aortic Valve Replacement (25mm ___ Porcine valve) <HISTORY OF PRESENT ILLNESS> ___ y/o female with know aortic stenosis who experienced a syncopal episode in ___. Otherwise she is relatively asymptomatic with mild dyspnea on exertion. Last echo revealed severe AS with ___ 0.5 cm2 and now presents for surgery. <PAST MEDICAL HISTORY> Aortic Stenosis, Hypertension, Hypercholesterolemia, Diabetes Mellitus, Dementia, Lung nodule, s/p Cholecystectomy <SOCIAL HISTORY> ___ <FAMILY HISTORY> Denies premature CAD. <PHYSICAL EXAM> Gen: WDWN male in NAD, poor historian Skin: Chronic venous stasis BLE HEENT: EOMI, PERRL, NCAT Neck: Supple, FROM, -JVD, Trans. murmur vs. carotid bruit Chest: CTAB -w/r/r Heart: RRR ___ SEM Abd: Soft, NT/ND +BS Ext: Warm, trace edema, -varicosities Neuro: Grossly intact w/ some difficulty following instructions <PERTINENT RESULTS> ___ Echo: Pre bypass: The left atrium is normal in size. A definite thrombus is seen in the left atrial appendage. No atrial septal defect is seen by 2D or color Doppler. Left ventricular wall thicknesses and cavity size are normal. Regional left ventricular wall motion is normal. Overall left ventricular systolic function is normal (LVEF>55%). Right ventricular chamber size and free wall motion are normal. There are complex (>4mm) atheroma in the ascending aorta. The aortic arch is mildly dilated. There are complex (>4mm) atheroma in the aortic arch. The descending thoracic aorta is mildly dilated. There are complex (>4mm), mobile atheroma in the descending thoracic aorta. There are three aortic valve leaflets. The aortic valve leaflets are severely thickened/deformed. There is moderate to severe aortic valve stenosis (area 0.8-1.0cm2). Mild (1+) aortic regurgitation is seen. The mitral valve leaflets are mildly thickened. Mild to moderate (___) mitral regurgitation is seen. There is no pericardial effusion. Post bypass: Patient is AV paced, on no drips. Perserved biventricular function. LVEF >55%. Septal motion is dyskinetic, c/w v pacing. A bioprosthetic arotic valve is seen and well seated. No AI. Peak gradients 37, mean 20 mm hg with Cardiac output 7 lpm, peak 18, mean 6 mm Hg with cardiac output 5 lpm. No paravalvular leaks on bioprosthesis. Left atrial appendage is poorly seen now, but is still suspicious for the presence of a clot. Mitral regurgitation is now 1+. Aortic contours intact. Remaining exam is unchanged. All findings discussed with the surgeons at the time of each exam. ___ 11: 23AM BLOOD WBC-3.0*# RBC-3.12*# Hgb-9.4*# Hct-26.8*# MCV-86 MCH-30.2 MCHC-35.1* RDW-14.7 Plt ___ ___ 05: 10AM BLOOD WBC-10.2 RBC-2.97* Hgb-9.0* Hct-25.7* MCV-86 MCH-30.1 MCHC-35.0 RDW-14.7 Plt ___ ___ 11: 23AM BLOOD ___ PTT-33.9 ___ ___ 01: 12PM BLOOD ___ PTT-39.6* ___ ___ 12: 43PM BLOOD UreaN-22* Creat-0.9 Cl-110* HCO3-28 ___ 05: 10AM BLOOD Glucose-74 UreaN-23* Creat-0.7 Na-137 K-3.2* Cl-98 HCO3-32 AnGap-10 ___ 08: 23AM BLOOD Glucose-98 Lactate-0.9 Na-140 K-4.1 Cl-101 RADIOLOGY Final Report CHEST (PA & LAT) ___ 12: 02 ___ CHEST (PA & LAT) Reason: eval for pleural effusions UNDERLYING MEDICAL CONDITION: ___ year old man s/p AVR REASON FOR THIS EXAMINATION: eval for pleural effusions HISTORY: Pleural effusion. Three radiographs of the chest demonstrate a right-sided pleural effusion. The left costophrenic angle is excluded. The patient is status post median sternotomy. Three markers from a non-radiopaque cardiac prosthetic valve remain unchanged in position compared with ___. No pneumothorax is evident. No consolidation is seen. Increased opacity projecting over the right apex and right lung base are less conspicuous than seen on the previous study. IMPRESSION: Persistent right-sided pleural effusion. Persistent right basilar atelectasis. Patchy airspace opacity projecting over the right upper lung is less typical for atelectasis. Diagnostic considerations would include pneumonia as well. ___. ___: SAT ___ 2: 04 ___ ___ 07: 35AM BLOOD WBC-7.5 RBC-2.86* Hgb-8.6* Hct-25.3* MCV-88 MCH-30.0 MCHC-33.9 RDW-14.8 Plt ___ ___ 06: 10AM BLOOD ___ PTT-30.3 ___ ___ 07: 35AM BLOOD Glucose-79 UreaN-20 Creat-0.9 Na-139 K-3.7 Cl-102 HCO3-30 AnGap-11 <MEDICATIONS ON ADMISSION> Lexapro 20mg qd, Lipitor 20mg qd, Quinapril 20mg qd, HCTZ 12.5mg qd, Zetia 10mg qd, Aspirin 325mg qd, Aricept 10mg qd, Trazadone, NPH Insulin <DISCHARGE MEDICATIONS> 1. Aspirin 81 mg Tablet, Delayed Release (E.C.) Sig: One (1) Tablet, Delayed Release (E.C.) PO DAILY (Daily). Disp: *30 Tablet, Delayed Release (E.C.)(s)* Refills: *0* 2. Atorvastatin 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). Disp: *30 Tablet(s)* Refills: *0* 3. Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day). Disp: *60 Capsule(s)* Refills: *0* 4. Ezetimibe 10 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). Disp: *30 Tablet(s)* Refills: *0* 5. Ranitidine HCl 150 mg Tablet Sig: One (1) Tablet PO once a day. Disp: *30 Tablet(s)* Refills: *0* 6. Lexapro 20 mg Tablet Sig: One (1) Tablet PO once a day. Disp: *30 Tablet(s)* Refills: *0* 7. Metoprolol Tartrate 25 mg Tablet Sig: One (1) Tablet PO BID (2 times a day). Disp: *60 Tablet(s)* Refills: *0* 8. Aricept 10 mg Tablet Sig: One (1) Tablet PO once a day. Disp: *30 Tablet(s)* Refills: *0* 9. Furosemide 20 mg Tablet Sig: One (1) Tablet PO once a day for 7 days. Disp: *7 Tablet(s)* Refills: *0* 10. Insulin NPH & Regular Human 100 unit/mL (70-30) Suspension Sig: ___ (38) units Subcutaneous once a day: please take in am before breakfast. Disp: *qs qs* Refills: *2* 11. Insulin NPH & Regular Human 100 unit/mL (70-30) Suspension Sig: ___ (28) units Subcutaneous once a day: please take before dinner. Disp: *qs qs* Refills: *2* 12. Quinapril 20 mg Tablet Sig: One (1) Tablet PO once a day. Disp: *30 Tablet(s)* Refills: *0* <DISCHARGE DISPOSITION> Home With Service Facility: ___ <DISCHARGE DIAGNOSIS> Aortic Stenosis s/p Aortic Valve Replacement PMH: Hypertension, Hypercholesterolemia, Diabetes Mellitus, Dementia, Lung nodule, s/p Cholecystectomy Post-operative Atrial Fibrillation <DISCHARGE CONDITION> Good <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Please shower daily including washing incisions, no baths or swimming Monitor wounds for infection - redness, drainage, or increased pain Report any fever greater than 101 Report any weight gain of greater than 2 pounds in 24 hours or 5 pounds in a week No creams, lotions, powders, or ointments to incisions No driving for approximately one month No lifting more than 10 pounds for 10 weeks Please call with any questions or concerns ___ ","Mr. ___ was a same day admit after undergoing pre-operative work-up as an outpatient. On day of admission he was brought directly to the operating room where he underwent an aortic valve replacement. Please see operative report for surgical details. Following surgery he was transferred to the CVICU for invasive monitoring in stable condition. Within 24 hours he was weaned from sedation, awoke neurologically intact and extubated. On post-op day one he was started on usual post-op medications but beta blockers were held due to junctional rhythm. Later on this day he appeared to be doing well and was transferred to the telemetry floor for further care. On post-op day two his chest tubes and epicardial pacing wires were removed. On post-op day three his rhythm between atrial fibrillation and AV-block and was therefor started on Coumadin. He continued to make good progress and worked with physical therapy for strength and mobility. On ___ he was discharged home with ___ services and the appropriate follow-up appointments. Dr. ___ will follow INR and adjust Coumadin. ",2118,220
10010440-DS-5,"<SEX> F <SERVICE> NEUROLOGY <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> CODE CORD: Leg weakness, known T12 lesion <MAJOR SURGICAL OR INVASIVE PROCEDURE> 1. Anterior arthrodesis T11-L1. 2. Application interbody cage T11-L1. 3. Biopsy of T12 vertebral body. 4. Posterior arthrodesis T10-L2. 5. Posterolateral posterior instrumentation T10-L2 segmental. 6. Open treatment fracture dislocation from metastatic disease and destruction of the T12 vertebral body. 7. Laminectomy of partial L1, all of T12, and the inferior aspect of T11. 8. Application of allograft. ANESTHESIA: General endotracheal. <HISTORY OF PRESENT ILLNESS> History obtain largely from Daughter in law and PCP, ___ (___) <HISTORY OF PRESENT ILLNESS> This is a ___ yo ___ female with a history of a ___ secondary to an aneurysm with residual aphasia, HTN, and hyperlipidemia and recent work-up initiated for multiple myeloma who presents with leg weakness and multiple falls. Per the patient's daughter in law on ___ the patient had a bad fall at home where she lives with her son and daughter in law. She was down for 4 hours. She reported to her PCP that her ""legs gave out"". She was seen at ___ where she had plain films and a head CT that were normal. She received 6 weeks of home ___ and was doing fairly well. When that concluded though, she began a slow decline. She has had decreased appetite, a rapid 30 lbs weight loss and a few more falls. She complains of back pain and it is unclear whether pain or weakness has been the cause of her falls. She also became incontinent of urine, but not stool. Ultimately, 2 weeks ago when she could not even walk two steps she went back to the ED where Xrays were negative. She went to rehab. A CT was not done. At the nursing home rehab she continued to have pain and weakness with not much improvement. Last night the patient was much more quiet than usual. This AM she woke upset and in a lot of pain. She was screaming and refusing to take her medications. The daughter encouraged the rehab nursing home to send her to the ED. At the ___ ED she received a spine CT that revealed, ""Findings consistent with multiple myeloma involving multiple levels and an associated mass arising from T12 extending into the canal and compressing the thecal sac significantly."" Of note the patient can not have an MRI due to the aneurysm clips. A left toes fracture was also found on plain films. The patient was sent to ___ for further evaluation and treatment. In the ED now the patient is in some mild pain, but reports feeling ok. Of note a year ago the patient began a w/u for multiple myeloma. She had a biopsy done of the T12 lytic lesion that was inconclusive. She then had a bone marrow biopsy that revealed pre Kappa light chains, but no conclusive evidence of multiple myeloma. Review of systems: (+) Per HPI (-) Denies recent weight gain. Denies nausea, vomiting, diarrhea, constipation or abdominal pain. No recent change in bowel habits. No dysuria. Denies arthralgias. Ten point review of systems is otherwise negative. On neuro ROS, No HA, visual aura. No loss of vision, lightheadedness, vertigo, diplopia, dizziness, dysarthria, dysphagia, tinnitus or hearing difficulty. Denies difficulties producing or comprehending speech. Weakness of ___. No numbness, parasthesiae. Bladder incontinence, but no bowel incontinence. Gait problems. <PAST MEDICAL HISTORY> SAH, s/p b/l Aneurysm clipping. With frontal craniotomy. Residual aphasia. HTN Hyperlipidemia Right knee replacement VP shunt <SOCIAL HISTORY> ___ <FAMILY HISTORY> Multiple family members, particularly cousins with brain aneurysms requiring clipping, some of who had strokes. No history of cancer in the family. <PHYSICAL EXAM> Vitals: T 98.2, HR 90, BP 106/72, RR 18, O2 99 % RA General: Awake, cooperative, in NAD. Obese. HEENT: NC/AT, no sclera icterus noted, MMM, no lesions noted in oropharynx Neck: Supple. No nuchal rigidity Pulmonary: Lungs CTA bilaterally without R/R/W Cardiac: RRR, nl. S1S2, no M/R/G noted. No carotid bruits Abdomen: soft, NT/ND Extremities: No C/C/E bilaterally, 2+ radial, DP pulses bilaterally. Skin: no rashes or lesions noted. Neurologic: -Mental Status: Alert, oriented to place, person, and year with choices (difficult exam as the patient's motor aphasia prevents answers to multiple questions). Naming impaired, perseverative. Follows commands, but again requires some mimicking to reliably follow. Per PCP and daughter in law this is her cognitive baseline. -Cranial Nerves: I: Olfaction not tested. II: PERRL 2.5 b/l, sluggishly reactive. Visual fields are difficult to assess reliably. Appears to be some impairment in peripheral fields. III, IV, VI: EOMI without nystagmus. No diplopia. V: Facial sensation intact to light touch. VII: No facial droop, facial musculature symmetric. VIII: Hearing intact to finger rub. IX, X: Palate elevates symmetrically. XI: ___ strength in trapezii and SCM bilaterally. XII: Tongue protrudes in midline. -Motor: Normal bulk, tone throughout. No pronator drift. No tremor or other adventitious movements. No asterixis noted. Nml finger tapping. Delt Bic Tri FFl FE IO IP Quad Ham TA ___ L 5 5 ___ 5 4- 4 ___- 3 R 5 5 ___ 5 2 4 4- 2 5- 5- -Sensory: Intact and symmetric sensation to light touch, temp and pinprick, although patient has some trouble understanding the questions. Normal rectal tone. - DTRs: Bi Tri ___ Pat Ach L 2 2 2 1 2 R 2 2 2 0* 2 Plantar response was extensor b/l. * Knee replacement -Coordination: No dysmetria on FNF. -Gait: Not assessed. Unable to sit or stand unassisted. <PERTINENT RESULTS> ___ PATHOLOGY report from surgical resection (PRELIM): Bone, T12 vertebra, lytic lesion; Bone and fibrous tissue with dense plasma cell infiltrate, consistent with plasma cell dyscrasia, see note. ___ ANKLE (AP, LAT & OBLIQU) FINAL There are moderate degenerative changes of the tibiotalar joint with narrowing and subchondral sclerosis. There is evidence of prior avulsive injury arising off the medial malleolus and likely the lateral malleolus as well. There is chronic deformity of the lateral malleolus. No acute fracture is identified. There is calcaneal enthesopathy. Soft tissue swelling is noted. IMPRESSION: Moderate tibiotalar joint degenerative change. No acute fracture appreciated. ___ CT HEAD IMPRESSION: 1. No acute intracranial hemorrhage status post right craniotomy and aneurysm clipping. 2. Hyperdensity of the left posterior cerebral hemisphere not corresponding to vascular territory could conceivably represent retained contrast related to the patient's recent myelogram. Attention on followup is recommended. 3. Stable bifrontal encephalomalacia. 4. Unchanged position of a right parietal ventriculostomy catheter. ___ TECHNIQUE: Thoracolumbar spine, five views. FINDINGS: The patient is status post posterior fusion from T10 through L2 with a T12 corpectomy including placement of a vertical fusion spacer. Moderate-to-severe degenerative changes are incompletely characterized, but suspected, along the facet joints along the mid through lower lumbar spine. Small anterior osteophytes are present along the lower thoracic spine. There is no evidence for hardware loosening. A PICC line terminates in the upper right atrium. A ventriculoperitoneal shunt is also noted. IMPRESSION: Unremarkable post-operative appearance. ___ MRI SPINE IMPRESSION: Status post T12 corpectomy and T10-L2 fusion. Posterior and right-sided intraspinal fluid collection communicates through the laminectomy defect and causes anterior and left lateral displacement of the thecal sac. This leads to severe encroachment on the distal spinal cord. There are no findings to suggest tumor in this location. The signal intensity characteristics are typical of simple fluid, rather than hemorrhage. ___ 05: 14AM BLOOD WBC-22.1* RBC-3.39* Hgb-10.2* Hct-30.8* MCV-91 MCH-30.2 MCHC-33.3 RDW-17.6* Plt ___ ___ 12: 06PM BLOOD Neuts-83.9* Lymphs-8.5* Monos-7.3 Eos-0.2 Baso-0.1 ___ 05: 14AM BLOOD Plt ___ ___ 06: 45AM BLOOD ___ PTT-30.2 ___ ___ 05: 49AM BLOOD Glucose-113* UreaN-27* Creat-0.9 Na-138 K-6.6* (HEMOLYZED FROM PICC - falsely elevated) Cl-106 HCO3-28 AnGap-11 ___ 04: 10AM BLOOD ALT-16 AST-29 LD(LDH)-425* AlkPhos-60 TotBili-0.3 DirBili-0.1 IndBili-0.2 ___ 04: 10AM BLOOD Hapto-422* ___ 9: 01 pm URINE Source: Catheter. **FINAL REPORT ___ URINE CULTURE (Final ___: ESCHERICHIA COLI. >100,000 ORGANISMS/ML.. PRESUMPTIVE IDENTIFICATION. Cefazolin interpretative criteria are based on a dosage regimen of 2g every 8h. SENSITIVITIES: MIC expressed in MCG/ML _________________________________________________________ ESCHERICHIA COLI | AMPICILLIN------------ <=2 S AMPICILLIN/SULBACTAM-- <=2 S CEFAZOLIN------------- <=4 S CEFEPIME-------------- <=1 S CEFTAZIDIME----------- <=1 S CEFTRIAXONE----------- <=1 S CIPROFLOXACIN---------<=0.25 S GENTAMICIN------------ <=1 S MEROPENEM-------------<=0.25 S NITROFURANTOIN-------- <=16 S PIPERACILLIN/TAZO----- <=4 S TOBRAMYCIN------------ <=1 S TRIMETHOPRIM/SULFA---- <=1 S <MEDICATIONS ON ADMISSION> Lasix 20 qd Pravastatin 80 qD Allopurinol ___ qD Colchicine PRN Aggrenox 25 BID Cozaar 50 qD Atenolol 25 BID <DISCHARGE MEDICATIONS> 1. Atenolol 25 mg PO DAILY 2. Diltiazem Extended-Release 240 mg PO DAILY 3. Furosemide 20 mg PO DAILY 4. Losartan Potassium 50 mg PO DAILY 5. Pravastatin 80 mg PO DAILY 6. Acetaminophen 650 mg PO Q6H: PRN pain 7. Bisacodyl 10 mg PO/PR DAILY: PRN Constipation 8. Docusate Sodium 100 mg PO BID 9. Fentanyl Patch 50 mcg/h TD Q72H RX *fentanyl 50 mcg/hour place one patch on skin change every 72 hours Disp #*10 Transdermal Patch Refills: *0 10. Heparin 5000 UNIT SC TID 11. Heparin Flush (10 units/ml) 2 mL IV PRN line flush 12. Insulin SC Sliding Scale Fingerstick QACHS Insulin SC Sliding Scale using REG Insulin 13. OxycoDONE (Immediate Release) 10 mg PO Q4H RX *oxycodone 10 mg 1 tablet(s) by mouth every 4 hours Disp #*120 Tablet Refills: *0 14. Polyethylene Glycol 17 g PO DAILY 15. Ranitidine 150 mg PO BID 16. Senna 1 TAB PO BID 17. Dipyridamole-Aspirin 1 CAP PO BID 18. Sulfameth/Trimethoprim DS 1 TAB PO BID Duration: 2 Days 19. Allopurinol ___ mg PO DAILY 20. Dexamethasone 4 mg IV Q24H (may switch over to PO once radiation therapy starts) <DISCHARGE DISPOSITION> Extended Care Facility: ___ <DISCHARGE DIAGNOSIS> Primary diagnosis: T12 destruction spinal lesion - resected Secondary diagnosis: Post-surgical leg weakness, likely related to pain and deconditioning <DISCHARGE CONDITION> Mental Status: Confused - always. Level of Consciousness: Alert and interactive. Activity Status: Out of Bed with assistance to chair or wheelchair - advance per ___ recs. TLSO brace to be worn with any and all attempts at ambulation. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> You were admitted for surgery to remove a lesion in your thoracic spine, and then was transferred to the Neurology service for leg weakness after the surgery. This did get better with pain control and supportive care, and we did not find any othe reason for your new leg weakness. You likely have a condition called multiple myeloma. This will require radiation therapy for treatment, which have set up for you (see below). ","___ w/ h/o of stroke ___ years ago with baseline of expressive aphasia and RLE weakness, although family claims that she can fully comprehend. Pt was found to have T12 mass concerning for malignancy in ___, however bx of mass and BM was inconclusive. She was asymptomatic at that time and family decided not to persue further work-up. Pt now p/w with a 2.5 month h/o of progressive weakness and recurrent falls unresponsive to ___, and weight loss from 250-->225. Pt had CT at OSH which demonstrated expanding lesion at T12 and was subsequently given 10mg IV dexamethasone and transfered to ___ for further management. Patient arrived on the floor afebrile and hemodynamically stable. Immediate neurology and neurosurgery consults were obtained. Her hospitalization course is as follows: # T12 lesion: Patient has profound lower extremity weakness bilaterally, some of which is baseline from her previous CVA. Her right sided neuro exam is notable for hyperreflexia and clonus which is likely left over from her distant stroke. She was continued on dexamethasone and ISS while on the high dose steroids. The patient was also given a TLSO brace for ambulation (although initially in too much pain to ambulate), and the head of her bed was kept at <45 degrees. She received a pre-op myelogram, consistent with an expanding T12 lesion from prior imaging. She was subsequently taken for decompression surgery by Ortho-Spine Team (s/p T10-L2 fusion, T12 Corpectomy) and transferred to the Ortho-Spine service for post-op management for two days. When she returned to the medicine service on POD2, the patient was unable to move her lower extremities bilaterally. Ortho-spine service indicated that the patient required additional pain control. After consult with Neuro-Onc, the patient was transitioned from dexamethasone 10mg Q8 hours to dexamethasone 4mg BID on POD4. She was transferred to the Neurology service for better management of her leg weakness. It was felt this was likely due to post-op pain and inability for her to express her pain level due to her aphasia. Her medications were titrated and she did better on a higher dose fentanyl patch with immediate release morphine and tylenol for breaththrough pain. Subsequently her leg movements improved on better pain control. She will require XRT for her other bony lesions, and will need to follow up in ___ clinic after XRT (to be arranged by XRT). # FED/GI: Patient was found to initially have very mild hypercalcemia on admission. She was NPO for procedure and started on maintenence fluids overnight however did not require agressive IVF. At the time of surgery, her hypercalcemia resolved. She was advanced to a dysphagia diet post-operatively and did well on that for the rest of her course. Electrolytes were stable with the exception of potassium which kept returning falsely elevated from hemolosis when drawn off her PICC. # Foot Fracture: The patient was found to have R foot fracture involving the base of the fifth proximal phalanx with extension to the fifth MTP joint. This was consistent with repeat imaging at ___. Her L foot and ankles were also imaged because the pt was complaining of additional pain, however, films did not reveal any additional acute fractures. The feet were vascularly intact. Orthopedics recommended a hard sole boot for when the patient became ambulatory, otherwise, no intervention necessary. # Pain: Patient was found in extreme pain when transfered back to medicine service on POD2. Unclear of origin as patient has difficulty communicating due to her aphasia. Patient's pain was controlled with standing acetaminophen, oxycodone, oxycontin, fentanyl patch and dilaudid IV PRN. The pain team was also consulted to help manage her pain. She was able to come off the oxycontin on a higher dose of fentanyl patch, and had PO ___ oxycodone and tylenol for break through pain. # Encephalopathy: On POD2, there was noted an increase in aphasia, and confusion, which was difficult to assess given baseline communication issues. HCHCT for acute bleed was negative. The Pt was afebrile and infectious work-up including UA was neg. Urine Ctx and blood ctx were negaitve for occult infection. Her mental status improved with better pain control. She got a little worse on ___ and was subsequently found to have a new UTI (E Coli), which improved after treating with first ceftriaxone and then Bactrim when sensitivies returned pan-sensitive. # Hct Drop: The patient Hct dropped from 32 on POD1-->22 on POD2, Hemavac drained only 185cc, pt responded appropriately to 2U PRBC. Unclear where bleed is. Patients Hct subsequent remained stable after transfusion. A T&L MRI revealed: ""Posterior and right-sided intraspinal fluid collection communicates through the laminectomy defect and causes anterior and left lateral displacement of the thecal sac. This leads to severe encroachment on the distal spinal cord. There are no findings to suggest tumor in this location. The signal intensity characteristics are typical of simple fluid, rather than hemorrhage."" Her Hct remained stable and the ultimate source of her Hct drop was never identified but felt to be possibly due to post-op hemolysis. The fluid collection was discussed with ortho spine service who felt it could be conservatively watched for now (likely just post-surgical changes). # History of Stroke: The patient was continued on home dose of aggrenox until the time of her surgery. When the patient was transfered back to Medicine on POD2, the aggrenox was held. It was restarted on ___ at the consent of orthopedics team. # HTN: The patient was continued on home dose of losartan, diltiazem and atenolol # HLD: The patient was continued on her home dose of pravastatin # ID: UTI discovered ___eveloped foul smelling urine and WBC bumped to 22 (but this was felt to partially be due to her dexamethasone as well). Treated with first Ceftriaxone, then Bactrim, and culture grew out pan-sensitive E Coli. # Access: Pt had a PICC line placed and confirmed in good position early on in her hopspitalization. Due to initial concerns with dysphagia and patient frequently spitting out her meds, we decided to keep her steroids IV to ensure she received this crucial medication post-operatively. Once she has started radiation therapy, however, the PICC may come out and the IV steroids may be converted to the PO form. ",3141,1434
10010440-DS-6,"<SEX> F <SERVICE> PLASTIC <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> Spine wound <MAJOR SURGICAL OR INVASIVE PROCEDURE> 1. Debridement of skin down to bone of thoracolumbar wound (25 x 10cm). 2. Paraspinous flap x2 coverage of the previous spinal fusion hardware. 3. Complex closure of back incision (25 cm). 4. Removal of spinous processes of T9, T10, and L2, L3. <HISTORY OF PRESENT ILLNESS> ___ s/p T11-L2 fusion and laminectomy and T12 corpectomy for T12 lumbar stenosis ___ multiple myeloma mets, performed by Dr. ___ on ___. The patient will undergo radiation treatment in the future, but no prior XRT. Patient was discharged to rehab following discharge on ___. She returned on ___ to the ED with lumbar wound dehiscence in addition to increasing confusion beyond baseline. She was discharged with wet to dry dressing changes to area and comes in today for closure of her lumber wound. <PAST MEDICAL HISTORY> SAH, s/p b/l Aneurysm clipping. With frontal craniotomy. Residual aphasia. HTN Hyperlipidemia Right knee replacement VP shunt Multiple myeloma T12 extracavitary corpectomy for removal of tumor ___ <SOCIAL HISTORY> ___ <FAMILY HISTORY> Multiple family members, particularly cousins with brain aneurysms requiring clipping, some of who had strokes. No history of cancer in the family. <PHYSICAL EXAM> AM vital signs: T97.9, P71, BP116/60, RR18, 100RA Gen: Sitting in bed, eating, NAD. Alert, expressive aphasia per baseline Lungs: Breathing nonlabored CV: RRR ABD: Soft, NT/ND Extrem: WWP x4 Back: Dressing changed on midline of back this AM. Incision intact with mild weeping, no gross bleeding or exudate. JP drains in place (1 midline, 1 Right Lateral, both with serrosang outtput). <MEDICATIONS ON ADMISSION> 1. Allopurinol ___ mg PO DAILY 2. Atenolol 25 mg PO DAILY 3. Atorvastatin 20 mg PO DAILY 4. Calcium Carbonate 1250 mg PO DAILY 5. Dexamethasone 4 mg PO DAILY 6. Cardizem CD *NF* 240 mg Oral Daily 7. Dipyridamole-Aspirin 1 CAP PO BID 8. Famotidine 20 mg PO DAILY 9. Furosemide 20 mg PO DAILY 10. Heparin 5000 UNIT SC TID 11. Losartan Potassium 50 mg PO DAILY 12. Polyethylene Glycol 17 g PO DAILY 13. Senna 1 TAB PO BID 14. TraZODone 25 mg PO HS 15. Acetaminophen 650 mg PO Q6H: PRN fever/pain 16. OxycoDONE (Immediate Release) ___ mg PO Q4H: PRN Pain <DISCHARGE MEDICATIONS> No change to discharge medications 1. Acetaminophen 650 mg PO Q6H: PRN fever/pain 2. Allopurinol ___ mg PO DAILY 3. Atenolol 25 mg PO DAILY 4. Atorvastatin 20 mg PO DAILY 5. Calcium Carbonate 1250 mg PO DAILY 6. Cardizem CD *NF* 240 mg ORAL DAILY 7. Dexamethasone 4 mg PO DAILY 8. Dipyridamole-Aspirin 1 CAP PO BID 9. Famotidine 20 mg PO DAILY 10. Furosemide 20 mg PO DAILY 11. Heparin 5000 UNIT SC TID 12. Losartan Potassium 50 mg PO DAILY 13. OxycoDONE (Immediate Release) ___ mg PO Q4H: PRN Pain 14. Polyethylene Glycol 17 g PO DAILY 15. Senna 1 TAB PO BID 16. TraZODone 25 mg PO HS <DISCHARGE DISPOSITION> Extended Care Facility: ___ <DISCHARGE DIAGNOSIS> Spine wound, takent to the OR for washout and closure <DISCHARGE CONDITION> Overall Condition - Good Mental status - Per usual, alert with expressive aphasia Ambulation - Non ambulatory per usual <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> POST OPERATIVE GENERAL DISCHARGE INSTRUCTIONS: Personal Care: 1. Clean around the drain site(s), where the tubing exits the skin, with soap and water. 2. Strip drain tubing, empty bulb(s), and record output(s) ___ times per day. 3. A written record of the daily output from each drain should be brought to every follow-up appointment. Your drains will be removed as soon as possible when the daily output tapers off to an acceptable amount. Activity: 1. You may resume your regular diet. 2. Activity as tolerated. OK to roll patient, but be careful not to tug on her incision (ie, roll from shoulder and hip, DO NOT pull from her back or side). Medications: 1. Resume your regular medications unless instructed otherwise and take any new meds as ordered . 2. You may take your prescribed pain medication for moderate to severe pain. You may switch to Tylenol or Extra Strength Tylenol for mild pain as directed on the packaging. Please note that Percocet and Vicodin have Tylenol as an active ingredient so do not take these meds with additional Tylenol. 3. Take prescription pain medications for pain not relieved by tylenol. 4. Take Colace, 100 mg by mouth 2 times per day, while taking the prescription pain medication. You may use a different stool softener if you wish. Call the office IMMEDIATELY if you have any of the following: 1. Signs of infection: fever with chills, increased redness, swelling, warmth or tenderness at the surgical site, or unusual drainage from the incision(s). 2. A large amount of bleeding from the incision(s) or drain(s). 3. Fever greater than 101.5 oF 4. Severe pain NOT relieved by your medication. . Return to the ER if: * If you are vomiting and cannot keep in fluids or your medications. * If you have shaking chills, fever greater than 101.5 (F) degrees or 38 (C) degrees, increased redness,swelling or discharge from incision, chest pain, shortness of breath, or anything else that is troubling you. * Any serious change in your symptoms, or any new symptoms that concern you. . DRAIN DISCHARGE INSTRUCTIONS You are being discharged with drains in place. Drain care is a clean procedure. Wash your hands thoroughly with soap and warm water before performing drain care. Perform drainage care twice a day. Try to empty the drain at the same time each day. Pull the stopper out of the drainage bottle and empty the drainage fluid into the measuring cup. Record the amount of drainage fluid on the record sheet. Reestablish drain suction. "," - ___ was admitted on ___ for spine wound washout and closure. The patient tolerated the procedure well without complications. Neuro: Post-operatively, the patient received PO Oxycodone with good effect and adequate pain control. CV: The patient was stable from a cardiovascular standpoint; vital signs were routinely monitored. Pulmonary: The patient was stable from a pulmonary standpoint; vital signs were routinely monitored. GI/GU: Post-operatively, the patient was given IV fluids until tolerating oral intake. Her diet was quickly advanced when appropriate, which was tolerated well. She continued her normal bowel regimen of Polyethylene Glycol 17g per day. Foley remained in place per usual. ID: As the wound did not appear infected, she recieved no post op antibiotics. The patient's temperature was closely watched for signs of infection. Prophylaxis: The patient received subcutaneous heparin during this stay as per her usual. At the time of discharge on POD#2, the patient was doing well, afebrile with stable vital signs, tolerating a regular diet, had her usual menal status, and pain was well controlled. ",1618,233
10010440-DS-7,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> No Known Allergies / Adverse Drug Reactions <ATTENDING> ___. <CHIEF COMPLAINT> altered mental status <MAJOR SURGICAL OR INVASIVE PROCEDURE> none <HISTORY OF PRESENT ILLNESS> Ms ___ is a ___ yo female patient with history of cognitive impairment after ruptured cerebral aneurysm, recent diagnosis of MM undergoing radiation treatment to lytic lesion to T12 vertebra who presents from her facility with altered mental status after she refused radiation treatment today. Per report, pt became increasingly agitated at her nursing home facility this afternoon, refused to go to radiation treatment so she was sectioned and sent to the ED for evaluation. On arrival the the ED, vitals were 97.7 65 133/67 18 100%. She was unable to say why she was in the emergency department. She denied any symptoms, including no chest pain, abdominal pain. No shortness of breath, cough, bladder or bowel symptoms. Her labs were notable for WBC 11.1, hct 32.5, cr 0.4, normal lytes. She had a UA with 10 WBC, no bacteria, small leuks, neg nit so she was given 1 dose of levaquin. Patient's daughter-in-law reports a more subacute decline in mental status, beginning most notably after her surgery in ___. She states that pt has been more agitated and confused since that surgery, though her symptoms have definitely worsened over the past few weeks to the point that her facility is having difficulty controlling her. Daughter-in-law has been told that pt's agitation is intermittently attributed to UTI, pneumonia, etc but she is frustrated that she does not feel that pt has improved at all despite treatment of multiple infections. In the past week, the patient has become physical with nursing staff. The daughter-in-law reports that pt has been hallucinating, seeing people and hearing voices over the past several weeks to months. Documentation from facility notes increasing paranoia. Psych was consulted at the facility and has been adjusting her seroquel dosing. It also appears that pt was treated for UTI recently with meropenem, last dose ___ with repeat culture from ___ at her facility negative. With regards to her MM, she has a long history of plasma cell disorder dating back to ___. Her evaluation at the time included bone marrow biopsy which showed ___ plasma cell, suboptimal core. FISH staining was negative for cytogenetic abnormalities, and since she had no other evidence of MM (no anemia, renal failure or hypercalcemia), she was managed with serial measurements of monoclonal proteins. However, in ___, pt suffered a fall and has been steadily declining since then with significant weight loss (at least 30 pounds), back pain, and urinary incontinence. She eventually had imaging that showed cord compression at the T12 level so she was transferred to ___ in ___, evaluated by neurology, neuro-onc and spine surgery and underwent T12 extracavitary corpectomy. Pathology showed plasma cells. MRI of C, T, L spine at the time also commented on marked heterogenous signal intensity which may be consistent with diffuse involvement of myeloma. Her post-op course was complicated by wound dehiscence necessitating surgical debridement and closure at the beginning of ___. <PAST MEDICAL HISTORY> SAH, s/p b/l Aneurysm clipping. With frontal craniotomy. Residual aphasia. HTN Hyperlipidemia Right knee replacement VP shunt Multiple myeloma T12 extracavitary corpectomy for removal of tumor ___ <SOCIAL HISTORY> ___ <FAMILY HISTORY> Multiple family members, particularly cousins with brain aneurysms requiring clipping, some of who had strokes. No history of cancer in the family. <PHYSICAL EXAM> ADMISSION PHYSICAL: Vitals- 97.6 144/79 69 20 100% RA General- Alert, no acute distress, interactive HEENT- Sclera anicteric, MMM, oropharynx clear Neck- supple, JVP not elevated, no LAD Lungs- Clear to auscultation bilaterally, no wheezes, rales, ronchi CV- Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Abdomen- soft, non-tender, non-distended, bowel sounds present, no rebound tenderness or guarding, no organomegaly, palpable nodules on abdomen, likely due to heparin injections GU- no foley Ext- warm, well perfused, 2+ pulses, trace edema Neuro- pt unable to reliably follow commands, CN grossly intact, able to move all extremities antigravity except RLE (horizontal movement), A&O x 1 Skin: scattered echymoses on right arm and over abdomen, back with well healing surgical wound, no surrounding redness or drainage, no fluctuance, small area of ulceration on right coccyx, as well as superficial ulceration on buttocks bilaterally DISCHARGE PHYSICAL: Vitals- T 98 BP 120s/60s HR ___ RR 18 sat 100% RA General- Alert and more calm this AM. HEENT- Sclera anicteric. MMM. Neck- supple Lungs- Clear to auscultation bilaterally, no wheezes, rales, ronchi CV- Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Abdomen- soft, non-tender, non-distended, bowel sounds present, no rebound tenderness or guarding. multiple ecchymoses. GU- foley draining yellow urine Ext- warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema Neuro- CNs2-12 grossly intact, moving all extremities symmetrically. AO to self only. Unable to follow commands or participate in full neuro exam. More calm this AM and responding appropriately to some questions. Skin - scattered echymoses on right arm and over abdomen, back with well healing surgical wound, no surrounding redness or drainage, no fluctuance, small area of ulceration on right coccyx, as well as superficial ulceration on buttocks bilaterally <PERTINENT RESULTS> ADMISSION LABS: ___ 09: 20PM BLOOD WBC-11.1* RBC-3.35* Hgb-10.5* Hct-32.5* MCV-97 MCH-31.4 MCHC-32.4 RDW-16.9* Plt ___ ___ 09: 20PM BLOOD Neuts-70.9* ___ Monos-5.4 Eos-0.1 Baso-0.4 ___ 09: 20PM BLOOD Glucose-79 UreaN-21* Creat-0.4 Na-138 K-4.7 Cl-106 HCO3-23 AnGap-14 ___ 07: 20AM BLOOD ALT-18 AST-21 LD(LDH)-434* AlkPhos-51 TotBili-0.2 ___ 09: 20PM BLOOD Calcium-8.8 Phos-2.8 Mg-1.9 ___ 09: 20PM BLOOD VitB12-948* Folate-14.1 ___ 09: 20PM BLOOD TSH-1.5 ___ 09: 31PM BLOOD Lactate-1.8 ___ 07: 20AM BLOOD PEP-AWAITING F IgG-625* IgA-372 IgM-37* IFE-PND MICRO: URINE CULTURE (Final ___: ESCHERICHIA COLI. >100,000 ORGANISMS/ML.. PRESUMPTIVE IDENTIFICATION. Cefazolin interpretative criteria are based on a dosage regimen of 2g every 8h. PROTEUS MIRABILIS. QUANTITATION NOT AVAILABLE. PRESUMPTIVE IDENTIFICATION. SENSITIVITIES: MIC expressed in MCG/ML _________________________________________________________ ESCHERICHIA COLI | PROTEUS MIRABILIS | | AMPICILLIN------------ =>32 R <=2 S AMPICILLIN/SULBACTAM-- =>32 R <=2 S CEFAZOLIN------------- <=4 S CEFEPIME-------------- <=1 S <=1 S CEFTAZIDIME----------- <=1 S <=1 S CEFTRIAXONE----------- <=1 S <=1 S CIPROFLOXACIN---------<=0.25 S <=0.25 S GENTAMICIN------------ <=1 S <=1 S MEROPENEM-------------<=0.25 S <=0.25 S NITROFURANTOIN-------- <=16 S PIPERACILLIN/TAZO----- <=4 S <=4 S TOBRAMYCIN------------ <=1 S <=1 S TRIMETHOPRIM/SULFA---- =>16 R <=1 S CT HEAD ___: IMPRESSION: No acute intracranial process. No change from prior. CXR ___: Left basilar opacity potentially atelectasis given low ___ ___ ng volumes however infection cannot be excluded. MRI BRAIN ___: A localizer sequence was obtained. Two attempts at sagittal T1-weighted images were made, both degraded by patient's motion. The exam was subsequently discontinued because the patient was trying to climb off the table. No diagnostic information was obtained. <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Atenolol 25 mg PO DAILY 2. Diltiazem Extended-Release 180 mg PO DAILY 3. Vitamin D 1000 UNIT PO BID 4. Multivitamins 1 TAB PO DAILY 5. Calcium Carbonate 500 mg PO BID 6. Heparin 5000 UNIT SC TID 7. Senna 2 TAB PO BID 8. Losartan Potassium 50 mg PO DAILY 9. OxycoDONE (Immediate Release) 5 mg PO Q4H: PRN pain 10. Polyethylene Glycol 17 g PO DAILY 11. Omeprazole 20 mg PO BID 12. Ferrous Sulfate 325 mg PO DAILY 13. Acetaminophen 650 mg PO Q6H: PRN pain or fever 14. Allopurinol ___ mg PO DAILY 15. Atorvastatin 20 mg PO DAILY 16. Dexamethasone 4 mg PO DAILY 17. Dipyridamole-Aspirin 1 CAP PO BID 18. OxycoDONE (Immediate Release) 5 mg PO BID 19. Ascorbic Acid ___ mg PO BID 20. Zinc Sulfate 220 mg PO DAILY 21. QUEtiapine Fumarate 50 mg PO QHS 22. QUEtiapine Fumarate 25 mg PO DAILY 23. Ondansetron 4 mg PO Q6H: PRN N/V 24. TraZODone 25 mg PO Q6H: PRN agitation 25. QUEtiapine Fumarate 25 mg PO TID: PRN agitation 26. HumaLOG (insulin lispro) 100 unit/mL Subcutaneous qACHS 27. TraZODone 25 mg PO HS 28. Acetaminophen 975 mg PO Q8H <DISCHARGE MEDICATIONS> 1. Acetaminophen 1000 mg PO Q8H Please transition to PRN when pain better controlled. 2. Allopurinol ___ mg PO DAILY 3. Ascorbic Acid ___ mg PO BID 4. Atenolol 25 mg PO DAILY hold for SBP < 100, HR < 55 5. Calcium Carbonate 500 mg PO BID 6. Diltiazem Extended-Release 180 mg PO DAILY hold if SBP < 100, HR < 55 7. Dipyridamole-Aspirin 1 CAP PO BID 8. Ferrous Sulfate 325 mg PO DAILY 9. Heparin 5000 UNIT SC TID 10. Losartan Potassium 50 mg PO DAILY hold for SBP < 100 11. Multivitamins 1 TAB PO DAILY 12. Omeprazole 20 mg PO BID 13. Polyethylene Glycol 17 g PO DAILY Hold for loose stool. 14. QUEtiapine Fumarate 100 mg PO QHS hold if sedated 15. QUEtiapine Fumarate 25 mg PO BID please give about 6 hours apart during the day as pt should receive 100mg qhs. hold if sedated 16. Senna 2 TAB PO BID Hold for loose stool. 17. Vitamin D 1000 UNIT PO BID 18. Zinc Sulfate 220 mg PO DAILY 19. CeftriaXONE 1 g IM DAILY please dilute in 2.1ml normal saline or 1% lidocaine if available. last dose should be given ___. Citalopram 10 mg PO DAILY Please uptitrate to 20mg daily if tolerated in 1wk (___) 21. Ondansetron 4 mg PO Q6H: PRN N/V 22. Atorvastatin 20 mg PO DAILY 23. Dexamethasone 2 mg PO DAILY Further management per Dr. ___. 24. Insulin SC Sliding Scale Fingerstick QACHS Insulin SC Sliding Scale using REG Insulin <DISCHARGE DISPOSITION> Extended Care Facility: ___ <DISCHARGE DIAGNOSIS> Primary diagnosis: encephalopathy, urinary tract infection Secondary diagnoses: multiple myeloma hyperglycemia <DISCHARGE CONDITION> Mental Status: Confused - always. Level of Consciousness: Alert and interactive. Activity Status: Bedbound. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Ms. ___, It was a pleasure taking care of you at ___. You were admitted for altered mental status and agitation. A CT head showed no evidence of a stroke or other acute changes. We attempted to obtain an MRI of the brain but you were not able to tolerate this. Neurology, oncology and psychiatry were consulted and all felt that your current mental status is either due to delirium (temporary confusion that is reversible) or a natural progression of your dementia. Delirium may be caused by steroids, recurrent urinary tract infections, or medication changes. As such, we began to taper your steroids. We also increased your dose of quetiapine and started you on anti-depressant called citalopram. For your multiple myeloma, please follow up with Dr. ___ at the appointment listed below for chemotherapy. You should be contacted at ___ House regarding completion of your radiation therapy. ","___ yo female with complicated past medical history who presents with subacute to acute altered mental status. . # encephalopathy: Per conversation with HCP, pt has not been herself since surgery in ___, though admittedly has gotten progressively worse since then and is now exhibiting aggressive behaviors at her facility, also concern for visual and auditory hallucinations, along with paranoia. Pt has had multiple medication changes recently, i.e. uptitrated seroquel, on and off antibiotics, also on narcotic pain medications. Pt also on steroids, which can cause AMS/psychosis. HCP also concerned that pt is depressed, which can certainly present as AMS in elderly. Neurology and psychiatry were consulted and both agreed encephalopathy likely ___ delirium and/or progression of underlying dementia +/- depression. CT negative for any acute processes. Given unlikely CNS infection or acute intracranial process given symptoms and time course held on LP and MRI. CXR negative. TSH, B12, folate all within normal limits. Oncology consulted and did not think CNS involvement of myeloma was likely (CNS myeloma extremely rare, especially in pt like Ms. ___ with limited disease burden). Per recommendations from neurology and psychiatry, we held her narcotics, increased seroquel to 25mg BID + 100mg qhs, and started her on citalopram 10mg daily. With permission from oncology and radiation oncology, we also initiated a decadron taper. Pt improved greatly with these measures. # UTI: Urine cx showed > 100,000 E coli sensitive to cipro and ceftriaxone, but not to bactrim. UCx also with unclear # of CFU of proteus. Attempted ceftriaxone IV, but pt would not tolerate IV. Now giving ceftriaxone IM. Chose to avoid cipro as this can worsen her encephalopathy. Pt to complete 5d course of CTX for complicated UTI to end on ___ # multiple myeloma: Pt received ___ tx of XRT today (___). Plan for 2 additional treatments, which have been scheduled. Pt will f/u with Dr. ___ in oncology re: initiation of chemotherapy. Family is aware that someone will need to accompany pt to appt with Dr. ___ to consent for chemo. # hyperglycemia: Secondary to decadron. Well controlled on sliding scale insulin with BG 115-175. # HTN: continued atenolol, diltiazem, losartan # HLD: continued statin # h/o CVA: continued aggrenox Transitional issues - UTI: on ceftriaxone IM as she could not tolerate maintaining an IV. E coli resistant to bactrim, sensitive to cipro but we avoided cipro as it could precipitate worsening encephalopathy. Pt should receive final dose ceftriaxone 1g IM in 2.1ml normal saline on ___ - encephalopathy: Increased quetiapine to 25mg BID during the day and 100mg qhs. Started pt on citalopram 10mg on ___. This can be increased to 20mg in one week. - multiple myeloma: Steroid taper. Pt received 3mg of decadron on ___ and will go to 2mg on ___. Dr ___ (___) should manage further tapering and management of decadron. Pt received ___ of 5 radiation treatments today (___). She should follow up with radiation oncology for remaining 2 treatments. She should also follow up with Dr. ___ at ___ listed below for initiation of chemotherapy. ",3235,769
10010471-DS-21,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> NSAIDS, ASA, statins <ATTENDING> ___ <CHIEF COMPLAINT> New Afib <MAJOR SURGICAL OR INVASIVE PROCEDURE> ECHO on ___ <HISTORY OF PRESENT ILLNESS> Ms. ___ is an ___ F with h/o CAD, severe aortic stenosis, COPD on 2 L NC, ESRD on HD MWF, hypothyroidism, chronic pain transferred from ___ for new onset Afib. She was apparently found to have new Afib at dialysis on ___ did not receive dialysis). She reports new SOB on morning of ___ that was so severe she had to sit on ___ couch and draw in deep breaths for 30 mins. SOB worse was with activity, and the patient stated she could not walk from bed to door without SOB. Patient denied chest pain, lightheadedness, cough, nausea, abd pain, urinary sx, diarrhea. Of note she had a recent hospitalization at OSH from ___ for SOB thought to be secondary to acute CHF. She had bibasilar infiltrates on CXR and a troponin elevated to 0.19, thought to be demand ischemia. ECHO showed >50% LVEF, critical AS with 0.5 cm2, moderate MR. ___ cardiologist recommended cath in the outpatient setting, followed by TAVR evaluation, and she had an appointment to see him on ___. She reports at that appointment she decided she did not want to pursue procedures/surgery (she didn't know what a TAVR meant when asked though) and wanted to ""live life as best I can."" On day of admission, she had a CXR at OSH that showed a questionable right sided PNA, and was treated with a dose of levofloxacin and CTX. She was initially hypotensive at the outside hospital and was given 1 L IVF, but then became volume overloaded. In the ED initial vitals were: ___ F, BP 136/68, HR 126, RR 22, 99% 3 L NC. EKG: Atrial fibrillation with left bundle branch block (LBBB is old) Labs/studies notable for: CBC: WBC 8.7, Hgb 9.1 (baseline unknown), plts 135. chem 10: Na 139, K 5.4, Cr 6.4 lactate 1.4 CK 103 INR 1.2 trop 0.33 MB 12 bnp >70,000 Patient was given: 500 cc IVF, as well as calcium gluconate/insulin for K 5.4. On the floor patient was comfortable with HR in the 100-110s max 120. BP 100s/60s. She reported feeling like she was not SOB. <PAST MEDICAL HISTORY> 1. CARDIAC RISK FACTORS: HLD 2. CARDIAC HISTORY - CAD: reported CAD, although no cath reports here - Pump: diastolic dysfunction with EF >50%, severe AS, moderate MR ___ ECHO below) - Rhythm: new afib, preexisting LBBB 3. OTHER PAST MEDICAL HISTORY aortic stenosis (aortic valve area of 0.6 cm2 and mild mitral stenosis and moderate mitral regurgitation) bradycardia ESRD MWF, initiated ___ COPD, baseline 2 L NC Anemia of chronic disease Hypothyroidism Carotid stenosis Chronic pain (back and left shoulder) L humerus fracture ___ Carpal tunnel <SOCIAL HISTORY> ___ <FAMILY HISTORY> Father had died of an MI at age ___. <PHYSICAL EXAM> PHYSICAL EXAM ON ADMISSION: VS: 97.4 F, BP 100/60s, HR 100-110s, RR 20, 100% 2 l nc GENERAL: Well developed, A/Ox3, pleasant elderly woman HEENT: Normocephalic atraumatic. Sclera anicteric. PERRL. EOMI. Conjunctiva were pink. No pallor or cyanosis of the oral mucosa. No xanthelasma. NECK: Supple. JVP not elevated, around 8 cm. CARDIAC: PMI located in ___ intercostal space, midclavicular line. Harsh systolic murmur and tachycardia, difficult to appreciate irregularity. LUNGS: No chest wall deformities or tenderness. Mild bibasilar crackles, very soft expiratory wheezes. ABDOMEN: Soft, non-tender, non-distended. No hepatomegaly. No splenomegaly. EXTREMITIES: Warm, well perfused. No clubbing, cyanosis, or peripheral edema. Right arm AVF (failed 2x fistulas on left, maybe had a graft on left arm too?) SKIN: No significant skin lesions or rashes. PULSES: Distal pulses palpable and symmetric. PHYSICAL EXAM ON DISCHARGE: VS: 98.5, BP 108-131/47-59, HR 69-72, RR 18, 98-99% 2L NC GENERAL: Well developed, A/Ox3, pleasant elderly woman HEENT: Normocephalic atraumatic. Sclera anicteric. PERRL. EOMI. Conjunctiva were pink. No pallor or cyanosis of the oral mucosa. No xanthelasma. NECK: Supple. JVP not elevated. CARDIAC: PMI located in ___ intercostal space, midclavicular line. Harsh systolic murmur and tachycardia. LUNGS: No chest wall deformities or tenderness. Mild bibasilar crackles, with soft expiratory wheezes. ABDOMEN: Soft, non-tender, non-distended. No hepatomegaly. No splenomegaly. <PERTINENT RESULTS> LABS ON ADMISSION: ___ Lactate-1.4 T4-4.7 TSH-4.7 Calcium-8.5 Phos-5.2 Mg-2.2 CK-MB-12 MB Indx-11.7 cTropnT-0.33 CK(CPK)-103 Glucose-108 UreaN-49 Creat-6.4 Na-139 K-5.4 Cl-96 HCO3-30 AnGap-18 ___ PTT-28.9 ___ WBC-8.7 RBC-2.82 Hgb-9.1 Hct-30.5 MCV-108 MCH-32.3 MCHC-29.8 RDW-13.3 RDWSD-52.4 Plt ___ LABS ON DISCHARGE: ___: Calcium-8.5 Phos-5.3 Mg-2.0 CK-MB-6 cTropnT-1.03 Glucose-102 UreaN-40 Creat-5.3 Na-134 K-4.3 Cl-93 HCO3-29 AnGap-16 ___ PTT-33.3 ___ WBC-6.4 RBC-2.80 Hgb-8.8 Hct-29.5 MCV-105 MCH-31.4 MCHC-29.8 RDW-13.1 RDWSD-50.9 Plt ___ MICRO: Blood culture: pending IMAGING STUDIES: CXR (___): FINDINGS: There are moderate bilateral pleural effusions with overlying atelectasis. The cardiac silhouette is mild to moderately enlarged. There is prominence of the bilateral central pulmonary vasculature worrisome for pulmonary edema. Right infrahilar opacity may be due to combination of pleural effusion and atelectasis, but underlying consolidation or other pulmonary lesion not excluded. Recommend follow-up chest imaging following acute episode/diuresis. The aorta is calcified. IMPRESSION: Moderate bilateral pleural effusions with overlying atelectasis. Pulmonary edema. Cardiomegaly. Constellation of findings suggest CHF. Right infrahilar opacity may be secondary to the above findings, but underlying consolidation or other pulmonary lesion not excluded. Recommend follow-up chest imaging after acute episode/ diuresis. CXR (___): FINDINGS: There are persisting small to moderate bilateral pleural effusions with subjacent atelectasis as well as pulmonary vascular engorgement and mild interstitial septal thickening. The right infrahilar opacity is unchanged. There is enlargement of the cardiac silhouette, unchanged. Calcification of the aortic arch is present. IMPRESSION: Findings are suggestive of pulmonary edema. Persisting right infrahilar opacity. ECHO (___): The left atrium is moderately dilated. No atrial septal defect is seen by 2D or color Doppler. There is mild symmetric left ventricular hypertrophy. The left ventricular cavity size is normal. There is mild global left ventricular hypokinesis (LVEF = 45-50 %). No masses or thrombi are seen in the left ventricle. There is no ventricular septal defect. The right ventricular cavity is mildly dilated with normal free wall contractility. The ascending aorta is mildly dilated. The aortic valve leaflets are moderately thickened. There is severe aortic valve stenosis (valve area <1.0cm2). The mitral valve leaflets are mildly thickened. Mild to moderate (___) mitral regurgitation is seen. The tricuspid valve leaflets are mildly thickened. Tricuspid regurgitation is present but cannot be quantified. The pulmonary artery systolic pressure could not be determined. There is no pericardial effusion. <MEDICATIONS ON ADMISSION> The Preadmission Medication list is accurate and complete. 1. Nephrocaps 1 CAP PO DAILY 2. Docusate Sodium 100 mg PO DAILY 3. Gabapentin 300 mg PO QHS 4. Gabapentin 100 mg PO QAM 5. Levothyroxine Sodium 100 mcg PO DAILY 6. Methadone 5 mg PO BID 7. Acetaminophen 650 mg PO Q8H: PRN Pain - Mild 8. Rosuvastatin Calcium 20 mg PO 5X/WEEK (___) <DISCHARGE MEDICATIONS> 1. Levofloxacin 500 mg PO Q48H First dose on ___, last dose on ___ RX *levofloxacin [Levaquin] 500 mg 1 tablet(s) by mouth every other day Disp #*2 Tablet Refills: *0 2. Metoprolol Succinate XL 25 mg PO DAILY RX *metoprolol succinate 25 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills: *0 3. Acetaminophen 650 mg PO Q8H: PRN Pain - Mild 4. Docusate Sodium 100 mg PO DAILY 5. Gabapentin 300 mg PO QHS 6. Gabapentin 100 mg PO QAM 7. Levothyroxine Sodium 100 mcg PO DAILY 8. Methadone 5 mg PO BID 9. Nephrocaps 1 CAP PO DAILY 10. Rosuvastatin Calcium 20 mg PO 5X/WEEK (___) <DISCHARGE DISPOSITION> Home <DISCHARGE DIAGNOSIS> New onset Afib Severe aortic stenosis COPD on 2 L NC ESRD on HD MWF Hypothyroidism Chronic pain <DISCHARGE CONDITION> Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. <FOLLOWUP INSTRUCTIONS> ___ <DISCHARGE INSTRUCTIONS> Dear Ms. ___, It was a pleasure taking care of you during your stay at ___ ___. While you were in the hospital, you were evaluated for an abnormal heart rhythym (atrial fibrillation) for which we started a new medication (metoprolol) for with good control of your heart rate and blood pressures. Since then, your heart rhythm has been in normal sinus rhythm. We also performed an echocardiogram of your heart which showed good contractility of your heart. During your hospital stay, a chest x-ray was obtained which showed an opacity in an area of your right lung for which we are treating for pneumonia. We recommend completing your course of antibiotics for 4 more days through ___. If you have any fevers, chills, worsening chest pain, shortness of breath, nausea, vomiting, or diarrhea, please return to the hospital for further care. We wish you all the best! Sincerely, Your ___ Team ","___ F with h/o CAD, severe aortic stenosis, COPD on 2 L NC, ESRD on HD MWF, hypothyroidism, chronic pain transferred from ___ ___ for new onset afib. #New onset Afib - various potential etiologies were considered for the patient's Afib, including infection, ischemia, CHF, thyroid dysfunction. TSH was 4.7 and FT4 at 4.7. Patient was started on metoprolol tartrate 6.25 mg BID and patient was not started on anticoagulation. ECHO revealed mild symmetric left ventricular hypertrophy with normal left ventricular cavity and mild global left ventricular hypokinesis (LVEF = 45-50 %). There were No masses or thrombi seen in the left ventricle. The patient was in SR with Metoprolol 6.25 mg BID and was discharged on ___ with 25 mg Metoprolol succinate daily. ___ Afib was thought likely ___ infection (right lobe PNA) for which we treated with an 8-day course of levofloxacin. #Right infrahilar opacity - the patient had a CXR showing a questionable right-sided PNA at an OSH for which she received a dose of CTX and levofloxacin. Given persisting right infrahilar opacity on CXR here, the patient was continued on a renally-dosed 8-day course of levofloxacin (500 mg Q48H) for community acquired PNA. The patient was afebrile without productive cough during ___ admission, though she did report mild shortness of breath during the first morning of ___ hospital stay that was alleviated with albuterol. #Elevated troponin level - the patient presented with elevated troponin to 0.33 and CKMB 12. There was no overt ischemic changes on EKG, and the patient had a known h/o LBBB. Though troponin levels increased from 0.33 --> 0.46 --> 1.03 during the ___ hospital stay, the patient had no CP during ___ admission, and elevated troponin's were thought to be likely ___ ESRD. #ESRD - patient had HD on ___ and ___ during ___ hospital stay. #COPD - patient was continued on oxygen and albuterol prn #Hypothyroidism - patient was continued on home synthroid #Chronic pain - patient reported being on methadone, has self-titrated dose to 5 mg BID. She was additionally continued on home Tylenol and gabapentin. TRANSITIONAL ISSUES: ==================== New Medications: Metoprolol, Levofloxacin Stopped Medications: None - after risk/benefit discussion, deferred starting AC with warfarin, consider as outpatient. - patient will resume HD on regular ___ schedule - please monitor clinically for resolution of PNA. # CODE: full, confirmed # CONTACT: ___, ___ ",2772,632
10010471-DS-22,"<SEX> F <SERVICE> MEDICINE <ALLERGIES> NSAIDS, ASA, statins <ATTENDING> ___. <CHIEF COMPLAINT> s/p cardiac arrest <MAJOR SURGICAL OR INVASIVE PROCEDURE> ___: RHC <HISTORY OF PRESENT ILLNESS> ___ y/o F with h/o severe aortic stenosis, ESRD on HD, paroxysmal atrial fibrillation, and PPM for LBBB/syncope presents following acute LOC while at HD with pulselessness. Patient underwent ___ minutes of CPR (no epi or defibrillation per ED report) before ROSC was achieved. Initial rhythm during the event is unclear. Of note, she was in dialysis for 1 hour and only 140 cc were removed prior to event. Patient was subsequently transferred to ___ where she was started on heparin gtt for possible NSTEMI given ST depressions on EKG and initial troponin of 0.08. While at A-J, SBP dropped to 35 and patient went into rapid atrial fibrillation. 12-lead EKG showed a left bundle branch block, which she is known to have and occurs intermittently. Patient was subsequently cardioverted and received 2 L NS and IV digoxin, prior to returning to NSR At A-J, she underwent CT angiogram which did not show aortic dissection or pulmonary embolus. Patient was awake and talking and denied CP or SOB, though she endorsed significant ongoing back pain, which has been a chronic issue. BP subsequently improved with initiation of Levophed. Cardiology was consulted due to concern for posterior STEMI given EKG findings; posterior MI was felt to be unlikely and ischemic findings were thought to be ___ hypotension and severe AS. She was subsequently transferred to ___ for CVVHD and further management. REVIEW OF SYSTEMS: She endorses back pain. She endorses dyspnea on exertion prior to HD sessions, which is relieved following HD. Otherwise review of systems was negative. In the ED initial vitals were: HR 82 BP 84/42 RR21 95% Nasal Cannula Labs/studies notable for: BNP >32000, Troponin 0.74, MB 136, WBC 18.9, H/H ___, Lactate 2.8, Cr 6.6, ALT 64, AST 119 CXR with marked enlargement of the central pulmonary vasculature suggesting severe pulmonary edema, underlying pulmonary hemorrhage/contusion not excluded. Small pleural effusions. Moderate to marked enlargement of the cardiac silhouette. Multiple bilateral rib fractures. No radiographic evidence of pneumothorax, but a small pneumothorax would be difficult to exclude. Patient was started on heparin gtt, levophed gtt, dilaudid IV 0.125 mg x 5 doses <PAST MEDICAL HISTORY> 1. CARDIAC RISK FACTORS -ESRD on the basis of hypertension, on hemodialysis with R AV fistula -Hypertension -Severe aortic stenosis, ___ 0.8. Declined TAVR due to age and co-morbidities, though unclear if discussion was fully addressed/understood -Mixed systolic/diastolic HF -Pacemaker (left-sided, single chamber) placed for syncope ___ transient heart block (has intermittent left bundle branch block) -Dyslipidemia. -Nonobstructive coronary artery disease. -Hypothyroidism. -Anemia of renal disease. -Venous insufficiency. -COPD, on home ___ L -Chronic upper back pain for which she takes methadone. -Left humerus fracture ___ after falling. -Bilateral fibular fractures in ___. -Right carpal tunnel syndrome. -Carotid stenosis. -Bradycardia. <SOCIAL HISTORY> ___ <FAMILY HISTORY> Father had died of an MI at age ___. <PHYSICAL EXAM> ADMISSION PHYSICAL EXAM -====== VITALS: 97.5 93 139/79 19 96% GENERAL AP